Citrus Sinensis ID: 043017

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------82
Protein Sequence
MAVALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEccccccEEEEEEcccccccccEEEEEEEccccccccEEEEEEEEcccccccccccccccEEEEEcccccccccccEEEEEEcccEEEEcccccEEEEcccccccccEEEEEccccEEEEEcccccccccccccccccccccEEccccEEEEccccccccccEEEEEEEccccEEEEEcccccEEccccccccccccccccccccEEEEEccccEEEEEEEccccEEEEEEEcccccEEEEEEcccccccEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccccccccccHHHHHHHHHccccEEEEEEcccccccccEEEcccccccccccccccccccEEEEEEEccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHcccccccccccccEEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHHcccccccEEEEccccccEEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccHHHcccccccccccccccccccccHHHcccccccccccccccccEEEEEccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccEEEEcccccccccccccccEEEEEccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHcccccccccccccccccccccEEEEEcccccccccccccccEEEccccEEEEEEEcccccccccccccEEEEEEEEEcccccccccEEEEEEccccccccccEEEEEcccEEEEEEccccEEEEEccccccccEEEEEccccEEEEcccccEEEEEccccccccccccccccccEEEEcccccccccccEEEEEccccccEEEEcccEEEEEccccccEEEcccccccccEEEEEEccccEEEEEEEEcccEEEEEEEccccEEEEEEEEccccccEEEEEEccccccccHccccccccccccccccccccccccHHHccccccccEEcccccccccccccEEEEcccccccccHEEEcccHHHHHHHHHHcccEEEEEEEcccccccEEEEEcccHHHHHHccccccccEEEEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccEcHHHHHHHHHccHHEEEEEccEEEEEEEEcccEEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccEccEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHccccHHHccHHHccccccHHHHHHHHHHHHHHHcccccccccHHHHHHEcccccccccccccccEEEEEcccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
MAVALELMIMIFIMNLcatnatqstahnntswqnnqgsaqesynfvdgshvRTLLVrkgtsksypkfgfgflrngttdEIFYLVTVRFMGTitsssnhqnhppvilwfangqspvkenatleftadgdlilkdvdgtrvwstetsgsnvtritldgngnlrlydaenrphwisflhptntwlpgqrlHVHKMMastnsttslsqgkfilslspkgIEVFLNMStvkrfqtipyrnyfLNMSSAVLNKSAILVFNksgshitydvaprskfhymrlepnghlniyqldngysdnadlsrdehygdciyptkcgnygvcsngectcpgsssyfkqsndsengfscaEVTHLSCQFKHLQRFLklenvtyfdfvphlinidaegcqraclgncscKAALFRYqgslstgncslpteiytlrnstkvisgynditfikvqlpsdqnKLSLLFMLLLSVSAFLLLVIGASIYLYKRWregkrrdkstdessVHVANHLVKFSSKAMKSATRDFQIrlgrggsgsvfegllndgtkvavkrlypgenrgkkefLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEylhdycnpkiihfdikpqnilldrdlnvKIADFGLARLIAqdqshvstmpkgtpgymapeltrgnsitakidIYSFGVVILEIICgrrssnpkggdylVDTLKVKAEADRLCDlvdkksedmqsHRDDAVKMIQIAISCLQknlhrrpsASMLVKVLQGltklepvtdygFLSFAVVEATtqevvpirsspitaatlsgpr
Flexible Loop (DISEMBL)
MAVALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLvrkgtsksypkfgfgflrngtTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRvwstetsgsnvtritldgngNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKrrdkstdessvhvanhlvkfsskamksATRDFQIRlgrggsgsvfegllndgtkvavkrlypgenrgkkeFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAqdqshvstmpkgtpgymaPELTRGNSITAKIDIYSFGVVILEIICgrrssnpkggdYLVDTLKVKAEADRLCDlvdkksedmqshRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAttqevvpirsspitaatlsgpr
Low Complexity Region (SEG)
MAVALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKlsllfmlllsvsaflllvIGASIYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR
Disordered region (IsUnstruct)
**VALELMIMIFIMNLCATNAT********************YNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMA*******LSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYF*******NGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWR*******************LV************DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD*************YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV*************AVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPI**************
Disordered Region (DISOPRED)
**VALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDG***************YPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETS****TRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYF**********SCA**TH*****KHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTK*************************FMLLLSVSAFLLLVIGASIYLYKRW*******************HLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDY*************************ATLSGP*
Disordered Region (DISEMBL)
MAVALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWRE*************HVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR
Disordered Region (DISPRO)
*AVALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRD**********ANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVV************SPITAATLS***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAVALELMIMIFIMNLCATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	818	2.2.26 [Sep-21-2011]
Q8RWZ5	821	G-type lectin S-receptor-	yes	no	0.830	0.827	0.314	5e-92
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.837	0.785	0.306	2e-80
O64477	828	G-type lectin S-receptor-	no	no	0.800	0.791	0.306	3e-79
Q39202	832	G-type lectin S-receptor-	no	no	0.809	0.795	0.296	4e-77
P17801	817	Putative receptor protein	N/A	no	0.814	0.815	0.288	1e-73
O64771	809	G-type lectin S-receptor-	no	no	0.864	0.873	0.301	1e-73
Q9SY89	842	Putative G-type lectin S-	no	no	0.845	0.821	0.286	4e-73
O65238	872	G-type lectin S-receptor-	no	no	0.794	0.745	0.295	5e-72
O81906	849	G-type lectin S-receptor-	no	no	0.832	0.802	0.297	6e-72
Q9XID3	829	G-type lectin S-receptor-	no	no	0.847	0.835	0.280	9e-72

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  339 bits (870), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 234/745 (31%), Positives = 383/745 (51%), Gaps = 66/745 (8%)

Query: 67  FGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTAD 126
           FGFGF+   TT +   L T+  +        H++   +I W AN  SPV  +    F  +
Sbjct: 55  FGFGFV---TTQDSVTLFTLSII--------HKSSTKLI-WSANRASPVSNSDKFVFDDN 102

Query: 127 GDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQR 186
           G++++   +GT VW  + SG N +RI L  +GNL +   +    W SF HPT+T +  Q 
Sbjct: 103 GNVVM---EGTEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQA 159

Query: 187 LHVHKMMASTNSTTSLS------QGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNM 240
                 + S+ S+++++       G  +LS++    +V+ +M+          R   +N 
Sbjct: 160 FKEGMKLTSSPSSSNMTYALEIKSGDMVLSVNSLTPQVYWSMANA--------RERIINK 211

Query: 241 SSAVLNKSAIL-----VFNKSG----SHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYS 291
              V+  S++L      F++        +  D    +      L  NG ++   L +G S
Sbjct: 212 DGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGAS 271

Query: 292 DNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTHLSC 351
             AD S       C  P  CG Y VCS G   C   S   +  +D + G +         
Sbjct: 272 -AADSSTKIPSDLCGTPEPCGPYYVCS-GSKVCGCVSGLSRARSDCKTGITSPCKKTKDN 329

Query: 352 QFKHLQRFLKLENVTYFDF---VPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNC 408
               LQ     + V YF      P     D + C+  C  NCSC    F+     S+GNC
Sbjct: 330 ATLPLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQN----SSGNC 385

Query: 409 SLPTEIYTLRNSTKVISGYNDITFIKVQ---------LPSDQNKLSLLFMLLLSVSAFLL 459
            L   I + + S    SG+  +++IK+             D      + ++++     + 
Sbjct: 386 FLFDYIGSFKTSGNGGSGF--VSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIA 443

Query: 460 LVIGASIYLYKRWR---EGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGG 516
           ++I  +  ++KR +   E  +     D    +++   ++F+ K ++SAT +F ++LG+GG
Sbjct: 444 VLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGG 503

Query: 517 SGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF 576
            GSV+EG L DG+++AVK+L  G  +GKKEF +EV  IG+IHH +LVRL G+CAE ++R 
Sbjct: 504 FGSVYEGTLPDGSRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRL 562

Query: 577 LVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ 635
           L YE++  GSL++WIF K D    L WD R  I    ++GL YLH+ C+ +I+H DIKP+
Sbjct: 563 LAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPE 622

Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGV 695
           NILLD + N K++DFGLA+L+ ++QSHV T  +GT GY+APE     +I+ K D+YS+G+
Sbjct: 623 NILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGM 682

Query: 696 VILEIICGRRSSNPKGGD---YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQI 752
           V+LE+I GR++ +P       +       K E  +L D+VD K +++    +   + ++ 
Sbjct: 683 VLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKT 742

Query: 753 AISCLQKNLHRRPSASMLVKVLQGL 777
           A+ C+Q+++  RPS S +V++L+G+
Sbjct: 743 ALWCIQEDMQTRPSMSKVVQMLEGV 767

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  301 bits (770), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 238/777 (30%), Positives = 371/777 (47%), Gaps = 92/777 (11%)

Query: 67  FGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTAD 126
           F  GF R   TD   +L+++ F              P I+W  N  SPV + A LE  A 
Sbjct: 52  FAIGFTRFKPTDR--FLLSIWFA--------QLPGDPTIVWSPNRNSPVTKEAVLELEAT 101

Query: 127 GDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAE---NRPHWISFLHPTNTWLP 183
           G+L+L D   T VW++ TS   V    +  +GN  L   E       W SF  P++T LP
Sbjct: 102 GNLVLSD-QNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLP 160

Query: 184 GQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFL----N 239
            Q L V   + S  S +    G + L +  +   + L ++        P+ NY      +
Sbjct: 161 NQPLTVSLELTSNPSPSR--HGHYSLKMLQQHTSLSLGLT--YNINLDPHANYSYWSGPD 216

Query: 240 MSSAVLNKSAIL--------VFNKSGSHITY------------------DVAPRSKFHYM 273
           +S+   + +A+L        V+ +S     Y                   +        +
Sbjct: 217 ISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRL 276

Query: 274 RLEPNGHLNIYQLDNGYSDNADLSRDEHY--GDCIYPTKCGNYGVCS------NGECTC- 324
            LE NG+L +Y+ DN  + ++    +       C     CGN GVC+      N +C C 
Sbjct: 277 VLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGICGN-GVCNLDRTKKNADCLCL 335

Query: 325 PGSSSYFKQSNDSENGFSCAEVTHL--SCQFKHLQR--FLKLENVT----YFDFVPHLIN 376
           PGS     +  D EN   C++ + L   C+  ++ R    K+  V     YF     + N
Sbjct: 336 PGSV----KLPDQENAKLCSDNSSLVQECE-SNINRNGSFKISTVQETNYYFSERSVIEN 390

Query: 377 I----DAEGCQRACLGNCSCKAALFRYQG---------SLSTGNCSLPTEIYTLRNSTKV 423
           I    +   C   CL +C C A+++             SL+ G    P    TL   T+ 
Sbjct: 391 ISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDPGS--TLFVKTRA 448

Query: 424 ISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRDKSTD 483
              Y   +          + L    +++  V   L+LV    + LY    + KR  K   
Sbjct: 449 NESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGMLLYYN-LDRKRTLKRAA 507

Query: 484 ESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG 543
           ++S+ + +  V F+ + +++ T +F   LG GG G+V++G +   T VAVKRL    + G
Sbjct: 508 KNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHG 567

Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-LSW 602
           ++EF++EV TIG++HH NLVRL GYC+E S+R LVYEYM NGSLDKWIF  ++    L W
Sbjct: 568 EREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDW 627

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
             R +I    ++G+ Y H+ C  +IIH DIKP+NILLD +   K++DFGLA+++ ++ SH
Sbjct: 628 RTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSH 687

Query: 663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPK--GGDYLVDTLK 720
           V TM +GT GY+APE      IT K D+YS+G+++LEI+ GRR+ +      D+      
Sbjct: 688 VVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWA 747

Query: 721 VKAEADRLC-DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG 776
            K   +      VDK+ + + +  ++ VK +++A  C+Q  +  RPS   +VK+L+G
Sbjct: 748 YKELTNGTSLKAVDKRLQGV-AEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEG 803

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  297 bits (760), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 223/727 (30%), Positives = 341/727 (46%), Gaps = 72/727 (9%)

Query: 105 ILWFANGQSPVKE-NATLEFTADGDLILKDVD-GTRVWST---ETSGSNVTRITLDGNGN 159
           ILW AN    V + N+++   ++G+LIL D +  T VWST    TS  +     L  +GN
Sbjct: 71  ILWVANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGN 130

Query: 160 LRLYDAENRPH----WISFLHPTNTWLPGQRLHVHKMMASTNSTTSL------SQGKFIL 209
           L L    +       W SF HP +TWLPG ++ + K    +   TS       S G F L
Sbjct: 131 LVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSL 190

Query: 210 SLSPKGIEVFLNMSTVKRFQTIPYR---NYFLNMSSAVLNKSAILVF--NKSGSHITYDV 264
            L        L   + + + + P+      F ++    LN      F  N + S+ TY +
Sbjct: 191 ELDESTAYKILWNGSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYFTYSI 250

Query: 265 APRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGE--- 321
             +       ++ +G +  +    G +   +L   +    C     CG++G+CS+     
Sbjct: 251 YNQLNVSRFVMDVSGQIKQFTWLEG-NKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPF 309

Query: 322 CTCPGSSSYFKQSNDSENGFS--CAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDA 379
           C CP       Q +     +S  C   T L C    + +F +L N+   D    L     
Sbjct: 310 CRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSL 369

Query: 380 EGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPS 439
             C  AC G+CSCKA  +                      S+K +    D+  + +Q   
Sbjct: 370 SICASACQGDCSCKAYAYD-------------------EGSSKCLVWSKDV--LNLQQLE 408

Query: 440 DQNKLSLLFMLLLSVS------------------AFLLLVIGASIYLYKRWREGKRRDKS 481
           D+N    +F L L+ S                    +L  +G  + +        R  + 
Sbjct: 409 DENSEGNIFYLRLAASDVPNVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYRRR 468

Query: 482 TDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN 541
                      L  FS + +++AT++F  +LG GG GSVF+G L D + +AVKRL  G +
Sbjct: 469 KRMRGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGIS 527

Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIF--HKDRIQT 599
           +G+K+F +EV TIG I H NLVRL G+C+E S + LVY+YM NGSLD  +F    +    
Sbjct: 528 QGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIV 587

Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
           L W +R +I    +RGL YLHD C   IIH DIKP+NILLD     K+ADFGLA+L+ +D
Sbjct: 588 LGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRD 647

Query: 660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR----SSNPKGGDYL 715
            S V T  +GT GY+APE   G +ITAK D+YS+G+++ E++ GRR    S N K   + 
Sbjct: 648 FSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFP 707

Query: 716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                +  +   +  LVD + E      ++  +  ++A  C+Q     RP+ S +V++L+
Sbjct: 708 SWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILE 767

Query: 776 GLTKLEP 782
           G+ ++ P
Sbjct: 768 GVLEVNP 774

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  290 bits (741), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 218/736 (29%), Positives = 364/736 (49%), Gaps = 74/736 (10%)

Query: 105 ILWFANGQSP----VKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNL 160
           I+W A   +     V   + +  TADG L++ D  G  +W    SG +V+R     +GN 
Sbjct: 84  IVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRA-LSGGSVSRGRFTDDGNF 142

Query: 161 RLY----DAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGI 216
            L+    +  +   W SF +PT+T LP Q + V + ++S  + TS  +G+F L L   G 
Sbjct: 143 VLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGN 202

Query: 217 EVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLE 276
               +++     ++  Y  Y+ + ++   N    LVFN+SG  I       S+F     +
Sbjct: 203 LQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSG-EIYVLQRNNSRFVVKDRD 261

Query: 277 PNGHLNI-YQLDNGYSDNADLSRDEH--YGDCIYP---------------TKCGNYGVCS 318
           P+  +   + +  G+  +  + ++     G C+                   CG   +CS
Sbjct: 262 PDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRDNMCSPDDALGNMACGYNNICS 321

Query: 319 NG-----ECTCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKH--------LQRFLKLENV 365
            G     +C CP    +  +   +E G    +    +C+ ++        L  F+ LE  
Sbjct: 322 LGNNKRPKCECP--ERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKT 379

Query: 366 TY-FDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVI 424
            + F       N D E C+ +CL +C C A +F     L       P     L +  +  
Sbjct: 380 NWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFP-----LSHGERSP 434

Query: 425 SGYNDITFIKVQ------LPSDQNKLSLLFMLLLSVSAFL---LLVIGASIYLYKRWREG 475
            G +D TFIKV+      +P   N+   L  L+++ S  L     VI  +   Y++ ++ 
Sbjct: 435 RGDSD-TFIKVRNRSIADVPVTGNRAKKLDWLIIACSVLLGTSAFVIFDTSCSYRKTKKS 493

Query: 476 KR--RDKSTD---ESSVHVAN--HLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLN-- 526
           K   ++++ D    ++   AN  +L  F+   +  ATRDF   LGRG  G V++G L   
Sbjct: 494 KNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVA 553

Query: 527 --DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN 584
                 VAVK+L   +   +KEF +EV+ IG IHH NLVRL+G+C E  ++ +VYE++  
Sbjct: 554 GGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQ 613

Query: 585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN 644
           G+L  ++F + R    SW+ RK I   I+RG+ YLH+ C+ +IIH DIKPQNILLD    
Sbjct: 614 GTLANFLFRRPRP---SWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYT 670

Query: 645 VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            +I+DFGLA+L+  +Q++  T  +GT GY+APE  R + IT+K+D+YS+GV++LEI+C +
Sbjct: 671 PRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCK 730

Query: 705 RSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRR 764
           ++ + +    L++         RL DL +  SE M    +   + ++IAI C+Q+    R
Sbjct: 731 KAVDLEDNVILINWAYDCFRQGRLEDLTEDDSEAMNDM-ETVERYVKIAIWCIQEEHGMR 789

Query: 765 PSASMLVKVLQGLTKL 780
           P+   + ++L+G+ ++
Sbjct: 790 PNMRNVTQMLEGVIQV 805

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  278 bits (711), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 230/796 (28%), Positives = 376/796 (47%), Gaps = 130/796 (16%)

Query: 74  NGTTDEIFYLV-------TVRFMGTITSSSNHQNHPPVILWFANGQSPV-KENATLEFTA 125
           +GT    FY V       +V +  T  +++N++     I+W AN   PV    + L    
Sbjct: 52  DGTFSSGFYEVYTHAFTFSVWYSKTEAAAANNKT----IVWSANPDRPVHARRSALTLQK 107

Query: 126 DGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPG 184
           DG+++L D DG  VW  + +  + V R  L   GNL + D+     W SF  PT+T+LP 
Sbjct: 108 DGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPT 167

Query: 185 QRLHVHKMMASTNSTTSLSQGKFILSLS-----------PKGIEVFLNMSTVKRFQTIPY 233
           Q +     +  T  T S S G +I   S           P+  +++        +Q    
Sbjct: 168 QLITAATRLVPT--TQSRSPGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQNLYQD--G 223

Query: 234 RNYFLNMSSAVLNKSAILV---FNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGY 290
           RN + +    +L  S +L    F    + +  DV P  K   + L+P+G+L +Y +++  
Sbjct: 224 RNQYNSTRLGMLTDSGVLASSDFADGQALVASDVGPGVK-RRLTLDPDGNLRLYSMND-- 280

Query: 291 SDNA-DLSRDEHYGDCIYPTKCGNYGVC---SNGECTCPGSSSYFKQSNDSENGFSCAEV 346
           SD +  +S       C     CG  G+C       C+CP   +     N +E    C  +
Sbjct: 281 SDGSWSVSMVAMTQPCNIHGLCGPNGICHYSPTPTCSCPPGYATRNPGNWTEG---CMAI 337

Query: 347 THLSCQF--KHLQRFLKLENVTYFDF-VPHLINIDAEGCQRACLGNCSCKAALFRYQGSL 403
            + +C    K   RF++L N  ++     HL+++    C+  C+ +C+CK   F+YQ   
Sbjct: 338 VNTTCDRYDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKG--FQYQEG- 394

Query: 404 STGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPS----------------------DQ 441
            TG+C     +++ R         +D+  I ++LP+                      D 
Sbjct: 395 -TGSCYPKAYLFSGRTYPT-----SDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDC 448

Query: 442 NKL------------------SLLFMLLLSVSAFLLLVIG--ASIYLYKRWREGKRRDKS 481
           +++                  S  F     ++AF ++ +   +  + +   RE +  +  
Sbjct: 449 DRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELW 508

Query: 482 TDESSVH-VANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE 540
             E     + ++  ++S + +  ATR F++ LGRG SG+V++G+L D   VAVK+L   E
Sbjct: 509 ASEKGYKAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKL---E 565

Query: 541 N--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ 598
           N  +GK+ F +E+  IG I+H NLVR+ G+C+E S+R LV EY+ NGSL   +F +    
Sbjct: 566 NVRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNI 625

Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-- 656
            L W+ R  I   +++GL YLH  C   +IH D+KP+NILLD+    KI DFGL +L+  
Sbjct: 626 LLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNR 685

Query: 657 ---AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD 713
               Q+ SHV    +GT GY+APE      ITAK+D+YS+GVV+LE++ G R S   GG 
Sbjct: 686 GGSTQNVSHV----RGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGG- 740

Query: 714 YLVDTLKVKAEADRLCDLVDKKSE-DMQSHRD--------------DAVKMIQIAISCLQ 758
               T +V +   +L  ++  K E + QS  D               A  +I++A+SCL+
Sbjct: 741 ----TDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLE 796

Query: 759 KNLHRRPSASMLVKVL 774
           ++  +RP+    V+ L
Sbjct: 797 EDRSKRPTMEHAVQTL 812

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2

 Score =  278 bits (711), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 237/786 (30%), Positives = 364/786 (46%), Gaps = 79/786 (10%)

Query: 42  SYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNH 101
           S+++   +    L + K  S S   +  GF     +   +  V + F G I         
Sbjct: 20  SFSYAGITRESPLSIGKTLSSSNGVYELGFFSFNNSQNQY--VGIWFKGII--------- 68

Query: 102 PPVILWFANGQSPVKENAT-LEFTADGDLILKDVDGTRVWST-ETSGSNVTRITLDGNGN 159
           P V++W AN + PV ++A  L  +++G L+L + + + VWS  ET  SN +R  L  NGN
Sbjct: 69  PRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSRAELTDNGN 128

Query: 160 LRLYDAEN-RPHWISFLHPTNTWLPGQRLHVH------KMMASTNSTTSLSQGKFILSLS 212
           L + D  + R  W SF H  +T LP   L  +      +++ S  S T  S G F + ++
Sbjct: 129 LVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGDFTVQIT 188

Query: 213 PKGIEVFLNMSTVK-----------RFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHIT 261
           P+       M   K           RF  IP  +       ++   +     N SGS   
Sbjct: 189 PQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDT-----NGSGSFTY 243

Query: 262 YDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNG- 320
           ++     K  Y+ +   G L I+Q  NG     +    E+  D IY   CG +G+C    
Sbjct: 244 FE--RNFKLSYIMITSEGSLKIFQ-HNGMDWELNFEAPENSCD-IYGF-CGPFGICVMSV 298

Query: 321 --ECTC-----PGSSSYFKQSNDSENGFSCAEVTHLSCQF----KHLQRFLKLENVTYFD 369
             +C C     P S   +K+ N ++    C   T L CQ     K +  F  + N+   D
Sbjct: 299 PPKCKCFKGFVPKSIEEWKRGNWTDG---CVRHTELHCQGNTNGKTVNGFYHVANIKPPD 355

Query: 370 FVPHLINIDAEGCQRACLGNCSCKA--------ALFRYQGSLSTGNCSLPTEIYTLRNST 421
           F      +DAEGC + CL NCSC A         L   Q  +     S   EI ++R ++
Sbjct: 356 FYEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSAGGEILSIRLAS 415

Query: 422 KVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRDKS 481
             + G      I   +      +SL   ++L+ +AF  L       +  +  +   ++  
Sbjct: 416 SELGGNKRNKIIVASI------VSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAW 469

Query: 482 TDESSVHVANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPG 539
            ++      + L  F    +++AT +F +  +LG+GG GSV++G L DG ++AVKRL   
Sbjct: 470 NNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSS 529

Query: 540 ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
             +GK+EF++E+  I  + H NLVR++G C E   R LVYE++ N SLD ++F   +   
Sbjct: 530 SGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLE 589

Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
           + W  R  II  I+RGL YLH     ++IH D+K  NILLD  +N KI+DFGLAR+    
Sbjct: 590 IDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGT 649

Query: 660 QSHVST-MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG----RRSSNPKGGDY 714
           +   +T    GT GYMAPE       + K DIYSFGV++LEII G    R S   +G   
Sbjct: 650 EYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTL 709

Query: 715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
           L    +   E+  + DL+DK   D   H  +  + +QI + C+Q     RP+   L+ +L
Sbjct: 710 LAYAWESWCESGGI-DLLDKDVAD-SCHPLEVERCVQIGLLCVQHQPADRPNTMELLSML 767

Query: 775 QGLTKL 780
              + L
Sbjct: 768 TTTSDL 773

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  276 bits (707), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 220/767 (28%), Positives = 382/767 (49%), Gaps = 75/767 (9%)

Query: 85  TVRFMGTITSSSNHQN-HPPVILWFANGQSPVKEN-ATLEFTADGDLILKDVDGTRVWST 142
           T+R++G       ++N  P  ++W AN + P+ ++   L+   DG+L++ +     +WST
Sbjct: 62  TLRYVGIW-----YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWST 116

Query: 143 ETSG-SNVTRITLDGNGNLRL-YDAENRP-HWISFLHPTNTWLPGQRLHVHKMMAST--- 196
                SN T   L   G+L L  D++ R  +W SF +PT+T+LPG R+ V+  +      
Sbjct: 117 NVEPESNNTVAVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAF 176

Query: 197 ---NSTTSLSQGKFILSLSPKG-IEVFLNMSTVKRFQTIPYRN-YFLNMSSAVLNKSAIL 251
               S +  S GK+ + + P G +E+ +     +++++ P+ +  F  +   +   + I 
Sbjct: 177 IPWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIY 236

Query: 252 VF------NKSGS-HITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGD 304
            F      ++ GS + TY  +  S F    + P+G    ++ +     N +L + +   +
Sbjct: 237 GFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIR-NWNLLQWKPSTE 295

Query: 305 CIYPTKCGNYGVCSN------GECTCPGSSSYFKQSNDSENGFS--CAEVTHLSCQFKHL 356
           C    +CGNY VC +      G+C+C        Q   +   FS  C     L+C    +
Sbjct: 296 CEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLV 355

Query: 357 ----QRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPT 412
                 F  L+ +   DF   +++ ++E C+  C  +CSCKA    Y   +  G      
Sbjct: 356 AGQEDGFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKA----YALVVGIGCMIWTR 411

Query: 413 EIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKR- 471
           ++  + +  +  +  N I     +L   +   +L  ++   + AFLL +    ++ +K+ 
Sbjct: 412 DLIDMEHFERGGNSIN-IRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKS 470

Query: 472 -----WREG--------KRRDKSTDESSVHVANH-----LVKFSSKAMKSATRDF--QIR 511
                W++         + RD S+    V V +      L  FS  ++ SAT DF  + +
Sbjct: 471 LKAFLWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENK 530

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           LG+GG G+V++G  ++G ++AVKRL     +G +EF +E+  I  + H NLVRL+G C E
Sbjct: 531 LGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIE 590

Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD 631
            + + L+YEYM N SLD+++F + +  +L W  R ++I  I+RGL YLH     KIIH D
Sbjct: 591 DNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRD 650

Query: 632 IKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPELTRGNSITAKIDI 690
           +K  NILLD ++N KI+DFG+AR+    Q H +T+   GT GYMAPE       + K D+
Sbjct: 651 LKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDV 710

Query: 691 YSFGVVILEIICGRRSSNPKGGDY-----LVDTLKVKAEADRLCDLVDKKSEDMQSHRDD 745
           YSFGV+ILEI+ GR++ + +G D+         L  + +   + D + K + D+     +
Sbjct: 711 YSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVT----E 766

Query: 746 AVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT-KLEPVTDYGFLSF 791
           A++ I + + C Q ++  RP+   ++ +L+  T +L P     F SF
Sbjct: 767 AMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSF 813

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  273 bits (697), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 221/749 (29%), Positives = 353/749 (47%), Gaps = 99/749 (13%)

Query: 106 LWFANGQSPVKENATLEFTADGDLILKDVDG-TRVWSTETSGSNVTRITLDGNGNLRLYD 164
           +W +N  SPV  + T+  T  G  +++D      VWST    S V  + L   GNL L D
Sbjct: 86  IWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLD 145

Query: 165 AENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQG--KFILSLSPKGIEVFLNM 222
             N   W SF  PT++ + GQRL +   ++ + S +  S G  KF++  S  G+  +   
Sbjct: 146 HLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGES-DGLMQWRGQ 204

Query: 223 STVK-RFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITYDVA--PRSKFHYMRLEPNG 279
           +  K R       +    +    +  S + +  ++G+ +   VA  P S F   +++ +G
Sbjct: 205 NYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDFRVAKMDSSG 264

Query: 280 HLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCS------NGECTCPGSSSYFKQ 333
              + +       N           C  P  CG  G+C+      N  C+CP      + 
Sbjct: 265 KFIVSRFSG---KNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPD-----EM 316

Query: 334 SNDSENGFSCAEVTH-----LSCQFKHLQRFLKLENVTYF-----DFVPHLINIDAEGCQ 383
             D+  G  C  V+      +SC+ +++        V+YF     D V H + + A  C 
Sbjct: 317 RMDAGKGV-CVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEHGLPLLA--CH 373

Query: 384 RACLGNCSCKAALFR------YQGSLSTGNCSLPTEIYTLRNSTK--VISGYNDITFIK- 434
             C  NCSC    +       Y    S G+ SL      ++NS +   + GY  ++  K 
Sbjct: 374 DICSKNCSCLGVFYENTSRSCYLVKDSFGSLSL------VKNSPENHDLIGYVKLSIRKT 427

Query: 435 -VQLPSDQNK----LSLLFMLLLSVSAFLLLVIGASIYLYKR---WREGKRRDK------ 480
             Q P + N+      ++ ++LL  S F LL I   +  ++R    R    R+K      
Sbjct: 428 NAQPPGNNNRGGSSFPVIALVLLPCSGFFLL-IALGLLWWRRCAVMRYSSIREKQVTRPG 486

Query: 481 ---STDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLY 537
              S D  S H+     KF  + ++ AT +F++++G GG GSV++G L D T +AVK++ 
Sbjct: 487 SFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKIT 546

Query: 538 PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
                G++EF +E+  IGNI H NLV+L G+CA      LVYEYM +GSL+K +F  +  
Sbjct: 547 NHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNG- 605

Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
             L W  R  I    +RGL YLH  C+ KIIH D+KP+NILL      KI+DFGL++L+ 
Sbjct: 606 PVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLN 665

Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS------SNPKG 711
           Q++S + T  +GT GY+APE     +I+ K D+YS+G+V+LE++ GR++      SN   
Sbjct: 666 QEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVT 725

Query: 712 GD--------------------YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQ 751
            D                    Y +D      E  R  +L D + E   + + +A K+++
Sbjct: 726 EDNNQNHSSTTTTSTGLVYFPLYALDM----HEQGRYMELADPRLEGRVTSQ-EAEKLVR 780

Query: 752 IAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           IA+ C+ +    RP+ + +V + +G   L
Sbjct: 781 IALCCVHEEPALRPTMAAVVGMFEGSIPL 809

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  273 bits (697), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 233/784 (29%), Positives = 372/784 (47%), Gaps = 103/784 (13%)

Query: 67  FGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVK-ENATLEFTA 125
           F  GF   G++       T RF+G    +   +     ++W AN  +P+  ++  L  + 
Sbjct: 51  FELGFFSPGSS-------THRFLGIWYGNIEDK----AVVWVANRATPISDQSGVLMISN 99

Query: 126 DGDLILKDVDGTRVWST----ETSGSNVTRITLDGNGNLRLYDAE-NRPHWISFLHPTNT 180
           DG+L+L D     VWS+     T+ +N   +++   GN  L + + +RP W SF HPT+T
Sbjct: 100 DGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDT 159

Query: 181 WLPGQRLHVHKM------MASTNSTTSLSQGKFILSLSPKGIE--VFLNMSTVKRFQTIP 232
           +LP  R+ V+          S  S T  S G + L + P G    V    +  +++++  
Sbjct: 160 FLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQ 219

Query: 233 YRN-YFLNMSSAVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYS 291
           + +  F  + +  L  + +  F  S      D      F Y+  +P+  L    L NG  
Sbjct: 220 WNSAIFTGIPNMSLLTNYLYGFKLSSPP---DETGSVYFTYVPSDPSVLLRFKVLYNGTE 276

Query: 292 D----NADLSR-----DEHYGDCIYPTKCGNYGVC----SNGECTCPGSSSYFKQSNDSE 338
           +    N  L +      E   +C    +CG +G+C    SNG C+C          N S 
Sbjct: 277 EELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSR 336

Query: 339 NGFSCAEVTHLSCQFK---HLQRFLKLENVTYFDF-VPHLINIDAEGCQRACLGNCSCKA 394
               C   T L C+         FL L++V   DF +P    +D E C+  CL NCSC A
Sbjct: 337 ---GCRRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNA 393

Query: 395 ALFRYQGSLSTG-NCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLS 453
                  SL  G  C +  +   L +  +  +G + +          +N+ + + +++  
Sbjct: 394 Y------SLVGGIGCMIWNQ--DLVDLQQFEAGGSSLHIRLADSEVGENRKTKIAVIV-- 443

Query: 454 VSAFLLLVIGASIYLYKRWREGKRRD-------KSTDESSVHVAN--------------- 491
             A L+ VI   I+    WR  +++D       K+TD +SV VA+               
Sbjct: 444 --AVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTD-TSVVVADLTKSKETTSAFSGSV 500

Query: 492 ------------HLVKFSSKAMKSATRDF--QIRLGRGGSGSVFEGLLNDGTKVAVKRLY 537
                        L  FS  A+  AT DF  +  LGRGG G V++G+L DG ++AVKRL 
Sbjct: 501 DIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLS 560

Query: 538 PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
               +G  EF +E+  I  + H NLVRL+G C E   + LVYEYM N SLD ++F + + 
Sbjct: 561 GKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQ 620

Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
             + W +R  II  I+RGL YLH     +IIH D+K  N+LLD ++N KI+DFG+AR+  
Sbjct: 621 ALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFG 680

Query: 658 QDQSHVSTMP-KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-- 714
            +Q+  +T+   GT GYM+PE       + K D+YSFGV++LEI+ G+R+++ +  ++  
Sbjct: 681 GNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGS 740

Query: 715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
           L+          R  +LVD K     S R +A++ I +A+ C+Q +   RP+ + ++ +L
Sbjct: 741 LIGYAWYLYTHGRSEELVDPKIRVTCSKR-EALRCIHVAMLCVQDSAAERPNMASVLLML 799

Query: 775 QGLT 778
           +  T
Sbjct: 800 ESDT 803

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  272 bits (695), Expect = 9e-72,   Method: Compositional matrix adjust.
 Identities = 216/769 (28%), Positives = 371/769 (48%), Gaps = 76/769 (9%)

Query: 53  TLLVRKGTSKSYPK----FGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWF 108
           +++   G+++++P     F   F+ + + +   +L  V F G+            V +W 
Sbjct: 31  SVIYASGSNQNWPSPNSTFSVSFVPSPSPNS--FLAAVSFAGS------------VPIWS 76

Query: 109 ANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENR 168
           A     V    +L     G L L +  GT VW ++T    VT  +++  G   L +  + 
Sbjct: 77  AG---TVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSV 133

Query: 169 PHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ-GKFILSLSPKGIEVFLNMSTVKR 227
           P W SF +PT+T +  Q     K++ S   +  L + G   L  +   I     +++   
Sbjct: 134 PVWSSFDNPTDTIVQSQNFTAGKILRSGLYSFQLERSGNLTLRWNTSAIYWNHGLNSSFS 193

Query: 228 FQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITY--DVAPRSKFHYMRLEPNGHLNIYQ 285
                 R          + +S +L     G+ I Y  D    + F +++L+ +G+L IY 
Sbjct: 194 SNLSSPRLSLQTNGVVSIFESNLL----GGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYS 249

Query: 286 LD--NGYSDNADLSRDEHYGDCIYPTKCGNYGVCS----NGECTCPGSSSYFKQSNDSEN 339
               N    NA  S  +    C+    CGN+G+CS    N  C+CP  +  F   ND   
Sbjct: 250 SASRNSGPVNAHWSAVDQ---CLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRK 306

Query: 340 GFSCAEVTHLS-CQFKHLQRFLKLENVTYFDFVPHLINIDA--EGCQRACLGNCSCKAAL 396
           G  C     LS C        L    +  ++  P+  +  A    C+  CL +  C A++
Sbjct: 307 G--CKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASV 364

Query: 397 FRYQGSLSTGNC--SLPTEIYTLRNSTKVISGYNDITFIKVQLP------------SDQN 442
               GS   GNC    P   +T      V S     +++KV  P             D N
Sbjct: 365 SMSDGS---GNCWQKHPGSFFTGYQWPSVPS----TSYVKVCGPVVANTLERATKGDDNN 417

Query: 443 KLSLLFMLLLSVSAFLLLVIGASIYLYKRW---REGKRRDKSTDESSV--HVANHLVKFS 497
               L+++ ++V A LL ++   I L+  W   R+  R    +   ++  + +   V+F+
Sbjct: 418 SKVHLWIVAVAVIAGLLGLVAVEIGLW--WCCCRKNPRFGTLSSHYTLLEYASGAPVQFT 475

Query: 498 SKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI 557
            K ++  T+ F+ +LG GG G+V+ G+L + T VAVK+L  G  +G+K+F  EV TI + 
Sbjct: 476 YKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL-EGIEQGEKQFRMEVATISST 534

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           HH NLVRL+G+C++  +R LVYE+M NGSLD ++F  D  + L+W+ R  I    ++G+ 
Sbjct: 535 HHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGIT 594

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAP 676
           YLH+ C   I+H DIKP+NIL+D +   K++DFGLA+L+  +D  +  +  +GT GY+AP
Sbjct: 595 YLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAP 654

Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADRLCDLV 732
           E      IT+K D+YS+G+V+LE++ G+R    S       + +   +   + +    L 
Sbjct: 655 EWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILD 714

Query: 733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
            + SED     +  ++M++ +  C+Q+   +RP+   +V++L+G+T+++
Sbjct: 715 TRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIK 763

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	818
338190111	830	lectin-domain receptor-like kinase [Nico	0.941	0.927	0.429	1e-177
116309112	838	OSIGBa0157N01.3 [Oryza sativa Indica Gro	0.955	0.933	0.391	1e-161
255569833	837	serine-threonine protein kinase, plant-t	0.976	0.954	0.402	1e-160
125547684	863	hypothetical protein OsI_15301 [Oryza sa	0.955	0.906	0.390	1e-160
255569825	870	serine-threonine protein kinase, plant-t	0.907	0.852	0.404	1e-159
38344588	838	OSJNBa0079M09.4 [Oryza sativa Japonica G	0.955	0.933	0.390	1e-158
116308953	864	H0215E01.7 [Oryza sativa Indica Group]	0.954	0.903	0.390	1e-158
125589797	863	hypothetical protein OsJ_14201 [Oryza sa	0.955	0.906	0.390	1e-158
359479303	832	PREDICTED: G-type lectin S-receptor-like	0.931	0.915	0.401	1e-158
70663992	864	OSJNBb0018A10.15 [Oryza sativa Japonica	0.954	0.903	0.389	1e-158

>gi|338190111|gb|AEI84329.1| lectin-domain receptor-like kinase [Nicotiana attenuata]

 Score =  627 bits (1618), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 355/826 (42%), Positives = 506/826 (61%), Gaps = 56/826 (6%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T+W N+  SA  S +F D S VR +L+R GT    P++  GF  NG  +   + +
Sbjct: 29  TANLSTTWVNSV-SAPHSVDFSDRSTVRAILLR-GTFG--PRYACGFYCNGNCESYIFAI 84

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            +    +I+  +      P ++W AN  +PVK N+TL+ TA GDL+L+D DGT  WST +
Sbjct: 85  FIVQTNSISLITMPAIGFPQVVWSANRNNPVKINSTLQLTAQGDLVLRDADGTLAWSTNS 144

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRL-HVHKMMASTNSTTSLS 203
           +G +V  + L   GNL L+D++N   W SF HPT++ +PGQ+L    K+ AS ++T    
Sbjct: 145 TGKSVAGLNLTDEGNLVLFDSKNATVWQSFDHPTDSLVPGQKLVPGMKLTASVSTTNWTK 204

Query: 204 QGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYF------LNMSSA-----VLNKSAILV 252
            G F  S +  G+  F+        ++ P + YF      LN S        LN S  L+
Sbjct: 205 GGLFSFSATNDGLVAFV--------ESNPPQTYFEKSIGGLNTSGGSNYVMYLNGSLALL 256

Query: 253 FNKSGSH---ITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPT 309
            N S S+       + P S   YM+LE +GHL +Y+  + +++  DL    + G+C YP 
Sbjct: 257 SNSSDSNNPRTLISIPPASSAQYMKLESDGHLKVYEWQSRWNEVNDLLTGFN-GECYYPM 315

Query: 310 KCGNYGVCSNGECTCPGSSS----YFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENV 365
            CG YG+CS G+C+CP SSS    YF+Q +D +    CAEVT L+C   +  RFL+L++V
Sbjct: 316 ICGRYGICSRGQCSCPKSSSNSTSYFRQIDDRQGNLGCAEVTRLTCNALNNHRFLELQDV 375

Query: 366 TYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVIS 425
            YF F   + N D   C+ ACL NCSCKAALFR   + STG+C LP+EIY+L N+ K  +
Sbjct: 376 DYFTFTADIKNTDMNACKDACLRNCSCKAALFRSGLNSSTGDCYLPSEIYSLANNEKEKT 435

Query: 426 GYNDITFIKVQLPSD----QNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRDKS 481
            YN   F+KVQ+ ++    + K  +  ++L SV    +L I  +I ++  W   K+R  +
Sbjct: 436 RYNSYAFVKVQVEAEPAAAKEKKRVSGVVLGSVIGLAILGILIAIAVFIIW---KKRKAN 492

Query: 482 TDESSV--HVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG 539
            DE +   HV     +FS   +K+AT +F  +LGRGG GSVFEG L DGTK+AVK L  G
Sbjct: 493 EDEENYLDHVPGMPTRFSYDDLKAATENFTKKLGRGGFGSVFEGCLEDGTKIAVKCL-DG 551

Query: 540 ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
             + KK FL+EVETIG+IHH NLV+L+G+CAE+S+R LVYE+M NGSL+KWI+H  +  T
Sbjct: 552 VGQVKKSFLAEVETIGSIHHVNLVQLIGFCAEKSHRLLVYEFMSNGSLEKWIYHGKQELT 611

Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
           L W+ R+KII  I++GL YLH+ C  KI+H DIKP NILLD   N K++DFGLA+LI ++
Sbjct: 612 LDWNCRRKIIQDIAKGLAYLHEECRQKILHLDIKPPNILLDEKHNAKLSDFGLAKLIDRN 671

Query: 660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR---SSNPKGGDYLV 716
           QS V TM +GTPGY+APE   G +IT K+D+YSFG+VILEI+ GRR   +S  +    ++
Sbjct: 672 QSQVMTMMRGTPGYLAPEWLSG-AITEKVDVYSFGIVILEILSGRRHFEASESEEQQVML 730

Query: 717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG 776
           +  K KAE  +L DL+DK SEDMQ ++++ +K +QIA  CLQ++  +RPS SM+VK ++G
Sbjct: 731 NLFKKKAEEGQLVDLIDKHSEDMQLYKEEVIKTMQIAAWCLQRDYTKRPSMSMVVKAMEG 790

Query: 777 LTKLEPVTDYGFLSFAVVEATTQEVVP----IRSSPITAATLSGPR 818
           +  +E   DY F         T  V+P      S+P+  + LSGPR
Sbjct: 791 VLDVEKSLDYSF------NPQTVSVIPNITFAHSTPLLPSVLSGPR 830

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116309112|emb|CAH66217.1| OSIGBa0157N01.3 [Oryza sativa Indica Group]

 Score =  574 bits (1479), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 320/817 (39%), Positives = 482/817 (58%), Gaps = 35/817 (4%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T W NN  + Q S  + DGS VR +++R   +   P +  GF  +   D   + V
Sbjct: 34  TANLSTRWVNNAAALQHSVGYSDGSAVRAIVLRSPKTFYGPSYAAGFFCSPPCDAFLFAV 93

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            + +  +    +      P ++W AN   PV+ENATLE T +G+L+L D DG+ VWS+ +
Sbjct: 94  YIVYTNSGAGITMTTTGIPQVVWSANRARPVRENATLELTYNGNLVLSDADGSLVWSSGS 153

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ 204
           SG +V  + +   GNL L+D  N   W SF HPT+T LPGQ L     + + ++TT+ ++
Sbjct: 154 SGRSVAGMEITDTGNLVLFDQRNVTVWQSFDHPTDTLLPGQSLMEGMKLRANSTTTNSTE 213

Query: 205 GKFILSLSPKGIEVFLNMSTVKRF--QTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITY 262
            +  +++ P G+  ++  +  + +   ++       + +       ++ +F +S      
Sbjct: 214 NQVYMAVQPDGLFAYVESTPPQLYYSHSVNTNKSGKDPTKVTFTNGSLSIFVQSTQPSNI 273

Query: 263 DVAPRSKFHYMRLEPNGHLNIYQLDNG------YSDNADLSRDEHYGDCIYPTKCGNYGV 316
            +   S   YMRLE +GHL +Y+  N        SD   +  D    DC +P  CG YG+
Sbjct: 274 SLPQASSTQYMRLEFDGHLRLYEWSNTGAKWTVVSDVIKVFPD----DCAFPMACGKYGI 329

Query: 317 CSNGECTCP----GSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVP 372
           C+ G+CTCP     S SYFK  ++ +    C+ +T +SCQ     + L L +V+YFD   
Sbjct: 330 CTGGQCTCPLQSNSSLSYFKPVDERKANLGCSPLTPISCQEMRSHQLLALTDVSYFDVSH 389

Query: 373 HLIN-IDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDIT 431
            ++N  + + C+++CL NCSC+A +FRY  + S G C   +E+++L+        YN   
Sbjct: 390 TILNATNRDDCKQSCLKNCSCRAVMFRYGQNDSDGTCFSVSEVFSLQTIQPEALHYNSSA 449

Query: 432 FIKVQL-----PSDQNKLSLLFMLLLSVSAFLLLVIGAS-IYLYKRWREGKRRDKSTDES 485
           ++KVQL      S  NK   +  L  ++SA L+LV+  + I LY + R+ +  D+  D  
Sbjct: 450 YLKVQLSPSASASTANKTKAI--LGATISAILILVLAVTVITLYVQRRKYQEIDEEIDFE 507

Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
            +      V+FS + ++  T+DF  +LG GG GSVFEG + +  +VAVKRL   + +GKK
Sbjct: 508 PL--PGMPVRFSYEKLRECTKDFSKKLGEGGFGSVFEGEIGE-ERVAVKRLESAK-QGKK 563

Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           EFL+EVETIG+I H NLVRL+G+CAE+SNR LVYEYM  GSLD+WI+++     L W  R
Sbjct: 564 EFLAEVETIGSIEHINLVRLIGFCAEKSNRLLVYEYMPRGSLDRWIYYRYNNDPLDWCTR 623

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
            +II  I++GL YLH+ C  KI H DIKPQNILLD   N K+ADFGL++LI +DQS V T
Sbjct: 624 CRIIMDIAKGLCYLHEECRRKIAHLDIKPQNILLDEKFNAKLADFGLSKLIDRDQSKVVT 683

Query: 666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGDYLVDTLKVK 722
           + +GTPGY+APE    + IT K+D+YSFGVV+LEIICGR++   S P+    L++ L+ K
Sbjct: 684 VMRGTPGYLAPEWLT-SQITEKVDVYSFGVVLLEIICGRKNIDISQPEESVQLINLLREK 742

Query: 723 AEADRLCDLVDKKSEDMQS-HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
           A+ + L D++DKKS DM S H+++ +KM+++A+ CLQ    RRPS SM+VKVL+G   +E
Sbjct: 743 AKDNVLIDIIDKKSTDMVSHHQEEVIKMLKLAMWCLQNESSRRPSMSMVVKVLEGAVSVE 802

Query: 782 PVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
              DY F +   V  + Q+     S+P +A+ LSGPR
Sbjct: 803 NCLDYSFANANSV-ISAQDNPSTYSAPPSASILSGPR 838

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255569833|ref|XP_002525880.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223534794|gb|EEF36484.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  573 bits (1477), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 341/847 (40%), Positives = 498/847 (58%), Gaps = 48/847 (5%)

Query: 2   AVALELMIMIFIMNLC-ATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGT 60
           ++ L  + +++ +NL  A      +A+ +TSW+N+  S   S  F DGS VR +L+R GT
Sbjct: 9   SLVLYFLGLLYFVNLSNAETFDYPSANLSTSWRNSP-SLPHSIEFTDGSTVRAILLR-GT 66

Query: 61  SKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHP----PVILWFANGQSPVK 116
               P+F  GF  NGT D   + + +      T+S+++   P    P ++W AN  +PV+
Sbjct: 67  FG--PRFACGFFCNGTCDSYLFAIFI----VQTNSASYITSPAIGFPQVVWSANRNNPVR 120

Query: 117 ENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLH 176
            NATL+FT+ GDLILKDVDGT  WST T+  +V  + L   GNL L+D ++R  W SF H
Sbjct: 121 INATLQFTSGGDLILKDVDGTIAWSTNTADKSVAGLNLTDMGNLVLFDDKDRVVWQSFDH 180

Query: 177 PTNTWLPGQRLHVHKMMASTNSTTSLSQGKFIL-SLSPKGIEVFLNMSTVKRFQTIPYRN 235
           PT++ +PGQ+L   K +  + S T+ +Q   +L S++ +G+   +  +  + ++ +    
Sbjct: 181 PTDSLVPGQKLVSGKKLIPSVSATNWTQLSLLLISVTDEGMFASVESNPPQVYEELQVYG 240

Query: 236 YFLNMSSAVL---NKSAILVFNKSGS---HITYDVAPRSKFHYMRLEPNGHLNIYQL-DN 288
              N     +   N S  L  N S      +  +V   S   Y R   +GHL +Y+   N
Sbjct: 241 KKTNREPTYVTLRNGSFALFANSSEPSEPDMFVNVPQASSTQYARFFADGHLRVYEWGTN 300

Query: 289 GYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGFSCAEVTH 348
           G++  ADL     Y +C YPT CGNYG+CS+ +C+CP S++YFKQ  D +    C+ +  
Sbjct: 301 GWTVVADLLSSPGY-ECFYPTVCGNYGICSDRQCSCP-STAYFKQITDRQPNLGCSAIIP 358

Query: 349 LSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNC 408
           LSC       FL+L++ TY  F   L N+D+E C+ AC  NCSCKAA+F+Y    ++G C
Sbjct: 359 LSCGASKNHSFLELKDTTYSSFQTDLENVDSESCKMACSKNCSCKAAIFQYGSDSASGFC 418

Query: 409 SLPTEIYTLRNSTKVISGYNDITFIKVQ--------------LPSDQNKLSLLFMLLLSV 454
            +P EI++L N+ K  + +N   ++KVQ              LP  + K     +L  S+
Sbjct: 419 YMPNEIFSLINNDKEKTHFNSTVYLKVQDVPVVQNAPTTEALLPQRKKKSRTATILWSSL 478

Query: 455 SAFLLLVIGASIYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGR 514
            +   L++   I     W++    D   ++    V     +FS + +KS T +F   LG 
Sbjct: 479 GSLSGLLLVIGILASLAWKKSDN-DGYEEDFLDQVPGMPTRFSYEDLKSLTENFSKMLGE 537

Query: 515 GGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN 574
           GG GSVFEG L +GTK+AVKRL  G  + KK FL+EVE+IG+IHH NLVRL+G+CA++S+
Sbjct: 538 GGFGSVFEGTLINGTKIAVKRLN-GLGQVKKSFLAEVESIGSIHHMNLVRLLGFCADKSH 596

Query: 575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKP 634
           R LVYE+M  GSL+KWIFH+     L W  RKKII  I++GL YLH+ C  KIIH DIKP
Sbjct: 597 RLLVYEFMSRGSLEKWIFHQSLEFVLDWRQRKKIILDIAKGLAYLHEDCTQKIIHLDIKP 656

Query: 635 QNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFG 694
           QNILLD+  + KI+DFGL++L+ +DQS V T  +GTPGY+APE    + IT K DIYSFG
Sbjct: 657 QNILLDQKFSAKISDFGLSKLMDRDQSKVVTAMRGTPGYLAPEWL-SSIITEKADIYSFG 715

Query: 695 VVILEIICGRRS---SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQ 751
           VV+LE++CGRR+   S P+   +L+   +  A+ D+L DLVD   EDMQ H  + V M++
Sbjct: 716 VVMLEMLCGRRNVDHSQPEEQMHLLTLFEKAAQEDKLKDLVDNFCEDMQLHMAEIVNMMK 775

Query: 752 IAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITA 811
           +A  CLQK+  +RPS S++VKVL+G+T++E   DY      +   T+   V   S+ +  
Sbjct: 776 VAAWCLQKDYAKRPSMSVVVKVLEGVTEVEHNLDYN-----ISNPTSITAVATNSTQMFP 830

Query: 812 ATLSGPR 818
           + LSGPR
Sbjct: 831 SVLSGPR 837

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|125547684|gb|EAY93506.1| hypothetical protein OsI_15301 [Oryza sativa Indica Group]

 Score =  572 bits (1475), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 319/817 (39%), Positives = 481/817 (58%), Gaps = 35/817 (4%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T W NN  + Q S  + DGS VR +++R   +   P +  GF  +   D   + V
Sbjct: 59  TANLSTRWVNNAAALQHSVGYSDGSAVRAIVLRSPKTFYGPSYAAGFFCSPPCDAFLFAV 118

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            V +  +    +      P ++W AN   PV+ENATLE T +G+L+L D DG+ VWS+ +
Sbjct: 119 YVVYTNSGAGITMTTTGIPQVVWSANRARPVRENATLELTYNGNLVLSDADGSLVWSSGS 178

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ 204
           SG +V  + +   GNL L+D  N   W SF HPT+T LPGQ L     + + ++TT+ ++
Sbjct: 179 SGRSVAGMEITDTGNLVLFDQRNVTVWQSFDHPTDTLLPGQSLMEGMKLRANSTTTNSTE 238

Query: 205 GKFILSLSPKGIEVFLNMSTVKRF--QTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITY 262
            +  +++ P G+  ++  +  + +   ++       + +       ++ +F +S      
Sbjct: 239 NQVYMAVQPDGLFAYVESTPPQLYYSHSVNTNKSGKDPTKVTFTNGSLSIFVQSTQPSNI 298

Query: 263 DVAPRSKFHYMRLEPNGHLNIYQLDNG------YSDNADLSRDEHYGDCIYPTKCGNYGV 316
            +   S   YMRLE +GHL +Y+  N        SD   +  D    DC +P  CG YG+
Sbjct: 299 SLPQASSTQYMRLEFDGHLRLYEWSNTGAKWTVVSDVIKVFPD----DCAFPMACGKYGI 354

Query: 317 CSNGECTCP----GSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVP 372
           C+ G+CTCP     S SYFK  ++ +    C+ +T +SCQ     + L L +V+YFD   
Sbjct: 355 CTGGQCTCPLQSNSSLSYFKPVDERKANLGCSPLTPISCQEMRSHQLLALTDVSYFDVSH 414

Query: 373 HLIN-IDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDIT 431
            ++N  + + C+++CL NCSC+A +FRY  + S G C   +E+++L+        YN   
Sbjct: 415 TILNATNRDDCKQSCLKNCSCRAVMFRYGQNDSDGTCFSVSEVFSLQTIQPEALHYNSSA 474

Query: 432 FIKVQL-----PSDQNKLSLLFMLLLSVSAFLLLVIGAS-IYLYKRWREGKRRDKSTDES 485
           ++KVQL      S  NK   +  L  ++SA L+L +  + I LY + R+ +  D+  D  
Sbjct: 475 YLKVQLSPSASASTANKTKAI--LGATISAILILFLAVTVITLYVQRRKYQEIDEEIDFE 532

Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
            +      V+FS + ++  T+DF  +LG GG GSVFEG + +  ++AVKRL   + +GKK
Sbjct: 533 PL--PGMPVRFSYEKLRECTKDFSKKLGEGGFGSVFEGEIGE-ERIAVKRLESAK-QGKK 588

Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           EFL+EVETIG+I H NLVRL+G+CAE+SNR LVYEYM  GSLD+WI+++     L W  R
Sbjct: 589 EFLAEVETIGSIEHINLVRLIGFCAEKSNRLLVYEYMPRGSLDRWIYYRYNNDPLDWCTR 648

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
            +II  I++GL YLH+ C  KI H DIKPQNILLD   N K+ADFGL++LI +DQS V T
Sbjct: 649 CRIIMDIAKGLCYLHEECRRKIAHLDIKPQNILLDEKFNAKLADFGLSKLIDRDQSKVVT 708

Query: 666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGDYLVDTLKVK 722
           + +GTPGY+APE    + IT K+D+YSFGVV+LEIICGR++   S P+    L++ L+ K
Sbjct: 709 VMRGTPGYLAPEWLT-SQITEKVDVYSFGVVLLEIICGRKNIDISQPEESVQLINVLREK 767

Query: 723 AEADRLCDLVDKKSEDMQS-HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
           A+ + L D++DKKS DM S H+++ +KM+++A+ CLQ    RRPS SM+VKVL+G   +E
Sbjct: 768 AKDNVLIDIIDKKSTDMVSHHQEEVIKMLKLAMWCLQNESSRRPSMSMVVKVLEGAVSVE 827

Query: 782 PVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
              DY F +   V  + Q+     S+P +A+ LSGPR
Sbjct: 828 NCLDYSFANANSV-ISAQDNPSTYSAPPSASILSGPR 863

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255569825|ref|XP_002525876.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223534790|gb|EEF36480.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  568 bits (1465), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 325/804 (40%), Positives = 470/804 (58%), Gaps = 62/804 (7%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +TSW+N   S + S +F DGS +R +LVR       P+FG GF  NG  +   + +
Sbjct: 35  TANLSTSWEN-IPSLRYSISFSDGSTIRPVLVRGFLG---PRFGCGFYCNGNCESYLFAI 90

Query: 85  TV--RFMGTITSSSNHQNHP------PVILWFANGQSPVKENATLEFTADGDLILKDVDG 136
            +    +G +  S +           P ++W AN  +PV+ NATL+ T+DGDL+LKD DG
Sbjct: 91  FIIQSELGPLFISPDAPVDTVLDFGFPQVVWSANRNNPVRINATLQLTSDGDLVLKDADG 150

Query: 137 TRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAST 196
           T  WST+T G +V+ + +   GNL L+D  N   W SF HPT+  +PGQ+L   + +  +
Sbjct: 151 TIAWSTDTGGQSVSGLNMTDMGNLVLFDDNNAIVWQSFDHPTDCLVPGQKLKEGQKLIPS 210

Query: 197 NSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSA----------VLN 246
            S T+ ++   +LSL+          + V   ++ P + Y+   SS           VL 
Sbjct: 211 VSATNWTELS-LLSLTVS------KTACVALIESSPPQAYYETYSSGTKTNEEPTYVVLE 263

Query: 247 KSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDN---GYSDNADLSRDEHYG 303
             +  +F  S +     +       Y+R    G L +Y+ +     +    D++     G
Sbjct: 264 NGSFTLFVDSNTRTYVTIPVALSAQYLRFGATGQLRLYEWNTQGAAWRIVTDVTSVTG-G 322

Query: 304 DCIYPTKCGNYGVCSNGECTCPGSSS----YFKQSNDSENGFSCAEVTHLSCQFKHLQRF 359
            C YPT CGNYG+CS G+C+CP S S    YF+  ND E    C+E T LSC+      F
Sbjct: 323 VCFYPTVCGNYGICSKGQCSCPASDSGRTTYFRHVNDREPNLGCSETTSLSCEVSEYHNF 382

Query: 360 LKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRN 419
           L+L + TYF F   L N+D++ C+ ACL NCSCKAA+FRY    + G+C LP +I +L N
Sbjct: 383 LELTDTTYFSFRTDLENVDSKRCKEACLQNCSCKAAIFRYGSDHANGSCHLPNQILSLIN 442

Query: 420 STKVISGYNDITFIKVQLPS--------------DQNKLSLLFMLLLSVSAFLLLVIGAS 465
           +    + YN   F+KVQ  S               +N+++++    L     LLL++G  
Sbjct: 443 NEPEATDYNSTVFVKVQNNSIDKVENNSTTARRKAKNRVAVILGSSLGSFFGLLLLVGIF 502

Query: 466 IYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL 525
           + L  + R G+  +   D+    V     +FS + +K+ T +F+  LG GG G+ FEG  
Sbjct: 503 VLLVWKERNGEAEEDYLDQ----VPGMPTRFSFEDLKAITENFRKVLGEGGFGTAFEGTT 558

Query: 526 NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
            DGTK+AVKRL  G ++ KK FL+EVE+IG++HH NLVRL+G+CAE+S+R LVYE+M NG
Sbjct: 559 ADGTKIAVKRLN-GLDQVKKSFLAEVESIGSLHHMNLVRLLGFCAEKSHRLLVYEFMSNG 617

Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV 645
           SLDKWIFH+ R   L W  RKKII  I++GL YLH+ C+ K+IH DIKPQNILLD   N 
Sbjct: 618 SLDKWIFHQSREFVLDWKQRKKIILDIAKGLTYLHEECSQKVIHLDIKPQNILLDNQFNA 677

Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR 705
           KI DFGL++LI +DQS V T  +GTPGY+APE    + IT K+DIYSFG+V+LE++CGRR
Sbjct: 678 KICDFGLSKLIHRDQSKVVTTMRGTPGYLAPEWL-SSVITEKVDIYSFGIVVLEMLCGRR 736

Query: 706 SSNPKGGDYLVDTLKV---KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLH 762
           + +P   + L+  L +   K E +RL DLVD   ED+  HR++ + ++++A  CLQ++  
Sbjct: 737 NIDPSQPEELMHLLSIFEKKVEENRLVDLVDSCIEDI--HREEVMNLMRLAAWCLQRDHT 794

Query: 763 RRPSASMLVKVLQGLTKLEPVTDY 786
           RRPS SM+VKVL+G+ ++E   DY
Sbjct: 795 RRPSMSMVVKVLEGVAEVEDDLDY 818

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38344588|emb|CAE05335.2| OSJNBa0079M09.4 [Oryza sativa Japonica Group]

 Score =  566 bits (1459), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 319/817 (39%), Positives = 481/817 (58%), Gaps = 35/817 (4%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T W NN  + Q S  + DGS VR +++R   +   P +  GF  +   D   + V
Sbjct: 34  TANLSTRWVNNAAALQHSVGYSDGSAVRAIVLRSPKTFYGPSYAAGFFCSPPCDAFLFAV 93

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            + +  +    +      P ++W AN   PV+ENATLE T +G+L+L D DG+ VWS+ +
Sbjct: 94  YIVYTNSGAGITMTTTGIPQVVWSANRARPVRENATLELTYNGNLVLSDADGSLVWSSGS 153

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ 204
           S  +V  + +   GNL L+D  N   W SF HPT+T LPGQ L     + + ++TT+ ++
Sbjct: 154 SSRSVAGMEITDTGNLVLFDQRNVTVWQSFDHPTDTLLPGQSLMEGMKLRANSTTTNSTE 213

Query: 205 GKFILSLSPKGIEVFLNMSTVKRF--QTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITY 262
            +  +++ P G+  ++  +  + +   ++       + +       ++ +F +S      
Sbjct: 214 NQVYMAVQPDGLFAYVESTPPQLYYSHSVNTNKSGKDPTKVTFTNGSLSIFVQSTQPSNI 273

Query: 263 DVAPRSKFHYMRLEPNGHLNIYQLDNG------YSDNADLSRDEHYGDCIYPTKCGNYGV 316
            +   S   YMRLE +GHL +Y+  N        SD   +  D    DC +P  CG YG+
Sbjct: 274 SLPQASSTQYMRLEFDGHLRLYEWSNTGAKWTVVSDVIKVFPD----DCAFPMACGKYGI 329

Query: 317 CSNGECTCP----GSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVP 372
           C+ G+CTCP     S SYFK  ++ +    C+ +T +SCQ     + L L +V+YFD   
Sbjct: 330 CTGGQCTCPLQSNSSLSYFKPVDERKANLGCSPLTPISCQEMRSHQLLALTDVSYFDVSH 389

Query: 373 HLIN-IDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDIT 431
            ++N  + + C+++CL NCSC+A +FRY  + S G C   +E+++L+        YN   
Sbjct: 390 TILNATNRDDCKQSCLKNCSCRAVMFRYGQNDSDGTCFSVSEVFSLQTIQPEALHYNSSA 449

Query: 432 FIKVQL-----PSDQNKLSLLFMLLLSVSAFLLLVIGAS-IYLYKRWREGKRRDKSTDES 485
           ++KVQL      S  NK   +  L  ++SA L+LV+  + I LY + R+ +  D+  D  
Sbjct: 450 YLKVQLSPSASASTANKTKAI--LGATISAILILVLAVTVITLYVQRRKYQEIDEEIDFE 507

Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
            +      V+FS + ++  T+DF  +LG GG GSVFEG + +  +VAVKRL   + +GKK
Sbjct: 508 PL--PGMPVRFSYEKLRECTKDFSKKLGEGGFGSVFEGEIGE-ERVAVKRLESAK-QGKK 563

Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           EFL+EVETIG+I H NLVRL+G+CAE+SNR LVYEYM  GSLD+WI+++     L W  R
Sbjct: 564 EFLAEVETIGSIEHINLVRLIGFCAEKSNRLLVYEYMPRGSLDRWIYYRYNNDPLDWCTR 623

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
            +II  I++GL YLH+ C  KI H DIKPQNILLD   N K+ADFGL++LI +DQS V T
Sbjct: 624 CRIIMDIAKGLCYLHEECRRKIAHLDIKPQNILLDEKFNAKLADFGLSKLIDRDQSKVVT 683

Query: 666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGDYLVDTLKVK 722
           + +GTPGY+APE    + IT K+D+YSFGVV+LEIICGR++   S P+    L++ L+ K
Sbjct: 684 VMRGTPGYLAPEWLT-SQITEKVDVYSFGVVLLEIICGRKNIDISQPEESVQLINLLREK 742

Query: 723 AEADRLCDLVDKKSEDMQS-HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
           A+ + L D++DKKS DM S H+++ +KM+++A+ CLQ    RRPS SM+VKVL+G   +E
Sbjct: 743 AKDNVLIDIIDKKSTDMVSHHQEEVIKMLKLAMWCLQNESSRRPSMSMVVKVLEGAVSVE 802

Query: 782 PVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
              DY F +   V  + Q+     S+P +A+ LSGPR
Sbjct: 803 NCLDYSFANANSV-ISAQDNPSTYSAPPSASILSGPR 838

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116308953|emb|CAH66079.1| H0215E01.7 [Oryza sativa Indica Group]

 Score =  566 bits (1459), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 328/839 (39%), Positives = 492/839 (58%), Gaps = 58/839 (6%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T W NN    Q S +F DGS VR++++R   +   P F  GF          + +
Sbjct: 39  TANLSTRWVNNAAVLQHSVDFTDGSAVRSIILRSPETIFGPSFAAGFFCAPPCKAFLFAI 98

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            + +  +  S ++ +N  P ++W AN   PV ENATLE T DG L+L++ DG  VWS+ T
Sbjct: 99  FIVYTDSGASITSVRNGIPQVVWSANRAHPVGENATLELTGDGILVLREADGRLVWSSGT 158

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ 204
           SG +V  + +   GNL L+D  N   W SF HPT+  +PGQ L     + +  S T+ ++
Sbjct: 159 SGRSVVGMQITEQGNLVLFDQRNVTVWQSFDHPTDALVPGQSLLQGMRLRANTSNTNWTE 218

Query: 205 GKFILSLSPKGI---------EVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNK 255
            K  +++   G+         +++   +T KR +  P R  F+N S ++  ++      +
Sbjct: 219 SKLYMTVLSDGLYGYVESTPPQLYYEQTTNKRGK-YPTRVTFMNGSLSIFIRT-----TQ 272

Query: 256 SGSHITYDVAPRSK-FHYMRLEPNGHLNIYQLDNGYSDNADLSR--DEHYGDCIYPTKCG 312
           +G        P +K   Y+RLE +GHL +Y+  +  S+   +S    +   DC +PT CG
Sbjct: 273 AGKPEAIIALPEAKSTQYIRLESDGHLRLYEWFDAGSNWTMVSDVIQKFPDDCAFPTVCG 332

Query: 313 NYGVCSNGECTCP----GSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYF 368
           +YG+C++G+C CP     SSSYF   ++ +    CA VT +SCQ     +FL L +V+YF
Sbjct: 333 DYGICTSGQCICPLQANSSSSYFHPVDERKANLGCAPVTPISCQEMQYHQFLSLTDVSYF 392

Query: 369 DFVPHLINI-DAEGCQRACLGNCSCKAALFRYQG-SLSTGNCSLPTEIYTLRNSTKVISG 426
           D    + N  + + C+ ACL NCSC+A +FRY G + S G C   TE+++L++    I  
Sbjct: 393 DEGQIIANAKNRDDCKEACLKNCSCRAVMFRYYGQNDSDGECQSVTEVFSLQSIQPEIVH 452

Query: 427 YNDITFIKVQL-PSD--------------------QNKLSLLFMLLLS-VSAFLLLVIGA 464
           YN   ++KVQL PS                     QNK + +  +L S ++A + LV+ A
Sbjct: 453 YNSSAYLKVQLTPSSAAPTQNSSSAPTQTSSFAPTQNKSNKMKAILGSTLAASITLVLVA 512

Query: 465 SIYLYKRWREGKRRDKSTDESSVH--VANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFE 522
            I +Y R R   R+ + TDE      +    ++FS + ++  T DF  ++G GG GSVFE
Sbjct: 513 IIVVYVRRR---RKYQETDEELDFDILPGMPLRFSLEKLRECTEDFSKKIGEGGFGSVFE 569

Query: 523 GLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           G L++  +VAVKRL     +GKKEFL+EVETIG+I H NLVR++G+CAE+SNR LVYEYM
Sbjct: 570 GKLSE-ERVAVKRL-ESARQGKKEFLAEVETIGSIEHINLVRMIGFCAEKSNRLLVYEYM 627

Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD 642
             GSLDKWI+++     L W  R +II  I++GL YLH+ C  KI+H DIKPQNILLD +
Sbjct: 628 PGGSLDKWIYYRHNNAPLDWSTRCRIILDIAKGLCYLHEECRRKIVHLDIKPQNILLDEN 687

Query: 643 LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC 702
            N K+ADFGL++LI +D S V T+ +GTPGY+APE    + IT K+D+YSFGVV++EII 
Sbjct: 688 FNAKLADFGLSKLIDRDHSKVMTVMRGTPGYLAPEWLT-SQITEKVDVYSFGVVLMEIIS 746

Query: 703 GRRS---SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQK 759
           GR++   S P+    L++ L+ KA+ ++L D++DK S DM S++++ ++M+++A+ CLQ 
Sbjct: 747 GRKNIDISQPEEAVQLINLLREKAQNNQLIDMIDKHSSDMVSYQEEVIQMMKLAMWCLQN 806

Query: 760 NLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
           +  RRPS S +VKVL+G  ++E   DY F +   V  + Q      S+P  A+ LS PR
Sbjct: 807 DSGRRPSMSTVVKVLEGAMRVENCLDYSFFNANSV-ISVQGNPSTYSAPPHASILSSPR 864

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|125589797|gb|EAZ30147.1| hypothetical protein OsJ_14201 [Oryza sativa Japonica Group]

 Score =  566 bits (1458), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 319/817 (39%), Positives = 481/817 (58%), Gaps = 35/817 (4%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T W NN  + Q S  + DGS VR +++R   +   P +  GF  +   D   + V
Sbjct: 59  TANLSTRWVNNAAALQHSVGYSDGSAVRAIVLRSPKTFYGPSYAAGFFCSPPCDAFLFAV 118

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            + +  +    +      P ++W AN   PV+ENATLE T +G+L+L D DG+ VWS+ +
Sbjct: 119 YIVYTNSGAGITMTTTGIPQVVWSANRARPVRENATLELTYNGNLVLSDADGSLVWSSGS 178

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ 204
           S  +V  + +   GNL L+D  N   W SF HPT+T LPGQ L     + + ++TT+ ++
Sbjct: 179 SSRSVAGMEITDTGNLVLFDQRNVTVWQSFDHPTDTLLPGQSLMEGMKLRANSTTTNSTE 238

Query: 205 GKFILSLSPKGIEVFLNMSTVKRF--QTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITY 262
            +  +++ P G+  ++  +  + +   ++       + +       ++ +F +S      
Sbjct: 239 NQVYMAVQPDGLFAYVESTPPQLYYSHSVNTNKSGKDPTKVTFTNGSLSIFVQSTQPSNI 298

Query: 263 DVAPRSKFHYMRLEPNGHLNIYQLDNG------YSDNADLSRDEHYGDCIYPTKCGNYGV 316
            +   S   YMRLE +GHL +Y+  N        SD   +  D    DC +P  CG YG+
Sbjct: 299 SLPQASSTQYMRLEFDGHLRLYEWSNTGAKWTVVSDVIKVFPD----DCAFPMACGKYGI 354

Query: 317 CSNGECTCP----GSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVP 372
           C+ G+CTCP     S SYFK  ++ +    C+ +T +SCQ     + L L +V+YFD   
Sbjct: 355 CTGGQCTCPLQSNSSLSYFKPVDERKANLGCSPLTPISCQEMRSHQLLALTDVSYFDVSH 414

Query: 373 HLIN-IDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDIT 431
            ++N  + + C+++CL NCSC+A +FRY  + S G C   +E+++L+        YN   
Sbjct: 415 TILNATNRDDCKQSCLKNCSCRAVMFRYGQNDSDGTCFSVSEVFSLQTIQPEALHYNSSA 474

Query: 432 FIKVQL-----PSDQNKLSLLFMLLLSVSAFLLLVIGAS-IYLYKRWREGKRRDKSTDES 485
           ++KVQL      S  NK   +  L  ++SA L+LV+  + I LY + R+ +  D+  D  
Sbjct: 475 YLKVQLSPSASASTANKTKAI--LGATISAILILVLAVTVITLYVQRRKYQEIDEEIDFE 532

Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
            +      V+FS + ++  T+DF  +LG GG GSVFEG + +  +VAVKRL   + +GKK
Sbjct: 533 PL--PGMPVRFSYEKLRECTKDFSKKLGEGGFGSVFEGEIGE-ERVAVKRLESAK-QGKK 588

Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           EFL+EVETIG+I H NLVRL+G+CAE+SNR LVYEYM  GSLD+WI+++     L W  R
Sbjct: 589 EFLAEVETIGSIEHINLVRLIGFCAEKSNRLLVYEYMPRGSLDRWIYYRYNNDPLDWCTR 648

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
            +II  I++GL YLH+ C  KI H DIKPQNILLD   N K+ADFGL++LI +DQS V T
Sbjct: 649 CRIIMDIAKGLCYLHEECRRKIAHLDIKPQNILLDEKFNAKLADFGLSKLIDRDQSKVVT 708

Query: 666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGDYLVDTLKVK 722
           + +GTPGY+APE    + IT K+D+YSFGVV+LEIICGR++   S P+    L++ L+ K
Sbjct: 709 VMRGTPGYLAPEWLT-SQITEKVDVYSFGVVLLEIICGRKNIDISQPEESVQLINLLREK 767

Query: 723 AEADRLCDLVDKKSEDMQS-HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
           A+ + L D++DKKS DM S H+++ +KM+++A+ CLQ    RRPS SM+VKVL+G   +E
Sbjct: 768 AKDNVLIDIIDKKSTDMVSHHQEEVIKMLKLAMWCLQNESSRRPSMSMVVKVLEGAVSVE 827

Query: 782 PVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
              DY F +   V  + Q+     S+P +A+ LSGPR
Sbjct: 828 NCLDYSFANANSV-ISAQDNPSTYSAPPSASILSGPR 863

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359479303|ref|XP_003632253.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  565 bits (1455), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 331/825 (40%), Positives = 485/825 (58%), Gaps = 63/825 (7%)

Query: 26  AHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVT 85
           A+ +T+W N +G   E  N  D + V+ +L+  G + S P F  GF  +   +    L  
Sbjct: 39  ANLSTAWTNTRG---EWVNSSDWALVKPILLSPGET-SGPGFLCGF--HCHYESFLCLFA 92

Query: 86  VRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETS 145
           +     + S        P ++W AN   PV+ NATL  T DG+LIL D DGT VWST T+
Sbjct: 93  ILIFQDVYS--------PQLVWSANRNRPVRFNATLRLTEDGNLILADADGTFVWSTNTA 144

Query: 146 GSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQG 205
           G +V+ + L   GNL L D  N   W SF HPT++ +  Q+L   K + S+ S ++ + G
Sbjct: 145 GKSVSGLNLTETGNLVLLDRNNEMVWQSFDHPTDSLVLQQKLVRGKKLISSVSASNWTHG 204

Query: 206 KFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSGSHIT-YDV 264
            F LS++  G + ++  +  + +    Y ++  ++     N S    +     + T +  
Sbjct: 205 LFSLSITNYGFDAYIQSNPPQLYYEWEY-SFLTSIQYTNGNLSVYYRWEDEEFNFTPFAP 263

Query: 265 APRS-KFHYMRLEPNGHLNIYQL-DNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGEC 322
            PR+    YMRL  +GHL ++Q  + G+ +  DL+ DE   +C YP  CG YG+CS G+C
Sbjct: 264 IPRTLSAQYMRLGSDGHLRVFQWQETGWQEAVDLT-DEFLTECDYPLACGKYGICSAGQC 322

Query: 323 TCPGSSS----YFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINID 378
           TCPG+S     YF+  N+ +    C+ +T +SCQ       L+L+N +Y  F   + + D
Sbjct: 323 TCPGASDNGTIYFRPINERQTNLGCSAITPISCQLSQYHSLLELQNTSYSTFQVDMQSTD 382

Query: 379 AEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKV--ISGYNDITFIKVQ 436
            E C++ CL NCSCKAALFR+  + S+G+C L ++++TL+N   +     ++   F+KV+
Sbjct: 383 VEICKQTCLKNCSCKAALFRHPSNHSSGDCCLLSDVFTLQNMETLNPTDYFSTSLFLKVE 442

Query: 437 LPSDQNKL-----SLLFMLLLSVSAF--LLLVIGASIYLYKRWREGKRRD-KSTDESSVH 488
               +N +     +   +L  S+ A   +L++IGA I+L+  W   KRRD K  +E  + 
Sbjct: 443 NSPTENVVEKKAGNARIILGSSLGALFGVLILIGAFIFLF--W---KRRDSKEAEEDHLD 497

Query: 489 -VANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEF 547
            +     +FS + +K+ T +F  +LG GG GSVF+G L++G KVAVK+L  G  + KK F
Sbjct: 498 CIPGMPTRFSFEDLKAITENFSCKLGEGGFGSVFQGTLSNGIKVAVKQL-EGLGQVKKSF 556

Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+EVETIG++HH NLVRL+G+CAE+S+R LVYE MCNGSLDKWIFH +R   L W  R+K
Sbjct: 557 LAEVETIGSVHHVNLVRLIGFCAEKSHRLLVYECMCNGSLDKWIFHGNRDLALGWQSRRK 616

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           II  I++GL YLH+ C  KI H DIKPQNILLD D N K++DFGL++LI +DQS V T  
Sbjct: 617 IILDIAKGLSYLHEDCRQKIFHLDIKPQNILLDEDFNAKVSDFGLSKLIDKDQSQVVTRM 676

Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGDYLVDTLKVKAE 724
           +GTPGY+APE    + IT K+D+YSFGVV+LEI+CGR++   S  +   +L+   K KAE
Sbjct: 677 RGTPGYLAPEWLT-SIITEKVDVYSFGVVVLEILCGRKNLDRSQTEEDMHLLGIFKRKAE 735

Query: 725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVT 784
            +RL D++DK SEDMQ H  D V+M+++   CLQ +  RRPS S++VKVL+GL  +E   
Sbjct: 736 ENRLADIIDKCSEDMQLHGADVVEMMKVGGWCLQSDFARRPSMSVVVKVLEGLVDIEDNL 795

Query: 785 DYGF-----------LSFAVVEATTQEVVPIRSSPITAATLSGPR 818
           +Y F           +     +A T E +P        + LSGPR
Sbjct: 796 EYSFSYSPRPPKIAGMGNKAADAATAEPIP--------SALSGPR 832

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|70663992|emb|CAE04686.2| OSJNBb0018A10.15 [Oryza sativa Japonica Group] gi|125589793|gb|EAZ30143.1| hypothetical protein OsJ_14197 [Oryza sativa Japonica Group]

 Score =  564 bits (1453), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 327/839 (38%), Positives = 491/839 (58%), Gaps = 58/839 (6%)

Query: 25  TAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLV 84
           TA+ +T W NN    Q S +F DGS VR++++R   +   P F  GF          + +
Sbjct: 39  TANLSTRWVNNAAVLQHSVDFTDGSAVRSIILRSPETIFGPSFAAGFFCAPPCKAFLFAI 98

Query: 85  TVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
            + +     S ++ +N  P ++W AN   PV ENATLE T DG L+L++ DG  VWS+ T
Sbjct: 99  FIVYTDGGASITSVRNGIPQVVWSANRAHPVGENATLELTGDGILVLREADGRLVWSSGT 158

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ 204
           SG +V  + +   GNL L+D  N   W SF HPT+  +PGQ L     + +  S T+ ++
Sbjct: 159 SGRSVVGMQITEQGNLVLFDQRNVTVWQSFDHPTDALVPGQSLLQGMRLRANTSNTNWTE 218

Query: 205 GKFILSLSPKGI---------EVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNK 255
            K  +++   G+         +++   +T KR +  P R  F+N S ++  ++      +
Sbjct: 219 SKLYMTVLSDGLYGYVESTPPQLYYEQTTNKRGK-YPTRVTFMNGSLSIFIRT-----TQ 272

Query: 256 SGSHITYDVAPRSK-FHYMRLEPNGHLNIYQLDNGYSDNADLSR--DEHYGDCIYPTKCG 312
           +G        P +K   Y+RLE +GHL +Y+  +  S+   +S    +   DC +PT CG
Sbjct: 273 AGKPEAIIALPEAKSTQYIRLESDGHLRLYEWFDAGSNWTMVSDVIQKFPDDCAFPTVCG 332

Query: 313 NYGVCSNGECTCP----GSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLENVTYF 368
           +YG+C++G+C CP     SSSYF   ++ +    CA VT +SCQ     +FL L +V+YF
Sbjct: 333 DYGICTSGQCICPLQANSSSSYFHPVDERKANLGCAPVTPISCQEMQYHQFLSLTDVSYF 392

Query: 369 DFVPHLINI-DAEGCQRACLGNCSCKAALFRYQG-SLSTGNCSLPTEIYTLRNSTKVISG 426
           D    + N  + + C+ ACL NCSC+A +FRY G + S G C   TE+++L++    I  
Sbjct: 393 DEGQIIANAKNRDDCKEACLKNCSCRAVMFRYYGQNDSDGECQSVTEVFSLQSIQPEIVH 452

Query: 427 YNDITFIKVQL-PSD--------------------QNKLSLLFMLLLS-VSAFLLLVIGA 464
           YN   ++KVQL PS                     QNK + +  +L S ++A + LV+ A
Sbjct: 453 YNSSAYLKVQLTPSSAAPTQNSSSAPTQTSSFALTQNKSNKMKAILGSTLAASITLVLVA 512

Query: 465 SIYLYKRWREGKRRDKSTDESSVH--VANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFE 522
            I +Y R R   R+ + TDE      +    ++ S + ++  T DF  ++G GG GSVFE
Sbjct: 513 IIVVYVRRR---RKYQETDEELDFDILPGMPLRLSLEKLRECTEDFSKKIGEGGFGSVFE 569

Query: 523 GLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           G L++  +VAVKRL     +GKKEFL+EVETIG+I H NLVR++G+CAE+SNR LVYEYM
Sbjct: 570 GKLSE-ERVAVKRL-ESARQGKKEFLAEVETIGSIEHINLVRMIGFCAEKSNRLLVYEYM 627

Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD 642
             GSLDKWI+++     L W  R +II  I++GL YLH+ C  KI+H DIKPQNILLD +
Sbjct: 628 PGGSLDKWIYYRHNNAPLDWSTRCRIILDIAKGLCYLHEECRRKIVHLDIKPQNILLDEN 687

Query: 643 LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC 702
            N K+ADFGL++LI +D S V T+ +GTPGY+APE    + IT K+D+YSFGVV++EII 
Sbjct: 688 FNAKLADFGLSKLIDRDHSKVMTVMRGTPGYLAPEWLT-SQITEKVDVYSFGVVLMEIIS 746

Query: 703 GRRS---SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQK 759
           GR++   S P+    L++ L+ KA+ ++L D++DK S DM S++++ ++M+++A+ CLQ 
Sbjct: 747 GRKNIDISQPEEAVQLINLLREKAQNNQLIDMIDKHSSDMVSYQEEVIQMMKLAMWCLQN 806

Query: 760 NLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
           +  RRPS S +VKVL+G+ ++E   DY F +   V  + Q      S+P  A+ LS PR
Sbjct: 807 DSGRRPSMSTVVKVLEGVMRVENCLDYSFFNANSV-ISVQGNPSTYSAPPHASILSSPR 864

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	818
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.834	0.831	0.325	8.6e-88
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.746	0.737	0.316	8.5e-75
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.849	0.838	0.281	5.5e-70
TAIR|locus:2137010	849	AT4G11900 [Arabidopsis thalian	0.328	0.316	0.417	4.4e-65
TAIR|locus:2197714	792	AT1G61440 [Arabidopsis thalian	0.799	0.825	0.306	5.2e-65
TAIR|locus:2197734	814	AT1G61370 [Arabidopsis thalian	0.661	0.664	0.306	1.6e-64
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.276	0.259	0.436	5.6e-64
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.356	0.346	0.386	7e-62
TAIR|locus:2197664	804	AT1G61490 [Arabidopsis thalian	0.777	0.791	0.308	1e-61
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.344	0.360	0.373	7.3e-61

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 877 (313.8 bits), Expect = 8.6e-88, P = 8.6e-88
 Identities = 241/741 (32%), Positives = 387/741 (52%)

Query:    67 FGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTAD 126
             FGFGF+   TT +   L T   +  I  SS        ++W AN  SPV  +    F  +
Sbjct:    55 FGFGFV---TTQDSVTLFT---LSIIHKSSTK------LIWSANRASPVSNSDKFVFDDN 102

Query:   127 GDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQR 186
             G++++   +GT VW  + SG N +RI L  +GNL +   +    W SF HPT+T +  Q 
Sbjct:   103 GNVVM---EGTEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQA 159

Query:   187 ----LHVHKMMASTNSTTSLS--QGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNM 240
                 + +    +S+N T +L    G  +LS++    +V+ +M+  +  + I  ++  +  
Sbjct:   160 FKEGMKLTSSPSSSNMTYALEIKSGDMVLSVNSLTPQVYWSMANAR--ERIINKDGGVVT 217

Query:   241 SSAVLNKSAILVFNKS---GSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLS 297
             SS++L  S      K       +  D    +      L  NG ++   L +G S  AD S
Sbjct:   218 SSSLLGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASA-ADSS 276

Query:   298 RDEHYGDCIYPTKCGNYGVCSNGE-CTCPGSSSYFKQSNDSENGF-SCAEVTHLSCQFKH 355
                    C  P  CG Y VCS  + C C    S  +  +D + G  S  + T  +     
Sbjct:   277 TKIPSDLCGTPEPCGPYYVCSGSKVCGCVSGLS--RARSDCKTGITSPCKKTKDNATLP- 333

Query:   356 LQRFLKLENVTYF--DFVPHLIN-IDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPT 412
             LQ     + V YF   + P      D + C+  C  NCSC   LF +Q S  +GNC L  
Sbjct:   334 LQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSC-LGLF-FQNS--SGNCFLFD 389

Query:   413 EIYTLRNSTKVISGYNDITFIKVQLPSD---QNKXXXXXXXXXXXXXXXXXXIGASIYLY 469
              I + + S    SG+  +++IK+         N                      ++ ++
Sbjct:   390 YIGSFKTSGNGGSGF--VSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIF 447

Query:   470 KRWREGKRR-------DKSTDESSV--HVANHLVKFSSKAMKSATRDFQIRLGRGGSGSV 520
               +R  KR+        +S++E +   +++   ++F+ K ++SAT +F ++LG+GG GSV
Sbjct:   448 VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSV 507

Query:   521 FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE 580
             +EG L DG+++AVK+L  G  +GKKEF +EV  IG+IHH +LVRL G+CAE ++R L YE
Sbjct:   508 YEGTLPDGSRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYE 566

Query:   581 YMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL 639
             ++  GSL++WIF K D    L WD R  I    ++GL YLH+ C+ +I+H DIKP+NILL
Sbjct:   567 FLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILL 626

Query:   640 DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
             D + N K++DFGLA+L+ ++QSHV T  +GT GY+APE     +I+ K D+YS+G+V+LE
Sbjct:   627 DDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686

Query:   700 IICGRRSSNPKGGD---YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC 756
             +I GR++ +P       +       K E  +L D+VD K +++    +   + ++ A+ C
Sbjct:   687 LIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWC 746

Query:   757 LQKNLHRRPSASMLVKVLQGL 777
             +Q+++  RPS S +V++L+G+
Sbjct:   747 IQEDMQTRPSMSKVVQMLEGV 767

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 725 (260.3 bits), Expect = 8.5e-75, Sum P(2) = 8.5e-75
 Identities = 210/664 (31%), Positives = 326/664 (49%)

Query:   155 DGNGNLRLYDAENRPH--WISFLHPTNTWLPGQRLHVHKMMASTNSTTSL------SQGK 206
             DGN  LR   +    +  W SF HP +TWLPG ++ + K    +   TS       S G 
Sbjct:   128 DGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGL 187

Query:   207 FILSLSPK-GIEVFLNMSTVKRFQTIPYR---NYFLNMSSAVLNKSAILVF--NKSGSHI 260
             F L L      ++  N S  + + + P+      F ++    LN      F  N + S+ 
Sbjct:   188 FSLELDESTAYKILWNGSN-EYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYF 246

Query:   261 TYDVAPRSKFHYMRLEPNGHLNIYQ-LDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSN 319
             TY +  +       ++ +G +  +  L+   + N   S+      C     CG++G+CS+
Sbjct:   247 TYSIYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQ--QCQVYRYCGSFGICSD 304

Query:   320 GE---CTCPGSSSYFKQSNDSENGFS--CAEVTHLSCQFKHLQRFLKLENVTYFDFVPHL 374
                  C CP       Q +     +S  C   T L C    + +F +L N+   D    L
Sbjct:   305 KSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVL 364

Query:   375 INIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSL-PTEIYTLRNSTKVISGYNDITFI 433
                    C  AC G+CSCKA  +  +GS     C +   ++  L+      S  N I ++
Sbjct:   365 TRTSLSICASACQGDCSCKAYAYD-EGS---SKCLVWSKDVLNLQQLEDENSEGN-IFYL 419

Query:   434 KV---QLP----SDQNKXXXXXXXXXXXXXXXXXXIGASIYLYKRWREGKR-RDKSTDES 485
             ++    +P    S ++                   +   + L  R+R  KR R +  D +
Sbjct:   420 RLAASDVPNVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDGT 479

Query:   486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
                    L  FS + +++AT++F  +LG GG GSVF+G L D + +AVKRL  G ++G+K
Sbjct:   480 -------LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQGEK 531

Query:   546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFH---KDRIQTLSW 602
             +F +EV TIG I H NLVRL G+C+E S + LVY+YM NGSLD  +F    +++I  L W
Sbjct:   532 QFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKI-VLGW 590

Query:   603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
              +R +I    +RGL YLHD C   IIH DIKP+NILLD     K+ADFGLA+L+ +D S 
Sbjct:   591 KLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSR 650

Query:   663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDT 718
             V T  +GT GY+APE   G +ITAK D+YS+G+++ E++ GRR    S N K   +    
Sbjct:   651 VLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWA 710

Query:   719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
               +  +   +  LVD + E      ++  +  ++A  C+Q     RP+ S +V++L+G+ 
Sbjct:   711 ATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVL 770

Query:   779 KLEP 782
             ++ P
Sbjct:   771 EVNP 774

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
 Identities = 212/753 (28%), Positives = 358/753 (47%)

Query:   104 VILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLY 163
             V +W A     V    +L     G L L +  GT VW ++T    VT  +++  G   L 
Sbjct:    72 VPIWSAG---TVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILL 128

Query:   164 DAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQ-GKFILSLSPKGIEVFLNM 222
             +  + P W SF +PT+T +  Q     K++ S   +  L + G   L  +   I  + N 
Sbjct:   129 NNRSVPVWSSFDNPTDTIVQSQNFTAGKILRSGLYSFQLERSGNLTLRWNTSAI--YWNH 186

Query:   223 STVKRFQT-IPYRNYFLNMSSAV-LNKSAILVFNKSGSHITY--DVAPRSKFHYMRLEPN 278
                  F + +      L  +  V + +S +L     G+ I Y  D    + F +++L+ +
Sbjct:   187 GLNSSFSSNLSSPRLSLQTNGVVSIFESNLL----GGAEIVYSGDYGDSNTFRFLKLDDD 242

Query:   279 GHLNIYQLDNGYSD--NADLSRDEHYGDCIYPTKCGNYGVCS----NGECTCPGSSSYFK 332
             G+L IY   +  S   NA  S  +    C+    CGN+G+CS    N  C+CP  +  F 
Sbjct:   243 GNLRIYSSASRNSGPVNAHWSAVDQ---CLVYGYCGNFGICSYNDTNPICSCPSRNFDFV 299

Query:   333 QSNDSENGFSCAEVTHLS-CQFKHLQRFLKLENVTYFDFVPHLINIDAEG--CQRACLGN 389
               ND   G  C     LS C        L    +  ++  P+  +  A    C+  CL +
Sbjct:   300 DVNDRRKG--CKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSS 357

Query:   390 CSCKAALFRYQGSLSTGNC--SLPTEIYTLRN-----STKVISGYNDI---TFIKVQLPS 439
               C A++    GS   GNC    P   +T        ST  +     +   T  +     
Sbjct:   358 VLCLASVSMSDGS---GNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGD 414

Query:   440 DQNKXXXXXXXXXXXXXXXXXXIGASIYLYKRW---REGKRRDKSTDESSV--HVANHLV 494
             D N                   +   I L+  W   R+  R    +   ++  + +   V
Sbjct:   415 DNNSKVHLWIVAVAVIAGLLGLVAVEIGLW--WCCCRKNPRFGTLSSHYTLLEYASGAPV 472

Query:   495 KFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETI 554
             +F+ K ++  T+ F+ +LG GG G+V+ G+L + T VAVK+L  G  +G+K+F  EV TI
Sbjct:   473 QFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL-EGIEQGEKQFRMEVATI 531

Query:   555 GNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR 614
              + HH NLVRL+G+C++  +R LVYE+M NGSLD ++F  D  + L+W+ R  I    ++
Sbjct:   532 SSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAK 591

Query:   615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGY 673
             G+ YLH+ C   I+H DIKP+NIL+D +   K++DFGLA+L+  +D  +  +  +GT GY
Sbjct:   592 GITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGY 651

Query:   674 MAPELTRGNSITAKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADRLC 729
             +APE      IT+K D+YS+G+V+LE++ G+R    S       + +   +   + +   
Sbjct:   652 LAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKA 711

Query:   730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE-PVTDYGF 788
              L  + SED     +  ++M++ +  C+Q+   +RP+   +V++L+G+T+++ P+     
Sbjct:   712 ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTI 771

Query:   789 --LSFAVVEATTQEV-VPIRSSPITAATLSGPR 818
               +SF+    +T    + + S P  +++ S  R
Sbjct:   772 SEVSFSGNSMSTSHASMFVASGPTRSSSFSATR 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)]

 Score = 490 (177.5 bits), Expect = 4.4e-65, Sum P(2) = 4.4e-65
 Identities = 116/278 (41%), Positives = 166/278 (59%)

Query:   504 ATRDF--QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN 561
             AT  F  + +LG GG G V++G L +G +VA+KRL    ++G  EF +EV  I  + H N
Sbjct:   533 ATNSFSRKKKLGEGGFGPVYKGKLPNGMEVAIKRLSKKSSQGLTEFKNEVVLIIKLQHKN 592

Query:   562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
             LVRL+GYC E   + L+YEYM N SLD  +F   + + L W+ R KI+   +RGL+YLH+
Sbjct:   593 LVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLHE 652

Query:   622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPELTR 680
             Y   +IIH D+K  NILLD ++N KI+DFG AR+    Q   ST    GT GYM+PE   
Sbjct:   653 YSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMSPEYAL 712

Query:   681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL--VDKKSED 738
             G  I+ K DIYSFGV++LEII G++++     D     +  + E+   C+   V    E 
Sbjct:   713 GGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYEWES--WCETKGVSIIDEP 770

Query:   739 MQ-SHR-DDAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
             M  S+  ++A++ I IA+ C+Q +   RP  S +V +L
Sbjct:   771 MCCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYML 808

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)]

 Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
 Identities = 217/707 (30%), Positives = 331/707 (46%)

Query:   102 PPVILWFANGQSPVKENAT-LEFTADGDLILKDVDGTRVWST-ETSGSNVTRITLDGNGN 159
             P V++W AN + PV ++A  L  ++ G L+L +     VWST E S S  +   L   GN
Sbjct:    62 PRVVVWVANREKPVTDSAANLVISSSGSLLLINGKHDVVWSTGEISASKGSHAELSDYGN 121

Query:   160 LRLYD-AENRPHWISFLHPTNTWLPGQRLHVHKM------MASTNSTTSLSQGKFILSLS 212
             L + D    R  W SF H  NT LP   +  + +      ++S  S T  S G F + ++
Sbjct:   122 LMVKDNVTGRTLWESFEHLGNTLLPLSTMMYNLVTGEKRGLSSWKSYTDPSPGDFWVQIT 181

Query:   213 PK-GIEVFLNMSTVKRFQTIPYRN--Y--FLNMSSAVLNKSAILV-FNKSGSHITYDVAP 266
             P+   + F+   +   ++T P+    Y     M  +  +  ++    N SG + +Y    
Sbjct:   182 PQVPSQGFVMRGSTPYYRTGPWAKTRYTGIPQMDESYTSPFSLHQDVNGSG-YFSY-FER 239

Query:   267 RSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNYGVCSNGE---CT 323
               K   + L   G + + +  NG    +      +  D IY   CG +G C   +   C 
Sbjct:   240 DYKLSRIMLTSEGSMKVLRY-NGLDWKSSYEGPANSCD-IYGV-CGPFGFCVISDPPKCK 296

Query:   324 C-----PGSSSYFKQSNDSENGFSCAEVTHLSCQF----KHLQRFLKLENVTYFDFVPHL 374
             C     P S   +K+ N +     CA  T L CQ     K    F  + N+   DF  + 
Sbjct:   297 CFKGFVPKSIEEWKRGNWTSG---CARRTELHCQGNSTGKDANVFHTVPNIKPPDFYEYA 353

Query:   375 INIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIK 434
              ++DAEGC ++CL NCSC A  F Y   +    C + ++   L ++ +  +G   ++   
Sbjct:   354 NSVDAEGCYQSCLHNCSCLA--FAYIPGIG---CLMWSK--DLMDTMQFSAGGEILSIRL 406

Query:   435 VQLPSDQNKXXXXXXXXXXXXXXXXXXIGASIYLYKRWREG-KRRDKSTDESSVHVANHL 493
                  D +K                  +G + + +  WR   K  D   ++        L
Sbjct:   407 AHSELDVHKRKMTIVASTVSLTLFVI-LGFATFGF--WRNRVKHHDAWRNDLQSQDVPGL 463

Query:   494 VKFSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEV 551
               F    +++AT +F +  +LG GG GSV++G L DG ++AVKRL     +GK+EF++E+
Sbjct:   464 EFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNEI 523

Query:   552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
               I  + H NLVR++G C E   + L+YE+M N SLD ++F   +   L W  R  II  
Sbjct:   524 VLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQG 583

Query:   612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GT 670
             I RGL YLH     ++IH D+K  NILLD  +N KI+DFGLARL    Q    T    GT
Sbjct:   584 IVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGT 643

Query:   671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DR 727
              GYM+PE       + K DIYSFGV++LEII G + S    G+     L    E     R
Sbjct:   644 LGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCETR 703

Query:   728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
               +L+D+  +D  SH  +  + +QI + C+Q     RP+   L+ +L
Sbjct:   704 GVNLLDQALDD-SSHPAEVGRCVQIGLLCVQHQPADRPNTLELLSML 749

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)]

 Score = 547 (197.6 bits), Expect = 1.6e-64, Sum P(2) = 1.6e-64
 Identities = 182/594 (30%), Positives = 284/594 (47%)

Query:   256 SGSHITYDVAPR-SKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGDCIYPTKCGNY 314
             +GS +TY +  R S   Y  L   G L I   +NG     DL       D +Y T CG +
Sbjct:   240 TGS-LTYSLERRNSNLSYTTLTSAGSLKIIW-NNGSGWVTDLEAPVSSCD-VYNT-CGPF 295

Query:   315 GVC--SNG-ECTCPGSSSYFKQSNDSENGFS----CAEVTHLSC--------QFKHLQRF 359
             G+C  SN  +C C     +  +S++  N  +    C   T+LSC        Q  +   F
Sbjct:   296 GLCIRSNPPKCEC--LKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIF 353

Query:   360 LKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRN 419
               + NV   DF  +L  I+ E CQ+ CLGNCSC A  F Y   +    C +      L +
Sbjct:   354 DIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCTA--FSYIEQIG---CLVWNR--ELVD 406

Query:   420 STKVISGYNDITFIKVQLPSDQNKXXXXXXXXXXXXXXXXXXIGASIYLYKRWR-EGKRR 478
               + ++G   ++   ++L S +                    +      Y  WR + K+ 
Sbjct:   407 VMQFVAGGETLS---IRLASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQN 463

Query:   479 DKSTD--ESSVHVANHLVK------FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDG 528
             D +    E+S       +K      F  + + + T +F +  +LG+GG G V++G L DG
Sbjct:   464 DSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDG 523

Query:   529 TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD 588
              ++A+KRL     +G +EF++E+  I  + H NLVRL+G C E   + L+YE+M N SL+
Sbjct:   524 KEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLN 583

Query:   589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH-DYCNPKIIHFDIKPQNILLDRDLNVKI 647
              +IF   +   L W  R +II  I+ GL YLH D C  +++H D+K  NILLD ++N KI
Sbjct:   584 TFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCL-RVVHRDMKVSNILLDEEMNPKI 642

Query:   648 ADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS 706
             +DFGLAR+    Q   +T    GT GYM+PE       + K DIY+FGV++LEII G+R 
Sbjct:   643 SDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRI 702

Query:   707 SNPKGGDYLVDTLKVKAEADRLCDL--VDKKSEDMQSH--RDDAVKMIQIAISCLQKNLH 762
             S+   G+    TL ++   D  C+    D   +D+ S     +  + +QI + C+Q+   
Sbjct:   703 SSFTIGEE-GKTL-LEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAG 760

Query:   763 RRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEATTQEVVPIRSSPITAATLSG 816
              RP+ + ++ +L     L P       +  V E+ ++       + IT   + G
Sbjct:   761 DRPNIAQVMSMLTTTMDL-PKPKQPVFAMQVQESDSESKTMYSVNNITQTAIVG 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 496 (179.7 bits), Expect = 5.6e-64, Sum P(3) = 5.6e-64
 Identities = 99/227 (43%), Positives = 147/227 (64%)

Query:   480 KSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG 539
             +S D  S H+     KF  + ++ AT +F++++G GG GSV++G L D T +AVK++   
Sbjct:   489 ESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNH 548

Query:   540 ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
                G++EF +E+  IGNI H NLV+L G+CA      LVYEYM +GSL+K +F  +    
Sbjct:   549 GLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNG-PV 607

Query:   600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
             L W  R  I    +RGL YLH  C+ KIIH D+KP+NILL      KI+DFGL++L+ Q+
Sbjct:   608 LEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQE 667

Query:   660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS 706
             +S + T  +GT GY+APE     +I+ K D+YS+G+V+LE++ GR++
Sbjct:   668 ESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 511 (184.9 bits), Expect = 7.0e-62, Sum P(2) = 7.0e-62
 Identities = 118/305 (38%), Positives = 185/305 (60%)

Query:   496 FSSKAMKSATRDF--QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVET 553
             FS  ++ SAT DF  + +LG+GG G+V++G  ++G ++AVKRL     +G +EF +E+  
Sbjct:   513 FSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILL 572

Query:   554 IGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
             I  + H NLVRL+G C E + + L+YEYM N SLD+++F + +  +L W  R ++I  I+
Sbjct:   573 IAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIA 632

Query:   614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPG 672
             RGL YLH     KIIH D+K  NILLD ++N KI+DFG+AR+    Q H +T+   GT G
Sbjct:   633 RGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYG 692

Query:   673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY--LVDT---LKVKAEADR 727
             YMAPE       + K D+YSFGV+ILEI+ GR++ + +G D+  L+     L  + +   
Sbjct:   693 YMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKE 752

Query:   728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT-KLEPVTDY 786
             + D + K + D+     +A++ I + + C Q ++  RP+   ++ +L+  T +L P    
Sbjct:   753 MIDPIVKDTRDVT----EAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQP 808

Query:   787 GFLSF 791
              F SF
Sbjct:   809 TFHSF 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)]

 Score = 631 (227.2 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 215/697 (30%), Positives = 336/697 (48%)

Query:   118 NATLEFTADGDLILKDVDGTRVWST-ETSGSNVTRITLDGNGNLRLYD-AENRPHWISFL 175
             +A L  +++G L+L +     VWS  E   SN +R  L  NGNL + D A  R  W SF 
Sbjct:    86 SANLAISSNGSLLLFNGKHGVVWSIGENFASNGSRAELTDNGNLVVIDNASGRTLWESFE 145

Query:   176 HPTNTWLPGQRLHVH------KMMASTNSTTSLSQGKFILSLSPK-GIEVFLNMSTVKRF 228
             H  +T LP   L  +      +++ S  + T  S G F+  ++P+   +V +   + + +
Sbjct:   146 HFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVFVGQITPQVPSQVLIMRGSTRYY 205

Query:   229 QTIPY-RNYFLN---MSSAVLNKSAILV-FNKSGSHITYDVAPRS-KFHYMRLEPNGHLN 282
             +T P+ +  F     M     +  ++    N SG    +D   RS K   + +   G + 
Sbjct:   206 RTGPWAKTRFTGIPLMDDTYASPFSLQQDANGSGFFTYFD---RSFKLSRIIISSEGSMK 262

Query:   283 IYQLDNGYSDNADLSRDEHYGDC-IYPTKCGNYGVCSNG---ECTC-----PGSSSYFKQ 333
              ++  NG +D  +LS       C IY   CG +G+C      +C C     P S+  +K+
Sbjct:   263 RFR-HNG-TD-WELSYMAPANSCDIYGV-CGPFGLCIVSVPLKCKCLKGFVPHSTEEWKR 318

Query:   334 SNDSENGFSCAEVTHLSCQF----KHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGN 389
              N +  G  CA +T L CQ     K +  F  + NV   DF  +  ++DAE C ++CL N
Sbjct:   319 GNWT--G-GCARLTELHCQGNSTGKDVNIFHPVTNVKLPDFYEYESSVDAEECHQSCLHN 375

Query:   390 CSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKV---QLPSDQNKXXX 446
             CSC A  F Y   +    C +  +   L ++ +  +G  +I  I++   +L  ++     
Sbjct:   376 CSCLA--FAYIHGIG---CLIWNQ--NLMDAVQFSAG-GEILSIRLAHSELGGNKRNKII 427

Query:   447 XXXXXXXXXXXXXXXIGASIYLYK-RWREGKRRDK-STDESSVHVANHLVKFSSKAMKSA 504
                                 + Y+ + +    +D    D  S  V   L  F    +++A
Sbjct:   428 VASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPG-LEFFEMNTIQTA 486

Query:   505 TRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
             T +F +  +LG+GG GSV++G L DG ++AVK+L     +GK+EF++E+  I  + H NL
Sbjct:   487 TNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNL 546

Query:   563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
             VR++G C E   + L+YE+M N SLD ++F   +   + W  R  I+  I+RGL YLH  
Sbjct:   547 VRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRD 606

Query:   623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRG 681
                K+IH D+K  NILLD  +N KI+DFGLAR+    Q    T    GT GYM+PE    
Sbjct:   607 SRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWT 666

Query:   682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DRLCDLVDKKSED 738
                + K DIYSFGV++LEII G + S    G+     L    E+    +  DL+D+   D
Sbjct:   667 GVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLAD 726

Query:   739 MQSHRDDAV-KMIQIAISCLQKNLHRRPSASMLVKVL 774
               S R   V + +QI + C+Q     RP+   L+ +L
Sbjct:   727 --SCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAML 761

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 507 (183.5 bits), Expect = 7.3e-61, Sum P(2) = 7.3e-61
 Identities = 108/289 (37%), Positives = 175/289 (60%)

Query:   501 MKSATRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH 558
             +  AT  F    +LG+GG G V++G L  G +VAVKRL     +G +EF +E++ I  + 
Sbjct:   458 VSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQ 517

Query:   559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
             H NLV+++GYC +   R L+YEY  N SLD +IF K+R + L W  R +II  I+RG+ Y
Sbjct:   518 HRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLY 577

Query:   619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPE 677
             LH+    +IIH D+K  N+LLD D+N KI+DFGLAR +  D++  +T    GT GYM+PE
Sbjct:   578 LHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPE 637

Query:   678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DRLCDLVDK 734
                    + K D++SFGV++LEI+ GRR+   +  ++ ++ L         D+  +++D+
Sbjct:   638 YQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDE 697

Query:   735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG-LTKLEP 782
                +  +   + +++I I + C+Q++   RP+ S++V +L   +  L+P
Sbjct:   698 AVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDP 746

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8RWZ5	SD25_ARATH	2, ., 7, ., 1, 1, ., 1	0.3140	0.8300	0.8270	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00027838001 SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (735 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	818
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-56
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-55
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-36
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-32
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-23
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	7e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-20
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-17
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-17
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-16
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-16
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-15
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-13
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-12
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	7e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-09
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	7e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-06
pfam08276	66	pfam08276, PAN_2, PAN-like domain	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	6e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003
cd01100	73	cd01100, APPLE_Factor_XI_like, Subfamily of PAN/AP	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  192 bits (490), Expect = 8e-56
 Identities = 91/266 (34%), Positives = 141/266 (53%), Gaps = 19/266 (7%)

Query: 511 RLGRGGSGSVFEG-LLNDGTKVAVKRL-YPGENRGK-KEFLSEVETIGNIHHFNLVRLVG 567
           +LG G  G+V++      G  VAVK L    E   K +    E+  +  + H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
              ++ + +LV EY   G L  ++        LS D  KKI  QI RGLEYLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-ITA 686
           IH D+KP+NILLD +  VKIADFGLA+ + +  S ++T   GTP YMAPE+  G +    
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYGP 178

Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA 746
           K+D++S GV++ E++ G+    P  G+ ++D L++      L   ++       S  ++A
Sbjct: 179 KVDVWSLGVILYELLTGK---PPFSGENILDQLQLIRR--ILGPPLEFDEPKWSSGSEEA 233

Query: 747 VKMIQIAISCLQKNLHRRPSASMLVK 772
                +   CL K+  +RP+A  +++
Sbjct: 234 ---KDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  190 bits (485), Expect = 3e-55
 Identities = 80/263 (30%), Positives = 125/263 (47%), Gaps = 21/263 (7%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGYC 569
           LG G  G V+       G  VA+K +   + +  +E  L E++ +  + H N+VRL    
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            +    +LV EY   G L   +  + R   LS D  +  + QI   LEYLH      I+H
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYLRQILSALEYLHSK---GIVH 120

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+KP+NILLD D +VK+ADFGLAR +   +   + +  GTP YMAPE+  G      +D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKAVD 178

Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           I+S GV++ E++ G+    P  GD  +  L       ++                +A  +
Sbjct: 179 IWSLGVILYELLTGK---PPFPGDDQLLEL-----FKKIGKPKPPFPPPEWDISPEAKDL 230

Query: 750 IQIAISCLQKNLHRRPSASMLVK 772
           I+     L K+  +R +A   ++
Sbjct: 231 IR---KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  188 bits (480), Expect = 5e-55
 Identities = 90/267 (33%), Positives = 132/267 (49%), Gaps = 56/267 (20%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           LG GG G+V+       G KVA+K +     +   +E L E+E +  ++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            + ++ +LV EY   GSL   +  K+    LS D   +I+ QI  GLEYLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115

Query: 630 FDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAK 687
            D+KP+NILLD  +  VK+ADFGL++L+  D+S + T+  GTP YMAPE+  G    + K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEK 174

Query: 688 IDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV 747
            DI+S GV++ E+                           L DL+ K             
Sbjct: 175 SDIWSLGVILYEL-------------------------PELKDLIRK------------- 196

Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVL 774
                    LQK+  +RPSA  +++ L
Sbjct: 197 --------MLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  167 bits (426), Expect = 6e-47
 Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 26/270 (9%)

Query: 512 LGRGGSGSVFEGLLND-----GTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V++G L         +VAVK L    +    +EFL E   +  + H N+V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C E    ++V EYM  G L    + +     LS         QI+RG+EYL      
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLS--YLRKNRPKLSLSDLLSFALQIARGMEYLESK--- 121

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
             IH D+  +N L+  +L VKI+DFGL+R +  D  +     K    +MAPE  +    T
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181

Query: 686 AKIDIYSFGVVILEII-CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +K D++SFGV++ EI   G +   P  G    + L+      RL      +  +      
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEYLKNGYRL-----PQPPNCPP--- 230

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
              ++  + + C  ++   RP+ S LV++L
Sbjct: 231 ---ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  167 bits (425), Expect = 7e-47
 Identities = 83/270 (30%), Positives = 130/270 (48%), Gaps = 25/270 (9%)

Query: 512 LGRGGSGSVFEGLLNDG-----TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V++G L         +VAVK L    + +  +EFL E   +  + H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C E     +V EYM  G L  ++  K+R + LS         QI+RG+EYL      
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK--- 122

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
             IH D+  +N L+  +L VKI+DFGL+R +  D  +     K    +MAPE  +    T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 686 AKIDIYSFGVVILEII-CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +K D++SFGV++ EI   G     P  G    + L+   +  RL      K  +      
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYLKKGYRL-----PKPPNCPP--- 231

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
              ++ ++ + C  ++   RP+ S LV++L
Sbjct: 232 ---ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  165 bits (421), Expect = 2e-46
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 508 FQIRLGRGGSGSVFEGLLND-----GTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFN 561
              +LG G  G V++G L        TKVAVK L  G     ++EFL E   +  + H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +VRL+G C +    ++V EYM  G L    F +   + L+     ++  QI++G+EYL  
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---YMAPEL 678
                 +H D+  +N L+  +L VKI+DFGL+R I +D  +      G      +MAPE 
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPES 175

Query: 679 TRGNSITAKIDIYSFGVVILEIICG 703
            +    T+K D++SFGV++ EI   
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  160 bits (407), Expect = 2e-44
 Identities = 88/276 (31%), Positives = 133/276 (48%), Gaps = 28/276 (10%)

Query: 512 LGRGGSGSVFEGLLNDG----TKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           LG G  G V++G L       T+VAVK L    +   +K+FL E   +  + H N+VRL+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWI------FHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           G C E    +LV EYM  G L  ++      F      TLS         QI++G+EYL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELT 679
              + K +H D+  +N L+  DL VKI+DFGL+R +  D  +        P  +MAPE  
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
           +    T+K D++SFGV++ EI      + P  G    + L+   +  RL      K E  
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT--LGATPYPGLSNEEVLEYLRKGYRL-----PKPEYC 232

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                   ++ ++ +SC Q +   RP+ S LV+ L+
Sbjct: 233 PD------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (380), Expect = 1e-40
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGY 568
           LGRG  GSV+  L  D G  +AVK +    +  +  +    E+  + ++ H N+VR  G 
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 569 CAERSNRFL-VY-EYMCNGSL-----DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
             +     L ++ EY+  GSL           +  I+  +         QI  GL YLH 
Sbjct: 68  ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT--------RQILEGLAYLHS 119

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM-PKGTPGYMAPELTR 680
                I+H DIK  NIL+D D  VK+ADFG A+ +   ++   T   +GTP +MAPE+ R
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 681 GNSITAKIDIYSFGVVILEIICGRR 705
           G       DI+S G  ++E+  G+ 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  136 bits (346), Expect = 5e-36
 Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 32/274 (11%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRLY-PGENRGKKEFLSEVETIGNIHHFNL 562
           D +    LG+G SG V++      G   A+K+++  G+   +K+ L E++T+ +     +
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 563 VRLVG-YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           V+  G +  E     +V EYM  GSL   +    ++  +   +   I  QI +GL+YLH 
Sbjct: 62  VKCYGAFYKEGE-ISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI----AQDQSHVSTMPKGTPGYMAPE 677
                IIH DIKP N+L++    VKIADFG+++++     Q  + V     GT  YM+PE
Sbjct: 118 --KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170

Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
             +G S +   DI+S G+ +LE   G+     P    +           + +  + D   
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF----------FELMQAICDGPP 220

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASML 770
             + +      +      +CLQK+  +RPSA+ L
Sbjct: 221 PSLPAEEFSP-EFRDFISACLQKDPKKRPSAAEL 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  139 bits (350), Expect = 1e-35
 Identities = 85/274 (31%), Positives = 119/274 (43%), Gaps = 20/274 (7%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKE---FLSEVETIGNI-HHFNLVRLVG 567
           LG G  G V+         VA+K L        KE   FL E++ + ++ H  N+V+L  
Sbjct: 8   LGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +  + +LV EY+  GSL+  +    R   LS      I+ QI   LEYLH      I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122

Query: 628 IHFDIKPQNILLDRDLN-VKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPELTRG 681
           IH DIKP+NILLDRD   VK+ DFGLA+L+    S  S         GTPGYMAPE+  G
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 682 NS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED 738
            S    ++  DI+S G+ + E++ G      +                    L    S  
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                  A     +    L K+   R S+S  + 
Sbjct: 243 NPELISKAAS--DLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  133 bits (337), Expect = 5e-35
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 26/270 (9%)

Query: 507 DFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +   ++G+GG G V++      G +VA+K +       K++ ++E++ +    H N+V+ 
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   ++   ++V E+   GSL   +  K   QTL+      +  ++ +GLEYLH     
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN--- 117

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            IIH DIK  NILL  D  VK+ DFGL+  ++  ++  + +  GTP +MAPE+  G    
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175

Query: 686 AKIDIYSFGVVILEIICGR---RSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
            K DI+S G+  +E+  G+       P    + + T                   + +  
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP------------PGLRNPEKW 223

Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            D+    +     CLQKN  +RP+A  L+K
Sbjct: 224 SDEFKDFL---KKCLQKNPEKRPTAEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 2e-34
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 18/200 (9%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGY 568
           +GRG  G V++GL L  G  VA+K++   + + +  K  + E++ + N+ H N+V+ +G 
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 569 CAERSNRFL--VYEYMCNGSLDKWI--FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
               ++  L  + EY  NGSL + I  F           +    ++Q+ +GL YLH    
Sbjct: 68  --IETSDSLYIILEYAENGSLRQIIKKFGP-----FPESLVAVYVYQVLQGLAYLH---E 117

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             +IH DIK  NIL  +D  VK+ADFG+A     D S       GTP +MAPE+   +  
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 685 TAKIDIYSFGVVILEIICGR 704
           +   DI+S G  ++E++ G 
Sbjct: 177 STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  130 bits (329), Expect = 7e-34
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 36/268 (13%)

Query: 512 LGRGGSGSVFEGL---LNDGTKVAVKR--LYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G+G  G V+  L    +DG    +K   L     + +++ L+EV+ +  ++H N+++  
Sbjct: 8   IGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYC 623
               E+    +V EY   G L + I  K +    +    +       Q+   L+YLH   
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHSR- 122

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             KI+H DIKPQNI L  +  VK+ DFG++++++       T+  GTP Y++PEL +   
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKP 179

Query: 684 ITAKIDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
              K DI+S G V+ E+   +      N      L   LK+          +  +   + 
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LA--LKI----------LKGQYPPIP 224

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSAS 768
           S      ++  +  S LQK+   RPS +
Sbjct: 225 SQYSS--ELRNLVSSLLQKDPEERPSIA 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  128 bits (323), Expect = 4e-33
 Identities = 73/201 (36%), Positives = 101/201 (50%), Gaps = 25/201 (12%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+ G  N  TKVAVK L PG     + FL E + +  + H  LV+L   C+
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 571 ERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCN 624
           E    ++V EYM  GSL  ++      K R+  L       +    QI+ G+ YL     
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-------VDMAAQIAEGMAYLESR-- 122

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMP-KGTPGYMAPELTR 680
              IH D+  +NIL+  +L  KIADFGLARLI  D+      +  P K T    APE   
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAAN 177

Query: 681 GNSITAKIDIYSFGVVILEII 701
               T K D++SFG+++ EI+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  126 bits (318), Expect = 2e-32
 Identities = 83/268 (30%), Positives = 122/268 (45%), Gaps = 31/268 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           LG G SG V + L    G  +AVK +    N    K+ L E++ +   +   +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
               +  +  EYM  GSLDK    K+    +   I  KI   + +GL YLH+    KIIH
Sbjct: 69  YNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIH 124

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGNSITA 686
            D+KP NIL++    +K+ DFG++  +      V+++ K   GT  YMAPE  +GN  + 
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYL--VDTLK--VKAEADRLCDLVDKKSEDMQSH 742
           K DI+S G+ ++E+  GR    P+        + L+  V     RL     K S D Q  
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--SGKFSPDFQDF 236

Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASML 770
            +           CL K+   RPS   L
Sbjct: 237 VNL----------CLIKDPRERPSYKEL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  126 bits (318), Expect = 4e-32
 Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 38/276 (13%)

Query: 507 DFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
               ++G G SG V++      G +VA+K++   +   K+  ++E+  + +  H N+V  
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDY 80

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                     ++V EYM  GSL   I        ++      +  ++ +GLEYLH   + 
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFV--RMNEPQIAYVCREVLQGLEYLH---SQ 135

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            +IH DIK  NILL +D +VK+ADFG A  + +++S  +++  GTP +MAPE+ +     
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYG 194

Query: 686 AKIDIYSFGVVILEIICG---RRSSNPKGGDYLVDTLKVKA--EADR----LCDLVDKKS 736
            K+DI+S G++ +E+  G        P    +L+ T  +      ++      D ++K  
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK-- 252

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                              CL K+  +RPSA  L++
Sbjct: 253 -------------------CLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 1e-30
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
              +LG G  G V+EGL N+ T VAVK L PG     K+FL+E + +  + H  L++L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL--HDYCNP 625
            C      ++V E M  GSL +++      + L       +  Q++ G+ YL   +Y   
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQNY--- 124

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
             IH D+  +N+L+  +   K+ADFGLAR+I +D        K    + APE    N  +
Sbjct: 125 --IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182

Query: 686 AKIDIYSFGVVILEII 701
            K D++SFG+++ EI+
Sbjct: 183 IKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  120 bits (302), Expect = 3e-30
 Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 29/276 (10%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEFL-SEVETIGNIHHFN 561
           D+++   +G+G  G+V +    +DG  +  K + Y      +K+ L SEV  +  + H N
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 562 LVRLVGYCAERSNR--FLVYEYMCNGSLDKWI--FHKDRIQTLSWDIRKKIIFQISRGLE 617
           +VR      +RSN+  ++V EY   G L + I    K+R + +  +   +I+ Q+   L 
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALY 119

Query: 618 YLH--DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
             H        ++H D+KP NI LD + NVK+ DFGLA+++  D S   T   GTP YM+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMS 178

Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEADRLCDLVDK 734
           PE     S   K DI+S G +I E +C      P    + L    K+K    +   +  +
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYE-LCALSP--PFTARNQLQLASKIK--EGKFRRIPYR 233

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASML 770
            S ++         +I+   S L  +  +RPS   L
Sbjct: 234 YSSELNE-------VIK---SMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 1e-28
 Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +LG G  G V++      G  VA+K  RL   E       L E+  +  + H N+V+L+ 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   +LV+EY     +D   +   R   LS ++ K I++Q+ RGL Y H +   +I
Sbjct: 66  VIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RI 119

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTRGN 682
           +H D+KPQNIL++RD  +K+ADFGLAR      +    +   T       Y APE+  G+
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 683 SI-TAKIDIYSFGVVILEIICGR 704
              +  +DI+S G +  E+I G+
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  115 bits (289), Expect = 1e-28
 Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 38/277 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK-----KEFLSEVETIGNIHHFNLVRL 565
           +G G +  V+  + L +  KVA+KR+    +  K      E   EV+ +   +H N+V+ 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                     +LV  Y+  GSL   +        L   I   ++ ++ +GLEYLH     
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD---QSHVSTMPKGTPGYMAPE-LTRG 681
             IH DIK  NILL  D +VKIADFG++  +A        V     GTP +MAPE + + 
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
           +    K DI+SFG+  +E+  G          Y    +KV      L   +      +++
Sbjct: 182 HGYDFKADIWSFGITAIELATGA----APYSKY--PPMKV------LMLTLQNDPPSLET 229

Query: 742 HRDDAV------KMIQIAISCLQKNLHRRPSASMLVK 772
             D         KMI     CLQK+  +RP+A  L+K
Sbjct: 230 GADYKKYSKSFRKMIS---LCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  115 bits (289), Expect = 2e-28
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 15/203 (7%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           +G G  G V+  + L+ G  +AVK  R+   + +  KE   E++ +  + H NLV+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
              R   ++  EY   G+L++ + H  RI      + +    Q+  GL YLH +    I+
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHG-RILDEH--VIRVYTLQLLEGLAYLHSH---GIV 121

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGNSIT 685
           H DIKP NI LD +  +K+ DFG A  +  + + +    +   GTP YMAPE+  G    
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 686 AK---IDIYSFGVVILEIICGRR 705
                 DI+S G V+LE+  G+R
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (289), Expect = 2e-28
 Identities = 68/213 (31%), Positives = 115/213 (53%), Gaps = 24/213 (11%)

Query: 512 LGRGGSGSVFEG---LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V       L D T  +VAVK L   GE + + +F  E+E +  + H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 566 VGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKII---FQISRGLEYL 619
            G C      +  L+ EY+ +GSL  ++  H+D+I        K+++    QI +G++YL
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN------LKRLLLFSSQICKGMDYL 125

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPG-YMAPE 677
               + + IH D+  +NIL++ +  VKI+DFGLA+++ +D+  +    P  +P  + APE
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 678 LTRGNSITAKIDIYSFGVVILEIIC-GRRSSNP 709
             R +  ++  D++SFGV + E+   G  S +P
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  113 bits (285), Expect = 5e-28
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 28/268 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK-----KEFLSEVETIGNIHHFNLVRL 565
           LG G  GSV+EGL L+DG   AVK +   ++        K+   E+  +  + H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G   E  N ++  E +  GSL K +    +  +    + +    QI  GLEYLHD    
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHD---R 121

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE-LTRGNSI 684
             +H DIK  NIL+D +  VK+ADFG+A+ + +  S   +  KG+P +MAPE + +    
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQGGY 179

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
               DI+S G  +LE+  G+    P      V  +     +  L  + D  S       D
Sbjct: 180 GLAADIWSLGCTVLEMATGK---PPWSQLEGVAAVFKIGRSKELPPIPDHLS-------D 229

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVK 772
           +A   I   + CLQ++   RP+A+ L++
Sbjct: 230 EAKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  111 bits (280), Expect = 3e-27
 Identities = 72/212 (33%), Positives = 116/212 (54%), Gaps = 21/212 (9%)

Query: 512 LGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL- 565
           LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 566 -VGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHD 621
            V Y A R N  LV EY+  GSL D    H++R+     D RK +++  QI +G+EYL  
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-----DHRKLLLYASQICKGMEYLG- 125

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGY-MAPELT 679
             + + +H D+  +NIL++ +  VKI DFGL +++ QD+  +    P  +P +  APE  
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 680 RGNSITAKIDIYSFGVVILEIIC-GRRSSNPK 710
             +  +   D++SFGVV+ E+     +S +P 
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 19/201 (9%)

Query: 512 LGRGGSGSVFEGL---LNDGTKVAVKRLYPGENRGKKEF---LSEVETIGNIHHFNLVRL 565
           LG+G  G V   L    + G   A+K L   +   +KE    L+E   +  I+H  +V+L
Sbjct: 1   LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 566 VGYCA--ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
             + A       +LV EY   G L     H  +    S +  +    +I   LEYLH   
Sbjct: 59  --HYAFQTEEKLYLVLEYAPGGEL---FSHLSKEGRFSEERARFYAAEIVLALEYLHSL- 112

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
              II+ D+KP+NILLD D ++K+ DFGLA+ ++ + S  +T   GTP Y+APE+  G  
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF-CGTPEYLAPEVLLGKG 169

Query: 684 ITAKIDIYSFGVVILEIICGR 704
               +D +S GV++ E++ G+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 6e-27
 Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 26/273 (9%)

Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L    K    VA+K L  G +  ++ +FL+E   +G   H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     ++ EYM NGSLDK++   D     +      ++  I+ G++YL +     
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN--- 126

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGNSIT 685
            +H D+  +NIL++ +L  K++DFGL+R +   ++  +T     P  + APE       T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186

Query: 686 AKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +  D++SFG+V+ E++  G R   P       D +K   +  RL               D
Sbjct: 187 SASDVWSFGIVMWEVMSYGER---PYWDMSNQDVIKAVEDGYRL-----------PPPMD 232

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
               + Q+ + C QK+ + RP+ S +V  L  +
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  109 bits (275), Expect = 3e-26
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 16/198 (8%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-----FLSEVETIGNIHHFNLVRL 565
           LG G    V++      G  VA+K++  GE +  K+      L E++ +  + H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIFQISRGLEYLHDYCN 624
           +     +SN  LV+E+M    L+K I  KD+   L+  DI K  +    RGLEYLH    
Sbjct: 68  LDVFGHKSNINLVFEFM-ETDLEKVI--KDKSIVLTPADI-KSYMLMTLRGLEYLHSN-- 121

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NS 683
             I+H D+KP N+L+  D  +K+ADFGLAR        ++     T  Y APEL  G   
Sbjct: 122 -WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARH 179

Query: 684 ITAKIDIYSFGVVILEII 701
               +D++S G +  E++
Sbjct: 180 YGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 4e-26
 Identities = 61/190 (32%), Positives = 100/190 (52%), Gaps = 12/190 (6%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +G+G  G V  G    G KVAVK L   ++   + FL+E   +  + H NLV+L+G   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD 631
            +  ++V EYM  GSL  ++  + R   ++   +      +  G+EYL +      +H D
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127

Query: 632 IKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPELTRGNSITAKIDI 690
           +  +N+L+  DL  K++DFGLA+  +Q Q     +P K T    APE  R    + K D+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWT----APEALREKKFSTKSDV 182

Query: 691 YSFGVVILEI 700
           +SFG+++ EI
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 6/191 (3%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 690 IYSFGVVILEI 700
           +++FGV++ EI
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (269), Expect = 6e-26
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 24/271 (8%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKV-AVKR--LYPGENRGKKEFLSEVETIGNIHHFN 561
           DF+I  ++G+G  G VF+ +     +V A+K+  L     R ++E + E   +  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           ++R      ++    +V EY  NG L K +    R + L  D   +   QI  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLH- 118

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
             + KI+H DIK  N+ LD   NVKI D G+A+L++ + +  +T+  GTP Y++PEL   
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCED 175

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
                K D+++ GVV+ E   G+   +      L+    +K        +    S+    
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI----LKIIRGVFPPVSQMYSQQ--- 228

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                  + Q+   CL K+  +RP    L++
Sbjct: 229 -------LAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  106 bits (265), Expect = 2e-25
 Identities = 67/193 (34%), Positives = 99/193 (51%), Gaps = 9/193 (4%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+ G  N+ TKVAVK L PG     + FL E   +  + H  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKII 628
           +    +++ EYM  GSL  ++   +  + L   + K I F  QI+ G+ Y+        I
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVL---LPKLIDFSAQIAEGMAYIE---RKNYI 125

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D++  N+L+   L  KIADFGLAR+I  ++       K    + APE     S T K 
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 689 DIYSFGVVILEII 701
           D++SFG+++ EI+
Sbjct: 186 DVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  105 bits (265), Expect = 2e-25
 Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 33/272 (12%)

Query: 510 IR-LGRGGSGS-VFEGLLNDGTKVAVKR--LYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           IR LG+G  G         D + V  K   L     + +++ L+E+  +  + H N++  
Sbjct: 5   IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  + +   +  EY   G+L   I  +   Q    ++    +FQI   + Y+H     
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHK---A 120

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            I+H DIK  NI L +   +K+ DFG+++++  + S   T+  GTP YM+PEL +G    
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYN 179

Query: 686 AKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD 745
            K DI++ G V+ E++                 LK   +A    +LV K    +Q +   
Sbjct: 180 FKSDIWALGCVLYELLT----------------LKRTFDATNPLNLVVKI---VQGNYTP 220

Query: 746 AV-----KMIQIAISCLQKNLHRRPSASMLVK 772
            V     ++I +  S LQ++  +RP+A  ++ 
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  106 bits (266), Expect = 3e-25
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 24/272 (8%)

Query: 511 RLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
           RLG G  GSV +  L N G   A+K +    N   +K+ L E+E   +     +V+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 569 CAER--SNRFLVYEYMCNGSLDKWIFHKDRIQT--LSWDIRKKIIFQISRGLEYLHDYCN 624
             +   S+  +  EY   GSLD  I+ K + +   +   +  KI   + +GL YLH    
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            KIIH DIKP NILL R   VK+ DFG++  +    +   T   GT  YMAPE  +G   
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPY 180

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +   D++S G+ +LE+   R    P+G   L          + L  +V+  + +++    
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-------GPIELLSYIVNMPNPELKDEPG 233

Query: 745 DAVK----MIQIAISCLQKNLHRRPSASMLVK 772
           + +K           CL+K+  RRP+   +++
Sbjct: 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (265), Expect = 4e-25
 Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 53/246 (21%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLS----------EVET 553
           DF+    +G G   +V          + A+K L        K  L           E E 
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKEV 54

Query: 554 IGNIHHF-NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
           +  ++    +++L     +  N + V EY  NG L ++I    +  +L     +    +I
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEI 111

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---- 668
              LEYLH      IIH D+KP+NILLD+D+++KI DFG A+++  + S  S        
Sbjct: 112 LLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 669 ---------------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR---RSSNPK 710
                          GT  Y++PEL          D+++ G +I +++ G+   R SN  
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-- 226

Query: 711 GGDYLV 716
             +YL 
Sbjct: 227 --EYLT 230

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 5e-25
 Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 41/213 (19%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEF--------LSEVETIGNI-HHF 560
           +LG G  GSV+     + G  VA+K++       KK+F        L EV+++  +  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR-IQTLSWDIRKKIIFQISRGLEYL 619
           N+V+L     E    + V+EYM  G+L + +  KDR  +  S  + + II+QI +GL ++
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLYQLM--KDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 620 HD--YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPG 672
           H   +      H D+KP+N+L+     VKIADFGLAR        + + P       T  
Sbjct: 116 HKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRW 163

Query: 673 YMAPE-LTRGNSITAKIDIYSFGVVILEIICGR 704
           Y APE L R  S ++ +DI++ G ++ E+   R
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 5e-25
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 38/214 (17%)

Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EGL          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHK-------------DRIQTLSWDIRKKIIFQ 611
           L+G  +      +V E M  G L  ++  +                + +          +
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA------E 127

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           I+ G+ YL      K +H D+  +N ++  DL VKI DFG+ R I +   +     KG  
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY----RKGGK 180

Query: 672 G-----YMAPELTRGNSITAKIDIYSFGVVILEI 700
           G     +MAPE  +    T K D++SFGVV+ E+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 8e-25
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNIHHFNLVRL 565
           ++G G  G V++      G  VA+K++   EN  K+ F    + E++ +  + H N+VRL
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKI-RMEN-EKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 566 VGYCAE--RSNRFLVYEYM---CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                   + + ++V+EYM     G LD            +    K  + Q+  GL+YLH
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK------FTESQIKCYMKQLLEGLQYLH 117

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  I+H DIK  NIL++ D  +K+ADFGLAR   +  S   T    T  Y  PEL  
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 681 G-NSITAKIDIYSFGVVILEIICGR 704
           G      ++D++S G ++ E+  G+
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (260), Expect = 1e-24
 Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 15/200 (7%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
           +F +   LG G  G V+EGL  +  +VA+K L   +   +++F  EV+ +  + H +L+ 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           L   C+     +++ E M  GSL  ++   + ++  ++  I   +  Q++ G+ YL +  
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI--DMACQVAEGMAYLEE-- 122

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--QSHVSTMP-KGTPGYMAPELTR 680
               IH D+  +NIL+  DL  K+ADFGLARLI +D   S    +P K T    APE   
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAAS 177

Query: 681 GNSITAKIDIYSFGVVILEI 700
             + + K D++SFG+++ E+
Sbjct: 178 HGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  103 bits (259), Expect = 2e-24
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLY--PGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           R+G G  G VF+      G  VA+K++     E     + L E++ +    H  +V+L+ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                S   LV EYM    L + +  +D  + L     K  +  + +G+ Y+H      I
Sbjct: 67  VFPHGSGFVLVMEYM-PSDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMH---ANGI 120

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITA 686
           +H D+KP N+L+  D  +KIADFGLARL ++++  + +    T  Y APEL  G      
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 687 KIDIYSFGVVILEIICGR 704
            +D+++ G +  E++ G 
Sbjct: 181 GVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (257), Expect = 2e-24
 Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 33/274 (12%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKR--LYPGE----NRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G+V+ GL N G  +AVK+  L         +  ++   EV+ + ++ H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C + +   +  E++  GS+   +   +R   L   +  K   QI  G+ YLH+ C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC-- 122

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV--STMPK---GTPGYMAPELTR 680
            ++H DIK  N++L  +  +K+ DFG AR +A    H   S M K   GTP +MAPE+  
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 681 GNSITAKIDIYSFGVVILEIICGRR--SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED 738
            +    K DI+S G  + E+  G+   +S  +    L     + A    +  L D  S  
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFYIGAHRGLMPRLPDSFSA- 236

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                  A+  +    SCL ++ H RPSA  L++
Sbjct: 237 ------AAIDFVT---SCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  102 bits (255), Expect = 4e-24
 Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 21/266 (7%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+ G  N  TKVAVK L PG     + FL E + +  + H  LV+L    +
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
           E    ++V EYM  GSL    F KD   + L       +  Q++ G+ Y+        IH
Sbjct: 72  EEP-IYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIH 125

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D++  NIL+   L  KIADFGLARLI  ++       K    + APE       T K D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           ++SFG+++ E++   R   P      ++  +V  + +R           M   +D  + +
Sbjct: 186 VWSFGILLTELVTKGRVPYPG-----MNNREVLEQVER--------GYRMPCPQDCPISL 232

Query: 750 IQIAISCLQKNLHRRPSASMLVKVLQ 775
            ++ + C +K+   RP+   L   L+
Sbjct: 233 HELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (254), Expect = 6e-24
 Identities = 66/193 (34%), Positives = 99/193 (51%), Gaps = 10/193 (5%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+ G  N  TKVA+K L  G +   + FL+E   +  + H  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYA-VV 70

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKII 628
            +   +++ EYM NGSL  ++   + I+     I K I    QI+ G+ ++        I
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEGIKL---TINKLIDMAAQIAEGMAFIE---RKNYI 124

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D++  NIL+   L  KIADFGLARLI  ++       K    + APE     + T K 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 689 DIYSFGVVILEII 701
           D++SFG+++ EI+
Sbjct: 185 DVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (270), Expect = 6e-24
 Identities = 86/368 (23%), Positives = 169/368 (45%), Gaps = 52/368 (14%)

Query: 448 FMLLLSVSAFLLLVIGASIYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRD 507
           F +  ++ AFL+L + A  +++ R R      +  +E        L  F SK  KS T +
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW---ELQFFDSKVSKSITIN 686

Query: 508 FQIR-------LGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH 559
             +        + RG  G+ ++G  + +G +  VK +    N       SE+  +G + H
Sbjct: 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSSEIADMGKLQH 742

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            N+V+L+G C      +L++EY+   +L       + ++ LSW+ R+KI   I++ L +L
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFL 796

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG---------- 669
           H  C+P ++  ++ P+ I++D                 +D+ H+     G          
Sbjct: 797 HCRCSPAVVVGNLSPEKIIID----------------GKDEPHLRLSLPGLLCTDTKCFI 840

Query: 670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG--DYLVDTLKVKAEADR 727
           +  Y+APE      IT K DIY FG++++E++ G+  ++ + G    +V+  +       
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900

Query: 728 LCDLVDKK-SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP--VT 784
           L   +D     D+  ++++ V+++ +A+ C   +   RP A+ ++K L+  ++     VT
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960

Query: 785 DYGFLSFA 792
              F S  
Sbjct: 961 GLKFSSLF 968

Length = 968

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (252), Expect = 1e-23
 Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 508 FQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGK-------KEFLSEVETIGNI 557
           F++   +G+G  G V      D  K+ A+K +    N+ K       +  L+E   +  +
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM----NKQKCVEKGSVRNVLNERRILQEL 57

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           +H  LV L     +  N +LV + +  G L    +H  +    S +  K  I +I   LE
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLR---YHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           YLH   +  IIH DIKP NILLD   +V I DF +A  +  D    ST   GTPGYMAPE
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPE 169

Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRR 705
           +      +  +D +S GV   E + G+R
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 19/198 (9%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           ++G+G  G V++G+L   T+VAVK      P + + K  FL E E +    H N+V+L+G
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK--FLQEAEILKQYDHPNIVKLIG 59

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLHDYC 623
            C ++   ++V E +  GSL         ++     +  K + Q+S     G+EYL    
Sbjct: 60  VCVQKQPIYIVMELVPGGSL------LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGN 682
               IH D+  +N L+  +  +KI+DFG++R        VS   K  P  + APE     
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 683 SITAKIDIYSFGVVILEI 700
             T++ D++S+G+++ E 
Sbjct: 171 RYTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  101 bits (253), Expect = 1e-23
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 512 LGRGGSGSVF---EGLLND--GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           + +G  G VF   +    D    KV  K     +N+   + L+E + +       +V+L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-VDQVLTERDILSQAQSPYVVKLY 59

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                + N +LV EY+  G L   +   + + +L  D+ +  I +I   LEYLH      
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLHSN---G 113

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-------GTPGYMAPELT 679
           IIH D+KP NIL+D + ++K+ DFGL+++    +       +       GTP Y+APE+ 
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 680 RGNSITAKIDIYSFGVVILEIICG 703
            G   +  +D +S G ++ E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 33/269 (12%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGY 568
            +G+G  G V++ +       VA+K +   E   + E +  E++ +       + +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             + S  +++ EY   GS         +   L       I+ ++  GLEYLH       I
Sbjct: 68  FLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKI 120

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  NILL  + +VK+ADFG++  +    S  +T   GTP +MAPE+ + +    K 
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEVIKQSGYDEKA 179

Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKSEDMQSHR 743
           DI+S G+  +E+  G     P   D     ++V     K     L    +K S+  +   
Sbjct: 180 DIWSLGITAIELAKG----EPPLSDL--HPMRVLFLIPKNNPPSLEG--NKFSKPFK--- 228

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            D V +      CL K+   RPSA  L+K
Sbjct: 229 -DFVSL------CLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 2e-23
 Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 54/294 (18%)

Query: 512 LGRGGSGSVFEGLLN--DGT--KVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  GSV EG L+  DG+  KVAVK  +L        +EFLSE   + +  H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 566 VGYCAERSNR------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK----KIIFQISRG 615
           +G C E S+        ++  +M +G L  ++ +  R+  L   +      K +  I+ G
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMVDIALG 125

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD----QSHVSTMPKGTP 671
           +EYL    N   IH D+  +N +L  D+ V +ADFGL++ I       Q  ++ MP    
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-------DYLVDTLKVKAE 724
            ++A E       T+K D+++FGV + EI    R   P  G       DYL    ++K  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYLRHGNRLKQP 237

Query: 725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
            D L +L D                  +  SC + +   RP+ + L +VL+ + 
Sbjct: 238 EDCLDELYD------------------LMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 33/272 (12%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLY--PGENRGKKEFLS---EVETIGNIHHFNLVRL 565
           LG+G  G V+    ++ G ++AVK++   P     KKE  +   E++ + N+ H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDY 622
            G   +     +  EYM  GS+      KD+++    L+  + +K   QI  G+EYLH  
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSV------KDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTR 680
               I+H DIK  NIL D   NVK+ DFG ++ +    S  + M    GTP +M+PE+  
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
           G     K D++S G  ++E++    +  P   ++         EA      +  +  + Q
Sbjct: 181 GEGYGRKADVWSVGCTVVEML----TEKPPWAEF---------EAMAAIFKIATQPTNPQ 227

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                +            +N  +RPSA  L++
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  100 bits (252), Expect = 2e-23
 Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 36/271 (13%)

Query: 526 NDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC 583
             G  VA+K+    E+    KK  + E+  +  + H NLV L+     +   +LV+E++ 
Sbjct: 24  ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83

Query: 584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL 643
           +  LD     +     L     +K +FQI RG+E+ H   +  IIH DIKP+NIL+ +  
Sbjct: 84  HTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSG 137

Query: 644 NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK-IDIYSFGVVILEIIC 702
            VK+ DFG AR +A     V T    T  Y APEL  G++   + +DI++ G ++ E++ 
Sbjct: 138 VVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Query: 703 GRRSSNPK-GGDYLVDTLK--VKAEAD------------------RLCDLVDKKSEDMQS 741
           G     P   GD  +D L   +K   +                  RL ++ + +  + + 
Sbjct: 197 G----EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF 252

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +   + ++ +A  CL+ +   RPS+S L+ 
Sbjct: 253 PKLSGL-VLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 22/206 (10%)

Query: 512 LGRGGSGSVFEGL---LNDGTK--VAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++G+     +  K  VA+K L    +    KE L E   + ++ H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRI---QTLSWDIRKKIIFQISRGLEYLHD 621
           +G C   S   L+ + M  G L  ++  HKD I     L+W +      QI++G+ YL +
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------QIAKGMSYLEE 127

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  D+          P  +MA E   
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 681 GNSITAKIDIYSFGVVILEIIC-GRR 705
               T K D++S+GV + E++  G +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (250), Expect = 2e-23
 Identities = 84/282 (29%), Positives = 136/282 (48%), Gaps = 43/282 (15%)

Query: 512 LGRGGSGSVFEGLLN-DGTK---VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G VF G+L   G K   VA+K L PG   + +++FLSE   +G   H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKD----RIQTLSWDIRKKIIFQISRGLEYLHDY 622
           G   +     ++ EYM NG+LDK++   D      Q +       ++  I+ G++YL D 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYLSDM 126

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTR 680
                +H D+  +NIL++ +L  K++DFGL+R++  D     T   G  P  + APE   
Sbjct: 127 ---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 681 GNSITAKIDIYSFGVVILEIIC-GRRS----SNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
               T+  D++SFG+V+ E++  G R     SN        + +K   +  RL   +D  
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGFRLPAPMDCP 236

Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           S            + Q+ + C Q++  RRP    +V +L  L
Sbjct: 237 S-----------AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKR--LYPGENRGKKEFL--------SEVETIGNIHHF 560
           +G+G  G V+  L +  G  +AVK+  L                    SE+ET+ ++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 561 NLVRLVGYCAERSNRFL--VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           N+V+ +G+  E +  +L    EY+  GS+   +    R +     + +    Q+  GL Y
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTEQVLEGLAY 123

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPE 677
           LH   +  I+H D+K  N+L+D D   KI+DFG+++       +   M  +G+  +MAPE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 678 L--TRGNSITAKIDIYSFGVVILEIICGRR 705
           +  +     +AK+DI+S G V+LE+  GRR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 8/190 (4%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           LG G  G V  G       VA+K +  G    + +F+ E + +  + H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 572 RSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +   F+V EYM NG L  ++   K ++ T   +    +   +   +EYL        IH 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N L+  D  VK++DFGLAR +  DQ   S   K    +  PE+   +  ++K D+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 691 YSFGVVILEI 700
           +SFGV++ E+
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 99.3 bits (247), Expect = 4e-23
 Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 6/193 (3%)

Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
               +G G  G V+ G   +  KVA+K +  G    +++F+ E + +  + H  LV+L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C ERS   LV+E+M +G L  ++  + +    S +    +   +  G+ YL       +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  VK++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 688 IDIYSFGVVILEI 700
            D++SFGV++ E+
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 21/206 (10%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
            F I  +LG G  GSV++ +    G  VA+K + P E    +E + E+  +       +V
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEE-DLQEIIKEISILKQCDSPYIV 61

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +  G   + ++ ++V EY   GS+   +  K   +TL+ +    I++Q  +GLEYLH   
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH--- 116

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPEL 678
           + K IH DIK  NILL+ +   K+ADFG++           TM K     GTP +MAPE+
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 679 TRGNSITAKIDIYSFGVVILEIICGR 704
            +      K DI+S G+  +E+  G+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 7e-23
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +G G  G V +      G  VA+K+      +   KK  L EV+ +  + H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 568 YCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQT-LSWDIRKKIIFQISRGLEYLHDYCNP 625
               R  R +LV+EY+    L+      +     L  D  +  I+Q+ + + Y H +   
Sbjct: 68  AF-RRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCHSH--- 119

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            IIH DIKP+NIL+     +K+ DFG AR +    +   T    T  Y APEL  G++  
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 686 AK-IDIYSFGVVILEIICGR 704
            K +D+++ G ++ E++ G 
Sbjct: 180 GKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score = 93.6 bits (233), Expect = 7e-23
 Identities = 36/83 (43%), Positives = 50/83 (60%), Gaps = 2/83 (2%)

Query: 107 WFANGQSPVKE-NATLEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYD 164
           W AN  +P+ + + TL   +DG+L+L D +G  VWS+ TSG  +     L  +GNL LYD
Sbjct: 6   WVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLVLYD 65

Query: 165 AENRPHWISFLHPTNTWLPGQRL 187
              +  W SF HPT+T LPGQ+ 
Sbjct: 66  NSGKVLWQSFDHPTDTLLPGQKD 88

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 99.5 bits (249), Expect = 1e-22
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 40/215 (18%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF---------LSEVETIGNIHHFN 561
           +G G  G V   +    G KVA+K++          F         L E++ + ++ H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 562 LVRLVG-YCAERSNRF----LVYEYMCNGS-LDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
           ++ L+          F    +V E M   + L K I      Q L+ D  +  ++QI RG
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSP---QPLTDDHIQYFLYQILRG 115

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--- 672
           L+YLH   N  +IH D+KP NIL++ + ++KI DFGLAR +  D+     +   T     
Sbjct: 116 LKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL---TEYVVT 169

Query: 673 --YMAPELTRGNS-ITAKIDIYSFGVVILEIICGR 704
             Y APEL   +S  T  IDI+S G +  E++  +
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 75/268 (27%), Positives = 126/268 (47%), Gaps = 22/268 (8%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYC 569
           LG G  GSV +   +  GT +A K ++ G     +K+ L E++ +       +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +N  +  E+M  GSLD+ I+ K     +  +I  KI   +  GL YL++    +I+H
Sbjct: 73  LNENNICMCMEFMDCGSLDR-IYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMH 127

Query: 630 FDIKPQNILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
            DIKP NIL++    +K+ DFG++  LI    + ++    GT  YM+PE  +G   T K 
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQGGKYTVKS 183

Query: 689 DIYSFGVVILEIICGRR--SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR--D 744
           D++S G+ I+E+  G+   + +    D   D + +    D L  +V +    + S    +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI---LDLLQQIVQEPPPRLPSSDFPE 240

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVK 772
           D    +     CL K+   RP+   L  
Sbjct: 241 DLRDFVDA---CLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++          K  L E++ +  ++H N+++L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
               + + +LV+E+M     D +   KDR + L   + K  ++Q+ +GL + H +    I
Sbjct: 66  VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS----HVSTMPKGTPGYMAPELTRGNS 683
           +H D+KP+N+L++ +  +K+ADFGLAR           +V T       Y APEL  G+ 
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174

Query: 684 I-TAKIDIYSFGVVILEIICGR 704
             +  +DI+S G +  E++  R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLY-PGENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G VF G        ND   VAVK L     N  +K+F  E E + N  H N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKW-----------IFHKDRIQTLSWDIRKKIIFQIS 613
             G C E     +V+EYM +G L+K+                 +  L+     +I  QI+
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHV--STMPKGT 670
            G+ YL    +   +H D+  +N L+  DL VKI DFG++R +   D   V   TM    
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM---L 186

Query: 671 P-GYMAPELTRGNSITAKIDIYSFGVVILEI 700
           P  +M PE       T + D++SFGVV+ EI
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 98.7 bits (246), Expect = 3e-22
 Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 37/273 (13%)

Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           R+G G  G+V++ +    G   A+K +Y   E+  +++   E+E + +++H N+V+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 569 CAERSNRFLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   ++ E+M  GSL+   I  +  +  ++         QI  G+ YLH      I
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA--------RQILSGIAYLH---RRHI 189

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQ--DQSHVSTMPKGTPGYMAPE-----LTR 680
           +H DIKP N+L++   NVKIADFG++R++AQ  D  + S    GT  YM+PE     L  
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPERINTDLNH 246

Query: 681 GNSITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
           G       DI+S GV ILE   GR      + GD+          A  +C +    S+  
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW----------ASLMCAIC--MSQPP 294

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           ++    + +       CLQ+   +R SA  L++
Sbjct: 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 97.2 bits (243), Expect = 4e-22
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 506 RDFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGE---NRGKKEFLSEVETIGNIHH 559
            DF+    LG G  G V         K  A+K L   +    +  +  L+E   + +I H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQTLSWDIRKKIIFQISRGLEY 618
             LV L G   + SN +LV EY+  G L    F H  +       + +    Q+   LEY
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL 678
           LH   +  I++ D+KP+N+LLD D  +KI DFG A+ +   +    T+  GTP Y+APE+
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLC-GTPEYLAPEI 169

Query: 679 TRGNSITAKIDIYSFGVVILEIICGR---RSSNP 709
                    +D ++ G++I E++ G       NP
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 95.5 bits (237), Expect = 9e-22
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 6/202 (2%)

Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
             ++LG+G  G V+ G  N  TKVA+K L PG     + FL E + +  + H  LV L  
Sbjct: 10  LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V E+M  GSL  ++   D  + L       +  QI+ G+ Y+        
Sbjct: 69  VVSEEP-IYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NY 123

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D++  NIL+  +L  KIADFGLARLI  ++       K    + APE       T K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E++   R   P
Sbjct: 184 SDVWSFGILLTELVTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 68/301 (22%)

Query: 511 RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRGKKE---FLSEVETIGNI-HHF 560
            LG G  G V +         N+ + VAVK L   ++  +K+    +SE+E +  I  H 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR---------------IQTLSWDIR 605
           N++ L+G C +    ++V EY  +G+L    F + R                +TL+    
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRD--FLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
               +Q++RG+E+L    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+  
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDY 187

Query: 666 MPKGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY------ 714
             K T G     +MAPE       T + D++SFGV++ EI          G  Y      
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF------TLGGSPYPGIPVE 241

Query: 715 -LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV 773
            L   LK   E  R+        E  Q+   +   +  +   C  +   +RP+   LV+ 
Sbjct: 242 ELFKLLK---EGYRM--------EKPQNCTQE---LYHLMRDCWHEVPSQRPTFKQLVED 287

Query: 774 L 774
           L
Sbjct: 288 L 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 80/296 (27%), Positives = 126/296 (42%), Gaps = 70/296 (23%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFN 561
           D+++  R+G G  G V++   +  G  VA+K  +L PG++   +    E+  +    H N
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF--EIIQQEISMLKECRHPN 61

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V   G    R   ++V EY   GSL   I+   R   LS      +  +  +GL YLH 
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRG-PLSELQIAYVCRETLKGLAYLH- 118

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAP 676
                 IH DIK  NILL  D +VK+ADFG++  +       +T+ K     GTP +MAP
Sbjct: 119 --ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT------ATIAKRKSFIGTPYWMAP 170

Query: 677 ELT---RGNSITAKIDIYSFGVVILEI-----------------ICGRRSSNPKGGDYLV 716
           E+    R      K DI++ G+  +E+                 +  + +  P       
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------ 224

Query: 717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             LK K          +K S        D +K       CL K+  +RP+A+ L++
Sbjct: 225 -KLKDK----------EKWSPVFH----DFIKK------CLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 8/203 (3%)

Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 10  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-LSWDIRKKIIFQISRGLEYLHDYCNPK 626
             +E    ++V EYM  GSL    F K  +   L       +  QI+ G+ Y+       
Sbjct: 69  VVSEEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T 
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 687 KIDIYSFGVVILEIICGRRSSNP 709
           K D++SFG+++ E+    R   P
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 29/269 (10%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           LG G  G V  G       VA+K +  G +  + EF+ E + +  + H  LV+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 572 RSNRFLVYEYMCNGSLDKWIF-HKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +   ++V EYM NG L  ++  H  R Q        ++   +  G+ YL      + IH 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QFIHR 124

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N L+D    VK++DFGL+R +  D+   S   K    +  PE+   +  ++K D+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 691 YSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL--CDLVDKKSEDMQSHRDDAV- 747
           ++FGV++ E+                 +L  K   +R    + V+K S+ ++ +R     
Sbjct: 185 WAFGVLMWEVY----------------SLG-KMPYERFNNSETVEKVSQGLRLYRPHLAS 227

Query: 748 -KMIQIAISCLQKNLHRRPSASMLVKVLQ 775
            K+  I  SC  +    RP+   L+  ++
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 94.2 bits (234), Expect = 5e-21
 Identities = 83/295 (28%), Positives = 140/295 (47%), Gaps = 36/295 (12%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA+K++   +   K+  ++E+  +    H N+V  +   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLHDYCNP 625
                 ++V EY+  GSL       D +     D  +  I  + R     LE+LH   + 
Sbjct: 86  LVGDELWVVMEYLAGGSL------TDVVTETCMD--EGQIAAVCRECLQALEFLH---SN 134

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           ++IH DIK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +  
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193

Query: 686 AKIDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
            K+DI+S G++ +E++ G     + NP    YL+ T       +      +K S   +  
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-----EKLSAIFRDF 248

Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAT 797
            +           CL+ ++ +R SA  L++    L   +P++    L  A  EAT
Sbjct: 249 LN----------RCLEMDVEKRGSAKELLQ-HPFLKIAKPLSSLTPLIAAAKEAT 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 14/203 (6%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+    N  TKVAVK + PG +   + FL+E   +  + H  LV+L     
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA-VV 70

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKD--RIQTLSWDIRKKIIF--QISRGLEYLHDYCNPK 626
            +   +++ E+M  GSL  ++   +  +       + K I F  QI+ G+ ++       
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKLIDFSAQIAEGMAFIEQR---N 122

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            IH D++  NIL+   L  KIADFGLAR+I  ++       K    + APE     S T 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 687 KIDIYSFGVVILEIICGRRSSNP 709
           K D++SFG++++EI+   R   P
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYP 205

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 94.5 bits (235), Expect = 8e-21
 Identities = 70/252 (27%), Positives = 124/252 (49%), Gaps = 38/252 (15%)

Query: 506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
            D +  LG G +G VF  + +D   +VAVK++   + +  K  L E++ I  + H N+V+
Sbjct: 8   MDLR-PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 565 L--------------VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
           +              VG   E ++ ++V EYM    L   +        LS +  +  ++
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQ----GPLSEEHARLFMY 121

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           Q+ RGL+Y+H   +  ++H D+KP N+ ++  DL +KI DFGLAR++    SH   + +G
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 670 --TPGYMAPELT-RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-------LVDTL 719
             T  Y +P L    N+ T  ID+++ G +  E++ G+       G +       +++++
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA---GAHELEQMQLILESV 235

Query: 720 KVKAEADRLCDL 731
            V  E DR   L
Sbjct: 236 PVVREEDRNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 82/282 (29%), Positives = 130/282 (46%), Gaps = 43/282 (15%)

Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L    K    VA+K L  G   + +++FLSE   +G   H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDR----IQTLSWDIRKKIIFQISRGLEYLHDY 622
           G   +     +V EYM NGSLD ++   D     IQ +       ++  I+ G++YL D 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG------MLRGIASGMKYLSDM 125

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTR 680
                +H D+  +NIL++ +L  K++DFGL+R++  D     T   G  P  + APE   
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 681 GNSITAKIDIYSFGVVILEIIC-GRRS----SNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
               T+  D++S+G+V+ E++  G R     SN        D +K   E  RL       
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGYRL------- 228

Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
                +  D    + Q+ + C QK+ + RP    +V +L  L
Sbjct: 229 ----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 512 LGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+GG G V        G L    K+  KRL   + +G +  + E   +  +H   +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYC 623
                 +++  LV   M  G L   I++ D  +   +   +   +  QI  GLE+LH   
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR- 116

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             +II+ D+KP+N+LLD D NV+I+D GLA  +   QS       GTPG+MAPEL +G  
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY-AGTPGFMAPELLQGEE 173

Query: 684 ITAKIDIYSFGVVILEIICGR 704
               +D ++ GV + E+I  R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 39/272 (14%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
            +G G  G+V +G    G KVAVK +    +   + FL E   +  +HH NLVRL+G   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDR-----IQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  ++V E M  G+L  ++  + R     IQ L + +       ++ G+EYL    + 
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL------DVAEGMEYLE---SK 119

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARL--IAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           K++H D+  +NIL+  D   K++DFGLAR+  +  D S +         + APE  +   
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKK 173

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            ++K D++S+GV++ E+    R+  PK        + +K   + +     +K   M+   
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPK--------MSLKEVKECV-----EKGYRMEPPE 220

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                +  +  SC +    +RPS   L + L+
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 73/272 (26%), Positives = 131/272 (48%), Gaps = 38/272 (13%)

Query: 507 DFQI--RLGRGGSGSVFE-GLLNDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFN 561
           DF++  +LG+G  GSV++   L+D    A+K +  G    + +++ ++E+  + +++H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 562 LVR-----LVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTL-SWDIRKKIIFQISR 614
           ++      L G      N+  +V EY   G L K I  + + + L       +I  Q+ R
Sbjct: 61  IISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           GL+ LH+    KI+H D+K  NILL  +  VKI D G+++++ ++ +       GTP YM
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYM 168

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
           APE+ +G   + K DI+S G ++ E+         +     +  L+ K +  +   +   
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS----MQDLRYKVQRGKYPPIPPI 224

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            S+D+Q              S LQ     RP+
Sbjct: 225 YSQDLQ----------NFIRSMLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 512 LGRGGSGSVFEG----LLNDGT---KVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLV 563
           LG G  G V+EG    +L  G+   +VAVK L  G  ++ KKEFL E   + N +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-----LSWDIRKKIIFQISRGLEY 618
           +L+G C     ++++ E M  G L  ++    R++      L+      I   +++G  Y
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 619 LHDYCNPKIIHFDIKPQNILL-----DRDLNVKIADFGLAR-LIAQDQSHVSTMPKGTPG 672
           L        IH D+  +N L+     D D  VKI DFGLAR +   D             
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEII 701
           +MAPE       T + D++SFGV++ EI+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGKKEFL-SEVETIGNI-HHFNLV 563
           LG G  G V E    GL       KVAVK L P  +  ++E L SE++ + ++ +H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L+G C       ++ EY C G L  ++  + R   L+ +      +Q+++G+ +L    
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL---A 158

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGN 682
           +   IH D+  +N+LL     VKI DFGLAR I  D ++V       P  +MAPE     
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218

Query: 683 SITAKIDIYSFGVVILEI 700
             T + D++S+G+++ EI
Sbjct: 219 VYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 36/273 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG G  G V++      G   A K +        ++F+ E++ +    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
             +  +++ E+   G+LD  +   +R  T    IR  +  Q+   L +LH +   K+IH 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEP-QIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 631 DIKPQNILLDRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPELT-----RGNSI 684
           D+K  NILL  D +VK+ADFG+ A+  +  Q   + +  GTP +MAPE+      + N  
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNPY 185

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKSEDM 739
             K DI+S G+ ++E+        P   +  ++ ++V     K+E   L    D+ S+  
Sbjct: 186 DYKADIWSLGITLIELAQME----PPHHE--LNPMRVLLKILKSEPPTL----DQPSKWS 235

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            S  D          SCL K+   RP+A+ L+K
Sbjct: 236 SSFND-------FLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 69/261 (26%), Positives = 129/261 (49%), Gaps = 21/261 (8%)

Query: 526 NDGTK--VAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGYCAERSNR--FLVYE 580
           NDGT   VAVK L     +     +  E+  +  ++H N+V+  G C+E+  +   L+ E
Sbjct: 29  NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88

Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNIL 638
           Y+  GSL      +D +     ++ + ++F  QI  G+ YLH   +   IH D+  +N+L
Sbjct: 89  YVPLGSL------RDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVL 139

Query: 639 LDRDLNVKIADFGLARLIAQDQSHVSTMPKG-TPGY-MAPELTRGNSITAKIDIYSFGVV 696
           LD D  VKI DFGLA+ + +   +      G +P +  A E  + N  +   D++SFGV 
Sbjct: 140 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVT 199

Query: 697 ILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAI 754
           + E++  C  + S PK  + ++   + +    RL +L+++    +   ++   ++  +  
Sbjct: 200 LYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG-MRLPCPKNCPQEVYILMK 258

Query: 755 SCLQKNLHRRPSASMLVKVLQ 775
           +C +     RP+   L+ +L+
Sbjct: 259 NCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 45/286 (15%)

Query: 506 RDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEFLSEVE-TIGNIHHF 560
            D ++   LGRG  G V +   +  GT +AVKR+     ++ +K  L +++ ++ ++   
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLE 617
             V   G      + ++  E M + SLDK  F+K   D+  T+  DI  KI   I + LE
Sbjct: 61  YTVTFYGALFREGDVWICMEVM-DTSLDK--FYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAP 676
           YLH      +IH D+KP N+L++R+  VK+ DFG++  L+    S   T+  G   YMAP
Sbjct: 118 YLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAP 172

Query: 677 EL----TRGNSITAKIDIYSFGVVILEIICGR----RSSNPKGGDYLVDTLK--VKAEAD 726
           E             K D++S G+ ++E+  GR        P         LK  V+  + 
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVVEEPSP 226

Query: 727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           +L    +K S + Q    D V        CL+KN   RP+   L++
Sbjct: 227 QLPA--EKFSPEFQ----DFVN------KCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.7 bits (227), Expect = 3e-20
 Identities = 77/284 (27%), Positives = 137/284 (48%), Gaps = 36/284 (12%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+VF  + +  G +VA+K++   +   K+  ++E+  +  + + N+V  +   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 F+V EY+  GSL   +     D  Q  +      +  +  + LE+LH     ++
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFLH---ANQV 136

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  N+LL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +   K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 195

Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +DI+S G++ +E++ G     + NP    YL+ T                 + ++Q+   
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------NGTPELQNPEK 240

Query: 745 DAVKMIQIAISCLQKNLHRRPSASML-----VKVLQGLTKLEPV 783
            +         CL+ ++ +R SA  L     +K+ + L+ L P+
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 91.3 bits (226), Expect = 4e-20
 Identities = 76/284 (26%), Positives = 137/284 (48%), Gaps = 36/284 (12%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA+K++   +   K+  ++E+  +    + N+V  +   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + L++LH   + ++
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLH---SNQV 136

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +   K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 195

Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +DI+S G++ +E++ G     + NP    YL+ T                 + ++Q+   
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------NGTPELQNPER 240

Query: 745 DAVKMIQIAISCLQKNLHRRPSASML-----VKVLQGLTKLEPV 783
            +         CL+ ++ RR SA  L     +K+ + L+ L P+
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 27/204 (13%)

Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           +++G G +G V      + G +VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFH----KDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
                  ++V E++  G+L   + H    +++I T        +   + + L +LH    
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--------VCLAVLKALSFLH---A 133

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPELT 679
             +IH DIK  +ILL  D  VK++DFG    ++++      +P+     GTP +MAPE+ 
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPEVI 187

Query: 680 RGNSITAKIDIYSFGVVILEIICG 703
                  ++DI+S G++++E++ G
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 22/203 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEF-LSEVETIGNIHHF---NLVR 564
            +G G  G+V++   LN G  VA+K++  P    G     L E+  +  +  F   N+VR
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 565 LVGYCA-ERSNR----FLVYEYMCNGSLDKWIFHKDRIQT--LSWDIRKKIIFQISRGLE 617
           L+  C   R++R     LV+E+  +  L  ++    +     L  +  K ++ Q+ RG++
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEH-VDQDLATYL---SKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +LH +    I+H D+KPQNIL+  D  VKIADFGLAR+ + + +  S +   T  Y APE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176

Query: 678 LTRGNSITAKIDIYSFGVVILEI 700
           +   +S    +D++S G +  E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 73/242 (30%), Positives = 112/242 (46%), Gaps = 33/242 (13%)

Query: 512 LGRGGSGSVFEGLLNDGT---KVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           LG G  GSV EG LN      KVAVK  ++        ++FLSE   +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 567 GYCAERSNR------FLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLE 617
           G C +           ++  +M +G L  ++ +    D  Q L   +  K +  I+ G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPGY 673
           YL    +   IH D+  +N +L+ ++NV +ADFGL++ I       Q  ++ MP     +
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV---KW 180

Query: 674 MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-------DYLVDTLKVKAEAD 726
           +A E       T K D++SFGV + EI    R   P  G       DYL    ++K   D
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEI--ATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238

Query: 727 RL 728
            L
Sbjct: 239 CL 240

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 35/225 (15%)

Query: 502 KSATRDFQIRLGRGGSGSVFEG---LLNDG---TKVAVKRLYP-GENRGKKEFLSEVETI 554
            SA R F   LG G  G V++G     N+    T VA+K L    E + ++EF  E E +
Sbjct: 4   LSAVR-FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM 62

Query: 555 GNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKK--- 607
            ++ H N+V L+G C +     +++EY+ +G L +++     H D       +  K    
Sbjct: 63  SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122

Query: 608 ------IIFQISRGLEYL--HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQ 658
                 I  QI+ G+EYL  H +      H D+  +N L+   L VKI+DFGL+R I + 
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 659 D---QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
           D       S +P     +M PE       T + DI+SFGVV+ EI
Sbjct: 178 DYYRVQSKSLLPV---RWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 62/186 (33%), Positives = 94/186 (50%), Gaps = 27/186 (14%)

Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
           Q LS D  K  ++QI RGL+YLH   +  I+H DIKP N+L++ +  +KI DFGLAR+  
Sbjct: 98  QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154

Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGR---RSSNPKGGD 713
            D+S   T    T  Y APE+  G+   T+ +DI+S G +  E++  R   ++ +P    
Sbjct: 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP---- 210

Query: 714 YLVDTLKVKAEADRLCDLVDKKS-EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             +  L      D + DL+   S E M+S  + A   I      L+   H+ PS  +L  
Sbjct: 211 --IQQL------DLITDLLGTPSLEAMRSACEGARAHI------LRGP-HKPPSLPVLYT 255

Query: 773 VLQGLT 778
           +    T
Sbjct: 256 LSSQAT 261

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 71/237 (29%), Positives = 104/237 (43%), Gaps = 52/237 (21%)

Query: 503 SATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-F----LSEVETI 554
           S  RD++I  +LG G  G V++   +  G  VA+K++       +K+ F    L E++ +
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKIL 61

Query: 555 GNIHHFNLVRLVGYCAERSNR--------FLVYEYMC---NGSLDKWIFHKDRIQTLSWD 603
             + H N+V L+    ER ++        ++V  YM    +G L         ++     
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-----ENPSVKLTESQ 116

Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
           I K  + Q+  G+ YLH   N  I+H DIK  NIL+D    +KIADFGLAR         
Sbjct: 117 I-KCYMLQLLEGINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGP---- 168

Query: 664 STMPKGTPG--------------YMAPELTRG--NSITAKIDIYSFGVVILEIICGR 704
              PKG  G              Y  PEL  G     TA +DI+  G V  E+   R
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 82/278 (29%), Positives = 124/278 (44%), Gaps = 49/278 (17%)

Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRGKKEFLSEVETIGNIHHF---NLVRLV 566
           +GRG  G+V+ G     G  VA+K +     +    +   EV  +  +      N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS--WDIRKKIIFQISR----GLEYLH 620
           G   +    +++ EY   GS          ++TL     I +K I  I R     L+Y+H
Sbjct: 69  GSYLKGPRLWIIMEYAEGGS----------VRTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE-LT 679
                 +IH DIK  NIL+    NVK+ DFG+A L+ Q+ S  ST   GTP +MAPE +T
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVIT 174

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV-----KAEADRLCDLVDK 734
            G     K DI+S G+ I E+  G    NP   D  VD  +      K++  RL D  + 
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG----NPPYSD--VDAFRAMMLIPKSKPPRLED--NG 226

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            S+ ++          +   +CL +    R SA  L+K
Sbjct: 227 YSKLLR----------EFVAACLDEEPKERLSAEELLK 254

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 512 LGRGGSGSVFEGLL----NDGTK--VAVKRLYPGENRGKKE--FLSEVETIGNIHHFNLV 563
           LG G  G V+EGL      D  +  VAVK L P     + E  FL E   +   +H N+V
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKIIFQISRGLEYL 619
           RL+G   ER  RF++ E M  G L  ++       +R  +L+          +++G +YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 620 HDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSH----VSTMPKGTPG 672
            +      IH DI  +N LL         KIADFG+AR I +   +     + +P     
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI---K 186

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M PE       T+K D++SFGV++ EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 2e-19
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 507 DFQIR--LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEF----LSEVETIGNIHH 559
            +Q    +G G  G V        G KVA+K++ P E    + F    L E++ +    H
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKH 62

Query: 560 ------FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
                  +++R   + +   + ++V E M    L K I    + Q LS D  +  ++QI 
Sbjct: 63  ENIIGILDIIRPPSFESFN-DVYIVQELM-ETDLYKLI----KTQHLSNDHIQYFLYQIL 116

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTP 671
           RGL+Y+H   N  ++H D+KP N+LL+ + ++KI DFGLAR+   +  H   + +   T 
Sbjct: 117 RGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 672 GYMAPE--LTRGNSITAKIDIYSFGVVILEIICGR 704
            Y APE  L      T  IDI+S G ++ E++  R
Sbjct: 174 WYRAPEIMLN-SKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 512 LGRGGSGSVFE-GLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG GG G V    + +     A+K +   +  E   ++   SE E +   +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
              ++   +++ EY   G L  W   +DR         +  I  +    EYLH   N  I
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL--WTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGI 114

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE--LTRGNSIT 685
           I+ D+KP+N+LLD +  VK+ DFG A+ +   Q   +    GTP Y+APE  L +G   +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEIILNKGYDFS 172

Query: 686 AKIDIYSFGVVILEIICGR 704
              D +S G+++ E++ GR
Sbjct: 173 V--DYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 510 IRLGRGGSGSVFEGLL----NDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLV 563
           +++ + G GS  + +L     DG +  +K +       + ++E   EV  + N+ H N+V
Sbjct: 3   VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-------FHKDRIQTLSWDIRKKIIFQISRGL 616
           +      E  N ++V +Y   G L K I       F +D  Q L W +      QI   L
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED--QILDWFV------QICLAL 114

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           +++HD    KI+H DIK QNI L +D  +K+ DFG+AR++        T   GTP Y++P
Sbjct: 115 KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSP 170

Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E+        K DI++ G V+ E+
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 14/197 (7%)

Query: 510 IRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVR 564
             LG G  GSV +G+         +VAVK L       GKKEFL E   +  + H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L+G C       LV E    G L K++  +  I     D+ K++  Q++ G+ YL     
Sbjct: 61  LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVS--DL-KELAHQVAMGMAYLES--- 113

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--VSTMPKGTPGYMAPELTRGN 682
              +H D+  +N+LL      KI+DFG++R +     +   +T  +    + APE     
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 683 SITAKIDIYSFGVVILE 699
             ++K D++S+GV + E
Sbjct: 174 KFSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 22/203 (10%)

Query: 512 LGRGGSGSVF------EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+GG G V        G +    K+  KRL   + +G++  L+E + +  +    +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 566 VGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDY 622
             Y  E  +   LV   M  G L    +H   +    +   + I +  QI  GLE+LH  
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLK---YHIYNVGEPGFPEARAIFYAAQIICGLEHLH-- 112

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAPELTRG 681
              +I++ D+KP+N+LLD   NV+I+D GLA  L    +        GTPGYMAPE+ +G
Sbjct: 113 -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQG 168

Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +D ++ G  + E+I GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 28/256 (10%)

Query: 528 GTKVAVKRL-YPGENRGKKE-----FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY 581
           GT +AVK++ Y      ++E        E+  +  ++H +++R++G   E S+  L  E+
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84

Query: 582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR 641
           M  GS+   +  K         +      Q+ RGL YLH+    +IIH D+K  N+L+D 
Sbjct: 85  MAGGSVSH-LLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDS 138

Query: 642 D-LNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGNSITAKIDIYSFGVVI 697
               ++IADFG A  +A   +          GT  +MAPE+ RG       D++S G VI
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198

Query: 698 LEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC 756
           +E+   +   +  K  ++L    K+ A A     + +  S  +   RD       + + C
Sbjct: 199 IEMATAKPPWNAEKHSNHLALIFKI-ASATTAPSIPEHLSPGL---RD-------VTLRC 247

Query: 757 LQKNLHRRPSASMLVK 772
           L+     RP +  L+K
Sbjct: 248 LELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 74/299 (24%), Positives = 136/299 (45%), Gaps = 53/299 (17%)

Query: 512 LGRGGSGSVFEGL------LNDGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVR 564
           LG G  G V +            T VAVK L    +  + ++ LSE   +  ++H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 565 LVGYCAERSNRFLVYEYMCNGSL----------------------DKWIFHKDRIQTLSW 602
           L G C++     L+ EY   GSL                        ++ + D  + L+ 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD-ERALTM 126

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
                  +QISRG++YL +    K++H D+  +N+L+     +KI+DFGL+R + ++ S+
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 663 VSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG---DYLVDT 718
           V       P  +MA E    +  T + D++SFGV++ EI+      NP  G   + L + 
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--LGGNPYPGIAPERLFNL 241

Query: 719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           LK     +R     +  SE+M +          + ++C ++   +RP+ + + K L+ +
Sbjct: 242 LKTGYRMER----PENCSEEMYN----------LMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.6 bits (217), Expect = 4e-19
 Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G      KVA+K +  G    +++F+ E + +  + H  LV+L G
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C ++   ++V E+M NG L  ++  + R   LS D+   +   +  G+EYL        
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+     VK++DFG+ R +  D+   S+  K    +  PE+   +  ++K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 688 IDIYSFGVVILEI 700
            D++SFGV++ E+
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 88.6 bits (219), Expect = 4e-19
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 32/293 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + LE+LH   + ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQV 137

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +   K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 196

Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +DI+S G++ +E+I G     + NP    YL+ T                 + ++Q+   
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---------------NGTPELQNPEK 241

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAT 797
            +         CL  ++ +R SA  L++  Q L   +P++    L  A  EAT
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ-HQFLKIAKPLSSLTPLIAAAKEAT 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 33/272 (12%)

Query: 512 LGRGGSGSVFEG-LLNDGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHF-NLVRLVGY 568
           +G G  G V++      G  +AVK++    N+   K  L +++ +   H    +V+  GY
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 569 CAERSNRFLVYEYM--CNGSLDKWIFHKDRIQT-LSWDIRKKIIFQISRGLEYLHDYCNP 625
               S+ F+  E M  C   LDK      RIQ  +  DI  K+   I + L YL +    
Sbjct: 83  FITDSDVFICMELMSTC---LDKL---LKRIQGPIPEDILGKMTVAIVKALHYLKE--KH 134

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            +IH D+KP NILLD   NVK+ DFG++ RL+    S   T   G   YMAPE       
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDP 191

Query: 685 TAKIDI----YSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
             K DI    +S G+ ++E+  G+        ++ V T  ++ E   L    +  S D  
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFSPDFC 250

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           S  D           CL K+  +RP    L++
Sbjct: 251 SFVDL----------CLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 20/202 (9%)

Query: 512 LGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLV 566
           +G+G  G V+ G L  +DG K+  AVK L    +  + ++FL E   + +  H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 567 GYCAERSNRFLV-YEYMCNGSLDKWIFHKDRIQTLSWDIRKKII---FQISRGLEYLHDY 622
           G C       LV   YM +G L  +I  +    T+     K +I    Q+++G+EYL   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV-----KDLIGFGLQVAKGMEYL--- 114

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAPELT 679
            + K +H D+  +N +LD    VK+ADFGLAR I        H  T  K    +MA E  
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 680 RGNSITAKIDIYSFGVVILEII 701
           +    T K D++SFGV++ E++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.0 bits (218), Expect = 5e-19
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 512 LGRGGSGSVFE----GLL--NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           +G+G  G VF+    GLL     T VAVK L    +   + +F  E   +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-------------------LSWDIR 605
           L+G CA      L++EYM  G L++++ H+                        LS   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVS 664
             I  Q++ G+ YL +    K +H D+  +N L+  ++ VKIADFGL+R I + D    S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
                   +M PE    N  T + D++++GVV+ EI
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLS---EVETIGNIHHFNLVRLVGY 568
           +GRG  G V         K+ + +  P E   K E L+   E + +  + H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             E     +V EY   G+L ++I  K     L  D       QI   L ++H      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 629 HFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           H D+K QNILLD+   V KI DFG++++++  +S   T+  GTP Y++PEL  G     K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTV-VGTPCYISPELCEGKPYNQK 181

Query: 688 IDIYSFGVVILEIICGRRS 706
            DI++ G V+ E+   +R+
Sbjct: 182 SDIWALGCVLYELASLKRA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 29/212 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL------YPGENRGKKEFLS----EVETIGNIHHF 560
           +G G  GSV+ G+  + G  +AVK++         ++R K+  L     E+  +  + H 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDR-KRSMLDALAREIALLKELQHE 66

Query: 561 NLVRLVGYC--AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           N+V+ +G    A+  N FL  EY+  GS+   +   +        + +  + QI +GL Y
Sbjct: 67  NIVQYLGSSLDADHLNIFL--EYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNY 121

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR------LIAQDQSHVSTMPKGTPG 672
           LH   N  IIH DIK  NIL+D    +KI+DFG+++      L  +      ++ +G+  
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           +MAPE+ +  S T K DI+S G +++E++ G+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 35/290 (12%)

Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G VF           D   VAVK L    +  +K+F  E E + N+ H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWI--FHKDRI--------QTLSWDIRKKIIFQISRG 615
            G C E     +V+EYM +G L+K++     D +          L+      I  QI+ G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQSHVSTMPKGTPGYM 674
           + YL    +   +H D+  +N L+  +L VKI DFG++R + + D   V         +M
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 675 APELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVD 733
            PE       T + D++S GVV+ EI   G++       + +++ +              
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-------------- 235

Query: 734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
            +   +Q  R    ++  + + C Q+  H R +   +  +LQ L K  PV
Sbjct: 236 TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 22/203 (10%)

Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L    K    VA+K L  G   + +++FLSE   +G   H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDR----IQTLSWDIRKKIIFQISRGLEYLHDY 622
           G   +     ++ E+M NG+LD ++   D     IQ +       ++  I+ G++YL + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYLSEM 125

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVSTMPKGTP-GYMAPEL 678
                +H D+  +NIL++ +L  K++DFGL+R +  D S   + S++    P  + APE 
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 679 TRGNSITAKIDIYSFGVVILEII 701
                 T+  D++S+G+V+ E++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 61/198 (30%), Positives = 86/198 (43%), Gaps = 14/198 (7%)

Query: 511 RLGRGGSGSVFEG----LLNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRL 565
           +LG G  G V  G           VAVK L   +      +FL E   + ++ H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 566 VGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
            G         +V E    GSL D+    KD +             QI+ G+ YL    +
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDR--LRKDALGHFLISTLCDYAVQIANGMRYLE---S 115

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQSHVSTMPKGTP-GYMAPELTRGN 682
            + IH D+  +NILL  D  VKI DFGL R L   +  +V       P  + APE  R  
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 683 SITAKIDIYSFGVVILEI 700
           + +   D++ FGV + E+
Sbjct: 176 TFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 505 TRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIH 558
             +F+I  ++G+G    V++ + L DG  VA+K++   E    K   + L E++ +  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTL-----SWDIRKKIIFQIS 613
           H N+++ +    E +   +V E    G L + I H  + + L      W    K   Q+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
             LE++H     +I+H DIKP N+ +     VK+ D GL R  +   +   ++  GTP Y
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYY 172

Query: 674 MAPELTRGNSITAKIDIYSFGVVILEIIC 702
           M+PE    N    K DI+S G ++ E+  
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 21/201 (10%)

Query: 512 LGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++G+     +  K+ V      E  G K   EF+ E   + ++ H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + LV + M +G L  ++  HKD I +   L+W +      QI++G+ YL +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV------QIAKGMMYLEE 127

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLARL+  D+   +      P  +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV I E++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 44/277 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG+G  G V+    L+   ++A+K +   ++R  +    E+     + H N+V+ +G  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 571 ERSNRFLVY-EYMCNGSLD-----KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           E +  F ++ E +  GSL      KW   KD  QT+ +  +     QI  GL+YLHD   
Sbjct: 76  E-NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHDN-- 127

Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT---- 679
            +I+H DIK  N+L++    V KI+DFG ++ +A       T   GT  YMAPE+     
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPEVIDKGP 185

Query: 680 RGNSITAKIDIYSFGVVILEIICGR----RSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
           RG    A  DI+S G  I+E+  G+        P+   + V   K+  E           
Sbjct: 186 RGYGAPA--DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP--------- 234

Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
               +S   +A   I   + C + +  +R SA  L++
Sbjct: 235 ----ESLSAEAKNFI---LRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 12/212 (5%)

Query: 500 AMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH 559
           A+          +G+G  G V  G    G KVAVK +    +   + FL+E   +  + H
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRH 58

Query: 560 FNLVRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
            NLV+L+G   E +   ++V EYM  GSL  ++  + R   L  D   K    +   +EY
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 117

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL 678
           L        +H D+  +N+L+  D   K++DFGL +  +  Q       K T    APE 
Sbjct: 118 LE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 170

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNPK 710
            R    + K D++SFG+++ EI    R   P+
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.8 bits (212), Expect = 4e-18
 Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 27/195 (13%)

Query: 526 NDGTKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMC 583
           N  TKVAVK L      +   + +SE+E +  I  H N++ L+G C +    +++ EY  
Sbjct: 48  NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107

Query: 584 NGSLDKWI-----------FHKDRI--QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
            G+L +++           ++  ++  + LS+       +Q++RG+EYL    + K IH 
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHR 164

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTRGNSIT 685
           D+  +N+L+  D  +KIADFGLAR    D  H+    K T G     +MAPE       T
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 220

Query: 686 AKIDIYSFGVVILEI 700
            + D++SFGV++ EI
Sbjct: 221 HQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 66/248 (26%), Positives = 109/248 (43%), Gaps = 34/248 (13%)

Query: 512 LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRL 565
           LG+G  GSV E  L        KVAVK L          +EFL E   +    H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 566 VGYCAERSNR------FLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGL 616
           +G       +       ++  +M +G L  ++      +   TL      + +  I+ G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPG 672
           EYL    +   IH D+  +N +L+ ++ V +ADFGL++ I       Q   S +P     
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV---K 180

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-------DYLVDTLKVKAEA 725
           ++A E    N  T   D+++FGV + EI+   R   P  G       +YL+   ++K   
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Query: 726 DRLCDLVD 733
           D L D+ +
Sbjct: 239 DCLEDVYE 246

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 510 IRLGRGGSGSVFEGLL------NDGTKVAVKRL-YPGENRGKKEFLSEVETIGNIHHFNL 562
             LGRG  G VF             T V VK L    +   + EF  E++    + H N+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWI------FHKDRIQTLSWDIRKKIIFQISRGL 616
           VRL+G C E    +++ EY   G L +++        K +   LS   +  +  QI+ G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           ++L    N + +H D+  +N L+     VK++   L++ +   + +          ++AP
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E  + +  + K D++SFGV++ E+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 22/204 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E+ G     + E+  +  ++H N+VRL+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR--KKIIFQISRGLEYLHDYCNP 625
                +  +LV+E++ +  L K   + D       D    K  ++Q+ +G+ Y H +   
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKK---YMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSH-VSTMPKGTPGYMAPE-LTR 680
           +++H D+KPQN+L+DR+  +K+ADFGLAR   +  +  +H V T+      Y APE L  
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL-----WYRAPEILLG 173

Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
               +  +DI+S G +  E++  R
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 85.7 bits (213), Expect = 5e-18
 Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 33/216 (15%)

Query: 507 DFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPG-EN-----RGKKE--FLSEVETIGNI 557
           +   +LG+G  G V++ +       VA+K+++    N     R  +E  FL E+      
Sbjct: 10  EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----- 64

Query: 558 HHFNLVRLVG-YCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK-IIFQIS 613
            H N+V+L+    AE +++  +LV+EYM    L   I        +  D+ K+ I++Q+ 
Sbjct: 65  DHPNIVKLLNVIKAE-NDKDIYLVFEYM-ETDLHAVIRAN-----ILEDVHKRYIMYQLL 117

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ----DQSHVSTMPKG 669
           + L+Y+H   +  +IH D+KP NILL+ D  VK+ADFGLAR +++     ++ V T    
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 670 TPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGR 704
           T  Y APE+  G    T  +D++S G ++ E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 11/145 (7%)

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            + +L      +   +LV EY+  G     I     +  L  D  K+ I ++  G+E LH
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
                 IIH DIKP+N+L+D+  ++K+ DFGL+R   +++  V     GTP Y+APE   
Sbjct: 115 Q---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETIL 166

Query: 681 GNSITAKIDIYSFGVVILEIICGRR 705
           G       D +S G VI E + G  
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 38/230 (16%)

Query: 512 LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFLSE------------VETIGNIH 558
           LG+G  G V    L    +  A+K L       KK+ + E            V  +   H
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 559 HFNLVRLVGYCA--ERSNRFLVYEYMCNGSLDKWIFHKDRIQ-TLSWDIRKKIIF--QIS 613
            F L  L  +C    + + F V EY+  G L   +FH   IQ +  +D  +   +  +I 
Sbjct: 56  PF-LTHL--FCTFQTKEHLFFVMEYLNGGDL---MFH---IQSSGRFDEARARFYAAEII 106

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
            GL++LH      II+ D+K  N+LLD+D ++KIADFG+ +     +   ST   GTP Y
Sbjct: 107 CGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDY 162

Query: 674 MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
           +APE+ +G      +D +SFGV++ E++ G+   + +  D L D++    
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 58/159 (36%), Positives = 83/159 (52%), Gaps = 20/159 (12%)

Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-------FHKDRIQTLSW 602
           EV  +  + H N+V       E    F+V EY   G L K I       F +D+I  LSW
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSW 106

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQS 661
            +      QIS GL+++HD    KI+H DIK QNI L ++  V K+ DFG+AR +  D  
Sbjct: 107 FV------QISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSM 156

Query: 662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
            ++    GTP Y++PE+ +      K DI+S G V+ E+
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 13/180 (7%)

Query: 531 VAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK 589
           VAVK L P  +   +++FL EV+ +  +   N+ RL+G C       ++ EYM NG L++
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 590 WI-FHKDRIQTLSWDIR-------KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR 641
           ++  H      L+ + +         +  QI+ G+ YL    +   +H D+  +N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 642 DLNVKIADFGLAR-LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
           +  +KIADFG++R L + D   V         +MA E       T K D+++FGV + EI
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)

Query: 512 LGRGGSGSVFEGLLN-DGTK----VAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL   +G K    VA+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL +
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLEE 127

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  D+          P  +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 84.0 bits (207), Expect = 2e-17
 Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 9/158 (5%)

Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY+  G L    FH  R +  S D  +
Sbjct: 43  LTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTR 98

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   + KI++ D+K +N++LD+D ++KI DFGL +    D + + T 
Sbjct: 99  FYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155

Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 156 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 76/269 (28%), Positives = 127/269 (47%), Gaps = 28/269 (10%)

Query: 512 LGRGGSGSVFEGLLN-DGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G  GSV++ L    G  +A+K  RL   E++   + + E++ +       +V   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYGA 67

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++  EYM  GSLDK        + +  D+ ++I + + +GL++L +  N  II
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 629 HFDIKPQNILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAPELTRGN----- 682
           H D+KP N+L++ +  VK+ DFG++  L+A     ++    G   YMAPE  +       
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 683 -SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
            + T + D++S G+ ILE+  GR    P+    +   L    + D    L    S+D Q 
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-PTLPSGYSDDAQ- 239

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASML 770
              D V        CL K  +RRP+ + L
Sbjct: 240 ---DFVA------KCLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 34/275 (12%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYP-GENRGKKEFLSEVETIGNIHHF-NLVRLVGY 568
           +GRG  G+V + L    GT +AVKR+    + + +K  L +++ +        +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 569 CAERSNRFLVYEYMCNGSLDKW--IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                + ++  E M + SLDK+    ++     +  +I  KI     + L YL +    K
Sbjct: 72  LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELK 128

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           IIH D+KP NILLDR+ N+K+ DFG++ +L+    S   T   G   YMAPE    ++  
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSARD 185

Query: 686 A---KIDIYSFGVVILEIICGR---RSSNPKGGDYLVDTLK--VKAEADRLCDLVDKKSE 737
               + D++S G+ + E+  G+      N      + D L   VK +   L       + 
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGDPPIL------SNS 234

Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           + +      V  I     CL K+  +RP    L++
Sbjct: 235 EEREFSPSFVNFIN---LCLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G VF+    + G  VA+K+    E+    KK  L E+  +  + H NLV L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 568 YCAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
               +    LV+EY C+ +    L+K                KKII+Q  + + + H + 
Sbjct: 68  VFRRKRKLHLVFEY-CDHTVLNELEKNPRGVPEHLI------KKIIWQTLQAVNFCHKH- 119

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
               IH D+KP+NIL+ +   +K+ DFG AR++        T    T  Y APEL  G++
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDT 176

Query: 684 -ITAKIDIYSFGVVILEIICG 703
                +D+++ G V  E++ G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 45/282 (15%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           +G G  G V++      G  VA+K +   E+  ++E   E   +    +H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 570 AERSNR------FLVYEYMCNGS---LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            +++        +LV E    GS   L K +  + + + L  +    I+ +  RGL YLH
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMA 675
           +    K+IH DIK QNILL ++  VK+ DFG++  +       ST+ +     GTP +MA
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181

Query: 676 PEL-----TRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD 730
           PE+         S  A+ D++S G+  +E+  G+    P     L D   ++A    L  
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGK----PP----LCDMHPMRA----LFK 229

Query: 731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           +       ++S  + + K       CL KN  +RP    L++
Sbjct: 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 13/154 (8%)

Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCNPKII 628
           +   F V EY+  G L   +FH   IQ        +  F   +I  GL++LH+     II
Sbjct: 68  KDRLFFVMEYVNGGDL---MFH---IQRSGRFDEPRARFYAAEIVLGLQFLHER---GII 118

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           + D+K  N+LLD + ++KIADFG+ +         ST   GTP Y+APE+         +
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYGPAV 177

Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           D ++ GV++ E++ G+        D L  ++   
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 82/278 (29%), Positives = 119/278 (42%), Gaps = 51/278 (18%)

Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRGKK--EFLSEVETIGNIHHFNLVRLVG 567
           +G G  G+V+          VA+K++ Y G+   +K  + + EV  +  + H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 568 YCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                   +LV EY C GS  D    HK  +Q +  +I   I     +GL YLH +    
Sbjct: 83  CYLREHTAWLVMEY-CLGSASDILEVHKKPLQEV--EI-AAICHGALQGLAYLHSHER-- 136

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG---NS 683
            IH DIK  NILL     VK+ADFG A L++   S V     GTP +MAPE+        
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQ 190

Query: 684 ITAKIDIYSFGVVILEIICGRR----SSNPKGGDYLV-----DTLKVKAEADRLCDLVDK 734
              K+D++S G+  +E +  R+    + N     Y +      TL     +D   + VD 
Sbjct: 191 YDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD- 248

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                               SCLQK    RPS+  L+K
Sbjct: 249 --------------------SCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 512 LGRGGSGSVFEGLLNDGTKVA---VKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G G  G V  G  + G   A   VK L        +  FL EV+    ++H N+++ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCN 624
            C E     LV E+   G L  ++   +R    Q    D+ +++  +++ GL +LH    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPEL--TRG 681
              IH D+  +N  L  DL+VKI D+GLA     +  +++      P  ++APEL   RG
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 682 NSI-----TAKIDIYSFGVVILEI 700
             +     T K +I+S GV + E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF--LSEVETIGNIHHFNLVRL-- 565
           R+G G  G V+       G  VA+K++     R       L E+  + N+ H N+V L  
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 566 --VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-LSWDIRKKIIFQISRGLEYLHDY 622
             VG   +  + FLV EY C   L   +   D + T  S    K ++ Q+ RGL+YLH+ 
Sbjct: 74  VVVGKHLD--SIFLVMEY-CEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRG 681
               IIH D+K  N+LL     +KIADFGLAR        ++  PK  T  Y APEL  G
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT--PKVVTLWYRAPELLLG 182

Query: 682 NSI-TAKIDIYSFGVVILEIICGR 704
            +  T  ID+++ G ++ E++  +
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 82.4 bits (204), Expect = 7e-17
 Identities = 66/215 (30%), Positives = 91/215 (42%), Gaps = 47/215 (21%)

Query: 512 LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKEFL---SEVE----------TI 554
           LGRG  G V   LL      G   A+K L       KK  +    EVE          T 
Sbjct: 7   LGRGHFGKV---LLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETA 56

Query: 555 GNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--- 610
            +  H  LV L   C +  +    V EY   G L     H D           + +F   
Sbjct: 57  NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL-MMHIHTDVFS------EPRAVFYAA 108

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-- 668
            +  GL+YLH+    KI++ D+K  N+LLD +  VKIADFGL +   +            
Sbjct: 109 CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFC 162

Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           GTP ++APE+    S T  +D +  GV+I E++ G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 82.0 bits (202), Expect = 8e-17
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 9/158 (5%)

Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 43  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 98

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + + T 
Sbjct: 99  FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 156 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 34/269 (12%)

Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGY 568
           R+G+G  G V++G+ N   +V A+K +   E   + E +  E+  +       + R  G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L      +  I T        I+ +I +GL+YLH   +
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--------ILREILKGLDYLH---S 119

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            + IH DIK  N+LL    +VK+ADFG+A  +   Q   +T   GTP +MAPE+ + ++ 
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 178

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS-EDMQSHR 743
             K DI+S G+  +E+  G     P   D             R+  L+ K S   ++   
Sbjct: 179 DFKADIWSLGITAIELAKGE----PPNSDL---------HPMRVLFLIPKNSPPTLEGQY 225

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
               K  +   +CL K+   RP+A  L+K
Sbjct: 226 SKPFK--EFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 81.7 bits (202), Expect = 9e-17
 Identities = 48/127 (37%), Positives = 72/127 (56%), Gaps = 12/127 (9%)

Query: 580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL 639
           E+M  GSLD+ +    RI     +I  KI   + RGL YL +    KI+H D+KP NIL+
Sbjct: 79  EHMDGGSLDQVLKKAGRIPE---NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILV 133

Query: 640 DRDLNVKIADFGLA-RLI-AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVI 697
           +    +K+ DFG++ +LI +   S V     GT  YM+PE  +G   T + DI+S G+ +
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 698 LEIICGR 704
           +E+  GR
Sbjct: 189 VEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF-LSEVETIGNIHHFNLVRLVGY 568
           +LG G   +V++G     G  VA+K ++     G     + E+  +  + H N+VRL   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 569 CAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
               +   LV+EYM +  L K++  H  R   L  +  K   +Q+ +G+ + H+    ++
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG--TPGYMAPELTRGN-SI 684
           +H D+KPQN+L+++   +K+ADFGLAR        V+T      T  Y AP++  G+ + 
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 685 TAKIDIYSFGVVILEIICGR 704
           +  IDI+S G ++ E+I GR
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 13/196 (6%)

Query: 512 LGRGGSGSVFEG----LLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLV 566
           +G G  G V++G      N+   VAVK      +   +E FL E   +    H ++V+L+
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           G   E +  ++V E    G L  ++  +K  +   S        +Q+S  L YL    + 
Sbjct: 74  GVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASL---ILYSYQLSTALAYLE---SK 126

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           + +H DI  +N+L+     VK+ DFGL+R +  +  + ++  K    +MAPE       T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 686 AKIDIYSFGVVILEII 701
           +  D++ FGV + EI+
Sbjct: 187 SASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 35/224 (15%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLY-PGEN--RGKKEFLSEVETIGNIHHFNLVRL-- 565
           +G G  G V        G KVA+K+L  P ++    K+ +  E+  + ++ H N++ L  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81

Query: 566 VGYCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           V   A     F    LV   M    L+  +    + Q LS D  + +++QI RGL+Y+H 
Sbjct: 82  VFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH- 135

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPE--L 678
             +  IIH D+KP NI ++ D  +KI DFGLAR    + + +V+T       Y APE  L
Sbjct: 136 --SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIML 188

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNP--KGGDYLVDTLK 720
              +     +DI+S G ++ E++ G+        G D+ +D LK
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGK----TLFPGSDH-IDQLK 226

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 512 LGRGGSGSVF----EGLLNDGTK--VAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G VF      LL +  K  VAVK L       +++F  E E +  + H ++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKW---------IFHKDRIQT---LSWDIRKKIIFQIS 613
            G C E     +V+EYM +G L+++         I           L+      I  QI+
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPG 672
            G+ YL    +   +H D+  +N L+ + L VKI DFG++R I + D   V         
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M PE       T + DI+SFGVV+ EI
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 44/303 (14%)

Query: 506 RDFQIR--LGRGGSGSVFEGL------LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI 557
           RD  ++  LG G  G VF           D   VAVK L       +K+F  E E + N+
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI--FHKDRIQTLSWDIRKK-------- 607
            H ++V+  G C +     +V+EYM +G L+K++     D +  +    R+         
Sbjct: 65  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 608 ---IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHV 663
              I  QI+ G+ YL    +   +H D+  +N L+  +L VKI DFG++R + + D   V
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVD--TLK 720
                    +M PE       T + D++SFGV++ EI   G++         +++  T  
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241

Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
              E  R+C                  ++  I + C Q+   +R +   + K+L  L K 
Sbjct: 242 RVLERPRVC----------------PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285

Query: 781 EPV 783
            P+
Sbjct: 286 TPI 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.1 bits (208), Expect = 2e-16
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 27/195 (13%)

Query: 528 GTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV--GYCAERSNRFLVYEYM 582
           G +VA+K L    P E   +  F  E      ++H N+V L+  G        F V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 583 CNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL 639
              +L      ++ +     L      +++ Q+   L   H   N  I+H D+KPQNI++
Sbjct: 62  PGRTL------REVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112

Query: 640 D-RDL--NVKIADFGLARL------IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
               +  + K+ DFG+  L              +T   GTP Y APE  RG  +T   D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 691 YSFGVVILEIICGRR 705
           Y++G++ LE + G+R
Sbjct: 173 YAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 21/201 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTK----VAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++G+ + DG      VA+K L    + +  KE L E   +  +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + LV + M  G L  ++  +KDRI +   L+W +      QI++G+ YL +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV------QIAKGMSYLEE 127

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLARL+  D++         P  +MA E   
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 27/204 (13%)

Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V      + G +VAVK++   + + ++   +EV  + + HH N+V +   
Sbjct: 28  IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFH----KDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
                  ++V E++  G+L   + H    +++I T        +   + R L YLH   N
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--------VCLSVLRALSYLH---N 136

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPELT 679
             +IH DIK  +ILL  D  +K++DFG    ++++      +PK     GTP +MAPE+ 
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSLVGTPYWMAPEVI 190

Query: 680 RGNSITAKIDIYSFGVVILEIICG 703
                  ++DI+S G++++E+I G
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGY 568
           R+G+G  G VF+G+ N   +V A+K +   E   + E +  E+  +       + +  G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L    F + +I T+        + +I +GL+YLH   +
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM--------LKEILKGLDYLH---S 119

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL    +VK+ADFG+A  +   Q   +T   GTP +MAPE+ + ++ 
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSAY 178

Query: 685 TAKIDIYSFGVVILEIICG 703
            +K DI+S G+  +E+  G
Sbjct: 179 DSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 13/160 (8%)

Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 43  LTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 98

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L YLH   +  +++ D+K +N++LD+D ++KI DFGL +   +  S  +TM
Sbjct: 99  FYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATM 152

Query: 667 PK--GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
               GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 58/240 (24%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFLSEVETIGNIHHFN-- 561
           DF++   +GRG  G V+     D  +V A+K L       +K  + +   I ++      
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERDI 54

Query: 562 --------LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
                   +V+L     +  + +LV EYM  G L   +  KD       +  +  I ++ 
Sbjct: 55  LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELV 111

Query: 614 RGLEYLHD--YCNPKIIHFDIKPQNILLDRDLNVKIADFGLA--------RLIAQDQSHV 663
             L+ +H   +     IH DIKP NIL+D D ++K+ADFGL         R    + SH 
Sbjct: 112 LALDSVHKLGF-----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 664 STMPK--------------------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                                    GTP Y+APE+ RG     + D +S GV++ E++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.8 bits (199), Expect = 3e-16
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 27/195 (13%)

Query: 526 NDGTKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMC 583
           N    VAVK L     ++   + +SE+E +  I  H N++ L+G C +    +++ EY  
Sbjct: 42  NKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS 101

Query: 584 NGSLDKWI-----------FHKDRI--QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
            G+L +++           F   ++  + L++       +Q++RG+EYL    + K IH 
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHR 158

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTRGNSIT 685
           D+  +N+L+  D  +KIADFGLAR    D  ++    K T G     +MAPE       T
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT 214

Query: 686 AKIDIYSFGVVILEI 700
            + D++SFGV++ EI
Sbjct: 215 HQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 44/134 (32%), Positives = 71/134 (52%), Gaps = 21/134 (15%)

Query: 591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF 650
           I H D  Q L+ +  +  ++Q+ RGL+Y+H      +IH D+KP N+L++ D  ++I DF
Sbjct: 97  IIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDF 151

Query: 651 GLARLIAQDQ--------SHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEII 701
           G+AR ++            +V+T       Y APEL       T  ID++S G +  E++
Sbjct: 152 GMARGLSSSPTEHKYFMTEYVATRW-----YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Query: 702 CGRRSSNPKGGDYL 715
            GRR   P G +Y+
Sbjct: 207 -GRRQLFP-GKNYV 218

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 512 LGRGGSGSVFE-GLLNDGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG G V    + N G   A K+L      +  G+K  L E E +  ++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNP 625
               +++  LV   M  G L   I++   +     ++ + I +  QI+ G+ +LH     
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSM--- 114

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            I++ D+KP+N+LLD   N +++D GLA  +   ++   T   GT GYMAPE+ +    +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172

Query: 686 AKIDIYSFGVVILEIICGR 704
             +D ++ G  I E++ GR
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 14/181 (7%)

Query: 531 VAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK 589
           VAVK L     +  + +FL E++ +  + + N++RL+G C       ++ EYM NG L++
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 590 WI---------FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD 640
           ++          H + I ++S      +  QI+ G++YL    +   +H D+  +N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 641 RDLNVKIADFGLAR-LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
               +KIADFG++R L + D   +         +MA E       T   D+++FGV + E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 700 I 700
           +
Sbjct: 224 M 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 5e-16
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 27/209 (12%)

Query: 513 GRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKKEFLSEVETIG---NIHHFNLVRLV 566
           GRG  G V++       DG + A+K+    + +      S    I     + H N+V LV
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 567 GYCAERSNR--FLVYEYMCN--GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
               E +++  +L+++Y  +    + K+     R+  +   + K +++QI  G+ YLH  
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS-IPPSMVKSLLWQILNGVHYLHS- 126

Query: 623 CNPKIIHFDIKPQNILLDRDLN----VKIADFGLARLIAQDQSHVSTMPKGTP-----GY 673
            N  ++H D+KP NIL+  +      VKI D GLARL     + +  +    P      Y
Sbjct: 127 -N-WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPLKPLADLDPVVVTIWY 181

Query: 674 MAPELTRG-NSITAKIDIYSFGVVILEII 701
            APEL  G    T  IDI++ G +  E++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 22/199 (11%)

Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVK---RLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           R+GRG  G VF G L  D T VAVK      P + + K  FL E   +    H N+VRL+
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLI 59

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLHDY 622
           G C ++   ++V E +  G    +      ++T    ++ K + Q+      G+EYL   
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTF------LRTEGPRLKVKELIQMVENAAAGMEYLESK 113

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST--MPKGTPGYMAPELTR 680
                IH D+  +N L+     +KI+DFG++R   +D  + ST  M +    + APE   
Sbjct: 114 H---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 681 GNSITAKIDIYSFGVVILE 699
               +++ D++SFG+++ E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 12/192 (6%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G  G VF+G L D T VAVK      P E   K +FLSE   +    H N+V+L+G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL--KIKFLSEARILKQYDHPNIVKLIGV 60

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
           C +R   ++V E +  G  D   F + +   L      K     + G+ YL    +   I
Sbjct: 61  CTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGNSITAK 687
           H D+  +N L+  +  +KI+DFG++R    D  + S+  K  P  + APE       +++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 688 IDIYSFGVVILE 699
            D++S+G+++ E
Sbjct: 175 SDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEF-LSEVETIGNIHHFNLVRLVG 567
           ++G G  G+VF+         VA+KR+    ++ G     L E+  +  + H N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ-TLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                    LV+EY C+  L K+    D     +  +I K  +FQ+ +GL + H +    
Sbjct: 67  VLHSDKKLTLVFEY-CDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRGN 682
           ++H D+KPQN+L++++  +K+ADFGLAR     +    + V T+      Y  P++  G 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL-----WYRPPDVLFGA 174

Query: 683 SI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
            + +  ID++S G +  E+    R   P  G+ + D LK
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLK 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 23/250 (9%)

Query: 512 LGRGGSGSVFEGLLNDG---TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G G  G V  G +N G    +V VK L    + + + +FL E +   ++ H NL++ +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR--KKIIFQISRGLEYLHDYCNP 625
            C E +   LV E+   G L  ++    + + ++ D    +++  +I+ GL +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPEL---TRG 681
             IH D+  +N LL  DL VKI D+GL+    ++  +V+      P  ++APEL     G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 682 NSI----TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD------L 731
           N +    T + +++S GV I E+            D  V T  V+ +  +L        L
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239

Query: 732 VDKKSEDMQS 741
            D+  E MQ 
Sbjct: 240 SDRWYEVMQF 249

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 42/216 (19%)

Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIG--NIHHFNL 562
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +     HH  +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--V 71

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR----------KKII--- 609
           VRL+G  ++     +V E M +G L      K  +++L  +            +++I   
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDL------KSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
            +I+ G+ YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY----RKG 178

Query: 670 TPG-----YMAPELTRGNSITAKIDIYSFGVVILEI 700
             G     +MAPE  +    T   D++SFGVV+ EI
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 79.3 bits (195), Expect = 7e-16
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 8/158 (5%)

Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 43  LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 98

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   N  +++ D+K +N++LD+D ++KI DFGL +   +D + + T 
Sbjct: 99  FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156

Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 157 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 79.7 bits (196), Expect = 7e-16
 Identities = 92/344 (26%), Positives = 138/344 (40%), Gaps = 97/344 (28%)

Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 564 RLVGYCAE---------------------RSNR--FLVY-----------EYMCNGSLDK 589
            L+G C +                     RS R  F+ Y               + S D 
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 590 WIFHKDRIQTL--------------------------SWDIRKKII---------FQISR 614
               K R+ ++                            D+ KK++         FQ+++
Sbjct: 135 ----KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAK 190

Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GY 673
           G+E+L    + K IH D+  +NILL  +  VKI DFGLAR I +D  +V       P  +
Sbjct: 191 GMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247

Query: 674 MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD 733
           MAPE       T + D++SFGV++ EI     S  P           VK + +    L  
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----------GVKIDEEFCRRL-- 295

Query: 734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           K+   M++      +M Q  + C      +RP+ S LV+ L  L
Sbjct: 296 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 36/208 (17%)

Query: 512 LGRGGSGSVFEGL----LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI---------- 557
           LG+ G G+  E L       G   A+K +       KK F S +E + N+          
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKS-LEQVNNLREIQALRRLS 55

Query: 558 HHFNLVRLVGYCAER-SNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
            H N++RL+    +R + R  LV+E M + +L + I  K R + L     K  ++Q+ + 
Sbjct: 56  PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELI--KGRKRPLPEKRVKSYMYQLLKS 112

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           L+++H      I H DIKP+NIL+  D+ +K+ADFG  R I     +  T    T  Y A
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY--TEYISTRWYRA 166

Query: 676 PE--LTRGNSITAKIDIYSFGVVILEII 701
           PE  LT G     K+DI++ G V  EI+
Sbjct: 167 PECLLTDG-YYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 79.0 bits (195), Expect = 9e-16
 Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 21/216 (9%)

Query: 510 IRLGRGGSGSVFEGLLND-GTKVAVKRLYPG-ENR-GKKEFLSEVETIGNIHHFNLVRLV 566
             +GRG  G V     ++   KVA+K++    +NR   K  L E++ + ++ H N++ + 
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 567 GYCAERSNR------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                  +R      ++VYE M +  L + I      QTLS D  +  ++Q+ RGL+Y+H
Sbjct: 71  D-IMPPPHREAFNDVYIVYELM-DTDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIH 125

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE-LT 679
              +  ++H D+KP N+LL+ + ++KI DFGLAR    ++    T    T  Y APE L 
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
             +  T  ID++S G +  E++ GR+   P G DY+
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL-GRKPLFP-GKDYV 215

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 24/204 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLY--PGENRGKKEFLS---EVETIGNIHHFNLVRL 565
           LG+G  G V+    ++ G ++A K++   P      KE  +   E++ + N+ H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 566 VGYCAERSNRFLV--YEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLH 620
            G   +R+ + L    EYM  GS+      KD+++    L+  + +K   QI  G+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAPE 677
              +  I+H DIK  NIL D   NVK+ DFG ++    I    + + ++  GTP +M+PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV-TGTPYWMSPE 179

Query: 678 LTRGNSITAKIDIYSFGVVILEII 701
           +  G     K D++S G  ++E++
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 27/214 (12%)

Query: 508 FQIRLGRGGSGSVFEGLLN-DGTKV--AVKRL--YPGENRGKKEFLSEVETIGNI-HHFN 561
           F+  +G G  G V   ++  DG K+  A+K L  +  EN   ++F  E+E +  + HH N
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-DHRDFAGELEVLCKLGHHPN 64

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--------------QTLSWDIRKK 607
           ++ L+G C  R   ++  EY   G+L  ++  K R+               TL+     +
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
               ++ G++YL +    + IH D+  +N+L+  +L  KIADFGL+R   ++     TM 
Sbjct: 124 FASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMG 178

Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           +    +MA E    +  T K D++SFGV++ EI+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 55/186 (29%), Positives = 95/186 (51%), Gaps = 19/186 (10%)

Query: 531 VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLD 588
           VAVK L     ++   + +SE+E +  I  H N++ L+G C +    +++ EY   G+L 
Sbjct: 47  VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106

Query: 589 KWI-FHKDRIQTLSWDIRK------------KIIFQISRGLEYLHDYCNPKIIHFDIKPQ 635
           +++   +      ++DI K               +Q++RG+EYL    + + IH D+  +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163

Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGNSITAKIDIYSFG 694
           N+L+  D  +KIADFGLAR +     +  T     P  +MAPE       T + D++SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223

Query: 695 VVILEI 700
           +++ EI
Sbjct: 224 ILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 33/269 (12%)

Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL-YPGENRGKK--EFLSEVETIGNIHHFNLVRLVG 567
           +G G  G+V F   + +   VA+K++ Y G+   +K  + + EV  +  + H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   +LV EY    + D    HK  +Q +       +     +GL YLH +    +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI---AAVTHGALQGLAYLHSH---NM 136

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG---NSI 684
           IH D+K  NILL     VK+ DFG A ++A     V     GTP +MAPE+         
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY 191

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS-HR 743
             K+D++S G+  +E+    R         L +   + A    L  +   +S  +QS H 
Sbjct: 192 DGKVDVWSLGITCIEL--AERKPP------LFNMNAMSA----LYHIAQNESPALQSGHW 239

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +  +      SCLQK    RP++ +L+K
Sbjct: 240 SEYFR--NFVDSCLQKIPQDRPTSEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 31/206 (15%)

Query: 511 RLGRGGSGSVFEG---LLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRL 565
           ++G G  G V++    + N+   +A+K++    E+ G     + E+  +  + H N+VRL
Sbjct: 9   KIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 566 --VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR--KKIIFQISRGLEYLHD 621
             V +  +R   +LV+EY+ +  L K   H D     + + R  K  ++QI RG+ Y H 
Sbjct: 67  QDVVHSEKR--LYLVFEYL-DLDLKK---HMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 622 YCNPKIIHFDIKPQNILLDRDLN-VKIADFGLAR---LIAQDQSH-VSTMPKGTPGYMAP 676
           +   +++H D+KPQN+L+DR  N +K+ADFGLAR   +  +  +H V T+      Y AP
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL-----WYRAP 172

Query: 677 ELTRGN-SITAKIDIYSFGVVILEII 701
           E+  G+   +  +DI+S G +  E++
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 18/199 (9%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK--EFLSEVETIGNIHHFNLVRLVGY 568
           ++G+G  G VF+G+ N   KV   ++   E    +  +   E+  +       + +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L+     + +I T        I+ +I +GL+YLH   +
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYLH---S 119

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL     VK+ADFG+A  +   Q   +T   GTP +MAPE+ + ++ 
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 178

Query: 685 TAKIDIYSFGVVILEIICG 703
            +K DI+S G+  +E+  G
Sbjct: 179 DSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 35/226 (15%)

Query: 507 DFQI--RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFL----------SEVET 553
           DFQI  ++G+GG G VF     D G  VA+KR+       KK  L          +E + 
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRM-------KKSLLFKLNEVRHVLTERDI 54

Query: 554 IGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
           +       LV+L+    +    +L  EY+  G     + +      LS D  +  + ++ 
Sbjct: 55  LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMF 111

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQSHVSTMPKGTPG 672
             ++ LH+      IH D+KP+N L+D   ++K+ DFGL++ ++    S V     G+P 
Sbjct: 112 EAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPD 163

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
           YMAPE+ RG      +D +S G ++ E +CG     P  G    +T
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG---FPPFSGSTPNET 206

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 20/197 (10%)

Query: 512 LGRGGSGSVFEGLLNDGTK--VAVKRL-YPGENRGKK--EFLSEVETIGNIHHFNLVRLV 566
           +G G  G+V+    N  T   VAVK++ Y G+   +K  + + EV+ +  + H N +   
Sbjct: 29  IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +    +LV EY    + D    HK  +Q +       I     +GL YLH +    
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI---AAITHGALQGLAYLHSHN--- 141

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG---NS 683
           +IH DIK  NILL     VK+ADFG A   +   S V     GTP +MAPE+        
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196

Query: 684 ITAKIDIYSFGVVILEI 700
              K+D++S G+  +E+
Sbjct: 197 YDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 35/242 (14%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHF---NLVRL 565
           +G G  G+V++    + G  VA+K  R+   E+      + EV  +  +  F   N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 566 VGYCAE-RSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           +  CA  R++R     LV+E++ +  L  ++  K     L  +  K ++ Q  RGL++LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPELT 679
             C   I+H D+KP+NIL+     VK+ADFGLAR+ +     ++  P   T  Y APE+ 
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVL 179

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC---DLVDKKS 736
             ++    +D++S G +  E+   RR     G           +EAD+L    DL+    
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMF--RRKPLFCG----------NSEADQLGKIFDLIGLPP 227

Query: 737 ED 738
           ED
Sbjct: 228 ED 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 9/198 (4%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++G     G  VA+K  RL   E       + E+  +  + H N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
              + S  +L++E++ +  L K++    + Q +  ++ K  ++QI +G+ + H     ++
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-ITA 686
           +H D+KPQN+L+D    +K+ADFGLAR        V T    T  Y APE+  G+   + 
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 687 KIDIYSFGVVILEIICGR 704
            +DI+S G +  E+   +
Sbjct: 182 PVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 50/148 (33%), Positives = 84/148 (56%), Gaps = 11/148 (7%)

Query: 576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIK 633
           F V E++  G L   I  K R     +D+ +   +  +I  GL++LH   +  II+ D+K
Sbjct: 72  FFVMEFLNGGDLMFHIQDKGR-----FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLK 123

Query: 634 PQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSF 693
             N++LDRD ++KIADFG+ +      +  ST   GTP Y+APE+ +G   T  +D +SF
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 694 GVVILEIICGRRSSNPKGGDYLVDTLKV 721
           GV++ E++ G+   +    D L ++++V
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN-LVR------ 564
           +G+G  G V++    D      +R+Y  +   KKE +++ E    I   N LVR      
Sbjct: 1   IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 565 --LVGY---CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
             +VG        S+ +LV +YM  G L    +H  +    S D  K  I ++   LE+L
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE-L 678
           H Y    I++ D+KP+NILLD   ++ + DFGL++    D    +T   GT  Y+APE L
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVL 168

Query: 679 TRGNSITAKIDIYSFGVVILEIICG 703
                 T  +D +S GV++ E+ CG
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 59/222 (26%), Positives = 89/222 (40%), Gaps = 36/222 (16%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL----YPGENRGKKEF----------LSEVETIGN 556
           LG G  G V +      G  VA+K++       +    ++           L E++ +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           I H N++ LV    E     LV + M    L K +  K R   L+    K I+ QI  GL
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR---LTESQVKCILLQILNGL 132

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--------QSHVSTMPK 668
             LH +     +H D+ P NI ++     KIADFGLAR                +    +
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 669 GTPG-----YMAPELTRG-NSITAKIDIYSFGVVILEIICGR 704
            T       Y APEL  G       +D++S G +  E++ G+
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 22/200 (11%)

Query: 512 LGRGGSGSVFEGLLNDGTKV--AVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           LG G  G V++   N  T V  A K +        ++++ E++ + +  H N+V+L+   
Sbjct: 13  LGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +N +++ E+   G++D  +   +R   L+    + +  Q    L YLH+    KIIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126

Query: 630 FDIKPQNILLDRDLNVKIADFGLA----RLIAQDQSHVSTMPKGTPGYMAPEL-----TR 680
            D+K  NIL   D ++K+ADFG++    R I +  S +     GTP +MAPE+     ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181

Query: 681 GNSITAKIDIYSFGVVILEI 700
                 K D++S G+ ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 27/194 (13%)

Query: 527 DGTKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCN 584
           +   VAVK L      +   + +SE+E +  I  H N++ L+G C +    +++ EY   
Sbjct: 46  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105

Query: 585 GSLDKWIFHKDRIQT-LSWDIRK------------KIIFQISRGLEYLHDYCNPKIIHFD 631
           G+L +++  +       S+DI +               +Q++RG+EYL    + K IH D
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162

Query: 632 IKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTRGNSITA 686
           +  +N+L+  +  +KIADFGLAR    D +++    K T G     +MAPE       T 
Sbjct: 163 LAARNVLVTENNVMKIADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218

Query: 687 KIDIYSFGVVILEI 700
           + D++SFGV++ EI
Sbjct: 219 QSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 50/142 (35%), Positives = 79/142 (55%), Gaps = 15/142 (10%)

Query: 568 YCA--ERSNRFLVYEYMCNGSLDKWIFHKDRIQTL-SWDIRKKIIF--QISRGLEYLHDY 622
           YC    + N F V EY+  G L   +FH   IQ+   +D+ +   +  +I  GL++LH  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFH---IQSCHKFDLPRATFYAAEIICGLQFLH-- 113

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
            +  I++ D+K  NILLD D ++KIADFG+ +      +   T   GTP Y+APE+  G 
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQ 171

Query: 683 SITAKIDIYSFGVVILEIICGR 704
                +D +SFGV++ E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 23/146 (15%)

Query: 571 ERSNRFLVYEYMCNGSL----DKW--IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           ++ N +LV EY   G L    +++   F +D  Q           F ++  +  +H    
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQ-----------FYLAELVLAIHSVHQ 120

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
              +H DIKP+N+L+DR  ++K+ADFG A  +  ++   S +P GTP Y+APE+    + 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 685 TAK------IDIYSFGVVILEIICGR 704
             K       D +S GV+  E+I GR
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 24/204 (11%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLY--PGENRGKKEFLS---EVETIGNIHHFNLVRL 565
           LGRG  G V+     D G ++AVK++   P      KE  +   E++ + N+ H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 566 VGYCAERSNRFL--VYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLH 620
            G   +   + L    EYM  GS+      KD+++    L+ ++ ++   QI +G+ YLH
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAPE 677
              +  I+H DIK  NIL D   NVK+ DFG ++ I Q      T  K   GTP +M+PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE 179

Query: 678 LTRGNSITAKIDIYSFGVVILEII 701
           +  G     K D++S    ++E++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 61/217 (28%), Positives = 115/217 (52%), Gaps = 21/217 (9%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RV 121

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSH-VSTMPKGTPGYMAPELTRGNS 683
           +H D+KPQN+L++ +  +K+ADFGLAR   +  +  +H V T+      Y APE+  G  
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL-----WYRAPEILLGCK 176

Query: 684 I-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 77.7 bits (191), Expect = 3e-15
 Identities = 91/302 (30%), Positives = 146/302 (48%), Gaps = 48/302 (15%)

Query: 501 MKSATRDFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLY---PGENRGKKEFLSEVETIGN 556
           +    RD + ++G G  G+V   L    G KVA+K+LY     E   K+ +  E+  + +
Sbjct: 13  VPDRYRDLK-QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKH 70

Query: 557 IHHFNLVRLVG-YCAERS-NRF----LVYEYMCNGSLDKWIFHK----DRIQTLSWDIRK 606
           + H N++ L+  +  + S +RF    LV  +M    L K + H+    DRIQ L      
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL------ 123

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
             ++Q+ +GL+Y+H      IIH D+KP N+ ++ D  +KI DFGLAR   Q  S + T 
Sbjct: 124 --VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM-TG 174

Query: 667 PKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNP--KGGDYLVDTLK--V 721
              T  Y APE+       T  +DI+S G ++ E++ G+    P  KG D+L D L   +
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGHDHL-DQLMEIM 229

Query: 722 KAEADRLCDLVDK-KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           K       + V K +SED +++     +  +     L  N +  P A   V VL+ +  L
Sbjct: 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNAN--PLA---VNVLEKMLVL 284

Query: 781 EP 782
           + 
Sbjct: 285 DA 286

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 27/204 (13%)

Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V      + G +VAVK +   + + ++   +EV  + +  H N+V +   
Sbjct: 27  IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 569 CAERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
                  +++ E++  G+L   +     ++++I T        +   + + L YLH   +
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--------VCESVLQALCYLH---S 135

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPELT 679
             +IH DIK  +ILL  D  VK++DFG    I++D      +PK     GTP +MAPE+ 
Sbjct: 136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSLVGTPYWMAPEVI 189

Query: 680 RGNSITAKIDIYSFGVVILEIICG 703
                  ++DI+S G++++E++ G
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHF 560
           +FQI  ++GRG    V+    L D   VA+K++   E    + +++ + E++ +  ++H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYL 619
           N+++ +    E +   +V E    G L + I + K + + +      K   Q+   +E++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           H   + +++H DIKP N+ +     VK+ D GL R  +   +   ++  GTP YM+PE  
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERI 178

Query: 680 RGNSITAKIDIYSFGVVILEI 700
             N    K DI+S G ++ E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 59/194 (30%), Positives = 104/194 (53%), Gaps = 22/194 (11%)

Query: 526 NDGTKVAVKRLYPGENRGKK--EFLSEVETIGNIHHFNLVRLVGYCAERSNRF--LVYEY 581
           N G +VAVK L P E+ G    +   E+E + N++H N+V+  G C E       L+ E+
Sbjct: 31  NTGEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89

Query: 582 MCNGSLDKWI-FHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI 637
           + +GSL +++  +K++I   Q L + +      QI +G++YL    + + +H D+  +N+
Sbjct: 90  LPSGSLKEYLPRNKNKINLKQQLKYAV------QICKGMDYLG---SRQYVHRDLAARNV 140

Query: 638 LLDRDLNVKIADFGLARLIAQDQSHVSTM-PKGTPGY-MAPELTRGNSITAKIDIYSFGV 695
           L++ +  VKI DFGL + I  D+ + +      +P +  APE    +      D++SFGV
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200

Query: 696 VILEII--CGRRSS 707
            + E++  C   SS
Sbjct: 201 TLYELLTYCDSESS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 507 DFQIRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           D  I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +
Sbjct: 23  DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 82

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFH----KDRIQTLSWDIRKKIIFQISRGLEYLHD 621
                     ++V E++  G+L   + H    +++I          +   + + L  LH 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLKALSVLH- 133

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                +IH DIK  +ILL  D  VK++DFG    ++++     ++  GTP +MAPEL   
Sbjct: 134 --AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISR 190

Query: 682 NSITAKIDIYSFGVVILEIICG 703
                ++DI+S G++++E++ G
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 27/210 (12%)

Query: 512 LGRGGSGSVFEGLLN-DGTKV--AVKRL--YPGENRGKKEFLSEVETIGNI-HHFNLVRL 565
           +G G  G V +  +  DG ++  A+KR+  Y  ++   ++F  E+E +  + HH N++ L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNIINL 61

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--------------QTLSWDIRKKIIFQ 611
           +G C  R   +L  EY  +G+L  ++  K R+               TLS          
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           ++RG++YL      + IH D+  +NIL+  +   KIADFGL+R   Q+     TM +   
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEII 701
            +MA E    +  T   D++S+GV++ EI+
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 21/208 (10%)

Query: 506 RDFQIRLGRGGSGSV------FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH 559
           R +++ LG+GG G V        G +    K+  KR+   + +G+   L+E + +  ++ 
Sbjct: 3   RQYRV-LGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGESMALNEKQILEKVNS 59

Query: 560 FNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGL 616
             +V L  Y  E  +   LV   M  G L   I+H   +    ++  + + +  +I  GL
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGL 115

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           E LH     +I++ D+KP+NILLD   +++I+D GLA  + + Q+    +  GT GYMAP
Sbjct: 116 EDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAP 170

Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGR 704
           E+ +    T   D ++ G ++ E+I G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 12/196 (6%)

Query: 510 IRLGRGGSGSVFEGLLNDGTK---VAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRL 565
           + LG G  G V +G+     K   VA+K L     +  + E + E E +  + +  +VR+
Sbjct: 1   VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C E     LV E    G L+K++  K    T+S  +  +++ Q+S G++YL      
Sbjct: 61  IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMKYLEG---K 114

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--VSTMPKGTPGYMAPELTRGNS 683
             +H D+  +N+LL      KI+DFGL++ +  D S+    +  K    + APE      
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 684 ITAKIDIYSFGVVILE 699
            +++ D++S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 22/206 (10%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLY--PGENRGKKEFLS---EVETIGNIHHFNLVRL 565
           LG+G  G V+     D G ++AVK++   P      KE  +   E++ + N+ H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 566 VGYCAERSNRFL--VYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLH 620
            G   +   R L    E+M  GS+      KD++++   L+ ++ +K   QI  G+ YLH
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPEL 678
              +  I+H DIK  NIL D   NVK+ DFG ++ +       + M    GTP +M+PE+
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 679 TRGNSITAKIDIYSFGVVILEIICGR 704
             G     K DI+S G  ++E++  +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 511 RLGRGGSGSVFEG-LLNDGTKVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLVRLV 566
           ++GRG    V+    L DG  VA+K++      + + + + + E++ +  ++H N+++  
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
               E +   +V E    G L + I H K + + +      K   Q+   LE++H   + 
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SR 125

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           +++H DIKP N+ +     VK+ D GL R  +   +   ++  GTP YM+PE    N   
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYN 184

Query: 686 AKIDIYSFGVVILEI 700
            K DI+S G ++ E+
Sbjct: 185 FKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 512 LGRGGSGSVFEG--LLNDGTKVAVKRL--------YPGENRGKKEFLSEVETIGNIHHFN 561
           +G G  G VF+   L N G  VA+KR+         P     +   L  +ET     H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPN 65

Query: 562 LVRLVGYCA-ERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           +VRL   C   R++R     LV+E++ +  L  ++  K     +  +  K ++FQ+ RGL
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGL 123

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           ++LH +   +++H D+KPQNIL+     +K+ADFGLAR+ +   +  S +   T  Y AP
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 178

Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E+   +S    +D++S G +  E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 9e-15
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 18/170 (10%)

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ++RG+E+L    + K IH D+  +NILL  +  VKI DFGLAR I +D  +V      
Sbjct: 180 FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE-ADR 727
            P  +MAPE       T + D++SFGV++ EI     S  P         +++  E   R
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG--------VQIDEEFCRR 288

Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           L     K+   M++      ++  I + C   N   RP+ S LV++L  L
Sbjct: 289 L-----KEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 27/214 (12%)

Query: 508 FQIRLGRGGSGSVFEGLL-NDGTKV--AVKRL--YPGENRGKKEFLSEVETIGNI-HHFN 561
           FQ  +G G  G V +  +  DG ++  A+KR+  Y  ++   ++F  E+E +  + HH N
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPN 69

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--------------QTLSWDIRKK 607
           ++ L+G C  R   +L  EY  +G+L  ++  K R+               TLS      
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
               ++RG++YL      + IH D+  +NIL+  +   KIADFGL+R   Q+     TM 
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 183

Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           +    +MA E    +  T   D++S+GV++ EI+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 18/196 (9%)

Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL-YPGENRGKK--EFLSEVETIGNIHHFNLVRLVG 567
           +G G  G+V F   +     VA+K++ Y G+   +K  + + EV+ +  I H N +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   +LV EY    + D    HK  +Q +       I     +GL YLH +    +
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI---AAITHGALQGLAYLHSH---NM 146

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG---NSI 684
           IH DIK  NILL     VK+ADFG A + +   S V     GTP +MAPE+         
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQY 201

Query: 685 TAKIDIYSFGVVILEI 700
             K+D++S G+  +E+
Sbjct: 202 DGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 30/210 (14%)

Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIG--NIHHFNL 562
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   N HH  +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--V 71

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRG 615
           VRL+G  ++     ++ E M  G L  ++       +     +    KK+I    +I+ G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--- 672
           + YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G   
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 184

Query: 673 --YMAPELTRGNSITAKIDIYSFGVVILEI 700
             +M+PE  +    T   D++SFGVV+ EI
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 21/189 (11%)

Query: 531 VAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK 589
           VAVK L P  N+  + +FL EV+ +  +   N++RL+G C +     ++ EYM NG L++
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 590 WIFHKD----------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIK 633
           ++                     +  +S+     +  QI+ G++YL        +H D+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165

Query: 634 PQNILLDRDLNVKIADFGLAR-LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYS 692
            +N L+  +L +KIADFG++R L A D   +         +MA E       T   D+++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 693 FGVVILEII 701
           FGV + EI+
Sbjct: 226 FGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 27/204 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTK----VAVKRLYPGENRGKKEFLSEVE----TIGNIHHFNL 562
           LG G  G+V +G+ + +G      VA+K +   ++R  ++   E+      +G++ H  +
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI---QDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRI---QTLSWDIRKKIIFQISRGLEY 618
           VRL+G C   S + LV +    GSL   +  H+D +   + L+W +      QI++G+ Y
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV------QIAKGMYY 124

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPE 677
           L ++    ++H ++  +NILL  D  V+IADFG+A L+   D+ +  +  K    +MA E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 678 LTRGNSITAKIDIYSFGVVILEII 701
                  T + D++S+GV + E++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 22/200 (11%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGYCA 570
           LG G  G V++    +   +A  ++   ++  + E ++ E+E +   +H  +V+L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
                +++ E+   G++D  +   DR   L+    + I  Q+   L+YLH   + KIIH 
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLH---SMKIIHR 134

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPELTRGNSIT 685
           D+K  N+LL  D ++K+ADFG++        +V T+ +     GTP +MAPE+    ++ 
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 686 A-----KIDIYSFGVVILEI 700
                 K DI+S G+ ++E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 34/215 (15%)

Query: 507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEF----LSEVETIGNIHHFN 561
           D   ++G G  G V++    D G  VA+K++   +N  K+ F    + E++ +  ++H N
Sbjct: 10  DIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-DNE-KEGFPITAIREIKILRQLNHRN 67

Query: 562 LVRL----------VGYCAERSNRFLVYEYMCN---GSLDKWI--FHKDRIQTLSWDIRK 606
           +V L          + +  ++   +LV+EYM +   G L+  +  F +D I++       
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF------ 121

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
             + Q+  GL Y H       +H DIK  NILL+    +K+ADFGLARL   ++S   T 
Sbjct: 122 --MKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 667 PKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEI 700
              T  Y  PEL  G       ID++S G ++ E+
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 49/143 (34%), Positives = 78/143 (54%), Gaps = 10/143 (6%)

Query: 565 LVGY--CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           LVG   C + ++R FLV EY+  G L   +FH  R + L  +  +    +I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                II+ D+K  N+LLD D ++K+ D+G+ +         ST   GTP Y+APE+ RG
Sbjct: 115 ---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRG 170

Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +D ++ GV++ E++ GR
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 56/170 (32%), Positives = 87/170 (51%), Gaps = 18/170 (10%)

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ++RG+E+L    + K IH D+  +NILL  +  VKI DFGLAR I +D  +V      
Sbjct: 181 FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237

Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE-ADR 727
            P  +MAPE       T + D++SFGV++ EI     S  P         +++  E   R
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG--------VQINEEFCQR 289

Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           L     K    M++  +   ++ +I ++C Q +   RP+ S LV++L  L
Sbjct: 290 L-----KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 21/222 (9%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-----HHFNLVRLV 566
           +GRG    V    L    ++   ++   E     E +  V+T  ++     +H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                 S  F V EY+  G L   +FH  R + L  +  +    +IS  L YLH+     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHER---G 116

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
           II+ D+K  N+LLD + ++K+ D+G+ +   +     ST   GTP Y+APE+ RG     
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGF 175

Query: 687 KIDIYSFGVVILEIICGR-------RSSNPKGG--DYLVDTL 719
            +D ++ GV++ E++ GR        S NP     DYL   +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 23/173 (13%)

Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKWIFHKDRIQTLS 601
           +K  L EV      H F ++RL  +  E   RFL  + EY+  G L  ++ +  R    +
Sbjct: 51  EKRVLKEVS-----HPF-IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST 102

Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
                    +I   LEYLH     +I++ D+KP+NILLD++ ++K+ DFG A+ + +D++
Sbjct: 103 GLFYAS---EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRT 155

Query: 662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR---RSSNPKG 711
              T+  GTP Y+APE+ +       +D ++ G++I E++ G       NP G
Sbjct: 156 W--TLC-GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 70/241 (29%), Positives = 109/241 (45%), Gaps = 49/241 (20%)

Query: 544 KKEFLSEVETIGNI----HHF----NLVRLVGY--CAERSNR-FLVYEYMCNGSLDKWIF 592
           KKE +++ E I  +    H F    N   LVG   C +  +R F V E++  G L   +F
Sbjct: 29  KKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MF 85

Query: 593 HKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL 652
           H  R + L  +  +    +IS  L +LH+     II+ D+K  N+LLD + ++K+ D+G+
Sbjct: 86  HMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGM 142

Query: 653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR------- 705
            +   +     ST   GTP Y+APE+ RG      +D ++ GV++ E++ GR        
Sbjct: 143 CKEGIRPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201

Query: 706 SSNPKGG--DYLVD-----------TLKVKAE-----------ADRLCDLVDKKSEDMQS 741
           S NP     DYL             +L VKA             +RL         D++S
Sbjct: 202 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261

Query: 742 H 742
           H
Sbjct: 262 H 262

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 75.1 bits (184), Expect = 4e-14
 Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 24/216 (11%)

Query: 502 KSATRDFQIR--LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH 558
           +S  + +++   +G G  G V+E + ++   KVA+K++        +E L     + N++
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117

Query: 559 HFNLVRLVGY----CAERS--NRFL--VYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKII 609
           H N++ L  Y    C +++  N FL  V E++   ++ K++ H  R    L   + K   
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPK 668
           +Q+ R L Y+H   +  I H D+KPQN+L+D     +K+ DFG A+ +   Q  VS +  
Sbjct: 177 YQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI-- 231

Query: 669 GTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICG 703
            +  Y APEL  G +  T  ID++S G +I E+I G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 73.8 bits (181), Expect = 5e-14
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 42/230 (18%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G G  GSV   +    G KVA+K+L   +  E   K+ +  E+  + ++ H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81

Query: 568 YCAERS------NRFLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLEY 618
                       + +LV  YM    L K + H    D++Q L        ++Q+  GL+Y
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYL--------VYQMLCGLKY 132

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG---TPGYMA 675
           +H   +  IIH D+KP N+ ++ D  +KI DFGLAR       H      G   T  Y A
Sbjct: 133 IH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRA 182

Query: 676 PELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDY---LVDTLKV 721
           PE+          +DI+S G ++ E++ G+  +  KG DY   L   LKV
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQLTQILKV 230

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.0 bits (187), Expect = 5e-14
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 49/230 (21%)

Query: 510 IRL-GRGGSGSVFEGLLND---GTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNL 562
           IRL G+GG G V+  L  D     +VA+K++          KK FL E +   ++ H  +
Sbjct: 7   IRLIGKGGMGEVY--LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 563 VRLVGYCAERSNRFLVYEYM--CNG----SLDKWIFHKDRIQTLSWDIRKK--------I 608
           V +   C++      VY  M    G    SL K ++ K+   +LS ++ +K        I
Sbjct: 65  VPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKE---SLSKELAEKTSVGAFLSI 118

Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-------- 660
             +I   +EY+H   +  ++H D+KP NILL     V I D+G A     ++        
Sbjct: 119 FHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 661 ------SHVSTMPK---GTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
                     T+P    GTP YMAPE   G   +   DIY+ GV++ +++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 32/274 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           +G G  G V++G  +  G   A+K +   E+  ++E   E+  +    HH N+    G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 570 AERS------NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            ++S        +LV E+   GS+   +    +   L  D    I  +I RGL +LH + 
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN- 682
             K+IH DIK QN+LL  +  VK+ DFG++  + +     +T   GTP +MAPE+   + 
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACDE 197

Query: 683 ----SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED 738
               +   + DI+S G+  +E+         +G   L D   ++A       L+ +    
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM--------AEGAPPLCDMHPMRA-----LFLIPRNPPP 244

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
               +  + K I     CL KN   RPS   L+K
Sbjct: 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)

Query: 503 SATRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGK-KEFLSEVETIGN 556
           SA R F   LG    G +++G L     +    VA+K L    N  +  EF  E   +  
Sbjct: 5   SAVR-FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKK----- 607
           +HH N+V L+G   +     +++EY+  G L +++     H D   +   D   K     
Sbjct: 64  LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 608 -----IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQS 661
                I  QI+ G+EYL  +     +H D+  +NIL+   L+VKI+D GL+R I + D  
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180

Query: 662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
            V         +M PE       ++  DI+SFGVV+ EI
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 18/203 (8%)

Query: 512 LGRGGSGSVF--EGLLNDGTKVAVKRLY---PGENRGKKEFLSEVETIGN--------IH 558
           LG G  G V+      N    +A+K +    P   + K+E    +  I +        + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           H N+VR      E    ++V + +    L + +   K++ Q  + +    I  Q+   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           YLH     +I+H D+ P NI+L  D  V I DFGLA+    +    S +  GT  Y  PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILYSCPE 183

Query: 678 LTRGNSITAKIDIYSFGVVILEI 700
           + +      K D+++FG ++ ++
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 27/207 (13%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKR-LYPGENRGKKEF----LSEVETIGNIHHFNLVR 564
           ++G+G  G VF+         VA+K+ L   EN  K+ F    L E++ +  + H N+V 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLM--ENE-KEGFPITALREIKILQLLKHENVVN 75

Query: 565 LVGYC---AERSNR-----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           L+  C   A   NR     +LV+E+ C   L   + +K+   TLS +I KK++  +  GL
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLS-EI-KKVMKMLLNGL 132

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGY 673
            Y+H     KI+H D+K  NIL+ +D  +K+ADFGLAR  +     + +  T    T  Y
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 674 MAPELTRGN-SITAKIDIYSFGVVILE 699
             PEL  G       ID++  G ++ E
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.4 bits (180), Expect = 2e-13
 Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 30/273 (10%)

Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL-YPGENRGKKEFLS-EVETIGNIHHFNLVRLVGY 568
           LG G +G+V     ++DG   AVK +   G +   K     EV  + N   F++V+    
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 569 CAERSNR--------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF-QISRGLEYL 619
            A++  R         LV +Y   G L + I  + +      +    ++F Q+   + ++
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPEL 678
           H   +  +IH DIK  NILL  +  VK+ DFG +++ A   S  V     GTP Y+APE+
Sbjct: 160 H---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED 738
            R    + K D++S GV++ E++  +R   P  G+ + + +  K  A R   L    S +
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKR---PFDGENMEEVMH-KTLAGRYDPLPPSISPE 272

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
           MQ          +I  + L  +  RRPS+S L+
Sbjct: 273 MQ----------EIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 1/81 (1%)

Query: 98  HQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDG 156
           ++     ++W AN  +P   + TL   +DG+L++ D  GT VWS+ T+  +    + L  
Sbjct: 36  YKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLD 95

Query: 157 NGNLRLYDAENRPHWISFLHP 177
           +GNL LYD++    W SF +P
Sbjct: 96  DGNLVLYDSDGNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 14/195 (7%)

Query: 512 LGRGGSGSVFEGLLN--DGTK-VAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLV 566
           LG G  G+V +G+       K VAVK L    N    K E L E   +  + +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G C E  +  LV E    G L+K++  K++  T       +++ Q+S G++YL +     
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNIT--ELVHQVSMGMKYLEET---N 115

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--VSTMPKGTPGYMAPELTRGNSI 684
            +H D+  +N+LL      KI+DFGL++ +  D+++    T  K    + APE       
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 685 TAKIDIYSFGVVILE 699
           ++K D++SFGV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 10/197 (5%)

Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLVGY 568
           +LG G   +VF+G        VA+K +      G     + EV  + N+ H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   LV+EY+ +  L +++ +   +  +S    K  +FQ+ RGL Y H     KI+
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNL--MSMHNVKIFMFQLLRGLSYCHKR---KIL 125

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-ITAK 687
           H D+KPQN+L++    +K+ADFGLAR  +      S     T  Y  P++  G++  +  
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN-EVVTLWYRPPDVLLGSTEYSTP 184

Query: 688 IDIYSFGVVILEIICGR 704
           ID++  G ++ E+  GR
Sbjct: 185 IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 31/272 (11%)

Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           LG G  G +  G L   +K    VA+  L  G  ++ ++ FL+E  T+G   H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G     +   +V EYM NG+LD   F +     L       ++  ++ G++YL +     
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---G 127

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV--STMPKGTPG-YMAPELTRGNS 683
            +H  +    +L++ DL  KI+ F   R + +D+S    +TM   +P  + APE  + + 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 684 ITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
            ++  D++SFG+V+ E++  G R      G    D +K   +  RL         +  + 
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFRL-----PAPRNCPNL 236

Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
                 + Q+ + C QK    RP  S +  +L
Sbjct: 237 ------LHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 10/119 (8%)

Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
           Q + W +      QI+  L+YLH+     I+H D+K QN+ L R   +K+ D G+AR++ 
Sbjct: 103 QVVEWFV------QIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153

Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV 716
                 ST+  GTP YM+PEL        K D+++ G  + E+   + + N K  + LV
Sbjct: 154 NQCDMASTL-IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 30/221 (13%)

Query: 508 FQIRLGRGGSGSVF----EGLL-------------NDGTKVAVKRLYPGENR-GKKEFLS 549
           F+ +LG G  G V     EG+              N    VAVK L    N+  + +FL 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------FHKDRIQTLS 601
           E++ +  +   N++RL+  C       ++ EYM NG L++++          K  + T+S
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQ 660
           +     +  QI+ G++YL        +H D+  +N L+ ++  +KIADFG++R L + D 
Sbjct: 129 YSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
             +         +M+ E       T   D+++FGV + EI+
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 509 QIRLGRGGSGSVFEGLLNDGTKVA-----------VKRLYPGENRGKKEFLSEVETIGNI 557
           Q RLG+G  G+V+  L+ D   VA           V  L P E     +   E + +  +
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKL 59

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGL 616
            H  +V+      ER    ++ EY     LD K    K   +TLS +   +   Q+  G+
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
            Y+H     +I+H D+K +NI L  +L +KI DFG++RL+      ++T   GTP YM+P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174

Query: 677 ELTRGNSITAKIDIYSFGVVILEIIC 702
           E  +     +K DI+S G ++ E+ C
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 511 RLGRGGSGSVFEGL--LNDGTKVAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLVG 567
           +LG G   +VF+G   L +   VA+K +      G     + EV  + ++ H N+V L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 568 YCAERSNRFLVYEYMCNGSLDKWI--FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                 +  LV+EY     LDK +  +  D    +S    K  ++QI RGL Y H     
Sbjct: 72  IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-I 684
           K++H D+KPQN+L++    +K+ADFGLAR  +      S     T  Y  P++  G+S  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN-EVVTLWYRPPDVLLGSSEY 182

Query: 685 TAKIDIYSFGVVILEIICGR 704
           + +ID++  G +  E+  GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 24/204 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLY-PGEN--RGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L  P ++    K+ +  E+  + ++ H N++ L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 137

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRG 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + + +V+T       Y APE+   
Sbjct: 138 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 191

Query: 682 -NSITAKIDIYSFGVVILEIICGR 704
                  +DI+S G ++ E++ GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRL 565
           +Q  LG G  G+V++       ++   ++ P +     +K+ +SE+E +       ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G     +   +  E+M  GSLD  ++ K     L      +I   + +GL YL      
Sbjct: 65  YGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWSL--- 114

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           KI+H D+KP N+L++    VK+ DFG++    Q  + ++    GT  YMAPE   G    
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 686 AKIDIYSFGVVILEIICGR 704
              D++S G+  +E+  GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 32/226 (14%)

Query: 512 LGRGGSG---SVFEGLLNDGTKVAVKRLYPGENRGKKEFLSE--VETIGNIHHF----NL 562
           LG+G  G   S      ++   VA+K++    N   K+ L++  +  +  + HF    N+
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKI---TNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 563 VRLVGYCAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
             L          F    +YE +    L + I      Q L+    +  I+QI  GL+Y+
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQ-IIRSG--QPLTDAHFQSFIYQILCGLKYI 121

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG---TPGYMAP 676
           H   +  ++H D+KP N+L++ D  +KI DFGLAR  +++    +        T  Y AP
Sbjct: 122 H---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 677 ELTRGN-SITAKIDIYSFGVVILEIICGRRSSNP--KGGDYLVDTL 719
           E+     S T  ID++S G ++ E++  +    P  KG DY VD L
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGKDY-VDQL 219

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 6e-13
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 10/126 (7%)

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE LH +    +I+ D+KP+NILLD   ++ + DFGL +L  +D    +T   GTP Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLA 161

Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL--KVKAEADRLCDLVD 733
           PEL  G+  T  +D ++ GV++ E++ G     P   D  V+ +  K+  E  R  D  D
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGL----PPFYDENVNEMYRKILQEPLRFPDGFD 217

Query: 734 KKSEDM 739
           + ++D+
Sbjct: 218 RDAKDL 223

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFN-LVRLV 566
           ++G G  G V++    N G  VA+K  RL   E       L E+  +  +     +VRL+
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 567 GYCAE-------RSNRFLVYEYMCNGSLDKWI--FHKDRIQTLSWDIRKKIIFQISRGLE 617
               E       + + +LV+EY+ +  L K++    +   + L     K  ++Q+ +G+ 
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKG------- 669
           + H +    ++H D+KPQN+L+D+   + KIAD GL R          ++P         
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--------SIPVKSYTHEIV 173

Query: 670 TPGYMAPELTRGNS-ITAKIDIYSFGVVILEII 701
           T  Y APE+  G++  +  +DI+S G +  E+ 
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.1 bits (171), Expect = 7e-13
 Identities = 43/130 (33%), Positives = 70/130 (53%), Gaps = 8/130 (6%)

Query: 580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL 639
           E+M  GSLD+ +    RI     +I  K+   + RGL YL +    +I+H D+KP NIL+
Sbjct: 83  EHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILV 137

Query: 640 DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
           +    +K+ DFG++    Q    ++    GT  YM+PE  +G   + + DI+S G+ ++E
Sbjct: 138 NSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194

Query: 700 IICGRRSSNP 709
           +  GR    P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 515 GGSGSVFEGLLNDGT-----KVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGY 568
           G  G +F G+L D       +V VK +    +  +    L E   +  + H N++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 569 CAERSNR-FLVYEYMCNGSLDKW-----IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           C E     F++Y YM  G+L  +     +   +  Q LS      +  QI+ G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRG 681
               +IH DI  +N ++D +L VKI D  L+R +     H     +  P  +MA E    
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193

Query: 682 NSITAKIDIYSFGVVILEII 701
              ++  D++SFGV++ E++
Sbjct: 194 KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.2 bits (172), Expect = 8e-13
 Identities = 37/98 (37%), Positives = 58/98 (59%), Gaps = 10/98 (10%)

Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
           ++QI RGL+Y+H   +  ++H D+KP NIL++ + ++KI DFGLAR+    Q    T   
Sbjct: 114 LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYV 166

Query: 669 GTPGYMAPE--LTRGNSITAKIDIYSFGVVILEIICGR 704
            T  Y APE  LT       ++DI+S G +  E++ G+
Sbjct: 167 STRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 1e-12
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 30/273 (10%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCA 570
           +G G  G V++G      ++A  ++       ++E   E+  +    HH N+    G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 571 ERS------NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +++        +LV E+   GS+   I    +  TL  +    I  +I RGL +LH +  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-- 682
            K+IH DIK QN+LL  +  VK+ DFG++  + +     +T   GTP +MAPE+   +  
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACDEN 188

Query: 683 ---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
              +   K D++S G+  +E+         +G   L D   ++A       L+ +     
Sbjct: 189 PDATYDFKSDLWSLGITAIEM--------AEGAPPLCDMHPMRA-----LFLIPRNPAPR 235

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              +  + K      SCL KN  +RP+   L+K
Sbjct: 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 37/209 (17%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKE-F----LSEVETIGNIHHFNLVR 564
           R+  G  G V+       G  VA+K+L   +   +KE F    L E+  +  + H N+V 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 565 L----VGYCAERSNR-FLVYEYMCNGSLDKWIFH--KDRIQTLSWDI----RKKIIFQIS 613
           +    VG      ++ ++V EY+          H  K  ++T+         K ++ Q+ 
Sbjct: 69  VKEVVVG---SNLDKIYMVMEYV---------EHDLKSLMETMKQPFLQSEVKCLMLQLL 116

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
            G+ +LHD     I+H D+K  N+LL+    +KI DFGLAR          T    T  Y
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWY 172

Query: 674 MAPELTRGNSI-TAKIDIYSFGVVILEII 701
            APEL  G    +  ID++S G +  E++
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 10/217 (4%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYC 569
           LG G  G VF+        +  ++L   E +   + + + E++ +   +   +V   G  
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                  +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+H
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIMH 127

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+KP NIL++    +K+ DFG++    Q    ++    GT  YM+PE  +G   + + D
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           I+S G+ ++E+  GR    P     L        E D
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 512 LGRGGSGSV------FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+GG G V        G +    K+  KR+   + +G+   L+E   +  ++   +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 566 VGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDY 622
             Y  E  +   LV   M  G L    FH   +    +D ++ I +  ++  GLE L   
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              +I++ D+KP+NILLD   +++I+D GLA  I + ++    +  GT GYMAPE+    
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176

Query: 683 SITAKIDIYSFGVVILEIICGR 704
             T   D +  G +I E+I G+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 30/206 (14%)

Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFL---SEVE---------TIGNIH 558
           LG+G  G V    L   G   AVK L       KK+ +    +VE         ++   H
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVL-------KKDVILQDDDVECTMTEKRILSLARNH 55

Query: 559 HFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
            F L +L   C +  +R F V E++  G L   +FH  + +       +    +I+  L 
Sbjct: 56  PF-LTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALM 110

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +LHD     II+ D+K  N+LLD + + K+ADFG+ +    +    ST   GTP Y+APE
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPE 166

Query: 678 LTRGNSITAKIDIYSFGVVILEIICG 703
           + +       +D ++ GV++ E++CG
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLVGY 568
           +LG G   +V++G    +G  VA+K +   E  G     + E   +  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQ-------TLSWDIRKKIIFQISRGLEYLHD 621
              +    LV+EY+          H D  Q        L  +  K  +FQ+ RGL Y+H 
Sbjct: 72  IHTKETLTLVFEYV----------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                I+H D+KPQN+L+     +K+ADFGLAR  +   SH  +    T  Y  P++  G
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLG 177

Query: 682 NS-ITAKIDIYSFGVVILEIICG 703
           ++  +  +D++  G + +E+I G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 33/215 (15%)

Query: 502 KSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGN 556
           ++   DF++  R+G G  G V++   +N G   A+K  +L PGE+    +   E+  + +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKD 62

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR-- 614
             H N+V   G    R   ++  E+   GSL   I+H      ++  + +  I  +SR  
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYH------VTGPLSESQIAYVSRET 115

Query: 615 --GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG----LARLIAQDQSHVSTMPK 668
             GL YLH   +   +H DIK  NILL  + +VK+ADFG    +   IA+ +S +     
Sbjct: 116 LQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI----- 167

Query: 669 GTPGYMAPELT---RGNSITAKIDIYSFGVVILEI 700
           GTP +MAPE+    R        DI++ G+  +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 14/198 (7%)

Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETI-GNIHHFNLVRLV 566
           +G+G  G V       DG   AVK L        + +K  ++E   +  N+ H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 567 GYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            Y  + + + + V +++  G L    FH  R ++      +    +I+  L YLH     
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHSI--- 115

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            I++ D+KP+NILLD   +V + DFGL +     QS  +T   GTP Y+APE+ R     
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 686 AKIDIYSFGVVILEIICG 703
             +D +  G V+ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFN 561
           R +++ LG+GG G V    +   G   A KRL      + +G+   L+E + +  ++   
Sbjct: 3   RQYRV-LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 562 LVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEY 618
           +V L  Y  E  +   LV   M  G L    FH   +    ++  + + +  +I  GLE 
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFEEERALFYAAEILCGLED 117

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL 678
           LH       ++ D+KP+NILLD   +++I+D GLA  I + +S    +  GT GYMAPE+
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEV 172

Query: 679 TRGNSITAKIDIYSFGVVILEIICGR 704
                 T   D +  G +I E+I G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 501 MKSATRDFQIRLGRGGSGSVFEGLLNDGT--KVAVKRLYPGENRGKKEF---LSEVETIG 555
           MK    +F   LG G  G V      +     VA+KR    +   +K+     SE + + 
Sbjct: 27  MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86

Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
            I+H   V L G   + S  +LV E++  G    ++    R      D+      QI   
Sbjct: 87  YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---DVGCFYAAQIVLI 143

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
            EYL       I++ D+KP+N+LLD+D  +K+ DFG A+++    +   T+  GTP Y+A
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEYIA 196

Query: 676 PELTRGNSITAKIDIYSFGVVILEIICG 703
           PE+          D ++ G+ I EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 512 LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE---FLSEVETI-GNIHHFNLV 563
           +G+G  G V   LL    +DG+  AVK L       KKE    ++E   +  N+ H  LV
Sbjct: 3   IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 564 RLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
            L  Y  + + + + V +Y+  G L    FH  R +       +    +++  + YLH  
Sbjct: 60  GL-HYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
               II+ D+KP+NILLD   +V + DFGL +   + +   ST   GTP Y+APE+ R  
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKE 171

Query: 683 SITAKIDIYSFGVVILEIICG 703
                +D +  G V+ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 25/207 (12%)

Query: 509 QIR-LGRGGSG---SVFEGLLNDGTKVAVKRL-YPGENRGK-KEFLSEVETIGNIHHFNL 562
           Q++ +G G  G   + F+ +L  G  VAVK+L  P +N+   K    E+  +  ++H N+
Sbjct: 25  QLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 563 VRLVGY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           + L+          E  + +LV E M + +L + + H +    L  +    +++Q+  G+
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQ-VIHME----LDHERMSYLLYQMLCGI 136

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           ++LH   +  IIH D+KP NI++  D  +KI DFGLAR    +   + T    T  Y AP
Sbjct: 137 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAP 191

Query: 677 ELTRGNSITAKIDIYSFGVVILEIICG 703
           E+  G      +DI+S G ++ E++ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 24/172 (13%)

Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT----- 599
           K F+   + I    +FN +  + +   + N   +  Y    +L   +   D I+      
Sbjct: 42  KLFV--QKII-KAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98

Query: 600 -------LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN-VKIADFG 651
                  LS    KKII Q+   L  LH +    IIH DIK +N+L DR  + + + D+G
Sbjct: 99  LLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155

Query: 652 LARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           L ++I     +      GT  Y +PE  +G++     D ++ GV+  E++ G
Sbjct: 156 LCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG G V    +   G   A K+L      + +G+   L+E + +  ++   +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 568 YCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCN 624
           Y  E  +   LV   M  G L    FH   +    +D  + + +  +I+ GLE LH    
Sbjct: 67  YAYETKDALCLVLTLMNGGDLK---FHIYNMGNPGFDEERAVFYAAEITCGLEDLH---R 120

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            +I++ D+KP+NILLD   +++I+D GLA  I + ++    +  GT GYMAPE+ +    
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERY 178

Query: 685 TAKIDIYSFGVVILEIICGR 704
           T   D +  G +I E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 26/205 (12%)

Query: 511 RLGRGGSGSVFEGL--LNDGTKVAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLVG 567
           +LG G   +V++G   L D   VA+K +      G     + EV  + ++ H N+V L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 +  LV+EY+ +  L +++   D   +++    K  +FQ+ RGL Y H     K+
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYL--DDCGNSINMHNVKLFLFQLLRGLNYCH---RRKV 125

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-------YMAPELTR 680
           +H D+KPQN+L++    +K+ADFGLAR          ++P  T         Y  P++  
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--------AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 681 GNS-ITAKIDIYSFGVVILEIICGR 704
           G++  + +ID++  G +  E+  GR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 24/197 (12%)

Query: 516 GSGSVFEGLL----NDGTKVAVKRL-YPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           G GS    LL    N   K A+K +  P  +   ++   E   +  + H N+V       
Sbjct: 9   GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE 68

Query: 571 ERSNRFLVYEYMCNGSLDKWI-------FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
              + ++V EY   G L + I       F +D I  L W        Q+  G++++H+  
Sbjct: 69  ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQW------FVQMCLGVQHIHE-- 118

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             +++H DIK +NI L ++  VK+ DFG ARL+    ++  T   GTP Y+ PE+     
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMP 176

Query: 684 ITAKIDIYSFGVVILEI 700
              K DI+S G ++ E+
Sbjct: 177 YNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 28/206 (13%)

Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLVGY 568
           +LG G   +V++G+   +G  VA+K +      G     + E   +  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS--------WDIRKKIIFQISRGLEYLH 620
              +     V+EYM          H D  Q +         +++R   +FQ+ RGL Y+H
Sbjct: 72  IHTKETLTFVFEYM----------HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH 120

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPGYMAPELT 679
                 I+H D+KPQN+L+     +K+ADFGLAR  +   Q++ S +   T  Y  P++ 
Sbjct: 121 ---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175

Query: 680 RGNS-ITAKIDIYSFGVVILEIICGR 704
            G +  ++ +DI+  G + +E++ G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 510 IRLGRGGSGSVFEGLLND---------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHH 559
             LG+G   ++++G+L           G +V+V     G + R    F      +  + H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            +LV+L G C    N  +V EY+  G LD ++  +    +L W +   +  Q++  L YL
Sbjct: 61  KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHYL 117

Query: 620 HDYCNPKIIHFDIKPQNILLDRD-------LNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
            D    K++H ++  +NIL+ R          +K++D G+   +   +  V  +P     
Sbjct: 118 ED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----- 169

Query: 673 YMAPELTRG--NSITAKIDIYSFGVVILEIICG 703
           ++APE  R    S+T   D +SFG  +LEI   
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.1 bits (164), Expect = 7e-12
 Identities = 61/197 (30%), Positives = 89/197 (45%), Gaps = 12/197 (6%)

Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKE---FLSEVET-IGNIHHFNLVRLV 566
           +G+G  G V       DG   AVK L       KKE    ++E    + N+ H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                    + V +Y+  G L    FH  R ++      +    +I+  L YLH      
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHSL---N 116

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
           II+ D+KP+NILLD   +V + DFGL +   +     ST   GTP Y+APE+ R      
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPYDR 175

Query: 687 KIDIYSFGVVILEIICG 703
            +D +  G V+ E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score = 62.7 bits (153), Expect = 7e-12
 Identities = 27/80 (33%), Positives = 46/80 (57%), Gaps = 1/80 (1%)

Query: 98  HQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET-SGSNVTRITLDG 156
           +++    ++W AN  +PV ++ TL   +DG+L+L D DG  VWS+ T   +    + L  
Sbjct: 35  YKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLD 94

Query: 157 NGNLRLYDAENRPHWISFLH 176
           +GNL +YD++    W SF +
Sbjct: 95  DGNLVIYDSDGNFLWQSFDY 114

Length = 114

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 34/210 (16%)

Query: 512 LGRGGSGSVFEGLLN--DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-----HHFNLVR 564
           +G+G  G V++ + N  DG+  AVK L P       +   E+E   NI     +H N+V+
Sbjct: 30  IGKGTYGKVYK-VTNKKDGSLAAVKILDP-----ISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 565 LVG--YCAER---SNRFLVYEYMCNG----SLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
             G  Y A++      +LV E +CNG     L K +      Q L   +   I++    G
Sbjct: 84  FYGMFYKADKLVGGQLWLVLE-LCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLG 140

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           L++LH   N +IIH D+K  NILL  +  VK+ DFG++  +   +   +T   GTP +MA
Sbjct: 141 LQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMA 196

Query: 676 PELTR-----GNSITAKIDIYSFGVVILEI 700
           PE+         S  A+ D++S G+  +E+
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 511 RLGRGGSGSVFEGL--LNDGTKVAVK--RLYPGENRGKKEF--LSEVETIGNIHHFNLVR 564
           +LG G   +V++G   L     VA+K  RL   E      F  + E   + ++ H N+V 
Sbjct: 12  KLGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVT 67

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR-------KKIIFQISRGLE 617
           L      +    LV+EY+            D  Q +            +  +FQ+ RGL 
Sbjct: 68  LHDIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSH-VSTMPKGTPGY 673
           Y H     +++H D+KPQN+L+     +K+ADFGLAR   + ++  S+ V T+      Y
Sbjct: 118 YCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL-----WY 169

Query: 674 MAPELTRGNS-ITAKIDIYSFGVVILEIICGR 704
             P++  G++  +  +D++  G +  E+  GR
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 507 DFQIR--LGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKE---FLSEVETIGNIHHF 560
           DF++   LG G  G V        G   A+K L   E    K+      E   +  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            +V ++    + +  + + E++  G L     H  +      D+ K    ++    EYLH
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGEL---FTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  II+ D+KP+N+LLD   +VK+ DFG A+ +      +     GTP Y+APE+ +
Sbjct: 136 ---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVIQ 188

Query: 681 GNSITAKIDIYSFGVVILEIICG 703
                  +D ++ GV++ E I G
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 36/211 (17%)

Query: 512 LGRGGSGSVFEGLLN--DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-----HHFNLVR 564
           +G+G  G VF+ +LN  +G+K AVK L P       +   E+E   NI      H N+V+
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKALSDHPNVVK 79

Query: 565 LVGYCAERSNR-----FLVYEYMCNG----SLDKWIFHK-DRIQTLSWDIRKKIIFQISR 614
             G   ++  +     +LV E +CNG     L K    + +R++     I   I+ +   
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLE-LCNGGSVTDLVKGFLKRGERMEEP---IIAYILHEALM 135

Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           GL++LH     K IH D+K  NILL  +  VK+ DFG++  +   +   +T   GTP +M
Sbjct: 136 GLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWM 191

Query: 675 APELTR-----GNSITAKIDIYSFGVVILEI 700
           APE+        ++  A+ D++S G+  +E+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 7/94 (7%)

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GLE++H   N  +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 158

Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICG 703
            GYMAPE L +G +  +  D +S G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 36/95 (37%), Positives = 62/95 (65%), Gaps = 8/95 (8%)

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +++  L++LH   +  II+ D+KP+NILLD + ++K+ DFGL++  + D    +    GT
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGT 161

Query: 671 PGYMAPELT--RGNSITAKIDIYSFGVVILEIICG 703
             YMAPE+   RG++ +A  D +SFGV++ E++ G
Sbjct: 162 VEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 8/129 (6%)

Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           L+ +Y+  G L   ++ ++        +    I +I   L++LH      II+ DIK +N
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRV---YIAEIVLALDHLHQL---GIIYRDIKLEN 135

Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI--TAKIDIYSFG 694
           ILLD + +V + DFGL++    ++   +    GT  YMAPE+ RG S      +D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195

Query: 695 VVILEIICG 703
           V+  E++ G
Sbjct: 196 VLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 41/132 (31%), Positives = 70/132 (53%), Gaps = 13/132 (9%)

Query: 576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCNPKIIHFDI 632
           + V EY+  G L   ++H   IQ +        +F   +I+ GL +LH   +  II+ D+
Sbjct: 77  YFVMEYVNGGDL---MYH---IQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDL 127

Query: 633 KPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYS 692
           K  N++LD + ++KIADFG+ +          T   GTP Y+APE+         +D ++
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 693 FGVVILEIICGR 704
           FGV++ E++ G+
Sbjct: 187 FGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 8/176 (4%)

Query: 531 VAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD 588
           VA+K+    E     K+  L E++ +  +   N+V L      R   +LV+EY+    L+
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIA 648
                 + +     +  +  I+Q+ + + + H      I+H DIKP+N+L+  +  +K+ 
Sbjct: 89  LLEEMPNGVPP---EKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC 142

Query: 649 DFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           DFG AR +++  +   T    T  Y +PEL  G      +D++S G ++ E+  G+
Sbjct: 143 DFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 46/137 (33%), Positives = 75/137 (54%), Gaps = 19/137 (13%)

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GLE++H   N  +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 158

Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL- 728
            GYMAPE L +G +  +  D +S G ++ +++   R  +P    +     K K E DR+ 
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL---RGHSP----FRQHKTKDKHEIDRMT 211

Query: 729 ----CDLVDKKSEDMQS 741
                +L D  S +++S
Sbjct: 212 LTVNVELPDSFSPELKS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 502 KSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGN 556
           ++   D+++  R+G G  G V++   L+ G   AVK  +L PG++    +   E+  +  
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKE 62

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK----DRIQTLSWDIRKKIIFQI 612
             H N+V   G    R   ++  EY   GSL   I+H       +Q +++  R+ +    
Sbjct: 63  CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ-IAYVCRETL---- 116

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---- 668
            +GL YLH       +H DIK  NILL  + +VK+ADFG+A  I       +T+ K    
Sbjct: 117 -QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKIT------ATIAKRKSF 166

Query: 669 -GTPGYMAPELT---RGNSITAKIDIYSFGVVILEI 700
            GTP +MAPE+    +        DI++ G+  +E+
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 15/102 (14%)

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +++Q+  G+++LH   +  IIH D+KP NI++  D  +KI DFGLAR      +  S M 
Sbjct: 123 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMM 174

Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             TP      Y APE+  G      +DI+S G ++ E+I G 
Sbjct: 175 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.2 bits (156), Expect = 6e-11
 Identities = 41/128 (32%), Positives = 69/128 (53%), Gaps = 7/128 (5%)

Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           L+ +Y+  G +   ++ +D     S D  +    +I   LE+LH      I++ DIK +N
Sbjct: 82  LILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLEN 135

Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK-IDIYSFGV 695
           ILLD + +V + DFGL++    ++   +    GT  YMAPE+ RG     K +D +S G+
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195

Query: 696 VILEIICG 703
           +I E++ G
Sbjct: 196 LIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 24/204 (11%)

Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 567 G-YCAERS-----NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
             +  ++S     + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
           G      +DI+S G ++ E+I G 
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.4 bits (157), Expect = 7e-11
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 7/100 (7%)

Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS--TM 666
           ++Q+ R L+Y+H      + H D+KP+NIL + D  +KI DFGLAR+   D       T 
Sbjct: 109 LYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 667 PKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGR 704
              T  Y APEL     +  T  IDI+S G +  E++ G+
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG----------ENRGKKEFLSEVETIGNI 557
           LG+GG G VF+     G       A+K L               + ++  L  V+     
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK----- 58

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           H F +V L+         +L+ EY+  G L     H +R      D     + +IS  LE
Sbjct: 59  HPF-IVDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLALE 114

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +LH      II+ D+KP+NILLD   +VK+ DFGL +    + +   T   GT  YMAPE
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPE 170

Query: 678 -LTRGNSITAKIDIYSFGVVILEIICG 703
            L R     A +D +S G ++ +++ G
Sbjct: 171 ILMRSGHGKA-VDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 35/212 (16%)

Query: 512 LGRGGSGSVFEGLLNDGT-------------KVAVKRLYPGENRGKKEFLSEVETIGNIH 558
           LGRG    ++ G+LN                KV +K L P        F      +  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           H ++V L G C       +V E++  G LD ++  K  + T  W    K+  Q++  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASALSY 120

Query: 619 LHDYCNPKIIHFDIKPQNILLDRD-------LNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           L D     ++H ++  +NILL R+         +K++D G+   +   Q  V  +P    
Sbjct: 121 LED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP---- 173

Query: 672 GYMAPEL---TRGNSITAKIDIYSFGVVILEI 700
            ++APE    ++  SI A  D +SFG  + EI
Sbjct: 174 -WIAPECVEDSKNLSIAA--DKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)

Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVY-EYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L E   + N++H +++R+       +   +V   Y      D + +   R + L  D   
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSRPLPIDQAL 160

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            I  QI  GL YLH     +IIH D+K +NI ++    V I D G A+      + +   
Sbjct: 161 IIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL- 216

Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
             GT    APE+   +   +K DI+S G+V+ E++
Sbjct: 217 -AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 4/92 (4%)

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           +Q++RG+E+L    +   +H D+  +N+LL +   VKI DFGLAR I  D ++VS     
Sbjct: 244 YQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEI 700
            P  +MAPE    N  T   D++S+G+++ EI
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 52/267 (19%)

Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSAT-----RDFQI--RLGRGGSGSVFEGLLNDGT 529
           R++K+ D       N L ++   A K         DF +   +GRG  G V         
Sbjct: 16  RKNKNID-------NFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK 68

Query: 530 KV-AVKRLYPGE--NRGKKEFLSEVETIGNIHHFN---LVRLVGYCAERSNRFL--VYEY 581
           +V A+K L   E   R    F  E   I  + H N   +V+L  + A + +++L  V EY
Sbjct: 69  QVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQL--HYAFQDDKYLYMVMEY 124

Query: 582 MCNGSLDKWIFHKDRIQTLS-WDIRKK----IIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           M  G         D +  +S +DI +K       ++   L+ +H       IH D+KP N
Sbjct: 125 MPGG---------DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDN 172

Query: 637 ILLDRDLNVKIADFGLA-RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA----KIDIY 691
           +LLD+  ++K+ADFG   ++ A       T   GTP Y++PE+ +          + D +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 692 SFGVVILEIICGRRSSNPKGGDYLVDT 718
           S GV + E++ G     P   D LV T
Sbjct: 232 SVGVFLYEMLVG---DTPFYADSLVGT 255

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 44/127 (34%), Positives = 73/127 (57%), Gaps = 13/127 (10%)

Query: 596 RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL 655
           + Q LS +  + +I+Q+ RGL+Y+H   +  IIH D+KP N+ ++ D  ++I DFGLAR 
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167

Query: 656 IAQDQS-HVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGD 713
              + + +V+T       Y APE+          +DI+S G ++ E++ G ++  P G D
Sbjct: 168 ADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG-KALFP-GND 220

Query: 714 YLVDTLK 720
           Y +D LK
Sbjct: 221 Y-IDQLK 226

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 4e-10
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 7/179 (3%)

Query: 530 KVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK 589
           KV  K +   + R      SE+  +    HF +V+            L+ EY   G L+K
Sbjct: 95  KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK 154

Query: 590 WIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI 647
            I    K+ +    +++   + +QI   L+ +H      ++H D+K  NI L     +K+
Sbjct: 155 QIKQRLKEHLPFQEYEV-GLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKL 210

Query: 648 ADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR 705
            DFG ++  +   S  V++   GTP Y+APEL      + K D++S GV++ E++   R
Sbjct: 211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 43/140 (30%), Positives = 74/140 (52%), Gaps = 14/140 (10%)

Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCN 624
           C +  +R + V EY+  G L   ++    IQ +        +F   +I+ GL +LH   +
Sbjct: 69  CFQTMDRLYFVMEYVNGGDL---MYQ---IQQVGRFKEPHAVFYAAEIAIGLFFLH---S 119

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             II+ D+K  N++LD + ++KIADFG+ +    D     T   GTP Y+APE+      
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPY 178

Query: 685 TAKIDIYSFGVVILEIICGR 704
              +D ++FGV++ E++ G+
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 44/140 (31%), Positives = 75/140 (53%), Gaps = 14/140 (10%)

Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCN 624
           C +  +R + V EY+  G L   ++H   IQ +      + +F   +IS GL +LH    
Sbjct: 69  CFQTVDRLYFVMEYVNGGDL---MYH---IQQVGKFKEPQAVFYAAEISVGLFFLHR--- 119

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             II+ D+K  N++LD + ++KIADFG+ +    D     T   GTP Y+APE+      
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQPY 178

Query: 685 TAKIDIYSFGVVILEIICGR 704
              +D +++GV++ E++ G+
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 62.0 bits (150), Expect = 6e-10
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 18/161 (11%)

Query: 549 SEVETIGNIHHFNLVRL--------VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTL 600
           +E+  +G ++H N++++          Y   +   F +Y +M + + D W   KDR   L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W---KDR--PL 265

Query: 601 SWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ 660
               R  I+ Q+   +EY+HD    K+IH DIK +NI L+ D  + + DFG A    +++
Sbjct: 266 LKQTRA-IMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
                   GT    +PE+  G+      DI+S G+++L+++
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 21/224 (9%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKE---FLSEVETIGNIHHF 560
           DF+I   +GRG  G V    L +  KV A+K L   E   + E   F  E + + N  + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYL 619
            +  L     + +N +LV +Y   G L   +   +DR   L  D+ +  + ++   ++ +
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEMVIAIDSV 118

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           H       +H DIKP NIL+D + ++++ADFG    + +D +  S++  GTP Y++PE+ 
Sbjct: 119 HQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 680 RG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
           +           + D +S GV + E++ G     P   + LV+T
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGE---TPFYAESLVET 216

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 8/129 (6%)

Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           L+ +Y+  G L   +  ++R +     I      +I   LE+LH      II+ DIK +N
Sbjct: 82  LILDYINGGELFTHLSQRERFKEQEVQI---YSGEIVLALEHLHKL---GIIYRDIKLEN 135

Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI--TAKIDIYSFG 694
           ILLD + +V + DFGL++   +D+   +    GT  YMAP++ RG        +D +S G
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMG 195

Query: 695 VVILEIICG 703
           V++ E++ G
Sbjct: 196 VLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.3 bits (148), Expect = 8e-10
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 24/201 (11%)

Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 136

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 681 GNSITAKIDIYSFGVVILEII 701
           G      +DI+S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 8/165 (4%)

Query: 540 ENRGKKEFLSEVETI-GNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ 598
           + + +K  +SE   +  N+ H  LV L          + V +Y+  G L    +H  R +
Sbjct: 35  KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRER 91

Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ 658
                  +    +I+  L YLH      I++ D+KP+NILLD   ++ + DFGL +   +
Sbjct: 92  CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148

Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                ST   GTP Y+APE+         +D +  G V+ E++ G
Sbjct: 149 HNGTTSTFC-GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.5 bits (146), Expect = 9e-10
 Identities = 81/304 (26%), Positives = 128/304 (42%), Gaps = 41/304 (13%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++GRG  G V++    DG       L   E  G       E+  +  + H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 570 AERSNR--FLVYEYMCNGSLDKW---IFHK-----DRIQTLSWDIRKKIIFQISRGLEYL 619
              S+R  +L+++Y      D W    FH+      +   L   + K +++QI  G+ YL
Sbjct: 68  LSHSDRKVWLLFDY---AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 620 HDYCNPKIIHFDIKPQNILL-----DRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPG 672
           H      ++H D+KP NIL+     +R   VKIAD G ARL       ++ +     T  
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 673 YMAPELTRG-NSITAKIDIYSFGVVILEIICGR----------RSSNPKGGDYLVDTLKV 721
           Y APEL  G    T  IDI++ G +  E++             ++SNP   D L     V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 722 KA-EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNL--HRRPSASMLVKVLQGLT 778
               AD+  + + K  E     +D   +    A S L K +  H+    S +  +LQ L 
Sbjct: 241 MGFPADKDWEDIRKMPEYPTLQKD--FRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298

Query: 779 KLEP 782
            ++P
Sbjct: 299 TMDP 302

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 31/191 (16%)

Query: 526 NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY-EYMCN 584
               KV VK +  G+  G      E++ +  I H  ++ L+     +S   +V  +Y C+
Sbjct: 117 EQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL----EYLHDYCNPKIIHFDIKPQNILLD 640
             L  ++   DR   L      +    I R L     YLH      IIH D+K +NI LD
Sbjct: 172 --LFTYV---DRSGPLPL----EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLD 219

Query: 641 RDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAPELTRGNSITAKIDIYSFGV 695
              N  + DFG A    +  +H  T P+     GT    +PEL   +   AK DI+S G+
Sbjct: 220 EPENAVLGDFGAA---CKLDAHPDT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGL 275

Query: 696 VILEIICGRRS 706
           V+ E+     +
Sbjct: 276 VLFEMSVKNVT 286

Length = 392

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 62/247 (25%), Positives = 104/247 (42%), Gaps = 55/247 (22%)

Query: 506 RDFQ-IR-LGRGGSGSVFEGLLND-GT------KVAVKRLYPGENRGK-KEFLSEVETIG 555
           + F+ I+ LG+G  G VF  L+   GT      KV  K+      R K K  L+E E + 
Sbjct: 1   KHFKKIKLLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEM--IKRNKVKRVLTEQEILA 56

Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQI 612
            + H  L  L       +   LV +Y   G L    F   + Q    LS ++ +    ++
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEV 112

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA-------RLIAQDQSHVST 665
              LEYLH      I++ D+KP+NILL    ++ ++DF L+         +++     S 
Sbjct: 113 LLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 666 MPK---------------------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
                                   GT  Y+APE+  G+   + +D ++ G+++ E++ G 
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Query: 705 ---RSSN 708
              + SN
Sbjct: 230 TPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 30/221 (13%)

Query: 504 ATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLY-PGENRGKKEFLSEVETIGN 556
           +T  F   LG    G V++G L           VA+K L    E   ++EF  E      
Sbjct: 5   STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKK----- 607
           + H N+V L+G   +     +++ Y  +  L +++     H D   T      K      
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 608 ----IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSH 662
               I+ QI+ G+E+L  +    ++H D+  +N+L+   LNVKI+D GL R + A D   
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181

Query: 663 V---STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
           +   S +P     +M+PE       +   DI+S+GVV+ E+
Sbjct: 182 LMGNSLLPI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 4/102 (3%)

Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
           LS+       +Q++ G+E+L    +   +H D+  +N+L+     VKI DFGLAR I +D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 660 QSHVSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEI 700
            +++S      P  +MAPE    N  T   D++SFG+++ EI
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 10/138 (7%)

Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           C +  +R F V EY+  G L   +F   R +       +    +++  L +LH +    +
Sbjct: 64  CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL-IAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
           I+ D+K  NILLD + + K+ADFG+ +  I       +T   GTP Y+APE+ +      
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGP 175

Query: 687 KIDIYSFGVVILEIICGR 704
            +D ++ GV++ E++ G+
Sbjct: 176 SVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 45/223 (20%)

Query: 512 LGRGGSGSVFEGLLN--------DGTKVAVKRLYPGENRGKK-----------------E 546
           LG+G   ++++G L         +        L  G N G++                  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 547 FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-LSWDIR 605
           F      +  + H +L  + G C   S   +V E++ +G LD  +  K++ +  ++W I 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAWKI- 120

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-------DLNVKIADFGLARLIAQ 658
             +  Q++  L YL D     ++H ++  +NILL R          +K++D G++     
Sbjct: 121 -TVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176

Query: 659 DQSHVSTMPKGTPGYMAPELTR-GNSITAKIDIYSFGVVILEI 700
            +  V  +P     ++APE    GNS++   D +SFG  +LEI
Sbjct: 177 REERVERIP-----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 574 NRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI 632
           N +LV +Y   G L   +   +DR+     D+ +  + ++   ++ +H       +H DI
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFEDRLPE---DMARFYLAEMVLAIDSVHQL---GYVHRDI 128

Query: 633 KPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-----NSITAK 687
           KP N+LLD++ ++++ADFG    +  D +  S +  GTP Y++PE+ +           +
Sbjct: 129 KPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPE 188

Query: 688 IDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
            D +S GV + E++ G     P   + LV+T
Sbjct: 189 CDWWSLGVCMYEMLYG---ETPFYAESLVET 216

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 43/306 (14%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++GRG  G V++    DG       L   E  G       E+  +  + H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 570 AERSNR--FLVYEYMCNGSLDKW---IFHK-----DRIQTLSWDIRKKIIFQISRGLEYL 619
              ++R  +L+++Y      D W    FH+      +   L   + K +++QI  G+ YL
Sbjct: 68  LSHADRKVWLLFDY---AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 620 HDYCNPKIIHFDIKPQNILL-----DRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPG 672
           H      ++H D+KP NIL+     +R   VKIAD G ARL       ++ +     T  
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 673 YMAPELTRG-NSITAKIDIYSFGVVILEIICGR----------RSSNPKGGDYLVDTLKV 721
           Y APEL  G    T  IDI++ G +  E++             ++SNP   D L     V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 722 KA-EADRLCDLVDKKSED---MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
               AD+  + + K  E    M+  R +      + I  ++K  H+    S    +LQ L
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL-IKYMEK--HKVKPDSKAFHLLQKL 297

Query: 778 TKLEPV 783
             ++P+
Sbjct: 298 LTMDPI 303

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 53.2 bits (128), Expect = 7e-09
 Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 8/90 (8%)

Query: 347 THLSCQFKHLQ-RFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLST 405
           T L+C        FLKL +V   D    +  I  E C+ ACL NCSC A  +       +
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN----GS 56

Query: 406 GNCSLPTEIYTLRNSTKVISGYNDITFIKV 435
           G C L   +  L N   + SG   + ++++
Sbjct: 57  GGCLLWNGL--LNNLRSLSSGGGTL-YLRL 83

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 22/152 (14%)

Query: 568 YCAERSNRFL--VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +C+  + R L  V EY+  G     + +   I  L  D+ +    +    LEYLH+Y   
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY--- 120

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARL-------------IAQD-QSHVSTMPKGTP 671
            I+H D+KP N+L+    ++K+ DFGL+++             I +D +  +     GTP
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            Y+APE+         +D ++ G+++ E + G
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.6 bits (141), Expect = 1e-08
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 34/194 (17%)

Query: 540 ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRI 597
           + R K + + EV  +  + H N+VR +     ++N+  +++ E+   G L + I    + 
Sbjct: 52  KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKC 108

Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCN--------PKIIHFDIKPQNILLD--------- 640
             +   I +  I  I+R L +   YC+         +++H D+KPQNI L          
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168

Query: 641 ----RDLN----VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT--RGNSITAKIDI 690
                +LN     KI DFGL++ I  +    S +  GTP Y +PEL      S   K D+
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDM 226

Query: 691 YSFGVVILEIICGR 704
           ++ G +I E+  G+
Sbjct: 227 WALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 31/229 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-- 562
           DF+I   +GRG  G V    +        +R+Y  +   K E L   ET       N+  
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKH-----TERIYAMKILNKWEMLKRAETACFREERNVLV 56

Query: 563 ------VRLVGYCAERSNR-FLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISR 614
                 +  + Y  +  N  +LV +Y   G L   +   +DR   L  D+ +  I ++  
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMVL 113

Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            +  +H       +H DIKP N+LLD + ++++ADFG    + QD +  S++  GTP Y+
Sbjct: 114 AIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170

Query: 675 APELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
           +PE+ +           + D +S GV + E++ G     P   + LV+T
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---TPFYAESLVET 216

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 512 LGRGGSGSVFEGLLNDGTKVA---VKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G G  G V    +   T VA   VK L    + + + EFL + +    + H N+++ +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 568 YCAERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            C E     LV+EY   G L  ++    +H+   Q L   + +++  +I+ G+ ++H + 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGVTHMHKH- 118

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELT--- 679
               +H D+  +N  L  DL VK+ D+G+     ++    +   K  P  ++APEL    
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 680 RGNSITAK----IDIYSFGVVILEI 700
            G  ITA+     ++++ GV + E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 23/264 (8%)

Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRL 536
           R++K+ D         + K     MK+   D    +GRG  G V         KV   +L
Sbjct: 16  RKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75

Query: 537 YPGENRGKKE----FLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKW 590
                  K+     F  E + +   +   +V+L  +CA + +++L  V EYM  G L   
Sbjct: 76  LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNL 133

Query: 591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF 650
           + + D  +   W   K    ++   L+ +H      +IH D+KP N+LLD+  ++K+ADF
Sbjct: 134 MSNYDVPE--KW--AKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF 186

Query: 651 GLARLIAQDQSHVSTMPKGTPGYMAPELTR---GNSITAK-IDIYSFGVVILEIICGRRS 706
           G    + +          GTP Y++PE+ +   G+    +  D +S GV + E++ G   
Sbjct: 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--- 243

Query: 707 SNPKGGDYLVDTL-KVKAEADRLC 729
             P   D LV T  K+    + L 
Sbjct: 244 DTPFYADSLVGTYSKIMDHKNSLN 267

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 61/230 (26%)

Query: 530 KVAVKRLYPGENRGKKEFL---------SEVETIGNIHHFNLVRLVGYCAERSNRFLVYE 580
           KV  K LY  +   KK+ L         +E + +    +  +VRL     ++ N + V +
Sbjct: 22  KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81

Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD 640
           Y+  G +   +    R+     D+ +  I +++  +E +H       IH DIKP NIL+D
Sbjct: 82  YIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILID 135

Query: 641 RDLNVKIADFGLA----------------------------------------------R 654
           RD ++K+ DFGL                                               R
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195

Query: 655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
              Q Q  ++    GTP Y+APE+      T   D +S GV++ E++ G+
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 16/167 (9%)

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D ++V      
Sbjct: 221 YQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++S+G+++ EI     S  P         + V ++  ++
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG--------MPVDSKFYKM 329

Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                K+   M S      +M  I  SC   +  +RP+   +V++++
Sbjct: 330 I----KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 48/185 (25%)

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V+L     ++ N + V +Y+  G +   +    R+     D+ +  I +++  +E +H 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVH- 118

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLA---------------------------R 654
                 IH DIKP NIL+DRD ++K+ DFGL                             
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 655 LIAQDQSHVSTMPK---------------GTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
               D+  +  + +               GTP Y+APE+      T   D +S GV++ E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 700 IICGR 704
           ++ G+
Sbjct: 237 MLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 46/199 (23%)

Query: 539 GENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ 598
           G  R +++ L E +++       +V++     ++ N +L+ E++  G +   +  KD   
Sbjct: 46  GHIRAERDILVEADSLW------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--- 96

Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL------ 652
           TL+ +  +  I +    ++ +H       IH DIKP N+LLD   +VK++DFGL      
Sbjct: 97  TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153

Query: 653 ----------------------------ARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
                                       A    +++  ++    GTP Y+APE+      
Sbjct: 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213

Query: 685 TAKIDIYSFGVVILEIICG 703
               D +S GV++ E++ G
Sbjct: 214 NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 4/101 (3%)

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
            Q+++G+++L    +   IH D+  +N+LL      KI DFGLAR I  D ++V      
Sbjct: 219 SQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275

Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP 709
            P  +MAPE       T + D++S+G+++ EI    +S  P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 512 LGRGGSGSVFEGL---LNDG-----TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           LG+G    +F+G+   + D      T+V +K L        + F      +  + H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
              G C       +V EY+  GSLD ++     +  +SW +  ++  Q++  L +L D  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL--EVAKQLAWALHFLED-- 118

Query: 624 NPKIIHFDIKPQNILLDRDLN--------VKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
              + H ++  +N+LL R+ +        +K++D G++  +   +  +  +P     ++ 
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-----WVP 172

Query: 676 PE-LTRGNSITAKIDIYSFGVVILEIICG 703
           PE +    +++   D +SFG  + EI  G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 66/251 (26%), Positives = 107/251 (42%), Gaps = 20/251 (7%)

Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKV-AVKR 535
           R++K+ D       + + K     MK+   +    +GRG  G V         KV A+K 
Sbjct: 16  RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 75

Query: 536 LYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKWI 591
           L   E   R    F  E   I    +   V  + Y A + +R+L  V EYM  G L   +
Sbjct: 76  LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYMPGGDLVNLM 134

Query: 592 FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG 651
            + D  +  +     +++      L+ +H       IH D+KP N+LLD+  ++K+ADFG
Sbjct: 135 SNYDVPEKWARFYTAEVVL----ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187

Query: 652 LARLIAQDQSHVSTMPKGTPGYMAPELTRGNS----ITAKIDIYSFGVVILEIICGRRSS 707
               + ++         GTP Y++PE+ +          + D +S GV + E++ G    
Sbjct: 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG---D 244

Query: 708 NPKGGDYLVDT 718
            P   D LV T
Sbjct: 245 TPFYADSLVGT 255

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 43/168 (25%)

Query: 573 SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI 632
           +  +L+ EY+  G +   +  KD   T + +  +  I +    ++ +H       IH DI
Sbjct: 74  NYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDI 127

Query: 633 KPQNILLDRDLNVKIADFGLA--------RLIAQDQSHV----------STMPK------ 668
           KP N+LLD   ++K++DFGL             +  SH             M        
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187

Query: 669 -------------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                        GTP Y+APE+        + D +S GV++ E++ G
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 52/174 (29%)

Query: 576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ 635
           +L+ E++  G L   +    +  T S D+ +  + +    +E +H       IH DIKP 
Sbjct: 77  YLIMEFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPD 130

Query: 636 NILLDRDLNVKIADFGLA-------------RLIAQD----------------------- 659
           NIL+DR  ++K++DFGL+             +L+                          
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS 190

Query: 660 QSHVSTMPK----------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +  ++T  K          GTP Y+APE+        + D +S G ++ E + G
Sbjct: 191 KDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           Q+   ++Y+H      IIH DIK +N+L++   ++ + DFG A       S  +    G 
Sbjct: 268 QLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS--TPFHYGI 322

Query: 671 PGYM---APELTRGNSITAKIDIYSFGVVILE 699
            G +   APE+  G+  T  +DI+S G+VI E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 40/167 (23%)

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           ++ N +L+ E++  G +   +  KD   TLS +  +  I +    ++ +H       IH 
Sbjct: 72  DKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHR 125

Query: 631 DIKPQNILLDRDLNVKIADFGL----------------------------------ARLI 656
           DIKP N+LLD   +VK++DFGL                                  A   
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185

Query: 657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            +++  ++    GTP Y+APE+          D +S GV++ E++ G
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 65/307 (21%), Positives = 110/307 (35%), Gaps = 58/307 (18%)

Query: 507 DFQIRLGRG--GSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFL---SEVETIGNIHHF 560
           +    +G+       V         T VAVK+    ++  K++      E+ T   + H 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-----LSWDIRKKIIFQISRG 615
           N++  V      S  ++V   M  GS       +D ++T     L       I+  +   
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSC------EDLLKTHFPEGLPELAIAFILKDVLNA 113

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQ----------SHVS 664
           L+Y+H   +   IH  +K  +ILL  D  V ++    +  +I   +          S V 
Sbjct: 114 LDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170

Query: 665 TMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIICGR----------------RS 706
            +P     +++PE+ + N      K DIYS G+   E+  G                 R 
Sbjct: 171 NLP-----WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG 225

Query: 707 SNPKGGD---YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHR 763
           + P   D   Y +    +           ++ S D    R  +    Q    CLQ++   
Sbjct: 226 TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285

Query: 764 RPSASML 770
           RPSAS L
Sbjct: 286 RPSASQL 292

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 13/188 (6%)

Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E   +  I+H ++++L G         L+   +     D + +   +      DI   I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILA-I 187

Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
              + R ++YLH     +IIH DIK +NI ++   +V + DFG A       ++      
Sbjct: 188 ERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244

Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
           GT    APEL   +     +DI+S G+V+ E+     S   K      D L    ++DR 
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK------DGLDGDCDSDRQ 298

Query: 729 CDLVDKKS 736
             L+ ++S
Sbjct: 299 IKLIIRRS 306

Length = 391

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 43/189 (22%), Positives = 75/189 (39%), Gaps = 52/189 (27%)

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V+L     ++ N + V +Y+  G +   +    R++     + +  I +++  +E +H 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHK 119

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLA---------------------------- 653
                 IH DIKP NIL+D D ++K+ DFGL                             
Sbjct: 120 M---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 654 ------------------RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGV 695
                             R   Q Q  ++    GTP Y+APE+      T   D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 696 VILEIICGR 704
           ++ E++ G+
Sbjct: 237 ILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 39/188 (20%), Positives = 83/188 (44%), Gaps = 20/188 (10%)

Query: 527 DGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRLVGYCAERSNRF----LVY 579
           +  +V ++         K       +E++ +  I   N++++ G+  +  +      L+ 
Sbjct: 42  NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101

Query: 580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL 639
           EY   G L + +   D+ + LS+  +  +     +GL  L+ Y N    + ++   + L+
Sbjct: 102 EYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLV 156

Query: 640 DRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVV 696
             +  +KI   GL ++++     +V+ M      Y + ++     +  T K DIYS GVV
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKNVNFM-----VYFSYKMLNDIFSEYTIKDDIYSLGVV 211

Query: 697 ILEIICGR 704
           + EI  G+
Sbjct: 212 LWEIFTGK 219

Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 9e-06
 Identities = 27/83 (32%), Positives = 49/83 (59%), Gaps = 6/83 (7%)

Query: 573 SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI 632
           +N +LV EY+  G + K + H         ++  K I +++  L+YLH +    IIH D+
Sbjct: 77  NNVYLVMEYLIGGDV-KSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDL 130

Query: 633 KPQNILLDRDLNVKIADFGLARL 655
           KP N+L+  + ++K+ DFGL+++
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 42.7 bits (101), Expect = 2e-05
 Identities = 16/55 (29%), Positives = 26/55 (47%), Gaps = 4/55 (7%)

Query: 358 RFLKLENVTYFDFVPHLIN--IDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSL 410
            FL+L N+   D    +++  I  + C++ CL NCSC A  + Y        C +
Sbjct: 6   GFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTA--YAYADIRGGSGCLI 58

Length = 66

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 22/114 (19%)

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-----------RDL-----NVKIADF 650
           +IIFQ    L+Y H      ++H D+KP+NIL++           R L      V+I D 
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 651 GLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           G       D+ H  T    T  Y +PE+  G       D++S G +I E+  G+
Sbjct: 293 GGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 16/155 (10%)

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           N+V L  Y     + FLV ++   G L   I     I     +  K+   ++   L+ LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE---ECVKRWAAEMVVALDALH 102

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ--DQSHVSTMPKGTPGYMAPEL 678
                 I+  D+ P NILLD   ++++  F     +    D   V  M      Y APE+
Sbjct: 103 R---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRR--SSNPKG 711
              +  T   D +S G ++ E++ G+     +P G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 17/156 (10%)

Query: 554 IGNIHHFNLVRLVGYCAERSN----RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           I NI H  + +  G  + +      RF++ E +   +  K IF   RI+  +  + K I+
Sbjct: 77  IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENT--KEIF--KRIKCKNKKLIKNIM 132

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS----- 664
             +   LEY+H++    I H DIKP+NI++D +    I D+G+A        H+      
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 665 -TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
             + +GT  Y   +   G  +T + D+ S G  +L+
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 15/147 (10%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLV-RLVGY 568
            L  G +  V+  LL    +  V ++ P   +G      EV  +  +      V +++  
Sbjct: 5   LLKGGLTNRVY--LLGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLAS 61

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  +L+ E++   +LD+          +S + ++ I  Q++  L  LH      + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARL 655
           H D+ P NIL+D    + I D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 39.1 bits (91), Expect = 6e-04
 Identities = 16/54 (29%), Positives = 23/54 (42%), Gaps = 6/54 (11%)

Query: 359 FLKLENVTYFDFVPHLIN-IDAEGCQRACL-GNCSCKAALFRYQGSLSTGNCSL 410
           F++L N     F   +I+    E C   CL  NCSC++  +       T  C L
Sbjct: 6   FVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLL 55

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 40/176 (22%), Positives = 66/176 (37%), Gaps = 34/176 (19%)

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q    L  LH            K  NILL  D  +K+   G       +QS      
Sbjct: 22  VCLQCLGALRELHR---------QAKSGNILLTWDGLLKL--DGSVAFKTPEQS------ 64

Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV---DTLKVKAE 724
           +  P +MAPE+ +G S T K DIYS G+ + E             DY +   +  ++ A 
Sbjct: 65  RPDPYFMAPEVIQGQSYTEKADIYSLGITLYE-----------ALDYELPYNEERELSAI 113

Query: 725 ADRLCDLVDKKSEDMQS--HRDDAVKMIQIAIS-CLQKNLHRRPSASMLVKVLQGL 777
            + L + +       +S      A +  +  +  C  +   RR +A+  +   + L
Sbjct: 114 LEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRAL 169

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 8/91 (8%)

Query: 512 LGRGGSGSVFE----GLLNDG--TKVAVKRLYPGENRGKKEFL-SEVETIGNI-HHFNLV 563
           LG G  G V E    GL  +    +VAVK L    +  ++E L SE++ + ++  H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHK 594
            L+G C       ++ EY C G L  ++  K
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 22/51 (43%), Positives = 31/51 (60%), Gaps = 3/51 (5%)

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA 653
           ++ K ++ Q+  GL  LH      I+H DIKP+N+L+  D  VKI DFG A
Sbjct: 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 9/98 (9%)

Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HHFNLV 563
           LG G  G V EG            KVAVK L P     +K+  +SE++ + ++  H N+V
Sbjct: 45  LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIV 104

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
            L+G C +    +++ EY   G L  ++ HK+R   LS
Sbjct: 105 NLLGACTKSGPIYIITEYCFYGDLVNYL-HKNRDNFLS 141

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 8/84 (9%)

Query: 512 LGRGGSGSVFE----GLLNDGTK--VAVKRLYPGENRGKKEFL-SEVETIGNI-HHFNLV 563
           LG G  G V E    GL        VAVK L P  +  ++E L SE++ +  + +H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102

Query: 564 RLVGYCAERSNRFLVYEYMCNGSL 587
            L+G C       ++ EY C G L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDL 126

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|238533 cd01100, APPLE_Factor_XI_like, Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

 Score = 36.6 bits (85), Expect = 0.003
 Identities = 18/50 (36%), Positives = 23/50 (46%), Gaps = 4/50 (8%)

Query: 378 DAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIYTLRNSTKVISGY 427
            AE CQ AC  +  C A  F Y  +  +  C L +   TL  ST  +SG 
Sbjct: 26  SAEQCQAACTADPGCLA--FTY--NTKSKKCFLKSSEGTLTKSTGAVSGP 71

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 73

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	818
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.89
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
PRK10345	210	hypothetical protein; Provisional	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.65
smart00090	237	RIO RIO-like kinase.	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.62
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.15
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.14
KOG1243	690	consensus Protein kinase [General function predict	99.1
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.08
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.98
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.9
KOG3087	229	consensus Serine/threonine protein kinase [General	98.86
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.71
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.71
COG4248	637	Uncharacterized protein with protein kinase and he	98.69
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	98.65
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.64
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.51
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	98.49
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.45
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.4
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.37
PRK09902	216	hypothetical protein; Provisional	98.35
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.08
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.02
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.9
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.81
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.81
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.76
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.74
PF01636	239	APH: Phosphotransferase enzyme family This family	97.74
PLN02876	822	acyl-CoA dehydrogenase	97.53
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.46
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.46
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.44
PRK10593	297	hypothetical protein; Provisional	97.39
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.34
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.25
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.22
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.2
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.17
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.85
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	96.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.66
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.21
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.17
PRK05231	319	homoserine kinase; Provisional	96.13
PLN02236	344	choline kinase	96.01
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.57
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.18
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	94.81
KOG2270	520	consensus Serine/threonine protein kinase involved	94.69
COG2334	331	Putative homoserine kinase type II (protein kinase	94.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.57
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	94.53
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.45

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-52  Score=456.32  Aligned_cols=287  Identities=44%  Similarity=0.752  Sum_probs=251.1

Q ss_pred             cccccCHHHHHHhhHHhh--hhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeee
Q 043017          492 HLVKFSSKAMKSATRDFQ--IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC  569 (818)
Q Consensus       492 ~~~~~~~~~l~~~t~~f~--~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~  569 (818)
                      ....|++.++..+|++|+  ..||+|+||.||+|.+++++.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            577899999999999999  489999999999999999999999998765443256699999999999999999999999


Q ss_pred             cccC-cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEe
Q 043017          570 AERS-NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIA  648 (818)
Q Consensus       570 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  648 (818)
                      .+.+ +++||||||++|+|.++|+..... .++|.+|.+||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999876544 89999999999999999999999988899999999999999999999999


Q ss_pred             ecCCceeccc-CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CCchHHHHHHHHhh
Q 043017          649 DFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPK---GGDYLVDTLKVKAE  724 (818)
Q Consensus       649 Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~---~~~~l~~~~~~~~~  724 (818)
                      |||+|+.... ........ .||.+|+|||++..+..++|+|||||||+|+||++|+++.+..   ....+.+|.+....
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976554 22222111 7999999999999999999999999999999999999988754   23447888877777


Q ss_pred             hhcchhhccccCcCccCcH-HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          725 ADRLCDLVDKKSEDMQSHR-DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       725 ~~~~~~~~d~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ..++.+++|+.+....... .+..++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            7789999999876433333 6888899999999999999999999999999766554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=394.90  Aligned_cols=258  Identities=31%  Similarity=0.460  Sum_probs=214.4

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhccCcceeEEEeeeecccC-cceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERS-NRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~  583 (818)
                      .+.+.||+|+||+||+|.+.....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3445699999999999999955559999997654322  569999999999999999999999999988 7999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC-eeecccccCeEEEcCCC-CEEEeecCCceecccCCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK-IIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQS  661 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~  661 (818)
                      +|+|.++|+.. ....+++..+++|+.|||+||.|||+.   + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999764 446799999999999999999999998   6 99999999999999997 99999999998765433 


Q ss_pred             ccccCCCCCCccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          662 HVSTMPKGTPGYMAPELTR--GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ...+...||+.|||||++.  ...++.|+||||||++||||+||+.||...........+.....             ..
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~-------------Rp  265 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL-------------RP  265 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-------------CC
Confidence            2223367999999999999  66999999999999999999999999987665333222211111             11


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      ..+......+..++.+||+.||+.||++.+++..|+.+.....
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            1122366788899999999999999999999999998876433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-45  Score=393.59  Aligned_cols=262  Identities=30%  Similarity=0.455  Sum_probs=227.7

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ++......+.++||+|-||+||.|.++...+||+|.++.. ....+.|.+|+++|.+|+|+|||+++|+|..++.++|||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            4455666778899999999999999998889999999765 344678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      |||+.|+|.+||.. .....++..+.+.++.|||+||+||++.   ++|||||.++||||+++..+||+|||||+....+
T Consensus       281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            99999999999976 3346789999999999999999999997   9999999999999999999999999999976666


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..+.....++.+.   ..           ..
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le---~G-----------yR  422 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE---RG-----------YR  422 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh---cc-----------Cc
Confidence            6655555667889999999999999999999999999999999 888888776655555443   11           22


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ++.+..++..+.+||..||+.+|++|||++.+...|+.+...
T Consensus       423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            334567888999999999999999999999999999877553

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=363.97  Aligned_cols=248  Identities=30%  Similarity=0.467  Sum_probs=210.3

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccC-cceeeeeccCCC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-NRFLVYEYMCNG  585 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~g  585 (818)
                      ..+||+|..|+|||++++ +++-+|+|.+... +...++++.+|+++++..+||+||.++|.|.... ...++||||.+|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            357999999999999987 5788999998544 4455789999999999999999999999999988 599999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|+.++...   +.+++...-+|+.++++||.|||+.  .+||||||||+|||++..|++||+|||.++.+...   ...
T Consensus       164 SLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~  235 (364)
T KOG0581|consen  164 SLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN  235 (364)
T ss_pred             CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence            999998543   4589999999999999999999963  49999999999999999999999999999987665   445


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--chHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG--DYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ..+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.+..+  ....+.+         ..+++...+..+.. 
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll---------~~Iv~~ppP~lP~~-  305 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL---------CAIVDEPPPRLPEG-  305 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH---------HHHhcCCCCCCCcc-
Confidence            57899999999999999999999999999999999999999976521  1222222         23344334333321 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ..+.++..++..||+.||.+||++.|++++=
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            4788999999999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-42  Score=391.65  Aligned_cols=266  Identities=29%  Similarity=0.447  Sum_probs=226.2

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeeccc
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAER  572 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~  572 (818)
                      ++......|.++||+|+||.||+|...      +.+.||||.++..... .+.+|++|+++++.++|||||+|+|.|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            445555566779999999999999854      3467999999877665 788999999999999999999999999999


Q ss_pred             CcceeeeeccCCCChhhHhhhcCC-----------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          573 SNRFLVYEYMCNGSLDKWIFHKDR-----------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      +..+||+|||..|+|.+||.....           ..+|+..+.+.||.|||.||+||-++   .+|||||.++|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            999999999999999999964321           23388999999999999999999998   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTL  719 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~  719 (818)
                      +..+||+||||++..-..+... .....-+.+||+||.+..+++|.+||||||||+|||+++ |+.|+.+...++.++.+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            9999999999999765443332 223345789999999999999999999999999999999 99999988887776665


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      +...    +          .+.+..++.++.+||..||+.+|++||+++||-..|+...+..+
T Consensus       719 ~~g~----l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  719 RAGQ----L----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HcCC----c----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            5211    1          23356778899999999999999999999999999988766543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-42  Score=374.12  Aligned_cols=247  Identities=28%  Similarity=0.431  Sum_probs=210.9

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +|...+.||+|||+.||+++. ..|+.||+|++.+.   +....+...+|+++.++|+|||||+++++|++.+..|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            445556899999999999997 78999999998653   34446778899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +|++++|.+++.   +.+.+++.+++.+..||+.||.|||++   +|||||||..|+||+++.++||+|||||..+..+.
T Consensus        99 LC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   99 LCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             ecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999884   456899999999999999999999998   99999999999999999999999999999887553


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ... .+..||+.|+|||++.....+..+||||+|||||-||.|++||+...-......++..               +..
T Consensus       173 Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~---------------~Y~  236 (592)
T KOG0575|consen  173 ERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN---------------EYS  236 (592)
T ss_pred             ccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc---------------Ccc
Confidence            333 3458999999999999999999999999999999999999999755433333333211               111


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+...+.+..+||..+|+++|.+|||+++|+.+
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            233455677789999999999999999999976

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=381.95  Aligned_cols=254  Identities=28%  Similarity=0.490  Sum_probs=219.0

Q ss_pred             hhhcccccceeEEEeEecC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          509 QIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++||.|.||+||+|.++.    ...||||.|+... +..+.+|+.|+.+|.++.||||++|.|+.......++|.|||+
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME  713 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME  713 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence            3469999999999999863    3569999998764 4556799999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ||+|+.||..++  ..+.+.++..++++||.||.||.+.   ++|||||.++|||++.+..+||+||||++.+.++....
T Consensus       714 NGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  714 NGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             CCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            999999997654  4599999999999999999999998   99999999999999999999999999999876655333


Q ss_pred             ccCC--CCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          664 STMP--KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       664 ~~~~--~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .+..  +-+.+|.|||.+...+++.++||||||++|||.++ |.+|+..+...+.+..+.   +.-           ..+
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---~gy-----------RLP  854 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---QGY-----------RLP  854 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH---hcc-----------CCC
Confidence            3322  33578999999999999999999999999999998 999998887765554433   221           123


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      .+.+++..|.+||+.|||.|-.+||.+.||+.+|+++...+
T Consensus       855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            35678889999999999999999999999999999887654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-42  Score=341.57  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=213.6

Q ss_pred             HHhhHHhhhhcccccceeEEEeE-ecCCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEee-eecccCc-ce
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVG-YCAERSN-RF  576 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g-~~~~~~~-~~  576 (818)
                      ..+.+.+.++||+|.||+|||+. +.+|..+|.|.+.-.  +.+..++...|+.+|++|+|||||++++ .+.+..+ ..
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            34667788899999999999998 568999999988643  3455678899999999999999999999 5555555 89


Q ss_pred             eeeeccCCCChhhHhhh-cCCccccchhhHHHHHHHHHHHHHHHHhcCC-CCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          577 LVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCN-PKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      ||||++..|+|...+.+ ++..+.+++..+++++.|+++||.++|+... .-|+||||||.||+|+.+|.+||+||||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999999976 3445779999999999999999999998321 239999999999999999999999999999


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      .+....... ...+|||.||+||.+....++.|+||||+||++|||+..+.||.+..-..+...+   . ....      
T Consensus       177 ~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI---~-qgd~------  245 (375)
T KOG0591|consen  177 FLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI---E-QGDY------  245 (375)
T ss_pred             HhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH---H-cCCC------
Confidence            887654433 3468999999999999999999999999999999999999999876322222222   1 1111      


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                        +.. ...-++.++..|+..|+..||+.||+...+++.+..-
T Consensus       246 --~~~-p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  246 --PPL-PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             --CCC-cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence              000 1256788999999999999999999976666666543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-42  Score=356.86  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=205.8

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-------cHHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      .+-+.+.||+|+||.|-+|..+ +|+.||||.+......       .....++|+++|++|+|||||++++++...+..|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            4455678999999999999864 6999999998754221       1234579999999999999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCc
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLA  653 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla  653 (818)
                      ||||||++|.|.+++..+   +.+.+.....+++|++.|+.|||++   +|+||||||+|||+..+   ..+||+|||+|
T Consensus       253 mVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999655   3588888899999999999999998   99999999999999665   77999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhhcch
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEADRLC  729 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~~~~  729 (818)
                      +....  ...+.+..||+.|.|||++.++.   +..|.|+||+||+||-+++|.+||.....+. +.+.+....    . 
T Consensus       327 K~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~----y-  399 (475)
T KOG0615|consen  327 KVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR----Y-  399 (475)
T ss_pred             hcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc----c-
Confidence            98763  34455678999999999997764   3348899999999999999999998775544 444443111    0 


Q ss_pred             hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       730 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                            ..........+++..++|.+||..||++|||+.|+|++=
T Consensus       400 ------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  400 ------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             ------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence                  011112346677888999999999999999999999863

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=351.63  Aligned_cols=207  Identities=30%  Similarity=0.517  Sum_probs=182.1

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .|.+.++||.|.||+||+|+++ ++.+||||.+...  .....+.+..|+.+|+.++|||||++++++..++..+|||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            3455677999999999999986 4889999998765  344566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC------CCEEEeecCCcee
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD------LNVKIADFGLARL  655 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfgla~~  655 (818)
                      |.+|+|.+||+.++   .+++.....++.|||.||++||+.   +||||||||+||||+..      -.+||+|||+|+.
T Consensus        91 C~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999996553   699999999999999999999997   99999999999999764      4589999999998


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHH
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL  719 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~  719 (818)
                      +...  ....+.+|++-|||||++...+|+.|+|+||+|++|||+++|+.||+.....++...+
T Consensus       165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            8643  3344568999999999999999999999999999999999999999877666555533

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=387.16  Aligned_cols=275  Identities=27%  Similarity=0.408  Sum_probs=223.6

Q ss_pred             HhhHHhhhhcccccceeEEEeEecC--Cc----EEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLND--GT----KVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~--g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  575 (818)
                      ...-.+...||+|.||.||+|...+  |.    .||||.+... +.+.+.+|++|..+|++++|||||+++|.|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3344455679999999999999764  33    4999999766 456678999999999999999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcC----CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          576 FLVYEYMCNGSLDKWIFHKD----RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      ++++|||++|+|..||.+..    ....++....+.++.|||+|+.|||+.   ++|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997652    134688999999999999999999997   99999999999999999999999999


Q ss_pred             CceecccCCCccccC-CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcch
Q 043017          652 LARLIAQDQSHVSTM-PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLC  729 (818)
Q Consensus       652 la~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~  729 (818)
                      ||+.+.......... ..-...|||||.+..+.++.|+|||||||+|||++| |..|+.......+.....   ..+   
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~---~gg---  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL---EGG---  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH---hCC---
Confidence            999544332222211 134578999999999999999999999999999999 788887666544433221   111   


Q ss_pred             hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchhhhh
Q 043017          730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVV  794 (818)
Q Consensus       730 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~  794 (818)
                              .++.+..+...+.+||..||+.+|++||++..+++.++.+...-...++........
T Consensus       922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~~  978 (1025)
T KOG1095|consen  922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADYE  978 (1025)
T ss_pred             --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccccC
Confidence                    223466778899999999999999999999999999998887655555555544433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=355.11  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=211.5

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      ++......+.+.||+|.||+||+|.+.  ..||||.+....  .+..+.|++|+..+++-+|.||+-+.|+|..... .+
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            333444455678999999999999998  479999997653  3456889999999999999999999999998877 99


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      |..++++.+|..+|+..+  ..|...+.+.||+|||+|+.|||..   +|||||||..||||.+++.+||+||||+..-.
T Consensus       465 iTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence            999999999999996543  5688999999999999999999996   99999999999999999999999999997543


Q ss_pred             cC-CCccccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          658 QD-QSHVSTMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       658 ~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      .- .......+.|...|||||++..   .+|+.++||||||+++|||++|..|+.....+.++-.+..-...+       
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p-------  612 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP-------  612 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc-------
Confidence            32 1122233568899999999964   469999999999999999999999998544443322211100000       


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                         ........+..+|.+|+..||..++++||.+.+|+..|+.+..
T Consensus       613 ---d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  613 ---DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               1111234567789999999999999999999999999988877

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=334.51  Aligned_cols=239  Identities=25%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .++.+.||+|+||.||.++.+ +++.+|+|++++..   ....+..++|..+|.+++||.||+++..|++.+..+||+||
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~  106 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY  106 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence            344578999999999999876 48899999997652   33466788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +.||.|..+|.++   ..++++.+.-++.+|+.||.|||+.   +||||||||+|||||++|+++|+||||++.......
T Consensus       107 ~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  107 LNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             cCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            9999999999654   4599999999999999999999997   999999999999999999999999999996544332


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       .+.+..||+.|||||++.+..++..+|.||+|+++|||++|.+||...+.....+.+....            ....  
T Consensus       181 -~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------~~~~--  245 (357)
T KOG0598|consen  181 -ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------LPLP--  245 (357)
T ss_pred             -ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------------CCCC--
Confidence             2334689999999999999999999999999999999999999998766544444433111            0110  


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP  765 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP  765 (818)
                      +.-...+..+++...|+.||++|.
T Consensus       246 p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  246 PGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CccCCHHHHHHHHHHhccCHHHhc
Confidence            112345677888899999999996

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=343.18  Aligned_cols=264  Identities=24%  Similarity=0.369  Sum_probs=220.0

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ...-.|.++||+|-||+|.......+.+||||.++.... ....+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            333446678999999999999999889999999987754 4458999999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      |++|+|.+||..++. +.+.-.....|+.|||.||+||.+.   ++|||||.++|+|+|.++++||+|||+++.+-....
T Consensus       617 mEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999976542 3356667788999999999999998   999999999999999999999999999997655444


Q ss_pred             cc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          662 HV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC--GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       662 ~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt--G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .. ....+-+.+|||+|.+..++++.++|||+||+.+||+++  ...|+....++..++........+......      
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l------  766 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL------  766 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec------
Confidence            32 333456789999999999999999999999999999765  788998877777766655443332221111      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                       ..+.-+...+.+++.+||..|.++||+++++...|.+.
T Consensus       767 -~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 -SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             12345667888999999999999999999999998754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=339.14  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=204.9

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC--cceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--NRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~  582 (818)
                      ....+.||+|.||.||++...+ |+..|||.+........+.+.+|+++|.+++|||||+.+|.....+  .+.+.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            3455689999999999999865 8999999986654333667899999999999999999999855554  589999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceeccc--C
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQ--D  659 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~--~  659 (818)
                      ++|+|.+++.....  .+++..+..+++||++||+|||++   +|+||||||+|||++. ++.+||+|||+++....  .
T Consensus        99 ~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999965432  699999999999999999999987   9999999999999999 79999999999998764  2


Q ss_pred             CCccccCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ........+||+.|||||++..+. ...++|||||||++.||+||+.||...  ......+-.....        ...+ 
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~--------~~~P-  242 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRE--------DSLP-  242 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhcc--------CCCC-
Confidence            222334467999999999999643 345999999999999999999998753  1111111111111        1011 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                       ..+...+.+..+++..|++.+|++|||+.++|++.--....
T Consensus       243 -~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  243 -EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             -CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence             22334566788999999999999999999999987544433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=342.59  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=216.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.|.++||+|.|++|++|+.. .++++|||++.+.   .....+.+..|-.+|.+| +||.|++|+-.|.++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            34567889999999999999965 5899999998654   334456677899999999 899999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +||+++|.|.++|.+-   ..|++...+.++.+|+.||+|||+.   +||||||||+|||||.++++||+|||-|+.+..
T Consensus       153 Le~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999654   5699999999999999999999998   999999999999999999999999999998865


Q ss_pred             CCCc---------c---ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh
Q 043017          659 DQSH---------V---STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       659 ~~~~---------~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      ....         .   ....+||..|.+||++..+..+..+|+|+||||||+|+.|++||....+-.+++.+...    
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l----  302 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL----  302 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh----
Confidence            3221         1   13357999999999999999999999999999999999999999876654444443321    


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH-------hcCcCCCCCCCCCC
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL-------QGLTKLEPVTDYGF  788 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L-------~~i~~~~~~~~~~~  788 (818)
                            +...     +..-.+.+.+|+.+.|..||.+|+|..||-++.       +.+-+..|++.+++
T Consensus       303 ------~y~f-----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py  360 (604)
T KOG0592|consen  303 ------DYEF-----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPY  360 (604)
T ss_pred             ------cccC-----CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCC
Confidence                  1111     122235667888899999999999999998874       34444555554444

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=345.99  Aligned_cols=245  Identities=29%  Similarity=0.445  Sum_probs=211.9

Q ss_pred             hhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          509 QIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      -++||+|+.|.||.+.. .+++.||||++.......++-+++|+.+|+..+|+|||++++.+..+++++.|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            35799999999999985 46889999999888888888899999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+.+.+    -.+++.++..|.+++++||+|||..   +|||||||.+|||++.++.+||+|||++..+........ ..
T Consensus       358 TDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~-Tm  429 (550)
T KOG0578|consen  358 TDVVTK----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS-TM  429 (550)
T ss_pred             hhhhhc----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc-cc
Confidence            998843    3489999999999999999999998   999999999999999999999999999998877665443 45


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      +||+.|||||++..+.|.+|.||||||+|++||+-|++||-...   -+..++.....+         .+....+...+.
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~ng---------~P~lk~~~klS~  497 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNG---------TPKLKNPEKLSP  497 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhcC---------CCCcCCccccCH
Confidence            89999999999999999999999999999999999999986432   233333333221         122233445677


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.+++.+||+.|+++||+++|+|++
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            88999999999999999999999986

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=354.31  Aligned_cols=262  Identities=28%  Similarity=0.397  Sum_probs=212.6

Q ss_pred             hhHHhhhhcccccceeEEEeEecCC----cE-EEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDG----TK-VAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g----~~-vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  575 (818)
                      ..-.+.++||+|+||.||+|++...    .. ||||..+..   ......+|++|+++|++++|||||+++|++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            3344557899999999999997632    23 899998752   355678999999999999999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++|||+|.||+|+++|...+  ..++..++..++.++|+||+|||+.   ++|||||.++|+|++.++.+||+||||++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence            99999999999999996543  3699999999999999999999997   999999999999999999999999999876


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      -... ........-+..|+|||.+....++.++|||||||++||+++ |..|+.+.....+...+..  ..         
T Consensus       312 ~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~--~~---------  379 (474)
T KOG0194|consen  312 GSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK--NG---------  379 (474)
T ss_pred             Ccce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh--cC---------
Confidence            4311 111112246789999999999999999999999999999999 8888877655433333210  00         


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVT  784 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  784 (818)
                        ...+.+...+.++..++..|+..+|++||+|.++.+.|+.+.+....+
T Consensus       380 --~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  380 --YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             --ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence              011112245567778888999999999999999999999998776543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-38  Score=347.56  Aligned_cols=260  Identities=30%  Similarity=0.443  Sum_probs=202.7

Q ss_pred             hhHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccC-c
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS-N  574 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~-~  574 (818)
                      ..+.+.++||+|+||.||+|..      .+++.||||++..... ...+.+.+|+.++.++ +||||++++++|.... .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            3455667899999999999974      2356899999865432 3346789999999999 8999999999887654 5


Q ss_pred             ceeeeeccCCCChhhHhhhcCC----------------------------------------------------------
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDR----------------------------------------------------------  596 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  596 (818)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            7899999999999999864211                                                          


Q ss_pred             -ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc-ccCCCCCCccc
Q 043017          597 -IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYM  674 (818)
Q Consensus       597 -~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~  674 (818)
                       ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence             13477888999999999999999997   99999999999999999999999999998664332221 12234667899


Q ss_pred             ccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHH
Q 043017          675 APELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIA  753 (818)
Q Consensus       675 aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li  753 (818)
                      |||.+.+..++.++||||||+++|||++ |+.||..........  ........           ...+......+.+++
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~--~~~~~~~~-----------~~~~~~~~~~l~~li  310 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC--QRLKDGTR-----------MRAPENATPEIYRIM  310 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHhcCCC-----------CCCCCCCCHHHHHHH
Confidence            9999999899999999999999999997 999987544322111  11111000           001223446788999


Q ss_pred             HHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          754 ISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       754 ~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+||+.||++|||+.++++.|+.+.+
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=330.00  Aligned_cols=266  Identities=26%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc--CcceeEEEeeeecccC----cceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRLVGYCAERS----NRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l--~H~niv~l~g~~~~~~----~~~lV~  579 (818)
                      -.+.+.||+|+||.||||++. ++.||||++..   +.++.|++|-++.+..  +|+||++++++-..+.    +++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            345678999999999999998 59999999853   4467888888877764  8999999999876665    889999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc------CCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY------CNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ||.++|+|.+||..    ..++|....+|+..+++||+|||+.      .++.|+|||||++||||..|+++.|+|||||
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999943    4799999999999999999999975      3678999999999999999999999999999


Q ss_pred             eecccCCCcc-ccCCCCCCcccccccccCCC-CC-----chhhHHHHHHHHHHHHhCCCCCCC-CC------------Cc
Q 043017          654 RLIAQDQSHV-STMPKGTPGYMAPELTRGNS-IT-----AKIDIYSFGVVILEIICGRRSSNP-KG------------GD  713 (818)
Q Consensus       654 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwS~Gvll~elltG~~p~~~-~~------------~~  713 (818)
                      ..+....... ....+||.+|||||++.+.. +.     .+.||||+|.+||||++.-.-+.+ ..            ..
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            9887654332 23368999999999998753 22     479999999999999997654431 11            11


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCC
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV  783 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  783 (818)
                      .-++.++......+....+....   ..+ .....+.+.+..||+.||+.|.|+.=|-+.+.++....+.
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W---~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAW---RKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhh---hcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            12222222222222111111111   111 4567788999999999999999999999999888776553

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=316.11  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             HhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +..-++|+|+||.|||.+.++ |+.||||++....+  .-.+-.++|+++|++++|+|+|.|+.+|......+||+||++
T Consensus         5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d   84 (396)
T KOG0593|consen    5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD   84 (396)
T ss_pred             hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence            334479999999999999874 99999999976543  234567899999999999999999999999999999999998


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ..-|.+ |.+..  ..++.+.+.++++|+++|+.|+|++   ++|||||||+||||+.++.+||+|||+|+.+... ...
T Consensus        85 hTvL~e-Le~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~  157 (396)
T KOG0593|consen   85 HTVLHE-LERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDN  157 (396)
T ss_pred             hHHHHH-HHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-cch
Confidence            766665 43332  3588899999999999999999998   9999999999999999999999999999988752 333


Q ss_pred             ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHH-hh-hhcchhhcc-------
Q 043017          664 STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK-AE-ADRLCDLVD-------  733 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~-~~-~~~~~~~~d-------  733 (818)
                      .+..+.|..|.|||++.+ .+|....|||++||++.||++|.+.|.+.++-+.+..+... .. .++...++.       
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            445678999999999988 67999999999999999999999998877654333333221 11 122222221       


Q ss_pred             ---ccCcCccC----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 ---KKSEDMQS----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ---~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         +.++.++.    ......-+++++..||+.||.+|++-+|++.+
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence               11111110    12234467899999999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-37  Score=333.12  Aligned_cols=246  Identities=18%  Similarity=0.290  Sum_probs=200.6

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhccCcceeEEEeeeecc----cCcceeeeeccC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG---KKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLVYEYMC  583 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~  583 (818)
                      .||+|++|.||+|++ +|+.||||++.......   .+.|.+|+.++.+++||||++++|++.+    ....++||||++
T Consensus        27 ~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             EEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            699999999999998 48999999997654333   4678899999999999999999999876    346789999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +|+|.+++...   +.+++....+++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||+++......   
T Consensus       106 ~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        106 RGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            99999999543   4688999999999999999999973  378899999999999999999999999998654322   


Q ss_pred             ccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          664 STMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.......+...+....  .           ....
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--~-----------~~~~  243 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN--N-----------SLKL  243 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--C-----------CCCC
Confidence             12357889999999976  679999999999999999999999998654433332221100  0           0011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            22345678899999999999999999999999987653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=334.06  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=207.2

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHH--HHHHHHHHhccC-cceeEEEeeeecccC-ccee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKE--FLSEVETIGNIH-HFNLVRLVGYCAERS-NRFL  577 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~--f~~Ev~~l~~l~-H~niv~l~g~~~~~~-~~~l  577 (818)
                      ...|...++||.|.||.||+|+-. ++..||||+++..-.. .++  =++|+..|.+|+ ||||++|...+.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346777789999999999999954 6899999999754221 333  367999999998 999999999999988 8999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||| ..+|.+.+.++  .+.++++.+..|+.||++||+|+|++   |+.|||+||+|||+.....+||+|||||+...
T Consensus        88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            99999 66899988654  57899999999999999999999998   99999999999999989999999999999887


Q ss_pred             cCCCccccCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhh--------c
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTR-GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEAD--------R  727 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~--------~  727 (818)
                      .....  +..+.|..|.|||++. .+.|+.+.|||++|||++|+.+-++.|.+..+.+ +...........        .
T Consensus       162 SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 SKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            65543  3356899999999885 4569999999999999999999999987665422 222111111110        0


Q ss_pred             chhhccccCcCcc------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          728 LCDLVDKKSEDMQ------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       728 ~~~~~d~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      +...+....+...      .......+..+++.+|+..||.+|||++|++++-
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1111111111111      1123678899999999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=326.88  Aligned_cols=260  Identities=28%  Similarity=0.346  Sum_probs=208.8

Q ss_pred             hhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ..|++.++||.|..++||+|+. +.++.||||++.... ....+.+.+|++.|+.++||||++++..|..+..+++||+|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            3466778999999999999984 568999999996553 33468899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      |.+|++.+++...-. ..+++..+..|.+++++||.|||.+   +.||||||+.||||+++|.+||+|||.+-.+.....
T Consensus       106 Ma~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999965432 3489999999999999999999998   999999999999999999999999998876654332


Q ss_pred             cc--c-cCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH-HHHHHHhhhhcchhhcccc
Q 043017          662 HV--S-TMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV-DTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       662 ~~--~-~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~  735 (818)
                      ..  . ...+|++.|||||++...  .|+.|+||||||+...||.+|..||....+...+ ..++..  .+.+. .   .
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~--pp~~~-t---~  255 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND--PPTLL-T---S  255 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--CCCcc-c---c
Confidence            11  1 345899999999997543  5899999999999999999999999877654322 222211  11111 0   0


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+.+........+.+++..||+.||.+|||+++++++
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11111133445688899999999999999999999874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.3e-37  Score=302.72  Aligned_cols=279  Identities=25%  Similarity=0.312  Sum_probs=215.5

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENR--GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +|.-.++||+|.||.||+|+. .+|+.||||+++.....  -.....+|+..|+.++|+||+.++++|.+.+..-||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            345567899999999999996 46999999998765332  245678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      | ..+|...+.++  ...++...+..++.++++||+|||+.   .|+||||||.|+|++++|.+||+|||+++.+.....
T Consensus        83 m-~tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   83 M-PTDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             c-cccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9 56898888554  35789999999999999999999997   999999999999999999999999999999876654


Q ss_pred             ccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc------chhhccc
Q 043017          662 HVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR------LCDLVDK  734 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~------~~~~~d~  734 (818)
                      .... .+-|..|.|||++.+. .|+...||||.|||+.||+-|.+-|.+.++-+-+..+-.....+.      +..+-|.
T Consensus       157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            4333 3678999999999875 599999999999999999999887776654332222211111111      1111110


Q ss_pred             ---c----CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchh
Q 043017          735 ---K----SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSF  791 (818)
Q Consensus       735 ---~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~  791 (818)
                         .    .........+..+..+++..++..||.+|++++|++++= -+...+.+..++.+..
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp~  298 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLPI  298 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCcC
Confidence               0    000012334566779999999999999999999999874 3444555555554443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2e-37  Score=328.69  Aligned_cols=256  Identities=24%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             HhhHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      ...+.+.+.||+|+||.||+|.+.    .+..||+|.+..... .....|.+|+..+.+++||||+++++++..+...++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            344556678999999999999864    356899999876532 334678999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999985432  4689999999999999999999997   99999999999999999999999999876543


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ...........++..|+|||.+.+..++.++||||||+++||+++ |+.||.......+...+.   ...        . 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~~--------~-  226 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE---DGF--------R-  226 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CCC--------C-
Confidence            222111122235678999999999999999999999999999875 999987654433322221   100        0 


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                        .+.+......+.+++..||+.+|++||++.++++.|+.+
T Consensus       227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              011223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-37  Score=326.92  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=206.6

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~  579 (818)
                      .++-.++||+|.||.||||+. .+|+.||+|++....  ........+|+.+|++|+||||++|.+...+.  ..+|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            444456899999999999995 569999999986553  34455678899999999999999999998876  6899999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      |||+. +|.-++..  ..-.+++.++.-+++|+++||+|||..   +|+|||||.+|||||.+|.+||+|||||+++...
T Consensus       198 eYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             ecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            99954 66666632  234689999999999999999999997   9999999999999999999999999999998887


Q ss_pred             CCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch-----hhcc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC-----DLVD  733 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~-----~~~d  733 (818)
                      .....+..+-|+.|.|||++.+. .|+.+.|+||.||||.||+.|++.+.+..+..-++.+-+....+.-.     .+-.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            77667777889999999999875 69999999999999999999999998776544334333332221100     0000


Q ss_pred             cc----CcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KK----SEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~----~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..    ......     ........++|+..+|..||.+|.|+.++|+.
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            00    000000     01122456788999999999999999999876

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.1e-37  Score=331.08  Aligned_cols=262  Identities=23%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             hHHhhhhcccccceeEEEeEecC-----------------CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEe
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-----------------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLV  566 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~  566 (818)
                      .+.+.++||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|++++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            34556789999999999997532                 3469999987543 23356799999999999999999999


Q ss_pred             eeecccCcceeeeeccCCCChhhHhhhcC----------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeec
Q 043017          567 GYCAERSNRFLVYEYMCNGSLDKWIFHKD----------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF  630 (818)
Q Consensus       567 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~  630 (818)
                      +++.+.+..++||||+++++|.+++....                ....+++..+.+++.||+.||+|||+.   +|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence            99999999999999999999999985421                113477888999999999999999997   99999


Q ss_pred             ccccCeEEEcCCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 043017          631 DIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC--GRRSS  707 (818)
Q Consensus       631 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt--G~~p~  707 (818)
                      ||||+|||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||++  +..|+
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999986543322 11223345788999999998899999999999999999987  55666


Q ss_pred             CCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          708 NPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       708 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ..................... ...   .   ..+......+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~-~~~---~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         243 GELTDEQVIENAGEFFRDQGR-QVY---L---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CcCCHHHHHHHHHHHhhhccc-ccc---c---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            654444333332221111000 000   0   0012234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=334.88  Aligned_cols=238  Identities=27%  Similarity=0.421  Sum_probs=200.7

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhhH
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKW  590 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~  590 (818)
                      =||.|+-|.||+|++. ++.||||+++...       ..+++-|++|+|+||+.+.|+|.....++||||||+.|.|...
T Consensus       131 WlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            4999999999999998 7899999875322       3578889999999999999999999999999999999999999


Q ss_pred             hhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCC
Q 043017          591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT  670 (818)
Q Consensus       591 l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt  670 (818)
                      |...   +.+.......+..+||.||.|||.+   +|||||||.-||||..+..+||+|||-++.......  .....||
T Consensus       203 Lka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kMSFaGT  274 (904)
T KOG4721|consen  203 LKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KMSFAGT  274 (904)
T ss_pred             Hhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh--hhhhhhh
Confidence            9543   4688888999999999999999998   999999999999999999999999999997755421  2235799


Q ss_pred             CcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHH
Q 043017          671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMI  750 (818)
Q Consensus       671 ~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  750 (818)
                      ..|||||++...+.++|+|||||||+|||||||..|+...+...++             --+.......+.+..+.+-+.
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------------wGVGsNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------------WGVGSNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------------EeccCCcccccCcccCchHHH
Confidence            9999999999999999999999999999999999998644322111             111122223344566777888


Q ss_pred             HHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          751 QIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       751 ~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      -|+..||+..|..||++++++.+|+-.
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            899999999999999999999999644

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-37  Score=327.55  Aligned_cols=248  Identities=32%  Similarity=0.563  Sum_probs=196.1

Q ss_pred             hhhcccccceeEEEeEec-----CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          509 QIRLGRGGSGSVFEGLLN-----DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.||.|.||.||+|.+.     .+..|+||.+..... ...++|.+|++.+.+++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            457999999999999987     257899999965433 34688999999999999999999999999888899999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-  661 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  661 (818)
                      ++|+|.++|... ....+++..+..|+.||++||+|||+.   +++|+||+++|||+++++.+||+|||++........ 
T Consensus        84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            999999999765 235689999999999999999999997   999999999999999999999999999988733222 


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+.......+...+.   +..+           ..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~---~~~~-----------~~  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK---QGQR-----------LP  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH---TTEE-----------TT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc-----------ce
Confidence            22233457789999999999889999999999999999999 678876554433333321   1111           01


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+......+.+++..||+.+|++||+|.++++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1223456788999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=335.72  Aligned_cols=262  Identities=28%  Similarity=0.423  Sum_probs=220.4

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +++.......++||.|-||.||.|.|+. .-.||||.++.+.. ..++|+.|+.+|+.++|||+|+|+|+|..+..+|||
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence            4444444455789999999999999985 56799999976543 478999999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      .|||.+|+|.+||....+ ..++--..+.++.||+.||.||...   ++|||||.++|+|+.++..+||+||||++++..
T Consensus       342 TEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            999999999999976543 4566677889999999999999986   999999999999999999999999999999988


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      +.........-...|.|||-+....++.|+|||+|||+||||.| |..|+.+.+-....+.+.             +. -
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------------kg-y  483 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------------KG-Y  483 (1157)
T ss_pred             CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------------cc-c
Confidence            77666555567889999999999999999999999999999999 777766543332222221             11 1


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .++.+..+..++.+||+.||+..|.+||++.|+-+.|+.+-..
T Consensus       484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            2334667888999999999999999999999999999876544

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-36  Score=320.53  Aligned_cols=250  Identities=26%  Similarity=0.442  Sum_probs=203.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.++||+|+||.||++.+.++..+|+|.+... .....+|.+|++++++++||||+++++++......++||||+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            4455689999999999999988889999988643 334578999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++............
T Consensus        85 ~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          85 CLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             cHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999885432  3588999999999999999999997   9999999999999999999999999999865433222222


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+..   ...        ..   .+..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~---~~~--------~~---~~~~  225 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR---GFR--------LY---RPKL  225 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCC--------CC---CCCC
Confidence            2345678999999998889999999999999999999 8889876544333333221   100        00   0112


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ....+.+++.+||+.+|.+||++.++++.|.
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            3457889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-36  Score=339.14  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=203.1

Q ss_pred             hhHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||.||+++.      .++..||||++.... ....+.+.+|++++..+ +||||++++++|.+++..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3466778999999999999974      235689999986543 23356788999999999 899999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC-----------------------------------------------------------
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR-----------------------------------------------------------  596 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  596 (818)
                      ++||||+++|+|.+++.....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999864211                                                           


Q ss_pred             -------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          597 -------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       597 -------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                                   ...++++.+.+++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         12478888999999999999999997   99999999999999999999999999998765433211


Q ss_pred             -ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch-HHHHHHHHhhhhcchhhccccCcCcc
Q 043017          664 -STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY-LVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       664 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+.   ...      ...     
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~~~------~~~-----  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK---EGY------RML-----  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH---hCc------cCC-----
Confidence             112335678999999999999999999999999999998 888886543221 111111   000      000     


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      .+.....++.+++.+||+.||++||++.+|+++|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0112245788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-36  Score=320.95  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=206.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG   86 (261)
T ss_pred             eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence            44557899999999999998888899999986533 34678999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++.... ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++............
T Consensus        87 ~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          87 SLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             cHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence            9999986432 34588899999999999999999997   9999999999999999999999999999876543322222


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||...........+...         .  ..+   ....
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------~--~~~---~~~~  228 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---------Y--RMP---RMEN  228 (261)
T ss_pred             CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---------C--CCC---CCCC
Confidence            2345678999999998889999999999999999998 99998755433333222110         0  001   1112


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ...++.+++.+|++.+|++||+++++.+.|+.+
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=320.27  Aligned_cols=256  Identities=28%  Similarity=0.434  Sum_probs=208.5

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ...+.+.+.||+|+||.||+|...+++.||+|.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34456667899999999999998888899999986543 34678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985533 34689999999999999999999997   9999999999999999999999999999877533222


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      .......+..|+|||.+.+..++.++||||||++++||++ |+.||.......+...+..   ...        .   +.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~--------~---~~  225 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---GYR--------M---PC  225 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCC--------C---CC
Confidence            1221223467999999998899999999999999999999 9989875543332222210   000        0   11


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      .......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            123456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.5e-37  Score=329.77  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      |.+.+.||+|.||.||||+.+ +.+.||+|.+.+...  ...+.+.+|++++++++|||||.++++|+...+.++|.||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            455678999999999999976 478899999865533  33456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      .+ +|..+|...   ..++++.+..|+.++..||.|||+.   +|+|||+||+|||++..+.+|++|||+|+.+.... .
T Consensus        84 ~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~  155 (808)
T KOG0597|consen   84 VG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S  155 (808)
T ss_pred             hh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence            66 999999654   4599999999999999999999998   99999999999999999999999999999876643 3


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ..+..+||+.|||||++.+.+++..+|+||+|||+||+..|++||....--.++..+.             ....  ..+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~-------------~d~v--~~p  220 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL-------------KDPV--KPP  220 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh-------------cCCC--CCc
Confidence            3455689999999999999999999999999999999999999986432222222211             1111  123


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+..+.+++...|+.||..|.+-.+++.+
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            4677889999999999999999999998865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=301.98  Aligned_cols=234  Identities=26%  Similarity=0.362  Sum_probs=199.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +++.+.||.|+||.|..++.+ +|..+|+|++.+...   ...+...+|..+|+.+.||.++++.+.+.+.+..+|||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            345568999999999999976 488999999976543   3345677899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      .++|.|..+|...   +.+++..++.+|.||+.||+|||+.   .|++|||||+|||||.+|.+||+|||.|+.....  
T Consensus       126 v~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  126 VPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             cCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            9999999999654   4699999999999999999999998   9999999999999999999999999999987553  


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        +.+.+||+.|+|||.+..+.+..++|-|+|||++|||+.|..||.......+.+.+-.   .            +...
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~---~------------~v~f  260 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE---G------------KVKF  260 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh---C------------cccC
Confidence              4456899999999999999999999999999999999999999987766444443321   1            1111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRR  764 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~R  764 (818)
                      ++--..++.+|+...|+.|-.+|
T Consensus       261 P~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  261 PSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CcccCHHHHHHHHHHHhhhhHhh
Confidence            33344567788889999999888

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-36  Score=325.63  Aligned_cols=249  Identities=25%  Similarity=0.314  Sum_probs=200.3

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.||+|+||.||++... +++.||+|.+....   ......+.+|++++.+++|+||+++++++.+.+..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence            3457999999999999864 68999999886432   2234568899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +|+|..++.... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++........  
T Consensus        84 ~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  157 (285)
T cd05631          84 GGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--  157 (285)
T ss_pred             CCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence            999998885432 24588999999999999999999997   999999999999999999999999999987543222  


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||.........+.+.......        .   .....
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------~---~~~~~  226 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--------Q---EEYSE  226 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--------c---ccCCc
Confidence            123468999999999999999999999999999999999999998654432222221111100        0   01122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      ....++.+|+.+||+.||++||+     +++++++
T Consensus       227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            34467889999999999999997     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=331.75  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=203.2

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC----CC-ccHHHHHHHHHHHhccC-cceeEEEeeeecccCcce
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG----EN-RGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~  576 (818)
                      ..+.+.+.||+|.||.|+.|... +++.||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++......+
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            45566778999999999999864 6899999976543    11 23456678999999998 999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCcee
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARL  655 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~  655 (818)
                      +||||+.+|.|.+++...   ..+.+..+.++++|++.|++|||+.   +|+||||||+|||++.+ +++||+|||++..
T Consensus        97 ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            999999999999999653   4688899999999999999999997   99999999999999999 9999999999998


Q ss_pred             cccCCCccccCCCCCCcccccccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNS-IT-AKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      .. ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......+...+.   ..        
T Consensus       171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~---~~--------  238 (370)
T KOG0583|consen  171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR---KG--------  238 (370)
T ss_pred             cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh---cC--------
Confidence            74 2223344568999999999999877 75 78999999999999999999998743332222211   10        


Q ss_pred             ccCcCccCcHHH-HHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          734 KKSEDMQSHRDD-AVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       734 ~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                       ..   ..+... +.++..++.+||+.+|.+|+++.++++
T Consensus       239 -~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  239 -EF---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -Cc---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             00   111112 678889999999999999999999994

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.6e-36  Score=372.64  Aligned_cols=257  Identities=25%  Similarity=0.496  Sum_probs=204.8

Q ss_pred             hhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          509 QIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ...||+|+||.||+|+. .+++.||||++......    ..+|++.+++++|||||+++|+|.++...++||||+++|+|
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence            34799999999999997 47899999998644322    23568899999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++.      .++|..+.+|+.|||+||+|||..+.++|+||||||+||+++.++.+++. |+........     ...
T Consensus       771 ~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~  838 (968)
T PLN00113        771 SEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC  838 (968)
T ss_pred             HHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCc
Confidence            99993      38899999999999999999997767799999999999999999888875 6665443221     123


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CchHHHHHHHHhhhhcchhhccccCcC-ccCcHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG--GDYLVDTLKVKAEADRLCDLVDKKSED-MQSHRD  744 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~  744 (818)
                      .++..|+|||++.+..++.|+|||||||++|||++|+.|+....  ...+.++.+...........+++.... .....+
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN  918 (968)
T ss_pred             cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence            57899999999999999999999999999999999999986432  223444443332222233334433321 122446


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      +..++.+++.+|++.+|++||+|+|++++|+.+.+..
T Consensus       919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            6778899999999999999999999999999886643

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.4e-36  Score=317.90  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=212.0

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.+.++||+|+||.||+|...+++.+|+|.+.........++.+|+++++.++|+||+++++++......++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            44667789999999999999998899999999876665567789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.||+.||+|||+.   +++|+||||+||++++++.+||+|||++..........
T Consensus        86 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          86 KGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             cCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            999999996543 35689999999999999999999997   99999999999999999999999999998764432221


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       ....++..|+|||.+....++.++||||||+++++|++ |+.|+...........+.   ....        .   +..
T Consensus       162 -~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~--------~---~~~  226 (261)
T cd05148         162 -SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGYR--------M---PCP  226 (261)
T ss_pred             -cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCCc--------C---CCC
Confidence             22346778999999988899999999999999999998 889987655333333222   1000        0   112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ......+.+++.+||+.+|++|||++++++.|+.+
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            23456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.8e-36  Score=319.22  Aligned_cols=253  Identities=28%  Similarity=0.414  Sum_probs=204.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.++||+|+||.||+|... .++.+|+|.+... .....++.+|++++++++|+||+++++++..+...+++|||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            445568999999999999976 4788999998643 33467899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++...........
T Consensus        87 ~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          87 GNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             CcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence            99999985432 34588999999999999999999997   999999999999999999999999999987654322222


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..|+...........+.   ..      ..  .   ..+.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~------~~--~---~~~~  228 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KG------YR--M---ERPE  228 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---CC------CC--C---CCCC
Confidence            22234668999999998899999999999999999998 888886544332222211   00      00  0   1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=314.89  Aligned_cols=260  Identities=26%  Similarity=0.364  Sum_probs=203.5

Q ss_pred             hhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhc--cCcceeEEEeeeecccC----cceeeeecc
Q 043017          509 QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGN--IHHFNLVRLVGYCAERS----NRFLVYEYM  582 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~~  582 (818)
                      .+.||+|+||+||+|.++ |+.||||++...+   ++.+.+|.++.+.  |+|+||+.+++.-..+.    +++||.+|.
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            356999999999999998 8999999996543   4567788887776  49999999999876554    679999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc-----CCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY-----CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ++|||.+||..    .+++.+..++++..+|.||+|||-+     .++.|.|||||++|||+..++.+.|+|+|||....
T Consensus       292 e~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  292 EHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             cCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            99999999943    5799999999999999999999964     47789999999999999999999999999999887


Q ss_pred             cCCCcc---ccCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCC-CCchHHH
Q 043017          658 QDQSHV---STMPKGTPGYMAPELTRGNS------ITAKIDIYSFGVVILEIICG----------RRSSNPK-GGDYLVD  717 (818)
Q Consensus       658 ~~~~~~---~~~~~gt~~y~aPE~~~~~~------~s~ksDVwS~Gvll~elltG----------~~p~~~~-~~~~l~~  717 (818)
                      ......   ....+||.+|||||++....      .-..+||||||+++||+...          +.||.+. ..+.-.+
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            664332   23467999999999997642      12369999999999999753          3455433 2222233


Q ss_pred             HHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .++...-..++...+..++    ...+....+.++|..||..+|..|.|+=.+-+.|.++.+.
T Consensus       448 eMrkVVCv~~~RP~ipnrW----~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRW----KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             HHhcceeecccCCCCCccc----ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            3322222222222222222    2457888999999999999999999999999999888754

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-36  Score=316.87  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=203.6

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.+.||+|+||.||++...++..+|+|.+... ....++|.+|++++.+++||||+++++++.+....++||||++++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            3455689999999999999887778999988643 334578999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++....  ..+++..+..++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||+++...........
T Consensus        85 ~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          85 CLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            9999985432  3689999999999999999999997   9999999999999999999999999999876543322222


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........+.   ...        ..   .....
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~--------~~---~~~~~  225 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS---QGL--------RL---YRPHL  225 (256)
T ss_pred             CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh---cCC--------CC---CCCCC
Confidence            2345678999999998889999999999999999999 999986554332222221   100        00   00112


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ....+.+++.+||+.+|.+||++.++++.|+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            3468889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.4e-36  Score=321.17  Aligned_cols=256  Identities=28%  Similarity=0.465  Sum_probs=206.8

Q ss_pred             hHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||+|....      ...||+|.+..... ....+|.+|++++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            45566789999999999998643      25799999865432 334678999999999999999999999999899999


Q ss_pred             eeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC
Q 043017          578 VYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN  644 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~  644 (818)
                      +|||+++++|.+++.....             ...+++..+..++.|+++||+|||+.   +++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence            9999999999999864321             14578889999999999999999997   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHH
Q 043017          645 VKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK  722 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~  722 (818)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......+...+.. 
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~-  241 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS-  241 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence            99999999986543322 22223356788999999998899999999999999999998 9999876554433332221 


Q ss_pred             hhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       723 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                         .        ...  ..+...+.++.+|+.+||+.+|.+||++.+|+++|+.+
T Consensus       242 ---~--------~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         242 ---R--------QLL--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ---C--------CcC--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence               0        000  11234557889999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-36  Score=336.31  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=202.9

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||.||+++..      ++..||||++.... ....+.+.+|+++++.+ +|+||++++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            34556788999999999998742      24579999997543 23346788999999999 899999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC-----------------------------------------------------------
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR-----------------------------------------------------------  596 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  596 (818)
                      ++||||+++|+|.+++.....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999854210                                                           


Q ss_pred             --------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-cccCC
Q 043017          597 --------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMP  667 (818)
Q Consensus       597 --------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~  667 (818)
                              ...+++..+.+++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    12477888999999999999999997   9999999999999999999999999999865443221 11223


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      .++..|+|||++....++.++||||||+++|||++ |+.||.............   ...     .....     +....
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---~~~-----~~~~~-----~~~~~  341 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---KRG-----YQMSR-----PDFAP  341 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---Hcc-----cCccC-----CCCCC
Confidence            35678999999998899999999999999999997 999987543322111111   000     00000     11124


Q ss_pred             HHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          747 VKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      .++.+++.+||+.+|++||++.+|+++|+++.
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            67889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=342.87  Aligned_cols=256  Identities=23%  Similarity=0.337  Sum_probs=210.5

Q ss_pred             hhhhcccccceeEEEeEecCC-cEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeee-cc------cCcceee
Q 043017          508 FQIRLGRGGSGSVFEGLLNDG-TKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYC-AE------RSNRFLV  578 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~-~~------~~~~~lV  578 (818)
                      +.+.|.+|||+.||.+....+ .++|+|++...++.+.+..++|+++|++|+ |+|||.+++.. ..      .-+.+|+
T Consensus        41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL  120 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL  120 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence            346799999999999998776 999999998888888899999999999996 99999999932 21      1367899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      ||||++|.|-+++...... .|++.++++|+.|+++|+++||.. .++|||||||.+||||..+++.||||||-+.....
T Consensus       121 mEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             hhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            9999999999999654433 399999999999999999999985 77899999999999999999999999999875432


Q ss_pred             CCCc--------cccCCCCCCcccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          659 DQSH--------VSTMPKGTPGYMAPELT---RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       659 ~~~~--------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ....        ......-|+-|.|||++   .+..+++|+|||+|||+||-|+....||+......             
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------------  265 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------------  265 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------------
Confidence            2210        01112368999999987   46789999999999999999999999997553321             


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                         ++.... ..+....+...|.+||..||+++|++||++-||+..+-++...+.
T Consensus       266 ---Ilng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  266 ---ILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ---EEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence               122222 122245788999999999999999999999999999999887654

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-36  Score=314.48  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=203.7

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ...+.+.||+|+||.||++...++..+|+|.+.... ....+|.+|++++++++|+||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            345677899999999999998877889999886432 3356789999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++....  ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999986433  3688999999999999999999997   999999999999999999999999999986643322222


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+..   .      ..  .   ..+.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~------~~--~---~~~~  224 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA---G------YR--L---YRPK  224 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc---C------Cc--C---CCCC
Confidence            22234567999999998899999999999999999999 7888875543332222210   0      00  0   1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ..+.++.+++.+||+.+|++||++.++++.|.
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            24567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.5e-36  Score=318.74  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=208.6

Q ss_pred             HhhHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  575 (818)
                      ..++.+.+.||+|+||.||+|...+      ++.||||.+...... ..+.|.+|++++.+++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4567778899999999999998643      478999998765443 457899999999999999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcC-----------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC
Q 043017          576 FLVYEYMCNGSLDKWIFHKD-----------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN  644 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~  644 (818)
                      ++||||+++++|.+++....           ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999996432           134578899999999999999999997   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHH
Q 043017          645 VKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK  722 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~  722 (818)
                      +||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........+.+.  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence            99999999986543221 11222345788999999999999999999999999999998 999987655443333322  


Q ss_pred             hhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       723 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                        ...        ...  .+......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus       239 --~~~--------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 --QGR--------LLQ--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --cCC--------cCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              000        000  012344678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=321.31  Aligned_cols=243  Identities=28%  Similarity=0.383  Sum_probs=207.1

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .+.||+|.||.||||... .++.||+|++.... ....++++.|+.++.+++|+||.+++|.+..+..++++||||.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            368999999999999975 58899999997653 4446789999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      +.+.|..   ...+.+..+.-|++++..||.|||.+   +.+|||||+.|||+..+|.+||+|||.+..+....... .+
T Consensus        98 v~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~t  170 (467)
T KOG0201|consen   98 VLDLLKS---GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KT  170 (467)
T ss_pred             hhhhhcc---CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cc
Confidence            9998843   23458888889999999999999998   99999999999999999999999999999887765554 55


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc-cCcCccCcHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK-KSEDMQSHRDD  745 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~  745 (818)
                      .+||+.|||||++....|+.|+||||||+..+||.+|.+|+....+..             +.-++.+ .++...  ...
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------------vlflIpk~~PP~L~--~~~  235 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------------VLFLIPKSAPPRLD--GDF  235 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------------EEEeccCCCCCccc--ccc
Confidence            689999999999998899999999999999999999999987655422             1112222 122222  256


Q ss_pred             HHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.+++..||+.+|+.||++.+++++
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            6779999999999999999999999976

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-36  Score=317.05  Aligned_cols=254  Identities=27%  Similarity=0.471  Sum_probs=205.4

Q ss_pred             hHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|.+..    ...||||.+.... .....+|.+|+.++++++|+||+++++++......++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            34556789999999999999752    4579999986543 333567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++|+|||+++.....
T Consensus        85 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          85 EYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999985432  3688999999999999999999997   9999999999999999999999999999987532


Q ss_pred             CCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......+.+.+..   ..        .. 
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~--------~~-  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---GY--------RL-  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CC--------CC-
Confidence            222 1222345678999999998899999999999999999998 9999865443332222210   00        00 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                        +.+......+.+++.+|++.+|++||++.+|+++|+++
T Consensus       228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              01223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-36  Score=329.46  Aligned_cols=246  Identities=25%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+.|.|-.|+.. +|+.+|||.+.+..   ......+.+|+.+|+.+.|||++++++.+.+..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            456678999999999999975 69999999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|-|.++|..+   +.+++.++.+++.||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|.+-..+  
T Consensus        94 v~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--  165 (786)
T KOG0588|consen   94 VPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--  165 (786)
T ss_pred             cCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence            9999999999655   4699999999999999999999998   9999999999999999999999999999875443  


Q ss_pred             ccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ....+.+|++.|.|||++.+.+| ..++||||-|||||.||+|+.||++..-..++..++.    +           ...
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~----G-----------~f~  230 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR----G-----------VFE  230 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc----C-----------ccc
Confidence            33445689999999999999987 6799999999999999999999985443333333221    1           112


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+...+.+.++|+.+|+..||++|.|++||+++-
T Consensus       231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            2445667888999999999999999999999974

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.5e-35  Score=311.30  Aligned_cols=253  Identities=29%  Similarity=0.469  Sum_probs=204.8

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.+.++||+|+||.||++...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            34567788999999999999988888999999875433 4567999999999999999999999885 456889999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++..+.......
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999985432 34588999999999999999999997   99999999999999999999999999998765433222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.........+.+..   ..        .   .+.+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~--------~---~~~~  225 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER---GY--------R---MPCP  225 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CC--------C---CCCC
Confidence            222235668999999988889999999999999999999 8888875543332222210   00        0   0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-36  Score=330.61  Aligned_cols=241  Identities=26%  Similarity=0.347  Sum_probs=197.3

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||+|+||.||+++.. +|+.+|||++....   ......+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5899999999999875 68899999986432   2334567889999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus        82 L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  154 (323)
T cd05571          82 LFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence            99988543   4688999999999999999999997   999999999999999999999999999875432221 1223


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||.......+...+..    .        .   ...+....
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~----~--------~---~~~p~~~~  219 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----E--------E---IRFPRTLS  219 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc----C--------C---CCCCCCCC
Confidence            4689999999999999999999999999999999999999975543322222110    0        0   01122345


Q ss_pred             HHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .++.+++.+||+.||++||     ++.+++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            6788999999999999999     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=330.21  Aligned_cols=241  Identities=27%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ....|..+||+|.||.|+++.++ +++.+|||.+++..   ....+..+.|.+++... +||.|+.++.+|...++.++|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            34455678999999999999986 47899999998763   45567788899988887 599999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+.||++..+.    +.+.+++..+..++..|+.||+|||++   +|||||||.+|||||.+|++||+||||++.--.
T Consensus       448 mey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            9999999944333    345799999999999999999999998   999999999999999999999999999997543


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ... .+.+..||+.|||||++.+..|+..+|-|||||+|||||.|+.||.+.+++++.+.+...               +
T Consensus       521 ~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------------~  584 (694)
T KOG0694|consen  521 QGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------------E  584 (694)
T ss_pred             CCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------C
Confidence            333 445678999999999999999999999999999999999999999988888877776421               1


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSA  767 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~  767 (818)
                      ...+...+.+.+.|+.++|..+|++|.-+
T Consensus       585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            12245567888999999999999999866

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.1e-36  Score=327.84  Aligned_cols=260  Identities=24%  Similarity=0.351  Sum_probs=202.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   86 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   86 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence            444567999999999999976 57889999886542 2335679999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...   ..+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++.......   
T Consensus        87 ~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  158 (331)
T cd06649          87 GGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (331)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence            99999998543   3588999999999999999999974  369999999999999999999999999997654321   


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh-----------------
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-----------------  726 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~-----------------  726 (818)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......+...+.......                 
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            223468999999999999899999999999999999999999997544332222111000000                 


Q ss_pred             ----------------cchh-hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          727 ----------------RLCD-LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       727 ----------------~~~~-~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                                      .+.. ++....+... ......++.+++.+||+.||++|||+.+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                            0000 0000000000 112456789999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.9e-36  Score=325.81  Aligned_cols=258  Identities=23%  Similarity=0.387  Sum_probs=203.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCc----EEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      ..+...+.||+|+||.||+|++. +++    .||||.+.... ....++|.+|+.+++.++|+||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            33445568999999999999864 233    48999986543 33457899999999999999999999999764 5679


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ++||+++|+|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999986432  3578899999999999999999997   99999999999999999999999999999775


Q ss_pred             cCCCccc-cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          658 QDQSHVS-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       658 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ....... .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+.......+...+.    ...       .
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~-------~  229 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----KGE-------R  229 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----CCC-------C
Confidence            4433221 12234678999999999999999999999999999998 999987543322221111    100       0


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      .   +.+.....++.+++.+||+.+|.+||++.+++..|..+...+
T Consensus       230 ~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            0   111223456889999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.6e-36  Score=320.13  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=207.9

Q ss_pred             HhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+...||+|+||.||+++..      ++..+++|.+........+.+.+|++++++++|+||+++++++......++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            34567999999999999843      355699999876655556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEE
Q 043017          581 YMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI  647 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl  647 (818)
                      |+++++|.+++....             ....+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence            999999999996432             123488999999999999999999997   9999999999999999999999


Q ss_pred             eecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhh
Q 043017          648 ADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEA  725 (818)
Q Consensus       648 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~  725 (818)
                      +|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........+.+.    .
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~  240 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT----Q  240 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----C
Confidence            99999986544322 12223446788999999999899999999999999999999 999986554333222211    1


Q ss_pred             hcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       726 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ...        ..  .....+..+.+++.+||+.+|++||++.+|+++|+.+.+.
T Consensus       241 ~~~--------~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         241 GRV--------LE--RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCC--------CC--CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            100        00  0122346788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.1e-36  Score=320.38  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=200.1

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ....||+|+||+||.++.+ +|..+|+|++++..   ....+.++.|-.+|....+++||+|+..|.+.+.+||||||+|
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            3457999999999999976 58999999998764   3445677889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC----
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD----  659 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~----  659 (818)
                      ||++..+|...   ..|+++.+..++.+++-||.-||+.   ++|||||||+|+|||..|++||+||||+.-+...    
T Consensus       225 GGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  225 GGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             CccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            99999999543   5799999999999999999999998   9999999999999999999999999998533110    


Q ss_pred             -------------------CC-----c------------------cccCCCCCCcccccccccCCCCCchhhHHHHHHHH
Q 043017          660 -------------------QS-----H------------------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVI  697 (818)
Q Consensus       660 -------------------~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll  697 (818)
                                         ..     .                  .....+|||.|||||++.+..++..+|.||+|||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                               00     0                  01113499999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCc---HHHHHHH
Q 043017          698 LEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS---ASMLVKV  773 (818)
Q Consensus       698 ~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~  773 (818)
                      ||||.|.+||....+......+..-...      +..+ .    ......+..+||.+|+. ||++|.-   +.||-++
T Consensus       379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~------l~fP-~----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETPQETYRKIVNWRET------LKFP-E----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhhh------ccCC-C----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            9999999999877765544433221111      1111 1    12233677788899999 9999975   6666554

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-35  Score=319.37  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=208.0

Q ss_pred             hHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .+.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++.+++|+||+++++++......++|
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            3445678999999999999852      3456899998766555567899999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcC----------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEe
Q 043017          579 YEYMCNGSLDKWIFHKD----------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIA  648 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  648 (818)
                      |||+++++|.+++....          +...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence            99999999999986432          223589999999999999999999997   99999999999999999999999


Q ss_pred             ecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhh
Q 043017          649 DFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       649 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      |||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||...........+..   . 
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---~-  238 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---G-  238 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-
Confidence            9999986543322 11222345778999999998899999999999999999998 8888865543332222211   1 


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ...     ..     ......++.+++.+||+.+|.+|||+.++++.|+.+.+.
T Consensus       239 ~~~-----~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVL-----QR-----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcC-----CC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            000     00     112345689999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-36  Score=321.21  Aligned_cols=262  Identities=21%  Similarity=0.259  Sum_probs=200.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.+.||+|+||.||+++.. +++.+|||++....  ....+.+.+|++++..++|+||+++++++...+..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            345568999999999999986 57889999986542  233567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++.+..+...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          83 EKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            98877654422   24588899999999999999999997   9999999999999999999999999999876543332


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh------------hhcchh
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE------------ADRLCD  730 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~------------~~~~~~  730 (818)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+.....            ......
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            23334689999999999988899999999999999999999999976543222211111100            000000


Q ss_pred             hccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+......     .....+..+.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000     001234578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.3e-36  Score=326.00  Aligned_cols=241  Identities=25%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||+|+||.||+++.. +|+.||+|.+...   .......+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5899999999999965 5899999998643   22334567889999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus        82 L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~  154 (323)
T cd05595          82 LFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKT  154 (323)
T ss_pred             HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-ccc
Confidence            99888543   3588999999999999999999997   9999999999999999999999999998754332211 223


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+..    .        ..   ..+....
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~----~--------~~---~~p~~~~  219 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----E--------EI---RFPRTLS  219 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc----C--------CC---CCCCCCC
Confidence            4689999999999999999999999999999999999999975544332222210    0        00   0112334


Q ss_pred             HHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .++.+++.+||+.||++||     ++.+++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            6778999999999999998     89888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.1e-35  Score=332.60  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             hhHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccC-cceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||.||+|+...      +..||||++..... ...+.|++|+++++++. ||||+++++++.+....
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            345566789999999999998531      34799999975433 33467999999999996 99999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC-----------------------------------------------------------
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR-----------------------------------------------------------  596 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  596 (818)
                      ++||||+++|+|.++|.....                                                           
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            999999999999998864210                                                           


Q ss_pred             ----------------------------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC
Q 043017          597 ----------------------------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       597 ----------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                                                        ...+++..+..++.||++||+|||+.   +|+|+||||+|||++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence                                              12477888899999999999999997   99999999999999999


Q ss_pred             CCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch-HHHHH
Q 043017          643 LNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY-LVDTL  719 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~-l~~~~  719 (818)
                      +.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +...+
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            999999999998764432221 122346788999999998899999999999999999997 888886543221 11111


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .    ..     .  ..   ........++.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus       354 ~----~~-----~--~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         354 K----SG-----Y--RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             h----cC-----C--CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1    00     0  00   1122345678899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-35  Score=317.42  Aligned_cols=255  Identities=27%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             hHHhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ...+.++||+|+||.||+|..     ..++.+++|.+.... .....+|.+|++++++++|+||+++++++..+...++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            445667899999999999985     246789999987543 23346789999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcC--------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC
Q 043017          579 YEYMCNGSLDKWIFHKD--------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN  644 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~  644 (818)
                      |||+++++|.+++....              ....+++.....++.|++.||+|||+.   +++|+||||+||++++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence            99999999999985321              123578889999999999999999997   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHH
Q 043017          645 VKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK  722 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~  722 (818)
                      +||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......+.+.+.. 
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  241 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-  241 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence            99999999987643322 11222345678999999988889999999999999999998 8888865543332222211 


Q ss_pred             hhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       723 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                         ...       .   ........++.+++.+|++.+|.+||++.+++++|..
T Consensus       242 ---~~~-------~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 ---RQL-------L---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---CCc-------C---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               000       0   0112234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=324.59  Aligned_cols=243  Identities=22%  Similarity=0.288  Sum_probs=199.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            345568999999999999976 58899999986432   23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          83 VPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            9999999998543   3588999999999999999999997   99999999999999999999999999998664321 


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                         ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+...            ..   ..
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------------~~---~~  217 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------------KL---EF  217 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------Cc---CC
Confidence               2245899999999999988999999999999999999999999765443333222110            00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      +......+.+++.+||+.||.+||+     +++++++
T Consensus       218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            1123456789999999999999995     8888766

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-35  Score=311.42  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=207.0

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ..++.+.++||+|+||.||+|..++++.+|+|.+.... ....+|.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            45666778999999999999999889999999987543 34578999999999999999999999874 45789999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999885433 34688999999999999999999987   9999999999999999999999999999876533322


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||...........+...   .        ..   +.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~--------~~---~~  224 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG---Y--------RM---PR  224 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC---C--------CC---CC
Confidence            2223345678999999998889999999999999999999 99999765443333222110   0        00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ......++.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            12234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-35  Score=316.17  Aligned_cols=257  Identities=23%  Similarity=0.347  Sum_probs=205.0

Q ss_pred             HhhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  575 (818)
                      ...+.+.++||+|+||.||+|...      +++.||||++...... ..+.|.+|+.++.+++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            355777889999999999999864      2578999999754332 246788999999999999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC
Q 043017          576 FLVYEYMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      ++++||+++++|.+++....             ....+++..+..++.|+++||+|||+.   +|+||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            99999999999999985321             123578888999999999999999997   99999999999999999


Q ss_pred             CCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHH
Q 043017          643 LNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLK  720 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~  720 (818)
                      +.+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..|+.........+.+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999886643322 11222345778999999988889999999999999999998 778876554333322221


Q ss_pred             HHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       721 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .   .         ...  +.+......+.+++..||+.+|++||++.+|++.|+.
T Consensus       241 ~---~---------~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 N---R---------QVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             c---C---------CcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1   1         000  1122345668899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=331.05  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=203.2

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++..++||||+++++++..+...++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            34568999999999999976 48899999986432   233567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....    
T Consensus        84 ~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          84 PGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            999999998543   3588999999999999999999997   999999999999999999999999999986543    


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+.....      .+..... ....
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~~~~~-~~~~  226 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------TLQRPVY-DDPR  226 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------cccCCCC-Cccc
Confidence            22334689999999999999999999999999999999999999976554433333221110      0111100 0001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++.+++.+||+.+|.+||++.+++++
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            2345678899999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-35  Score=311.32  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=204.5

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.+.++||+|+||.||+|+..+...||+|.+.... ...++|.+|++++++++|+||+++++.+.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            3466778899999999999998877789999987432 345689999999999999999999998754 56789999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...++++.+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++..........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999996432 24578999999999999999999997   99999999999999999999999999998765443222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||...........+.   ...        .   ....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~---~~~--------~---~~~~  225 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGY--------R---MPCP  225 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh---cCC--------C---CCCc
Confidence            223346778999999988899999999999999999999 788886554332222111   000        0   0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ......+.+++.+|++.+|++||++.++++.|+..
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            24456788999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-35  Score=315.18  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=201.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      ..+++.++||+|+||.||+|...      .+..||||.+..... ....+|.+|+.+++.++|+||+++++++.++...+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            34556678999999999998753      256799999864332 33457899999999999999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCC-------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          577 LVYEYMCNGSLDKWIFHKDR-------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                      +||||+++++|.+++.....       ...+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence            99999999999999864321       13467788999999999999999997   999999999999999999999999


Q ss_pred             cCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...........+.   .. .
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~---~~-~  238 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM---EG-G  238 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---cC-C
Confidence            99997654332211 122345778999999998899999999999999999999 688886554332222111   10 0


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .        ..  ........+.+++.+||+.+|++||++.|++++|++
T Consensus       239 ~--------~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         239 L--------LD--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             c--------CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0        00  011234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-35  Score=324.56  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ...+++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            345666778999999999999976 57889999876542 2334678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||+.  .+|+|+||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            99999999998543   3578899999999999999999973  379999999999999999999999999997653321


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc-------------
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR-------------  727 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~-------------  727 (818)
                         .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......+...+........             
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence               1234588999999999988899999999999999999999999875433222111100000000             


Q ss_pred             ---------------chhhcc----ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 ---------------LCDLVD----KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ---------------~~~~~d----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                                     .....+    ...+... ......++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                           000000    0000000 01134568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-36  Score=324.98  Aligned_cols=240  Identities=22%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||.||++... +++.||+|.+...   .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 4789999998643   233456788899999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  153 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF  153 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence            9998543   3588999999999999999999997   999999999999999999999999999986433222 22334


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.   .         ...   ..+.....
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~---~---------~~~---~~~~~~~~  218 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL---Q---------EPL---RFPDGFDR  218 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH---c---------CCC---CCCCcCCH
Confidence            68999999999999999999999999999999999999997544322221111   1         001   01123446


Q ss_pred             HHHHHHHHccccCCCCCCc---HHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPS---ASMLVKV  773 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt---~~evl~~  773 (818)
                      ++.+++.+||+.||++||+   +.|++++
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            7789999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=340.02  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=203.2

Q ss_pred             HHhhhhcccccceeEEEeEec-C-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-D-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||++... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            445678999999999999864 3 57889998765555555678889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-
Q 043017          584 NGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-  661 (818)
Q Consensus       584 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  661 (818)
                      +|+|.++|... .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988542 2334688999999999999999999997   999999999999999999999999999987654322 


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   . .    ..      +.
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~---~-~----~~------~~  291 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY---G-K----YD------PF  291 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---C-C----CC------CC
Confidence            122334689999999999999999999999999999999999999975443322222110   0 0    00      01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.....++.+++.+||+.+|++||++.+++.+
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            12334678899999999999999999998753

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-36  Score=309.12  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=211.9

Q ss_pred             HhhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .-.++|.+.||+|.||.|-++.. ..|+.||||.+++..-   ++.-.+.+|+++|..|+||||+.++.+|+..+.+++|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45788999999999999999986 5699999999977643   3445678899999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||..+|.|.+|+...   +.|++.++..+++||..|+.|+|++   +++|||||.+|||||+++++||+||||+-++..
T Consensus       132 MEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999554   4699999999999999999999998   999999999999999999999999999988765


Q ss_pred             CCCccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ...  ..+..|++-|.+||++.+.+| .+..|-||||++||.|+.|..||++.+-..++..+....            ..
T Consensus       206 ~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga------------Yr  271 (668)
T KOG0611|consen  206 KKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA------------YR  271 (668)
T ss_pred             ccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc------------cc
Confidence            433  234579999999999999987 578999999999999999999999876555555443211            11


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      +.    +......-||++||..+|++|.|+.+|..+..
T Consensus       272 EP----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 EP----ETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             CC----CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            11    12234557889999999999999999999873

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=324.79  Aligned_cols=261  Identities=24%  Similarity=0.424  Sum_probs=219.8

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecC---Cc--EEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccC
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLND---GT--KVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS  573 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~---g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~  573 (818)
                      ++.++.....+.||+|-||.||+|++.+   |+  .||||..+.+ .....+.|+.|..+|++++||||++|+|.|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            4455555667789999999999999643   33  5899988775 34557889999999999999999999999986 4


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++|||.++-|.|..||...+  ..|+......++.||+.+|+|||+.   ++|||||.++|||+.+.--+||+||||+
T Consensus       464 P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence            6799999999999999996543  5788999999999999999999996   9999999999999999999999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      +.+..+.........-+..|||||.+.-.+++.++|||.|||.+||+++ |.+||.+....+....+             
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------------  605 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------------  605 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------------
Confidence            9988776666666667889999999999999999999999999999998 99999866443221111             


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                       ...+..+.+..++..|..++.+||..+|.+||++.|+...|+.+.+.
T Consensus       606 -EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  606 -ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             -cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence             12233445667888999999999999999999999999999877653

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-35  Score=326.28  Aligned_cols=246  Identities=27%  Similarity=0.392  Sum_probs=193.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++.++||+|+||.||+++.. +++.||||.+..... ...+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            345578999999999999975 589999999865432 334678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|....       ...+..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus       156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  224 (353)
T PLN00034        156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P  224 (353)
T ss_pred             CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence            99986532       345677889999999999999997   999999999999999999999999999987643321 1


Q ss_pred             ccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          664 STMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .....|+..|+|||.+..     ...+.++|||||||++|||++|+.||..................        ...  
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~--  294 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--------QPP--  294 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc--------CCC--
Confidence            223468999999998853     23456899999999999999999999743322222111111000        000  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ........++.+++.+||+.||++||++.|++++
T Consensus       295 -~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 -EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1122345678899999999999999999999986

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=295.28  Aligned_cols=263  Identities=26%  Similarity=0.282  Sum_probs=209.9

Q ss_pred             hhHHhhhhcccccceeEEEeE-ecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC-----ccee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFL  577 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~l  577 (818)
                      ..|.+.++||+|||+-||.++ +.+++.+|+|++.-...++.+..++|++..++++||||+++++++..+.     ..+|
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            356677899999999999998 5678899999998777778889999999999999999999999986544     4899


Q ss_pred             eeeccCCCChhhHhhhcCC-ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          578 VYEYMCNGSLDKWIFHKDR-IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +++|...|+|.+.+...+. +..+++.+++.|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.+...
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            9999999999999976443 34799999999999999999999996 446999999999999999999999999998765


Q ss_pred             ccCCC---c-----cccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh
Q 043017          657 AQDQS---H-----VSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA  725 (818)
Q Consensus       657 ~~~~~---~-----~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~  725 (818)
                      .-.-.   .     .......|..|.|||++.   +..+++++|||||||+||+|+.|..||+..-           ...
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~-----------~~G  248 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY-----------QQG  248 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh-----------hcC
Confidence            42111   0     011234788999999985   4468999999999999999999999986321           011


Q ss_pred             hcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       726 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      +.+.-.+.......+.....++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus       249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11111111111111122337889999999999999999999999999998654

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-35  Score=324.94  Aligned_cols=259  Identities=31%  Similarity=0.451  Sum_probs=203.1

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeeccc-Cc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAER-SN  574 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~-~~  574 (818)
                      ..+.+.+.||+|+||.||+|...      +++.||+|++..... ...+.+..|++++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            35677789999999999999743      257899999864432 2345678899999999 899999999988654 56


Q ss_pred             ceeeeeccCCCChhhHhhhcCC----------------------------------------------------------
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDR----------------------------------------------------------  596 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  596 (818)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999998854221                                                          


Q ss_pred             ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccc
Q 043017          597 IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMA  675 (818)
Q Consensus       597 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~a  675 (818)
                      ...+++..+.+++.||++||+|||+.   +|+||||||+||++++++.+||+|||++..+....... .....++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            12578999999999999999999997   99999999999999999999999999998764433222 222346778999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchH-HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHH
Q 043017          676 PELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYL-VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIA  753 (818)
Q Consensus       676 PE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li  753 (818)
                      ||++.+..++.++|||||||+++||++ |+.||........ ...+.    ....          ...+.....++.+++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~----------~~~~~~~~~~~~~l~  309 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK----EGTR----------MRAPEYATPEIYSIM  309 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh----ccCC----------CCCCccCCHHHHHHH
Confidence            999999999999999999999999998 9999865433221 11111    0000          001123346788999


Q ss_pred             HHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          754 ISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       754 ~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+||+.+|++||++.|++++|+.+.+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.8e-36  Score=326.41  Aligned_cols=241  Identities=27%  Similarity=0.359  Sum_probs=197.3

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||+|+||.||++... +++.||||.+...   .......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5899999999999865 5899999998643   22345678899999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus        82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  154 (328)
T cd05593          82 LFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT  154 (328)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence            99888543   3588999999999999999999997   999999999999999999999999999875433222 1223


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+.   ..            ....+....
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~---~~------------~~~~p~~~~  219 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---ME------------DIKFPRTLS  219 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc---cC------------CccCCCCCC
Confidence            468999999999998899999999999999999999999997544322222111   00            001112334


Q ss_pred             HHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .++.+++.+||+.||++||     ++.+++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            6788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.8e-35  Score=307.06  Aligned_cols=246  Identities=26%  Similarity=0.385  Sum_probs=199.7

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhh
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      .||+|+||.||+|...+++.+|+|.+..... .....|.+|+++++.++|+||+++++++......++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            5899999999999988899999999865532 234578899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCC
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG  669 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  669 (818)
                      ++....  ..+++..+..++.|++.+|.|||+.   +++|+||||+||+++.++.+||+|||++...............+
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            885432  3578999999999999999999987   99999999999999999999999999997644322222222234


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHH
Q 043017          670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK  748 (818)
Q Consensus       670 t~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  748 (818)
                      +..|+|||++....++.++||||||+++|||++ |..||...........+.   ....        .   ........+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~~~~--------~---~~~~~~~~~  222 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---KGYR--------M---SCPQKCPDD  222 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCC--------C---CCCCCCCHH
Confidence            678999999998889999999999999999998 888987553322222111   1100        0   011223467


Q ss_pred             HHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          749 MIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       749 l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      +.+++.+|++.+|++||++.++++.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.4e-35  Score=308.27  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=202.8

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+..+||+|+||.||++....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            345566899999999999998877789999886443 34567899999999999999999999875 4568899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++...........
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            99999996532 24578999999999999999999997   999999999999999999999999999987644332222


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||...+..++.++||||||+++|||++ |+.|+...........+.   ...        ..   ..+.
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~--------~~---~~~~  226 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE---RGY--------RM---PCPQ  226 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC--------CC---CCCc
Confidence            22345678999999998899999999999999999999 888887554332222211   000        00   1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .....+.+++.+||+.+|++||++.++++.|+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.6e-35  Score=313.72  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=200.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCc----EEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.||+|+||.||+|++. +++    ++++|.+..... ....++..|+..+++++||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            34468999999999999974 343    478888754332 234677888889999999999999998864 55788999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++....  ..+++..+..++.||+.||+|||+.   +++|+||||+||++++++.+||+|||+++......
T Consensus        89 ~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          89 LSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             eCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            999999999995432  4689999999999999999999997   99999999999999999999999999998765432


Q ss_pred             Cc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          661 SH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       661 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........+.+.    ....       .. 
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~~~-------~~-  231 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE----KGER-------LA-  231 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----CCCc-------CC-
Confidence            22 2223456778999999998899999999999999999998 999987654433222221    1000       00 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                        .+......+.+++.+|++.+|++||++.|+++.|..+.+.+
T Consensus       232 --~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 --QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence              01123346778999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-36  Score=328.22  Aligned_cols=243  Identities=22%  Similarity=0.305  Sum_probs=199.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +++.||||.+....   ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            455678999999999999976 58899999986432   23356788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..++++.+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       100 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263        100 VVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             CCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999998643   3578889999999999999999997   99999999999999999999999999998764322 


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                         ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+.   ..         ...   .
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~---~~---------~~~---~  234 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL---AG---------RLK---F  234 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh---cC---------CcC---C
Confidence               22468999999999999999999999999999999999999997544322222111   10         000   0


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      +.....++.+++.+||+.||.+||+     +.+++++
T Consensus       235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1123456789999999999999996     7888766

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-35  Score=316.95  Aligned_cols=261  Identities=24%  Similarity=0.300  Sum_probs=198.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            445578999999999999875 58899999986443 2334578899999999999999999999999989999999997


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       ++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        87 -~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-  159 (288)
T cd07871          87 -SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-  159 (288)
T ss_pred             -cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence             58988885432  3578889999999999999999997   9999999999999999999999999999865432221 


Q ss_pred             ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh------------cchh
Q 043017          664 STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD------------RLCD  730 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~------------~~~~  730 (818)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+......+            ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            223457899999998865 568999999999999999999999997655433333222111100            0000


Q ss_pred             hccccCcCc---cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDM---QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.....   ........++.+++.+||+.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000000   0001123567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.7e-35  Score=307.61  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=197.1

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +||+|+||.||+|+.. +++.+|+|.+.... ......|.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            6899999999999975 68899999876432 334567999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc-cCC
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS-TMP  667 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  667 (818)
                      +++...  ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++........... ...
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            998533  24588999999999999999999997   999999999999999999999999999876433211111 111


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+.   ..      .  ..   ..+...+
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~~------~--~~---~~~~~~~  222 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---QG------V--RL---PCPELCP  222 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---cC------C--CC---CCcccCC
Confidence            23457999999998899999999999999999998 888876443322111111   00      0  00   1122335


Q ss_pred             HHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          747 VKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ..+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-36  Score=330.67  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=212.5

Q ss_pred             hhcccccceeEEEeEe-cCC----cEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLL-NDG----TKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~-~~g----~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ++||+|+||+||||.+ ++|    .+||+|++... ..+..++|++|+-.|.+++||||++|+|+|.... ..||.+|||
T Consensus       702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP  780 (1177)
T KOG1025|consen  702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP  780 (1177)
T ss_pred             ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence            5799999999999996 333    46899998654 4556789999999999999999999999998866 889999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      .|+|.+|++.+  +..+..+..+.|..|||+||.|||++   +++||||.++||||.+-.++||.|||+++.+..+....
T Consensus       781 ~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  781 LGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             cchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999999653  35688889999999999999999997   99999999999999999999999999999988776544


Q ss_pred             ccC-CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          664 STM-PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       664 ~~~-~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ... .+-.+.|||-|.+....++.++|||||||.+||++| |..|+.....+++.+.+.    .          .++...
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----~----------geRLsq  921 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----K----------GERLSQ  921 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----c----------cccCCC
Confidence            332 345678999999999999999999999999999999 999988776554433332    1          112333


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      +..+..++..++.+||..|+..||+++++...+.+..+.
T Consensus       922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            567888999999999999999999999999998776554

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.3e-35  Score=308.34  Aligned_cols=245  Identities=26%  Similarity=0.443  Sum_probs=197.6

Q ss_pred             hcccccceeEEEeEec---CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN---DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +||+|+||.||+|.++   ++..+|+|++.....  ...+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   578899999864432  23567899999999999999999999885 45678999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc-
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS-  664 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-  664 (818)
                      +|.+++...   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999998543   3588999999999999999999997   999999999999999999999999999987654432211 


Q ss_pred             -cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          665 -TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       665 -~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       ....++..|+|||.+....++.++||||||+++|||++ |+.||.......+...+.   ... .          .+.+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~---~~~-~----------~~~~  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE---SGE-R----------MECP  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CCC-C----------CCCC
Confidence             12234578999999988889999999999999999998 999997654433333222   100 0          0111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .....++.+++.+||+.+|++||++.+|.+.|++
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            2344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-36  Score=321.95  Aligned_cols=250  Identities=25%  Similarity=0.354  Sum_probs=214.8

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCc-ceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN-RFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-~~lV~e  580 (818)
                      .|...+++|+|+||.++..+.+ ++..+++|.+...  .....+..++|+.++++++|||||.+.+.+.+++. .++||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            4566789999999999998876 4778999987644  33445578899999999999999999999999998 899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |++||+|.+.|...+ +..++++.+.+++.||+.|+.|||+.   .|+|||||+.|||++.+..+||+|||+|+.+....
T Consensus        85 Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             ecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999886543 56799999999999999999999986   99999999999999999999999999999987765


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      . ......||+.||.||++.+.+|..|+|||||||++|||++-+++|...+...+...+-...              -.+
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--------------~~P  225 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--------------YSP  225 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--------------CCC
Confidence            3 3345689999999999999999999999999999999999999998776655554433211              112


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+..+..++..++..||+.+|+.||++.++|.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            245677889999999999999999999999987

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.5e-35  Score=307.82  Aligned_cols=247  Identities=23%  Similarity=0.416  Sum_probs=197.7

Q ss_pred             hcccccceeEEEeEec---CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN---DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +||+|+||.||+|++.   ++..||+|.+..... ...++|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   355799999865533 33467999999999999999999999885 457899999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc--
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS--  664 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--  664 (818)
                      |.+++...  ...+++..+.+++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...........  
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99998543  24689999999999999999999997   999999999999999999999999999986654432221  


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||...........+.   ...           ....+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~-----------~~~~~~  221 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE---QGK-----------RLDCPA  221 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CCC-----------CCCCCC
Confidence            11234578999999988889999999999999999996 999987654433222211   100           001122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ....++.+++..||+.+|++||++.+|.+.|+.+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-35  Score=310.45  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=201.8

Q ss_pred             hhhhcccccceeEEEeEecC----CcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCc------c
Q 043017          508 FQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN------R  575 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------~  575 (818)
                      +.+.||+|+||.||+|.+..    +..||+|++....  .....++.+|++.++.++|+||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            45689999999999998753    3679999987542  2334678999999999999999999998876554      7


Q ss_pred             eeeeeccCCCChhhHhhhcC---CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCC
Q 043017          576 FLVYEYMCNGSLDKWIFHKD---RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      +++|||+++++|..++....   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence            89999999999999985432   234688999999999999999999997   999999999999999999999999999


Q ss_pred             ceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          653 ARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       653 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      ++......... ......+..|+|||.+....++.++||||||+++|||++ |..|+.......+.+.+..   ..    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~----  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH---GN----  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC----
Confidence            98765432221 112235678999999988889999999999999999999 8888865544333322211   00    


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                          ..   ..+.....++.+++.+||+.+|.+||++.|+++.|+.+
T Consensus       233 ----~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 ----RL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----CC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                00   11223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.6e-35  Score=313.94  Aligned_cols=247  Identities=28%  Similarity=0.395  Sum_probs=197.7

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999865 68899999986432   22345678899999999999999999999999999999999999999


Q ss_pred             hhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          588 DKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       588 ~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      ..++... .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            9887542 2335689999999999999999999997   9999999999999999999999999999876543322 223


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...............        ......   ..+...+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~  225 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--------ILNDSV---TYPDKFS  225 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh--------hcccCC---CCcccCC
Confidence            46899999999999999999999999999999999999999755432211111110        011111   1122345


Q ss_pred             HHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      ..+.+++.+||+.+|++||     ++++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            6788999999999999999     77787765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-35  Score=320.92  Aligned_cols=272  Identities=28%  Similarity=0.401  Sum_probs=212.1

Q ss_pred             HHhhHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecc
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE  571 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~  571 (818)
                      ....+.+.+.||+|+||.||++...        ++..||+|.+.... ....+++.+|++++.++ +|+||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3445667788999999999999742        12368999886432 33456899999999999 89999999999999


Q ss_pred             cCcceeeeeccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEE
Q 043017          572 RSNRFLVYEYMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL  638 (818)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIl  638 (818)
                      ....+++|||+++|+|.+++....             ....+++..+..++.|+++||+|||+.   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence            999999999999999999986432             123578889999999999999999997   9999999999999


Q ss_pred             EcCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHH
Q 043017          639 LDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLV  716 (818)
Q Consensus       639 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~  716 (818)
                      ++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....+...
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999998664432211 122234567999999999999999999999999999998 88888655433332


Q ss_pred             HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCch
Q 043017          717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLS  790 (818)
Q Consensus       717 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~  790 (818)
                      ..+.   ...        .   ...+.....++.+++.+|++.+|++||++.|+++.|+.+........+....
T Consensus       247 ~~~~---~~~--------~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~~~~~~~  306 (334)
T cd05100         247 KLLK---EGH--------R---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLS  306 (334)
T ss_pred             HHHH---cCC--------C---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCCCeeeee
Confidence            2221   100        0   0111233457889999999999999999999999999998766554444333

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.5e-35  Score=310.09  Aligned_cols=253  Identities=30%  Similarity=0.442  Sum_probs=198.8

Q ss_pred             hhhhcccccceeEEEeEecCCc---EEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeeccc------Ccce
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGT---KVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNRF  576 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~---~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~  576 (818)
                      +.++||+|+||.||+|...+..   .+|+|.+...  .....+.|.+|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            4568999999999999976532   6899988654  233456789999999999999999999987432      2468


Q ss_pred             eeeeccCCCChhhHhhhc---CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          577 LVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ++|||+++|+|.+++...   .....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            999999999999987432   1234588999999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          654 RLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       654 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      +......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+.+.+.   ....    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~----  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR---QGNR----  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---cCCC----
Confidence            8765432211 122345678999999999999999999999999999999 788886544333322221   1110    


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                          ..   ........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       233 ----~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 ----LK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ----CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                00   0112345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.5e-35  Score=315.40  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=194.6

Q ss_pred             HHhhhhcccccceeEEEeEec--CCcEEEEEEcCCCC--CccHHHHHHHHHHHhcc---CcceeEEEeeeec-----ccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN--DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI---HHFNLVRLVGYCA-----ERS  573 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~-----~~~  573 (818)
                      |.+.++||+|+||.||+++..  +++.||+|++....  ......+.+|+.+++.+   +||||+++++++.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            445678999999999999863  46889999886442  22234566777777665   6999999999885     234


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++||||++ ++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            6789999996 68988885432 24588999999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh---cchh
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD---RLCD  730 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~---~~~~  730 (818)
                      +.....  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+......+   ....
T Consensus       158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            876433  22233458999999999998899999999999999999999999998665443333322111100   0000


Q ss_pred             -------hccccCcCc--cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 -------LVDKKSEDM--QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 -------~~d~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                             .+.......  .........+.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                   000000000  0011234567799999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-35  Score=306.38  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=200.4

Q ss_pred             hhcccccceeEEEeEecC----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLND----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++||+|+||.||+|++..    +..+|+|.+..... ...+++.+|+++++.+.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            369999999999998642    26899999875543 24567999999999999999999999876 4568999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999996433   688999999999999999999997   999999999999999999999999999987654433221


Q ss_pred             c--CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 T--MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 ~--~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      .  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+...   ..           ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---~~-----------~~~  219 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---ER-----------LPR  219 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---Cc-----------CCC
Confidence            1  1224567999999998899999999999999999998 99998765543333322211   00           011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      +......+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            2234467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.5e-35  Score=313.73  Aligned_cols=260  Identities=25%  Similarity=0.345  Sum_probs=207.1

Q ss_pred             HhhHHhhhhcccccceeEEEeEecC-----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecc-cCcc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLND-----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAE-RSNR  575 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~  575 (818)
                      ...+.+.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3445566789999999999999875     6889999986543 3335678899999999999999999998776 4678


Q ss_pred             eeeeeccCCCChhhHhhhcCCc-----cccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeec
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRI-----QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF  650 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  650 (818)
                      ++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322     4689999999999999999999997   9999999999999999999999999


Q ss_pred             CCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          651 GLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       651 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      |+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.......+...+.   ...  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~--  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK---DGY--  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH---cCC--
Confidence            9998664433221 122346778999999998889999999999999999999 999987544322222111   100  


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                            ...   .......++.+++.+|++.+|++|||+.++++.|+.+.+
T Consensus       237 ------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 ------RLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ------CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  000   011234578899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-35  Score=307.86  Aligned_cols=254  Identities=30%  Similarity=0.481  Sum_probs=206.8

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.+.++||+|+||.||++..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            3445667899999999999998888899999987543 346789999999999999999999999998889999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++..........
T Consensus        85 ~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          85 KGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             CCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence            999999985532 24689999999999999999999997   99999999999999999999999999998765432222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ......+..|+|||.+.+..++.++||||||++++||++ |+.||...........+..   .      .  ..   +.+
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---~------~--~~---~~~  226 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---G------Y--RM---PRP  226 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C------C--CC---CCC
Confidence            222234568999999998889999999999999999999 9999875543332222211   0      0  00   001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .....++.+++.+|++.+|++||+++++++.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1224578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=292.45  Aligned_cols=252  Identities=26%  Similarity=0.360  Sum_probs=209.5

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..+++.++||+|.|+.||+.... +|+++|+|.+...  ...+.+++.+|+++.+.|+|||||+|.....+....+||+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            34667789999999999998864 6889999877433  34567889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCceecc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIA  657 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~  657 (818)
                      +|.++.|..-|...   ..+++..+-..++||+++|.|+|.+   +|||||+||+|+++.+.   ..+||+|||+|..+.
T Consensus        91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999997655433   4678888899999999999999998   99999999999999543   458999999999887


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                        .........|||+|||||+++..+++..+|||+-||+||-|+.|..||.+.+...+.+.+...        ..|...+
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------~yd~~~~  234 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------AYDYPSP  234 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--------ccCCCCc
Confidence              233344567999999999999999999999999999999999999999987777776665422        2333333


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .++.   ..++..+|+.+||..||.+|.|+.|.|++=
T Consensus       235 ~w~~---is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  235 EWDT---VTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             ccCc---CCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            4443   344556788899999999999999998753

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.5e-35  Score=308.32  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=206.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.++||+|+||.||+|+.. +++.||||.+....   ......+.+|+++++.++||||+++++++...+..++++||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            455678999999999999975 68999999875432   23345788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          582 MCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++++|.+++.... ....+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999999885432 234578899999999999999999997   99999999999999999999999999998765432


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........      ..+.    .
T Consensus       161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~------~~~~----~  228 (267)
T cd08228         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQC------DYPP----L  228 (267)
T ss_pred             HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhcC------CCCC----C
Confidence            21 12245788999999999888999999999999999999999998643321 11111111100      0000    0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      .......++.+++.+||+.+|++||++.+|++.|+++.
T Consensus       229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            12234567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.1e-35  Score=309.18  Aligned_cols=253  Identities=30%  Similarity=0.514  Sum_probs=202.8

Q ss_pred             HHhhhhcccccceeEEEeEecC-C---cEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-G---TKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ++..+.||+|+||.||+|+... +   ..+|+|.+.... ....+++.+|++++.+++|+|++++.+++...+..++|||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE   86 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence            3445689999999999999753 3   379999986543 3335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          87 YMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999985432  4688999999999999999999997   99999999999999999999999999998765432


Q ss_pred             Ccccc--CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          661 SHVST--MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       661 ~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .....  ....+..|+|||.+....++.++||||||+++|||++ |+.|+...........+..   ..        .  
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~--------~--  228 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GF--------R--  228 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CC--------C--
Confidence            22111  1223467999999998889999999999999999998 9999875544332222211   00        0  


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                       .+........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       229 -~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 -LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             011122346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-35  Score=313.34  Aligned_cols=263  Identities=21%  Similarity=0.357  Sum_probs=202.4

Q ss_pred             hhHHhhhhcccccceeEEEeEecC---------------CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND---------------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVG  567 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g  567 (818)
                      ..+.+.++||+|+||.||++...+               ...||+|.+.... ......|.+|++++.+++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            345667789999999999987642               2358999987542 233467999999999999999999999


Q ss_pred             eecccCcceeeeeccCCCChhhHhhhcC---------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEE
Q 043017          568 YCAERSNRFLVYEYMCNGSLDKWIFHKD---------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL  638 (818)
Q Consensus       568 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIl  638 (818)
                      ++......++||||+++++|.+++....         ....+++..+..++.|+++||+|||+.   +++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            9999999999999999999999985432         112468889999999999999999997   9999999999999


Q ss_pred             EcCCCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCchH
Q 043017          639 LDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC--GRRSSNPKGGDYL  715 (818)
Q Consensus       639 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt--G~~p~~~~~~~~l  715 (818)
                      ++.++.+||+|||++......... ......++..|+|||.+.++.++.++||||||++++||++  +..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            999999999999999865433221 1122345678999999998899999999999999999998  5567765544433


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .................       ......+..+.+++.+|++.+|++||+|.+|++.|+.
T Consensus       242 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            33222111110000000       0011234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=308.83  Aligned_cols=258  Identities=26%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc--------------cHHHHHHHHHHHhccCcceeEEEee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR--------------GKKEFLSEVETIGNIHHFNLVRLVG  567 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--------------~~~~f~~Ev~~l~~l~H~niv~l~g  567 (818)
                      ...|.+.++||+|.||.|-+|... +++.||||.+.+....              ..+....|+.+|++++|||||+|+.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            356677789999999999999865 6899999998654211              1247889999999999999999999


Q ss_pred             eeccc--CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCE
Q 043017          568 YCAER--SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV  645 (818)
Q Consensus       568 ~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~  645 (818)
                      +..+.  +..|||+|||..|.+...   ......+++.++++|++++..||+|||.+   +||||||||+|+||+++|++
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcE
Confidence            98654  578999999999887542   12223399999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCceecccCCC----ccccCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHH
Q 043017          646 KIADFGLARLIAQDQS----HVSTMPKGTPGYMAPELTRGNS----ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVD  717 (818)
Q Consensus       646 kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~  717 (818)
                      ||+|||.+..+.....    .......||+.|+|||+..++.    .+.+.||||+||.||.|+.|+.||-......+.+
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            9999999987743211    1112257999999999987733    4678999999999999999999997554333333


Q ss_pred             HHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+.            ...+. .+...++.+++.+||.++|+.||+.|.+..+|..+......
T Consensus       330 KIv------------n~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  330 KIV------------NDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHh------------cCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            322            11111 12233567788899999999999999999999988865554

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-35  Score=322.24  Aligned_cols=242  Identities=25%  Similarity=0.329  Sum_probs=195.9

Q ss_pred             hhcccccceeEEEeEec----CCcEEEEEEcCCC----CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          510 IRLGRGGSGSVFEGLLN----DGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.||+|+||.||+++..    .++.||||.+...    .......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            46999999999999853    5789999998643    122345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+.+..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999988543   3578888999999999999999997   999999999999999999999999999975433222


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+.   ..         ..   ..
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~---~~---------~~---~~  219 (323)
T cd05584         156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL---KG---------KL---NL  219 (323)
T ss_pred             -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH---cC---------CC---CC
Confidence             2223468999999999998889999999999999999999999997654322222111   00         00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      +.....++.+++.+||+.+|++||     ++.+++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            122345778999999999999999     88888774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-35  Score=322.23  Aligned_cols=250  Identities=24%  Similarity=0.309  Sum_probs=198.2

Q ss_pred             HhhhhcccccceeEEEeEe----cCCcEEEEEEcCCC----CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCccee
Q 043017          507 DFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~----~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.||+|+||.||+++.    .+++.||+|++...    .....+.+..|+.++.++ +|+||+++++++......++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            3456899999999999875    35789999998643    122345678899999999 59999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++|+|.+++...   ..++++.+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        83 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          83 ILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999988543   3588999999999999999999997   99999999999999999999999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+......      .+.. 
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~~-  229 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDPP-  229 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCCC-
Confidence            4433333345689999999999865 4789999999999999999999999754332222222111100      0011 


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                          .+......+.+++.+||+.||++||     ++++++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                1122345678899999999999999     77888865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-34  Score=324.22  Aligned_cols=263  Identities=26%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccC-cceeEEEeeeecc
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIH-HFNLVRLVGYCAE  571 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~  571 (818)
                      ++......+.++||+|+||.||+|++.      .++.||||++..... ...+.+++|++++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344445556689999999999999864      246899999975432 22457889999999997 9999999999999


Q ss_pred             cCcceeeeeccCCCChhhHhhhcCC-------------------------------------------------------
Q 043017          572 RSNRFLVYEYMCNGSLDKWIFHKDR-------------------------------------------------------  596 (818)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------  596 (818)
                      ....++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999964321                                                       


Q ss_pred             ----------------------------------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCe
Q 043017          597 ----------------------------------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN  636 (818)
Q Consensus       597 ----------------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~N  636 (818)
                                                              ...+++..+..++.||+.||+|||+.   +++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                    12467778889999999999999986   99999999999


Q ss_pred             EEEcCCCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 043017          637 ILLDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY  714 (818)
Q Consensus       637 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~  714 (818)
                      ||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |+.|+.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            99999999999999999865432221 1122346788999999998889999999999999999998 888886443222


Q ss_pred             HHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       715 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      .....   .....       ..   ..+.....++.+++.+||+.+|++||++++|++.|+.+.
T Consensus       350 ~~~~~---~~~~~-------~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 QFYNA---IKRGY-------RM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHH---HHcCC-------CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            11111   00000       00   011223467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=305.63  Aligned_cols=249  Identities=27%  Similarity=0.451  Sum_probs=204.9

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++.+++|+||+++++++......++||||+++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            4456678999999999999876 78999999975543 567899999999999999999999999998999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.......   
T Consensus        85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            999999854332 3689999999999999999999997   999999999999999999999999999987633222   


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                       ....+..|+|||.+....++.++||||||++++||++ |+.||.......+...+..   ..        ..   ..+.
T Consensus       158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~--------~~---~~~~  222 (256)
T cd05039         158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---GY--------RM---EAPE  222 (256)
T ss_pred             -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---CC--------CC---CCcc
Confidence             2234668999999998889999999999999999998 9998865543332222211   00        00   0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            2346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.3e-35  Score=311.50  Aligned_cols=253  Identities=27%  Similarity=0.416  Sum_probs=202.5

Q ss_pred             HhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.++||+|+||.||++...      ++..+|+|.+..........|.+|+++++.++|+||+++++++..+...+++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            44578999999999999742      356899999876666667789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCC------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEe
Q 043017          581 YMCNGSLDKWIFHKDR------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIA  648 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  648 (818)
                      |+++++|.+++.....            ...+++..+..++.|++.||+|||+.   +++|+||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence            9999999999865321            13478999999999999999999997   99999999999999999999999


Q ss_pred             ecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhh
Q 043017          649 DFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       649 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      |||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.............   ...
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~  241 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT---QGR  241 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---cCc
Confidence            99999865433221 1122335678999999999899999999999999999998 888886543322221111   000


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                              ..   ..+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       242 --------~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         242 --------EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             --------cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                    00   0112334568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.8e-35  Score=312.47  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             hhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          508 FQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +.+.||+|+||.||+|...      ....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++++|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            4568999999999999853      235789998865432 234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcC---------------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE
Q 043017          581 YMCNGSLDKWIFHKD---------------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL  639 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll  639 (818)
                      |+++++|.+++....                     ....+++..+..++.|++.||+|||+.   +++||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence            999999999985421                     123578899999999999999999987   99999999999999


Q ss_pred             cCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHH
Q 043017          640 DRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVD  717 (818)
Q Consensus       640 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~  717 (818)
                      ++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||.......+.+
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  240 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN  240 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999998654332211 122345678999999988889999999999999999998 998886554433332


Q ss_pred             HHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+..    .     ..     ...+.....++.+++.+|++.+|++||++.++++.|+.+..
T Consensus       241 ~~~~----~-----~~-----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         241 LLKT----G-----YR-----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHhC----C-----CC-----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            2210    0     00     01122344678899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-36  Score=289.34  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=208.6

Q ss_pred             hHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..++.+.||+|.||.||.|+.+. +-.||+|++.+..   .+-..++.+|+++-..|+||||++++++|.+....||++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            34556789999999999999764 6789999987542   3445688999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |.++|.|...|+.. +...+++.....++.|+|.||.|+|..   ++|||||||+|+|++.++..||+|||-+..-..  
T Consensus       103 ya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--  176 (281)
T KOG0580|consen  103 YAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  176 (281)
T ss_pred             ecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence            99999999999643 345689999999999999999999986   999999999999999999999999999876542  


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       ....+..||..|++||...+...+...|+|++|++.||++.|.+||...........+....       +.        
T Consensus       177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-------~~--------  240 (281)
T KOG0580|consen  177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-------LK--------  240 (281)
T ss_pred             -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-------cc--------
Confidence             22334579999999999999999999999999999999999999998766544444443211       11        


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+........++|..|+..+|.+|.+..|++.+-
T Consensus       241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            1234456777899999999999999999998763

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-35  Score=326.23  Aligned_cols=245  Identities=24%  Similarity=0.335  Sum_probs=199.8

Q ss_pred             hhHHhhhhcccccceeEEEeEecC--CcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND--GTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+|+...  +..||+|++...   .....+.+.+|++++..++||||+++++++.++...++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            345566789999999999998653  368999988543   223356788999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999998543   3588999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ..    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   ..         ... 
T Consensus       184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~---~~---------~~~-  246 (340)
T PTZ00426        184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL---EG---------IIY-  246 (340)
T ss_pred             Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh---cC---------CCC-
Confidence            21    23468999999999998889999999999999999999999997654332222221   10         000 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                        .+......+.+++.+|++.+|++|+     ++++++++
T Consensus       247 --~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 --FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              0112234677899999999999995     89998876

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.7e-35  Score=314.95  Aligned_cols=256  Identities=28%  Similarity=0.419  Sum_probs=204.3

Q ss_pred             HHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCccee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (818)
                      +.+.+.||+|+||.||++...+      ...+|+|.+.... .....++.+|++++.++ +|+||+++++++..++..++
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   93 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV   93 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence            4455689999999999998642      3679999987542 23346788999999999 89999999999999999999


Q ss_pred             eeeccCCCChhhHhhhc-------------CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC
Q 043017          578 VYEYMCNGSLDKWIFHK-------------DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN  644 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~  644 (818)
                      +|||+++++|.+++...             .....+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence            99999999999998542             1234688999999999999999999987   9999999999999999999


Q ss_pred             EEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHH
Q 043017          645 VKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK  722 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~  722 (818)
                      +||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+...........+.  
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--  248 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK--  248 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH--
Confidence            9999999998765432211 122335678999999988899999999999999999998 888886554333222221  


Q ss_pred             hhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       723 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                       ...        ..   ..+.....++.+++.+|++.+|++|||+.++++.|+.+.
T Consensus       249 -~~~--------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         249 -EGY--------RM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -cCC--------cC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             100        00   112234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-35  Score=305.13  Aligned_cols=253  Identities=29%  Similarity=0.370  Sum_probs=195.1

Q ss_pred             hhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~  583 (818)
                      +.+|.|.||.||+|++.+ ++.||||+...+..-    --.|+++|+.+.|||||+|+-+|....     ...+||||||
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            479999999999999764 689999998655432    236899999999999999999885432     3458999996


Q ss_pred             CCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCceecccCCC
Q 043017          584 NGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       584 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~  661 (818)
                      . +|.+.+.+- ..++.++.-.+.-+..||.+||+|||+.   +|+||||||+|+|+|.+ |.+||+|||.|+.+...+.
T Consensus       106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            5 788877642 2235677778888999999999999997   99999999999999977 8999999999999887766


Q ss_pred             ccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhhcchhh--------
Q 043017          662 HVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEADRLCDL--------  731 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~~~~~~--------  731 (818)
                      ..+.  ..|..|.|||++.+. .|+.+.||||.||++.||+-|+..|.+.+... +...++.... +...++        
T Consensus       182 niSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~-Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  182 NISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT-PTREDIKSMNPNYT  258 (364)
T ss_pred             ceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC-CCHHHHhhcCcccc
Confidence            5443  478899999999775 69999999999999999999999998876533 3333332221 111111        


Q ss_pred             --ccccCcCcc----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 --VDKKSEDMQ----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 --~d~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        -.+......    .......+..+++.++|+.+|.+|.++.|++++
T Consensus       259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              000111100    123456788999999999999999999999875

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=307.79  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             hcccccceeEEEeEecC-Cc--EEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLND-GT--KVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+|.+.+ +.  .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999999864 33  57889886432 33456789999999999 8999999999999999999999999999


Q ss_pred             ChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCC
Q 043017          586 SLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       586 sL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      +|.+++....             ....++++.+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            9999986432             123578999999999999999999987   999999999999999999999999999


Q ss_pred             ceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       653 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      +......  ........+..|+|||++....++.++||||||++++||++ |..||...........+.   ...     
T Consensus       159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~-----  228 (270)
T cd05047         159 SRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---QGY-----  228 (270)
T ss_pred             ccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---CCC-----
Confidence            8632211  11111234567999999988889999999999999999997 999986543322222211   000     


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                         ..   ........++.+++.+|++.+|.+||++.++++.|+.+.
T Consensus       229 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ---RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---CC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence               00   011223457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6e-35  Score=310.05  Aligned_cols=254  Identities=26%  Similarity=0.469  Sum_probs=202.8

Q ss_pred             hHHhhhhcccccceeEEEeEecC-C---cEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-G---TKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|.... +   ..||||.+... ......+|..|+.++++++||||+++++++..+...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            34566789999999999999753 3   36999998654 2334568999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999985432  4588999999999999999999997   9999999999999999999999999999866443


Q ss_pred             CCcccc--CCC--CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          660 QSHVST--MPK--GTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       660 ~~~~~~--~~~--gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ......  ...  .+..|+|||.+....++.++||||||+++|||++ |..||...........+.   ..      .  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~------~--  228 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QD------Y--  228 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cC------C--
Confidence            221111  111  2457999999998899999999999999999987 999987554333222221   00      0  


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..   +...+.+..+.+++.+||+.+|.+||++.+++++|+.+
T Consensus       229 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00   11123345688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-35  Score=310.30  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=204.2

Q ss_pred             hHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.++||+|+||.||+|...+      +..||+|.+.... ......+.+|++++..++|+||+++++++......++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            33445689999999999998753      4689999986543 2335678999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCC-------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeec
Q 043017          578 VYEYMCNGSLDKWIFHKDR-------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF  650 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  650 (818)
                      ||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence            9999999999999864321       23478889999999999999999987   9999999999999999999999999


Q ss_pred             CCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          651 GLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       651 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      |+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........+.   .. ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~-~~  239 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---DG-GH  239 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---cC-CC
Confidence            99986644322 12223346788999999988889999999999999999998 888887554433333222   10 00


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                             .   ..+.....++.+++.+||+.+|++|||+.++++.|+.
T Consensus       240 -------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         240 -------L---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -------C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                   0   0112235678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.3e-35  Score=315.34  Aligned_cols=264  Identities=27%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             HHhhHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecc
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE  571 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~  571 (818)
                      ....+.+.+.||+|+||.||+++..        ++..||+|.+.... .....++.+|+.++..+ +|+||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3445556678999999999999742        24579999886432 34456789999999999 89999999999999


Q ss_pred             cCcceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEE
Q 043017          572 RSNRFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL  638 (818)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIl  638 (818)
                      ....++||||+++++|.+++.....             ...+++..+..++.||++||+|||+.   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            9999999999999999999965321             23578888999999999999999997   9999999999999


Q ss_pred             EcCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHH
Q 043017          639 LDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLV  716 (818)
Q Consensus       639 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~  716 (818)
                      ++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.......+.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            9999999999999998765433221 222345678999999988889999999999999999998 77777654433322


Q ss_pred             HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       717 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      ..+.   ....        .   ..+......+.+++.+||+.+|.+||++.++++.|+++.....
T Consensus       250 ~~~~---~~~~--------~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         250 KLLK---EGHR--------M---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHH---cCCc--------C---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            2221   1100        0   0112345678899999999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.7e-35  Score=309.38  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=205.2

Q ss_pred             hhHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|++++++++|+||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            345566789999999999998653    2468999886554 3445689999999999999999999998875 557899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999995432  3589999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..........++..|+|||.+....++.++||||||++++||++ |+.||...........+.   ....        . 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~--------~-  227 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NGER--------L-  227 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCc--------C-
Confidence            43222222335568999999988889999999999999999996 999997654433322221   1100        0 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                        ..+......+.+++.+|+..+|.+|||+.++++.|+.+...
T Consensus       228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              01123346788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.2e-35  Score=318.25  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+|... +++.||||.+...   .....+.+..|..++..+ +||||+++++++..++..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999975 4788999998643   223345566677777654 8999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        82 ~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          82 DLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            999988543   3588999999999999999999997   99999999999999999999999999998654332 2223


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......+...+..   .         ..   ..+...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~---------~~---~~~~~~  219 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN---D---------RP---HFPRWI  219 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---C---------CC---CCCCCC
Confidence            34689999999999998999999999999999999999999976554333322210   0         00   011223


Q ss_pred             HHHHHHHHHHccccCCCCCCcHH-HHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSAS-MLVK  772 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~-evl~  772 (818)
                      ..++.+++.+||+.+|++||++. ++++
T Consensus       220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         220 SKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            45678899999999999999876 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-35  Score=313.17  Aligned_cols=250  Identities=25%  Similarity=0.319  Sum_probs=200.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +..+.||+|+||+||++... +++.||||.+....   ......+.+|++++++++|+||+++++.+..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            34467999999999999965 68899999986432   222356788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          83 NGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             CCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            9999998885432 24589999999999999999999997   9999999999999999999999999999875432221


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                        ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.....         ....  ...
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~--~~~  225 (285)
T cd05605         159 --RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK---------EDQE--EYS  225 (285)
T ss_pred             --ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh---------hccc--ccC
Confidence              223588999999999988899999999999999999999999986544322222211110         0000  112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      ......+.+++.+||+.||.+||     ++.+++++
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            23456788999999999999999     78888665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.8e-35  Score=306.85  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=205.2

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.+.++||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+||+++.+++.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            4455677899999999999998888889999886442 335678999999999999999999999887 77899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999986532 34578889999999999999999987   99999999999999999999999999998765433222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      .....++..|+|||.+....++.++||||||++++||++ |+.||.......+...+.   ...        ..   +..
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~~--------~~---~~~  225 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGY--------RM---PRP  225 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---CCC--------CC---CCc
Confidence            222345678999999998889999999999999999999 888887554333322221   000        00   111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .....++.+++.+|++.+|++||++.++++.|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.9e-35  Score=314.55  Aligned_cols=262  Identities=24%  Similarity=0.302  Sum_probs=195.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+++++.++||||+++++++......++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            3455678999999999999976 688999999865432 23456788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      + ++|.+++...  ...++++.+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....... .
T Consensus        86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          86 H-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             C-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence            5 6787777533  24588889999999999999999997   99999999999999999999999999997543322 1


Q ss_pred             cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-hHHHHHHHHhhhhcc------hhh--c
Q 043017          663 VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGD-YLVDTLKVKAEADRL------CDL--V  732 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-~l~~~~~~~~~~~~~------~~~--~  732 (818)
                      ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+. .....+......+..      ...  .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            2223457899999998865 45889999999999999999999999765331 111111111000000      000  0


Q ss_pred             cc-cCcC--ccC------cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DK-KSED--MQS------HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~-~~~~--~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+ ....  ...      .......+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00 0000  000      00112467789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-34  Score=309.33  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=194.5

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||.||++... +|+.+|+|.+....   ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 58999999986432   22234566799999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~  154 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR  154 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence            98885433 24588899999999999999999997   999999999999999999999999999987654322  2234


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||...........+....        +......  .......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT--------LEDEVKF--EHQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh--------hcccccc--ccccCCH
Confidence            58899999999998889999999999999999999999987543221111111110        0000000  0112355


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ++.+++..||+.+|++||+++|+++.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhh
Confidence            68899999999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.5e-35  Score=311.89  Aligned_cols=264  Identities=27%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             HhhhhcccccceeEEEeEec-----CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc--cCcceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-----DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~  579 (818)
                      .+.+.||+|+||.||++...     +++.||+|++........+.|.+|++++++++||||+++++++..  ....++||
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            34567999999999999753     578999999876665566789999999999999999999998754  34678999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++...  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        87 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          87 EYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            999999999998543  23589999999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh----hcchhhcc
Q 043017          660 QSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA----DRLCDLVD  733 (818)
Q Consensus       660 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~----~~~~~~~d  733 (818)
                      ....  .....++..|+|||.+.+..++.++||||||++++||++|..++...... ...........    ..+.+.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHHHh
Confidence            3211  11122345699999999888999999999999999999987765322111 10000000000    00001111


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ... ..+.......++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       241 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            100 1111223446788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-34  Score=309.44  Aligned_cols=253  Identities=28%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             HhhhhcccccceeEEEeEecC------CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.||+|+||.||+|...+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            344689999999999999753      5679999886443 233467999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCC----ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---CEEEeecCC
Q 043017          580 EYMCNGSLDKWIFHKDR----IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---NVKIADFGL  652 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgl  652 (818)
                      ||+++++|.+++.....    ...+++..+..++.||+.||+|||+.   +++|+||||+||+++.++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence            99999999999865421    23588999999999999999999997   999999999999998754   599999999


Q ss_pred             ceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          653 ARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       653 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      ++......... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||.......+.+.+..   ...   
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~~---  239 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG---GGR---  239 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CCc---
Confidence            98763322111 112233568999999998899999999999999999997 9999875544333222110   000   


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                           .   ..+...+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus       240 -----~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         240 -----L---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -----C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                 0   0112234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.5e-35  Score=320.45  Aligned_cols=241  Identities=23%  Similarity=0.310  Sum_probs=196.3

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+|+.. +++.||||++...   .....+.+..|.+++..+ +||||+++++++...+..++||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5899999999999976 4789999998653   223345677899988876 8999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||++........ ...
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05591          82 DLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT  154 (321)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence            999888543   3588999999999999999999997   999999999999999999999999999976433222 123


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..   ..         .   ..+...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~---~~---------~---~~p~~~  219 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH---DD---------V---LYPVWL  219 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc---CC---------C---CCCCCC
Confidence            34689999999999998999999999999999999999999986654333332211   00         0   001123


Q ss_pred             HHHHHHHHHHccccCCCCCC-------cHHHHHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRP-------SASMLVKV  773 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RP-------t~~evl~~  773 (818)
                      ..++.+++..||+.+|++||       ++.+++++
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            45778999999999999999       88888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-34  Score=312.67  Aligned_cols=262  Identities=24%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             hHHhhhhcccccceeEEEeEecC-----------------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEe
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-----------------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLV  566 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~  566 (818)
                      .+.+.++||+|+||.||++...+                 +..||+|.+..... ...+++.+|++++++++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            45566789999999999988643                 24689999875532 3456889999999999999999999


Q ss_pred             eeecccCcceeeeeccCCCChhhHhhhcC--------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEE
Q 043017          567 GYCAERSNRFLVYEYMCNGSLDKWIFHKD--------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL  638 (818)
Q Consensus       567 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIl  638 (818)
                      +++..++..+++|||+++++|.+++....        ....+++..+..++.|+++||+|||+.   +++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence            99999999999999999999999986532        123589999999999999999999997   9999999999999


Q ss_pred             EcCCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCchH
Q 043017          639 LDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC--GRRSSNPKGGDYL  715 (818)
Q Consensus       639 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt--G~~p~~~~~~~~l  715 (818)
                      ++.++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++  +..|+........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            99999999999999986543322 12223456788999999988889999999999999999998  6677754443333


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ...+............       ...+...+.++.+++.+|++.+|++||++.||++.|+.
T Consensus       243 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         243 IENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            3222211111000000       01112234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.8e-35  Score=314.55  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=202.3

Q ss_pred             HHhhhhcccccceeEEEeEecC-C--cEEEEEEcCCC-CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-G--TKVAVKRLYPG-ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g--~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +.+.+.||+|+||.||+|...+ +  ..+++|.+... .....+.|.+|++++.++ +||||+++++++......++|||
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            3456689999999999998764 3  34788888643 333456789999999999 79999999999999999999999


Q ss_pred             ccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEE
Q 043017          581 YMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI  647 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl  647 (818)
                      |+++++|.+++....             ....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence            999999999995432             113588899999999999999999997   9999999999999999999999


Q ss_pred             eecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhh
Q 043017          648 ADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       648 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      +|||++.......  .......+..|+|||.+....++.++|||||||++|||++ |+.||...........+.   .. 
T Consensus       161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~---~~-  234 (297)
T cd05089         161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP---QG-  234 (297)
T ss_pred             CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---cC-
Confidence            9999986432211  1111223567999999998889999999999999999998 999987554333222211   00 


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                           ..     ...+......+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus       235 -----~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         235 -----YR-----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -----CC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                 00     0011224467889999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-35  Score=321.96  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLV  578 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV  578 (818)
                      .+.++||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++||||+++++++....     ..++|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            34568999999999999965 5899999998643  2233457889999999999999999999885432     47999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+. ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          83 FELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            99995 6898888533   3589999999999999999999997   999999999999999999999999999986533


Q ss_pred             CCC--ccccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh--------
Q 043017          659 DQS--HVSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD--------  726 (818)
Q Consensus       659 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~--------  726 (818)
                      ...  .......|++.|+|||++.+  ..++.++|||||||++|||++|+.||...........+......+        
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            221  11223468999999999876  678999999999999999999999997654322221111110000        


Q ss_pred             ---cchhhccccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 ---RLCDLVDKKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ---~~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         .....+.......+.     .......+.+++.+||+.+|++||+++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence               000000000000000     01123567899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-35  Score=324.40  Aligned_cols=242  Identities=26%  Similarity=0.345  Sum_probs=196.4

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||+|+||.||++... +++.||+|.+...   .......+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            5899999999999864 6889999998643   22334567889999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |..++...   ..+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++.+||+|||+++........ ...
T Consensus        82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~  155 (325)
T cd05594          82 LFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKT  155 (325)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-ccc
Confidence            99888543   3589999999999999999999972  38999999999999999999999999998764332222 223


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||.....+.....+..    ..           ...+....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~----~~-----------~~~p~~~~  220 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EE-----------IRFPRTLS  220 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc----CC-----------CCCCCCCC
Confidence            4689999999999998999999999999999999999999975543322222110    00           00112234


Q ss_pred             HHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .++.+++.+||+.||++|+     ++.+++++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            5778999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-35  Score=328.87  Aligned_cols=252  Identities=20%  Similarity=0.249  Sum_probs=200.2

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ..+.+.+.||+|+||.||+++.. +++.+|+|++...   .......+.+|+.+++.++||||+++++++.++...++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            34445568999999999999975 5889999998542   2233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++..    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       123 Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         123 EYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             cCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999998843    2478888999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCccccCCCCCCcccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN----SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .........||+.|+|||.+...    .++.++|||||||++|||++|+.||...........+.   .....       
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---~~~~~-------  265 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---DHKNS-------  265 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH---cCCCc-------
Confidence            33233345699999999998653    47899999999999999999999997654332222221   10000       


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCC--CCcHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHR--RPSASMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~  773 (818)
                       ...+.....+.++.+++.+||+.+|.+  ||++.+++++
T Consensus       266 -~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 -LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             001111124567788999999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1e-34  Score=308.03  Aligned_cols=254  Identities=28%  Similarity=0.483  Sum_probs=203.6

Q ss_pred             hHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|...    .+..+|+|.+.... ....+.|.+|+.++.+++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3455678999999999999864    23479999986543 233568899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        85 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          85 EYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999985432  4578999999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCccccC--CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          660 QSHVSTM--PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       660 ~~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      .......  ..++..|+|||.+.+..++.++||||||++++|+++ |+.||...........+.   ...        ..
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~~--------~~  228 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---EGY--------RL  228 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---CCC--------cC
Confidence            3222211  223568999999998889999999999999999887 999987554333322221   100        00


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                         +.....+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               11122346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-34  Score=309.56  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=203.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCc----EEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ..+.++||+|+||+||+|++. +++    .||+|.+.... .....++.+|+.++..++|+||+++++++.. ...++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence            344568999999999999854 344    48999986543 3335678899999999999999999999875 4567999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++...  ...+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++.....
T Consensus        88 ~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          88 QLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            999999999998543  24588999999999999999999997   9999999999999999999999999999877543


Q ss_pred             CCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.......+...+...   .        .. 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~--------~~-  230 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG---E--------RL-  230 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---C--------cC-
Confidence            3221 112235678999999998899999999999999999998 88888755443332222110   0        00 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                        +.......++.+++..||+.||++||++.++++.|+.+...+
T Consensus       231 --~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 --PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence              111234567889999999999999999999999998886654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-34  Score=304.72  Aligned_cols=250  Identities=27%  Similarity=0.473  Sum_probs=202.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.+.||+|+||.||++.+.+++.+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            44557899999999999998878899999886432 33567999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++....  ..++++.+..++.|++.+|+|||+.   +++|+||||+||+++.++.+||+|||++............
T Consensus        85 ~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          85 CLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             cHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999885432  3578999999999999999999997   9999999999999999999999999999866443222222


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ...++.+|+|||.+.++.++.++||||||+++|||++ |+.||.......+.+.+..   ...      ..     .+..
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~------~~-----~~~~  225 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA---GFR------LY-----KPRL  225 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC---CCC------CC-----CCCC
Confidence            2235678999999998889999999999999999998 8999875544333332211   000      00     0112


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ....+.+++.+||+.+|++||++.++++.|.
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            3467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-34  Score=306.64  Aligned_cols=239  Identities=23%  Similarity=0.371  Sum_probs=189.5

Q ss_pred             hcccccceeEEEeEecC-------------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          511 RLGRGGSGSVFEGLLND-------------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .||+|+||.||+|++.+             ..+|++|.+..........|.+|+.++..++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            58999999999998642             23589998876555556688999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC-------EEEeec
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN-------VKIADF  650 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~Df  650 (818)
                      ||||+++++|..++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.       ++++||
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          82 VEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999887543  24589999999999999999999997   9999999999999987664       899999


Q ss_pred             CCceecccCCCccccCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          651 GLARLIAQDQSHVSTMPKGTPGYMAPELTR-GNSITAKIDIYSFGVVILEII-CGRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       651 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvll~ell-tG~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      |++.......     ...++..|+|||.+. ...++.++||||||+++|||+ .|+.|+........    ...... . 
T Consensus       157 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~-~-  225 (262)
T cd05077         157 GIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEG-Q-  225 (262)
T ss_pred             CCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhc-C-
Confidence            9987653321     234678899999886 466899999999999999998 47777654322111    111000 0 


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                             ..   .......++.+++.+||+.||.+||++.++++.|+
T Consensus       226 -------~~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         226 -------CM---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -------cc---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                   00   01122356889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-35  Score=325.94  Aligned_cols=256  Identities=22%  Similarity=0.269  Sum_probs=194.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .|.+.++||+|+||.||++... +++.||+|...      ...+.+|++++++++||||+++++++......++|+|++.
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            3555678999999999999975 58899999653      3457899999999999999999999999999999999984


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       167 -~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        167 -TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             -CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence             7888887443   3588999999999999999999997   99999999999999999999999999997543322222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------chHHHHHHHHhhhh---------
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG--------DYLVDTLKVKAEAD---------  726 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~--------~~l~~~~~~~~~~~---------  726 (818)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+-....        ..+...+......+         
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            3335699999999999999999999999999999999999987643221        01111111000000         


Q ss_pred             cchhhc-------cccCcC---ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 RLCDLV-------DKKSED---MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ~~~~~~-------d~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+....       ......   .........++.+++.+||+.||++|||++|++++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000       000000   00112345678899999999999999999999964

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.2e-35  Score=319.54  Aligned_cols=235  Identities=25%  Similarity=0.347  Sum_probs=191.6

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+++.. +++.||||++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5899999999999976 5789999998643   233456678888888876 7999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (320)
T cd05590          82 DLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS  154 (320)
T ss_pred             hHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence            999888543   3588999999999999999999997   999999999999999999999999999876433222 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.......+...+.   ..         ..   ..+...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~---~~---------~~---~~~~~~  219 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---ND---------EV---VYPTWL  219 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh---cC---------CC---CCCCCC
Confidence            3468999999999999899999999999999999999999997654433322221   00         00   001123


Q ss_pred             HHHHHHHHHHccccCCCCCCcH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSA  767 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~  767 (818)
                      ..++.+++.+||+.||++||++
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         220 SQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CHHHHHHHHHHcccCHHHCCCC
Confidence            4577899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-35  Score=324.48  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=200.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||++... +++.+|+|++....   ....+.+.+|+.++..++|+||+++++++.+....++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            44568999999999999875 58899999986532   234567888999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++....  ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||++..+......
T Consensus        84 ~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          84 PGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            9999999985432  4688999999999999999999997   9999999999999999999999999999877654433


Q ss_pred             cccCCCCCCccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          663 VSTMPKGTPGYMAPELTR------GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ......|++.|+|||++.      ...++.++|||||||++|||++|+.||...........+.   .....   .    
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~---~~~~~---~----  228 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM---NFQRF---L----  228 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH---cCCCc---c----
Confidence            333456899999999986      4567899999999999999999999997554332222111   11110   0    


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..+.......++.+++..|++ +|.+||++.+++++
T Consensus       229 -~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         229 -KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             011111234567788889998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=303.38  Aligned_cols=249  Identities=33%  Similarity=0.510  Sum_probs=205.8

Q ss_pred             hhcccccceeEEEeEecC----CcEEEEEEcCCCCCcc-HHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLND----GTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.||+|+||.||++....    +..+++|.+....... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            368999999999999764    7889999987654433 67899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCC------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          585 GSLDKWIFHKDR------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       585 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      ++|.+++.....      ...+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      36789999999999999999999997   999999999999999999999999999987765


Q ss_pred             CCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          659 DQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       659 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ... .......++..|+|||.+....++.++||||||++++||++ |..||.......+.+.+..   ..          
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~----------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GY----------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CC----------
Confidence            432 11223457889999999998889999999999999999999 6899876644333332221   00          


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                       ....+.....++.+++.+|++.+|++||++.+++++|+
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 -RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             00112233568889999999999999999999999884

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=328.23  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=202.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++... +++.||||++....   ......+.+|++++..++|+||+++++++.++...++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            344568999999999999976 68999999986432   23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC-
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-  660 (818)
                      +++++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....... 
T Consensus        83 ~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          83 MPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            9999999998644   4688999999999999999999997   99999999999999999999999999998765433 


Q ss_pred             ---------------------------CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 043017          661 ---------------------------SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD  713 (818)
Q Consensus       661 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~  713 (818)
                                                 ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       11223346899999999999999999999999999999999999999765532


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCc-HHHHHHH
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS-ASMLVKV  773 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~  773 (818)
                      .....+....      ...  ..   +.......++.+++..|++ +|.+||+ +.+++++
T Consensus       237 ~~~~~i~~~~------~~~--~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ETYNKIINWK------ESL--RF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHhccC------Ccc--cC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2222111100      000  00   0011145678889999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.1e-35  Score=315.50  Aligned_cols=260  Identities=28%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS  573 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  573 (818)
                      ..+.+.+.||+|+||.||+++..        +...+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            45566778999999999999753        23579999987542 33456788999999999 7999999999999999


Q ss_pred             cceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                      ..++||||+++++|.+++.....             ...+++.++.+++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999965321             23588899999999999999999987   999999999999999


Q ss_pred             CCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHH
Q 043017          641 RDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDT  718 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~  718 (818)
                      .++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....+.+...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            99999999999997654322111 111234568999999998889999999999999999998 8888865433222222


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      +.    ...       ..   ..+.....++.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus       255 ~~----~~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         255 LK----EGH-------RM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HH----cCC-------CC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            21    100       00   11223346788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-34  Score=304.51  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=202.1

Q ss_pred             hhcccccceeEEEeEecC--C--cEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLND--G--TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.||+|++|.||+|.+.+  +  ..+|||.+..... ...+.|.+|++++++++|+||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999999753  2  3699999976655 556789999999999999999999999988 888999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc--
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--  662 (818)
                      ++|.+++..... ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||+++........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999965432 4689999999999999999999997   9999999999999999999999999999877543221  


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......++..|+|||.+....++.++||||||++++||++ |+.|+...........+...  .           .....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--~-----------~~~~~  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--G-----------ERLER  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--C-----------CcCCC
Confidence            1122457789999999998899999999999999999999 99998655443333222210  0           00011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ....+..+.+++.+|++.+|++||++.++++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1233467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=318.34  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=212.0

Q ss_pred             hHHhhhhcccccceeEEEeEecC--Cc--EEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND--GT--KVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ...+.++||+|.||.|++|.|..  |+  .||||.+...... ...+|+.|+.+|.+|+|+|+++|+|...+ ...+||+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            33456789999999999999863  44  5899999876544 57899999999999999999999999988 7789999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      |+++.|+|.+.|.. .....|-......++.|||.||.||...   ++|||||.++|+||.....+||+||||.+-+...
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999976 4456788899999999999999999986   9999999999999999999999999999988765


Q ss_pred             CCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          660 QSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       660 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      +...  .....-...|+|||.+....++.++|||+|||.||||++ |+.||.+..+..+++.+.              .-
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD--------------~~  331 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID--------------AG  331 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc--------------cc
Confidence            4432  223345678999999999999999999999999999999 788988776655444332              12


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      +..+.+..+.+++.+++..||..+|.+|||+..|.+.+
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            22334567889999999999999999999999997443

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-34  Score=309.08  Aligned_cols=239  Identities=23%  Similarity=0.362  Sum_probs=188.9

Q ss_pred             hcccccceeEEEeEecC-------------------------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEE
Q 043017          511 RLGRGGSGSVFEGLLND-------------------------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL  565 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l  565 (818)
                      .||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999998521                         13589999875544445678899999999999999999


Q ss_pred             eeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC--
Q 043017          566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL--  643 (818)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~--  643 (818)
                      ++++......++||||+++++|..++...  ...+++..+..++.||++||+|||+.   +|+||||||+||+++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999988543  24578899999999999999999987   999999999999997643  


Q ss_pred             -----CEEEeecCCceecccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCchHH
Q 043017          644 -----NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEII-CGRRSSNPKGGDYLV  716 (818)
Q Consensus       644 -----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~ell-tG~~p~~~~~~~~l~  716 (818)
                           .+|++|||++.......     ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                 38999999986543221     1246778999998865 56899999999999999995 688888755433221


Q ss_pred             HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       717 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .....   .        ...     +.....++.+++.+||+.+|++||++.++++.|+
T Consensus       232 ~~~~~---~--------~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RFYEK---K--------HRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHh---c--------cCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11110   0        000     1112246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-34  Score=309.75  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=201.9

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      ..+.+.++||+|+||.||+|...      .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+....+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            44556678999999999999754      245899998864432 23456889999999999999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCC-------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          577 LVYEYMCNGSLDKWIFHKDR-------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                      +||||+++|+|.+++.....       ...+.+..+.+++.|++.||+|||+.   +|+||||||+||++++++.++|+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence            99999999999999964221       23456778889999999999999997   999999999999999999999999


Q ss_pred             cCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+.....+.   ... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---~~~-  238 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM---DGG-  238 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC-
Confidence            9999865432221 1122235678999999998899999999999999999999 788886544332222111   100 


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                              ...  .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus       239 --------~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 --------YLD--QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --------CCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                    000  01123467899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-34  Score=305.09  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||++.. .+++.+|||.+....   .....++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            356678899999999999996 478999999875432   2234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          581 YMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      |+++++|.+++... .....+++..+..++.||++||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999988642 2235689999999999999999999997   9999999999999999999999999998866443


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .........      ....+..   
T Consensus       160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~------~~~~~~~---  228 (267)
T cd08229         160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE------QCDYPPL---  228 (267)
T ss_pred             Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh------cCCCCCC---
Confidence            221 12235788999999999888999999999999999999999998644321 111111110      0000000   


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                       ........+.+++.+||+.+|++||||.+|+++++++.
T Consensus       229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence             11235567889999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-34  Score=316.41  Aligned_cols=243  Identities=28%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHH---hccCcceeEEEeeeecccCcceeeee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETI---GNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l---~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +.+.||+|+||.||++... +++.||||++....   ....+.+..|++++   .+++||||+++++++..+...++|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            4467999999999999875 58899999986432   22345566676654   56689999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|..++..    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          83 YAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             CCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999887732    3589999999999999999999997   99999999999999999999999999987543322


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      . ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+..   .         ...   
T Consensus       156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~---~---------~~~---  219 (324)
T cd05589         156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN---D---------EVR---  219 (324)
T ss_pred             C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---C---------CCC---
Confidence            2 12234689999999999999999999999999999999999999976544333222211   0         000   


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .+......+.+++.+||+.||.+||     ++.+++++
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            1122346678999999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-34  Score=304.11  Aligned_cols=258  Identities=22%  Similarity=0.371  Sum_probs=207.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|... +++.+|+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            456678999999999999987 7899999988643   223356889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          582 MCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++++|.+++.+. .....+++..+..++.++++||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            9999999988653 2235588999999999999999999997   99999999999999999999999999998664432


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..+....... .        .....+
T Consensus       161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~--------~~~~~~  229 (267)
T cd08224         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEK-C--------DYPPLP  229 (267)
T ss_pred             cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhc-C--------CCCCCC
Confidence            22 22245788999999999888999999999999999999999998644321 1111111100 0        000010


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                       .......+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus       230 -~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 -ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             1244567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-35  Score=315.32  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=201.8

Q ss_pred             hHHhhhhcccccceeEEEeEecC-Cc--EEEEEEcCCC-CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GT--KVAVKRLYPG-ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|...+ +.  .+++|++... ......+|.+|++++.++ +|+||+++++++.+++..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            44566789999999999999753 43  4688877643 233456788999999999 8999999999999999999999


Q ss_pred             eccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEE
Q 043017          580 EYMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVK  646 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k  646 (818)
                      ||+++++|.+++....             ....+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence            9999999999996432             123578999999999999999999987   999999999999999999999


Q ss_pred             EeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhh
Q 043017          647 IADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEA  725 (818)
Q Consensus       647 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~  725 (818)
                      |+|||++......  ........+..|+|||.+.+..++.++||||||++++||++ |..||...........+.   ..
T Consensus       165 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~  239 (303)
T cd05088         165 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---QG  239 (303)
T ss_pred             eCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh---cC
Confidence            9999998643211  11112234668999999988889999999999999999998 999986554333222211   00


Q ss_pred             hcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       726 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                            .  ...   .+......+.+++.+|++.+|++||++.++++.|+.+.+.
T Consensus       240 ------~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         240 ------Y--RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             ------C--cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                  0  000   1112345678999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9e-35  Score=316.35  Aligned_cols=240  Identities=26%  Similarity=0.359  Sum_probs=192.6

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+|... +++.||||.+....   ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5899999999999976 47899999986531   23345567788888764 8999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++...   ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05619          82 DLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC  154 (316)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence            999988543   3588899999999999999999997   999999999999999999999999999975432221 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||.......+...+...          ....     +...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~----------~~~~-----~~~~  219 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD----------NPCY-----PRWL  219 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------CCCC-----CccC
Confidence            345899999999999989999999999999999999999999765443333222110          0000     1123


Q ss_pred             HHHHHHHHHHccccCCCCCCcHH-HHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSAS-MLVK  772 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~-evl~  772 (818)
                      ..++.+++.+||+.+|++||++. ++++
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            45678999999999999999997 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.7e-35  Score=327.06  Aligned_cols=250  Identities=20%  Similarity=0.278  Sum_probs=194.0

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.++||+|+||.||+|+.. +++.+|||++....   ......+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            34467999999999999865 57899999986432   233467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-  661 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  661 (818)
                      ++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        84 ~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          84 PGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999998543   3588889999999999999999997   999999999999999999999999999864321100 


Q ss_pred             ---------------------------------------------ccccCCCCCCcccccccccCCCCCchhhHHHHHHH
Q 043017          662 ---------------------------------------------HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVV  696 (818)
Q Consensus       662 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvl  696 (818)
                                                                   .......||+.|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00122469999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHH--ccccCCCCCCcHHHHHHH
Q 043017          697 ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAIS--CLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       697 l~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPt~~evl~~  773 (818)
                      +|||++|+.||...........+.   .....   +  ..+   .......++.+++.+  |+..++..||++.+++++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~---~~~~~---~--~~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVI---NWENT---L--HIP---PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHH---ccccc---c--CCC---CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999997654322221111   00000   0  001   111233456667766  556677779999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.9e-35  Score=318.23  Aligned_cols=238  Identities=24%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             hhcccccceeEEEeEe----cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.||+|+||.||++..    .+|+.+|+|++....  ......+..|++++.+++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999875    357899999986532  2234567889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-  154 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-  154 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence            99999988543   3589999999999999999999997   9999999999999999999999999999865443222 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.   ..         ..   ..+.
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~---~~---------~~---~~p~  219 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL---KA---------KL---GMPQ  219 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH---cC---------CC---CCCC
Confidence            223468999999999998889999999999999999999999997654332222211   00         00   0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASM  769 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~e  769 (818)
                      .....+.+++.+||+.||++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            23456789999999999999999444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7e-35  Score=317.23  Aligned_cols=239  Identities=27%  Similarity=0.363  Sum_probs=192.3

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||++... +++.||+|.+....   ......+..|..++..+ +|+||+++++++.+.+..++||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            6899999999999976 57899999986432   23345667788888764 8999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05620          82 DLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAS  154 (316)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-cee
Confidence            999988543   3588899999999999999999997   999999999999999999999999999875322211 223


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.......+...+...          ....     +...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~----------~~~~-----~~~~  219 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD----------TPHY-----PRWI  219 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------CCCC-----CCCC
Confidence            356899999999999999999999999999999999999999765443333222110          0001     1123


Q ss_pred             HHHHHHHHHHccccCCCCCCcHH-HHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSAS-MLV  771 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~-evl  771 (818)
                      ..++.+++.+||+.||++||++. +++
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            45678899999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3e-34  Score=302.33  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=199.3

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeec-ccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA-ERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~  583 (818)
                      .+.+.++||+|+||.||++... +..+|+|.+...  ...+.|.+|+.++++++|+|++++++++. .++..+++|||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            3455678999999999999876 788999988643  23567899999999999999999999764 4567899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......   
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999999986433 24588999999999999999999997   99999999999999999999999999988654322   


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....+..|+|||++....++.++||||||+++|||++ |+.|+.......+...+..   ..        .   ....
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~--------~---~~~~  221 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GY--------K---MDAP  221 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CC--------C---CCCC
Confidence             12234678999999998889999999999999999998 8888864433222222211   00        0   0111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            23456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-34  Score=309.34  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=200.4

Q ss_pred             HhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceee
Q 043017          507 DFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLV  578 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV  578 (818)
                      .+.+.||+|+||+||++..     .+++.||+|.+..... .....|.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4556899999999988653     3578899999865432 3456788999999999999999999988654  357899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++++|.+++..    ..+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||+++....
T Consensus        87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999999853    2489999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHH---hhhhcchhhcc
Q 043017          659 DQSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK---AEADRLCDLVD  733 (818)
Q Consensus       659 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~---~~~~~~~~~~d  733 (818)
                      .....  .....++..|+|||.+....++.++||||||++++||++|+.|+...... ..+.....   .....+.+.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence            32211  12223566799999999888999999999999999999999987543221 11111000   00011111111


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      ... ..+.+.....++.+++..||+.+|++||+++++++.|+.+.
T Consensus       239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111 11112234568889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-34  Score=299.82  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=200.0

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhh
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      +||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            68999999999999887999999988755433 45689999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc-cCCC
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS-TMPK  668 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  668 (818)
                      ++....  ..+++..+..++.+++.+|+|||+.   +++||||||+||+++.++.+||+|||++........... ....
T Consensus        82 ~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          82 FLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            985432  3578899999999999999999997   999999999999999999999999999986543221111 1123


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       669 gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .+..|+|||.+.+..++.++||||||++++||++ |..|+...........+..   ..           ....+.....
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~  222 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---GY-----------RMPAPQLCPE  222 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc---CC-----------CCCCCccCCH
Confidence            4567999999988899999999999999999999 7888765443222222110   00           0011223346


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ++.+++.+|++.+|.+||++.|+++.|+
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            7889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=332.73  Aligned_cols=252  Identities=27%  Similarity=0.349  Sum_probs=200.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC--------
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--------  573 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------  573 (818)
                      .|.+.+.||+|+||+||+++.. +++.||||++....  ......+.+|+..+..++|+|++++...+...+        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            4556678999999999999864 68999999986542  334567889999999999999999988765432        


Q ss_pred             cceeeeeccCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCC
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            2579999999999999986432 235688999999999999999999997   999999999999999999999999999


Q ss_pred             ceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          653 ARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       653 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      ++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+.   . ..    
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~---~-~~----  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL---A-GR----  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---c-CC----
Confidence            987654322 22233568999999999999999999999999999999999999997544322222111   0 00    


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...      .+.....++.+++.+||+.+|.+||++.+++++
T Consensus       262 ~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            000      122345678899999999999999999999875

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-34  Score=309.13  Aligned_cols=254  Identities=27%  Similarity=0.416  Sum_probs=200.9

Q ss_pred             HHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +.+...||+|+||.||++...      ++..+|+|.+.... .....+|.+|+.++++++||||+++++++..+...++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            344568999999999999864      46789999986543 23356799999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcC-------------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE
Q 043017          579 YEYMCNGSLDKWIFHKD-------------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL  639 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll  639 (818)
                      |||+++++|.+++....                   ....+++..+..++.|++.||+|||+.   +++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence            99999999999996421                   113477888999999999999999997   99999999999999


Q ss_pred             cCCCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHH
Q 043017          640 DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVD  717 (818)
Q Consensus       640 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~  717 (818)
                      +.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~  243 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY  243 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998865433211 1122234667999999998899999999999999999998 878876543332222


Q ss_pred             HHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      .+.   . ...        .  ..+.....++.+++.+||+.+|++||++.|+++.|+.
T Consensus       244 ~~~---~-~~~--------~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 YVR---D-GNV--------L--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHh---c-CCC--------C--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            111   1 100        0  0112234678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-34  Score=295.38  Aligned_cols=269  Identities=26%  Similarity=0.317  Sum_probs=205.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-c-cHHHHHHHHHHHhccCcce-eEEEeeeecccC------
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-R-GKKEFLSEVETIGNIHHFN-LVRLVGYCAERS------  573 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~-~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~------  573 (818)
                      ..+...++||+|.||+||+|+.. +|+.||+|++....+ + ......+|+.++++++|+| ||+|++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34445567999999999999965 688999999876543 2 3355688999999999999 999999998877      


Q ss_pred             cceeeeeccCCCChhhHhhhcCCc-cccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCC
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      ..++|+||+ .-+|..++...... ..++...+..+.+||++||+|||++   +|+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            678999998 77899998654422 3466688999999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc----
Q 043017          653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR----  727 (818)
Q Consensus       653 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~----  727 (818)
                      |+.+.-+... .+..+.|..|.|||++.+. .|+...||||+|||+.||++++..|.+..+...+..+-.....+.    
T Consensus       167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            9966533222 3446789999999999886 699999999999999999999999987765333333322222111    


Q ss_pred             --chhhcccc--CcCccCcH-------HHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcC
Q 043017          728 --LCDLVDKK--SEDMQSHR-------DDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGL  777 (818)
Q Consensus       728 --~~~~~d~~--~~~~~~~~-------~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i  777 (818)
                        +..+.+..  ........       ....+..+++.+||+.+|.+|.|++.++++  +..+
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence              11111111  11111011       111467889999999999999999999997  5544

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-34  Score=302.79  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||++... +++.+++|.+...  ......++.+|++++++++||||+++++++.+....++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            34567999999999999975 5889999988643  33446788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++........ 
T Consensus        83 ~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-  157 (256)
T cd08529          83 NGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-  157 (256)
T ss_pred             CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence            999999986542 35688999999999999999999987   9999999999999999999999999999876543322 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....+++.|+|||++.+..++.++||||||++++||++|+.||...........+.    .        .....  ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~--------~~~~~--~~~  223 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII----R--------GVFPP--VSQ  223 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----c--------CCCCC--Ccc
Confidence            223457889999999999899999999999999999999999997554322211111    0        00111  112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            345678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-34  Score=289.63  Aligned_cols=274  Identities=23%  Similarity=0.244  Sum_probs=206.3

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-c-HHHHHHHHHHHhccCcceeEEEeeeeccc--CcceeeeeccC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-G-KKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYEYMC  583 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~  583 (818)
                      ..+|++|.||.||+|+.+ +++.||+|+++...+. + --.-++|+.+|.+.+|||||.+..+....  +..|||||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            357999999999999975 5889999999755322 1 23468899999999999999998877543  47999999995


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       -+|...+...+  +++...+..-+..|+++|++|||.+   .|+|||||++|+|+...|.+||+|||||+.+..... .
T Consensus       161 -hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k-~  233 (419)
T KOG0663|consen  161 -HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK-P  233 (419)
T ss_pred             -hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc-c
Confidence             47888775443  5799999999999999999999998   999999999999999999999999999998877533 3


Q ss_pred             ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--c------hhhcc-
Q 043017          664 STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--L------CDLVD-  733 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--~------~~~~d-  733 (818)
                      .+..+-|+.|.|||++.+. .|+...|+||+|||+.||+++++.|.+.....-++.+-.....+.  +      ...+. 
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            4445679999999999875 599999999999999999999999987765443333322221111  0      01010 


Q ss_pred             ccCcCccC------cH--HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCch
Q 043017          734 KKSEDMQS------HR--DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLS  790 (818)
Q Consensus       734 ~~~~~~~~------~~--~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~  790 (818)
                      ......+.      ..  ...+.-.+++...|..||.+|.|+++.|++= -..+.+.+.+++++.
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P~~~P  377 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDPSMFP  377 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCChhhcC
Confidence            00000000      00  1235667888999999999999999999872 334444445555444

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.9e-34  Score=304.39  Aligned_cols=254  Identities=24%  Similarity=0.297  Sum_probs=200.6

Q ss_pred             hhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ..+.+.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            3456677899999999999996 468899999987555455667889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            999999988543   3588999999999999999999997   999999999999999999999999999987643221 


Q ss_pred             cccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          663 VSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ......++..|+|||.+.   ...++.++||||||++++||++|+.|+...........   . ...   . .  .....
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~---~-~~~---~-~--~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---M-SKS---N-F--QPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee---e-ecC---C-C--CCCCC
Confidence            112245788999999884   34578899999999999999999999853322110000   0 000   0 0  00011


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .........+.+++.+||+.+|++||++++++++|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11123456788999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.6e-35  Score=325.28  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=197.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+++.+.||+|+||.||++... +++.+|+|.+...   .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            3445568999999999999976 4789999998542   22334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++..    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       124 y~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         124 YMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             CCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            9999999998843    2478889999999999999999997   99999999999999999999999999998765433


Q ss_pred             CccccCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNS----ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ........||+.|+|||.+....    ++.++|||||||++|||++|+.||...........+.   .....       .
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~---~~~~~-------~  266 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM---DHKNS-------L  266 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCcc-------c
Confidence            32333457999999999987543    7889999999999999999999997554322222111   10000       0


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCC--CCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHR--RPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~  773 (818)
                       ..+........+.+++..|++.++.+  ||++.|++++
T Consensus       267 -~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 -NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             01111223456778888999865544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-34  Score=317.53  Aligned_cols=261  Identities=30%  Similarity=0.416  Sum_probs=200.9

Q ss_pred             HhhHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeeccc-C
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAER-S  573 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~-~  573 (818)
                      ...+.+.+.||+|+||.||+|..      .+++.||||++..... .....+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            34567778999999999999973      3478899999865432 2345788999999999 789999999988654 4


Q ss_pred             cceeeeeccCCCChhhHhhhcCC---------------------------------------------------------
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDR---------------------------------------------------------  596 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  596 (818)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999854210                                                         


Q ss_pred             -------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-cccCCC
Q 043017          597 -------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMPK  668 (818)
Q Consensus       597 -------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~  668 (818)
                             ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   12367888899999999999999997   9999999999999999999999999999875433221 112234


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       669 gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+..........  ........      ...     +.....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~~~~------~~~-----~~~~~~  309 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRLKEGTR------MRA-----PDYTTP  309 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH--HHHhccCC------CCC-----CCCCCH
Confidence            5678999999988899999999999999999997 888886543221111  11111000      000     111235


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ++.+++..||+.+|++||++.+|+++|+.+.+
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            68899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-34  Score=323.05  Aligned_cols=259  Identities=27%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceeee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLVY  579 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV~  579 (818)
                      ..++||+|+||.||++... +++.||||++...  .....+++.+|+++++.++|+||+++++++....     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            4467999999999999964 6899999998643  2233467889999999999999999999998776     789999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+. ++|.+++..   ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          84 ELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9986 578777743   24689999999999999999999997   9999999999999999999999999999876544


Q ss_pred             CCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc----------
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL----------  728 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~----------  728 (818)
                      .........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+......+..          
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            33333334678999999998774 4799999999999999999999999766543333322211110000          


Q ss_pred             hhhccccCcCc-------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 CDLVDKKSEDM-------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 ~~~~d~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.......       ........++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00000000000       0011234678899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.6e-34  Score=302.67  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=191.8

Q ss_pred             hcccccceeEEEeEecC---CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLND---GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||+|+||.||+|+..+   +..+|+|.+..... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998653   45799998865432 334578999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCC--ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc-
Q 043017          587 LDKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-  663 (818)
Q Consensus       587 L~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  663 (818)
                      |.+++.....  ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999964322  23456778889999999999999997   99999999999999999999999999997543322211 


Q ss_pred             ccCCCCCCcccccccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          664 STMPKGTPGYMAPELTRGN-------SITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .....++..|+|||++...       .++.++||||||+++|||++ |+.||.............   . ........+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~-~~~~~~~~~~  234 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---R-EQQLKLPKPR  234 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---h-cccCCCCCCc
Confidence            1223467889999998642       35789999999999999996 999986544332211110   0 0000111111


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .     .......+.+++..|+ .+|++|||+.+|++.|+
T Consensus       235 ~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 L-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             c-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1     1123345778888998 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3e-34  Score=310.29  Aligned_cols=256  Identities=26%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             hHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  576 (818)
                      .+.+.+.||+|+||.||++...      .+..+|||++..... ...+.+.+|+++++++ +|+||+++++++...+..+
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            4455678999999999999742      355899999875432 3346789999999999 7999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++++|.+++.... ...+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||+++..
T Consensus       116 lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            9999999999999985432 23489999999999999999999997   9999999999999999999999999999866


Q ss_pred             ccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          657 AQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       657 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........   .....     .  
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~---~~~~~-----~--  261 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK---LIKEG-----Y--  261 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH---HHHcC-----C--
Confidence            543221 1122345778999999999899999999999999999998 9999865443221111   11100     0  


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..   ........++.+++.+|++.+|++||++.++++.|+.+
T Consensus       262 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00   00112345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-34  Score=316.96  Aligned_cols=245  Identities=22%  Similarity=0.299  Sum_probs=195.3

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCc-ceeEEEeeeecccCcceeeeec
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHH-FNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .+.+.||+|+||.||+|+.. +++.||||++...   .....+.+..|.+++..++| ++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            45568999999999999976 4678999998643   23345678889999999965 5688899999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          83 VNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999988543   3578899999999999999999997   999999999999999999999999999875432221


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..   .         ..   ..
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~---~---------~~---~~  220 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME---H---------NV---SY  220 (324)
T ss_pred             -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc---C---------CC---CC
Confidence             12234689999999999999999999999999999999999999976544333322211   0         00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcH-----HHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSA-----SMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~  773 (818)
                      +.....++.+++.+||+.+|.+|++.     .+++++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            12234577899999999999999976     565543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-34  Score=315.86  Aligned_cols=241  Identities=25%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||++... +++.+|||.+...   .......+..|.+++..+ +||||+++++++...+..++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999976 4789999998643   223345677888998888 7999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (318)
T cd05570          82 DLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS  154 (318)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence            999888543   3589999999999999999999997   999999999999999999999999999875332222 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||...........+..   .         ..   ..+...
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~---~---------~~---~~~~~~  219 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE---D---------EV---RYPRWL  219 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---C---------CC---CCCCcC
Confidence            34589999999999999999999999999999999999999976543332222210   0         00   011223


Q ss_pred             HHHHHHHHHHccccCCCCCCcH-----HHHHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSA-----SMLVKV  773 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~-----~evl~~  773 (818)
                      ...+.+++.+||+.||.+||++     .+++++
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            4678899999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=303.33  Aligned_cols=249  Identities=26%  Similarity=0.336  Sum_probs=199.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-----ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-----RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +...+.||+|++|.||++... +++++|+|.+.....     ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            344568999999999999864 589999998764321     12356888999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||+++.....
T Consensus        84 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          84 EYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999988543   3588899999999999999999997   9999999999999999999999999999865432


Q ss_pred             CCccc--cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QSHVS--TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...........   ......          
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~----------  224 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK---IATQPT----------  224 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH---HhccCC----------
Confidence            22111  224577899999999998899999999999999999999999865432211111   110000          


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+......+.+++.+||+.+|.+||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            011122345678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-35  Score=322.85  Aligned_cols=249  Identities=21%  Similarity=0.295  Sum_probs=196.6

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||+++.. +++.||||++....   ......+.+|++++..++|+||+++++++.++...++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            34568999999999999975 58899999986432   233456788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+......
T Consensus        84 ~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          84 PGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            999999998543   3589999999999999999999997   9999999999999999999999999999765322110


Q ss_pred             -------------------------------------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 043017          663 -------------------------------------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR  705 (818)
Q Consensus       663 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~  705 (818)
                                                           ......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0112358999999999999899999999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCc---HHHHHHH
Q 043017          706 SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS---ASMLVKV  773 (818)
Q Consensus       706 p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~  773 (818)
                      ||...........+.   .....   +  ..+.   .......+.+++.+|+. +|.+|++   +.+++++
T Consensus       238 Pf~~~~~~~~~~~i~---~~~~~---~--~~~~---~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         238 PFCSDNPQETYRKII---NWKET---L--QFPD---EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCHHHHHHHHH---cCCCc---c--CCCC---CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            997654332222111   10000   0  0000   11224566788888886 8999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=326.06  Aligned_cols=249  Identities=21%  Similarity=0.282  Sum_probs=194.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.++||+|+||.||++... +++.||||++....   ....+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            34568999999999999865 68899999985432   233467888999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus        84 ~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          84 PGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999998543   4588899999999999999999997   9999999999999999999999999999643211000


Q ss_pred             ----------------------------------------------cccCCCCCCcccccccccCCCCCchhhHHHHHHH
Q 043017          663 ----------------------------------------------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVV  696 (818)
Q Consensus       663 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvl  696 (818)
                                                                    ......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012358999999999999899999999999999


Q ss_pred             HHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCC---CCcHHHHHHH
Q 043017          697 ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHR---RPSASMLVKV  773 (818)
Q Consensus       697 l~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~---RPt~~evl~~  773 (818)
                      +|||++|+.||...........+..   ....   +  ..   +.......++.+++.+|++ +|.+   |+++.+++++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~---~~~~---~--~~---p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIIN---WRET---L--YF---PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHc---cCCc---c--CC---CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            9999999999976543322222111   0000   0  00   1111234567788889997 6655   5699999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.2e-34  Score=311.88  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             hHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSN  574 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  574 (818)
                      .+.+.++||+|+||.||+++..        ....+|+|.+.... .....++.+|++++.++ +||||+++++++.....
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            4446678999999999999742        24579999887542 23356788999999999 69999999999999899


Q ss_pred             ceeeeeccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      .+++|||+++|+|.+++....             ....+++..+..++.|++.||.|||+.   +++||||||+||+++.
T Consensus        93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~  169 (314)
T cd05099          93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE  169 (314)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC
Confidence            999999999999999996532             124588899999999999999999997   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTL  719 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~  719 (818)
                      ++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......+...+
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~  249 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL  249 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999998664322211 112234567999999998889999999999999999999 88888655433333322


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ..   . ..       .   ..+.....++.+++.+||+.+|++||++.++++.|+.+...
T Consensus       250 ~~---~-~~-------~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         250 RE---G-HR-------M---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             Hc---C-CC-------C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            11   0 00       0   11123345788999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5e-34  Score=302.97  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=189.8

Q ss_pred             hcccccceeEEEeEecC---CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLND---GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +||+|+||.||+|...+   ...+++|.+.... ......|.+|++.++.++|+||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997643   4578999876443 2334678999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCC--ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc-
Q 043017          587 LDKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-  663 (818)
Q Consensus       587 L~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  663 (818)
                      |.+++.....  ....++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999965432  23356778899999999999999997   99999999999999999999999999987543322111 


Q ss_pred             ccCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          664 STMPKGTPGYMAPELTRG-------NSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..|+............   ....      ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~------~~~  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV---VREQ------DIK  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---hhcc------Ccc
Confidence            122345678999998743       356889999999999999999 77777654332221111   1110      001


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .............+.+++..|+ .||++||++++|++.|.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111112234456667788888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5e-34  Score=301.56  Aligned_cols=249  Identities=27%  Similarity=0.384  Sum_probs=192.3

Q ss_pred             hcccccceeEEEeEecC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeec-ccCcceeeeeccCC
Q 043017          511 RLGRGGSGSVFEGLLND----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCA-ERSNRFLVYEYMCN  584 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~~  584 (818)
                      .||+|+||.||+|...+    ...+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+...+++|||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            58999999999998642    4579999985432 334568889999999999999999999775 45567899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc--
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--  662 (818)
                      ++|.+++....  ..+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++........  
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          82 GDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999985432  3466778889999999999999997   9999999999999999999999999999865432211  


Q ss_pred             -cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR-RSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       663 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       ......++..|+|||.+....++.++||||||+++|||++|+ .|+.......+...+   ....        ..   .
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~---~~~~--------~~---~  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL---LQGR--------RL---L  222 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---hcCC--------CC---C
Confidence             111234567899999998889999999999999999999964 455433222211111   1000        00   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      .+...+..+.+++..||+.+|++||++.++++.|+.+.
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            01122457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-34  Score=315.53  Aligned_cols=245  Identities=22%  Similarity=0.297  Sum_probs=196.1

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeec
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ++.+.||+|+||.||++... +++.+|||.+....   ....+.+..|..++..+ +|++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            34567999999999999876 47899999986532   22344567788888777 689999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          83 VNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999888543   3588999999999999999999997   999999999999999999999999999986433221


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......+...+...            ..   ..
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------~~---~~  220 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------NV---AY  220 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CC---CC
Confidence             122346899999999999999999999999999999999999999866544333332210            00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcH-----HHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSA-----SMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~  773 (818)
                      +.....++.+++.+||+.+|.+|++.     .+++++
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            12334677899999999999999984     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-34  Score=316.34  Aligned_cols=245  Identities=26%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||++... +++.+|+|.+...   .......+..|+.++.++ +||||+++++++......++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            5899999999999975 5789999998653   223345677888888777 8999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (329)
T cd05618          82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS  154 (329)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence            999887543   4588999999999999999999997   999999999999999999999999999975432221 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-----hHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD-----YLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-----~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||......     .....+......        ...   .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~~~---~  223 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------KQI---R  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------CCC---C
Confidence            346899999999999999999999999999999999999999632111     111111111100        000   1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCc------HHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPS------ASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~~  773 (818)
                      .+.....++.+++.+||+.||++||+      +.+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            12233467789999999999999998      4666554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.8e-34  Score=307.06  Aligned_cols=262  Identities=22%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-----------------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEe
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-----------------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLV  566 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~  566 (818)
                      .+.+.++||+|+||.||++...                 +...+|+|++.... .....+|.+|++++..++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3456678999999999998532                 23468999987543 33456899999999999999999999


Q ss_pred             eeecccCcceeeeeccCCCChhhHhhhcCC--------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEE
Q 043017          567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDR--------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL  638 (818)
Q Consensus       567 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIl  638 (818)
                      +++...+..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||+.   +++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil  162 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence            999999999999999999999999865321        13477888999999999999999997   9999999999999


Q ss_pred             EcCCCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCchH
Q 043017          639 LDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC--GRRSSNPKGGDYL  715 (818)
Q Consensus       639 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt--G~~p~~~~~~~~l  715 (818)
                      ++.++.++|+|||+++.+...... ......++..|+|||....+.++.++|||||||++|||++  |..|+........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999865443221 1122334678999999888889999999999999999998  6677765444333


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ............. ...   .   +.+..+...+.+++.+||+.+|++||++.+|++.|+.
T Consensus       243 ~~~~~~~~~~~~~-~~~---~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 IENTGEFFRDQGR-QVY---L---PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHhhccc-ccc---C---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            3222111100000 000   0   1112234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.4e-34  Score=319.30  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=192.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ++.+.||+|+||+||++... +++.+|||++....   ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            34568999999999999865 58899999986432   223456888999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-  661 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  661 (818)
                      ++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        84 ~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          84 PGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999998543   4589999999999999999999997   999999999999999999999999999976532110 


Q ss_pred             ---------------------------------ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 043017          662 ---------------------------------HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSN  708 (818)
Q Consensus       662 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~  708 (818)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00122469999999999999999999999999999999999999997


Q ss_pred             CCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccc--cCCCCCCcHHHHHHH
Q 043017          709 PKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQ--KNLHRRPSASMLVKV  773 (818)
Q Consensus       709 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPt~~evl~~  773 (818)
                      ..........+.....     ...   .+...   ....++.+++.+++.  .++..||++.|++++
T Consensus       238 ~~~~~~~~~~i~~~~~-----~~~---~p~~~---~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SETPQETYKKVMNWKE-----TLI---FPPEV---PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCHHHHHHHHHcCcC-----ccc---CCCcC---CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            6544333322211000     000   01101   122344455555333  344567999999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.3e-34  Score=299.98  Aligned_cols=237  Identities=24%  Similarity=0.403  Sum_probs=190.0

Q ss_pred             hcccccceeEEEeEecCCc-----------EEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          511 RLGRGGSGSVFEGLLNDGT-----------KVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .||+|+||.||+|.+.+..           .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            6899999999999986433           5788877654433 6789999999999999999999999988 7789999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-------CEEEeecCC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-------NVKIADFGL  652 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~Dfgl  652 (818)
                      ||+++++|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++       .+||+|||+
T Consensus        80 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          80 EYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999986543  2688999999999999999999987   999999999999999888       799999999


Q ss_pred             ceecccCCCccccCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcch
Q 043017          653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLC  729 (818)
Q Consensus       653 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~  729 (818)
                      +......     ....++..|+|||.+...  .++.++||||||+++|||++ |..|+............   ...    
T Consensus       155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~---~~~----  222 (259)
T cd05037         155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY---QDQ----  222 (259)
T ss_pred             ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH---hcC----
Confidence            9865431     123466789999999876  78999999999999999999 46666544322111111   000    


Q ss_pred             hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       730 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                          ....     ......+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 ----~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 ----HRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----CCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                0000     011267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.7e-34  Score=303.36  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=200.6

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +++.++||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|+||+++++++..+...++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            4566789999999999999764 778899998765555567889999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|..++...  ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++........ ..
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~  160 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  160 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence            9999887542  24689999999999999999999997   999999999999999999999999999976543221 12


Q ss_pred             cCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          665 TMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ....++..|+|||++.     ...++.++|||||||++|||++|+.||...........+.   ..         .....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~---------~~~~~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KS---------EPPTL  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hc---------CCCCC
Confidence            2345889999999984     3457889999999999999999999986543222111111   00         00000


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ..+.....++.+++.+||+.+|.+||++.+++++-
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            11223346788999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-34  Score=314.37  Aligned_cols=236  Identities=26%  Similarity=0.371  Sum_probs=188.8

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHH-HHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVE-TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||+||+++.. +++.||||++....   .....++..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5899999999999975 58999999986432   222344555554 567889999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (323)
T cd05575          82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTS  154 (323)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccc
Confidence            999988543   3588899999999999999999997   999999999999999999999999999875432221 222


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.......+.+.+..            .....   ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------~~~~~---~~~~  219 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN------------KPLRL---KPNI  219 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc------------CCCCC---CCCC
Confidence            34689999999999999999999999999999999999999976543332222210            00100   1123


Q ss_pred             HHHHHHHHHHccccCCCCCCcHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      ...+.+++.+||+.+|.+||++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCC
Confidence            56788999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-34  Score=303.32  Aligned_cols=253  Identities=25%  Similarity=0.385  Sum_probs=201.1

Q ss_pred             hhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          508 FQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ....||+|+||.||+++..      +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+....++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3457999999999999964      3467999988654433 35789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCc------cccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          581 YMCNGSLDKWIFHKDRI------QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      |+++++|.+++......      ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence            99999999999654321      2589999999999999999999997   99999999999999999999999999987


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      ..............++..|+|||.+.+...+.++||||||++++||++ |..||.............    .....    
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~----~~~~~----  237 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----AGKLE----  237 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH----cCCcC----
Confidence            554332222223346778999999988889999999999999999999 777886443332222211    00000    


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                           ..........+.+++.+||+.+|++||++.++++.|++
T Consensus       238 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                 00112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.6e-34  Score=307.25  Aligned_cols=248  Identities=26%  Similarity=0.401  Sum_probs=201.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.++||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            334467999999999999864 6889999998766555667889999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++..    ..+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++......... .
T Consensus       102 ~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~  173 (296)
T cd06654         102 GSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  173 (296)
T ss_pred             CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence            999998843    3478899999999999999999997   9999999999999999999999999998865443222 1


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....+++.|+|||.+.+...+.++|||||||++|||++|+.||.......   ........        .. .....+..
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~~~--------~~-~~~~~~~~  241 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATN--------GT-PELQNPEK  241 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHhcC--------CC-CCCCCccc
Confidence            22358889999999998889999999999999999999999996543311   11111000        00 00111223


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+.+++.+||+.+|++||++.+++++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            44678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.8e-34  Score=302.26  Aligned_cols=249  Identities=29%  Similarity=0.461  Sum_probs=198.5

Q ss_pred             hcccccceeEEEeEecC-------CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLND-------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .||+|+||.||+|+..+       ++.+|+|.+.... .....+|.+|+++++.++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999998653       3579999886543 244678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcC----CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-----CEEEeecCCc
Q 043017          583 CNGSLDKWIFHKD----RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-----NVKIADFGLA  653 (818)
Q Consensus       583 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfgla  653 (818)
                      ++++|.+++....    ....+++..+..++.|+++||+|||+.   +++|+||||+||+++.+.     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999996532    223478899999999999999999987   999999999999999877     8999999999


Q ss_pred             eecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          654 RLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       654 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      ......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   ...     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~-----  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT---AGG-----  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh---cCC-----
Confidence            865432211 1112345678999999999999999999999999999998 999886443322222111   000     


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                         ..   ......+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       231 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ---RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               00   1122345678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.7e-34  Score=299.23  Aligned_cols=249  Identities=28%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             hHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||+++..+ ++.+++|.+.....  .+++.+|++++++++|+||+++++++......++++||++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            35567789999999999999875 78999999865433  6789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...  ...+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||++........ .
T Consensus        82 ~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          82 AGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            99999998532  25689999999999999999999997   999999999999999999999999999987654332 1


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+.            .........+.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~  223 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP------------NKPPPTLSDPE  223 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc------------cCCCCCCCchh
Confidence            222347889999999998899999999999999999999999987543221111100            00011111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....++.+++.+|++.+|++||++.+++++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            344678899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6e-34  Score=302.19  Aligned_cols=248  Identities=25%  Similarity=0.308  Sum_probs=195.8

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      ..||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            47999999999999965 57889999987666666778999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceecccCCCccccCC
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      +++.........++..+..++.||++||+|||+.   +|+||||||+||+++. ++.++|+|||++......... ....
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~  169 (268)
T cd06624          94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TETF  169 (268)
T ss_pred             HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-cccC
Confidence            9996532211227788889999999999999987   9999999999999976 678999999999866433221 2223


Q ss_pred             CCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          668 KGTPGYMAPELTRGNS--ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      .++..|+|||.+....  ++.++||||||+++|||++|+.|+...........  ...        ......  ..+...
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--~~~--------~~~~~~--~~~~~~  237 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--KVG--------MFKIHP--EIPESL  237 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--hhh--------hhccCC--CCCccc
Confidence            5788999999986643  78999999999999999999999864332111110  000        000000  112234


Q ss_pred             HHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..++.+++.+||+.+|.+||++.+++++
T Consensus       238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         238 SAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            5678899999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.2e-34  Score=304.39  Aligned_cols=266  Identities=24%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             hHHhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~  576 (818)
                      ++...++||+|+||.||+++.     .+++.||+|.+.... ......+.+|++++++++|+||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            344556799999999999984     347889999987553 33346799999999999999999999998775  5678


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999999985432  3589999999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHH---HHhhhhcchhh
Q 043017          657 AQDQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK---VKAEADRLCDL  731 (818)
Q Consensus       657 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~---~~~~~~~~~~~  731 (818)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++++.|....... ......   ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL-FLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch-hhhhcccccccccHHHHHHH
Confidence            543221  112344677899999998888999999999999999999987654321100 000000   00000000000


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      +... ...+.......++.+++.+||+.+|++||++.++++.|+.+
T Consensus       239 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000 00111223456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-34  Score=313.77  Aligned_cols=245  Identities=24%  Similarity=0.325  Sum_probs=194.0

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||++... +++.||||.+...   .....+.+..|..++.++ +||||+++++++......++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5899999999999975 5889999998653   223345688899999888 7999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (329)
T cd05588          82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS  154 (329)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence            999888543   4589999999999999999999997   999999999999999999999999999875322221 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-----hHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD-----YLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-----~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......     ...+.+.....        ....   .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~  223 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--------EKQI---R  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH--------cCCC---C
Confidence            346899999999999999999999999999999999999999632211     11111111110        0111   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCc------HHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPS------ASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~~  773 (818)
                      .+.....++.+++.+||+.||.+||+      +.+++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            11223456889999999999999997      6777754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-34  Score=312.62  Aligned_cols=236  Identities=25%  Similarity=0.381  Sum_probs=187.8

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHH-HHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVE-TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +||+|+||.||+++.. +++.+|+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999975 57899999986432   222345555554 678899999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05603          82 ELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTS  154 (321)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccc
Confidence            998888543   3578888999999999999999997   999999999999999999999999999875432221 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...+.+.+.            ....   ..+...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------------~~~~---~~~~~~  219 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL------------HKPL---QLPGGK  219 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh------------cCCC---CCCCCC
Confidence            3468999999999998899999999999999999999999997654332222211            0011   111233


Q ss_pred             HHHHHHHHHHccccCCCCCCcHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      ...+.+++.+||+.+|.+||++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCC
Confidence            45788999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-34  Score=306.18  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.||+|+||.||++... +++.+|||.+.....   .....+.+|+.++++++|++++++++.+.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            3457999999999999876 588999999865422   223567889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......... 
T Consensus        84 g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  158 (285)
T cd05630          84 GGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-  158 (285)
T ss_pred             CCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence            999999885433 24588999999999999999999987   9999999999999999999999999999765433221 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                       ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..................      ....     ...
T Consensus       159 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------~~~~-----~~~  226 (285)
T cd05630         159 -KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------VQEE-----YSE  226 (285)
T ss_pred             -cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------hhhh-----cCc
Confidence             2236899999999999989999999999999999999999999754332211111111000      0000     011


Q ss_pred             HHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      ....++.+++..||+.||++|||     +.|++++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            23456789999999999999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-33  Score=301.75  Aligned_cols=248  Identities=26%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34555678999999999999865 47889999886443 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++..    ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999998842    3588999999999999999999987   999999999999999999999999999986654322


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ......++..|+|||.+.+..++.++||||||++++||++|+.|+...........+.            ......  .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------~~~~~~--~  221 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP------------KNSPPT--L  221 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh------------cCCCCC--C
Confidence             1222457889999999998889999999999999999999999986443322111110            000001  1


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......+.+++.+|++.+|.+||+|.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            12345678899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-34  Score=302.67  Aligned_cols=251  Identities=31%  Similarity=0.507  Sum_probs=199.3

Q ss_pred             hhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccH--HHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~--~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.||+|+||+||+++... ++.+|+|.+........  .....|+.++.+++|+||+++++++.+....++|||++++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence            45679999999999999865 66899999976643322  2345699999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.   +...+++..+..++.||++||++||+.   +++|+||||+||+++.++.++|+|||.+..... .....
T Consensus        83 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~  155 (260)
T PF00069_consen   83 GSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF  155 (260)
T ss_dssp             EBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred             cccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence            99999996   234689999999999999999999998   999999999999999999999999999986522 22233


Q ss_pred             cCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTR-GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+. ....+.++||||+|+++++|++|..|+...........+....... ...    ....   ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~----~~~~---~~  227 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-LPS----SSQQ---SR  227 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-HHH----HTTS---HT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-ccc----cccc---cc
Confidence            3456899999999998 8889999999999999999999999987652222222221111110 000    0000   01


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++..||+.+|++||++.+++++
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112788999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-34  Score=303.28  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=204.4

Q ss_pred             hHHhhhhcccccceeEEEeEecC-Cc----EEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GT----KVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .+.+.+.||+|+||.||+|...+ ++    .+|+|.+..... ....++.+|++++++++|+||+++++++.. ...++|
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            34555789999999999998653 32    589998865543 345678999999999999999999999987 788999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.+++....  ..+++..+..++.||++||+|||+.   +++|+||||+||++++++.+||+|||+++....
T Consensus        87 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          87 TQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999985432  3589999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCCccc-cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          659 DQSHVS-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       659 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ...... ....++..|+|||.+....++.++||||||++++|+++ |+.|+.......+...+..   ..        ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~--------~~  230 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK---GE--------RL  230 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---CC--------CC
Confidence            332221 11224568999999988889999999999999999999 9999876544333222211   00        00


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                         ..+.....++.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus       231 ---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 ---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence               11112335688999999999999999999999999988664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3e-34  Score=314.52  Aligned_cols=252  Identities=20%  Similarity=0.272  Sum_probs=195.0

Q ss_pred             HhhhhcccccceeEEEeEecC-CcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.++||+|+||.||+++.+. ++.+|+|.+...   .......+.+|+.++..++|+||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            445689999999999999764 778999998542   2223445888999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.+++....  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        84 ~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          84 VGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999996432  3588899999999999999999997   9999999999999999999999999999866544333


Q ss_pred             cccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          663 VSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+.   ......     ..+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---~~~~~~-----~~p  230 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHKERF-----QFP  230 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh---CCCccc-----cCC
Confidence            333456999999999986     3457899999999999999999999997554322222211   110000     000


Q ss_pred             CccCcHHHHHHHHHHHHHccccCC--CCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNL--HRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp--~~RPt~~evl~~  773 (818)
                        ........++.+++.+|+..++  ..|+++.+++++
T Consensus       231 --~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 --AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0011234567778888775544  447899999888

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-34  Score=321.87  Aligned_cols=253  Identities=20%  Similarity=0.257  Sum_probs=197.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ..+.+.+.||+|+||.||++... +++.+|+|.+...   .......+.+|+.+++.++||||+++++.+.++...++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            44555568999999999999976 5788999998532   2233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++..    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       123 Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         123 EYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             cCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            99999999998843    2478888999999999999999997   9999999999999999999999999999876544


Q ss_pred             CCccccCCCCCCcccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN----SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .........||+.|+|||++...    .++.++|||||||++|||++|+.||...........+.   ......      
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~~~~~------  266 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---NHKNSL------  266 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH---cCCCcc------
Confidence            33333345699999999998754    37899999999999999999999997554322222211   110000      


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCC--CCcHHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHR--RPSASMLVKVL  774 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L  774 (818)
                        ..+........+.+++..||+.++.+  ||++.+++++.
T Consensus       267 --~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         267 --TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             --cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence              01111234566778889999854443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.8e-34  Score=305.39  Aligned_cols=248  Identities=25%  Similarity=0.304  Sum_probs=197.1

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.||+|+||+||++... +++.+|+|.+....   ......+.+|++++++++|+|++++.+++..++..++||||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            357999999999999875 58899999986542   22234578899999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........  .
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  158 (285)
T cd05632          85 GDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--I  158 (285)
T ss_pred             ccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--c
Confidence            99998886433 24689999999999999999999997   999999999999999999999999999976543221  1


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.......     ..      .....
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-----~~------~~~~~  227 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-----EE------VYSAK  227 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-----cc------ccCcc
Confidence            23468999999999998899999999999999999999999997554322222221111100     00      00122


Q ss_pred             HHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      ....+.+++..|++.+|++||+     +.+++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            3456788999999999999999     5666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.8e-34  Score=313.48  Aligned_cols=240  Identities=23%  Similarity=0.314  Sum_probs=193.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +++.+.||+|+||.||++... +++.||||.+...   .....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            345678999999999999865 5889999998643   2233456788999988885 6788889999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999988543   3588999999999999999999997   99999999999999999999999999997543322


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      . ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+...            ..   .
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------~~---~  219 (323)
T cd05615         156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------NV---S  219 (323)
T ss_pred             c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CC---C
Confidence            1 122345899999999999989999999999999999999999999765543333322210            00   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSA  767 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~  767 (818)
                      .+.....++.+++.+||+.+|.+|++.
T Consensus       220 ~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            112234567889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-33  Score=303.16  Aligned_cols=267  Identities=26%  Similarity=0.356  Sum_probs=206.3

Q ss_pred             HHhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +...+.+.+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+++++.++|+||+++++++......++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            3456677789999999999999965 58899999876443 334578999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++...   ..+++..+..++.+++.+|.|||+.  .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999999988442   3588999999999999999999973  37999999999999999999999999998754322


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .   .....++..|+|||.+.+..++.++|||||||++|||++|+.||................ ...+...+.......
T Consensus       158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (284)
T cd06620         158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-LDLLQQIVQEPPPRL  233 (284)
T ss_pred             c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH-HHHHHHHhhccCCCC
Confidence            1   123468899999999988899999999999999999999999997543321000000000 000011111111111


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      . ......++.+++.+|++.+|++||++.|++++..-++
T Consensus       234 ~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         234 P-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             C-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            1 1124467889999999999999999999999865444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-34  Score=324.61  Aligned_cols=248  Identities=22%  Similarity=0.284  Sum_probs=191.4

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.++||+|+||.||+|+.. +++.+|||.+....   ......+.+|++++++++|+||+++++.+.+++..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            4467999999999999975 57899999986432   2334578899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC---
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~---  660 (818)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....   
T Consensus        85 gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          85 GGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            99999988543   3578889999999999999999997   99999999999999999999999999975432100   


Q ss_pred             -------------------------------------------CccccCCCCCCcccccccccCCCCCchhhHHHHHHHH
Q 043017          661 -------------------------------------------SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVI  697 (818)
Q Consensus       661 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll  697 (818)
                                                                 ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       0001123589999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCc---HHHHHHH
Q 043017          698 LEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS---ASMLVKV  773 (818)
Q Consensus       698 ~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~  773 (818)
                      |||++|+.||...........+.   ..       .... ..+.......++.+++.+++ .+|++|++   +.+++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~---~~-------~~~~-~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVI---NW-------QTSL-HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHH---cc-------CCCc-CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            99999999997654322211111   00       0000 00101122345566666665 48999987   8887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-33  Score=300.65  Aligned_cols=251  Identities=27%  Similarity=0.364  Sum_probs=196.1

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeeccc------Ccc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAER------SNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~------~~~  575 (818)
                      ..+++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +|+||+++++++...      ...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            34556678999999999999875 57889999986443 3456788999999998 799999999998653      357


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            89999999999999886432 34688999999999999999999997   999999999999999999999999999986


Q ss_pred             cccCCCccccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      ...... ......|+..|+|||++.     ...++.++|||||||++|||++|+.|+............   ...     
T Consensus       161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---~~~-----  231 (272)
T cd06637         161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN-----  231 (272)
T ss_pred             cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---hcC-----
Confidence            543222 223346889999999986     335788999999999999999999998644321111110   000     


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       .....    ........+.+++.+||+.+|.+||++.+++++
T Consensus       232 -~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 -PAPRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -CCCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence             00000    011234578899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.8e-34  Score=303.54  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=202.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++.+.||+|+||.||++... .++.+|+|.+... .......+.+|++++++++|+||+++++++......++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            566788999999999999986 6899999988643 23335678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|..++........+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++..+....   
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  157 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---  157 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence            999999886543334689999999999999999999963  389999999999999999999999999997653321   


Q ss_pred             ccCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          664 STMPKGTPGYMAPELTRGNS------ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~------~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||...........+....         .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~  228 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV---------DGDPP  228 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh---------hcCCC
Confidence            22245788999999986543      4889999999999999999999997543332222221111         11111


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .  .+.....++.+++.+||+.+|++||++.+++.+
T Consensus       229 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         229 T--LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             C--CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1  122356778899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.8e-34  Score=308.57  Aligned_cols=261  Identities=24%  Similarity=0.314  Sum_probs=197.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+||+++++++..++..++||||++
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   87 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD   87 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence            445568999999999999875 57889999986543 2334567899999999999999999999999999999999997


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      + +|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++......... 
T Consensus        88 ~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  160 (309)
T cd07872          88 K-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-  160 (309)
T ss_pred             C-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence            5 8888775432  3578889999999999999999997   9999999999999999999999999999865433221 


Q ss_pred             ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---ch------hhcc
Q 043017          664 STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---LC------DLVD  733 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---~~------~~~d  733 (818)
                      .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+.   ..      ...+
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            122457889999998865 4689999999999999999999999976554333322221111000   00      0000


Q ss_pred             ccCcCc------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDM------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ......      ........++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            000000      0011234567899999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=316.80  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             hcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhh
Q 043017          511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      +||+|.||+||.|+..+ ...+|||.+.....+..+.+++|+.+-++|+|+|||+++|.+.+++..-+.||.+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999764 56899999987777777889999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCcccc--chhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEeecCCceecccCCCccccC
Q 043017          590 WIFHKDRIQTL--SWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       590 ~l~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      .|..+  =.++  ++.++-.+.+||++||.|||++   .|||||||-+||||+ -.|.+||+|||-++.+..-++. +.+
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TET  735 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TET  735 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-ccc
Confidence            88542  2345  7788889999999999999998   999999999999995 4688999999999987654433 334


Q ss_pred             CCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          667 PKGTPGYMAPELTRGNS--ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      .-||+-|||||++..++  |..++|||||||.+.||.||++||......... .++    .+    +.   -.-.+.+.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFk----VG----my---KvHP~iPee  803 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFK----VG----MY---KVHPPIPEE  803 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhh----hc----ce---ecCCCCcHH
Confidence            56999999999998765  889999999999999999999999765432110 000    00    00   011223567


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.+...+|.+|+.++|.+||+++++|+-
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            78889999999999999999999999863

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-34  Score=303.92  Aligned_cols=239  Identities=21%  Similarity=0.367  Sum_probs=189.4

Q ss_pred             hcccccceeEEEeEecC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLND--------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .||+|+||.||+|....        ..++++|.+........+++.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            68999999999998642        2358888886555455678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC--------EEEeecCCce
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN--------VKIADFGLAR  654 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Dfgla~  654 (818)
                      ++|+|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.        ++++|||++.
T Consensus        82 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          82 KFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999986433  3688999999999999999999997   9999999999999987765        6999999887


Q ss_pred             ecccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGR-RSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      .....     ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+........   ......        
T Consensus       157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~--------  220 (258)
T cd05078         157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFYED--------  220 (258)
T ss_pred             ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHHHc--------
Confidence            54322     123477889999999864 5799999999999999999985 45443222111   111100        


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                        .. .  .+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       221 --~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 --RH-Q--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --cc-c--CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              00 0  01123356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.3e-35  Score=325.12  Aligned_cols=250  Identities=21%  Similarity=0.264  Sum_probs=194.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +++.||||.+....   ......+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            344568999999999999965 58899999986432   23356788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC-
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-  660 (818)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        83 ~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          83 IPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999998543   3578888999999999999999997   99999999999999999999999999975331100 


Q ss_pred             -----------------------------------------CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHH
Q 043017          661 -----------------------------------------SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE  699 (818)
Q Consensus       661 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~e  699 (818)
                                                               ........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000112368999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCC---cHHHHHHH
Q 043017          700 IICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRP---SASMLVKV  773 (818)
Q Consensus       700 lltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~evl~~  773 (818)
                      |++|+.||...........+..   ...  . .  ..   +.......++.+++.+|+ .+|.+|+   ++.+++++
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~---~~~--~-~--~~---~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVIN---WET--T-L--HI---PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhc---cCc--c-c--cC---CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999976543322221110   000  0 0  00   001123345666777765 5999999   89999877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.1e-34  Score=303.26  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=195.6

Q ss_pred             HhhhhcccccceeEEEeEe-cCCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.||+|+||.||+++. .+++.+|+|.+... .....++|.+|++++.+++||||+++++++......++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            4556799999999999986 46889999998644 233356789999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|..+.       .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++.......   .
T Consensus        84 ~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~  150 (279)
T cd06619          84 GSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A  150 (279)
T ss_pred             CChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence            9997543       367888899999999999999997   99999999999999999999999999998654322   2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH-HHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV-DTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ......      ....+...... ...
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~~~  223 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL------QCIVDEDPPVL-PVG  223 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH------HHHhccCCCCC-CCC
Confidence            2346889999999999889999999999999999999999998643221100 000000      00000111111 012


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ....++.+++.+|++.+|++||++.+++++-
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            2345788999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-34  Score=312.37  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=194.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +++.||+|.+...   .....+.|.+|+.++..++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            345568999999999999975 5889999998642   223345688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.....
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999999998542  24588899999999999999999997   999999999999999999999999999987654433


Q ss_pred             ccccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          662 HVSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      .......|++.|+|||++..     ..++.++|||||||++|||++|+.||...........+.   .......+    .
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~---~~~~~~~~----~  230 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHKEHFQF----P  230 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH---cCCCcccC----C
Confidence            33333468999999999863     457889999999999999999999997543322222111   11100000    0


Q ss_pred             cCccCcHHHHHHHHHHHHHcccc--CCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQK--NLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~--dp~~RPt~~evl~~  773 (818)
                      ..   .......+.+++.+|+..  ++..||++.+++++
T Consensus       231 ~~---~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 PD---VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Cc---cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00   112345566777776654  44448899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2e-33  Score=297.94  Aligned_cols=253  Identities=24%  Similarity=0.292  Sum_probs=200.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ..+.+.+.||+|+||.||++... +++.+|+|.+..........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45667789999999999999875 58899999987655555567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            999999988543   3588999999999999999999997   999999999999999999999999999986643322 


Q ss_pred             cccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          663 VSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+............   ...    ......... 
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~~~----~~~~~~~~~-  233 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---TKS----NFQPPKLKD-  233 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---hcc----CCCCCcccc-
Confidence            122346889999999874   456889999999999999999999998544322111110   000    000000000 


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        .......+.+++.+||+.+|++||++++++++
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             --cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence              11234567899999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=309.50  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=210.9

Q ss_pred             hhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCc---cHHHHHHHHHHHhccC-cceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENR---GKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..|.+.++||+|.||.||+++.+. |+.+|+|.+.+....   ..+.+.+|+++|+++. |||||.+.+.+......++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            456667899999999999999875 999999999765433   3468999999999998 99999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC----CCEEEeecCCce
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD----LNVKIADFGLAR  654 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~  654 (818)
                      ||++.+|.|.+.+.+.    .+++..+..++.|++.++.|||+.   +|+||||||+|+|+...    +.+|++|||++.
T Consensus       115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999665    299999999999999999999997   99999999999999543    579999999999


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ....  ........||+.|+|||++....++..+||||+|+++|.|++|..||...........+....        .+.
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~--------~~f  257 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD--------FDF  257 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC--------CCC
Confidence            8876  334455689999999999999999999999999999999999999998776544433222110        111


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+.   .......+.+++..++..||.+|+|+.++|++
T Consensus       258 ~~~~---w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  258 TSEP---WDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCC---ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1111   33456777889999999999999999999997

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-33  Score=301.70  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=201.1

Q ss_pred             hhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ..+.+.++||+|+||.||+|.... ++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            356677889999999999999764 8899999987665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|..++....  ..+++..+..++.|++++|+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999988775432  3588999999999999999999997   9999999999999999999999999998764332211


Q ss_pred             cccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          663 VSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                       .....++..|+|||.+.     ...++.++||||||+++|||++|+.|+............   ...         ...
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~---------~~~  233 (292)
T cd06644         167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKS---------EPP  233 (292)
T ss_pred             -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---hcC---------CCc
Confidence             12245788999999984     345788999999999999999999998654322111111   100         001


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+.....++.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111122344578899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-33  Score=302.11  Aligned_cols=266  Identities=26%  Similarity=0.425  Sum_probs=203.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecc--cCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-----DGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~  576 (818)
                      .+.+.+.||+|+||.||++++.     .++.+|||.+...... ..++|.+|+++++.++|+||+++++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3455678999999999999864     3678999998755443 46789999999999999999999999877  55789


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ++|||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            9999999999999995432  3589999999999999999999997   9999999999999999999999999999877


Q ss_pred             ccCCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHH---hhhhcchhh
Q 043017          657 AQDQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK---AEADRLCDL  731 (818)
Q Consensus       657 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~---~~~~~~~~~  731 (818)
                      ......  ......++..|+|||.+....++.++||||||++++||++|+.|+......... .....   .....+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHHH
Confidence            633221  111223556799999998889999999999999999999999887543221100 00000   000000011


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      +.... ..........++.+++.+||+.+|++||+|.||+++|+.+
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11100 0111223346788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.6e-34  Score=314.82  Aligned_cols=252  Identities=21%  Similarity=0.272  Sum_probs=195.8

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.++||+|+||.||+++.. +++.+|+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            44568999999999999976 5788999998642   2223456888999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.+++....  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        84 ~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          84 VGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999996432  3588899999999999999999997   9999999999999999999999999999876554433


Q ss_pred             cccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          663 VSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ......|++.|+|||++.+     ..++.++||||||+++|||++|+.||...........+.   ....       ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---~~~~-------~~~  228 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHEE-------RFQ  228 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH---cCCC-------ccc
Confidence            3333569999999999875     467889999999999999999999997544322222111   1100       000


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCC--CCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHR--RPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~  773 (818)
                      ..........++.+++.+|++.++++  |+++.+++++
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00011123456778888888865544  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.2e-34  Score=325.46  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=189.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc--------Ccce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--------SNRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--------~~~~  576 (818)
                      +.+.++||+|+||.||+|... +++.||||++....    ....+|+.+++.++|+||+++++++...        ...+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            445568999999999999975 58899999885332    2345799999999999999999876432        1356


Q ss_pred             eeeeccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCce
Q 043017          577 LVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLAR  654 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~  654 (818)
                      +||||+++ +|.+++... .....+++..+..++.||++||+|||+.   +|+||||||+|||++.++ .+||+|||+++
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            89999974 677766432 2345688999999999999999999997   999999999999998665 69999999998


Q ss_pred             ecccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh--
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL--  731 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~--  731 (818)
                      .+......  ....+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+......+....+  
T Consensus       220 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        220 NLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             hccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            76543322  224579999999988654 6899999999999999999999999765443222222111110000000  


Q ss_pred             ccc-----cCcCcc-------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDK-----KSEDMQ-------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~-----~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+     ..+...       .+...+.++.+++.+||+.+|.+|||+.|++++
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000     000000       011234578899999999999999999999965

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-33  Score=296.11  Aligned_cols=249  Identities=31%  Similarity=0.504  Sum_probs=202.5

Q ss_pred             hhhhcccccceeEEEeEecC-----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          508 FQIRLGRGGSGSVFEGLLND-----GTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.||.|+||.||+++..+     +..||+|.+...... ..+.+.+|++.+..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            44679999999999999864     478999999765443 567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       83 MEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             cCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999854322 2289999999999999999999997   999999999999999999999999999987765433


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .......++..|+|||.+.+..++.++||||+|++++||++ |+.|+...........+..   ..        ..   .
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~--------~~---~  224 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK---GY--------RL---P  224 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CC--------CC---C
Confidence            22222346789999999988889999999999999999998 7788765443333322211   10        00   1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .......++.+++.+|++.+|++|||+.++++.|
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1122456788999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-34  Score=314.88  Aligned_cols=236  Identities=25%  Similarity=0.359  Sum_probs=188.6

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHH-HHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVE-TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+++.. +|+.+|+|++...   ......++..|.. +++.++||||+++++++...+..++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5899999999999865 5889999998643   2223345566655 567789999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (325)
T cd05604          82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT  154 (325)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence            999888543   4588999999999999999999997   999999999999999999999999999875432221 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.......+...+.   ..         ....   ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~---~~---------~~~~---~~~~  219 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL---HK---------PLVL---RPGA  219 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH---cC---------CccC---CCCC
Confidence            3468999999999999999999999999999999999999997654333222211   10         0000   1123


Q ss_pred             HHHHHHHHHHccccCCCCCCcHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      ...+.+++.+|++.+|.+||++.
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCC
Confidence            45677899999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.3e-34  Score=308.59  Aligned_cols=195  Identities=27%  Similarity=0.386  Sum_probs=159.6

Q ss_pred             hhcccccceeEEEeEec---CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc--cCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLN---DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~  584 (818)
                      .+||+|+||+||+|+..   +++.+|+|.+....  ....+.+|++++++++||||+++++++..  +...+++|||+. 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            57999999999999865   46789999986432  24567889999999999999999998854  346789999985 


Q ss_pred             CChhhHhhhcC------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE----cCCCCEEEeecCCce
Q 043017          585 GSLDKWIFHKD------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----DRDLNVKIADFGLAR  654 (818)
Q Consensus       585 gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla~  654 (818)
                      ++|.+++....      ....+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            57877764321      123588899999999999999999997   99999999999999    456789999999998


Q ss_pred             ecccCCCc--cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 043017          655 LIAQDQSH--VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPK  710 (818)
Q Consensus       655 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~  710 (818)
                      ........  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            76543221  12234689999999998764 5899999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.5e-34  Score=306.54  Aligned_cols=253  Identities=25%  Similarity=0.426  Sum_probs=198.9

Q ss_pred             hhhhcccccceeEEEeEec-CCc----EEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ..+.||+|+||.||+|... +++    .+|+|.+..... ....++.+|+.+++.++|+||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            3457999999999999864 343    579998865433 2245788999999999999999999998754 46799999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        90 ~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          90 MPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             cCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence            99999999985432  3578899999999999999999997   999999999999999999999999999987654332


Q ss_pred             cc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          662 HV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       662 ~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........+.+.   ...        ...  
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~--------~~~--  231 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---KGE--------RLP--  231 (303)
T ss_pred             ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CCC--------CCC--
Confidence            21 122345678999999998899999999999999999997 889886543322222211   000        010  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                       ........+.+++..|+..+|++||++.++++.|+.+.+.
T Consensus       232 -~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         232 -QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             0112345788999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-33  Score=309.33  Aligned_cols=261  Identities=21%  Similarity=0.257  Sum_probs=195.0

Q ss_pred             hhhhcccc--cceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          508 FQIRLGRG--GSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       508 f~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +..+||+|  +|++||++... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  78999999875 68999999986542  223456778999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 23588999999999999999999997   9999999999999999999999999876543221110


Q ss_pred             ------cccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh----
Q 043017          663 ------VSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD----  730 (818)
Q Consensus       663 ------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~----  730 (818)
                            ......++..|+|||++.+  ..++.++|||||||++|||++|+.||............... ..+...+    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccccccch
Confidence                  0111246778999999976  45899999999999999999999999754332211111100 0000000    


Q ss_pred             ----h--------ccc----------c------CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 ----L--------VDK----------K------SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ----~--------~d~----------~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          .        .+.          .      ....+........+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                0        000          0      00000112345678899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-33  Score=303.23  Aligned_cols=260  Identities=25%  Similarity=0.289  Sum_probs=192.9

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhcc---CcceeEEEeeeeccc-----Ccc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI---HHFNLVRLVGYCAER-----SNR  575 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~-----~~~  575 (818)
                      .+.++||+|+||.||++... +++.||+|.+....  ......+.+|++++..+   +||||+++++++...     ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            34567999999999999876 58899999886542  22234566777777665   799999999988642     357


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +++|||++ ++|.+++.... ...++++.+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            89999997 58888885432 24589999999999999999999997   999999999999999999999999999987


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh---h-
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD---L-  731 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~---~-  731 (818)
                      ......  .....++..|+|||.+.+..++.++|||||||++|||++|+.||...........+...........   . 
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            643221  2234578999999999988999999999999999999999999876544332222221111000000   0 


Q ss_pred             ------ccccCcC--ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 ------VDKKSED--MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ------~d~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            .......  .........++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  0000000  00011234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-34  Score=314.29  Aligned_cols=239  Identities=23%  Similarity=0.327  Sum_probs=189.0

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHH-HHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVE-TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||+++.. +++.+|+|++....   ......+..|.. +++.++|+||+++++++...+..++||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5899999999999976 46789999986432   222334455544 567889999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++...   ..+.+..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~  154 (325)
T cd05602          82 ELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS  154 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence            999988543   3577888889999999999999997   999999999999999999999999999975433222 223


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..   .         ...   .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~---------~~~---~~~~~  219 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---K---------PLQ---LKPNI  219 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh---C---------CcC---CCCCC
Confidence            34689999999999999999999999999999999999999975543333222211   0         000   01123


Q ss_pred             HHHHHHHHHHccccCCCCCCcHHHHH
Q 043017          746 AVKMIQIAISCLQKNLHRRPSASMLV  771 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~evl  771 (818)
                      ...+.+++.+||+.+|.+||++.+.+
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         220 TNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            45678999999999999999877433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=300.40  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=202.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.++||+|+||.||++... ++..+|+|.+........+.|..|++++++++|+||+++++.+..+...++||||++
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            4667788999999999999975 588999999876655556789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++....  ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++........ .
T Consensus        86 ~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (280)
T cd06611          86 GGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K  159 (280)
T ss_pred             CCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence            999999885432  4689999999999999999999997   999999999999999999999999999876543222 1


Q ss_pred             ccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          664 STMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .....++..|+|||.+.     ...++.++||||||+++|||++|+.||...........+.   ..         ....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~---------~~~~  227 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL---KS---------EPPT  227 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh---cC---------CCCC
Confidence            22345888999999874     3457789999999999999999999987554322221111   00         0001


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.....++.+++..||+.+|.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11122334578899999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-33  Score=298.18  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=197.4

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCcc---------HHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRG---------KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~---------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      +...||+|+||.||+|... +++.+|+|.+.......         .+.+.+|+.++++++|+||+++++++.+....++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            4567999999999999865 57899999886543221         2568889999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          84 FLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            99999999999998543   4588899999999999999999997   99999999999999999999999999998775


Q ss_pred             cCCCc-----cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          658 QDQSH-----VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       658 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      .....     ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......   .+.....      ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~------~~  228 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFKIGE------NA  228 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHHHhc------cC
Confidence            32111     1112347889999999998889999999999999999999999997543211   1111110      00


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+     ..+......+.+++.+||+.+|.+||++.+++++
T Consensus       229 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         229 SP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            00     1122345678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-33  Score=332.81  Aligned_cols=260  Identities=24%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.++||+|+||.||+|... +++.||||++.....   ...++|.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            344568999999999999975 589999999865422   2346799999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcC--------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          582 MCNGSLDKWIFHKD--------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       582 ~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      +++++|.+++....        ....+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence            99999999885421        123456677889999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCC-----------------ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH
Q 043017          654 RLIAQDQS-----------------HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV  716 (818)
Q Consensus       654 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~  716 (818)
                      +.......                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            87622110                 0011235899999999999999999999999999999999999999754332221


Q ss_pred             HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCC-cHHHHHHHHhcCcCC
Q 043017          717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRP-SASMLVKVLQGLTKL  780 (818)
Q Consensus       717 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~  780 (818)
                      ...       ..   ..  ..........+..+.+++.+|++.||++|| ++.++++.|+...+.
T Consensus       241 ~~~-------~i---~~--P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        241 YRD-------VI---LS--PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh-------hc---cC--hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            110       00   00  000011123446688999999999999995 778888888776543

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-33  Score=297.40  Aligned_cols=248  Identities=22%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+..+...+++|||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            34568999999999999975 5889999988543 233456788999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++... ....++++.+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++......... .
T Consensus        83 ~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~  157 (255)
T cd08219          83 GDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-A  157 (255)
T ss_pred             CcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc-c
Confidence            9999988532 234578999999999999999999997   9999999999999999999999999999876443221 2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.   . ...    .      +.+..
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~---~-~~~----~------~~~~~  223 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC---Q-GSY----K------PLPSH  223 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh---c-CCC----C------CCCcc
Confidence            23458889999999998889999999999999999999999997543322221111   0 000    0      00122


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+.+++.+||+.+|++||++.+++..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            34568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-33  Score=306.52  Aligned_cols=259  Identities=25%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++..++..++||||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            34568999999999999975 57888999876442 22345688999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...   ..+++..+..++.|+++||.|||+.  .+++|+||||+|||++.++.+||+|||++.......   .
T Consensus        84 ~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~  155 (308)
T cd06615          84 GSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A  155 (308)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---c
Confidence            9999998543   4588999999999999999999973  389999999999999999999999999987653321   1


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc-----------------
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR-----------------  727 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~-----------------  727 (818)
                      ....++..|+|||.+.+..++.++||||||++++||++|+.|+...........+........                 
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            234578999999999888899999999999999999999999864432222211110000000                 


Q ss_pred             -------chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          728 -------LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       728 -------~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                             .........+..+ ......++.+++.+||+.+|++||++.+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                   0000000000000 112345688999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-33  Score=312.35  Aligned_cols=258  Identities=23%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC------cce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~  576 (818)
                      +.+.+.||+|+||.||++... +++.||||++...  .......+.+|+.+++.++||||+++++++....      ..+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            444568999999999999875 5889999998643  2334567889999999999999999999986543      468


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++ +|.+.+.     ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         103 LVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             EEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            99999965 5655552     2478888999999999999999997   9999999999999999999999999999764


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh----------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD----------  726 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~----------  726 (818)
                      ....  ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+......+          
T Consensus       174 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         174 CTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            3322  1223468899999999999999999999999999999999999997554322111111000000          


Q ss_pred             cchhhccccC--c---------------CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          727 RLCDLVDKKS--E---------------DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       727 ~~~~~~d~~~--~---------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .....+....  .               ..........++.+++.+||+.||++|||+.|++++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            0000000000  0               0000112245678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-33  Score=301.54  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=196.7

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.||+|+||.||+|... +++.||||.+....  ....+.+.+|+.++.+++|+||+++++++.++...++||||++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            4467999999999999975 58899999986432  2334678899999999999999999999999999999999997 


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++........+++..+..++.||++||+|||+.   +++|+||||+||+++.++.+||+|||++........ ..
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  158 (285)
T cd07861          83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VY  158 (285)
T ss_pred             CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cc
Confidence            68888886544446789999999999999999999997   999999999999999999999999999986543321 12


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHH-HHHhhh-----------hcchhh
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL-KVKAEA-----------DRLCDL  731 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~-~~~~~~-----------~~~~~~  731 (818)
                      ....+++.|+|||.+.+. .++.++||||||++++||++|+.||............ ......           ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            223568899999988654 4789999999999999999999998754322111110 000000           000000


Q ss_pred             ccccCcC--ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDKKSED--MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +......  .........++.+++.+||+.||.+|||+.+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000  00011234577899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.6e-34  Score=311.14  Aligned_cols=245  Identities=25%  Similarity=0.300  Sum_probs=193.3

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||++... +++.+|+|++....   ....+.+.+|+.++.++ +|+||+++++++......++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5899999999999975 47889999987542   23345688899999888 6999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (327)
T cd05617          82 DLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS  154 (327)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence            999888543   3589999999999999999999997   999999999999999999999999999975332221 122


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch---HHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY---LVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~---l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.......   ..+.+......        ... .  .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~-~--~p  223 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KPI-R--IP  223 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CCC-C--CC
Confidence            3468999999999999999999999999999999999999996432211   11111111100        011 0  11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcH------HHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSA------SMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~  773 (818)
                      .....++.+++.+||+.||++|+++      .+++++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            2234567899999999999999984      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.7e-33  Score=297.39  Aligned_cols=252  Identities=19%  Similarity=0.344  Sum_probs=188.8

Q ss_pred             hcccccceeEEEeEecCC---cEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLNDG---TKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +||+|+||.||++...++   ..+++|.+.... ....+.|.+|+..++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999986543   356677765443 2345789999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC-Cccc
Q 043017          587 LDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-SHVS  664 (818)
Q Consensus       587 L~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~  664 (818)
                      |.+++.... ....+.+..+..++.||++||+|||+.   +++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999996532 223466777889999999999999997   99999999999999999999999999986432211 1112


Q ss_pred             cCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          665 TMPKGTPGYMAPELTRG-------NSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..|+...........+..   . ......++..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~  234 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK---D-QQVKLFKPQL  234 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---h-cccccCCCcc
Confidence            23457889999998853       245789999999999999997 4667754433222222111   1 1111111111


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .     .....++.+++..|+ .+|++||++++|++.|.
T Consensus       235 ~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 E-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1     123456778888999 57999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.8e-33  Score=296.89  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+...++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3445578999999999999975 58899999886443 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++..    ..+++.....++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            99999998843    3578889999999999999999987   999999999999999999999999999987654322 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...........+.             ... .....
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------------~~~-~~~~~  222 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-------------KNN-PPTLT  222 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-------------cCC-CCCCc
Confidence            1222357889999999998889999999999999999999999987554322211110             000 01113


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ......+.+++.+||+.+|++||++.+++++-
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            34567888999999999999999999998873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.4e-33  Score=296.46  Aligned_cols=253  Identities=22%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             HHhhhhcccccceeEEEeEecC--CcEEEEEEcCCCC----------CccHHHHHHHHHHHhc-cCcceeEEEeeeeccc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND--GTKVAVKRLYPGE----------NRGKKEFLSEVETIGN-IHHFNLVRLVGYCAER  572 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~----------~~~~~~f~~Ev~~l~~-l~H~niv~l~g~~~~~  572 (818)
                      +.+.+.||+|+||.||++....  ++.+|+|.+....          .....++..|+.++.+ ++|+||+++++++.++
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            3456789999999999999865  6889999875321          1223457778888865 7999999999999999


Q ss_pred             CcceeeeeccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          573 SNRFLVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      +..+++|||+++++|.+++... .....+++..+.+++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence            9999999999999999988542 2335688999999999999999999963  379999999999999999999999999


Q ss_pred             CceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          652 LARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       652 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      ++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+.    ....   
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~----~~~~---  230 (269)
T cd08528         160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV----EAVY---  230 (269)
T ss_pred             ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh----hccC---
Confidence            998765443  2233458889999999998889999999999999999999999986443222111111    0000   


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                       . ...    .......+.+++.+||+.||++||++.|+.++|+
T Consensus       231 -~-~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 -E-PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -C-cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             0 000    1123467889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-33  Score=304.09  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=200.9

Q ss_pred             hhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          508 FQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..+...++|+||+++++
T Consensus        23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  102 (296)
T cd06655          23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS  102 (296)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence            445799999999999986 4689999999876655567788999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |.+++..    ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......... ...
T Consensus       103 L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~  174 (296)
T cd06655         103 LTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RST  174 (296)
T ss_pred             HHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCC
Confidence            9998843    3588999999999999999999997   9999999999999999999999999998866543322 122


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+   ....         ......+....
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~  242 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNG---------TPELQNPEKLS  242 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcC---------CcccCCcccCC
Confidence            45788999999999888999999999999999999999999755432111111   1000         00011122334


Q ss_pred             HHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+.+++.+||+.+|++||++.+++++
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            567889999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=291.58  Aligned_cols=251  Identities=27%  Similarity=0.383  Sum_probs=213.1

Q ss_pred             hhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ...++..+||+|.||.|||+.+++ |+.+|||.+...  .+.+++.+|+.++++.+.|++|+++|.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            345666789999999999999874 899999998543  45789999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ..|+..+++...  +++|+++++..+++..++||+|||..   +-||||||+.||||+.+|.+||+|||.+..+......
T Consensus       111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            999999998543  46899999999999999999999998   8899999999999999999999999999876543322


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       ..++.||+.|||||++..-.|..++||||+|+...||..|++|+..-.+...            +.-+-..+++....+
T Consensus       186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------------IFMIPT~PPPTF~KP  252 (502)
T KOG0574|consen  186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------------IFMIPTKPPPTFKKP  252 (502)
T ss_pred             -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------------eEeccCCCCCCCCCh
Confidence             2346799999999999999999999999999999999999999875433211            111112233444456


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ...+.++-+++..||-..|++|-|+-+++++-
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            77889999999999999999999999999874

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-33  Score=303.49  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=202.2

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||++
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA   99 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence            344556899999999999996 4689999999976655566778999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......... 
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656         100 GGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            9999998843    3478889999999999999999997   9999999999999999999999999999876443322 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.............   .         ........+.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---~---------~~~~~~~~~~  239 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---T---------NGTPELQNPE  239 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---c---------CCCCCCCCcc
Confidence            122357889999999999889999999999999999999999996543211110000   0         0000111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.+|++||++.+++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            344567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-33  Score=294.97  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=203.2

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||.++.. +++.+++|.+...  .....+++.+|++++++++|+||+++++++.+....+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            44568999999999998864 5889999987543  33446778999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++........ .
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~  157 (256)
T cd08221          83 GGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M  157 (256)
T ss_pred             CCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence            999999986442 34688999999999999999999997   999999999999999999999999999987655432 2


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....+++.|+|||.+.+...+.++||||||++++||++|+.||...........+.   . ..        ..  +...
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---~-~~--------~~--~~~~  223 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV---Q-GN--------YT--PVVS  223 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---c-CC--------CC--CCcc
Confidence            233468899999999988889999999999999999999999987544322222211   0 00        00  0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ....++.+++.+||+.+|.+||++.++++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            3456788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=291.74  Aligned_cols=259  Identities=27%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCC--CCCccHHHHHHHHHHHhccCcceeEEEeeeecc-----cCcceeeee
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYP--GENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE-----RSNRFLVYE  580 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e  580 (818)
                      .+.||+|+||.|..+... +|+.||||++..  ......++..+|+.+|+.++|+||+.+++.+..     -...++|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            356999999999999965 689999999873  344556778899999999999999999999876     236799999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC-
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD-  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~-  659 (818)
                      +| ..+|...+...   +.|+.+.+..+++||++||.|+|+.   +|+||||||+|+|++.+-..||+|||||+..... 
T Consensus       107 lM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  107 LM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             HH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99 77888888432   4599999999999999999999998   9999999999999999999999999999987653 


Q ss_pred             CCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh-----------c
Q 043017          660 QSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-----------R  727 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~-----------~  727 (818)
                      .....+..+.|..|.|||++.. ..|+...||||.|||+.||++|+..|.+.+.-.-+..+......+           .
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            1222345678999999998754 579999999999999999999999997664322111111111000           0


Q ss_pred             chhhccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          728 LCDLVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       728 ~~~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ....+........     .........++++.+||..||.+|+|++|+|++-
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            1111111110000     1123446778899999999999999999999863

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-33  Score=298.02  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=197.9

Q ss_pred             hhhhcccccceeEEEeEec----CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC------cc
Q 043017          508 FQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NR  575 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~  575 (818)
                      +.+.||+|+||.||+|.+.    .++.+|||++....  ....+++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4567999999999999864    36889999986542  334567899999999999999999999886542      23


Q ss_pred             eeeeeccCCCChhhHhhhcC---CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCC
Q 043017          576 FLVYEYMCNGSLDKWIFHKD---RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      ++++||+++|+|.+++....   ....+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence            68899999999998875321   223478889999999999999999987   999999999999999999999999999


Q ss_pred             ceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          653 ARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       653 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      ++........ ......++..|++||.+....++.++||||||+++|||++ |+.|+.......+...+.   ....   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~---  233 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---KGNR---  233 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---cCCc---
Confidence            9876443221 1122345678999999998889999999999999999999 888876543322222211   1100   


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                           .   .........+.+++.+|++.+|++||++.++++.|+++
T Consensus       234 -----~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 -----L---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0   01123346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=298.35  Aligned_cols=247  Identities=26%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+...||.|+||.||+|+.. +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            456678999999999999976 58899999986543 3445678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...    .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++....... .
T Consensus        83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  154 (274)
T cd06609          83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K  154 (274)
T ss_pred             CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence            99999988432    689999999999999999999997   999999999999999999999999999987764422 1


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...........+...         ..+....    .
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---------~~~~~~~----~  221 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---------NPPSLEG----N  221 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------CCCCCcc----c
Confidence            22345788999999999888999999999999999999999998654432221111100         0001110    1


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.+|++||++++++++
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            144578899999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-34  Score=281.49  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=199.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC----cc----HHHHHHHHHHHhcc-CcceeEEEeeeecccCcce
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN----RG----KKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~----~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  576 (818)
                      +-.++||.|..++|-+...+ +|++.|+|++.....    +.    .++-..|+.+|+++ .||+|+.+.++++.....+
T Consensus        20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F   99 (411)
T KOG0599|consen   20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF   99 (411)
T ss_pred             ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence            33467999999999988865 588999998864421    11    23445689999998 7999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +|+|.|+.|.|.++|..   .-.+++.+..+|++|+.+|++|||..   +|+||||||+|||+|++.++||+|||+++.+
T Consensus       100 lVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen  100 LVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeecc
Confidence            99999999999999943   35799999999999999999999997   9999999999999999999999999999988


Q ss_pred             ccCCCccccCCCCCCcccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      .+.+..  ....||++|+|||.++-      ..|+...|+|+.|||+|.|+.|.+||.......++..+.   +. +   
T Consensus       174 ~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im---eG-k---  244 (411)
T KOG0599|consen  174 EPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM---EG-K---  244 (411)
T ss_pred             CCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH---hc-c---
Confidence            765443  33579999999999853      348889999999999999999999986432222222111   11 0   


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                       .....++   ..+.+....+|+.+||+.||.+|.|++|+|++=
T Consensus       245 -yqF~spe---Wadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  245 -YQFRSPE---WADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             -cccCCcc---hhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence             1111222   235566788999999999999999999999763

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-33  Score=317.08  Aligned_cols=258  Identities=22%  Similarity=0.222  Sum_probs=197.0

Q ss_pred             hhHHhhhhcccccceeEEEeEec---CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN---DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..+.+.+.||+|+||.||++...   .++.||+|.+...     ..+.+|++++++++|+||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            34566678999999999999754   3578999987543     245689999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      ++. ++|.+++..   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       167 ~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        167 KYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            985 688888832   34689999999999999999999997   99999999999999999999999999998665432


Q ss_pred             Cc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh---hc---------
Q 043017          661 SH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DR---------  727 (818)
Q Consensus       661 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~---~~---------  727 (818)
                      .. ......||+.|+|||++....++.++|||||||++|||++|+.||...........+......   ..         
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            22 222346899999999999999999999999999999999999999765432211111111100   00         


Q ss_pred             -----chhhccccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 -----LCDLVDKKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 -----~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           +.............     ......++.+++.+||+.||++||++.|++.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 00000000000000     01124567889999999999999999999987

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.8e-33  Score=303.43  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=199.5

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ..+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            347999999999999875 6889999998665555567889999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++..    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......... ....
T Consensus       106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~  177 (297)
T cd06659         106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL  177 (297)
T ss_pred             HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence            987733    3588999999999999999999997   9999999999999999999999999998765433221 2234


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .++..|+|||.+.+..++.++||||||++++||++|+.||...........+.   ...      ....   ........
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~------~~~~---~~~~~~~~  245 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DSP------PPKL---KNAHKISP  245 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---ccC------CCCc---cccCCCCH
Confidence            58899999999998889999999999999999999999987543322221111   100      0000   11112345


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.+++.+||+.+|++||++++++++
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            67899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-33  Score=296.72  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=197.3

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCC------ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ..+.||+|+||.||+|...+++.+|||.+.....      .....+.+|++++++++|+||+++++++.+....+++|||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            3457999999999999988899999998864321      1235688899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC-
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-  660 (818)
                      +++++|.+++...   ..+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          84 VPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            9999999998543   3578899999999999999999997   99999999999999999999999999998653211 


Q ss_pred             ----CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          661 ----SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 ----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                          ........++..|+|||.+.+..++.++||||||++++||++|+.||...........   .....   ..    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~~~---~~----~  227 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY---IGAHR---GL----M  227 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH---hhhcc---CC----C
Confidence                1111224588899999999988899999999999999999999999965432211111   11000   00    0


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      +.  .......++.+++.+||+.+|++||++.++++
T Consensus       228 ~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 PR--LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC--CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00  12234567889999999999999999999886

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.1e-33  Score=294.20  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=197.5

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||++.. +++.+|+|.+....  ..+.+.+|+.++.+++|+|++++++++... ..++||||+++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            355667899999999999975 57889999885432  346789999999999999999999998764 47899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.......    
T Consensus        83 ~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          83 GNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            99999986543 24578999999999999999999997   99999999999999999999999999997643221    


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   .. .       ..   ....
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~-~-------~~---~~~~  220 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE---KG-Y-------RM---EPPE  220 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---CC-C-------CC---CCCC
Confidence            11234568999999998899999999999999999998 888886554332222211   00 0       00   0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                      ..+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            344678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=296.14  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||+++
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~   84 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG   84 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence            345567999999999999975 5788999998766555678899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........ ..
T Consensus        85 ~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  158 (262)
T cd06613          85 GSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR  158 (262)
T ss_pred             CcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence            9999988543  24688999999999999999999997   999999999999999999999999999986644321 11


Q ss_pred             cCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 TMPKGTPGYMAPELTRGN---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ....++..|+|||.+...   .++.++||||||+++|||++|+.|+..............   .    .. .  ......
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~---~----~~-~--~~~~~~  228 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK---S----NF-P--PPKLKD  228 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---c----cC-C--Cccccc
Confidence            224578899999999776   789999999999999999999999875443221111110   0    00 0  001111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ......++.+++.+||+.+|.+||++++++.+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            23455678999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-33  Score=296.63  Aligned_cols=245  Identities=31%  Similarity=0.430  Sum_probs=198.3

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-----CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-----NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ..+.||+|+||.||+|... +++.|++|.+....     .+..+.+.+|+++++.++|+||+++++++..+...+++|||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4467999999999999986 68999999875433     22456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          84 VPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            9999999998543   3588999999999999999999997   99999999999999999999999999998764433 


Q ss_pred             ccccCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.........   .........        .  .
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~--------~--~  222 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV---FKIGRSKEL--------P--P  222 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH---HHHHhcccC--------C--C
Confidence             122345788999999987766 899999999999999999999998754421111   111110000        0  0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.....++.+++.+||+.+|.+||++.+++++
T Consensus       223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            112234677889999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-33  Score=310.10  Aligned_cols=191  Identities=26%  Similarity=0.316  Sum_probs=161.5

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ...+.+.+.||+|+||.||+|+.. +++.||+|.....      ....|+.++++++|+||+++++++..+...++|||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            334566678999999999999976 4678999975322      235699999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      + .++|.+++...  ...+++..+..|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       139 ~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        139 Y-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             c-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence            8 56888888543  34689999999999999999999997   999999999999999999999999999975432221


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSS  707 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~  707 (818)
                        .....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              12345899999999999999999999999999999999965554

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-33  Score=300.35  Aligned_cols=261  Identities=25%  Similarity=0.353  Sum_probs=201.9

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++|+||+++++++..+...++||||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            45567999999999999975 68999999986543  333568999999999999999999999999999999999999 


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++....  ..+++..+..++.||++||+|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        82 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          82 PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            999999885433  5689999999999999999999997   99999999999999999999999999998776544322


Q ss_pred             ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh------cchhhcccc-
Q 043017          664 STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD------RLCDLVDKK-  735 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~------~~~~~~d~~-  735 (818)
                      .....++..|+|||.+.+. .++.++||||+|++++||++|+.++...........+......+      ...++.+.. 
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            3345688999999998654 46899999999999999999988776544332222221111000      000000000 


Q ss_pred             --CcCc------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 --SEDM------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 --~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ....      ....+....+.+++.+||+.+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0000      0011234788899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-33  Score=293.20  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC-cceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-NRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~  581 (818)
                      +.+.+.||+|++|.||+++.. +++.+|+|++....  ....+.+.+|++++++++|+|++++++.+...+ ..+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            345678999999999999975 47889999986432  234567889999999999999999999876444 57899999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++... ....+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999988653 234689999999999999999999997   999999999999999999999999999987644322


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ......+++.|+|||.+.+..++.++||||||++++||++|+.||...........+   . ...        ...  .
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~---~-~~~--------~~~--~  222 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI---I-EGK--------LPP--M  222 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H-hcC--------CCC--C
Confidence             222345788999999999999999999999999999999999998754322211111   1 110        101  1


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......+.+++.+|++.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            22345678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.6e-33  Score=303.83  Aligned_cols=195  Identities=27%  Similarity=0.389  Sum_probs=158.8

Q ss_pred             hhcccccceeEEEeEec---CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc--cCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLN---DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~  584 (818)
                      .+||+|+||.||+|+..   ++..+|+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            46999999999999975   35789999886432  23567899999999999999999998854  456789999986 


Q ss_pred             CChhhHhhhc------CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE----cCCCCEEEeecCCce
Q 043017          585 GSLDKWIFHK------DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----DRDLNVKIADFGLAR  654 (818)
Q Consensus       585 gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla~  654 (818)
                      ++|.+++...      .....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            4777766421      1223578889999999999999999997   99999999999999    566789999999998


Q ss_pred             ecccCCCc--cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 043017          655 LIAQDQSH--VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPK  710 (818)
Q Consensus       655 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~  710 (818)
                      ........  ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76543221  12234578999999998764 5899999999999999999999998644

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-33  Score=302.44  Aligned_cols=244  Identities=24%  Similarity=0.406  Sum_probs=198.9

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      ..||+|+||.||++... +++.||||.+........+.+.+|+..+..++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            56999999999999875 58899999986655555677899999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCC
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK  668 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  668 (818)
                      +++.+    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++......... .....
T Consensus       108 ~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~  179 (292)
T cd06658         108 DIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV  179 (292)
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence            98843    3478999999999999999999997   9999999999999999999999999999765433221 12245


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHH
Q 043017          669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK  748 (818)
Q Consensus       669 gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  748 (818)
                      ++..|+|||.+.+..++.++||||||++++||++|+.||...........+.         .........   .......
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~---~~~~~~~  247 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR---------DNLPPRVKD---SHKVSSV  247 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------hcCCCcccc---ccccCHH
Confidence            7889999999988889999999999999999999999987543322211111         011111111   1233456


Q ss_pred             HHHHHHHccccCCCCCCcHHHHHHH
Q 043017          749 MIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       749 l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.+++.+|++.+|.+|||+++++++
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhC
Confidence            7889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-33  Score=316.06  Aligned_cols=256  Identities=22%  Similarity=0.287  Sum_probs=192.2

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+...||+|+||.||++.... ++.||||...      ...+.+|++++++++|+|||++++++..++..++|||++ .
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~  243 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R  243 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence            4455689999999999999864 7889999642      234678999999999999999999999999999999998 5


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-c
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-V  663 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  663 (818)
                      ++|.+++...  ...+++..+..|+.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .
T Consensus       244 ~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        244 SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            7888887543  23689999999999999999999997   9999999999999999999999999999876443221 1


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-C-------chHHHHHHHHhhh-hcch-----
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG-G-------DYLVDTLKVKAEA-DRLC-----  729 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~-~-------~~l~~~~~~~~~~-~~~~-----  729 (818)
                      .....||..|+|||++.+..++.++|||||||+||||++|..++-... .       ..+...+...... ..+.     
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            223468999999999999999999999999999999999876543211 1       1112222111000 0000     


Q ss_pred             ---hhccc------cC----cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 ---DLVDK------KS----EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 ---~~~d~------~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         .....      ..    ..+........++.+|+.+||+.||++|||+.|+|++
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               00000      00    0000001123467889999999999999999999986

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-33  Score=288.15  Aligned_cols=254  Identities=23%  Similarity=0.285  Sum_probs=206.0

Q ss_pred             HhhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ....++.+.||+|.-|+||++.+.+ +..+|+|++.+...   ....+.+.|-++|+.++||.+..|++.++.....+||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3445566789999999999999885 58899999976543   3345677899999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      ||||+||+|...++ ++..+.++++.++.++.+++-||+|||-.   |||+|||||+||||.++|++.|+||.|+.....
T Consensus       156 meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999988664 44567899999999999999999999998   999999999999999999999999998753311


Q ss_pred             C----------------------------------CC---------------------ccccCCCCCCcccccccccCCC
Q 043017          659 D----------------------------------QS---------------------HVSTMPKGTPGYMAPELTRGNS  683 (818)
Q Consensus       659 ~----------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~  683 (818)
                      .                                  ..                     ......+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                  00                     0011135889999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCC
Q 043017          684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHR  763 (818)
Q Consensus       684 ~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  763 (818)
                      .+.++|.|+|||++|||+.|+.||.+...+..+..+            +.+.+. .+.....+..+.+||+..|..||++
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI------------v~~~l~-Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI------------VGQPLK-FPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH------------hcCCCc-CCCCCcchhHHHHHHHHHhccChhh
Confidence            999999999999999999999999988765433322            111111 1112255677889999999999999


Q ss_pred             CCc----HHHHHHH
Q 043017          764 RPS----ASMLVKV  773 (818)
Q Consensus       764 RPt----~~evl~~  773 (818)
                      |..    +.||-++
T Consensus       379 Rlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRH  392 (459)
T ss_pred             hhccccchHHhhcC
Confidence            998    7777664

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.9e-33  Score=298.56  Aligned_cols=261  Identities=25%  Similarity=0.364  Sum_probs=198.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +++...||+|+||.||+++.. +++.||+|++....  ....+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            345567999999999999986 58899999886432  223466889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++.|..++...   ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          83 DHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             CccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            999888776432   3589999999999999999999997   9999999999999999999999999999876543321


Q ss_pred             cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHh-hh-hcchhhc-------
Q 043017          663 VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA-EA-DRLCDLV-------  732 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~-~~-~~~~~~~-------  732 (818)
                       .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... .. .......       
T Consensus       157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence             122347788999999876 457899999999999999999999997654322222211110 00 0000000       


Q ss_pred             ---cccCcCccC----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 ---DKKSEDMQS----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 ---d~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         .+.......    .......+.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence               000000000    01234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.3e-34  Score=316.22  Aligned_cols=248  Identities=21%  Similarity=0.281  Sum_probs=193.6

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.||+|+||.||++... +++.||||.+...   .......+.+|+.++.+++|+||+++++.+.++...++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            3467999999999999976 5889999998643   22335678889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC--
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS--  661 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~--  661 (818)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........  
T Consensus        85 gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          85 GGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999998543   4588999999999999999999997   999999999999999999999999999875432110  


Q ss_pred             --------------------------------ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 043017          662 --------------------------------HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP  709 (818)
Q Consensus       662 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~  709 (818)
                                                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001124689999999999999999999999999999999999999976


Q ss_pred             CCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCc---HHHHHHH
Q 043017          710 KGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS---ASMLVKV  773 (818)
Q Consensus       710 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~  773 (818)
                      .........+..   ..   ..+.  .+.   ......++.+++.+++. +|.+|++   +.+++++
T Consensus       239 ~~~~~~~~~i~~---~~---~~~~--~p~---~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYRKVMN---WK---ETLV--FPP---EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHHHHHc---CC---Ccee--cCC---CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            554333222211   00   0000  000   11123456677777664 9999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.6e-33  Score=298.97  Aligned_cols=260  Identities=27%  Similarity=0.345  Sum_probs=198.7

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-----cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-----GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.||+|+||.||+|... +++.||||++......     ....+.+|++++++++|+||+++++++.+....++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34567999999999999975 5899999998755322     23567789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+ +++|.+++....  ..+++..+..++.||++||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          83 FM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             cc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            99 999999985432  3689999999999999999999997   99999999999999999999999999998765433


Q ss_pred             CccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---------chh
Q 043017          661 SHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---------LCD  730 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---------~~~  730 (818)
                      ... ....++..|+|||.+.+ ..++.++||||||++++||++|..+|....+......+......+.         +..
T Consensus       157 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 RKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            221 22346788999998855 4578999999999999999999877765544322222211100000         000


Q ss_pred             hcccc----CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKK----SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....    ............++.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000    00000012345788899999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-33  Score=329.98  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=195.4

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Cccee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFL  577 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~l  577 (818)
                      ...+.+.++||+|+||+||+++.. .++.+|+|.+....  ......|..|+.++.+++|||||++++++...  ...+|
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            345566678999999999999976 46789999886442  23356789999999999999999999988543  46889


Q ss_pred             eeeccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcC----CCCeeecccccCeEEEcCC----------
Q 043017          578 VYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYC----NPKIIHFDIKPQNILLDRD----------  642 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~----~~~iiH~Dlkp~NIll~~~----------  642 (818)
                      ||||+++++|.++|... .....+++..++.|+.||+.||+|||+..    ..+||||||||+||||+.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999999998642 22346899999999999999999999852    1359999999999999642          


Q ss_pred             -------CCEEEeecCCceecccCCCccccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 043017          643 -------LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGD  713 (818)
Q Consensus       643 -------~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~  713 (818)
                             ..+||+|||++..+.....  .....||+.|+|||++..  ..++.++|||||||+||||++|+.||......
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                   3489999999987643321  223468999999999854  45889999999999999999999999644321


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                        ...+......+        .++    ......++.+||..||+.+|.+||++.|+++
T Consensus       250 --~qli~~lk~~p--------~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        250 --SQLISELKRGP--------DLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             --HHHHHHHhcCC--------CCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence              11111111100        000    1123467889999999999999999999995

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-34  Score=311.12  Aligned_cols=241  Identities=25%  Similarity=0.332  Sum_probs=188.3

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc---CcceeEEEeeeecccCcceeeeeccCC
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI---HHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ||+|+||.||+++.. +++.||||++....   ......+..|..++.++   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999975 58899999985432   12233455566666655   699999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~  153 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-T  153 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-c
Confidence            9999888543   4588999999999999999999997   9999999999999999999999999999754332221 2


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....||..|+|||.+.+. .++.++|||||||++|||++|+.||.......+...+.   .. .      ....    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~---~~-~------~~~~----~~  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA---FG-K------VRFP----KN  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH---cC-C------CCCC----Cc
Confidence            234689999999998764 47999999999999999999999997654333222211   00 0      0011    11


Q ss_pred             HHHHHHHHHHHHccccCCCCCC----cHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRP----SASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RP----t~~evl~~  773 (818)
                      ....++.+++.+||+.+|.+||    ++.+++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            2345677899999999999998    57777764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-33  Score=300.60  Aligned_cols=261  Identities=28%  Similarity=0.383  Sum_probs=197.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.++||+|+||.||++... +++.+|+|++.....  ...+.+.+|+++++.++|+||+++++++..+...++||||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            344568999999999999986 488999999865432  23567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.++....   ..+++..+..++.||++||+|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        83 ~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          83 DHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             CccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999998866432   3489999999999999999999997   999999999999999999999999999987654332 


Q ss_pred             cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hcchhhcc------
Q 043017          663 VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DRLCDLVD------  733 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~~~~~~d------  733 (818)
                      ......++..|+|||++.+ ..++.++||||||++++||++|+.||...........+......  .......+      
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2223457889999999875 44788999999999999999999888644322111111100000  00000000      


Q ss_pred             c-cCcCcc-------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 K-KSEDMQ-------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~-~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      . ......       ........+.+++.+||+.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0 000000       011235678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-33  Score=293.06  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.++||+|+||.||+++.. +++.+|+|++...  .....+++.+|++++++++|+||+++++++...+..++||||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            44568999999999999865 5889999998643  23345688999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  157 (256)
T cd08218          83 GGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-  157 (256)
T ss_pred             CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence            999999885432 23578899999999999999999997   9999999999999999999999999999876443221 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....+++.|+|||.+.+...+.++||||||++++||++|+.|+...........+.   ..         ...  ..+.
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---~~---------~~~--~~~~  223 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII---RG---------SYP--PVSS  223 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh---cC---------CCC--CCcc
Confidence            122457889999999998889999999999999999999999986543322221111   00         000  0122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....++.+++.+||+.+|.+||++.+|+++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            345678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.7e-33  Score=300.75  Aligned_cols=261  Identities=23%  Similarity=0.298  Sum_probs=197.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            445568999999999999875 57899999986443 3334567899999999999999999999999999999999996


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       ++|.+++...  ...+++..+..++.||++||+|||+.   +|+|+||||+||+++.++.+||+|||++......... 
T Consensus        88 -~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-  160 (301)
T cd07873          88 -KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-  160 (301)
T ss_pred             -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence             6898888543  23578899999999999999999997   9999999999999999999999999999765432221 


Q ss_pred             ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh---hcchhhccc-----
Q 043017          664 STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DRLCDLVDK-----  734 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~---~~~~~~~d~-----  734 (818)
                      .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+......   .........     
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            1223468899999988654 5789999999999999999999999765433222222111110   000000000     


Q ss_pred             -cCcCcc------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 -KSEDMQ------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 -~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..+...      ........+.+++.+||+.||.+|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             000000      001234567899999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.1e-33  Score=296.79  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=195.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeec-----ccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCA-----ERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~-----~~~~~~l  577 (818)
                      ++.+.+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.++.++ +|+||+++++++.     .+...++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            3445568999999999999875 57899999876432 2346788999999999 7999999999874     3456899


Q ss_pred             eeeccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          578 VYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ||||+++++|.+++... .....+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            99999999999987532 2335688899999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      ..... ......|+..|+|||.+..     ..++.++|||||||++|||++|+.|+...........   ....      
T Consensus       175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~---~~~~------  244 (286)
T cd06638         175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK---IPRN------  244 (286)
T ss_pred             ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh---cccc------
Confidence            43322 2223468999999999853     4478899999999999999999999865432111110   0000      


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                         .......+.....++.+++.+||+.+|++||++.|+++++
T Consensus       245 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         245 ---PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ---CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence               0000001112345688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.4e-33  Score=292.61  Aligned_cols=256  Identities=28%  Similarity=0.379  Sum_probs=203.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..+...++|||+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            345678999999999999965 57889999986443 3356789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  662 (818)
                      +++|.+++........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......... 
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            999999986543334688999999999999999999997   9999999999999999999999999999876554322 


Q ss_pred             --cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          663 --VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       663 --~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                        ......++..|+|||.+... ..+.++|+||||++++||++|+.||...............  .       .......
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~-------~~~~~~~  230 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--D-------PPSLETG  230 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--C-------CCCcCCc
Confidence              12233588899999998776 7899999999999999999999999755432222111100  0       0011111


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .........+.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1012345678899999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-33  Score=310.05  Aligned_cols=257  Identities=23%  Similarity=0.276  Sum_probs=192.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC------cce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~  576 (818)
                      +.+.+.||+|+||.||++... .++.+|||++....  ......+.+|+.+++.++|+||+++++++....      ..+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            344567999999999999865 58899999986542  233467888999999999999999999886432      468


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++ +|.+.+.     ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        99 lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          99 LVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             EEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            99999965 6666662     2478888999999999999999997   9999999999999999999999999999865


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHH-HHHhh---------hh
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL-KVKAE---------AD  726 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~-~~~~~---------~~  726 (818)
                      ....  ......++..|+|||++.+..++.++|||||||++|||++|+.||............ .....         .+
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            4322  122346899999999999989999999999999999999999999754322111111 00000         00


Q ss_pred             cchhhcccc----------------Cc-CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 RLCDLVDKK----------------SE-DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ~~~~~~d~~----------------~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++..                .. ..........++.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000000                00 000011234577899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=294.85  Aligned_cols=248  Identities=26%  Similarity=0.389  Sum_probs=210.0

Q ss_pred             hhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..|++.+.||+|.|+.|-.+++ -+|.+||||++.++..  .....+..|++.|+.++|||||+|+.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4578889999999999999885 4799999999977643  345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceecccC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQD  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~  659 (818)
                      +-.+|+|.+||..++  ..++++...+++.||+.||.|+|+.   .+|||||||+||.+-+ -|-+||.|||++-.+.+.
T Consensus        98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999996554  4699999999999999999999998   9999999999998854 578999999999887665


Q ss_pred             CCccccCCCCCCcccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSIT-AKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ...  ++..|++.|-|||++.+..|. ++.||||||||||-|++|+.||+...+.+.+..+            +|-..  
T Consensus       173 ~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI------------mDCKY--  236 (864)
T KOG4717|consen  173 KKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI------------MDCKY--  236 (864)
T ss_pred             chh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh------------hcccc--
Confidence            433  345799999999999998875 6899999999999999999999865543332222            12111  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..+...+.+..+||..||..||.+|.+.+||+..
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence             2255677889999999999999999999999865

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.8e-33  Score=294.34  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=190.6

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-----ccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-----RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLV  578 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV  578 (818)
                      ...+.||+|+||.||++... +++.+|+|++.....     +....+.+|+.++++++|+||+++++++.+.  ...+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            34468999999999999875 588999998754321     2235688899999999999999999988653  467899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +||+++++|.+++...   ..+++.....++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          85 MEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            9999999999998543   3478899999999999999999987   999999999999999999999999999986543


Q ss_pred             CCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          659 DQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       659 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......   .+.......        ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~~~~~~~~--------~~  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIATQP--------TN  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HHHHHhcCC--------CC
Confidence            2111  1122357889999999998889999999999999999999999987542211   111111000        00


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .  ..+......+..++ +|+..+|++||+++||+++
T Consensus       228 ~--~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         228 P--QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             C--CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            0  11122334555666 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.6e-33  Score=307.50  Aligned_cols=258  Identities=23%  Similarity=0.286  Sum_probs=193.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC------cc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~  575 (818)
                      .+.+.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++....      ..
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            3445568999999999999865 5789999998653  2333567889999999999999999999875432      46


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++||||+++ +|.+++.     ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         105 YIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             EEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            999999964 6776663     2477888999999999999999997   999999999999999999999999999986


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hc------
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DR------  727 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~------  727 (818)
                      .....  ......++..|+|||++.+..++.++|||||||++|||++|+.||...........+......  +.      
T Consensus       176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            54322  122346899999999999999999999999999999999999999765432222111110000  00      


Q ss_pred             --chhhccccC-----------cC------ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 --LCDLVDKKS-----------ED------MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 --~~~~~d~~~-----------~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        +...+....           ..      .........++.+++.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000000           00      00011123567899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.4e-33  Score=292.68  Aligned_cols=249  Identities=28%  Similarity=0.461  Sum_probs=199.7

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR--GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ...+.||+|+||.||++... +++.+++|.+......  ..+.+.+|++++++++|+||+++++.+...+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            34467999999999999975 6889999998755442  56789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...   ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          83 GGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999988543   3478899999999999999999997   99999999999999999999999999998775543322


Q ss_pred             cc---CCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          664 ST---MPKGTPGYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       664 ~~---~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..   ...++..|+|||.+....   .+.++||||||++++||++|+.||...........  ....         ....
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~--~~~~---------~~~~  225 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF--HVGA---------GHKP  225 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH--HHhc---------CCCC
Confidence            21   245788999999998766   88999999999999999999999975432211111  0000         0011


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      ..+........+.+++.+||+.+|++||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111223566789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=298.69  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            345568999999999999976 4789999988643  2334578899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++.+..++..   ...+++..+..++.||+.||+|||+.   +++|+||+|+||++++++.+||+|||++.........
T Consensus        83 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          83 ERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            98777665532   23488999999999999999999997   9999999999999999999999999999877655432


Q ss_pred             cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hcchhhcc--c---
Q 043017          663 VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DRLCDLVD--K---  734 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~~~~~~d--~---  734 (818)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||..................  +.......  .   
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            33334578899999999888 7899999999999999999999998754332211111111000  00000000  0   


Q ss_pred             --cCcCc--------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 --KSEDM--------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 --~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        .....        ........++.+++.+||+.+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              00000        0011236788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.9e-33  Score=290.68  Aligned_cols=247  Identities=26%  Similarity=0.347  Sum_probs=199.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||++... +++.+|||++...  .....+.+.+|++++++++|+||+++++.+..+...++||||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            34567999999999999875 5789999998654  23345789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++|.+++.... ...+++..+..++.+++++|+|||+.   +++|+||+|+||+++++. .+||+|||++.........
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          83 GGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            999999996432 34588999999999999999999997   999999999999998654 5899999999876543221


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                        ....++..|+|||.+.....+.++||||||+++|+|++|+.|+...........+..    ..        ..  +..
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----~~--------~~--~~~  222 (256)
T cd08220         159 --YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS----GT--------FA--PIS  222 (256)
T ss_pred             --cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh----cC--------CC--CCC
Confidence              224578899999999988899999999999999999999999876543322222110    00        00  011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++.+++.+||+.+|++|||+.|++++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1245678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.6e-33  Score=293.92  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=202.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++.+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++|+||+++++.+......++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456678999999999999986 58899999986653 3445678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++|.+++....  ..+++..+..++.|+++||+|||+ .   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            999999985432  568889999999999999999998 6   9999999999999999999999999998765432221


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--chHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG--DYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .   ..++..|+|||.+.+..++.++||||||+++++|++|+.|+.....  ....+.+......         ......
T Consensus       158 ~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  225 (265)
T cd06605         158 T---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---------PPPRLP  225 (265)
T ss_pred             c---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---------CCCCCC
Confidence            1   4578899999999998999999999999999999999999865421  2222222211111         111111


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ......++.+++.+||..+|++||++.+++.+
T Consensus       226 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 -SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             11155678899999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-33  Score=305.91  Aligned_cols=257  Identities=25%  Similarity=0.307  Sum_probs=192.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc------Ccc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~  575 (818)
                      .+...+.||+|+||.||++... +++.||||++....  ....+.+.+|++++++++|+||+++++++...      ...
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            3445568999999999999864 57899999986432  22345678899999999999999999987543      346


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++++|++ +++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          96 YLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             EEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence            8999987 7889887732    3589999999999999999999997   999999999999999999999999999986


Q ss_pred             cccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh--cchhhc
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD--RLCDLV  732 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~--~~~~~~  732 (818)
                      ....    .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......  .....+
T Consensus       168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            5432    123458999999999876 568999999999999999999999997544322222211111000  000000


Q ss_pred             --------cccCcCccC------cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 --------DKKSEDMQS------HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 --------d~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                              .......+.      .......+.+++.+||+.||.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    000000000      00122457799999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.1e-32  Score=291.91  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=200.4

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.++||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++.+++|+||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4555678999999999999864 57899999876443 233467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++..    ..+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999998842    3588999999999999999999997   9999999999999999999999999999876443221


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....++..|+|||.+.+...+.++||||||+++|||++|+.|+...........+.   ..         ....  ..
T Consensus       158 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~---------~~~~--~~  222 (277)
T cd06641         158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP---KN---------NPPT--LE  222 (277)
T ss_pred             -hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh---cC---------CCCC--CC
Confidence             222457889999999988889999999999999999999999986543322221111   00         0000  11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ......+.+++.+|++.+|.+||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            2344678899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-32  Score=295.82  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            4455678999999999999864 678999999865555556788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus       100 ~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647         100 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             CCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            9999998843    3478889999999999999999997   99999999999999999999999999987665433222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                       ....+++.|+|||.+....++.++||||||+++||+++|+.||...........+.   ..         .........
T Consensus       173 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---~~---------~~~~~~~~~  239 (293)
T cd06647         173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TN---------GTPELQNPE  239 (293)
T ss_pred             -ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---cC---------CCCCCCCcc
Confidence             22357889999999988889999999999999999999999997543321111110   00         000111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.+|++||++.+++.+
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            344568899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-32  Score=290.56  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecc--cCcceeeeec
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRFLVYEY  581 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~  581 (818)
                      ++.+.||.|+||.||++... +++.+|+|.+....  ....+++.+|++++++++|+||+++++++..  +...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            34567999999999999864 57899999886432  3335678899999999999999999998754  3457899999


Q ss_pred             cCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcC--CCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          582 MCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYC--NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       582 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +++++|.+++... .....+++..+..++.||++||+|||...  ..+++|+||+|+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            9999999998653 22356899999999999999999999221  23999999999999999999999999999987755


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .... .....++..|+|||.+....++.++||||||+++++|++|+.|+.......+...+.    ...        .. 
T Consensus       163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~--------~~-  228 (265)
T cd08217         163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK----EGK--------FR-  228 (265)
T ss_pred             Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh----cCC--------CC-
Confidence            4321 223458899999999999889999999999999999999999997654322222211    000        00 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..+.....++.+++.+|++.+|++||++.+|+++
T Consensus       229 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             1122445688899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.9e-33  Score=317.31  Aligned_cols=258  Identities=20%  Similarity=0.263  Sum_probs=188.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC------cceeEEEeeeeccc-Ccce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH------HFNLVRLVGYCAER-SNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~------H~niv~l~g~~~~~-~~~~  576 (818)
                      .+.+.++||+|+||.||++... .++.||||++.... ....++..|++++..++      |.+++++++++... .+.+
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            3445568999999999999875 47889999986432 22345566777776664      45689999988765 4688


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-------------
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-------------  643 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-------------  643 (818)
                      +|||++ +++|.+++...   ..+++..+..|+.||+.||+|||+.  .+||||||||+|||++.++             
T Consensus       209 iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             EEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            999987 77888888543   3589999999999999999999972  3899999999999998765             


Q ss_pred             ---CEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHH
Q 043017          644 ---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK  720 (818)
Q Consensus       644 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~  720 (818)
                         .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus       283 ~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence               499999998764322    2233568999999999999999999999999999999999999998665433222221


Q ss_pred             HHhhh-----------hcchhhccccC---cC-------------ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          721 VKAEA-----------DRLCDLVDKKS---ED-------------MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       721 ~~~~~-----------~~~~~~~d~~~---~~-------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....           ....+++....   ..             ..........+.+|+.+||+.||++|||++|++++
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            11000           00000000000   00             00001123567899999999999999999999985

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.2e-33  Score=296.94  Aligned_cols=260  Identities=25%  Similarity=0.308  Sum_probs=194.3

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||+++.. +|+.+|+|++....  ......+.+|++++++++|+||+++++++.+....++|+||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            34567999999999999975 58899999986432  2234567889999999999999999999999999999999996


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       ++|.+++...  ...+++..+..++.||++||.|||+.   +++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-  155 (284)
T cd07839          83 -QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-  155 (284)
T ss_pred             -CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence             5788877543  24589999999999999999999997   9999999999999999999999999999865433221 


Q ss_pred             ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC-chHHHHHHHHhhhhc------chhhcccc
Q 043017          664 STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGG-DYLVDTLKVKAEADR------LCDLVDKK  735 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~~~~~~~~~~~------~~~~~d~~  735 (818)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ......+........      +....+..
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            1223578899999998764 478999999999999999999988643322 111111111100000      00000000


Q ss_pred             -CcCc-------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 -SEDM-------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 -~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ....       ........++.+++.+||+.||.+|||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence             0000       0011234677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-32  Score=289.69  Aligned_cols=249  Identities=29%  Similarity=0.445  Sum_probs=204.7

Q ss_pred             HhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++.+.||+|++|.||+++..+ ++.++||++..... ....++.+|++.+.+++|+||+++++++......++||||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            345689999999999999874 89999999876543 4467899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ++|.+++...   ..+++..+..++.|+++||+|||+ .   +++|+||+|+||+++.++.++|+|||++..........
T Consensus        84 ~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          84 GSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            9999999543   468999999999999999999999 7   99999999999999999999999999998775443322


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                       ....++..|+|||.+....++.++||||||+++|||++|+.|+.........+.......         ......  ..
T Consensus       158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~--~~  225 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---------GPPPSL--PA  225 (264)
T ss_pred             -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---------CCCCCC--Cc
Confidence             234578899999999998999999999999999999999999876542122222211111         011111  11


Q ss_pred             H-HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 D-DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~-~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      . ....+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            2 45788999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-32  Score=290.87  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=198.7

Q ss_pred             hhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC------ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          508 FQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..+.||+|+||.||++.. .+++.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            346799999999999986 4688999999864331      124678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQD  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  659 (818)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++ .+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          84 WMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             ccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            99999999998543   3588999999999999999999997   999999999999998776 5999999999876543


Q ss_pred             CCcc---ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          660 QSHV---STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       660 ~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ....   .....++..|+|||.+.+..++.++||||+|+++++|++|+.|+...........+......          .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~  227 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----------T  227 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc----------C
Confidence            2111   12235788999999998888999999999999999999999998644322222211111100          0


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.....++.+++.+|++.+|.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            0111123455778899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.4e-32  Score=292.84  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+...||+|+||.||++... +++.+++|++..... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            3455678999999999999987 688999999875544 56788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  172 (286)
T cd06614          99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K  172 (286)
T ss_pred             CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence            999999996543  3689999999999999999999997   999999999999999999999999999876543322 1


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....++..|++||.+.+..++.++||||||+++|+|++|+.|+...........+.   .         ..........
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~---------~~~~~~~~~~  240 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---T---------KGIPPLKNPE  240 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---------cCCCCCcchh
Confidence            122347889999999988889999999999999999999999986543322111111   0         0111111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .....+.+++.+|++.+|.+||++.+++++.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            2456788999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=293.99  Aligned_cols=244  Identities=22%  Similarity=0.390  Sum_probs=199.2

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            57999999999999864 68899999986555555677899999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCC
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK  668 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  668 (818)
                      +++..    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......... ....
T Consensus       105 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  176 (285)
T cd06648         105 DIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-KSLV  176 (285)
T ss_pred             HHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc-cccc
Confidence            98854    3588899999999999999999997   99999999999999999999999999987654432221 2245


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHH
Q 043017          669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK  748 (818)
Q Consensus       669 gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  748 (818)
                      |+..|+|||.+.+..++.++||||||++++||++|+.||...........+.   ..      .....   .........
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~---~~------~~~~~---~~~~~~~~~  244 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR---DN------LPPKL---KNLHKVSPR  244 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH---hc------CCCCC---cccccCCHH
Confidence            8889999999988889999999999999999999999986543322221111   10      00011   111124467


Q ss_pred             HHHHHHHccccCCCCCCcHHHHHHH
Q 043017          749 MIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       749 l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.+++.+||+.+|++||++.+++++
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHccC
Confidence            8899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-32  Score=286.61  Aligned_cols=247  Identities=29%  Similarity=0.468  Sum_probs=203.2

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      ..+.||+|++|.||++... +++.+++|++........+++.+|++.+++++|+|++++++++......++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            3467999999999999986 688999999976655567889999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |.+++....  ..+++..+..++.|++++|.|||+.   +++|+||+|+||++++++.++|+|||.+........  ...
T Consensus        84 L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~  156 (253)
T cd05122          84 LKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT  156 (253)
T ss_pred             HHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence            999885432  4689999999999999999999997   999999999999999999999999999987655432  233


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..++..|+|||.+.....+.++||||||+++++|++|+.|+..............            .............
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~  224 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT------------NGPPGLRNPEKWS  224 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh------------cCCCCcCcccccC
Confidence            4688899999999988899999999999999999999999875432222111110            0000111111125


Q ss_pred             HHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+.+++.+||+.+|++|||+.+++++
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            678899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=291.30  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=198.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccC---cceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +.+.+.||+|+||.||+|... +++.+|+|.+... ......++.+|+.++++++   |+|++++++++..+...++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            445678999999999999974 6889999998654 3344567889999999986   9999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++..    ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            9999999998843    2688999999999999999999997   99999999999999999999999999998775543


Q ss_pred             CccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .. .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||...........+   .      ..   .....
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~------~~---~~~~~  222 (277)
T cd06917         156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---P------KS---KPPRL  222 (277)
T ss_pred             cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---c------cC---CCCCC
Confidence            22 2234688899999988654 4789999999999999999999998754322111110   0      00   00111


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      . ......++.+++.+||+.+|++||++.+++++
T Consensus       223 ~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 E-DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             C-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            0 11144678899999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-32  Score=298.29  Aligned_cols=252  Identities=19%  Similarity=0.306  Sum_probs=197.7

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||++... .++.|++|.+....   ......+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            34567999999999999976 47899999886543   223457889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC--
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ--  660 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~--  660 (818)
                      ++++|.+++...   ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          84 EGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            999999999543   3588999999999999999999997   99999999999999999999999999987421110  


Q ss_pred             ------------CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          661 ------------SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       661 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                                  ........++..|+|||.+....++.++||||||+++|||++|+.||.......+.....   ...  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~---~~~--  232 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI---SDD--  232 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcc--
Confidence                        001112347889999999988889999999999999999999999987554332222211   000  


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                         ..  ...  ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus       233 ---~~--~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         233 ---IE--WPE--GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ---cC--CCC--ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence               00  000  011234568899999999999999997666666653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-32  Score=292.54  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=195.1

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---c-------cHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---R-------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.||+|+||.||+|... +++.+|+|.+.....   .       ..+.+..|+.++.+++|+|++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            357999999999999864 588999998753211   1       12467889999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||+++...
T Consensus        86 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            99999999999998543   4588899999999999999999997   99999999999999999999999999998654


Q ss_pred             cCCCc-cccCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          658 QDQSH-VSTMPKGTPGYMAPELTRGNS--ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       658 ~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ..... ......++..|+|||.+....  ++.++|+||||++++|+++|+.|+......   .......... ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~-~~~~~~~  235 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKR-SAPPIPP  235 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccc-cCCcCCc
Confidence            32211 123345888999999987654  789999999999999999999998643221   1111111000 0000000


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           .........+.+++.+||+.+|.+||++.+++++
T Consensus       236 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         236 -----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 0112345678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-32  Score=289.74  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=192.0

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--C---ccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceeee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--N---RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVY  579 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~  579 (818)
                      ..+.||+|+||.||++... +++.||||.+....  .   ...+.+.+|++++++++|+||+++++++.+.  ...+++|
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            3467999999999999975 48899999875321  1   2235788899999999999999999988764  3577999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++...   ..+++....+++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        86 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          86 EHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            999999999988543   3478888999999999999999997   9999999999999999999999999999865432


Q ss_pred             CC--ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QS--HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......   .+......        .  .
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~--------~--~  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIFKIATQ--------P--T  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHHHHhcC--------C--C
Confidence            11  11122357889999999988889999999999999999999999986442211   11111100        0  0


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+......+.+++.+|+. +|++||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            111133455677888889985 89999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-33  Score=307.45  Aligned_cols=245  Identities=26%  Similarity=0.402  Sum_probs=194.8

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCC----CCCccHHHHHHHHHHHhccCcceeEEEeeeecccCc--ceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYP----GENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN--RFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~--~~lV~  579 (818)
                      .|.++||+|.|=+||||... +|.+||--.++.    .+....+.|..|+.+|+.|+|+||++++.++.+...  ..+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            35678999999999999975 366666433321    123345789999999999999999999999987665  77899


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  658 (818)
                      |.|..|+|..|+...+   .++...+..|++||++||.|||++ .++|||||||.+||||+. .|.+||+|+|||.+.+.
T Consensus       123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999996543   478889999999999999999996 789999999999999965 58999999999998765


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG-GDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ....   ...|||.|||||++. ..|.+..||||||+.++||+|+..|+..-. ...++    ++...+.....+.    
T Consensus       199 s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY----KKV~SGiKP~sl~----  266 (632)
T KOG0584|consen  199 SHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY----KKVTSGIKPAALS----  266 (632)
T ss_pred             cccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH----HHHHcCCCHHHhh----
Confidence            4332   267999999999998 689999999999999999999999986432 22222    2222221111111    


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           .-...++.++|.+|+.. .++|||+.|+|+.
T Consensus       267 -----kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  267 -----KVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -----ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                 11235778999999999 9999999999975

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.6e-32  Score=293.42  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=194.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeeccc-----Ccceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAER-----SNRFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~-----~~~~lV~  579 (818)
                      .+.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++...     ...++||
T Consensus        25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~  103 (291)
T cd06639          25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL  103 (291)
T ss_pred             EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence            34457999999999999975 58899999986432 2346778899999999 899999999998654     3579999


Q ss_pred             eccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      ||+++++|.+++... .....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus       104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            999999999988542 2234688999999999999999999997   999999999999999999999999999986543


Q ss_pred             CCCccccCCCCCCcccccccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNS-----ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      .... .....++..|+|||.+....     ++.++||||||+++|||++|+.|+...........+.   ..        
T Consensus       181 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~--------  248 (291)
T cd06639         181 TRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RN--------  248 (291)
T ss_pred             cccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---cC--------
Confidence            3221 12245788999999986433     6889999999999999999999987543321111111   00        


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..............+.+++.+||+.+|++||++.|++++
T Consensus       249 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         249 -PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             000111122334578899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.1e-32  Score=292.13  Aligned_cols=262  Identities=23%  Similarity=0.229  Sum_probs=198.0

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|+.. +++.+|+|.+.....  .....+.+|+.++.+++||||+++++++...  ...++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4556678999999999999986 578999999864432  2234677899999999999999999998877  7899999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||++ ++|.+++....  ..+++..+..++.||++||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          86 EYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             hhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9997 58988875432  3689999999999999999999997   9999999999999999999999999999876554


Q ss_pred             CCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh---------cch
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD---------RLC  729 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~---------~~~  729 (818)
                      ... .....++..|+|||.+.+. ..+.++||||||++++||++|+.||...........+......+         .+.
T Consensus       160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            221 1223478899999998764 46899999999999999999999997655433322221111000         000


Q ss_pred             hhc-----cc---cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 DLV-----DK---KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 ~~~-----d~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...     ..   .+............+.+++.+||+.+|++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000     00   000000000135678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=299.32  Aligned_cols=240  Identities=28%  Similarity=0.359  Sum_probs=198.4

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCcc---HHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRG---KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.||.|.||.||-+... +.+.||||++.....+.   ..+++.|+..|.+++|||++.+.||+..+...+|||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            47999999999999864 57889999997664443   468999999999999999999999999999999999998 56


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +-.++|.-.+  +++-+-++..|..+.+.||+|||++   +.||||||+.||||.+.|.+||+|||.|....+.+     
T Consensus       111 SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-----  180 (948)
T KOG0577|consen  111 SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-----  180 (948)
T ss_pred             cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-----
Confidence            7777774333  5788889999999999999999998   99999999999999999999999999998765533     


Q ss_pred             CCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          666 MPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ..+|||.|||||++.   .+.|+-|+||||||+...||.-.++|.-.+....-+.   .+...         ..+... .
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY---HIAQN---------esPtLq-s  247 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQN---------ESPTLQ-S  247 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH---HHHhc---------CCCCCC-C
Confidence            356999999999884   5789999999999999999999999865444322211   11111         111111 4


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.+..+.+++..||+.-|.+|||..+++++
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            5778899999999999999999999998875

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-32  Score=297.90  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=198.9

Q ss_pred             hhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCc---cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.||+|+||.||++...+ ++.+|+|.+......   ..+.+.+|++++.+++|+||+++++.+..+...++||||+.
T Consensus         5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (316)
T cd05574           5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP   84 (316)
T ss_pred             EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence            44579999999999999864 899999998754322   44678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  662 (818)
                      +++|.+++... ....+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++......... 
T Consensus        85 ~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          85 GGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            99999988543 235689999999999999999999997   9999999999999999999999999998755322110 


Q ss_pred             ---------------------------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH
Q 043017          663 ---------------------------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL  715 (818)
Q Consensus       663 ---------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l  715 (818)
                                                 ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       01123578899999999988899999999999999999999999975543322


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCc----HHHHHHH
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS----ASMLVKV  773 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~~  773 (818)
                      ...+.            ..... ..........+.+++.+||+.+|++||+    +.|++++
T Consensus       241 ~~~~~------------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         241 FSNIL------------KKEVT-FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HHHHh------------cCCcc-CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            11111            11110 1111125678899999999999999999    6666664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=294.52  Aligned_cols=274  Identities=24%  Similarity=0.327  Sum_probs=211.1

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      ++||+||||+||-.+.. +|+-+|.|.+.+.   ..++..-.++|-++|.+++.+.||.+-..++..+.++||+..|.+|
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            57999999999999865 5888999988543   3455567789999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.-+|.+..+ +.++++.++.++.+|+.||++||+.   +||+|||||+|||||+.|+++|+|+|||..+........ 
T Consensus       271 DLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~-  345 (591)
T KOG0986|consen  271 DLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG-  345 (591)
T ss_pred             ceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc-
Confidence            99999977654 6799999999999999999999998   999999999999999999999999999999877655443 


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                       .+||.+|||||++.+..|+...|-||+||+||||+.|+.||.......-.+.+.....         .....  .+..-
T Consensus       346 -rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~---------~~~~e--y~~kF  413 (591)
T KOG0986|consen  346 -RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL---------EDPEE--YSDKF  413 (591)
T ss_pred             -ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh---------cchhh--ccccc
Confidence             3799999999999999999999999999999999999999975433221111111110         01111  12334


Q ss_pred             HHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchhhhhhcc--ccccCCCC
Q 043017          746 AVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAT--TQEVVPIR  805 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  805 (818)
                      +++...+....|+.||++|.--..-     +-.++...+-+.++.+-..++.  .|+-.|++
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw~rleagml~PPfiPdp  470 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP  470 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence            4556667778899999999754321     3333333344444455444442  34444443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.1e-32  Score=293.04  Aligned_cols=245  Identities=23%  Similarity=0.376  Sum_probs=199.4

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ..+||+|+||.||++... +++.||||++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            467999999999999875 6889999998655555567799999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++..    ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......... ....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~~  176 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSL  176 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc-cccc
Confidence            998743    2478899999999999999999997   9999999999999999999999999998766443221 1224


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+...         ......   .......
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~  244 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---------LPPKLK---NLHKVSP  244 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---------CCcccC---CcccCCH
Confidence            5788999999998888999999999999999999999998754332222221110         011111   1122345


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.+++.+||+.+|.+||++.+++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            67889999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-32  Score=291.85  Aligned_cols=256  Identities=29%  Similarity=0.377  Sum_probs=198.4

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeeccc--CcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~  583 (818)
                      +.++||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++.+.  ...++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            3457999999999999985 578999999865432 3456789999999999999999999988654  36799999999


Q ss_pred             CCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++|.+++... .....+++..+..++.||++||+|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  160 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-  160 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence            99999987542 2334588899999999999999999997   999999999999999999999999999876543221 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--chHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG--DYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                        ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ....+........ .... +...   ..
T Consensus       161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~---~~  233 (287)
T cd06621         161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPE-LKDE---PG  233 (287)
T ss_pred             --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cchh-hccC---CC
Confidence              123467889999999988999999999999999999999999975522  1111211111110 0000 0000   01


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ........+.+++.+||+.+|++|||+.|++++-
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            0122456788999999999999999999999853

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-32  Score=295.33  Aligned_cols=253  Identities=26%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ..+...+.||+|+||.||+++.. ++..+|+|.+.....   ....++.+|++++++++|+|++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34556678999999999999965 588999999864422   23457889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||++ |+|.+.+...  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus       105 e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         105 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9996 5777766433  24588999999999999999999997   9999999999999999999999999998754332


Q ss_pred             CCccccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          660 QSHVSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                           ....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+...........+.   ...         .
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~~---------~  241 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNE---------S  241 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---hcc---------C
Confidence                 2235788999999973   4568999999999999999999999986543222211111   000         0


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .. .........+.+++.+||+.+|.+||++.++++++-.....
T Consensus       242 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         242 PT-LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             CC-CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            00 01223445688999999999999999999999987655544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-32  Score=288.51  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=195.7

Q ss_pred             cccccceeEEEeEecC-CcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||.||+++... ++.+|+|.+....   ....+.+.+|+.++++++|+||+++++.+.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999999864 8899999986542   23346789999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++...   ..+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            9998543   3488999999999999999999997   99999999999999999999999999998765432  12234


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .++..|++||.+....++.++|+||||+++|||++|+.|+.....+. .+.........          .....+.....
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~  221 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDILKGN----------GKLEFPNYIDK  221 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHhccC----------CCCCCCcccCH
Confidence            57889999999988889999999999999999999999997654311 11111111000          00011112256


Q ss_pred             HHHHHHHHccccCCCCCCc-----HHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPS-----ASMLVK  772 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt-----~~evl~  772 (818)
                      ++.+++.+||+.+|++||+     ++|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            8899999999999999999     677766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-32  Score=292.21  Aligned_cols=260  Identities=24%  Similarity=0.306  Sum_probs=199.1

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceeeeecc
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYEYM  582 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~  582 (818)
                      +.++||+|+||.||+|+.. +++.+|+|++....  ......+.+|++++++++|+|++++++++...  ...++||||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            3457999999999999976 48899999997653  33456788999999999999999999999887  7899999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++ +|.+++....  ..+++..+..++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++.........
T Consensus        83 ~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          83 DH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            74 8888875432  4689999999999999999999997   9999999999999999999999999999877654432


Q ss_pred             cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch------hh----
Q 043017          663 VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC------DL----  731 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~------~~----  731 (818)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+..........      .+    
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            2333456788999998764 457899999999999999999999987655433333222211110000      00    


Q ss_pred             -ccccCcCc----cCcHH-HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 -VDKKSEDM----QSHRD-DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 -~d~~~~~~----~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ........    ..... +...+.+++.+||+.+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             00000000    00001 25678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-33  Score=296.06  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=198.3

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCC--CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ...|++.++||+||.+.||++.-.+.+.+|+|++...  +.+...-|.+|+..|.+| .|.+|++|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3456677899999999999999998889999876433  445567899999999999 5999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      |+ ...+|..+|..... ....| .+..+..||+.++.+.|++   +|||.||||.|+|+ ..|.+||+|||+|..+..+
T Consensus       440 E~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 EC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            97 47899999965433 22233 7888999999999999998   99999999999999 5679999999999988776


Q ss_pred             CC-ccccCCCCCCcccccccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          660 QS-HVSTMPKGTPGYMAPELTRGN-----------SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       660 ~~-~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      .. ......+||+.||+||.+...           +++.++||||+|||||+|+.|+.||...     ...+      .+
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~------aK  581 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQI------AK  581 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHH------HH
Confidence            44 334557899999999998532           2678999999999999999999998532     1111      12


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +..+.++..+..........++++++..||+.||.+||++.|+|++
T Consensus       582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            2223333221111111122238999999999999999999999986

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=289.79  Aligned_cols=252  Identities=26%  Similarity=0.373  Sum_probs=198.0

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccC------cce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~------~~~  576 (818)
                      .+.+.+.||+|+||.||+|... +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++....      ..+
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            4455678999999999999985 578899998865433 356799999999999 7999999999997644      479


Q ss_pred             eeeeccCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          577 LVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +||||+++++|.+++.... ....+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            9999999999999886432 235689999999999999999999997   999999999999999999999999999986


Q ss_pred             cccCCCccccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      ....... .....++..|+|||.+..     ..++.++||||||++++||++|+.||...........+.          
T Consensus       163 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------  231 (275)
T cd06608         163 LDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP----------  231 (275)
T ss_pred             cccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh----------
Confidence            5433221 223458889999998753     346789999999999999999999996443221111110          


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ...............++.+++.+||..||++|||+.+++++
T Consensus       232 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         232 --RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             --ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              01111111122355688899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-32  Score=292.61  Aligned_cols=260  Identities=22%  Similarity=0.314  Sum_probs=194.8

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ..+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.++...++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            3457999999999999875 58899999886442  2234678999999999999999999999999999999999995 


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++......... .
T Consensus        83 ~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~  157 (284)
T cd07860          83 QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-Y  157 (284)
T ss_pred             cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-c
Confidence            68888885433 35688999999999999999999997   9999999999999999999999999998765433221 1


Q ss_pred             cCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh------------cchhh
Q 043017          665 TMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD------------RLCDL  731 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~------------~~~~~  731 (818)
                      ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...........+......+            .....
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            2234678899999887644 6889999999999999999999987544322111111110000            00000


Q ss_pred             ccccCcCc--cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDKKSEDM--QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.......  ........++.+++.+|++.||.+||++++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00000000  0001123567789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=285.57  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=208.8

Q ss_pred             hhcccccceeEEEeEecC------CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeeccc-Ccceeeeec
Q 043017          510 IRLGRGGSGSVFEGLLND------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER-SNRFLVYEY  581 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~  581 (818)
                      ..+-+|.||.||+|++.+      .+.|.||.++... ......++.|...+..+.|||+..+.+.+.+. ...+.+|.+
T Consensus       290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~  369 (563)
T KOG1024|consen  290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA  369 (563)
T ss_pred             hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence            468999999999997653      4568888886553 34456788999999999999999999998765 467899999


Q ss_pred             cCCCChhhHhh-----hcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          582 MCNGSLDKWIF-----HKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       582 ~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +.-|+|..||.     +....+.++..+...++.|++.|++|||++   ++||.||.++|.+||+..++||+|=.|++-+
T Consensus       370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL  446 (563)
T KOG1024|consen  370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDL  446 (563)
T ss_pred             cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcccc
Confidence            99999999997     334456788889999999999999999998   9999999999999999999999999999865


Q ss_pred             ccC-CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          657 AQD-QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       657 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      -+. ..........+..||+||.+....++.++||||||++||||+| |+.|+..-++.++...++   ++.++      
T Consensus       447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk---dGyRl------  517 (563)
T KOG1024|consen  447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK---DGYRL------  517 (563)
T ss_pred             CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh---cccee------
Confidence            543 3334444557889999999999999999999999999999999 888887665544433332   33333      


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                           ..+.+++.++..+|.-||...|++||+++|++.-|.+.
T Consensus       518 -----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  518 -----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                 22557888999999999999999999999999999765

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4e-32  Score=294.38  Aligned_cols=246  Identities=27%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.++||+|+||.||+|+.. +++.||+|.+.....   ...+++.+|+++++.++||||+++.+++......++||||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            556678999999999999975 588999998864332   2335788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      ++ |+|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        97 ~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-  169 (307)
T cd06607          97 CL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-  169 (307)
T ss_pred             hC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence            96 67777664322  3589999999999999999999997   99999999999999999999999999997654321 


Q ss_pred             ccccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          662 HVSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                          ...++..|+|||.+.   ...++.++||||||+++|||++|+.|+...........+.   ..         ....
T Consensus       170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---~~---------~~~~  233 (307)
T cd06607         170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QN---------DSPT  233 (307)
T ss_pred             ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---cC---------CCCC
Confidence                235778999999874   4568899999999999999999999986543222111110   00         0001


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      . ........+.+++.+||+.+|++||++.+++++.-
T Consensus       234 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         234 L-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             C-CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            1 12234567899999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-32  Score=294.64  Aligned_cols=242  Identities=27%  Similarity=0.368  Sum_probs=197.8

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            44568999999999999976 58899999886432   233567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||++......   
T Consensus        84 ~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          84 PGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            999999998544   4688999999999999999999997   9999999999999999999999999999876543   


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....+++.|+|||.+.+...+.++||||||+++++|++|+.||...........+.   .         ...   ..+
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~---------~~~---~~~  218 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL---E---------GKV---RFP  218 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---c---------CCc---cCC
Confidence             223458899999999988889999999999999999999999987554222111111   0         000   011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      ......+.+++.+||+.+|.+||     ++++++++
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            22356788999999999999999     67777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=297.43  Aligned_cols=263  Identities=24%  Similarity=0.301  Sum_probs=194.4

Q ss_pred             HhhhhcccccceeEEEeEecC---CcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceee
Q 043017          507 DFQIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLV  578 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV  578 (818)
                      .+..+||+|+||.||+|....   ++.||+|.+....   ....+.+.+|+.++.+++||||+++++++...  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            445679999999999999754   7899999987643   33346778899999999999999999999888  789999


Q ss_pred             eeccCCCChhhHhhhcC-C-ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC----CCCEEEeecCC
Q 043017          579 YEYMCNGSLDKWIFHKD-R-IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR----DLNVKIADFGL  652 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfgl  652 (818)
                      |||+++ +|.+++.... . ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999965 6666664322 1 23688999999999999999999997   9999999999999999    89999999999


Q ss_pred             ceecccCCC--ccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH------HHHHHHHh
Q 043017          653 ARLIAQDQS--HVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYL------VDTLKVKA  723 (818)
Q Consensus       653 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l------~~~~~~~~  723 (818)
                      +........  .......++..|+|||.+.+. .++.++||||||++++||++|+.||........      ...+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            987644322  112234578899999987664 578999999999999999999999975543220      00000000


Q ss_pred             h---------------hhcchh---hcc-ccCcCccCc------HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          724 E---------------ADRLCD---LVD-KKSEDMQSH------RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       724 ~---------------~~~~~~---~~d-~~~~~~~~~------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .               .+....   ... .........      .....++.+++.+||+.+|++|||+.|++++
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0               000000   000 000000000      0234578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.7e-32  Score=290.09  Aligned_cols=244  Identities=27%  Similarity=0.391  Sum_probs=193.8

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||+||++... +|+.+|+|.+....   ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 58899999886432   22345678899999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++..... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........  ....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence            999865432 4689999999999999999999997   999999999999999999999999999876543221  1223


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .++..|+|||.+.+..++.++||||||+++++|++|+.||...........+....        .....   ..+.....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--------LEMAV---EYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--------ccccc---cCCccCCH
Confidence            57789999999988889999999999999999999999997554322112111110        00000   11122356


Q ss_pred             HHHHHHHHccccCCCCCC-----cHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRP-----SASMLVK  772 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RP-----t~~evl~  772 (818)
                      .+.+++.+||+.+|++||     ++.++++
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.9e-32  Score=289.91  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=199.8

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.++||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34568999999999999986 588999999875533 3356778899999999999999999999999999999999975


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                       +|.+++........+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||++........ ..
T Consensus        83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  157 (284)
T cd07836          83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF  157 (284)
T ss_pred             -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence             8888886554445689999999999999999999987   999999999999999999999999999976543222 11


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---c---h--hhcccc
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---L---C--DLVDKK  735 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---~---~--~~~d~~  735 (818)
                      ....++..|++||.+.+. .++.++||||||+++|||++|+.||...........+......+.   .   .  ......
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            223568899999988664 478999999999999999999999976554333222211110000   0   0  000000


Q ss_pred             CcCc------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 SEDM------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 ~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....      .........+.+++.+|++.+|.+||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000      0011234677899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-32  Score=291.55  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=193.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+....++||||++
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            344568999999999999976 588999999865432 233567889999999999999999999999999999999997


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       ++|.+++....  ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||+++........ 
T Consensus        87 -~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-  159 (291)
T cd07844          87 -TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-  159 (291)
T ss_pred             -CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence             48998885433  3678999999999999999999997   9999999999999999999999999998754322111 


Q ss_pred             ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-chHHHHHHHHhhhh---cchh------hc
Q 043017          664 STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGG-DYLVDTLKVKAEAD---RLCD------LV  732 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~~~~~~~~~~---~~~~------~~  732 (818)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+.......   ....      ..
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            122346788999998875 4588999999999999999999999864431 11111111110000   0000      00


Q ss_pred             cccCcCc--------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDM--------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......        ........++.+++.+||+.+|++||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000000        0000112567799999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-32  Score=288.40  Aligned_cols=245  Identities=24%  Similarity=0.393  Sum_probs=197.7

Q ss_pred             cccccceeEEEeEecC-CcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||.||+++... ++.+++|.+.....   ...+.+.+|++++++++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 89999999865433   3456788999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC------
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS------  661 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------  661 (818)
                      .+++...   ..+++..+..++.||++||+|||+.   +++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9988543   2689999999999999999999997   999999999999999999999999999876543321      


Q ss_pred             -ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 -HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       .......++..|+|||.......+.++||||||++++||++|+.||...........+..    ..        . ..+
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~--------~-~~~  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN----GK--------I-EWP  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CC--------c-CCC
Confidence             122234578899999999888899999999999999999999999875543332222211    00        0 000


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ........+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            01112567889999999999999999966666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-32  Score=303.30  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=199.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-c-----ceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-H-----FNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H-----~niv~l~g~~~~~~~~~l  577 (818)
                      +|.+.+.||+|.||.|-|+... +++.||||+++.... -..+-+.|+.+|..|+ |     -|+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            5666778999999999999865 589999999975432 3456678999999996 4     499999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC--CCEEEeecCCcee
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD--LNVKIADFGLARL  655 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfgla~~  655 (818)
                      |+|.+ ..+|.++|... +...++...++.|+.||++||..||+.   +|||+||||+||||-+.  ..+||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99988 77999999654 346699999999999999999999998   99999999999999654  3699999999987


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh---------hh
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE---------AD  726 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~---------~~  726 (818)
                      ....-.    ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+....+.+..+.....         ..
T Consensus       341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            544322    34567899999999999999999999999999999999888766543221111110000         00


Q ss_pred             cchhhccc---------------------------------cCc-Ccc-----CcHHHHHHHHHHHHHccccCCCCCCcH
Q 043017          727 RLCDLVDK---------------------------------KSE-DMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSA  767 (818)
Q Consensus       727 ~~~~~~d~---------------------------------~~~-~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~  767 (818)
                      +....++.                                 ..+ ...     ........+++++.+||+.||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence            00000000                                 000 000     011344678999999999999999999


Q ss_pred             HHHHHHH
Q 043017          768 SMLVKVL  774 (818)
Q Consensus       768 ~evl~~L  774 (818)
                      .|++++=
T Consensus       497 ~qal~Hp  503 (586)
T KOG0667|consen  497 AQALNHP  503 (586)
T ss_pred             HHHhcCc
Confidence            9999873

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.6e-32  Score=287.32  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=198.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||++... +|..+|+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            34567999999999999986 47889999986432  2345678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC-EEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN-VKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~  662 (818)
                      +++|.+++.... ...+++..+..++.|+++||+|||+.   +++|+||||+||++++++. +||+|||.+.........
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          83 GGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            999999885432 23578999999999999999999997   9999999999999988854 699999999876543222


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....|+..|+|||.+....++.++||||||++++||++|+.|+.......   ........     .+...      .
T Consensus       159 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-----~~~~~------~  223 (257)
T cd08225         159 -AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LVLKICQG-----YFAPI------S  223 (257)
T ss_pred             -ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHhcc-----cCCCC------C
Confidence             223458889999999988889999999999999999999999986443221   11111110     01110      1


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++.+++.+|++.+|++||++.+++++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1234578899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=4.2e-32  Score=290.32  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=195.5

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.++||+|++|.||+|... +|+.||+|++....  ......+.+|++.+++++|+|++++++++.++...+++|||+ +
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-D   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-C
Confidence            4567999999999999875 68999999986443  223467889999999999999999999999999999999999 4


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++..... ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++......... .
T Consensus        82 ~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~  156 (283)
T cd07835          82 LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y  156 (283)
T ss_pred             cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence            789998854332 4689999999999999999999997   9999999999999999999999999999765432211 1


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHH-hhhh-----------cchhh
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK-AEAD-----------RLCDL  731 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~-~~~~-----------~~~~~  731 (818)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+... ....           .....
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            223468899999988654 5789999999999999999999998754332111111100 0000           00000


Q ss_pred             cccc-CcC-ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDKK-SED-MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~~-~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +... ... .........++.+++.+|++.+|.+||+++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000 000 00011233578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=5.8e-32  Score=290.13  Aligned_cols=253  Identities=27%  Similarity=0.386  Sum_probs=193.7

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+..+||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+.
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~   86 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD   86 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence            34568999999999999975 58899999986543 234567889999999996 9999999999999889999999985


Q ss_pred             CCChhhHhhh--cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          584 NGSLDKWIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       584 ~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                       ++|.++...  ......+++..+..++.|+++||+|||+.  .+++||||||+||+++.++.+||+|||++........
T Consensus        87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence             455543321  11235689999999999999999999973  4899999999999999999999999999976543322


Q ss_pred             ccccCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          662 HVSTMPKGTPGYMAPELTRGN---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .  ....++..|+|||.+...   .++.++||||||+++|||++|+.||....  ...+.+.......      .+... 
T Consensus       164 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~------~~~~~-  232 (288)
T cd06616         164 K--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGD------PPILS-  232 (288)
T ss_pred             c--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCC------CCcCC-
Confidence            1  223578899999999776   68999999999999999999999986443  1112211111000      00110 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .........++.+++.+||+.+|++||++.+|+++
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01112355678999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.98  E-value=4e-32  Score=290.43  Aligned_cols=251  Identities=27%  Similarity=0.368  Sum_probs=194.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecc------cCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE------RSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~------~~~~  575 (818)
                      ..+.+.+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..      ....
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            34555678999999999999975 57899999885443 3346788899999998 79999999999853      3567


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +++|||+++++|.+++.... ...+++..+..++.||++||+|||+.   +|+|+||+|+||+++.++.++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            99999999999999886433 24578888999999999999999997   999999999999999999999999999886


Q ss_pred             cccCCCccccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                      ...... ......++..|+|||.+.     ...++.++||||||+++|||++|+.||...........+.          
T Consensus       171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~----------  239 (282)
T cd06636         171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP----------  239 (282)
T ss_pred             hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh----------
Confidence            543221 122345888999999885     3457889999999999999999999986543211111100          


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ..............++.+++.+||+.+|.+||++.|++++
T Consensus       240 ---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         240 ---RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ---hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence               0000000112345678999999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=7e-32  Score=288.26  Aligned_cols=257  Identities=22%  Similarity=0.243  Sum_probs=193.5

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccC-cceeEEEeeeeccc--Ccceeeeecc
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIH-HFNLVRLVGYCAER--SNRFLVYEYM  582 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~~  582 (818)
                      +.++||+|+||.||++... +++.+|+|++.... ........+|+..+.++. |+|++++++++.+.  +..++||||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            4467999999999999965 58899999986542 222344567888999885 99999999999887  7899999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      + ++|.+++....  ..+++..+..++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||++.........
T Consensus        83 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          83 D-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             C-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            6 58888775432  4689999999999999999999997   9999999999999999 99999999999876443222


Q ss_pred             cccCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hcchhhcc------
Q 043017          663 VSTMPKGTPGYMAPELTR-GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DRLCDLVD------  733 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~~~~~~d------  733 (818)
                        ....++..|+|||.+. ...++.++|||||||++|||++|+.||...+.......+......  ..+...+.      
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence              2234788999999764 455789999999999999999999999765543333322211100  00000000      


Q ss_pred             ccCcCc------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDM------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+..      ......+..+.+++.+||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000      0012346789999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=5e-32  Score=289.66  Aligned_cols=250  Identities=29%  Similarity=0.432  Sum_probs=191.8

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHH-HhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVET-IGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.. ++.++|+||+++++++..+...+++|||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            34567999999999999976 58999999986542 2334556666665 566789999999999999999999999996


Q ss_pred             CCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                       ++|.+++.+. .....+++..+..++.||+.||+|||+.  .+++||||||+||+++.++.+||+|||++.......  
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--  158 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence             7888877542 2335689999999999999999999973  389999999999999999999999999998654322  


Q ss_pred             cccCCCCCCcccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          663 VSTMPKGTPGYMAPELTRG----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+......  .+.+.....         .....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~---------~~~~~  227 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVE---------EPSPQ  227 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHh---------cCCCC
Confidence            1122457889999998865    44688999999999999999999998643221  111111111         00000


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+ ....+.++.+++.+||+.+|.+||++.+++++
T Consensus       228 ~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         228 LP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CC-ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 11234678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-32  Score=318.93  Aligned_cols=254  Identities=27%  Similarity=0.417  Sum_probs=206.8

Q ss_pred             HhhhhcccccceeEEEeEecC--------CcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcce
Q 043017          507 DFQIRLGRGGSGSVFEGLLND--------GTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  576 (818)
                      .+.+.||+|.||.|++|....        ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            455689999999999998541        4579999997653 34567899999999999 6999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcC-------C----c--cccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC
Q 043017          577 LVYEYMCNGSLDKWIFHKD-------R----I--QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL  643 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~  643 (818)
                      +|+||+..|+|.++|.+..       .    .  ..++....+.++.|||.|++||++.   ++|||||.++|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence            9999999999999997755       0    1  2388899999999999999999997   999999999999999999


Q ss_pred             CEEEeecCCceecccCCCccccCCC--CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-CchHHHHH
Q 043017          644 NVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKG-GDYLVDTL  719 (818)
Q Consensus       644 ~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~-~~~l~~~~  719 (818)
                      .+||+|||+++..............  -+..|||||.+....++.|+||||||++||||+| |..|+.... ...+.+. 
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~-  534 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF-  534 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH-
Confidence            9999999999976555444322222  3556999999999999999999999999999999 677775432 2222221 


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                        ..+..           .++.+..+..++.++|..||+.+|++||++.++++.|+..
T Consensus       535 --l~~G~-----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  535 --LKEGN-----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --HhcCC-----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              11111           2223445678899999999999999999999999999884

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=1.7e-32  Score=289.23  Aligned_cols=245  Identities=28%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            34568999999999999976 58899999986442   234578899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        83 ~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  155 (258)
T cd05578          83 LGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-  155 (258)
T ss_pred             CCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence            999999998543   4688999999999999999999997   999999999999999999999999999987654321 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....++..|+|||.+.....+.++|+||||+++|+|++|+.|+............. ....        .   ....+
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~--------~---~~~~~  222 (258)
T cd05578         156 -TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA-KQET--------A---DVLYP  222 (258)
T ss_pred             -ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-Hhcc--------c---cccCc
Confidence             223457889999999998889999999999999999999999998655431111111 1100        0   00112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcH--HHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSA--SMLV  771 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~--~evl  771 (818)
                      ......+.+++.+||+.+|.+||++  +|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            2344788899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=9.9e-32  Score=288.86  Aligned_cols=260  Identities=22%  Similarity=0.273  Sum_probs=191.9

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+++++.++|+||+++++++..+...++||||+. 
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-   86 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence            34567999999999999865 588999999865433 234567899999999999999999999999999999999995 


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++....  ..+.+..+..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||+++........ .
T Consensus        87 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~  160 (291)
T cd07870          87 TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-Y  160 (291)
T ss_pred             CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-C
Confidence            77777764332  3577888899999999999999997   9999999999999999999999999999764332211 1


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-hHHHHHHHHhhh------------hcchh
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGD-YLVDTLKVKAEA------------DRLCD  730 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-~l~~~~~~~~~~------------~~~~~  730 (818)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+......            +....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            223468899999998764 5788999999999999999999999754331 111111100000            00000


Q ss_pred             hccccC-----cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKS-----EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ......     ............+.+++.+|++.||++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000000     0000001123567789999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=2.8e-32  Score=268.19  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=197.6

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +...||.|..|.|++.+.. .|..+|||.+.... .+..++++..++++..-+ +|+||+.+|||......++.||.| .
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            3457999999999999976 48899999997664 344567888888777764 999999999999999999999998 4


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ..++..|....  +++++..+-++...+.+||.||.+.  .+|||||+||+|||+|+.|++|++|||++..+.....  .
T Consensus       175 ~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--h  248 (391)
T KOG0983|consen  175 TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--H  248 (391)
T ss_pred             HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc--c
Confidence            45555554332  4688888999999999999999975  6999999999999999999999999999987765433  3


Q ss_pred             cCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 TMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      +...|-+.|||||.+.-   ..|..++||||||+.|+||.||+.|+.....+...-.  +..         +..++..+.
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt--kvl---------n~ePP~L~~  317 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT--KVL---------NEEPPLLPG  317 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH--HHH---------hcCCCCCCc
Confidence            44568999999999964   4688999999999999999999999987654432211  111         111122222


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...-+..+++++..||+.|+.+||...+++++
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            33356789999999999999999999999876

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=1.2e-31  Score=286.58  Aligned_cols=242  Identities=22%  Similarity=0.295  Sum_probs=187.6

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHH---hccCcceeEEEeeeecccCcceeeeeccC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETI---GNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l---~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..++   ...+|+||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999975 588999998864422   1223344554433   33479999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...   ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            99999988543   3589999999999999999999997   999999999999999999999999999976543221  


Q ss_pred             ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       ....|+..|+|||.+.. ..++.++|||||||+++||++|+.||......... .+.....      ...     ...+
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~------~~~-----~~~~  219 (279)
T cd05633         153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL------TVN-----VELP  219 (279)
T ss_pred             -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh------cCC-----cCCc
Confidence             22358999999998864 56899999999999999999999999754332211 1111100      000     0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .....++.+++.+||+.||++||     ++++++++
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            23456788999999999999999     69998886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=6.1e-32  Score=290.92  Aligned_cols=262  Identities=22%  Similarity=0.273  Sum_probs=193.2

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCc-----cee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSN-----RFL  577 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~-----~~l  577 (818)
                      .+.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++.+ +|+||+++++++...+.     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            34567999999999999975 58899999876442  22346788999999999 56999999999877665     799


Q ss_pred             eeeccCCCChhhHhhhcCC--ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCce
Q 043017          578 VYEYMCNGSLDKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLAR  654 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~  654 (818)
                      ||||+++ +|.+++.....  ...+++..+..++.||++||+|||+.   +|+||||||+||+++. ++.+||+|||++.
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999985 88888754322  34689999999999999999999997   9999999999999998 8899999999998


Q ss_pred             ecccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc-----
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL-----  728 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~-----  728 (818)
                      .+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+..     
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         160 AFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             ecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            65432211 122346788999998865 45799999999999999999999998754432221111111000000     


Q ss_pred             -hhh---ccccC-cCc---cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 -CDL---VDKKS-EDM---QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 -~~~---~d~~~-~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ...   ..... ...   ........++.+++.+||+.+|.+||++.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             000   00000 000   0011245678899999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=1.2e-31  Score=281.58  Aligned_cols=247  Identities=29%  Similarity=0.435  Sum_probs=202.3

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeeccc--CcceeeeeccC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYEYMC  583 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~  583 (818)
                      .+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+..+++++|+||+++++.+...  ...++++||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            457999999999999987 688999999865543  4467899999999999999999999999988  78999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  662 (818)
                      +++|.+++....   .+++..+..++.|++++|+|||+.   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        85 ~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          85 GGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999985433   789999999999999999999997   9999999999999999999999999999877654431 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ......++..|+|||.+.....+.++||||||+++++|++|+.|+......  ...........        ..  ...+
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------~~--~~~~  226 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSG--------EP--PEIP  226 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccccC--------CC--cCCC
Confidence            122345888999999999888999999999999999999999999765411  11111111000        00  0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ......+.+++.+|++.+|.+||++.+++++
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            2335788999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.2e-31  Score=289.76  Aligned_cols=264  Identities=23%  Similarity=0.299  Sum_probs=197.1

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC-------
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-------  573 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-------  573 (818)
                      ..+.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            34556678999999999999986 58899999986543  233456788999999999999999999987654       


Q ss_pred             ---cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeec
Q 043017          574 ---NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF  650 (818)
Q Consensus       574 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  650 (818)
                         ..++|+||+++ +|...+...  ...+++..+..++.||+.||+|||+.   +|+|+||||+||++++++.+||+||
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence               78999999976 676666432  34689999999999999999999997   9999999999999999999999999


Q ss_pred             CCceecccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--
Q 043017          651 GLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--  727 (818)
Q Consensus       651 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--  727 (818)
                      |++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+........  
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9998765443222222346778999998865 4578999999999999999999999975543332222222111110  


Q ss_pred             -chhhcccc--------CcC----ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 -LCDLVDKK--------SED----MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 -~~~~~d~~--------~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..++....        ...    ..........+.+++..||+.+|.+||++.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00000000        000    00001124678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=6.8e-32  Score=283.81  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=202.4

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|+||.||+++.. +++.+|+|.+....  .....++.+|++++++++|+||+++++++.+....++||||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            34567999999999999865 57899999986542  2335678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +++|.+++.+.. ....++++.+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++......   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            999999986522 235688999999999999999999997   9999999999999999999999999999876554   


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ......++..|++||.+.+..++.++|+||||++++||++|+.|+...+...+...+.    ..        ....  ..
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~--------~~~~--~~  222 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ----RG--------KYPP--IP  222 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cC--------CCCC--Cc
Confidence            2222457889999999999889999999999999999999999997654332222111    11        0111  12


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++.+++.+|++.+|++||++.+++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2456778999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=5.7e-32  Score=291.32  Aligned_cols=256  Identities=21%  Similarity=0.287  Sum_probs=182.2

Q ss_pred             hHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCCCccH-----------HHHHHHHHHHhccCcceeEEEeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGENRGK-----------KEFLSEVETIGNIHHFNLVRLVGYC  569 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~-----------~~f~~Ev~~l~~l~H~niv~l~g~~  569 (818)
                      .+.+.++||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            45566789999999999999764    34566665432221111           1122334456677899999999977


Q ss_pred             cccC----cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCE
Q 043017          570 AERS----NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV  645 (818)
Q Consensus       570 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~  645 (818)
                      ....    ..++++|++. .++.+.+...   ...++..+..|+.|+++||+|||+.   +|+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence            6544    3367777763 3555555322   2356778899999999999999997   99999999999999999999


Q ss_pred             EEeecCCceecccCCCc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-chHHHH
Q 043017          646 KIADFGLARLIAQDQSH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-DYLVDT  718 (818)
Q Consensus       646 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~~  718 (818)
                      +|+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ..+...
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999876533211      11224699999999999999999999999999999999999999986632 222221


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ..... ..++   ..... .   .......+.+++..|++.+|++||++.++++.|+
T Consensus       246 ~~~~~-~~~~---~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        246 AKCDF-IKRL---HEGKI-K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHH-HHHh---hhhhh-c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11100 0000   00000 0   1123467889999999999999999999999874

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=286.97  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ..+.||+|++|.||++... +++.+++|++.....  .....+.+|++++++++|+||+++++++..+...++||||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            3457999999999999975 688999999865432  2456788999999999999999999999999999999999975


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                       +|.+++....  ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||.+........ ..
T Consensus        83 -~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~  155 (283)
T cd05118          83 -DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY  155 (283)
T ss_pred             -CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence             8888875432  4689999999999999999999997   999999999999999999999999999987765431 12


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh--c-chhhcc-------
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD--R-LCDLVD-------  733 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~--~-~~~~~d-------  733 (818)
                      ....++..|+|||.+.+. ..+.++||||||+++++|++|+.||...+.......+.......  . ......       
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            224577889999998776 78999999999999999999999987554432222221110000  0 000000       


Q ss_pred             ----cc-CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 ----KK-SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ----~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          .. ............++.+++..||+.+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                00 00000112346788999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=2e-31  Score=289.80  Aligned_cols=262  Identities=21%  Similarity=0.227  Sum_probs=194.7

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.+|.|+++.||+++. +++.||||++...  .....+.+..|++++++++|+||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666666777666 5899999998654  3345578999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc---
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH---  662 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~---  662 (818)
                      +|.+++.... ...+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.+.........   
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999986432 23578889999999999999999997   9999999999999999999999999998765432111   


Q ss_pred             ---cccCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH-HHHHHHhh-----------h
Q 043017          663 ---VSTMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV-DTLKVKAE-----------A  725 (818)
Q Consensus       663 ---~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~-~~~~~~~~-----------~  725 (818)
                         ......++..|+|||.+...  .++.++||||||+++|||++|+.||......... +.......           .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence               11223467789999998763  5789999999999999999999999754322211 11100000           0


Q ss_pred             hcchh----hccc---cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          726 DRLCD----LVDK---KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       726 ~~~~~----~~d~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .....    ..+.   .............++.+++.+||+.+|++|||+++++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            00000    0000   0001111233456788999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=283.30  Aligned_cols=243  Identities=25%  Similarity=0.318  Sum_probs=189.6

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHH-hccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETI-GNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l-~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.||+|+||.||+|... +++.||||.+.....   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            45899999999999875 588999999865432   1223345555444 445899999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...   ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||++.....     .
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            9999998543   3588999999999999999999997   999999999999999999999999999876433     1


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....++..|+|||.+.+..++.++||||||++++||++|..||...........+...    .    ....   ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~----~~~~---~~~~~~  219 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR----R----INWP---EEVKEF  219 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----c----cCCC---Cccccc
Confidence            2235788999999998888899999999999999999999999765443332222110    0    0000   001113


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ....+.+++.+||+.+|++||++.++.+.|
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            456788999999999999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=1.1e-31  Score=296.76  Aligned_cols=257  Identities=24%  Similarity=0.282  Sum_probs=193.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeeccc------Ccce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~  576 (818)
                      +...+.||+|+||.||++... +++.||||.+...  ......++.+|+.++++++|+||+++++++...      ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            334467999999999999965 6899999998643  223345778899999999999999999988643      3569


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+. ++|.+.+..     .++...+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        98 lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          98 LVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             EEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            9999995 588777732     278889999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hc-------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DR-------  727 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~-------  727 (818)
                      .....  .....++..|+|||.+.+..++.++||||||+++++|++|+.||...+.......+......  ..       
T Consensus       169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            44322  22345788999999999999999999999999999999999999754322111111100000  00       


Q ss_pred             ----------------chhhccccCc---CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 ----------------LCDLVDKKSE---DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ----------------~~~~~d~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                                      +...+.....   ...........+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                            0000000000   000011345677899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.6e-31  Score=292.44  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=193.1

Q ss_pred             hhcccc--cceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRG--GSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++||+|  +||+||++... +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467777  89999999975 689999999865432  2346788999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc-
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-  663 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  663 (818)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886532 23588889999999999999999987   99999999999999999999999998654332211110 


Q ss_pred             -----ccCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH-HHHHHHhhhh---------
Q 043017          664 -----STMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV-DTLKVKAEAD---------  726 (818)
Q Consensus       664 -----~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~-~~~~~~~~~~---------  726 (818)
                           .....++..|+|||++.+.  .++.++|||||||+++||++|+.||......... ..+......+         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0112345679999999764  4789999999999999999999999754322111 1100000000         


Q ss_pred             ---------c----ch----------hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          727 ---------R----LC----------DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       727 ---------~----~~----------~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                               .    +.          ...+.. ...+........+.+++.+||+.||++|||+.|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSER-LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhhccchhhhhcccccchhcccccccccccc-ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                     0    00          000000 01111234567889999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=3.7e-32  Score=313.18  Aligned_cols=265  Identities=22%  Similarity=0.336  Sum_probs=186.1

Q ss_pred             hhHHhhhhcccccceeEEEeEecC--CcEEEEE------------------EcCCCCCccHHHHHHHHHHHhccCcceeE
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND--GTKVAVK------------------RLYPGENRGKKEFLSEVETIGNIHHFNLV  563 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~--g~~vAVK------------------~l~~~~~~~~~~f~~Ev~~l~~l~H~niv  563 (818)
                      ..|.+.++||+|+||+||++.++.  +...++|                  .+. ........+.+|++++++++|+||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcC
Confidence            445566789999999999987542  2222222                  111 1122345688999999999999999


Q ss_pred             EEeeeecccCcceeeeeccCCCChhhHhhhcCC--ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       564 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      ++++++...+..++|+|++ .++|.+++.....  ........+..|+.||+.||+|||+.   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            9999999999999999998 5677777654221  12234566778999999999999997   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCCch---HHH
Q 043017          642 DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSS-NPKGGDY---LVD  717 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~-~~~~~~~---l~~  717 (818)
                      ++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|+.++ .......   +..
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            999999999999877554333333456899999999999999999999999999999999987543 3222221   111


Q ss_pred             HHHHHhh-hh-------cchhhcccc-----CcCcc---CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          718 TLKVKAE-AD-------RLCDLVDKK-----SEDMQ---SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       718 ~~~~~~~-~~-------~~~~~~d~~-----~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+..... ..       .+.+.++..     .....   .......++.+++.+||+.||++|||+.|++++
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1110000 00       001111100     00000   000122456778999999999999999999975

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=1.7e-31  Score=293.54  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhcc-CcceeEEEeeeeccc--Cccee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAER--SNRFL  577 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~--~~~~l  577 (818)
                      ..+.+.+.||+|+||.||+|... +++.+|||++...  .......+.+|+.+++++ +|+||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            34666789999999999999976 5789999988543  233345678899999999 999999999998654  36799


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||++ ++|..++...    .+++..+..++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          87 VFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             Eecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            999996 5898887432    678889999999999999999997   99999999999999999999999999998765


Q ss_pred             cCCCc----cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-------
Q 043017          658 QDQSH----VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-------  725 (818)
Q Consensus       658 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-------  725 (818)
                      .....    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            43321    2223458889999998765 45789999999999999999999998654432221111111000       


Q ss_pred             ----hcchhhccccC----cC-ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          726 ----DRLCDLVDKKS----ED-MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       726 ----~~~~~~~d~~~----~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          .....+++...    .. .........++.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                00000110000    00 00011135678899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=1.1e-31  Score=291.24  Aligned_cols=262  Identities=25%  Similarity=0.282  Sum_probs=196.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e  580 (818)
                      +++.++||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.++.+++|+||+++++++...  +..++|||
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            445567999999999999975 589999999864322  2234567899999999999999999998755  45799999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+. ++|.+++....  ..+++..+..++.||++||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          89 YCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             cCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            996 58888875432  4689999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--ch--------
Q 043017          661 SHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--LC--------  729 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--~~--------  729 (818)
                      .. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+.  ..        
T Consensus       163 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         163 KP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            21 122345788999999865 4578999999999999999999999976554433333222111100  00        


Q ss_pred             -hhccccCcCccC----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          730 -DLVDKKSEDMQS----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       730 -~~~d~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                       ..+.........    ......++.+++.+||+.||++|||+.+++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             000000000000    011356678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=1.3e-31  Score=288.28  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=193.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.++||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|+||+++++++......++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            344568999999999999976 688999998864422  33467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceecccCCC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~  661 (818)
                      + ++|.+++.... ...+++..+..++.||+.||+|||+.   +++|+||+|+||+++. ++.+||+|||++........
T Consensus        84 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         84 D-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             c-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            5 57877774332 23457788889999999999999997   9999999999999985 55799999999976543321


Q ss_pred             ccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh---c------chhh
Q 043017          662 HVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD---R------LCDL  731 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~---~------~~~~  731 (818)
                      . .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+   .      +.+.
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence            1 122357889999998866 457899999999999999999999987554322211111100000   0      0000


Q ss_pred             ccc--cCcCc---cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDK--KSEDM---QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~--~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...  .....   ........++.+++.+|++.+|++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000  00000   0011234568899999999999999999999874

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=7.3e-32  Score=296.22  Aligned_cols=265  Identities=27%  Similarity=0.358  Sum_probs=195.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV  578 (818)
                      +.+.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++.+++|+||+++++++....     ..++|
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            344568999999999999864 68999999986432 233567889999999999999999999876543     57899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +||++ ++|.+++..    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        87 ~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          87 QELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             ehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99996 477776632    4589999999999999999999997   999999999999999999999999999987644


Q ss_pred             CCCcc--ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh---hcchhhc
Q 043017          659 DQSHV--STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DRLCDLV  732 (818)
Q Consensus       659 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~---~~~~~~~  732 (818)
                      .....  .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+......   .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            32211  122457889999998754 56899999999999999999999998654321111111100000   0000000


Q ss_pred             cc--------cCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCc
Q 043017          733 DK--------KSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLT  778 (818)
Q Consensus       733 d~--------~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~  778 (818)
                      +.        ......     .......++.+++.+||+.+|++||++.|++++  |+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00        000000     011234678899999999999999999999998  55544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=1.3e-31  Score=290.21  Aligned_cols=262  Identities=23%  Similarity=0.305  Sum_probs=192.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC--------c
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--------N  574 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------~  574 (818)
                      +.+.++||+|+||.||++... +++.||||.+....  ......+.+|++++++++||||+++++++....        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            445568999999999999975 58899999885432  222345678999999999999999999986654        3


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      .++||||+. ++|.+++...  ...+++.++..++.||++||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence            499999986 5787777432  23589999999999999999999997   99999999999999999999999999998


Q ss_pred             ecccCCCc---cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hcc
Q 043017          655 LIAQDQSH---VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DRL  728 (818)
Q Consensus       655 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~~  728 (818)
                      ........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+......  +..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            76543221   11223567889999988664 4788999999999999999999998765443333322221110  000


Q ss_pred             -h-----hhccc-cCcCcc--------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 -C-----DLVDK-KSEDMQ--------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 -~-----~~~d~-~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       .     +..+. ......        ........+.+++.+||+.+|.+|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence             0     00000 000000        001123466789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=279.36  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=200.7

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.||+|++|.||+++.. +++.+++|.+.....  ...+.+.+|++++.+++|+|++++++++..+...+++|||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            34568999999999999876 578999999876543  345789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        83 ~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          83 NGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            99999988543   4689999999999999999999987   9999999999999999999999999999877654332 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....++..|+|||...+...+.++|||++|+++++|++|+.|+........   ...... ..     ...     .+.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~~~~-~~-----~~~-----~~~  221 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFRIVQ-DD-----HPP-----LPE  221 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhc-cC-----CCC-----CCC
Confidence            2234578899999999888889999999999999999999999864432111   111100 00     000     112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.+|++||++.+++..
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            234678899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=294.85  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=205.4

Q ss_pred             hHHhhhhcccccceeEEEeEecCC-cEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDG-TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..++.-.||.|+||.|||++.++. -..|.|++...+....++|+-|+++|+...||+||+|++.|..++.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            344555799999999999997753 3457787776677778899999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ||-.+.++..-+  ..|.+.++.-+++|++.||.|||+.   +|||||||+.|||++-+|.++|+|||.+....... ..
T Consensus       113 GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk  186 (1187)
T KOG0579|consen  113 GGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK  186 (1187)
T ss_pred             CchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence            999999886544  5799999999999999999999998   99999999999999999999999999986543321 22


Q ss_pred             ccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          664 STMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .....||+.|||||+..     ..+|..++||||||+.|.||.-+.+|-........+-.+.            ...++.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia------------KSePPT  254 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------------KSEPPT  254 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh------------hcCCCc
Confidence            23356999999999874     4679999999999999999999998865443322222111            112222


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+......+.+++.+||..+|..||++++++++
T Consensus       255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            33366788899999999999999999999999876

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-33  Score=321.68  Aligned_cols=245  Identities=29%  Similarity=0.410  Sum_probs=197.3

Q ss_pred             hcccccceeEEEeEe-cCCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          511 RLGRGGSGSVFEGLL-NDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      .||.|.||.||-+.. ++|.-.|||-+...  .....+...+|+.++..++|||+|+++|.-.+.+..+|.||||.+|+|
T Consensus      1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred             ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence            699999999999985 56888999976543  334456788999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC---ccc
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVS  664 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~  664 (818)
                      .+.+.+..   ..++.....+..|++.|++|||++   +||||||||.||+|+.+|.+|++|||.|..+.....   ...
T Consensus      1322 a~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1322 ASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             HHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            99986543   456666777889999999999998   999999999999999999999999999998866531   111


Q ss_pred             cCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 TMPKGTPGYMAPELTRGN---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ....||+.|||||.+.+.   ....+.||||+||+++||+||++||...+.+.-.   ..+...+.          ..+.
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI---My~V~~gh----------~Pq~ 1462 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI---MYHVAAGH----------KPQI 1462 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH---HhHHhccC----------CCCC
Confidence            234699999999999764   3567899999999999999999999876654311   11111111          1111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      +...+.+-.+++..||+.||+.|.++.|++++=
T Consensus      1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            333555667889999999999999999988763

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.2e-31  Score=289.12  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=193.3

Q ss_pred             hHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .+.+.+.||+|+||.||+++..+ ++.||||++..... ....++..|+.++.+.. |+||+++++++..+...+++|||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            34556789999999999999875 88999999865432 33456777887777774 99999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      ++ ++|.+++....  ..+++..+..++.|+++||+|||+.  .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus        96 ~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          96 MS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             cC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            84 57777664432  3688999999999999999999973  3899999999999999999999999999976543222


Q ss_pred             ccccCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNS----ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .  ....++..|+|||.+....    ++.++||||||+++|||++|+.||......  .+.+......         ...
T Consensus       171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~---------~~~  237 (296)
T cd06618         171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQE---------EPP  237 (296)
T ss_pred             c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcC---------CCC
Confidence            1  2234778999999987553    788999999999999999999998643221  1111111110         011


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ..+.......++.+++.+||+.+|++||++.+++++-
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            1111112346788999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=2e-31  Score=280.15  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.||.|+||.||++... +++.+++|++.....  ...+++.+|+++++.++|+|++++++.+..+...++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence            3457999999999999976 588999999875533  4567889999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          585 GSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       585 gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ++|.+++.... ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~  159 (258)
T cd08215          84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-L  159 (258)
T ss_pred             CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc-e
Confidence            99999886532 235789999999999999999999997   999999999999999999999999999987655431 2


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....+++.|+|||.+....++.++||||+|+++++|++|+.|+.......+.....    ..        .....  +.
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~--------~~~~~--~~  225 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL----KG--------QYPPI--PS  225 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh----cC--------CCCCC--CC
Confidence            223457889999999988889999999999999999999999986554222222111    00        01111  11


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            344678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.4e-31  Score=288.42  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=198.1

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..++...+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            344555678999999999999975 5788999988643   222345788999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+. ++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99996 68877764332  3588999999999999999999997   999999999999999999999999999986543


Q ss_pred             CCCccccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ..     ...++..|+|||.+.   ....+.++||||||+++|||++|+.|+.............   ..         .
T Consensus       168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~---------~  230 (308)
T cd06634         168 AN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QN---------E  230 (308)
T ss_pred             cc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh---hc---------C
Confidence            22     234788999999874   3567889999999999999999999986543221111110   00         0


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .... ........+.+++.+||+.+|++||++.+++++......
T Consensus       231 ~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         231 SPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             CCCc-CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            0000 022345678899999999999999999999988654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.1e-31  Score=287.96  Aligned_cols=252  Identities=24%  Similarity=0.303  Sum_probs=197.9

Q ss_pred             hhhhcccccceeEEEeEec----CCcEEEEEEcCCCC----CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          508 FQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGE----NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +.+.||+|+||.||++...    +++.+|||.+....    ....+.+.+|++++.++ +|+||+++++.+..+...++|
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   83 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI   83 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence            4467999999999998853    57889999886432    22345788999999999 699999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++++|.+++...   ..+++..+..++.|++++|.|||+.   +++|+||+|+||+++.++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          84 LDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            9999999999988543   3588899999999999999999987   999999999999999999999999999987654


Q ss_pred             CCCccccCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNS--ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..........++..|+|||.+.+..  .+.++||||||++++||++|+.|+...........+.....        ....
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~  229 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--------KSKP  229 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--------ccCC
Confidence            4333333345788999999987665  78899999999999999999999864332221111111100        0000


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                         ..+......+.+++.+||+.+|++|||+.++.+.|+-
T Consensus       230 ---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         230 ---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence               1112234567889999999999999999988887753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=300.26  Aligned_cols=268  Identities=27%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             hhhcccccceeEEEeEe-cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccC------cceeeee
Q 043017          509 QIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRFLVYE  580 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV~e  580 (818)
                      .+.||+|+||.||+|+. ..|+.||||.+.... ....+...+|+++|++++|+|||++++.-.+..      ..++|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            45799999999999995 569999999997653 344567789999999999999999999865543      5689999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc--CCC--CEEEeecCCceec
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD--RDL--NVKIADFGLARLI  656 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~Dfgla~~~  656 (818)
                      ||.+|+|+..|..-++...|++.+.+.++.+++.||.|||++   +|+||||||.||++-  ++|  ..||+|||.|+.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999998878888899999999999999999999998   999999999999993  333  4799999999988


Q ss_pred             ccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhh-c-chh--
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEAD-R-LCD--  730 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~-~-~~~--  730 (818)
                      ..+.  ......||..|++||++.. +.++..+|.|||||++|+.+||..||.+..... ..+.++...... . +.-  
T Consensus       175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            6655  3445689999999999994 889999999999999999999999998875542 111111111110 0 000  


Q ss_pred             ------hcccc--Cc-CccCcHHHHHHHHHHHHHccccCCCCCC--cHHHHHHHHhcCcCCC
Q 043017          731 ------LVDKK--SE-DMQSHRDDAVKMIQIAISCLQKNLHRRP--SASMLVKVLQGLTKLE  781 (818)
Q Consensus       731 ------~~d~~--~~-~~~~~~~~~~~l~~li~~cl~~dp~~RP--t~~evl~~L~~i~~~~  781 (818)
                            -++..  ++ .....+....++.+.+..+|.-+|++|.  ...+....+..|....
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence                  00000  01 1111345667777888889999999998  6666666666555443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=4e-31  Score=283.07  Aligned_cols=259  Identities=25%  Similarity=0.306  Sum_probs=194.0

Q ss_pred             hhhhcccccceeEEEeEecC-CcEEEEEEcCCCCC--ccHHHHHHHHHHHhcc---CcceeEEEeeeecccCc-----ce
Q 043017          508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN--RGKKEFLSEVETIGNI---HHFNLVRLVGYCAERSN-----RF  576 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~~~-----~~  576 (818)
                      +.+.||+|+||.||+|+.+. ++.+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            34579999999999999874 89999999864422  2234566787776665   69999999999988776     89


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ++|||++ ++|.+++..... ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++...
T Consensus        83 l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          83 LVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            9999996 588888854332 3589999999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc--------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL--------  728 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~--------  728 (818)
                      ......  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...........+.........        
T Consensus       158 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         158 SFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             cCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            443221  1234688899999999989999999999999999999999988765443322222111100000        


Q ss_pred             --hhhccccCcC--ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 --CDLVDKKSED--MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 --~~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ..........  ..........+.+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence              0000000000  00012334677899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=284.14  Aligned_cols=259  Identities=26%  Similarity=0.350  Sum_probs=195.5

Q ss_pred             hhhhcccccceeEEEeEecC-CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.||+|+||+||+|+..+ ++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+ +
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~   81 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E   81 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence            45679999999999999864 78899999865422 22334567999999998 999999999999999999999999 8


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||++.........  
T Consensus        82 ~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (283)
T cd07830          82 GNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--  155 (283)
T ss_pred             CCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence            89988885433 24689999999999999999999997   9999999999999999999999999999876443221  


Q ss_pred             cCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh---------hcchhhccc
Q 043017          665 TMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---------DRLCDLVDK  734 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~---------~~~~~~~d~  734 (818)
                      ....++..|+|||.+.. ..++.++|+||||++++||++|+.||...........+......         ..+...++.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            22347889999998754 45799999999999999999999998655432222111110000         000000000


Q ss_pred             cCcCcc------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDMQ------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ......      .......++.+++.+||+.+|++||+++|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000      001124678899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-31  Score=292.71  Aligned_cols=266  Identities=26%  Similarity=0.338  Sum_probs=203.8

Q ss_pred             HhhhhcccccceeEEEeEecC-CcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceee
Q 043017          507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLV  578 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV  578 (818)
                      .+.+.||+|+||.||+++... ++.+|||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+++
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            455689999999999999764 8899999987543  344568899999999999999999999988775     78999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||++ ++|.+++...   ..+++..+..++.||++||+|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          83 TELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             ecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99997 5888887432   3689999999999999999999997   999999999999999999999999999997655


Q ss_pred             CCC--ccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--------
Q 043017          659 DQS--HVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--------  727 (818)
Q Consensus       659 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--------  727 (818)
                      ...  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+........        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            431  112234578899999999887 789999999999999999999999976654332222221111000        


Q ss_pred             ---chhhccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCcC
Q 043017          728 ---LCDLVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLTK  779 (818)
Q Consensus       728 ---~~~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~  779 (818)
                         ....+........     ........+.+++.+||+.+|++||++.+++++  ++++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence               0000000000000     011235678899999999999999999999986  555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=281.37  Aligned_cols=248  Identities=24%  Similarity=0.323  Sum_probs=193.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-----CCccHHHHHHHHHHHhccCcceeEEEeeeeccc--Cccee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-----ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFL  577 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~l  577 (818)
                      +.+.+.||+|+||.||++... +++.+|+|.+...     ..+....+.+|++++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            345678999999999999965 5889999987432     122345788999999999999999999998664  35789


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ++||+++++|.+++...   ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          84 FVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            99999999999988543   3478888999999999999999997   99999999999999999999999999998654


Q ss_pred             cCCC--ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          658 QDQS--HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       658 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ....  .......++..|+|||.+.+...+.++||||||++++||++|+.||.......   .+......+         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~---------  225 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIFKIATQP---------  225 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHHHHHcCC---------
Confidence            3111  11122457889999999998889999999999999999999999986442221   111111000         


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       .....+......+.+++.+|++ +|.+||++.+++.+
T Consensus       226 -~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 -TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             0011123445678899999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.6e-31  Score=285.40  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=194.5

Q ss_pred             HhhhhcccccceeEEEeEe----cCCcEEEEEEcCCCC----CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCccee
Q 043017          507 DFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGE----NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.||+|+||.||++..    .+|+.||+|++....    ....+.+.+|++++.++ +|+||+++++++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            3456799999999999986    368899999986532    22346788899999999 69999999999999889999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++...   ..+++..+..++.|+++||.|||+.   +++||||+|+|||++.++.+||+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          83 ILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999998543   3578889999999999999999997   99999999999999999999999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ...........++..|+|||.+...  ..+.++||||||+++|+|++|+.|+...........+.....     .   ..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~---~~  228 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-----K---SE  228 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-----c---cC
Confidence            4333322334588899999998753  467899999999999999999999864322211111111100     0   00


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .   +.+......+.+++.+|++.+|++||     ++.+++.+
T Consensus       229 ~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 P---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             C---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            0   01122446778999999999999997     66666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4e-31  Score=290.26  Aligned_cols=259  Identities=27%  Similarity=0.281  Sum_probs=195.5

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCCcc--------------HHHHHHHHHHHhccCcceeEEEeeeecccC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRG--------------KKEFLSEVETIGNIHHFNLVRLVGYCAERS  573 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~  573 (818)
                      .+.||+|+||.||++... +++.||||.+.......              ...+.+|++++.+++|+||+++++++..++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            456999999999999965 58999999886442221              125788999999999999999999999999


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++||||+. ++|.+++...   ..++++....++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence            9999999996 6898888532   3588999999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCC-------------CccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHH
Q 043017          654 RLIAQDQ-------------SHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL  719 (818)
Q Consensus       654 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~  719 (818)
                      .......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            8765111             0111123467889999998764 4689999999999999999999999766544333322


Q ss_pred             HHHhhhhcch---hhcc--------cc-CcC-ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          720 KVKAEADRLC---DLVD--------KK-SED-MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       720 ~~~~~~~~~~---~~~d--------~~-~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ......+.-.   +...        .. ... .........++.+++.+||+.+|++||++.+++.+-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            2211111000   0000        00 000 000112346788999999999999999999999864

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.9e-31  Score=292.75  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=197.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecc----cCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV  578 (818)
                      +.+.+.||+|+||.||++... +++.||+|++....  ......+.+|+.++.+++|+||+++++++..    ....++|
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv   86 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV   86 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence            344567999999999999965 58999999986542  2345677889999999999999999998753    3467999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+. ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        87 ~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          87 MDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             Eehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99995 6898887432   3589999999999999999999997   999999999999999999999999999987644


Q ss_pred             CCCcc---ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh---------
Q 043017          659 DQSHV---STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---------  725 (818)
Q Consensus       659 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~---------  725 (818)
                      .....   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            32211   123468889999999865 45889999999999999999999999765432222211111000         


Q ss_pred             --hcchhhccccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          726 --DRLCDLVDKKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       726 --~~~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                        ..+...++........     ......++.+++.+||+.+|++||++++++.+-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence              0011111100000000     122457789999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=4.7e-31  Score=281.79  Aligned_cols=242  Identities=22%  Similarity=0.284  Sum_probs=187.8

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHH---HHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVE---TIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|..   .+....|++|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999875 588999998865421   22223444544   3444579999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...   ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++..+.....  
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            99999888532   4689999999999999999999997   999999999999999999999999999976543221  


Q ss_pred             ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............. ....      ....     .+
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~------~~~~-----~~  219 (278)
T cd05606         153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLT------MAVE-----LP  219 (278)
T ss_pred             -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hhhc------cCCC-----CC
Confidence             224589999999999754 68999999999999999999999997553322111111 0000      0001     11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      ...+.++.+++.+|++.+|.+||     ++.+++++
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            12356788999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=9.3e-31  Score=277.79  Aligned_cols=234  Identities=24%  Similarity=0.309  Sum_probs=183.6

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCChhh
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      ||+|+||.||++... +++.+|+|.+........     |+.....+ +|+||+++++.+...+..++||||+++++|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            599999999999865 578899998754322111     22222222 79999999999999999999999999999999


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccCCCccccCCC
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQSHVSTMPK  668 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~  668 (818)
                      ++...   ..++++.+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++.......     ...
T Consensus        99 ~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~  167 (267)
T PHA03390         99 LLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYD  167 (267)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCC
Confidence            98543   2689999999999999999999997   999999999999999998 99999999998654322     235


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH-HHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV-DTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       669 gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      ++..|+|||++.+..++.++||||||++++||++|+.||.......+. .......         ....   ........
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~  235 (267)
T PHA03390        168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---------QKKL---PFIKNVSK  235 (267)
T ss_pred             CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---------cccC---CcccccCH
Confidence            788999999999889999999999999999999999999744333211 1111110         0111   11224556


Q ss_pred             HHHHHHHHccccCCCCCCc-HHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPS-ASMLVKV  773 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt-~~evl~~  773 (818)
                      .+.+++.+||+.+|.+||+ +++++++
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        236 NANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHHHHHHHHhccChhhCCchHHHHhcC
Confidence            7889999999999999995 6888853

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-30  Score=287.27  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=193.1

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC------cceeee
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRFLVY  579 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV~  579 (818)
                      ...||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++|+||+++++++....      ..++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            357999999999999964 6899999998643  2223456889999999999999999999987543      458999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+. .+|..++.     ..++++.+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus       100 e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879         100 PYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             cccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            9986 46766541     3588899999999999999999997   9999999999999999999999999998764322


Q ss_pred             CCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh--hhcchh------
Q 043017          660 QSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE--ADRLCD------  730 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~--~~~~~~------  730 (818)
                          .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.....  .+.+.+      
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence                122356788999999876 4688999999999999999999999975543222211111000  000000      


Q ss_pred             ---hccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCcCCCC
Q 043017          731 ---LVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLTKLEP  782 (818)
Q Consensus       731 ---~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~  782 (818)
                         .+........     .......++.+++.+||+.||++||++.+++.+  ++...+.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~  308 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE  308 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence               0000000000     001234568899999999999999999999976  776665443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=7.6e-31  Score=285.20  Aligned_cols=241  Identities=26%  Similarity=0.346  Sum_probs=190.8

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .++||+|+||.||+|+.. +++.|++|.+.....   ...+.+.+|++++++++|+|++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            356999999999999975 588999999864432   233568899999999999999999999999999999999995 


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...  ...+++..+..++.||+.+|+|||+.   +++|+||+|+||+++.++.+||+|||++......     
T Consensus       105 ~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----  174 (313)
T cd06633         105 GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----  174 (313)
T ss_pred             CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence            5777776433  24588999999999999999999997   9999999999999999999999999998643221     


Q ss_pred             cCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 TMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ....++..|+|||++.   ...++.++||||||+++|||++|+.|+.............   .. .        .... .
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~-~--------~~~~-~  241 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QN-D--------SPTL-Q  241 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hc-C--------CCCC-C
Confidence            2345788999999984   4568899999999999999999999986554322221111   00 0        0000 0


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......+.+++.+||+.+|.+||++.+++++
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11233567889999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=6e-31  Score=280.91  Aligned_cols=259  Identities=28%  Similarity=0.362  Sum_probs=198.7

Q ss_pred             hhhhcccccceeEEEeEecC-CcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.||+|+||.||+|+..+ ++.+|+|.+....  ....+.+..|+.++++++|+||+++++++.+.+..++||||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            34579999999999999864 8999999987653  3335678899999999999999999999999999999999997 


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++....  ..+++..+..++.|+++||+|||+.   +|+|+||+|+||++++++.+||+|||++......... .
T Consensus        82 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~  155 (282)
T cd07829          82 MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y  155 (282)
T ss_pred             cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence            58999986532  3689999999999999999999997   9999999999999999999999999999876543221 1


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc------chhh--cccc
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR------LCDL--VDKK  735 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~------~~~~--~d~~  735 (818)
                      ....++..|+|||.+.+. .++.++||||||++++||++|+.||...........+........      ....  .+..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            223456789999998776 789999999999999999999999876543322222211110000      0000  0000


Q ss_pred             CcCcc------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 SEDMQ------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 ~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+...      ........+.+++.+||+.+|++||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000      011224678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-32  Score=271.35  Aligned_cols=248  Identities=28%  Similarity=0.350  Sum_probs=205.7

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHH---HHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~---~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ...+|.+.||+|.||.|-..+-+ .++.+|+|.+++.-...+.   .-+.|-++|+..+||.+..|...|...+++++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            45677889999999999999865 5899999999765433333   3466889999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||..+|.|.-+|.+   .+.+++...+.+-..|..||.|||+.   +||+||||.+|.|+|.+|++||+||||++.-...
T Consensus       248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999888844   45799999999999999999999997   9999999999999999999999999999875444


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ... +....||+.|+|||++....|....|-|.+||++|||++|+.||...+.+.+.+.+-.               ++.
T Consensus       322 g~t-~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~---------------ed~  385 (516)
T KOG0690|consen  322 GDT-TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM---------------EDL  385 (516)
T ss_pred             cce-eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---------------hhc
Confidence            333 3446899999999999999999999999999999999999999987766655554321               111


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      ..++....+...|+.-.|..||.+|.     .+.||.++
T Consensus       386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            22344456677888899999999994     56666654

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=3.6e-31  Score=290.88  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=195.8

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceeee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLVY  579 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV~  579 (818)
                      ..+.||+|+||.||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++....     ..++||
T Consensus         9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858           9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence            3457999999999999865 5899999998643  2333557788999999999999999999886542     479999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+. ++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        89 e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          89 ELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             eCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            9995 7888887432   4589999999999999999999997   9999999999999999999999999999876443


Q ss_pred             CCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-----------hc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-----------DR  727 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-----------~~  727 (818)
                      . .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+.......+......           ..
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         162 G-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             c-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            2 12223457889999998865 46899999999999999999999999654322211111111000           00


Q ss_pred             chhhccccCcCc-----cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcC
Q 043017          728 LCDLVDKKSEDM-----QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGL  777 (818)
Q Consensus       728 ~~~~~d~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i  777 (818)
                      ....+.......     ........++.+++.+||+.+|++|||+++++++  |+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000000000     0012345678899999999999999999999988  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.2e-31  Score=283.86  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeec
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|++++++++ |+||+++++++...+..++|||+
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            34567999999999999976 6899999998653   2233467889999999998 99999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          84 APNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            9999999998543   3699999999999999999999997   999999999999999999999999999987654322


Q ss_pred             -------------------ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHH
Q 043017          662 -------------------HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK  722 (818)
Q Consensus       662 -------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~  722 (818)
                                         .......++..|+|||.......+.++||||||++++++++|+.|+.............  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--  235 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--  235 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence                               11122357889999999988889999999999999999999999987554221111111  


Q ss_pred             hhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcH----HHHHHH
Q 043017          723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSA----SMLVKV  773 (818)
Q Consensus       723 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~~  773 (818)
                       ..            ....+......+.+++.+||+.+|++||++    .+++++
T Consensus       236 -~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         236 -KL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -hc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence             00            001122335678899999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=5.5e-31  Score=278.03  Aligned_cols=249  Identities=25%  Similarity=0.333  Sum_probs=194.0

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCC-----CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPG-----ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +.+.++||+|+||.||+++... +..+++|.++..     ......++..|+.++.+++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            3456789999999999998754 444555555432     1223346778999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      ||+++++|.+++... .....+++..+..++.|+++||.|||+.   +++|+||+|+||+++. +.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            999999999988542 2345689999999999999999999997   9999999999999975 5699999999987644


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.....   .........         .... 
T Consensus       158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~---------~~~~-  223 (260)
T cd08222         158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVE---------GPTP-  223 (260)
T ss_pred             Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHc---------CCCC-
Confidence            322 22234578899999999888889999999999999999999999864322   111111110         0010 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..+.....++.+++.+|++.+|++||++.+++++
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             1123455688899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.6e-31  Score=308.53  Aligned_cols=254  Identities=29%  Similarity=0.395  Sum_probs=183.1

Q ss_pred             HHhhHHhhh--hcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccC----
Q 043017          502 KSATRDFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS----  573 (818)
Q Consensus       502 ~~~t~~f~~--~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----  573 (818)
                      .+...+|++  .||+||||.|||++-+ ||+.+|||++.... ......+.+|+.++++|+|||||+++..+.+..    
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345567765  6999999999999965 89999999986553 333456889999999999999999976431100    


Q ss_pred             --------------------------------------------------------------------------------
Q 043017          574 --------------------------------------------------------------------------------  573 (818)
Q Consensus       574 --------------------------------------------------------------------------------  573 (818)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHH
Q 043017          574 -----------------------------------NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY  618 (818)
Q Consensus       574 -----------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~y  618 (818)
                                                         ..|+=||||+...|++++..+....  .....++++++|++||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                               0245567777777766664322110  356788999999999999


Q ss_pred             HHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc-----------------cCCCccccCCCCCCcccccccccC
Q 043017          619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-----------------QDQSHVSTMPKGTPGYMAPELTRG  681 (818)
Q Consensus       619 LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~  681 (818)
                      +|+.   +||||||||.|||+|++..+||+|||+|....                 .......+...||.-|+|||++.+
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9998   99999999999999999999999999998721                 001112344679999999999976


Q ss_pred             C---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccc
Q 043017          682 N---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQ  758 (818)
Q Consensus       682 ~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~  758 (818)
                      .   .|+.|+|+||+|+||+||+.   ||...  .+-...+.... .+.+       +.......+....-.++|.++++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-~g~i-------P~~~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-KGSI-------PEPADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-cCCC-------CCCcccccccchHHHHHHHHHhc
Confidence            4   49999999999999999994   45421  11112221111 1111       00011123344455688999999


Q ss_pred             cCCCCCCcHHHHHHH
Q 043017          759 KNLHRRPSASMLVKV  773 (818)
Q Consensus       759 ~dp~~RPt~~evl~~  773 (818)
                      +||.+|||+.|+|..
T Consensus       857 hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  857 HDPSKRPTATELLNS  871 (1351)
T ss_pred             CCCccCCCHHHHhhc
Confidence            999999999999864

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=6.3e-31  Score=285.09  Aligned_cols=262  Identities=25%  Similarity=0.302  Sum_probs=191.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC--------c
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--------N  574 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------~  574 (818)
                      +.+.+.||+|+||.||+|+.. +++.+|||++....  ......+.+|++++++++|+||+++++++.+..        .
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            344567999999999999975 58899999885432  222356788999999999999999999875443        4


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      .++||||+.. +|...+...  ...+++..+..++.|+++||+|||+.   +|+|+||||+||++++++.+||+|||++.
T Consensus        90 ~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          90 VYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             EEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence            5899999864 676666432  24689999999999999999999997   99999999999999999999999999998


Q ss_pred             ecccCCCcc----------ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHh
Q 043017          655 LIAQDQSHV----------STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA  723 (818)
Q Consensus       655 ~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~  723 (818)
                      .........          .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            654332211          1123467889999987654 58899999999999999999999987654433222222111


Q ss_pred             hhhc---------chhhcc-ccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          724 EADR---------LCDLVD-KKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       724 ~~~~---------~~~~~d-~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....         +....+ ......+.     .......+.+++.+||+.+|++|||+.|++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1000         000000 00000000     01123578899999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=265.82  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=195.7

Q ss_pred             hhcccccceeEEEeE-ecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          510 IRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      +.||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++.+. .|+||++|+.+|+++...|||||.|.+|+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            479999999999887 567999999999888777788999999999998 599999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC---EEEeecCCceecccCCC---
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQS---  661 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~~~~---  661 (818)
                      ..+|+.+   +.+++.++.++.++|+.||.+||..   +|.||||||+|||......   +||+||.|..-......   
T Consensus       164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            9988654   4699999999999999999999996   9999999999999966544   89999999865432211   


Q ss_pred             ---ccccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-------HHHHHHHHhhhh
Q 043017          662 ---HVSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-------LVDTLKVKAEAD  726 (818)
Q Consensus       662 ---~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-------l~~~~~~~~~~~  726 (818)
                         ....+++|+..|||||+..     ...|..++|.||||||||-||+|..||.+.-+..       .....++..-. 
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe-  316 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE-  316 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH-
Confidence               1123467999999999873     2358889999999999999999999998663321       11111111000 


Q ss_pred             cch-hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          727 RLC-DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       727 ~~~-~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      .+. .....+-+++.   ..+.+..+++...+..++..|.++.+++.
T Consensus       317 sIQEGkYeFPdkdWa---hIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWA---HISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHhccCCcCChhhhH---HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            000 00111111222   33445567777888899999999999988

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=273.76  Aligned_cols=236  Identities=27%  Similarity=0.371  Sum_probs=193.1

Q ss_pred             cccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ||+|+||.||++... +++.+|+|.+.....   .....+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 488999999865432   2356789999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCC
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP  667 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  667 (818)
                      .+++...   ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF  153 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence            9998543   3589999999999999999999997   999999999999999999999999999987654321 22334


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       668 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      .++..|+|||.+.+...+.++|+||||+++|||++|+.||...+.......+.   .         ...   ..+.....
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~---------~~~---~~~~~~~~  218 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL---K---------DPL---RFPEFLSP  218 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---c---------CCC---CCCCCCCH
Confidence            57889999999988889999999999999999999999996544322222111   0         000   11122256


Q ss_pred             HHHHHHHHccccCCCCCCcHHH
Q 043017          748 KMIQIAISCLQKNLHRRPSASM  769 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~e  769 (818)
                      .+.+++.+||+.+|++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            7889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=5.6e-31  Score=289.91  Aligned_cols=260  Identities=25%  Similarity=0.334  Sum_probs=191.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc------------
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------------  572 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------------  572 (818)
                      +.+.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...            
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            444567999999999999975 5889999998766656667899999999999999999999876544            


Q ss_pred             --CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEee
Q 043017          573 --SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIAD  649 (818)
Q Consensus       573 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D  649 (818)
                        ...++||||++ ++|.+++..    ..+++..+..++.||++||.|||+.   +++||||||+||+++ +++.+||+|
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence              24689999996 588887732    3588999999999999999999997   999999999999997 456789999


Q ss_pred             cCCceecccCCCcc--ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-
Q 043017          650 FGLARLIAQDQSHV--STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-  725 (818)
Q Consensus       650 fgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-  725 (818)
                      ||++..........  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.................. 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998764322211  122357889999998754 56888999999999999999999999755432221111110000 


Q ss_pred             -----hcch----hhcc--ccCcCcc---CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          726 -----DRLC----DLVD--KKSEDMQ---SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       726 -----~~~~----~~~d--~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           ....    ....  ......+   .......++.+++.+||+.+|++||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                 0000    0000  0000000   011234678899999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=267.67  Aligned_cols=248  Identities=27%  Similarity=0.394  Sum_probs=195.6

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      ..||.|.||+|+|-.++ .|+.+|||++..... ..+++++.|.++..+- ++||||+++|.+-.++..++.||.| ..|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            36999999999999876 589999999976644 5577889998866555 7999999999999999999999999 677


Q ss_pred             hhhHhhh--cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          587 LDKWIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       587 L~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+.+...  .-+...+++..+-+|..-...||.||.+.  .+|||||+||+|||||..|.+||+|||++..+...  ...
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iAk  224 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IAK  224 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HHh
Confidence            7765422  12234588888899999999999999986  68999999999999999999999999999766443  223


Q ss_pred             cCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          665 TMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      +.-.|-..|||||.+..  ..+..++||||||+.|+|+.||+.|+..-..  ..+.+.         ..+...++.....
T Consensus       225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~---------~Vv~gdpp~l~~~  293 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLC---------QVVIGDPPILLFD  293 (361)
T ss_pred             hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHH---------HHHcCCCCeecCc
Confidence            34468889999999964  3489999999999999999999999864432  222222         2222222211112


Q ss_pred             ---HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 ---RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ---~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         .+....+.+++..|+-.|-++||...+++++
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               3466789999999999999999999998765

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=3.3e-30  Score=281.96  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=191.6

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecc-cCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE-RSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~  582 (818)
                      .+.+.||+|+||.||++... +++.||||++...  .....+.+.+|++++.+++||||+++++++.. ....++++||+
T Consensus        13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~   92 (328)
T cd07856          13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL   92 (328)
T ss_pred             EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence            34468999999999999865 6899999987543  22335678899999999999999999998865 55788999998


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                       +++|.+++..    ..+++.....++.|+++||+|||+.   +|+|+||+|+||++++++.+||+|||++.......  
T Consensus        93 -~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--  162 (328)
T cd07856          93 -GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--  162 (328)
T ss_pred             -ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence             5688887742    3477888889999999999999997   99999999999999999999999999987543221  


Q ss_pred             cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh-----------hhcchh
Q 043017          663 VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE-----------ADRLCD  730 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~-----------~~~~~~  730 (818)
                        ....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.....           .....+
T Consensus       163 --~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         163 --TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             --CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence              22346788999998765 5689999999999999999999999875543222111111100           000000


Q ss_pred             hccccCcCccCc-----HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDMQSH-----RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.........+     .....++.+++.+||+.+|++||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000001     1234678899999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=5.3e-30  Score=280.97  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=190.2

Q ss_pred             HhhhhcccccceeEEEeEecC---CcEEEEEEcCCCC--CccHHHHHHHHHHHhcc-CcceeEEEeeeeccc----Ccce
Q 043017          507 DFQIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGE--NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAER----SNRF  576 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~----~~~~  576 (818)
                      .+.+.||+|+||.||++....   +..+|+|++....  ....+.+.+|+++++++ +|+||+++++.+...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            345679999999999999753   6789999886432  22346788999999999 599999999975432    3467


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +++||+. ++|.+++..   ...+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          83 LYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            8888875 689888843   24688999999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCc---cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh--------
Q 043017          657 AQDQSH---VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE--------  724 (818)
Q Consensus       657 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~--------  724 (818)
                      ......   ......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||...........+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            543221   1122458899999998765 4689999999999999999999999875543222221111100        


Q ss_pred             ---hhcchhhcc---ccC-cCc-cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          725 ---ADRLCDLVD---KKS-EDM-QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       725 ---~~~~~~~~d---~~~-~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         .......+.   ... ... .........+.+++.+|++.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               000000000   000 000 0001124578899999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=281.15  Aligned_cols=244  Identities=29%  Similarity=0.437  Sum_probs=201.3

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +.||.|-||+||-|+.+ +|+.||||++.+.  ...+..++.+|+.+|++++||.||.+...|+..+..+.|||.+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            57999999999999975 6999999998654  3445678999999999999999999999999999999999998 666


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCceecccCCCcc
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ..+.|...++ ..|++.....++.||+.||.|||..   +|+|+||||+|||+.+.   -++||+|||.|+.+.+...  
T Consensus       649 MLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  649 MLEMILSSEK-GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             HHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            6666654433 5688888889999999999999997   99999999999999654   4699999999998865432  


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....+||+.|+|||++..+.|...-|+||.|||+|--++|..||.  +++++.+.+++..        +..+..   ...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAa--------FMyPp~---PW~  789 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAA--------FMYPPN---PWS  789 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccc--------cccCCC---chh
Confidence            334689999999999999999999999999999999999999985  4455666655332        111111   134


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.+...+++|...||..-++|-+..+.+.+
T Consensus       790 eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  790 EISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            566778888999999999999999887654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.8e-30  Score=281.93  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=190.0

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC------cceee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRFLV  578 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV  578 (818)
                      +.+.||+|+||.||++... +++.||||++....  ......+.+|++++++++|+||+++++++....      ..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            4457999999999999864 68999999985432  223457889999999999999999999987654      35899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+ +++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        99 ~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          99 MPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             EecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            9998 7789887742    3588999999999999999999997   999999999999999999999999999986543


Q ss_pred             CCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-----------h
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-----------D  726 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-----------~  726 (818)
                      ..    ....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+......           .
T Consensus       171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         171 EM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             Cc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            21    22357889999999876 45889999999999999999999999754332111111110000           0


Q ss_pred             cchhhccccCcCc-----cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 RLCDLVDKKSEDM-----QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ~~~~~~d~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .............     ........++.+++.+|++.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000000     0011234568899999999999999999999943

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.4e-30  Score=282.41  Aligned_cols=254  Identities=25%  Similarity=0.326  Sum_probs=189.4

Q ss_pred             hhhcccccceeEEEeEe-cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc------Ccceeee
Q 043017          509 QIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNRFLVY  579 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~lV~  579 (818)
                      .+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++.+++|+||+++++++...      ...++++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  101 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  101 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence            35799999999999986 468899999986532  22346788899999999999999999988543      2357788


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      +++ +++|.+++..    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus       102 ~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~  173 (345)
T cd07877         102 HLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  173 (345)
T ss_pred             hhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence            876 7899887742    3488999999999999999999997   9999999999999999999999999998764322


Q ss_pred             CCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh--hhcchh------
Q 043017          660 QSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE--ADRLCD------  730 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~--~~~~~~------  730 (818)
                          .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.....  .+.+..      
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         174 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             ----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence                122357889999998866 5688999999999999999999999865443222222111100  000000      


Q ss_pred             ------hccccCcCc--cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          731 ------LVDKKSEDM--QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       731 ------~~d~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                            .+.......  ........++.+++.+|++.+|.+||++.+++.+=
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence                  000000000  00001345688999999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.9e-30  Score=284.29  Aligned_cols=255  Identities=25%  Similarity=0.341  Sum_probs=193.0

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCc------cee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN------RFL  577 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------~~l  577 (818)
                      .+...||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.      .++
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            34467999999999999986 5789999998643  22334667889999999999999999998876654      899


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      |+||+ +++|.+++..    ..+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus        98 v~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          98 VTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            99998 6799888843    3589999999999999999999997   99999999999999999999999999998664


Q ss_pred             cCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--hcc------
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--DRL------  728 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~~~------  728 (818)
                      ..    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......  +.+      
T Consensus       170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            32    122357888999999865 36789999999999999999999998754432222221111000  000      


Q ss_pred             ---hhhccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 ---CDLVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 ---~~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ...+........     .......++.+++.+||+.+|++|||+.+|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               000000000000     001235688899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.4e-30  Score=283.92  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=202.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR--GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..+.+...||+|.|+.|..++.. ++.+||||.+.+..-.  ..+.+.+|+++|..++|||||+++.+......+++|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            34556678999999999999975 5899999998766432  23458899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |..+|.+.++|.+..+   ..+..+..++.|+.++++|||+.   .|+|||||++||||+.+.++||+|||++..+....
T Consensus       136 ya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             eccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999999976654   45588889999999999999997   99999999999999999999999999999886432


Q ss_pred             CccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                        ......|++.|.|||++.+..+ .+++|+||+|++||-|++|..||++..-..+.+...           +.    ..
T Consensus       210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl-----------~g----k~  272 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL-----------RG----KY  272 (596)
T ss_pred             --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe-----------ee----ee
Confidence              3344679999999999998775 689999999999999999999998653222111110           00    00


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ..+.-...+..++++++|-.+|.+|+++.++.+.-
T Consensus       273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            11222334566889999999999999999998764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=271.19  Aligned_cols=245  Identities=24%  Similarity=0.316  Sum_probs=203.0

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCc
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSN  574 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  574 (818)
                      .++....+|..+||+|+||.|.++..+. .+.+|||+++++-   ..+.+--+.|-++|+.. +-|.++++..++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4556677888999999999999998764 5679999997652   23334456788888887 57899999999999999


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      +++||||+.+|+|--++++-   ..+.+..+..+|.+||-||-+||+.   +||+||||..||+||.+|++||+|||+++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence            99999999999998877544   4588889999999999999999997   99999999999999999999999999998


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      .-.-+. ..+.+..||+.|+|||++...+|+..+|.|||||+||||+.|+.||++.+.+.+...+..+..          
T Consensus       499 Eni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv----------  567 (683)
T KOG0696|consen  499 ENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV----------  567 (683)
T ss_pred             ccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC----------
Confidence            643322 223446899999999999999999999999999999999999999999888777766653221          


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCc
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS  766 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt  766 (818)
                           ..+...+.+...+....|-..|.+|.-
T Consensus       568 -----syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 -----SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -----cCcccccHHHHHHHHHHhhcCCccccC
Confidence                 123445667778888889999999953

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-30  Score=258.22  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=197.5

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecc----cCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE----RSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~  583 (818)
                      ++||-|-.|.|-....+ +|+++|+|++...     ....+|+++--.. .|+|||.+++.+..    ...+++|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            47999999999988765 6889999998633     2345777766555 69999999998864    345689999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~  660 (818)
                      ||.|.+.+..+. .+.+++.++..|+.||+.|+.|||+.   +|.||||||+|+|...   +-.+||+|||+|+.-.+. 
T Consensus       143 GGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-  217 (400)
T KOG0604|consen  143 GGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-  217 (400)
T ss_pred             chHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC-
Confidence            999999886654 35699999999999999999999998   9999999999999954   456899999999976542 


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       ....++..|+.|.|||++...++....|+||+||++|-|++|.+||..+.+..+-.-.+.....+.    .+.+.++  
T Consensus       218 -~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq----y~FP~pE--  290 (400)
T KOG0604|consen  218 -GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ----YEFPEPE--  290 (400)
T ss_pred             -ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC----ccCCChh--
Confidence             233456789999999999999999999999999999999999999987766544443333322221    1111222  


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                       ....++...++|+.+|..+|.+|.|+.+++.+=
T Consensus       291 -Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  291 -WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             -HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence             335567778899999999999999999998763

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=9.5e-30  Score=302.22  Aligned_cols=142  Identities=25%  Similarity=0.389  Sum_probs=126.0

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.++||+|+||.||+|... +++.||||++.....   .....+..|+.++..++|+||+++++++......++||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            34568999999999999976 588999999865432   22467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      ++++|.+++...   ..+++..++.|+.||+.||.|||..   +|+||||||+||||+.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999998543   3578889999999999999999997   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=299.12  Aligned_cols=254  Identities=24%  Similarity=0.279  Sum_probs=204.1

Q ss_pred             HHhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      ....+++.+.||+|+||.|..++.+ .++.+|+|++.+-   ......-|.+|-.+|..-+.+-|+.+.-.|.+...+||
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            3455666778999999999999986 5788999999762   34445678999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      |||||+||+|...+...   ..+++..+..++..|.-||.-||+.   |+|||||||+|||||..|++||+|||-+-.+.
T Consensus       153 VMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            99999999999988433   3699999999999999999999998   99999999999999999999999999999998


Q ss_pred             cCCCccccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      .+..-.....+|||.|++||++..     +.|.+.+|-||+||++|||+.|..||...   .++++..++........+ 
T Consensus       227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad---slveTY~KIm~hk~~l~F-  302 (1317)
T KOG0612|consen  227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD---SLVETYGKIMNHKESLSF-  302 (1317)
T ss_pred             CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH---HHHHHHHHHhchhhhcCC-
Confidence            888777778899999999999942     56899999999999999999999999643   344444444333222111 


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCc---HHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS---ASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~  773 (818)
                        +  .   ....+++..+||.+.+. +|+.|..   +.++-.+
T Consensus       303 --P--~---~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  303 --P--D---ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             --C--c---ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence              1  1   11234455556555443 5667766   6666544

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=2.5e-30  Score=258.64  Aligned_cols=265  Identities=24%  Similarity=0.330  Sum_probs=194.8

Q ss_pred             HHhhhhcccccceeEEEeEecC-----CcEEEEEEcCCCCCc--cHHHHHHHHHHHhccCcceeEEEeeeecc-cCccee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-----GTKVAVKRLYPGENR--GKKEFLSEVETIGNIHHFNLVRLVGYCAE-RSNRFL  577 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~l  577 (818)
                      ++....||+|.||.|||++-.+     ...+|+|+++..++.  -.....+|+.+++.++|+||+.|..++.. +...+|
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            4445679999999999996432     237999999755332  23456789999999999999999999987 668899


Q ss_pred             eeeccCCCChhhHhhhc--CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC----CCEEEeecC
Q 043017          578 VYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD----LNVKIADFG  651 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg  651 (818)
                      ++||.+ -+|.++|+.+  .+.+.++...+..|+.||+.|+.|||++   -|+||||||.|||+..+    |.+||+|||
T Consensus       106 ~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence            999985 4777777543  2345788999999999999999999998   99999999999999877    899999999


Q ss_pred             CceecccCCCcc--ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC------chHHHHHHHH
Q 043017          652 LARLIAQDQSHV--STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGG------DYLVDTLKVK  722 (818)
Q Consensus       652 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~------~~l~~~~~~~  722 (818)
                      +++++...-...  ...++-|..|.|||++.+. .|+.+.|||+.|||+.||++.++.|...+.      .+-.+.+.+.
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            999987653322  2345678999999999875 589999999999999999999888865422      1112222222


Q ss_pred             hhh---h---c---------chhhc-cccCcCccC---------cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          723 AEA---D---R---------LCDLV-DKKSEDMQS---------HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       723 ~~~---~---~---------~~~~~-d~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+.   +   .         ....+ +.+......         .........+|+..+|+.||-+|.|+++.+++.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            110   0   0         00000 000000000         000112366788999999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=281.90  Aligned_cols=239  Identities=21%  Similarity=0.273  Sum_probs=193.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .++|...+|.|+|+.|-++... +++..+||++....    .+-.+|+.++.+. +|+||+++.+.+.++.+.++|||.+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            4566678999999999998865 57889999986552    2234567666665 7999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE-cCCCCEEEeecCCceecccCCC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      .++-|.+.+....   .+. ..+..|+.+|+.++.|||++   ++|||||||+|||+ ++.++++|+|||.++....+  
T Consensus       399 ~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  399 DGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             cccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9998877774432   233 77788999999999999997   99999999999999 69999999999999987665  


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        ...++-|..|.|||++....+++++|+||||++||+||+|+.||.....+   ..+......++.             
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~-------------  531 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF-------------  531 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc-------------
Confidence              33346788999999999999999999999999999999999999866554   122211111111             


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ....+....+|+..||+.||.+||+|.++..+=
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            134456677888899999999999999998764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2.8e-29  Score=260.59  Aligned_cols=237  Identities=30%  Similarity=0.422  Sum_probs=194.3

Q ss_pred             cceeEEEeEecC-CcEEEEEEcCCCCCcc-HHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhhHhhh
Q 043017          516 GSGSVFEGLLND-GTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFH  593 (818)
Q Consensus       516 ~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  593 (818)
                      +||.||+++..+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8999999997665544 78999999999999999999999999999999999999999999998854


Q ss_pred             cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcc
Q 043017          594 KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY  673 (818)
Q Consensus       594 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  673 (818)
                      ..   .+++..+..++.+++++|.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  ......++..|
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            32   288899999999999999999997   99999999999999999999999999998776543  22234578899


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHH
Q 043017          674 MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPK-GGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQI  752 (818)
Q Consensus       674 ~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l  752 (818)
                      ++||.+....++.++|||+||+++++|++|..|+... ......+.+.   ..         .............++.++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~---------~~~~~~~~~~~~~~~~~~  220 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KP---------KPPFPPPEWKISPEAKDL  220 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---cc---------CCCCccccccCCHHHHHH
Confidence            9999999888999999999999999999999998653 2222222111   00         000000000144678899


Q ss_pred             HHHccccCCCCCCcHHHHHH
Q 043017          753 AISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       753 i~~cl~~dp~~RPt~~evl~  772 (818)
                      +.+|+..+|++||++.++++
T Consensus       221 i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      221 IRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHccCCchhccCHHHHhh
Confidence            99999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.2e-30  Score=265.63  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=198.0

Q ss_pred             CHHHHHHhhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC---cc----HHHHHHHHHHHhccCcceeEEEeee
Q 043017          497 SSKAMKSATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN---RG----KKEFLSEVETIGNIHHFNLVRLVGY  568 (818)
Q Consensus       497 ~~~~l~~~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~----~~~f~~Ev~~l~~l~H~niv~l~g~  568 (818)
                      .........|-+.+.||+|||++|||+.. .+.+.||||.-.....   +.    .+...+|.++-+.|.||-||+++++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            33334445555667899999999999984 5688999998654321   11    2345679999999999999999999


Q ss_pred             ecc-cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCC
Q 043017          569 CAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLN  644 (818)
Q Consensus       569 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~  644 (818)
                      +.- .+.++-|+||+++.+|+-||..+   +.+++.+++.|+.||+.||.||.+. +++|||-||||.||||-.   -|.
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence            864 55788999999999999999543   5689999999999999999999985 779999999999999944   478


Q ss_pred             EEEeecCCceecccCCC------ccccCCCCCCcccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-
Q 043017          645 VKIADFGLARLIAQDQS------HVSTMPKGTPGYMAPELTRGN----SITAKIDIYSFGVVILEIICGRRSSNPKGGD-  713 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-  713 (818)
                      +||+||||++.+..+..      ..+....||..|++||.+.-+    .++.|+||||.|||+|+.+.|++||...... 
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            99999999998865432      233445799999999988543    4889999999999999999999999755322 


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHH
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV  771 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl  771 (818)
                      .+++       ...+..   ......+..+....+...+|++||++.-++|....++.
T Consensus       692 dILq-------eNTIlk---AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 DILQ-------ENTILK---ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHh-------hhchhc---ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            1111       111111   11111222223445666788999999999999887754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=2e-29  Score=262.65  Aligned_cols=219  Identities=21%  Similarity=0.188  Sum_probs=175.5

Q ss_pred             ccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhhHhhh
Q 043017          515 GGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFH  593 (818)
Q Consensus       515 G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  593 (818)
                      |.||.||++... +++.+|+|++....     .+..|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999975 58899999986543     234455556666799999999999999999999999999999998854


Q ss_pred             cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcc
Q 043017          594 KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY  673 (818)
Q Consensus       594 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  673 (818)
                      .   ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||++.......    ....++..|
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y  148 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY  148 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence            3   3488999999999999999999997   99999999999999999999999999886554321    123456789


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHH
Q 043017          674 MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIA  753 (818)
Q Consensus       674 ~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li  753 (818)
                      +|||.+....++.++||||+|++++||++|+.|+......     .         .....     ...+.....++.+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------~~~~~-----~~~~~~~~~~~~~li  209 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------NTHTT-----LNIPEWVSEEARSLL  209 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------ccccc-----cCCcccCCHHHHHHH
Confidence            9999998888999999999999999999999876432110     0         00000     001122346788999


Q ss_pred             HHccccCCCCCCcH
Q 043017          754 ISCLQKNLHRRPSA  767 (818)
Q Consensus       754 ~~cl~~dp~~RPt~  767 (818)
                      .+|++.||++||++
T Consensus       210 ~~~l~~dp~~R~~~  223 (237)
T cd05576         210 QQLLQFNPTERLGA  223 (237)
T ss_pred             HHHccCCHHHhcCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.9e-29  Score=282.69  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=177.3

Q ss_pred             hHHhhhhcccccceeEEEeEe-----------------cCCcEEEEEEcCCCCCccHHHHH--------------HHHHH
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-----------------NDGTKVAVKRLYPGENRGKKEFL--------------SEVET  553 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~~~~f~--------------~Ev~~  553 (818)
                      .+.+.++||+|+||+||+|.+                 .+++.||||++........++|.              .|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            344556899999999999964                 23568999998654433333333              46667


Q ss_pred             HhccCccee-----EEEeeeecc--------cCcceeeeeccCCCChhhHhhhcCC---------------------ccc
Q 043017          554 IGNIHHFNL-----VRLVGYCAE--------RSNRFLVYEYMCNGSLDKWIFHKDR---------------------IQT  599 (818)
Q Consensus       554 l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~  599 (818)
                      +.+++|.++     ++++++|..        .+..+|||||+++++|.++|+....                     ...
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777766654     677787753        3567999999999999999864211                     123


Q ss_pred             cchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccc
Q 043017          600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT  679 (818)
Q Consensus       600 l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~  679 (818)
                      +++..+..++.|++++|.|||+.   +|+||||||+|||++.++.+||+|||++...............+++.|+|||.+
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            46778889999999999999997   999999999999999999999999999976544322222222357899999988


Q ss_pred             cCCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCCchHHHHHHHHh-hhhcchhhcccc
Q 043017          680 RGNSI----------------------TAKIDIYSFGVVILEIICGRR-SSNPKGGDYLVDTLKVKA-EADRLCDLVDKK  735 (818)
Q Consensus       680 ~~~~~----------------------s~ksDVwS~Gvll~elltG~~-p~~~~~~~~l~~~~~~~~-~~~~~~~~~d~~  735 (818)
                      .....                      ..+.||||+||+++||++|.. |+.....  ......... ....... ....
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~--f~~~~~~~~~~~~~~r~-~~~~  459 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL--FNTELRQYDNDLNRWRM-YKGQ  459 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh--hhhHHhhccchHHHHHh-hccc
Confidence            64321                      134799999999999999875 5532110  000000000 0000000 0000


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCC---CCCCcHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNL---HRRPSASMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~~  773 (818)
                      ...............+++.++|..+|   .+|+|++|+|++
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            01111122334667788889998765   789999999976

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.9e-29  Score=279.91  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=208.1

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecc-----cCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE-----RSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~-----~~~~~l  577 (818)
                      +.+|.++||+|.+|.||+++. ++++.+|+|++..... ..+++..|.++++.+ +|||++.++|++..     +++++|
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            455677899999999999995 4688899998876543 356778899999998 79999999999853     568999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      |||||.+||..+.+.... ...+.|+.+..|++.++.|++|||.+   .++|||||=.|||++.++.+|+.|||.+..+.
T Consensus        99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            999999999999886654 67799999999999999999999998   99999999999999999999999999998775


Q ss_pred             cCCCccccCCCCCCcccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGN-----SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      .... ...+..||+.|||||++...     .|+.++|+||||++..||--|.+|+-.+.+...            +..+.
T Consensus       175 sT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------------LF~Ip  241 (953)
T KOG0587|consen  175 STVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------------LFLIP  241 (953)
T ss_pred             cccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------------hccCC
Confidence            5433 23445799999999999653     377899999999999999999999876544221            12222


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+++....+.....++.++|..||..|-++||++.+++++
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            22334444467788999999999999999999999998865

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.9e-29  Score=290.90  Aligned_cols=258  Identities=22%  Similarity=0.246  Sum_probs=165.8

Q ss_pred             hHHhhhhcccccceeEEEeEecC-----CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeee------ecccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-----GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY------CAERS  573 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~------~~~~~  573 (818)
                      .+.+.++||+|+||.||+|++.+     ++.||||++.....  .+.+.+|  .+....+.++..++..      +..+.
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence            34456789999999999999764     68999998754321  1222222  1122222222222211      24566


Q ss_pred             cceeeeeccCCCChhhHhhhcCCc-----------------cccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCe
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRI-----------------QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN  636 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~N  636 (818)
                      ..++||||+++++|.+++......                 .......+..++.||++||+|||+.   +|+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence            889999999999999988643210                 0112334567999999999999997   99999999999


Q ss_pred             EEEcC-CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCC----------------------CCCchhhHHHH
Q 043017          637 ILLDR-DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN----------------------SITAKIDIYSF  693 (818)
Q Consensus       637 Ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDVwS~  693 (818)
                      ||++. ++.+||+|||+++.+............+++.|+|||.+...                      .+..++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            99986 57899999999987654433333445689999999965322                      23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh----hcchhhccccCc-C----ccCcHHHHHHHHHHHHHccccCCCCC
Q 043017          694 GVVILEIICGRRSSNPKGGDYLVDTLKVKAEA----DRLCDLVDKKSE-D----MQSHRDDAVKMIQIAISCLQKNLHRR  764 (818)
Q Consensus       694 Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~----~~~~~~~d~~~~-~----~~~~~~~~~~l~~li~~cl~~dp~~R  764 (818)
                      ||+||||+++..+.+..    +..........    ......+..... +    ............+|+.+||+.||++|
T Consensus       366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999976554311    11111100000    000111111100 0    00000112345589999999999999


Q ss_pred             CcHHHHHHH
Q 043017          765 PSASMLVKV  773 (818)
Q Consensus       765 Pt~~evl~~  773 (818)
                      ||+.+++++
T Consensus       442 ~ta~e~L~H  450 (566)
T PLN03225        442 ISAKAALAH  450 (566)
T ss_pred             CCHHHHhCC
Confidence            999999987

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=258.72  Aligned_cols=261  Identities=20%  Similarity=0.281  Sum_probs=200.5

Q ss_pred             HHhhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cc-----eeEEEeeeecccCc
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HF-----NLVRLVGYCAERSN  574 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~-----niv~l~g~~~~~~~  574 (818)
                      ....+.+-..+|+|.||.|-+..... +..||||+++.... -.+..+-|+++++++. +.     -+|.+.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            34566666789999999999988654 68999999865432 2455677999999993 22     47788899999999


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-------------
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-------------  641 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-------------  641 (818)
                      .++|+|.| +.|+.++|... +..+++...+..|+.|+++++++||+.   +++|-||||+|||+-+             
T Consensus       166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence            99999987 77999999543 346789999999999999999999998   9999999999999932             


Q ss_pred             -------CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch
Q 043017          642 -------DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY  714 (818)
Q Consensus       642 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~  714 (818)
                             +..+||+|||-|.......    ...+.|..|.|||++.+-.++.++||||+||||.|+.+|...|...++.+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   2358999999998765544    33467899999999999999999999999999999999999988665433


Q ss_pred             HHHHHHHHhhhhcchhh--------------cc--------------c----cCcCccCcHHHHHHHHHHHHHccccCCC
Q 043017          715 LVDTLKVKAEADRLCDL--------------VD--------------K----KSEDMQSHRDDAVKMIQIAISCLQKNLH  762 (818)
Q Consensus       715 l~~~~~~~~~~~~~~~~--------------~d--------------~----~~~~~~~~~~~~~~l~~li~~cl~~dp~  762 (818)
                      -+..+..... +.-..+              +|              .    ....+.....+..+|++|+..||..||.
T Consensus       317 HLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  317 HLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            2222211111 000000              00              0    0011122446788999999999999999


Q ss_pred             CCCcHHHHHHH
Q 043017          763 RRPSASMLVKV  773 (818)
Q Consensus       763 ~RPt~~evl~~  773 (818)
                      +|+|+.|++.+
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.7e-29  Score=245.74  Aligned_cols=266  Identities=24%  Similarity=0.354  Sum_probs=196.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCC-CCCcc-HHHHHHHHHHHhccCcceeEEEeeeeccc--------
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYP-GENRG-KKEFLSEVETIGNIHHFNLVRLVGYCAER--------  572 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~-~~~~~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--------  572 (818)
                      .+++-..+||+|.||+|++++.. +|++||+|++.- ....+ -...++|+.+|..|+|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34444568999999999999975 478889987532 22222 35668899999999999999999988543        


Q ss_pred             CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCC
Q 043017          573 SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      ..++||+++++ -+|.-.|.+  ....++..++.++..++..||.|+|..   .|+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            24789999984 467666632  235688999999999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCcc---ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--h
Q 043017          653 ARLIAQDQSHV---STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--D  726 (818)
Q Consensus       653 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~  726 (818)
                      ++.+.......   .+..+-|+.|.+||.+.+ ..++++.|||.-||++.||+++.+.+.+.....-+..+......  +
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            98776543322   233456999999998876 46999999999999999999999988877654444444332211  1


Q ss_pred             c---------chhhcc-ccCcCcc--CcHHH------HHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          727 R---------LCDLVD-KKSEDMQ--SHRDD------AVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       727 ~---------~~~~~d-~~~~~~~--~~~~~------~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .         +.+.+. ++++.-.  ...+.      ..+..+++..++..||.+|+++.+++.+--
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence            1         111110 0010000  01111      125678889999999999999999998753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=225.34  Aligned_cols=259  Identities=25%  Similarity=0.333  Sum_probs=189.3

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      --++||+|.||+|+||+.. .++.||+|++...+  +......++|+-+++.++|+|||++++....+...-+|+||+ .
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-d   84 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-D   84 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-h
Confidence            3468999999999999965 47889999986543  233467889999999999999999999999999999999998 5


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      .+|..+....  ...++.+.+..++.|+++||.++|++   ++.|||+||.|.||+.+|..|++|||+++-+.-.-... 
T Consensus        85 qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcy-  158 (292)
T KOG0662|consen   85 QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY-  158 (292)
T ss_pred             HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence            5676666332  34688889999999999999999998   99999999999999999999999999999876543322 


Q ss_pred             cCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCCch-HHHHHHHHhhh-----hcchhhccccC
Q 043017          665 TMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY-LVDTLKVKAEA-----DRLCDLVDKKS  736 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~-l~~~~~~~~~~-----~~~~~~~d~~~  736 (818)
                      ...+-|..|.+|.++.+.+ ++...|+||-|||+.|+.. |++.|.+.+-+. +....+.....     +.+..+-|...
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            2235688999999998765 8999999999999999998 555565544322 22222221111     01111111111


Q ss_pred             -cCccC---cHHHHH----HHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 -EDMQS---HRDDAV----KMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 -~~~~~---~~~~~~----~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       +..+.   ......    .=.+++...+.-+|..|.+++..+++
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence             11110   111111    22355667777799999999888764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-29  Score=279.15  Aligned_cols=242  Identities=30%  Similarity=0.396  Sum_probs=185.9

Q ss_pred             hhcccccce-eEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          510 IRLGRGGSG-SVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       510 ~~LG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      +.+|.|.-| .||+|... |+.||||++-...   ..-.++|++.|+.- +|||||++++.-.+....|+..|.| ..+|
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL  589 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL  589 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence            468999887 67999997 8899999985332   34557899999888 6999999999999999999999998 7799


Q ss_pred             hhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---C--CCEEEeecCCceecccCCC
Q 043017          588 DKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---D--LNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       588 ~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~~~~~~  661 (818)
                      ++++... .......-...+.+..|+++||+|||+.   +||||||||.||||+.   +  .+++|+|||+++.+..+..
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9999653 1111122244577889999999999997   9999999999999976   2  5699999999999887655


Q ss_pred             ccc--cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          662 HVS--TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG-RRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       662 ~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG-~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ...  ....||-+|+|||.+....-+.++||||+||++|+.++| .+||...-.    ...........+..        
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~----R~~NIl~~~~~L~~--------  734 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE----RQANILTGNYTLVH--------  734 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH----hhhhhhcCccceee--------
Confidence            433  345799999999999998888899999999999999995 899964321    11110111111111        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++  +..+||.+|++++|..||++.+|+.+
T Consensus       735 L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  735 LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0101111  66789999999999999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-28  Score=229.09  Aligned_cols=196  Identities=31%  Similarity=0.438  Sum_probs=165.2

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCC-CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .+||+|++|.|-+-++. .|+..|+|++... ..+.+++.+.|+.+..+- .+|.+|+++|........++.||.| ..|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence            47999999999887764 6899999998655 345567788899877665 7999999999999999999999999 678


Q ss_pred             hhhHhhh-cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          587 LDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       587 L~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      |+.+-.+ -.+...+++..+-+||..+.+||.|||+.  ..+||||+||+|||++.+|++|++|||++-.+...-  ..+
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Akt  206 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AKT  206 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HHH
Confidence            8876643 23456789999999999999999999986  789999999999999999999999999998775532  222


Q ss_pred             CCCCCCcccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 043017          666 MPKGTPGYMAPELTRG----NSITAKIDIYSFGVVILEIICGRRSSNPK  710 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~----~~~s~ksDVwS~Gvll~elltG~~p~~~~  710 (818)
                      ...|-..|||||.+..    ..|+.|+||||||+.+.||.+++.|++.-
T Consensus       207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            2457889999999853    46899999999999999999999998644

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=259.65  Aligned_cols=243  Identities=22%  Similarity=0.280  Sum_probs=202.7

Q ss_pred             hcccccceeEEEeEecCCcE-EEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTK-VAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~-vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||-|+||.|-..+.+..+. +|+|.+++.   +...++.+..|-.+|...+.+.||+++-.|.+....|++||-|-+|.
T Consensus       427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE  506 (732)
T KOG0614|consen  427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE  506 (732)
T ss_pred             hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence            69999999999998875443 788877543   44456678889999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |...|...   ..++..+...++..+.+|++|||..   +||+|||||+|.+||.+|-+||.|||+|+.+.....  +-+
T Consensus       507 lWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--TwT  578 (732)
T KOG0614|consen  507 LWTILRDR---GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TWT  578 (732)
T ss_pred             hhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc--eee
Confidence            99999544   4688999999999999999999997   999999999999999999999999999998876543  334


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..||+.|.|||++.++.....+|.||||++++||++|.+||...++......+-+-.             .....++...
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------------d~i~~Pr~I~  645 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------------DKIEFPRRIT  645 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------------hhhhcccccc
Confidence            679999999999999999999999999999999999999998776655444432211             1122244556


Q ss_pred             HHHHHHHHHccccCCCCCCc-----HHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRPS-----ASMLVKVL  774 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt-----~~evl~~L  774 (818)
                      +...+++.+.+..+|.+|.-     +.++-++-
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            67778999999999999975     66666553

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.5e-26  Score=232.34  Aligned_cols=211  Identities=40%  Similarity=0.637  Sum_probs=184.4

Q ss_pred             cccccceeEEEeEecC-CcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhh
Q 043017          512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      ||+|.+|.||++...+ ++++++|.+...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999875 899999998755432 35789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceecccCCCccccCCC
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQDQSHVSTMPK  668 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  668 (818)
                      ++....  ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            985432  3588999999999999999999997   9999999999999999 89999999999987755432 122245


Q ss_pred             CCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHH
Q 043017          669 GTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV  747 (818)
Q Consensus       669 gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  747 (818)
                      +...|++||.+... ..+.+.|+|++|+++++|                                              .
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~  188 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P  188 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence            77899999999887 788999999999999998                                              4


Q ss_pred             HHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          748 KMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       748 ~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+.+++..|++.+|++||++.++++.|
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            677899999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-28  Score=242.32  Aligned_cols=258  Identities=26%  Similarity=0.338  Sum_probs=196.7

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC-----cceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-----NRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~  582 (818)
                      -||-|+||.||....+ +|+.||+|++...  .-...+.+.+|+.+|.-++|.|++..++......     +.|.+.|.|
T Consensus        60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm  139 (449)
T KOG0664|consen   60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM  139 (449)
T ss_pred             cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence            5899999999999875 6999999988543  2233567889999999999999999988765443     567888988


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                       ..+|.++|..   -+.++-+.+.-+.+||++||.|||+.   +|.||||||.|.|++++-..||+|||+++....++..
T Consensus       140 -QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  140 -QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             -Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence             6677776632   24688888889999999999999998   9999999999999999999999999999988777766


Q ss_pred             cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc-----------chh
Q 043017          663 VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR-----------LCD  730 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~-----------~~~  730 (818)
                      .++..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|...++..-++.+-.....+.           ...
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            66666778899999999886 589999999999999999999888876554333332222211111           111


Q ss_pred             hccccCc--------CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          731 LVDKKSE--------DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       731 ~~d~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      ++....+        ....+.....+...+...++..||.+|.+..+.+..+.
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1111111        11112233345567778899999999999999988763

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=239.03  Aligned_cols=237  Identities=26%  Similarity=0.384  Sum_probs=190.0

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeec
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ++..+||+|.|+.|..+.+. +.+.+|+|++++.   ..++..-.+.|-.+..+. +||.+|-+..+|..+..+++|.||
T Consensus       253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey  332 (593)
T KOG0695|consen  253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY  332 (593)
T ss_pred             eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence            44568999999999999976 4677899988653   344556667788777776 799999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|--++   ++.+.++++.++.+..+|+-||.|||+.   +||+||||..|||+|.+|++||+|+|+++.--.+..
T Consensus       333 v~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  333 VNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             ecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            9999985444   4556799999999999999999999998   999999999999999999999999999986544333


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CchHHHHHHHHhhhhcchhhcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG--------GDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~--------~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                       .+.+..||+.|+|||++.+..|....|.|++||+++||+.|+.||+...        .+++.+.+-            +
T Consensus       407 -~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil------------e  473 (593)
T KOG0695|consen  407 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL------------E  473 (593)
T ss_pred             -ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh------------h
Confidence             3345689999999999999999999999999999999999999997321        112222211            1


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRP  765 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  765 (818)
                      +.+   ..++..+-+...++..-|..||.+|.
T Consensus       474 kqi---riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 KQI---RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hcc---cccceeehhhHHHHHHhhcCCcHHhc
Confidence            111   11333445566777888999999884

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5.6e-27  Score=253.13  Aligned_cols=196  Identities=26%  Similarity=0.389  Sum_probs=168.1

Q ss_pred             hcccccceeEEEeEecC-CcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||-|+||+|.++..-| ...+|+|.|.+.+.   ......+.|-.+|+....+-||+|+-.|.+++.+|+||||+++|+
T Consensus       636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD  715 (1034)
T KOG0608|consen  636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD  715 (1034)
T ss_pred             eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence            49999999999998654 56789999976543   334567889999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc--------
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ--------  658 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~--------  658 (818)
                      +-.+|...   ..+.++.++.++.++..|+++.|+.   ++|||||||+|||||.+|++||+||||+.-+.-        
T Consensus       716 mMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  716 MMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             HHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            99988644   4688999999999999999999998   999999999999999999999999999864420        


Q ss_pred             -CC--------------------------------CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 043017          659 -DQ--------------------------------SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR  705 (818)
Q Consensus       659 -~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~  705 (818)
                       ..                                .......+||+.|+|||++....++..+|.||.|||||||+-|+.
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence             00                                001112359999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 043017          706 SSNPKGG  712 (818)
Q Consensus       706 p~~~~~~  712 (818)
                      ||-....
T Consensus       870 pf~~~tp  876 (1034)
T KOG0608|consen  870 PFLADTP  876 (1034)
T ss_pred             CccCCCC
Confidence            9975543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=2.4e-26  Score=221.10  Aligned_cols=256  Identities=21%  Similarity=0.381  Sum_probs=192.6

Q ss_pred             hhHHhhhhcccccceeEEEeE-ecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccC--cceeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERS--NRFLVY  579 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~--~~~lV~  579 (818)
                      ..+++.+++|+|.+++|+.|. ..+.++++||.+++..   .+.+.+|+.+|+.|. ||||++|++...+..  ...||+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            456677899999999999998 4567899999997654   567889999999996 999999999987754  567999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  658 (818)
                      ||+.+.+.....      +.++...+..++.++++||.|+|+.   ||.|||+||.|++||.. -..+|+|+|||.+...
T Consensus       115 E~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  115 EYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999998876654      5688888999999999999999998   99999999999999865 4599999999997755


Q ss_pred             CCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-C-CchHHHHHHHHhhh----------
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPK-G-GDYLVDTLKVKAEA----------  725 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~-~-~~~l~~~~~~~~~~----------  725 (818)
                      ....  ...+.+..|--||++.. ..+...-|+|||||+|.+|+..+.||-.- + .++++...+.....          
T Consensus       186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            4322  22346677888998854 55888999999999999999999998422 2 23333332222111          


Q ss_pred             ----hcchhhcccc----CcCc---cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          726 ----DRLCDLVDKK----SEDM---QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       726 ----~~~~~~~d~~----~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          ++..+++..-    +...   ....-...+.++++...|..|-.+|||++|.+.+
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                1111111110    0000   0011123677888999999999999999998764

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.94  E-value=1.6e-27  Score=215.95  Aligned_cols=101  Identities=41%  Similarity=0.673  Sum_probs=75.4

Q ss_pred             CeEEEEeCCCCCCCC---CceEEEeecccEEEEcCCCcEEEee-ccCCC--ceeEEEEcCCCcEEEecCCCCcceecccC
Q 043017          103 PVILWFANGQSPVKE---NATLEFTADGDLILKDVDGTRVWST-ETSGS--NVTRITLDGNGNLRLYDAENRPHWISFLH  176 (818)
Q Consensus       103 ~~~vW~anr~~p~~~---~~~l~l~~~g~Lvl~~~~~~~vWst-~~~~~--~~~~~~l~d~GNlvl~~~~~~~lWqSFd~  176 (818)
                      +||||+|||++|+.+   ..+|.|+.||+|||+|.++++||++ ++.+.  ....|+|+|+|||||+|..+.++||||||
T Consensus         2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~   81 (114)
T PF01453_consen    2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDY   81 (114)
T ss_dssp             --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTS
T ss_pred             cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCC
Confidence            689999999999943   4899999999999999999999999 55554  47899999999999999999999999999


Q ss_pred             CCCcccCCCeeccce------eEeeccCCCCCC
Q 043017          177 PTNTWLPGQRLHVHK------MMASTNSTTSLS  203 (818)
Q Consensus       177 Ptdtllpg~kl~~~~------~l~s~~s~~d~s  203 (818)
                      ||||+||+|+|+.+.      .++||++.+|||
T Consensus        82 ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   82 PTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             SS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             CccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            999999999998732      389999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=4.2e-25  Score=226.89  Aligned_cols=197  Identities=37%  Similarity=0.573  Sum_probs=170.9

Q ss_pred             hhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            44679999999999999875 889999999766544 5778999999999999999999999999989999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++.....  .+++.....++.+++.+|.+||+.   +++|+||+|+||+++.++.++|+|||++............
T Consensus        83 ~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       83 DLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            99998854321  178899999999999999999997   9999999999999999999999999999887654311222


Q ss_pred             CCCCCCcccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 043017          666 MPKGTPGYMAPELT-RGNSITAKIDIYSFGVVILEIICGRRSSNP  709 (818)
Q Consensus       666 ~~~gt~~y~aPE~~-~~~~~s~ksDVwS~Gvll~elltG~~p~~~  709 (818)
                      ...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34577889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=224.90  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=183.2

Q ss_pred             cccccceeEEEeEe-cCCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC------cceeeeecc
Q 043017          512 LGRGGSGSVFEGLL-NDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRFLVYEYM  582 (818)
Q Consensus       512 LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~~  582 (818)
                      +|.|.- .|..+-. -.++.||+|++...  .....+...+|..++..++|+|+++++.++....      +.++|||+|
T Consensus        25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m  103 (369)
T KOG0665|consen   25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM  103 (369)
T ss_pred             cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence            455555 3333332 24789999987543  2344566788999999999999999999986543      579999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                       ..+|...+.     -.++-+++..|..|++.|+.|||+.   +|+||||||+||++..+..+||.|||+++....+  .
T Consensus       104 -~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~  172 (369)
T KOG0665|consen  104 -DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F  172 (369)
T ss_pred             -hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence             678888774     2366778889999999999999998   9999999999999999999999999999865443  4


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh----------------
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD----------------  726 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~----------------  726 (818)
                      ..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+..|.+..  .+.++.+.....+                
T Consensus       173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d--~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD--HIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch--HHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            5566778999999999998889999999999999999999998886432  1111111110000                


Q ss_pred             ------c-----chhhcccc--CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 ------R-----LCDLVDKK--SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ------~-----~~~~~d~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            +     ....+...  +............+.+++.+||-.+|++|-++.++|++
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                  0     00000000  00111122334566789999999999999999999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8e-25  Score=231.55  Aligned_cols=132  Identities=27%  Similarity=0.348  Sum_probs=108.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC--------cceeEEEeeeecc---
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH--------HFNLVRLVGYCAE---  571 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~--------H~niv~l~g~~~~---  571 (818)
                      +.|-..++||-|.|++||++... ..+.||+|+.+.. ..-.+..+.|+++|++++        ..+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            44556678999999999999864 5788999988643 223456788999999883        3489999999965   


Q ss_pred             -cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          572 -RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       572 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                       +.+.+||+|++ +-+|..+|.... -+.++...+.+|++||+.||.|||..  .+|||-||||+|||+-
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence             45899999998 778888886543 35689999999999999999999987  5999999999999993

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-25  Score=217.59  Aligned_cols=249  Identities=18%  Similarity=0.257  Sum_probs=181.5

Q ss_pred             hhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeee-ecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGY-CAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~-~~~~~~~~lV~e  580 (818)
                      ..+++.+.||+|.||.+-++.++. .+.+++|.+... ....++|.+|..---.| .|.||+.-++. |...+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            357788899999999999999874 678899977533 33467888887654445 69999987764 566678889999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE-c-CCCCEEEeecCCceeccc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL-D-RDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll-~-~~~~~kl~Dfgla~~~~~  658 (818)
                      |+|.|+|.+-+..    ..+.+....+++.|++.||.|+|+.   ++||||||.+|||| + +..++||+|||+.+....
T Consensus       103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999987743    3477888899999999999999996   99999999999999 3 334799999999876533


Q ss_pred             CCCccccCCCCCCcccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC--CchHHHHHHHHhhhhcchhh
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGN-----SITAKIDIYSFGVVILEIICGRRSSNPKG--GDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwS~Gvll~elltG~~p~~~~~--~~~l~~~~~~~~~~~~~~~~  731 (818)
                      .-.    ....+..|.+||.....     ...+.+|||.||++++.+++|+.||....  +....++.+..  .....  
T Consensus       176 tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~--~rk~~--  247 (378)
T KOG1345|consen  176 TVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL--KRKNP--  247 (378)
T ss_pred             eeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--cccCc--
Confidence            211    12346789999987543     25678999999999999999999997432  22222332221  11111  


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ..+  .......+++.++..+-|.+++++|--..++.++
T Consensus       248 ---~~P--~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  248 ---ALP--KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             ---cCc--hhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence               111  1123345677788889999999999444444433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=1.7e-25  Score=237.39  Aligned_cols=273  Identities=19%  Similarity=0.229  Sum_probs=209.4

Q ss_pred             ccccCHHHHHHhhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccC------cceeEEE
Q 043017          493 LVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIH------HFNLVRL  565 (818)
Q Consensus       493 ~~~~~~~~l~~~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~------H~niv~l  565 (818)
                      .-++...++....|...-..|+|-|++|.+|.... |..||||++.....- .+.=+.|+++|.+|+      -.|.++|
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            33455566777777777789999999999999754 789999999765322 344467999999994      3588999


Q ss_pred             eeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-C
Q 043017          566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-N  644 (818)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~  644 (818)
                      +-.|....++|||+|-+ ..+|.+.|..-++.-.|....+..++.|+.-||..|...   +|+|.||||.|||+.+.. .
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            99999999999999976 789999997766667789999999999999999999997   999999999999998764 5


Q ss_pred             EEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHh-
Q 043017          645 VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA-  723 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~-  723 (818)
                      +||||||-|......+...   ..-+..|.|||++.+.+|....|+||.||.||||.||+..|.+.....++....... 
T Consensus       576 LKLCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeeccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            7999999998776544322   224567999999999999999999999999999999999998776655443221110 


Q ss_pred             h--------hhcchhhccccCc------------------------------------CccCcHHHHHHHHHHHHHcccc
Q 043017          724 E--------ADRLCDLVDKKSE------------------------------------DMQSHRDDAVKMIQIAISCLQK  759 (818)
Q Consensus       724 ~--------~~~~~~~~d~~~~------------------------------------~~~~~~~~~~~l~~li~~cl~~  759 (818)
                      .        ..-..+.+|..+.                                    ...........|.+|+..||..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            0        0001111111110                                    0001223455778899999999


Q ss_pred             CCCCCCcHHHHHHH
Q 043017          760 NLHRRPSASMLVKV  773 (818)
Q Consensus       760 dp~~RPt~~evl~~  773 (818)
                      ||++|.|..++|++
T Consensus       733 dP~KRit~nqAL~H  746 (752)
T KOG0670|consen  733 DPEKRITVNQALKH  746 (752)
T ss_pred             ChhhcCCHHHHhcC
Confidence            99999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=5.8e-25  Score=236.25  Aligned_cols=191  Identities=26%  Similarity=0.388  Sum_probs=160.6

Q ss_pred             hhhcccccceeEEEeEecC-CcEEEEEEcCCCC--------CccHHHHHHHHHHHhccC---cceeEEEeeeecccCcce
Q 043017          509 QIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE--------NRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--------~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~  576 (818)
                      ...||+|+||.|+.++++. ..+|+||.+.+..        ....-..-.|+++|+.++   |+||++++++|++.+.++
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            3579999999999999875 5678888876432        111123456999999997   999999999999999999


Q ss_pred             eeeecc-CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          577 LVYEYM-CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       577 lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      |+||-. ++.+|.++|..+   +.+++.++..|++|++.|+++||++   +|||||||-+||.++.+|-+||+|||.+..
T Consensus       646 l~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             EEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence            999965 456888888543   5689999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSN  708 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~  708 (818)
                      ......   ...+||.+|.|||++.+.+| ...-|||++|++||.++....|+.
T Consensus       720 ~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            644332   33579999999999998876 567899999999999998888764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=2.8e-24  Score=261.67  Aligned_cols=196  Identities=19%  Similarity=0.256  Sum_probs=139.4

Q ss_pred             ccCc-ceeEEEeeee-------cccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCe
Q 043017          556 NIHH-FNLVRLVGYC-------AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI  627 (818)
Q Consensus       556 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i  627 (818)
                      .++| +||++++++|       .+....++++|++ +++|.++|...  ...+++.++..++.||++||+|||+.   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            4456 6888888877       2234567888987 66999999532  34689999999999999999999997   99


Q ss_pred             eecccccCeEEEcC-------------------CCCEEEeecCCceecccCC---------------CccccCCCCCCcc
Q 043017          628 IHFDIKPQNILLDR-------------------DLNVKIADFGLARLIAQDQ---------------SHVSTMPKGTPGY  673 (818)
Q Consensus       628 iH~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y  673 (818)
                      +||||||+||||+.                   ++.+||+|||+++......               ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456666777665421100               0001113478889


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHH
Q 043017          674 MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIA  753 (818)
Q Consensus       674 ~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li  753 (818)
                      +|||++.+..++.++|||||||+||||++|..|+....  .....+...        ...+.      ......+...++
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~--------~~~~~------~~~~~~~~~~~~  245 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR--------VLPPQ------ILLNWPKEASFC  245 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh--------hcChh------hhhcCHHHHHHH
Confidence            99999999999999999999999999999887754211  111111100        00000      111233456788


Q ss_pred             HHccccCCCCCCcHHHHHHH
Q 043017          754 ISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       754 ~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+||+++|.+||+|.|++++
T Consensus       246 ~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHhCCCChhhCcChHHHhhc
Confidence            89999999999999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=4.7e-24  Score=209.90  Aligned_cols=253  Identities=19%  Similarity=0.355  Sum_probs=195.2

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ..-+|..+|.+...|+.|+|+++ |..+++|.+...  .....++|.+|.-.|+-+.||||++++|.|.......++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            34456678999999999999998 556777777543  233456899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      |+.|+|...|+... .-.++..++.+++.+||+|++|||+. ++-|.--.|..+.+++|++.+++|. ++-+++.-.   
T Consensus       269 mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfq---  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ---  342 (448)
T ss_pred             ccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeee---
Confidence            99999999986543 35678889999999999999999996 4445555799999999999998874 222222111   


Q ss_pred             ccccCCCCCCcccccccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSI---TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                        .....-.+.||+||.+..++.   -..+|+|||++++|||.|...||....+.+.--.+...    -    +     .
T Consensus       343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----g----l-----r  407 (448)
T KOG0195|consen  343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----G----L-----R  407 (448)
T ss_pred             --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----c----c-----c
Confidence              111234678999999987653   35799999999999999999999866554332221110    0    0     1


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      ...+...+..+.+++.-|+..||.+||.+.+++-.||.++
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            1224466778899999999999999999999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=9.1e-24  Score=221.37  Aligned_cols=254  Identities=25%  Similarity=0.322  Sum_probs=188.6

Q ss_pred             hhhcccccceeEEEeEec----CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccC
Q 043017          509 QIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .++||+|.|++||++.+.    ..+.||+|.+...+.  ...+.+|++.|..+ .+.||+++.+++...+...+|+||++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            357999999999999864    367899999976543  45688999999999 69999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCceecccCC--
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQ--  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~--  660 (818)
                      .-...+++.      .++...+..+++.+..||+++|..   +||||||||+|+|.+.. +.-.|.|||||.......  
T Consensus       119 H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  119 HDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             ccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence            999988883      477888999999999999999998   99999999999999754 568999999997211000  


Q ss_pred             -----------------------------------------CccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHH
Q 043017          661 -----------------------------------------SHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVIL  698 (818)
Q Consensus       661 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~  698 (818)
                                                               ........||++|.|||++.. ...+.++||||-|+|++
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                                                     001112359999999999865 45789999999999999


Q ss_pred             HHHhCCCCCCCCCC--chHHHHHH--------HHh-hhhc--chh---------------hcc--ccCc-------CccC
Q 043017          699 EIICGRRSSNPKGG--DYLVDTLK--------VKA-EADR--LCD---------------LVD--KKSE-------DMQS  741 (818)
Q Consensus       699 elltG~~p~~~~~~--~~l~~~~~--------~~~-~~~~--~~~---------------~~d--~~~~-------~~~~  741 (818)
                      .+++++.||-...+  +.+.+.+.        +.. ..++  +.+               .++  ...+       ....
T Consensus       270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            99999999853322  11211111        100 0111  000               000  0000       0000


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......+.+++.+|++.||.+|.|+++.|++
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            11122367899999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-24  Score=235.69  Aligned_cols=250  Identities=25%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++...++|.|.||.|||++.. .++..|||.++........-++.|+-+++.-+|+||+.++|.+...+..++.|||+.+
T Consensus        17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg   96 (829)
T KOG0576|consen   17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG   96 (829)
T ss_pred             hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence            344567999999999999965 5888999999877666677788899999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|++.-+..   .++++.++..+.++..+||+|||+.   +-+|||||-.|||+++.+.+|++|||.+-.+...-... 
T Consensus        97 gslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr-  169 (829)
T KOG0576|consen   97 GSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR-  169 (829)
T ss_pred             Ccccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhh-
Confidence            9999966433   4688999999999999999999997   88999999999999999999999999987664432221 


Q ss_pred             cCCCCCCcccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 TMPKGTPGYMAPELT---RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~---~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ....||+.|||||+.   ..+.+..++|||+.|+...|+--.+.|.-............     .   ...+  .+....
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----k---S~~q--pp~lkD  239 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----K---SGFQ--PPTLKD  239 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----c---cCCC--CCcccC
Confidence            224699999999987   34568999999999999999988777643222211111000     0   0011  111112


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      .......+.+++..|+-.+|++||++..+++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            3345677889999999999999999988765

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=9.3e-23  Score=201.98  Aligned_cols=168  Identities=24%  Similarity=0.271  Sum_probs=126.4

Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++...  ...+++..+..|+.||++||+|||+.   +      ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            6888988543  34699999999999999999999997   3      999999999999999  99998764422    


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                        ..|++.|+|||++.+..++.++|||||||++|||++|+.|+......  ...+......  ...   ...........
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~--~~~---~~~~~~~~~~~  134 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNG--MPA---DDPRDRSNLES  134 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHH--hcc---CCccccccHHH
Confidence              25789999999999999999999999999999999999998644321  1111111100  000   00000011122


Q ss_pred             HHH--HHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          745 DAV--KMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       745 ~~~--~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      ...  ++.+++.+||+.+|.+||++.|+++++..+.
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            222  6899999999999999999999999986553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.89  E-value=1e-22  Score=186.26  Aligned_cols=109  Identities=30%  Similarity=0.531  Sum_probs=92.7

Q ss_pred             eeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCceEEEeecccEEE
Q 043017           52 RTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLIL  131 (818)
Q Consensus        52 ~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~l~l~~~g~Lvl  131 (818)
                      .++|+|++     +.|++|||.+....       ..+.+|||.    +.+ .++||+||++.|....+.|.|+.||+|+|
T Consensus         7 ~~~l~s~~-----~~f~~G~~~~~~q~-------~dgnlv~~~----~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl   69 (116)
T cd00028           7 GQTLVSSG-----SLFELGFFKLIMQS-------RDYNLILYK----GSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVI   69 (116)
T ss_pred             CCEEEeCC-----CcEEEecccCCCCC-------CeEEEEEEe----CCC-CeEEEECCCCCCCCCCEEEEEecCCCeEE
Confidence            45799988     99999999986442       234567773    223 67999999999966678999999999999


Q ss_pred             EcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceecccCC
Q 043017          132 KDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWISFLHP  177 (818)
Q Consensus       132 ~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~P  177 (818)
                      +|.+|.+||+|++.+ ....+|+|+|+|||||++..+.++|||||||
T Consensus        70 ~~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P  116 (116)
T cd00028          70 YDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP  116 (116)
T ss_pred             EcCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence            999999999999875 5667899999999999999999999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.86  E-value=1.8e-21  Score=177.61  Aligned_cols=107  Identities=30%  Similarity=0.535  Sum_probs=90.6

Q ss_pred             eeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCceEEEeecccEEE
Q 043017           52 RTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLIL  131 (818)
Q Consensus        52 ~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~l~l~~~g~Lvl  131 (818)
                      .+.|+|++     +.|++|||.+....        .+.+|||.    ..+ .++||+||++.|+..++.|.|..||+|||
T Consensus         7 ~~~l~s~~-----~~f~~G~~~~~~q~--------dgnlV~~~----~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl   68 (114)
T smart00108        7 GQTLVSGN-----SLFELGFFTLIMQN--------DYNLILYK----SSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVL   68 (114)
T ss_pred             CCEEecCC-----CcEeeeccccCCCC--------CEEEEEEE----CCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEE
Confidence            35788888     99999999875431        23466773    223 67999999999988778999999999999


Q ss_pred             EcCCCcEEEeeccC-CCceeEEEEcCCCcEEEecCCCCcceecccC
Q 043017          132 KDVDGTRVWSTETS-GSNVTRITLDGNGNLRLYDAENRPHWISFLH  176 (818)
Q Consensus       132 ~~~~~~~vWst~~~-~~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~  176 (818)
                      +|.+|.+||+|++. +....+|+|+|+|||||++..+.++||||||
T Consensus        69 ~~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~  114 (114)
T smart00108       69 YDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY  114 (114)
T ss_pred             EeCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence            99999999999986 5566789999999999999999999999997

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=5.7e-21  Score=208.00  Aligned_cols=272  Identities=18%  Similarity=0.187  Sum_probs=198.4

Q ss_pred             hHHhhhhcccccceeEEEeEecCC--cEEEEEEcCCCCCccHHHHHHHHHHHhccCc----ceeEEEeeee-cccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDG--TKVAVKRLYPGENRGKKEFLSEVETIGNIHH----FNLVRLVGYC-AERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H----~niv~l~g~~-~~~~~~~l  577 (818)
                      .+.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            455667899999999999997653  5788888765433333377889998888863    5888888888 47778899


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-----CCEEEeecCC
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-----LNVKIADFGL  652 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfgl  652 (818)
                      ||+.+ +.+|.++..... .+.++..+...|+.|++.+|.+||+.   +++||||||.|+.+...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99976 899999764444 56799999999999999999999997   99999999999999765     4699999999


Q ss_pred             ce--ecccCCCc----c---ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHh
Q 043017          653 AR--LIAQDQSH----V---STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA  723 (818)
Q Consensus       653 a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~  723 (818)
                      ++  .+......    .   .....||..|.+++...+...+.+.|+||++.++.|++.|..||................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99  33222211    1   122459999999999999999999999999999999999999986554322222222111


Q ss_pred             hhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchh
Q 043017          724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSF  791 (818)
Q Consensus       724 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~  791 (818)
                      .......       .   ......++.++...+-..+..++|....+...|+.............+++
T Consensus       254 ~~~~~~~-------~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw  311 (322)
T KOG1164|consen  254 RKLLTDR-------F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW  311 (322)
T ss_pred             hhhcccc-------c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence            1111100       0   11122344455545555889999999999999877766544444444443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=3.5e-21  Score=209.22  Aligned_cols=162  Identities=22%  Similarity=0.196  Sum_probs=125.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec--CCcEEEEEEcCCC-----CCccHHHHHHHHHHHhccCcceeEE-EeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN--DGTKVAVKRLYPG-----ENRGKKEFLSEVETIGNIHHFNLVR-LVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~-l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||+||+|...  +++.+|||++...     .....+.|.+|++++.+++|+|+++ ++++    +..
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~   93 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD   93 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence            34566778999999999999875  4777899987533     1123456899999999999999985 4432    457


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeeccc-ccCeEEEcCCCCEEEeecCCce
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI-KPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfgla~  654 (818)
                      ++||||+++++|.. + . .. .      ...++.+++++|.|||+.   +|+|||| ||+|||++.++++||+|||+++
T Consensus        94 ~LVmE~~~G~~L~~-~-~-~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         94 GLVRGWTEGVPLHL-A-R-PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEEEEccCCCCHHH-h-C-cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            99999999999963 2 1 10 1      146788999999999997   9999999 9999999999999999999999


Q ss_pred             ecccCCCccc-------cCCCCCCcccccccccCC
Q 043017          655 LIAQDQSHVS-------TMPKGTPGYMAPELTRGN  682 (818)
Q Consensus       655 ~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~  682 (818)
                      .+........       ....++..|+|||++...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            8765421111       234578889999999643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=4.2e-20  Score=187.42  Aligned_cols=276  Identities=19%  Similarity=0.226  Sum_probs=208.2

Q ss_pred             hHHhhhhcccccceeEEEeE-ecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+...++||+|.||.++.|+ +-+++.||||.-...  ....++..|.+..+.| ..++|...+-+-.++-+-.||+|++
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            34567899999999999998 557999999954322  2345788899999888 5889999999889998999999987


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-----CCEEEeecCCceecc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-----LNVKIADFGLARLIA  657 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfgla~~~~  657 (818)
                       +.||++...-..  +.++..++..||.|++.-++|+|+.   .+|.|||||+|+||...     ..+.|+|||+|+...
T Consensus       107 -GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 -GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             -CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence             889998664444  4699999999999999999999997   99999999999999643     358999999999887


Q ss_pred             cCCCccc------cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          658 QDQSHVS------TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       658 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      .......      ....||.+||+-....+.+.+.+.|+-|+|-++++.|-|..||.+......-+...++.+..+...+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            6543322      2245999999999999999999999999999999999999999987665544444443333222111


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchhhhhh
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVE  795 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~  795 (818)
                       +...      ...++++..-+.-.=..+..+-|...-+...+..+.+.-..++-.-++++-.+
T Consensus       261 -~~Lc------~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  261 -EVLC------EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             -HHHH------hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence             1111      11223444444444456777889999988888877766555555555555333

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=6e-19  Score=190.65  Aligned_cols=255  Identities=31%  Similarity=0.429  Sum_probs=194.8

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhccCcc-eeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHF-NLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ....||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++.+.+......+++++++.
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            3457899999999999988  78999998765433   367899999999999888 79999999977777899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++.+++........+.......++.|++.++.|+|+.   +++|||+||+||+++... .++++|||+++.+......
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999996664322112688889999999999999999998   899999999999999988 7999999999866554332


Q ss_pred             -----cccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc----hHHHHHHHHhhhhcchh
Q 043017          663 -----VSTMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGD----YLVDTLKVKAEADRLCD  730 (818)
Q Consensus       663 -----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~----~l~~~~~~~~~~~~~~~  730 (818)
                           ......++..|+|||.+..   .......|+|++|++++++++|..|+......    .....+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  237 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLAS  237 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cccc
Confidence                 2344679999999999987   57899999999999999999999997654431    111211111100 0000


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          ..... ........+.+++..|+..+|..|.++.+....
T Consensus       238 ----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         238 ----PLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ----ccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                00000 001223567788999999999999999887764

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.81  E-value=4.4e-20  Score=166.99  Aligned_cols=101  Identities=17%  Similarity=0.296  Sum_probs=89.8

Q ss_pred             eeecccccceeccccccc---ccceeEEecCCCceEEEeeCCCCceEEEEECCCCcEEEEEecCCCCCCeeeeccCCCCC
Q 043017          228 FQTIPYRNYFLNMSSAVL---NKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHYGD  304 (818)
Q Consensus       228 ~~~~p~~~~~~~~~~~~~---~~~~~~~~n~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~~~~~~~~~~~~~  304 (818)
                      ||+|||+|..|++.+...   ...+.|+.+++|.+++|.+.+.+.++|++|+++|++|+|.|.+..+.|..++. .|.++
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~-~p~d~   79 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWS-APKDQ   79 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEE-ecccC
Confidence            789999999999888664   24467889999999999999999999999999999999999998899988874 58899


Q ss_pred             CCCCCCCCCCcccCC---CCCCCCCCCC
Q 043017          305 CIYPTKCGNYGVCSN---GECTCPGSSS  329 (818)
Q Consensus       305 Cd~~~~CG~~g~C~~---~~C~C~~g~~  329 (818)
                      ||+|+.||+||+|+.   +.|+|++||+
T Consensus        80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~  107 (110)
T PF00954_consen   80 CDVYGFCGPNGICNSNNSPKCSCLPGFE  107 (110)
T ss_pred             CCCccccCCccEeCCCCCCceECCCCcC
Confidence            999999999999973   5799999964

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=3.4e-19  Score=173.35  Aligned_cols=262  Identities=18%  Similarity=0.255  Sum_probs=195.4

Q ss_pred             HhhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ...+.+.++||.|+||.+|.|.. ..|.+||||.-...  ....++..|..+...|+ ...|..+..+..++..-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            34455667899999999999984 57999999976433  33457788999999986 4677788888889999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCceecc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIA  657 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~  657 (818)
                      .+ +.+|.+...-.+  +.++..+.+-.+-|++.-++|+|..   ++|||||||+|+|+.-+   .++.++||||++.+.
T Consensus        92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            87 889998764443  3588889999999999999999997   99999999999999654   458999999999876


Q ss_pred             cCCCcc------ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          658 QDQSHV------STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       658 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      ......      .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||.+.....-.+......+. ++...
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek-K~s~~  244 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK-KMSTP  244 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-hcCCC
Confidence            543221      22245999999998888888899999999999999999999999876543322222111111 11110


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +....      ...+.++...+.-|-..-.++-|+...+-+.+..+-.
T Consensus       245 ie~LC------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  245 IEVLC------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHHh------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            11001      1223466667778888888888988877777765543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.1e-19  Score=210.44  Aligned_cols=252  Identities=23%  Similarity=0.238  Sum_probs=183.8

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcC----CCCC-c-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLY----PGEN-R-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~----~~~~-~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ...+|.|.+|.|+..... .....+.|...    .... . ....+..|+-+-..++|+|++..+..+.+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            457999999977766543 23333333222    1111 1 111256677788889999999988888877776666999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++ +|..++...   ..+...++.-++.|+..|+.|||+.   +|.|||+|++|+++..++.+||+|||.+..+.....
T Consensus       403 ~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             ccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            999 999988543   3578888999999999999999998   999999999999999999999999999998865433


Q ss_pred             ---ccccCCCCCCcccccccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          662 ---HVSTMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       662 ---~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                         .......|+..|+|||.+....+.+ ..||||.|+++..|++|+.||.......-..  ........    ......
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~----~~~~~~  549 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQ----RNIFEG  549 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccccc----cccccC
Confidence               3445567999999999999998865 6899999999999999999987443221100  00000000    000011


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..........+...++.++|+.+|.+|.|+++|++.
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            111133455677789999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=8e-19  Score=175.50  Aligned_cols=138  Identities=16%  Similarity=0.182  Sum_probs=106.3

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCc--c-------HHHH-----------------HHHHHHHhccCcceeE
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR--G-------KKEF-----------------LSEVETIGNIHHFNLV  563 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~-------~~~f-----------------~~Ev~~l~~l~H~niv  563 (818)
                      ..||+|+||.||+|...+|+.||||+++.....  .       ...|                 ..|++.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            469999999999999888999999998654211  1       1122                 3499999999877653


Q ss_pred             EEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHH-HhcCCCCeeecccccCeEEEcCC
Q 043017          564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL-HDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       564 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      ....+.  ....+|||||++++++...+..   ...++......++.|++.+|.|| |+.   +|+||||||+||+++ +
T Consensus        83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            332221  1234899999998877654322   23578899999999999999999 676   999999999999998 4


Q ss_pred             CCEEEeecCCceec
Q 043017          643 LNVKIADFGLARLI  656 (818)
Q Consensus       643 ~~~kl~Dfgla~~~  656 (818)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=1.1e-18  Score=192.77  Aligned_cols=220  Identities=25%  Similarity=0.367  Sum_probs=163.7

Q ss_pred             HhccCcceeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccc
Q 043017          554 IGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIK  633 (818)
Q Consensus       554 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlk  633 (818)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+...  ...+++.-...++++|++||+|||..  +-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            45688999999999999999999999999999999999653  24688888899999999999999987  333999999


Q ss_pred             cCeEEEcCCCCEEEeecCCceecccC-CCccccCCCCCCcccccccccCC-------CCCchhhHHHHHHHHHHHHhCCC
Q 043017          634 PQNILLDRDLNVKIADFGLARLIAQD-QSHVSTMPKGTPGYMAPELTRGN-------SITAKIDIYSFGVVILEIICGRR  705 (818)
Q Consensus       634 p~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwS~Gvll~elltG~~  705 (818)
                      ++|.++|..+.+||+|||+....... .........-...|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999999876431 11111112245679999999763       15778999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          706 SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       706 p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      ||.........+.+-..... .....+.+....   ..+...++..++..||..+|++||++.++-..++.+....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-GGSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccccCChHHHHHHHHh-cCCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            99854322111111111111 001111111111   1133347889999999999999999999999998877653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=1.2e-18  Score=176.38  Aligned_cols=171  Identities=16%  Similarity=0.129  Sum_probs=130.2

Q ss_pred             HHhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHH---------HHHHHHHHhccCcceeEEEeeeeccc
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKE---------FLSEVETIGNIHHFNLVRLVGYCAER  572 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~---------f~~Ev~~l~~l~H~niv~l~g~~~~~  572 (818)
                      ....+...+.||.|+||.||.... +++.+|||.+.+........         +.+|++.+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            344455556899999999999655 57789999997553332222         67899999999999999999886533


Q ss_pred             --------CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC
Q 043017          573 --------SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN  644 (818)
Q Consensus       573 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~  644 (818)
                              ...+|||||++|.+|.++.       .++.    ....+++.+|..||+.   +++|||++|+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                    3578999999999998763       1222    3456999999999998   999999999999999988 


Q ss_pred             EEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHH
Q 043017          645 VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII  701 (818)
Q Consensus       645 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ell  701 (818)
                      ++|+|||.......+....             .+.....+..++|+|+||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            9999999987653322111             1233344667899999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=1.6e-18  Score=199.33  Aligned_cols=250  Identities=22%  Similarity=0.260  Sum_probs=179.9

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC-CccHHHHHHHHHH--HhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE-NRGKKEFLSEVET--IGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ..+.+.||.++|=.|.+++.++|. |+||++.+.. ....+.|.++++-  ...++|||.+++.-.-......|||-+|.
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            344567999999999999999887 9999986554 3444555554433  45568999999988877777788998987


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec--ccCC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI--AQDQ  660 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~--~~~~  660 (818)
                       .-+|.+.|   ..++.+..-+..-|+.|++.||.-+|+.   +|.|||||.+||||+.=.=+.|+||.-.+..  .+++
T Consensus       104 -khnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  104 -KHNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             -hhhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence             45777766   3346678888888999999999999997   9999999999999999888999999877633  2332


Q ss_pred             Ccc----ccCCCCCCcccccccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhh
Q 043017          661 SHV----STMPKGTPGYMAPELTRGN----------S-ITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAE  724 (818)
Q Consensus       661 ~~~----~~~~~gt~~y~aPE~~~~~----------~-~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~  724 (818)
                      +..    ..+...-..|+|||.+...          . .+++-||||+||++.||++ |+++|..      -+-+..+..
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~~  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRSG  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhcc
Confidence            211    1122344579999987431          2 6789999999999999998 6777742      111111111


Q ss_pred             hhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       725 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      .....+.+-..+        +...+.+++..|++.||++|.++++.|+.-.++
T Consensus       251 ~~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  251 NADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             CccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            011111111111        123677999999999999999999999985443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=7e-18  Score=169.25  Aligned_cols=140  Identities=16%  Similarity=0.131  Sum_probs=109.7

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCc--c------------------------HHHHHHHHHHHhccCcceeE
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR--G------------------------KKEFLSEVETIGNIHHFNLV  563 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~------------------------~~~f~~Ev~~l~~l~H~niv  563 (818)
                      ..||+|+||.||+|...+|+.||||++......  .                        ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            469999999999999888999999998754211  0                        11235788999999988875


Q ss_pred             EEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCC
Q 043017          564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       564 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      ....+...  ..+|||||++++++.......   ..++......++.|++.++.+||+ .   +|+||||||+||+++ +
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~  153 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence            44433322  348999999988654432221   346778899999999999999999 6   999999999999999 8


Q ss_pred             CCEEEeecCCceeccc
Q 043017          643 LNVKIADFGLARLIAQ  658 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~  658 (818)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.2e-17  Score=162.26  Aligned_cols=181  Identities=16%  Similarity=0.073  Sum_probs=137.2

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCcc----HHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG----KKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~----~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ..|++|+||+||.+.- ++++++.+.+.....-.    ...|.+|+++|++|+ |+++.+++++    ...+++|||+++
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            4699999999997666 57888888776554311    225889999999994 5889998886    446999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeeccc-ccCeEEEcCCCCEEEeecCCceecccCCCc-
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI-KPQNILLDRDLNVKIADFGLARLIAQDQSH-  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  662 (818)
                      .+|.+.+..          ....++.|++++|.++|+.   +|+|||| ||.|||++.++.++|+|||++......... 
T Consensus        83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            998654310          1235778999999999998   9999999 799999999999999999999865543321 


Q ss_pred             ---c--------ccCCCCCCcccccccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCC
Q 043017          663 ---V--------STMPKGTPGYMAPELTRGN-SIT-AKIDIYSFGVVILEIICGRRSSN  708 (818)
Q Consensus       663 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwS~Gvll~elltG~~p~~  708 (818)
                         .        ......++.|++|+...-- ..+ ...+.++-|..+|.++|++.+..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence               0        1112367778888755332 233 57788999999999999988754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.73  E-value=1.7e-17  Score=172.91  Aligned_cols=228  Identities=23%  Similarity=0.314  Sum_probs=147.5

Q ss_pred             hhcccccceeEEEeEecC-CcEEEEEEcCCCC---CccHHHHHHHHHHHhccC----------cceeEEEeeee------
Q 043017          510 IRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE---NRGKKEFLSEVETIGNIH----------HFNLVRLVGYC------  569 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~----------H~niv~l~g~~------  569 (818)
                      ..||.|+++.||.++..+ ++++|||.+....   ....+++++|.-.+..+.          |-.++..++..      
T Consensus        18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~   97 (288)
T PF14531_consen   18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP   97 (288)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred             cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence            469999999999999875 8999999875332   334567777776665542          22222222221      


Q ss_pred             ---cccC--------cceeeeeccCCCChhhHhh---hcCC-ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeeccccc
Q 043017          570 ---AERS--------NRFLVYEYMCNGSLDKWIF---HKDR-IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKP  634 (818)
Q Consensus       570 ---~~~~--------~~~lV~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp  634 (818)
                         ....        ..+++|+-+ .++|.+++.   .... ...+....+..+..|+++.+++||..   +++|+||+|
T Consensus        98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~  173 (288)
T PF14531_consen   98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKP  173 (288)
T ss_dssp             SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SG
T ss_pred             cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccce
Confidence               1111        236677776 778887753   2222 23455556677779999999999998   999999999


Q ss_pred             CeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccC--------CCCCchhhHHHHHHHHHHHHhCCCC
Q 043017          635 QNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG--------NSITAKIDIYSFGVVILEIICGRRS  706 (818)
Q Consensus       635 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwS~Gvll~elltG~~p  706 (818)
                      +|++++.+|.++|+||+...........    ...+..|.+||....        -.++.+.|.|++|+++|.|+++..|
T Consensus       174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            9999999999999999888765443221    234578999997743        2478899999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCC
Q 043017          707 SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRR  764 (818)
Q Consensus       707 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  764 (818)
                      |.....+...++                ....  .. +.++.+..||..+|+.+|++|
T Consensus       250 f~~~~~~~~~~~----------------~f~~--C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW----------------DFSR--CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG----------------GGTT--SS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc----------------cchh--cC-CcCHHHHHHHHHHccCCcccC
Confidence            975533221111                0111  12 566788899999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=3.7e-18  Score=188.17  Aligned_cols=225  Identities=22%  Similarity=0.273  Sum_probs=179.1

Q ss_pred             hcccccceeEEEeEe----cCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccC
Q 043017          511 RLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENR--GKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+|+|.||.|+....    +.|.-+|+|.+.+....  .......|..++...+ ||.+|++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999987653    34677899988665321  1224556888888886 9999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +|.|...+.+   ...+.+.....+...++-+++++|+.   +|+|||+|++||+++.+|++++.|||+++..-..+.. 
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            9999877743   34577777788888999999999998   9999999999999999999999999999977654433 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                          .||..|||||++.  ......|-||||++++||++|..||..    +....+..               .+...+.
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~---------------~~~~~p~  208 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK---------------AELEMPR  208 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh---------------hccCCch
Confidence                6899999999998  567889999999999999999999875    11111111               0122355


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSA  767 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~  767 (818)
                      +.......++..++..+|..|.-.
T Consensus       209 ~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhHHHHHHHHHHHhhCHHHHhcc
Confidence            666777788888889999888644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.4e-17  Score=192.88  Aligned_cols=198  Identities=22%  Similarity=0.248  Sum_probs=154.3

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC---cceeEEEeeeecccCcce
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~  576 (818)
                      ++....+.+.+.||+|+||.||+|...+|+.||+|+-++...-   +|--=.+++.+|+   -+.|..+..+..-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3444555667789999999999999998999999987665432   2222233444444   233444455555567789


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-------CCCCEEEee
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-------RDLNVKIAD  649 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~D  649 (818)
                      ||+||.+.|+|.+++.   ..+..+|.....++.|+++.+.+||..   +|||+||||+|++|.       +..-++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999985   345789999999999999999999998   999999999999993       234589999


Q ss_pred             cCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 043017          650 FGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS  706 (818)
Q Consensus       650 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p  706 (818)
                      ||.+--+..-... .....++|-.+-.+|+..+..++.+.|.|.|+-+++-||.|+..
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9998755432222 22335678889999999999999999999999999999999753

>PRK10345 hypothetical protein; Provisional

Probab=99.69  E-value=1.4e-16  Score=160.86  Aligned_cols=134  Identities=20%  Similarity=0.286  Sum_probs=104.6

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-----CcceeEEEeeeecccC---c-ceeeee
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-----HHFNLVRLVGYCAERS---N-RFLVYE  580 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV~e  580 (818)
                      ..||+|+||.||.  .++....+||++........+.+.+|+.++..+     .||||++++|++.+..   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            4699999999996  443333479988765555667899999999999     5799999999998864   2 337899


Q ss_pred             c--cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHH-HHHHhcCCCCeeecccccCeEEEcC----CCCEEEeecCCc
Q 043017          581 Y--MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL-EYLHDYCNPKIIHFDIKPQNILLDR----DLNVKIADFGLA  653 (818)
Q Consensus       581 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfgla  653 (818)
                      |  +++++|.+++.+.    .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +.+++|+||+-+
T Consensus        86 ~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         86 FDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            9  5579999999432    24444  35677888777 899998   9999999999999974    347999995544


Q ss_pred             e
Q 043017          654 R  654 (818)
Q Consensus       654 ~  654 (818)
                      .
T Consensus       157 ~  157 (210)
T PRK10345        157 S  157 (210)
T ss_pred             c
Confidence            3

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=6.6e-16  Score=160.38  Aligned_cols=196  Identities=23%  Similarity=0.321  Sum_probs=138.0

Q ss_pred             CcceeEEEeeeeccc---------------------------CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHH
Q 043017          558 HHFNLVRLVGYCAER---------------------------SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF  610 (818)
Q Consensus       558 ~H~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  610 (818)
                      +|||||++.++|.+.                           ...|+||.-+ ..+|.+++...    ..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence            699999999887532                           2347888765 56888888543    356677788999


Q ss_pred             HHHHHHHHHHhcCCCCeeecccccCeEEE--cCCC--CEEEeecCCceecccCC-----CccccCCCCCCcccccccccC
Q 043017          611 QISRGLEYLHDYCNPKIIHFDIKPQNILL--DRDL--NVKIADFGLARLIAQDQ-----SHVSTMPKGTPGYMAPELTRG  681 (818)
Q Consensus       611 qia~gL~yLH~~~~~~iiH~Dlkp~NIll--~~~~--~~kl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~  681 (818)
                      |+++|+.|||++   +|.|||+|++||||  |+|.  ...|+|||++---....     ........|....||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999998   99999999999999  4443  47899999875332211     111112347778999999865


Q ss_pred             CC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHH
Q 043017          682 NS------ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAIS  755 (818)
Q Consensus       682 ~~------~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~  755 (818)
                      .+      --.|+|.|+.|.+.||++....||.......+ +...  .++.++        +  ..+......+.+++..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~--Yqe~qL--------P--alp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT--YQESQL--------P--ALPSRVPPVARQLVFD  492 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh--hhhhhC--------C--CCcccCChHHHHHHHH
Confidence            43      23589999999999999999999986433222 1111  111111        1  1133445677899999


Q ss_pred             ccccCCCCCCcHHHHHHHH
Q 043017          756 CLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       756 cl~~dp~~RPt~~evl~~L  774 (818)
                      .|+.||++|++..-....|
T Consensus       493 lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HhcCCccccCCccHHHhHH
Confidence            9999999999876655554

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=9.1e-16  Score=156.68  Aligned_cols=134  Identities=23%  Similarity=0.325  Sum_probs=112.8

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR--------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.||+|++|.||+|.. .|..+++|+.......        ....+.+|++++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            3689999999999988 5778999986543221        124578899999999999988777777777788999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +++++|.+++....      . .+..++.+++.+|.+||+.   +++|+|++|.||+++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999884321      1 7889999999999999997   999999999999999 78999999999874

>smart00090 RIO RIO-like kinase

Probab=99.64  E-value=9.6e-16  Score=158.59  Aligned_cols=140  Identities=17%  Similarity=0.168  Sum_probs=108.1

Q ss_pred             HHhhhhcccccceeEEEeE--ecCCcEEEEEEcCCCCCc------------------------cHHHHHHHHHHHhccCc
Q 043017          506 RDFQIRLGRGGSGSVFEGL--LNDGTKVAVKRLYPGENR------------------------GKKEFLSEVETIGNIHH  559 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~Ev~~l~~l~H  559 (818)
                      +.+.+.||+|+||.||+|.  ..+|+.||||.+......                        ....+..|++.+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4556789999999999998  568999999988643210                        01235689999999975


Q ss_pred             c--eeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC-eeecccccCe
Q 043017          560 F--NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK-IIHFDIKPQN  636 (818)
Q Consensus       560 ~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-iiH~Dlkp~N  636 (818)
                      .  .+.+++++    ...++||||+++.+|...+...   ..+.......++.||+.+|.+||+.   + ++||||||+|
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N  179 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN  179 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence            3  33444443    2358999999998887654221   2355566789999999999999998   8 9999999999


Q ss_pred             EEEcCCCCEEEeecCCceec
Q 043017          637 ILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       637 Ill~~~~~~kl~Dfgla~~~  656 (818)
                      |+++ ++.++|+|||++...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.6e-15  Score=153.45  Aligned_cols=130  Identities=23%  Similarity=0.361  Sum_probs=106.2

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR--------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .||+|+||.||+|.+ +++.+++|+.......        ...++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999996 4788999986543211        1256778999999998887665555556666789999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++++|.+++....    .      .++.+++++|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998773221    0      8899999999999997   999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.62  E-value=2e-15  Score=152.66  Aligned_cols=137  Identities=20%  Similarity=0.226  Sum_probs=108.1

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCC----------------------ccHHHHHHHHHHHhccCcc--e
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN----------------------RGKKEFLSEVETIGNIHHF--N  561 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~----------------------~~~~~f~~Ev~~l~~l~H~--n  561 (818)
                      +.+.+.||+|+||.||++...+|+.||||++.....                      .....+..|...+..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            555678999999999999998899999998654320                      0112356788889888777  4


Q ss_pred             eEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       562 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      +.+.++.    ...++||||+++++|.....         ......++.++++++.++|+.   +++|+||||+||++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~  160 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence            4444442    34589999999999876441         134567889999999999997   9999999999999999


Q ss_pred             CCCEEEeecCCceeccc
Q 043017          642 DLNVKIADFGLARLIAQ  658 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~  658 (818)
                      ++.++|+|||++.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=2.3e-16  Score=171.05  Aligned_cols=123  Identities=31%  Similarity=0.544  Sum_probs=110.1

Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++.|+++...+|.+||.+.......++.....++.|++.|+.|   .   +.+|+|+||.||+...+.++||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999887777888999999999999999999   2   8999999999999999999999999999


Q ss_pred             eecccCC-----CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh
Q 043017          654 RLIAQDQ-----SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC  702 (818)
Q Consensus       654 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt  702 (818)
                      .......     ....+...||..||+||.+.+..++.|+||||||+||+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8765544     223344679999999999999999999999999999999997

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.61  E-value=2.5e-15  Score=174.92  Aligned_cols=132  Identities=18%  Similarity=0.290  Sum_probs=108.6

Q ss_pred             hhhcccccceeEEEeEecCCcEEEEEEc-CCC-CC------ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          509 QIRLGRGGSGSVFEGLLNDGTKVAVKRL-YPG-EN------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l-~~~-~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.||+|+||.||+|.+.+.. +++|+. ... ..      ...+.+.+|++++..++|++++....++......++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            467999999999999886544 444432 211 11      123568899999999999999988888877778899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      |+++++|.+++.           ....++.+++++|.|||+.   +++||||||+|||+ .++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999998873           3567899999999999997   99999999999999 6779999999999753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=8.1e-14  Score=133.36  Aligned_cols=133  Identities=21%  Similarity=0.207  Sum_probs=113.8

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCc--ceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH--FNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      +.||+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++.+++++....+..+++|||++++.+
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            468999999999999865 7899999865433  5678999999999976  5899999998888889999999988877


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ..+          +......++.+++++|++||.....+++|+|++|+||+++..+.+++.|||++..
T Consensus        81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            542          4556678899999999999987556799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=6.1e-14  Score=140.26  Aligned_cols=137  Identities=24%  Similarity=0.290  Sum_probs=97.0

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCc--cHHHH----------------------HHHHHHHhccCcc--eeE
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR--GKKEF----------------------LSEVETIGNIHHF--NLV  563 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~~~~f----------------------~~Ev~~l~~l~H~--niv  563 (818)
                      +.||+|+||.||++...+++.||||++......  ....+                      ..|.+.+.++.+.  .+.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            569999999999999888999999987653211  11111                      2455555555332  233


Q ss_pred             EEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCC
Q 043017          564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       564 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      +.+++    ...++||||++++.+.........   . ......++.+++.++.++|. .   +|+|+||||+||+++ +
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D  150 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence            33332    246899999999554321111100   1 16678999999999999998 6   999999999999999 8


Q ss_pred             CCEEEeecCCceeccc
Q 043017          643 LNVKIADFGLARLIAQ  658 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~  658 (818)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            9999999999975533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.45  E-value=3.8e-13  Score=139.49  Aligned_cols=135  Identities=20%  Similarity=0.231  Sum_probs=104.5

Q ss_pred             hhcc-cccceeEEEeEecCCcEEEEEEcCCCC-------------CccHHHHHHHHHHHhccCccee--EEEeeeecccC
Q 043017          510 IRLG-RGGSGSVFEGLLNDGTKVAVKRLYPGE-------------NRGKKEFLSEVETIGNIHHFNL--VRLVGYCAERS  573 (818)
Q Consensus       510 ~~LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------~~~~~~f~~Ev~~l~~l~H~ni--v~l~g~~~~~~  573 (818)
                      ..|| .|+.|+||+.... ++.++||++....             ......+.+|++++.+++|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            3688 8999999999886 7789999875321             1223567889999999988774  67777654432


Q ss_pred             c----ceeeeeccCC-CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEe
Q 043017          574 N----RFLVYEYMCN-GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIA  648 (818)
Q Consensus       574 ~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  648 (818)
                      .    .++|||++++ .+|.+++..    ..++.    ..+.+|+++|.+||+.   +|+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 689888743    12333    2467899999999998   99999999999999998899999


Q ss_pred             ecCCceec
Q 043017          649 DFGLARLI  656 (818)
Q Consensus       649 Dfgla~~~  656 (818)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.43  E-value=7.1e-14  Score=161.69  Aligned_cols=201  Identities=22%  Similarity=0.304  Sum_probs=136.2

Q ss_pred             hhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          510 IRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +.|..|+||.||..++++ .+.+|+|.-+ ..     .+++-  ++.....|.+|                     |+=.
T Consensus        89 klisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   89 KLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             EeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee---------------------chhh
Confidence            468899999999999875 5567774321 11     11110  22222344333                     1111


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC--------
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ--------  660 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~--------  660 (818)
                      ..+.   ..+.++.+        ++.+++|||+.   +|+|||+||+|.+|..-|++|++|||+.+......        
T Consensus       140 tllk---~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  140 TLLK---NIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             hhcc---cCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence            2121   11233322        27789999997   99999999999999999999999999987542110        


Q ss_pred             ------CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          661 ------SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       661 ------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                            ........||+.|+|||++....|...+|.|++|+|+||.+-|+.||.+...+.++..+-..        .+..
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd--------~i~w  277 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD--------DIEW  277 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh--------hccc
Confidence                  01122347999999999999999999999999999999999999999988777766544211        1111


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRP  765 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  765 (818)
                      .-+    ......+..+++...|+.+|..|-
T Consensus       278 pE~----dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 PEE----DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ccc----CcCCCHHHHHHHHHHHHhChHhhc
Confidence            111    122335666778889999999995

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=2.9e-12  Score=144.42  Aligned_cols=140  Identities=24%  Similarity=0.288  Sum_probs=100.3

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccH----------------------------------------HHHHHH
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK----------------------------------------KEFLSE  550 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~----------------------------------------~~f~~E  550 (818)
                      -||.|++|.||+|++.+|+.||||+.++......                                        -+|.+|
T Consensus       124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E  203 (437)
T TIGR01982       124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE  203 (437)
T ss_pred             ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence            4999999999999999999999999876421100                                        124456


Q ss_pred             HHHHhcc----CcceeEEEeeee-cccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHH-HHHHHHhcCC
Q 043017          551 VETIGNI----HHFNLVRLVGYC-AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR-GLEYLHDYCN  624 (818)
Q Consensus       551 v~~l~~l----~H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~~~  624 (818)
                      ++.+.++    +|.+-+.+-..+ ......+|||||+++++|.++......  .+   .+.+++..+++ .+..+|..  
T Consensus       204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC--
Confidence            5555554    232223333333 334567999999999999887643211  11   34567777766 46788886  


Q ss_pred             CCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                       +++|+|++|.||+++.+++++++|||++..+..
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             999999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=1.4e-13  Score=159.75  Aligned_cols=251  Identities=23%  Similarity=0.261  Sum_probs=182.8

Q ss_pred             HHhhhhcccccceeEEEeEecC--CcEEEEEEcCCCC--CccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND--GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +.+.+.||+|.|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++++++.....+..+++.|
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            3445569999999998777643  4456666665442  222334445777767775 9999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHH-hcCCCCeeecccccCeEEEcCCC-CEEEeecCCceeccc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH-DYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQ  658 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  658 (818)
                      |..++++.+.+.+. .....+......+..|+..++.|+| +.   ++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus       102 ~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  102 YSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccccccccccccC-CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            99999998877421 1224566778889999999999999 76   999999999999999999 999999999998876


Q ss_pred             -CCC-ccccCCCC-CCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCch--HHHHHHHHhhhhcchhhc
Q 043017          659 -DQS-HVSTMPKG-TPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDY--LVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       659 -~~~-~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~--l~~~~~~~~~~~~~~~~~  732 (818)
                       ... .......| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.......  ...+....   .      
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~------  248 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---G------  248 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---c------
Confidence             332 23334567 9999999999884 45788999999999999999999986443221  11111100   0      


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                         ...............++...++..+|..|.+.+++..
T Consensus       249 ---~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 ---RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence               0000112233445667788888899999999777644

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=2.4e-12  Score=131.44  Aligned_cols=203  Identities=25%  Similarity=0.361  Sum_probs=141.9

Q ss_pred             HHhccCcceeEEEeeeeccc-----CcceeeeeccCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCC
Q 043017          553 TIGNIHHFNLVRLVGYCAER-----SNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPK  626 (818)
Q Consensus       553 ~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  626 (818)
                      -|-++.|.|||+++.|+.+.     .+..++.|||..|+|..+|.+.. ....+....-.++..||..||.|||+ +.+.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            34455799999999988543     35689999999999999997643 34567788888999999999999998 5889


Q ss_pred             eeecccccCeEEEcCCCCEEEeecCCceecccC---CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 043017          627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQD---QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG  703 (818)
Q Consensus       627 iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG  703 (818)
                      |+|+++..+.|++..++-+||+--.-......-   .........+-++|.|||.=...+.+-.+|||+||+..+||.-+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999999998532211111100   01111223467899999998888888999999999999999887


Q ss_pred             CCCCCCCCCchHH-HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          704 RRSSNPKGGDYLV-DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       704 ~~p~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ..-.......... ..+...         + ..++        ...-..++..|++.+|..||+|.+++.+.
T Consensus       279 Eiq~tnseS~~~~ee~ia~~---------i-~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANV---------I-IGLE--------NGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceeehhhhhhhh---------e-eecc--------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence            6542222111111 111100         0 0000        00112456799999999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=4e-11  Score=133.21  Aligned_cols=254  Identities=26%  Similarity=0.274  Sum_probs=178.6

Q ss_pred             HHhhHHhhhhccc--ccceeEEEeEe---cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcc-CcceeEEEeeeecccC
Q 043017          502 KSATRDFQIRLGR--GGSGSVFEGLL---NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS  573 (818)
Q Consensus       502 ~~~t~~f~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  573 (818)
                      ......+.+.+|.  |.+|.||++..   .++..+|+|+-+..-  ......=.+|+....++ .|+|.++....+..++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3444555667999  99999999987   357889999743221  22223334566666666 4999999888888889


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHH----HHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEe
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIA  648 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~  648 (818)
                      ..++-.|++ +.+|..+.+..  ...++...++.+..+..+    ||.++|..   .++|-|+||.||++..+ ..++++
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            999989986 57887776432  234667777888888888    99999997   99999999999999999 889999


Q ss_pred             ecCCceecccCCCc----cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh
Q 043017          649 DFGLARLIAQDQSH----VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE  724 (818)
Q Consensus       649 Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~  724 (818)
                      |||+...+......    ......+...|++||.+.+ .++...|||++|.++.+..++...........   |.+    
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---W~~----  337 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS---WSQ----  337 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC---ccc----
Confidence            99999988765421    1222357889999998865 57889999999999999998876544221110   000    


Q ss_pred             hhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       725 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                             ++......+....-..++..++..+++.+|..|++.+.+. .|..|
T Consensus       338 -------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i  382 (524)
T KOG0601|consen  338 -------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVI  382 (524)
T ss_pred             -------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-ccccc
Confidence                   0011111111112223444588899999999999866544 34344

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.15  E-value=1.7e-11  Score=99.46  Aligned_cols=60  Identities=33%  Similarity=0.615  Sum_probs=48.9

Q ss_pred             cccceeeccccccccccccc--ccCChhhHHHhhhccCccccccccccCCcccCcccccc-cccc
Q 043017          355 HLQRFLKLENVTYFDFVPHL--INIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPT-EIYT  416 (818)
Q Consensus       355 ~~~~f~~~~~~~~~d~~~~~--~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~-~l~~  416 (818)
                      ..|+|+++++|++|++....  .++++++|+..|++||||+||+|....  ++++|++|+ ++++
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~--~~~~C~lW~~~L~d   65 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS--GGGGCLLWYGDLVD   65 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC--CCCEEEEEcCEeec
Confidence            46899999999999986655  458999999999999999999985322  468999997 4543

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.14  E-value=1.5e-10  Score=113.65  Aligned_cols=129  Identities=19%  Similarity=0.125  Sum_probs=95.8

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeE-EEeeeecccCcceeeeeccCCCChhh
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV-RLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      .|+.|.++.||+.... ++.+++|....... ....+..|+..+..+.+.+++ +++.+.  ....++||||+++.++..
T Consensus         5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             ecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            4788999999999876 77899998754432 233567899999988655544 444443  234589999999988754


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC--CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC--NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      .           ......++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        81 ~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 E-----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             c-----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            2           0112346789999999999872  22369999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=3.7e-10  Score=126.47  Aligned_cols=243  Identities=16%  Similarity=0.155  Sum_probs=154.8

Q ss_pred             ecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhh
Q 043017          525 LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI  604 (818)
Q Consensus       525 ~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~  604 (818)
                      ..++.+|.|...+...........+-++.|+.++||||++++.........|||.|-+  -.|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence            3468888888876555433455677888999999999999999999999999999976  456666632      33555


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCC
Q 043017          605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI  684 (818)
Q Consensus       605 ~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  684 (818)
                      ..-.+.||+.||.+||+.  .+++|++|....|++++.|..||++|.++.....-.. .......--.|..|+.+.... 
T Consensus       106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence            666789999999999965  6899999999999999999999999999875433221 001111122456666544332 


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCC
Q 043017          685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRR  764 (818)
Q Consensus       685 s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  764 (818)
                       -..|.|.||++++|++.|..+-.  .+......+.+     .......+.....+  ..... ..+++..|.....--|
T Consensus       182 -~s~D~~~Lg~li~el~ng~~~~~--~~~~~~~~ipk-----~~~~~~~k~~~~~~--~~r~n-~~~~~~~~~~~~gff~  250 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSLLTK--TDLSNTGKIPK-----ALIELYCKKLGATE--LKRPN-KLRFILECRLLGGFFR  250 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcccCcc--hhhhccCccch-----hHHHHHHHHhcccc--ccccc-hhhHHHHHHhcccccc
Confidence             34699999999999999932211  00000000000     00000000000000  00011 4466667777777777


Q ss_pred             CcHHHHHHHHhcCcCCCCCCCCCCch
Q 043017          765 PSASMLVKVLQGLTKLEPVTDYGFLS  790 (818)
Q Consensus       765 Pt~~evl~~L~~i~~~~~~~~~~~~~  790 (818)
                      =.+-+++..|+++.-.+......++.
T Consensus       251 n~fvd~~~fLeel~lks~~eK~~Ff~  276 (690)
T KOG1243|consen  251 NDFVDTLLFLEELRLKSVEEKQKFFS  276 (690)
T ss_pred             chHHHHHHHHHhcccCcHHHHHHHHH
Confidence            77777777777776555444334433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.08  E-value=3.6e-10  Score=128.90  Aligned_cols=138  Identities=19%  Similarity=0.219  Sum_probs=91.4

Q ss_pred             hcccccceeEEEeEecC-CcEEEEEEcCCCCCcc----------------------------------H------HHHHH
Q 043017          511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRG----------------------------------K------KEFLS  549 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~----------------------------------~------~~f~~  549 (818)
                      -||.|++|.||+|++++ |++||||++.+.....                                  .      -+|.+
T Consensus       126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~  205 (537)
T PRK04750        126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR  205 (537)
T ss_pred             hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence            59999999999999987 9999999997652110                                  0      12344


Q ss_pred             HHHHHhccC----cceeEEEeeeecc-cCcceeeeeccCCCChhhHh--hhcC-CccccchhhHHHHHHHHHHHHHHHHh
Q 043017          550 EVETIGNIH----HFNLVRLVGYCAE-RSNRFLVYEYMCNGSLDKWI--FHKD-RIQTLSWDIRKKIIFQISRGLEYLHD  621 (818)
Q Consensus       550 Ev~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~  621 (818)
                      |+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.+.++-  ...+ ..+.+.......++.|+.       .
T Consensus       206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~  278 (537)
T PRK04750        206 EAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------R  278 (537)
T ss_pred             HHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h
Confidence            554444442    3333333333322 45678999999999998742  1111 111233333333344433       3


Q ss_pred             cCCCCeeecccccCeEEEcCCC----CEEEeecCCceeccc
Q 043017          622 YCNPKIIHFDIKPQNILLDRDL----NVKIADFGLARLIAQ  658 (818)
Q Consensus       622 ~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~  658 (818)
                         .+++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       279 ---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        279 ---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence               3999999999999999888    999999999987754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.98  E-value=6.3e-09  Score=103.43  Aligned_cols=135  Identities=16%  Similarity=0.193  Sum_probs=96.5

Q ss_pred             hcccccceeEEEeEecC-------CcEEEEEEcCCCC------------C----------ccHHHHH----HHHHHHhcc
Q 043017          511 RLGRGGSGSVFEGLLND-------GTKVAVKRLYPGE------------N----------RGKKEFL----SEVETIGNI  557 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~------------~----------~~~~~f~----~Ev~~l~~l  557 (818)
                      .||.|.-+.||.|.-.+       +..+|||..+...            .          ...+.+.    +|.+.|.++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            58999999999998653       4799999764321            0          0012233    789999888


Q ss_pred             Cc--ceeEEEeeeecccCcceeeeeccCCCChhhH-hhhcCCccccchhhHHHHHHHHHHHHHHH-HhcCCCCeeecccc
Q 043017          558 HH--FNLVRLVGYCAERSNRFLVYEYMCNGSLDKW-IFHKDRIQTLSWDIRKKIIFQISRGLEYL-HDYCNPKIIHFDIK  633 (818)
Q Consensus       558 ~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiH~Dlk  633 (818)
                      ..  -++.+++++    ...+|||||+.+..+... +.+    ..++.+....+..+++.+|..| |+.   +++|+||+
T Consensus        84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs  152 (197)
T cd05146          84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS  152 (197)
T ss_pred             HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            42  345555554    467899999976543221 211    1244456677889999999999 776   99999999


Q ss_pred             cCeEEEcCCCCEEEeecCCceecc
Q 043017          634 PQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       634 p~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      +.||+++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.97  E-value=3.7e-09  Score=108.50  Aligned_cols=141  Identities=21%  Similarity=0.334  Sum_probs=108.6

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCc--ceeEEEeeeecccC---cceeeeeccCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHH--FNLVRLVGYCAERS---NRFLVYEYMCN  584 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~~  584 (818)
                      .|+.|..+.||++...+|+.+++|....... ....++..|++++..+++  .++.+++.+.....   ..++||||+++
T Consensus         5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G   84 (223)
T cd05154           5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG   84 (223)
T ss_pred             ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence            4889999999999987778999998754332 235678899999999965  34566777766543   56899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC-----------------------------------------  623 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----------------------------------------  623 (818)
                      .++.+.+..    ..++.+.+..++.+++++|.+||+..                                         
T Consensus        85 ~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          85 RVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             EecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            988765421    24666777788888888888888521                                         


Q ss_pred             ------------CCCeeecccccCeEEEcC--CCCEEEeecCCcee
Q 043017          624 ------------NPKIIHFDIKPQNILLDR--DLNVKIADFGLARL  655 (818)
Q Consensus       624 ------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~  655 (818)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        245799999999999998  66789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=2.7e-08  Score=108.24  Aligned_cols=168  Identities=18%  Similarity=0.286  Sum_probs=131.7

Q ss_pred             eeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc----cCcceeeeeccCC-CChhhHh
Q 043017          518 GSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLVYEYMCN-GSLDKWI  591 (818)
Q Consensus       518 G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~l  591 (818)
                      .+.||+... ||..+++||++....+.......-++.++++.|.|+|++..++..    +..+++||+|+|+ ++|.+..
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            578898864 799999999955444433334566889999999999999998873    3467999999986 5777766


Q ss_pred             hhcC------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          592 FHKD------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       592 ~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      +...            .....++..++.++.|+..||.++|+.   |+.-+-|.+++||++.+.+++|+..|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            5422            123467889999999999999999998   9999999999999999999999999988876654


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS  706 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p  706 (818)
                      ...               -+   +--.+-|.=.||.+++.|.||...
T Consensus       447 ~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            311               11   112367889999999999999654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.90  E-value=1.3e-08  Score=97.57  Aligned_cols=130  Identities=20%  Similarity=0.308  Sum_probs=100.1

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCC-C-------ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGE-N-------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~-------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+++|+-+.+|.+.+. |.++++|.-.+.. .       -....-.+|++++.+++--.|.-..-+..+.....++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999775 4456666432221 1       11245678999999987656555566667777889999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++..|.+.+...          ...++..+-+-+.-||..   +|+|+||.++||++..+. +.++||||+..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888432          356778888888999998   999999999999997764 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=2.4e-08  Score=95.17  Aligned_cols=142  Identities=18%  Similarity=0.211  Sum_probs=103.4

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEc-CCCC-------CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRL-YPGE-------NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l-~~~~-------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ..|-||+-+.|+++.+. |+...||.- .+.-       .-.....++|++.+.+++--.|.-..-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            35779999999999988 666666643 2221       11235677899999988655555555556666777899999


Q ss_pred             cCC-CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---CEEEeecCCceec
Q 043017          582 MCN-GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---NVKIADFGLARLI  656 (818)
Q Consensus       582 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgla~~~  656 (818)
                      +++ .++.+++...-..+ ...+....++..|-+.+.-||.+   .|||+||.++||+|..++   .+.++|||++...
T Consensus        92 ~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            977 47888886543222 22223378889999999999998   999999999999996554   3689999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.80  E-value=3e-09  Score=118.50  Aligned_cols=243  Identities=23%  Similarity=0.242  Sum_probs=170.7

Q ss_pred             hhhcccccceeEEEeEec--CCcEEEEEEcCCCCCccHHH--HHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccC
Q 043017          509 QIRLGRGGSGSVFEGLLN--DGTKVAVKRLYPGENRGKKE--FLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~--f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ...||.|.|+.|++...+  ++..+++|.+.........+  -+.|+.+...+ .|.++++....+..-.+.++=-||++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            346999999999987754  57789999886553332222  24466666666 58888888877777777789999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++...+   .-...+.+..++++..|++.++.++|+.   .++|+|+||+||++..+ +..+++|||++..+.-....
T Consensus       350 ~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~  423 (524)
T KOG0601|consen  350 GGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV  423 (524)
T ss_pred             Ccchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceeccc
Confidence            99887655   1234577888999999999999999985   99999999999999876 78899999998643211111


Q ss_pred             cccCCCCCCcc-cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGY-MAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y-~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                         ....+..| .+++......+..+.|++|||.-+.|.+++.........     +.          .+.....+.   
T Consensus       424 ---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~----------~i~~~~~p~---  482 (524)
T KOG0601|consen  424 ---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SL----------TIRSGDTPN---  482 (524)
T ss_pred             ---ccccccccccchhhccccccccccccccccccccccccCcccCccccc-----ce----------eeecccccC---
Confidence               11123334 356666667789999999999999999998654321110     00          000011111   


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      ......++..+...+..+++..||.+.++..+.+.+.
T Consensus       483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            1223366777788889999999999999887766544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.71  E-value=6e-09  Score=121.66  Aligned_cols=240  Identities=21%  Similarity=0.234  Sum_probs=161.8

Q ss_pred             hcccccceeEEEeEecC-CcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      -+-.|.++.+..+.-.. |.-.++|......   ..+.+....+-.++-..+||-+++..-.+.-.....|+++|+.+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            35667777777655332 2222333322111   1111222223233333356777766666666778899999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC-------
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD-------  659 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~-------  659 (818)
                      |...|+...   ..+.+.....+..+...++|||..   .+.|+|++|.|+|+..+++.+++||++......-       
T Consensus       891 ~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s  964 (1205)
T KOG0606|consen  891 LPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS  964 (1205)
T ss_pred             chhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence            988885433   456666677778889999999996   6999999999999999999999999844322100       


Q ss_pred             --------------C-----C----ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH
Q 043017          660 --------------Q-----S----HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV  716 (818)
Q Consensus       660 --------------~-----~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~  716 (818)
                                    .     .    .......+|+.|.+||.+.+......+|.|++|+.++|.++|..||........+
T Consensus       965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen  965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred             cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence                          0     0    0112245899999999999999999999999999999999999999876665544


Q ss_pred             HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHH
Q 043017          717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       717 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      +.+..            ........+.+...+..+++...+..+|.+|-.|.
T Consensus      1045 ~ni~~------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 ENILN------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hcccc------------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            33211            11111122334556677788888899999987765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=1.2e-07  Score=93.93  Aligned_cols=126  Identities=27%  Similarity=0.329  Sum_probs=84.5

Q ss_pred             eEEEeEecCCcEEEEEEcCCCC-------------Cc-------------cHHHHHHHHHHHhccCcc--eeEEEeeeec
Q 043017          519 SVFEGLLNDGTKVAVKRLYPGE-------------NR-------------GKKEFLSEVETIGNIHHF--NLVRLVGYCA  570 (818)
Q Consensus       519 ~Vy~~~~~~g~~vAVK~l~~~~-------------~~-------------~~~~f~~Ev~~l~~l~H~--niv~l~g~~~  570 (818)
                      .||.|...+|..+|||......             ..             ......+|.+.|.++...  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            3899999999999999765421             00             012457799999999654  45555544  


Q ss_pred             ccCcceeeeeccC--CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHH-HHhcCCCCeeecccccCeEEEcCCCCEEE
Q 043017          571 ERSNRFLVYEYMC--NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY-LHDYCNPKIIHFDIKPQNILLDRDLNVKI  647 (818)
Q Consensus       571 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  647 (818)
                        ....|||||++  +..+.... ..    .++.+....++.++++.+.. +|+.   +|+|+||.+.||+++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence              24589999998  55554422 11    12355677888888886666 4676   99999999999999888 9999


Q ss_pred             eecCCceecc
Q 043017          648 ADFGLARLIA  657 (818)
Q Consensus       648 ~Dfgla~~~~  657 (818)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.69  E-value=3.1e-07  Score=97.60  Aligned_cols=259  Identities=16%  Similarity=0.197  Sum_probs=156.2

Q ss_pred             hhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeee------ecccC-cceeeee
Q 043017          509 QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGY------CAERS-NRFLVYE  580 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~------~~~~~-~~~lV~e  580 (818)
                      ...||+|+-+.+|..--  -+..+.|+..........+.   +..|... .||-+-.=+.+      --.++ ..-++|+
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            34699999999985321  12234466554433322222   2233333 45543321111      01122 2557777


Q ss_pred             ccCCCC-hhhHhh---hcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          581 YMCNGS-LDKWIF---HKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       581 ~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      .+++.. +..++.   ....-+...|+-.++.++.+|.+.+.||++   +.+-+|+.++|+|+.+++.+.|.|-......
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            776642 222221   122334578999999999999999999998   9999999999999999999999987665544


Q ss_pred             ccCCCccccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-----CchHHHHHH-HHhh
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICG-RRSSNPKG-----GDYLVDTLK-VKAE  724 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG-~~p~~~~~-----~~~l~~~~~-~~~~  724 (818)
                      .  +.....-++|...|.+||.-.     +..-+...|-|.+|+++++++.| ++||.+..     +......+. -...
T Consensus       168 ~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         168 A--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             c--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            2  222333467899999999765     33456789999999999999986 99987541     111110110 0000


Q ss_pred             --hhcchhhccccCcCccCcHHHHHHHHHHHHHccccC--CCCCCcHHHHHHHHhcCcC
Q 043017          725 --ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKN--LHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       725 --~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~d--p~~RPt~~evl~~L~~i~~  779 (818)
                        ...-.... +.+.. .........+.-+..+|+...  +.-|||++-.+..|..+..
T Consensus       246 ya~~~~~g~~-p~P~~-~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         246 YASDQRRGLK-PPPRS-IPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             echhccCCCC-CCCCC-CChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence              00000000 00111 112233455666777888653  6789999999999876643

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=98.65  E-value=2.5e-08  Score=85.58  Aligned_cols=64  Identities=34%  Similarity=0.622  Sum_probs=49.3

Q ss_pred             cccccccc-ccceeecccccccccccccccCChhhHHHhhhccCccccccccccCCcccCccccccccc
Q 043017          348 HLSCQFKH-LQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEIY  415 (818)
Q Consensus       348 ~l~C~~~~-~~~f~~~~~~~~~d~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~~l~  415 (818)
                      +++|.... .++|+.++++++|+........++++|++.|++||+|.|++|..    ++++|.+|...+
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~----~~~~C~~~~~~~   66 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN----GSGGCLLWNGLL   66 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecC----CCCeEEEEecee
Confidence            45675432 46899999999997754445579999999999999999999853    257899886533

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.64  E-value=2.1e-07  Score=97.74  Aligned_cols=133  Identities=17%  Similarity=0.154  Sum_probs=95.1

Q ss_pred             eeEEEeEecCCcEEEEEEcCCCCCc-----------cHHHHHHHHHHHhccCcc--eeEEEeeeecc-----cCcceeee
Q 043017          518 GSVFEGLLNDGTKVAVKRLYPGENR-----------GKKEFLSEVETIGNIHHF--NLVRLVGYCAE-----RSNRFLVY  579 (818)
Q Consensus       518 G~Vy~~~~~~g~~vAVK~l~~~~~~-----------~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~-----~~~~~lV~  579 (818)
                      ..|.+..+ +|+.+.||+.......           ....+.+|.+.+.++...  ...+++++...     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34666655 4788999977443311           112477898888887422  23334445432     23468999


Q ss_pred             eccCCC-ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-------CCCEEEeecC
Q 043017          580 EYMCNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-------DLNVKIADFG  651 (818)
Q Consensus       580 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-------~~~~kl~Dfg  651 (818)
                      |++++. +|.+++.+.. ....+...+..++.++++.+.-||..   +|+|+|++++|||++.       +..+.++||+
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999886 8988874321 12345667789999999999999998   9999999999999975       4679999999


Q ss_pred             Ccee
Q 043017          652 LARL  655 (818)
Q Consensus       652 la~~  655 (818)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8864

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.51  E-value=4.1e-07  Score=82.95  Aligned_cols=85  Identities=31%  Similarity=0.463  Sum_probs=63.2

Q ss_pred             EEEeecccEEEEcCC-CcEEEeeccCC--CceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeecc
Q 043017          121 LEFTADGDLILKDVD-GTRVWSTETSG--SNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTN  197 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~-~~~vWst~~~~--~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~~  197 (818)
                      +.+..+|+||+++.. +.+||++++..  .....+.|.++|||||++.++.++|+|=.                      
T Consensus        24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t----------------------   81 (114)
T smart00108       24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT----------------------   81 (114)
T ss_pred             cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc----------------------
Confidence            344579999999755 58999998753  23367899999999999998899999811                      


Q ss_pred             CCCCCCccEEEEEEccCCcEEEEeccceeeeee
Q 043017          198 STTSLSQGKFILSLSPKGIEVFLNMSTVKRFQT  230 (818)
Q Consensus       198 s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~  230 (818)
                         ....|.+.+.|+.+|+.+++.......|.+
T Consensus        82 ---~~~~~~~~~~L~ddGnlvl~~~~~~~~W~S  111 (114)
T smart00108       82 ---TGANGNYVLVLLDDGNLVIYDSDGNFLWQS  111 (114)
T ss_pred             ---cCCCCceEEEEeCCCCEEEECCCCCEEeCC
Confidence               013567889999999998875544444543

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=98.49  E-value=9.5e-08  Score=80.12  Aligned_cols=56  Identities=20%  Similarity=0.185  Sum_probs=44.9

Q ss_pred             ccceeecccccccccccccccCChhhHHHhhhc---cCccccccccccCCcccCccccccc-c-ccccc
Q 043017          356 LQRFLKLENVTYFDFVPHLINIDAEGCQRACLG---NCSCKAALFRYQGSLSTGNCSLPTE-I-YTLRN  419 (818)
Q Consensus       356 ~~~f~~~~~~~~~d~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~~C~~~~~-l-~~l~~  419 (818)
                      ..+|+++.++++||+..    +++++|++.|++   ||||+||+|...    +++|.+|.+ + .+++.
T Consensus         8 ~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~----~~gC~~W~~~l~~d~~~   68 (80)
T cd00129           8 AGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKA----RKQCLWFPFNSMSGVRK   68 (80)
T ss_pred             CCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCC----CCCeEEecCcchhhHHh
Confidence            46799999999998754    689999999999   999999998532    358999974 5 45543

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=9.2e-07  Score=90.04  Aligned_cols=136  Identities=21%  Similarity=0.259  Sum_probs=96.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC----------------------CccHHHHHHHHHHHhccCcc--e
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE----------------------NRGKKEFLSEVETIGNIHHF--N  561 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------------~~~~~~f~~Ev~~l~~l~H~--n  561 (818)
                      +.+..+||.|.-+.||.|..++|.++|||--....                      .-.....++|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34556899999999999999999999999432210                      00123456788899888543  4


Q ss_pred             eEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       562 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      +.+.+++    +...+|||++++-.|...        .++.+....|+..|++-+.-+-..   ++||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            4444443    456899999988666431        123444555566666655555454   9999999999999999


Q ss_pred             CCCEEEeecCCceec
Q 043017          642 DLNVKIADFGLARLI  656 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~  656 (818)
                      +|.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999877643

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.45  E-value=5.8e-07  Score=82.19  Aligned_cols=83  Identities=27%  Similarity=0.415  Sum_probs=63.2

Q ss_pred             Eee-cccEEEEcCC-CcEEEeeccCC--CceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeeccC
Q 043017          123 FTA-DGDLILKDVD-GTRVWSTETSG--SNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNS  198 (818)
Q Consensus       123 l~~-~g~Lvl~~~~-~~~vWst~~~~--~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~~s  198 (818)
                      ... +|+||+++.. +.+||++++..  .....+.|.++|||||++.++.++|+|--.                      
T Consensus        26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~----------------------   83 (116)
T cd00028          26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT----------------------   83 (116)
T ss_pred             CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc----------------------
Confidence            344 8999999754 58999999864  345678999999999999989999997320                      


Q ss_pred             CCCCCccEEEEEEccCCcEEEEeccceeeeee
Q 043017          199 TTSLSQGKFILSLSPKGIEVFLNMSTVKRFQT  230 (818)
Q Consensus       199 ~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~  230 (818)
                         ...+.+.+.|+.+|+.+++.......|.+
T Consensus        84 ---~~~~~~~~~L~ddGnlvl~~~~~~~~W~S  112 (116)
T cd00028          84 ---RVNGNYVLVLLDDGNLVLYDSDGNFLWQS  112 (116)
T ss_pred             ---CCCCceEEEEeCCCCEEEECCCCCEEEcC
Confidence               12567889999999999875544445544

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=8.5e-07  Score=100.83  Aligned_cols=141  Identities=21%  Similarity=0.301  Sum_probs=93.6

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccH------------------------------H----------HHHHH
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK------------------------------K----------EFLSE  550 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~------------------------------~----------~f~~E  550 (818)
                      -|+.++-|.||+|++++|++||||+.++.-....                              +          ++..|
T Consensus       132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E  211 (517)
T COG0661         132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE  211 (517)
T ss_pred             chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence            4889999999999999999999998877521100                              0          23345


Q ss_pred             HHHHhcc-----CcceeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCC
Q 043017          551 VETIGNI-----HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP  625 (818)
Q Consensus       551 v~~l~~l-----~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~  625 (818)
                      ..-+.++     +.+++.-..-+..-....+|+|||++|..+.+......  ...+   +..++..++++.  +.+.-+.
T Consensus       212 A~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         212 AANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHH--HHHHHhc
Confidence            4444444     23333333333334567899999999999988753322  1233   334444444431  1111123


Q ss_pred             CeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       626 ~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=8.8e-08  Score=108.22  Aligned_cols=151  Identities=21%  Similarity=0.334  Sum_probs=104.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc--------cccCCCCCCccccccccc
Q 043017          609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--------VSTMPKGTPGYMAPELTR  680 (818)
Q Consensus       609 ~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  680 (818)
                      +.+++.|+.|+|.+  .++||++|.|++|.++..+..||+.|+.+.........        ..........|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            44566999999986  79999999999999999999999999998765442111        111123566899999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHcccc
Q 043017          681 GNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQK  759 (818)
Q Consensus       681 ~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~  759 (818)
                      ....+.++|+||+|+++|-+.. |+..+................+..           ......+...++.+=+.+++..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-----------~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-----------AFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-----------cccccccCcHHHHHHHHHHhcC
Confidence            9889999999999999999995 554444332221111111111100           0011234455677777889999


Q ss_pred             CCCCCCcHHHHHH
Q 043017          760 NLHRRPSASMLVK  772 (818)
Q Consensus       760 dp~~RPt~~evl~  772 (818)
                      ++.-||++.+++.
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.37  E-value=2e-06  Score=87.28  Aligned_cols=123  Identities=23%  Similarity=0.316  Sum_probs=90.3

Q ss_pred             CcEEEEEEcCCCC-------CccHHHHHHHHHHHhccC--cceeEEEeeeecccC----cceeeeeccCCC-ChhhHhhh
Q 043017          528 GTKVAVKRLYPGE-------NRGKKEFLSEVETIGNIH--HFNLVRLVGYCAERS----NRFLVYEYMCNG-SLDKWIFH  593 (818)
Q Consensus       528 g~~vAVK~l~~~~-------~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~  593 (818)
                      ++.+.+|.+...-       .-......+|...+..|.  .-...+.+++.....    ..++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            5566666543211       123456778888777774  333455556554432    348999999884 79998854


Q ss_pred             cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---CEEEeecCCceec
Q 043017          594 KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---NVKIADFGLARLI  656 (818)
Q Consensus       594 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgla~~~  656 (818)
                      ...   ++......++.++++.++-||+.   +|+|+|++++|||++.+.   .+.++||+-++..
T Consensus       112 ~~~---~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WEQ---LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hcc---cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            322   56677889999999999999998   999999999999998887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.35  E-value=6.3e-06  Score=82.26  Aligned_cols=138  Identities=20%  Similarity=0.253  Sum_probs=103.3

Q ss_pred             cccccceeEEEeEecCCcEEEEEEcCCC---C---CccHHHHHHHHHHHhccCc--ceeEEEeeeeccc-----Ccceee
Q 043017          512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG---E---NRGKKEFLSEVETIGNIHH--FNLVRLVGYCAER-----SNRFLV  578 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~---~---~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~-----~~~~lV  578 (818)
                      -|+||-+-|++-.+. |+.+-+|+-...   +   ..+...|.+|...|.+|..  -.+.+++ ++...     -..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367899999998776 447999986522   1   3467899999999999842  2344444 33211     245799


Q ss_pred             eeccCC-CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC--EEEeecCCcee
Q 043017          579 YEYMCN-GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN--VKIADFGLARL  655 (818)
Q Consensus       579 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla~~  655 (818)
                      +|-+++ -+|.+++.... ....+...+..++.++++.++-||..   ++.|+|+.++||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997754 58888874432 23467777889999999999999998   9999999999999986667  99999987764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.08  E-value=3e-05  Score=79.77  Aligned_cols=139  Identities=17%  Similarity=0.248  Sum_probs=83.9

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce--eEEEeeeecccCcceeeeeccCCCC-
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN--LVRLVGYCAERSNRFLVYEYMCNGS-  586 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs-  586 (818)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            35899999999984   25567888875432  3456788999998885433  3566777767777789999998863 


Q ss_pred             hhhHhh--------------------hcCCccccchhhHH-HHHH----------HHHH-HHHHHHhc-CCCCeeecccc
Q 043017          587 LDKWIF--------------------HKDRIQTLSWDIRK-KIIF----------QISR-GLEYLHDY-CNPKIIHFDIK  633 (818)
Q Consensus       587 L~~~l~--------------------~~~~~~~l~~~~~~-~i~~----------qia~-gL~yLH~~-~~~~iiH~Dlk  633 (818)
                      +...+.                    |.-........... .+..          .+.+ ...+|... ....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            221110                    10000000100000 0000          0111 12222211 13457899999


Q ss_pred             cCeEEEcCCCCEEEeecCCce
Q 043017          634 PQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       634 p~NIll~~~~~~kl~Dfgla~  654 (818)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=2.3e-05  Score=88.89  Aligned_cols=142  Identities=23%  Similarity=0.340  Sum_probs=90.9

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCcc-------------------------------------HHHHHHHHHH
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-------------------------------------KKEFLSEVET  553 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~f~~Ev~~  553 (818)
                      -||....|.||+|++++|+.||||+-++.-...                                     +-+|.+|++-
T Consensus       168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N  247 (538)
T KOG1235|consen  168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN  247 (538)
T ss_pred             hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence            589999999999999999999999877642110                                     1134555543


Q ss_pred             Hhc----cCccee---EEEeeee-cccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCC
Q 043017          554 IGN----IHHFNL---VRLVGYC-AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP  625 (818)
Q Consensus       554 l~~----l~H~ni---v~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~  625 (818)
                      ..+    ++|-++   |.+=..+ .-...++|+||||+|..+.+.-.-.+  ..++..   .|+..+.++  |++.--..
T Consensus       248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~---~i~~~l~~~--~~~qIf~~  320 (538)
T KOG1235|consen  248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPH---DILNKLVEA--YLEQIFKT  320 (538)
T ss_pred             HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHH---HHHHHHHHH--HHHHHHhc
Confidence            333    345551   1122222 22347899999999998887643222  123333   333333332  22222223


Q ss_pred             CeeecccccCeEEEcC----CCCEEEeecCCceecccC
Q 043017          626 KIIHFDIKPQNILLDR----DLNVKIADFGLARLIAQD  659 (818)
Q Consensus       626 ~iiH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~~  659 (818)
                      |++|+|-+|.||+++.    ++.+.+.|||+.......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            8999999999999984    678999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.90  E-value=8.5e-05  Score=75.28  Aligned_cols=135  Identities=20%  Similarity=0.238  Sum_probs=88.9

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCcc---------HHH---------------HHHHHHHHhccC--cceeEE
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG---------KKE---------------FLSEVETIGNIH--HFNLVR  564 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---------~~~---------------f~~Ev~~l~~l~--H~niv~  564 (818)
                      .|..|.-+.||+|.-.++..+|||++.......         ...               ..+|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            377888999999998889999999876442111         011               134555555552  223333


Q ss_pred             EeeeecccCcceeeeeccCCCChhhHhhhcCCcc--ccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC
Q 043017          565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ--TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       565 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      .+++.    .-.|||||+....+-     .+...  .+..+....+..++++.+.-|-..  .++||+||+.-|||+. +
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~p-----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLP-----APRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCC-----CCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence            33332    237999998654210     11111  122235777788888888877662  3999999999999999 8


Q ss_pred             CCEEEeecCCceecc
Q 043017          643 LNVKIADFGLARLIA  657 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~  657 (818)
                      +.+.|+|++.+....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            899999999997654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.85  E-value=0.00014  Score=75.81  Aligned_cols=138  Identities=15%  Similarity=0.101  Sum_probs=84.1

Q ss_pred             ccccc-eeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCCCChhhH
Q 043017          513 GRGGS-GSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKW  590 (818)
Q Consensus       513 G~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~  590 (818)
                      -.|.. ..||+.... +..+.||+.....   ..++..|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus         7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            34444 789999765 4788888875433   345677888888873 44556777777666678999999999887643


Q ss_pred             hh------------------hcCCcc--ccch--hhHHHHH-H-------------------HHHHHHHHHHhc----CC
Q 043017          591 IF------------------HKDRIQ--TLSW--DIRKKII-F-------------------QISRGLEYLHDY----CN  624 (818)
Q Consensus       591 l~------------------~~~~~~--~l~~--~~~~~i~-~-------------------qia~gL~yLH~~----~~  624 (818)
                      ..                  |.-...  .+..  ....... .                   .+.+.+..|-..    ..
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            20                  000000  0000  0000000 0                   011112222111    13


Q ss_pred             CCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          625 PKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      +.++|+|+.|.||+++++....|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            468999999999999998778899999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.81  E-value=0.00013  Score=73.17  Aligned_cols=114  Identities=20%  Similarity=0.241  Sum_probs=73.0

Q ss_pred             CCcEEEEEEcCCCCCccHHHHH---------HHHHHHhcc---CcceeEEEeeeec-----ccCcceeeeeccCCCChhh
Q 043017          527 DGTKVAVKRLYPGENRGKKEFL---------SEVETIGNI---HHFNLVRLVGYCA-----ERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       527 ~g~~vAVK~l~~~~~~~~~~f~---------~Ev~~l~~l---~H~niv~l~g~~~-----~~~~~~lV~e~~~~gsL~~  589 (818)
                      +|+.+++|.........++.|+         +++..+.++   ....+..++.+..     -....+|+|||++|..|.+
T Consensus        53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d  132 (229)
T PF06176_consen   53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND  132 (229)
T ss_pred             CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence            4788889987654332222222         233333333   2223333222222     2234579999999988866


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +.       .++.    .++..+.+++.-||+.   |++|+|+.|.|++++.+ .+++.||+..+.
T Consensus       133 ~~-------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  133 IE-------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             ch-------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            43       1221    3556778889999998   99999999999999865 599999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.81  E-value=5.5e-05  Score=75.28  Aligned_cols=106  Identities=24%  Similarity=0.265  Sum_probs=83.7

Q ss_pred             HHHHHHHhccCc-ceeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC
Q 043017          548 LSEVETIGNIHH-FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK  626 (818)
Q Consensus       548 ~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  626 (818)
                      .+|.-+++.+++ +++.+++|+|-.    ++|.||.+.+++...-..-......+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888865 699999999943    789999987765421000011124689999999999999999999865556


Q ss_pred             eeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          627 IIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       627 iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      +...|++++|+-+++++++|+.|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8899999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.76  E-value=0.0001  Score=66.90  Aligned_cols=74  Identities=22%  Similarity=0.399  Sum_probs=49.6

Q ss_pred             CeEEEEeC-CCCCCCCCceEEEeecccEEEEcCCCcEEEeeccCCCceeEEEEcC--CCcEEEecCCCCcceecccCCC
Q 043017          103 PVILWFAN-GQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDG--NGNLRLYDAENRPHWISFLHPT  178 (818)
Q Consensus       103 ~~~vW~an-r~~p~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~~~~~~l~d--~GNlvl~~~~~~~lWqSFd~Pt  178 (818)
                      .++||.++ ..........+.|.+||||||+|.++.+||+|.. ....+.+..++  .||++ ......+.|.|=+.|+
T Consensus        38 ~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   38 GSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD-YPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT-SSS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred             CCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC-CCccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence            46799994 3334335688999999999999999999999932 22334555555  88888 6656678899988774

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.74  E-value=9.2e-06  Score=91.06  Aligned_cols=182  Identities=19%  Similarity=0.148  Sum_probs=131.0

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce-eEEEeeeecccCcceeeeeccCCC-
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN-LVRLVGYCAERSNRFLVYEYMCNG-  585 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-  585 (818)
                      |-+.+++|+++.+||.+-...+....+.+...     ....-++++|.+++||| .++.++-+..+...+++++++..+ 
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            44567899999999988654454545544322     44556889999999999 777777777778889999998776 


Q ss_pred             -ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          586 -SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       586 -sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                       +.....   .....+..-+...+.+.-.++++|||+.   .-+|+|    ||+..+ ...|..||+....+.+..  ..
T Consensus       321 s~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~  387 (829)
T KOG0576|consen  321 SSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP  387 (829)
T ss_pred             cccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence             211110   0011233344455666778899999986   458888    777655 688999999987765543  22


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSS  707 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~  707 (818)
                      ....+++.++|||....+.+..+.|+|+.|+-..++--|-.|-
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            3346899999999999999999999999998877777776553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.74  E-value=0.00019  Score=73.85  Aligned_cols=142  Identities=21%  Similarity=0.288  Sum_probs=83.4

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc--eeEEEeeeeccc---CcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF--NLVRLVGYCAER---SNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~~---~~~~lV~e~~~~g  585 (818)
                      .|+.|..+.||+....+ +.+++|.....  .....+..|+.+++.+...  .+.+++.+....   ...+++|+++++.
T Consensus         4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            47889999999999987 68999986543  3456778888888888432  345666544322   2468999999998


Q ss_pred             Chhh----------------Hhh---hc-CCccccch-h--------hHHHH------------HHHHHH-HHHHHHhc-
Q 043017          586 SLDK----------------WIF---HK-DRIQTLSW-D--------IRKKI------------IFQISR-GLEYLHDY-  622 (818)
Q Consensus       586 sL~~----------------~l~---~~-~~~~~l~~-~--------~~~~i------------~~qia~-gL~yLH~~-  622 (818)
                      .+..                .+.   .. .....+.. .        .....            ...+.+ .+..+++. 
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8877                110   11 00000000 0        00000            112222 33444432 


Q ss_pred             ---CCCCeeecccccCeEEEc-CCCCEEEeecCCcee
Q 043017          623 ---CNPKIIHFDIKPQNILLD-RDLNVKIADFGLARL  655 (818)
Q Consensus       623 ---~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~  655 (818)
                         ....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               345799999999999999 666678999998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.53  E-value=0.00079  Score=82.75  Aligned_cols=77  Identities=17%  Similarity=0.401  Sum_probs=56.3

Q ss_pred             hcccccceeEEEeEecCC---cEEEEEEcCCCC-CccHHHHHHHHHHHhccC-ccee--EEEeeeeccc---Ccceeeee
Q 043017          511 RLGRGGSGSVFEGLLNDG---TKVAVKRLYPGE-NRGKKEFLSEVETIGNIH-HFNL--VRLVGYCAER---SNRFLVYE  580 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~e  580 (818)
                      .++.|.+..+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   +..++|||
T Consensus        45 ~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME  124 (822)
T PLN02876         45 QFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME  124 (822)
T ss_pred             EeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence            578899999999877654   467778764332 223457889999999995 6654  7778887664   36789999


Q ss_pred             ccCCCCh
Q 043017          581 YMCNGSL  587 (818)
Q Consensus       581 ~~~~gsL  587 (818)
                      |+++..+
T Consensus       125 ~v~G~~~  131 (822)
T PLN02876        125 YLEGRIF  131 (822)
T ss_pred             ecCCccc
Confidence            9987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.46  E-value=0.0013  Score=65.86  Aligned_cols=126  Identities=18%  Similarity=0.307  Sum_probs=87.7

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCC----------------CccHHHHHHHHHHHhccC------cceeEEEeee
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGE----------------NRGKKEFLSEVETIGNIH------HFNLVRLVGY  568 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------~~~~~~f~~Ev~~l~~l~------H~niv~l~g~  568 (818)
                      .||+|+.-.||.  +++.....||++....                ....+++.+|+.-...+.      +.+|.+++|+
T Consensus         8 ~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~   85 (199)
T PF10707_consen    8 LIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF   85 (199)
T ss_pred             ccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence            589999999995  4445667788876554                223466777776655554      8899999999


Q ss_pred             ecccCcceeeeeccCC------CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC
Q 043017          569 CAERSNRFLVYEYMCN------GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       569 ~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      ..+....-+|+|.+.+      -+|.+++.+.    .++. .   +...+-+-..||-++   .|+.+|++|.||++...
T Consensus        86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence            9999999999998754      3577777332    2333 2   333333444566666   89999999999999543


Q ss_pred             C----CEEEee
Q 043017          643 L----NVKIAD  649 (818)
Q Consensus       643 ~----~~kl~D  649 (818)
                      .    .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence            2    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.46  E-value=0.00093  Score=69.30  Aligned_cols=72  Identities=13%  Similarity=0.171  Sum_probs=44.1

Q ss_pred             hcccccce-eEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc---eeEEEeeeeccc---CcceeeeeccC
Q 043017          511 RLGRGGSG-SVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF---NLVRLVGYCAER---SNRFLVYEYMC  583 (818)
Q Consensus       511 ~LG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~~  583 (818)
                      .|+.|+.. .||+.    +..+++|....  ......+..|++++..+...   .+.++++.....   ...+++|++++
T Consensus         4 ~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           4 PVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            36666665 58875    24567776443  22345788899988877421   233344433322   23478999999


Q ss_pred             CCChh
Q 043017          584 NGSLD  588 (818)
Q Consensus       584 ~gsL~  588 (818)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.44  E-value=0.0014  Score=62.97  Aligned_cols=127  Identities=21%  Similarity=0.278  Sum_probs=85.5

Q ss_pred             hhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEE-EeeeecccCcceeeeeccCCCCh
Q 043017          509 QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR-LVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      ...|++|.+|.||++.+. |.++|+|.-..++  ....+..|+++|..++-.++.+ ++.|-.    -++.|||+.+-.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            457999999999999998 5588888765443  3678889999999887555443 333322    2455999988888


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccc-cCeEEEcCCCCEEEeecCCcee
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIK-PQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~Dfgla~~  655 (818)
                      .+.-...      +    .+-+..+++.---|-..   +|-|+.|. |..++|..+..+.|+||.-|..
T Consensus       100 ~~~~~~~------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7644211      1    12223344443334433   88898886 5555555566999999998873

>PRK10593 hypothetical protein; Provisional

Probab=97.39  E-value=0.0015  Score=70.25  Aligned_cols=74  Identities=8%  Similarity=0.002  Sum_probs=54.6

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-c--ceeEEEeeeecc---cCcceeeeeccCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-H--FNLVRLVGYCAE---RSNRFLVYEYMCN  584 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H--~niv~l~g~~~~---~~~~~lV~e~~~~  584 (818)
                      .||+|..+.||+....++ ++++|..+.  ......|..|.+.|+.|. +  ..+.++++++..   .+..+||||++++
T Consensus        21 ~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         21 CISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             ecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            599999999999877666 466676432  112457889999998884 2  367788887754   3568999999998


Q ss_pred             CCh
Q 043017          585 GSL  587 (818)
Q Consensus       585 gsL  587 (818)
                      .++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.34  E-value=0.0017  Score=64.61  Aligned_cols=135  Identities=27%  Similarity=0.376  Sum_probs=93.6

Q ss_pred             ccccccCHHHHHHhhHHhhhhcccccc-eeEEEeEecCCcEEEEEEcCC---CCC------------------ccHHHHH
Q 043017          491 NHLVKFSSKAMKSATRDFQIRLGRGGS-GSVFEGLLNDGTKVAVKRLYP---GEN------------------RGKKEFL  548 (818)
Q Consensus       491 ~~~~~~~~~~l~~~t~~f~~~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~---~~~------------------~~~~~f~  548 (818)
                      ..+..|+...   ...+|.+.||.|.- |.|||+.+. |+.+|+|.+..   ...                  .-...|.
T Consensus        27 PKL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~  102 (207)
T PF13095_consen   27 PKLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN  102 (207)
T ss_pred             CCcCCcCCCC---CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence            3455666622   56667788999999 999999997 77999999321   110                  1123588


Q ss_pred             HHHHHHhccC---ccee--EEEeeeecccC------------------cceeeeeccCCCChhhHhhhcCCccccchhhH
Q 043017          549 SEVETIGNIH---HFNL--VRLVGYCAERS------------------NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR  605 (818)
Q Consensus       549 ~Ev~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~  605 (818)
                      .|.+...+|+   +.++  |+.+||..-..                  ...+|.||.+...                ...
T Consensus       103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~  166 (207)
T PF13095_consen  103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQ  166 (207)
T ss_pred             HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccc
Confidence            9999998884   4455  99999873221                  1245666654332                112


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       606 ~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      .+-+.+|.+-|..+|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            33456777788889987   9999999999986     5689999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.25  E-value=0.0011  Score=79.91  Aligned_cols=195  Identities=21%  Similarity=0.268  Sum_probs=134.4

Q ss_pred             HHHHHHHhccCcceeEEEeeeecccCcc----eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC
Q 043017          548 LSEVETIGNIHHFNLVRLVGYCAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC  623 (818)
Q Consensus       548 ~~Ev~~l~~l~H~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~  623 (818)
                      ..|...+.++.|+|++.++.|-.+....    .+.-|++..-++...+.+.   ..++.+..+.+..++.+||+|+|+. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHh-
Confidence            3467788888999999999987665432    2344677777777777543   4578888999999999999999997 


Q ss_pred             CCCeeecccccC---eEEEcCCCCEEEe--ecCCceecccCCCccccCCCCCCcccccccccCCCCCc--hhhHHHHHHH
Q 043017          624 NPKIIHFDIKPQ---NILLDRDLNVKIA--DFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA--KIDIYSFGVV  696 (818)
Q Consensus       624 ~~~iiH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVwS~Gvl  696 (818)
                        ...|.-+..+   +.-.+.++...++  ||+..+..........  ...+..+.+||.........  ..|+|.+|.+
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence              4555544444   5555666677777  8888876654433322  22456788888887766544  4799999999


Q ss_pred             HHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          697 ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       697 l~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      +..+..|..+......            .   ..+.     ...    ....+......|+..++++|+++.+++.+.
T Consensus       382 ~~~~~~~~~i~~~~~~------------~---~~~l-----~~~----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV------------P---VSLL-----DVL----STSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HhhhhhcCcccccccc------------h---hhhh-----ccc----cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9999988655321100            0   0000     000    001456777899999999999999999875

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.22  E-value=0.0022  Score=66.34  Aligned_cols=139  Identities=17%  Similarity=0.173  Sum_probs=79.4

Q ss_pred             hcccccceeEEEeEecC--CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce-eEEEeeeecccCcceeeeeccCCCCh
Q 043017          511 RLGRGGSGSVFEGLLND--GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN-LVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      .|..|-...+|+....+  ++.+++|........ ......|+.++..+...+ ..++++.+.    ..++|||+++.++
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            46677788999998764  678889976543221 123346888888874322 334444332    2479999998776


Q ss_pred             hhH-------h----------hhcCCc--------cccc-hhhHHHHHH----------------------HHHHHHHHH
Q 043017          588 DKW-------I----------FHKDRI--------QTLS-WDIRKKIIF----------------------QISRGLEYL  619 (818)
Q Consensus       588 ~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------qia~gL~yL  619 (818)
                      ...       +          +.....        .... ++.+..+..                      .+.+.+..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            322       1          110100        0111 112111111                      111111122


Q ss_pred             ----Hhc-CCCCeeecccccCeEEEcC-CCCEEEeecCCce
Q 043017          620 ----HDY-CNPKIIHFDIKPQNILLDR-DLNVKIADFGLAR  654 (818)
Q Consensus       620 ----H~~-~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~  654 (818)
                          ... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence                111 2346999999999999998 5789999999875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.20  E-value=0.0044  Score=68.76  Aligned_cols=74  Identities=19%  Similarity=0.161  Sum_probs=52.9

Q ss_pred             hcccccceeEEEeEecCC-cEEEEEEcCCCC-------CccHHHHHHHHHHHhccC---cceeEEEeeeecccCcceeee
Q 043017          511 RLGRGGSGSVFEGLLNDG-TKVAVKRLYPGE-------NRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~-------~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .||.|.+..||+....+| +.++||.-.+..       ....+.+..|.+.|..+.   -.++.+++.+  +.+..++||
T Consensus        33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVM  110 (401)
T PRK09550         33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVM  110 (401)
T ss_pred             EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEE
Confidence            689999999999999877 589999853221       123456777888888762   2345666666  335678999


Q ss_pred             eccCCCC
Q 043017          580 EYMCNGS  586 (818)
Q Consensus       580 e~~~~gs  586 (818)
                      |++++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.17  E-value=0.0019  Score=68.02  Aligned_cols=138  Identities=14%  Similarity=0.128  Sum_probs=77.6

Q ss_pred             cccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee-EEEeeeecccCcceeeeeccCCCChhhH
Q 043017          512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-VRLVGYCAERSNRFLVYEYMCNGSLDKW  590 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~  590 (818)
                      +..|-...+|+.. .+++.+++|........-.....+|.++++.+....+ .++++...    ..+||||+++..+..-
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            4567778999887 4467888887644322211235778888888853323 23343332    3689999998766421


Q ss_pred             -------h----------hhcCC-ccccchh-hHHHHHHHH---------HHHHHHHHhc-----CCCCeeecccccCeE
Q 043017          591 -------I----------FHKDR-IQTLSWD-IRKKIIFQI---------SRGLEYLHDY-----CNPKIIHFDIKPQNI  637 (818)
Q Consensus       591 -------l----------~~~~~-~~~l~~~-~~~~i~~qi---------a~gL~yLH~~-----~~~~iiH~Dlkp~NI  637 (818)
                             +          +.... ...++.. ....+..++         .+.+..+...     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                   1          11110 1111111 111111111         1112222211     134689999999999


Q ss_pred             EEcCCCCEEEeecCCcee
Q 043017          638 LLDRDLNVKIADFGLARL  655 (818)
Q Consensus       638 ll~~~~~~kl~Dfgla~~  655 (818)
                      ++++++ +.|+||+.+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999998853

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.85  E-value=0.0044  Score=66.68  Aligned_cols=141  Identities=13%  Similarity=0.122  Sum_probs=83.8

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc--eeEEEeeee------cccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF--NLVRLVGYC------AERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~------~~~~~~~lV~e~~  582 (818)
                      .|..|....+|+....+ ..+++|+...   ........|++++..+.+.  .+.+++...      ...+..++|++++
T Consensus        21 ~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          21 GISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             cccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            46677778999987654 4688888754   2345566788887777432  244444321      2234568999999


Q ss_pred             CCCChhh----Hh----------hhcCC--------ccccchhhHH----------HHHHHHHHHHHHHHh----cCCCC
Q 043017          583 CNGSLDK----WI----------FHKDR--------IQTLSWDIRK----------KIIFQISRGLEYLHD----YCNPK  626 (818)
Q Consensus       583 ~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~qia~gL~yLH~----~~~~~  626 (818)
                      +|..+..    .+          +....        .....|....          .....+...+.++.+    .....
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9877542    11          10000        0011111110          111223344455543    12347


Q ss_pred             eeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          627 IIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       627 iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++|+|+.|.||+++++..+.|.||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            99999999999999987788999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=96.79  E-value=0.00083  Score=56.18  Aligned_cols=52  Identities=29%  Similarity=0.563  Sum_probs=41.6

Q ss_pred             cceeeccccccccccccc-ccCChhhHHHhhhc-cCccccccccccCCcccCcccccc
Q 043017          357 QRFLKLENVTYFDFVPHL-INIDAEGCQRACLG-NCSCKAALFRYQGSLSTGNCSLPT  412 (818)
Q Consensus       357 ~~f~~~~~~~~~d~~~~~-~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~~C~~~~  412 (818)
                      ..|.+++++.+++..... ...++++|++.|+. +|+|.++.|..    .++.|.+|.
T Consensus         4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~----~~~~C~l~~   57 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLLWS   57 (78)
T ss_pred             ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC----CCCEEEEee
Confidence            468889999988654432 34699999999999 99999998853    467899886

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.66  E-value=0.0088  Score=64.54  Aligned_cols=138  Identities=19%  Similarity=0.202  Sum_probs=80.5

Q ss_pred             cccccceeEEEeEecC-------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce-eEEEeeeecccCcceeeeeccC
Q 043017          512 LGRGGSGSVFEGLLND-------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN-LVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      |..|-...+|+....+       ++.+++|...... ....+...|.+++..+.... ..++++++..    .+|+||++
T Consensus         6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            4556667899888765       5788899865433 22345567888887774322 2345555432    35899998


Q ss_pred             CCChhhHhh----------------hcCCcc-------cc--chhhHHH--------------------------HHHHH
Q 043017          584 NGSLDKWIF----------------HKDRIQ-------TL--SWDIRKK--------------------------IIFQI  612 (818)
Q Consensus       584 ~gsL~~~l~----------------~~~~~~-------~l--~~~~~~~--------------------------i~~qi  612 (818)
                      |..+.....                |.....       ..  -+.....                          +...+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            877643210                110000       00  0111101                          11222


Q ss_pred             HHHHHHHHh------cCCCCeeecccccCeEEEcCC----CCEEEeecCCce
Q 043017          613 SRGLEYLHD------YCNPKIIHFDIKPQNILLDRD----LNVKIADFGLAR  654 (818)
Q Consensus       613 a~gL~yLH~------~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~  654 (818)
                      .+.+..|..      .....++|+|+.+.||+++++    +.++++||..+.
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            233334432      234578999999999999885    789999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.28  E-value=0.019  Score=61.14  Aligned_cols=71  Identities=18%  Similarity=0.321  Sum_probs=46.4

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC---cceeEEEeeeecccCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .++.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   --.+.+.+++....+..+||+||++.+
T Consensus        24 ~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   24 PVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             ecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            48889999999987 567889999764   333467888888888773   445777888877777789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.21  E-value=0.0057  Score=64.24  Aligned_cols=136  Identities=13%  Similarity=0.131  Sum_probs=92.1

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCC--C---------------Cc-----cHHHHHHHHHHHhccCc-c-
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG--E---------------NR-----GKKEFLSEVETIGNIHH-F-  560 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~---------------~~-----~~~~f~~Ev~~l~~l~H-~-  560 (818)
                      .+.+.++||-|.-+.||.+...+|++.++|.-...  +               ..     ..-...+|...|..|.. . 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            34456789999999999999999999999843211  0               00     01134567777877742 2 


Q ss_pred             eeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       561 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                      -+.+.++    ....++|||++.+-.|...-+ .        .....+...+..-+.-|..+   ++||+|..-=||+++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-v--------~d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-V--------EDPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeee-c--------CChHHHHHHHHHHHHHHHHc---CceecccchheeEEe
Confidence            2223333    345689999998888765321 1        12233444455555666666   999999999999999


Q ss_pred             CCCCEEEeecCCceec
Q 043017          641 RDLNVKIADFGLARLI  656 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~  656 (818)
                      ++..++++||-.....
T Consensus       237 dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVST  252 (465)
T ss_pred             cCCCEEEeechHhhcc
Confidence            9999999999876543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.17  E-value=0.041  Score=59.56  Aligned_cols=141  Identities=16%  Similarity=0.174  Sum_probs=80.5

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc--eeEEEeeee------cccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF--NLVRLVGYC------AERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~------~~~~~~~lV~e~~  582 (818)
                      .++.|-...+|+....++ .+++|+.....  ...+...|++++..|...  .+.+++...      ...+..++++||+
T Consensus        29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        29 GIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            366666689998876545 57788764422  234455667777666322  233443321      1234568999999


Q ss_pred             CCCChhhH--------------hhhcCCc---------cccchhhHH------------HHHHHHHHHHHHHHh----cC
Q 043017          583 CNGSLDKW--------------IFHKDRI---------QTLSWDIRK------------KIIFQISRGLEYLHD----YC  623 (818)
Q Consensus       583 ~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~qia~gL~yLH~----~~  623 (818)
                      +|..+...              ++.....         ..-.|....            .....+.+.++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            88654211              1110000         001111110            111223344555543    23


Q ss_pred             CCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          624 NPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      ..+++|+|+++.||+++.++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5689999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.13  E-value=0.034  Score=60.47  Aligned_cols=140  Identities=14%  Similarity=0.156  Sum_probs=75.1

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-----cceeEEEe-e--eecccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-----HFNLVRLV-G--YCAERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~e~~  582 (818)
                      .|+.|....+|+....+| .+++|+...   ...+....|+.++..|.     .|.+++-. |  +....+..++++||+
T Consensus        29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         29 GIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             hhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            366777789999887655 688888752   12233344555555542     33333211 0  112244578999999


Q ss_pred             CCCChhh-----H------h---hhcCC--------ccccch-hhHHH------------HH-HHHHHHHHHHHhc----
Q 043017          583 CNGSLDK-----W------I---FHKDR--------IQTLSW-DIRKK------------II-FQISRGLEYLHDY----  622 (818)
Q Consensus       583 ~~gsL~~-----~------l---~~~~~--------~~~l~~-~~~~~------------i~-~qia~gL~yLH~~----  622 (818)
                      +|..+..     .      |   +....        ...+.| .....            .. ..+...+..+.+.    
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            8875421     1      1   11000        001111 11110            11 1111222333211    


Q ss_pred             CCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       623 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      ...+++|+|+.+.||+++.+...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            34589999999999999977556899999885

>PLN02236 choline kinase

Probab=96.01  E-value=0.046  Score=60.08  Aligned_cols=139  Identities=22%  Similarity=0.258  Sum_probs=79.4

Q ss_pred             cccccceeEEEeEecC-----CcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee-EEEeeeecccCcceeeeeccCCC
Q 043017          512 LGRGGSGSVFEGLLND-----GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-VRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      |-.|-.-.+|+....+     ++.+++|.......... .-.+|..++..+...++ .++++.+..+    .|+||+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            4446677889887542     36788998765433222 23678888888743333 3455665432    579999877


Q ss_pred             ChhhH-------h---------hhcCC----ccccchhhHHHHHHH-----------------HHHHHHHHHh-----cC
Q 043017          586 SLDKW-------I---------FHKDR----IQTLSWDIRKKIIFQ-----------------ISRGLEYLHD-----YC  623 (818)
Q Consensus       586 sL~~~-------l---------~~~~~----~~~l~~~~~~~i~~q-----------------ia~gL~yLH~-----~~  623 (818)
                      +|...       +         .|...    .....+++..++..+                 +...+..|.+     ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            76421       0         01111    001112333233211                 1122222221     12


Q ss_pred             CCCeeecccccCeEEEcC-CCCEEEeecCCcee
Q 043017          624 NPKIIHFDIKPQNILLDR-DLNVKIADFGLARL  655 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~  655 (818)
                      ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            346899999999999986 46899999998863

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.81  E-value=0.076  Score=57.04  Aligned_cols=135  Identities=21%  Similarity=0.278  Sum_probs=76.5

Q ss_pred             eEEEeEecCCcEEEEEEcCC--CCCccHHHHHHHHHHHhccC--cceeEEEeeeecccC--cceeeeeccCCCChhhHhh
Q 043017          519 SVFEGLLNDGTKVAVKRLYP--GENRGKKEFLSEVETIGNIH--HFNLVRLVGYCAERS--NRFLVYEYMCNGSLDKWIF  592 (818)
Q Consensus       519 ~Vy~~~~~~g~~vAVK~l~~--~~~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~  592 (818)
                      .+|..... ++++++. ...  ..........+|.++|+.+.  -.-+-+.++.|.++.  ..+.||+|.++..+...+.
T Consensus        40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            33443333 6777777 321  12233445567888888773  234445677777766  6799999998743322221


Q ss_pred             hcCC-----------------------------------ccccchhhHHHHH--------HHHHHHHHHHHhcC-----C
Q 043017          593 HKDR-----------------------------------IQTLSWDIRKKII--------FQISRGLEYLHDYC-----N  624 (818)
Q Consensus       593 ~~~~-----------------------------------~~~l~~~~~~~i~--------~qia~gL~yLH~~~-----~  624 (818)
                      ....                                   .+.-.|....+.+        -....-..+|+++.     .
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence            0000                                   0000111111000        01222344454432     3


Q ss_pred             CCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          625 PKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ..++|+|+++.||+++.+.-+-|.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            5699999999999999988899999999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.57  E-value=0.076  Score=56.43  Aligned_cols=31  Identities=29%  Similarity=0.569  Sum_probs=25.8

Q ss_pred             CCeeecccccCeEEEcCCCC-EEEeecCCcee
Q 043017          625 PKIIHFDIKPQNILLDRDLN-VKIADFGLARL  655 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll~~~~~-~kl~Dfgla~~  655 (818)
                      ..++|+|+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.18  E-value=0.012  Score=72.77  Aligned_cols=159  Identities=14%  Similarity=0.067  Sum_probs=111.4

Q ss_pred             HHHHHHHhccCcceeEEEeeeeccc--CcceeeeeccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcC-
Q 043017          548 LSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYC-  623 (818)
Q Consensus       548 ~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~-  623 (818)
                      ..|...++...|+++.....-....  .+.+.+++|+..|.+.+.|... ++.+.+...-+...-.+......-.|... 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3445555666899887765544332  3568899999999999988543 33344444444433333344445555432 


Q ss_pred             -CCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh
Q 043017          624 -NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC  702 (818)
Q Consensus       624 -~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt  702 (818)
                       ..-.+|+++|+-|.+|..+.++|++++|+.+......... ....+++.|++|+....-.++.++|+|..|+.+|+...
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~-Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF-GLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHhhh-hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence             2236899999999999999999999999999443332222 22457888999999888889999999999999999887


Q ss_pred             CCCCC
Q 043017          703 GRRSS  707 (818)
Q Consensus       703 G~~p~  707 (818)
                      |..++
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            76654

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=94.81  E-value=0.023  Score=46.97  Aligned_cols=35  Identities=29%  Similarity=0.518  Sum_probs=28.7

Q ss_pred             cCChhhHHHhhhccCccccccccccCCcccCcccccccc
Q 043017          376 NIDAEGCQRACLGNCSCKAALFRYQGSLSTGNCSLPTEI  414 (818)
Q Consensus       376 ~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~~l  414 (818)
                      ..+.++|++.|+.+|+|.++.|.    ...+.|+++...
T Consensus        24 ~~s~~~Cq~~C~~~~~C~afT~~----~~~~~C~lk~~~   58 (73)
T cd01100          24 ASSAEQCQAACTADPGCLAFTYN----TKSKKCFLKSSE   58 (73)
T ss_pred             cCCHHHHHHHcCCCCCceEEEEE----CCCCeEEcccCC
Confidence            45889999999999999999884    235789987653

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.69  E-value=0.04  Score=59.05  Aligned_cols=136  Identities=21%  Similarity=0.290  Sum_probs=88.9

Q ss_pred             cccccceeEEEeEecCCcEEEEEEcCCCC---------CccHH-----------------HHHHHHHHHhccCcceeEEE
Q 043017          512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGE---------NRGKK-----------------EFLSEVETIGNIHHFNLVRL  565 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~---------~~~~~-----------------~f~~Ev~~l~~l~H~niv~l  565 (818)
                      |..|.-+.||.+.-.+|..+|||+++...         ..+.-                 -...|++-|.+++.-.|.  
T Consensus       152 iSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP--  229 (520)
T KOG2270|consen  152 ISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP--  229 (520)
T ss_pred             cccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC--
Confidence            77788999999999999999999764321         00100                 123466666665422211  


Q ss_pred             eeeeccc---CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC
Q 043017          566 VGYCAER---SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       566 ~g~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                         |.+.   ...+|||+|+..-.   |-.-.-+...++...+..+-.+++.-|.-|-+.  .++||.||.--|+|+. +
T Consensus       230 ---~PePIlLk~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  230 ---CPEPILLKNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             ---CCCceeeecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence               1111   13478999985321   111111223466777888888888888888765  4899999999999995 4


Q ss_pred             CCEEEeecCCceeccc
Q 043017          643 LNVKIADFGLARLIAQ  658 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~  658 (818)
                      |.+.|+|.+.+.....
T Consensus       301 G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             CEEEEEEccccccCCC
Confidence            6899999998876543

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.66  E-value=0.25  Score=53.68  Aligned_cols=136  Identities=24%  Similarity=0.325  Sum_probs=81.2

Q ss_pred             cceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC---cceeEE---Eeeee--ccc--CcceeeeeccCCC
Q 043017          516 GSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH---HFNLVR---LVGYC--AER--SNRFLVYEYMCNG  585 (818)
Q Consensus       516 ~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~---l~g~~--~~~--~~~~lV~e~~~~g  585 (818)
                      .-..+|+....+|+. ++|.....  ....++..|...+..|.   .+-.++   +-|-.  .-.  ...+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            345788888887777 78877654  44566777778777773   222222   22211  112  3678899999998


Q ss_pred             Chhh-H----h----------hh--------cC-Cccccchhh-------------HHHHHHHHHHHHHHHHhc----CC
Q 043017          586 SLDK-W----I----------FH--------KD-RIQTLSWDI-------------RKKIIFQISRGLEYLHDY----CN  624 (818)
Q Consensus       586 sL~~-~----l----------~~--------~~-~~~~l~~~~-------------~~~i~~qia~gL~yLH~~----~~  624 (818)
                      .+.. .    +          +.        +. ......|..             ......++...+..+++.    ..
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8872 1    1          00        00 011233331             011223444444444443    22


Q ss_pred             CC---eeecccccCeEEEcCCCC-EEEeecCCce
Q 043017          625 PK---IIHFDIKPQNILLDRDLN-VKIADFGLAR  654 (818)
Q Consensus       625 ~~---iiH~Dlkp~NIll~~~~~-~kl~Dfgla~  654 (818)
                      ..   +||+|+.|.||+++.+.. +.+.||+.+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            23   999999999999999885 8999999886

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.57  E-value=0.1  Score=53.05  Aligned_cols=31  Identities=39%  Similarity=0.595  Sum_probs=22.2

Q ss_pred             CCeeecccccCeEEE-cCCCCEEEeecCCcee
Q 043017          625 PKIIHFDIKPQNILL-DRDLNVKIADFGLARL  655 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll-~~~~~~kl~Dfgla~~  655 (818)
                      .-+.|.|+.+.||++ +.++.++++||..+..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            368999999999999 8889999999999864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=94.53  E-value=0.24  Score=54.00  Aligned_cols=73  Identities=18%  Similarity=0.164  Sum_probs=46.3

Q ss_pred             hcccccceeEEEeEecCC-cEEEEEEcCCC------C-CccHHHHHHHHHHHhccC--cceeEE-EeeeecccCcceeee
Q 043017          511 RLGRGGSGSVFEGLLNDG-TKVAVKRLYPG------E-NRGKKEFLSEVETIGNIH--HFNLVR-LVGYCAERSNRFLVY  579 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~------~-~~~~~~f~~Ev~~l~~l~--H~niv~-l~g~~~~~~~~~lV~  579 (818)
                      +||.|....||++..++| +.|+||.-.+.      + .-..++..-|.+.|....  .|..|+ ++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999998765 58999974321      1 222344556777776652  343333 4333  445567899


Q ss_pred             eccCCC
Q 043017          580 EYMCNG  585 (818)
Q Consensus       580 e~~~~g  585 (818)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.45  E-value=0.22  Score=53.76  Aligned_cols=30  Identities=30%  Similarity=0.332  Sum_probs=26.2

Q ss_pred             CCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          624 NPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            457999999999999987 678999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	818
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-21
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-21
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-19
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-19
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-19
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-18
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-18
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-18
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-18
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-18
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-18
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-18
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-18
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-18
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-18
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-17
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-17
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-15
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-15
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-15
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-15
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-15
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-15
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-15
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-15
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-15
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-15
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-15
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-15
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-15
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-15
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-15
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-15
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-12
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-10
3soa_A	444	Full-Length Human Camkii Length = 444		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		9e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  196 bits (498), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 118/307 (38%), Positives = 182/307 (59%), Gaps = 15/307 (4%)
Query: 481 STDESSVHVANHLVKFSSKAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYP 538
           + ++  VH+   L +FS + ++ A+ +F  +  LGRGG G V++G L DGT VAVKRL  
Sbjct: 14  AEEDPEVHLG-QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 72
Query: 539 GENRGKK-EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
              +G + +F +EVE I    H NL+RL G+C   + R LVY YM NGS+   +  +   
Sbjct: 73  ERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 132
Query: 598 QT-LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
           Q  L W  R++I    +RGL YLHD+C+PKIIH D+K  NILLD +    + DFGLA+L+
Sbjct: 133 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192
Query: 657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGD 713
                HV    +GT G++APE       + K D++ +GV++LE+I G+R+   +     D
Sbjct: 193 DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 714 --YLVDTLKVKAEADRLCDLVDKKSEDMQ-SHRDDAV-KMIQIAISCLQKNLHRRPSASM 769
              L+D +K   +  +L  LVD    D+Q +++D+ V ++IQ+A+ C Q +   RP  S 
Sbjct: 253 DVMLLDWVKGLLKEKKLEALVDV---DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 309
Query: 770 LVKVLQG 776
           +V++L+G
Sbjct: 310 VVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  192 bits (488), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 116/307 (37%), Positives = 180/307 (58%), Gaps = 15/307 (4%)
Query: 481 STDESSVHVANHLVKFSSKAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYP 538
           + ++  VH+   L +FS + ++ A+ +F  +  LGRGG G V++G L DG  VAVKRL  
Sbjct: 6   AEEDPEVHLG-QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE 64
Query: 539 GENRGKK-EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
              +G + +F +EVE I    H NL+RL G+C   + R LVY YM NGS+   +  +   
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 598 QT-LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
           Q  L W  R++I    +RGL YLHD+C+PKIIH D+K  NILLD +    + DFGLA+L+
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGD 713
                HV    +G  G++APE       + K D++ +GV++LE+I G+R+   +     D
Sbjct: 185 DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 714 --YLVDTLKVKAEADRLCDLVDKKSEDMQ-SHRDDAV-KMIQIAISCLQKNLHRRPSASM 769
              L+D +K   +  +L  LVD    D+Q +++D+ V ++IQ+A+ C Q +   RP  S 
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDV---DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 770 LVKVLQG 776
           +V++L+G
Sbjct: 302 VVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 108/310 (34%), Positives = 173/310 (55%), Gaps = 28/310 (9%)
Query: 490 ANHLVKFSSKA-----MKSATRDF--QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR 542
           +++LV F S       ++ AT +F  +  +G G  G V++G+L DG KVA+KR  P  ++
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 543 GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR-IQTLS 601
           G +EF +E+ET+    H +LV L+G+C ER+   L+Y+YM NG+L + ++  D    ++S
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQ 660
           W+ R +I    +RGL YLH      IIH D+K  NILLD +   KI DFG+++   + DQ
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           +H+  + KGT GY+ PE      +T K D+YSFGVV+ E++C R +        +V+  +
Sbjct: 195 THLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 721 VKAEA------DRLCD--LVDK-KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
              E+      +++ D  L DK + E ++   D AVK       CL  +   RPS   ++
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK-------CLALSSEDRPSMGDVL 307
Query: 772 KVLQGLTKLE 781
             L+   +L+
Sbjct: 308 WKLEYALRLQ 317

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 172/310 (55%), Gaps = 28/310 (9%)
Query: 490 ANHLVKFSSKA-----MKSATRDF--QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR 542
           +++LV F S       ++ AT +F  +  +G G  G V++G+L DG KVA+KR  P  ++
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 543 GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR-IQTLS 601
           G +EF +E+ET+    H +LV L+G+C ER+   L+Y+YM NG+L + ++  D    ++S
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQ 660
           W+ R +I    +RGL YLH      IIH D+K  NILLD +   KI DFG+++   +  Q
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQ 194
Query: 661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           +H+  + KGT GY+ PE      +T K D+YSFGVV+ E++C R +        +V+  +
Sbjct: 195 THLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 721 VKAEA------DRLCD--LVDK-KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
              E+      +++ D  L DK + E ++   D AVK       CL  +   RPS   ++
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK-------CLALSSEDRPSMGDVL 307
Query: 772 KVLQGLTKLE 781
             L+   +L+
Sbjct: 308 WKLEYALRLQ 317

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  147 bits (370), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 158/298 (53%), Gaps = 22/298 (7%)
Query: 496 FSSKAMKSATRDFQIR--------LGRGGSGSVFEGLLNDGTKVAVKRLYP----GENRG 543
           FS   +K+ T +F  R        +G GG G V++G +N+ T VAVK+L           
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K++F  E++ +    H NLV L+G+ ++  +  LVY YM NGSL   +   D    LSW 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSH 662
           +R KI    + G+ +LH+  +   IH DIK  NILLD     KI+DFGLAR   +  Q+ 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV--DTLK 720
           + +   GT  YMAPE  RG  IT K DIYSFGVV+LEII G  + +      L+     +
Sbjct: 191 MXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
           ++ E   + D +DKK  D  S   +A  M  +A  CL +  ++RP    + ++LQ +T
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  146 bits (369), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 157/298 (52%), Gaps = 22/298 (7%)
Query: 496 FSSKAMKSATRDFQIR--------LGRGGSGSVFEGLLNDGTKVAVKRLYP----GENRG 543
           FS   +K+ T +F  R        +G GG G V++G +N+ T VAVK+L           
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K++F  E++ +    H NLV L+G+ ++  +  LVY YM NGSL   +   D    LSW 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSH 662
           +R KI    + G+ +LH+  +   IH DIK  NILLD     KI+DFGLAR   +  Q+ 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV--DTLK 720
           +     GT  YMAPE  RG  IT K DIYSFGVV+LEII G  + +      L+     +
Sbjct: 191 MXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
           ++ E   + D +DKK  D  S   +A  M  +A  CL +  ++RP    + ++LQ +T
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  145 bits (366), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 156/298 (52%), Gaps = 22/298 (7%)
Query: 496 FSSKAMKSATRDFQIR--------LGRGGSGSVFEGLLNDGTKVAVKRLYP----GENRG 543
           FS   +K+ T +F  R        +G GG G V++G +N+ T VAVK+L           
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K++F  E++ +    H NLV L+G+ ++  +  LVY YM NGSL   +   D    LSW 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSH 662
           +R KI    + G+ +LH+  +   IH DIK  NILLD     KI+DFGLAR   +  Q  
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV--DTLK 720
           +     GT  YMAPE  RG  IT K DIYSFGVV+LEII G  + +      L+     +
Sbjct: 185 MXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 243
Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
           ++ E   + D +DKK  D  S   +A  M  +A  CL +  ++RP    + ++LQ +T
Sbjct: 244 IEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 106/298 (35%), Positives = 149/298 (50%), Gaps = 22/298 (7%)
Query: 496 FSSKAMKSATRDFQIR--------LGRGGSGSVFEGLLNDGTKVAVKRLYP----GENRG 543
           FS   +K+ T +F  R         G GG G V++G +N+ T VAVK+L           
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K++F  E++      H NLV L+G+ ++  +  LVY Y  NGSL   +   D    LSW 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSH 662
            R KI    + G+ +LH+  +   IH DIK  NILLD     KI+DFGLAR   +  Q  
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV--DTLK 720
             +   GT  Y APE  RG  IT K DIYSFGVV+LEII G  + +      L+     +
Sbjct: 182 XXSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 240
Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
           ++ E   + D +DKK  D  S   +A     +A  CL +  ++RP    + ++LQ  T
Sbjct: 241 IEDEEKTIEDYIDKKXNDADSTSVEA--XYSVASQCLHEKKNKRPDIKKVQQLLQEXT 296

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 137/271 (50%), Gaps = 18/271 (6%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK--EFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G+V     + G+ VAVK L   +   ++  EFL EV  +  + H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             +  N  +V EY+  GSL + +      + L    R  + + +++G+ YLH+  NP I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+K  N+L+D+   VK+ DFGL+RL A      S    GTP +MAPE+ R      K 
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKAS-XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK 748
           D+YSFGV++ E+   ++   P G    ++  +V A        V  K + ++  R+   +
Sbjct: 221 DVYSFGVILWELATLQQ---PWGN---LNPAQVVAA-------VGFKCKRLEIPRNLNPQ 267
Query: 749 MIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
           +  I   C      +RPS + ++ +L+ L K
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 18/271 (6%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK--EFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G+V     + G+ VAVK L   +   ++  EFL EV  +  + H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             +  N  +V EY+  GSL + +      + L    R  + + +++G+ YLH+  NP I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H ++K  N+L+D+   VK+ DFGL+RL A      S    GTP +MAPE+ R      K 
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK 748
           D+YSFGV++ E+   ++   P G    ++  +V A        V  K + ++  R+   +
Sbjct: 221 DVYSFGVILWELATLQQ---PWGN---LNPAQVVAA-------VGFKCKRLEIPRNLNPQ 267
Query: 749 MIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
           +  I   C      +RPS + ++ +L+ L K
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N+ TKVAVK L PG     + FL E   +  + H  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKII 628
                +++ EYM  GSL  ++   +  + L   + K I F  QI+ G+ Y+        I
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL---LPKLIDFSAQIAEGMAYIE---RKNYI 132
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D++  N+L+   L  KIADFGLAR+I  ++       K    + APE       T K 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK 748
           D++SFG+++ EI+   +   P  G    D +   ++  R+      + E+      D +K
Sbjct: 193 DVWSFGILLYEIVTYGKIPYP--GRTNADVMTALSQGYRM-----PRVENCPDELYDIMK 245
Query: 749 MIQIAISCLQKNLHRRPSASMLVKVL 774
           M      C ++    RP+   L  VL
Sbjct: 246 M------CWKEKAEERPTFDYLQSVL 265

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVA+K L PG     + FL E + +  + H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPG-TMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
           E    ++V EYM  GSL    F KD   + L       +  Q++ G+ Y+        IH
Sbjct: 75  EEPI-YIVTEYMNKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIH 128
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D++  NIL+   L  KIADFGLARLI  ++       K    + APE       T K D
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           ++SFG+++ E++   R   P      ++  +V  + +R           M   +D  + +
Sbjct: 189 VWSFGILLTELVTKGRVPYPG-----MNNREVLEQVER--------GYRMPCPQDCPISL 235
Query: 750 IQIAISCLQKNLHRRPSASMLVKVLQG-LTKLEP 782
            ++ I C +K+   RP+   L   L+   T  EP
Sbjct: 236 HELMIHCWKKDPEERPTFEYLQSFLEDYFTATEP 269

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 22/266 (8%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+ G  N+ TKVAVK L PG     + FL E   +  + H  LVRL     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKII 628
           +    +++ E+M  GSL  ++   +  + L   + K I F  QI+ G+ Y+        I
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL---LPKLIDFSAQIAEGMAYIE---RKNYI 131
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D++  N+L+   L  KIADFGLAR+I  ++       K    + APE       T K 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVK 748
           +++SFG+++ EI+   +   P  G    D +   ++  R+      + E+      D +K
Sbjct: 192 NVWSFGILLYEIVTYGKIPYP--GRTNADVMSALSQGYRM-----PRMENCPDELYDIMK 244
Query: 749 MIQIAISCLQKNLHRRPSASMLVKVL 774
           M      C ++    RP+   L  VL
Sbjct: 245 M------CWKEKAEERPTFDYLQSVL 264

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 23/280 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 193 VWAFGVLLWEIATYGMSPYP-GID-----------PSQVYELLEK---DYRMERPEGCPE 237
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYG 787
           K+ ++  +C Q N   RPS + + +  + + +   ++D G
Sbjct: 238 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEG 277

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 147/300 (49%), Gaps = 37/300 (12%)
Query: 493 LVKFSSKAMKS-ATRDFQIRLGRGGSGSVFEGLL--NDGTK---VAVKRLYPGENRGKK- 545
           ++KF+++   S  TR  Q  +G G  G V++G+L  + G K   VA+K L  G    ++ 
Sbjct: 34  VLKFTTEIHPSCVTR--QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV 91
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKD---RIQTLSW 602
           +FL E   +G   H N++RL G  ++     ++ EYM NG+LDK++  KD    +  L  
Sbjct: 92  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
            +R      I+ G++YL    N   +H D+  +NIL++ +L  K++DFGL+R++  D   
Sbjct: 152 MLRG-----IAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203
Query: 663 VSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTL 719
             T   G     + APE       T+  D++SFG+V+ E++  G R   P       + +
Sbjct: 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVM 260
Query: 720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
           K   +  RL   +D  S            + Q+ + C Q+   RRP  + +V +L  L +
Sbjct: 261 KAINDGFRLPTPMDCPS-----------AIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 141/311 (45%), Gaps = 34/311 (10%)
Query: 484 ESSVHVANHLVKFSSKAMKSATRDFQIR-------LGRGGSGSVFEGLL----NDGTKVA 532
           E   +   H  +   +A +S TR+ +         +G G SG V  G L         VA
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 533 VKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI 591
           +K L  G   R +++FLSE   +G   H N++RL G         +V EYM NGSLD ++
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 592 FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG 651
              D   T+   +   ++  +  G+ YL D      +H D+  +N+L+D +L  K++DFG
Sbjct: 142 RTHDGQFTIMQLV--GMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 652 LARLIAQ--DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSN 708
           L+R++    D ++ +T  K    + APE     + ++  D++SFGVV+ E++  G R   
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER--- 253
Query: 709 PKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
           P       D +    E  RL   +                + Q+ + C  K+  +RP  S
Sbjct: 254 PYWNMTNRDVISSVEEGYRLPAPMGCPH-----------ALHQLMLDCWHKDRAQRPRFS 302
Query: 769 MLVKVLQGLTK 779
            +V VL  L +
Sbjct: 303 QIVSVLDALIR 313

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 34/311 (10%)
Query: 484 ESSVHVANHLVKFSSKAMKSATRDFQIR-------LGRGGSGSVFEGLL----NDGTKVA 532
           E   +   H  +   +A +S TR+ +         +G G SG V  G L         VA
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 533 VKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI 591
           +K L  G   R +++FLSE   +G   H N++RL G         +V EYM NGSLD ++
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 592 FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG 651
              D   T+   +   ++  +  G+ YL D      +H D+  +N+L+D +L  K++DFG
Sbjct: 142 RTHDGQFTIMQLV--GMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 652 LARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSN 708
           L+R++  D     T   G     + APE     + ++  D++SFGVV+ E++  G R   
Sbjct: 197 LSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER--- 253
Query: 709 PKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
           P       D +    E  RL   +                + Q+ + C  K+  +RP  S
Sbjct: 254 PYWNMTNRDVISSVEEGYRLPAPMGCPH-----------ALHQLMLDCWHKDRAQRPRFS 302
Query: 769 MLVKVLQGLTK 779
            +V VL  L +
Sbjct: 303 QIVSVLDALIR 313

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAV-KRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG+G  G   +    +  +V V K L   +   ++ FL EV+ +  + H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +      + EY+  G+L   I   D      W  R      I+ G+ YLH      IIH 
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSH---VSTMPK----------GTPGYMAPE 677
           D+   N L+  + NV +ADFGLARL+  +++    + ++ K          G P +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT----LKVKAEADRLCDLVD 733
           +  G S   K+D++SFG+V+ EII GR +++P   DYL  T    L V+   DR C    
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVNADP---DYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
             S               I + C   +  +RPS   L   L+ L
Sbjct: 249 PPS------------FFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 195 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 239
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G +G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI   +       K    + APE     + T K D+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 194 WSFGILLTEIVTHGRIPYP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 195 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 239
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 195 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 239
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 200 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 244
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 282

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 195 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 239
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 193 VWAFGVLLWEIATYGMSPYP-GID-----------PSQVYELLEK---DYRMERPEGCPE 237
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 238 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 87  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 141
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 202 WSFGILLTEIVTHGRIPYP 220

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 81  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 135
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 196 WSFGILLTEIVTHGRIPYP 214

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 193 VWAFGVLLWEIATYGMSPYP-GID-----------PSQVYELLEK---DYRMERPEGCPE 237
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 238 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 85  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 200 WSFGILLTEIVTHGRIPYP 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 80  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 195 WSFGILLTEIVTHGRIPYP 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 194 WSFGILLTEIVTHGRIPYP 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGLAR++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 88  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 142
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 203 WSFGILLTEIVTHGRIPYP 221

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 194 WSFGILLTEIVTHGRIPYP 212

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 89  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 143
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 204 WSFGILLTEIVTHGRIPYP 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 196 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 240
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 241 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 278

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 85  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 200 WSFGILLTEIVTHGRIPYP 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 74  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 189 WSFGILLTEIVTHGRIPYP 207

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 84  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 199 WSFGILLTEIVTHGRIPYP 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL        IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            ++  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P      +D  +V        +L++K   D +  R +    
Sbjct: 402 VWAFGVLLWEIATYGMSPYPG-----IDLSQV-------YELLEK---DYRMERPEGCPE 446
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 147
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 208 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 252
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 253 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 290

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 194 WSFGILLTEIVTHGRIPYP 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 197 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 241
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 279

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 196 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 240
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 241 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 278

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 197 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 241
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 279

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 200 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 244
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 282

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 140/289 (48%), Gaps = 23/289 (7%)
Query: 490 ANHLVKFSSKAMKSATRDFQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGK 544
           ++++ +F  + +K     F  +LG+G  GSV    ++ L  N G  VAVK+L        
Sbjct: 19  SHNMTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 73
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLS 601
           ++F  E+E + ++ H N+V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  + 
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 133
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
                +   QI +G+EYL      + IH D+  +NIL++ +  VKI DFGL +++ QD+ 
Sbjct: 134 L---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187
Query: 662 HVSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
                  G     + APE    +  +   D++SFGVV+ E+      S     +++    
Sbjct: 188 XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 247
Query: 720 KVKAEADRLCDLVDKKSEDMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
             K     +  L++    + +  R D    ++  I   C   N+++RPS
Sbjct: 248 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 296

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 197 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 241
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 279

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 140/289 (48%), Gaps = 23/289 (7%)
Query: 490 ANHLVKFSSKAMKSATRDFQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGK 544
           ++++ +F  + +K     F  +LG+G  GSV    ++ L  N G  VAVK+L        
Sbjct: 19  SHNMTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 73
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLS 601
           ++F  E+E + ++ H N+V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  + 
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 133
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
                +   QI +G+EYL      + IH D+  +NIL++ +  VKI DFGL +++ QD+ 
Sbjct: 134 L---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187
Query: 662 HVSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
                  G     + APE    +  +   D++SFGVV+ E+      S     +++    
Sbjct: 188 XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 247
Query: 720 KVKAEADRLCDLVDKKSEDMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
             K     +  L++    + +  R D    ++  I   C   N+++RPS
Sbjct: 248 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 296

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 511 RLGRGGSGSVF---EGLLNDGTKVAVKRLY--PGENRGK-KEFLSEVETIGNIHHFNLVR 564
           +LG GG  +V+   + +LN   KVA+K ++  P E     K F  EV     + H N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           ++    E    +LV EY+   +L ++I   +    LS D       QI  G+++ HD   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            +I+H DIKPQNIL+D +  +KI DFG+A+ +++     +    GT  Y +PE  +G + 
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 685 TAKIDIYSFGVVILEIICGR 704
               DIYS G+V+ E++ G 
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG N   + FL E + +  + H  LV+L  
Sbjct: 189 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-NMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 248 VVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGL RLI  ++       K    + APE       T K
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 363 SDVWSFGILLTELTTKGRVPYP 384

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 362 SDVWSFGILLTELTTKGRVPYP 383

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 23/270 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 200 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 244
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           K+ ++  +C Q N   RPS + + +  + +
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 23/270 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 200 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 244
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           K+ ++  +C Q N   RPS + + +  + +
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 362 SDVWSFGILLTELTTKGRVPYP 383

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 138
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 199 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 248
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 249 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 165
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 225
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 226 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 275
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 276 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 155
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 215
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 216 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 265
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 266 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 124/259 (47%), Gaps = 23/259 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 200 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 244
Query: 748 KMIQIAISCLQKNLHRRPS 766
           K+ ++  +C Q N   RPS
Sbjct: 245 KVYELMRACWQWNPSDRPS 263

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  I H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 124/259 (47%), Gaps = 23/259 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 195 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 239
Query: 748 KMIQIAISCLQKNLHRRPS 766
           K+ ++  +C Q N   RPS
Sbjct: 240 KVYELMRACWQWNPSDRPS 258

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 161
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 162 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 309

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V EYM NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL R++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 445 SDVWSFGILLTELTTKGRVPYP 466

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 124/259 (47%), Gaps = 23/259 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 195 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 239
Query: 748 KMIQIAISCLQKNLHRRPS 766
           K+ ++  +C Q N   RPS
Sbjct: 240 KVYELMRACWQWNPSDRPS 258

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 23/270 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P G D             ++ +L++K   D +  R +    
Sbjct: 199 VWAFGVLLWEIATYGMSPYP-GID-----------LSQVYELLEK---DYRMERPEGCPE 243
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           K+ ++  +C Q N   RPS + + +  + +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 130
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 131 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 278

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 247 VVSEEPI-YIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 362 SDVWSFGILLTELTTKGRVPYP 383

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 27/297 (9%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKK 545
           N  V   +K ++++    +  +G G  G V  G L    K    VA+K L  G   + ++
Sbjct: 9   NQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR 68
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           +FL E   +G   H N++ L G   +     +V EYM NGSLD ++   D   T+   + 
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLV- 127
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
             ++  IS G++YL D      +H D+  +NIL++ +L  K++DFGL+R++  D     T
Sbjct: 128 -GMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 666 MPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK 722
              G     + APE       T+  D++S+G+V+ E++  G R   P       D +K  
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER---PYWEMTNQDVIKAV 240
Query: 723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            E  RL            S  D    + Q+ + C QK  + RP    +V +L  L +
Sbjct: 241 EEGYRL-----------PSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 130
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 131 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 278

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 137
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 138 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 254
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 255 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 285

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 130
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 131 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 278

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 134
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 135 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 251
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 252 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 282

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G +     FL+E   +  + H  LVRL     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 75  QEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 129
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           +++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + T K D+
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 691 YSFGVVILEIICGRRSSNP 709
           +SFG+++ EI+   R   P
Sbjct: 190 WSFGILLTEIVTHGRIPYP 208

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 128
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 129 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 245
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 246 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 276

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 129
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 130 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 246
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 247 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 277

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 136
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 137 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 253
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 254 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 284

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 135
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 136 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 252
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 253 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 283

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 133
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 250
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 251 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 281

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 23/278 (8%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++   +R Q ++  +   +  QIS  +EYL        IH
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIH 380
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            ++  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAV-- 747
           +++FGV++ EI     S  P      +D  +V        +L++K   D +  R +    
Sbjct: 441 VWAFGVLLWEIATYGMSPYPG-----IDLSQV-------YELLEK---DYRMERPEGCPE 485
Query: 748 KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
           K+ ++  +C Q N   RPS + + +  + + +   ++D
Sbjct: 486 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 523

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 11  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 70  VVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 185 SDVWSFGILLTELTTKGRVPYP 206

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 13  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 72  VVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 187 SDVWSFGILLTELTTKGRVPYP 208

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 15  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 74  VVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 189 SDVWSFGILLTELTTKGRVPYP 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 128/276 (46%), Gaps = 24/276 (8%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +GRG  G V +        VA+K++     R  K F+ E+  +  ++H N+V+L G C  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD 631
            +   LV EY   GSL   +   + +   +         Q S+G+ YLH      +IH D
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 632 IKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           +KP N+LL     V KI DFG A  I   Q+H++   KG+  +MAPE+  G++ + K D+
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSEKCDV 187
Query: 691 YSFGVVILEIICGRRSSNPKGGDYLVDTLKV-KAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           +S+G+++ E+I  R+  +  GG        V       L   + K  E + +        
Sbjct: 188 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR------- 240
Query: 750 IQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
                 C  K+  +RPS   +VK++  L +  P  D
Sbjct: 241 ------CWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 270

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  HK+RI  +      +   QI +G+EYL
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 131
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH ++  +NIL++ +  VKI DFGL +++ QD+ +      G     + APE
Sbjct: 132 ---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 248
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 249 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 279

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 128/276 (46%), Gaps = 24/276 (8%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +GRG  G V +        VA+K++     R  K F+ E+  +  ++H N+V+L G C  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD 631
            +   LV EY   GSL   +   + +   +         Q S+G+ YLH      +IH D
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 632 IKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           +KP N+LL     V KI DFG A  I   Q+H++   KG+  +MAPE+  G++ + K D+
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSEKCDV 186
Query: 691 YSFGVVILEIICGRRSSNPKGGDYLVDTLKV-KAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           +S+G+++ E+I  R+  +  GG        V       L   + K  E + +        
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR------- 239
Query: 750 IQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
                 C  K+  +RPS   +VK++  L +  P  D
Sbjct: 240 ------CWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ E++  GSL +++  HK+RI  +      +   QI +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL---LQYTSQICKGMEYL 133
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 250
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 251 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 281

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 12  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E     +V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 71  VVSEEPIX-IVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 186 SDVWSFGILLTELTTKGRVPYP 207

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D+   NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 19  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 78  VVSEEPI-YIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 193 SDVWSFGILLTELTTKGRVPYP 214

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 19  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  GSL  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 78  VVSEEPI-YIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 193 SDVWSFGILLTELTTKGRVPYP 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 130/271 (47%), Gaps = 18/271 (6%)
Query: 508 FQIRLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           F  +LG+G  GSV    ++ L  N G  VAVK+L        ++F  E+E + ++ H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 563 VRLVGYC--AERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           V+  G C  A R N  L+ EY+  GSL  ++  H +RI  +      +   QI +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYL 133
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPE 677
                 + IH D+  +NIL++ +  VKI DFGL +++ QD+        G     + APE
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
               +  +   D++SFGVV+ E+      S     +++      K     +  L++    
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 250
Query: 738 DMQSHRDDAV--KMIQIAISCLQKNLHRRPS 766
           + +  R D    ++  I   C   N+++RPS
Sbjct: 251 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 281

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  G L  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V E M NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 136/297 (45%), Gaps = 27/297 (9%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKK 545
           N  V+  +K + ++    +  +G G  G V  G L    K    VA+K L  G  ++ ++
Sbjct: 16  NQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR 75
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           +FLSE   +G   H N++ L G   +     ++ EYM NGSLD ++   D   T+   + 
Sbjct: 76  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV- 134
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
             ++  I  G++YL D      +H D+  +NIL++ +L  K++DFG++R++  D     T
Sbjct: 135 -GMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 666 MPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK 722
              G     + APE       T+  D++S+G+V+ E++  G R   P       D +K  
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER---PYWDMSNQDVIKAI 247
Query: 723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            E  RL               D  + + Q+ + C QK    RP    +V +L  L +
Sbjct: 248 EEGYRL-----------PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 6/202 (2%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
            +++LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L  
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +E    ++V EYM  G L  ++   +  + L       +  QI+ G+ Y+        
Sbjct: 81  VVSEEPI-YIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 688 IDIYSFGVVILEIICGRRSSNP 709
            D++SFG+++ E+    R   P
Sbjct: 196 SDVWSFGILLTELTTKGRVPYP 217

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 131/287 (45%), Gaps = 34/287 (11%)
Query: 512 LGRGGSGSVFE----GLLNDGTK--VAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDRIQTLSWDIRKKII---------FQIS 613
            L+G C +     +V    C  G+L  ++  K        D+ K  +         FQ++
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-G 672
           +G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V       P  
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV 732
           +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R     
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFXRRL--- 260
Query: 733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 261 -KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V E M NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 167
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 228 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 277
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 27/276 (9%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   +     +V E M NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDM---G 138
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSI 684
            +H D+  +NIL++ +L  K++DFGL+R++  D     T   G     + +PE       
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 685 TAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           T+  D++S+G+V+ E++  G R   P       D +K   E  RL   +D  +       
Sbjct: 199 TSASDVWSYGIVLWEVMSYGER---PYWEMSNQDVIKAVDEGYRLPPPMDCPA------- 248
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                + Q+ + C QK+ + RP    +V +L  L +
Sbjct: 249 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 136/297 (45%), Gaps = 27/297 (9%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKK 545
           N  V+  +K + ++    +  +G G  G V  G L    K    VA+K L  G  ++ ++
Sbjct: 1   NQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR 60
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           +FLSE   +G   H N++ L G   +     ++ EYM NGSLD ++   D   T+   + 
Sbjct: 61  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV- 119
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
             ++  I  G++YL D      +H D+  +NIL++ +L  K++DFG++R++  D     T
Sbjct: 120 -GMLRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 666 MPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVK 722
              G     + APE       T+  D++S+G+V+ E++  G R   P       D +K  
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER---PYWDMSNQDVIKAI 232
Query: 723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            E  RL               D  + + Q+ + C QK    RP    +V +L  L +
Sbjct: 233 EEGYRL-----------PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 131/287 (45%), Gaps = 34/287 (11%)
Query: 512 LGRGGSGSVFE----GLLNDGTK--VAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDRIQTLSWDIRKKII---------FQIS 613
            L+G C +     +V    C  G+L  ++  K        D+ K  +         FQ++
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-G 672
           +G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V       P  
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV 732
           +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R     
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRRL--- 260
Query: 733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 261 -KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           LGRGG G VFE     D    A+KR+  P     +++ + EV+ +  + H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 570 AER---------SNRFLVYEYM--CNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
            E+         S +  +Y  M  C   +L  W+  +  I+     +   I  QI+  +E
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD---QSHVSTMPK------ 668
           +LH   +  ++H D+KP NI    D  VK+ DFGL   + QD   Q+ ++ MP       
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 669 --GTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
             GT  YM+PE   GNS + K+DI+S G+++ E++
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+L G
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C E++   LV+E+M +G L  ++  + +    + +    +   +  G+ YL + C   +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 688 IDIYSFGVVILEII 701
            D++SFGV++ E+ 
Sbjct: 185 SDVWSFGVLMWEVF 198

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+L G
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C E++   LV+E+M +G L  ++  + +    + +    +   +  G+ YL + C   +
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 688 IDIYSFGVVILEII 701
            D++SFGV++ E+ 
Sbjct: 188 SDVWSFGVLMWEVF 201

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+L G
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C E++   LV+E+M +G L  ++  + +    + +    +   +  G+ YL + C   +
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 688 IDIYSFGVVILEII 701
            D++SFGV++ E+ 
Sbjct: 183 SDVWSFGVLMWEVF 196

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   +G G  G V  G   +  KVA+K +  G +  + +F+ E E +  + H  LV+L G
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C E++   LV+E+M +G L  ++  + +    + +    +   +  G+ YL + C   +
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 688 IDIYSFGVVILEII 701
            D++SFGV++ E+ 
Sbjct: 205 SDVWSFGVLMWEVF 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 16/214 (7%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + LE+LH   + ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQV 137
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +   K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 196
Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDT 718
           +DI+S G++ +E+I G     + NP    YL+ T
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 140/299 (46%), Gaps = 29/299 (9%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKK 545
           N  V+  +K +  +    +  +G G  G V  G L    K    VA+K L  G   + ++
Sbjct: 20  NEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR 79
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           +FLSE   +G   H N++ L G   + +   ++ E+M NGSLD ++   D   T+   + 
Sbjct: 80  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV- 138
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---H 662
             ++  I+ G++YL D      +H D+  +NIL++ +L  K++DFGL+R +  D S   +
Sbjct: 139 -GMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 663 VSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLK 720
            S +    P  + APE  +    T+  D++S+G+V+ E++  G R   P       D + 
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---PYWDMTNQDVIN 251
Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
              +  RL   +D  S            + Q+ + C QK+ + RP    +V  L  + +
Sbjct: 252 AIEQDYRLPPPMDCPS-----------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 114/215 (53%), Gaps = 28/215 (13%)
Query: 507 DFQIRLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGK-------KEFLSEVETIGNIH 558
           +++ ++G+GG G V +G L+ D + VA+K L  G++ G+       +EF  EV  + N++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGL 616
           H N+V+L G         +V E++  G L    +H+  D+   + W ++ +++  I+ G+
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDL----YHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 617 EYLHDYCNPKIIHFDIKPQNIL---LDRDLNV--KIADFGLARLIAQDQSHVSTMPKGTP 671
           EY+ +  NP I+H D++  NI    LD +  V  K+ADFGL    +Q   H  +   G  
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL----SQQSVHSVSGLLGNF 190
Query: 672 GYMAPEL--TRGNSITAKIDIYSFGVVILEIICGR 704
            +MAPE       S T K D YSF +++  I+ G 
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+ G+       VAVK L   +    +EFL E   +  I H NLV+L+G C
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 ++V EYM  G+L  ++   +R + ++  +   +  QIS  +EYL        IH
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYLRECNR-EEVTAVVLLYMATQISSAMEYLE---KKNFIH 153
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N+ + K D
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           +++FGV++ EI     S  P              +  ++ DL++K    M+       K+
Sbjct: 214 VWAFGVLLWEIATYGMSPYP------------GIDLSQVYDLLEKGYR-MEQPEGCPPKV 260
Query: 750 IQIAISCLQKNLHRRPS 766
            ++  +C + +   RPS
Sbjct: 261 YELMRACWKWSPADRPS 277

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 27/305 (8%)
Query: 483 DESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYP 538
           D  +    N  V   +K + ++    +  +G G  G V  G L    K    VA+K L  
Sbjct: 22  DPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKV 81
Query: 539 G-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
           G   + +++FL E   +G   H N+V L G         +V E+M NG+LD ++   D  
Sbjct: 82  GYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ 141
Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
            T+   +   ++  I+ G+ YL D      +H D+  +NIL++ +L  K++DFGL+R+I 
Sbjct: 142 FTVIQLV--GMLRGIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIE 196
Query: 658 QDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY 714
            D   V T   G     + APE  +    T+  D++S+G+V+ E++  G R   P     
Sbjct: 197 DDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---PYWDMS 253
Query: 715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL 774
             D +K   E  RL            +  D    + Q+ + C QK    RP    +V +L
Sbjct: 254 NQDVIKAIEEGYRL-----------PAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302
Query: 775 QGLTK 779
             + +
Sbjct: 303 DKMIR 307

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 140/293 (47%), Gaps = 32/293 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + LE+LH   + ++
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQV 138
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  NILL  D +VK+ DFG    I  +QS  S M  GTP +MAPE+    +   K
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVTRKAYGPK 197
Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +DI+S G++ +E+I G     + NP    YL+ T                 + ++Q+   
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---------------NGTPELQNPEK 242
Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAT 797
            +         CL+ ++ +R SA  L++  Q L   +P++    L  A  EAT
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQ-HQFLKIAKPLSSLTPLIAAAKEAT 294

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 32/293 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + LE+LH   + ++
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQV 138
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH +IK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +   K
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 197
Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +DI+S G++ +E+I G     + NP    YL+ T                 + ++Q+   
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---------------NGTPELQNPEK 242
Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAT 797
            +         CL+ ++ +R SA  L++  Q L   +P++    L  A  EAT
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQ-HQFLKIAKPLSSLTPLIAAAKEAT 294

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 27/290 (9%)
Query: 498 SKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVE 552
           +K + ++    +  +G G  G V  G L    K    VA+K L  G  ++ +++FLSE  
Sbjct: 2   AKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 61
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
            +G   H N++ L G   +     ++ EYM NGSLD ++   D   T+   +   ++  I
Sbjct: 62  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV--GMLRGI 119
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
             G++YL D      +H D+  +NIL++ +L  K++DFG++R++  D     T   G   
Sbjct: 120 GSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 673 --YMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLC 729
             + APE       T+  D++S+G+V+ E++  G R   P       D +K   E  RL 
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER---PYWDMSNQDVIKAIEEGYRL- 232
Query: 730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                         D  + + Q+ + C QK    RP    +V +L  L +
Sbjct: 233 ----------PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+    N  TKVAVK + PG +   + FL+E   +  + H  LV+L     
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKII 628
            +   +++ E+M  GSL  ++   +  +     + K I F  QI+ G+ ++        I
Sbjct: 81  -KEPIYIITEFMAKGSLLDFLKSDEGSKQ---PLPKLIDFSAQIAEGMAFIEQR---NYI 133
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D++  NIL+   L  KIADFGLAR+I  ++       K    + APE     S T K 
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 689 DIYSFGVVILEIICGRRSSNP 709
           D++SFG++++EI+   R   P
Sbjct: 194 DVWSFGILLMEIVTYGRIPYP 214

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 108/226 (47%), Gaps = 20/226 (8%)
Query: 496 FSSKAMKSATRD----------FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
            SSK  K   +D           + +LG G  G V+    N  TKVAVK + PG +   +
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVE 228
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
            FL+E   +  + H  LV+L      +   +++ E+M  GSL  ++   +  +     + 
Sbjct: 229 AFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQ---PLP 284
Query: 606 KKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
           K I F  QI+ G+ ++        IH D++  NIL+   L  KIADFGLAR+I  ++   
Sbjct: 285 KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP 709
               K    + APE     S T K D++SFG++++EI+   R   P
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 140/293 (47%), Gaps = 32/293 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + LE+LH   + ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQV 137
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  NILL  D +VK+ DFG    I  +QS  S M  GTP +MAPE+    +   K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVTRKAYGPK 196
Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           +DI+S G++ +E+I G     + NP    YL+ T                 + ++Q+   
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---------------NGTPELQNPEK 241
Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVEAT 797
            +         CL+ ++ +R SA  L++  Q L   +P++    L  A  EAT
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ-HQFLKIAKPLSSLTPLIAAAKEAT 293

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 53/297 (17%)
Query: 512 LGRGGSGSVFEGLL--NDGT--KVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  GSV EG L   DGT  KVAVK  +L     R  +EFLSE   + +  H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 566 VGYCAERSNR-----FLVYEYMCNGSLDKWIFHKDRIQT----LSWDIRKKIIFQISRGL 616
           +G C E S++      ++  +M  G L  ++ +  R++T    +      K +  I+ G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVDIALGM 160
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPG 672
           EYL    N   +H D+  +N +L  D+ V +ADFGL++ I       Q  ++ MP     
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 214
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-------DYLVDTLKVKAEA 725
           ++A E       T+K D+++FGV + EI    R   P  G       DYL+   ++K   
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEI--ATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272
Query: 726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
           D L +L                   +I  SC + +   RP+ S+L   L+ L +  P
Sbjct: 273 DCLDELY------------------EIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 254
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 255 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 254
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 255 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 512 LGRGGSGSVFE----GLLNDGTK--VAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHK--DRIQTLSWDIRKKII---------FQ 611
            L+G C +     +V    C  G+L  ++  K  + +     D+ K  +         FQ
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           +++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D   V       P
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 672 -GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD 730
             +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRRL- 264
Query: 731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
              K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 265 ---KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+L G
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C E++   LV E+M +G L  ++  + +    + +    +   +  G+ YL + C   +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 688 IDIYSFGVVILEII 701
            D++SFGV++ E+ 
Sbjct: 186 SDVWSFGVLMWEVF 199

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
            LG G  G V  G       VAVK +  G +  + EF  E +T+  + H  LV+  G C+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    ++V EY+ NG L  ++  +   + L      ++ + +  G+ +L  +   + IH 
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N L+DRDL VK++DFG+ R +  DQ   S   K    + APE+      ++K D+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 691 YSFGVVILEII 701
           ++FG+++ E+ 
Sbjct: 189 WAFGILMWEVF 199

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 28/215 (13%)
Query: 507 DFQIRLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGK-------KEFLSEVETIGNIH 558
           +++ ++G+GG G V +G L+ D + VA+K L  G++ G+       +EF  EV  + N++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGL 616
           H N+V+L G         +V E++  G L    +H+  D+   + W ++ +++  I+ G+
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDL----YHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 617 EYLHDYCNPKIIHFDIKPQNIL---LDRDLNV--KIADFGLARLIAQDQSHVSTMPKGTP 671
           EY+ +  NP I+H D++  NI    LD +  V  K+ADFG     +Q   H  +   G  
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----TSQQSVHSVSGLLGNF 190
Query: 672 GYMAPEL--TRGNSITAKIDIYSFGVVILEIICGR 704
            +MAPE       S T K D YSF +++  I+ G 
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H        ++++K   I  Q +RG++YLH      II
Sbjct: 79  K--PQLAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  D  VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           + + D+Y+FG+V+ E++ G+   SN    D +++ +   +            S D+   R
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-----------LSPDLSKVR 239
Query: 744 DDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            +  K M ++   CL+K    RPS   ++  ++ L +
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 300
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 301 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 131/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D   V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 254
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 255 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 263
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 264 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 265
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 266 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 16/214 (7%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++V EY+  GSL   +     D  Q  +      +  +  + LE+LH   + ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQV 137
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH DIK  NILL  D +VK+ DFG    I  +QS  S M  GTP +MAPE+    +   K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM-VGTPYWMAPEVVTRKAYGPK 196
Query: 688 IDIYSFGVVILEIICGRR---SSNPKGGDYLVDT 718
           +DI+S G++ +E+I G     + NP    YL+ T
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 28/215 (13%)
Query: 507 DFQIRLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGK-------KEFLSEVETIGNIH 558
           +++ ++G+GG G V +G L+ D + VA+K L  G++ G+       +EF  EV  + N++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGL 616
           H N+V+L G         +V E++  G L    +H+  D+   + W ++ +++  I+ G+
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDL----YHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 617 EYLHDYCNPKIIHFDIKPQNIL---LDRDLNV--KIADFGLARLIAQDQSHVSTMPKGTP 671
           EY+ +  NP I+H D++  NI    LD +  V  K+ADF L    +Q   H  +   G  
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL----SQQSVHSVSGLLGNF 190
Query: 672 GYMAPEL--TRGNSITAKIDIYSFGVVILEIICGR 704
            +MAPE       S T K D YSF +++  I+ G 
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 134/291 (46%), Gaps = 39/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDRIQTLSW----DIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K R + + +    D+ K  +         
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D   V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 263
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 264 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGY 568
           +G GG G V+    + D   V   R  P E+  +  +    E +    + H N++ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
           C +  N  LV E+   G L++ +    RI     DI      QI+RG+ YLHD     II
Sbjct: 75  CLKEPNLCLVMEFARGGPLNR-VLSGKRIPP---DILVNWAVQIARGMNYLHDEAIVPII 130
Query: 629 HFDIKPQNILL-----DRDLN---VKIADFGLARLIAQDQSHVSTM--PKGTPGYMAPEL 678
           H D+K  NIL+     + DL+   +KI DFGLAR     + H +T     G   +MAPE+
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPEV 185
Query: 679 TRGNSITAKIDIYSFGVVILEIICGR 704
            R +  +   D++S+GV++ E++ G 
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+L G
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C E++   LV+E+M +G L  ++  + +    + +    +   +  G+ YL +     +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 688 IDIYSFGVVILEII 701
            D++SFGV++ E+ 
Sbjct: 185 SDVWSFGVLMWEVF 198

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 131/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D   V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 254
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 255 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 131/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D   V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 263
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 264 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 131/291 (45%), Gaps = 38/291 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGK-KEFLSEVETIGNI-HHFNLV 563
           LGRG  G V E    G+    T   VAVK L  G    + +  +SE++ + +I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 RLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDR----IQTLSWDIRKKII--------- 609
            L+G C +     +V    C  G+L  ++  K       +    D+ K  +         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D   V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 263
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 264 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLS-------EVETIGNIHHFNLV 563
           LG G  G V  G     G KVAVK L    NR K   L        E++ +    H +++
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL----NRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +L    +  S+ F+V EY+  G L  +I    R+        +++  QI  G++Y H + 
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE---SRRLFQQILSGVDYCHRHM 136
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
              ++H D+KP+N+LLD  +N KIADFGL+ +++  +    +   G+P Y APE+  G  
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC--GSPNYAAPEVISGRL 191
Query: 684 ITA-KIDIYSFGVVILEIICG 703
               ++DI+S GV++  ++CG
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 27/277 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
             + +  +    C GS    ++H        ++++K   I  Q +RG++YLH      II
Sbjct: 91  --APQLAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  D  VKI DFGLA   ++   SH      G+  +MAPE+ R    N  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           + + D+Y+FG+V+ E++ G+   SN    D +++ +   +            S D+   R
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-----------LSPDLSKVR 251
Query: 744 DDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            +  K M ++   CL+K    RPS   ++  ++ L +
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 136/299 (45%), Gaps = 29/299 (9%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKK 545
           N  V+  +K +  +    +  +G G  G V  G L    K    VA+K L  G   R ++
Sbjct: 3   NEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR 62
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           EFLSE   +G   H N++RL G         ++ E+M NG+LD ++   D   T+   + 
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV- 121
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSH 662
             ++  I+ G+ YL +      +H D+  +NIL++ +L  K++DFGL+R + +   D + 
Sbjct: 122 -GMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 663 VSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLK 720
            S++    P  + APE       T+  D +S+G+V+ E++  G R         +++ + 
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI- 236
Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                        ++   +    D    + Q+ + C QK+ + RP    +V  L  + +
Sbjct: 237 -------------EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 27/277 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H        ++++K   I  Q +RG++YLH      II
Sbjct: 91  K--PQLAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  D  VKI DFGLA   ++   SH      G+  +MAPE+ R    N  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           + + D+Y+FG+V+ E++ G+   SN    D +++ +   +            S D+   R
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-----------LSPDLSKVR 251
Query: 744 DDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            +  K M ++   CL+K    RPS   ++  ++ L +
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 129/278 (46%), Gaps = 29/278 (10%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L    K    VA+K L  G   R ++EFLSE   +G   H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G         ++ E+M NG+LD ++   D   T+   +   ++  I+ G+ YL +     
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV--GMLRGIASGMRYLAEM---S 136
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTP-GYMAPELTRGN 682
            +H D+  +NIL++ +L  K++DFGL+R + +   D ++ S++    P  + APE     
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 683 SITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
             T+  D +S+G+V+ E++  G R         +++ +              ++   +  
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI--------------EQDYRLPP 242
Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
             D    + Q+ + C QK+ + RP    +V  L  + +
Sbjct: 243 PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 29/278 (10%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V  G L    K    VA+K L  G   + +++FLSE   +G   H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G   + +   ++ E+M NGSLD ++   D   T+   +   ++  I+ G++YL D     
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV--GMLRGIAAGMKYLADM---N 129
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVSTMPKGTP-GYMAPELTRGN 682
            +H  +  +NIL++ +L  K++DFGL+R +  D S   + S +    P  + APE  +  
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 683 SITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
             T+  D++S+G+V+ E++  G R   P       D +    +  RL   +D  S     
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGER---PYWDMTNQDVINAIEQDYRLPPPMDCPS----- 241
Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                  + Q+ + C QK+ + RP    +V  L  + +
Sbjct: 242 ------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 155 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 267
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 268 PD---------PLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 31/281 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 262
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
            D          + ++ + C       RPS S LV  +  +
Sbjct: 263 PD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 263
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 264 PD---------PLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 263
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 264 PD---------PLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 125/290 (43%), Gaps = 35/290 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G VF           D   VAVK L    +  +K+F  E E + N+ H ++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWI----------FHKDRIQTLSWDIRKKIIFQISRG 615
            G C E     +V+EYM +G L+K++             +    L+      I  QI+ G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQSHVSTMPKGTPGYM 674
           + YL    +   +H D+  +N L+  +L VKI DFG++R + + D   V         +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 675 APELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVD 733
            PE       T + D++S GVV+ EI   G++       + +++ +              
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-------------- 243
Query: 734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
            +   +Q  R    ++ ++ + C Q+  H R +   +  +LQ L K  PV
Sbjct: 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 260
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 261 PD---------PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 20/203 (9%)
Query: 511 RLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV-- 563
           +LG+G  GSV    ++ L  N G  VAVK+L       +++F  E++ +  +H   +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIF--QISRGLEYLH 620
           R V Y   R +  LV EY+ +G L  ++  H+ R+     D  + +++  QI +G+EYL 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-----DASRLLLYSSQICKGMEYLG 144
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTP-GYMAPEL 678
              + + +H D+  +NIL++ + +VKIADFGLA+L+  D+  +V   P  +P  + APE 
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 679 TRGNSITAKIDIYSFGVVILEII 701
              N  + + D++SFGVV+ E+ 
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 31/281 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 321
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
            D          + ++ + C       RPS S LV  +  +
Sbjct: 322 PD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYP---------GENRGKKEFLSEVETIGNI 557
           DF++ LGRGG G VF   +      A  +LY           + +G +  + E + +  +
Sbjct: 189 DFRV-LGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRG 615
           H   +V L      +++  LV   M  G +   I++ D      +   + I +  QI  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSG 301
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE+LH      II+ D+KP+N+LLD D NV+I+D GLA  +   Q+       GTPG+MA
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMA 357
Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG 711
           PEL  G      +D ++ GV + E+I  R     +G
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 20/203 (9%)
Query: 511 RLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV-- 563
           +LG+G  GSV    ++ L  N G  VAVK+L       +++F  E++ +  +H   +V  
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIF--QISRGLEYLH 620
           R V Y   R +  LV EY+ +G L  ++  H+ R+     D  + +++  QI +G+EYL 
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-----DASRLLLYSSQICKGMEYLG 131
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTP-GYMAPEL 678
              + + +H D+  +NIL++ + +VKIADFGLA+L+  D+  +V   P  +P  + APE 
Sbjct: 132 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 679 TRGNSITAKIDIYSFGVVILEII 701
              N  + + D++SFGVV+ E+ 
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G+++L
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ---DQSHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +     D  H  T  K    +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 262
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 263 PD---------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 261
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 262 PD---------PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 20/203 (9%)
Query: 511 RLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV-- 563
           +LG+G  GSV    ++ L  N G  VAVK+L       +++F  E++ +  +H   +V  
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIF--QISRGLEYLH 620
           R V Y   R +  LV EY+ +G L  ++  H+ R+     D  + +++  QI +G+EYL 
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-----DASRLLLYSSQICKGMEYLG 132
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTP-GYMAPEL 678
              + + +H D+  +NIL++ + +VKIADFGLA+L+  D+  +V   P  +P  + APE 
Sbjct: 133 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 679 TRGNSITAKIDIYSFGVVILEII 701
              N  + + D++SFGVV+ E+ 
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYP---------GENRGKKEFLSEVETIGNI 557
           DF++ LGRGG G VF   +      A  +LY           + +G +  + E + +  +
Sbjct: 189 DFRV-LGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRG 615
           H   +V L      +++  LV   M  G +   I++ D      +   + I +  QI  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSG 301
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE+LH      II+ D+KP+N+LLD D NV+I+D GLA  +   Q+       GTPG+MA
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMA 357
Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG 711
           PEL  G      +D ++ GV + E+I  R     +G
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYP---------GENRGKKEFLSEVETIGNI 557
           DF++ LGRGG G VF   +      A  +LY           + +G +  + E + +  +
Sbjct: 189 DFRV-LGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRG 615
           H   +V L      +++  LV   M  G +   I++ D      +   + I +  QI  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSG 301
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE+LH      II+ D+KP+N+LLD D NV+I+D GLA  +   Q+       GTPG+MA
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMA 357
Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG 711
           PEL  G      +D ++ GV + E+I  R     +G
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 257
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 258 PD---------PLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 262
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 263 PD---------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYP---------GENRGKKEFLSEVETIGNI 557
           DF++ LGRGG G VF   +      A  +LY           + +G +  + E + +  +
Sbjct: 189 DFRV-LGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRG 615
           H   +V L      +++  LV   M  G +   I++ D      +   + I +  QI  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSG 301
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE+LH      II+ D+KP+N+LLD D NV+I+D GLA  +   Q+       GTPG+MA
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMA 357
Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG 711
           PEL  G      +D ++ GV + E+I  R     +G
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 261
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 262 PD---------PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 260
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 261 PD---------PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 140
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 201 KSDIWAFGVLMWEI 214

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 262
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 263 PD---------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 169 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 281
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 282 PD---------PLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 100/184 (54%), Gaps = 20/184 (10%)
Query: 528 GTKVAVKRLYPGENRGKKEFLS-------EVETIGNIHHFNLVRLVGYCAERSNRFLVYE 580
           G KVAVK L    NR K   L        E++ +    H ++++L    +  ++ F+V E
Sbjct: 36  GHKVAVKIL----NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD 640
           Y+  G L  +I    R++ +     +++  QI   ++Y H +    ++H D+KP+N+LLD
Sbjct: 92  YVSGGELFDYICKHGRVEEME---ARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLD 145
Query: 641 RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILE 699
             +N KIADFGL+ +++  +   ++   G+P Y APE+  G      ++DI+S GV++  
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 700 IICG 703
           ++CG
Sbjct: 204 LLCG 207

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 168 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 280
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 281 PD---------PLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 142 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 254
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 255 PD---------PLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 508 FQIRLGRGGSGSVFEGLL--NDGTKV--AVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L  NDG K+  AVK L    + G+  +FL+E   + +  H N+
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 563 VRLVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYL 619
           + L+G C     +  +V  YM +G L  +I    R +T +  ++  I F  Q+++G++YL
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAP 676
               + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA 
Sbjct: 147 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +    T K D++SFGV++ E++   R + P       D      +  RL  L  +  
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRL--LQPEYC 259
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
            D          + ++ + C       RPS S LV
Sbjct: 260 PD---------PLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 20/184 (10%)
Query: 528 GTKVAVKRLYPGENRGKKEFLS-------EVETIGNIHHFNLVRLVGYCAERSNRFLVYE 580
           G KVAVK L    NR K   L        E++ +    H ++++L    +  ++ F+V E
Sbjct: 36  GHKVAVKIL----NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD 640
           Y+  G L  +I    R++ +     +++  QI   ++Y H +    ++H D+KP+N+LLD
Sbjct: 92  YVSGGELFDYICKHGRVEEME---ARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLD 145
Query: 641 RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILE 699
             +N KIADFGL+ +++  +    +   G+P Y APE+  G      ++DI+S GV++  
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRDSC--GSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 700 IICG 703
           ++CG
Sbjct: 204 LLCG 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 140
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 201 KSDIWAFGVLMWEI 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 124
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 185 KSDIWAFGVLMWEI 198

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 17/228 (7%)
Query: 506 RDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH---- 558
            DF++   LG+G    V+    ++ G +VA+K +   +   K   +  V+    IH    
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           H +++ L  Y  + +  +LV E   NG +++++  K+R++  S +  +  + QI  G+ Y
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLY 127
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL 678
           LH +    I+H D+   N+LL R++N+KIADFGLA  +        T+  GTP Y++PE+
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEI 183
Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
              ++   + D++S G +   ++ GR    P   D + +TL     AD
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRP---PFDTDTVKNTLNKVVLAD 228

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 125
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 186 KSDIWAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 78  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 131
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 192 KSDIWAFGVLMWEI 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 120
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 181 KSDIWAFGVLMWEI 194

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 118/250 (47%), Gaps = 33/250 (13%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG--- 567
           +G GG G VF+     DG    +KR+     + ++E    V+ +  + H N+V   G   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWD 74
Query: 568 ---YCAERSNR----------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR 614
              Y  E S++          F+  E+   G+L++WI  K R + L   +  ++  QI++
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           G++Y+H   + K+I+ D+KP NI L     VKI DFGL   +  D     +  KGT  YM
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KGTLRYM 188
Query: 675 APELTRGNSITAKIDIYSFGVVILEI--ICGRRSSNPKG----GDYLVDTLKVKAEADRL 728
           +PE         ++D+Y+ G+++ E+  +C       K      D ++  +  K E   L
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLL 248
Query: 729 CDLVDKKSED 738
             L+ KK ED
Sbjct: 249 QKLLSKKPED 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           F   LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
            C ++   F++ EYM NG L  ++   + R QT       ++   +   +EYL    + +
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLE---SKQ 125
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 687 KIDIYSFGVVILEI 700
           K DI++FGV++ EI
Sbjct: 186 KSDIWAFGVLMWEI 199

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G + K       +Q LS +D ++  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYK------ELQKLSKFDEQRTA 116
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL 171
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 172 C-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 123/256 (48%), Gaps = 23/256 (8%)
Query: 530 KVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD 588
           KVA+KR+   +      E L E++ +   HH N+V        +   +LV + +  GS+ 
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 589 KWIFH-----KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL 643
             I H     + +   L       I+ ++  GLEYLH       IH D+K  NILL  D 
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 644 NVKIADFGLARLIAQ----DQSHVSTMPKGTPGYMAPEL---TRGNSITAKIDIYSFGVV 696
           +V+IADFG++  +A      ++ V     GTP +MAPE+    RG    A  DI+SFG+ 
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA--DIWSFGIT 211
Query: 697 ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC 756
            +E+  G    + K     V  L ++ +   L   V  K E ++ +     KMI +   C
Sbjct: 212 AIELATGAAPYH-KYPPMKVLMLTLQNDPPSLETGVQDK-EMLKKYGKSFRKMISL---C 266
Query: 757 LQKNLHRRPSASMLVK 772
           LQK+  +RP+A+ L++
Sbjct: 267 LQKDPEKRPTAAELLR 282

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 111/203 (54%), Gaps = 20/203 (9%)
Query: 511 RLGRGGSGSV----FEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV-- 563
           +LG+G  GSV    ++ L  N G  VAVK+L       +++F  E++ +  +H   +V  
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIF--QISRGLEYLH 620
           R V Y   R    LV EY+ +G L  ++  H+ R+     D  + +++  QI +G+EYL 
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL-----DASRLLLYSSQICKGMEYLG 128
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTP-GYMAPEL 678
                + +H D+  +NIL++ + +VKIADFGLA+L+  D+   V   P  +P  + APE 
Sbjct: 129 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 679 TRGNSITAKIDIYSFGVVILEII 701
              N  + + D++SFGVV+ E+ 
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELF 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
             + +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 75  --APQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKK--SEDMQS 741
           + + D+Y+FG+V+ E++ G+   SN                 D++  +V +   S D+  
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNIN-------------NRDQIIFMVGRGYLSPDLSK 233
Query: 742 HRDDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            R +  K M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 123/256 (48%), Gaps = 23/256 (8%)
Query: 530 KVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD 588
           KVA+KR+   +      E L E++ +   HH N+V        +   +LV + +  GS+ 
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 589 KWIFH-----KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL 643
             I H     + +   L       I+ ++  GLEYLH       IH D+K  NILL  D 
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 644 NVKIADFGLARLIAQ----DQSHVSTMPKGTPGYMAPEL---TRGNSITAKIDIYSFGVV 696
           +V+IADFG++  +A      ++ V     GTP +MAPE+    RG    A  DI+SFG+ 
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA--DIWSFGIT 216
Query: 697 ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC 756
            +E+  G    + K     V  L ++ +   L   V  K E ++ +     KMI +   C
Sbjct: 217 AIELATGAAPYH-KYPPMKVLMLTLQNDPPSLETGVQDK-EMLKKYGKSFRKMISL---C 271
Query: 757 LQKNLHRRPSASMLVK 772
           LQK+  +RP+A+ L++
Sbjct: 272 LQKDPEKRPTAAELLR 287

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 80  K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKK--SEDMQS 741
           + + D+Y+FG+V+ E++ G+   SN                 D++  +V +   S D+  
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNIN-------------NRDQIIFMVGRGYLSPDLSK 238
Query: 742 HRDDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            R +  K M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 239 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 510 IRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLV 563
           +RL + G GS  + +L     DG +  +K +      ++ ++E   EV  + N+ H N+V
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-------FHKDRIQTLSWDIRKKIIFQISRGL 616
           +      E  + ++V +Y   G L K I       F +D+I  L W +      QI   L
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFV------QICLAL 138
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           +++HD    KI+H DIK QNI L +D  V++ DFG+AR++      ++    GTP Y++P
Sbjct: 139 KHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSP 194
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E+        K DI++ G V+ E+
Sbjct: 195 EICENKPYNNKSDIWALGCVLYEL 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++G+     +  K+ V      E  G K   EF+ E   + ++ H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + LV + M +G L +++  HKD I +   L+W +      QI++G+ YL +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV------QIAKGMMYLEE 158
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLARL+  D+   +      P  +MA E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV I E++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELM 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 75  K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKK--SEDMQS 741
           + + D+Y+FG+V+ E++ G+   SN                 D++  +V +   S D+  
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNIN-------------NRDQIIFMVGRGYLSPDLSK 233
Query: 742 HRDDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            R +  K M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 77  K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 128
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKK--SEDMQS 741
           + + D+Y+FG+V+ E++ G+   SN                 D++  +V +   S D+  
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNIN-------------NRDQIIFMVGRGYLSPDLSK 235
Query: 742 HRDDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            R +  K M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 236 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 277

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 80  K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKK--SEDMQS 741
           + + D+Y+FG+V+ E++ G+   SN                 D++  +V +   S D+  
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNIN-------------NRDQIIFMVGRGYLSPDLSK 238
Query: 742 HRDDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            R +  K M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 239 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
           +G G  G V +    D G  VA+K+    ++    KK  + E++ +  + H NLV L+  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
           C ++   +LV+E++ +  LD      +    L + + +K +FQI  G+ + H +    II
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK- 687
           H DIKP+NIL+ +   VK+ DFG AR +A     V      T  Y APEL  G+    K 
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 688 IDIYSFGVVILEIICGR 704
           +D+++ G ++ E+  G 
Sbjct: 206 VDVWAIGCLVTEMFMGE 222

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++G+     +  K+ V      E  G K   EF+ E   + ++ H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + LV + M +G L +++  HKD I +   L+W +      QI++G+ YL +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV------QIAKGMMYLEE 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLARL+  D+   +      P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV I E++
Sbjct: 193 YRKFTHQSDVWSYGVTIWELM 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V + ++        + F +EV  +    H N++  +GY  
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
            + N  +V ++ C GS    ++    +Q   + + +   I  Q ++G++YLH      II
Sbjct: 103 -KDNLAIVTQW-CEGSS---LYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNII 154
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L   L VKI DFGLA + ++   S     P G+  +MAPE+ R    N  
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 685 TAKIDIYSFGVVILEIICG 703
           + + D+YS+G+V+ E++ G
Sbjct: 215 SFQSDVYSYGIVLYELMTG 233

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 496 FSSKAMKSATRD----------FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
            SSK  K   +D           + +LG G  G V+    N  TKVAVK + PG +   +
Sbjct: 164 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVE 222
Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
            FL+E   +  + H  LV+L      +   +++ E+M  GSL  ++   +  +     + 
Sbjct: 223 AFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQ---PLP 278
Query: 606 KKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
           K I F  QI+ G+ ++        IH D++  NIL+   L  KIADFGLAR+ A      
Sbjct: 279 KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVGA------ 329
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP 709
               K    + APE     S T K D++SFG++++EI+   R   P
Sbjct: 330 ----KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 371

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 102 K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 153
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 685 TAKIDIYSFGVVILEIICGR 704
           + + D+Y+FG+V+ E++ G+
Sbjct: 214 SFQSDVYAFGIVLYELMTGQ 233

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/311 (28%), Positives = 136/311 (43%), Gaps = 50/311 (16%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL-VS 154
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 207
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 265
Query: 723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            E  R+    +  +E     RD           C      +RP+   LV+ L  +  L  
Sbjct: 266 KEGHRMDKPSNCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRIVALTS 314
Query: 783 VTDYGFLSFAV 793
             +Y  LS  +
Sbjct: 315 NQEYLDLSMPL 325

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 103 K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R    N  
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 685 TAKIDIYSFGVVILEIICGR 704
           + + D+Y+FG+V+ E++ G+
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G + K       +Q LS +D ++  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYK------ELQKLSKFDEQRTA 116
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S     
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXX 170
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 171 LXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++  G+    +E    ++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 84  SSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGA 197
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 131/298 (43%), Gaps = 50/298 (16%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL-VS 195
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 248
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 306
Query: 723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
            E  R+    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 307 KEGHRMDKPSNCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 113/217 (52%), Gaps = 21/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSE 550
            SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   E
Sbjct: 16  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKII 609
           VE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTAT 129
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+ 
Sbjct: 130 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLC 184
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 185 -GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL-VS 154
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXXK 207
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 265
Query: 723 AEADRL 728
            E  R+
Sbjct: 266 KEGHRM 271

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 113/217 (52%), Gaps = 21/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSE 550
            SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   E
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKII 609
           VE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTAT 138
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+ 
Sbjct: 139 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL- 192
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTA 114
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL 169
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 170 C-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSV-FEGLLNDGTKVAVK-----RLYPGENRGKKEFL 548
           SS A  +   ++QI   LG G  G V        G KVA+K      L   + +G+ E  
Sbjct: 4   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE-- 61
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
            E+  +  + H ++++L      +    +V EY  N   D +I  +D+   +S    ++ 
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRF 117
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             QI   +EY H +   KI+H D+KP+N+LLD  LNVKIADFGL+  I  D + + T   
Sbjct: 118 FQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKT-SC 172
Query: 669 GTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICGR 704
           G+P Y APE+  G      ++D++S GV++  ++C R
Sbjct: 173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSV-FEGLLNDGTKVAVK-----RLYPGENRGKKEFL 548
           SS A  +   ++QI   LG G  G V        G KVA+K      L   + +G+ E  
Sbjct: 5   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE-- 62
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
            E+  +  + H ++++L      +    +V EY  N   D +I  +D+   +S    ++ 
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRF 118
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             QI   +EY H +   KI+H D+KP+N+LLD  LNVKIADFGL+  I  D + + T   
Sbjct: 119 FQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKT-SC 173
Query: 669 GTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICGR 704
           G+P Y APE+  G      ++D++S GV++  ++C R
Sbjct: 174 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTA 116
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL 171
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 172 C-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 24/200 (12%)
Query: 516 GSGSVFEGLLNDGTK----VAVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGYCA 570
           G+G+  E +L +  +    VA+K +      GK+  +  E+  +  I H N+V L     
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 86
Query: 571 ERSNRFLVYEYMCNGSL-DKWI---FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
              + +L+ + +  G L D+ +   F+ +R  +       ++IFQ+   ++YLHD     
Sbjct: 87  SGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHDLG--- 136
Query: 627 IIHFDIKPQNIL---LDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           I+H D+KP+N+L   LD D  + I+DFGL+++  +D   V +   GTPGY+APE+     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 684 ITAKIDIYSFGVVILEIICG 703
            +  +D +S GV+   ++CG
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 75  K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA   ++   SH      G+  +MAPE+ R    N  
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 685 TAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADRLCDLVDKK--SEDMQS 741
           + + D+Y+FG+V+ E++ G+   SN                 D++  +V +   S D+  
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINN-------------RDQIIFMVGRGYLSPDLSK 233
Query: 742 HRDDAVK-MIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
            R +  K M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 46/263 (17%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG--- 567
           +G GG G VF+     DG    ++R+     + ++E    V+ +  + H N+V   G   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWD 75
Query: 568 ---YCAERSNR-----------------------FLVYEYMCNGSLDKWIFHKDRIQTLS 601
              Y  E S+                        F+  E+   G+L++WI  K R + L 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLD 134
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
             +  ++  QI++G++Y+H   + K+IH D+KP NI L     VKI DFGL   +  D  
Sbjct: 135 KVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI--ICGRRSSNPKG----GDYL 715
              T  KGT  YM+PE         ++D+Y+ G+++ E+  +C       K      D +
Sbjct: 192 R--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI 249
Query: 716 VDTLKVKAEADRLCDLVDKKSED 738
           +  +  K E   L  L+ KK ED
Sbjct: 250 ISDIFDKKEKTLLQKLLSKKPED 272

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL-VS 147
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 148 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 200
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 258
Query: 723 AEADRL 728
            E  R+
Sbjct: 259 KEGHRM 264

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL-VS 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 147 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 199
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 257
Query: 723 AEADRL 728
            E  R+
Sbjct: 258 KEGHRM 263

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL-VS 154
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 207
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 265
Query: 723 AEADRL 728
            E  R+
Sbjct: 266 KEGHRM 271

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL-VS 154
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 207
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 265
Query: 723 AEADRL 728
            E  R+
Sbjct: 266 KEGHRM 271

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTA 114
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL 169
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 170 C-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL-VS 139
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 140 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 192
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 250
Query: 723 AEADRL 728
            E  R+
Sbjct: 251 KEGHRM 256

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 115/246 (46%), Gaps = 39/246 (15%)
Query: 512 LGRGGSGSVFE----GLLNDG----TKVAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      GL  D     TKVAVK L      +   + +SE+E +  I  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--------------FHKDRIQTLSWDIRKK 607
           ++ L+G C +    +++ EY   G+L +++               H    Q  S D+   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL-VS 143
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL    + K IH D+  +N+L+  D  +KIADFGLAR    D  H+    
Sbjct: 144 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 196
Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           K T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+ 
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELFKLL 254
Query: 723 AEADRL 728
            E  R+
Sbjct: 255 KEGHRM 260

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 24/200 (12%)
Query: 516 GSGSVFEGLLNDGTK----VAVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGYCA 570
           G+G+  E +L +  +    VA+K +      GK+  +  E+  +  I H N+V L     
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 86
Query: 571 ERSNRFLVYEYMCNGSL-DKWI---FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
              + +L+ + +  G L D+ +   F+ +R  +       ++IFQ+   ++YLHD     
Sbjct: 87  SGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHDL---G 136
Query: 627 IIHFDIKPQNIL---LDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           I+H D+KP+N+L   LD D  + I+DFGL+++  +D   V +   GTPGY+APE+     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 684 ITAKIDIYSFGVVILEIICG 703
            +  +D +S GV+   ++CG
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 512 LGRGGSGSVFEG--LLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHF---NLVR 564
           +G G  G VF+   L N G  VA+KR+    GE       + EV  + ++  F   N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 565 LVGYC-AERSNR----FLVYEYMCNGSLDKWIFHKDRIQT--LSWDIRKKIIFQISRGLE 617
           L   C   R++R     LV+E++ +  L  ++   D++    +  +  K ++FQ+ RGL+
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +LH +   +++H D+KPQNIL+     +K+ADFGLAR+ +   +  S +   T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPE 189
Query: 678 LTRGNSITAKIDIYSFGVVILEII----CGRRSSNPKGGDYLVDTLKVKAEAD 726
           +   +S    +D++S G +  E+       R SS+      ++D + +  E D
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 24/200 (12%)
Query: 516 GSGSVFEGLLNDGTK----VAVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGYCA 570
           G+G+  E +L +  +    VA+K +      GK+  +  E+  +  I H N+V L     
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 86
Query: 571 ERSNRFLVYEYMCNGSL-DKWI---FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
              + +L+ + +  G L D+ +   F+ +R  +       ++IFQ+   ++YLHD     
Sbjct: 87  SGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHDL---G 136
Query: 627 IIHFDIKPQNIL---LDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           I+H D+KP+N+L   LD D  + I+DFGL+++  +D   V +   GTPGY+APE+     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 684 ITAKIDIYSFGVVILEIICG 703
            +  +D +S GV+   ++CG
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V        G KVA+K      L   + +G+ E   E+  +  + H ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                 +    +V EY  N   D +I  +D+   +S    ++   QI   +EY H +   
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYCHRH--- 122
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           KI+H D+KP+N+LLD  LNVKIADFGL+  I  D + + T   G+P Y APE+  G    
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKT-SCGSPNYAAPEVISGKLYA 180
Query: 686 A-KIDIYSFGVVILEIICGR 704
             ++D++S GV++  ++C R
Sbjct: 181 GPEVDVWSCGVILYVMLCRR 200

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 103 K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA   ++   SH      G+  +MAPE+ R    N  
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 685 TAKIDIYSFGVVILEIICGR 704
           + + D+Y+FG+V+ E++ G+
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 112/216 (51%), Gaps = 21/216 (9%)
Query: 498 SKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEV 551
           SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EV
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF 610
           E   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATY 114
Query: 611 --QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S   T+  
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLC- 168
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 512 LGRGGSGSVF---EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G  G V    + +      V V      +N+     L EVE +  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             + S+ ++V E    G L   I  + R    S     +II Q+  G+ Y+H +    I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 629 HFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           H D+KP+NILL   ++D ++KI DFGL+    Q+      +  GT  Y+APE+ RG +  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYD 200
Query: 686 AKIDIYSFGVVILEIICG 703
            K D++S GV++  ++ G
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +G+G  G V  G    G KVAVK +    +   + FL+E   +  + H NLV+L+G   E
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 572 -RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
            +   ++V EYM  GSL  ++  + R   L  D   K    +   +EYL        +H 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N+L+  D   K++DFGL +    + S      K    + APE  R    + K D+
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 691 YSFGVVILEIICGRRSSNPK 710
           +SFG+++ EI    R   P+
Sbjct: 370 WSFGILLWEIYSFGRVPYPR 389

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++  +GY  
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDYCNPKII 628
           +   +  +    C GS    ++H   I    +++ K   I  Q ++G++YLH      II
Sbjct: 95  K--PQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 146
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTR---GNSI 684
           H D+K  NI L  DL VKI DFGLA   ++   SH      G+  +MAPE+ R    N  
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 685 TAKIDIYSFGVVILEIICGR 704
           + + D+Y+FG+V+ E++ G+
Sbjct: 207 SFQSDVYAFGIVLYELMTGQ 226

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V        G KVA+K      L   + +G+ E   E+  +  + H ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                 +    +V EY  N   D +I  +D+   +S    ++   QI   +EY H +   
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYCHRH--- 126
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           KI+H D+KP+N+LLD  LNVKIADFGL+  I  D + + T   G+P Y APE+  G    
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKT-SCGSPNYAAPEVISGKLYA 184
Query: 686 A-KIDIYSFGVVILEIICGR 704
             ++D++S GV++  ++C R
Sbjct: 185 GPEVDVWSCGVILYVMLCRR 204

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 24/200 (12%)
Query: 516 GSGSVFEGLLNDGTK----VAVKRLYPGENRGKKEFLS-EVETIGNIHHFNLVRLVGYCA 570
           G+G+  E +L +  +    VA+K +      GK+  +  E+  +  I H N+V L     
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 86
Query: 571 ERSNRFLVYEYMCNGSL-DKWI---FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
              + +L+ + +  G L D+ +   F+ +R  +       ++IFQ+   ++YLHD     
Sbjct: 87  SGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHDL---G 136
Query: 627 IIHFDIKPQNIL---LDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           I+H D+KP+N+L   LD D  + I+DFGL+++  +D   V +   GTPGY+APE+     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 684 ITAKIDIYSFGVVILEIICG 703
            +  +D +S GV+   ++CG
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +G+G  G V  G    G KVAVK +    +   + FL+E   +  + H NLV+L+G   E
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 572 -RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
            +   ++V EYM  GSL  ++  + R   L  D   K    +   +EYL        +H 
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 132
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N+L+  D   K++DFGL +    + S      K    + APE  R  + + K D+
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 691 YSFGVVILEIICGRRSSNPK 710
           +SFG+++ EI    R   P+
Sbjct: 189 WSFGILLWEIYSFGRVPYPR 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSE 550
            SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKII 609
           VE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTAT 117
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+ 
Sbjct: 118 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLC 172
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            GT  Y+ PE   G     K+D++S GV+  E + G+
Sbjct: 173 -GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 526 NDGTKVAVKRL-YPGENRGKKEFL-SEVETIGNIHHFNLVRLVGYCAERSNR--FLVYEY 581
           +DG  +  K L Y      +K+ L SEV  +  + H N+VR      +R+N   ++V EY
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 582 MCNGSLDKWIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP--KIIHFDIKPQNI 637
              G L   I    K+R Q L  +   +++ Q++  L+  H   +    ++H D+KP N+
Sbjct: 89  CEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 638 LLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVI 697
            LD   NVK+ DFGLAR++  D S   T   GTP YM+PE     S   K DI+S G ++
Sbjct: 148 FLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 698 LEI 700
            E+
Sbjct: 207 YEL 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 499 KAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVE 552
           K  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF- 610
              ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYI 115
Query: 611 -QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
            +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   G
Sbjct: 116 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSG 169
Query: 670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           T  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +G+G  G V  G    G KVAVK +    +   + FL+E   +  + H NLV+L+G   E
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 572 -RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
            +   ++V EYM  GSL  ++  + R   L  D   K    +   +EYL        +H 
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N+L+  D   K++DFGL +    + S      K    + APE  R    + K D+
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 691 YSFGVVILEIICGRRSSNPK 710
           +SFG+++ EI    R   P+
Sbjct: 198 WSFGILLWEIYSFGRVPYPR 217

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 21/216 (9%)
Query: 498 SKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEV 551
           SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EV
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF 610
           E   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATY 114
Query: 611 --QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLC 168
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++  G+    +E    ++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 197
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 512 LGRGGSGSVFEG--LLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHF---NLVR 564
           +G G  G VF+   L N G  VA+KR+    GE       + EV  + ++  F   N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 565 LVGYC-AERSNR----FLVYEYMCNGSLDKWIFHKDRIQT--LSWDIRKKIIFQISRGLE 617
           L   C   R++R     LV+E++ +  L  ++   D++    +  +  K ++FQ+ RGL+
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +LH +   +++H D+KPQNIL+     +K+ADFGLAR+ +   +  S +   T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPE 189
Query: 678 LTRGNSITAKIDIYSFGVVILEII----CGRRSSNPKGGDYLVDTLKVKAEAD 726
           +   +S    +D++S G +  E+       R SS+      ++D + +  E D
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 21/216 (9%)
Query: 498 SKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEV 551
           SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EV
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF 610
           E   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATY 118
Query: 611 --QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   
Sbjct: 119 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLC 172
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 122/239 (51%), Gaps = 31/239 (12%)
Query: 512 LGRGGSGSVFEGLLNDGTK-VAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL----- 565
           LG GG+G VF  + ND  K VA+K++   + +  K  L E++ I  + H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 566 ---------VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
                    VG   E ++ ++V EYM    L   +     ++  +    +  ++Q+ RGL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHA----RLFMYQLLRGL 133
Query: 617 EYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPKG--TPGY 673
           +Y+H   +  ++H D+KP N+ ++  DL +KI DFGLAR++    SH   + +G  T  Y
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 674 MAPELTRG-NSITAKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADR 727
            +P L    N+ T  ID+++ G +  E++ G+     +   +    +++++ V  E DR
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +G+G  G V  G    G KVAVK +    +   + FL+E   +  + H NLV+L+G   E
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 572 -RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
            +   ++V EYM  GSL  ++  + R   L  D   K    +   +EYL        +H 
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 126
Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N+L+  D   K++DFGL +    + S      K    + APE  R    + K D+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 691 YSFGVVILEIICGRRSSNPK 710
           +SFG+++ EI    R   P+
Sbjct: 183 WSFGILLWEIYSFGRVPYPR 202

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++  G+    +E    ++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 197
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 512 LGRGGSGSVFEG--LLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHF---NLVR 564
           +G G  G VF+   L N G  VA+KR+    GE       + EV  + ++  F   N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 565 LVGYC-AERSNR----FLVYEYMCNGSLDKWIFHKDRIQT--LSWDIRKKIIFQISRGLE 617
           L   C   R++R     LV+E++ +  L  ++   D++    +  +  K ++FQ+ RGL+
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +LH +   +++H D+KPQNIL+     +K+ADFGLAR+ +   +  S +   T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPE 189
Query: 678 LTRGNSITAKIDIYSFGVVILEII----CGRRSSNPKGGDYLVDTLKVKAEAD 726
           +   +S    +D++S G +  E+       R SS+      ++D + +  E D
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 512 LGRGGSGSVF---EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G  G V    + +      V V      +N+     L EVE +  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             + S+ ++V E    G L   I  + R    S     +II Q+  G+ Y+H +    I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 629 HFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           H D+KP+NILL   ++D ++KI DFGL+    Q+      +  GT  Y+APE+ RG +  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYD 200
Query: 686 AKIDIYSFGVVILEIICG 703
            K D++S GV++  ++ G
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 512 LGRGGSGSVF---EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G  G V    + +      V V      +N+     L EVE +  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             + S+ ++V E    G L   I  + R    S     +II Q+  G+ Y+H +    I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 629 HFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           H D+KP+NILL   ++D ++KI DFGL+    Q+      +  GT  Y+APE+ RG +  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYD 200
Query: 686 AKIDIYSFGVVILEIICG 703
            K D++S GV++  ++ G
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 8/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 196 LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 251
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   N  +++ D+K +N++LD+D ++KI DFGL +   +D + + T 
Sbjct: 252 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 310 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 117
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 175
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGA 231
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 8/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 199 LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 254
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   N  +++ D+K +N++LD+D ++KI DFGL +   +D + + T 
Sbjct: 255 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 313 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 113/217 (52%), Gaps = 21/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSE 550
            SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   E
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKII 609
           VE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTAT 114
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  +++  L Y H   + ++IH DIKP+N+LL     +KIA+FG +  +    S  +T+ 
Sbjct: 115 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLC 169
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 170 -GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSE 550
            SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   E
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKII 609
           VE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTAT 114
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S      
Sbjct: 115 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXL 168
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 111
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 112 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 169
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 170 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 225
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 272

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 83
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGAT 198
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTA 114
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIA+FG +  +    S  +T+
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTL 169
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 170 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+  GT  Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL-CGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 117
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 175
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 231
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 91
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 149
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 150 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGAT 206
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 252

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 102
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 160
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 161 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGAT 217
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 263

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 88
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 89  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 146
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 147 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 202
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 249

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+     N    +A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + K+IH DIKP+N+LL     +KIADFG +  +    S  + +  GT  Y+
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAAL-CGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 121
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 122 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 179
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 180 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 235
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 282

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 119
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 120 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 177
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 178 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 233
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 280

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 95
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 96  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 153
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 154 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGA 209
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 95
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 96  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 153
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 154 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGA 209
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 256

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 84
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 142
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 143 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGAT 199
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 245

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 87
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 88  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 145
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 146 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGA 201
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 248

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 83
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGAT 198
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 162
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
              E+ +     LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H + 
Sbjct: 163 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 220
Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G 
Sbjct: 221 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGA 276
Query: 683 S-ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
           +  T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 323

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 123
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+  GT  Y+
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL-CGTLDYL 177
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 116/226 (51%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL-VGYC 569
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 83
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDR-----IQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +    + +VY  +    + + ++   R      QTL     K  ++Q+ R L Y+H +  
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--CSRYYRAPELIFGAT 198
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   GT  Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 118
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  +T+  GT  Y+
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTL-CGTLDYL 172
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 21/218 (9%)
Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLS 549
             SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKI 608
           EVE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTA 114
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S     
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXX 168
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 96
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 154
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 155 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGAT 211
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 212 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 257

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 21/217 (9%)
Query: 497 SSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSE 550
            SK  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   E
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKII 609
           VE   ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTAT 138
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S    + 
Sbjct: 139 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDL- 192
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            GT  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 499 KAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVE 552
           K  + A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF- 610
              ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   + 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYI 114
Query: 611 -QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
            +++  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   G
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCG 168
Query: 670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           T  Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 93/183 (50%), Gaps = 10/183 (5%)
Query: 526 NDGTKVAVKRL-YPGENRGKKEFL-SEVETIGNIHHFNLVRLVGYCAERSNR--FLVYEY 581
           +DG  +  K L Y      +K+ L SEV  +  + H N+VR      +R+N   ++V EY
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 582 MCNGSLDKWIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP--KIIHFDIKPQNI 637
              G L   I    K+R Q L  +   +++ Q++  L+  H   +    ++H D+KP N+
Sbjct: 89  CEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 638 LLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVI 697
            LD   NVK+ DFGLAR++  D S       GTP YM+PE     S   K DI+S G ++
Sbjct: 148 FLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 698 LEI 700
            E+
Sbjct: 207 YEL 209

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTK---VAVKRLYPG--ENRG-KKEFLSEVETIG 555
           A  DF+I   LG+G  G+V+  L  +  +   +A+K L+    E  G + +   EVE   
Sbjct: 3   ALEDFEIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QI 612
           ++ H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  ++
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITEL 114
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
           +  L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   GT  
Sbjct: 115 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLD 168
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V      + G +VAVK++   + + ++   +EV  + + HH N+V +   
Sbjct: 51  IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFH----KDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
                  ++V E++  G+L   + H    +++I T        +   + R L YLH   N
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--------VCLSVLRALSYLH---N 159
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             +IH DIK  +ILL  D  +K++DFG    ++++      +  GTP +MAPE+      
Sbjct: 160 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL-VGTPYWMAPEVISRLPY 218
Query: 685 TAKIDIYSFGVVILEIICG 703
             ++DI+S G++++E+I G
Sbjct: 219 GTEVDIWSLGIMVIEMIDG 237

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   GT  Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY-- 568
           +G G  G V++  L D G  VA+K++   + R K     E++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 83
Query: 569 -CAERSNRF---LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
              E+ +     LV +Y+          +    QTL     K  ++Q+ R L Y+H +  
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 625 PKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
             I H DIKPQN+LLD D  V K+ DFG A+ + + + +VS +   +  Y APEL  G +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAPELIFGAT 198
Query: 684 -ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
             T+ ID++S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +       S   T   GT  Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 89/156 (57%), Gaps = 10/156 (6%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E+  +  + H ++++L       ++  +V EY   G L  +I  K R   ++ D  ++  
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFF 114
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
            QI   +EY H +   KI+H D+KP+N+LLD +LNVKIADFGL+ ++  D + + T   G
Sbjct: 115 QQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKT-SCG 169
Query: 670 TPGYMAPELTRGNSITA-KIDIYSFGVVILEIICGR 704
           +P Y APE+  G      ++D++S G+V+  ++ GR
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 110/218 (50%), Gaps = 39/218 (17%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSE--VETIGNIHHFNLVR-LVG- 567
           +GRG  G+V++G L D   VAVK ++   NR  + F++E  +  +  + H N+ R +VG 
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVK-VFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 568 ---YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH---- 620
                  R    LV EY  NGSL K++     + T  W    ++   ++RGL YLH    
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 621 --DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA------RLI---AQDQSHVSTMPKG 669
             D+  P I H D+  +N+L+  D    I+DFGL+      RL+    +D + +S +  G
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--G 190
Query: 670 TPGYMAPELTRG-------NSITAKIDIYSFGVVILEI 700
           T  YMAPE+  G        S   ++D+Y+ G++  EI
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 10/183 (5%)
Query: 526 NDGTKVAVKRL-YPGENRGKKEFL-SEVETIGNIHHFNLVRLVGYCAERSNR--FLVYEY 581
           +DG  +  K L Y      +K+ L SEV  +  + H N+VR      +R+N   ++V EY
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 582 MCNGSLDKWIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP--KIIHFDIKPQNI 637
              G L   I    K+R Q L  +   +++ Q++  L+  H   +    ++H D+KP N+
Sbjct: 89  CEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 638 LLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVI 697
            LD   NVK+ DFGLAR++  D+        GTP YM+PE     S   K DI+S G ++
Sbjct: 148 FLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 698 LEI 700
            E+
Sbjct: 207 YEL 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKR----LYPGENRGKKEFLSEVETIGNIHHFN 561
           + + RLG GG G V   +  D G +VA+K+    L P   + ++ +  E++ +  ++H N
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP---KNRERWCLEIQIMKKLNHPN 73
Query: 562 LVRL------VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
           +V        +   A      L  EY   G L K++   +    L     + ++  IS  
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
           L YLH+    +IIH D+KP+NI+L    + L  KI D G A+ +  DQ  + T   GT  
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQ 188
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP 709
           Y+APEL      T  +D +SFG +  E I G R   P
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 502 KSATRDFQI--RLGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKKEF---LSEVET 553
           K + +DFQI   LG G  G V   L+   ++G   A+K L       KKE    L +VE 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRV--HLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEH 52
Query: 554 IGN-------IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
             +       + H  ++R+ G   +    F++ +Y+  G L   +    R       + K
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN---PVAK 109
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               ++   LEYLH   +  II+ D+KP+NILLD++ ++KI DFG A+ +      V+  
Sbjct: 110 FYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYX 162
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             GTP Y+APE+         ID +SFG++I E++ G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 507 DFQIRLGRGGSGSVFEGLLND-GTKVAVKR----LYPGENRGKKEFLSEVETIGNIHHFN 561
           + + RLG GG G V   +  D G +VA+K+    L P   + ++ +  E++ +  ++H N
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP---KNRERWCLEIQIMKKLNHPN 74
Query: 562 LVRL------VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
           +V        +   A      L  EY   G L K++   +    L     + ++  IS  
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
           L YLH+    +IIH D+KP+NI+L    + L  KI D G A+ +  DQ  + T   GT  
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQ 189
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP 709
           Y+APEL      T  +D +SFG +  E I G R   P
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 18/201 (8%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G V++   + G  VA+KR+    E+ G     + E+  +  +HH N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI-IFQISRGLEYLHDYCNPKI 627
                   LV+E+M    L K +   D  +T   D + KI ++Q+ RG+ + H +   +I
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAPELTRGN-S 683
           +H D+KPQN+L++ D  +K+ADFGLAR   +  +  +H       T  Y AP++  G+  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKK 196
Query: 684 ITAKIDIYSFGVVILEIICGR 704
            +  +DI+S G +  E+I G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 526 NDGT--KVAVKRLY----PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL-- 577
           NDGT   VAVK L     P    G K+   E++ +  ++H ++++  G C ++  + L  
Sbjct: 39  NDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQL 95
Query: 578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQ 635
           V EY+  GSL      +D +   S  + + ++F  QI  G+ YLH   +   IH ++  +
Sbjct: 96  VMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAAR 146
Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSF 693
           N+LLD D  VKI DFGLA+ + +   +      G     + APE  +        D++SF
Sbjct: 147 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 206
Query: 694 GVVILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQ 751
           GV + E++  C    S P     L+   + +    RL +L++ + E +        ++  
Sbjct: 207 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGERLPRPDKCPCEVYH 265
Query: 752 IAISCLQKNLHRRPSASMLVKVLQ 775
           +  +C +     RP+   L+ +L+
Sbjct: 266 LMKNCWETEASFRPTFENLIPILK 289

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 130/266 (48%), Gaps = 35/266 (13%)
Query: 508 FQIR-LGRGGSGSVFEGLLNDG-TKVAVKRL---------YPGENRGKKEF----LSEVE 552
           F++R LG G  G V      +G ++ A+K +         Y  +N+  ++F     +E+ 
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
            + ++ H N+++L     ++   +LV E+   G L + I ++ +           I+ QI
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD---AANIMKQI 155
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIAQDQSHVSTMPKG 669
             G+ YLH +    I+H DIKP+NILL+     LN+KI DFGL+   ++D      +  G
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--G 210
Query: 670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC 729
           T  Y+APE+ +      K D++S GV++  ++CG     P GG    D +K   +     
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP---PFGGQNDQDIIKKVEKGKYYF 266
Query: 730 DLVDKKSEDMQSHRDDAVKMIQIAIS 755
           D       D ++  D+A ++I++ ++
Sbjct: 267 DF-----NDWKNISDEAKELIKLMLT 287

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 18/201 (8%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G V++   + G  VA+KR+    E+ G     + E+  +  +HH N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI-IFQISRGLEYLHDYCNPKI 627
                   LV+E+M    L K +   D  +T   D + KI ++Q+ RG+ + H +   +I
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAPELTRGN-S 683
           +H D+KPQN+L++ D  +K+ADFGLAR   +  +  +H       T  Y AP++  G+  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKK 196
Query: 684 ITAKIDIYSFGVVILEIICGR 704
            +  +DI+S G +  E+I G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 26/231 (11%)
Query: 509 QIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           ++ LG+G  G V+ G  L++  ++A+K +   ++R  +    E+    ++ H N+V+ +G
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 568 YCAERSNRFLVYEYMCNGSL-----DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
             +E     +  E +  GSL      KW   KD  QT+ +  +     QI  GL+YLHD 
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN 141
Query: 623 CNPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT-- 679
              +I+H DIK  N+L++    V KI+DFG ++ +A       T   GT  YMAPE+   
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDK 197
Query: 680 --RGNSITAKIDIYSFGVVILEIICGRRS----SNPKGGDYLVDTLKVKAE 724
             RG    A  DI+S G  I+E+  G+        P+   + V   KV  E
Sbjct: 198 GPRGYGKAA--DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 246

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 122
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  + +  GT  Y+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAAL-CGTLDYL 176
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  GSV++ +  + G  VA+K++ P E+   +E + E+  +      ++V+  G  
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQV-PVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            + ++ ++V EY   GS+   I  + R +TL+ D    I+    +GLEYLH     + IH
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            DIK  NILL+ + + K+ADFG+A  +    +  + +  GTP +MAPE+ +        D
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV-IGTPFWMAPEVIQEIGYNCVAD 207
Query: 690 IYSFGVVILEIICGR 704
           I+S G+  +E+  G+
Sbjct: 208 IWSLGITAIEMAEGK 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 153
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 214 SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 144
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 205 SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 58  LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 113
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   N  +++ D+K +N++LD+D ++KI DFGL +   +D + +   
Sbjct: 114 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 171
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 172 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 155
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 216 SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 26/231 (11%)
Query: 509 QIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           ++ LG+G  G V+ G  L++  ++A+K +   ++R  +    E+    ++ H N+V+ +G
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 568 YCAERSNRFLVYEYMCNGSL-----DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
             +E     +  E +  GSL      KW   KD  QT+ +  +     QI  GL+YLHD 
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN 127
Query: 623 CNPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT-- 679
              +I+H DIK  N+L++    V KI+DFG ++ +A       T   GT  YMAPE+   
Sbjct: 128 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDK 183
Query: 680 --RGNSITAKIDIYSFGVVILEIICGRRS----SNPKGGDYLVDTLKVKAE 724
             RG    A  DI+S G  I+E+  G+        P+   + V   KV  E
Sbjct: 184 GPRGYGKAA--DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 57  LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 112
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   N  +++ D+K +N++LD+D ++KI DFGL +   +D + +   
Sbjct: 113 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 170
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 171 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S  + +  GT  Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAAL-CGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 12/211 (5%)
Query: 501 MKSATRDFQI-RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI 557
           M S+++  Q+ +LG G   +V++GL    G  VA+K +      G     + E+  +  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISR 614
            H N+VRL       +   LV+E+M N  L K++  +    T   L  ++ K   +Q+ +
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           GL + H+    KI+H D+KPQN+L+++   +K+ DFGLAR      +  S+    T  Y 
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-EVVTLWYR 175
Query: 675 APELTRGN-SITAKIDIYSFGVVILEIICGR 704
           AP++  G+ + +  IDI+S G ++ E+I G+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 512 LGRGGSGSVFEGLLND---GTKVAVK---RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G V   L  D   G + AVK   +    +   K+  L EV+ +  + H N+++L
Sbjct: 57  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  ++   +LV E    G L   I  + R   +      +II Q+  G+ Y+H     
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KN 168
Query: 626 KIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
           KI+H D+KP+N+LL+   +D N++I DFGL+      +     +  GT  Y+APE+  G 
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG- 225
Query: 683 SITAKIDIYSFGVVILEIICG 703
           +   K D++S GV++  ++ G
Sbjct: 226 TYDEKCDVWSTGVILYILLSG 246

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 512 LGRGGSGSVFEGLLND---GTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G V   L  D   G + AVK +   + +    K+  L EV+ +  + H N+++L
Sbjct: 34  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  ++   +LV E    G L   I  + R   +      +II Q+  G+ Y+H     
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KN 145
Query: 626 KIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
           KI+H D+KP+N+LL+   +D N++I DFGL+      +     +  GT  Y+APE+  G 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG- 202
Query: 683 SITAKIDIYSFGVVILEIICG 703
           +   K D++S GV++  ++ G
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L+E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  S D  +
Sbjct: 56  LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 111
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   L+YLH   N  +++ D+K +N++LD+D ++KI DFGL +   +D + +   
Sbjct: 112 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 169
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 170 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 512 LGRGGSGSVFEGLLND---GTKVAVK---RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G V   L  D   G + AVK   +    +   K+  L EV+ +  + H N+++L
Sbjct: 58  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  ++   +LV E    G L   I  + R   +      +II Q+  G+ Y+H     
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KN 169
Query: 626 KIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
           KI+H D+KP+N+LL+   +D N++I DFGL+      +     +  GT  Y+APE+  G 
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG- 226
Query: 683 SITAKIDIYSFGVVILEIICG 703
           +   K D++S GV++  ++ G
Sbjct: 227 TYDEKCDVWSTGVILYILLSG 247

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 136
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 194 HRIYTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 137
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 526 NDGT--KVAVKRLY----PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL-- 577
           NDGT   VAVK L     P    G K+   E++ +  ++H ++++  G C ++  + L  
Sbjct: 39  NDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQL 95
Query: 578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQ 635
           V EY+  GSL      +D +   S  + + ++F  QI  G+ YLH       IH ++  +
Sbjct: 96  VMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAAR 146
Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSF 693
           N+LLD D  VKI DFGLA+ + +   +      G     + APE  +        D++SF
Sbjct: 147 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 206
Query: 694 GVVILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQ 751
           GV + E++  C    S P     L+   + +    RL +L++ + E +        ++  
Sbjct: 207 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGERLPRPDKCPCEVYH 265
Query: 752 IAISCLQKNLHRRPSASMLVKVLQ 775
           +  +C +     RP+   L+ +L+
Sbjct: 266 LMKNCWETEASFRPTFENLIPILK 289

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 139
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 197 HRIYTHQSDVWSYGVTVWELM 217

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVK---RLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           ++GRG  G VF G L  D T VAVK      P + + K  FL E   +    H N+VRL+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLI 178
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI----SRGLEYLHDY 622
           G C ++   ++V E +  G    +      ++T    +R K + Q+    + G+EYL   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTF------LRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRG 681
           C    IH D+  +N L+     +KI+DFG++R  A      S   +  P  + APE    
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 682 NSITAKIDIYSFGVVILE 699
              +++ D++SFG+++ E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  ++E   EV  +  + H N++ L      R++  L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++LS +     I QI  G+ YLH     KI HFD+KP+NI LLD+
Sbjct: 98  SGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++   ++K+ DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 210 ILLSG---ASPFLGDTKQETL 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  ++E   EV  +  + H N++ L      R++  L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++LS +     I QI  G+ YLH     KI HFD+KP+NI LLD+
Sbjct: 98  SGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++   ++K+ DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 210 ILLSG---ASPFLGDTKQETL 227

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 111/201 (55%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 136
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+ A+++ + +   K    +MA E   
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 194 HRIYTHQSDVWSYGVTVWELM 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  ++E   EV  +  + H N++ L      R++  L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++LS +     I QI  G+ YLH     KI HFD+KP+NI LLD+
Sbjct: 98  SGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++   ++K+ DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 210 ILLSG---ASPFLGDTKQETL 227

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 20/198 (10%)
Query: 528 GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL 587
           G K+A K +     + K+E  +E+  +  + H NL++L      +++  LV EY+  G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 588 DKWIFHKDRIQTLSWDIRK--KIIF--QISRGLEYLHDYCNPKIIHFDIKPQNIL-LDRD 642
                  DRI   S+++ +   I+F  QI  G+ ++H      I+H D+KP+NIL ++RD
Sbjct: 174 ------FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRD 224
Query: 643 L-NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
              +KI DFGLAR     +        GTP ++APE+   + ++   D++S GV+   ++
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 702 CGRRSSNPKGGDYLVDTL 719
            G    +P  GD   +TL
Sbjct: 283 SGL---SPFLGDNDAETL 297

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 129/275 (46%), Gaps = 45/275 (16%)
Query: 529 TKVAVKRLY----PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN 584
           T VAVK L     P E R   + LSE   +  ++H ++++L G C++     L+ EY   
Sbjct: 54  TTVAVKMLKENASPSELR---DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 110
Query: 585 GSLDKWIFHKDRI---------------------QTLSWDIRKKIIFQISRGLEYLHDYC 623
           GSL  ++    ++                     + L+        +QIS+G++YL +  
Sbjct: 111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM- 169
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGN 682
             K++H D+  +NIL+     +KI+DFGL+R + ++ S+V       P  +MA E    +
Sbjct: 170 --KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
             T + D++SFGV++ EI+      NP  G             +RL +L+ K    M+  
Sbjct: 228 IYTTQSDVWSFGVLLWEIVT--LGGNPYPG----------IPPERLFNLL-KTGHRMERP 274
Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
            + + +M ++ + C ++   +RP  + + K L+ +
Sbjct: 275 DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 506 RDFQIR--LGRGGSGSVF----EGLLNDGTK--VAVKRLYPGENRGKKEFLSEVETIGNI 557
           RD  ++  LG G  G VF      LL +  K  VAVK L       +++F  E E +  +
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSW--DIRK-------- 606
            H ++VR  G C E     +V+EYM +G L++++  H    + L+   D+          
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 607 -KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVS 664
             +  Q++ G+ YL        +H D+  +N L+ + L VKI DFG++R I + D   V 
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKA 723
                   +M PE       T + D++SFGVV+ EI   G++          +D +    
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 273
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
                      +  +++  R    ++  I   C Q+   +R S   +   LQ L +  PV
Sbjct: 274 ----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 138
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  ++E   EV  +  + H N++ L      R++  L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++LS +     I QI  G+ YLH     KI HFD+KP+NI LLD+
Sbjct: 98  SGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++   ++K+ DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 210 ILLSG---ASPFLGDTKQETL 227

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 137
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 119
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +       S       GT  Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 141
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 142 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 199 HRIYTHQSDVWSYGVTVWELM 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  ++E   EV  +  + H N++ L      R++  L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++LS +     I QI  G+ YLH     KI HFD+KP+NI LLD+
Sbjct: 98  SGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++   ++K+ DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 210 ILLSG---ASPFLGDTKQETL 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  ++E   EV  +  + H N++ L      R++  L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++LS +     I QI  G+ YLH     KI HFD+KP+NI LLD+
Sbjct: 98  SGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++   ++K+ DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 210 ILLSG---ASPFLGDTKQETL 227

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 138
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 507 DFQIRLGRGGSGSVFE----GLLNDGT--KVAVKRLYPGENRGKKE-FLSEVETIGNI-H 558
           +F   LG G  G V      G+   G   +VAVK L    +  ++E  +SE++ +  +  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI------FHKDRIQ-------------- 598
           H N+V L+G C      +L++EY C G L  ++      F +D I+              
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ 658
            L+++      +Q+++G+E+L        +H D+  +N+L+     VKI DFGLAR I  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 659 DQSHVSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEII 701
           D ++V       P  +MAPE       T K D++S+G+++ EI 
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 138
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 145
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 146 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 203 HRIYTHQSDVWSYGVTVWELM 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 111/201 (55%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 129
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+ A+++ + +   K    +MA E   
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELM 207

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 160
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 161 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 218 HRIYTHQSDVWSYGVTVWELM 238

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVK---RLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           ++GRG  G VF G L  D T VAVK      P + + K  FL E   +    H N+VRL+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLI 178
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI----SRGLEYLHDY 622
           G C ++   ++V E +  G    +      ++T    +R K + Q+    + G+EYL   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTF------LRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRG 681
           C    IH D+  +N L+     +KI+DFG++R  A      S   +  P  + APE    
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 682 NSITAKIDIYSFGVVILE 699
              +++ D++SFG+++ E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 138
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 142
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA++++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+       T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 512 LGRGGSGSVFEGLLND---GTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G V   L  D   G + AVK +   + +    K+  L EV+ +  + H N+++L
Sbjct: 40  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  ++   +LV E    G L   I  + R   +      +II Q+  G+ Y+H     
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KN 151
Query: 626 KIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
           KI+H D+KP+N+LL+   +D N++I DFGL+      +     +  GT  Y+APE+  G 
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG- 208
Query: 683 SITAKIDIYSFGVVILEIICG 703
           +   K D++S GV++  ++ G
Sbjct: 209 TYDEKCDVWSTGVILYILLSG 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 22/207 (10%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK-----KEFLSEVETIGNIHHFNL 562
           F+ +LG G  G V    L +     ++R+    N+ +     ++  +E+E + ++ H N+
Sbjct: 26  FKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 563 VRLVGYCAERSNRFLVYEYMCNGS--LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           +++     +  N ++V E  C G   L++ +  + R + LS     +++ Q+   L Y H
Sbjct: 83  IKIFEVFEDYHNMYIVME-TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 621 DYCNPKIIHFDIKPQNILLDRDLN----VKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
              +  ++H D+KP+NIL  +D +    +KI DFGLA L   D+   ST   GT  YMAP
Sbjct: 142 ---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAP 195
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICG 703
           E+ + + +T K DI+S GVV+  ++ G
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           R+G+G  G VF+G+ N   +V   ++          ++   E+  +       + +  G 
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + S  +++ EY+  GS    L    F + +I T+        + +I +GL+YLH   +
Sbjct: 90  YLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATM--------LKEILKGLDYLH---S 138
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL    +VK+ADFG+A  +   Q   +T   GTP +MAPE+ + ++ 
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSAY 197
Query: 685 TAKIDIYSFGVVILEIICGR 704
            +K DI+S G+  +E+  G 
Sbjct: 198 DSKADIWSLGITAIELAKGE 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 56  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 111
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + + T 
Sbjct: 112 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 168
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 169 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 506 RDFQIR--LGRGGSGSVF----EGLLNDGTK--VAVKRLYPGENRGKKEFLSEVETIGNI 557
           RD  ++  LG G  G VF      LL +  K  VAVK L       +++F  E E +  +
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 77
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSW--DIRK-------- 606
            H ++VR  G C E     +V+EYM +G L++++  H    + L+   D+          
Sbjct: 78  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 607 -KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVS 664
             +  Q++ G+ YL        +H D+  +N L+ + L VKI DFG++R I + D   V 
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKA 723
                   +M PE       T + D++SFGVV+ EI   G++          +D +    
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 250
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
                      +  +++  R    ++  I   C Q+   +R S   +   LQ L +  PV
Sbjct: 251 ----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + + T 
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 166 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 27/264 (10%)
Query: 526 NDGT--KVAVKRLY----PGENRGKKEFLSEVETIGNIHHFNLVRLVGYC--AERSNRFL 577
           NDGT   VAVK L     P    G K+   E++ +  ++H ++++  G C  A  ++  L
Sbjct: 56  NDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQL 112
Query: 578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQ 635
           V EY+  GSL      +D +   S  + + ++F  QI  G+ YLH       IH D+  +
Sbjct: 113 VMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAAR 163
Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSF 693
           N+LLD D  VKI DFGLA+ + +          G     + APE  +        D++SF
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 694 GVVILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQ 751
           GV + E++  C    S P     L+   + +    RL +L++ + E +        ++  
Sbjct: 224 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGERLPRPDKCPAEVYH 282
Query: 752 IAISCLQKNLHRRPSASMLVKVLQ 775
           +  +C +     RP+   L+ +L+
Sbjct: 283 LMKNCWETEASFRPTFENLIPILK 306

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + + T 
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 166 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 506 RDFQIR--LGRGGSGSVF----EGLLNDGTK--VAVKRLYPGENRGKKEFLSEVETIGNI 557
           RD  ++  LG G  G VF      LL +  K  VAVK L       +++F  E E +  +
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 71
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSW--DIRK-------- 606
            H ++VR  G C E     +V+EYM +G L++++  H    + L+   D+          
Sbjct: 72  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 607 -KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVS 664
             +  Q++ G+ YL        +H D+  +N L+ + L VKI DFG++R I + D   V 
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKA 723
                   +M PE       T + D++SFGVV+ EI   G++          +D +    
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 244
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
                      +  +++  R    ++  I   C Q+   +R S   +   LQ L +  PV
Sbjct: 245 ----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 497 SSKAMKS-ATRDFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVET 553
           S KA  S   +DF +   +GRG    V    L    ++   R+   E     E +  V+T
Sbjct: 42  SGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT 101
Query: 554 IGNI-----HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
             ++     +H  LV L       S  F V EY+  G L   +FH  R + L  +  +  
Sbjct: 102 EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFY 158
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             +IS  L YLH+     II+ D+K  N+LLD + ++K+ D+G+ +   +     ST   
Sbjct: 159 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-C 214
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           GTP Y+APE+ RG      +D ++ GV++ E++ GR
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 511 RLGRGGSGSVF---EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +LG G  G V    + + +    + + R          + L EV  +  + H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  ++ N +LV E    G L   I H+ +   +   +   II Q+  G+ YLH +    I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLHKH---NI 157
Query: 628 IHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
           +H D+KP+N+LL   ++D  +KI DFGL+ +    +     +  GT  Y+APE+ R    
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR-KKY 214
Query: 685 TAKIDIYSFGVVILEIICG 703
             K D++S GV++  ++ G
Sbjct: 215 DEKCDVWSIGVILFILLAG 233

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNIHHF 560
           DF I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++ H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISRGLE 617
           N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++  L 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSRFDEQRTATYITELANALS 126
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           Y H   + ++IH DIKP+N+LL  +  +KIADFG +       S   T   GT  Y+ PE
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 180
Query: 678 LTRGNSITAKIDIYSFGVVILEIICG 703
           +  G     K+D++S GV+  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     N +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    +   ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSITA 686
            D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 21/210 (10%)
Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNI 557
           A  DF+I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISR 614
            H N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++ 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSKFDEQRTATYITELAN 122
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
            L Y H   + ++IH DIKP+N+LL     +KIADFG +  +    S    +  GT  Y+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDL-CGTLDYL 176
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
            PE+  G     K+D++S GV+  E + G+
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 500 AMKSATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           AM S+TRD++I+         +G G  G V +G+     N    VA+K      +   +E
Sbjct: 25  AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE 84
Query: 547 -FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
            FL E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+ 
Sbjct: 85  KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLA 139
Query: 606 KKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             I++  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + 
Sbjct: 140 SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 196
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           ++  K    +MAPE       T+  D++ FGV + EI+
Sbjct: 197 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 110/201 (54%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI+ G+ YL D
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAEGMNYLED 132
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+ A+++ + +   K    +MA E   
Sbjct: 133 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 190 HRIYTHQSDVWSYGVTVWELM 210

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 136/307 (44%), Gaps = 48/307 (15%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR    D +++    K
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDXXKK 215
Query: 669 GTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
            T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLK 273
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
           E  R+    +  +E     RD           C      +RP+   LV+ L  +  L   
Sbjct: 274 EGHRMDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTLTTN 322
Query: 784 TDYGFLS 790
            +Y  LS
Sbjct: 323 EEYLDLS 329

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 500 AMKSATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           AM S+TRD++I+         +G G  G V +G+     N    VA+K      +   +E
Sbjct: 2   AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE 61
Query: 547 -FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
            FL E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+ 
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLA 116
Query: 606 KKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             I++  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + 
Sbjct: 117 SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           ++  K    +MAPE       T+  D++ FGV + EI+
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 508 FQIRLGRGGSGSVFE----GLL--NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E    GL+  +    VAVK L P  +  ++E  +SE++ +  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSL--------DKWIFHKDRIQTLSWDIRKKII-- 609
            N+V L+G C       ++ EY C G L        D +I  K     +  D     +  
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 610 -----FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
                +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D ++V 
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 665 TMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
                 P  +MAPE       T + D++S+G+ + E+      S+P  G      + V +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--SLGSSPYPG------MPVDS 255
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
           +  ++     K+   M S      +M  I  +C   +  +RP+   +V++++
Sbjct: 256 KFYKMI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 136/307 (44%), Gaps = 48/307 (15%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR    D +++    K
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDXXKK 215
Query: 669 GTPG-----YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
            T G     +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLK 273
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
           E  R+    +  +E     RD           C      +RP+   LV+ L  +  L   
Sbjct: 274 EGHRMDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTLTTN 322
Query: 784 TDYGFLS 790
            +Y  LS
Sbjct: 323 EEYLDLS 329

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 508 FQIRLGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E      G  +   KVAVK L    +  +KE  +SE++ + ++  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK-----DRIQTLSWDIRKKIIF--QI 612
            N+V L+G C       ++ EY C G L  ++  K     D+      ++R  + F  Q+
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP- 671
           ++G+ +L    +   IH D+  +N+LL      KI DFGLAR I  D +++       P 
Sbjct: 162 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEII 701
            +MAPE       T + D++S+G+++ EI 
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 508 FQIRLGRGGSGSVFE----GLL--NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E    GL+  +    VAVK L P  +  ++E  +SE++ +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSL--------DKWIFHKDRIQTLSWDIRKKII-- 609
            N+V L+G C       ++ EY C G L        D +I  K     +  D     +  
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 610 -----FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
                +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D ++V 
Sbjct: 170 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 665 TMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
                 P  +MAPE       T + D++S+G+ + E+      S+P  G      + V +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--SLGSSPYPG------MPVDS 278
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
           +  ++     K+   M S      +M  I  +C   +  +RP+   +V++++
Sbjct: 279 KFYKMI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 45/275 (16%)
Query: 529 TKVAVKRLY----PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN 584
           T VAVK L     P E R   + LSE   +  ++H ++++L G C++     L+ EY   
Sbjct: 54  TTVAVKMLKENASPSELR---DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 110
Query: 585 GSLDKWIFHKDRI---------------------QTLSWDIRKKIIFQISRGLEYLHDYC 623
           GSL  ++    ++                     + L+        +QIS+G++YL +  
Sbjct: 111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM- 169
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGN 682
             K++H D+  +NIL+     +KI+DFGL+R + ++ S V       P  +MA E    +
Sbjct: 170 --KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDH 227
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
             T + D++SFGV++ EI+      NP  G             +RL +L+ K    M+  
Sbjct: 228 IYTTQSDVWSFGVLLWEIVT--LGGNPYPG----------IPPERLFNLL-KTGHRMERP 274
Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
            + + +M ++ + C ++   +RP  + + K L+ +
Sbjct: 275 DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 508 FQIRLGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E      G  +   KVAVK L    +  +KE  +SE++ + ++  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK-----DRIQTLSWDIRKKIIF--QI 612
            N+V L+G C       ++ EY C G L  ++  K     D+      ++R  + F  Q+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP- 671
           ++G+ +L    +   IH D+  +N+LL      KI DFGLAR I  D +++       P 
Sbjct: 170 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEII 701
            +MAPE       T + D++S+G+++ EI 
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 508 FQIRLGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E      G  +   KVAVK L    +  +KE  +SE++ + ++  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI-----------QTLSWDIRKKI 608
            N+V L+G C       ++ EY C G L  ++  K R+            TLS   R  +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS--TRDLL 167
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
            F  Q+++G+ +L    +   IH D+  +N+LL      KI DFGLAR I  D +++   
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 667 PKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEII 701
               P  +MAPE       T + D++S+G+++ EI 
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 20/200 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGYC 569
            LG G  G V++    + + +A  ++   ++  + E ++ E++ + +  H N+V+L+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +N +++ E+   G++D  +   +R  T S    + +  Q    L YLHD    KIIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ--IQVVCKQTLDALNYLHDN---KIIH 158
Query: 630 FDIKPQNILLDRDLNVKIADFGLA----RLIAQDQSHVSTMPKGTPGYMAPEL-----TR 680
            D+K  NIL   D ++K+ADFG++    R I +  S +     GTP +MAPE+     ++
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 213
Query: 681 GNSITAKIDIYSFGVVILEI 700
                 K D++S G+ ++E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 508 FQIRLGRGGSGSVFE----GLL--NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E    GL+  +    VAVK L P  +  ++E  +SE++ +  + +H
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSL--------DKWIFHKDRIQTLSWDIRKKII-- 609
            N+V L+G C       ++ EY C G L        D +I  K     +  D     +  
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 610 -----FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
                +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D ++V 
Sbjct: 165 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 665 TMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
                 P  +MAPE       T + D++S+G+ + E+      S+P  G      + V +
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--SLGSSPYPG------MPVDS 273
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
           +  ++     K+   M S      +M  I  +C   +  +RP+   +V++++
Sbjct: 274 KFYKMI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 20/200 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGYC 569
            LG G  G V++    + + +A  ++   ++  + E ++ E++ + +  H N+V+L+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +N +++ E+   G++D  +   +R  T S    + +  Q    L YLHD    KIIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ--IQVVCKQTLDALNYLHDN---KIIH 158
Query: 630 FDIKPQNILLDRDLNVKIADFGLA----RLIAQDQSHVSTMPKGTPGYMAPEL-----TR 680
            D+K  NIL   D ++K+ADFG++    R I +  S +     GTP +MAPE+     ++
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-----GTPYWMAPEVVMCETSK 213
Query: 681 GNSITAKIDIYSFGVVILEI 700
                 K D++S G+ ++E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 512 LGRGGSGSVFEGLLND---GTKVAVK---RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G V   L  D   G + AVK   +    +   K+  L EV+ +  + H N+ +L
Sbjct: 34  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             +  ++   +LV E    G L   I  + R   +      +II Q+  G+ Y H     
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYXH---KN 145
Query: 626 KIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
           KI+H D+KP+N+LL+   +D N++I DFGL+      +     +  GT  Y+APE+  G 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI--GTAYYIAPEVLHG- 202
Query: 683 SITAKIDIYSFGVVILEIICG 703
           +   K D++S GV++  ++ G
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNIHHF 560
           DF I   LG+G  G+V+         + A+K L+    E  G + +   EVE   ++ H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS-WDIRKKIIF--QISRGLE 617
           N++RL GY  + +  +L+ EY   G++ +       +Q LS +D ++   +  +++  L 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYR------ELQKLSRFDEQRTATYITELANALS 126
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           Y H   + ++IH DIKP+N+LL  +  +KIADFG +  +    S   T+  GT  Y+ PE
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTL-CGTLDYLPPE 180
Query: 678 LTRGNSITAKIDIYSFGVVILEIICG 703
           +  G     K+D++S GV+  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 508 FQIRLGRGGSGSVFE----GLL--NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E    GL+  +    VAVK L P  +  ++E  +SE++ +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSL--------DKWIFHKDRIQTLSWDIRKKII-- 609
            N+V L+G C       ++ EY C G L        D +I  K     +  D     +  
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 610 -----FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
                +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D ++V 
Sbjct: 170 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 665 TMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
                 P  +MAPE       T + D++S+G+ + E+      S+P  G      + V +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--SLGSSPYPG------MPVDS 278
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
           +  ++     K+   M S      +M  I  +C   +  +RP+   +V++++
Sbjct: 279 KFYKMI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 506 RDFQIR--LGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRGKKEFLSEVETIGNI 557
           RD  ++  LG G  G VF           D   VAVK L       +K+F  E E + N+
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI--FHKDRIQTLSWDIRKK-------- 607
            H ++V+  G C +     +V+EYM +G L+K++     D +  +    R+         
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 608 ---IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-LIAQDQSHV 663
              I  QI+ G+ YL    +   +H D+  +N L+  +L VKI DFG++R + + D   V
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
                    +M PE       T + D++SFGV++ EI
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPAFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 508 FQIRLGRGGSGSVFE----GLL--NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E    GL+  +    VAVK L P  +  ++E  +SE++ +  + +H
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSL--------DKWIFHKDRIQTLSWDIRKKII-- 609
            N+V L+G C       ++ EY C G L        D +I  K     +  D     +  
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 610 -----FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
                +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D ++V 
Sbjct: 163 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 665 TMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA 723
                 P  +MAPE       T + D++S+G+ + E+      S+P  G      + V +
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--SLGSSPYPG------MPVDS 271
Query: 724 EADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
           +  ++     K+   M S      +M  I  +C   +  +RP+   +V++++
Sbjct: 272 KFYKMI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 512 LGRGGSGSVFEGLLNDGTKV-AVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G+G  G V     ND  K+ A+K +      E    +    E++ +  + H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
              +  + F+V + +  G L    +H  +      +  K  I ++   L+YL    N +I
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLR---YHLQQNVHFKEETVKLFICELVMALDYLQ---NQRI 136
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL---TRGNSI 684
           IH D+KP NILLD   +V I DF +A ++ + ++ ++TM  GT  YMAPE+    +G   
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTM-AGTKPYMAPEMFSSRKGAGY 194
Query: 685 TAKIDIYSFGVVILEIICGRR 705
           +  +D +S GV   E++ GRR
Sbjct: 195 SFAVDWWSLGVTAYELLRGRR 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G+G  G VF+G+ N   KV   ++          ++   E+  +       + +  G 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L+     + +I T        I+ +I +GL+YLH   +
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYLH---S 122
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL     VK+ADFG+A  +   Q   +T   GTP +MAPE+ + ++ 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 181
Query: 685 TAKIDIYSFGVVILEIICGR 704
            +K DI+S G+  +E+  G 
Sbjct: 182 DSKADIWSLGITAIELARGE 201

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 18/225 (8%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           +G G  G VF+  L +  +VA+K++   + R K     E++ +  + H N+V L  +   
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVL-QDKRFKNR---ELQIMRIVKHPNVVDLKAFFYS 103
Query: 572 RSNRF------LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             ++       LV EY+          +    QT+   + K  ++Q+ R L Y+H     
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--- 160
Query: 626 KIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NS 683
            I H DIKPQN+LLD    V K+ DFG A+++   + +VS +   +  Y APEL  G  +
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI--CSRYYRAPELIFGATN 218
Query: 684 ITAKIDIYSFGVVILEIICGRRS-SNPKGGDYLVDTLKVKAEADR 727
            T  IDI+S G V+ E++ G+       G D LV+ +KV     R
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 35/276 (12%)
Query: 510 IRLGRGGSGSVFEGL--LNDGTKVAVKRLYPGEN-RGKKEFLSEVE-TIGNIHHFNLVRL 565
           + LGRG  G V E +  +  G  +AVKR+    N + +K  L +++ ++  +     V  
Sbjct: 57  MELGRGAYG-VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLEYLHDY 622
            G      + ++  E M + SLDK  F+K   D+ QT+  DI  KI   I + LE+LH  
Sbjct: 116 YGALFREGDVWICMELM-DTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT--- 679
            +  +IH D+KP N+L++    VK+ DFG++  +    S   T+  G   YMAPE     
Sbjct: 173 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTIDAGCKPYMAPERINPE 228
Query: 680 ---RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
              +G S+  K DI+S G+ ++E+   R   +  G  +            +L  +V++ S
Sbjct: 229 LNQKGYSV--KSDIWSLGITMIELAILRFPYDSWGTPF-----------QQLKQVVEEPS 275
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             + + +  A + +     CL+KN   RP+   L++
Sbjct: 276 PQLPADKFSA-EFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G+G  G VF+G+ N   KV   ++          ++   E+  +       + +  G 
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L+     + +I T        I+ +I +GL+YLH   +
Sbjct: 94  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYLH---S 142
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL     VK+ADFG+A  +   Q   +T   GTP +MAPE+ + ++ 
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 201
Query: 685 TAKIDIYSFGVVILEIICGR 704
            +K DI+S G+  +E+  G 
Sbjct: 202 DSKADIWSLGITAIELARGE 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     + +T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 507 DFQIRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           D  +++G G +G V      + G +VAVK +   + + ++   +EV  + +  HFN+V +
Sbjct: 48  DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
                     +++ E++  G+L   +     ++++I T        +   + + L YLH 
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT--------VCEAVLQALAYLH- 158
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                +IH DIK  +ILL  D  VK++DFG    I++D      +  GTP +MAPE+   
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXL-VGTPYWMAPEVISR 215
Query: 682 NSITAKIDIYSFGVVILEIICG 703
           +    ++DI+S G++++E++ G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 511 RLGRGGSGSVFEG-LLNDGTKVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLVRLV 566
           ++GRG    V+    L DG  VA+K++      + + + + + E++ +  ++H N+++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
               E +   +V E    G L + I H K + + +      K   Q+   LE++H   + 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           +++H DIKP N+ +     VK+ D GL R  +   +   ++  GTP YM+PE    N   
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYN 214
Query: 686 AKIDIYSFGVVILEI 700
            K DI+S G ++ E+
Sbjct: 215 FKSDIWSLGCLLYEM 229

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    FE    D  +V   ++ P     +   +++   E+    ++ H ++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    F+V E     SL +   HK R + L+    +  + QI  G +YLH     ++
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE--LHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ DL VKI DFGLA  +  D     T+  GTP Y+APE+      + +
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSFE 201
Query: 688 IDIYSFGVVILEIICGR 704
           +D++S G ++  ++ G+
Sbjct: 202 VDVWSIGCIMYTLLVGK 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 508 FQIRLGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E      G  +   KVAVK L    +  +KE  +SE++ + ++  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR---------IQTLSWDIRKKIIF 610
            N+V L+G C       ++ EY C G L  ++  K R         I   +   R  + F
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 611 --QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             Q+++G+ +L    +   IH D+  +N+LL      KI DFGLAR I  D +++     
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEII 701
             P  +MAPE       T + D++S+G+++ EI 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    FE    D  +V   ++ P     +   +++   E+    ++ H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    F+V E     SL +   HK R + L+    +  + QI  G +YLH     ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE--LHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ DL VKI DFGLA  +  D     T+  GTP Y+APE+      + +
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSFE 197
Query: 688 IDIYSFGVVILEIICGR 704
           +D++S G ++  ++ G+
Sbjct: 198 VDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    FE    D  +V   ++ P     +   +++   E+    ++ H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    F+V E     SL +   HK R + L+    +  + QI  G +YLH     ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE--LHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ DL VKI DFGLA  +  D     T+  GTP Y+APE+      + +
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSFE 197
Query: 688 IDIYSFGVVILEIICGR 704
           +D++S G ++  ++ G+
Sbjct: 198 VDVWSIGCIMYTLLVGK 214

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 526 NDGT--KVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF--LVYE 580
           NDGT   VAVK L  G   + +  +  E+E +  ++H ++V+  G C ++  +   LV E
Sbjct: 34  NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 93
Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNIL 638
           Y+  GSL      +D +      + + ++F  QI  G+ YLH       IH  +  +N+L
Sbjct: 94  YVPLGSL------RDYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVL 144
Query: 639 LDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVV 696
           LD D  VKI DFGLA+ + +   +      G     + APE  +        D++SFGV 
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 204
Query: 697 ILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAI 754
           + E++  C    S       L+   + +    RL +L++ + E +        ++  +  
Sbjct: 205 LYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE-RGERLPRPDRCPCEIYHLMK 263
Query: 755 SCLQKNLHRRPSASMLVKVLQ 775
           +C +     RP+   LV +LQ
Sbjct: 264 NCWETEASFRPTFQNLVPILQ 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 526 NDGT--KVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF--LVYE 580
           NDGT   VAVK L  G   + +  +  E+E +  ++H ++V+  G C ++  +   LV E
Sbjct: 33  NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 92
Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNIL 638
           Y+  GSL      +D +      + + ++F  QI  G+ YLH       IH  +  +N+L
Sbjct: 93  YVPLGSL------RDYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVL 143
Query: 639 LDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--YMAPELTRGNSITAKIDIYSFGVV 696
           LD D  VKI DFGLA+ + +   +      G     + APE  +        D++SFGV 
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 203
Query: 697 ILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAI 754
           + E++  C    S       L+   + +    RL +L++ + E +        ++  +  
Sbjct: 204 LYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE-RGERLPRPDRCPCEIYHLMK 262
Query: 755 SCLQKNLHRRPSASMLVKVLQ 775
           +C +     RP+   LV +LQ
Sbjct: 263 NCWETEASFRPTFQNLVPILQ 283

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 137
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFG A+L+  ++          P  +MA E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 508 FQIRLGRGGSGSVFEGLLN-DGTKV--AVKRLYPGENRGK-KEFLSEVETIGNI-HHFNL 562
           FQ  +G G  G V +  +  DG ++  A+KR+    ++   ++F  E+E +  + HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--------------QTLSWDIRKKI 608
           + L+G C  R   +L  EY  +G+L  ++  K R+               TLS       
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
              ++RG++YL      + IH D+  +NIL+  +   KIADFGL+R   Q+     TM +
Sbjct: 138 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 192
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
               +MA E    +  T   D++S+GV++ EI+
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           L  G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 142
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 137
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPELTR 680
               +++H D+  +N+L+    +VKI DFG A+L+ A+++ + +   K    +MA E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 513 GRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
            RG  G V++  LLN+   VAVK ++P +++   +   EV ++  + H N+++ +G  AE
Sbjct: 33  ARGRFGCVWKAQLLNE--YVAVK-IFPIQDKQSWQNEYEVYSLPGMKHENILQFIG--AE 87
Query: 572 RS------NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH----- 620
           +       + +L+  +   GSL  ++    +   +SW+    I   ++RGL YLH     
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 621 --DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPE 677
             D   P I H DIK +N+LL  +L   IADFGLA      +S   T  + GT  YMAPE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 678 LTRG-----NSITAKIDIYSFGVVILEI 700
           +  G          +ID+Y+ G+V+ E+
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           L  G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 508 FQIRLGRGGSGSVFEGLLN-DGTKV--AVKRLYPGENRGK-KEFLSEVETIGNI-HHFNL 562
           FQ  +G G  G V +  +  DG ++  A+KR+    ++   ++F  E+E +  + HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--------------QTLSWDIRKKI 608
           + L+G C  R   +L  EY  +G+L  ++  K R+               TLS       
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
              ++RG++YL      + IH D+  +NIL+  +   KIADFGL+R   Q+     TM +
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
               +MA E    +  T   D++S+GV++ EI+
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 139
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFG A+L+  ++          P  +MA E   
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 197 HRIYTHQSDVWSYGVTVWELM 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 58  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 113
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + +   
Sbjct: 114 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 170
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 171 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +   +  S  +TM
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATM 162
Query: 667 PK--GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
               GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 163 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 137
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFG A+L+  ++          P  +MA E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + +   
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 166 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           L  G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 142
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+  ++          P  +MA E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+  L    + +  KE L E   + ++ + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 169
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLA+L+ A+++ + +   K    +MA E   
Sbjct: 170 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 227 HRIYTHQSDVWSYGVTVWELM 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           ++E   + N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +
Sbjct: 53  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
               +I   LEYLH   +  +++ DIK +N++LD+D ++KI DFGL +    D + +   
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
             GTP Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 166 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 142
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFG A+L+  ++          P  +MA E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKV----AVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++GL + +G KV    A+K L    + +  KE L E   + ++ + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIF-HKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   + + L+ + M  G L  ++  HKD I +   L+W +      QI++G+ YL D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFG A+L+  ++          P  +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYC 569
           +G G  G V     +   T+VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +   +   Y+    ++  ++   + Q LS D     ++QI RGL+Y+H   +  ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELT-RGNSITA 686
            D+KP N+L++   ++KI DFGLAR+   +  H   + +   T  Y APE+       T 
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 687 KIDIYSFGVVILEIICGR 704
            IDI+S G ++ E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 36  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 96  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 149
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 208 ILLSG---ASPFLGDTKQETL 225

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 27/209 (12%)
Query: 507 DFQI--RLGRGGSGSVFEGLLNDGT-KVAVKRLYPG--ENRG-KKEFLSEVETIGNIHHF 560
           DF+I   LG+G  G+V+          VA+K L+    E  G + +   E+E   ++HH 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK--IIFQISRGLEY 618
           N++RL  Y  +R   +L+ EY   G L     +K+  ++ ++D ++   I+ +++  L Y
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGEL-----YKELQKSCTFDEQRTATIMEELADALMY 138
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK----GTPGYM 674
            H     K+IH DIKP+N+LL     +KIADFG +        H  ++ +    GT  Y+
Sbjct: 139 CH---GKKVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKTMCGTLDYL 188
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICG 703
            PE+  G     K+D++  GV+  E++ G
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 127/275 (46%), Gaps = 45/275 (16%)
Query: 529 TKVAVKRLY----PGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN 584
           T VAVK L     P E R   + LSE   +  ++H ++++L G C++     L+ EY   
Sbjct: 54  TTVAVKMLKENASPSELR---DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 110
Query: 585 GSLDKWIFHKDRI---------------------QTLSWDIRKKIIFQISRGLEYLHDYC 623
           GSL  ++    ++                     + L+        +QIS+G++YL +  
Sbjct: 111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS 170
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGN 682
              ++H D+  +NIL+     +KI+DFGL+R + ++ S V       P  +MA E    +
Sbjct: 171 ---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDH 227
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
             T + D++SFGV++ EI+      NP  G             +RL +L+ K    M+  
Sbjct: 228 IYTTQSDVWSFGVLLWEIVT--LGGNPYPG----------IPPERLFNLL-KTGHRMERP 274
Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
            + + +M ++ + C ++   +RP  + + K L+ +
Sbjct: 275 DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 34/269 (12%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           R+G+G  G V++G+ N   +V   ++          ++   E+  +       + R  G 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L      +  I T        I+ +I +GL+YLH   +
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--------ILREILKGLDYLH---S 134
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            + IH DIK  N+LL    +VK+ADFG+A  +   Q   +    GTP +MAPE+ + ++ 
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF-VGTPFWMAPEVIKQSAY 193
Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED-MQSHR 743
             K DI+S G+  +E+  G     P   D             R+  L+ K S   ++   
Sbjct: 194 DFKADIWSLGITAIELAKG----EPPNSDL---------HPMRVLFLIPKNSPPTLEGQH 240
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
               K  +   +CL K+   RP+A  L+K
Sbjct: 241 SKPFK--EFVEACLNKDPRFRPTAKELLK 267

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRLVG 567
           LG GG   V     L D   VAVK L     R       F  E +    ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 568 YCAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
                +      ++V EY+ +G   + I H +   T    I  ++I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQN- 135
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRG 681
              IIH D+KP NIL+     VK+ DFG+AR IA   + V       GT  Y++PE  RG
Sbjct: 136 --GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 682 NSITAKIDIYSFGVVILEIICG 703
           +S+ A+ D+YS G V+ E++ G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTG 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 266
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 267 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 36  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 96  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 149
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 208 ILLSG---ASPFLGDTKQETL 225

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L          + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  ++IADFGLAR I     +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 35/276 (12%)
Query: 510 IRLGRGGSGSVFEGL--LNDGTKVAVKRLYPGEN-RGKKEFLSEVE-TIGNIHHFNLVRL 565
           + LGRG  G V E +  +  G  +AVKR+    N + +K  L +++ ++  +     V  
Sbjct: 13  MELGRGAYG-VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLEYLHDY 622
            G      + ++  E M + SLDK  F+K   D+ QT+  DI  KI   I + LE+LH  
Sbjct: 72  YGALFREGDVWICMELM-DTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT--- 679
            +  +IH D+KP N+L++    VK+ DFG++  +  D +    +  G   YMAPE     
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPE 184
Query: 680 ---RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
              +G S+  K DI+S G+ ++E+   R   +  G  +            +L  +V++ S
Sbjct: 185 LNQKGYSV--KSDIWSLGITMIELAILRFPYDSWGTPF-----------QQLKQVVEEPS 231
Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             + + +  A + +     CL+KN   RP+   L++
Sbjct: 232 PQLPADKFSA-EFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLVGYC 569
            LG G  G V++    + + +A  ++   ++  + E ++ E++ + +  H N+V+L+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
              +N +++ E+   G++D  +   +R  T S    + +  Q    L YLHD    KIIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ--IQVVCKQTLDALNYLHDN---KIIH 158
Query: 630 FDIKPQNILLDRDLNVKIADFGLA----RLIAQDQSHVSTMPKGTPGYMAPEL-----TR 680
            D+K  NIL   D ++K+ADFG++    R I +    +     GTP +MAPE+     ++
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-----GTPYWMAPEVVMCETSK 213
Query: 681 GNSITAKIDIYSFGVVILEI 700
                 K D++S G+ ++E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 269
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 270 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 117/236 (49%), Gaps = 47/236 (19%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG G SG+V F+G    G  VAVKR+   +      + + L+E +      H N++R   
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVIRY-- 74
Query: 568 YCAERSNRFL-VYEYMCNGSLDKWIFHKDRIQTLSWDIRKK-----IIFQISRGLEYLHD 621
           YC+E ++RFL +   +CN +L   +  K+ +   +  ++K+     ++ QI+ G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 622 YCNPKIIHFDIKPQNILLD-------------RDLNVKIADFGLARLIAQDQSHVST--- 665
               KIIH D+KPQNIL+               +L + I+DFGL + +   QS   T   
Sbjct: 134 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 666 MPKGTPGYMAPELTRGNS-------ITAKIDIYSFGVVILEIICGRRSSNPKGGDY 714
            P GT G+ APEL   ++       +T  IDI+S G V   I+   +  +P G  Y
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS--KGKHPFGDKY 244

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 96/182 (52%), Gaps = 12/182 (6%)
Query: 526 NDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGYCAERSNR--FLVYEY 581
           N G +VAVK L P E+ G    +   E+E + N++H N+V+  G C E       L+ E+
Sbjct: 36  NTGEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 94
Query: 582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR 641
           + +GSL +++        L   ++  +  QI +G++YL    + + +H D+  +N+L++ 
Sbjct: 95  LPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG---SRQYVHRDLAARNVLVES 149
Query: 642 DLNVKIADFGLARLIAQDQSHVSTM-PKGTPGY-MAPELTRGNSITAKIDIYSFGVVILE 699
           +  VKI DFGL + I  D+   +    + +P +  APE    +      D++SFGV + E
Sbjct: 150 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 209
Query: 700 II 701
           ++
Sbjct: 210 LL 211

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 12/228 (5%)
Query: 489 VANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFL 548
           V ++ +  S++   S   + +  LGRG +  V+      GT+         +   KK   
Sbjct: 38  VPDYWIDGSNRDALSDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTVDKKIVR 96
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+  +  + H N+++L       +   LV E +  G L   I  K              
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD---AADA 153
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHVST 665
           + QI   + YLH+     I+H D+KP+N+L      D  +KIADFGL++++ + Q  + T
Sbjct: 154 VKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKT 209
Query: 666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD 713
           +  GTPGY APE+ RG +   ++D++S G++   ++CG      + GD
Sbjct: 210 V-CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 26/223 (11%)
Query: 513 GRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
            RG  G V++  L+ND   VAVK ++P +++   +   E+ +   + H NL++ +     
Sbjct: 24  ARGRFGCVWKAQLMNDF--VAVK-IFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 572 RSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD---YC- 623
            SN     +L+  +   GSL  ++    +   ++W+    +   +SRGL YLH+   +C 
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 624 ----NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPEL 678
                P I H D K +N+LL  DL   +ADFGLA      +    T  + GT  YMAPE+
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 679 TRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV 716
             G          +ID+Y+ G+V+ E++   ++++    +Y++
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYML 239

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 96/182 (52%), Gaps = 12/182 (6%)
Query: 526 NDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGYCAERSNR--FLVYEY 581
           N G +VAVK L P E+ G    +   E+E + N++H N+V+  G C E       L+ E+
Sbjct: 48  NTGEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR 641
           + +GSL +++        L   ++  +  QI +G++YL    + + +H D+  +N+L++ 
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG---SRQYVHRDLAARNVLVES 161
Query: 642 DLNVKIADFGLARLIAQDQSHVSTM-PKGTPGY-MAPELTRGNSITAKIDIYSFGVVILE 699
           +  VKI DFGL + I  D+   +    + +P +  APE    +      D++SFGV + E
Sbjct: 162 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 700 II 701
           ++
Sbjct: 222 LL 223

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 264
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 265 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G+G  G VF+G+ N   KV   ++          ++   E+  +       + +  G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L+     + +I T        I+ +I +GL+YLH   +
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYLH---S 137
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL     VK+ADFG+A  +   Q   +    GTP +MAPE+ + ++ 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF-VGTPFWMAPEVIKQSAY 196
Query: 685 TAKIDIYSFGVVILEIICGR 704
            +K DI+S G+  +E+  G 
Sbjct: 197 DSKADIWSLGITAIELARGE 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++ EY   G+L +++   +      S+DI +              
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 323
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 324 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRLVG 567
           LG GG   V     L D   VAVK L     R       F  E +    ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 568 YCAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
                +      ++V EY+ +G   + I H +   T    I  ++I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQN- 135
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRG 681
              IIH D+KP NI++     VK+ DFG+AR IA   + V+      GT  Y++PE  RG
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 682 NSITAKIDIYSFGVVILEIICG 703
           +S+ A+ D+YS G V+ E++ G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTG 215

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 528 GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
             K   KR      RG  ++E   EV  +  I H N++ L      +++  L+ E +  G
Sbjct: 41  AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG 100
Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDRDL- 643
            L  ++  K   ++L+ D   + + QI  G+ YLH   + +I HFD+KP+NI LLD+++ 
Sbjct: 101 ELFDFLAEK---ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 154
Query: 644 --NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
              +K+ DFG+A  I       +    GTP ++APE+     +  + D++S GV+   ++
Sbjct: 155 NPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 702 CGRRSSNPKGGDYLVDTL 719
            G   ++P  G+   +TL
Sbjct: 213 SG---ASPFLGETKQETL 227

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKK---EFLSEVETIGNIHHFNLVRLVG 567
           LG GG   V     L D   VAVK L     R       F  E +    ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 568 YCAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
                +      ++V EY+ +G   + I H +   T    I  ++I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQN- 135
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRG 681
              IIH D+KP NI++     VK+ DFG+AR IA   + V+      GT  Y++PE  RG
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 682 NSITAKIDIYSFGVVILEIICG 703
           +S+ A+ D+YS G V+ E++ G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTG 215

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 528 GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
             K   KR      RG  ++E   EV  +  I H N++ L      +++  L+ E +  G
Sbjct: 34  AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG 93
Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDRDL- 643
            L  ++  K   ++L+ D   + + QI  G+ YLH   + +I HFD+KP+NI LLD+++ 
Sbjct: 94  ELFDFLAEK---ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 147
Query: 644 --NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
              +K+ DFG+A  I       +    GTP ++APE+     +  + D++S GV+   ++
Sbjct: 148 NPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
Query: 702 CGRRSSNPKGGDYLVDTL 719
            G   ++P  G+   +TL
Sbjct: 206 SG---ASPFLGETKQETL 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G+G  G VF+G+ N   KV   ++          ++   E+  +       + +  G 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 569 CAERSNRFLVYEYMCNGS----LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             + +  +++ EY+  GS    L+     + +I T        I+ +I +GL+YLH   +
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYLH---S 122
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            K IH DIK  N+LL     VK+ADFG+A  +   Q   +    GTP +MAPE+ + ++ 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF-VGTPFWMAPEVIKQSAY 181
Query: 685 TAKIDIYSFGVVILEIICGR 704
            +K DI+S G+  +E+  G 
Sbjct: 182 DSKADIWSLGITAIELARGE 201

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 511 RLGRGGSGSVFEGLLND---GTKVAVKRLYPGE-----NRGKKEFLSEVETIGNIHHFNL 562
           +LG G  G V   L  D   G + A+K +         N G    L EV  +  + H N+
Sbjct: 11  KLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQLDHPNI 66
Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           ++L  +  ++ N +LV E    G L   I  + +   +   +   I+ Q+  G  YLH +
Sbjct: 67  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHKH 123
Query: 623 CNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYM 674
               I+H D+KP+N+LL+   RD  +KI DFGL+       +H     K     GT  Y+
Sbjct: 124 ---NIVHRDLKPENLLLESKSRDALIKIVDFGLS-------AHFEVGGKMKERLGTAYYI 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICG 703
           APE+ R      K D++S GV++  ++CG
Sbjct: 174 APEVLR-KKYDEKCDVWSCGVILYILLCG 201

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 528 GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
             K   KR      RG  ++E   EV  +  I H N++ L      +++  L+ E +  G
Sbjct: 55  AAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG 114
Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDRDL- 643
            L  ++  K   ++L+ D   + + QI  G+ YLH   + +I HFD+KP+NI LLD+++ 
Sbjct: 115 ELFDFLAEK---ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 168
Query: 644 --NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
              +K+ DFG+A  I       +    GTP ++APE+     +  + D++S GV+   ++
Sbjct: 169 NPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 226
Query: 702 CGRRSSNPKGGDYLVDTL 719
            G   ++P  G+   +TL
Sbjct: 227 SG---ASPFLGETKQETL 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 184 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 125
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 184
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 185 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    FE    D  +V   ++ P     +   +++   E+    ++ H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    F+V E     SL +   HK R + L+    +  + QI  G +YLH     ++
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE--LHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRV 160
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ DL VKI DFGLA  +  D      +  GTP Y+APE+      + +
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGHSFE 219
Query: 688 IDIYSFGVVILEIICGR 704
           +D++S G ++  ++ G+
Sbjct: 220 VDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    FE    D  +V   ++ P     +   +++   E+    ++ H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    F+V E     SL +   HK R + L+    +  + QI  G +YLH     ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE--LHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ DL VKI DFGLA  +  D      +  GTP Y+APE+      + +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGHSFE 221
Query: 688 IDIYSFGVVILEIICGR 704
           +D++S G ++  ++ G+
Sbjct: 222 VDVWSIGCIMYTLLVGK 238

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 212

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 131
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-ITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGXKYYST 190
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 191 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 525 LNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
           L    K   KR      RG  +++   EV  +  I H N++ L      +++  L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELV 96
Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI-LLDR 641
             G L  ++  K   ++L+ +   + + QI  G+ YLH     +I HFD+KP+NI LLDR
Sbjct: 97  AGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150
Query: 642 DL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
           ++    +KI DFGLA  I       +    GTP ++APE+     +  + D++S GV+  
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 699 EIICGRRSSNPKGGDYLVDTL 719
            ++ G   ++P  GD   +TL
Sbjct: 209 ILLSG---ASPFLGDTKQETL 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    FE    D  +V   ++ P     +   +++   E+    ++ H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    F+V E     SL +   HK R + L+    +  + QI  G +YLH     ++
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE--LHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ DL VKI DFGLA  +  D      +  GTP Y+APE+      + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGHSFE 195
Query: 688 IDIYSFGVVILEIICGR 704
           +D++S G ++  ++ G+
Sbjct: 196 VDVWSIGCIMYTLLVGK 212

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G VF+    D G  VA+K+    E+    KK  L E+  +  + H NLV L+ 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHK-DRIQT-LSWDIRKKIIFQISRGLEYLHDYCNP 625
               +    LV+EY      D  + H+ DR Q  +   + K I +Q  + + + H +   
Sbjct: 70  VFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH--- 121
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-I 684
             IH D+KP+NIL+ +   +K+ DFG ARL+     +       T  Y +PEL  G++  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVATRWYRSPELLVGDTQY 180
Query: 685 TAKIDIYSFGVVILEIICG 703
              +D+++ G V  E++ G
Sbjct: 181 GPPVDVWAIGCVFAELLSG 199

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 184 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 17/194 (8%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRFYT 138
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--QSHVSTMP 667
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +  Q+  ++  
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF- 194
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD- 726
            GT  Y++PEL    S +   D+++ G +I +++ G       G +YL+    +K E D 
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDF 253
Query: 727 ------RLCDLVDK 734
                 +  DLV+K
Sbjct: 254 PEKFFPKARDLVEK 267

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 131
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 190
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 191 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 220

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 184 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-ITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGXKYYST 183
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 184 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ 635
           ++V EY+ +G   + I H +   T    I  ++I    + L + H      IIH D+KP 
Sbjct: 92  YIVMEYV-DGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRGNSITAKIDIYSF 693
           NI++     VK+ DFG+AR IA   + V+      GT  Y++PE  RG+S+ A+ D+YS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 694 GVVILEIICG 703
           G V+ E++ G
Sbjct: 206 GCVLYEVLTG 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 508 FQIRLGRGGSGSVFEGLLN-DGTKV--AVKRLYPGENRGK-KEFLSEVETIGNI-HHFNL 562
           FQ  +G G  G V +  +  DG ++  A+KR+    ++   ++F  E+E +  + HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--------------QTLSWDIRKKI 608
           + L+G C  R   +L  EY  +G+L  ++  K R+               TLS       
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
              ++RG++YL      + IH ++  +NIL+  +   KIADFGL+R   Q+     TM +
Sbjct: 145 AADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 199
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
               +MA E    +  T   D++S+GV++ EI+
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 128
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 187
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 188 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ 635
           ++V EY+ +G   + I H +   T    I  ++I    + L + H      IIH D+KP 
Sbjct: 92  YIVMEYV-DGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRGNSITAKIDIYSF 693
           NI++     VK+ DFG+AR IA   + V+      GT  Y++PE  RG+S+ A+ D+YS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 694 GVVILEIICG 703
           G V+ E++ G
Sbjct: 206 GCVLYEVLTG 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 497 SSKAMKS-ATRDFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVET 553
           S KA  S   +DF +   +GRG    V    L    ++   ++   E     E +  V+T
Sbjct: 10  SGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 69
Query: 554 IGNI-----HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
             ++     +H  LV L       S  F V EY+  G L   +FH  R + L  +  +  
Sbjct: 70  EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFY 126
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             +IS  L YLH+     II+ D+K  N+LLD + ++K+ D+G+ +   +     S    
Sbjct: 127 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC- 182
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           GTP Y+APE+ RG      +D ++ GV++ E++ GR
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV  +  ++H N+V+L          +L+ EY   G +  ++    R++    + 
Sbjct: 56  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK--EKEA 113
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H     +I+H D+K +N+LLD D+N+KIADFG +         + 
Sbjct: 114 RSKF-RQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLD 168
Query: 665 TMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
           T   G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 169 TFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 138
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 254
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 255 EKFFPKARDLVEK 267

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 141
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 142 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 198
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 199 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 257
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 258 AAFFPKARDLVEK 270

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 139
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--QSHVSTMP 667
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +  Q+  ++  
Sbjct: 140 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF- 195
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD- 726
            GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D 
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDF 254
Query: 727 ------RLCDLVDK 734
                 +  DLV+K
Sbjct: 255 PEKFFPKARDLVEK 268

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++  Y   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 138
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 254
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 255 EKFFPKARDLVEK 267

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 136
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 252
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 253 EKFFPKARDLVEK 265

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 138
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 254
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 255 EKFFPKARDLVEK 267

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 512 LGRGGSGSVFE----GLL--NDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVR 564
           +G G  G VF+    GLL     T VAVK L    +   + +F  E   +    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWI-----------FHKD-----RIQT-----LSWD 603
           L+G CA      L++EYM  G L++++            H D     R+ +     LS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
            +  I  Q++ G+ YL +    K +H D+  +N L+  ++ VKIADFGL+R I     + 
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 664 STMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEII 701
           +      P  +M PE    N  T + D++++GVV+ EI 
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 139
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 140 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 196
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 255
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 256 EKFFPKARDLVEK 268

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 25/182 (13%)
Query: 547 FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
            L EV  +  + H N+++L  +  ++ N +LV E    G L   I  + +   +   +  
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-- 125
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHV 663
            I+ Q+  G  YLH +    I+H D+KP+N+LL+   RD  +KI DFGL+       +H 
Sbjct: 126 -IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS-------AHF 174
Query: 664 STMPK-----GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
               K     GT  Y+APE+ R      K D++S GV++  ++CG     P GG    + 
Sbjct: 175 EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCG---YPPFGGQTDQEI 230
Query: 719 LK 720
           LK
Sbjct: 231 LK 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 136
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 252
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 253 EKFFPKARDLVEK 265

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 136
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV 193
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 252
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 253 EKFFPKARDLVEK 265

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 136
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 252
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 253 EKFFPKARDLVEK 265

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-----HHFNLVRLV 566
           +GRG    V    L    ++   ++   E     E +  V+T  ++     +H  LV L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                 S  F V EY+  G L   +FH  R + L  +  +    +IS  L YLH+     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 126
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
           II+ D+K  N+LLD + ++K+ D+G+ +   +     S    GTP Y+APE+ RG     
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIAPEILRGEDYGF 185
Query: 687 KIDIYSFGVVILEIICGR 704
            +D ++ GV++ E++ GR
Sbjct: 186 SVDWWALGVLMFEMMAGR 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 135
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 136 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 192
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 251
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 252 EKFFPKARDLVEK 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    +E    D  +V   ++ P     +   K++  +E+    ++ + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    ++V E     SL +   HK R      + R   + Q  +G++YLH   N ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRV 163
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ D++VKI DFGLA  I  D     T+  GTP Y+APE+      + +
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVLCKKGHSFE 222
Query: 688 IDIYSFGVVILEIICGR 704
           +DI+S G ++  ++ G+
Sbjct: 223 VDIWSLGCILYTLLVGK 239

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-----HHFNLVRLV 566
           +GRG    V    L    ++   ++   E     E +  V+T  ++     +H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                 S  F V EY+  G L   +FH  R + L  +  +    +IS  L YLH+     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 130
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
           II+ D+K  N+LLD + ++K+ D+G+ +   +     S    GTP Y+APE+ RG     
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIAPEILRGEDYGF 189
Query: 687 KIDIYSFGVVILEIICGR 704
            +D ++ GV++ E++ GR
Sbjct: 190 SVDWWALGVLMFEMMAGR 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ 635
           ++V EY+ +G   + I H +   T    I  ++I    + L + H      IIH D+KP 
Sbjct: 109 YIVMEYV-DGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPA 162
Query: 636 NILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRGNSITAKIDIYSF 693
           NI++     VK+ DFG+AR IA   + V+      GT  Y++PE  RG+S+ A+ D+YS 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 694 GVVILEIICG 703
           G V+ E++ G
Sbjct: 223 GCVLYEVLTG 232

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++V E++  G+L   + H      ++ +    +   + + L  LH      +I
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VI 269
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  +ILL  D  VK++DFG    ++++      +  GTP +MAPEL        ++
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEV 328
Query: 689 DIYSFGVVILEIICG 703
           DI+S G++++E++ G
Sbjct: 329 DIWSLGIMVIEMVDG 343

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R    D        KG  G    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 135
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--QSHVSTMP 667
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +  Q+  ++  
Sbjct: 136 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF- 191
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD- 726
            GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D 
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDF 250
Query: 727 ------RLCDLVDK 734
                 +  DLV+K
Sbjct: 251 PEKFFPKARDLVEK 264

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R    D        KG  G    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 11/179 (6%)
Query: 528 GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
           G +VAVK +   +  +   ++   EV  +  ++H N+V+L          +LV EY   G
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV 645
            +  ++    R++    + R K   QI   ++Y H      I+H D+K +N+LLD D+N+
Sbjct: 99  EVFDYLVAHGRMK--EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
           KIADFG +       + + T   G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 153 KIADFGFSNEFTFG-NKLDTFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 143
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 144 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 200
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 201 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 259
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 260 EKFFPKARDLVEK 272

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 113
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 114 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 229
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 230 EKFFPKARDLVEK 242

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R    D        KG  G    
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 193
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 115
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 116 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 231
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 232 EKFFPKARDLVEK 244

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 11/179 (6%)
Query: 528 GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
           G +VAVK +   +  +   ++   EV  +  ++H N+V+L          +LV EY   G
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV 645
            +  ++    R++    + R K   QI   ++Y H      I+H D+K +N+LLD D+N+
Sbjct: 99  EVFDYLVAHGRMK--EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
           KIADFG +       + + T   G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 153 KIADFGFSNEFTFG-NKLDTFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 116
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 117 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 232
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 233 EKFFPKARDLVEK 245

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 41/224 (18%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG------ENRGKKEFLSEVETIGNIHHFNLV 563
           +LG+G  G V++ +    G  VAVK+++          R  +E +   E  G   H N+V
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG---HENIV 72
Query: 564 RLVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
            L+      ++R  +LV++YM    L   I    R   L    ++ +++Q+ + ++YLH 
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM-ETDLHAVI----RANILEPVHKQYVVYQLIKVIKYLH- 126
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-------------- 667
             +  ++H D+KP NILL+ + +VK+ADFGL+R     +   + +P              
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 668 ------KGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGR 704
                   T  Y APE+  G++  T  ID++S G ++ EI+CG+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV  +  ++H N+V+L          +LV EY   G +  ++    R++    + 
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK--EKEA 115
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H      I+H D+K +N+LLD D+N+KIADFG +       + + 
Sbjct: 116 RAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLD 170
Query: 665 TMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
           T   G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 171 TFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 37  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++V E++  G+L   + H      ++ +    +   + + L  LH      +I
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VI 149
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  +ILL  D  VK++DFG    ++++      +  GTP +MAPEL        ++
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEV 208
Query: 689 DIYSFGVVILEIICG 703
           DI+S G++++E++ G
Sbjct: 209 DIWSLGIMVIEMVDG 223

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 40/293 (13%)
Query: 512 LGRGGSGSVFE----GLLNDGTK----VAVKRLYP-GENRGKKEFLSEVETIGNI-HHFN 561
           LG G  G V      G+  D  K    VAVK L      +   + +SE+E +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRK------------KI 608
           ++ L+G C +    +++  Y   G+L +++   +      S+DI +              
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
            +Q++RG+EYL    + K IH D+  +N+L+  +  +KIADFGLAR I     +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 669 GTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
             P  +MAPE       T + D++SFGV++ EI       +P  G  + +  K+  E  R
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHR 277
Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +    +  +E     RD           C      +RP+   LV+ L  +  L
Sbjct: 278 MDKPANCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 179
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 120
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 121 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 177
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 236
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 237 EKFFPKARDLVEK 249

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 114
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 115 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD-- 726
           GT  Y++PEL    S     D+++ G +I +++ G       G +YL+    +K E D  
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFP 230
Query: 727 -----RLCDLVDK 734
                +  DLV+K
Sbjct: 231 EKFFPKARDLVEK 243

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 35  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++V E++  G+L   + H      ++ +    +   + + L  LH      +I
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VI 147
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  +ILL  D  VK++DFG    ++++      +  GTP +MAPEL        ++
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEV 206
Query: 689 DIYSFGVVILEIICG 703
           DI+S G++++E++ G
Sbjct: 207 DIWSLGIMVIEMVDG 221

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL-YPGENRGKK--EFLSEVETIGNIHHFNLVRLVG 567
           +G G  G+V F   + +   VA+K++ Y G+   +K  + + EV  +  + H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   +LV EY    + D    HK  +Q +       +     +GL YLH +    +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI---AAVTHGALQGLAYLHSH---NM 175
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG---NSI 684
           IH D+K  NILL     VK+ DFG A ++A     V     GTP +MAPE+         
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY 230
Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS-HR 743
             K+D++S G+  +E+      +  K   + ++ +        L  +   +S  +QS H 
Sbjct: 231 DGKVDVWSLGITCIEL------AERKPPLFNMNAMSA------LYHIAQNESPALQSGHW 278
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +  +      SCLQK    RP++ +L+K
Sbjct: 279 SEYFR--NFVDSCLQKIPQDRPTSEVLLK 305

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 125
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 180
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 214

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G V++   N G   A+K++    E+ G     + E+  +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 569 CAERSNRFLVYEYM----------CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
              +    LV+E++          C G L+                 K  + Q+  G+ Y
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT-------------AKSFLLQLLNGIAY 115
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMA 675
            HD    +++H D+KPQN+L++R+  +KIADFGLAR   +  +  +H       T  Y A
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRA 168
Query: 676 PELTRGN-SITAKIDIYSFGVVILEIICG 703
           P++  G+   +  IDI+S G +  E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNIHHF 560
           DF I   LG+G  G+V+         + A+K L+    E  G + +   E+E   ++ H 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEY 618
           N++R+  Y  +R   +L+ E+   G L K +    R     +D ++   F  +++  L Y
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHY 130
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK----GTPGYM 674
            H+    K+IH DIKP+N+L+     +KIADFG +        H  ++ +    GT  Y+
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYL 180
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICG 703
            PE+  G +   K+D++  GV+  E + G
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 179
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 178
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 212

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPG--ENRG-KKEFLSEVETIGNIHHF 560
           DF I   LG+G  G+V+         + A+K L+    E  G + +   E+E   ++ H 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEY 618
           N++R+  Y  +R   +L+ E+   G L K +    R     +D ++   F  +++  L Y
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHY 129
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK----GTPGYM 674
            H+    K+IH DIKP+N+L+     +KIADFG +        H  ++ +    GT  Y+
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYL 179
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICG 703
            PE+  G +   K+D++  GV+  E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G V++   N G   A+K++    E+ G     + E+  +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 569 CAERSNRFLVYEYM----------CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
              +    LV+E++          C G L+                 K  + Q+  G+ Y
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT-------------AKSFLLQLLNGIAY 115
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMA 675
            HD    +++H D+KPQN+L++R+  +KIADFGLAR   +  +  +H       T  Y A
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRA 168
Query: 676 PELTRGN-SITAKIDIYSFGVVILEIICG 703
           P++  G+   +  IDI+S G +  E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 26  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++V E++  G+L   + H      ++ +    +   + + L  LH      +I
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VI 138
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  +ILL  D  VK++DFG    ++++      +  GTP +MAPEL        ++
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEV 197
Query: 689 DIYSFGVVILEIICG 703
           DI+S G++++E++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 127
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 182
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 216

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 126
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 181
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 503 SATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FL 548
           ++TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL
Sbjct: 2   ASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 61
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
            E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLI 116
Query: 609 IF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
           ++  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + ++ 
Sbjct: 117 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
            K    +MAPE       T+  D++ FGV + EI+
Sbjct: 174 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 126
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 181
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 215

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 127
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 182
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 216

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 125
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 180
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV  +  ++H N+V+L          +LV EY   G +  ++    R++    + 
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK--EKEA 116
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H      I+H D+K +N+LLD D+N+KIADFG +       + + 
Sbjct: 117 RAKF-RQIVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLD 171
Query: 665 TMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
           T   G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 172 TFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 30  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++V E++  G+L   + H      ++ +    +   + + L  LH      +I
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VI 142
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  +ILL  D  VK++DFG    ++++      +  GTP +MAPEL        ++
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEV 201
Query: 689 DIYSFGVVILEIICG 703
           DI+S G++++E++ G
Sbjct: 202 DIWSLGIMVIEMVDG 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 179
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV  +  ++H N+V+L          +L+ EY   G +  ++    R++    + 
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK--EKEA 116
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H     +I+H D+K +N+LLD D+N+KIADFG +          +
Sbjct: 117 RSKF-RQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 665 TMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
               G P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 173 FC--GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 568 YCAERSNRFLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                +  +LV+E++   S+D K       +  +   + K  +FQ+ +GL + H +   +
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG- 681
           ++H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGC 181
Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
           ++G G  G V++   N G   A+K++    E+ G     + E+  +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 569 CAERSNRFLVYEYM----------CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
              +    LV+E++          C G L+                 K  + Q+  G+ Y
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT-------------AKSFLLQLLNGIAY 115
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMA 675
            HD    +++H D+KPQN+L++R+  +KIADFGLAR   +  +  +H       T  Y A
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRA 168
Query: 676 PELTRGN-SITAKIDIYSFGVVILEIICG 703
           P++  G+   +  IDI+S G +  E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 441 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLIL 495
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + ++  
Sbjct: 496 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 568 YCAERSNRFLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                +  +LV+E++   S+D K       +  +   + K  +FQ+ +GL + H +   +
Sbjct: 72  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG- 681
           ++H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGC 180
Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 215

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 179
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 510 IRLGRGGSGSV-FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           I++G G +G V    + + G  VAVK++   + + ++   +EV  + +  H N+V +   
Sbjct: 80  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                  ++V E++  G+L   + H      ++ +    +   + + L  LH      +I
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VI 192
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H DIK  +ILL  D  VK++DFG    ++++      +  GTP +MAPEL        ++
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEV 251
Query: 689 DIYSFGVVILEIICG 703
           DI+S G++++E++ G
Sbjct: 252 DIWSLGIMVIEMVDG 266

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLIL 115
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + ++  
Sbjct: 116 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 128
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 183
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 184 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 36/235 (15%)
Query: 501 MKSATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLY---PGENRGKKEFLSEVETIGN 556
           +++  RD Q  +G G  G+V   +    G KVA+K+LY     E   K+ +  E+  + +
Sbjct: 23  VRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKH 80
Query: 557 IHHFNLVRLVGYCA------ERSNRFLVYEYMCNGSLDKWIFHK----DRIQTLSWDIRK 606
           + H N++ L+          + ++ +LV  +M    L K + H+    DRIQ L      
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL------ 133
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
             ++Q+ +GL Y+H      IIH D+KP N+ ++ D  +KI DFGLAR    +       
Sbjct: 134 --VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV- 187
Query: 667 PKGTPGYMAPE-LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
              T  Y APE +      T  +DI+S G ++ E+I G+  +  KG D+L D LK
Sbjct: 188 ---TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK--TLFKGSDHL-DQLK 236

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLIL 115
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +       ++  
Sbjct: 116 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG 172
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 178
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 85/162 (52%), Gaps = 13/162 (8%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV  +  ++H N+V+L          +LV EY   G +  ++    R++    + 
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK--EKEA 115
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H      I+H D+K +N+LLD D+N+KIADFG     + + +  +
Sbjct: 116 RAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF----SNEFTFGN 167
Query: 665 TMPK--GTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
            + +  G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 168 KLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R    D    +   KG  G    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKGLLPV 196
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLIL 115
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + ++  
Sbjct: 116 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL-YPGENRGKK--EFLSEVETIGNIHHFNLVRLVG 567
           +G G  G+V F   + +   VA+K++ Y G+   +K  + + EV  +  + H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   +LV EY    + D    HK  +Q +       +     +GL YLH +    +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE---IAAVTHGALQGLAYLHSH---NM 136
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG---NSI 684
           IH D+K  NILL     VK+ DFG A ++A     V     GTP +MAPE+         
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY 191
Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS-HR 743
             K+D++S G+  +E+      +  K   + ++ +        L  +   +S  +QS H 
Sbjct: 192 DGKVDVWSLGITCIEL------AERKPPLFNMNAMSA------LYHIAQNESPALQSGHW 239
Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +  +      SCLQK    RP++ +L+K
Sbjct: 240 SEYFR--NFVDSCLQKIPQDRPTSEVLLK 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV  +  ++H N+V+L          +LV EY   G +  ++    R++    + 
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK--EKEA 115
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H      I+H D+K +N+LLD D+N+KIADFG +          +
Sbjct: 116 RAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA 171
Query: 665 TMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
               G P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 172 FC--GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 64  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLIL 118
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+  +  VK+ DFGL+R +     + ++  
Sbjct: 119 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 175
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLIL 115
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+     VK+ DFGL+R +     + ++  
Sbjct: 116 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 510 IRLGRGGSGSVFEGLLNDGTK---VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRL 565
           I LG G  GSV +G+     K   VA+K L  G E    +E + E + +  + +  +VRL
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C   +   LV E    G L K++  K   + +      +++ Q+S G++YL +    
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT--PGYMAPELTRGNS 683
             +H D+  +N+LL      KI+DFGL++ +  D S+ +    G     + APE      
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 684 ITAKIDIYSFGVVILEII 701
            +++ D++S+GV + E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 43/232 (18%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG G SG+V F+G    G  VAVKR+   +      + + L+E +      H N++R   
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVIRY-- 92
Query: 568 YCAERSNRFL-VYEYMCNGSLDKWIFHKDRIQTLSWDIRKK-----IIFQISRGLEYLHD 621
           YC+E ++RFL +   +CN +L   +  K+ +   +  ++K+     ++ QI+ G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 622 YCNPKIIHFDIKPQNILLD-------------RDLNVKIADFGLARLIAQDQSHVS---T 665
               KIIH D+KPQNIL+               +L + I+DFGL + +   Q        
Sbjct: 152 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 666 MPKGTPGYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDY 714
            P GT G+ APEL   ++   +T  IDI+S G V   I+   +  +P G  Y
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS--KGKHPFGDKY 258

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 43/232 (18%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG G SG+V F+G    G  VAVKR+   +      + + L+E +      H N++R   
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVIRY-- 92
Query: 568 YCAERSNRFL-VYEYMCNGSLDKWIFHKDRIQTLSWDIRKK-----IIFQISRGLEYLHD 621
           YC+E ++RFL +   +CN +L   +  K+ +   +  ++K+     ++ QI+ G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 622 YCNPKIIHFDIKPQNILLD-------------RDLNVKIADFGLARLIAQDQSHVS---T 665
               KIIH D+KPQNIL+               +L + I+DFGL + +   Q        
Sbjct: 152 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 666 MPKGTPGYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDY 714
            P GT G+ APEL   ++   +T  IDI+S G V   I+   +  +P G  Y
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS--KGKHPFGDKY 258

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR  A + +        T  Y APE+    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNW 204
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR  A + +        T  Y APE+    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNW 204
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 196
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR  A + +        T  Y APE+    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNW 204
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 195
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 498 SKAMKSATRDFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-----FLSEV 551
           S+A +    DF   LG G   +V++    N    VA+K++  G     K+      L E+
Sbjct: 7   SRAKRYEKLDF---LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
           + +  + H N++ L+     +SN  LV+++M     D  +  KD    L+    K  +  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGT 670
             +GLEYLH +    I+H D+KP N+LLD +  +K+ADFGLA+   + ++++   +   T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV--VT 175
Query: 671 PGYMAPELTRGNSI-TAKIDIYSFGVVILEII 701
             Y APEL  G  +    +D+++ G ++ E++
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++      K       +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 69  VIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITA 686
           +H D+KPQN+L++ +  +K+ADFGLAR          T    T  Y APE+  G    + 
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
            +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 AVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 212

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 115/232 (49%), Gaps = 26/232 (11%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHF---NLVRL 565
           +G G  G+V++    + G  VA+K  R+  GE       + EV  +  +  F   N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 566 VGYCA-ERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           +  CA  R++R     LV+E++ +  L  ++  K     L  +  K ++ Q  RGL++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
             C   I+H D+KP+NIL+     VK+ADFGLAR+ +   +    +   T  Y APE+  
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVV--VTLWYRAPEVLL 184
Query: 681 GNSITAKIDIYSFGVVILE------IICGRRSSNPKGGDYLVDTLKVKAEAD 726
            ++    +D++S G +  E      + CG   ++  G   + D + +  E D
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFDLIGLPPEDD 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG+G  G V +     D    A+K++   E +     LSEV  + +++H  +VR      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 571 ERSN-------------RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           ER N              F+  EY  NG+L   I  ++  Q    D   ++  QI   L 
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-------LIAQDQSHVS------ 664
           Y+H   +  IIH D+KP NI +D   NVKI DFGLA+       ++  D  ++       
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 665 TMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEII 701
           T   GT  Y+A E+  G      KID+YS G++  E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++      K       +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 73  VIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 127
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 182
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 216

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 93/173 (53%), Gaps = 10/173 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           + E+  +  ++H N+V+L+      +  +LV+E++ +  L K++     +  +   + K 
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKS 107
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
            +FQ+ +GL + H +   +++H D+KPQN+L++ +  +K+ADFGLAR          T  
Sbjct: 108 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHE 163
Query: 668 KGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             T  Y APE+  G    +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 93/173 (53%), Gaps = 10/173 (5%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           + E+  +  ++H N+V+L+      +  +LV+E++ +  L K++     +  +   + K 
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKS 106
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
            +FQ+ +GL + H +   +++H D+KPQN+L++ +  +K+ADFGLAR          T  
Sbjct: 107 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHE 162
Query: 668 KGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             T  Y APE+  G    +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 568 YCAERSNRFLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                +  +LV+E++   S+D K       +  +   + K  +FQ+ +GL + H +   +
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG- 681
           ++H D+KP+N+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGC 181
Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 86/153 (56%), Gaps = 13/153 (8%)
Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTL-SWDIRKKIIF--QISRGLEYLHDYCNPKII 628
           + N F V EY+  G L   ++H   IQ+   +D+ +   +  +I  GL++LH   +  I+
Sbjct: 91  KENLFFVMEYLNGGDL---MYH---IQSCHKFDLSRATFYAAEIILGLQFLH---SKGIV 141
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           + D+K  NILLD+D ++KIADFG+ +      +  +    GTP Y+APE+  G      +
Sbjct: 142 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-GTPDYIAPEILLGQKYNHSV 200
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV 721
           D +SFGV++ E++ G+   + +  + L  ++++
Sbjct: 201 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 89/155 (57%), Gaps = 17/155 (10%)
Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTL-SWDIRKKIIF--QISRGLEYLHDYCNPKII 628
           + N F V EY+  G L   ++H   IQ+   +D+ +   +  +I  GL++LH   +  I+
Sbjct: 90  KENLFFVMEYLNGGDL---MYH---IQSCHKFDLSRATFYAAEIILGLQFLH---SKGIV 140
Query: 629 HFDIKPQNILLDRDLNVKIADFGLAR--LIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
           + D+K  NILLD+D ++KIADFG+ +  ++   +++      GTP Y+APE+  G     
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC---GTPDYIAPEILLGQKYNH 197
Query: 687 KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV 721
            +D +SFGV++ E++ G+   + +  + L  ++++
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 568 YCAERSNRFLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                +  +LV+E++   S+D K       +  +   + K  +FQ+ +GL + H +   +
Sbjct: 71  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG- 681
           ++H D+KP+N+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGC 179
Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 214

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EYM  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +K+ADFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 73  VIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 127
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KPQN+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 182
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EYM  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +K+ADFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 508 FQIRLGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E      G  +   KVAVK L    +  +KE  +SE++ + ++  H
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK------------------DRIQTLS 601
            N+V L+G C       ++ EY C G L  ++  K                  D+     
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 602 WDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
            ++R  + F  Q+++G+ +L    +   IH D+  +N+LL      KI DFGLAR I  D
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 660 QSHVSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEII 701
            +++       P  +MAPE       T + D++S+G+++ EI 
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 115/232 (49%), Gaps = 26/232 (11%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHF---NLVRL 565
           +G G  G+V++    + G  VA+K  R+  GE       + EV  +  +  F   N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 566 VGYCA-ERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           +  CA  R++R     LV+E++ +  L  ++  K     L  +  K ++ Q  RGL++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
             C   I+H D+KP+NIL+     VK+ADFGLAR+ +   +    +   T  Y APE+  
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV--VTLWYRAPEVLL 184
Query: 681 GNSITAKIDIYSFGVVILE------IICGRRSSNPKGGDYLVDTLKVKAEAD 726
            ++    +D++S G +  E      + CG   ++  G   + D + +  E D
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFDLIGLPPEDD 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 504 ATRDFQIR---------LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLS 549
           +TRD++I+         +G G  G V +G+     N    VA+K      +   +E FL 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E  T+    H ++V+L+G   E +  +++ E    G L  ++    +++  S D+   I+
Sbjct: 441 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLIL 495
Query: 610 F--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
           +  Q+S  L YL    + + +H DI  +N+L+     VK+ DFGL+R +     + ++  
Sbjct: 496 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
           K    +MAPE       T+  D++ FGV + EI+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R    D        KG  G     
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 199
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 512 LGRGGSGSVFEGLLNDGTK----VAVKRL-YPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           +G+G  G V+ G   D  +     A+K L    E +  + FL E   +  ++H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 567 G-YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII---FQISRGLEYLHDY 622
           G          ++  YMC+G L ++I    R  T+     K +I    Q++RG+EYL   
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV-----KDLISFGLQVARGMEYL--- 140
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-------AQDQSHVSTMPKGTPGYMA 675
              K +H D+  +N +LD    VK+ADFGLAR I        Q   H     K T    A
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 676 PELTRGNSITAKIDIYSFGVVILEII 701
            E  +    T K D++SFGV++ E++
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R    D        KG  G     
Sbjct: 138 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 190
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV     +  G K+AVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 171
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 172 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 226
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 516 GSGSVFEGLLND----GTKVAVKRLYPGENRGKKEFL-SEVETIGNIHHFNLVRLVGYCA 570
           G+G+  E +L +    G   AVK +     +GK+  + +E+  +  I H N+V L     
Sbjct: 31  GTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYE 90
Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK---IIFQISRGLEYLHDYCNPKI 627
             ++ +LV + +  G L       DRI    +   K    +I Q+   + YLH      I
Sbjct: 91  SPNHLYLVMQLVSGGEL------FDRIVEKGFYTEKDASTLIRQVLDAVYYLH---RMGI 141
Query: 628 IHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
           +H D+KP+N+L    D +  + I+DFGL+++  + +  V +   GTPGY+APE+      
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLAQKPY 199
Query: 685 TAKIDIYSFGVVILEIICG 703
           +  +D +S GV+   ++CG
Sbjct: 200 SKAVDCWSIGVIAYILLCG 218

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 125
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KP+N+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 180
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 214

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++ +  L K++     +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 126
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KP+N+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 181
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 511 RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI-------FHKDRIQTLSWDIRKKIIFQISRGL 616
           RL+G  ++     ++ E M  G L  ++        +   +   S     ++  +I+ G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+   N K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 152 AYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 204
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +M+PE  +    T   D++SFGVV+ EI
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 139/316 (43%), Gaps = 49/316 (15%)
Query: 511 RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGL 616
           RL+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 197
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL 731
            +M+PE  +    T   D++SFGVV+ EI     +  P  G      L+   E      L
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQVLRFVMEG----GL 251
Query: 732 VDKKSEDMQSHRDDAVKMI-QIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGF-- 788
           +DK         D+   M+ ++   C Q N   RPS   ++  ++   ++EP    GF  
Sbjct: 252 LDKP--------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK--EEMEP----GFRE 297
Query: 789 LSFAVVEATTQEVVPI 804
           +SF   E    E  P+
Sbjct: 298 VSFYYSEENKMENNPV 313

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    +E    D  +V   ++ P     +   K++  +E+    ++ + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    ++V E     SL +   HK R      + R   + Q  +G++YLH   N ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRV 163
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ D++VKI DFGLA  I  D      +  GTP Y+APE+      + +
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-CGTPNYIAPEVLCKKGHSFE 222
Query: 688 IDIYSFGVVILEIICGR 704
           +DI+S G ++  ++ G+
Sbjct: 223 VDIWSLGCILYTLLVGK 239

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 511 RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGL 616
           RL+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+   N K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 152 AYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 204
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +M+PE  +    T   D++SFGVV+ EI
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWI-------FHKDRIQTLSWDIRKKIIFQISRGLE 617
           L+G  ++     ++ E M  G L  ++        +   +   S     ++  +I+ G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 143 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 195
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 115/236 (48%), Gaps = 47/236 (19%)
Query: 512 LGRGGSGSV-FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG G SG+V F+G    G  VAVKR+   +      + + L+E +      H N++R   
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVIRY-- 74
Query: 568 YCAERSNRFL-VYEYMCNGSLDKWIFHKDRIQTLSWDIRKK-----IIFQISRGLEYLHD 621
           YC+E ++RFL +   +CN +L   +  K+ +   +  ++K+     ++ QI+ G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 622 YCNPKIIHFDIKPQNILLD-------------RDLNVKIADFGLARLIAQDQSHVS---T 665
               KIIH D+KPQNIL+               +L + I+DFGL + +   Q        
Sbjct: 134 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 666 MPKGTPGYMAPELTRGNS-------ITAKIDIYSFGVVILEIICGRRSSNPKGGDY 714
            P GT G+ APEL   ++       +T  IDI+S G V   I+   +  +P G  Y
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS--KGKHPFGDKY 244

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    +E    D  +V   ++ P     +   K++  +E+    ++ + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    ++V E     SL +   HK R      + R   + Q  +G++YLH   N ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRV 163
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ D++VKI DFGLA  I  D      +  GTP Y+APE+      + +
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVLCKKGHSFE 222
Query: 688 IDIYSFGVVILEIICGR 704
           +DI+S G ++  ++ G+
Sbjct: 223 VDIWSLGCILYTLLVGK 239

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G V++      G  VA+K++    E  G     + E+  +  ++H N+V+L+ 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                +  +LV+E++     D        +  +   + K  +FQ+ +GL + H +   ++
Sbjct: 70  VIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPELTRG-N 682
           +H D+KP+N+L++ +  +K+ADFGLAR     +      V T+      Y APE+  G  
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-----WYRAPEILLGCK 179
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
             +  +DI+S G +  E++  RR+  P  GD  +D L
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFP--GDSEIDQL 213

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 144 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPVR 196
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 199
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG+GG    +E    D  +V   ++ P     +   K++  +E+    ++ + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           +  +    ++V E     SL +   HK R      + R   + Q  +G++YLH   N ++
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRV 147
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           IH D+K  N+ L+ D++VKI DFGLA  I  D      +  GTP Y+APE+      + +
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVLCKKGHSFE 206
Query: 688 IDIYSFGVVILEIICGR 704
           +DI+S G ++  ++ G+
Sbjct: 207 VDIWSLGCILYTLLVGK 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT-RG 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNA 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 510 IRLGRGGSGSVFEGLLNDGTK---VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRL 565
           I LG G  GSV +G+     K   VA+K L  G E    +E + E + +  + +  +VRL
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C +     LV E    G L K++  K   + +      +++ Q+S G++YL +    
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTRGNS 683
             +H ++  +N+LL      KI+DFGL++ +  D S+ +    G  P  + APE      
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 684 ITAKIDIYSFGVVILEII 701
            +++ D++S+GV + E +
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 116/236 (49%), Gaps = 34/236 (14%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHF---NLVRL 565
           +G G  G+V++    + G  VA+K  R+  GE       + EV  +  +  F   N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 566 VGYCA-ERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           +  CA  R++R     LV+E++ +  L  ++  K     L  +  K ++ Q  RGL++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAP 676
             C   I+H D+KP+NIL+     VK+ADFGLAR+    +A D   V+        Y AP
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLW------YRAP 180
Query: 677 ELTRGNSITAKIDIYSFGVVILE------IICGRRSSNPKGGDYLVDTLKVKAEAD 726
           E+   ++    +D++S G +  E      + CG   ++  G   + D + +  E D
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFDLIGLPPEDD 234

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 121/248 (48%), Gaps = 30/248 (12%)
Query: 500 AMKSATRDF---QIR----LGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKKEFLS 549
           AMK   R F   ++R    LG G  G+V +G+     +  K+ V      +  G++ F +
Sbjct: 2   AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 550 EVE---TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQT---LSW 602
             +    IG++ H ++VRL+G C   S + LV +Y+  GSL D    H+  +     L+W
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
            +      QI++G+ YL ++    ++H ++  +N+LL     V++ADFG+A L+  D   
Sbjct: 121 GV------QIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 663 VSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV 721
           +      TP  +MA E       T + D++S+GV + E++     + P  G  L +   +
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT--FGAEPYAGLRLAEVPDL 229
Query: 722 KAEADRLC 729
             + +RL 
Sbjct: 230 LEKGERLA 237

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 198
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 140 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPVR 192
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 175 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 227
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 508 FQIRLGRGGSGSVFE------GLLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNI-HH 559
           F   LG G  G V E      G  +   KVAVK L    +  +KE  +SE++ + ++  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI------------RKK 607
            N+V L+G C       ++ EY C G L  ++  K R   L +              R  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK-RPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 608 IIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
           + F  Q+++G+ +L    +   IH D+  +N+LL      KI DFGLAR I  D +++  
Sbjct: 169 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 666 MPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEII 701
                P  +MAPE       T + D++S+G+++ EI 
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 189
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 246
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           DI+S G+ ++E+  GR    P     L      + E D
Sbjct: 247 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 284

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 122/251 (48%), Gaps = 30/251 (11%)
Query: 497 SSKAMKSATRDF---QIR----LGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRGKKE 546
           S KA K   R F   ++R    LG G  G+V +G+     +  K+ V      +  G++ 
Sbjct: 17  SEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 76
Query: 547 FLSEVE---TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQT--- 599
           F +  +    IG++ H ++VRL+G C   S + LV +Y+  GSL D    H+  +     
Sbjct: 77  FQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLL 135
Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
           L+W +      QI++G+ YL ++    ++H ++  +N+LL     V++ADFG+A L+  D
Sbjct: 136 LNWGV------QIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 186
Query: 660 QSHVSTMPKGTP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
              +      TP  +MA E       T + D++S+GV + E++     + P  G  L + 
Sbjct: 187 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT--FGAEPYAGLRLAEV 244
Query: 719 LKVKAEADRLC 729
             +  + +RL 
Sbjct: 245 PDLLEKGERLA 255

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 184
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           DI+S G+ ++E+  GR    P     L      + E D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H ++  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 196
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 202
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           D    LG G  G V        G   A K +       K+    E++T+  + H  LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
                + +   ++YE+M  G L    F K  D    +S D   + + Q+ +GL ++H+  
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 274
Query: 624 NPKIIHFDIKPQNILL--DRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPELTR 680
               +H D+KP+NI+    R   +K+ DFGL A L  +    V+T   GT  + APE+  
Sbjct: 275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           G  +    D++S GV+   ++ G    +P GG+   +TL+
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGL---SPFGGENDDETLR 366

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 138
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           GT  Y++PEL    S     D+++ G +I +++ G
Sbjct: 196 GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG   D       T+VAVK +    + R + EFL+E   +      ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--------ISRGL 616
           L+G  ++     +V E M +G L  ++    R +  +   R     Q        I+ G+
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---- 672
            YL+     K +H ++  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 197
Query: 673 -YMAPELTRGNSITAKIDIYSFGVVILEI 700
            +MAPE  +    T   D++SFGVV+ EI
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 184
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           DI+S G+ ++E+  GR    P     L      + E D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 130
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +  + ++      GT  YM+PE  +G   + + 
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV---GTRSYMSPERLQGTHYSVQS 187
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
           DI+S G+ ++E+  GR    P     L+D +
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFELLDYI 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           D    LG G  G V        G   A K +       K+    E++T+  + H  LV L
Sbjct: 54  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 113
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHK--DRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
                + +   ++YE+M  G L    F K  D    +S D   + + Q+ +GL ++H+  
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 168
Query: 624 NPKIIHFDIKPQNILL--DRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPELTR 680
               +H D+KP+NI+    R   +K+ DFGL A L  +    V+T   GT  + APE+  
Sbjct: 169 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           G  +    D++S GV+   ++ G    +P GG+   +TL+
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSGL---SPFGGENDDETLR 260

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    +     T    T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGXVATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    +     T    T  Y APE+    
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNW 203
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 512 LGRGGSGSVFEGL-LNDG----TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G+V++G+ + DG      VA+K L    + +  KE L E   +  +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 566 VGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHD 621
           +G C   S   LV + M  G L D    ++ R+ +   L+W        QI++G+ YL D
Sbjct: 85  LGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLED 137
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTR 680
               +++H D+  +N+L+    +VKI DFGLARL+  D++         P  +MA E   
Sbjct: 138 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 681 GNSITAKIDIYSFGVVILEII 701
               T + D++S+GV + E++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELM 215

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E + +  + H   V+L     +    +    Y  NG L K+I    +I +      +   
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYT 138
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-STMPK 668
            +I   LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           GT  Y++PEL    S     D+++ G +I +++ G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 202
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 511 RLGRGGSGSVFE-GLLNDGTKVAVKR-LYPGENRGKKEFLSEVETIGN----IHHFNLVR 564
           RLG G  G VF+     DG   AVKR + P   RG K+   ++  +G+      H   VR
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 565 LVGYCAERSNRFLVYEYMCNGSL----DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           L     E    +L  E +C  SL    + W       Q   W   +  +      L +LH
Sbjct: 122 LEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQV--WGYLRDTLL----ALAHLH 174
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
                 ++H D+KP NI L      K+ DFGL  L+    +    + +G P YMAPEL +
Sbjct: 175 SQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGD 713
           G+  TA  D++S G+ ILE+ C      P GG+
Sbjct: 230 GSYGTAA-DVFSLGLTILEVAC--NMELPHGGE 259

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 184
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           DI+S G+ ++E+  GR    P     L      + E D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 184
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           DI+S G+ ++E+  GR    P     L      + E D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 499 KAMKSATR---DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN---RGKKEFLSE 550
           + M + TR   D+Q+   LG+G    V   +    T+    ++   +    R  ++   E
Sbjct: 21  QXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLERE 80
Query: 551 VETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
                 + H N+VRL    +E    +LV++ +  G L + I  ++             I 
Sbjct: 81  ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIH 137
Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTMP 667
           QI   + ++H +    I+H D+KP+N+LL    +   VK+ADFGLA +  Q +       
Sbjct: 138 QILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGF 193
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTPGY++PE+ R +     +DI++ GV++  ++ G
Sbjct: 194 AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 203
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +K+ADFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    +     T    T  Y APE+    
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNW 203
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 153
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 154 -SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 208
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 154
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 209
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 199
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 202
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 154
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 209
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 154
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 209
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 204
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 202
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 198 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 306
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 307 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 199
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 87
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 141
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 142 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 196
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 554 IGNIHHFNLVRLVGYCAERSNRFLVYEYM--CNG-SLDKWIFHKDRIQTLSWDIRKKIIF 610
           I  +  F+    VG     S +  +Y  M  C   +L  W+  +  ++     +   I  
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD---QSHVSTMP 667
           QI+  +E+LH   +  ++H D+KP NI    D  VK+ DFGL   + QD   Q+ ++ MP
Sbjct: 172 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 668 K--------GTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
                    GT  YM+PE   GN+ + K+DI+S G+++ E++
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 200 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 308
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 309 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 165
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 166 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 220
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 193
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNW 193
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 139
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 194
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 86
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 140
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 141 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 195
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 199
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 153
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 154 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 208
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 139
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 194
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 98
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 152
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 153 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 207
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 20/180 (11%)
Query: 558 HHFNLVRLVGYCA-ERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
            H N+VRL+  CA  R++R     LV+E++ +  L  ++  K     L  +  K ++ Q 
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQF 129
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
            RGL++LH  C   I+H D+KP+NIL+     VK+ADFGLAR+ +   +    +   T  
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV--VTLW 184
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILE------IICGRRSSNPKGGDYLVDTLKVKAEAD 726
           Y APE+   ++    +D++S G +  E      + CG   ++  G   + D + +  E D
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFDLIGLPPEDD 242

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 154
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 211
Query: 689 DIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
           DI+S G+ ++E+  GR    P     L      + E D
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 165
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG---TPGYMAPELT 679
            +  IIH D+KP N+ ++ D  +KI DFGLAR       H      G   T  Y APE+ 
Sbjct: 166 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPEIM 217
Query: 680 RG-NSITAKIDIYSFGVVILEIICGR 704
                    +DI+S G ++ E++ GR
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 162
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 217
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 161
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 162 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 216
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 149 -SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 203
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 193
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 13/180 (7%)
Query: 528 GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
           G +VAVK +   +  +   ++   EV  +  ++H N+V+L          +LV EY   G
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 91
Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK-IIHFDIKPQNILLDRDLN 644
                +F  D +    W +++K      R +     YC+ K I+H D+K +N+LLD D+N
Sbjct: 92  E----VF--DYLVAHGW-MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 144
Query: 645 VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
           +KIADFG +       + + T   G+P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 145 IKIADFGFSNEFTFG-NKLDTFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ + A  +A  D   R+   G+GS    +L      G   A+K L   +    KE
Sbjct: 25  DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE 84
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY   G +     H  RI   S  
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEP 141
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+++D+   +K+ DFGLA+ +      +
Sbjct: 142 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL 198
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 199 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 207 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 315
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 316 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +V      
Sbjct: 205 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       T + D++SFGV++ EI     S  P         +K+  E  R 
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--------GVKIDEEFCRR 313
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
                K+   M++      +M Q  + C      +RP+ S LV+ L  L +
Sbjct: 314 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 27/273 (9%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFN-LVRLVG 567
            +GRG  GSV + +    G  +AVKR+    + + +K+ L +++ +        +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS----RGLEYLHDYC 623
                 + ++  E M + S DK  F+K     L   I ++I+ +I+    + L +L +  
Sbjct: 89  ALFREGDCWICMELM-STSFDK--FYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-- 143
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           N KIIH DIKP NILLDR  N+K+ DFG++  +    S   T   G   YMAPE    ++
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSA 201
Query: 684 ----ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
                  + D++S G+ + E+  GR         +   T  VK +  +L +         
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN--------- 252
Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              R+ +   I     CL K+  +RP    L+K
Sbjct: 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           +  E+M  GSLD+ +    RI     +I  K+   + RGL YL +    +I+H D+KP N
Sbjct: 91  ICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSN 145
Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVV 696
           IL++    +K+ DFG++  +    ++      GT  YMAPE  +G   + + DI+S G+ 
Sbjct: 146 ILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMAPERLQGTHYSVQSDIWSMGLS 202
Query: 697 ILEIICGRRSSNP 709
           ++E+  GR    P
Sbjct: 203 LVELAVGRYPIPP 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 145 -SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 199
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 161
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 162 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 216
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           LV+L     + SN ++V EY   G +     H  RI   S    +    QI    EYLH 
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                +I+ D+KP+N+L+D+   +K+ADFG A+ +      +     GTP Y+APE+   
Sbjct: 161 L---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILS 213
Query: 682 NSITAKIDIYSFGVVILEIICG 703
                 +D ++ GV+I E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 162
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 217
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
           ++   EV     ++H N+V+L          +LV EY   G +  ++    R +    + 
Sbjct: 58  QKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK--EKEA 115
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS 664
           R K   QI   ++Y H      I+H D+K +N+LLD D N+KIADFG +          +
Sbjct: 116 RAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA 171
Query: 665 TMPKGTPGYMAPELTRGNSITA-KIDIYSFGVVILEIICG 703
               G P Y APEL +G      ++D++S GV++  ++ G
Sbjct: 172 FC--GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN-RGKKEFLSEVE-TIGNIHHFNLVRLVG 567
            LGRG  G V +   +  G   AVKR+    N + +K  L +++ +   +     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
                 + ++  E + + SLDK  F+K   D+ QT+  DI  KI   I + LE+LH   +
Sbjct: 101 ALFREGDVWICXE-LXDTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH---VSTMPKGTPGYMAPELTRG 681
             +IH D+KP N+L++    VK  DFG++  +  D +        P   P  + PEL + 
Sbjct: 158 --VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQ- 214
Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
              + K DI+S G+  +E+   R   +  G  +            +L  +V++ S  + +
Sbjct: 215 KGYSVKSDIWSLGITXIELAILRFPYDSWGTPF-----------QQLKQVVEEPSPQLPA 263
Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +  A + +     CL+KN   RP+   L +
Sbjct: 264 DKFSA-EFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
           LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIF----HKDRIQTLSWDIRKKII---FQISRGLE 617
           L+G  ++     ++ E M  G L  ++       +    L+     K+I    +I+ G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           YL+     K +H D+  +N  +  D  VKI DFG+ R I +   +     KG  G     
Sbjct: 140 YLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPVR 192
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M+PE  +    T   D++SFGVV+ EI
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 512 LGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLV 566
           +G G  G V +G+     N    VA+K      +   +E FL E  T+    H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCN 624
           G   E +  +++ E    G L  ++    +++  S D+   I++  Q+S  L YL    +
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            + +H DI  +N+L+  +  VK+ DFGL+R +     + ++  K    +MAPE       
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 685 TAKIDIYSFGVVILEII 701
           T+  D++ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTK-VAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G+VF+    +  + VA+KR+    ++ G     L E+  +  + H N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                    LV+E+ C+  L K+    +    L  +I K  +FQ+ +GL + H      +
Sbjct: 69  VLHSDKKLTLVFEF-CDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPGYMAPELTRGNS 683
           +H D+KPQN+L++R+  +K+ADFGLAR          + V T+      Y  P++  G  
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTL-----WYRPPDVLFGAK 177
Query: 684 I-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           + +  ID++S G +  E+    R   P  G+ + D LK
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFP--GNDVDDQLK 213

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      ++   
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG+G  G V +     D    A+K++   E +     LSEV  + +++H  +VR      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 571 ERSN-------------RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           ER N              F+  EY  N +L   I  ++  Q    D   ++  QI   L 
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-------LIAQDQSHVS------ 664
           Y+H   +  IIH D+KP NI +D   NVKI DFGLA+       ++  D  ++       
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 665 TMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEII 701
           T   GT  Y+A E+  G      KID+YS G++  E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 573 SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI 632
           S   L+ EY   G +       +  + +S +   ++I QI  G+ YLH      I+H D+
Sbjct: 102 SEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDL 157
Query: 633 KPQNILLDRDL---NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
           KPQNILL       ++KI DFG++R I         M  GTP Y+APE+   + IT   D
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNYDPITTATD 215
Query: 690 IYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKM 749
           +++ G++   ++     ++P  G+   +T    ++ +     VD   E   S    A   
Sbjct: 216 MWNIGIIAYMLLT---HTSPFVGEDNQETYLNISQVN-----VDYSEETFSSVSQLATDF 267
Query: 750 IQIAISCLQKNLHRRPSASM 769
           IQ   S L KN  +RP+A +
Sbjct: 268 IQ---SLLVKNPEKRPTAEI 284

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+  +  I H N+V L       ++ +LV + +  G L   I  +         +   +
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---V 111
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVST 665
           I Q+   ++YLH+     I+H D+KP+N+L    + +  + I DFGL+++   +Q+ + +
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMS 165
Query: 666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
              GTPGY+APE+      +  +D +S GV+   ++CG
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 113
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 114 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 184
Query: 689 DIYSFGVVILEIICGRRSSNP 709
           DI+S G+ ++E+  GR    P
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPP 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYC 569
           L  GG   V+E   +  G + A+KRL   E    +  + EV  +  +  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 570 A---ERSN----RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           +   E S+     FL+   +C G L +++   +    LS D   KI +Q  R ++++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI---------AQDQSHV--STMPKGTP 671
             P IIH D+K +N+LL     +K+ DFG A  I         AQ ++ V        TP
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 672 GYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRR 705
            Y  PE+    S   I  K DI++ G  IL ++C R+
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQ 250

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 14/153 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICGR 704
           Y+APEL +     A+ +D++S G+V+  ++ G 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI D+GLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 162
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    +          T  Y APE+    
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV----ATRWYRAPEIMLNW 217
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 114
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGT------KVAVKRLYPGENRGKKEFLSEVETIGNIHHFN 561
           F I +GRG   +V++GL  + T      ++  ++L   E   ++ F  E E +  + H N
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEXLKGLQHPN 86
Query: 562 LVRLV----GYCAERSNRFLVYEYMCNGSLDKWI--FHKDRIQTL-SWDIRKKIIFQISR 614
           +VR           +    LV E   +G+L  ++  F   +I+ L SW        QI +
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILK 140
Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
           GL++LH    P IIH D+K  NI +     +VKI D GLA L    ++  +    GTP +
Sbjct: 141 GLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEF 196
Query: 674 MAPELTRGNSITAKIDIYSFGVVILE 699
            APE          +D+Y+FG   LE
Sbjct: 197 XAPEXYE-EKYDESVDVYAFGXCXLE 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQIS 613
           ++H N+V+  G+  E + ++L  EY   G L       DRI+    +     ++   Q+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA-QDQSHVSTMPKGTPG 672
            G+ YLH      I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 673 YMAPELTRGNSITAK-IDIYSFGVVILEIICG 703
           Y+APEL +     A+ +D++S G+V+  ++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 18  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 77
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S  
Sbjct: 78  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEP 134
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +
Sbjct: 135 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 191
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 192 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 26  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 85
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S  
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEP 142
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +
Sbjct: 143 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 199
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ + A  +A  D   R+   G+GS    +L      G   A+K L   +    KE
Sbjct: 25  DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE 84
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY   G +     H  RI   S  
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEP 141
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+++D+   +++ DFGLA+ +      +
Sbjct: 142 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL 198
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 199 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 26  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 85
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S  
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEP 142
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +
Sbjct: 143 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 199
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
            LG G  G V++    + G   A K +        ++++ E+E +    H  +V+L+G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+   G++D  +   DR   L+    + +  Q+   L +LH   + +IIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLH---SKRIIH 132
Query: 630 FDIKPQNILLDRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-- 686
            D+K  N+L+  + ++++ADFG+ A+ +   Q   S +  GTP +MAPE+    ++    
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTP 190
Query: 687 ---KIDIYSFGVVILEI 700
              K DI+S G+ ++E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 26  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 85
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S  
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEP 142
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +
Sbjct: 143 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 199
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
            LG G  G V++    + G   A K +        ++++ E+E +    H  +V+L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+   G++D  +   DR   L+    + +  Q+   L +LH   + +IIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLH---SKRIIH 140
Query: 630 FDIKPQNILLDRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA-- 686
            D+K  N+L+  + ++++ADFG+ A+ +   Q   S +  GTP +MAPE+    ++    
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTP 198
Query: 687 ---KIDIYSFGVVILEI 700
              K DI+S G+ ++E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 166
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 167 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC--- 220
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 221 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 26  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 85
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY   G +     H  RI   S  
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEP 142
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+++D+   +K+ DFG A+ +      +
Sbjct: 143 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL 199
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 46  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 105
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S  
Sbjct: 106 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEP 162
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +
Sbjct: 163 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 219
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 220 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 39/221 (17%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G G  GSV   +    G KVA+K+L   +  E   K+ +  E+  + ++ H N++ L+ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90
Query: 568 YCAERS------NRFLVYEYMCNGSLDKWI---FHKDRIQTLSWDIRKKIIFQISRGLEY 618
                S      + +LV  +M    L K +   F +++IQ L        ++Q+ +GL+Y
Sbjct: 91  VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYL--------VYQMLKGLKY 141
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG---TPGYMA 675
           +H   +  ++H D+KP N+ ++ D  +KI DFGLAR       H      G   T  Y A
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRA 191
Query: 676 PELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           PE+          +DI+S G ++ E++ G+  +  KG DYL
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYL 230

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSW 602
           ++   E+  +  + H N+V+LV    +    + ++V+E +  G     +     ++ LS 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLSE 136
Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
           D  +     + +G+EYLH     KIIH DIKP N+L+  D ++KIADFG++       + 
Sbjct: 137 DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 663 VSTMPKGTPGYMAPE-LTRGNSITA--KIDIYSFGVVILEIICGR 704
           +S    GTP +MAPE L+    I +   +D+++ GV +   + G+
Sbjct: 194 LSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRLVGY 568
            LG G  G VF+        V  ++L   E +   + + + E++ +   +   +V   G 
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +  E+M  GSLD+ +    RI      I  K+   + +GL YL +    KI+
Sbjct: 92  FYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE--KHKIM 146
Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI 688
           H D+KP NIL++    +K+ DFG++  +    ++      GT  YM+PE  +G   + + 
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 203
Query: 689 DIYSFGVVILEIICGR 704
           DI+S G+ ++E+  GR
Sbjct: 204 DIWSMGLSLVEMAVGR 219

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 12/150 (8%)
Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLE 617
           H N+V+L     ++ + FLV E +  G L + I  K    +T +  I +K++  +S    
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS---- 120
Query: 618 YLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           ++HD     ++H D+KP+N+L    + +L +KI DFG ARL   D   + T P  T  Y 
Sbjct: 121 HMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYA 176
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
           APEL   N      D++S GV++  ++ G+
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 511 RLGRGGSGSVFEGL--LNDGTKVAVKRLYPGENRGKK-EFLSEVETIGNIHHFNLVRLVG 567
           +LG G   +V++G   L D   VA+K +      G     + EV  + ++ H N+V L  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 +  LV+EY+ +  L +++   D    ++    K  +FQ+ RGL Y H     K+
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-------YMAPELTR 680
           +H D+KPQN+L++    +K+ADFGLAR          ++P  T         Y  P++  
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR--------AKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 681 GNS-ITAKIDIYSFGVVILEIICGR 704
           G++  + +ID++  G +  E+  GR
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 512 LGRGGSGSVFEGLLND--GTK--VAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLV 566
           LG G  G V+EG+  +  G K  VAVK          KE F+SE   + N+ H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           G   E    +++ E    G L  ++  +K+ ++ L+  +      QI + + YL      
Sbjct: 92  GIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI--- 144
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
             +H DI  +NIL+     VK+ DFGL+R I  +  + +++ +    +M+PE       T
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 686 AKIDIYSFGVVILEII 701
              D++ F V + EI+
Sbjct: 205 TASDVWMFAVCMWEIL 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 11/157 (7%)
Query: 550 EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           E      + H N+VRL     E S  +LV++ +  G L + I  +   +  S       I
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCI 134
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQSHVSTM 666
            QI   + Y H   +  I+H ++KP+N+LL    +   VK+ADFGLA  I  + S     
Sbjct: 135 QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG 189
Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             GTPGY++PE+ + +  +  +DI++ GV++  ++ G
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 512 LGRGGSGSVFEGLLND--GTK--VAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLV 566
           LG G  G V+EG+  +  G K  VAVK          KE F+SE   + N+ H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           G   E    +++ E    G L  ++  +K+ ++ L+  +      QI + + YL      
Sbjct: 76  GIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI--- 128
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
             +H DI  +NIL+     VK+ DFGL+R I  +  + +++ +    +M+PE       T
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 686 AKIDIYSFGVVILEII 701
              D++ F V + EI+
Sbjct: 189 TASDVWMFAVCMWEIL 204

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 548 LSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L EV+ +  +  H N+++L       +  FLV++ M  G L  ++  K    TLS    +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETR 127
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
           KI+  +   +  LH      I+H D+KP+NILLD D+N+K+ DFG +  +   +   S  
Sbjct: 128 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC 184
Query: 667 PKGTPGYMAPELTRGN------SITAKIDIYSFGVVILEIICG 703
             GTP Y+APE+   +          ++D++S GV++  ++ G
Sbjct: 185 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 512 LGRGGSGSVFEGLLND--GTK--VAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRLV 566
           LG G  G V+EG+  +  G K  VAVK          KE F+SE   + N+ H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           G   E    +++ E    G L  ++  +K+ ++ L+  +      QI + + YL      
Sbjct: 80  GIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI--- 132
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
             +H DI  +NIL+     VK+ DFGL+R I  +  + +++ +    +M+PE       T
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 686 AKIDIYSFGVVILEII 701
              D++ F V + EI+
Sbjct: 193 TASDVWMFAVCMWEIL 208

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   F+ +L  G  VAVK+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR    +   + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G    A +DI+S G ++ E++ G
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKG 221

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I  ++H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +   +    T+ 
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLC 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I  ++H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 132
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D    +++ DFG A+ +      +    
Sbjct: 133 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC--- 186
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 187 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 39/221 (17%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +G G  GSV   +    G KVA+K+L   +  E   K+ +  E+  + ++ H N++ L+ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 108
Query: 568 YCAERS------NRFLVYEYMCNGSLDKWI---FHKDRIQTLSWDIRKKIIFQISRGLEY 618
                S      + +LV  +M    L K +   F +++IQ L        ++Q+ +GL+Y
Sbjct: 109 VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGMEFSEEKIQYL--------VYQMLKGLKY 159
Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG---TPGYMA 675
           +H   +  ++H D+KP N+ ++ D  +KI DFGLAR       H      G   T  Y A
Sbjct: 160 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRA 209
Query: 676 PELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           PE+          +DI+S G ++ E++ G+  +  KG DYL
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYL 248

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
           FQ++RG+E+L    + K IH D+  +NILL  +  VKI DFGLAR I ++  +V      
Sbjct: 206 FQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTR 262
Query: 670 TP-GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL 728
            P  +MAPE       + K D++S+GV++ EI     S  P           V+ + D  
Sbjct: 263 LPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYP----------GVQMDED-F 311
Query: 729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           C  + ++   M++      ++ QI + C  ++   RP  + LV+ L  L
Sbjct: 312 CSRL-REGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCA 570
           +G G  G V++G      ++A  ++       ++E   E+  +    HH N+    G   
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 571 ERS------NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +++        +LV E+   GS+   I    +  TL  +    I  +I RGL +LH +  
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-- 682
            K+IH DIK QN+LL  +  VK+ DFG++  + +     +T   GTP +MAPE+   +  
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACDEN 206
Query: 683 ---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
              +   K D++S G+  +E+         +G   L D   ++A       L+ +     
Sbjct: 207 PDATYDFKSDLWSLGITAIEMA--------EGAPPLCDMHPMRA-----LFLIPRNPAPR 253
Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              +  + K      SCL KN  +RP+   L+K
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   +    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFAEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    +   L+ D  + +I+QI RGL+Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCAKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGLAR    + +        T  Y APE+    
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 193
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY   G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +K+ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
           R  ++   E      + H N+VRL     E S  +LV++ +  G L + I  ++      
Sbjct: 46  RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 105
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQ 658
                  I QI   + Y H   +  I+H ++KP+N+LL    +   VK+ADFGLA  I  
Sbjct: 106 ---ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEV 157
Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           + S       GTPGY++PE+ + +  +  +DI++ GV++  ++ G
Sbjct: 158 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
           R  ++   E      + H N+VRL     E S  +LV++ +  G L + I  ++      
Sbjct: 47  RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 106
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQ 658
                  I QI   + Y H   +  I+H ++KP+N+LL    +   VK+ADFGLA  I  
Sbjct: 107 ---ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEV 158
Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           + S       GTPGY++PE+ + +  +  +DI++ GV++  ++ G
Sbjct: 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
           R  ++   E      + H N+VRL     E S  +LV++ +  G L + I  ++      
Sbjct: 47  RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 106
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQ 658
                  I QI   + Y H   +  I+H ++KP+N+LL    +   VK+ADFGLA  I  
Sbjct: 107 ---ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEV 158
Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           + S       GTPGY++PE+ + +  +  +DI++ GV++  ++ G
Sbjct: 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI  FGLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KSQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DFGL R    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 511 RLGRGGSGSVFEGLLNDGTK-VAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G+VF+    +  + VA+KR+    ++ G     L E+  +  + H N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                    LV+E+ C+  L K+    +    L  +I K  +FQ+ +GL + H      +
Sbjct: 69  VLHSDKKLTLVFEF-CDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPGYMAPELTRGNS 683
           +H D+KPQN+L++R+  +K+A+FGLAR          + V T+      Y  P++  G  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-----WYRPPDVLFGAK 177
Query: 684 I-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           + +  ID++S G +  E+    R   P  G+ + D LK
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLK 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 106
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 107 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 163 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I ++  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 112
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 113 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 169 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 470
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 471 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
           R  ++   E      + H N+VRL    +E    +LV++ +  G L + I  ++      
Sbjct: 45  RDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD 104
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQ 658
                  I QI   + + H      ++H D+KP+N+LL    +   VK+ADFGLA  +  
Sbjct: 105 ---ASHCIQQILEAVLHCHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 158
Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           DQ        GTPGY++PE+ R  +    +DI++ GV++  ++ G
Sbjct: 159 DQQAWFGFA-GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 471
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 472 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 528 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 108
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 109 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ + A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 11  DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ 70
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S  
Sbjct: 71  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEP 127
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +   +   
Sbjct: 128 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRT 181
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            T+  GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 182 WTLC-GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 118
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 119 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI D GLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 126
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 127 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 183 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 491 NHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE 546
           + L K+ S A  +A  D   R+   G+GS    +L      G   A+K L   +    K+
Sbjct: 18  DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ 77
Query: 547 F---LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
               L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI      
Sbjct: 78  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEP 134
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV 663
             +    QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +
Sbjct: 135 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 191
Query: 664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
                GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 192 C----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 128
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 129 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 185 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 128
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH- 662
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D+++ 
Sbjct: 129 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 663 -VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 185 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF 166
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 167 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 220
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 221 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI DF LAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAP 676
           +      IH DI  +N LL         KI DFG+AR I +   +        P  +M P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 677 ELTRGNSITAKIDIYSFGVVILEI 700
           E       T+K D +SFGV++ EI
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPGY 673
           +      IH DI  +N LL         KI DFG+AR I +     +   + +P     +
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV---KW 252
Query: 674 MAPELTRGNSITAKIDIYSFGVVILEI 700
           M PE       T+K D +SFGV++ EI
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQD----QSHVSTMPKGTPGY 673
           +      IH DI  +N LL         KI DFG+AR I +     +   + +P     +
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV---KW 229
Query: 674 MAPELTRGNSITAKIDIYSFGVVILEI 700
           M PE       T+K D +SFGV++ EI
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI D GLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
           R  ++   E      + H N+VRL    +E  + +L+++ +  G L + I  ++      
Sbjct: 63  RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD 122
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQ 658
                  I QI   + + H      ++H D+KP+N+LL   L    VK+ADFGLA  +  
Sbjct: 123 ---ASHCIQQILEAVLHCHQM---GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG 176
Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +Q        GTPGY++PE+ R +     +D+++ GV++  ++ G
Sbjct: 177 EQQAWFGF-AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLV 563
           LG G  G V+EG    + ND +  +VAVK L P     + + +FL E   I   +H N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYL 619
           R +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 620 HDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMA 675
            +      IH DI  +N LL         KI DFG+AR I +   +        P  +M 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 676 PELTRGNSITAKIDIYSFGVVILEI 700
           PE       T+K D +SFGV++ EI
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 548 LSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L EV+ +  +  H N+++L       +  FLV++ M  G L  ++  K    TLS    +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETR 127
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
           KI+  +   +  LH      I+H D+KP+NILLD D+N+K+ DFG +  +   +      
Sbjct: 128 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 667 PKGTPGYMAPELTRGN------SITAKIDIYSFGVVILEIICG 703
             GTP Y+APE+   +          ++D++S GV++  ++ G
Sbjct: 185 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRLV- 566
           +G G  GSV        G +VAVK+L   +      K+ +  E+  + ++ H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                   E  N   +  ++    L+  +    + Q L+ D  + +I+QI RGL+Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
            +  IIH D+KP N+ ++ D  +KI D GLAR    + +        T  Y APE+    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 682 NSITAKIDIYSFGVVILEIICGR 704
                 +DI+S G ++ E++ GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF 140
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 141 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 194
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 195 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 548 LSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           L EV+ +  +  H N+++L       +  FLV++ M  G L  ++  K    TLS    +
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETR 114
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
           KI+  +   +  LH      I+H D+KP+NILLD D+N+K+ DFG +  +   +      
Sbjct: 115 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 171
Query: 667 PKGTPGYMAPELTRGN------SITAKIDIYSFGVVILEIICG 703
             GTP Y+APE+   +          ++D++S GV++  ++ G
Sbjct: 172 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 512 LGRGGSGSVFEG----LLNDGT--KVAVKRLYP-GENRGKKEFLSEVETIGNIHHFNLVR 564
           LG G  G V+EG    + ND +  +VAVK L      + + +FL E   I   +H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----GLEYLH 620
            +G   +   RF++ E M  G L  ++       +    +    +  ++R    G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
           +      IH DI  +N LL         KI DFG+    AQD    S   KG        
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM----AQDIYRASYYRKGGCAMLPVK 211
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEI 700
           +M PE       T+K D +SFGV++ EI
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 544 KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWD 603
           K E L+E   +  + +  +VR++G C E  +  LV E    G L+K++     ++  +  
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN-- 112
Query: 604 IRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-- 661
              +++ Q+S G++YL +      +H D+  +N+LL      KI+DFGL++ +  D++  
Sbjct: 113 -IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
              T  K    + APE       ++K D++SFGV++ E
Sbjct: 169 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+AP +         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY   G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 503 SATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI 557
           S T ++Q+   LG+G    V   + +  G + A K +   +   R  ++   E      +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
            H N+VRL    +E    +LV++ +  G L + I  ++             I QI   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILESVN 117
Query: 618 YLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           + H   N  I+H D+KP+N+LL    +   VK+ADFGLA  +  DQ        GTPGY+
Sbjct: 118 HCH--LN-GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF-AGTPGYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICG 703
           +PE+ R +     +D+++ GV++  ++ G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 512 LGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVE--TIGNIH-------HFN 561
           +GRG S  V   +    G + AVK +     R   E L EV   T    H       H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           ++ L+      S  FLV++ M  G L  ++  K     LS    + I+  +   + +LH 
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHA 218
Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----GTPGYMAP 676
                I+H D+KP+NILLD ++ ++++DFG +        H+    K     GTPGY+AP
Sbjct: 219 N---NIVHRDLKPENILLDDNMQIRLSDFGFS-------CHLEPGEKLRELCGTPGYLAP 268
Query: 677 ELTRGN------SITAKIDIYSFGVVILEIICG 703
           E+ + +          ++D+++ GV++  ++ G
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   L +L     + SN ++V EY   G +     H  RI   S    + 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +K+ DFG A+ +      +    
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--- 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 507 DFQIR--LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEF----LSEVETIGNIHH 559
           DFQ++  LG G  G V        G  VA+K++ P +   K  F    L E++ + +  H
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKH 68
Query: 560 FNLVRLVGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
            N++ +         E  N   + + +    L + I      Q LS D  +  I+Q  R 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI---AQDQSHVSTMPKGTPG 672
           ++ LH      +IH D+KP N+L++ + ++K+ DFGLAR+I   A D S  +    G   
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 673 YMAPELTRGNSI---TAK----IDIYSFGVVILEIICGRRSSNPKGGDY 714
           Y+A    R   +   +AK    +D++S G ++ E+   RR   P G DY
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP-GRDY 228

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   F+ +L  G  VAVK+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 141
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR  + +   + T    T  Y APE+  
Sbjct: 142 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRYYRAPEVIL 196
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E++ G
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKG 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY   G +     H  RI        + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFXEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +K+ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG+G  G V +     D    A+K++   E +     LSEV  + +++H  +VR      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 571 ERSN-------------RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           ER N              F+  EY  N +L   I  ++  Q    D   ++  QI   L 
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR-------LIAQDQSHVS------ 664
           Y+H   +  IIH ++KP NI +D   NVKI DFGLA+       ++  D  ++       
Sbjct: 131 YIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 665 TMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEII 701
           T   GT  Y+A E+  G      KID YS G++  E I
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 503 SATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI 557
           S T ++Q+   LG+G    V   + +  G + A K +   +   R  ++   E      +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
            H N+VRL    +E    +LV++ +  G L + I  ++             I QI   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILESVN 117
Query: 618 YLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           + H      I+H D+KP+N+LL    +   VK+ADFGLA  +  DQ        GTPGY+
Sbjct: 118 HCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF-AGTPGYL 173
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICG 703
           +PE+ R +     +D+++ GV++  ++ G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   L +L     + SN ++V EY   G +     H  RI   S    + 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +K+ DFG A+ +      +    
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--- 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           LG G  G++    + D   VAVKR+ P      +R + + L E +      H N++R   
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR-EVQLLRESDE-----HPNVIRY-- 83
Query: 568 YCAERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           +C E+  +F  +   +C  +L +++  KD        I   ++ Q + GL +LH      
Sbjct: 84  FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI--TLLQQTTSGLAHLHSL---N 138
Query: 627 IIHFDIKPQNILLDR-----DLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAPEL 678
           I+H D+KP NIL+        +   I+DFGL + +A  +   S  S +P GT G++APE+
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEM 197
Query: 679 TRGN---SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
              +   + T  +DI+S G V   +I     S+P G   L     +   A  L  L  +K
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVIS--EGSHPFGKS-LQRQANILLGACSLDCLHPEK 254
Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            ED+ + R+   KMI +       +  +RPSA  ++K
Sbjct: 255 HEDVIA-RELIEKMIAM-------DPQKRPSAKHVLK 283

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI        + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 112/234 (47%), Gaps = 21/234 (8%)
Query: 481 STDE---SSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLY 537
           S DE     + + +H+   S KA  S     ++ LG+G  G VF  L+   T+     LY
Sbjct: 3   SKDEGVLKEISITHHVKAGSEKADPSHFELLKV-LGQGSFGKVF--LVRKVTRPDSGHLY 59
Query: 538 PGEN--------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK 589
             +         R +     E + + +++H  +V+L          +L+ +++  G L  
Sbjct: 60  AMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFT 119
Query: 590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD 649
            +     +     D+ K  + +++ GL++LH      II+ D+KP+NILLD + ++K+ D
Sbjct: 120 RL--SKEVMFTEEDV-KFYLAELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTD 173
Query: 650 FGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           FGL++  A D    +    GT  YMAPE+      +   D +S+GV++ E++ G
Sbjct: 174 FGLSK-EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 507 DFQIR--LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEF----LSEVETIGNIHH 559
           DFQ++  LG G  G V        G  VA+K++ P +   K  F    L E++ + +  H
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKH 68
Query: 560 FNLVRLVGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
            N++ +         E  N   + + +    L + I      Q LS D  +  I+Q  R 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI---AQDQSHVSTMPKG--- 669
           ++ LH      +IH D+KP N+L++ + ++K+ DFGLAR+I   A D S  +    G   
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 670 ---TPGYMAPELTRGNSITAK-IDIYSFGVVILEIICGRRSSNPKGGDY 714
              T  Y APE+   ++  ++ +D++S G ++ E+   RR   P G DY
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP-GRDY 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 527 DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS 586
           +  K+++K  Y        +F +E++ I +I +   +   G        +++YEYM N S
Sbjct: 77  NNDKISIKSKYD-------DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 587 L---DKWIFHKDRIQT--LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR 641
           +   D++ F  D+  T  +   + K II  +     Y+H+  N  I H D+KP NIL+D+
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDK 187
Query: 642 DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT--AKIDIYSFGVVI 697
           +  VK++DFG +  +   +   S   +GT  +M PE     S    AK+DI+S G+ +
Sbjct: 188 NGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 507 DFQIR--LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEF----LSEVETIGNIHH 559
           DFQ++  LG G  G V        G  VA+K++ P +   K  F    L E++ + +  H
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKH 68
Query: 560 FNLVRLVGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
            N++ +         E  N   + + +    L + I      Q LS D  +  I+Q  R 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI---AQDQSHVSTMPKG--- 669
           ++ LH      +IH D+KP N+L++ + ++K+ DFGLAR+I   A D S  +    G   
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 670 ---TPGYMAPELTRGNSITAK-IDIYSFGVVILEIICGRRSSNPKGGDY 714
              T  Y APE+   ++  ++ +D++S G ++ E+   RR   P G DY
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP-GRDY 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 132
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 133 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 236
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 237 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 502 KSATRDFQIRLGRGGSGSVFEGLLNDGTKV----AVKRLYPGENRGKKEFLSEVETIGNI 557
           K+  R +++ LG+GG G V    +    K+     +++    + +G+   L+E + +  +
Sbjct: 183 KNTFRQYRV-LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRG 615
           +   +V L      +    LV   M  G L   I+H   +    +   + + +  +I  G
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCG 298
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE LH     +I++ D+KP+NILLD   +++I+D GLA  + + Q+    +  GT GYMA
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMA 353
Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGR 704
           PE+ +    T   D ++ G ++ E+I G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 129/293 (44%), Gaps = 34/293 (11%)
Query: 508 FQIRLGRGGSGSV--FEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           F  +LG GG   V   EGL +DG   A+KR+   E + ++E   E +     +H N++RL
Sbjct: 33  FIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 566 VGYCA-ERSNR---FLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLH 620
           V YC  ER  +   +L+  +   G+L   I   KD+   L+ D    ++  I RGLE +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFG---LARLIAQDQSHVSTM-----PKGTPG 672
                   H D+KP NILL  +    + D G    A +  +      T+      + T  
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 673 YMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC 729
           Y APEL    S   I  + D++S G V+  ++ G        G Y +    V  + D + 
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE-------GPYDM----VFQKGDSVA 257
Query: 730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
             V  +    QS R  +  + Q+  S +  + H+RP   +L+  L+ L    P
Sbjct: 258 LAVQNQLSIPQSPRHSSA-LWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 503 SATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLY-PGENRGKKEFLSEVETIG 555
           SA R F   LG    G V++G L           VA+K L    E   ++EF  E     
Sbjct: 26  SAVR-FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA 84
Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK---------DRIQTLSWDIRK 606
            + H N+V L+G   +     +++ Y  +G L +++  +         D  +T+   +  
Sbjct: 85  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 144
Query: 607 K----IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQS 661
                ++ QI+ G+EYL  +    ++H D+  +N+L+   LNVKI+D GL R + A D  
Sbjct: 145 PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 201
Query: 662 HV---STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
            +   S +P     +MAPE       +   DI+S+GVV+ E+ 
Sbjct: 202 KLLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 502 KSATRDFQIRLGRGGSGSVFEGLLNDGTKV----AVKRLYPGENRGKKEFLSEVETIGNI 557
           K+  R +++ LG+GG G V    +    K+     +++    + +G+   L+E + +  +
Sbjct: 183 KNTFRQYRV-LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRG 615
           +   +V L      +    LV   M  G L   I+H   +    +   + + +  +I  G
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCG 298
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE LH     +I++ D+KP+NILLD   +++I+D GLA  + + Q+    +  GT GYMA
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMA 353
Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGR 704
           PE+ +    T   D ++ G ++ E+I G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   LV+L     + SN ++V EY+  G +     H  RI   S    + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF 145
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+L+D+   +++ DFG A+ +      +    
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP  +APE+         +D ++ GV+I E+  G
Sbjct: 200 -GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 37/238 (15%)
Query: 502 KSATRDFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-- 557
           ++  RD  +   +G+G  G V+ G    G  VAVK      +R +K +  E E    +  
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVML 59
Query: 558 HHFNLVRLVGYCAERSNR------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
            H N++  +   ++ ++R      +L+  Y   GSL  ++    ++ TL      +I+  
Sbjct: 60  RHENILGFIA--SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 612 ISRGLEYLH-----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ--DQSHVS 664
           I+ GL +LH         P I H D+K +NIL+ ++    IAD GLA + +Q  +Q  V 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 665 TMPK-GTPGYMAPELTRGNSITA-------KIDIYSFGVVILEIICGRRSSNPKGGDY 714
             P+ GT  YMAPE+    +I         ++DI++FG+V+ E +  R  SN    DY
Sbjct: 174 NNPRVGTKRYMAPEVL-DETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDY 229

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 503 SATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLY-PGENRGKKEFLSEVETIG 555
           SA R F   LG    G V++G L           VA+K L    E   ++EF  E     
Sbjct: 9   SAVR-FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA 67
Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK---------DRIQTLSWDIRK 606
            + H N+V L+G   +     +++ Y  +G L +++  +         D  +T+   +  
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 607 K----IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQS 661
                ++ QI+ G+EYL  +    ++H D+  +N+L+   LNVKI+D GL R + A D  
Sbjct: 128 PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184
Query: 662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
            +         +MAPE       +   DI+S+GVV+ E+ 
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 128
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 232
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLVGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S GV++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 35/226 (15%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRLVGYC 569
           +G+G  G V+ G    G  VAVK      +R +K +  E E    +   H N++  +   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA-- 69
Query: 570 AERSNR------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH--- 620
           ++ ++R      +L+  Y   GSL  ++    ++ TL      +I+  I+ GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 621 --DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ--DQSHVSTMPK-GTPGYMA 675
                 P I H D+K +NIL+ ++    IAD GLA + +Q  +Q  V   P+ GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 676 PELTRGNSITA-------KIDIYSFGVVILEIICGRRSSNPKGGDY 714
           PE+    +I         ++DI++FG+V+ E +  R  SN    DY
Sbjct: 186 PEVL-DETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDY 229

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 128
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 232
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 35/226 (15%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRLVGYC 569
           +G+G  G V+ G    G  VAVK      +R +K +  E E    +   H N++  +   
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA-- 98
Query: 570 AERSNR------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH--- 620
           ++ ++R      +L+  Y   GSL  ++    ++ TL      +I+  I+ GL +LH   
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 621 --DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ--DQSHVSTMPK-GTPGYMA 675
                 P I H D+K +NIL+ ++    IAD GLA + +Q  +Q  V   P+ GT  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 676 PELTRGNSITA-------KIDIYSFGVVILEIICGRRSSNPKGGDY 714
           PE+    +I         ++DI++FG+V+ E +  R  SN    DY
Sbjct: 215 PEVL-DETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDY 258

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 128
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 232
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 138
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 242
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 21/232 (9%)
Query: 499 KAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKE---FLSEVE 552
           K M+    DF+I   +GRG  G V    L +  KV A+K L   E   + E   F  E +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQ 611
            + N     +  L     + +N +LV +Y   G L   +   +DR   L  ++ +  + +
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR---LPEEMARFYLAE 183
Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           +   ++ +H       +H DIKP NIL+D + ++++ADFG    + +D +  S++  GTP
Sbjct: 184 MVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240
Query: 672 GYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
            Y++PE+ +           + D +S GV + E++ G     P   + LV+T
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG---ETPFYAESLVET 289

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 132
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 133 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 236
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 237 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLVGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S GV++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGT----KVAVKRLYP---GENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +  +     VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDR--IQTLSWDIRKKIIFQISRGLEYLH 620
           RL G       + +V E    GSL D+   H+    + TLS     +   Q++ G+ YL 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLE 138
Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPE 677
              + + IH D+  +N+LL  RDL VKI DFGL R + Q+  H V    +  P  + APE
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
             +  + +   D + FGV + E+        P  G              ++   +DK+ E
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT--YGQEPWIG----------LNGSQILHKIDKEGE 242
Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
            +    D    +  + + C       RP+
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 508 FQIR--LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
           FQ+    G+G  G+V  G     G  VA+K++   + R +   L  ++ +  +HH N+V+
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 565 LVGY---CAERSNRFL----VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI-IFQISRGL 616
           L  Y     ER  R +    V EY+ + +L +   +  R Q     I  K+ +FQ+ R +
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
             LH   +  + H DIKP N+L++  D  +K+ DFG A+ ++  + +V+ +   +  Y A
Sbjct: 143 GCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI--CSRYYRA 199
Query: 676 PELTRGNS-ITAKIDIYSFGVVILEIICG 703
           PEL  GN   T  +DI+S G +  E++ G
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
           R  ++   E      + H N+VRL    +E  + +L+++ +  G L + I  ++      
Sbjct: 52  RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD 111
Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQ 658
                  I QI   + + H      ++H ++KP+N+LL   L    VK+ADFGLA  +  
Sbjct: 112 ---ASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +Q        GTPGY++PE+ R +     +D+++ GV++  ++ G
Sbjct: 166 EQQAWFGF-AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 14/196 (7%)
Query: 509 QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETI-GNIHHFNLVRLVG 567
           ++ L R  +  VF  +     K  +K+      + +K  +SE   +  N+ H  LV L  
Sbjct: 53  KVLLARHKAEEVFYAVKVLQKKAILKK------KEEKHIMSERNVLLKNVKHPFLVGLHF 106
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                   + V +Y+  G L    +H  R +       +    +I+  L YLH      I
Sbjct: 107 SFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHSL---NI 160
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           ++ D+KP+NILLD   ++ + DFGL +   +  S  ST   GTP Y+APE+         
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-CGTPEYLAPEVLHKQPYDRT 219
Query: 688 IDIYSFGVVILEIICG 703
           +D +  G V+ E++ G
Sbjct: 220 VDWWCLGAVLYEMLYG 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRL----YPGENRGKKEFLSEVETIGNIHHFNL 562
           D    LG G  G V   +     +V V +     YP +    K   +E+  +  +HH  L
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKL 110
Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF----QISRGLEY 618
           + L     ++    L+ E++  G L       DRI    + + +  +     Q   GL++
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGEL------FDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 619 LHDYCNPKIIHFDIKPQNILLD--RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           +H++    I+H DIKP+NI+ +  +  +VKI DFGLA  +  D+  +  +   T  + AP
Sbjct: 165 MHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAP 219
Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           E+     +    D+++ GV+   ++ G    +P  G+  ++TL+
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGL---SPFAGEDDLETLQ 260

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           L+E   +  ++   L +L     + SN ++V EY   G +     H  RI        + 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFXEPHARF 146
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
              QI    EYLH      +I+ D+KP+N+++D+   +K+ DFG A+ +      +    
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--- 200
Query: 668 KGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            GTP Y+APE+         +D ++ GV+I E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 512 LGRGGSGSVFEGLL--NDGT--KVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  GSV E  L   DG+  KVAVK L      +   +EFL E   +    H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 566 VGYCAERSNR------FLVYEYMCNGSLDKWIFHKDRIQ----TLSWDIRKKIIFQISRG 615
           VG       +       ++  +M +G L  ++    RI      L      + +  I+ G
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYM 674
           +EYL    +   IH D+  +N +L  D+ V +ADFGL+R I     +        P  ++
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG 712
           A E    N  T   D+++FGV + EI+   R   P  G
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMT--RGQTPYAG 242

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 231

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 512 LGRGGSGSVFEGLLNDGT--------KVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           LG+GG G VF+     G         KV  K +     +      +E   +  + H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L+         +L+ EY+  G L       +R      D     + +IS  L +LH   
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLH--- 138
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
              II+ D+KP+NI+L+   +VK+ DFGL +    D +   T   GT  YMAPE+   + 
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRSG 197
Query: 684 ITAKIDIYSFGVVILEIICG 703
               +D +S G ++ +++ G
Sbjct: 198 HNRAVDWWSLGALMYDMLTG 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLH 136
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
           G      +DI+S G ++ E++  R      G DY+    KV  +    C    KK
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 231

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GLE++H   N  +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICG 703
            GYMAPE L +G +  +  D +S G ++ +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GLE++H   N  +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT
Sbjct: 299 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 352
Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICG 703
            GYMAPE L +G +  +  D +S G ++ +++ G
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 231

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 181
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 236
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 269

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GLE++H   N  +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICG 703
            GYMAPE L +G +  +  D +S G ++ +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GLE++H   N  +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICG 703
            GYMAPE L +G +  +  D +S G ++ +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 21/191 (10%)
Query: 528 GTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRL-------VGYCAERSNRFLV 578
           G +VA+K++    +     K  L E++ + +  H N++ +       V Y  E  + ++V
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY-GEFKSVYVV 138
Query: 579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL 638
            + M    L + I H    Q L+ +  +  ++Q+ RGL+Y+H   + ++IH D+KP N+L
Sbjct: 139 LDLM-ESDLHQ-IIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLL 191
Query: 639 LDRDLNVKIADFGLAR-LIAQDQSHVSTMPK--GTPGYMAPELTRG-NSITAKIDIYSFG 694
           ++ +  +KI DFG+AR L      H   M +   T  Y APEL    +  T  ID++S G
Sbjct: 192 VNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 251
Query: 695 VVILEIICGRR 705
            +  E++  R+
Sbjct: 252 CIFGEMLARRQ 262

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 512 LGRGGSGSVFEGLLNDGT--------KVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           LG+GG G VF+     G         KV  K +     +      +E   +  + H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L+         +L+ EY+  G L       +R      D     + +IS  L +LH   
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLH--- 138
Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
              II+ D+KP+NI+L+   +VK+ DFGL +    D + V+    GT  YMAPE+   + 
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMRSG 197
Query: 684 ITAKIDIYSFGVVILEIICG 703
               +D +S G ++ +++ G
Sbjct: 198 HNRAVDWWSLGALMYDMLTG 217

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLVGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 137
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
           G      +D++S G ++ E++C +
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 21/191 (10%)
Query: 528 GTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRL-------VGYCAERSNRFLV 578
           G +VA+K++    +     K  L E++ + +  H N++ +       V Y  E  + ++V
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY-GEFKSVYVV 137
Query: 579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL 638
            + M    L + I H    Q L+ +  +  ++Q+ RGL+Y+H   + ++IH D+KP N+L
Sbjct: 138 LDLM-ESDLHQ-IIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLL 190
Query: 639 LDRDLNVKIADFGLAR-LIAQDQSHVSTMPK--GTPGYMAPELTRG-NSITAKIDIYSFG 694
           ++ +  +KI DFG+AR L      H   M +   T  Y APEL    +  T  ID++S G
Sbjct: 191 VNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 250
Query: 695 VVILEIICGRR 705
            +  E++  R+
Sbjct: 251 CIFGEMLARRQ 261

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 148
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 149 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
           G      +D++S G ++ E++C +
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 231

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +G G  GSV   ++  L    KVAVK+L   +      ++ +  E+  + ++ H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 84
Query: 566 VG-YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +  +    S       Y+    +   + +  + Q LS +  + +++Q+ RGL+Y+H   +
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---S 141
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRG-N 682
             IIH D+KP N+ ++ D  ++I DFGLAR   ++ + +V+T       Y APE+     
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWM 196
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
                +DI+S G ++ E++ G+  +   G DY +D LK
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGK--ALFPGSDY-IDQLK 231

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           C +  +R F V E++  G L   +FH  + +       +    +I   L +LHD     I
Sbjct: 92  CFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHD---KGI 145
Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK 687
           I+ D+K  N+LLD + + K+ADFG+ +    +    +T   GTP Y+APE+ +       
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-CGTPDYIAPEILQEMLYGPA 204
Query: 688 IDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
           +D ++ GV++ E++CG      +  D L + +
Sbjct: 205 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRLVGYC 569
           +G+G  G V+ GL + G  VAVK      +R ++ +  E E    +   H N++  +   
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 570 AERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH----- 620
               N     +L+  Y  +GSL  ++    + QTL   +  ++    + GL +LH     
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFG 127
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ--DQSHVSTMPK-GTPGYMAPE 677
               P I H D K +N+L+  +L   IAD GLA + +Q  D   +   P+ GT  YMAPE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 678 LTRGNSIT------AKIDIYSFGVVILEIICGRRS 706
           +      T         DI++FG+V+ EI   RR+
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRT 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 181
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 236
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
           G      +DI+S G ++ E++  R      G DY+    KV  +    C    KK
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKR-LYPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G+G  G VF+      G KVA+K+ L   E  G     L E++ +  + H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 568 YCAERS---NR-----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            C  ++   NR     +LV+++ C   L   + +     TLS +I K+++  +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLS-EI-KRVMQMLLNGLYYI 141
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAP 676
           H     KI+H D+K  N+L+ RD  +K+ADFGLAR   L    Q +       T  Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 677 ELTRGN-SITAKIDIYSFGVVILEI 700
           EL  G       ID++  G ++ E+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S +      T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
           G      +DI+S G ++ E++C +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 509 QIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           Q+RLGRG  G V    + D   G + AVK++     R +     E+     +    +V L
Sbjct: 98  QLRLGRGSFGEVHR--MEDKQTGFQCAVKKV-----RLEVFRAEELMACAGLTSPRIVPL 150
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   E     +  E +  GSL + +  +     L  D     + Q   GLEYLH     
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLHSR--- 204
Query: 626 KIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMP----KGTPGYMAPELTR 680
           +I+H D+K  N+LL  D  +  + DFG A  +  D    S +      GT  +MAPE+  
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G S  AK+D++S   ++L ++ G
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 136
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
           G      +DI+S G ++ E++  R      G DY+    KV  +    C    KK
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 231

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 144
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 232

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 142
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 143 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 197
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 198 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 230

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN---- 541
            + + +H+ +   KA  S     ++ LG+G  G VF  L+   +    ++LY  +     
Sbjct: 7   EIAITHHVKEGHEKADPSQFELLKV-LGQGSFGKVF--LVKKISGSDARQLYAMKVLKKA 63
Query: 542 ----RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
               R +     E + +  ++H  +V+L          +L+ +++  G L   +     +
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEV 121
Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
                D+ K  + +++  L++LH      II+ D+KP+NILLD + ++K+ DFGL++   
Sbjct: 122 MFTEEDV-KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177
Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             +    +   GT  YMAPE+      T   D +SFGV++ E++ G
Sbjct: 178 DHEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 137
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
           G      +DI+S G ++ E++  R      G DY+    KV  +    C    KK
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 137
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
           G      +DI+S G ++ E++  R      G DY+    KV  +    C    KK
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 231

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 503 SATRDFQIR---LGRGGSGSVFEGL-LNDGTKVAVKRLYPG-----------ENRGKKEF 547
           + T D+Q+    LG G +G V E      G K A+K LY             +  G    
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHI 84
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           +  ++   N+HH     L+           + E M  G L   I  +   Q  +     +
Sbjct: 85  VCILDVYENMHHGKRCLLI-----------IMECMEGGELFSRIQERGD-QAFTEREAAE 132
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVS 664
           I+  I   +++LH +    I H D+KP+N+L    ++D  +K+ DFG A+   Q+     
Sbjct: 133 IMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 188
Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 189 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L+    VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + +LV E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 144
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
           G      +DI+S G ++ E++  R      G DY+
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYI 232

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 503 SATRDFQIR---LGRGGSGSVFEGL-LNDGTKVAVKRLYPG-----------ENRGKKEF 547
           + T D+Q+    LG G +G V E      G K A+K LY             +  G    
Sbjct: 6   AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHI 65
Query: 548 LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
           +  ++   N+HH     L+           + E M  G L   I  +   Q  +     +
Sbjct: 66  VCILDVYENMHHGKRCLLI-----------IMECMEGGELFSRIQERGD-QAFTEREAAE 113
Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVS 664
           I+  I   +++LH +    I H D+KP+N+L    ++D  +K+ DFG A+   Q+     
Sbjct: 114 IMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 169
Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 170 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +G G  GSV   ++  L    KVAVK+L   +      ++ +  E+  + ++ H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 566 VG-YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +  +    S       Y+    +   + +  + Q LS +  + +++Q+ RGL+Y+H   +
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---S 149
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRG-N 682
             IIH D+KP N+ ++ D  ++I DFGLAR   ++ + +V+T       Y APE+     
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWM 204
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
                +DI+S G ++ E++ G+  +   G DY +D LK
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK--ALFPGSDY-IDQLK 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKR-LYPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G+G  G VF+      G KVA+K+ L   E  G     L E++ +  + H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 568 YCAERS---NR-----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            C  ++   NR     +LV+++ C   L   + +     TLS +I K+++  +  GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDF-CEHDLAGLLSNVLVKFTLS-EI-KRVMQMLLNGLYYI 141
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAP 676
           H     KI+H D+K  N+L+ RD  +K+ADFGLAR   L    Q +       T  Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 677 ELTRGN-SITAKIDIYSFGVVILEI 700
           EL  G       ID++  G ++ E+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFN-LVRLVGY 568
           +G G  G V++      G  +AVK++    N+ + K  L +++ +   H    +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 569 CAERSNRFLVYEYM--CNGSLDKWIFHKDRIQ-TLSWDIRKKIIFQISRGLEYLHDYCNP 625
               ++ F+  E M  C   L K      R+Q  +   I  K+   I + L YL +    
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKK------RMQGPIPERILGKMTVAIVKALYYLKE--KH 144
Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            +IH D+KP NILLD    +K+ DFG++  +  D++   +   G   YMAPE       T
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPT 202
Query: 686 A-----KIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
                 + D++S G+ ++E+  G+        D+ V T KV  E   L       S D Q
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT-KVLQEEPPLLPGHMGFSGDFQ 261
Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           S   D          CL K+  +RP  + L++
Sbjct: 262 SFVKD----------CLTKDHRKRPKYNKLLE 283

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKR-LYPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G+G  G VF+      G KVA+K+ L   E  G     L E++ +  + H N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 568 YCAERS---NR-----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            C  ++   NR     +LV+++ C   L   + +     TLS +I K+++  +  GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLS-EI-KRVMQMLLNGLYYI 140
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAP 676
           H     KI+H D+K  N+L+ RD  +K+ADFGLAR   L    Q +       T  Y  P
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 677 ELTRGN-SITAKIDIYSFGVVILEI 700
           EL  G       ID++  G ++ E+
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN---- 541
            + + +H+ +   KA  S     ++ LG+G  G VF  L+   +    ++LY  +     
Sbjct: 7   EIAITHHVKEGHEKADPSQFELLKV-LGQGSFGKVF--LVKKISGSDARQLYAMKVLKKA 63
Query: 542 ----RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
               R +     E + +  ++H  +V+L          +L+ +++  G L   +     +
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEV 121
Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
                D+ K  + +++  L++LH      II+ D+KP+NILLD + ++K+ DFGL++   
Sbjct: 122 MFTEEDV-KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177
Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             +    +   GT  YMAPE+      T   D +SFGV++ E++ G
Sbjct: 178 DHEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRG 615
           + H ++V L+   +     ++V+E+M    L   I  + D     S  +    + QI   
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQSHVSTMPKGTPG 672
           L Y HD     IIH D+KP+N+LL    N   VK+ DFG+A  + +    V+    GTP 
Sbjct: 143 LRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE-SGLVAGGRVGTPH 198
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +MAPE+ +       +D++  GV++  ++ G
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKR-LYPGENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G+G  G VF+      G KVA+K+ L   E  G     L E++ +  + H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 568 YCAERS---NR-----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            C  ++   NR     +LV+++ C   L   + +     TLS +I K+++  +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLS-EI-KRVMQMLLNGLYYI 141
Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAP 676
           H     KI+H D+K  N+L+ RD  +K+ADFGLAR   L    Q +       T  Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 677 ELTRGN-SITAKIDIYSFGVVILEI 700
           EL  G       ID++  G ++ E+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 486 SVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN---- 541
            + + +H+ +   KA  S     ++ LG+G  G VF  L+   +    ++LY  +     
Sbjct: 8   EIAITHHVKEGHEKADPSQFELLKV-LGQGSFGKVF--LVKKISGSDARQLYAMKVLKKA 64
Query: 542 ----RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
               R +     E + +  ++H  +V+L          +L+ +++  G L   +     +
Sbjct: 65  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEV 122
Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
                D+ K  + +++  L++LH      II+ D+KP+NILLD + ++K+ DFGL++   
Sbjct: 123 MFTEEDV-KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 178
Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
             +    +   GT  YMAPE+      T   D +SFGV++ E++ G
Sbjct: 179 DHEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 144
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL---YPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +G G  GSV   ++  L    KVAVK+L   +      ++ +  E+  + ++ H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 566 VG-YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +  +    S       Y+    +   + +  + Q LS +  + +++Q+ RGL+Y+H   +
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---S 149
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRG-N 682
             IIH D+KP N+ ++ D  ++I DFGLAR   ++ + +V+T       Y APE+     
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWM 204
Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
                +DI+S G ++ E++ G+  +   G DY +D LK
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK--ALFPGSDY-IDQLK 239

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S +      T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
           G      +D++S G ++ E++C +
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 509 QIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           Q RLGRG  G V    + D   G + AVK++     R +   + E+     +    +V L
Sbjct: 77  QPRLGRGSFGEVHR--MKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPL 129
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   E     +  E +  GSL + I    ++  L  D     + Q   GLEYLH     
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--- 183
Query: 626 KIIHFDIKPQNILLDRDLN-VKIADFGLARLIAQDQSHVSTMP----KGTPGYMAPELTR 680
           +I+H D+K  N+LL  D +   + DFG A  +  D    S +      GT  +MAPE+  
Sbjct: 184 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G    AK+DI+S   ++L ++ G
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+E +  ++H  ++++  +  +  + ++V E M  G L   +    R++  +    K  
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLY 125
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVST 665
            +Q+   ++YLH+     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T
Sbjct: 126 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRT 181
Query: 666 MPKGTPGYMAPELTRGNSITA---KIDIYSFGVVILEIICG 703
           +  GTP Y+APE+            +D +S GV++   + G
Sbjct: 182 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR      S + T    T  Y APE+  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYC 569
           LG G    V   + L +G + AVK +       +     EVET+     + N++ L+ + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            + +  +LV+E +  GS+   + H  + +  +     +++  ++  L++LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLH---TKGIAH 134
Query: 630 FDIKPQNILLDRDLN---VKIADFGLARLIAQDQSHVS------TMPKGTPGYMAPELTR 680
            D+KP+NIL +       VKI DF L   +  + S         T P G+  YMAPE+  
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 681 GNSITA-----KIDIYSFGVVILEIICG 703
             +  A     + D++S GVV+  ++ G
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRLVGY 568
           ++G+G  G V+ G    G KVAVK  +  E   +  +  E E    +   H N++  +  
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99
Query: 569 ----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK--KIIFQISRGLEYLHDY 622
                   +  +L+ +Y  NGSL       D +++ + D +   K+ +    GL +LH  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSL------YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 623 C-----NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGYM 674
                  P I H D+K +NIL+ ++    IAD GLA     D + V   P    GT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 675 APEL----TRGNSITAKI--DIYSFGVVILEI 700
            PE+       N   + I  D+YSFG+++ E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVK-----RLYPGENRGKKEFL---SEVETIGNIHHF 560
           LG G  G V   FE       KVA+K     +   G  R     L   +E+E +  ++H 
Sbjct: 18  LGSGACGEVKLAFER--KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            ++++  +  +  + ++V E M  G L   +    R++  +    K   +Q+   ++YLH
Sbjct: 76  CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLYFYQMLLAVQYLH 131
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T+  GTP Y+APE
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC-GTPTYLAPE 186
Query: 678 LTRGNSITA---KIDIYSFGVVILEIICG 703
           +            +D +S GV++   + G
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVK-----RLYPGENRGKKEFL---SEVETIGNIHHF 560
           LG G  G V   FE       KVA+K     +   G  R     L   +E+E +  ++H 
Sbjct: 18  LGSGACGEVKLAFER--KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            ++++  +  +  + ++V E M  G L   +    R++  +    K   +Q+   ++YLH
Sbjct: 76  CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLYFYQMLLAVQYLH 131
Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           +     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T+  GTP Y+APE
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC-GTPTYLAPE 186
Query: 678 LTRGNSITA---KIDIYSFGVVILEIICG 703
           +            +D +S GV++   + G
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+E +  ++H  ++++  +  +  + ++V E M  G L   +    R++  +    K  
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLY 119
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVST 665
            +Q+   ++YLH+     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRT 175
Query: 666 MPKGTPGYMAPELTRGNSITA---KIDIYSFGVVILEIICG 703
           +  GTP Y+APE+            +D +S GV++   + G
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+E +  ++H  ++++  +  +  + ++V E M  G L   +    R++  +    K  
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLY 118
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVST 665
            +Q+   ++YLH+     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T
Sbjct: 119 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRT 174
Query: 666 MPKGTPGYMAPELTRGNSITA---KIDIYSFGVVILEIICG 703
           +  GTP Y+APE+            +D +S GV++   + G
Sbjct: 175 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+E +  ++H  ++++  +  +  + ++V E M  G L   +    R++  +    K  
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLY 258
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVST 665
            +Q+   ++YLH+     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T
Sbjct: 259 FYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRT 314
Query: 666 MPKGTPGYMAPELTRGNSITA---KIDIYSFGVVILEIICG 703
           +  GTP Y+APE+            +D +S GV++   + G
Sbjct: 315 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCN 624
           C +  +R + V EY+  G L   ++H   IQ +      + +F   +IS GL +LH    
Sbjct: 88  CFQTVDRLYFVMEYVNGGDL---MYH---IQQVGKFKEPQAVFYAAEISIGLFFLH---K 138
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             II+ D+K  N++LD + ++KIADFG+ +    D         GTP Y+APE+      
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREF-CGTPDYIAPEIIAYQPY 197
Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +D +++GV++ E++ G+   + +  D L  ++
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 543 GKKEFLSEVETIGNIHHFNLVRLVG--YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTL 600
           G+     E++ +  + H N+++LV   Y  E+   ++V EY   G  +      D +   
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML----DSVPEK 104
Query: 601 SWDIRKK--IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-- 656
            + + +      Q+  GLEYLH   +  I+H DIKP N+LL     +KI+  G+A  +  
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 657 --AQDQSHVSTMPKGTPGYMAPELTRGNSITA--KIDIYSFGVVILEIICG 703
             A D    S   +G+P +  PE+  G    +  K+DI+S GV +  I  G
Sbjct: 162 FAADDTCRTS---QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 512 LGRGGSGSVFEGLLNDGTKV--AVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +GRG  G V +  +  GT++  A K++          F  E+E + ++ H N++RL    
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            + ++ +LV E    G L + + HK   +        +I+  +   + Y H      + H
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAH 146
Query: 630 FDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            D+KP+N L      D  +K+ DFGLA      +   + +  GTP Y++P++  G     
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG-LYGP 203
Query: 687 KIDIYSFGVVILEIICG 703
           + D +S GV++  ++CG
Sbjct: 204 ECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 512 LGRGGSGSVFEGLLNDGTKV--AVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +GRG  G V +  +  GT++  A K++          F  E+E + ++ H N++RL    
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            + ++ +LV E    G L + + HK   +        +I+  +   + Y H      + H
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAH 129
Query: 630 FDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA 686
            D+KP+N L      D  +K+ DFGLA      +   + +  GTP Y++P++  G     
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG-LYGP 186
Query: 687 KIDIYSFGVVILEIICG 703
           + D +S GV++  ++CG
Sbjct: 187 ECDEWSAGVMMYVLLCG 203

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 8/129 (6%)
Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           L+ +Y+  G L   +  ++R       I    + +I   LE+LH      II+ DIK +N
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQI---YVGEIVLALEHLHKLG---IIYRDIKLEN 189
Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI--TAKIDIYSFG 694
           ILLD + +V + DFGL++    D++  +    GT  YMAP++ RG        +D +S G
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249
Query: 695 VVILEIICG 703
           V++ E++ G
Sbjct: 250 VLMYELLTG 258

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +E+E +  ++H  ++++  +  +  + ++V E M  G L   +    R++  +    K  
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC---KLY 244
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVST 665
            +Q+   ++YLH+     IIH D+KP+N+LL   + D  +KI DFG ++++ +  S + T
Sbjct: 245 FYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRT 300
Query: 666 MPKGTPGYMAPELTRGNSITA---KIDIYSFGVVILEIICG 703
           +  GTP Y+APE+            +D +S GV++   + G
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 509 QIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           Q+RLGRG  G V    + D   G + AVK++     R +     E+     +    +V L
Sbjct: 79  QLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPL 131
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   E     +  E +  GSL + +  +     L  D     + Q   GLEYLH     
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLHSR--- 185
Query: 626 KIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMP----KGTPGYMAPELTR 680
           +I+H D+K  N+LL  D  +  + DFG A  +  D      +      GT  +MAPE+  
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G S  AK+D++S   ++L ++ G
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 512 LGRGGSGSV---FEGLLNDGTKVAVKRL-YPGENRG-KKEFLSEVETIGNIHHFNLVRLV 566
           +G G  G V   ++ +L     VA+K+L  P +N+   K    E+  +  ++H N++ L+
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 567 GY------CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                     E  + ++V E M + +L + I  +   + +S+     +++Q+  G+++LH
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 145
Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  IIH D+KP NI++  D  +KI DFGLAR        V  +   T  Y APE+  
Sbjct: 146 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFV--VTRYYRAPEVIL 200
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G      +DI+S G ++ E+I G
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 25/265 (9%)
Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRL 536
           R++K+ D         + K     MK+   D    +GRG  G V         KV   +L
Sbjct: 48  RKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKL 107
Query: 537 YPGENRGKKE----FLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKW 590
                  K+     F  E + +   +   +V+L  +CA + +++L  V EYM  G L   
Sbjct: 108 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNL 165
Query: 591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF 650
           + + D  +  +    K    ++   L+ +H   +  +IH D+KP N+LLD+  ++K+ADF
Sbjct: 166 MSNYDVPEKWA----KFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADF 218
Query: 651 GLA-RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITA----KIDIYSFGVVILEIICGRR 705
           G   ++      H  T   GTP Y++PE+ +          + D +S GV + E++ G  
Sbjct: 219 GTCMKMDETGMVHCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 275
Query: 706 SSNPKGGDYLVDTL-KVKAEADRLC 729
              P   D LV T  K+    + LC
Sbjct: 276 -DTPFYADSLVGTYSKIMDHKNSLC 299

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 509 QIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           Q R+GRG  G V    + D   G + AVK++     R +   + E+     +    +V L
Sbjct: 63  QPRVGRGSFGEVHR--MKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPL 115
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   E     +  E +  GSL + I    ++  L  D     + Q   GLEYLH     
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 626 KIIHFDIKPQNILLDRDLN-VKIADFGLARLIAQDQSHVSTMP----KGTPGYMAPELTR 680
           +I+H D+K  N+LL  D +   + DFG A  +  D    S +      GT  +MAPE+  
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G    AK+DI+S   ++L ++ G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 538 PGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR 596
           PG  R +     EVE +     H N++ L+ +  E    +LV+E M  GS+   I  +  
Sbjct: 50  PGHIRSR--VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH 107
Query: 597 IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLA 653
              L   +   ++  ++  L++LH   N  I H D+KP+NIL +       VKI DFGL 
Sbjct: 108 FNELEASV---VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLG 161
Query: 654 RLIA--QDQSHVST----MPKGTPGYMAPELTRGNSITAKI-----DIYSFGVVILEIIC 702
             I    D S +ST     P G+  YMAPE+    S  A I     D++S GV++  ++ 
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 703 G 703
           G
Sbjct: 222 G 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 509 QIRLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           Q R+GRG  G V    + D   G + AVK++     R +   + E+     +    +V L
Sbjct: 79  QPRVGRGSFGEVHR--MKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPL 131
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   E     +  E +  GSL + I    ++  L  D     + Q   GLEYLH     
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--- 185
Query: 626 KIIHFDIKPQNILLDRDLN-VKIADFGLARLIAQDQSHVSTMP----KGTPGYMAPELTR 680
           +I+H D+K  N+LL  D +   + DFG A  +  D    S +      GT  +MAPE+  
Sbjct: 186 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 681 GNSITAKIDIYSFGVVILEIICG 703
           G    AK+DI+S   ++L ++ G
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 541 NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
           ++ K++   E+E +     H N++ L     +    ++V E M  G L   I    R + 
Sbjct: 56  DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKF 112
Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL-LDRDLN---VKIADFGLARL 655
            S      ++F I++ +EYLH      ++H D+KP NIL +D   N   ++I DFG A+ 
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +  +   + T P  T  ++APE+       A  DI+S GV++  ++ G
Sbjct: 170 LRAENGLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 499 KAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKE---FLSEVE 552
           K M+    DF+I   +GRG  G V    + +  ++ A+K L   E   + E   F  E +
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
            + N     +  L     + ++ +LV +Y   G L   +   +    L  D+ +  I ++
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFE--DKLPEDMARFYIGEM 200
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
              ++ +H       +H DIKP N+LLD + ++++ADFG    +  D +  S++  GTP 
Sbjct: 201 VLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD 257
Query: 673 YMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
           Y++PE+ +           + D +S GV + E++ G     P   + LV+T
Sbjct: 258 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---TPFYAESLVET 305

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 499 KAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKE---FLSEVE 552
           K M+    DF+I   +GRG  G V    + +  ++ A+K L   E   + E   F  E +
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
            + N     +  L     + ++ +LV +Y   G L   +   +    L  D+ +  I ++
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFE--DKLPEDMARFYIGEM 184
Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
              ++ +H       +H DIKP N+LLD + ++++ADFG    +  D +  S++  GTP 
Sbjct: 185 VLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD 241
Query: 673 YMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT 718
           Y++PE+ +           + D +S GV + E++ G     P   + LV+T
Sbjct: 242 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG---ETPFYAESLVET 289

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCN 624
           C +  +R + V EY+  G L   ++H   IQ +        +F   +I+ GL +L    +
Sbjct: 410 CFQTMDRLYFVMEYVNGGDL---MYH---IQQVGRFKEPHAVFYAAEIAIGLFFLQ---S 460
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             II+ D+K  N++LD + ++KIADFG+ +    D         GTP Y+APE+      
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF-CGTPDYIAPEIIAYQPY 519
Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +D ++FGV++ E++ G+     +  D L  ++
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 511 RLGRGGSGSVFEGL---LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVG 567
           +LG G  G V++ +    N+   +   RL   E       + EV  +  + H N++ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                    L++EY  N  L K++   D+   +S  + K  ++Q+  G+ + H     + 
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSR---RC 153
Query: 628 IHFDIKPQNILL-----DRDLNVKIADFGLARL----IAQDQSHVSTMPKGTPGYMAPEL 678
           +H D+KPQN+LL          +KI DFGLAR     I Q    + T+      Y  PE+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL-----WYRPPEI 208
Query: 679 TRGNS-ITAKIDIYSFGVVILEII 701
             G+   +  +DI+S   +  E++
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 569 CAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF---QISRGLEYLHDYCN 624
           C +  +R + V EY+  G L   ++H   IQ +        +F   +I+ GL +L    +
Sbjct: 89  CFQTMDRLYFVMEYVNGGDL---MYH---IQQVGRFKEPHAVFYAAEIAIGLFFLQ---S 139
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             II+ D+K  N++LD + ++KIADFG+ +    D         GTP Y+APE+      
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF-CGTPDYIAPEIIAYQPY 198
Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
              +D ++FGV++ E++ G+     +  D L  ++
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 129/269 (47%), Gaps = 33/269 (12%)
Query: 490 ANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE 546
           A+H+V++ ++       D+Q+  +LGRG    VFE + + +  KV VK L P +   K +
Sbjct: 27  ASHVVEWGNQD------DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KNK 77
Query: 547 FLSEVETIGNIHH-FNLVRLVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLS-W 602
              E++ + N+    N++ L     +  +R   LV+E++ N         K   QTL+ +
Sbjct: 78  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDY 131
Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQS 661
           DIR   +++I + L+Y H      I+H D+KP N+++D +   +++ D+GLA      Q 
Sbjct: 132 DIRF-YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 662 HVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRS--SNPKGGDYLVDT 718
           +   +   +  +  PEL     +    +D++S G ++  +I  +          D LV  
Sbjct: 188 Y--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 719 LKVKAEADRLCDLVDKKSEDMQSHRDDAV 747
            KV    D L D +DK + ++    +D +
Sbjct: 246 AKVLGTED-LYDYIDKYNIELDPRFNDIL 273

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK-----------KEFLSEVETIGNIHHF 560
           +  G  G+V  G+ ++G  VA+KR++   + G+           K  L E+  + + HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 561 NLVRL----VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           N++ L    V +     ++  +   +    L + + H  RI  +S    +  ++ I  GL
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-VIHDQRI-VISPQHIQYFMYHILLGL 147
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--QSHVSTMPKGTPGYM 674
             LH+     ++H D+ P NILL  + ++ I DF LAR    D  ++H  T       Y 
Sbjct: 148 HVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT----HRWYR 200
Query: 675 APELT-RGNSITAKIDIYSFGVVILEI 700
           APEL  +    T  +D++S G V+ E+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK-----------KEFLSEVETIGNIHHF 560
           +  G  G+V  G+ ++G  VA+KR++   + G+           K  L E+  + + HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 561 NLVRL----VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           N++ L    V +     ++  +   +    L + + H  RI  +S    +  ++ I  GL
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-VIHDQRI-VISPQHIQYFMYHILLGL 147
Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD--QSHVSTMPKGTPGYM 674
             LH+     ++H D+ P NILL  + ++ I DF LAR    D  ++H  T       Y 
Sbjct: 148 HVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT----HRWYR 200
Query: 675 APELT-RGNSITAKIDIYSFGVVILEI 700
           APEL  +    T  +D++S G V+ E+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE 571
           LGRG  G V   +     K  + +    +   +     E+  +    H N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF----QISRGLEYLHDYCNPKI 627
                +++E++    LD  IF  +RI T ++++ ++ I     Q+   L++LH +    I
Sbjct: 73  MEELVMIFEFI--SGLD--IF--ERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 628 IHFDIKPQNILLD--RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            HFDI+P+NI+    R   +KI +FG AR +    +    +    P Y APE+ + + ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVS 181
Query: 686 AKIDIYSFGVVILEIICG----------RRSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
              D++S G ++  ++ G          +   N    +Y  D    K  +    D VD+
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYC 569
           LG G    V   + L    + AVK +       +     EVE +     H N++ L+ + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            E    +LV+E M  GS+   I  +     L   +   ++  ++  L++LH   N  I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKGIAH 134
Query: 630 FDIKPQNILLDRDLN---VKIADFGLARLIA--QDQSHVST----MPKGTPGYMAPELTR 680
            D+KP+NIL +       VKI DF L   I    D S +ST     P G+  YMAPE+  
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 681 GNSITAKI-----DIYSFGVVILEIICG 703
             S  A I     D++S GV++  ++ G
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 110/238 (46%), Gaps = 28/238 (11%)
Query: 485 SSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGEN 541
           S V +    + F S ++K        ++G GGS  VF+ +LN+  ++ A+K   L   +N
Sbjct: 9   SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADN 67
Query: 542 RGKKEFLSEVETIGNI--HHFNLVRLVGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQ 598
           +    + +E+  +  +  H   ++RL  Y  E +++++     C N  L+ W+  K  I 
Sbjct: 68  QTLDSYRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSID 125
Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ 658
              W+ RK     +   LE +H      I+H D+KP N L+  D  +K+ DFG+A  +  
Sbjct: 126 --PWE-RKSYWKNM---LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQP 178
Query: 659 DQSHVSTMPK-GTPGYMAPELTRGNSITAK-----------IDIYSFGVVILEIICGR 704
           D + V    + GT  YM PE  +  S + +            D++S G ++  +  G+
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 541 NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
           ++ K++   E+E +     H N++ L     +    ++V E    G L   I    R + 
Sbjct: 56  DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKF 112
Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL-LDRDLN---VKIADFGLARL 655
            S      ++F I++ +EYLH      ++H D+KP NIL +D   N   ++I DFG A+ 
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +  +   + T P  T  ++APE+       A  DI+S GV++   + G
Sbjct: 170 LRAENGLLXT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 28/238 (11%)
Query: 485 SSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGEN 541
           S V +    + F S ++K        ++G GGS  VF+ +LN+  ++ A+K   L   +N
Sbjct: 9   SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADN 67
Query: 542 RGKKEFLSEVETIGNI--HHFNLVRLVGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQ 598
           +    + +E+  +  +  H   ++RL  Y  E +++++     C N  L+ W+  K  I 
Sbjct: 68  QTLDSYRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSID 125
Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ 658
              W+ RK     +   LE +H      I+H D+KP N L+  D  +K+ DFG+A  +  
Sbjct: 126 --PWE-RKSYWKNM---LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQP 178
Query: 659 DQSHVSTMPK-GTPGYMAPELTRGNSITAK-----------IDIYSFGVVILEIICGR 704
           D   V    + GT  YM PE  +  S + +            D++S G ++  +  G+
Sbjct: 179 DXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 541 NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
           ++ K++   E+E +     H N++ L     +  + +LV E M  G L   I    R + 
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL---RQKF 117
Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL-LDRDLN---VKIADFGLARL 655
            S      ++  I + +EYLH   +  ++H D+KP NIL +D   N   ++I DFG A+ 
Sbjct: 118 FSEREASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ 174
Query: 656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +  +   + T P  T  ++APE+ +        DI+S G+++  ++ G
Sbjct: 175 LRAENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 541 NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
           ++ K++   E+E +     H N++ L     +  + +LV E M  G L   I    R + 
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL---RQKF 117
Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL-LDRDLN---VKIADFGLARL 655
            S      ++  I + +EYLH   +  ++H D+KP NIL +D   N   ++I DFG A+ 
Sbjct: 118 FSEREASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ 174
Query: 656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +  +   + T P  T  ++APE+ +        DI+S G+++  ++ G
Sbjct: 175 LRAENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 86/179 (48%), Gaps = 18/179 (10%)
Query: 531 VAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKW 590
           VAVK +  GE +  +    E+    ++ H N+VR        ++  +V EY   G L + 
Sbjct: 47  VAVKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL--NVKIA 648
           I +  R    S D  +    Q+  G+ Y H     ++ H D+K +N LLD      +KIA
Sbjct: 106 ICNAGR---FSEDEARFFFQQLISGVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIA 159
Query: 649 DFGLAR---LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKI-DIYSFGVVILEIICG 703
           DFG ++   L +Q +S V     GTP Y+APE+        K+ D++S GV +  ++ G
Sbjct: 160 DFGYSKASVLHSQPKSAV-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
            Q  +G+G  G V+ G    G +VAVK      +R ++ +  E E    +   H N++  
Sbjct: 33  LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 88
Query: 566 VGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH- 620
           +          +  +LV +Y  +GSL    F      T++ +   K+    + GL +LH 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 144
Query: 621 ----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGY 673
                   P I H D+K +NIL+ ++    IAD GLA         +   P    GT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 674 MAPELTRGNSITAK-------IDIYSFGVVILEIICGRRSS 707
           MAPE+   +SI  K        DIY+ G+V  EI   RR S
Sbjct: 205 MAPEVL-DDSINMKHFESFKRADIYAMGLVFWEI--ARRCS 242

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 60/124 (48%), Gaps = 10/124 (8%)
Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           +V+E + +  L KWI  K   Q L     KKII Q+ +GL+YLH  C  +IIH DIKP+N
Sbjct: 122 MVFEVLGHHLL-KWII-KSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPEN 177
Query: 637 ILLD------RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           ILL       R L  +  ++  +       S VST P     ++   L   N+   K+ I
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 691 YSFG 694
              G
Sbjct: 238 ADLG 241

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 49/200 (24%)
Query: 549 SEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS--LDKW-IFHKDRIQTLSWDI- 604
           +EV  +  +HH N+ RL     +     LV E +C+G   LDK  +F  D     + D+ 
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVME-LCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 605 ------------------------------RKKIIFQISR----GLEYLHDYCNPKIIHF 630
                                         R+K+I  I R     L YLH   N  I H 
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHR 192
Query: 631 DIKPQNILL--DRDLNVKIADFGLAR---LIAQDQSHVSTMPKGTPGYMAPEL--TRGNS 683
           DIKP+N L   ++   +K+ DFGL++    +   + +  T   GTP ++APE+  T   S
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 684 ITAKIDIYSFGVVILEIICG 703
              K D +S GV++  ++ G
Sbjct: 253 YGPKCDAWSAGVLLHLLLMG 272

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRG 615
           + H ++V L+   +     ++V+E+M    L   I  + D     S  +    + QI   
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQSHVSTMPKGTPG 672
           L Y HD     IIH D+KP  +LL    N   VK+  FG+A  + +    V+    GTP 
Sbjct: 145 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPH 200
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +MAPE+ +       +D++  GV++  ++ G
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 60/124 (48%), Gaps = 10/124 (8%)
Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           +V+E + +  L KWI  K   Q L     KKII Q+ +GL+YLH  C  +IIH DIKP+N
Sbjct: 106 MVFEVLGHHLL-KWII-KSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPEN 161
Query: 637 ILLD------RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           ILL       R L  +  ++  +       S VST P     ++   L   N+   K+ I
Sbjct: 162 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 221
Query: 691 YSFG 694
              G
Sbjct: 222 ADLG 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
            Q  +G+G  G V+ G    G +VAVK      +R ++ +  E E    +   H N++  
Sbjct: 8   LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 63
Query: 566 VGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH- 620
           +          +  +LV +Y  +GSL    F      T++ +   K+    + GL +LH 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 119
Query: 621 ----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGY 673
                   P I H D+K +NIL+ ++    IAD GLA         +   P    GT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 674 MAPELTRGNSITAK-------IDIYSFGVVILEIICGRRSS 707
           MAPE+   +SI  K        DIY+ G+V  EI   RR S
Sbjct: 180 MAPEVL-DDSINMKHFESFKRADIYAMGLVFWEI--ARRCS 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
            Q  +G+G  G V+ G    G +VAVK      +R ++ +  E E    +   H N++  
Sbjct: 46  LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 566 VGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH- 620
           +          +  +LV +Y  +GSL    F      T++ +   K+    + GL +LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 621 ----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGY 673
                   P I H D+K +NIL+ ++    IAD GLA         +   P    GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 674 MAPELTRGNSITAK-------IDIYSFGVVILEIICGRRSS 707
           MAPE+   +SI  K        DIY+ G+V  EI   RR S
Sbjct: 218 MAPEVL-DDSINMKHFESFKRADIYAMGLVFWEI--ARRCS 255

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
            Q  +G+G  G V+ G    G +VAVK      +R ++ +  E E    +   H N++  
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 62
Query: 566 VGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH- 620
           +          +  +LV +Y  +GSL    F      T++ +   K+    + GL +LH 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 621 ----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGY 673
                   P I H D+K +NIL+ ++    IAD GLA         +   P    GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 674 MAPELTRGNSITAK-------IDIYSFGVVILEIICGRRSS 707
           MAPE+   +SI  K        DIY+ G+V  EI   RR S
Sbjct: 179 MAPEVL-DDSINMKHFESFKRADIYAMGLVFWEI--ARRCS 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
            Q  +G+G  G V+ G    G +VAVK      +R ++ +  E E    +   H N++  
Sbjct: 13  LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 68
Query: 566 VGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH- 620
           +          +  +LV +Y  +GSL    F      T++ +   K+    + GL +LH 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 124
Query: 621 ----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGY 673
                   P I H D+K +NIL+ ++    IAD GLA         +   P    GT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 674 MAPELTRGNSITAK-------IDIYSFGVVILEIICGRRSS 707
           MAPE+   +SI  K        DIY+ G+V  EI   RR S
Sbjct: 185 MAPEVL-DDSINMKHFESFKRADIYAMGLVFWEI--ARRCS 222

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
            Q  +G+G  G V+ G    G +VAVK      +R ++ +  E E    +   H N++  
Sbjct: 10  LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 65
Query: 566 VGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH- 620
           +          +  +LV +Y  +GSL    F      T++ +   K+    + GL +LH 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 121
Query: 621 ----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGY 673
                   P I H D+K +NIL+ ++    IAD GLA         +   P    GT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 674 MAPELTRGNSITAK-------IDIYSFGVVILEIICGRRSS 707
           MAPE+   +SI  K        DIY+ G+V  EI   RR S
Sbjct: 182 MAPEVL-DDSINMKHFESFKRADIYAMGLVFWEI--ARRCS 219

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 20/251 (7%)
Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKV-AVKR 535
           R++K+ D       + + K     MK+   +    +GRG  G V         KV A+K 
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 536 LYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKWI 591
           L   E   R    F  E   I    +   V  + Y A + +R+L  V EYM  G L   +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 592 FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG 651
            + D  +  +    +    ++   L+ +H   +   IH D+KP N+LLD+  ++K+ADFG
Sbjct: 161 SNYDVPEKWA----RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 652 LARLIAQDQSHVSTMPKGTPGYMAPELTR---GNSITAK-IDIYSFGVVILEIICGRRSS 707
               + ++         GTP Y++PE+ +   G+    +  D +S GV + E++ G    
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG---D 270
Query: 708 NPKGGDYLVDT 718
            P   D LV T
Sbjct: 271 TPFYADSLVGT 281

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 20/251 (7%)
Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKV-AVKR 535
           R++K+ D       + + K     MK+   +    +GRG  G V         KV A+K 
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 536 LYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKWI 591
           L   E   R    F  E   I    +   V  + Y A + +R+L  V EYM  G L   +
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYMPGGDLVNLM 165
Query: 592 FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG 651
            + D  +  +    +    ++   L+ +H   +   IH D+KP N+LLD+  ++K+ADFG
Sbjct: 166 SNYDVPEKWA----RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 218
Query: 652 LARLIAQDQSHVSTMPKGTPGYMAPELTR---GNSITAK-IDIYSFGVVILEIICGRRSS 707
               + ++         GTP Y++PE+ +   G+    +  D +S GV + E++ G    
Sbjct: 219 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG---D 275
Query: 708 NPKGGDYLVDT 718
            P   D LV T
Sbjct: 276 TPFYADSLVGT 286

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 20/251 (7%)
Query: 477 RRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKV-AVKR 535
           R++K+ D       + + K     MK+   +    +GRG  G V         KV A+K 
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 536 LYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKWI 591
           L   E   R    F  E   I    +   V  + Y A + +R+L  V EYM  G L   +
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYMPGGDLVNLM 165
Query: 592 FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG 651
            + D  +  +    +    ++   L+ +H   +   IH D+KP N+LLD+  ++K+ADFG
Sbjct: 166 SNYDVPEKWA----RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 218
Query: 652 LARLIAQDQSHVSTMPKGTPGYMAPELTR---GNSITAK-IDIYSFGVVILEIICGRRSS 707
               + ++         GTP Y++PE+ +   G+    +  D +S GV + E++ G    
Sbjct: 219 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG---D 275
Query: 708 NPKGGDYLVDT 718
            P   D LV T
Sbjct: 276 TPFYADSLVGT 286

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRG 615
           + H ++V L+   +     ++V+E+M    L   I  + D     S  +    + QI   
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQSHVSTMPKGTPG 672
           L Y HD     IIH D+KP  +LL    N   VK+  FG+A  + +    V+    GTP 
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPH 198
Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           +MAPE+ +       +D++  GV++  ++ G
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 35/302 (11%)
Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++GRG  G V++    DG       L   E  G       E+  +  + H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 570 AERSNR--FLVYEYMCNGSLDKWIFHK-----DRIQTLSWDIRKKIIFQISRGLEYLHDY 622
              ++R  +L+++Y  +       FH+      +   L   + K +++QI  G+ YLH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 623 CNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAP 676
               ++H D+KP NIL+         VKIAD G ARL       ++ +     T  Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 677 ELTRG-NSITAKIDIYSFGVVILEIICGR----------RSSNPKGGDYLVDTLKVKA-E 724
           EL  G    T  IDI++ G +  E++             ++SNP   D L     V    
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 725 ADRLCDLVDKKSED---MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
           AD+  + + K  E    M+  R +      + I  ++K  H+    S    +LQ L  ++
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL-IKYMEK--HKVKPDSKAFHLLQKLLTMD 321
Query: 782 PV 783
           P+
Sbjct: 322 PI 323

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
           ++G GGS  VF+ +LN+  ++ A+K   L   +N+    + +E+  +  +  H   ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 566 VGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             Y  E +++++     C N  L+ W+  K  I    W+ RK     +   LE +H    
Sbjct: 122 YDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDP--WE-RKSYWKNM---LEAVHTIHQ 173
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNS 683
             I+H D+KP N L+  D  +K+ DFG+A  +  D + V    + GT  YM PE  +  S
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 684 ITAK-----------IDIYSFGVVILEIICGR 704
            + +            D++S G ++  +  G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
           ++G GGS  VF+ +LN+  ++ A+K   L   +N+    + +E+  +  +  H   ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 566 VGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             Y  E +++++     C N  L+ W+  K  I    W+ RK     +   LE +H    
Sbjct: 122 YDY--EITDQYIYMVMECGNIDLNSWLKKKKSID--PWE-RKSYWKNM---LEAVHTIHQ 173
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNS 683
             I+H D+KP N L+  D  +K+ DFG+A  +  D + V    + GT  YM PE  +  S
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 684 ITAK-----------IDIYSFGVVILEIICGR 704
            + +            D++S G ++  +  G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMP 667
           I+Q+ R + ++H      I H DIKPQN+L++ +D  +K+ DFG A+ +   +  V+ + 
Sbjct: 147 IYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXI- 202
Query: 668 KGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGR 704
             +  Y APEL  G    T  ID++S G V  E+I G+
Sbjct: 203 -CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 45/228 (19%)
Query: 511 RLGRGGSGSVF----EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           ++G G   SV+    +  +    K+A+K L P  +  +    +E++ +      + V  V
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAGGQDNVMGV 85
Query: 567 GYCAERSNRFLV-YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            YC  +++  ++   Y+ + S        D + +LS+   ++ +  + + L+ +H +   
Sbjct: 86  KYCFRKNDHVVIAMPYLEHESF------LDILNSLSFQEVREYMLNLFKALKRIHQF--- 136
Query: 626 KIIHFDIKPQNILLDRDLN-VKIADFGLAR--------LIAQDQSHVS------------ 664
            I+H D+KP N L +R L    + DFGLA+        L+   QS               
Sbjct: 137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSIC 196
Query: 665 ------TMPK-GTPGYMAPE-LTRGNSITAKIDIYSFGVVILEIICGR 704
                   P+ GTPG+ APE LT+  + T  ID++S GV+ L ++ GR
Sbjct: 197 LSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 36/238 (15%)
Query: 492 HLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLND--GTKVAVKRL-----YPGENRGK 544
           HL+  S   + SA  +    LG G  G V E + +   G  VAVK +     Y    R +
Sbjct: 3   HLICQSGDVL-SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
            + L  + T      F  V+++ +     +  +V+E +   + D     ++       D 
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD--FIKENGFLPFRLDH 119
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----------------DRDL---NV 645
            +K+ +QI + + +LH   + K+ H D+KP+NIL                 +R L   ++
Sbjct: 120 IRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           K+ DFG A     D  H ST+   T  Y APE+      +   D++S G +++E   G
Sbjct: 177 KVVDFGSA---TYDDEHHSTLV-STRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 135 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 188
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 189 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 119 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 173 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 55/302 (18%)
Query: 500 AMKSA-TRDFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRLYP--GENRGKKEFLSEVET 553
           AMKS  T +F    ++G G  GSVF+ +   DG   A+KR       +  ++  L EV  
Sbjct: 2   AMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 61
Query: 554 IGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR-KKIIFQ 611
              +  H ++VR     AE  +  +  EY   GSL   I    RI +   +   K ++ Q
Sbjct: 62  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 121
Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDR-------------------DLNVKIADFGL 652
           + RGL Y+H      ++H DIKP NI + R                    +  KI D G 
Sbjct: 122 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 178
Query: 653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSN-PK 710
              I+  Q     + +G   ++A E+ + N +   K DI++     L ++C   +   P+
Sbjct: 179 VTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALA---LTVVCAAGAEPLPR 230
Query: 711 GGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASML 770
            GD   +  +      RL  +    S++         +++++ I     +  RRPSA  L
Sbjct: 231 NGDQWHEIRQ-----GRLPRIPQVLSQEF-------TELLKVMI---HPDPERRPSAMAL 275
Query: 771 VK 772
           VK
Sbjct: 276 VK 277

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 120 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 173
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 125 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 178
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
           ++G GGS  VF+ +LN+  ++ A+K   L   +N+    + +E+  +  +  H   ++RL
Sbjct: 16  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 566 VGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             Y  E +++++     C N  L+ W+  K  I    W+ RK     +   LE +H    
Sbjct: 75  YDY--EITDQYIYMVMECGNIDLNSWLKKKKSID--PWE-RKSYWKNM---LEAVHTIHQ 126
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNS 683
             I+H D+KP N L+  D  +K+ DFG+A  +  D + V    + GT  YM PE  +  S
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 684 ITAK-----------IDIYSFGVVILEIICGR 704
            + +            D++S G ++  +  G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 121 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 127 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 180
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 126 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 179
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 171 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 224
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 165 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 121 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 18/179 (10%)
Query: 531 VAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKW 590
           VAVK +  GE +  +    E+    ++ H N+VR        ++  +V EY   G L + 
Sbjct: 46  VAVKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 104
Query: 591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL--NVKIA 648
           I +  R    S D  +    Q+  G+ Y H     ++ H D+K +N LLD      +KI 
Sbjct: 105 ICNAGR---FSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKIC 158
Query: 649 DFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGNSITAKI-DIYSFGVVILEIICG 703
           DFG ++      S + + PK   GTP Y+APE+        K+ D++S GV +  ++ G
Sbjct: 159 DFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHV 663
           +I+  I   ++YLH      I H D+KP+N+L      +  +K+ DFG A+   +  SH 
Sbjct: 119 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 664 S-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S T P  TP Y+APE+          D++S GV++  ++CG
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 52/288 (18%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYP--GENRGKKEFLSEVETIGNI-HHFNLVRLV 566
           ++G G  GSVF+ +   DG   A+KR       +  ++  L EV     +  H ++VR  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR-KKIIFQISRGLEYLHDYCNP 625
              AE  +  +  EY   GSL   I    RI +   +   K ++ Q+ RGL Y+H     
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-- 133
Query: 626 KIIHFDIKPQNILLDR-------------------DLNVKIADFGLARLIAQDQSHVSTM 666
            ++H DIKP NI + R                    +  KI D G    I+  Q     +
Sbjct: 134 -LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----V 187
Query: 667 PKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSN-PKGGDYLVDTLKVKAE 724
            +G   ++A E+ + N +   K DI++     L ++C   +   P+ GD   +  +    
Sbjct: 188 EEGDSRFLANEVLQENYTHLPKADIFALA---LTVVCAAGAEPLPRNGDQWHEIRQ---- 240
Query: 725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             RL  +    S++         +++++ I     +  RRPSA  LVK
Sbjct: 241 -GRLPRIPQVLSQEF-------TELLKVMI---HPDPERRPSAMALVK 277

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 24/182 (13%)
Query: 531 VAVKRLYPGENRG---KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL 587
           VAVK +  GE      K+E ++      ++ H N+VR        ++  +V EY   G L
Sbjct: 47  VAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL--NV 645
            + I +  R    S D  +    Q+  G+ Y H     ++ H D+K +N LLD      +
Sbjct: 103 FERICNAGR---FSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRL 156
Query: 646 KIADFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGNSITAKI-DIYSFGVVILEII 701
           KI DFG ++      S + + PK   GTP Y+APE+        K+ D++S GV +  ++
Sbjct: 157 KICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 702 CG 703
            G
Sbjct: 212 VG 213

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
           ++G GGS  VF+ +LN+  ++ A+K   L   +N+    + +E+  +  +  H   ++RL
Sbjct: 19  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 77
Query: 566 VGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             Y  E +++++     C N  L+ W+  K  I    W+ RK     +   +  +H +  
Sbjct: 78  YDY--EITDQYIYMVMECGNIDLNSWLKKKKSID--PWE-RKSYWKNMLEAVHTIHQH-- 130
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNS 683
             I+H D+KP N L+  D  +K+ DFG+A  +  D + V    + GT  YM PE  +  S
Sbjct: 131 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 684 ITAK-----------IDIYSFGVVILEIICGR 704
            + +            D++S G ++  +  G+
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
           ++ H N+VR        ++  ++ EY   G L + I +  R    S D  +    Q+  G
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSG 128
Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDL--NVKIADFGLARLIAQDQSHVSTMPK---GT 670
           + Y H     +I H D+K +N LLD      +KI DFG ++      S + + PK   GT
Sbjct: 129 VSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGT 180
Query: 671 PGYMAPELTRGNSITAKI-DIYSFGVVILEIICG 703
           P Y+APE+        KI D++S GV +  ++ G
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
           ++G GGS  VF+ +LN+  ++ A+K   L   +N+    + +E+  +  +  H   ++RL
Sbjct: 15  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 73
Query: 566 VGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             Y  E +++++     C N  L+ W+  K  I    W+ RK     +   LE +H    
Sbjct: 74  YDY--EITDQYIYMVMECGNIDLNSWLKKKKSID--PWE-RKSYWKNM---LEAVHTIHQ 125
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNS 683
             I+H D+KP N L+  D  +K+ DFG+A  +  D + V    + GT  YM PE  +  S
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 684 ITAK-----------IDIYSFGVVILEIICGR 704
            + +            D++S G ++  +  G+
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 52/288 (18%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYP--GENRGKKEFLSEVETIGNI-HHFNLVRLV 566
           ++G G  GSVF+ +   DG   A+KR       +  ++  L EV     +  H ++VR  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR-KKIIFQISRGLEYLHDYCNP 625
              AE  +  +  EY   GSL   I    RI +   +   K ++ Q+ RGL Y+H     
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-- 135
Query: 626 KIIHFDIKPQNILLDR-------------------DLNVKIADFGLARLIAQDQSHVSTM 666
            ++H DIKP NI + R                    +  KI D G    I+  Q     +
Sbjct: 136 -LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----V 189
Query: 667 PKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSN-PKGGDYLVDTLKVKAE 724
            +G   ++A E+ + N +   K DI++     L ++C   +   P+ GD   +  +    
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALA---LTVVCAAGAEPLPRNGDQWHEIRQ---- 242
Query: 725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             RL  +    S++         +++++ I     +  RRPSA  LVK
Sbjct: 243 -GRLPRIPQVLSQEF-------TELLKVMI---HPDPERRPSAMALVK 279

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 12/113 (10%)
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL------DRDLNVKIADFGLARLIAQD 659
           K+I  Q+  GL+Y+H  C   IIH DIKP+N+L+      +  + +KIAD G A     D
Sbjct: 134 KQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYD 189
Query: 660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG 712
           + + +++   T  Y +PE+  G       DI+S   +I E+I G     P  G
Sbjct: 190 EHYTNSIQ--TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 12/113 (10%)
Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL------DRDLNVKIADFGLARLIAQD 659
           K+I  Q+  GL+Y+H  C   IIH DIKP+N+L+      +  + +KIAD G A     D
Sbjct: 134 KQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYD 189
Query: 660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG 712
           + + +++   T  Y +PE+  G       DI+S   +I E+I G     P  G
Sbjct: 190 EHYTNSIQ--TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 511 RLGRGGSGSVFEGLLNDGTKV-AVK--RLYPGENRGKKEFLSEVETIGNI--HHFNLVRL 565
           ++G GGS  VF+ +LN+  ++ A+K   L   +N+    + +E+  +  +  H   ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 566 VGYCAERSNRFLVYEYMC-NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
             Y  E +++++     C N  L+ W+  K  I    W+ RK     +   LE +H    
Sbjct: 122 YDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDP--WE-RKSYWKNM---LEAVHTIHQ 173
Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNS 683
             I+H D+KP N L+  D  +K+ DFG+A  +  D + V    + G   YM PE  +  S
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 684 ITAK-----------IDIYSFGVVILEIICGR 704
            + +            D++S G ++  +  G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 50/287 (17%)
Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYP--GENRGKKEFLSEVETIGNI-HHFNLVRLV 566
           ++G G  GSVF+ +   DG   A+KR       +  ++  L EV     +  H ++VR  
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 73
Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR-KKIIFQISRGLEYLHDYCNP 625
              AE  +  +  EY   GSL   I    RI +   +   K ++ Q+ RGL Y+H     
Sbjct: 74  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-- 131
Query: 626 KIIHFDIKPQNILLDR-------------------DLNVKIADFGLARLIAQDQSHVSTM 666
            ++H DIKP NI + R                    +  KI D G    I+  Q     +
Sbjct: 132 -LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----V 185
Query: 667 PKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA 725
            +G   ++A E+ + N +   K DI++  + +  +        P+ GD   +  +     
Sbjct: 186 EEGDSRFLANEVLQENYTHLPKADIFALALTV--VXAAGAEPLPRNGDQWHEIRQ----- 238
Query: 726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            RL  +    S++         +++++ I     +  RRPSA  LVK
Sbjct: 239 GRLPRIPQVLSQEF-------TELLKVMI---HPDPERRPSAMALVK 275

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH------FNLVRL 565
           +G+G  G V +   +   +    ++   E R  ++   E+  + ++         N++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +     R++  + +E +     +  +  K++ Q  S  + +K    I + L+ LH     
Sbjct: 165 LENFTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRKFAHSILQCLDALH---KN 219
Query: 626 KIIHFDIKPQNILLDRD--LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           +IIH D+KP+NILL +     +K+ DFG +     +   V T  + +  Y APE+  G  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQ-SRFYRAPEVILGAR 275
Query: 684 ITAKIDIYSFGVVILEIICG 703
               ID++S G ++ E++ G
Sbjct: 276 YGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH------FNLVRL 565
           +G+G  G V +   +   +    ++   E R  ++   E+  + ++         N++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +     R++  + +E +     +  +  K++ Q  S  + +K    I + L+ LH     
Sbjct: 165 LENFTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRKFAHSILQCLDALH---KN 219
Query: 626 KIIHFDIKPQNILLDRD--LNVKIADFGLA-----RLIAQDQSHVSTMPKGTPGYMAPEL 678
           +IIH D+KP+NILL +     +K+ DFG +     R+    QS           Y APE+
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF---------YRAPEV 270
Query: 679 TRGNSITAKIDIYSFGVVILEIICG 703
             G      ID++S G ++ E++ G
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 36/238 (15%)
Query: 492 HLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLLND--GTKVAVKRL-----YPGENRGK 544
           HL+  S   + SA  +    LG G  G V E + +   G  VAVK +     Y    R +
Sbjct: 3   HLICQSGDVL-SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 545 KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI 604
            + L  + T      F  V+++ +     +  +V+E +   + D     ++       D 
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD--FIKENGFLPFRLDH 119
Query: 605 RKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----------------DRDL---NV 645
            +K+ +QI + + +LH   + K+ H D+KP+NIL                 +R L   ++
Sbjct: 120 IRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           K+ DFG A     D  H ST+      Y APE+      +   D++S G +++E   G
Sbjct: 177 KVVDFGSA---TYDDEHHSTLVXXR-HYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	818
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-110
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-108
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-54
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-47
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-45
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-44
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-43
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-42
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-42
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-41
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-36
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-35
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-33
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-31
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-31
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-31
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-31
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-30
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-30
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-30
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-30
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-29
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-29
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-28
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-26
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-23
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-23
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	2e-09
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	2e-09
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	3e-07
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	3e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	5e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	1e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	2e-05
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-08
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-05
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	2e-08
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	3e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	2e-08
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	7e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-08
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	1e-07
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	1e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-07
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	7e-07
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	4e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	2e-06
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	6e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	3e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  351 bits (903), Expect = e-115
 Identities = 116/299 (38%), Positives = 178/299 (59%), Gaps = 16/299 (5%)

Query: 495 KFSSKAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-KKEFLSEV 551
           +FS + ++ A+ +F  +  LGRGG G V++G L DGT VAVKRL     +G + +F +EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ-TLSWDIRKKIIF 610
           E I    H NL+RL G+C   + R LVY YM NGS+   +  +   Q  L W  R++I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
             +RGL YLHD+C+PKIIH D+K  NILLD +    + DFGLA+L+    +HV+T  +GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 671 PGYMAPE-LTRGNSITAKIDIYSFGVVILEIICGRRS---SNPKGGD--YLVDTLKVKAE 724
            G++APE L+ G   + K D++ +GV++LE+I G+R+   +     D   L+D +K   +
Sbjct: 199 IGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 725 ADRLCDLVDKKSEDMQSH--RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
             +L  LVD     +Q +   ++  ++IQ+A+ C Q +   RP  S +V++L+G    E
Sbjct: 258 EKKLEALVDVD---LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  337 bits (867), Expect = e-110
 Identities = 107/311 (34%), Positives = 161/311 (51%), Gaps = 22/311 (7%)

Query: 483 DESSVHVANHLVKFSSKAMKSATRDF--------QIRLGRGGSGSVFEGLLNDGTKVAVK 534
           ++S          FS   +K+ T +F          ++G GG G V++G + + T VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 535 RLYPGENR----GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKW 590
           +L    +      K++F  E++ +    H NLV L+G+ ++  +  LVY YM NGSL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 591 IFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF 650
           +   D    LSW +R KI    + G+ +LH+      IH DIK  NILLD     KI+DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 651 GLARLIAQ-DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP 709
           GLAR   +  Q+ +++   GT  YMAPE  RG  IT K DIYSFGVV+LEII G  + + 
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 710 -KGGDYLVD-TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSA 767
            +    L+D   +++ E   + D +DKK  D  +       M  +A  CL +  ++RP  
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 768 SMLVKVLQGLT 778
             + ++LQ +T
Sbjct: 295 KKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  332 bits (854), Expect = e-108
 Identities = 107/319 (33%), Positives = 169/319 (52%), Gaps = 11/319 (3%)

Query: 470 KRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDF--QIRLGRGGSGSVFEGLLND 527
            ++ +          SS  V     +     ++ AT +F  +  +G G  G V++G+L D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 528 GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL 587
           G KVA+KR  P  ++G +EF +E+ET+    H +LV L+G+C ER+   L+Y+YM NG+L
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 588 DKWIFHKDR-IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVK 646
            + ++  D    ++SW+ R +I    +RGL YLH      IIH D+K  NILLD +   K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179

Query: 647 IADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR 705
           I DFG+++   + DQ+H+ST+ KGT GY+ PE      +T K D+YSFGVV+ E++C R 
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 706 ---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLH 762
               S P+    L +         +L  +VD    D +   +   K    A+ CL  +  
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSE 298

Query: 763 RRPSASMLVKVLQGLTKLE 781
            RPS   ++  L+   +L+
Sbjct: 299 DRPSMGDVLWKLEYALRLQ 317

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  246 bits (630), Expect = 3e-75
 Identities = 70/313 (22%), Positives = 132/313 (42%), Gaps = 33/313 (10%)

Query: 496 FSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVET 553
             ++ +   +   Q+     RG  G V++  L     VAVK     + +   +   EV +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 554 IGNIHHFNLVRLVGYCAERSN----RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKII 609
           +  + H N+++ +G     ++     +L+  +   GSL  ++    +   +SW+    I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 610 FQISRGLEYLH-------DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
             ++RGL YLH       D   P I H DIK +N+LL  +L   IADFGLA      +S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 663 VSTMPK-GTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV 716
             T  + GT  YMAPE+  G          +ID+Y+ G+V+ E+     +++    +Y++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 717 ---DTLKVKAEADRLCDLVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSAS 768
              + +      + + ++V  K +                + +    C   +   R SA 
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 769 MLVKVLQGLTKLE 781
            + + +  + +L 
Sbjct: 308 CVGERITQMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  219 bits (560), Expect = 2e-65
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 5/200 (2%)

Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVR 564
           + + ++G G  G+V     + G+ VAVK L   +   +   EFL EV  +  + H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
            +G   +  N  +V EY+  GSL + +      + L    R  + + +++G+ YLH+  N
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RN 157

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
           P I+H ++K  N+L+D+   VK+ DFGL+RL A      S    GTP +MAPE+ R    
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPS 216

Query: 685 TAKIDIYSFGVVILEIICGR 704
             K D+YSFGV++ E+   +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  217 bits (553), Expect = 4e-64
 Identities = 69/319 (21%), Positives = 128/319 (40%), Gaps = 48/319 (15%)

Query: 504 ATRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVE--TIGNIHH 559
              + ++   +GRG  G+V++G L+    VAVK         ++ F++E     +  + H
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEH 66

Query: 560 FNLVRLVGYCAERS-----NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR 614
            N+ R +      +        LV EY  NGSL K++       T  W    ++   ++R
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTR 122

Query: 615 GLEYLH------DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD-------QS 661
           GL YLH      D+  P I H D+  +N+L+  D    I+DFGL+  +  +       + 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 662 HVSTMPKGTPGYMAPELTRG-------NSITAKIDIYSFGVVILEIICGRRSSNPKGG-- 712
           + +    GT  YMAPE+  G        S   ++D+Y+ G++  EI        P     
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 713 DYLV---DTLKVKAEADRLCDLVDKK------SEDMQSHRDDAVKMIQIAISCLQKNLHR 763
           +Y +     +      + +  LV ++       E  + +      + +    C  ++   
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302

Query: 764 RPSASMLVKVLQGLTKLEP 782
           R +A    + +  L  +  
Sbjct: 303 RLTAQXAEERMAELMMIWE 321

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (530), Expect = 4e-61
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 32/285 (11%)

Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLV 566
           + +  +GRG  G V +        VA+K++     R  K F+ E+  +  ++H N+V+L 
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLY 67

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G C   +   LV EY   GSL   +   + +   +         Q S+G+ YLH      
Sbjct: 68  GAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 627 IIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           +IH D+KP N+LL     V KI DFG A     D     T  KG+  +MAPE+  G++ +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYS 181

Query: 686 AKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK-----SEDMQ 740
            K D++S+G+++ E+I  R+   P           +   A R+   V         +++ 
Sbjct: 182 EKCDVFSWGIILWEVITRRK---PFDE--------IGGPAFRIMWAVHNGTRPPLIKNLP 230

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
                   +  +   C  K+  +RPS   +VK++  L +  P  D
Sbjct: 231 K------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (512), Expect = 5e-59
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)

Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN----RGKKEFLSEVETIGNIHHFNL 562
             +  +G GG G V+      G +VAVK      +    +  +    E +    + H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           + L G C +  N  LV E+   G L++ +      + +  DI      QI+RG+ YLHD 
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDE 124

Query: 623 CNPKIIHFDIKPQNILLDRDL--------NVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
               IIH D+K  NIL+ + +         +KI DFGLAR   +          G   +M
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWM 181

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
           APE+ R +  +   D++S+GV++ E++ G 
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  200 bits (510), Expect = 1e-58
 Identities = 55/281 (19%), Positives = 114/281 (40%), Gaps = 31/281 (11%)

Query: 507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVR 564
           +F  +L    SG +++G    G  + VK L   +   R  ++F  E   +    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 565 LVGYCAE--RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           ++G C      +  L+  +M  GSL   + H+     +      K    ++RG+ +LH  
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHT- 129

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG- 681
             P I    +  +++++D D+  +I+   +        S  S      P ++APE  +  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKK 183

Query: 682 --NSITAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEADRLCDLVDKKSED 738
             ++     D++SF V++ E++       P      +   +KV  E  R           
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREV---PFADLSNMEIGMKVALEGLRP-----TIPPG 235

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
           +  H      + ++   C+ ++  +RP   M+V +L+ +  
Sbjct: 236 ISPH------VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (508), Expect = 3e-58
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 24/214 (11%)

Query: 507 DFQIRLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGK-------KEFLSEVETIGNIH 558
           +++ ++G+GG G V +G L+ D + VA+K L  G++ G+       +EF  EV  + N++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           H N+V+L G         +V E++  G L   +  K     + W ++ +++  I+ G+EY
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137

Query: 619 LHDYCNPKIIHFDIKPQNILLD-----RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
           + +  NP I+H D++  NI L        +  K+ADFGL++       H  +   G   +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQW 192

Query: 674 MAPELTRGNSI--TAKIDIYSFGVVILEIICGRR 705
           MAPE         T K D YSF +++  I+ G  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  197 bits (503), Expect = 3e-57
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 31/283 (10%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
            LG+G  G   +    + G  + +K L   +   ++ FL EV+ +  + H N+++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            +      + EY+  G+L   I  K       W  R      I+ G+ YLH      IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-------------GTPGYMAP 676
            D+   N L+  + NV +ADFGLARL+  +++    +               G P +MAP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E+  G S   K+D++SFG+V+ EII    +        +   L V+   DR C       
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC------P 245

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            +             I + C   +  +RPS   L   L+ L  
Sbjct: 246 PNCPP------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (493), Expect = 4e-56
 Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 25/276 (9%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGY 568
           R+G G  G+V++G  +    VAVK L       +  + F +EV  +    H N++  +GY
Sbjct: 31  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
                   +V ++    SL   + H    +         I  Q +RG++YLH      II
Sbjct: 89  STA-PQLAIVTQWCEGSSLYHHL-HASETK-FEMKKLIDIARQTARGMDYLH---AKSII 142

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-SHVSTMPKGTPGYMAPELTRG---NSI 684
           H D+K  NI L  D  VKI DFGLA   ++   SH      G+  +MAPE+ R    N  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 685 TAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
           + + D+Y+FG+V+ E++ G+    P    +     +++        DL       ++S+ 
Sbjct: 203 SFQSDVYAFGIVLYELMTGQL---PYSNINNRDQIIEMVGRGSLSPDL-----SKVRSNC 254

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
              +K  ++   CL+K    RPS   ++  ++ L +
Sbjct: 255 PKRMK--RLMAECLKKKRDERPSFPRILAEIEELAR 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 3e-55
 Identities = 57/285 (20%), Positives = 106/285 (37%), Gaps = 36/285 (12%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFNLVRLVGY 568
            +G+G  G V+ G  +   +VA++ +    +     K F  EV       H N+V  +G 
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
           C    +  ++       +L   +    +I  L  +  ++I  +I +G+ YLH      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVV-RDAKIV-LDVNKTRQIAQEIVKGMGYLH---AKGIL 152

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIA----QDQSHVSTMPKGTPGYMAPELTRGNSI 684
           H D+K +N+  D +  V I DFGL  +        +     +  G   ++APE+ R  S 
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 685 ---------TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
                    +   D+++ G +  E+        P           +  +          K
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREW---PFKT---QPAEAIIWQMGT-----GMK 260

Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
               Q      +    I + C       RP+ + L+ +L+ L K 
Sbjct: 261 PNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKR 303

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  191 bits (486), Expect = 2e-54
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 37/297 (12%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVE--TIGNIHHFNLVRLVGY 568
           ++G+G  G V+ G    G KVAVK  +  E   +  +  E E      + H N++  +  
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99

Query: 569 CAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH---- 620
             + +      +L+ +Y  NGSL  ++    +  TL      K+ +    GL +LH    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 621 -DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAP 676
                P I H D+K +NIL+ ++    IAD GLA     D + V   P    GT  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 677 ELTRGNSITA------KIDIYSFGVVILEIICGRRSSNPKGGDYLV---DTLKVKAEADR 727
           E+   +            D+YSFG+++ E+   R  S     +Y +   D +      + 
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 728 LCDLVDKKSE-----DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
           + ++V  K       +  S  +   +M ++   C   N   R +A  + K L  +++
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  189 bits (483), Expect = 4e-54
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 37/297 (12%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVE--TIGNIHHFNLVRLVGY 568
            +G+G  G V+ G    G +VAVK     E   ++ +  E E      + H N++  +  
Sbjct: 49  SIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 569 CAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH---- 620
             + +      +LV +Y  +GSL  ++ ++    T++ +   K+    + GL +LH    
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-NR---YTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 621 -DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAP 676
                P I H D+K +NIL+ ++    IAD GLA         +   P    GT  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 677 ELTRGNSITA------KIDIYSFGVVILEIICGRRSSNPKGGDYLV---DTLKVKAEADR 727
           E+   +          + DIY+ G+V  EI   R S      DY +   D +      + 
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 728 LCDLVDKKSE-----DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
           +  +V ++       +     +    M +I   C   N   R +A  + K L  L++
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  188 bits (480), Expect = 4e-54
 Identities = 72/304 (23%), Positives = 122/304 (40%), Gaps = 41/304 (13%)

Query: 505 TRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVE--TIGNIHHF 560
            RD  +   +G+G  G V+ G    G  VAVK     +   +K +  E E      + H 
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62

Query: 561 NLVRLVGYC----AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           N++  +          +  +L+  Y   GSL  ++    ++ TL      +I+  I+ GL
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118

Query: 617 EYLH-----DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--- 668
            +LH         P I H D+K +NIL+ ++    IAD GLA + +Q  + +        
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 669 GTPGYMAPELTRG------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV---DTL 719
           GT  YMAPE+              ++DI++FG+V+ E+   R  SN    DY     D +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVV 237

Query: 720 KVKAEADRLCDLVDKK------SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV 773
                 + +  +V              S       + ++   C  +N   R +A  + K 
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLT-SLAKLMKECWYQNPSARLTALRIKKT 296

Query: 774 LQGL 777
           L  +
Sbjct: 297 LTKI 300

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  170 bits (433), Expect = 1e-47
 Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 46/293 (15%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEFLSEVETIGNIHHFNL 562
           DF+    LGRGG G VFE     D    A+KR+  P     +++ + EV+ +  + H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 563 VRLVGYCAERSNR------------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
           VR      E++              ++  +     +L  W+  +  I+     +   I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-- 668
           QI+  +E+LH      ++H D+KP NI    D  VK+ DFGL   + QD+   + +    
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 669 ---------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL 719
                    GT  YM+PE   GNS + K+DI+S G+++ E++       P          
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVRT 236

Query: 720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                  +   L  +K             M+Q     L  +   RP A  +++
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEY-------VMVQ---DMLSPSPMERPEAINIIE 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  164 bits (418), Expect = 4e-45
 Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 34/296 (11%)

Query: 483 DESSVHVANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG 539
              S  V         ++M+     +    ++G G  G         DG +  +K +   
Sbjct: 5   HHHSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS 60

Query: 540 E--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI 597
              ++ ++E   EV  + N+ H N+V+      E  + ++V +Y   G L K I +  + 
Sbjct: 61  RMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKG 119

Query: 598 QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
                D       QI   L+++HD    KI+H DIK QNI L +D  V++ DFG+AR++ 
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176

Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR---SSNPKGGDY 714
                      GTP Y++PE+        K DI++ G V+ E+   +    + + K    
Sbjct: 177 STVELARAC-IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--- 232

Query: 715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASML 770
               L +K  +     +    S D++S       ++       ++N   RPS + +
Sbjct: 233 ----LVLKIISGSFPPVSLHYSYDLRS-------LVS---QLFKRNPRDRPSVNSI 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  161 bits (410), Expect = 9e-45
 Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 48/286 (16%)

Query: 506 RDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
            DF+    +G GG G VF+     DG    +KR+        ++   EV+ +  + H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 563 VRLVGYCAERSNR----------------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK 606
           V   G                        F+  E+   G+L++WI  K R + L   +  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
           ++  QI++G++Y+H     K+I+ D+KP NI L     VKI DFGL   +  D     + 
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181

Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
            KGT  YM+PE         ++D+Y+ G+++ E++    +            L+      
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLR------ 232

Query: 727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                 D    D+         ++Q     L K    RP+ S +++
Sbjct: 233 ------DGIISDIFD--KKEKTLLQ---KLLSKKPEDRPNTSEILR 267

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  162 bits (411), Expect = 1e-44
 Identities = 79/316 (25%), Positives = 123/316 (38%), Gaps = 36/316 (11%)

Query: 465 SIYLYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATR-DFQI--RLGRGGSGSVF 521
           ++Y     +   RR     E+S  + +    +     +S  +  FQ   RLG G  G VF
Sbjct: 17  NLYFQSMHQLQPRRVSFRGEASETLQS--PGYDPSRPESFFQQSFQRLSRLGHGSYGEVF 74

Query: 522 EGL-LNDGTKVAVKRLYPGENRGKKE---FLSEVETIGNI-HHFNLVRLVGYCAERSNRF 576
           +     DG   AVKR      RG K+    L+EV +   +  H   VRL     E    +
Sbjct: 75  KVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133

Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           L  E  C  SL +    +    +L        +      L +LH      ++H D+KP N
Sbjct: 134 LQTEL-CGPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPAN 187

Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVV 696
           I L      K+ DFGL   +           +G P YMAPEL +G+      D++S G+ 
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTA-GAGEVQ-EGDPRYMAPELLQGS-YGTAADVFSLGLT 244

Query: 697 ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC 756
           ILE+ C      P GG+     L+           +   S +++S       ++      
Sbjct: 245 ILEVACNMEL--PHGGE-GWQQLRQGYLPPEFTAGL---SSELRS-------VLV---MM 288

Query: 757 LQKNLHRRPSASMLVK 772
           L+ +   R +A  L+ 
Sbjct: 289 LEPDPKLRATAEALLA 304

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  159 bits (404), Expect = 6e-44
 Identities = 75/283 (26%), Positives = 119/283 (42%), Gaps = 27/283 (9%)

Query: 501 MKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGE--NRGKKEFLSEVETIG 555
           M S   D+++   +G G  G   +    +DG  +  K L  G      K+  +SEV  + 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60

Query: 556 NIHHFNLVRLVGYCAERSNRFL--VYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQI 612
            + H N+VR      +R+N  L  V EY   G L   I       Q L  +   +++ Q+
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 613 SRGLEYLHD--YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +  L+  H        ++H D+KP N+ LD   NVK+ DFGLAR++  D S   T   GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGT 179

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEADRLC 729
           P YM+PE     S   K DI+S G ++ E+        P          L  K    +  
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQ--KELAGKIREGKFR 234

Query: 730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +  + S+++         +I      L    + RPS   +++
Sbjct: 235 RIPYRYSDELNE-------IIT---RMLNLKDYHRPSVEEILE 267

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  158 bits (401), Expect = 2e-43
 Identities = 72/276 (26%), Positives = 113/276 (40%), Gaps = 34/276 (12%)

Query: 508 FQIRLGRGGSGSVFEGL-LNDGTKVAVK--RLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
           F I +GRG   +V++GL      +VA    +        ++ F  E E +  + H N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 565 LVGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                      +    LV E M +G+L  ++    R + +   + +    QI +GL++LH
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 621 DYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
               P IIH D+K  NI +     +VKI D GLA L     S    +  GTP +MAPE+ 
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAV-IGTPEFMAPEMY 202

Query: 680 RGNSITAKIDIYSFGVVILEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
                   +D+Y+FG+ +LE+                Y   T  VK  +           
Sbjct: 203 E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----------- 250

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                     VK  +I   C+++N   R S   L+ 
Sbjct: 251 --FDKVAIPEVK--EIIEGCIRQNKDERYSIKDLLN 282

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  159 bits (403), Expect = 2e-43
 Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 40/284 (14%)

Query: 506 RDFQI--RLGRGGSGSVFEGLLNDGTKVAVKR--LYPGENRGKKEFLSEVETIGNIHHFN 561
           R + I  ++G GGS  VF+ L       A+K   L   +N+    + +E+  +  +   +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 562 L--VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
              +RL  Y       ++V E   N  L+ W+  K     +    RK     +   +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTI 143

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-SHVSTMPKGTPGYMAPEL 678
           H +    I+H D+KP N L+     +K+ DFG+A  +  D  S V     GT  YM PE 
Sbjct: 144 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 679 TRGNS-----------ITAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEAD 726
            +  S           I+ K D++S G ++  +  G+    P +     +  L    + +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---PFQQIINQISKLHAIIDPN 256

Query: 727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASML 770
              +  D   +       D   +++    CL+++  +R S   L
Sbjct: 257 HEIEFPDIPEK-------DLQDVLK---CCLKRDPKQRISIPEL 290

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  158 bits (402), Expect = 2e-43
 Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 26/276 (9%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHF 560
           +F+I  ++GRG    V+    L DG  VA+K++   +    + + + + E++ +  ++H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           N+++      E +   +V E    G L + I   K + + +      K   Q+   LE++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           H     +++H DIKP N+ +     VK+ D GL R  +   +   ++  GTP YM+PE  
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERI 208

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL-VDTLKVKAEADRLCDL-VDKKSE 737
             N    K DI+S G ++ E+   +    P  GD + + +L  K E      L  D  SE
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV 773
           +++          Q+   C+  +  +RP  + +  V
Sbjct: 266 ELR----------QLVNMCINPDPEKRPDVTYVYDV 291

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  157 bits (398), Expect = 2e-42
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 40/284 (14%)

Query: 506 RDFQI--RLGRGGSGSVFEGLLNDGTKVAVKR--LYPGENRGKKEFLSEVETIGNI--HH 559
           R + I  ++G GGS  VF+ L       A+K   L   +N+    + +E+  +  +  H 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
             ++RL  Y       ++V E   N  L+ W+  K   +++    RK     +   +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTI 124

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-SHVSTMPKGTPGYMAPEL 678
           H +    I+H D+KP N L+     +K+ DFG+A  +  D  S V     GT  YM PE 
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 679 TRGNS-----------ITAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEAD 726
            +  S           I+ K D++S G ++  +  G+    P +     +  L    + +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---PFQQIINQISKLHAIIDPN 237

Query: 727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASML 770
              +  D   +       D   +++    CL+++  +R S   L
Sbjct: 238 HEIEFPDIPEK-------DLQDVLK---CCLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  156 bits (397), Expect = 6e-42
 Identities = 63/314 (20%), Positives = 123/314 (39%), Gaps = 40/314 (12%)

Query: 476 KRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKVAV 533
           +R+   + +      +     +++ +    R + I  ++G GGS  VF+ L       A+
Sbjct: 26  ERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAI 85

Query: 534 KR--LYPGENRGKKEFLSEVETIGNIHHFNL--VRLVGYCAERSNRFLVYEYMCNGSLDK 589
           K   L   +N+    + +E+  +  +   +   +RL  Y       ++V E   N  L+ 
Sbjct: 86  KYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNS 144

Query: 590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD 649
           W+  K     +    RK     +   +  +H +    I+H D+KP N L+     +K+ D
Sbjct: 145 WLKKKKS---IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLID 197

Query: 650 FGLARLIAQDQ-SHVSTMPKGTPGYMAPELTRGNS-----------ITAKIDIYSFGVVI 697
           FG+A  +  D  S V     G   YM PE  +  S           I+ K D++S G ++
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

Query: 698 LEIICGRRSSNP-KGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC 756
             +  G+    P +     +  L    + +   +  D   +       D   +++    C
Sbjct: 258 YYMTYGKT---PFQQIINQISKLHAIIDPNHEIEFPDIPEK-------DLQDVLK---CC 304

Query: 757 LQKNLHRRPSASML 770
           L+++  +R S   L
Sbjct: 305 LKRDPKQRISIPEL 318

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  156 bits (397), Expect = 2e-41
 Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 39/276 (14%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLS----EVETIGNI-HHFNLVRLV 566
           LG G  G++    + D   VAVKR+         E  S    EV+ +     H N++R  
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
               +R  +++  E  C  +L +++  KD            ++ Q + GL +LH      
Sbjct: 85  CTEKDRQFQYIAIEL-CAATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---N 138

Query: 627 IIHFDIKPQNILL-----DRDLNVKIADFGLARLIAQDQSHVSTM--PKGTPGYMAPELT 679
           I+H D+KP NIL+        +   I+DFGL + +A  +   S      GT G++APE+ 
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 680 RGNSI---TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
             +     T  +DI+S G V   +I      +P G         +               
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGS--HPFGKSLQRQANILLGACS------LDCL 250

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              +     A ++I+     +  +  +RPSA  ++K
Sbjct: 251 HPEKHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  152 bits (387), Expect = 2e-41
 Identities = 79/300 (26%), Positives = 119/300 (39%), Gaps = 53/300 (17%)

Query: 505 TRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN 561
             DF+    LG+G  G V +     D    A+K++   E +     LSEV  + +++H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 562 LVRLVGYCAERSNR-------------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           +VR      ER N              F+  EY  NG+L   I           D   ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121

Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             QI   L Y+H      IIH D+KP NI +D   NVKI DFGLA+ + +    +    +
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 669 -------------GTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDY 714
                        GT  Y+A E+  G      KID+YS G++  E+I          G  
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGME 233

Query: 715 LVDTLKV--KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            V+ LK       +   D  D K +          K+I+     +  + ++RP A  L+ 
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMK-------VEKKIIR---LLIDHDPNKRPGARTLLN 283

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (386), Expect = 2e-40
 Identities = 68/275 (24%), Positives = 112/275 (40%), Gaps = 23/275 (8%)

Query: 511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           ++GRG  G VF G L  D T VAVK          K +FL E   +    H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
           C ++   ++V E +  G      F +     L      +++   + G+EYL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGNSITAK 687
           H D+  +N L+     +KI+DFG++R  A      S   +  P  + APE       +++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 688 IDIYSFGVVILEII-CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA 746
            D++SFG+++ E    G     P        T +   +  R           +       
Sbjct: 296 SDVWSFGILLWETFSLGAS---PYPNLSNQQTREFVEKGGR-----------LPCPELCP 341

Query: 747 VKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
             + ++   C      +RPS S + + LQ + K  
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  150 bits (380), Expect = 3e-40
 Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 36/300 (12%)

Query: 506 RDFQIR--LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
           + +     LG GG   V     L+DG   A+KR+   E + ++E   E +     +H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 563 VRLVGYCAERSNR----FLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLE 617
           +RLV YC          +L+  +   G+L   I   KD+   L+ D    ++  I RGLE
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--------G 669
            +H        H D+KP NILL  +    + D G                          
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 670 TPGYMAPEL---TRGNSITAKIDIYSFGVVILEIICGRRSSNP-KGGDYLVDTLKVKAEA 725
           T  Y APEL        I  + D++S G V+  ++ G     P        D++ +  + 
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG---PYDMVFQKGDSVALAVQN 262

Query: 726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
                   + S  +         ++    S +  + H+RP   +L+  L+ L    P   
Sbjct: 263 QLSIPQSPRHSSALWQ-------LLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  153 bits (387), Expect = 3e-40
 Identities = 72/286 (25%), Positives = 117/286 (40%), Gaps = 46/286 (16%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLS-EVET-IGNIHHFNLVRLVGYC 569
           LG G SG+V       G  VAVKR+         +    E++    +  H N++R     
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIRYYCSE 78

Query: 570 AERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                 ++  E  CN +L   +       + ++         ++ QI+ G+ +LH     
Sbjct: 79  TTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--- 134

Query: 626 KIIHFDIKPQNILLD-------------RDLNVKIADFGLARLIAQDQSHVSTM---PKG 669
           KIIH D+KPQNIL+               +L + I+DFGL + +   QS   T    P G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 670 TPGYMAPELTRGNSI-------TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK 722
           T G+ APEL   ++        T  IDI+S G V   I+      +P G  Y  ++  ++
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK--GKHPFGDKYSRESNIIR 252

Query: 723 AEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
                   L + K    +S   +A  +I      +  +  +RP+A 
Sbjct: 253 GI----FSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAM 291

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  148 bits (375), Expect = 8e-40
 Identities = 67/269 (24%), Positives = 117/269 (43%), Gaps = 28/269 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG+G  G V+ G  L++  ++A+K +   ++R  +    E+    ++ H N+V+ +G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           E     +  E +  GSL   +  K      +         QI  GL+YLHD    +I+H 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 631 DIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI--TAK 687
           DIK  N+L++     +KI+DFG ++ +A       T   GT  YMAPE+           
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKA 205

Query: 688 IDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            DI+S G  I+E+  G+        P+   + V   KV  E      + +  S + +   
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE------IPESMSAEAK--- 256

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              +        C + +  +R  A+ L+ 
Sbjct: 257 -AFILK------CFEPDPDKRACANDLLV 278

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  149 bits (377), Expect = 1e-39
 Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 41/318 (12%)

Query: 470 KRWREG----KRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQ--IRLGRGGSGSVFEG 523
           K W  G    +R    T+++   +    +K      +          R+GRG  G V   
Sbjct: 18  KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77

Query: 524 L-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM 582
                G + AVK++     R +   + E+     +    +V L G   E     +  E +
Sbjct: 78  KDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132

Query: 583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD 642
             GSL + I        L  D     + Q   GLEYLH     +I+H D+K  N+LL  D
Sbjct: 133 EGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSD 186

Query: 643 -LNVKIADFGLARLIAQDQSHVSTMP----KGTPGYMAPELTRGNSITAKIDIYSFGVVI 697
                + DFG A  +  D    S +      GT  +MAPE+  G    AK+DI+S   ++
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246

Query: 698 LEIICGRR---SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAI 754
           L ++ G               +             ++    +         A++      
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLKI----ASEPPPIR-EIPPSCAPLTA----QAIQE----- 292

Query: 755 SCLQKNLHRRPSASMLVK 772
             L+K    R SA  L +
Sbjct: 293 -GLRKEPVHRASAMELRR 309

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  145 bits (368), Expect = 1e-38
 Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 21/210 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFL-SEVETIGNIHHFNLVRL--V 566
            LG+G + +VF G     G   A+K           +    E E +  ++H N+V+L  +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                  ++ L+ E+   GSL   +        L       ++  +  G+ +L +     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---G 132

Query: 627 IIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
           I+H +IKP NI+     D     K+ DFG AR + +D     ++  GT  Y+ P++    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSL-YGTEEYLHPDMYERA 190

Query: 683 SI--------TAKIDIYSFGVVILEIICGR 704
            +         A +D++S GV       G 
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  151 bits (383), Expect = 2e-38
 Identities = 73/284 (25%), Positives = 113/284 (39%), Gaps = 28/284 (9%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFL-SEVETIGNIHHFNLVRLV-- 566
           RLG GG G V   +  + G +VA+K+     +   +E    E++ +  ++H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 567 ----GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
                  A      L  EY   G L K++   +    L     + ++  IS  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 623 CNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
              +IIH D+KP+NI+L      L  KI D G A+ +       +    GT  Y+APEL 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEF-VGTLQYLAPELL 195

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
                T  +D +SFG +  E I G R   P   ++       K         V +KS + 
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFR---PFLPNWQPVQWHGK---------VREKSNEH 243

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV 783
               DD    ++ +      N      A  L + LQ +      
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  143 bits (362), Expect = 3e-38
 Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 53/301 (17%)

Query: 500 AMKSA-TRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKR--LYPGENRGKKEFLSEVET 553
            MKS  T +F    ++G G  GSVF+ +   DG   A+KR       +  ++  L EV  
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 554 IGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQ 611
              +  H ++VR     AE  +  +  EY   GSL   I  +   +        K ++ Q
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-------------------LNVKIADFGL 652
           + RGL Y+H      ++H DIKP NI + R                    +  KI D G 
Sbjct: 124 VGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKG 711
              I+  Q        G   ++A E+ + N +   K DI++  + ++          P+ 
Sbjct: 181 VTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PRN 233

Query: 712 GDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
           GD        +    RL  +    S++          +++     +  +  RRPSA  LV
Sbjct: 234 GDQW-----HEIRQGRLPRIPQVLSQEFTE-------LLK---VMIHPDPERRPSAMALV 278

Query: 772 K 772
           K
Sbjct: 279 K 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  142 bits (361), Expect = 3e-38
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 7/196 (3%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
            +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+L G C 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           E++   LV E+M +G L    + + +    + +    +   +  G+ YL +     +IH 
Sbjct: 74  EQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 128

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  ++K D+
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188

Query: 691 YSFGVVILEII-CGRR 705
           +SFGV++ E+   G+ 
Sbjct: 189 WSFGVLMWEVFSEGKI 204

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  142 bits (360), Expect = 8e-38
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +LG+G  GSV          N G  VAVK+L        ++F  E+E + ++ H N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 566 VGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            G C     R   L+ EY+  GSL    + +   + +      +   QI +G+EYL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPELTRG 681
             + IH D+  +NIL++ +  VKI DFGL +++ QD+       P  +P  + APE    
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191

Query: 682 NSITAKIDIYSFGVVILEII 701
           +  +   D++SFGVV+ E+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  141 bits (357), Expect = 9e-38
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
            LG G  G V  G       VAVK +  G    + EF  E +T+  + H  LV+  G C+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    ++V EY+ NG L    + +   + L      ++ + +  G+ +L  +   + IH 
Sbjct: 74  KEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMP-KGTPGYMAPELTRGNSITA 686
           D+  +N L+DRDL VK++DFG+ R +  DQ   S  +  P K    + APE+      ++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WSAPEVFHYFKYSS 184

Query: 687 KIDIYSFGVVILEII-CGRR 705
           K D+++FG+++ E+   G+ 
Sbjct: 185 KSDVWAFGILMWEVFSLGKM 204

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  142 bits (359), Expect = 1e-37
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G V          N G +VAVK L P        +   E+E + N++H N+V+
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 565 LVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
             G C E       L+ E++ +GSL +  +       ++   + K   QI +G++YL   
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPE 677
              + +H D+  +N+L++ +  VKI DFGL + I  D+ + +             + APE
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT---VKDDRDSPVFWYAPE 199

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CGRRSSNPK 710
               +      D++SFGV + E++      S+P 
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  141 bits (357), Expect = 1e-37
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 7/196 (3%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
            LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           ++   F++ EYM NG L    + ++           ++   +   +EYL      + +H 
Sbjct: 90  KQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   +  ++K DI
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204

Query: 691 YSFGVVILEII-CGRR 705
           ++FGV++ EI   G+ 
Sbjct: 205 WAFGVLMWEIYSLGKM 220

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  141 bits (357), Expect = 1e-37
 Identities = 57/213 (26%), Positives = 110/213 (51%), Gaps = 12/213 (5%)

Query: 498 SKAMKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGE---NRGKKEFLSEV 551
           +  +     DF++   LG+G    V+    ++ G +VA+K +           +   +EV
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
           +    + H +++ L  Y  + +  +LV E   NG +++++  K+R++  S +  +  + Q
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQ 120

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           I  G+ YLH +    I+H D+   N+LL R++N+KIADFGLA  +        T+  GTP
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTP 176

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            Y++PE+   ++   + D++S G +   ++ GR
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (370), Expect = 2e-37
 Identities = 62/192 (32%), Positives = 96/192 (50%), Gaps = 6/192 (3%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L        +EFL E   +  I H NLV+L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++  +   Q +S  +   +  QIS  +EYL        IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            ++  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N  + K D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 690 IYSFGVVILEII 701
           +++FGV++ EI 
Sbjct: 402 VWAFGVLLWEIA 413

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (367), Expect = 2e-37
 Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 6/191 (3%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           E    ++V EYM  GSL  +    +  + L       +  QI+ G+ Y+        +H 
Sbjct: 250 E-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K D+
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 691 YSFGVVILEII 701
           +SFG+++ E+ 
Sbjct: 365 WSFGILLTELT 375

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  141 bits (358), Expect = 3e-37
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +LG+G  GSV          N G  VAVK+L        ++F  E+E + ++ H N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 566 VGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            G C     R   L+ EY+  GSL    + +   + +      +   QI +G+EYL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 164

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPELTRG 681
             + IH D+  +NIL++ +  VKI DFGL +++ QD+ +     P  +P  + APE    
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222

Query: 682 NSITAKIDIYSFGVVILEII 701
           +  +   D++SFGVV+ E+ 
Sbjct: 223 SKFSVASDVWSFGVVLYELF 242

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (358), Expect = 3e-37
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 21/202 (10%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G+V++GL           VA+K L      +  KE L E   + ++ + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L+G C   S   L+ + M  G L    + ++    +          QI++G+ YL D   
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST----MP-KGTPGYMAPELT 679
            +++H D+  +N+L+    +VKI DFGLA+L+  ++         +P K    +MA E  
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESI 191

Query: 680 RGNSITAKIDIYSFGVVILEII 701
                T + D++S+GV + E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELM 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  143 bits (362), Expect = 3e-37
 Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 21/209 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFL-SEVETIGNIHHFNLVRL--VG 567
           LG+G + +VF G     G   A+K           +    E E +  ++H N+V+L  + 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                 ++ L+ E+   GSL   +        L       ++  +  G+ +L +     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133

Query: 628 IHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           +H +IKP NI+     D     K+ DFG AR + +D     ++  GT  Y+ P++     
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSL-YGTEEYLHPDMYERAV 191

Query: 684 I--------TAKIDIYSFGVVILEIICGR 704
           +         A +D++S GV       G 
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 7e-37
 Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 6/191 (3%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           E    ++V EYM  GSL  +    +  + L       +  QI+ G+ Y+        +H 
Sbjct: 333 EEPI-YIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       T K D+
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 691 YSFGVVILEII 701
           +SFG+++ E+ 
Sbjct: 448 WSFGILLTELT 458

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  141 bits (356), Expect = 7e-37
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 32/224 (14%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVK----------RLYPGENRGKKEFLS----- 549
           D++I   L +G    +      D    A+K          R +   N  K    S     
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 550 --EVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWI-----FHKDRIQTLSW 602
             E++ I +I +   +   G        +++YEYM N S+ K+        K+    +  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
            + K II  +     Y+H+  N  I H D+KP NIL+D++  VK++DFG +         
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKK 206

Query: 663 VSTMPKGTPGYMAPELTRGNSIT--AKIDIYSFGVVILEIICGR 704
           +    +GT  +M PE     S    AK+DI+S G+ +  +    
Sbjct: 207 IKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  138 bits (349), Expect = 2e-36
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 14/195 (7%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           RLG G  G V+ G  N  TKVAVK L  G       FL+E   +  + H  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ EYM NGSL  ++        L+ +    +  QI+ G+ ++ +      IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMP-KGTPGYMAPELTRGNSITA 686
           D++  NIL+   L+ KIADFGLARLI  ++      +  P K    + APE     + T 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEAINYGTFTI 189

Query: 687 KIDIYSFGVVILEII 701
           K D++SFG+++ EI+
Sbjct: 190 KSDVWSFGILLTEIV 204

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  139 bits (352), Expect = 2e-36
 Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 27/283 (9%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +LG+G  GSV          N G  VAVK+L       +++F  E++ +  +H   +V+ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 566 VGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            G       +   LV EY+ +G L    F +     L          QI +G+EYL    
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLGSR- 146

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP-GYMAPELTRG 681
             + +H D+  +NIL++ + +VKIADFGLA+L+  D+ + V   P  +P  + APE    
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204

Query: 682 NSITAKIDIYSFGVVILEII--CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
           N  + + D++SFGVV+ E+   C +  S       ++   +      RL +L++      
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE------ 258

Query: 740 QSHRDDA-----VKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           +  R  A      ++ ++   C   +   RPS S L   L  L
Sbjct: 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (349), Expect = 2e-36
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 14/196 (7%)

Query: 511 RLGRGGSGSVFEGLLNDG-TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  G V+EG+       VAVK L        +EFL E   +  I H NLV+L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+M  G+L  ++  +   Q +S  +   +  QIS  +EYL        IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST---MP-KGTPGYMAPELTRGNSIT 685
            D+  +N L+  +  VK+ADFGL+RL+  D          P K    + APE    N  +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPESLAYNKFS 190

Query: 686 AKIDIYSFGVVILEII 701
            K D+++FGV++ EI 
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  140 bits (353), Expect = 2e-36
 Identities = 41/338 (12%), Positives = 79/338 (23%), Gaps = 53/338 (15%)

Query: 469 YKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKS-ATRDFQI--RLGRGGSGSVFEGL- 524
           Y R    K      +  +  V     + +  ++ S   R  ++   L  G    VF    
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83

Query: 525 LNDGTKVAVKRLYPGENRGKKE---FLSEVETIGNIHHFNLVRLVGYC------------ 569
           +      A+K    G    + E             +   +                    
Sbjct: 84  VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143

Query: 570 --------------AERSNRFLVYEYMCNGSLDKWIFHKDRIQT----LSWDIRKKIIFQ 611
                            +N  L+     +  L+      D +              +  Q
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           + R    L       ++H    P N+ +  D  + + D      +               
Sbjct: 203 LIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV----GTRGPASSVPV 255

Query: 672 GYMAPELTRGNSI--TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC 729
            Y   E    ++   T  ++ +  G+ I  + C      P G          K  + R+ 
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL---PFGLVTPGIKGSWKRPSLRVP 312

Query: 730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSA 767
                         D    +I      L  +  RR   
Sbjct: 313 GTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLP 347

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  138 bits (348), Expect = 5e-36
 Identities = 47/243 (19%), Positives = 94/243 (38%), Gaps = 32/243 (13%)

Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLS 601
                   ++  +      N V  +   + +   ++  +     +L  W+  +  ++   
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
             +   I  QI+  +E+LH      ++H D+KP NI    D  VK+ DFGL   + QD+ 
Sbjct: 163 HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219

Query: 662 HVSTMPK-----------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPK 710
             + +             GT  YM+PE   GN+ + K+DI+S G+++ E++    +   +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279

Query: 711 GGDYLVDTLKVKAEADRLCDLVDKK-SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASM 769
                            + D+ + K              M+Q     L  +   RP A+ 
Sbjct: 280 --------------VRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATD 322

Query: 770 LVK 772
           +++
Sbjct: 323 IIE 325

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (356), Expect = 5e-36
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 7/196 (3%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +LG G  G V+    N  TKVAVK + PG +   + FL+E   +  + H  LV+L     
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    +++ E+M  GSL  ++   +               QI+ G+ ++        IH 
Sbjct: 254 KEPI-YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308

Query: 631 DIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDI 690
           D++  NIL+   L  KIADFGLAR+I  ++       K    + APE     S T K D+
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368

Query: 691 YSFGVVILEII-CGRR 705
           +SFG++++EI+  GR 
Sbjct: 369 WSFGILLMEIVTYGRI 384

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  137 bits (348), Expect = 6e-36
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETI-GNIHHFN 561
           D +    +GRG  GSV + +    G  +AVKR+    +  + K+ L +++ +  +     
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI--FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           +V+  G      + ++  E M + S DK+    +      +  +I  KI     + L +L
Sbjct: 83  IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPE- 677
            +  N KIIH DIKP NILLDR  N+K+ DFG+  +L+    S   T   G   YMAPE 
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPER 196

Query: 678 ---LTRGNSITAKIDIYSFGVVILEIICGR---RSSNPKGGDYLVDTLK--VKAEADRLC 729
                       + D++S G+ + E+  GR      N      + D L   VK +  +L 
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS-----VFDQLTQVVKGDPPQLS 251

Query: 730 DLVDKK-SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           +  +++ S    +        +     CL K+  +RP    L+K
Sbjct: 252 NSEEREFSPSFIN-------FVN---LCLTKDESKRPKYKELLK 285

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  136 bits (345), Expect = 7e-36
 Identities = 76/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGK-KEFLSEVETI-GNIHHFN 561
           D +    LGRG  G V +      G  +AVKR+    N  + K  L +++     +    
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            V   G      + ++  E M + SLDK+     D+ QT+  DI  KI   I + LE+LH
Sbjct: 68  TVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK----GTPGYMAP 676
                 +IH D+KP N+L++    VK+ DFG++  +      V  + K    G   YMAP
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178

Query: 677 E----LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV 732
           E           + K DI+S G+ ++E+   R   +  G  +      V+  + +L    
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA-- 236

Query: 733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           DK S +      D          CL+KN   RP+   L++
Sbjct: 237 DKFSAEFV----DFTS------QCLKKNSKERPTYPELMQ 266

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (345), Expect = 7e-36
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 509 QIRLGRGGSGSVFEGLLNDG---TKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVR 564
            I LG G  GSV +G+         VA+K L  G E    +E + E + +  + +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L+G C +     LV E    G L K  F   + + +      +++ Q+S G++YL +   
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 129

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTRGN 682
              +H D+  +N+LL      KI+DFGL++ +  D S+ +    G  P  + APE     
Sbjct: 130 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 683 SITAKIDIYSFGVVILEII 701
             +++ D++S+GV + E +
Sbjct: 189 KFSSRSDVWSYGVTMWEAL 207

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  136 bits (344), Expect = 7e-36
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 15/213 (7%)

Query: 498 SKAMKSATRDFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGE---NRGKKEFLSEV 551
           SK  + A  DF+I   LG+G  G+V+          +A+K L+  +      + +   EV
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 552 ETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
           E   ++ H N++RL GY  + +  +L+ EY   G++ + +    +            I +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITE 117

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           ++  L Y H     ++IH DIKP+N+LL     +KIADFG +      +     +  GT 
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DLC-GTL 171

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            Y+ PE+  G     K+D++S GV+  E + G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  136 bits (345), Expect = 8e-36
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 512 LGRGGSGSVFEG-LLNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+GG    FE    +     A K      L     R K     E+    ++ H ++V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 80

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G+  +    F+V E     SL +    +     L+    +  + QI  G +YLH     
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN--- 134

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           ++IH D+K  N+ L+ DL VKI DFGLA  +  D      +  GTP Y+APE+      +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 193

Query: 686 AKIDIYSFGVVILEIICGR 704
            ++D++S G ++  ++ G+
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  137 bits (346), Expect = 9e-36
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 26/215 (12%)

Query: 511 RLGRGGSGSVFEGLLND-----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G V     +      G  VAVK L      + +  +  E++ +  ++H ++++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 565 LVGYCAERSNR--FLVYEYMCNGSLDKWI-FHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
             G C +       LV EY+  GSL  ++  H   +  L          QI  G+ YLH 
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHA 152

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAP 676
                 IH D+  +N+LLD D  VKI DFGLA+ + +   +         G     + AP
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGDSPVFWYAP 206

Query: 677 ELTRGNSITAKIDIYSFGVVILEII-CGRRSSNPK 710
           E  +        D++SFGV + E++     S +P 
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (342), Expect = 1e-35
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 500 AMKSATRDFQI---------RLGRGGSGSVFEGLL----NDGTKVAVKRLYPG-ENRGKK 545
           AM S+TRD++I          +G G  G V +G+     N    VA+K       +  ++
Sbjct: 2   AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE 61

Query: 546 EFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR 605
           +FL E  T+    H ++V+L+G     +  +++ E    G L    F + R  +L     
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASL 118

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SH 662
               +Q+S  L YL      + +H DI  +N+L+  +  VK+ DFGL+R +       + 
Sbjct: 119 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175

Query: 663 VSTMP-KGTPGYMAPELTRGNSITAKIDIYSFGVVILEII 701
              +P K    +MAPE       T+  D++ FGV + EI+
Sbjct: 176 KGKLPIK----WMAPESINFRRFTSASDVWMFGVCMWEIL 211

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  136 bits (345), Expect = 2e-35
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 21/202 (10%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G+V++GL           VA+K L      +  KE L E   + ++ + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L+G C   S   L+ + M  G L    + ++    +          QI++G+ YL D   
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST----MP-KGTPGYMAPELT 679
            +++H D+  +N+L+    +VKI DFGLA+L+  ++         +P K    +MA E  
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESI 191

Query: 680 RGNSITAKIDIYSFGVVILEII 701
                T + D++S+GV + E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELM 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  136 bits (344), Expect = 2e-35
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 511 RLGRGGSGSVFEGLL----NDGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRL 565
            +G G SG V  G L         VA+K L  G   R +++FLSE   +G   H N++RL
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G         +V EYM NGSLD   F +      +      ++  +  G+ YL D    
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL--- 170

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTRGNS 683
             +H D+  +N+L+D +L  K++DFGL+R++  D     T   G  P  + APE     +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 684 ITAKIDIYSFGVVILEII 701
            ++  D++SFGVV+ E++
Sbjct: 231 FSSASDVWSFGVVMWEVL 248

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (342), Expect = 2e-35
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLS----EVETIGNIHHFNLVRL 565
           +LG GG  +V+         KVA+K ++    R K+E L     EV     + H N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDY 622
           +    E    +LV EY+   +L       + I++   LS D       QI  G+++ HD 
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTL------SEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              +I+H DIKPQNIL+D +  +KI DFG+A+ +++     +    GT  Y +PE  +G 
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 683 SITAKIDIYSFGVVILEIICGRR 705
           +     DIYS G+V+ E++ G  
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  135 bits (341), Expect = 2e-35
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 18/202 (8%)

Query: 511 RLGRGGSGSVFEGLLNDG----TKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRL 565
            +G+G  G V+ G   D      + A+K L    E +  + FL E   +  ++H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 566 VGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +G          ++  YMC+G L ++I    R  T+   I      Q++RG+EYL +   
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI--SFGLQVARGMEYLAEQ-- 143

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELT 679
            K +H D+  +N +LD    VK+ADFGLAR I   + +     +         + A E  
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ--QHRHARLPVKWTALESL 200

Query: 680 RGNSITAKIDIYSFGVVILEII 701
           +    T K D++SFGV++ E++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL 222

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  136 bits (344), Expect = 2e-35
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 512 LGRGGSGSVFEG-LLNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+GG    FE    +     A K      L     R K     E+    ++ H ++V  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 106

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G+  +    F+V E     SL +    +     L+    +  + QI  G +YLH     
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRN--- 160

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           ++IH D+K  N+ L+ DL VKI DFGLA  +  D      +  GTP Y+APE+      +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 219

Query: 686 AKIDIYSFGVVILEIICGR 704
            ++D++S G ++  ++ G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  137 bits (347), Expect = 3e-35
 Identities = 40/297 (13%), Positives = 83/297 (27%), Gaps = 63/297 (21%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE----------------------- 546
            LG+    +  E      G    V   Y  E                             
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 547 -----FLSEVETIGNIHHFNLVRLVGYCAERS--NRFLVYEYM--CNGSLDKWIFHKDRI 597
                F+   + + +     ++R+     +    +RF +Y  M     +  + +      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 598 Q-TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
             +L    R ++  Q+ R L  LH Y    ++H  ++P +I+LD+   V +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 657 AQDQSHVSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKG 711
                         P   A  +          +T   D ++ G+ I  I C      P  
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL---PNT 318

Query: 712 GDYLVDTL-KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSA 767
            D  +     +      +        + +++       +++     L+     R   
Sbjct: 319 DDAALGGSEWIFRSCKNI-------PQPVRA-------LLE---GFLRYPKEDRLLP 358

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (340), Expect = 4e-35
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 31/215 (14%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G VF     +         VAVK L       +K+F  E E + N+ H ++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKW-------------IFHKDRIQTLSWDIRKKIIFQ 611
             G C +     +V+EYM +G L+K+                +     L       I  Q
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           I+ G+ YL        +H D+  +N L+  +L VKI DFG++R +     +      G  
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----VGGH 194

Query: 672 G-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
                 +M PE       T + D++SFGV++ EI 
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  134 bits (339), Expect = 4e-35
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 15/204 (7%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHF 560
           DF I   LG+G  G+V+      +   +A+K L+  +      + +   E+E   ++ H 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           N++R+  Y  +R   +L+ E+   G L K +    R            + +++  L Y H
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH 131

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
           +    K+IH DIKP+N+L+     +KIADFG +      +    TM  GT  Y+ PE+  
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TMC-GTLDYLPPEMIE 185

Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
           G +   K+D++  GV+  E + G 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  133 bits (338), Expect = 5e-35
 Identities = 43/214 (20%), Positives = 85/214 (39%), Gaps = 39/214 (18%)

Query: 511 RLGRGGSGSVFEGLLND--------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL 562
            LG+G    +F+G+  +         T+V +K L        + F      +  + H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           V   G C       LV E++  GSLD ++        + W +  ++  Q++  + +L + 
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFLEEN 132

Query: 623 CNPKIIHFDIKPQNILLDRDLN--------VKIADFGLARLIAQDQSHVSTMPKGTPGY- 673
               +IH ++  +NILL R+ +        +K++D G++  +                  
Sbjct: 133 ---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQ 178

Query: 674 -----MAPE-LTRGNSITAKIDIYSFGVVILEII 701
                + PE +    ++    D +SFG  + EI 
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (342), Expect = 5e-35
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 16/205 (7%)

Query: 511 RLGRGGSGSVFEGLLNDGT-----KVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVR 564
            +G G  G V++G+L   +      VA+K L  G   + + +FL E   +G   H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L G  ++     ++ EYM NG+LDK  F +++    S      ++  I+ G++YL +   
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYLANM-- 166

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT--P-GYMAPELTRG 681
              +H D+  +NIL++ +L  K++DFGL+R++ +D    +    G   P  + APE    
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 682 NSITAKIDIYSFGVVILEII-CGRR 705
              T+  D++SFG+V+ E++  G R
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGER 249

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (338), Expect = 5e-35
 Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 14/193 (7%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC- 569
            +G+G  G V  G    G KVAVK +        + FL+E   +  + H NLV+L+G   
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            E+   ++V EYM  GSL  ++  + R   L  D   K    +   +EYL        +H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPELTRGNSITAKI 688
            D+  +N+L+  D   K++DFGL +  +        +P K    + APE  R    + K 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVK----WTAPEALREKKFSTKS 195

Query: 689 DIYSFGVVILEII 701
           D++SFG+++ EI 
Sbjct: 196 DVWSFGILLWEIY 208

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (343), Expect = 6e-35
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 511 RLGRGGSGSVFEGLLNDGTK----VAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRL 565
            +G G  G V  G L   +K    VA+K L  G   + +++FL E   +G   H N++RL
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G   +     +V EYM NGSLD   F +      +      ++  I+ G++YL D    
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS--HVSTMPKGTPGYMAPELTRGNS 683
             +H D+  +NIL++ +L  K++DFGL R++  D    + +   K    + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 684 ITAKIDIYSFGVVILEII 701
            T+  D++S+G+V+ E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  134 bits (339), Expect = 6e-35
 Identities = 81/331 (24%), Positives = 127/331 (38%), Gaps = 61/331 (18%)

Query: 511 RLGRGGSGSVFEG---LLNDGTKVAVKRLYPGENRGKKEFLS----EVETIGNIHHFNLV 563
            LG GG   V        +    VAVK L   +      F      E +    ++H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRDHR--DVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 564 RL--VG--YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGL 616
            +   G          ++V EY+   +L      +D + T   ++     ++I    + L
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIADACQAL 129

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV--STMPKGTPGYM 674
            + H      IIH D+KP NI++     VK+ DFG+AR IA   + V  +    GT  Y+
Sbjct: 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT-LK-VKAEADRLCDLV 732
           +PE  RG+S+ A+ D+YS G V+ E++ G     P  GD  V    + V+ +        
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVREDPIPPSARH 243

Query: 733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKVLQGLTKLEPVTDYG 787
           +  S D+ +          + +  L KN   R        + LV+V  G     P     
Sbjct: 244 EGLSADLDA----------VVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP----- 288

Query: 788 FLSFAVVEATTQEVVPIRSSPITAATLSGPR 818
                     T  +         A  LSGPR
Sbjct: 289 --KVLTDAERTSLL------SSAAGNLSGPR 311

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  134 bits (339), Expect = 8e-35
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 511 RLGRGGSGSVFEGLL-----NDGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G+V +G+      +    V +K +      +  +     +  IG++ H ++VR
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L+G C   S   LV +Y+  GSL      +     L   +      QI++G+ YL ++  
Sbjct: 80  LLGLCPGSS-LQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLEEH-- 134

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGNS 683
             ++H ++  +N+LL     V++ADFG+A L+  D   +      TP  +MA E      
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 684 ITAKIDIYSFGVVILEII 701
            T + D++S+GV + E++
Sbjct: 194 YTHQSDVWSYGVTVWELM 211

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  134 bits (340), Expect = 9e-35
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           L  GG   V+E   +  G + A+KRL   E    +  + EV  +  +  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 570 AERSNR-------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           +            FL+   +C G L +++   +    LS D   KI +Q  R ++++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK-----------GTP 671
             P IIH D+K +N+LL     +K+ DFG A  I+    +  +  +            TP
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 672 GYMAPEL---TRGNSITAKIDIYSFGVVILEIICGR 704
            Y  PE+        I  K DI++ G ++  +   +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (337), Expect = 1e-34
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 512 LGRGGSGSVFEGLLNDG----TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLV 566
           +GRG  G V+ G L D        AVK L    +     +FL+E   + +  H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 567 GYCAERSN-RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           G C        +V  YM +G L  +I ++    T+   I      Q+++G++YL      
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKYLASK--- 147

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTR 680
           K +H D+  +N +LD    VK+ADFGLAR +   + +  ++   T       +MA E  +
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQ 205

Query: 681 GNSITAKIDIYSFGVVILEII 701
               T K D++SFGV++ E++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELM 226

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (338), Expect = 1e-34
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 26/210 (12%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKW-------IFHKDRIQTLSWDIRKKIIFQISRGL 616
           RL+G  ++     ++ E M  G L  +       + +   +   S     ++  +I+ G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY--- 673
            YL+     K +H D+  +N ++  D  VKI DFG+ R I +   +     KG  G    
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 204

Query: 674 --MAPELTRGNSITAKIDIYSFGVVILEII 701
             M+PE  +    T   D++SFGVV+ EI 
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (338), Expect = 1e-34
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
            LG G  G VF    ++         VAVK L       +++F  E E +  + H ++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK------------KIIFQI 612
             G C E     +V+EYM +G L++++        L                   +  Q+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
           + G+ YL        +H D+  +N L+ + L VKI DFG++R I     +      G   
Sbjct: 168 AAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGRT 220

Query: 673 -----YMAPELTRGNSITAKIDIYSFGVVILEII 701
                +M PE       T + D++SFGVV+ EI 
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  132 bits (335), Expect = 1e-34
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 511 RLGRGGSGSVFEGLLNDG----TKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRL 565
            LG G  G V+EG+  +       VAVK          K++F+SE   + N+ H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G   E    +++ E    G L    + +    +L          QI + + YL      
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLESI--- 132

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMP-KGTPGYMAPELTRG 681
             +H DI  +NIL+     VK+ DFGL+R I  +    + V+ +P K    +M+PE    
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESINF 188

Query: 682 NSITAKIDIYSFGVVILEII 701
              T   D++ F V + EI+
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (335), Expect = 1e-34
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)

Query: 509 QIRLGRGGSGSVFEGLLNDG---TKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLV 563
              LG G  G+V +G          VAVK L     +   K E L+E   +  + +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           R++G C E  +  LV E    G L+K++     ++  +     +++ Q+S G++YL +  
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES- 136

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTRG 681
               +H D+  +N+LL      KI+DFGL++ +  D+++      G  P  + APE    
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194

Query: 682 NSITAKIDIYSFGVVILEII-CGRR 705
              ++K D++SFGV++ E    G++
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  132 bits (335), Expect = 1e-34
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 15/200 (7%)

Query: 511 RLGRGGSGSVFEGLLN----DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLV 563
           +LG G  G V  G  +        VAVK L P    +     +F+ EV  + ++ H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           RL G         +V E    GSL      +            +   Q++ G+ YL    
Sbjct: 85  RLYGVVLTPPM-KMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG-TP-GYMAPELTRG 681
             + IH D+  +N+LL     VKI DFGL R + Q+  H         P  + APE  + 
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 682 NSITAKIDIYSFGVVILEII 701
            + +   D + FGV + E+ 
Sbjct: 199 RTFSHASDTWMFGVTLWEMF 218

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  134 bits (340), Expect = 2e-34
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)

Query: 512 LGRGGSGSVFEGLLNDG----TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLV 566
           +GRG  G V+ G L D        AVK L    +     +FL+E   + +  H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 567 GYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           G C     +  +V  YM +G L  +I ++    T+   I      Q+++G+++L      
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKFLASK--- 211

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTR 680
           K +H D+  +N +LD    VK+ADFGLAR +   +         T       +MA E  +
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 269

Query: 681 GNSITAKIDIYSFGVVILEII 701
               T K D++SFGV++ E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (338), Expect = 2e-34
 Identities = 72/335 (21%), Positives = 125/335 (37%), Gaps = 48/335 (14%)

Query: 475 GKRRDK-STDESSVHVANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGLLN-DGTK 530
           GK+ ++   DE         +    K  +    DF+    LG G  G VF+      G  
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 531 VAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK 589
           +A K ++         + + E++ +   +   +V   G         +  E+M  GSLD+
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD 649
               K +   +   I  K+   + +GL YL +    KI+H D+KP NIL++    +K+ D
Sbjct: 121 --VLK-KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 650 FGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS 706
           FG++  +      + +M     GT  YM+PE  +G   + + DI+S G+ ++E+  GR  
Sbjct: 176 FGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

Query: 707 SNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAI------------ 754
             P     L      + E D        ++     ++        +AI            
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289

Query: 755 -----------------SCLQKNLHRRPSASMLVK 772
                             CL KN   R     L+ 
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (335), Expect = 2e-34
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 35/242 (14%)

Query: 488 HVANHLVKFSSKAMKSATRDFQI---------RLGRGGSGSVFEGLLNDG----TKVAVK 534
           H ++ LV   S+ +++   D  I          LG G  GSV EG L        KVAVK
Sbjct: 9   HHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK 68

Query: 535 RLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR-----FLVYEYMCNGSL 587
            +       R  +EFLSE   + +  H N++RL+G C E S++      ++  +M  G L
Sbjct: 69  TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 588 DKWI-FHKDRIQTLSWDIRKKIIF--QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN 644
             ++ + +         ++  + F   I+ G+EYL +      +H D+  +N +L  D+ 
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185

Query: 645 VKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPELTRGNSITAKIDIYSFGVVILE 699
           V +ADFGL++ I     +     +G        ++A E       T+K D+++FGV + E
Sbjct: 186 VCVADFGLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241

Query: 700 II 701
           I 
Sbjct: 242 IA 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (334), Expect = 4e-34
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG G  G V+EG ++         +VAVK L    + + + +FL E   I   +H N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           R +G   +   RF++ E M  G L  ++        +  +L+      +   I+ G +YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 620 HDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHVSTMPKGTPGY--- 673
            +      IH DI  +N LL         KI DFG+AR I +     S   KG       
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLPV 209

Query: 674 --MAPELTRGNSITAKIDIYSFGVVILEII 701
             M PE       T+K D +SFGV++ EI 
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  133 bits (336), Expect = 5e-34
 Identities = 39/239 (16%), Positives = 76/239 (31%), Gaps = 53/239 (22%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLY----------------------------PGEN 541
            LG+    +  E      G    V   Y                              + 
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--NRFLVYEYM--CNGSLDKWIFHKDRI 597
           +    F+   + + +     ++R+     +    +RF +Y  M     +  + +      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 598 Q-TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
             +L    R ++  Q+ R L  LH Y    ++H  ++P +I+LD+   V +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 657 AQDQSHVSTMPKGTPGYMAPELT-----------RGNSITAKIDIYSFGVVILEIICGR 704
              +     +   + G+  PEL            R   +T   D ++ G+VI  I C  
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (339), Expect = 9e-34
 Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 14/193 (7%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
            +G+G  G V  G    G KVAVK +        + FL+E   +  + H NLV+L+G   
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 571 ERSNRF-LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
           E      +V EYM  GSL  ++  + R   L  D   K    +   +EYL        +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP-KGTPGYMAPELTRGNSITAKI 688
            D+  +N+L+  D   K++DFGL +  +        +P K    + APE  R    + K 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVK----WTAPEALREKKFSTKS 367

Query: 689 DIYSFGVVILEII 701
           D++SFG+++ EI 
Sbjct: 368 DVWSFGILLWEIY 380

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  131 bits (331), Expect = 1e-33
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 27/211 (12%)

Query: 511 RLGRGGSGSVFEGLLNDG----TKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVR 564
            LG+G  GSV E  L        KVAVK L      +   +EFL E   +    H ++ +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 565 LVGYCAERSNR------FLVYEYMCNGSLDKWI---FHKDRIQTLSWDIRKKIIFQISRG 615
           LVG       +       ++  +M +G L  ++      +    L      + +  I+ G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG--- 672
           +EYL        IH D+  +N +L  D+ V +ADFGL+R I     +     +G      
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKLP 202

Query: 673 --YMAPELTRGNSITAKIDIYSFGVVILEII 701
             ++A E    N  T   D+++FGV + EI+
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  130 bits (328), Expect = 1e-33
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 32/216 (14%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG    G V++G L           VA+K L        ++EF  E      + H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKW-------------IFHKDRIQTLSWDIRKKIIF 610
            L+G   +     +++ Y  +G L ++                +     L       ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           QI+ G+EYL  +    ++H D+  +N+L+   LNVKI+D GL R +              
Sbjct: 136 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKLLG 188

Query: 671 PG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
                  +MAPE       +   DI+S+GVV+ E+ 
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (343), Expect = 1e-33
 Identities = 72/302 (23%), Positives = 128/302 (42%), Gaps = 14/302 (4%)

Query: 411 PTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYK 470
              IY L+ +    S  N        LP+  + L+     + ++++       A I    
Sbjct: 244 DGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPD 303

Query: 471 RWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGLL---ND 527
           + R     D S  ES       L        +       I LG G  GSV +G+      
Sbjct: 304 KPRP-MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362

Query: 528 GTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS 586
              VA+K L  G E    +E + E + +  + +  +VRL+G C +     LV E    G 
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421

Query: 587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVK 646
           L K  F   + + +      +++ Q+S G++YL +      +H ++  +N+LL      K
Sbjct: 422 LHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAK 476

Query: 647 IADFGLARLIAQDQSHVSTMPKGT-P-GYMAPELTRGNSITAKIDIYSFGVVILEII-CG 703
           I+DFGL++ +  D S+ +    G  P  + APE       +++ D++S+GV + E +  G
Sbjct: 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536

Query: 704 RR 705
           ++
Sbjct: 537 QK 538

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (344), Expect = 2e-33
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 13/197 (6%)

Query: 511 RLGRGGSGSVFEGLL----NDGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRL 565
            +G G  G V +G+     N    VA+K       +  +++FL E  T+    H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G     +  +++ E    G L    F + R  +L         +Q+S  L YL      
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP-GYMAPELTRGNSI 684
           + +H DI  +N+L+  +  VK+ DFGL+R + +D ++        P  +MAPE       
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 685 TAKIDIYSFGVVILEII 701
           T+  D++ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  131 bits (331), Expect = 2e-33
 Identities = 44/288 (15%), Positives = 91/288 (31%), Gaps = 34/288 (11%)

Query: 505 TRDFQIR--LGRGGSGSVFEG------LLNDGTKVAVKRLYPGENRGKKEF---LSEVET 553
           ++   +   LG G    V+E          +  K  +K   P       EF      +E 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMER 120

Query: 554 IGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI--QTLSWDIRKKIIFQ 611
           +        ++       ++   LV E    G+L   I        + +   +      +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILL-----------DRDLNVKIADFGLAR-LIAQD 659
           +   +E +HD    +IIH DIKP N +L           D    + + D G +  +    
Sbjct: 181 MLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR--RSSNPKGGDYLVD 717
           +  + T    T G+   E+        +ID +     +  ++ G   +  N  G      
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

Query: 718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISC-LQKNLHRR 764
             +     D   +           H   ++ +++  +    Q++   +
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (330), Expect = 3e-33
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG G  G V+EG ++         +VAVK L    + + + +FL E   I   +H N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWI----FHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           R +G   +   RF++ E M  G L  ++        +  +L+      +   I+ G +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 620 HDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHVSTMPKGTPGY--- 673
            +      IH DI  +N LL         KI DFG+AR I +         KG       
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPV 250

Query: 674 --MAPELTRGNSITAKIDIYSFGVVILEII 701
             M PE       T+K D +SFGV++ EI 
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  129 bits (326), Expect = 4e-33
 Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 30/277 (10%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN-DGTKVAVKRL-YPGENRGKKEFLSEVETIGN-IHHFN 561
           D +    +G G  G V++      G  +AVK++   G     K  L +++ +        
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V+  G     ++ F+  E M     +K    K     +   I  K+   I + L YL +
Sbjct: 86  IVQCFGTFITNTDVFIAMELM-GTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGL-ARLIAQDQSHVSTMPKGTPGYMAPE--- 677
                +IH D+KP NILLD    +K+ DFG+  RL+            G   YMAPE   
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERID 197

Query: 678 --LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
                      + D++S G+ ++E+  G+        D+ V T  ++ E   L       
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL------P 251

Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                S   D    ++    CL K+  +RP  + L++
Sbjct: 252 GHMGFS--GDFQSFVK---DCLTKDHRKRPKYNKLLE 283

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  129 bits (327), Expect = 5e-33
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 31/215 (14%)

Query: 511 RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNL 562
            LG G  G V E         +   KVAVK L    +   K+  +SE++ + ++  H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK-----------KIIFQ 611
           V L+G C       ++ EY C G L  ++  K R+                        Q
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           +++G+ +L        IH D+  +N+LL      KI DFGLAR I  D +++        
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VKGN 225

Query: 672 G-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
                 +MAPE       T + D++S+G+++ EI 
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  129 bits (327), Expect = 6e-33
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 16/205 (7%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +G+G    V   +    G + AVK     +         ++   E      + H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 566 VGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           +   +     ++V+E+M    L  + +   D     S  +    + QI   L Y HD   
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149

Query: 625 PKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
             IIH D+KP  +LL   +    VK+  FG+A  + +          GTP +MAPE+ + 
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVVKR 207

Query: 682 NSITAKIDIYSFGVVILEII-CGRR 705
                 +D++  G VIL I+  G  
Sbjct: 208 EPYGKPVDVWGCG-VILFILLSGCL 231

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (323), Expect = 1e-32
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 40/224 (17%)

Query: 511 RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            LG G  G V +            T VAVK L    +    ++ LSE   +  ++H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 564 RLVGYCAERSNRFLVYEYMCNGSL---------------------DKWIFHKDRIQTLSW 602
           +L G C++     L+ EY   GSL                     +         + L+ 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
                  +QIS+G++YL +    K++H D+  +NIL+     +KI+DFGL+R + ++ S+
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 663 VSTMPKGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
           V    K + G     +MA E    +  T + D++SFGV++ EI+
Sbjct: 207 V----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  127 bits (321), Expect = 1e-32
 Identities = 81/317 (25%), Positives = 139/317 (43%), Gaps = 53/317 (16%)

Query: 490 ANHLVKFSSKAMKSATRD----FQI--RLGRGGSGSVFEGL-LNDGTKVAVKR--LYPGE 540
           A+  V+     M++   D    F    ++G+G  G VF+G+       VA+K   L   E
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61

Query: 541 NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD----KWIFHKDR 596
           +   ++   E+  +       + +  G   + +  +++ EY+  GS           + +
Sbjct: 62  DE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 120

Query: 597 IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
           I T        I+ +I +GL+YLH   + K IH DIK  N+LL     VK+ADFG+A  +
Sbjct: 121 IAT--------ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169

Query: 657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV 716
              Q   +T   GTP +MAPE+ + ++  +K DI+S G+  +E+  G     P   +   
Sbjct: 170 TDTQIKRNTF-VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG----EPPHSEL-- 222

Query: 717 DTLKV-----KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLV 771
             +KV     K        L    S+ ++    + V+       CL K    RP+A  L+
Sbjct: 223 HPMKVLFLIPKNNPPT---LEGNYSKPLK----EFVEA------CLNKEPSFRPTAKELL 269

Query: 772 K---VLQGLTKLEPVTD 785
           K   +L+   K   +T+
Sbjct: 270 KHKFILRNAKKTSYLTE 286

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  127 bits (322), Expect = 1e-32
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 35/219 (15%)

Query: 511 RLGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNL 562
            LG G  G V E              VAVK L P  +   ++  +SE++ +  + +H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSL---------------DKWIFHKDRIQTLSWDIRKK 607
           V L+G C       ++ EY C G L                     +D    L  +    
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q+++G+ +L        IH D+  +NILL      KI DFGLAR I  D ++V    
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV---- 202

Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
                     +MAPE       T + D++S+G+ + E+ 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 2e-32
 Identities = 63/275 (22%), Positives = 125/275 (45%), Gaps = 37/275 (13%)

Query: 507 DFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           D  +++G G +G V      + G +VAVK +   + + ++   +EV  + +  HFN+V +
Sbjct: 48  DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                     +++ E++  G+L   +        L+ +    +   + + L YLH     
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQ 160

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            +IH DIK  +ILL  D  VK++DFG    I++D     ++  GTP +MAPE+   +   
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLYA 219

Query: 686 AKIDIYSFGVVILEIICG---RRSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKSE 737
            ++DI+S G++++E++ G     S +P         ++       +   +L +   K S 
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSP---------VQAMKRLRDSPPPKLKNS-HKVSP 269

Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            ++    D ++        L ++   R +A  L+ 
Sbjct: 270 VLR----DFLER------MLVRDPQERATAQELLD 294

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  128 bits (323), Expect = 2e-32
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 511 RLGRGGSGSVFEGLL--------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHF 560
            LG G  G V              +   VAVK L      +   + +SE+E +  I  H 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSL---------DKWIFHKDRIQTLSWDIRKK---- 607
           N++ L+G C +    +++ EY   G+L             +  D  +     +  K    
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL      K IH D+  +N+L+  +  +KIADFGLAR I     +     
Sbjct: 162 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK---- 214

Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
           K T G     +MAPE       T + D++SFGV++ EI 
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (336), Expect = 2e-32
 Identities = 60/325 (18%), Positives = 113/325 (34%), Gaps = 57/325 (17%)

Query: 511 RLGRGGSGSVFEG--LLNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNLVRL-- 565
            +  GG G ++       +G  V +K L    +   +   ++E + +  + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 566 VGYCAERSNR---FLVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHD 621
                +R      ++V EY+   SL      K    Q L        + +I   L YLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                +++ D+KP+NI+L  +  +K+ D G    I            GTPG+ APE+ R 
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----GTPGFQAPEIVRT 251

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDY---LVDTLKVKAEADRLCDLVDKKSED 738
              T   DIY+ G  +  +         + G Y   L +   V    D    L+ +    
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP---TRNGRYVDGLPEDDPVLKTYDSYGRLLRR---- 303

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKVLQGLTKLEPVTDYGFLSFAV 793
                             +  +  +R +     ++ L  VL+ +   +       LS   
Sbjct: 304 -----------------AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIF 346

Query: 794 VEATTQEVVPIRSSPITAATLSGPR 818
             + +   V +  +           
Sbjct: 347 SPSRSTFGVDLLVAHTDVYLDGQVH 371

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  126 bits (319), Expect = 2e-32
 Identities = 72/275 (26%), Positives = 130/275 (47%), Gaps = 45/275 (16%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 570 AERSNRFLVYEYMCNGSL----DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                 ++V EY+  GSL     +    + +I          +  +  + LE+LH   + 
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEFLH---SN 135

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           ++IH DIK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+    +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 194

Query: 686 AKIDIYSFGVVILEIICGR---RSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKSE 737
            K+DI+S G++ +E+I G     + NP         L+            L +  +K S 
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENP---------LRALYLIATNGTPELQN-PEKLSA 244

Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             +    D +        CL+ ++ +R SA  L++
Sbjct: 245 IFR----DFLN------RCLEMDVEKRGSAKELLQ 269

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (320), Expect = 2e-32
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 511 RLGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNL 562
            LGRG  G V E              VAVK L  G      +  +SE++ + +I HH N+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 563 VRLVGYCAERSN-RFLVYEYMCNGSL-----------DKWIFHKDRIQTLSWDIRKKIIF 610
           V L+G C +      ++ E+   G+L             +    + +      +   I +
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 611 --QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
             Q+++G+E+L      K IH D+  +NILL     VKI DFGLAR I +D  +V    +
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----R 206

Query: 669 GTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
                    +MAPE       T + D++SFGV++ EI 
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  126 bits (319), Expect = 3e-32
 Identities = 78/289 (26%), Positives = 123/289 (42%), Gaps = 40/289 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKR--LYPGENRGKKEFLSEVETIGNIHHFN 561
           D+++   +G G +  V          KVA+KR  L   +     E L E++ +   HH N
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQCHHPN 74

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSL-----DKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           +V        +   +LV + +  GS+           + +   L       I+ ++  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK----GTPG 672
           EYLH       IH D+K  NILL  D +V+IADFG++  +A          +    GTP 
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 673 YMAPE-LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV-----KAEAD 726
           +MAPE + +      K DI+SFG+  +E+  G          Y    +KV     + +  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG----AAPYHKY--PPMKVLMLTLQNDPP 245

Query: 727 RLCDLVDKKSEDMQ---SHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            L   V  K    +   S R     MI     CLQK+  +RP+A+ L++
Sbjct: 246 SLETGVQDKEMLKKYGKSFRK----MIS---LCLQKDPEKRPTAAELLR 287

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (321), Expect = 3e-32
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 40/224 (17%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNL 562
            LG G  G V               +VAVK L    +   ++  +SE++ +  +  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSL------------DKWIFHKDRIQTLSWDIRKKII- 609
           V L+G C      +L++EY C G L            +  I ++++ +    +    +  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 610 -------FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
                  +Q+++G+E+L        +H D+  +N+L+     VKI DFGLAR I  D ++
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228

Query: 663 VSTMPKGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
           V              +MAPE       T K D++S+G+++ EI 
Sbjct: 229 V----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  126 bits (319), Expect = 5e-32
 Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 50/229 (21%)

Query: 511 RLGRGGSGSVFEGLLNDG------TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLV 563
            +G G  G VF+            T VAVK L    +   + +F  E   +    + N+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 564 RLVGYCAERSNRFLVYEYMCNGSL-----------DKWIFHKDRIQTLSWDIRK------ 606
           +L+G CA      L++EYM  G L              + H D                 
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 607 ----KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
                I  Q++ G+ YL +    K +H D+  +N L+  ++ VKIADFGL+R I     +
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 663 VSTMPKGTPGY-----MAPELTRGNSI-----TAKIDIYSFGVVILEII 701
                           M PE     SI     T + D++++GVV+ EI 
Sbjct: 231 K----ADGNDAIPIRWMPPE-----SIFYNRYTTESDVWAYGVVLWEIF 270

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  126 bits (318), Expect = 1e-31
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 511 RLGRGGSGSVFEGLL--------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHF 560
            LG G  G V              +   VAVK L      +   + +SE+E +  I  H 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSL-------------DKWIFHKDRIQTLSWDIRKK 607
           N++ L+G C +    +++ EY   G+L               +  ++   + +++     
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL      K IH D+  +N+L+  +  +KIADFGLAR I     +     
Sbjct: 208 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK---- 260

Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
           K T G     +MAPE       T + D++SFGV++ EI 
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  126 bits (318), Expect = 2e-31
 Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 511 RLGRGGSGSVFEGLL--------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHF 560
            LG G  G V             N  TKVAVK L      +   + +SE+E +  I  H 
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSL---------DKWIFHKDRIQTLSWDIRKK---- 607
           N++ L+G C +    +++ EY   G+L             +  +        +  K    
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP 667
             +Q++RG+EYL      K IH D+  +N+L+  D  +KIADFGLAR I           
Sbjct: 196 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DYYK 248

Query: 668 KGTPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
           K T G     +MAPE       T + D++SFGV++ EI 
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  123 bits (311), Expect = 2e-31
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G    V   +    G + A K +       R  ++   E      + H N+VRL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             E S  +LV++ +  G L    F  + I   +  S       I QI   + Y H     
Sbjct: 74  IQEESFHYLVFDLVTGGEL----F--EDIVAREFYSEADASHCIQQILESIAYCHSN--- 124

Query: 626 KIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
            I+H ++KP+N+LL    +   VK+ADFGLA  +   ++       GTPGY++PE+ + +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKKD 182

Query: 683 SITAKIDIYSFGVVILEII-CG 703
             +  +DI++ G VIL I+  G
Sbjct: 183 PYSKPVDIWACG-VILYILLVG 203

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (313), Expect = 3e-31
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 33/217 (15%)

Query: 508 FQIRLGRGGSGSVFEGLLNDG---TKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNL 562
           FQ  +G G  G V +  +         A+KR+    +    ++F  E+E +  + HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKW-------------IFHKDRIQTLSWDIRKKII 609
           + L+G C  R   +L  EY  +G+L  +                     TLS        
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 610 FQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
             ++RG++YL      + IH D+  +NIL+  +   KIADFGL+R     Q       K 
Sbjct: 149 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV---KK 198

Query: 670 TPG-----YMAPELTRGNSITAKIDIYSFGVVILEII 701
           T G     +MA E    +  T   D++S+GV++ EI+
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  123 bits (311), Expect = 3e-31
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--------RLYPGENRGKKE-FLSEVETIGNI-HHF 560
           LGRG S  V   +      + AVK             E +  +E  L EV+ +  +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLE 617
           N+++L       +  FLV++ M  G L    F  D +    TLS    +KI+  +   + 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGEL----F--DYLTEKVTLSEKETRKIMRALLEVIC 138

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
            LH      I+H D+KP+NILLD D+N+K+ DFG +  +      +  +  GTP Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVC-GTPSYLAPE 193

Query: 678 LTRGNSITA------KIDIYSFGVVILEII-CG 703
           +   +          ++D++S G VI+  +  G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAG 225

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  125 bits (316), Expect = 3e-31
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 39/310 (12%)

Query: 474 EGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIR------LGRGGSGSVFEGLLND 527
            GK      ++      +   K+  + ++               LG G  G V   +   
Sbjct: 15  RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74

Query: 528 -GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS 586
            G     K +       K    +E+  +  +HH  L+ L     ++    L+ E++  G 
Sbjct: 75  TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134

Query: 587 LDKWIFHKDRI----QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL--D 640
           L    F  DRI      +S       + Q   GL+++H++    I+H DIKP+NI+    
Sbjct: 135 L----F--DRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETK 185

Query: 641 RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
           +  +VKI DFGLA  +  D+    T    T  + APE+     +    D+++ G V+  +
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIG-VLGYV 242

Query: 701 I-CGRRSSNPKGGDYLVDTL-KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQ 758
           +  G    +P  G+  ++TL  VK      CD  +   +   S   +A   I+   + LQ
Sbjct: 243 LLSG---LSPFAGEDDLETLQNVKR-----CD-WEFDEDAFSSVSPEAKDFIK---NLLQ 290

Query: 759 KNLHRRPSAS 768
           K   +R +  
Sbjct: 291 KEPRKRLTVH 300

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  123 bits (311), Expect = 5e-31
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKE---FLSEVETIGNIHHFNL 562
           LG G  G V          KVA+K     +   G  R         +E+E +  ++H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYL 619
           +++  +  +  + ++V E M  G L    F  D++   + L     K   +Q+   ++YL
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGEL----F--DKVVGNKRLKEATCKLYFYQMLLAVQYL 130

Query: 620 HDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           H+     IIH D+KP+N+LL   + D  +KI DFG ++++  + S + T+  GTP Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAP 185

Query: 677 ELTRGNSI---TAKIDIYSFGVVILEII-CG 703
           E+            +D +S G VIL I   G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLG-VILFICLSG 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  126 bits (319), Expect = 6e-31
 Identities = 74/310 (23%), Positives = 125/310 (40%), Gaps = 32/310 (10%)

Query: 468 LYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIRLGRGGSGSVFEGL-LN 526
           ++        R+    +  +     +   S K   S       +LG G  G V       
Sbjct: 1   MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60

Query: 527 DGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN 584
              + A+K +           + L EV  +  + H N+++L  +  ++ N +LV E    
Sbjct: 61  THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 585 GSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL-- 639
           G L    F  D I      +      II Q+  G+ YLH +    I+H D+KP+N+LL  
Sbjct: 121 GEL----F--DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLES 171

Query: 640 -DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVIL 698
            ++D  +KI DFGL+ +    +     +  GT  Y+APE+ R      K D++S GV++ 
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRKK-YDEKCDVWSIGVILF 228

Query: 699 EIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQ 758
            ++ G     P GG     T +               S + ++  + A  +I+     LQ
Sbjct: 229 ILLAGYP---PFGG----QTDQEILRKVEKGKY-TFDSPEWKNVSEGAKDLIK---QMLQ 277

Query: 759 KNLHRRPSAS 768
            +  RR SA 
Sbjct: 278 FDSQRRISAQ 287

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (309), Expect = 6e-31
 Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 24/206 (11%)

Query: 511 RLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRGKKEFLS----EVETIGNIHHFNLV 563
            +GRGG G V+E    D      VA+K +          F +    E  T G +   ++V
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            +  +       ++    +    L   +    R   L+      I+ QI   L+  H   
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV----STMPKGTPGYMAPELT 679
                H D+KP+NIL+  D    + DFG+A   A     +    +T+  GT  YMAPE  
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTV--GTLYYMAPERF 207

Query: 680 RGNSITAKIDIYSFGVVILEIICGRR 705
             +  T + DIY+   V+ E + G  
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  121 bits (307), Expect = 7e-31
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 29/208 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKE-FLSEVETIGNIHHFNLVR 564
           LG G    V +      G + A K     RL        +E    EV  +  I H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHD 621
           L      +++  L+ E +  G L    F  D +   ++L+ D   + + QI  G+ YLH 
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL----F--DFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 622 YCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
               +I HFD+KP+NI+L      +  +K+ DFG+A  I       +    GTP ++APE
Sbjct: 127 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPE 181

Query: 678 LTRGNSITAKIDIYSFGVV--ILEIICG 703
           +     +  + D++S GV+  IL  + G
Sbjct: 182 IVNYEPLGLEADMWSIGVITYIL--LSG 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  125 bits (315), Expect = 8e-31
 Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 41/258 (15%)

Query: 475 GKRRD-KSTDESSV-HVANHLVKFSSKAMKSATR---------DFQIRLGRGGSGSVFEG 523
           GKRR   +  E ++    N +  F    +   +               LG G  G V   
Sbjct: 95  GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154

Query: 524 L-LNDGTKVAVK-----RLYPGENRGKKE---FLSEVETIGNIHHFNLVRLVGYCAERSN 574
                  KVA++     +   G  R         +E+E +  ++H  ++++  +  +  +
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAED 213

Query: 575 RFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD 631
            ++V E M  G L    F  D++   + L     K   +Q+   ++YLH+     IIH D
Sbjct: 214 YYIVLELMEGGEL----F--DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRD 264

Query: 632 IKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI---T 685
           +KP+N+LL   + D  +KI DFG ++++  + S + T+  GTP Y+APE+          
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAGYN 322

Query: 686 AKIDIYSFGVVILEIICG 703
             +D +S GV++   + G
Sbjct: 323 RAVDCWSLGVILFICLSG 340

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  125 bits (317), Expect = 9e-31
 Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 37/269 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG+G  G V        G + AVK     ++    +  K+  L EV+ +  + H N+++L
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPNIMKL 91

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDY 622
             +  ++   +LV E    G L    F  D I +    S     +II Q+  G+ Y+H  
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL----F--DEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 623 CNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
              KI+H D+KP+N+LL    +D N++I DFGL+      +     +  GT  Y+APE+ 
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVL 200

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
            G     K D++S GV++  ++ G     P  G           +          +    
Sbjct: 201 HGT-YDEKCDVWSTGVILYILLSGCP---PFNG----ANEYDILKKVEKGKY-TFELPQW 251

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
           +   + A  +I+     L      R SA 
Sbjct: 252 KKVSESAKDLIR---KMLTYVPSMRISAR 277

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (308), Expect = 1e-30
 Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 37/271 (13%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G  GSV++ +    G  VA+K++    +   +E + E+  +      ++V+  G  
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
            + ++ ++V EY   GS+   I  + R +TL+ D    I+    +GLEYLH     + IH
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIH 148

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKID 689
            DIK  NILL+ + + K+ADFG+A  +    +  +T+  GTP +MAPE+ +        D
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQEIGYNCVAD 207

Query: 690 IYSFGVVILEIICGR---RSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKSEDMQS 741
           I+S G+  +E+  G+      +P         ++                 +  S++   
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHP---------MRAIFMIPTNPPPTFRK-PELWSDNFT- 256

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              D VK       CL K+  +R +A+ L++
Sbjct: 257 ---DFVKQ------CLVKSPEQRATATQLLQ 278

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  121 bits (305), Expect = 1e-30
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 21/200 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +GRG  G V   +      + A K++          F  E+E + ++ H N++RL     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
           + ++ +LV E    G L    F  +R+   +        +I+  +   + Y H      +
Sbjct: 77  DNTDIYLVMELCTGGEL----F--ERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NV 127

Query: 628 IHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
            H D+KP+N L      D  +K+ DFGLA      +   + +  GTP Y++P++  G   
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGLY- 184

Query: 685 TAKIDIYSFGVVILEII-CG 703
             + D +S G V++ ++ CG
Sbjct: 185 GPECDEWSAG-VMMYVLLCG 203

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (310), Expect = 2e-30
 Identities = 56/331 (16%), Positives = 104/331 (31%), Gaps = 55/331 (16%)

Query: 492 HLVKFSSKAMKSA---TRDFQI--RLGRGGS--GSVFEGL-LNDGTKVAVKR--LYPGEN 541
           H+     + M S       +++   +G+G     +V        G  V V+R  L    N
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 542 RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQTL 600
                   E+      +H N+V         +  ++V  +M  GS  D  +     +  +
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGM 125

Query: 601 SWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ 660
           +      I+  + + L+Y+H       +H  +K  +IL+  D  V ++       +    
Sbjct: 126 NELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182

Query: 661 SHVSTMPK------GTPGYMAPELTRGNSI--TAKIDIYSFGVVILEIICGR-------- 704
                +            +++PE+ + N     AK DIYS G+   E+  G         
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242

Query: 705 -----------------------RSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
                                            + ++    +         +  S     
Sbjct: 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           HR  +         CLQ+N   RPSAS L+ 
Sbjct: 303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  121 bits (306), Expect = 2e-30
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKE-FLSEVETIGNIHHFNLVR 564
           LG G    V +    + G + A K     +         +E    EV  +  + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHD 621
           L      R++  L+ E +  G L    F  D +   ++LS +     I QI  G+ YLH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL----F--DFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 622 YCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
               KI HFD+KP+NI+L        ++K+ DFGLA  I       +    GTP ++APE
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPE 188

Query: 678 LTRGNSITAKIDIYSFGVV--ILEIICG 703
           +     +  + D++S GV+  IL  + G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYIL--LSG 214

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  120 bits (304), Expect = 2e-30
 Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 20/228 (8%)

Query: 489 VANHLVKFSSKAMKSATRDFQIR------LGRGGSGSVFEG-LLNDGTKVAVKRLYPGEN 541
           + +H    S +                  LG G  G V      + G +  +K +    +
Sbjct: 1   MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60

Query: 542 RGKKE-FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL-DKWIFHKDRIQT 599
           +   E   +E+E + ++ H N++++     +  N ++V E    G L ++ +  + R + 
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120

Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLI 656
           LS     +++ Q+   L Y H      ++H D+KP+NIL         +KI DFGLA L 
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177

Query: 657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII-CG 703
             D+   +    GT  YMAPE+ + + +T K DI+S G V++  +  G
Sbjct: 178 KSDEHSTNAA--GTALYMAPEVFKRD-VTFKCDIWSAG-VVMYFLLTG 221

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (304), Expect = 2e-30
 Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 40/276 (14%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
            LG G  G V++      G   A K +        ++++ E+E +    H  +V+L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
                 +++ E+   G++D  +   DR   L+    + +  Q+   L +LH   + +IIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLH---SKRIIH 140

Query: 630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL-----TRGNSI 684
            D+K  N+L+  + ++++ADFG++    +      +   GTP +MAPE+      +    
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETMKDTPY 199

Query: 685 TAKIDIYSFGVVILEIICGR---RSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKS 736
             K DI+S G+ ++E+          NP         ++V     K++   L     K S
Sbjct: 200 DYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLKIAKSDPPTLLT-PSKWS 249

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            + +    D +K        L KN   RPSA+ L++
Sbjct: 250 VEFR----DFLK------IALDKNPETRPSAAQLLE 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  120 bits (304), Expect = 3e-30
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 507 DFQIRLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
            F   LG G    VF       G   A+K +            +E+  +  I H N+V L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDY 622
                  ++ +LV + +  G L    F  DRI      +      +I Q+   ++YLH+ 
Sbjct: 72  EDIYESTTHYYLVMQLVSGGEL----F--DRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 623 CNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
               I+H D+KP+N+L    + +  + I DFGL+++    Q+ + +   GTPGY+APE+ 
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAPEVL 179

Query: 680 RGNSITAKIDIYSFGVVILEII-CG 703
                +  +D +S G VI  I+ CG
Sbjct: 180 AQKPYSKAVDCWSIG-VITYILLCG 203

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  121 bits (306), Expect = 5e-30
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFL-SEVETIGNIHHFNLVR 564
           LG G    V +    + G + A K     +         +E +  EV  +  + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHD 621
           L      R++  L+ E +  G L    F  D +   ++LS +     I QI  G+ YLH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL----F--DFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 622 YCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
               KI HFD+KP+NI+L        ++K+ DFGLA  I       +    GTP ++APE
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPE 188

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CG 703
           +     +  + D++S G VI  I+  G
Sbjct: 189 IVNYEPLGLEADMWSIG-VITYILLSG 214

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  121 bits (306), Expect = 5e-30
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG G  G V +      G K+A K +     + K+E  +E+  +  + H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRI----QTLS-WDIRKKIIFQISRGLEYLHDYCNP 625
            +++  LV EY+  G L    F  DRI      L+  D     + QI  G+ ++H     
Sbjct: 157 SKNDIVLVMEYVDGGEL----F--DRIIDESYNLTELDTIL-FMKQICEGIRHMHQM--- 206

Query: 626 KIIHFDIKPQNILLDR--DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
            I+H D+KP+NIL        +KI DFGLAR     +        GTP ++APE+   + 
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNYDF 264

Query: 684 ITAKIDIYSFGVVILEII-CG 703
           ++   D++S G VI  ++  G
Sbjct: 265 VSFPTDMWSVG-VIAYMLLSG 284

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  120 bits (303), Expect = 5e-30
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 31/208 (14%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK----RLYPGENRGKKEFLSEVETIGNI-HHFNLVRL 565
           LGRG    V + +  + G + A K    R    + R   E L E+  +        ++ L
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR--AEILHEIAVLELAKSCPRVINL 94

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI-----QTLSWDIRKKIIFQISRGLEYLH 620
                  S   L+ EY   G +    F          + +S +   ++I QI  G+ YLH
Sbjct: 95  HEVYENTSEIILILEYAAGGEI----F--SLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
                 I+H D+KPQNILL       ++KI DFG++R I         M  GTP Y+APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPE 203

Query: 678 LTRGNSITAKIDIYSFGVV--ILEIICG 703
           +   + IT   D+++ G++  +L  +  
Sbjct: 204 ILNYDPITTATDMWNIGIIAYML--LTH 229

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  120 bits (303), Expect = 5e-30
 Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 23/201 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LGRG  G V   +  +       K +   +   +     E+  +    H N++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRI----QTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                 +++E++    +    F  +RI      L+       + Q+   L++LH +    
Sbjct: 72  SMEELVMIFEFISGLDI----F--ERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122

Query: 627 IIHFDIKPQNILL--DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
           I HFDI+P+NI+    R   +KI +FG AR +    +         P Y APE+ + + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVV 180

Query: 685 TAKIDIYSFGVV--ILEIICG 703
           +   D++S G +  +L  + G
Sbjct: 181 STATDMWSLGTLVYVL--LSG 199

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  124 bits (312), Expect = 6e-30
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 43/277 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL-------------YPGENRGKKEFLSEVETIGNI 557
           LG G  G V      N  ++ A+K +                  +  +E  +E+  + ++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISR 614
            H N+++L     ++   +LV E+   G L    F  ++I             I+ QI  
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----F--EQIINRHKFDECDAANIMKQILS 157

Query: 615 GLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           G+ YLH +    I+H DIKP+NILL   +  LN+KI DFGL+   ++D      +  GT 
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTA 212

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL 731
            Y+APE+ +      K D++S GV++  ++CG     P GG       +   +       
Sbjct: 213 YYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYP---PFGG----QNDQDIIKKVEKGKY 264

Query: 732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
                 D ++  D+A ++I+     L  + ++R +A 
Sbjct: 265 -YFDFNDWKNISDEAKELIK---LMLTYDYNKRCTAE 297

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  123 bits (310), Expect = 8e-30
 Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 32/266 (12%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G  G V +        + AVK +     +N+     L EVE +  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDYCNP 625
             + S+ ++V E    G L    F  D I      S     +II Q+  G+ Y+H +   
Sbjct: 90  LEDSSSFYIVGELYTGGEL----F--DEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140

Query: 626 KIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
            I+H D+KP+NILL   ++D ++KI DFGL+    Q+      +  GT  Y+APE+ RG 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRGT 198

Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
               K D++S GV++  ++ G     P  G           +               ++ 
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTP---PFYG----KNEYDILKRVETGKY-AFDLPQWRTI 249

Query: 743 RDDAVKMIQIAISCLQKNLHRRPSAS 768
            DDA  +I+     L  +   R +A+
Sbjct: 250 SDDAKDLIR---KMLTFHPSLRITAT 272

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (299), Expect = 9e-30
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 29/231 (12%)

Query: 489 VANHLVKFSSKAMKSATRDFQIR------LGRGGSGSVFEGL-LNDGTKVAVKRL--YPG 539
           + +H    S +        F  R      LG+G  G V +        + AVK +     
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 540 ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI-- 597
           +N+     L EVE +  + H N+++L     + S+ ++V E    G L    F  D I  
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----F--DEIIK 114

Query: 598 -QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLA 653
            +  S     +II Q+  G+ Y+H +    I+H D+KP+NILL   ++D ++KI DFGL+
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

Query: 654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEII-CG 703
               Q+      +  GT  Y+APE+ RG     K D++S G VIL I+  G
Sbjct: 172 TCFQQNTKMKDRI--GTAYYIAPEVLRGTY-DEKCDVWSAG-VILYILLSG 218

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  120 bits (302), Expect = 1e-29
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL--YPGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G    V   +    G + A K +       R  ++   E      + H N+VRL   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNP 625
             E S  +LV++ +  G L    F  + I   +  S       I QI   + Y H     
Sbjct: 97  IQEESFHYLVFDLVTGGEL----F--EDIVAREFYSEADASHCIQQILESIAYCHSN--- 147

Query: 626 KIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
            I+H ++KP+N+LL    +   VK+ADFGLA  +   ++       GTPGY++PE+ + +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKKD 205

Query: 683 SITAKIDIYSFGVVILEII-CG 703
             +  +DI++ G VIL I+  G
Sbjct: 206 PYSKPVDIWACG-VILYILLVG 226

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 1e-29
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFL-SEVETIGNIHHFNLVR 564
           LG G    V +    + G + A K     R         +E +  EV  +  I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHD 621
           L      +++  L+ E +  G L    F  D +   ++L+ +   + + QI  G+ YLH 
Sbjct: 79  LHEVYENKTDVILILELVAGGEL----F--DFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 622 YCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
               +I HFD+KP+NI+L         +KI DFGLA  I       +    GTP ++APE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPE 187

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CG 703
           +     +  + D++S G VI  I+  G
Sbjct: 188 IVNYEPLGLEADMWSIG-VITYILLSG 213

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  120 bits (302), Expect = 2e-29
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVK-------RLYPGENRGKKEFL-SEVETIGNIH-HFN 561
           +GRG S  V   +    G + AVK       RL P +    +E    E   +  +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEY 618
           ++ L+      S  FLV++ M  G L    F  D +     LS    + I+  +   + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL----F--DYLTEKVALSEKETRSIMRSLLEAVSF 215

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL 678
           LH      I+H D+KP+NILLD ++ ++++DFG +  + +    +  +  GTPGY+APE+
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELC-GTPGYLAPEI 270

Query: 679 TRGNSITA------KIDIYSFGVVILEII-CG 703
            + +          ++D+++ G VIL  +  G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACG-VILFTLLAG 301

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (299), Expect = 2e-29
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 37/208 (17%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIG-NIHHFNLVRLVGYC 569
           +G G        +      + AVK +    ++ K++   E+E +     H N++ L    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK---------IIFQISRGLEYLH 620
            +    ++V E M  G L       D+I      +R+K         ++F I++ +EYLH
Sbjct: 86  DDGKYVYVVTELMKGGEL----L--DKI------LRQKFFSEREASAVLFTITKTVEYLH 133

Query: 621 DYCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
                 ++H D+KP NIL         +++I DFG A+ +  +   + T P  T  ++AP
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAP 189

Query: 677 ELTRGNSITAKIDIYSFGVVILEII-CG 703
           E+       A  DI+S G V+L  +  G
Sbjct: 190 EVLERQGYDAACDIWSLG-VLLYTMLTG 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  120 bits (304), Expect = 3e-29
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 21/202 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLY--PGENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           LG+G    V   + +  G + A   +       R  ++   E      + H N+VRL   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            +E  + +L+++ +  G L    F  + I   +  S       I QI   + + H     
Sbjct: 79  ISEEGHHYLIFDLVTGGEL----F--EDIVAREYYSEADASHCIQQILEAVLHCHQM--- 129

Query: 626 KIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
            ++H ++KP+N+LL    +   VK+ADFGLA  +  +Q        GTPGY++PE+ R +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKD 188

Query: 683 SITAKIDIYSFGVVILEII-CG 703
                +D+++ G VIL I+  G
Sbjct: 189 PYGKPVDLWACG-VILYILLVG 209

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  117 bits (295), Expect = 3e-29
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 40/225 (17%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK----------------------RLYPGENRGKKEFL 548
           +G+G  G V      ND T  A+K                      R  PG     +  +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 549 S----EVETIGNIHHFNLVRL--VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSW 602
                E+  +  + H N+V+L  V       + ++V+E +  G +         ++ LS 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSE 136

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
           D  +     + +G+EYLH     KIIH DIKP N+L+  D ++KIADFG++       + 
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 663 VSTMPKGTPGYMAPELTRGNSIT---AKIDIYSFGVVILEIICGR 704
           +S    GTP +MAPE             +D+++ GV +   + G+
Sbjct: 194 LSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  121 bits (306), Expect = 4e-29
 Identities = 65/310 (20%), Positives = 122/310 (39%), Gaps = 37/310 (11%)

Query: 473 REGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIR------LGRGGSGSVFEGLLN 526
           +  + +   +     +V +   ++  + ++               LG G  G V      
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 527 D-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
             G   A K +       K+    E++T+  + H  LV L     + +   ++YE+M  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 586 SLDKWIFHKDRI----QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL-- 639
            L    F  +++      +S D   + + Q+ +GL ++H+      +H D+KP+NI+   
Sbjct: 240 EL----F--EKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTT 290

Query: 640 DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILE 699
            R   +K+ DFGL   +   QS   T   GT  + APE+  G  +    D++S G V+  
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVG-VLSY 347

Query: 700 II-CGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQ 758
           I+  G    +P GG+   +TL+     D      +          +D    I+     L 
Sbjct: 348 ILLSGL---SPFGGENDDETLRNVKSCD-----WNMDDSAFSGISEDGKDFIR---KLLL 396

Query: 759 KNLHRRPSAS 768
            + + R +  
Sbjct: 397 ADPNTRMTIH 406

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (294), Expect = 7e-29
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 46/309 (14%)

Query: 485 SSVHVANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN 541
           +S   A  L +    A++     F++   +G G  G V++G  +  G   A+K +     
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTG 61

Query: 542 RGKKEFLSEVETIGNI-HHFNLVRLVG------YCAERSNRFLVYEYMCNGSL-DKWIFH 593
             ++E   E+  +    HH N+    G              +LV E+   GS+ D  +  
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIK 119

Query: 594 KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA 653
             +  TL  +    I  +I RGL +LH     K+IH DIK QN+LL  +  VK+ DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 654 RLIAQDQSHVSTMPKGTPGYMAPEL-----TRGNSITAKIDIYSFGVVILEIICGRRSSN 708
             + +     +T   GTP +MAPE+         +   K D++S G+  +E+  G     
Sbjct: 177 AQLDRTVGRRNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG----A 231

Query: 709 PKGGDYLVDTLKV-----KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHR 763
           P   D  +  ++      +  A RL     K S+  Q      ++       CL KN  +
Sbjct: 232 PPLCD--MHPMRALFLIPRNPAPRLKS--KKWSKKFQ----SFIES------CLVKNHSQ 277

Query: 764 RPSASMLVK 772
           RP+   L+K
Sbjct: 278 RPATEQLMK 286

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  117 bits (294), Expect = 8e-29
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 35/207 (16%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           LG G      + +        AVK +     R +     E+  +     H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK---------IIFQISRGLEYLH 620
            ++ + FLV E +  G L    F  +RI       +KK         I+ ++   + ++H
Sbjct: 76  HDQLHTFLVMELLNGGEL----F--ERI------KKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           D     ++H D+KP+N+L    + +L +KI DFG ARL   D   + T P  T  Y APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE 179

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CG 703
           L   N      D++S G VIL  +  G
Sbjct: 180 LLNQNGYDESCDLWSLG-VILYTMLSG 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  116 bits (291), Expect = 3e-28
 Identities = 52/243 (21%), Positives = 86/243 (35%), Gaps = 53/243 (21%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           +G+G  G V   +        A+K     ++     +  +   +EV  +  +HH N+ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR-------------------- 605
                +     LV E    G L   +       T    +                     
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 606 -----------------KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL--DRDLNVK 646
                              I+ QI   L YLH+     I H DIKP+N L   ++   +K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 647 IADFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGN--SITAKIDIYSFGVVILEII 701
           + DFGL++   +  +          GTP ++APE+      S   K D +S GV++  ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 702 CGR 704
            G 
Sbjct: 271 MGA 273

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  115 bits (291), Expect = 3e-28
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 22/200 (11%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LGRG +  V+           A+K L   +   KK   +E+  +  + H N+++L     
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRI---QTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
             +   LV E +  G L    F  DRI      S       + QI   + YLH+     I
Sbjct: 119 TPTEISLVLELVTGGEL----F--DRIVEKGYYSERDAADAVKQILEAVAYLHEN---GI 169

Query: 628 IHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
           +H D+KP+N+L      D  +KIADFGL++++       +    GTPGY APE+ RG + 
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGCAY 227

Query: 685 TAKIDIYSFGVVILEII-CG 703
             ++D++S G +I  I+ CG
Sbjct: 228 GPEVDMWSVG-IITYILLCG 246

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (287), Expect = 5e-28
 Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 42/218 (19%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           LG G    V   + L    + AVK +       +     EVE +     H N++ L+ + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK---------IIFQISRGLEYLH 620
            E    +LV+E M  GS+         I       +++         ++  ++  L++LH
Sbjct: 81  EEEDRFYLVFEKMRGGSI----L--SHI------HKRRHFNELEASVVVQDVASALDFLH 128

Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPK------GTP 671
              N  I H D+KP+NIL    ++   VKI DF L   I  +               G+ 
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 672 GYMAPELTRGNSITAK-----IDIYSFGVVILEII-CG 703
            YMAPE+    S  A       D++S G VIL I+  G
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSG 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  115 bits (290), Expect = 6e-28
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRL--VGY 568
            G+G  G+V  G     G  VA+K++   + R +   L  ++ +  +HH N+V+L    Y
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89

Query: 569 CAERSNR-----FLVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDY 622
                +R      +V EY+   +L +   +  R        + K  +FQ+ R +  LH  
Sbjct: 90  TLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148

Query: 623 CNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
               + H DIKP N+L++  D  +K+ DFG A+ ++  + +V+ +   +  Y APEL  G
Sbjct: 149 S-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI--CSRYYRAPELIFG 205

Query: 682 NSI-TAKIDIYSFGVVILEIICGR 704
           N   T  +DI+S G +  E++ G 
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGE 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (291), Expect = 7e-28
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 31/208 (14%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGY 568
           +G G  G VF+  L +  +VA+K++      +NR       E++ +  + H N+V L  +
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAF 100

Query: 569 CAERSNR------FLVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHD 621
                ++       LV EY+   ++ +   H  ++ QT+   + K  ++Q+ R L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159

Query: 622 YCNPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQ---SHVSTMPKGTPGYMAPE 677
                I H DIKPQN+LLD    V K+ DFG A+++   +   S++ +       Y APE
Sbjct: 160 I---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE 211

Query: 678 LTRGNSI-TAKIDIYSFGVVILEIICGR 704
           L  G +  T  IDI+S G V+ E++ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  114 bits (287), Expect = 7e-28
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLS------EVETIGNIHHFNLVR 564
           +G+G    V     +  G +VA+K +    ++ +    S      EV  +  ++H N+V+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L          +L+ EY   G +  ++    R   +     +    QI   ++Y H    
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR- 134

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             I+H D+K +N+LLD D+N+KIADFG +         +     G P Y APEL +G   
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA-FCGAPPYAAPELFQGKKY 190

Query: 685 T-AKIDIYSFGVVILEIICGR 704
              ++D++S GV++  ++ G 
Sbjct: 191 DGPEVDVWSLGVILYTLVSGS 211

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  114 bits (287), Expect = 8e-28
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 21/205 (10%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK--------RLYPGENRGKKEFLSEVETIGNIHHFNL 562
           LG G  G V+  +      +V VK             E+    +   E+  +  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 563 VRLVGYCAERSNRFLVYEYMCNGS-LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           ++++     +    LV E   +G  L  +I    R   L   +   I  Q+   + YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRL 148

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTR 680
                IIH DIK +NI++  D  +K+ DFG A  + + +  +      GT  Y APE+  
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLM 202

Query: 681 GNS-ITAKIDIYSFGVVILEIICGR 704
           GN     +++++S GV +  ++   
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEE 227

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  115 bits (291), Expect = 9e-28
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +G G  G V++  L D G  VA+K++     + K+    E++ +  + H N+VRL  +  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 571 ERSNRF------LVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYC 623
               +       LV +Y+   ++ +   H  R  QTL     K  ++Q+ R L Y+H   
Sbjct: 118 SSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 173

Query: 624 NPKIIHFDIKPQNILLDRDLNV-KIADFGLARLIAQDQ---SHVSTMPKGTPGYMAPELT 679
           +  I H DIKPQN+LLD D  V K+ DFG A+ + + +   S++ +       Y APEL 
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 228

Query: 680 RGNSI-TAKIDIYSFGVVILEIICGR 704
            G +  T+ ID++S G V+ E++ G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (286), Expect = 1e-27
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 41/274 (14%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRG--KKEFLSEVETIGNIHHFNLVRLV 566
            +G G  G+V+    + +   VA+K++ Y G+      ++ + EV  +  + H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
           G        +LV EY    + D     +   + L       +     +GL YLH   +  
Sbjct: 121 GCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHN 174

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL---TRGNS 683
           +IH D+K  NILL     VK+ DFG A ++A   S V     GTP +MAPE+        
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 229

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV-----KAEADRLCDLVDKKSED 738
              K+D++S G+  +E+        P   +  ++ +       + E+  L       SE 
Sbjct: 230 YDGKVDVWSLGITCIELAER----KPPLFN--MNAMSALYHIAQNESPALQS--GHWSEY 281

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +    + V        CLQK    RP++ +L+K
Sbjct: 282 FR----NFVDS------CLQKIPQDRPTSEVLLK 305

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  112 bits (283), Expect = 2e-27
 Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 31/211 (14%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI------------- 557
           LG+GG G+VF G  L D  +VA+K +     R +    S +                   
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVI----PRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94

Query: 558 -HHFNLVRLVGYCAERSNRFLVYEYMCNGS-LDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
             H  ++RL+ +   +    LV E       L  +I  K     L     +    Q+   
Sbjct: 95  GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAA 151

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           +++ H      ++H DIK +NIL+D      K+ DFG   L+  +         GT  Y 
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYS 205

Query: 675 APELTRGNSIT-AKIDIYSFGVVILEIICGR 704
            PE    +        ++S G+++ +++CG 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  112 bits (282), Expect = 2e-27
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 17/204 (8%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V E L      + AVK     +L    N        E++ +  + H N+++L
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK-KEIQLLRRLRHKNVIQL 71

Query: 566 --VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
             V Y  E+   ++V EY   G  +  +      +            Q+  GLEYLH   
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ- 128

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKGTPGYMAPELTRGN 682
              I+H DIKP N+LL     +KI+  G+A  +            +G+P +  PE+  G 
Sbjct: 129 --GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186

Query: 683 SI--TAKIDIYSFGVVILEIICGR 704
                 K+DI+S GV +  I  G 
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGL 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  108 bits (273), Expect = 2e-26
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V  G     G KVAVK     ++   +  GK +   E++ +    H ++++L
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
               +  ++ F+V EY+  G L  +I    R   +     +++  QI   ++Y H +   
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRH--- 130

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
            ++H D+KP+N+LLD  +N KIADFGL+ +++  +  + T   G+P Y APE+  G    
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAAPEVISGRLYA 188

Query: 686 -AKIDIYSFGVVILEIICGR 704
             ++DI+S GV++  ++CG 
Sbjct: 189 GPEVDIWSCGVILYALLCGT 208

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  109 bits (275), Expect = 2e-26
 Identities = 55/248 (22%), Positives = 100/248 (40%), Gaps = 30/248 (12%)

Query: 481 STDESSVHVANHLVKFSSKAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLY 537
           + +      +    +   +  K    DF+    LG G   +V        ++  A+K L 
Sbjct: 5   AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL- 63

Query: 538 PGENRGKKEF----------LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL 587
                 +K              E + +  + H   V+L     +    +    Y  NG L
Sbjct: 64  ------EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117

Query: 588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI 647
              + +  +I +      +    +I   LEYLH      IIH D+KP+NILL+ D++++I
Sbjct: 118 ---LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 171

Query: 648 ADFGLARLIAQDQSHVSTMPK-GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR-- 704
            DFG A++++ +          GT  Y++PEL    S     D+++ G +I +++ G   
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

Query: 705 -RSSNPKG 711
            R+ N   
Sbjct: 232 FRAGNEYL 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  109 bits (275), Expect = 2e-26
 Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 23/206 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRL-------YPGENRGKKEFLSEVETIGNIHHF--N 561
           LG GG GSV+ G+ ++D   VA+K +       +     G +  + EV  +  +      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSG 109

Query: 562 LVRLVGYCAERSNRFLVYEYMCN-GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           ++RL+ +     +  L+ E       L  +I  +     L  ++ +   +Q+   + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 166

Query: 621 DYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           +     ++H DIK +NIL+D +   +K+ DFG   L+            GT  Y  PE  
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWI 220

Query: 680 RGNSITA-KIDIYSFGVVILEIICGR 704
           R +        ++S G+++ +++CG 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (275), Expect = 2e-26
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG-ENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
           ++G G  G VF+    + G  VA+K+     ++   KK  L E+  +  + H NLV L+ 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
               +    LV+EY  + ++   +      + +   + K I +Q  + + + H +     
Sbjct: 70  VFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH---NC 123

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SH-VSTMPKGTPGYMAPELTRGNS 683
           IH D+KP+NIL+ +   +K+ DFG ARL+          V+T       Y +PEL  G++
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDT 178

Query: 684 I-TAKIDIYSFGVVILEIICGR 704
                +D+++ G V  E++ G 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGV 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  108 bits (271), Expect = 3e-26
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLS-----EVETIGNIHHFNLVRL 565
           LG G  G V   +       VAVK +    +  +          E+     ++H N+V+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--ISRGLEYLHDYC 623
            G+  E + ++L  EY   G L   I     +     D ++   F   ++ G+ YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF--FHQLMA-GVVYLH--- 122

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRG 681
              I H DIKP+N+LLD   N+KI+DFGLA +  +  +    + K  GT  Y+APEL + 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 682 NSIT-AKIDIYSFGVVILEIICGR 704
                  +D++S G+V+  ++ G 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  108 bits (272), Expect = 8e-26
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V          KVA+K      L   +   + E   E+  +  + H ++++L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
                  ++  +V EY   G L  +I  K R   ++ D  ++   QI   +EY H +   
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRH--- 127

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSIT 685
           KI+H D+KP+N+LLD +LNVKIADFGL+ ++      + T   G+P Y APE+  G    
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPEVINGKLYA 185

Query: 686 -AKIDIYSFGVVILEIICGR 704
             ++D++S G+V+  ++ GR
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (280), Expect = 8e-26
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEF---LSEVETIGNIHHF 560
            F     LGRGG G VF   +    K+ A K+L     + +K +   + E + +  +H  
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245

Query: 561 NLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR----- 614
            +V L  Y  E      LV   M  G +    +H      +         FQ  R     
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIMNGGDI---RYH------IYNVDEDNPGFQEPRAIFYT 295

Query: 615 -----GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKG 669
                GLE+LH      II+ D+KP+N+LLD D NV+I+D GLA  +   Q+       G
Sbjct: 296 AQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-G 351

Query: 670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           TPG+MAPEL  G      +D ++ GV + E+I  R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  107 bits (268), Expect = 2e-25
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLS-----EVETIGNIHHFNLVRL 565
           LG G  G V   +       VAVK +    +  +          E+     ++H N+V+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ--ISRGLEYLHDYC 623
            G+  E + ++L  EY   G L   I     +     D ++   F   ++ G+ YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF--FHQLMA-GVVYLHGI- 124

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRG 681
              I H DIKP+N+LLD   N+KI+DFGLA +  +  +    + K  GT  Y+APEL + 
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 682 NSIT-AKIDIYSFGVVILEIICGR 704
                  +D++S G+V+  ++ G 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  110 bits (277), Expect = 2e-25
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEF---LSEVETIGNIHHF 560
            F+    LG+GG G V    +    K+ A K+L     + +K     L+E + +  ++  
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244

Query: 561 NLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF--QISRGLE 617
            +V L  Y  E  +   LV   M  G L    FH   +    +   + + +  +I  GLE
Sbjct: 245 FVVSLA-YAYETKDALCLVLTLMNGGDL---KFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
            LH     +I++ D+KP+NILLD   +++I+D GLA  + + Q+ +     GT GYMAPE
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE 355

Query: 678 LTRGNSITAKIDIYSFGVVILEIICGR 704
           + +    T   D ++ G ++ E+I G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  105 bits (264), Expect = 5e-25
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 32/232 (13%)

Query: 488 HVANHLVKFSSKAMKSATRDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKK 545
           H  +H     +   +     +Q   ++G G  G V++   + G  VA+KR+     R   
Sbjct: 3   HHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDA 57

Query: 546 EF-------LSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQ 598
           E        + E+  +  +HH N+V L+          LV+E+M     D      +   
Sbjct: 58  EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM---EKDLKKVLDENKT 114

Query: 599 TLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ 658
            L     K  ++Q+ RG+ + H +   +I+H D+KPQN+L++ D  +K+ADFGLAR    
Sbjct: 115 GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-- 169

Query: 659 DQSHVSTMPKGTPG-----YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
               V +    T       Y AP++  G+   +  +DI+S G +  E+I G+
Sbjct: 170 -GIPVRSY---THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  105 bits (264), Expect = 9e-25
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 26/218 (11%)

Query: 501 MKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-----FLSEVE 552
           +KS  + ++    LG G   +V++    N    VA+K++  G     K+      L E++
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 553 TIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
            +  + H N++ L+     +SN  LV+++M     D  +  KD    L+    K  +   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
            +GLEYLH +    I+H D+KP N+LLD +  +K+ADFGLA+      S        T  
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG---SPNRAY---THQ 172

Query: 673 -----YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
                Y APEL  G  +    +D+++ G ++ E++   
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (263), Expect = 1e-24
 Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG-ENRG-KKEFLSEVETIGNIHHFNLVRLVG 567
            +G G  G V +    + G  VA+K+     +++  KK  + E++ +  + H NLV L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
            C ++   +LV+E++ + ++   +  +     L + + +K +FQI  G+ + H +    I
Sbjct: 92  VCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH---NI 145

Query: 628 IHFDIKPQNILLDRDLNVKIADFGLARLIA---QDQSH-VSTMPKGTPGYMAPELTRGNS 683
           IH DIKP+NIL+ +   VK+ DFG AR +A   +     V+T       Y APEL  G+ 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDV 200

Query: 684 I-TAKIDIYSFGVVILEIICGR 704
                +D+++ G ++ E+  G 
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (273), Expect = 1e-24
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEF---LSE---VETIGNI 557
           DF +   +GRGG G V+     D  K+ A+K L     + K+     L+E   +  +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249

Query: 558 HHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
               +V +  Y     ++   + + M  G L    +H  +    S    +    +I  GL
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
           E++H+     +++ D+KP NILLD   +V+I+D GLA   ++ + H S    GT GYMAP
Sbjct: 306 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 359

Query: 677 E-LTRGNSITAKIDIYSFGVVILEIICGR 704
           E L +G +  +  D +S G ++ +++ G 
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  104 bits (262), Expect = 1e-24
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 53/248 (21%)

Query: 484 ESSVHVANHLVKFSSKAMKSATRDFQIR--LGRGGSGSVF---EGLLNDGTKV-AVKRLY 537
           E S+              K+    F++   LG+G  G VF   +   +D  ++ A+K L 
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL- 60

Query: 538 PGENRGKKEFL---SEVETIG--NI-----HHFNLVRLVGYCAERSNR-FLVYEYMCNGS 586
                 KK  L     V T    +I     H F +V+L  Y  +   + +L+ +++  G 
Sbjct: 61  ------KKATLKVRDRVRTKMERDILVEVNHPF-IVKLH-YAFQTEGKLYLILDFLRGGD 112

Query: 587 LDKWIFHKDRIQTLSWDIRKKIIF----------QISRGLEYLHDYCNPKIIHFDIKPQN 636
           L                + K+++F          +++  L++LH      II+ D+KP+N
Sbjct: 113 L---FTR----------LSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPEN 156

Query: 637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVV 696
           ILLD + ++K+ DFGL++     +    +   GT  YMAPE+      T   D +SFGV+
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVL 215

Query: 697 ILEIICGR 704
           + E++ G 
Sbjct: 216 MFEMLTGT 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (264), Expect = 2e-24
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFLSEVETIGNI------ 557
            F+I   +G+G  G V     ND  K+ A+K +        K+   E   + N+      
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQI 68

Query: 558 -----HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
                H F LV L     +  + F+V + +  G L    +H  +      +  K  I ++
Sbjct: 69  MQGLEHPF-LVNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKEETVKLFICEL 124

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
              L+YL +    +IIH D+KP NILLD   +V I DF +A ++ ++    +    GT  
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKP 179

Query: 673 YMAPEL---TRGNSITAKIDIYSFGVVILEIICGRR 705
           YMAPE+    +G   +  +D +S GV   E++ GRR
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  106 bits (266), Expect = 2e-24
 Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVK-----RLYPGENRGKKEFLSEVETIGNIHHFNLVRL 565
           LG G  G V  G     G KVAVK     ++   +  GK     E++ +    H ++++L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
               +  S+ F+V EY+  G L  +I    R   L     +++  QI  G++Y H +   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRH--- 135

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-I 684
            ++H D+KP+N+LLD  +N KIADFGL+ +++  +  + T   G+P Y APE+  G    
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAAPEVISGRLYA 193

Query: 685 TAKIDIYSFGVVILEIICGR 704
             ++DI+S GV++  ++CG 
Sbjct: 194 GPEVDIWSSGVILYALLCGT 213

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  105 bits (265), Expect = 2e-24
 Identities = 70/252 (27%), Positives = 110/252 (43%), Gaps = 30/252 (11%)

Query: 468 LYKRWREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIR--LGRGGSGSVFEGLL 525
           L K+          +   +       V  +    +    +F+    LG+G  G V     
Sbjct: 110 LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKE 169

Query: 526 NDGTKV-AVKRLYPGENRGKKEFL---SEVE-TIG--NI-----HHFNLVRLVGYCAERS 573
               +  A+K L       KKE +    EV  T+    +     H F L  L  Y  +  
Sbjct: 170 KATGRYYAMKIL-------KKEVIVAKDEVAHTLTENRVLQNSRHPF-LTALK-YSFQTH 220

Query: 574 NR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDI 632
           +R   V EY   G L    FH  R +  S D  +    +I   L+YLH   N  +++ D+
Sbjct: 221 DRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDL 275

Query: 633 KPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYS 692
           K +N++LD+D ++KI DFGL +   +D + + T   GTP Y+APE+   N     +D + 
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWG 334

Query: 693 FGVVILEIICGR 704
            GVV+ E++CGR
Sbjct: 335 LGVVMYEMMCGR 346

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  103 bits (259), Expect = 4e-24
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 33/207 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIG-NIHHFNLVRLVGYC 569
           LG G +G V E      G K A+K L         +   EV+         ++V ++   
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDVY 91

Query: 570 AERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDI---RK--KIIFQISRGLEYLH 620
               +      ++ E M  G L    F   RIQ         R+  +I+  I   +++LH
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL----F--SRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
            +    I H D+KP+N+L    ++D  +K+ DFG A+   Q+   + T P  TP Y+APE
Sbjct: 146 SH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAPE 199

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CG 703
           +          D++S G VI+ I+ CG
Sbjct: 200 VLGPEKYDKSCDMWSLG-VIMYILLCG 225

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (263), Expect = 4e-24
 Identities = 60/245 (24%), Positives = 109/245 (44%), Gaps = 27/245 (11%)

Query: 479 DKSTDESSVHVANHLVKFSS-----KAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKV 531
           + S      ++  +L          K M+    DF+I   +GRG  G V    L +  KV
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101

Query: 532 -AVKRLYPGENRGKKE---FLSEVETIGNIHHFNLVRLVGYCA--ERSNRFLVYEYMCNG 585
            A+K L   E   + E   F  E + + N     +  L  + A  + +N +LV +Y   G
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGG 159

Query: 586 SLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN 644
            L   +    +    L  ++ +  + ++   ++ +H       +H DIKP NIL+D + +
Sbjct: 160 DL---LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH 213

Query: 645 VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK-----IDIYSFGVVILE 699
           +++ADFG    + +D +  S++  GTP Y++PE+ +             D +S GV + E
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

Query: 700 IICGR 704
           ++ G 
Sbjct: 274 MLYGE 278

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  101 bits (255), Expect = 6e-24
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 30/207 (14%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEF-------LSEVETIGNIHHFNLV 563
           ++G G  G V++   N G   A+K++     R +KE        + E+  +  + H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +L      +    LV+E++ +  L K +        L     K  + Q+  G+ Y HD  
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPEL 678
             +++H D+KPQN+L++R+  +KIADFGLAR        V      T       Y AP++
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKY---THEIVTLWYRAPDV 171

Query: 679 TRGNSI-TAKIDIYSFGVVILEIICGR 704
             G+   +  IDI+S G +  E++ G 
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  104 bits (260), Expect = 8e-24
 Identities = 55/243 (22%), Positives = 100/243 (41%), Gaps = 26/243 (10%)

Query: 479 DKSTDESSVHVANHLVKFSSKAMKSATR-----DFQIR--LGRGGSGSVFEGLLNDGTKV 531
           D      + ++ N L ++     K         D+++   +GRG  G V         KV
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96

Query: 532 -AVKRLYPGENRGKKE---FLSEVETIGNIHHFNLVRLVGYCA--ERSNRFLVYEYMCNG 585
            A+K L   E   + +   F  E + +   +   +V+L  + A  +    ++V EYM  G
Sbjct: 97  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGG 154

Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV 645
            L     +      +     +    ++   L+ +H       IH D+KP N+LLD+  ++
Sbjct: 155 DL----VNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL 207

Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAK----IDIYSFGVVILEII 701
           K+ADFG    + ++         GTP Y++PE+ +            D +S GV + E++
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

Query: 702 CGR 704
            G 
Sbjct: 268 VGD 270

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (253), Expect = 1e-23
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 31/209 (14%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF-------LSEVETIGNIHHFNL 562
           ++G G  G+VF+         VA+KR+     R   +        L E+  +  + H N+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           VRL           LV+E+  +  L K+         L  +I K  +FQ+ +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPE 677
               ++H D+KPQN+L++R+  +K+A+FGLAR        V      +       Y  P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCY---SAEVVTLWYRPPD 171

Query: 678 LTRGNSI-TAKIDIYSFGVVILEIICGRR 705
           +  G  + +  ID++S G +  E+    R
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  103 bits (258), Expect = 1e-23
 Identities = 56/247 (22%), Positives = 103/247 (41%), Gaps = 29/247 (11%)

Query: 479 DKSTDESSVHVANHLVKFSSKAMKSATR-----DFQIR--LGRGGSGSVFEGLLNDGTKV 531
             S      +VA+ L       ++         DF+I   +GRG    V    +    +V
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88

Query: 532 -AVKRLYPGENRGKKE---FLSEVETIGNIHHFNLVRLVGYCA--ERSNRFLVYEYMCNG 585
            A+K +   +   + E   F  E + + N     + +L  + A  + +  +LV EY   G
Sbjct: 89  YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGG 146

Query: 586 SLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN 644
            L   +    +  + +  ++ +  + +I   ++ +H       +H DIKP NILLDR  +
Sbjct: 147 DL---LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200

Query: 645 VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIY-------SFGVVI 697
           +++ADFG    +  D +  S +  GTP Y++PE+ +          Y       + GV  
Sbjct: 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260

Query: 698 LEIICGR 704
            E+  G+
Sbjct: 261 YEMFYGQ 267

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (254), Expect = 1e-23
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 42/213 (19%)

Query: 511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKE------FLSEVETIGNIHHFNLV 563
           +LG G   +V++G        VA+K +     R + E       + EV  + ++ H N+V
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIV 63

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L        +  LV+EY+ +  L +++   D    ++    K  +FQ+ RGL Y H   
Sbjct: 64  TLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG----------- 672
             K++H D+KPQN+L++    +K+ADFGLAR             K  P            
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLAR------------AKSIPTKTYDNEVVTLW 165

Query: 673 YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
           Y  P++  G++  + +ID++  G +  E+  GR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  101 bits (255), Expect = 1e-23
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFL---SEVETI------ 554
           DF     LG+G  G V         +  A+K L       +KE +    EV         
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRV 58

Query: 555 -GNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQI 612
             N  H  L  L  Y  +  +R   V EY   G L    FH  R +  + +  +    +I
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 114

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG 672
              LEYLH      +++ DIK +N++LD+D ++KI DFGL +    D + + T   GTP 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPE 170

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           Y+APE+   N     +D +  GVV+ E++CGR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  101 bits (254), Expect = 2e-23
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 26/204 (12%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRL--V 566
           +LGRG    VFE + + +  KV VK L P +   KK+   E++ + N+    N++ L  +
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADI 99

Query: 567 GYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                     LV+E++ N    +        QTL+    +  +++I + L+Y H      
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---G 150

Query: 627 IIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQS---HVSTMPKGTPGYMAPELTRGN 682
           I+H D+KP N+++D +   +++ D+GLA      Q     V++       +  PEL    
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDY 205

Query: 683 SI-TAKIDIYSFGVVILEIICGRR 705
            +    +D++S G ++  +I  + 
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKE 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (256), Expect = 2e-23
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 42/222 (18%)

Query: 510 IRLGRGGSGSVFEG---LLNDGTKVAVKRL----YPGENRGKKEFLSEVETIGNIHHFNL 562
            ++GRG  G V++       D    A+K++           +   L E      + H N+
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE------LKHPNV 80

Query: 563 VRLVGYCAERSNR--FLVYEYMCNGSLD-KWIFH-------KDRIQTLSWDIRKKIIFQI 612
           + L       ++R  +L+++Y      D   I           +   L   + K +++QI
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 613 SRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN----VKIADFGLARLIAQDQSHVSTMPK 668
             G+ YLH      ++H D+KP NIL+  +      VKIAD G ARL     S +  +  
Sbjct: 138 LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLAD 191

Query: 669 GTPG-----YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
             P      Y APEL  G    T  IDI++ G +  E++   
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  101 bits (255), Expect = 2e-23
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 24/216 (11%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVG-Y 568
           +G G  G V       +  +VA+K++ P E++   +  L E++ +    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94

Query: 569 CAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
            A    +     +V + M    L K +    + Q LS D     ++QI RGL+Y+H   +
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH---S 146

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPELTRGN 682
             ++H D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE+   +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206

Query: 683 SI-TAKIDIYSFGVVILEIICGRRSSNP--KGGDYL 715
              T  IDI+S G ++ E++  R    P   G  YL
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYL 238

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  100 bits (252), Expect = 2e-23
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRL-YPGENRGKKEF----LSEVET---IGNIHHFN 561
            +G G  G+V++    + G  VA+K +  P    G        + EV     +    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 562 LVRLVGYCAERSNR-----FLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRG 615
           +VRL+  CA           LV+E++     D +    K     L  +  K ++ Q  RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPG 672
           L++LH      I+H D+KP+NIL+     VK+ADFGLAR+ +        V T+      
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL-----W 184

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           Y APE+   ++    +D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  101 bits (254), Expect = 2e-23
 Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 25/203 (12%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK--KEFLS-EVETIGNIHHFNLVRLVG 567
           +G G  G             VAVK +     RG    E +  E+    ++ H N+VR   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 568 YCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKI 627
                ++  ++ EY   G L + I +  R    S D  +    Q+  G+ Y H     +I
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSM---QI 137

Query: 628 IHFDIKPQNILLDRD--LNVKIADFGLARLIAQDQSHVSTMPK---GTPGYMAPELTRGN 682
            H D+K +N LLD      +KI DFG ++            PK   GTP Y+APE+    
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRQ 192

Query: 683 SIT-AKIDIYSFGVVILEIICGR 704
                  D++S GV +  ++ G 
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA 215

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  101 bits (254), Expect = 2e-23
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFL---SEVE-------- 552
           DF     LG+G  G V         ++ AVK L       KK+ +    +VE        
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRV 73

Query: 553 -TIGNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
             +     F L +L   C +  +R + V EY+  G L   ++H  ++             
Sbjct: 74  LALPGKPPF-LTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA 128

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I+ GL +L       II+ D+K  N++LD + ++KIADFG+ +    D     T   GT
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GT 184

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           P Y+APE+         +D ++FGV++ E++ G+
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  101 bits (254), Expect = 3e-23
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 32/214 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFL---SEVE-------- 552
           +F+    LG+G  G V    + +   + AVK L       KK+ +    +VE        
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-------KKDVILQDDDVECTMTEKRI 76

Query: 553 -TIGNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
            ++   H F L +L   C +  +R F V E++  G L   +FH  + +       +    
Sbjct: 77  LSLARNHPF-LTQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAA 131

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I   L +LHD     II+ D+K  N+LLD + + K+ADFG+ +    +    +T   GT
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GT 187

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           P Y+APE+ +       +D ++ GV++ E++CG 
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  102 bits (255), Expect = 3e-23
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 32/207 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           LG G +G V +        K A+K L     +   +   EVE         ++VR+V   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 124

Query: 570 ----AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI---RK--KIIFQISRGLEYLH 620
               A R    +V E +  G L    F   RIQ         R+  +I+  I   ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----F--SRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
                 I H D+KP+N+L      +  +K+ DFG A+      S  +  P  TP Y+APE
Sbjct: 179 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPE 233

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CG 703
           +          D++S G VI+ I+ CG
Sbjct: 234 VLGPEKYDKSCDMWSLG-VIMYILLCG 259

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  101 bits (254), Expect = 3e-23
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 52/235 (22%)

Query: 512 LGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           LG G  G V E    + G + A+K++             E++ +  + H N+++LV Y  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK----NRELDIMKVLDHVNIIKLVDYFY 70

Query: 571 ERSNRF--------------------------------------LVYEYMCNGSLDKWIF 592
              +                                        ++ EY+   +L K + 
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLK 129

Query: 593 HKDRI-QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADF 650
              R  +++  ++    I+Q+ R + ++H   +  I H DIKPQN+L++ +D  +K+ DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 651 GLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
           G A+ +   +  V+ +   +  Y APEL  G +  T  ID++S G V  E+I G+
Sbjct: 187 GSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  101 bits (253), Expect = 4e-23
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK-----------KEFLSEVETIGNIHHF 560
           +  G  G+V  G+ ++G  VA+KR++   + G+           K  L E+  + + HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 561 NLVRLVG-YCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
           N++ L   +            LV E M    L + I   D+   +S    +  ++ I  G
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI--HDQRIVISPQHIQYFMYHILLG 146

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVSTMPKGTPG 672
           L  LH      ++H D+ P NILL  + ++ I DF LAR    D +   +V+        
Sbjct: 147 LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW----- 198

Query: 673 YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
           Y APEL       T  +D++S G V+ E+   +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  100 bits (251), Expect = 4e-23
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 32/214 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFL---SEVE-------- 552
           DF +   LG+G  G VF        +  A+K L       KK+ +    +VE        
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKRV 70

Query: 553 -TIGNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
            ++   H F L  +     +     F V EY+  G L   ++H                 
Sbjct: 71  LSLAWEHPF-LTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA 125

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +I  GL++LH      I++ D+K  NILLD+D ++KIADFG+ +      +  +T   GT
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GT 181

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           P Y+APE+  G      +D +SFGV++ E++ G+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  100 bits (251), Expect = 5e-23
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 16/204 (7%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEF---LSEVETIGNIHHF 560
            F     LG G  G V      +     A+K L   +    K+    L+E   +  ++  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            LV+L     + SN ++V EY+  G +     H  RI   S    +    QI    EYLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
                 +I+ D+KP+N+L+D+   +++ DFG A+   + +    T+  GTP  +APE+  
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLC-GTPEALAPEIIL 211

Query: 681 GNSITAKIDIYSFGVVILEIICGR 704
                  +D ++ GV+I E+  G 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGY 235

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  100 bits (251), Expect = 7e-23
 Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 53/253 (20%)

Query: 479 DKSTDESSVHVANHLVKFSSKAMKSAT-RDFQIR--LGRGGSGSVFEGLLNDGTKV-AVK 534
             + + +     +  +     +   A   DF     +G+G  G V            AVK
Sbjct: 10  LMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK 69

Query: 535 RLYPGENRGKKEFL---SEVE-TIG--NI------HHFNLVRLVGYCAERSNR-FLVYEY 581
            L       +K+ +    E +  +   N+      H F LV L  +  + +++ + V +Y
Sbjct: 70  VL-------QKKAILKKKEEKHIMSERNVLLKNVKHPF-LVGLH-FSFQTADKLYFVLDY 120

Query: 582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIF----------QISRGLEYLHDYCNPKIIHFD 631
           +  G L    +H          ++++  F          +I+  L YLH      I++ D
Sbjct: 121 INGGEL---FYH----------LQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRD 164

Query: 632 IKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIY 691
           +KP+NILLD   ++ + DFGL +   +  S  ST   GTP Y+APE+         +D +
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQPYDRTVDWW 223

Query: 692 SFGVVILEIICGR 704
             G V+ E++ G 
Sbjct: 224 CLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 99.6 bits (249), Expect = 9e-23
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFL---SEVE-------- 552
           DF +   +GRG    V    L    ++ A+K +       KKE +    +++        
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTEKHV 62

Query: 553 -TIGNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
               + H F LV L   C +  +R F V EY+  G L   +FH  R + L  +  +    
Sbjct: 63  FEQASNHPF-LVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA 117

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +IS  L YLH+     II+ D+K  N+LLD + ++K+ D+G+ +   +     ST   GT
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GT 173

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           P Y+APE+ RG      +D ++ GV++ E++ GR
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  102 bits (256), Expect = 1e-22
 Identities = 81/424 (19%), Positives = 149/424 (35%), Gaps = 45/424 (10%)

Query: 310 KCGNYGVCSNGEC------TCPGSSSYFKQSNDSENGFSCAEVTHLSCQFKHLQRFLKLE 363
           KC    +  +  C       C    +  +     +       +  +    K+L       
Sbjct: 132 KCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNG 191

Query: 364 NVTYFDFVPHLINIDAEGCQRACLGNCSCKAAL---FRYQGSLSTGNCSLPTEIYTL-RN 419
               +  +  + +  +E  Q+      S        FR+Q   S  +  L  EI+     
Sbjct: 192 LSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLT 251

Query: 420 STKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLLLVIGASIYLYKRWREGKRRD 479
           S     G       ++Q         LL           +   G+      R +  + + 
Sbjct: 252 SRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKI 311

Query: 480 KSTDESSVHVANHLV---KFSSKAMKSATRDFQIR--LGRGGSGSVFEGLLNDGTKV-AV 533
               ++      + +     +    +    DF     LG+G  G V         ++ AV
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAV 371

Query: 534 KRLYPGENRGKKEFL---SEVE---------TIGNIHHFNLVRLVGYCAERSNR-FLVYE 580
           K L       KK+ +    +VE          +     F L +L   C +  +R + V E
Sbjct: 372 KIL-------KKDVVIQDDDVECTMVEKRVLALPGKPPF-LTQLH-SCFQTMDRLYFVME 422

Query: 581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD 640
           Y+  G L   ++H  ++             +I+ GL +L       II+ D+K  N++LD
Sbjct: 423 YVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLD 476

Query: 641 RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEI 700
            + ++KIADFG+ +    D     T   GTP Y+APE+         +D ++FGV++ E+
Sbjct: 477 SEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535

Query: 701 ICGR 704
           + G+
Sbjct: 536 LAGQ 539

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.8 bits (247), Expect = 1e-22
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 55/227 (24%)

Query: 507 DFQIR--LGRGGSGSVF---EGLLNDGTKV-AVKRLYPGENRGKKEFL----SEVE-TIG 555
            F++   LG+GG G VF   +    +  K+ A+K L       KK  +     +   T  
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTKA 70

Query: 556 --NI-----HHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKK 607
             NI     H F +V L+ Y  +   + +L+ EY+  G L                + ++
Sbjct: 71  ERNILEEVKHPF-IVDLI-YAFQTGGKLYLILEYLSGGEL---FMQ----------LERE 115

Query: 608 IIF----------QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA 657
            IF          +IS  L +LH      II+ D+KP+NI+L+   +VK+ DFGL +   
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172

Query: 658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            D +   T   GT  YMAPE+   +     +D +S G ++ +++ G 
Sbjct: 173 HDGTVTHTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 98.0 bits (245), Expect = 2e-22
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 27/208 (12%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNIHHFNLVRL 565
           +LG G   +V++GL    G  VA+K +      G        + E+  +  + H N+VRL
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRL 68

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT---LSWDIRKKIIFQISRGLEYLHDY 622
                  +   LV+E+M +  L K++  +    T   L  ++ K   +Q+ +GL + H+ 
Sbjct: 69  YDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-----YMAPE 677
              KI+H D+KPQN+L+++   +K+ DFGLAR        V+T    +       Y AP+
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAF---GIPVNTF---SSEVVTLWYRAPD 178

Query: 678 LTRGNSI-TAKIDIYSFGVVILEIICGR 704
           +  G+   +  IDI+S G ++ E+I G+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 99.7 bits (249), Expect = 2e-22
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEFL---SEVE-------- 552
           DF +   +GRG    V    L    ++ A++ +       KKE +    +++        
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHV 105

Query: 553 -TIGNIHHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIF 610
               + H F LV L   C +  +R F V EY+  G L   +FH  R + L  +  +    
Sbjct: 106 FEQASNHPF-LVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA 160

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +IS  L YLH+     II+ D+K  N+LLD + ++K+ D+G+ +   +     ST   GT
Sbjct: 161 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GT 216

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           P Y+APE+ RG      +D ++ GV++ E++ GR
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRL-- 565
            +G G  G+V   +    G KVA+K+LY P ++    K    E+  + ++ H N++ L  
Sbjct: 32  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91

Query: 566 VGYCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           V    E  + F    LV  +M    L K +    + + L  D  + +++Q+ +GL Y+H 
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIH- 145

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTR 680
                IIH D+KP N+ ++ D  +KI DFGLAR    + + +V T       Y APE+  
Sbjct: 146 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVIL 198

Query: 681 GNSI-TAKIDIYSFGVVILEIICGR 704
                T  +DI+S G ++ E+I G+
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 98.1 bits (245), Expect = 4e-22
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNLVRLVG- 567
            LG G  G V        G  VA+K++ P +        L E++ + +  H N++ +   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77

Query: 568 YCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
              +    F    ++ E M    L + I      Q LS D  +  I+Q  R ++ LH   
Sbjct: 78  QRPDSFENFNEVYIIQELM-QTDLHRVI----STQMLSDDHIQYFIYQTLRAVKVLHG-S 131

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---------YM 674
           N  +IH D+KP N+L++ + ++K+ DFGLAR+I +  +  S       G         Y 
Sbjct: 132 N--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 675 APELTRGNSI-TAKIDIYSFGVVILEIICGR 704
           APE+   ++  +  +D++S G ++ E+   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLV--- 566
            LG GG+G VF  +  +   +VA+K++   + +  K  L E++ I  + H N+V++    
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77

Query: 567 -------GYCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
                                +V EYM    L   +        L  +  +  ++Q+ RG
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLLEEHARLFMYQLLRG 132

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPK--GTPG 672
           L+Y+H   +  ++H D+KP N+ ++  DL +KI DFGLAR++    SH   + +   T  
Sbjct: 133 LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 673 YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
           Y +P L    +  T  ID+++ G +  E++ G+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.4 bits (241), Expect = 7e-22
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 507 DFQIR--LGRGGSGSVFEGLLNDGTKV-AVKRLYPGENRGKKEF----------LSEVET 553
           DFQI   LG G  G V         +  A+K L       KKE             E   
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLM 59

Query: 554 IGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
           +  + H  ++R+ G   +    F++ +Y+  G L        + Q     + K    ++ 
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL---FSLLRKSQRFPNPVAKFYAAEVC 116

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
             LEYLH      II+ D+KP+NILLD++ ++KI DFG A+          T+  GTP Y
Sbjct: 117 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYTLC-GTPDY 169

Query: 674 MAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           +APE+         ID +SFG++I E++ G 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 37/213 (17%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF-------LSEVETIGNIHHFNL 562
           +LG G  G V++ +       VA+KR+     R + E        + EV  +  + H N+
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           + L           L++EY     L K++   D+   +S  + K  ++Q+  G+ + H  
Sbjct: 96  IELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHS- 150

Query: 623 CNPKIIHFDIKPQNILLDRDL-----NVKIADFGLARLIAQDQSHVSTMPKGTPG----- 672
              + +H D+KPQN+LL          +KI DFGLAR        +      T       
Sbjct: 151 --RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIRQF---THEIITLW 202

Query: 673 YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
           Y  PE+  G+   +  +DI+S   +  E++   
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 20/156 (12%)

Query: 558 HHFNLVRL----VGYCAERSNR-FLVYEYMCNGSLD-KWIFHKDRIQTLSWDIRKKIIFQ 611
            H N+VRL         +R  +  LV+E++     D      K     +  +  K ++FQ
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ--SH-VSTMPK 668
           + RGL++LH +   +++H D+KPQNIL+     +K+ADFGLAR+ +     +  V T+  
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL-- 183

Query: 669 GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
               Y APE+   +S    +D++S G +  E+   +
Sbjct: 184 ---WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 62/256 (24%), Positives = 112/256 (43%), Gaps = 40/256 (15%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRLVG 567
            +G G  G V           VA+K+L  P +N+   K    E+  +  ++H N++ L+ 
Sbjct: 32  PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91

Query: 568 -YCAERSNR-----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
            +  ++S       ++V E M + +L + I        L  +    +++Q+  G+++LH 
Sbjct: 92  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS 145

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVSTMPKGTPGYMAPEL 678
                IIH D+KP NI++  D  +KI DFGLAR          +V T       Y APE+
Sbjct: 146 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 197

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNP--KGGDYLVDTLKVKAEADRLCDLVDKKS 736
             G      +DI+S G ++ E+I G         G D+ +D        +++ + +    
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDH-IDQW------NKVIEQLGTPC 246

Query: 737 -EDMQSHRDDAVKMIQ 751
            E M+  +      ++
Sbjct: 247 PEFMKKLQPTVRTYVE 262

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 94.2 bits (235), Expect = 5e-21
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 43/225 (19%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF-------LSEVETIGN 556
            ++   ++G+G  G VF+      G KVA+K++       + E        L E++ +  
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQL 72

Query: 557 IHHFNLVRLVGYCAERSNR--------FLVYEYMCN---GSLDKWIFHKDRIQTLSWDIR 605
           + H N+V L+  C  +++         +LV+++  +   G L       + +   +    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEI 126

Query: 606 KKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST 665
           K+++  +  GL Y+H     KI+H D+K  N+L+ RD  +K+ADFGLAR  +  ++  S 
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--SQ 181

Query: 666 MPKGTPG-----YMAPELTRGNSI-TAKIDIYSFGVVILEIICGR 704
             + T       Y  PEL  G       ID++  G ++ E+    
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 64/255 (25%), Positives = 107/255 (41%), Gaps = 37/255 (14%)

Query: 472 WREGKRRDKSTDESSVHVANHLVKFSSKAMKSATRDFQIR--LGRGGSGSVF---EGLLN 526
                  D      +V         +  A K    +F++   LG G  G VF   +   +
Sbjct: 20  GTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGH 79

Query: 527 DGTKV-AVKRLYPGENRGKKEFL-SEVETIGNI-----------HH-FNLVRLVGYCAER 572
           D  K+ A+K L       KK  +  + +T  +               F LV L  Y  + 
Sbjct: 80  DTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIRQSPF-LVTLH-YAFQT 130

Query: 573 SNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD 631
             +  L+ +Y+  G L     H  + +  +    +  + +I   LE+LH      II+ D
Sbjct: 131 ETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRD 184

Query: 632 IKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI--TAKID 689
           IK +NILLD + +V + DFGL++    D++  +    GT  YMAP++ RG        +D
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 244

Query: 690 IYSFGVVILEIICGR 704
            +S GV++ E++ G 
Sbjct: 245 WWSLGVLMYELLTGA 259

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 25/204 (12%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRL--V 566
           +G G  GSV   +    G KVA+K+L  P ++    K    E+  + ++ H N++ L  V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91

Query: 567 GYCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
              A     F    LV  +M    L K +         S +  + +++Q+ +GL+Y+H  
Sbjct: 92  FTPASSLRNFYDFYLVMPFM-QTDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH-- 143

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRG 681
            +  ++H D+KP N+ ++ D  +KI DFGLAR    + +  V T       Y APE+   
Sbjct: 144 -SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILS 197

Query: 682 NSI-TAKIDIYSFGVVILEIICGR 704
                  +DI+S G ++ E++ G+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRL-- 565
            +G G  GSV        G +VAVK+L  P ++    K    E+  + ++ H N++ L  
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95

Query: 566 VGYCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           V   A     F    LV   M    L+  +    + Q L+ D  + +I+QI RGL+Y+H 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH- 149

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTR 680
             +  IIH D+KP N+ ++ D  +KI DFGLAR  A + + +V+T       Y APE+  
Sbjct: 150 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIML 202

Query: 681 GNSI-TAKIDIYSFGVVILEIICGR 704
                   +DI+S G ++ E++ GR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 92.6 bits (230), Expect = 7e-20
 Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 52/259 (20%)

Query: 480 KSTDESSVHVANHLVKFSSKAMKSATRDFQI--------RLGRGGSGSVFEGL-LNDGTK 530
             + +       H     + +M     D+QI         +G G  G V E     +   
Sbjct: 21  SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80

Query: 531 VAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRLVG-YCAERSNRF----LVYEYMC 583
           VA+K++    E+    K  L E+  +  ++H ++V+++     +   +F    +V E   
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA- 139

Query: 584 NGSLD-KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD 642
               D K +F       L+    K +++ +  G++Y+H      I+H D+KP N L+++D
Sbjct: 140 --DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQD 192

Query: 643 LNVKIADFGLARLIAQDQSHVSTMPKGTPG--------------------------YMAP 676
            +VK+ DFGLAR +   ++  S +P                               Y AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 677 ELTRGNSI-TAKIDIYSFG 694
           EL       T  ID++S G
Sbjct: 253 ELILLQENYTEAIDVWSIG 271

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 92.2 bits (229), Expect = 8e-20
 Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 40/255 (15%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRL--V 566
           +G G  G V           VA+K+L  P +N+   K    E+  +  ++H N++ L  V
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129

Query: 567 GYCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
               +    F    LV E M + +L + I        L  +    +++Q+  G+++LH  
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-DANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS- 182

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS---HVSTMPKGTPGYMAPELT 679
               IIH D+KP NI++  D  +KI DFGLAR          +V T       Y APE+ 
Sbjct: 183 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVI 235

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNP--KGGDYLVDTLKVKAEADRLCDLVDK-KS 736
            G      +DI+S G ++ E++  +        G DY +D        +++ + +     
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDY-IDQW------NKVIEQLGTPCP 284

Query: 737 EDMQSHRDDAVKMIQ 751
           E M+  +      ++
Sbjct: 285 EFMKKLQPTVRNYVE 299

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.0 bits (223), Expect = 2e-19
 Identities = 67/264 (25%), Positives = 99/264 (37%), Gaps = 76/264 (28%)

Query: 511 RLGRGGSGSVFEGLLND------GTKVAVKRLYPGENRG-KKEFLSEVETIGNI-HHFNL 562
            LGRG  G V E              VAVK L  G      +  +SE++ + +I HH N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 563 VRLVG--------------YCAE-------RSNRFLVYEYMCNGS--------------- 586
           V L+G              +C         RS R     Y   G+               
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148

Query: 587 --------------------LDKWIFHKDRIQTLSWDIRKKI--------IFQISRGLEY 618
                                +K +   +  +      +  +         FQ+++G+E+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG-YMAPE 677
           L    + K IH D+  +NILL     VKI DFGLAR I +D  +V       P  +MAPE
Sbjct: 209 L---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 678 LTRGNSITAKIDIYSFGVVILEII 701
                  T + D++SFGV++ EI 
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIF 289

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 37/233 (15%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLY-PGENRGK-KEFLSEVETIGNIHHFNLVRLVG 567
            +GRG  G V+     N    VA+K++    E+    K  L E+  +  +    ++RL  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92

Query: 568 -YCAERSNRF----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
               +   +F    +V E   +  L K +F       L+ +  K I++ +  G  ++H  
Sbjct: 93  LIIPDDLLKFDELYIVLEIA-DSDLKK-LFKTP--IFLTEEHIKTILYNLLLGENFIH-- 146

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPG---------- 672
               IIH D+KP N LL++D +VK+ DFGLAR I  ++                      
Sbjct: 147 -ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205

Query: 673 -----------YMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGD 713
                      Y APEL       T  IDI+S G +  E++   +S      +
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 46/283 (16%), Positives = 86/283 (30%), Gaps = 57/283 (20%)

Query: 511 RLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRG---KKEFLSEVETIGNIHHFNLVR 564
             G       ++ L  D     +VA+  + P         +E LS    +  I    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-LSWDIRKKIIFQISRGLEYLHDYC 623
           ++     R+   +V E++  GSL      ++   T  S     + +  ++   +  H   
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSL------QEVADTSPSPVGAIRAMQSLAAAADAAHRA- 148

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
              +      P  + +  D +V +A                      P  M         
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA------ 179

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
              + DI   G  +  ++  R    P     +   L   AE D     ++    D     
Sbjct: 180 -NPQDDIRGIGASLYALLVNRW---PLPEAGVRSGLAP-AERDTAGQPIEPADIDRDIPF 234

Query: 744 D-DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD 785
              AV         +Q +   R  AS L+ ++Q  T +   T+
Sbjct: 235 QISAVAA-----RSVQGDGGIRS-ASTLLNLMQQATAVADRTE 271

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 66/247 (26%), Positives = 118/247 (47%), Gaps = 53/247 (21%)

Query: 505 TRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLY-PGEN-----RGKKE--FLSEVET 553
            R +++  +LG+G  G V++ +    G  VAVK+++   +N     R  +E   L+E+  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS- 66

Query: 554 IGNIHHFNLVRLVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
                H N+V L+      ++R  +LV++YM    L   I    R   L    ++ +++Q
Sbjct: 67  ----GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI----RANILEPVHKQYVVYQ 117

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           + + ++YLH      ++H D+KP NILL+ + +VK+ADFGL+R     +   + +P    
Sbjct: 118 LIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 672 G--------------------YMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNP- 709
                                Y APE+  G++  T  ID++S G ++ EI+CG+    P 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK----PI 230

Query: 710 -KGGDYL 715
             G   +
Sbjct: 231 FPGSSTM 237

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.8 bits (197), Expect = 5e-16
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 41/220 (18%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNIH-------- 558
           LG G   +V+    + + T VA+K +     RG K +      E++ +  ++        
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 559 ---HFNLVRLVGY----CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQ 611
                ++++L+ +         +  +V+E +   +L   I  K   + +     K+I  Q
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALI-KKYEHRGIPLIYVKQISKQ 139

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDR------DLNVKIADFGLARLIAQDQS-HVS 664
           +  GL+Y+H  C   IIH DIKP+N+L++        + +KIAD G A    +  +  + 
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
           T       Y +PE+  G       DI+S   +I E+I G 
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 53/207 (25%), Positives = 78/207 (37%), Gaps = 53/207 (25%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYC 569
           LG G +G V +        K A+K L     +   +   EVE         ++VR+V   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 570 ----AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDI---RK--KIIFQISRGLEYLH 620
               A R    +V E +  G L    F   RIQ         R+  +I+  I   ++YLH
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL----F--SRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 621 DYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
                 I H D+KP+N+L      +  +K+ DFG                       A E
Sbjct: 135 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AKE 169

Query: 678 LTRGNSITAKIDIYSFGVVILEII-CG 703
            T         D++S G VI+ I+ CG
Sbjct: 170 TTGEKY-DKSCDMWSLG-VIMYILLCG 194

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 74.6 bits (183), Expect = 3e-14
 Identities = 50/191 (26%), Positives = 68/191 (35%), Gaps = 57/191 (29%)

Query: 577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN 636
           +V+E + +  L KWI  K   Q L     KKII Q+ +GL+YLH  C   IIH DIKP+N
Sbjct: 122 MVFEVLGH-HLLKWI-IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPEN 177

Query: 637 ILL-------------------------------------------------DRDLNVKI 647
           ILL                                                    L VKI
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 648 ADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSS 707
           AD G A  + +  +        T  Y + E+  G+      DI+S   +  E+  G    
Sbjct: 238 ADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

Query: 708 NPKGGDYLVDT 718
            P  G+     
Sbjct: 294 EPHSGEEYTRD 304

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 41/213 (19%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNI------HHF 560
           +G+G  G V +         VA+K +     R +K F      E+  + ++      +  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYL 619
           N++ ++     R++  + +E +   S++ +   K  + Q  S  + +K    I + L+ L
Sbjct: 160 NVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 620 HDYCNPKIIHFDIKPQNILL--DRDLNVKIADFGLARLIAQD-----QS-HVSTMPKGTP 671
           H     +IIH D+KP+NILL       +K+ DFG +    Q      QS           
Sbjct: 217 HKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--------- 264

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
            Y APE+  G      ID++S G ++ E++ G 
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNI------HHF 560
           +G+G  G V +     +   VA+K +     + KK F      EV  +  +        +
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYL 619
            +V L  +   R++  LV+E +   S + +   ++   + +S ++ +K   Q+   L +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 620 HDYCNPKIIHFDIKPQNILL--DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
                  IIH D+KP+NILL   +   +KI DFG +    Q    +    + +  Y +PE
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQ-SRFYRSPE 228

Query: 678 LTRGNSITAKIDIYSFGVVILEIICGR 704
           +  G      ID++S G +++E+  G 
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.8 bits (162), Expect = 2e-11
 Identities = 66/453 (14%), Positives = 131/453 (28%), Gaps = 143/453 (31%)

Query: 413 EIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLS-----VSAFLLLVIGASIY 467
           +   +++  K I    +I  I +      +    LF  LLS     V  F+  V+  + Y
Sbjct: 34  DCKDVQDMPKSILSKEEIDHI-IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-Y 91

Query: 468 --LYKRWREGKR------------RDKSTDESSV----HVA-NHLVKFSSKAMKSATRDF 508
             L    +  +R            RD+  +++ V    +V+         +A+       
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151

Query: 509 QIRL-GRGGSG-SVF--EGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
            + + G  GSG +    +  L+      V+                      I   N   
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYK----VQCKMD----------------FKIFWLN--- 188

Query: 565 LVGYCAERSNRF-----LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS---RGL 616
            +  C            L+Y+   N +         +++  S     + + +       L
Sbjct: 189 -LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247

Query: 617 EYLHDYCNPKII-HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
             L +  N K    F++  + +L  R   V   DF    L A   +H+S +   +     
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQV--TDF----LSAATTTHIS-LDHHSMTLTP 300

Query: 676 PELTRGNSITAKIDIYSFGVVILEIICGR-----RSSNPKGGDYLVDTLKVKAEADRLCD 730
            E+    S+  K          L+           ++NP                 R   
Sbjct: 301 DEVK---SLLLK---------YLDCRPQDLPREVLTTNP-----------------RRLS 331

Query: 731 LVDKKSEDMQSHRD-------DAV-KMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
           ++ +   D  +  D       D +  +I+ +++ L+   +R+                  
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM----------------- 374

Query: 783 VTDYGFLSFAVVEATTQEVVPIRSSPITAATLS 815
                F   +V            S+ I    LS
Sbjct: 375 -----FDRLSVFPP---------SAHIPTILLS 393

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 5e-05
 Identities = 76/478 (15%), Positives = 141/478 (29%), Gaps = 152/478 (31%)

Query: 58  KGTSKSY------------PKFGFG-F---LRNGTTDE--IFYLVT--VRFMGTITSSSN 97
            G+ K++             K  F  F   L+N  + E  +  L     +     TS S+
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 98  HQNHPPVILWFANG------QSPVKENATLEFTADGDLILKDVDGTRVW----------- 140
           H ++  + +           +S   EN  L       L+L +V   + W           
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENC-L-------LVLLNVQNAKAWNAFNLSCKILL 270

Query: 141 -------STETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVH--- 190
                  +   S +  T I+LD + ++ L   E +   + +L      LP + L  +   
Sbjct: 271 TTRFKQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329

Query: 191 -KMMASTNSTTSLSQG----KFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVL 245
             ++A      S+  G         ++   +   +  S +   +   YR  F  +S    
Sbjct: 330 LSIIA-----ESIRDGLATWDNWKHVNCDKLTTIIESS-LNVLEPAEYRKMFDRLS---- 379

Query: 246 NKSAILVFNKSGSHITYDVAPR--------------SKFHYMRL-EPNGHLNIYQLDNGY 290
                 VF  S +HI   +                 +K H   L E     +   + + Y
Sbjct: 380 ------VFPPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 291 -------SDNADLSRD--EHYGDCIYPTKCGNYGVCSNGECTCPGSSSYFKQSNDSENGF 341
                   +   L R   +HY       K       S+     P    YF     S  G 
Sbjct: 433 LELKVKLENEYALHRSIVDHYN----IPKT----FDSDD-LIPPYLDQYFY----SHIGH 479

Query: 342 SCAEVTHLSCQFKHLQRFLKLENVTYFDFVPHLINIDAEGCQRACLGNCSCKAALFRYQG 401
                 HL    +H +R      V + DF    +                 +  + R+  
Sbjct: 480 ------HLK-NIEHPERMTLFRMV-FLDF--RFL-----------------EQKI-RHDS 511

Query: 402 SLSTGNCSLPTEIYTLRNSTKVISGYNDITFIKVQLPSDQNKLSLLFMLLLSVSAFLL 459
           +    + S+   +  L+        Y    +I    P  +  ++ +   L  +   L+
Sbjct: 512 TAWNASGSILNTLQQLKF-------YKP--YICDNDPKYERLVNAILDFLPKIEENLI 560

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 54.9 bits (132), Expect = 2e-09
 Identities = 13/62 (20%), Positives = 30/62 (48%), Gaps = 1/62 (1%)

Query: 105 ILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLY 163
            +W +N     K+       +DG+ ++ D +G  +W++ +   N    + L  +GN+ +Y
Sbjct: 39  SVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY 98

Query: 164 DA 165
            +
Sbjct: 99  GS 100

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 53.7 bits (129), Expect = 5e-09
 Identities = 23/69 (33%), Positives = 30/69 (43%), Gaps = 3/69 (4%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETS--GSNVTRITLDGNGNLRLYD 164
               GQS   E        D +L+L D   T VW++ T   G    +  L  +GN  +YD
Sbjct: 9   GLYAGQSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYD 67

Query: 165 AENRPHWIS 173
           AE R  W S
Sbjct: 68  AEGRSLWAS 76

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 41/267 (15%), Positives = 90/267 (33%), Gaps = 45/267 (16%)

Query: 511 RLGRGGSGSVFEGL---------LNDGTKVAVK------------RLYPGENRGKKEFLS 549
              R   G ++E                K ++K              +  +   K   ++
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFF--QRAAKPLQVN 106

Query: 550 EVETIGNIHHFNLVRLVGY-CAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRKK 607
           + + + +     +   +G+   +   RFLV   +  G SL            LS     +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQ 163

Query: 608 IIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI--ADFGLARLIAQDQSHV-- 663
           +  ++   LE+LH+      +H ++  +NI +D +   ++  A +G A        HV  
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220

Query: 664 ----STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR------RSSNPKGGD 713
                +  +G   +++ +L +G   + + D+ S G  +L+ + G         +      
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK 280

Query: 714 YLVDTLKVKAEADRLCDLVDKKSEDMQ 740
                +         C    + SE +Q
Sbjct: 281 QKQKFVDKPGPFVGPCGHWIRPSETLQ 307

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 2e-09
 Identities = 32/204 (15%), Positives = 57/204 (27%), Gaps = 54/204 (26%)

Query: 498 SKAMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGK--------KEFLS 549
           S  + +       ++G G  G VF+ +  D T VA+K +                +E L 
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 550 EVE---------TIGNIHHFNLVRLVGYC------------------------------A 570
           E+                    + L                                   
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHF 630
           +    F+V E    G +D     + R +  S    K I+ Q++  L         +  H 
Sbjct: 133 KDDQLFIVLE-FEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186

Query: 631 DIKPQNILLDRDLNVKIADFGLAR 654
           D+   N+LL +    K+      +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 57.6 bits (138), Expect = 2e-09
 Identities = 37/203 (18%), Positives = 73/203 (35%), Gaps = 17/203 (8%)

Query: 95  SSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITL 154
             +H+   P  L     QS    +      +D +L+L D    RVW++ T+G+   R  L
Sbjct: 6   GLSHEGSHPQTLH--AAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVL 62

Query: 155 DGNGNLRLYDAENRPHWISFLHPTN-----TWLPGQRLHVHKMMASTNSTTSLSQGKFIL 209
             +G L +  A+N   W S    +         P + + ++      + T++        
Sbjct: 63  QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVAN 122

Query: 210 SLSPKGIEVFLNMSTVKRF---QTIPYRNYFLNMSSAVLNKSAILVFNKSGSHITY-DVA 265
           + +        N +  +     Q++    Y L+M +        LV       +   + A
Sbjct: 123 NGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMET-----DCNLVLFDRDDRVWSTNTA 177

Query: 266 PRSKFHYMRLEPNGHLNIYQLDN 288
            +       L+PNG +++    N
Sbjct: 178 GKGTGCRAVLQPNGRMDVLTNQN 200

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 51.5 bits (122), Expect = 3e-07
 Identities = 22/84 (26%), Positives = 31/84 (36%), Gaps = 2/84 (2%)

Query: 97  NHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLD 155
           + Q +          QS       L    D +L+L D    RVWST T+G     R  L 
Sbjct: 130 STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVLQ 188

Query: 156 GNGNLRLYDAENRPHWISFLHPTN 179
            NG + +   +N   W S    + 
Sbjct: 189 PNGRMDVLTNQNIAVWTSGNSRSA 212

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 48.4 bits (114), Expect = 3e-06
 Identities = 10/68 (14%), Positives = 21/68 (30%), Gaps = 4/68 (5%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDA 165
            ++   +            +G + +       VW++  S S       L  + NL +Y  
Sbjct: 171 VWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIY-- 228

Query: 166 ENRPHWIS 173
                W +
Sbjct: 229 -GGALWTT 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 44/226 (19%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAV--------------------KRLYPGENRGKKEFLS 549
           ++G GG G ++     N   K A                     +R+   +   K     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 550 EVETIG--NIHHFNLVRLVGYCAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRK 606
           +++ +G    +   L         RS RF+V E +  G  L K I  ++   T       
Sbjct: 104 QLDYLGIPLFYGSGLTE----FKGRSYRFMVMERL--GIDLQK-ISGQNG--TFKKSTVL 154

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLN-VKIADFGLARLIAQDQSHVS 664
           ++  ++   LEY+H+      +H DIK  N+LL   + + V +AD+GL+     + +H  
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211

Query: 665 TMPK------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR 704
                     GT  + + +  +G +++ + D+   G  +L  +CG+
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 53.7 bits (129), Expect = 5e-09
 Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 9/68 (13%)

Query: 118 NATLEFTADGDLILKDVDGTRVWSTETSGSNVT-RITLDGNGNLRLYDAENRPHWISFLH 176
           +  L  T  G+L++K+ DG+ VW +            +  +G L ++           + 
Sbjct: 50  DCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVF 101

Query: 177 PTNTWLPG 184
             + W+ G
Sbjct: 102 KIDPWVRG 109

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 46/271 (16%), Positives = 94/271 (34%), Gaps = 53/271 (19%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLY-----PGENR------------GKKEFLSEVET 553
            +G+GG G ++   +N    V           P +N              K E + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 554 IGNIHHFNLVRLVGY----CAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRKKI 608
              + +  + +  G        +S RF++ +    G  L K      +    S    +K 
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK--RFS----RKT 153

Query: 609 IFQ-----ISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLN-VKIADFGLARLIAQDQS 661
           + Q     +   LEY+H++     +H DIK  N+LL+ ++ + V + D+GLA     +  
Sbjct: 154 VLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 662 HVSTMPK------GTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR------RSSNP 709
           H +          GT  + + +   G + + + D+   G  +++ + G            
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269

Query: 710 KGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
              D  +   +  A     C        ++ 
Sbjct: 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIA 300

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 56.2 bits (134), Expect = 1e-08
 Identities = 32/181 (17%), Positives = 55/181 (30%), Gaps = 13/181 (7%)

Query: 18  ATNATQSTAHNNTSWQNNQGSAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTT 77
            +        N+T   N+Q +        DG+ V    +             G + +   
Sbjct: 90  YSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLL 149

Query: 78  DEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSP------VKENATLEFTADGDLIL 131
                LV     G   S    Q    ++ +  NG +        K      F  DG+L++
Sbjct: 150 APGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVV 209

Query: 132 KDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHK 191
                  +W + T G     + L  NG++ + D   +P W  F      + P  R     
Sbjct: 210 YGAGNAVLWHSHTGGHASAVLRLQANGSIAILD--EKPVWARF-----GFQPTYRHIRKI 262

Query: 192 M 192
            
Sbjct: 263 N 263

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 8/82 (9%)

Query: 100 NHPPV--ILW----FANGQSPVKENATLEFTADGDLILKDVD-GTRVWSTETSGSNV-TR 151
           N P V  +L+      +       + +L    D +L+L        VW + TSG      
Sbjct: 1   NIPRVRNVLFSSQVMYDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCF 60

Query: 152 ITLDGNGNLRLYDAENRPHWIS 173
           + L  +G L + D      ++S
Sbjct: 61  MRLGHSGELDITDDRLNTVFVS 82

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 2/67 (2%)

Query: 99  QNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVT-RITLDGN 157
           +     I+W  +G S   ++  +     G+L + D     V+ + T G      + L  N
Sbjct: 40  KGSKTNIVW-ESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQIN 98

Query: 158 GNLRLYD 164
           G   +Y 
Sbjct: 99  GQAVVYG 105

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 52.1 bits (125), Expect = 2e-08
 Identities = 23/67 (34%), Positives = 31/67 (46%), Gaps = 2/67 (2%)

Query: 108 FANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDAE 166
           F      V  +  L    D + +L D  G  VW++ T G     R+TL  NGNL +YD  
Sbjct: 11  FTGHSLEVGPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS 69

Query: 167 NRPHWIS 173
           NR  W +
Sbjct: 70  NRVIWQT 76

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 11/49 (22%), Positives = 22/49 (44%), Gaps = 1/49 (2%)

Query: 118 NATLEFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYDA 165
              L    +G+L++ D     +W T+T+G      + L  + N+ +Y  
Sbjct: 52  GCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP 100

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 52.2 bits (125), Expect = 2e-08
 Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 5/91 (5%)

Query: 82  YLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWS 141
            L        +    N   +     W +N     + +  L     G+LI+KD D   +WS
Sbjct: 20  RLTAKNHQLVMQGDCNLVLYGGKYGWQSNTHGNGE-HCFLRLNHKGELIIKDDDFKTIWS 78

Query: 142 TETSGSNVT-RITLDGNGNLRLYDAENRPHW 171
           + +S       + L  +G   +Y       +
Sbjct: 79  SRSSSKQGEYVLILQDDGFGVIYG---PAIF 106

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 51.4 bits (123), Expect = 3e-08
 Identities = 14/64 (21%), Positives = 24/64 (37%), Gaps = 3/64 (4%)

Query: 111 GQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDAENRP 169
                 +N  L    D +L+L        W + T G+     + L+  G L + D + + 
Sbjct: 18  DGRLTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKT 75

Query: 170 HWIS 173
            W S
Sbjct: 76  IWSS 79

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 44/223 (19%), Positives = 87/223 (39%), Gaps = 45/223 (20%)

Query: 512 LGRGGSGSVFEG--LLNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNIHH------ 559
           LG G  G V E        ++VA+K +     R   ++      E+  +  I        
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKENK 81

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           F  V +  +     +  + +E +   +  +++  ++  Q       + + +Q+   L +L
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFL-KENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 620 HDYCNPKIIHFDIKPQNILL-------------------DRDLNVKIADFGLARLIAQDQ 660
           H+    ++ H D+KP+NIL                     ++ ++++ADFG A     D 
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDH 193

Query: 661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            H +T+   T  Y  PE+          D++S G ++ E   G
Sbjct: 194 EHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 51.8 bits (124), Expect = 2e-08
 Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 4/85 (4%)

Query: 92  ITSSSNHQNHPPVILWFANGQSPVKENA--TLEFTADGDLILKDVDGTRVWSTETSGSNV 149
           I  S    ++ P IL        +            D +L+L D +   +W+T T G   
Sbjct: 3   IIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGLGN 61

Query: 150 -TRITLDGNGNLRLYDAENRPHWIS 173
             R  L  +G L +   EN   W S
Sbjct: 62  GCRAVLQPDGVLVVITNENVTVWQS 86

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 48.0 bits (114), Expect = 7e-07
 Identities = 12/70 (17%), Positives = 24/70 (34%), Gaps = 5/70 (7%)

Query: 105 ILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLY 163
            +W A     +          DG L++   +   VW +  +G      + L  + N+ +Y
Sbjct: 50  PIW-ATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108

Query: 164 DAENRPHWIS 173
                  W +
Sbjct: 109 ---GDALWAT 115

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 55/230 (23%)

Query: 512 LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNI-----HHFN 561
           +G G  G V     +++    AVK +     R  K++      E + +  I     ++ N
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNNN 97

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V+  G      +  L++E     SL + I  ++       +  K    +I + L YL  
Sbjct: 98  IVKYHGKFMYYDHMCLIFE-PLGPSLYEII-TRNNYNGFHIEDIKLYCIEILKALNYLRK 155

Query: 622 YCNPKIIHFDIKPQNILL-------------------------DRDLNVKIADFGLARLI 656
                + H D+KP+NILL                          +   +K+ DFG A   
Sbjct: 156 M---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--T 210

Query: 657 AQDQSH---VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
            +   H   ++T       Y APE+          D++SFG V+ E+  G
Sbjct: 211 FKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 49.9 bits (119), Expect = 1e-07
 Identities = 16/74 (21%), Positives = 33/74 (44%), Gaps = 2/74 (2%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDA 165
            +A+G +       L+   DG+L++       +W++ T+  N    + L  + N+ +YD 
Sbjct: 40  VWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN 98

Query: 166 ENRPHWISFLHPTN 179
            N   W +  +  N
Sbjct: 99  SNNAIWATHTNVGN 112

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 44.1 bits (104), Expect = 1e-05
 Identities = 18/74 (24%), Positives = 31/74 (41%), Gaps = 3/74 (4%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDA 165
               G S  +         D +L+L D +   VW++ T+G      + +  +GNL +Y  
Sbjct: 9   QLDTGGSLAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG 67

Query: 166 ENRPHWISFLHPTN 179
            +R  W S  +  N
Sbjct: 68  -SRAIWASNTNRQN 80

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 47/224 (20%)

Query: 512 LGRGGSGSVFEG--LLNDGTKVAVKRLYPGENRGKKEF----LSEVETIGNI------HH 559
           LG G  G V E       G  VAVK +     +    +     SE++ + ++        
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
           F  V+++ +     +  +V+E +   S   +I  ++       D  +K+ +QI + + +L
Sbjct: 77  FRCVQMLEWFEHHGHICIVFE-LLGLSTYDFI-KENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 620 HDYCNPKIIHFDIKPQNILLD-------------------RDLNVKIADFGLARLIAQDQ 660
           H     K+ H D+KP+NIL                      + ++K+ DFG A    +  
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191

Query: 661 S-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICG 703
           S  VST       Y APE+      +   D++S G +++E   G
Sbjct: 192 STLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 35/242 (14%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVE-----TIGNIHHFNLVR 564
           ++G G  G ++ G  +  G +VA+K     E    K     +E      +          
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIYKMMQGGVGI--PT 69

Query: 565 LVGYCAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +    AE     +V E +  G SL+       R  +L   +   +  Q+   +EY+H   
Sbjct: 70  IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIHSKN 125

Query: 624 NPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQSHVSTMPK------GTPGYM 674
               IH D+KP N L+        V I DFGLA+     ++H     +      GT  Y 
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR------RSSNPKGGDYLVDTLKVKAEADRL 728
           +     G   + + D+ S G V++    G       +++  +     +   K+    + L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242

Query: 729 CD 730
           C 
Sbjct: 243 CK 244

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 25/156 (16%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVE-----TIGNIHHFNLVR 564
           ++G G  G +  G  L     VA+K     E    +     +E      +G+       +
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGI--PQ 69

Query: 565 LVGYCAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +  +        +V E +  G SL+      DR  +L   +   I  Q+   +EY+H   
Sbjct: 70  VYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLM--IAIQLISRMEYVHSKN 125

Query: 624 NPKIIHFDIKPQNILLDRDLN-----VKIADFGLAR 654
              +I+ D+KP+N L+ R  N     + I DF LA+
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 47.6 bits (113), Expect = 7e-07
 Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 2/74 (2%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVT-RITLDGNGNLRLYDA 165
                 S      TL      +L+    +G ++W++ T       R+TL  +GNL +YD 
Sbjct: 10  TLHADHSLQAGAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH 68

Query: 166 ENRPHWISFLHPTN 179
            N   W S     N
Sbjct: 69  NNNDVWGSACWGDN 82

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 43.0 bits (101), Expect = 4e-05
 Identities = 12/48 (25%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 118 NATLEFTADGDLILKDVDGTRVWSTETSGSNVT-RITLDGNGNLRLYD 164
              L   +DG+L++ D +   VW +   G N    + L  +G   +Y 
Sbjct: 52  GCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG 99

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 52/241 (21%), Positives = 89/241 (36%), Gaps = 35/241 (14%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE--FLSEVE---TIGNIHHFNLVR 564
           ++G G  G ++ G  +    +VA+K     EN   K    L E +    +          
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKIYRILQGGTGI--PN 67

Query: 565 LVGYCAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +  +  E     LV + +  G SL+       R  +L   +   +  Q+   +E++H   
Sbjct: 68  VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQMINRVEFVHSKS 123

Query: 624 NPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQSHVSTMPK------GTPGYM 674
               +H DIKP N L+        V I DFGLA+      +H     +      GT  Y 
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR------RSSNPKGGDYLVDTLKVKAEADRL 728
           +     G   + + D+ S G V++  + G       ++   K     +   KV    + L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240

Query: 729 C 729
           C
Sbjct: 241 C 241

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 46.0 bits (109), Expect = 2e-06
 Identities = 17/64 (26%), Positives = 28/64 (43%), Gaps = 2/64 (3%)

Query: 111 GQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDAENRP 169
           G+             D +L+L D     +W+T T G +    +++  +GNL +Y   N P
Sbjct: 13  GEFLNNGRYVFIMQEDCNLVLYD-VDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNP 71

Query: 170 HWIS 173
            W S
Sbjct: 72  IWAS 75

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 44.9 bits (106), Expect = 6e-06
 Identities = 12/57 (21%), Positives = 23/57 (40%), Gaps = 4/57 (7%)

Query: 118 NATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDAENRPHWIS 173
              L   +DG+L++       +W++ T G N      L  + N+ +Y       W +
Sbjct: 51  RCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY---GTARWAT 104

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 48/243 (19%), Positives = 90/243 (37%), Gaps = 37/243 (15%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVE-----TIGNIHHFNLVR 564
           R+G G  G +FEG  L +  +VA+K     E R         E      +          
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRTYKLLAGCTGI--PN 70

Query: 565 LVGYCAERSNRFLVYEYMCNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +  +  E  +  LV + +  G SL+  +    R  ++          Q+   ++ +H+  
Sbjct: 71  VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS 126

Query: 624 NPKIIHFDIKPQNILLDRDLN-----VKIADFGLARLI--AQDQSHVSTMPK----GTPG 672
              +++ DIKP N L+ R  +     + + DFG+ +       + H+    K    GT  
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 673 YMAPELTRGNSITAKIDIYSFGVVILEIICGR------RSSNPKGGDYLVDTLKVKAEAD 726
           YM+     G   + + D+ + G V +  + G       +++  K     +   K      
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 727 RLC 729
            LC
Sbjct: 244 ELC 246

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111

 Score = 45.9 bits (109), Expect = 3e-06
 Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 111 GQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGNLRLYDAE-NR 168
                 E+A      D +L+L   +    + + T G  V   + L+  G L ++ A  N 
Sbjct: 14  DNQLSYESAAFVMQGDCNLVL--YNEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNT 71

Query: 169 PHWIS 173
           P W+ 
Sbjct: 72  PVWVY 76

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	818
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.71
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.69
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.68
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.66
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.63
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.55
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.54
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.53
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.5
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.45
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.4
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.38
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.33
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.22
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.09
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.06
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.03
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	98.98
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.98
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	98.97
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	98.92
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.85
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.8
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.73
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.05
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.04
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.0
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.97
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.66
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.61
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.45
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.33
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.22
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.8
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.72
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.69
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.67
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.49
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.48
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.91
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.86
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.66
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.87
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.48
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	85.5
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	84.82

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.5e-52  Score=444.53  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=217.7

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeeccc
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER  572 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~  572 (818)
                      ++..++..|.++||+|+||+||+|.+.      +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            344456677889999999999999973      46789999997543 34467899999999999999999999999999


Q ss_pred             CcceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE
Q 043017          573 SNRFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL  639 (818)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll  639 (818)
                      +..+||||||++|+|.++|.....             ...++|..+.+|+.|||+||+|||+.   +||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            999999999999999999965321             24589999999999999999999997   99999999999999


Q ss_pred             cCCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHH
Q 043017          640 DRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVD  717 (818)
Q Consensus       640 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~  717 (818)
                      ++++++||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||.......+..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332 23344679999999999999999999999999999999999 899998766544443


Q ss_pred             HHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+.   ...        .   .+.+..++.++.+|+.+||+.||++||||+||+++|+....
T Consensus       259 ~i~---~~~--------~---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          259 MIR---NRQ--------V---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             HHH---TTC--------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             HHH---cCC--------C---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            332   111        0   11123455678899999999999999999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=443.56  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             HhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.++||+|+||.||+|++.      +++.||||++........++|++|+++|++++|||||+++|+|.+.+..+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34568999999999999864      478899999987766667899999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCC------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEe
Q 043017          581 YMCNGSLDKWIFHKDR------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIA  648 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  648 (818)
                      ||++|+|.++|.....            ...++|.++..|+.|||+||+|||+.   +||||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence            9999999999965321            24689999999999999999999997   99999999999999999999999


Q ss_pred             ecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhh
Q 043017          649 DFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       649 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      |||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.......+...+..   ..
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~---g~  277 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ---GR  277 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH---TC
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CC
Confidence            9999997654432 22334579999999999999999999999999999999999 8999987655444333321   11


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      +        +   +.+...+.++.+|+.+||+.||++||||+||+++|+.+.+.++
T Consensus       278 ~--------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          278 E--------L---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             C--------C---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             C--------C---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            0        1   1122345678899999999999999999999999999877643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-52  Score=442.78  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=215.7

Q ss_pred             HHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|||
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~   94 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   94 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            345678999999999999864      47789999998776666789999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcC----------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          580 EYMCNGSLDKWIFHKD----------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                      |||++|+|.++|....          ....++|.++..|+.|||+||+|||+.   +||||||||+||||++++.+||+|
T Consensus        95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence            9999999999996532          234699999999999999999999997   999999999999999999999999


Q ss_pred             cCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++......... .....||+.|||||++.+..++.++|||||||+||||+| |+.||.......+...+..   ...
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~---~~~  248 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---GRV  248 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH---TCC
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CCC
Confidence            99998765443322 233468999999999999999999999999999999999 8999987665444433321   110


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                              +   +.+...+.++.+|+.+||+.||++||||+||++.|+.+.+..
T Consensus       249 --------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          249 --------L---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             --------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             --------C---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                    1   112234567889999999999999999999999999886643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-50  Score=428.00  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=202.5

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.++||+|+||+||+|++.+  .||||+++...  .+..++|.+|++++++++|||||+++|++.+ +..+||||||++
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g  115 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG  115 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred             EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence            456789999999999999863  69999986443  3345789999999999999999999999865 568999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC-Ccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-SHV  663 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~  663 (818)
                      |+|.++|...+  ..+++..+..|+.|||+||+|||+.   +||||||||+||||++++++||+|||+|+...... ...
T Consensus       116 GsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          116 SSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             CBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             CCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            99999996432  4699999999999999999999997   99999999999999999999999999998765432 223


Q ss_pred             ccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          664 STMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .....||+.|||||++.+   +.++.++|||||||+||||+||+.||..............   ..    ...+...  .
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~---~~----~~~p~~~--~  261 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG---RG----YASPDLS--K  261 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---TT----CCCCCST--T
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh---cC----CCCCCcc--c
Confidence            344679999999999964   4689999999999999999999999986554332222111   10    0111111  1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .....+.++.+|+.+||+.||++||||.||+++|+.++.
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            123445678899999999999999999999999987754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-48  Score=420.52  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=209.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            344567999999999999975 6899999999766666677899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++.+    ..+++..+..|+.||+.||+|||+.   +||||||||+||||+.++++||+|||+++.+...... .
T Consensus       156 g~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~  227 (346)
T 4fih_A          156 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R  227 (346)
T ss_dssp             EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred             CcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence            999998854    3489999999999999999999997   9999999999999999999999999999987654332 3


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....||+.|||||++.+..++.++|||||||++|||++|+.||...........+..   .      ...   .......
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~------~~~---~~~~~~~  295 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---N------LPP---RLKNLHK  295 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---S------SCC---CCSCGGG
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---C------CCC---CCCcccc
Confidence            346799999999999999999999999999999999999999976554333332221   0      111   1111233


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.++.+|+.+||+.||++|||+.|++++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            45678899999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.4e-48  Score=416.70  Aligned_cols=265  Identities=25%  Similarity=0.299  Sum_probs=200.9

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC----cceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS----NRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~~  583 (818)
                      +.++||+|+||+||+|++. |+.||||++..... ....+..|+..+.+++|||||+++|+|.+.+    ..+||||||+
T Consensus         7 L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            4568999999999999985 89999999864321 1222344666677889999999999998764    4789999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc-----CCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY-----CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +|+|.++|..    ..++|+.+.+|+.|+++||+|||+.     ..++||||||||+||||+.++++||+|||+++....
T Consensus        85 ~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           85 HGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             TCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            9999999954    3589999999999999999999975     245899999999999999999999999999998765


Q ss_pred             CCCcc---ccCCCCCCcccccccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-----------hHHHH
Q 043017          659 DQSHV---STMPKGTPGYMAPELTRGN------SITAKIDIYSFGVVILEIICGRRSSNPKGGD-----------YLVDT  718 (818)
Q Consensus       659 ~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-----------~l~~~  718 (818)
                      .....   .....||+.|||||++.+.      .++.++|||||||+||||+||+.|+......           .....
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  240 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence            44322   2235799999999999764      3678999999999999999998776432211           11122


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      +......    ...++..+......+....+.+|+.+||+.||++||||.||++.|+++.+.+.
T Consensus       241 ~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          241 MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            2111111    11122222222234567789999999999999999999999999998876543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.6e-48  Score=414.97  Aligned_cols=251  Identities=26%  Similarity=0.262  Sum_probs=205.9

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      .+.++||+|+||.||+|+.. +|+.||||++.....     +.+|+.++++++|||||++++++.+++..+|||||+++|
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            34467999999999999975 589999999865432     246999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccCCCc--
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQDQSH--  662 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~--  662 (818)
                      +|.++|...   ..+++..+..|+.||+.||+|||+.   +||||||||+||||+.++ ++||+|||+|+.+......  
T Consensus       136 ~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          136 SLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             BHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            999999654   3599999999999999999999997   999999999999999987 6999999999987654321  


Q ss_pred             --cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          663 --VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       663 --~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||.......+...+....  ....          .
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~~----------~  277 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPIR----------E  277 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGGG----------G
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCch----------h
Confidence              1223579999999999999999999999999999999999999998766555544433211  0000          1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .+...+..+.+++.+||+.||.+|||+.|++++|......
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            1223456788999999999999999999999998776543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-48  Score=424.73  Aligned_cols=262  Identities=30%  Similarity=0.419  Sum_probs=212.3

Q ss_pred             HHHhhHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCc-ceeEEEeeeeccc
Q 043017          501 MKSATRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHH-FNLVRLVGYCAER  572 (818)
Q Consensus       501 l~~~t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~  572 (818)
                      +....+.+.++||+|+||.||+|.+..      ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            334455666789999999999998653      46899999976543 335679999999999955 9999999999764


Q ss_pred             -CcceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEE
Q 043017          573 -SNRFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNIL  638 (818)
Q Consensus       573 -~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIl  638 (818)
                       ...++|||||++|+|.++|.....             ...+++..+..|+.|||+||+|||+.   +||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence             568999999999999999965321             24589999999999999999999997   9999999999999


Q ss_pred             EcCCCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch-H
Q 043017          639 LDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY-L  715 (818)
Q Consensus       639 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~-l  715 (818)
                      +++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||....... +
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999999977654433 2334568999999999999999999999999999999998 899998765433 2


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ...+.   ...+        +   ..+...+.++.+++.+||+.||++||||.||+++|+.+.+
T Consensus       298 ~~~i~---~g~~--------~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          298 CRRLK---EGTR--------M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             HHHHH---HTCC--------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH---cCCC--------C---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            22221   1110        1   1122345678899999999999999999999999988754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-48  Score=422.16  Aligned_cols=249  Identities=24%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      |.+.++||+|+||+||+|+.. +|+.||||++....  ....+.|.+|++++++++|||||++++++.+++..+|||||+
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            455678999999999999975 68999999986543  234568999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.++|...+ ...+++..+..|+.||+.||+|||+.   +||||||||+||||+.++.+||+|||+++.+..... 
T Consensus       106 ~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  180 (350)
T 4b9d_A          106 EGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-  180 (350)
T ss_dssp             TTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred             CCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence            9999999996433 34578899999999999999999997   999999999999999999999999999987644221 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ......||+.|||||++.+..++.++|||||||+||||++|+.||.......+...+..   . .        .+  +..
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---~-~--------~~--~~~  246 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS---G-S--------FP--PVS  246 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---T-C--------CC--CCC
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---C-C--------CC--CCC
Confidence            12234699999999999999999999999999999999999999986654333332221   1 0        00  011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.++.+|+.+||+.||++|||+.|++++
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2344678899999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4e-47  Score=403.27  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=195.9

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecc----cCcceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~  579 (818)
                      .|.++||+|+||+||+|... +++.||||++...  .....+.|.+|++++++++|||||++++++..    +...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            35568999999999999975 5889999998643  23345679999999999999999999999865    34579999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  658 (818)
                      |||++|+|.++|...   ..+++..+..|+.||++||+|||+. .++||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999653   4689999999999999999999986 123999999999999974 78999999999986433


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .   ......||+.|||||++.+ .++.++|||||||+||||++|+.||.........  ........      .+    
T Consensus       185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~~i~~~~------~~----  248 (290)
T 3fpq_A          185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGV------KP----  248 (290)
T ss_dssp             T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTTTC------CC----
T ss_pred             C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HHHHHcCC------CC----
Confidence            2   2334579999999999875 6999999999999999999999999754432211  11111110      00    


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111223468899999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=421.97  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=209.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            445568999999999999975 5899999999776666678899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++..    ..+++..+..|+.||+.||+|||+.   +||||||||+||||+.++.+||+|||+|+.+...... .
T Consensus       233 G~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~  304 (423)
T 4fie_A          233 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R  304 (423)
T ss_dssp             EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred             CcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence            999999854    3489999999999999999999998   9999999999999999999999999999987654332 2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....||+.|||||++.+..++.++|||||||++|||++|+.||...........+..   .      ......   ....
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~------~~~~~~---~~~~  372 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---N------LPPRLK---NLHK  372 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---S------CCCCCS---CTTS
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---C------CCCCCc---cccc
Confidence            345799999999999999999999999999999999999999976554333333221   1      111111   1223


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.++.+|+.+||+.||++|||+.|++++
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            45678899999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-47  Score=406.87  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=208.1

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+++.++||+|+||+||+++.. +++.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..+||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            3566778999999999999975 6899999998643   23446789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.++|...   ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++++||+|||+|+.+....
T Consensus       113 y~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          113 YAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999654   3599999999999999999999997   99999999999999999999999999999876543


Q ss_pred             C-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          661 S-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       661 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      . .......||+.|||||++.+..++.++||||+||++|||++|+.||...+...+...+..   ..     +  ..   
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~-----~--~~---  253 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK---LE-----Y--DF---  253 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TC-----C--CC---
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CC-----C--CC---
Confidence            2 233456899999999999999999999999999999999999999986654444333321   10     0  01   


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                        +...+.++.+|+.+||+.||++|||+.|++.
T Consensus       254 --p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          254 --PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             --CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             --CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence              1223456789999999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-46  Score=393.62  Aligned_cols=245  Identities=25%  Similarity=0.384  Sum_probs=191.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .|.+.++||+|+||+||+|+.. +|+.||||++...   .....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4566678999999999999965 6899999998654   23345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+ +|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+|+......
T Consensus        94 y~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             CC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             CC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            98 78999998654   3599999999999999999999997   99999999999999999999999999998765432


Q ss_pred             CccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .  .....||+.|||||++.+..+ +.++||||+||++|||++|+.||.......+...+..   ..       ...   
T Consensus       167 ~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~---~~-------~~~---  231 (275)
T 3hyh_A          167 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN---GV-------YTL---  231 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TC-------CCC---
T ss_pred             c--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---CC-------CCC---
Confidence            2  234579999999999998876 5899999999999999999999976544333332221   10       001   


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        +...+.++.+++.+||+.||++|||+.|++++
T Consensus       232 --p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          232 --PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             --CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              12234577899999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-46  Score=401.53  Aligned_cols=246  Identities=23%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             hHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .|++.++||+|+||+||+|+..    .++.||||++....  ......+.+|++++++++|||||++++++.+++..++|
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4566778999999999999852    47899999986542  23345788999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.++|...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+|+....
T Consensus       105 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             ECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            9999999999999654   3599999999999999999999997   999999999999999999999999999987544


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .... .....||+.|||||++.+..++.++|||||||++|||++|+.||...+...+...+..   .         ..  
T Consensus       179 ~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---~---------~~--  243 (304)
T 3ubd_A          179 HEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK---A---------KL--  243 (304)
T ss_dssp             --CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C---------CC--
T ss_pred             CCcc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc---C---------CC--
Confidence            3322 2345799999999999999999999999999999999999999986654443333221   1         00  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCc-----HHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVK  772 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  772 (818)
                       ..+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             011223467889999999999999998     466665

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-45  Score=392.47  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=187.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccC----------
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERS----------  573 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----------  573 (818)
                      +++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            344568999999999999975 689999999865433 33567999999999999999999999987544          


Q ss_pred             --cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          574 --NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       574 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                        ..++||||+++|+|.+++..........+..+..|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence              3689999999999999997655545566677889999999999999997   99999999999999999999999999


Q ss_pred             CceecccCCCc-----------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHH
Q 043017          652 LARLIAQDQSH-----------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK  720 (818)
Q Consensus       652 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~  720 (818)
                      +|+.+......           ......||+.|||||++.+..++.++|||||||++|||++   ||....  .....+.
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~  238 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLT  238 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHH
Confidence            99987653321           1123469999999999999999999999999999999996   664211  1111111


Q ss_pred             HHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       721 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....         ...  .+........+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~---------~~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          239 DVRN---------LKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHT---------TCC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhc---------CCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1110         000  01122344566789999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=386.13  Aligned_cols=261  Identities=22%  Similarity=0.312  Sum_probs=201.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecc------cCcce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAE------RSNRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------~~~~~  576 (818)
                      |.+.++||+|+||.||+|+.. +|+.||||++.....  ...+.+++|+++|++++|||||++++++..      ....+
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            455678999999999999975 689999999965432  334678899999999999999999998754      35789


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ||||||+ |+|.+++..   ...+++..+..|+.||+.||+|||+.   +||||||||+|||++.++.+||+|||+++.+
T Consensus       136 ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            9999995 789998854   35699999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCC---CccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc----
Q 043017          657 AQDQ---SHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL----  728 (818)
Q Consensus       657 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~----  728 (818)
                      ....   ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+....+..+......+..    
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            5432   2223446899999999998775 5699999999999999999999999876554444433322111110    


Q ss_pred             -------hhhccccCcCccCc-----HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 -------CDLVDKKSEDMQSH-----RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 -------~~~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                             ...+.......+..     .....++.+|+.+||+.||++|||+.|++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                   00000000000000     1124577899999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.8e-42  Score=371.07  Aligned_cols=290  Identities=39%  Similarity=0.657  Sum_probs=237.0

Q ss_pred             ccccccCHHHHHHhhHHhh--hhcccccceeEEEeEecCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEee
Q 043017          491 NHLVKFSSKAMKSATRDFQ--IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVG  567 (818)
Q Consensus       491 ~~~~~~~~~~l~~~t~~f~--~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g  567 (818)
                      ..+..++..++...+.+|.  +.||+|+||.||+|...+++.||||++..... .....+.+|++++.+++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4466788888888877775  57999999999999988899999999975532 23447999999999999999999999


Q ss_pred             eecccCcceeeeeccCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEE
Q 043017          568 YCAERSNRFLVYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVK  646 (818)
Q Consensus       568 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k  646 (818)
                      ++......++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999996543 334589999999999999999999997666999999999999999999999


Q ss_pred             EeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-----CCCchHHHHHHH
Q 043017          647 IADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNP-----KGGDYLVDTLKV  721 (818)
Q Consensus       647 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~-----~~~~~l~~~~~~  721 (818)
                      |+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||..     .......+++..
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999999998766555555556799999999999888899999999999999999999999952     222333344333


Q ss_pred             HhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          722 KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       722 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      ......+....+..... .....+...+.+++.+||+.||.+|||+.||+++|++....+
T Consensus       255 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             TTSSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HhhchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            33333333333333322 235678899999999999999999999999999998765443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.3e-42  Score=376.26  Aligned_cols=258  Identities=21%  Similarity=0.344  Sum_probs=195.8

Q ss_pred             hHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .|.+.++||+|+||+||+|+.+    .++.||||++....  ...++.+|+++|..+ +|||||++++++.+.++.++||
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            3556678999999999999853    46889999986543  356788999999998 6999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  658 (818)
                      ||+++|+|.+++      +.+++.++..++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus       100 E~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          100 PYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             ECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             eCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999988      2488999999999999999999998   99999999999999877 7999999999986543


Q ss_pred             CCC---------------------------ccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 043017          659 DQS---------------------------HVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPK  710 (818)
Q Consensus       659 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~  710 (818)
                      ...                           .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            221                           112234699999999999775 4899999999999999999999999654


Q ss_pred             CCc-hHHHHHHHHhhhhc-------------------------chhhc---cccC-----------cCccCcHHHHHHHH
Q 043017          711 GGD-YLVDTLKVKAEADR-------------------------LCDLV---DKKS-----------EDMQSHRDDAVKMI  750 (818)
Q Consensus       711 ~~~-~l~~~~~~~~~~~~-------------------------~~~~~---d~~~-----------~~~~~~~~~~~~l~  750 (818)
                      .++ ..+..+......+.                         ..+.+   +...           .........+.++.
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            432 11111111000000                         00000   0000           00000112335678


Q ss_pred             HHHHHccccCCCCCCcHHHHHHH
Q 043017          751 QIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       751 ~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +|+.+||+.||++|||++|++++
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHCcCChhHCcCHHHHhcC
Confidence            99999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.5e-42  Score=397.15  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=208.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      |++.++||+|+||.||+++.. +|+.||||.+........+.+.+|+++|+.++|||||++++++.+....+||||||++
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            556678999999999999975 5899999999766655677899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC--CCEEEeecCCceecccCCCc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD--LNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~~~  662 (818)
                      |+|.++|...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.+  +.+||+|||+++.+..... 
T Consensus       239 g~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~-  312 (573)
T 3uto_A          239 GELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-  312 (573)
T ss_dssp             CBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence            9999998532  34699999999999999999999998   99999999999999854  8999999999998755432 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....||+.|||||++.+..++.++||||+||++|||++|+.||...........+..   ..     .  ... ....
T Consensus       313 -~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~---~~-----~--~~~-~~~~  380 (573)
T 3uto_A          313 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS---CD-----W--NMD-DSAF  380 (573)
T ss_dssp             -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT---TC-----C--CCC-SGGG
T ss_pred             -eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh---CC-----C--CCC-cccc
Confidence             2334699999999999999999999999999999999999999986654433333221   10     0  000 0011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.++.+|+.+||+.||++|||+.|++++
T Consensus       381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          381 SGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2334677899999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.8e-41  Score=363.29  Aligned_cols=269  Identities=36%  Similarity=0.604  Sum_probs=222.7

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      +.+.||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            34579999999999999988999999999877666778899999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCC-ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-cccc
Q 043017          588 DKWIFHKDR-IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVST  665 (818)
Q Consensus       588 ~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~  665 (818)
                      .+++..... ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus       123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  199 (321)
T 2qkw_B          123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST  199 (321)
T ss_dssp             GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred             HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence            999865432 23589999999999999999999997   999999999999999999999999999987553322 2223


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch---HHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY---LVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~---l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   ...+.........+...+++.... ...
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  278 (321)
T 2qkw_B          200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIR  278 (321)
T ss_dssp             CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CSC
T ss_pred             ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-ccC
Confidence            3458999999999988899999999999999999999999997654332   222222222233333444433322 235


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ......+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus       279 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            67888999999999999999999999999999988654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.9e-41  Score=388.60  Aligned_cols=247  Identities=22%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHH---HHHHhccCcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSE---VETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E---v~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +++.++||+|+||.||+++.. +|+.||||++.+.   .......+.+|   +.++..++|||||++++++.+.+..+||
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            445568999999999999976 5899999998543   12223334444   6677788999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.++|...   ..+++..+..++.||+.||+|||+.   +||||||||+||||+.+|++||+|||+|+.+..
T Consensus       271 mEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             ECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999654   3599999999999999999999997   999999999999999999999999999997754


Q ss_pred             CCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..   .....||+.|||||++.. ..++.++|||||||+||||++|+.||..................         .. 
T Consensus       345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------~~-  411 (689)
T 3v5w_A          345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------AV-  411 (689)
T ss_dssp             CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---------CC-
T ss_pred             CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---------CC-
Confidence            32   234579999999999965 57999999999999999999999999765433322222211111         01 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                        ..+...+.++.+|+.+||+.||.+|++     +.||+++
T Consensus       412 --~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          412 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence              012234567889999999999999998     6888764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.7e-41  Score=361.90  Aligned_cols=259  Identities=29%  Similarity=0.488  Sum_probs=204.1

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||+|+. +++.||||++.....  ...++|.+|++++++++||||+++++++......++||||+
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL  116 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred             HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence            444556899999999999987 488999999875532  33467899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC--eeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK--IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      ++++|.+++........+++..+..++.||++||+|||+.   +  |+||||||+|||++.++.+||+|||+++......
T Consensus       117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            9999999997654445699999999999999999999997   7  9999999999999999999999999998654332


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+....             ....
T Consensus       194 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------~~~~  259 (309)
T 3p86_A          194 L-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------------KRLE  259 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-------------CCCC
T ss_pred             c-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------CCCC
Confidence            1 2233568999999999999999999999999999999999999997655433322221110             0011


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      .+.....++.+++.+||+.+|++|||+.++++.|+.+.+..
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            12234467889999999999999999999999999987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-39  Score=351.96  Aligned_cols=281  Identities=37%  Similarity=0.587  Sum_probs=229.4

Q ss_pred             cccccCHHHHHHhhHHhhh--------hcccccceeEEEeEecCCcEEEEEEcCCCC----CccHHHHHHHHHHHhccCc
Q 043017          492 HLVKFSSKAMKSATRDFQI--------RLGRGGSGSVFEGLLNDGTKVAVKRLYPGE----NRGKKEFLSEVETIGNIHH  559 (818)
Q Consensus       492 ~~~~~~~~~l~~~t~~f~~--------~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l~H  559 (818)
                      ....|+++++..++.+|..        .||+|+||.||+|.. +++.||||++....    ....+.+.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            3567899999999999874        499999999999997 48899999986532    2335789999999999999


Q ss_pred             ceeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE
Q 043017          560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL  639 (818)
Q Consensus       560 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll  639 (818)
                      |||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+.   +|+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999997554456799999999999999999999997   99999999999999


Q ss_pred             cCCCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHH
Q 043017          640 DRDLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT  718 (818)
Q Consensus       640 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~  718 (818)
                      +.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999999876543322 2233568999999998875 588999999999999999999999986654333322


Q ss_pred             HHHH-hh-hhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          719 LKVK-AE-ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       719 ~~~~-~~-~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +... .. ...+.+.++.....  ........+.+++.+||+.+|.+|||+.+++++|+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2221 11 12233333333322  245677889999999999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-40  Score=348.28  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=213.6

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||++...++..||||++.... ...+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN   87 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             heeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence            445567899999999999999988899999997543 3457899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++...........
T Consensus        88 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           88 GCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             CBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             CcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            9999999653  24689999999999999999999997   999999999999999999999999999987765544444


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   ....        .   ..+.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~--------~---~~~~  228 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS---QGHR--------L---YRPH  228 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCC--------C---CCCT
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH---cCCC--------C---CCCC
Confidence            44557788999999998889999999999999999999 999997655433222221   1100        0   0011


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      .....+.+++.+||+.+|++|||+.++++.|+.+.+..
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            23457889999999999999999999999999997753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.6e-40  Score=363.81  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=212.1

Q ss_pred             hHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSN  574 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  574 (818)
                      .+.+.+.||+|+||.||+|...        ++..||||++..... ...+++.+|+++++++ +||||+++++++...+.
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  161 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  161 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence            3445678999999999999852        356799999975532 3456799999999999 89999999999999999


Q ss_pred             ceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      .++||||+++|+|.+++.....             ...+++..+..++.||++||+|||+.   +|+||||||+|||++.
T Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE  238 (370)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence            9999999999999999975431             23578999999999999999999997   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTL  719 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~  719 (818)
                      ++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......+...+
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~  318 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  318 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999999976544322 2233457889999999999999999999999999999999 99999876554444332


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ...   .        .   ...+.....++.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus       319 ~~~---~--------~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          319 KEG---H--------R---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HTT---C--------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcC---C--------C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            211   0        0   011223456788999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-39  Score=353.30  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=215.0

Q ss_pred             ccCHHHHHHhhHH------------hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce
Q 043017          495 KFSSKAMKSATRD------------FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN  561 (818)
Q Consensus       495 ~~~~~~l~~~t~~------------f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n  561 (818)
                      .+++++++.++..            +.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4677777777654            2247999999999999986 69999999998776677788999999999999999


Q ss_pred             eEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       562 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      |+++++++...+..++||||+++++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence            99999999999999999999999999998843    3589999999999999999999997   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV  721 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~  721 (818)
                      ++.+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~  255 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD  255 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            999999999999877554322 2335699999999999999999999999999999999999999975543322222211


Q ss_pred             HhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          722 KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       722 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                         .         ..............+.+++.+||+.||++|||+.|++++-
T Consensus       256 ---~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          256 ---S---------PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             ---S---------SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             ---C---------CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence               0         0111111223346788999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-40  Score=348.70  Aligned_cols=255  Identities=25%  Similarity=0.448  Sum_probs=212.2

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||++...+++.||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            344556899999999999999889999999997543 3457899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        90 ~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           90 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             CBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            9999999543  24689999999999999999999997   999999999999999999999999999987654333333


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+..   .      ...     ..+.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~---~------~~~-----~~~~  230 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---G------FRL-----YKPR  230 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---T------CCC-----CCCT
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc---C------ccC-----CCCC
Confidence            33457788999999998899999999999999999999 9999976554433332211   0      000     0122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .....+.+++.+||+.+|++||++.+++++|+++.+
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            234678899999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=359.26  Aligned_cols=260  Identities=28%  Similarity=0.462  Sum_probs=210.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+|...    .+..||||++... .....+.|.+|+.++++++||||+++++++.++...++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            34455578999999999999974    3556999999755 333456899999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999543  24689999999999999999999997   999999999999999999999999999998765


Q ss_pred             CCCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          659 DQSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       659 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .....  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+..   ..         
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~---------  271 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE---GY---------  271 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TC---------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---CC---------
Confidence            43222  222346778999999998899999999999999999999 9999976654433332221   10         


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                        ..+.+......+.+++..||+.||++|||+.++++.|+.+.+.+.
T Consensus       272 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          272 --RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             --CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence              001122345678899999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-39  Score=350.43  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            34456899999999999986 46899999998766666678899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......... .
T Consensus       102 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~  173 (297)
T 3fxz_A          102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  173 (297)
T ss_dssp             CBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred             CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-c
Confidence            9999998543    488999999999999999999997   9999999999999999999999999999877554332 2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..   ..         ......+..
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~---------~~~~~~~~~  241 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NG---------TPELQNPEK  241 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HC---------SCCCSCGGG
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CC---------CCCCCCccc
Confidence            335699999999999999999999999999999999999999975543222221111   00         011111233


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            45678899999999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=353.78  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=209.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||++... +++.||+|.+........+.|.+|++++++++||||+++++++.++...++||||+++
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   91 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG   91 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence            344568999999999999975 5899999998766666678899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc-
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV-  663 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  663 (818)
                      ++|.+++....  ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......... 
T Consensus        92 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           92 GTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             CBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            99999996532  4689999999999999999999997   99999999999999999999999999998765432211 


Q ss_pred             ------------ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          664 ------------STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       664 ------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                                  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............       .....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------~~~~~  239 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------NVRGF  239 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-------CHHHH
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-------hhhcc
Confidence                        11346999999999999999999999999999999999999988654321110000       00000


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .+...     +......+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       240 ~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          240 LDRYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHHTC-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00000     112234688999999999999999999999999988654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.4e-40  Score=374.82  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=212.2

Q ss_pred             hhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ..+.+.++||+|+||.||+|.+.+++.||||++.... ...++|++|++++++++||||+++++++. .+..++||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            3445567899999999999999989999999997543 45788999999999999999999999986 567899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +|+|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       266 ~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          266 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             TCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence            999999995432 23578889999999999999999997   99999999999999999999999999998765432222


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.......+...+..   ..        .   .+.+
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~--------~---~~~~  407 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GY--------R---MPRP  407 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH---TC--------C---CCCC
T ss_pred             cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC--------C---CCCC
Confidence            233456789999999998899999999999999999999 9999976654433333221   10        0   0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ...+.++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            23456788999999999999999999999999998654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-39  Score=375.43  Aligned_cols=257  Identities=28%  Similarity=0.405  Sum_probs=215.0

Q ss_pred             hHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.++||+|+||.||+|++.. ++.||||.+.... ...++|.+|++++++++||||++++++|......++||||++
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            44556789999999999999875 8899999997543 347889999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +|+|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       300 ~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          300 YGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             TCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence            999999996543 24588999999999999999999997   99999999999999999999999999999775543333


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.......+...+..   ..           ....+
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~-----------~~~~~  441 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DY-----------RMERP  441 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TC-----------CCCCC
T ss_pred             cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC-----------CCCCC
Confidence            333456789999999998899999999999999999999 9999987655444333221   00           01112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .....++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            23456788999999999999999999999999988654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-39  Score=346.70  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=209.4

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||++...+++.||||++.... ...+++.+|++++.+++|+||+++++++.+....++||||+++
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  103 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN  103 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence            444557899999999999999988999999997543 3457899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus       104 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A          104 GCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             CBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             CcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence            9999999542  24689999999999999999999997   999999999999999999999999999987654333333


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   ..      .....     +.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~------~~~~~-----~~  244 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QG------LRLYR-----PH  244 (283)
T ss_dssp             TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TT------CCCCC-----CT
T ss_pred             cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh---cc------cCCCC-----CC
Confidence            33457788999999998899999999999999999998 999997655433332221   11      00001     12


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .....+.+++.+||+.+|.+|||+.+++++|+.+.+.
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            2345788999999999999999999999999887643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-40  Score=364.53  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=199.1

Q ss_pred             hhHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+|+..    ++..||||++.... ....++|.+|++++++++||||+++++++.+....++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            34555678999999999999875    47789999997553 33456899999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999543  24689999999999999999999997   999999999999999999999999999987755


Q ss_pred             CCCcccc--CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          659 DQSHVST--MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       659 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .......  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+.   ....        
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~---~~~~--------  268 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---EGYR--------  268 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH---TTEE--------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCC--------
Confidence            4322211  1235678999999999999999999999999999998 999997655433322221   1100        


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .   +........+.+++.+||+.+|++||++.+|++.|+.+.+.
T Consensus       269 ~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             C---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            0   11223456788999999999999999999999999988653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.9e-40  Score=364.15  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=208.1

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||+|... +++.||||.+..... ...++|.+|++++++++||||+++++++...+..++||||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  194 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV  194 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence            3445578999999999999986 689999999875432 23457889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       195 ~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          195 QGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            999999999643  24588999999999999999999997   9999999999999999999999999999865432211


Q ss_pred             cc-cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          663 VS-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       663 ~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .. ....++..|+|||.+....++.++||||||+++|||++ |+.||...........+.   ...           ..+
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~-----------~~~  335 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---KGG-----------RLP  335 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH---TTC-----------CCC
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC-----------CCC
Confidence            11 11235678999999998899999999999999999998 999987655433222221   110           011


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            122344678899999999999999999999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.8e-39  Score=369.54  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.++||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~  262 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  262 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence            344567899999999999999988899999997544 346789999999999999999999999876 678999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       263 gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          263 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence            99999995421 23588999999999999999999997   999999999999999999999999999987654433333


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||...........+.   ...           ..+.+.
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~-----------~~~~~~  404 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGY-----------RMPCPP  404 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC-----------CCCCCT
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC-----------CCCCCC
Confidence            33457789999999998899999999999999999999 999997655433332221   110           011122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      ..+..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            34567889999999999999999999999999887553

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-39  Score=354.20  Aligned_cols=270  Identities=24%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCc----ceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN----RFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~----~~lV~e  580 (818)
                      .+.+.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.....    .++|||
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            3445568999999999999886 7999999986432 234456678999999999999999999987553    699999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc-------CCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY-------CNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      |+++|+|.+++..    ..+++..+..++.||++||+|||+.       .+++|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          103 FHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            9999999999954    3489999999999999999999974       1238999999999999999999999999999


Q ss_pred             eecccCCCc-cccCCCCCCcccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          654 RLIAQDQSH-VSTMPKGTPGYMAPELTRGN-----SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       654 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      +........ ......||+.|+|||.+.+.     .++.++|||||||++|||++|+.||..................+.
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            877654332 22335699999999999863     466789999999999999999999976533221111111000000


Q ss_pred             ---chh-----hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          728 ---LCD-----LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       728 ---~~~-----~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                         +..     ...+.............++.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               000     01111111112335667799999999999999999999999999988654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=360.68  Aligned_cols=269  Identities=29%  Similarity=0.411  Sum_probs=215.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS  573 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  573 (818)
                      ..+.+.++||+|+||.||+|...        .+..||||++..... ...+++.+|+++++++ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            34455678999999999999853        246799999975533 3347789999999999 9999999999999999


Q ss_pred             cceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                      ..++||||+++|+|.+++.....             ...+++..+..|+.||++||+|||+.   +|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence            99999999999999999965431             24589999999999999999999997   999999999999999


Q ss_pred             CCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHH
Q 043017          641 RDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDT  718 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~  718 (818)
                      .++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~  305 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  305 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999987654332 22233457889999999999999999999999999999999 9999876554333322


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCc
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFL  789 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~  789 (818)
                      +..   ...           ...+.....++.+++.+||+.+|++|||+.||++.|+.+.......+.+..
T Consensus       306 ~~~---~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  362 (382)
T 3tt0_A          306 LKE---GHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY  362 (382)
T ss_dssp             HHT---TCC-----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred             HHc---CCC-----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            221   100           001123346788999999999999999999999999999876655444443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=343.84  Aligned_cols=267  Identities=21%  Similarity=0.286  Sum_probs=210.8

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccC--cceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--NRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence            4455689999999999999764 8999999987543 344677889999999999999999999987655  67999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE----cCCCCEEEeecCCceecc
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIA  657 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla~~~~  657 (818)
                      +++++|.+++........+++..+..++.||++||+|||+.   +|+||||||+|||+    +.++.+||+|||+++...
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999997654444599999999999999999999998   99999999999999    788889999999998775


Q ss_pred             cCCCccccCCCCCCccccccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH-HHHHHHHhhhhc-
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTR--------GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL-VDTLKVKAEADR-  727 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l-~~~~~~~~~~~~-  727 (818)
                      .....  ....||+.|+|||++.        +..++.++|||||||++|||++|+.||........ ...+........ 
T Consensus       168 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          168 DDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             TTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             CCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            54332  2346899999999986        56789999999999999999999999976543222 222222211110 


Q ss_pred             --chhh-------c---cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          728 --LCDL-------V---DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       728 --~~~~-------~---d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                        ....       +   ................+.+++.+||+.||++|||+.|++++....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence              0000       0   001111123457778899999999999999999999999998744

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3e-39  Score=351.74  Aligned_cols=245  Identities=23%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|++++++++||||+++++++......++||||+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~   96 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA   96 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence            44556899999999999997 578999999986542  234567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        97 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           97 SGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             TTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            999999999654   3588999999999999999999997   999999999999999999999999999987654332 


Q ss_pred             cccCCCCCCcccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSIT-AKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       .....||+.|+|||.+.+..+. .++|||||||++|||++|+.||.......+...+..   .         ..   ..
T Consensus       170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~---------~~---~~  233 (328)
T 3fe3_A          170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR---G---------KY---RI  233 (328)
T ss_dssp             -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C---------CC---CC
T ss_pred             -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---C---------CC---CC
Confidence             2345799999999999888765 899999999999999999999986654333322211   0         00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +...+.++.+++.+||+.||.+|||+.|++++
T Consensus       234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11234567899999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-38  Score=347.60  Aligned_cols=270  Identities=18%  Similarity=0.186  Sum_probs=214.8

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||+|+. .+++.||||.+.....  .+.+.+|+++++++ +|+||+++++++..+...++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            34556899999999999996 5689999999864432  34688999999999 9999999999999999999999999 


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC-----EEEeecCCceeccc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN-----VKIADFGLARLIAQ  658 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfgla~~~~~  658 (818)
                      +++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.     +||+|||+++....
T Consensus        88 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           88 GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            99999998654  24699999999999999999999997   9999999999999998887     99999999997655


Q ss_pred             CCCcc------ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          659 DQSHV------STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       659 ~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      .....      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+.............  
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~--  240 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP--  240 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC--
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC--
Confidence            43221      2345699999999999999999999999999999999999999987665555444433322111000  


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchh
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSF  791 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~  791 (818)
                         ....  ....+ ++.+++..||+.+|.+||++.+|++.|+.+.+.........+++
T Consensus       241 ---~~~~--~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  293 (330)
T 2izr_A          241 ---IEVL--CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW  293 (330)
T ss_dssp             ---HHHH--TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred             ---HHHH--hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence               0000  00112 78899999999999999999999999998876544433333444

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-39  Score=357.75  Aligned_cols=282  Identities=19%  Similarity=0.230  Sum_probs=212.3

Q ss_pred             hHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCCCcc-----------HHHHHHHHHHHhccCcceeEEEee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGENRG-----------KKEFLSEVETIGNIHHFNLVRLVG  567 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~-----------~~~f~~Ev~~l~~l~H~niv~l~g  567 (818)
                      .+.+.+.||+|+||.||+|.+..      ++.||||++.......           ...+..|+..+..++|+||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            45566789999999999998764      4789999986543211           123445566777888999999999


Q ss_pred             eeccc----CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc--C
Q 043017          568 YCAER----SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD--R  641 (818)
Q Consensus       568 ~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~--~  641 (818)
                      ++...    ...++||||+ +++|.+++...  ...+++..+..|+.||+.||+|||+.   +|+||||||+|||++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence            98765    4579999999 99999998653  24699999999999999999999997   999999999999999  8


Q ss_pred             CCCEEEeecCCceecccCCCcc------ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH
Q 043017          642 DLNVKIADFGLARLIAQDQSHV------STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL  715 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l  715 (818)
                      ++.+||+|||+++.+.......      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998775432211      1223599999999999999999999999999999999999999985433322


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchhhhhh
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFAVVE  795 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~  795 (818)
                      ............+..+++..+..    ...+.++.+++..||+.+|++||++.+|++.|+.+.+.........+++...+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~  345 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE  345 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred             HHHHHHHHhhhhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence            22222222222233333322211    12346788999999999999999999999999998876666666666665444


Q ss_pred             c
Q 043017          796 A  796 (818)
Q Consensus       796 ~  796 (818)
                      .
T Consensus       346 ~  346 (364)
T 3op5_A          346 N  346 (364)
T ss_dssp             -
T ss_pred             C
Confidence            3

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.7e-39  Score=343.72  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++... +++.||+|.+.....   ...+.|.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            445578999999999999965 588999999854432   2346789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        93 ~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           93 IEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999654   3589999999999999999999997   999999999999999999999999999987655443


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .....  ........      ..
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~--~~~~~~~~------~~  236 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQ--DSVPNVTT------DV  236 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHS--SCCCCHHH------HS
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhh--ccCCCcch------hc
Confidence            3334456899999999999999999999999999999999999999765432211  11110  00000000      01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-cHHHHHHHHhcCcCCCC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-SASMLVKVLQGLTKLEP  782 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~~  782 (818)
                      ....+..+.+++.+||+.||.+|| ++.++.+.|+.+.....
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            122346788999999999999998 99999999998876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-38  Score=362.66  Aligned_cols=250  Identities=27%  Similarity=0.429  Sum_probs=206.9

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC-cceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS-NRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~  584 (818)
                      +.+.++||+|+||.||+|.+. ++.||||.++...  ..+.|.+|++++++++||||+++++++.+.. ..++||||+++
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            344568999999999999986 7899999997543  4678999999999999999999999987665 78999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++..... ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......    
T Consensus       272 g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----  343 (450)
T 1k9a_A          272 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  343 (450)
T ss_dssp             CBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence            999999975432 3478999999999999999999997   99999999999999999999999999998653321    


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+..   ..+           ...+.
T Consensus       344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~-----------~~~p~  409 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYK-----------MDAPD  409 (450)
T ss_dssp             ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT---TCC-----------CCCCT
T ss_pred             cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCC-----------CCCCC
Confidence            12357889999999999999999999999999999998 9999987665544433221   100           11122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ..+.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            3456788999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.6e-40  Score=350.93  Aligned_cols=270  Identities=26%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             hhHHhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccce
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRF  576 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~  576 (818)
                      ..+.+.++||+|+||.||++++     .+++.||||++........+.|.+|++++.+++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            3445667899999999999984     35889999999876666667899999999999999999999998653  4689


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999996542  4589999999999999999999997   9999999999999999999999999999877


Q ss_pred             ccCCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh----hhcchh
Q 043017          657 AQDQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE----ADRLCD  730 (818)
Q Consensus       657 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~----~~~~~~  730 (818)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........    ...+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-HHHHHCTTCCTHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-HHhhhcCccccchhHHHHHH
Confidence            544322  222345777899999999999999999999999999999999887532110 0000000000    000001


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .+... ...+.+...+.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       244 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          244 LLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11110 01111334457889999999999999999999999999987643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-38  Score=341.86  Aligned_cols=257  Identities=25%  Similarity=0.352  Sum_probs=199.9

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhc--cCcceeEEEeeeeccc----Ccceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGN--IHHFNLVRLVGYCAER----SNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~----~~~~lV~  579 (818)
                      +.+.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...++||
T Consensus        10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            44557899999999999998 5899999998543   34566677777666  7999999999986543    4578999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHH--------hcCCCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH--------DYCNPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      ||+++|+|.+++..    ..+++..+..++.||++||+|||        +.   +|+||||||+|||++.++.+||+|||
T Consensus        86 e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           86 HYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             CCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             hhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence            99999999999932    46899999999999999999999        65   99999999999999999999999999


Q ss_pred             CceecccCCCcc---ccCCCCCCcccccccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 043017          652 LARLIAQDQSHV---STMPKGTPGYMAPELTRGN------SITAKIDIYSFGVVILEIICG----------RRSSNPKGG  712 (818)
Q Consensus       652 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvll~elltG----------~~p~~~~~~  712 (818)
                      +++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            998776544332   2234699999999999876      455799999999999999999          778764422


Q ss_pred             -chHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          713 -DYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       713 -~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                       ......+........    .....+..........++.+++.+||+.||++|||+.++++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence             122222222111111    1111111112345778899999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-39  Score=356.65  Aligned_cols=259  Identities=29%  Similarity=0.397  Sum_probs=206.9

Q ss_pred             hHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccC-cc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS-NR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~-~~  575 (818)
                      .+.+.+.||+|+||.||+|.+      .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+ ..
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~  102 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  102 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence            344556899999999999974      2468999999976433 3346799999999999 8999999999988765 48


Q ss_pred             eeeeeccCCCChhhHhhhcCC-----------------------------------------------------------
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR-----------------------------------------------------------  596 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  596 (818)
                      ++||||+++|+|.+++.....                                                           
T Consensus       103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (359)
T 3vhe_A          103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP  182 (359)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence            999999999999999965432                                                           


Q ss_pred             ----ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-cccCCCCCC
Q 043017          597 ----IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-VSTMPKGTP  671 (818)
Q Consensus       597 ----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~  671 (818)
                          ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ......+|+
T Consensus       183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          183 EDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             -CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             cchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence                12288999999999999999999998   9999999999999999999999999999876543322 223356889


Q ss_pred             cccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHH
Q 043017          672 GYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMI  750 (818)
Q Consensus       672 ~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  750 (818)
                      .|+|||++.+..++.++||||||+++|||++ |+.||................   ..     .     ..+.....++.
T Consensus       260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~-----~-----~~~~~~~~~l~  326 (359)
T 3vhe_A          260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---TR-----M-----RAPDYTTPEMY  326 (359)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT---CC-----C-----CCCTTCCHHHH
T ss_pred             eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC---CC-----C-----CCCCCCCHHHH
Confidence            9999999999999999999999999999998 999997665433222111110   00     0     01122345788


Q ss_pred             HHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          751 QIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       751 ~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +++..||+.||.+|||+.|++++|+.+.+
T Consensus       327 ~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          327 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            99999999999999999999999988753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-38  Score=344.86  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=211.8

Q ss_pred             hHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||++..      .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  103 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL  103 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence            344556899999999999986      235789999997543 3345778999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCC---------------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCe
Q 043017          578 VYEYMCNGSLDKWIFHKDR---------------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN  636 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~N  636 (818)
                      ||||+++++|.+++.....                     ...+++..+..++.||++||+|||+.   +|+||||||+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N  180 (314)
T 2ivs_A          104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN  180 (314)
T ss_dssp             EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence            9999999999999975432                     23589999999999999999999997   99999999999


Q ss_pred             EEEcCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 043017          637 ILLDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY  714 (818)
Q Consensus       637 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~  714 (818)
                      |+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998775543322 223457889999999998889999999999999999999 999998766554


Q ss_pred             HHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       715 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +...+....              ....+.....++.+++.+||+.||++||++.+++++|+.+.+
T Consensus       261 ~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          261 LFNLLKTGH--------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             HHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhhcCC--------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            443332110              001122345678899999999999999999999999988754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.2e-39  Score=338.83  Aligned_cols=254  Identities=26%  Similarity=0.443  Sum_probs=210.4

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.+.||+|+||.||++...+++.||+|.+.... ...+++.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            44556899999999999999888999999997543 34578999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.+++....  ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++............
T Consensus        89 ~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (267)
T 3t9t_A           89 CLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  163 (267)
T ss_dssp             BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             cHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence            9999996532  4588999999999999999999997   9999999999999999999999999999876443222223


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+..   .      ...     ..+..
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~---~------~~~-----~~~~~  229 (267)
T 3t9t_A          164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---G------FRL-----YKPRL  229 (267)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---T------CCC-----CCCTT
T ss_pred             cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc---C------CcC-----CCCcc
Confidence            3457789999999998899999999999999999999 8999876544333222211   1      000     01122


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ....+.+++.+||+.+|++||++.+++++|+.+.+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34678899999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-39  Score=351.23  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=209.8

Q ss_pred             hHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||+++..      +++.||||.+..... ...+.|.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  127 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL  127 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence            3445568999999999999975      348899999975533 335679999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCC---------------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCe
Q 043017          578 VYEYMCNGSLDKWIFHKDR---------------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN  636 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~N  636 (818)
                      ||||+++++|.+++.....                     ...+++..+..++.||++||+|||+.   +|+||||||+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N  204 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  204 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence            9999999999999965321                     15689999999999999999999997   99999999999


Q ss_pred             EEEcCCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 043017          637 ILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY  714 (818)
Q Consensus       637 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~  714 (818)
                      ||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  284 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  284 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence            9999999999999999987644322 22233457899999999998899999999999999999999 999997654433


Q ss_pred             HHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       715 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      +...+.   .. ..        .  ..+.....++.+++.+||+.||++||++.+++++|+.+.+.
T Consensus       285 ~~~~~~---~~-~~--------~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          285 VIYYVR---DG-NI--------L--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HHHHHH---TT-CC--------C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             HHHHHh---CC-Cc--------C--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            322221   11 10        0  01223346788999999999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=341.66  Aligned_cols=256  Identities=28%  Similarity=0.459  Sum_probs=201.4

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      +.+.+.||+|+||.||+++.. ++.||||++...  ...+.|.+|++++++++||||+++++++.+  ..++||||++++
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            345568999999999999986 789999998643  346789999999999999999999999874  589999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC-EEEeecCCceecccCCCccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN-VKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~~~  664 (818)
                      +|.+++........+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......    
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----  160 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----  160 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc----
Confidence            99999976655556788999999999999999999943348999999999999998887 7999999997654321    


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ........ .       ..   .....
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~-~-------~~---~~~~~  228 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNG-T-------RP---PLIKN  228 (307)
T ss_dssp             ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTT-C-------CC---CCBTT
T ss_pred             ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcC-C-------CC---Ccccc
Confidence            2235899999999999999999999999999999999999999765443221 11111110 0       00   11123


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      ....+.+++.+||+.||++|||+.+++++|+.+.+..+
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            34578899999999999999999999999999876544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.7e-39  Score=350.31  Aligned_cols=256  Identities=23%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCc----EEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .+.+.+.||+|+||.||+|+.. +++    +||+|.+... .....++|.+|+.++++++||||+++++++.++. .++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v   94 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence            3445568999999999999964 343    4689988644 3355678999999999999999999999998754 7899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +||+++|+|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999996543  4689999999999999999999997   999999999999999999999999999987755


Q ss_pred             CCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          659 DQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       659 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+....             
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  236 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------------  236 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-------------
Confidence            43322 223456889999999999999999999999999999999 999998765554433322110             


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                       ....+.....++.+++.+||+.+|++||++.+++++|+.+.+.
T Consensus       237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence             0011223446788999999999999999999999999887653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4e-39  Score=342.87  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=197.0

Q ss_pred             hHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|....    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   94 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   94 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence            44556789999999999998753    4579999987543 334567999999999999999999999984 46788999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++....  ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             ECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            9999999999996432  4589999999999999999999997   9999999999999999999999999999877554


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .........+++.|+|||.+....++.++||||||+++|||++ |+.||...........+...   ..           
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---~~-----------  235 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ER-----------  235 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CC-----------
T ss_pred             cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---CC-----------
Confidence            4333333457789999999998899999999999999999997 99999876555443333211   00           


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .+.+......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            01122345678899999999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-38  Score=349.60  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=204.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc------cHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +.+.+.||+|+||.||+++.. +|+.||||.+......      ..+.+.+|+.++.+++||||+++++++.+....++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            455678999999999999976 5899999998654321      357899999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC----CEEEeecCCce
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL----NVKIADFGLAR  654 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla~  654 (818)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+++
T Consensus        94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           94 LELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            9999999999999542   4689999999999999999999997   999999999999998877    79999999998


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      .......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....        .+.
T Consensus       168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------~~~  237 (361)
T 2yab_A          168 EIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS--------YDF  237 (361)
T ss_dssp             ECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--------CCC
T ss_pred             EcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------CCC
Confidence            7655322  233569999999999999999999999999999999999999997655443333222100        000


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..   .........+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          238 DE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             Cc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00   0011234568899999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-38  Score=342.50  Aligned_cols=261  Identities=25%  Similarity=0.299  Sum_probs=202.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||.||+++..+++.||||++.....  .....+.+|++++++++||||+++++++.++...++||||++
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  102 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME  102 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence            445568999999999999998899999999865432  234678999999999999999999999999999999999997


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                       ++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       103 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-  175 (311)
T 3niz_A          103 -KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-  175 (311)
T ss_dssp             -EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred             -CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc-
Confidence             5788877543  24589999999999999999999997   9999999999999999999999999999876543222 


Q ss_pred             ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh---------cc
Q 043017          664 STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL---------VD  733 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~---------~d  733 (818)
                      .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+.....         ..
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            233468999999999876 56899999999999999999999999877655544444332211110000         00


Q ss_pred             ccC---cCc---cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKS---EDM---QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~---~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...   ...   ........++.+++.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000   000   0011234578899999999999999999999984

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.6e-39  Score=338.95  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=193.3

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCC----ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN----RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|... ++.||||++.....    ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF   87 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred             eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence            445568999999999999976 88999999865432    3357889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC--------CCCEEEeecCCc
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR--------DLNVKIADFGLA  653 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~--------~~~~kl~Dfgla  653 (818)
                      +++++|.+++.    ...+++..+..++.|+++||+|||+....+|+||||||+||+++.        ++.+||+|||++
T Consensus        88 ~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           88 ARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             CTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             CCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            99999999883    246899999999999999999999972122999999999999986        778999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      .........   ...|++.|+|||.+.+..++.++||||||++++||++|+.||.............   .. ..     
T Consensus       164 ~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~-~~-----  231 (271)
T 3dtc_A          164 REWHRTTKM---SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA---MN-KL-----  231 (271)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---TS-CC-----
T ss_pred             ccccccccc---CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh---cC-CC-----
Confidence            866543222   3468999999999999899999999999999999999999997654332221111   00 00     


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                          ....+......+.+++.+||+.+|++|||+.|++++|+.+
T Consensus       232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                0111223446788999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=356.01  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=209.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      ..+.+.+.||+|+||.||+|++.      +++.||||++... ......++.+|+.++.+++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            34455678999999999999953      4678999999654 3344567899999999999999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcC----CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---CEEEee
Q 043017          577 LVYEYMCNGSLDKWIFHKD----RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---NVKIAD  649 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~D  649 (818)
                      +||||+++|+|.+++....    ....+++..+..++.||++||+|||+.   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997543    224588999999999999999999997   999999999999998554   599999


Q ss_pred             cCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......+...+..   ...
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~---~~~  304 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS---GGR  304 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---TCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCC
Confidence            999986543222 12223457899999999999999999999999999999998 9999976654433332221   100


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                                 ...+......+.+++.+||+.+|++||++.+|+++|+.+.+.
T Consensus       305 -----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          305 -----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                       011223345788999999999999999999999999887654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=349.99  Aligned_cols=266  Identities=26%  Similarity=0.373  Sum_probs=208.3

Q ss_pred             hhHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||.||+|..      .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4455567899999999999996      246689999997542 34457899999999999 899999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC--------------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccC
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR--------------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ  635 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~  635 (818)
                      ++||||+++|+|.+++.....                    ...+++..+..++.||++||+|||+.   +|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence            999999999999999965432                    13478999999999999999999997   9999999999


Q ss_pred             eEEEcCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 043017          636 NILLDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGD  713 (818)
Q Consensus       636 NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~  713 (818)
                      |||++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            9999999999999999998775543322 223457889999999998899999999999999999998 99999766543


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCC
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD  785 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~  785 (818)
                      ........   ..     ...     ..+.....++.+++.+||+.||.+|||+.+++++|+.+........
T Consensus       282 ~~~~~~~~---~~-----~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  340 (344)
T 1rjb_A          282 ANFYKLIQ---NG-----FKM-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM  340 (344)
T ss_dssp             HHHHHHHH---TT-----CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred             HHHHHHHh---cC-----CCC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence            32221111   10     000     1122235678899999999999999999999999999877654433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-38  Score=347.09  Aligned_cols=246  Identities=25%  Similarity=0.334  Sum_probs=204.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +++.+.||+|+||.||+++.. +++.||||++...   .......+.+|++++++++||||+++++++...+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~   86 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence            345568999999999999976 5899999998643   234467789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus        87 ~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           87 ANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             CTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            9999999988643   3589999999999999999999997   999999999999999999999999999986433322


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......+...+..   . .        .   ..
T Consensus       161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~-~--------~---~~  224 (337)
T 1o6l_A          161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---E-E--------I---RF  224 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C-C--------C---CC
T ss_pred             -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---C-C--------C---CC
Confidence             22335689999999999999999999999999999999999999976544333322211   0 0        0   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      +.....++.+++.+||+.||++||     ++.|++++
T Consensus       225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            123346788999999999999999     89999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=343.90  Aligned_cols=250  Identities=23%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC------ccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||++... +++.||||.+.....      ...+.+.+|+.++.+++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3556678999999999999976 589999999865432      236789999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC----CEEEeecCCc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL----NVKIADFGLA  653 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla  653 (818)
                      ||||+++++|.+++..   ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           92 ILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            9999999999999953   24689999999999999999999997   999999999999998887    7999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      +.......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+....  .       
T Consensus       166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~-------  234 (326)
T 2y0a_A          166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN--Y-------  234 (326)
T ss_dssp             EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC--C-------
T ss_pred             eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC--C-------
Confidence            87754322  223469999999999999999999999999999999999999997654433322221110  0       


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ... ..........+.+++.+||+.||++|||+.|++++
T Consensus       235 -~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 -EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -CCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             000 00011234567899999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-39  Score=341.28  Aligned_cols=258  Identities=28%  Similarity=0.410  Sum_probs=215.0

Q ss_pred             hhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ..+.+.+.||+|+||.||+|.... ++.||+|.+... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            345556789999999999999875 889999998754 334678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        92 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           92 TYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             TTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred             CCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence            9999999996543 35689999999999999999999998   9999999999999999999999999999877655444


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+....         .     ...
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------~-----~~~  233 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------R-----MER  233 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---------C-----CCC
T ss_pred             cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC---------C-----CCC
Confidence            4444457889999999998899999999999999999999 999987665544433332110         0     011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      +......+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            223346788999999999999999999999999877543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-38  Score=346.60  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             hHHhhhhcccccceeEEEeEecCCc----EEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcc---
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGT----KVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR---  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~----~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~---  575 (818)
                      .+.+.+.||+|+||.||+|......    .||||.+...  .....+.+.+|++++++++||||+++++++......   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            3455678999999999999976432    7999998754  334467899999999999999999999999877655   


Q ss_pred             ---eeeeeccCCCChhhHhhhcC---CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          576 ---FLVYEYMCNGSLDKWIFHKD---RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       576 ---~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                         ++||||+++++|.+++....   ....+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence               89999999999999986432   122589999999999999999999997   999999999999999999999999


Q ss_pred             cCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+...   . 
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~-  256 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG---N-  256 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---C-
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC---C-
Confidence            9999876543322 1223456789999999999999999999999999999999 89999876655443332210   0 


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                             ..   ..+.....++.+++.+||+.||++|||+.++++.|+++.+-+.
T Consensus       257 -------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          257 -------RL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             -------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             -------CC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                   00   1122344678899999999999999999999999999877644

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-38  Score=345.48  Aligned_cols=250  Identities=18%  Similarity=0.287  Sum_probs=204.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            445568999999999999976 5889999998643 33456789999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC--CCCEEEeecCCceecccCCCc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR--DLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.  ++.+||+|||+++........
T Consensus        86 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           86 LDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            9999998432  24689999999999999999999997   9999999999999987  789999999999887544322


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                        ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.....        ...   ....
T Consensus       161 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--------~~~---~~~~  227 (321)
T 1tki_A          161 --RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY--------TFD---EEAF  227 (321)
T ss_dssp             --EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------CCC---HHHH
T ss_pred             --ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC--------CCC---hhhh
Confidence              234589999999999998899999999999999999999999976654433333221100        000   0001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ...+.++.+++.+||+.||++|||+.|++++-
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          228 KEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            12346788999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.2e-39  Score=349.03  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=204.4

Q ss_pred             HHhhhhcccccceeEEEeEecC-Cc----EEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GT----KVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +.+.+.||+|+||.||+|+... ++    +||+|.+.... ......+.+|+.++.+++||||+++++++. +...++||
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~   93 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT   93 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence            3445689999999999999653 43    48888875443 344567889999999999999999999986 56788999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           94 QYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             ECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            999999999998543  35789999999999999999999998   9999999999999999999999999999987554


Q ss_pred             CCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+...   ...         
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~---------  236 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---ERL---------  236 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---CBC---------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCC---------
Confidence            332 2233467889999999998999999999999999999999 99999876655443333211   000         


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                        ..+.....++.+++.+||+.||++||++.+++++|+.+.+.
T Consensus       237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          237 --AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             --CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             --CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              00112334577899999999999999999999999988654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.2e-39  Score=373.04  Aligned_cols=256  Identities=28%  Similarity=0.446  Sum_probs=210.8

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.++||+|+||.||+|.+.++..||||++.... ...++|++|+++|++++|+||+++++++.+ +..++||||+++
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~  345 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  345 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence            345567899999999999999988899999997544 346789999999999999999999999876 678999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.++|.... ...+++..+..|+.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       346 gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          346 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             EEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             CcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999995421 23588999999999999999999997   999999999999999999999999999987653322222


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+....++.++||||||++||||++ |+.||.......+...+.   ...+           ...+.
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~-----------~~~~~  487 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYR-----------MPCPP  487 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH---TTCC-----------CCCCT
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCC-----------CCCCC
Confidence            23456789999999998899999999999999999999 899997655433333221   1100           11122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .....+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            3456788999999999999999999999999988654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.8e-38  Score=342.14  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=196.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCc---------
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN---------  574 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~---------  574 (818)
                      +.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...         
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            344568999999999999986 68999999986543 3346789999999999999999999999865432         


Q ss_pred             ------------------------------------------------ceeeeeccCCCChhhHhhhcCCccccchhhHH
Q 043017          575 ------------------------------------------------RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRK  606 (818)
Q Consensus       575 ------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~  606 (818)
                                                                      .++||||+++++|.+++..........+..+.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  167 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL  167 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence                                                            78999999999999999776655666777899


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-----------ccccCCCCCCcccc
Q 043017          607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-----------HVSTMPKGTPGYMA  675 (818)
Q Consensus       607 ~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y~a  675 (818)
                      .++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......           .......||+.|+|
T Consensus       168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            9999999999999997   999999999999999999999999999998765422           11223469999999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHH
Q 043017          676 PELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAIS  755 (818)
Q Consensus       676 PE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~  755 (818)
                      ||.+.+..++.++||||||+++|||++|..|+.     .......... .        ...  .........++.+++.+
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~-~--------~~~--~~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVR-N--------LKF--PLLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHH-T--------TCC--CHHHHHHCHHHHHHHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhh-c--------cCC--CcccccCChhHHHHHHH
Confidence            999999999999999999999999999876531     0111111000 0        000  01123445677899999


Q ss_pred             ccccCCCCCCcHHHHHHH
Q 043017          756 CLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       756 cl~~dp~~RPt~~evl~~  773 (818)
                      ||+.||++|||+.|++++
T Consensus       309 ~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCSSGGGSCCHHHHHHS
T ss_pred             HccCCCCcCCCHHHHhhc
Confidence            999999999999999974

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-38  Score=344.57  Aligned_cols=251  Identities=25%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   88 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence            345568999999999999976 68999999986443 2334678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  662 (818)
                      +++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        89 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           89 GGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             TEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            99999988432   4589999999999999999999997   9999999999999999999999999999876543322 


Q ss_pred             cccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.............  .....          ....
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~----------~~~~  230 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKKT----------YLNP  230 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH--HTTCT----------TSTT
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--hcccc----------cCCc
Confidence            2234579999999999987765 789999999999999999999997654432211111  00000          0011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .......+.+++.+||+.||++|||+.|++++-
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            123446778999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-38  Score=336.39  Aligned_cols=255  Identities=30%  Similarity=0.442  Sum_probs=209.4

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++.+++||||+++++++.. +..++||||+++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   91 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence            445567899999999999999888899999986543 346789999999999999999999999864 568999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++.... ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++...........
T Consensus        92 ~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           92 GSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             CBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             CCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            99999985321 23589999999999999999999997   999999999999999999999999999998765443333


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....++..|+|||.+.+..++.++||||||++++||++ |+.||...........+.   ...      ..     ..+.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~------~~-----~~~~  233 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RGY------RM-----VRPD  233 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC------CC-----CCCT
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh---ccc------CC-----CCcc
Confidence            34457889999999998889999999999999999999 899987654433322221   110      00     0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ....++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            334678899999999999999999999999988754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.8e-38  Score=332.99  Aligned_cols=251  Identities=28%  Similarity=0.467  Sum_probs=201.0

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCcc-------HHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRG-------KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      .+.+.+.||+|+||.||+|+.. +++.||||++.......       .+.+.+|++++++++||||+++++++.+..  +
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   97 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R   97 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence            3455678999999999999975 68999999986543322       167899999999999999999999987654  7


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC--eeecccccCeEEEcCCCC-----EEEee
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK--IIHFDIKPQNILLDRDLN-----VKIAD  649 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiH~Dlkp~NIll~~~~~-----~kl~D  649 (818)
                      +||||+++++|.+++...  ...+++..+..++.|+++||+|||+.   +  |+||||||+||+++.++.     +||+|
T Consensus        98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             EEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            999999999999988543  34689999999999999999999997   7  999999999999988776     99999


Q ss_pred             cCCceecccCCCccccCCCCCCccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSHVSTMPKGTPGYMAPELTR--GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++....    ......|++.|+|||.+.  ...++.++||||||+++|||++|+.||............. ..... 
T Consensus       173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~-  246 (287)
T 4f0f_A          173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM-IREEG-  246 (287)
T ss_dssp             CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-HHHSC-
T ss_pred             CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-HhccC-
Confidence            999975433    223356899999999984  4567899999999999999999999998665443321111 11100 


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      .         ....+.....++.+++.+||+.||++|||+.++++.|+++
T Consensus       247 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 L---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             C---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            0         0011223456788999999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.8e-38  Score=335.38  Aligned_cols=271  Identities=16%  Similarity=0.187  Sum_probs=213.9

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||+|.. .+++.||||++....  ..+.+.+|++++.++ +|+|++++++++.++...++||||+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            44556899999999999996 568999999985433  345688999999999 8999999999999999999999999 


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC-----EEEeecCCceeccc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN-----VKIADFGLARLIAQ  658 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfgla~~~~~  658 (818)
                      +++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.     +||+|||+++....
T Consensus        89 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           89 GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            999999996542  3589999999999999999999997   9999999999999987776     99999999997765


Q ss_pred             CCCc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          659 DQSH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       659 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      ....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....................... .
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  242 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-L  242 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-H
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-H
Confidence            4321      12345699999999999999999999999999999999999999987544333222222111110000 0


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchh
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSF  791 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~  791 (818)
                      ...      ....+.++.+++.+||+.+|++||++.+|++.|+.+.+.........+++
T Consensus       243 ~~~------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          243 REL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             HHH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             HHH------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            000      11234678899999999999999999999999999876544444444443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-38  Score=346.89  Aligned_cols=267  Identities=27%  Similarity=0.404  Sum_probs=211.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec--------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccC
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS  573 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  573 (818)
                      ..+.+.+.||+|+||.||+|...        +++.||||++..... ...+.+.+|++++.++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            44556678999999999999863        467899999975432 3456789999999999 8999999999999999


Q ss_pred             cceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                      ..++||||+++++|.+++.....             ...+++..+..++.||++||+|||+.   +|+||||||+||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence            99999999999999999965431             23488999999999999999999997   999999999999999


Q ss_pred             CCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHH
Q 043017          641 RDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDT  718 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~  718 (818)
                      .++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence            99999999999998775543322 223457889999999988889999999999999999999 9999876544333322


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCC
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYG  787 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~  787 (818)
                      +...   ..           ...+.....++.+++.+||+.+|.+||++.++++.|+.+.......++.
T Consensus       272 ~~~~---~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~  326 (334)
T 2pvf_A          272 LKEG---HR-----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYL  326 (334)
T ss_dssp             HHHT---CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred             HhcC---CC-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCccc
Confidence            2111   00           0012234467889999999999999999999999999997765444433

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=349.04  Aligned_cols=246  Identities=26%  Similarity=0.347  Sum_probs=198.8

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +.||+|+||.||+|... +|+.||+|++........+++.+|++++.+++||||+++++++.+.+..++||||+++++|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            46999999999999975 58999999997665556788999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE--cCCCCEEEeecCCceecccCCCccccC
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL--DRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      +++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||+  +.++.+||+|||+++........  ..
T Consensus       175 ~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--~~  247 (373)
T 2x4f_A          175 DRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KV  247 (373)
T ss_dssp             HHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--CC
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--cc
Confidence            988543  24689999999999999999999997   99999999999999  56788999999999977544322  23


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      ..||+.|+|||++....++.++|||||||++|||++|+.||...........+...   .     ......   ......
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---~-----~~~~~~---~~~~~~  316 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC---R-----WDLEDE---EFQDIS  316 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---C-----CCSCSG---GGTTSC
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---c-----CCCChh---hhccCC
Confidence            46999999999999999999999999999999999999999766543333222211   0     000000   012234


Q ss_pred             HHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .++.+++.+||+.||++|||+.|++++
T Consensus       317 ~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          317 EEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            678899999999999999999999984

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=338.79  Aligned_cols=247  Identities=25%  Similarity=0.363  Sum_probs=194.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--------------------------ccHHHHHHHHHHHhccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--------------------------RGKKEFLSEVETIGNIH  558 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------------------~~~~~f~~Ev~~l~~l~  558 (818)
                      +.+.+.||+|+||.||+|... +++.||||++.....                          ...+.+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            445678999999999999865 588999999865421                          12357899999999999


Q ss_pred             cceeEEEeeeecc--cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCe
Q 043017          559 HFNLVRLVGYCAE--RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQN  636 (818)
Q Consensus       559 H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~N  636 (818)
                      ||||+++++++.+  ....++||||+++++|.+++.    ...+++..+..++.||++||+|||+.   +|+||||||+|
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  167 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN  167 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence            9999999999986  567899999999999988652    34689999999999999999999998   99999999999


Q ss_pred             EEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 043017          637 ILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGD  713 (818)
Q Consensus       637 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvll~elltG~~p~~~~~~~  713 (818)
                      ||++.++.+||+|||+++........ .....||+.|+|||.+.+..   .+.++||||||+++|||++|+.||......
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            99999999999999999877544322 23356999999999998765   478999999999999999999999755432


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+...+..    ..    .     ..+.......++.+++.+||+.||++||++.|++++
T Consensus       247 ~~~~~~~~----~~----~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          247 CLHSKIKS----QA----L-----EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHHHH----CC----C-----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHHHhc----cc----C-----CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            22221111    00    0     001112234678899999999999999999999764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-38  Score=335.00  Aligned_cols=251  Identities=18%  Similarity=0.334  Sum_probs=203.3

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||+|+.. ++.||||++....  ....+.|.+|+.++++++||||+++++++.+.  ...++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            3445678999999999999986 8899999987553  23356799999999999999999999999877  67899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC--eeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK--IIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |+++++|.+++.... ...+++..+..++.||++||+|||+.   +  |+||||||+||+++.++.++|.|||++.....
T Consensus        90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             CCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999996532 23689999999999999999999987   7  99999999999999999999999998764322


Q ss_pred             CCCccccCCCCCCcccccccccCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSIT---AKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                            ....+|+.|+|||.+.+...+   .++||||||+++|||++|+.||..............   ..     ... 
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~-----~~~-  230 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL---EG-----LRP-  230 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH---SC-----CCC-
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh---cC-----CCC-
Confidence                  223578999999999876544   489999999999999999999976543332222111   00     000 


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                          ..+.....++.+++..||+.||++|||+.++++.|+.+.+
T Consensus       231 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 ----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                1122345678899999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-38  Score=343.80  Aligned_cols=262  Identities=25%  Similarity=0.353  Sum_probs=197.5

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhccCcceeEEEeeeecccCcc----e
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR----F  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~----~  576 (818)
                      .+.+.+.||+|+||.||+++. .+++.||||++......   ....+.+|++++.+++||||+++++++......    +
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            345567899999999999996 56899999999765332   245788999999999999999999998776554    9


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        93 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            999999999999999654   3589999999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          657 AQDQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       657 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............   .....      
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~---~~~~~------  237 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---REDPI------  237 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HCCCC------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh---cCCCC------
Confidence            543322  2223468999999999999999999999999999999999999997654332221111   11000      


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHH-HHHHHhcCcCCCCC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASM-LVKVLQGLTKLEPV  783 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-vl~~L~~i~~~~~~  783 (818)
                        .........+.++.+++.+||+.||++||++.+ +.+.|..+....++
T Consensus       238 --~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~  285 (311)
T 3ork_A          238 --PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP  285 (311)
T ss_dssp             --CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred             --CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence              000001123467889999999999999995554 55566655554443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.7e-39  Score=363.62  Aligned_cols=250  Identities=21%  Similarity=0.274  Sum_probs=203.5

Q ss_pred             hhhcccccceeEEEeEecC-CcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          509 QIRLGRGGSGSVFEGLLND-GTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .++||+|+||.||+++... ++.||||++...   .......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g  158 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG  158 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence            3579999999999999874 788999998642   122234588999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++...  ...+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++..........
T Consensus       159 g~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~  233 (437)
T 4aw2_A          159 GDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  233 (437)
T ss_dssp             CBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence            9999999642  24689999999999999999999997   999999999999999999999999999988766555444


Q ss_pred             cCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          665 TMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+.......        ..+. 
T Consensus       234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p~-  304 (437)
T 4aw2_A          234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------QFPT-  304 (437)
T ss_dssp             CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------CCCS-
T ss_pred             ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc--------cCCc-
Confidence            5567999999999997     5678999999999999999999999998665444333332111100        0000 


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCC--CCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHR--RPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~  773 (818)
                       .......++.+++.+||+.+|++  ||+++|++++
T Consensus       305 -~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          305 -QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             01123456788999999888888  9999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-38  Score=341.02  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=211.7

Q ss_pred             hhHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||.||+|..      .+++.||||++..... ...+.+.+|++++.++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            3455667899999999999985      3468899999975543 3357799999999999 999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC---------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR---------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                      ++||||+++|+|.+++.....               ...+++..+..++.||++||+|||+.   +|+||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence            999999999999999965432               12589999999999999999999997   999999999999999


Q ss_pred             CCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHH
Q 043017          641 RDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDT  718 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~  718 (818)
                      .++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence            99999999999998776543322 223457789999999998899999999999999999999 9999976654332222


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .....        ....     ........+.+++.+||+.||.+|||+.|++++|+.+.+.
T Consensus       260 ~~~~~--------~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          260 MIKEG--------FRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHT--------CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhccC--------CCCC-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11110        0000     1123346788999999999999999999999999887653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.7e-38  Score=347.21  Aligned_cols=251  Identities=27%  Similarity=0.371  Sum_probs=204.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..+.+.+.||+|+||.||++... +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34555678999999999999975 58999999986543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCceecc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIA  657 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~  657 (818)
                      |+++|+|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.+   +.+||+|||++....
T Consensus       109 ~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          109 LVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999988543   4689999999999999999999998   99999999999999765   459999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+....        .+....
T Consensus       183 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~--------~~~~~~  252 (362)
T 2bdw_A          183 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--------YDYPSP  252 (362)
T ss_dssp             TCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------CCCCTT
T ss_pred             CCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------CCCCcc
Confidence            4322  233569999999999999999999999999999999999999997655433333322110        000000


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .   ......++.+++.+||+.||++||++.+++++
T Consensus       253 ~---~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          253 E---WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             G---GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c---ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0   12334678899999999999999999999876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-38  Score=349.42  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=205.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||+|... +++.+|+|.+..........+.+|++++.+++||||+++++++.+....++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            455678999999999999976 5889999998765555567899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC--CCCEEEeecCCceecccCCCc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR--DLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|.+++...  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++........
T Consensus       133 g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  207 (387)
T 1kob_A          133 GELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  207 (387)
T ss_dssp             CBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             CcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence            9999988533  24689999999999999999999997   9999999999999974  477999999999987554322


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..   ..     ..  . .....
T Consensus       208 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~-----~~--~-~~~~~  274 (387)
T 1kob_A          208 --KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---CD-----WE--F-DEDAF  274 (387)
T ss_dssp             --EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---CC-----CC--C-CSSTT
T ss_pred             --eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh---CC-----CC--C-Ccccc
Confidence              223689999999999999999999999999999999999999976544333222211   00     00  0 00111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....++.+++.+||+.||++|||+.|++++
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            2345678899999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-38  Score=338.19  Aligned_cols=264  Identities=25%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             hHHhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~  576 (818)
                      .+.+.+.||+|+||.||++++     .+++.||||++.... ....+.+.+|++++.+++||||+++++++...  ...+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            345557899999999999984     368999999997543 34467899999999999999999999999876  5689


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       102 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence            9999999999999995433  3589999999999999999999997   9999999999999999999999999999987


Q ss_pred             ccCCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHh------hhhcc
Q 043017          657 AQDQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA------EADRL  728 (818)
Q Consensus       657 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~------~~~~~  728 (818)
                      ......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....    ........      ....+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGGHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCcccccCHHHH
Confidence            654432  2233468888999999998899999999999999999999998753210    00000000      00000


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      ...+... .....+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       253 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEG-KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcc-CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0001000 011112344567889999999999999999999999998765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.3e-38  Score=336.21  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=199.2

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.||+|+||.||+++..+++.||||++....  ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            4456899999999999999889999999986543  22347789999999999999999999999999999999999975


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                       +|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .
T Consensus        85 -~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~  157 (288)
T 1ob3_A           85 -DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y  157 (288)
T ss_dssp             -EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             -CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-c
Confidence             8988885432  4688999999999999999999997   9999999999999999999999999999876433221 2


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc------chh--hcccc
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR------LCD--LVDKK  735 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~------~~~--~~d~~  735 (818)
                      ....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...........+........      ...  ..+..
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            234689999999999764 589999999999999999999999976554333332222111100      000  00000


Q ss_pred             CcC------ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 SED------MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 ~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...      .........++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000      00012245678899999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-38  Score=355.93  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=203.8

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.++||+|+||.||+++.. +++.||||++...   .....+.+.+|+.++..++||||+++++++.+....++||||+
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            34457999999999999976 4889999998542   2233456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++........
T Consensus       152 ~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          152 PGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             TTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999998854    2488999999999999999999997   9999999999999999999999999999887655444


Q ss_pred             cccCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          663 VSTMPKGTPGYMAPELTRGNS----ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+......      +  ..+.
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------~--~~p~  296 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------L--TFPD  296 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------C--CCCT
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc------c--cCCC
Confidence            444567999999999997665    789999999999999999999999865544333333211100      0  0111


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCC--CCcHHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHR--RPSASMLVKVL  774 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L  774 (818)
                         ....+.++.+++.+||+.+|.+  ||++.|++++-
T Consensus       297 ---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          297 ---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             ---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             ---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence               1123467788999999999988  99999999873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.9e-38  Score=353.95  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=203.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .+.+.++||+|+||.||++... +|+.+|+|.+.....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            3455578999999999999864 689999999865432  3356789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc---CCCCEEEeecCCceeccc
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~  658 (818)
                      +++|+|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++   .++.+||+|||++.....
T Consensus        92 ~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           92 VTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            9999999988654   3589999999999999999999997   999999999999998   457899999999987654


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+....        .+...+.
T Consensus       166 ~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------~~~~~~~  236 (444)
T 3soa_A          166 EQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA--------YDFPSPE  236 (444)
T ss_dssp             TCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------CCCCTTT
T ss_pred             CCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--------CCCCccc
Confidence            4322 233579999999999999999999999999999999999999997665444433332111        0111111


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ....+.++.+++.+||+.||++|||+.|++++
T Consensus       237 ---~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          237 ---WDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               11234678899999999999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=350.06  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=201.2

Q ss_pred             HHhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcce
Q 043017          502 KSATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       502 ~~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  576 (818)
                      ....+.+.+.||+|+||.||+++.. +++.||||++...   .....+.+.+|.+++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3345566678999999999999976 5899999998643   233456788999999988 7999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999999654   3589999999999999999999998   9999999999999999999999999999864


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+...            ..
T Consensus       175 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------~~  241 (353)
T 3txo_A          175 ICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------EV  241 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------CC
T ss_pred             ccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------CC
Confidence            33222 223357999999999999888999999999999999999999999866554443333210            00


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcH------HHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSA------SMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~  773 (818)
                         ..+.....++.+++.+||+.||.+||++      .+++++
T Consensus       242 ---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 ---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence               0112234568899999999999999998      777763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.5e-38  Score=333.96  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=204.1

Q ss_pred             hHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+|+...    +..||||.+.... ....+.|.+|++++++++||||+++++++.+ +..++||
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   91 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM   91 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence            34455689999999999998653    3469999987653 3345789999999999999999999999865 4568999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++....  ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        92 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           92 ELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             ECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             ecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999999996532  4588999999999999999999997   9999999999999999999999999999876554


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+....   .        .  
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~---~--------~--  233 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD---R--------L--  233 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC---C--------C--
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC---C--------C--
Confidence            4333344557889999999998899999999999999999998 999997665544443332110   0        0  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                       ..+......+.+++.+||+.+|++||++.|++++|+.+.+
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence             0112234678899999999999999999999999988754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-38  Score=349.31  Aligned_cols=262  Identities=27%  Similarity=0.380  Sum_probs=199.0

Q ss_pred             HhhhhcccccceeEEEeEecC--C--cEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecc-cCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLND--G--TKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAE-RSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e  580 (818)
                      .+.+.||+|+||.||+|.+.+  +  ..||||.+.... ....++|.+|+.++++++||||+++++++.+ ++..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            345689999999999998642  2  468999986543 3445789999999999999999999998754 457899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       172 ~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          172 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            99999999999543  34688999999999999999999997   99999999999999999999999999998764432


Q ss_pred             Cc---cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          661 SH---VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 ~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+.   ....        .
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~---~~~~--------~  315 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRR--------L  315 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH---TTCC--------C
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH---cCCC--------C
Confidence            21   1122457789999999999999999999999999999999 667776555444333221   1100        0


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYG  787 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~  787 (818)
                         ..+......+.+++.+||+.+|++||++.|+++.|+.+........+.
T Consensus       316 ---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~  363 (373)
T 3c1x_A          316 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV  363 (373)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence               011223457889999999999999999999999999987655444443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.6e-38  Score=338.04  Aligned_cols=260  Identities=27%  Similarity=0.418  Sum_probs=195.7

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ...+.+.++||+|+||.||+|+...  .+|||.+....  ....+.|.+|++++++++|+||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            3455566789999999999998753  59999986543  23356799999999999999999999965 4566899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999998543  35689999999999999999999997   99999999999999999999999999998665322


Q ss_pred             -CccccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          661 -SHVSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 -~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                       ........|++.|+|||.+.   ...++.++||||||+++|||++|+.||.............   ......    ...
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~----~~~  247 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV---GRGSLS----PDL  247 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH---HHTSCC----CCT
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh---cccccC----cch
Confidence             22223346899999999986   5678899999999999999999999997654432221111   111110    111


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ..  .....+.++.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus       248 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 SK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11  122345678999999999999999999999999998864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=332.75  Aligned_cols=249  Identities=24%  Similarity=0.423  Sum_probs=206.0

Q ss_pred             hcccccceeEEEeEec---CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN---DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .||+|+||.||+|...   +++.||||.+.... ....+++.+|++++.+++||||+++++++ ..+..++||||+++++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence            7999999999999864   57889999997653 33457899999999999999999999999 5567899999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc--
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS--  664 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--  664 (818)
                      |.+++...  ...+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||++...........  
T Consensus        96 L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  170 (287)
T 1u59_A           96 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  170 (287)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             HHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence            99998532  34689999999999999999999997   999999999999999999999999999998755433222  


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+..   ..        .   ...+.
T Consensus       171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~--------~---~~~~~  236 (287)
T 1u59_A          171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GK--------R---MECPP  236 (287)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TC--------C---CCCCT
T ss_pred             ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CC--------c---CCCCC
Confidence            22346889999999988889999999999999999998 9999976655443332221   10        0   01122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ....++.+++..||+.+|++||++.+++++|+.+..
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            345678899999999999999999999999988754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-38  Score=367.80  Aligned_cols=248  Identities=23%  Similarity=0.418  Sum_probs=202.3

Q ss_pred             hcccccceeEEEeEec---CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN---DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +||+|+||.||+|.+.   ++..||||++.... ....++|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999874   46689999997653 3457889999999999999999999999976 56899999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc--
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS--  664 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--  664 (818)
                      |.+++...  ...+++..+..|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++..........  
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99999543  35689999999999999999999997   999999999999999999999999999987654332221  


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....+++.|+|||++....++.++|||||||++|||++ |+.||.......+...+..   ..           ....+.
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~-----------~~~~p~  562 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GK-----------RMECPP  562 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT---TC-----------CCCCCT
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CC-----------CCCCCC
Confidence            22345689999999998999999999999999999998 9999987665544433221   11           011122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                      ....++.+++..||+.+|++||++.+|++.|+.+.
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            34578889999999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=342.21  Aligned_cols=270  Identities=21%  Similarity=0.285  Sum_probs=201.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCCCc-----------cHHHHHHHHHHHhccCcceeEEEeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGENR-----------GKKEFLSEVETIGNIHHFNLVRLVGY  568 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~-----------~~~~f~~Ev~~l~~l~H~niv~l~g~  568 (818)
                      ..+.+.+.||+|+||.||+|...    ++..+|||++......           ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            34556678999999999999976    5778999998655321           12346778889999999999999999


Q ss_pred             ecc----cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-
Q 043017          569 CAE----RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-  643 (818)
Q Consensus       569 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-  643 (818)
                      +..    ....++||||+ +++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence            987    67889999999 99999998543   3689999999999999999999997   999999999999999887 


Q ss_pred             -CEEEeecCCceecccCCCc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH-
Q 043017          644 -NVKIADFGLARLIAQDQSH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL-  715 (818)
Q Consensus       644 -~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l-  715 (818)
                       .+||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ 
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             9999999999877543211      11335699999999999999999999999999999999999999964322221 


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCC
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD  785 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~  785 (818)
                      ....... ....+...+.....    ....+.++.+++..||+.||++||++.+|++.|+.+.......+
T Consensus       270 ~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d  334 (345)
T 2v62_A          270 VQTAKTN-LLDELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD  334 (345)
T ss_dssp             HHHHHHH-HHHTTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred             HHHHHHh-hcccccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence            1111111 11111111111000    11234578899999999999999999999999998765433333

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=342.88  Aligned_cols=256  Identities=23%  Similarity=0.385  Sum_probs=201.8

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCc----EEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .+.+.+.||+|+||.||+|... +++    +||+|.+... .....+++.+|+.++++++||||+++++++.... .++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v   94 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence            3445568999999999999964 343    4688887544 3455788999999999999999999999998754 7899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      +||+++|+|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             ECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999996543  4689999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          659 DQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       659 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+....             
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-------------  236 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------------  236 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            33222 222346789999999999999999999999999999999 999998766555443332110             


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                       ..+.+.....++.+++.+||+.||.+||++.|+++.|+.+.+.
T Consensus       237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence             0011223445788999999999999999999999999988765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.3e-39  Score=343.07  Aligned_cols=253  Identities=21%  Similarity=0.357  Sum_probs=201.5

Q ss_pred             hHHhhhhcccccceeEEEeEecC-C-------cEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-G-------TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g-------~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      .+.+.+.||+|+||.||+|.... +       +.||+|.+........+.+.+|++++++++||||+++++++..++..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            44556789999999999998653 3       579999997666666788999999999999999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC--------EEEe
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN--------VKIA  648 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~  648 (818)
                      +||||+++++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.        +||+
T Consensus        89 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999999999653  24589999999999999999999997   9999999999999998887        9999


Q ss_pred             ecCCceecccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          649 DFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       649 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      |||++......     ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+........  ..........
T Consensus       164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~~~~~~~~  236 (289)
T 4fvq_A          164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYEDRHQ  236 (289)
T ss_dssp             CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCC
T ss_pred             cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHHHhhccCC
Confidence            99998754322     11247889999999987 6799999999999999999996555433322111  1111111100


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                              .     +.....++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       237 --------~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          237 --------L-----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             --------C-----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             --------C-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                    0     11113457899999999999999999999999999877543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.4e-38  Score=341.50  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=209.5

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcce
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRF  576 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  576 (818)
                      ..+.+.+.||+|+||.||+|+..      +++.||||.+..... .....+.+|++++++++||||+++++++.+....+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            34555678999999999999865      367899999975433 33457899999999999999999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcC-------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          577 LVYEYMCNGSLDKWIFHKD-------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                      +||||+++++|.+++....       ....+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence            9999999999999986432       124568899999999999999999997   999999999999999999999999


Q ss_pred             cCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   .. .
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~-~  257 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM---EG-G  257 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH---TT-C
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH---cC-C
Confidence            9999866543322 2223356889999999998899999999999999999999 888887654433222221   11 0


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .        .  .........+.+++.+||+.+|++|||+.|++++|+.+.+
T Consensus       258 ~--------~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          258 L--------L--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             C--------C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             c--------C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            0        0  0122344678899999999999999999999999998765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7e-38  Score=344.53  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=202.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-----CCccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-----ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      ..+.+.+.||+|+||.||++... +++.||||++...     .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34566678999999999999875 5899999988532     22346789999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC---EEEeecCCc
Q 043017          578 VYEYMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLA  653 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgla  653 (818)
                      ||||+++++|.+++.... ....+++..+..++.||++||+|||+.   +|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999988875432 234589999999999999999999997   9999999999999987655   999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      ........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...+.   .. ..    .
T Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~---~~-~~----~  250 (351)
T 3c0i_A          181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII---KG-KY----K  250 (351)
T ss_dssp             EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHH---HT-CC----C
T ss_pred             eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHH---cC-CC----C
Confidence            87755332 22335699999999999999999999999999999999999999975321 1111111   00 00    0


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...   ........++.+++.+||+.||++|||+.|++++
T Consensus       251 ~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 MNP---RQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000   0011234678899999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-38  Score=346.92  Aligned_cols=261  Identities=26%  Similarity=0.360  Sum_probs=209.2

Q ss_pred             HhhHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSN  574 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  574 (818)
                      ...+.+.+.||+|+||.||+|....      .+.||+|.+..... ...+.+.+|++++.++ +||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            3445556789999999999999643      34799999975533 3456789999999999 89999999999999999


Q ss_pred             ceeeeeccCCCChhhHhhhcCC-----------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDR-----------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL  643 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~  643 (818)
                      .++||||+++|+|.+++.....           ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence            9999999999999999964321           23578999999999999999999997   999999999999999999


Q ss_pred             CEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHH
Q 043017          644 NVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKV  721 (818)
Q Consensus       644 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~  721 (818)
                      .+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..............
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            9999999999876544332 2223457789999999998899999999999999999999 8999876554332222111


Q ss_pred             HhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          722 KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       722 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ..        ....     .+......+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       282 ~~--------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          282 DG--------YQMA-----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HT--------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC--------CCCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            10        0000     011234678899999999999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-38  Score=346.02  Aligned_cols=272  Identities=27%  Similarity=0.366  Sum_probs=208.7

Q ss_pred             hHHhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeec--ccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA--ERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++|+||+++++++.  +....++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            445567899999999999984     358899999998766666678999999999999999999999886  4456889


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999996432  3589999999999999999999997   99999999999999999999999999999875


Q ss_pred             cCCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHH--HHHhhhhcchhhcc
Q 043017          658 QDQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL--KVKAEADRLCDLVD  733 (818)
Q Consensus       658 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~--~~~~~~~~~~~~~d  733 (818)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............  ........+...+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            54332  223345888899999999888999999999999999999999997532211100000  00000000111111


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      ... ....+......+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus       259 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          259 EGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             ccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            111 111133455778899999999999999999999999998876543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=346.67  Aligned_cols=266  Identities=24%  Similarity=0.317  Sum_probs=193.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeec--------ccCc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCA--------ERSN  574 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~--------~~~~  574 (818)
                      .+.+.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++.        ....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            3455678999999999999975 68999999986665556678999999999996 999999999983        3345


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC--eeecccccCeEEEcCCCCEEEeecCC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK--IIHFDIKPQNILLDRDLNVKIADFGL  652 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfgl  652 (818)
                      .++||||+. |+|.+++........+++..+..++.||+.||+|||+.   +  |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            789999995 79999886544445699999999999999999999997   7  99999999999999999999999999


Q ss_pred             ceecccCCCcc-----------ccCCCCCCcccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHH
Q 043017          653 ARLIAQDQSHV-----------STMPKGTPGYMAPELT---RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDT  718 (818)
Q Consensus       653 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~  718 (818)
                      ++.........           .....+++.|+|||.+   .+..++.++||||||+++|||++|+.||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            98765432211           1133589999999998   566789999999999999999999999864432211110


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchh
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSF  791 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~  791 (818)
                                  ......     .......+.+++.+||+.||++||++.|++++|+.+.........+.+..
T Consensus       265 ------------~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~~  320 (337)
T 3ll6_A          265 ------------KYSIPP-----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITE  320 (337)
T ss_dssp             -------------CCCCT-----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCHH
T ss_pred             ------------cccCCc-----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHHH
Confidence                        000000     11122357789999999999999999999999999876554444443333

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-37  Score=335.70  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=194.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            4556678999999999999875 58999999986543 334578899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcC---CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          583 CNGSLDKWIFHKD---RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       583 ~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      + ++|.+++....   ....+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            7 69999886432   224588999999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh--cchhhccc--
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD--RLCDLVDK--  734 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~--~~~~~~d~--  734 (818)
                      ... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.......  .....+..  
T Consensus       162 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          162 VNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             ccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            222 2234689999999999764 68999999999999999999999998765544433332221110  00000000  


Q ss_pred             ----cCcC-----------ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 ----KSED-----------MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ----~~~~-----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          ....           .........++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                0000           00011234578899999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=337.56  Aligned_cols=243  Identities=24%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~   87 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   87 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence            445568999999999999975 6899999998643   223456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus        88 ~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           88 IEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            9999999999653   3588999999999999999999997   9999999999999999999999999999875432  


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.   ..         ..   ..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~---------~~---~~  222 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---NA---------EL---RF  222 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HC---------CC---CC
T ss_pred             --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hC---------CC---CC
Confidence              233569999999999999999999999999999999999999997654333222221   11         00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      +.....++.+++.+||+.||++||     ++.+++++
T Consensus       223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            122345788999999999999999     89999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-38  Score=342.17  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=201.1

Q ss_pred             HhhhhcccccceeEEEeEecC-----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLND-----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.||+|+||.||+|....     +..||||.+..... .....+.+|++++.+++||||+++++++......++|||
T Consensus        47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  126 (333)
T 1mqb_A           47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE  126 (333)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence            345679999999999998753     24699999975432 335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       127 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          127 YMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             CCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             CCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            99999999999643  24689999999999999999999997   99999999999999999999999999998765433


Q ss_pred             Ccc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          661 SHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       661 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ...  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+.   ....        . 
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~---~~~~--------~-  269 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---DGFR--------L-  269 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCC--------C-
T ss_pred             ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---CCCc--------C-
Confidence            221  122346788999999999999999999999999999999 999997654433322221   1100        0 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                        +........+.+++.+||+.+|++||++.+++++|+.+.+.
T Consensus       270 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          270 --PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             --CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              11223446788999999999999999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-37  Score=329.39  Aligned_cols=248  Identities=21%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG   90 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence            4455689999999999999764 778999998766566678999999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceecccCCC
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      ++|.+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+||++   +.++.+||+|||++........
T Consensus        91 ~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           91 GELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             CBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999988654   3589999999999999999999997   99999999999999   7889999999999987654332


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||...........+....    .      .... ..
T Consensus       165 --~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~------~~~~-~~  230 (277)
T 3f3z_A          165 --MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT----F------TFPE-KD  230 (277)
T ss_dssp             --BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----C------CCCH-HH
T ss_pred             --hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----C------CCCc-hh
Confidence              2334689999999998764 8999999999999999999999997654433322221100    0      0000 00


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01234678899999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-37  Score=334.16  Aligned_cols=258  Identities=27%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             HHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeec-ccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCA-ERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-~~~~~~lV~  579 (818)
                      +.+.+.||+|+||.||+|...+    ...+|+|.+..... ...+.+.+|+.++++++||||+++++++. .+...++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            3445689999999999998653    23689999875433 34567999999999999999999999864 456789999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       107 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          107 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             ECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence            999999999999543  34688999999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCc---cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          660 QSH---VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       660 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ...   ......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...........+..   ...        
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~--------  250 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRR--------  250 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---TCC--------
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---CCC--------
Confidence            221   1223457889999999999999999999999999999999 5555554444333322211   000        


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      .   ..+......+.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus       251 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          251 L---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             C---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            0   0011234578899999999999999999999999998876543

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=3.5e-38  Score=330.50  Aligned_cols=225  Identities=18%  Similarity=0.214  Sum_probs=173.7

Q ss_pred             CCCcceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCC
Q 043017           38 SAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKE  117 (818)
Q Consensus        38 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~  117 (818)
                      ++.|+|+.++.+...++|||++     |+|+||||.++  +  .|+         |    +  +.+ |||+|||++|+.+
T Consensus        12 ~~~~~l~~g~~l~~~~~l~S~~-----g~F~lgf~~~~--~--~~l---------y----~--~~~-vvW~Anr~~p~~~   66 (276)
T 3m7h_A           12 VGTSVLPAYQTLSAGQYLLSPN-----QRFKLLLQGDG--N--LVI---------Q----D--NGA-TVWVANEQQPFSS   66 (276)
T ss_dssp             TTSSEECTTEEBCTTCEEECTT-----SSEEEEECTTS--C--EEE---------E----E--TTE-EEEECSTTSTTEE
T ss_pred             ccCCEecCCCEecCCCEEEcCC-----CcEEEEEECCC--C--eEE---------E----C--CCC-eEEECCCCCCcCC
Confidence            3457888888888889999999     99999999543  2  332         3    1  345 9999999999987


Q ss_pred             -----CceEEEeecccEEE--EcCCCcEEEeeccCC------CceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCC
Q 043017          118 -----NATLEFTADGDLIL--KDVDGTRVWSTETSG------SNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPG  184 (818)
Q Consensus       118 -----~~~l~l~~~g~Lvl--~~~~~~~vWst~~~~------~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg  184 (818)
                           +++|+|+.||+|||  .|++|++||+|+++.      ..++.|+|+|+|||||+|  +.++|||  |||||+|||
T Consensus        67 ~~~~~~~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg  142 (276)
T 3m7h_A           67 TIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPG  142 (276)
T ss_dssp             EEECCCTTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCS
T ss_pred             cccccceEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccc
Confidence                 68999999999999  788899999999865      346789999999999998  7899999  999999999


Q ss_pred             Ce----eccceeEeeccCCCCCCccEEEEEEccCCcEEEEeccceeeeeecccccceecccccccccceeEEe-cCCCce
Q 043017          185 QR----LHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVF-NKSGSH  259 (818)
Q Consensus       185 ~k----l~~~~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-n~~~~~  259 (818)
                      ||    |..++.|   ++.+||++|.|+++++++|..++++.+...+|++++|+...   ....+.....++. +.++..
T Consensus       143 ~~~~~~l~~g~~L---~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~---~~l~l~~dGnLvl~d~~~~~  216 (276)
T 3m7h_A          143 AIDSLLLAPGSEL---VQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGA---VRAVFQGDGNLVVYGAGNAV  216 (276)
T ss_dssp             CTTCEEECSSEEE---CTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTTC---CEEEECTTSCEEEECTTSCE
T ss_pred             cccccccccCccc---ccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCcc---EEEEEcCCCeEEEEeCCCcE
Confidence            99    6667787   56789999999999999998766655568899999986432   1122233333333 333344


Q ss_pred             EEEeeCCCCceEEEEECCCCcEEEEEecCCCCCCeeeeccC
Q 043017          260 ITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDE  300 (818)
Q Consensus       260 ~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~~~~~~~~~  300 (818)
                      +.++........|++|+.||++++|.|   ...|..++.++
T Consensus       217 vWsS~t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P  254 (276)
T 3m7h_A          217 LWHSHTGGHASAVLRLQANGSIAILDE---KPVWARFGFQP  254 (276)
T ss_dssp             EEECSCTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCT
T ss_pred             EEEecCCCCCCEEEEEcCCccEEEEcC---CCeEEccCccC
Confidence            444433334458999999999999999   24576666543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-37  Score=345.24  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=198.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.++||+|+||.||+++.. +++.||||++...   .....+.+..|..++.++ +||||+++++++.+.+..++||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            3445578999999999999976 4788999998654   223345688999999887 8999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.....
T Consensus       133 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999998654   3589999999999999999999997   9999999999999999999999999999864332


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-----HHHHHHHHhhhhcchhhccc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-----LVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-----l~~~~~~~~~~~~~~~~~d~  734 (818)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ..+.+....        ...
T Consensus       207 ~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~  277 (396)
T 4dc2_A          207 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEK  277 (396)
T ss_dssp             TC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------HHC
T ss_pred             CC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------hcc
Confidence            22 2334579999999999999999999999999999999999999996432211     011111110        001


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcH------HHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSA------SMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~  773 (818)
                      ..   ..+.....++.+++.+||+.||++||++      .|++++
T Consensus       278 ~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          278 QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             CC---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             cc---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            11   1122345678899999999999999985      677664

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=335.69  Aligned_cols=246  Identities=26%  Similarity=0.332  Sum_probs=192.4

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ...+.+.++||+|+||+||+|+.. +++.||||++.....  ....++..|+..+.++ +|+||+++++++.++...++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            344555668999999999999986 689999999865432  2334556666666555 899999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+ +++|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 779999886543  4699999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ...  .....||+.|+|||++.+ .++.++||||||+++|||++|..|+....   ....+   .. ...         .
T Consensus       210 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~---~~-~~~---------~  270 (311)
T 3p1a_A          210 AGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQL---RQ-GYL---------P  270 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHH---TT-TCC---------C
T ss_pred             CCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH---hc-cCC---------C
Confidence            322  233468999999999876 78999999999999999999977654221   11111   00 000         0


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .........++.+++.+||+.||++|||+.|++++
T Consensus       271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            00011234678899999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-37  Score=342.77  Aligned_cols=248  Identities=22%  Similarity=0.288  Sum_probs=203.9

Q ss_pred             hhHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+++... ++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            344556789999999999999864 788999998643   234467788999999988 899999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus       100 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999654   3589999999999999999999997   999999999999999999999999999986433


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   .         ..  
T Consensus       174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~---------~~--  238 (353)
T 2i0e_A          174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---H---------NV--  238 (353)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C---------CC--
T ss_pred             CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh---C---------CC--
Confidence            222 22345799999999999999999999999999999999999999976554433333221   0         00  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                       ..+.....++.+++.+||+.||.+||     ++.+++++
T Consensus       239 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             01123346788999999999999999     46888765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-37  Score=340.91  Aligned_cols=255  Identities=22%  Similarity=0.255  Sum_probs=199.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-----CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-----ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .+.+.+.||+|+||.||++... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            4455578999999999999975 5789999988543     234467899999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhc-------------------------------------CCccccchhhHHHHHHHHHHHHHHHHh
Q 043017          579 YEYMCNGSLDKWIFHK-------------------------------------DRIQTLSWDIRKKIIFQISRGLEYLHD  621 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~  621 (818)
                      |||+++|+|.+++...                                     .....+++..+..++.||++||+|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999988421                                     012235677888999999999999999


Q ss_pred             cCCCCeeecccccCeEEEcCCC--CEEEeecCCceecccCCCc---cccCCCCCCcccccccccC--CCCCchhhHHHHH
Q 043017          622 YCNPKIIHFDIKPQNILLDRDL--NVKIADFGLARLIAQDQSH---VSTMPKGTPGYMAPELTRG--NSITAKIDIYSFG  694 (818)
Q Consensus       622 ~~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~G  694 (818)
                      .   +|+||||||+|||++.++  .+||+|||+++.+......   ......||+.|+|||.+.+  ..++.++||||||
T Consensus       187 ~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             T---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             C---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            7   999999999999998776  8999999999876543221   2234569999999999975  6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          695 VVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       695 vll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +++|||++|+.||...........+..   ...        ....+........+.+++.+||+.+|.+||++.+++++
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLN---KKL--------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHH---CCC--------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHh---ccc--------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            999999999999976554332222211   100        00001112235678899999999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-37  Score=338.90  Aligned_cols=248  Identities=24%  Similarity=0.311  Sum_probs=194.1

Q ss_pred             hhHHhhhhcccccceeEEEeEe----cCCcEEEEEEcCCCC----CccHHHHHHHHHHHhccCcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGE----NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.+.||+|+||.||+++.    .+++.||||++....    ......+.+|++++++++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            3455667899999999999987    468999999987542    23345688999999999999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++||||+++++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999653   3588999999999999999999997   999999999999999999999999999986


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..   .         .
T Consensus       171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~---------~  237 (327)
T 3a62_A          171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK---C---------K  237 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---T---------C
T ss_pred             cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---C---------C
Confidence            543322 22335689999999999999999999999999999999999999976544333322211   0         0


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .   ..+.....++.+++.+||+.||++||     ++.|++++
T Consensus       238 ~---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 L---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             C---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             C---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            0   01122346788999999999999999     78888875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=343.30  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||++... +++.||||.+...   .....+.+.+|++++..++||||+++++++.+....++|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            3455678999999999999976 4889999998543   23445788999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        96 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           96 LLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             CCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999998543   4589999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CccccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          661 SHVSTMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .  .....||+.|+|||++..   ..++.++|||||||++|||++|+.||..................         .. 
T Consensus       170 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------~~-  237 (384)
T 4fr4_A          170 Q--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---------VV-  237 (384)
T ss_dssp             C--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------CC-
T ss_pred             c--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------cc-
Confidence            2  234579999999999964   45899999999999999999999999765444333222221111         00 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCc-HHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS-ASMLVK  772 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~  772 (818)
                        ..+......+.+++.+||+.||.+||+ +.++++
T Consensus       238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              112234567889999999999999998 777665

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.4e-38  Score=345.55  Aligned_cols=246  Identities=24%  Similarity=0.341  Sum_probs=202.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+++.. +++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~   97 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   97 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4445678999999999999986 58899999986431   33456788899999887 9999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.....
T Consensus        98 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           98 EYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            999999999999653   3589999999999999999999997   9999999999999999999999999999865332


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+...   .       ...   
T Consensus       172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~-------~~~---  237 (345)
T 1xjd_A          172 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---N-------PFY---  237 (345)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---C-------CCC---
T ss_pred             CC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------CCC---
Confidence            22 233457999999999999999999999999999999999999999866544333332210   0       001   


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHH-HHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSAS-MLVK  772 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~  772 (818)
                        +.....++.+++.+||+.||++||++. ++++
T Consensus       238 --p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          238 --PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             --CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence              112346788999999999999999997 6654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-37  Score=330.88  Aligned_cols=257  Identities=25%  Similarity=0.352  Sum_probs=204.3

Q ss_pred             hhhcccccceeEEEeEecC----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcc-eeeeecc
Q 043017          509 QIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR-FLVYEYM  582 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~-~lV~e~~  582 (818)
                      .+.||+|+||.||+|...+    +..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            3679999999999998643    23799999875433 3457889999999999999999999999876655 9999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC--
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ--  660 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~--  660 (818)
                      .+++|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus       106 ~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          106 CHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             cCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999542  35688999999999999999999998   99999999999999999999999999998654332  


Q ss_pred             -CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          661 -SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSN-PKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       661 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~-~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                       ........+++.|+|||.+.+..++.++||||||+++|||++|..|+. ......+...+..   ...           
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---~~~-----------  246 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---GRR-----------  246 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---TCC-----------
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---CCC-----------
Confidence             112233457889999999999999999999999999999999665543 3333332222211   100           


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVT  784 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  784 (818)
                      ...+......+.+++.+||+.+|.+|||+.++++.|+++.+.-...
T Consensus       247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            0112223467889999999999999999999999999887654433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=348.12  Aligned_cols=270  Identities=20%  Similarity=0.270  Sum_probs=211.8

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccC--cceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--NRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            4455689999999999999764 8999999987543 344677889999999999999999999987755  67999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE----cCCCCEEEeecCCceecc
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----DRDLNVKIADFGLARLIA  657 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla~~~~  657 (818)
                      +++|+|.+++........+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++...
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            99999999996554444599999999999999999999997   99999999999999    778889999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhhc-
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRG--------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEADR-  727 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~~-  727 (818)
                      ....  .....||+.|+|||++..        ..++.++|||||||++|||++|+.||.+..... ..+.+........ 
T Consensus       168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             CCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            4322  223468999999999865        467889999999999999999999997543321 1222222211110 


Q ss_pred             --chhh----------ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          728 --LCDL----------VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       728 --~~~~----------~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                        ....          .................+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence              0000          0001111122456778899999999999999999999999999888764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-37  Score=341.61  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=203.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +++.||||++...   .....+.+.+|+++++.++||||+++++++.+....++||||
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  122 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            444568999999999999976 5899999998543   224457889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       123 ~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          123 VAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             CTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999654   3589999999999999999999997   9999999999999999999999999999876432  


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   . .        .   ..
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~-~--------~---~~  257 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---G-K--------V---RF  257 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C-C--------C---CC
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc---C-C--------C---CC
Confidence              2234689999999999999999999999999999999999999976544333322221   1 0        0   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      +.....++.+++.+||+.||.+||+     +.+++++
T Consensus       258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            1223467889999999999999998     8888865

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-38  Score=351.70  Aligned_cols=250  Identities=21%  Similarity=0.242  Sum_probs=202.0

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus        65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            3457999999999999985 68999999986421   2233458899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +|+|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.........
T Consensus       145 gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          145 GGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             SCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence            999999996532  3689999999999999999999997   99999999999999999999999999999876554444


Q ss_pred             ccCCCCCCccccccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          664 STMPKGTPGYMAPELTR-------GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      .....||+.|+|||++.       ...++.++|||||||++|||++|+.||...........+........        .
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~  291 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------L  291 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------C
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------C
Confidence            44567999999999997       45689999999999999999999999976654433333221111000        0


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCC---CcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRR---PSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~~  773 (818)
                      +.  .....+.++.+++.+||+ +|++|   |+++|++++
T Consensus       292 p~--~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          292 PL--VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             C------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             Cc--cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            00  011234678899999999 99888   699999876

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4e-37  Score=334.11  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=204.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc------cHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||++... +++.||||.+......      ..+++.+|+.++.+++||||+++++++.+....++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4556678999999999999976 5899999998654321      36789999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC----CEEEeecCCc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL----NVKIADFGLA  653 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla  653 (818)
                      ||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++    .+||+|||++
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999543   4689999999999999999999997   999999999999999887    7999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      ........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..   ..     . 
T Consensus       167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~---~~-----~-  235 (321)
T 2a2a_A          167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS---VS-----Y-  235 (321)
T ss_dssp             EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT---TC-----C-
T ss_pred             eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---cc-----c-
Confidence            87655332  2234689999999999999999999999999999999999999976543332222211   00     0 


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ... ..........+.+++.+||+.||++|||+.|++++
T Consensus       236 -~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 -DFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             -CCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             -ccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000 00011234578899999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.2e-38  Score=338.21  Aligned_cols=262  Identities=26%  Similarity=0.349  Sum_probs=205.4

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeec----ccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA----ERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~----~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.    .....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            455667899999999999997 568999999987655566778999999999999999999999986    344778999


Q ss_pred             eccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      ||+++++|.+++... .....+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            999999999998652 2335689999999999999999999998   999999999999999999999999999886542


Q ss_pred             CCCc--------cccCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC--CCchHHHHHHHHhhh
Q 043017          659 DQSH--------VSTMPKGTPGYMAPELTRGNS---ITAKIDIYSFGVVILEIICGRRSSNPK--GGDYLVDTLKVKAEA  725 (818)
Q Consensus       659 ~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvll~elltG~~p~~~~--~~~~l~~~~~~~~~~  725 (818)
                      ....        ......|++.|+|||.+....   ++.++||||||+++|||++|+.||...  ..........     
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----  261 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-----  261 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-----
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-----
Confidence            2111        011234789999999987654   689999999999999999999998521  1111111110     


Q ss_pred             hcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCC
Q 043017          726 DRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV  783 (818)
Q Consensus       726 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  783 (818)
                              ... ..+........+.+++.+||+.||.+||++.+++++|+.+....+.
T Consensus       262 --------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          262 --------NQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             --------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             --------ccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                    000 0011123346788999999999999999999999999998766554

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.6e-38  Score=338.02  Aligned_cols=258  Identities=31%  Similarity=0.432  Sum_probs=206.9

Q ss_pred             hHHhhhhcccccceeEEEeEe------cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccC-cc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERS-NR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~-~~  575 (818)
                      .+.+.+.||+|+||.||+|..      .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  107 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  107 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence            444557899999999999974      3468999999975533 3346789999999999 7999999999987755 58


Q ss_pred             eeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD  642 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~  642 (818)
                      ++||||+++++|.+++.....             ...+++..+..++.||++||.|||+.   +|+||||||+||+++.+
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK  184 (316)
T ss_dssp             EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence            999999999999999965432             12388999999999999999999997   99999999999999999


Q ss_pred             CCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHH-HHH
Q 043017          643 LNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLV-DTL  719 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~-~~~  719 (818)
                      +.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  264 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  264 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence            99999999999876544332 2223457889999999999999999999999999999998 99999765433221 111


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .   ....      .     ..+.....++.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       265 ~---~~~~------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          265 K---EGTR------M-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             H---HTCC------C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c---cCcc------C-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1   1000      0     0112234578899999999999999999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-37  Score=335.18  Aligned_cols=268  Identities=24%  Similarity=0.353  Sum_probs=202.8

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc--CcceeEEEeeeeccc----Ccce
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI--HHFNLVRLVGYCAER----SNRF  576 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l--~H~niv~l~g~~~~~----~~~~  576 (818)
                      ...+.+.+.||+|+||.||+|+.. ++.||||++...   ....+..|.+++..+  +||||+++++++...    ...+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            345556678999999999999986 899999998532   234556666666655  899999999999877    6789


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC-----CCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC-----NPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      +||||+++|+|.+++..    ..+++..+..++.|++.||+|||+..     +.+|+||||||+|||++.++.+||+|||
T Consensus       112 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence            99999999999999954    35899999999999999999999741     3489999999999999999999999999


Q ss_pred             CceecccCCCccc---cCCCCCCcccccccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 043017          652 LARLIAQDQSHVS---TMPKGTPGYMAPELTRGNSITAK------IDIYSFGVVILEIICG----------RRSSNPKGG  712 (818)
Q Consensus       652 la~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k------sDVwS~Gvll~elltG----------~~p~~~~~~  712 (818)
                      +++..........   ....||+.|+|||.+.+.....+      +|||||||++|||++|          +.|+.....
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            9987654433221   23469999999999987766654      9999999999999999          666654322


Q ss_pred             -chHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          713 -DYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       713 -~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                       ...............    .....+..........++.+++.+||+.||.+|||+.+++++|+.+.+...
T Consensus       268 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             SSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCchhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence             111222221111111    111111111234677889999999999999999999999999998876543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-37  Score=337.40  Aligned_cols=268  Identities=25%  Similarity=0.313  Sum_probs=209.6

Q ss_pred             HHHHhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhc--cCcceeEEEeeeecccC----
Q 043017          500 AMKSATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGN--IHHFNLVRLVGYCAERS----  573 (818)
Q Consensus       500 ~l~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~~----  573 (818)
                      +.....+.+.+.||+|+||.||+|+.. ++.||||.+...   ....+.+|++++..  ++||||+++++++....    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            344455666778999999999999985 899999998532   35678889888887  78999999999998776    


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHH--------hcCCCCeeecccccCeEEEcCCCCE
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH--------DYCNPKIIHFDIKPQNILLDRDLNV  645 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~iiH~Dlkp~NIll~~~~~~  645 (818)
                      ..++||||+++|+|.+++..    ..+++..+..++.|+++||+|||        +.   +|+||||||+|||++.++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence            78999999999999999954    35899999999999999999999        55   99999999999999999999


Q ss_pred             EEeecCCceecccCCCc---cccCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhC----------CCC
Q 043017          646 KIADFGLARLIAQDQSH---VSTMPKGTPGYMAPELTRGNS------ITAKIDIYSFGVVILEIICG----------RRS  706 (818)
Q Consensus       646 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwS~Gvll~elltG----------~~p  706 (818)
                      ||+|||++.........   ......||+.|+|||.+.+..      ++.++||||||+++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999877654432   123346999999999998752      34789999999999999999          677


Q ss_pred             CCCCCCc-hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          707 SNPKGGD-YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       707 ~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      |...... .....+........    ..+..+...........+.+++.+||+.||++|||+.+|+++|+.+.+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             ccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            7654321 11222221111111    111111111234677889999999999999999999999999998876543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-37  Score=367.86  Aligned_cols=247  Identities=26%  Similarity=0.403  Sum_probs=200.1

Q ss_pred             hhcccccceeEEEeEec---CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLN---DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++||+|+||.||+|.+.   .++.||||++....  ....++|.+|++++.+++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            36999999999999753   46789999997543  2336789999999999999999999999964 568899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc--
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--  662 (818)
                      |+|.+++...   ..+++..+..|+.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.+......  
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999543   4589999999999999999999997   9999999999999999999999999999877544322  


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......+...+..   ..           ....
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~-----------~~~~  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GE-----------RMGC  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TC-----------CCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC-----------CCCC
Confidence            2223356789999999999999999999999999999998 9999987655443333221   10           0111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      +.....++.+++..||+.||++||++.+|++.|+.+
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            223456788999999999999999999999999865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-37  Score=341.66  Aligned_cols=250  Identities=22%  Similarity=0.267  Sum_probs=192.6

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            4556678999999999999976 68999999986543 334678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC--EEEeecCCceecccCCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN--VKIADFGLARLIAQDQS  661 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~~~~  661 (818)
                      +|+|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.  +||+|||+++.......
T Consensus       100 ~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A          100 GGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             SCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            99999998654   3589999999999999999999997   9999999999999987765  99999999975433221


Q ss_pred             ccccCCCCCCcccccccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhhcchhhccccCcCc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAK-IDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                        .....||+.|+|||.+.+..+..+ +|||||||++|||++|+.||....... ....+.......       ...   
T Consensus       174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~---  241 (361)
T 3uc3_A          174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK-------YSI---  241 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC-------CCC---
T ss_pred             --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC-------CCC---
Confidence              223469999999999988887665 899999999999999999998654322 222222111110       000   


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.......++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            1111234678899999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.9e-38  Score=343.79  Aligned_cols=245  Identities=25%  Similarity=0.354  Sum_probs=200.3

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      |.+.+.||+|+||.||+|.. .+++.||||.+...   .......+.+|+.+++.++||||+++++++......++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            44567899999999999997 46899999998543   123346789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      + +|+|.+++...   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        91 ~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           91 A-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             C-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             C-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            9 78999988654   3589999999999999999999998   999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                        .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......+.             ..+....  ..
T Consensus       164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------~~i~~~~--~~  226 (336)
T 3h4j_B          164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------KKVNSCV--YV  226 (336)
T ss_dssp             --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------CCCCSSC--CC
T ss_pred             --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHHcCC--CC
Confidence              233469999999999988775 78999999999999999999999754322111             0011100  01


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            1223346788999999999999999999998863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-37  Score=345.93  Aligned_cols=270  Identities=20%  Similarity=0.245  Sum_probs=204.9

Q ss_pred             hHHhhhhcccc--cceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRG--GSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.++||+|  +||.||+++.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            34556789999  99999999986 68999999986543  233467888999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       106 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          106 SFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             ECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999986542 24589999999999999999999997   9999999999999999999999999998765432


Q ss_pred             CC------ccccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc----
Q 043017          660 QS------HVSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR----  727 (818)
Q Consensus       660 ~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~----  727 (818)
                      ..      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....................    
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence            11      11122368999999999987  5789999999999999999999999986554333221110000000    


Q ss_pred             -------------------chhhcc--------ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCc
Q 043017          728 -------------------LCDLVD--------KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLT  778 (818)
Q Consensus       728 -------------------~~~~~d--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~  778 (818)
                                         ..+.+.        ......+.......++.+|+.+||+.||++|||+.|++++  ++.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                               000000        0000001122345678899999999999999999999976  44443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-37  Score=329.15  Aligned_cols=260  Identities=25%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.++||+|+||+||+|... +++.||||++.....  ...+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            44568999999999999975 588999999865432  334778999999999999999999999999999999999997


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      + +|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        85 ~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  157 (292)
T 3o0g_A           85 Q-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             E-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred             C-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence            5 555555432  24689999999999999999999998   9999999999999999999999999999876543222 


Q ss_pred             ccCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC-CchHHHHHHHHhhhhc------chhhcccc
Q 043017          664 STMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKG-GDYLVDTLKVKAEADR------LCDLVDKK  735 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~-~~~l~~~~~~~~~~~~------~~~~~d~~  735 (818)
                      .....+|+.|+|||.+.+.. ++.++||||||+++|||++|+.|+.... .......+........      .....+..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            23346899999999998766 7999999999999999999888854332 2222222221111100      00000000


Q ss_pred             --------CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          736 --------SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       736 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                              ............++.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                    00000112345678899999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=341.45  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=186.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|++++.+++||||+++++++......++||||+++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            445568999999999999986 47899999986543  346788999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCceecccCCC
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~  661 (818)
                      ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.   ++.+||+|||+++.......
T Consensus       133 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          133 GELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             CBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            9999998543   4589999999999999999999997   9999999999999975   88999999999987644321


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-HHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-LVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.   ... . ....      +
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~---~~~-~-~~~~------~  273 (349)
T 2w4o_A          207 --MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---NCE-Y-YFIS------P  273 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH---TTC-C-CCCT------T
T ss_pred             --cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH---hCC-C-ccCC------c
Confidence              223468999999999999999999999999999999999999997654432 111111   100 0 0000      0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......++.+++.+||+.||++|||+.|++++
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112344678899999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-37  Score=335.40  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=198.5

Q ss_pred             hhHHhhhhcccccceeEEEeEec----CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCc---
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN---  574 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~---  574 (818)
                      ..+.+.+.||+|+||.||+|...    .++.||||.+....  ....+.+.+|+.++.+++||||+++++++.+...   
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            34445568999999999999865    34589999986543  2334678999999999999999999999977653   


Q ss_pred             --ceeeeeccCCCChhhHhhhc---CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          575 --RFLVYEYMCNGSLDKWIFHK---DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       575 --~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                        .++||||+++++|.+++...   .....+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence              49999999999999998542   2335689999999999999999999997   999999999999999999999999


Q ss_pred             cCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          650 FGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       650 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      ||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+....    
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----  266 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH----  266 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC----
Confidence            9999876543321 2223457889999999999999999999999999999999 888987665544433322100    


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                             ..   ..+.....++.+++.+||+.+|.+||++.+++++|+.+.+.
T Consensus       267 -------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          267 -------RL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             -------CC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                   00   11223446788999999999999999999999999987653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.6e-37  Score=330.58  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=203.4

Q ss_pred             HHhhh-hcccccceeEEEeEec---CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQI-RLGRGGSGSVFEGLLN---DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +.+.+ .||+|+||.||+|...   .++.||||.+.....  ...+++.+|++++++++||||+++++++ ..+..++||
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            33445 7999999999999643   468899999875432  2357899999999999999999999999 567789999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        97 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           97 EMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             ECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            999999999999653   3588999999999999999999997   9999999999999999999999999999887654


Q ss_pred             CCccc--cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          660 QSHVS--TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       660 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      .....  ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+..   . .       . 
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~-~-------~-  238 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---G-E-------R-  238 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---T-C-------C-
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---C-C-------C-
Confidence            43222  22346788999999988889999999999999999999 9999976554333222211   0 0       0 


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                        ...+......+.+++.+||+.||++||++.++++.|+.+..
T Consensus       239 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              01122345678899999999999999999999999987743

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.3e-38  Score=355.34  Aligned_cols=246  Identities=25%  Similarity=0.335  Sum_probs=193.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +++.||||++...   .......+.+|++++++++||||+++++++...+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            445568999999999999965 5899999998643   333456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++|+|.+++...   ..+++..+..++.||++||+|||+ .   +|+||||||+||||+.++.+||+|||+++......
T Consensus       230 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          230 ANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             CSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999998653   358999999999999999999997 6   99999999999999999999999999998644332


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+...            ..   .
T Consensus       304 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------~~---~  367 (446)
T 4ejn_A          304 AT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------EI---R  367 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------CC---C
T ss_pred             cc-cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------CC---C
Confidence            22 23357999999999999999999999999999999999999999765544333332210            00   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      .+.....++.+++.+||+.||.+||     ++.|++++
T Consensus       368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            1122346788999999999999999     99999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-37  Score=333.83  Aligned_cols=259  Identities=20%  Similarity=0.241  Sum_probs=197.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc---cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||++... +++.||||.+......   ..+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            3455678999999999999975 6889999998654322   24678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       115 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          115 LINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             CCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999654   3589999999999999999999997   99999999999999999999999999998765543


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ........+++.|+|||.+.+..++.++||||||+++|||++|+.||.......+...+.   ..      ....   ..
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~------~~~~---~~  256 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QA------IPRP---ST  256 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SC------CCCG---GG
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cC------CCCc---cc
Confidence            333334568999999999999999999999999999999999999997543221111110   00      0000   00


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-cHHHHHHHHhcCcCCC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRP-SASMLVKVLQGLTKLE  781 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~  781 (818)
                      .....+.++.+++.+||+.||++|| ++.++++.|+......
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            1123345788999999999999999 9999999999886654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-37  Score=327.12  Aligned_cols=268  Identities=19%  Similarity=0.254  Sum_probs=208.1

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeee-cccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC-AERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||+|+. .+++.||||++.....  .+++.+|+.++..++|++++..+..+ .++...++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            34556899999999999996 5689999999865432  35789999999999988766666655 5566779999999 


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||+   +.++.+||+|||+++......
T Consensus        88 ~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           88 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            999999996432  4689999999999999999999998   99999999999999   588999999999999876543


Q ss_pred             Cc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc---hHHHHHHHHhhhhcchhh
Q 043017          661 SH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD---YLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       661 ~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~---~l~~~~~~~~~~~~~~~~  731 (818)
                      ..      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......   .....+........... 
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH-
Confidence            31      123356999999999999999999999999999999999999999864322   22222221111100000 


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchh
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSF  791 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~  791 (818)
                      +         ....+.++.+++.+||+.||++||++.++++.|+.+.+.........+++
T Consensus       242 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 3uzp_A          242 L---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             H---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred             H---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence            0         11234678899999999999999999999999999876554433333433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.2e-38  Score=342.36  Aligned_cols=265  Identities=25%  Similarity=0.390  Sum_probs=205.7

Q ss_pred             HhhhhcccccceeEEEeEec-----CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeeccc--Ccceee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-----DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAER--SNRFLV  578 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV  578 (818)
                      .+.++||+|+||.||++.+.     +++.||||++..... ...+.+.+|++++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            45568999999999988753     588999999975532 3356799999999999999999999999874  567899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++++|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       114 ~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             ECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999543    489999999999999999999997   999999999999999999999999999998765


Q ss_pred             CCCc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHH---HHhhhhcchhhcc
Q 043017          659 DQSH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK---VKAEADRLCDLVD  733 (818)
Q Consensus       659 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~---~~~~~~~~~~~~d  733 (818)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....   .......+...+.
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHh
Confidence            4332  22334578889999999988899999999999999999999999853211100 0000   0000001111111


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ... ....+.....++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       266 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          266 RGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            111 1111334557889999999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-37  Score=327.50  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=202.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   87 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   87 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence            344568999999999999975 58899999986442  233467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC---EEEeecCCceecccC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQD  659 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~~  659 (818)
                      ++++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++......
T Consensus        88 ~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           88 TGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            999999988654   3589999999999999999999997   9999999999999987655   999999999876543


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ...  ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+....        ....... 
T Consensus       162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~-  230 (284)
T 3kk8_A          162 EAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--------YDYPSPE-  230 (284)
T ss_dssp             CBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------CCCCTTT-
T ss_pred             ccc--cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc--------ccCCchh-
Confidence            322  23468999999999999999999999999999999999999997655433333222110        0001111 


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ......++.+++.+||+.||++|||+.|++++
T Consensus       231 --~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          231 --WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              12234678899999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=344.91  Aligned_cols=268  Identities=18%  Similarity=0.218  Sum_probs=206.2

Q ss_pred             hHHhhhhcccccceeEEEeEecC---------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEE-----------
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND---------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR-----------  564 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~-----------  564 (818)
                      .+.+.+.||+|+||.||+|+...         ++.||||.+...     +.+.+|++++.+++||||++           
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            44566789999999999999764         789999998643     46889999999999999998           


Q ss_pred             ----Eeeeecc-cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE
Q 043017          565 ----LVGYCAE-RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL  639 (818)
Q Consensus       565 ----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll  639 (818)
                          +++++.. +...++||||+ +++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||+
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~  192 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV  192 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence                5666655 66789999999 999999996532 35699999999999999999999997   99999999999999


Q ss_pred             cCCC--CEEEeecCCceecccCCCc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 043017          640 DRDL--NVKIADFGLARLIAQDQSH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG  711 (818)
Q Consensus       640 ~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~  711 (818)
                      +.++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  8999999999876543221      1123469999999999999999999999999999999999999997654


Q ss_pred             Cc-hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCC
Q 043017          712 GD-YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYG  787 (818)
Q Consensus       712 ~~-~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~  787 (818)
                      .. .......... ......+.....    .......++.+++.+||+.||++||++.++++.|+.+.+........
T Consensus       273 ~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          273 PNTEDIMKQKQKF-VDKPGPFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             TCHHHHHHHHHHH-HHSCCCEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             cCHHHHHHHHHhc-cCChhhhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            22 1111111110 011111111000    01123467889999999999999999999999999987665444333

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.8e-37  Score=336.78  Aligned_cols=250  Identities=26%  Similarity=0.328  Sum_probs=199.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|..++.++ +||||+++++++.+....++|||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            445568999999999999976 58899999986542   22345688899999988 89999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus        91 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           91 YVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999998653   3589999999999999999999997   99999999999999999999999999998643322


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCch-----HHHHHHHHhhhhcchhhcccc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDY-----LVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~-----l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ....+.....        ...
T Consensus       165 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--------~~~  235 (345)
T 3a8x_A          165 D-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQ  235 (345)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--------HCC
T ss_pred             C-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--------cCC
Confidence            2 2334579999999999999999999999999999999999999997532111     0111111100        001


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcH------HHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSA------SMLVKV  773 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~  773 (818)
                      .   ..+.....++.+++.+||+.||++||++      .+++++
T Consensus       236 ~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          236 I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             C---CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            1   0122344678899999999999999985      677654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-37  Score=328.86  Aligned_cols=251  Identities=27%  Similarity=0.383  Sum_probs=197.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.++||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            4555678999999999999975 58899999986543 345678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceeccc
Q 043017          583 CNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       583 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~  658 (818)
                      ++++|.+++... .....+++..+..++.||++||+|||+.   +|+||||||+||++   +.++.+||+|||++.....
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999999988543 2235689999999999999999999997   99999999999999   4567899999999987654


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ...  .....|++.|+|||.+. ..++.++||||||+++|||++|+.||................          .....
T Consensus       180 ~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~~~~  246 (285)
T 3is5_A          180 DEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----------PNYAV  246 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------CCCCC
T ss_pred             ccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----------ccccc
Confidence            322  23346899999999986 468999999999999999999999997654333222221100          00000


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        .......++.+++.+||+.||++|||+.|++++
T Consensus       247 --~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          247 --ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             --ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              001134577899999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-37  Score=350.86  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=203.8

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++||||+++++++...+..++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3445678999999999999976 68999999986432   2335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        97 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           97 YVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             CCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999532   4589999999999999999999997   99999999999999999999999999998765432


Q ss_pred             CccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .  .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......+...+.   ..         ...  
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~---------~~~--  234 (476)
T 2y94_A          171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC---DG---------IFY--  234 (476)
T ss_dssp             C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH---TT---------CCC--
T ss_pred             c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh---cC---------CcC--
Confidence            2  233569999999999988765 789999999999999999999998655443333221   10         000  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       .+.....++.+++.+||+.||++|||+.|++++
T Consensus       235 -~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          235 -TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence             011234568899999999999999999999984

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-37  Score=328.82  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=198.5

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc-CcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER-SNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||++... ++.||||.+...  ...+.+.+|++++.+++||||+++++++.+. +..++||||++
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            3445568999999999999875 889999998644  3467899999999999999999999987654 47899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++.... ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......   
T Consensus        99 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A           99 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             TEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence            999999995432 23478999999999999999999997   99999999999999999999999999998654322   


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   ..      ..     ...+
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~------~~-----~~~~  236 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KG------YK-----MDAP  236 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT---TT------CC-----CCCC
T ss_pred             -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cC------CC-----CCCc
Confidence             12347889999999998899999999999999999998 999987655443332221   00      00     0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ......+.+++.+||+.||++||++.++++.|+.+...
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            23456788999999999999999999999999987643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-37  Score=330.42  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=197.9

Q ss_pred             hHHhhhhcccccceeEEEeEec--CCc--EEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN--DGT--KVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||+|++.  +++  .||||.+....   ....+.+.+|++++.+++||||+++++++.... .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            4455678999999999999864  233  68999986542   334578999999999999999999999998765 889


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++....  ..+++..+..++.||++||+|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus        98 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999999996532  4689999999999999999999997   99999999999999999999999999998875


Q ss_pred             cCCCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          658 QDQSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       658 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   ...        
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~--------  241 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---KEG--------  241 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TSC--------
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH---ccC--------
Confidence            543322  223457888999999998889999999999999999999 999997665433332221   100        


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                        ...+.......++.+++.+||+.+|++|||+.++++.|+++.....
T Consensus       242 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          242 --ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             --CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence              0011122345678899999999999999999999999998876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.6e-37  Score=325.74  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=200.8

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC------ccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||++... +++.||+|.+.....      ...+.+.+|++++++++||||+++++++......++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            3455678999999999999986 589999998865421      236789999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC----CEEEeecCCc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL----NVKIADFGLA  653 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla  653 (818)
                      ||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +++||||||+||+++.++    .+||+|||++
T Consensus        86 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999643   3589999999999999999999997   999999999999998877    8999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      .........  ....+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+..   ..       
T Consensus       160 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~-------  227 (283)
T 3bhy_A          160 HKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA---VN-------  227 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---TC-------
T ss_pred             eeccCCCcc--cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh---cc-------
Confidence            876543322  234589999999999999999999999999999999999999976543322222110   00       


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ... ...........+.+++.+||+.||++||++.+++++
T Consensus       228 ~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          228 YDF-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCC-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             cCC-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            000 000011234578899999999999999999999984

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.8e-37  Score=329.52  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS   89 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence            4455678999999999999975 689999999976655556778999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++.......
T Consensus        90 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           90 GGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             SCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             CccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            99999988654   3588999999999999999999997   99999999999999   788999999999997654321


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                         .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......+...+....        ....   .+
T Consensus       164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------~~~~---~~  229 (304)
T 2jam_A          164 ---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY--------YEFE---SP  229 (304)
T ss_dssp             ---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC--------CCCC---TT
T ss_pred             ---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--------CCCC---cc
Confidence               122358999999999999999999999999999999999999997655433333222110        0000   00


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......++.+++.+||+.||++||++.|++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          230 FWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            112334678899999999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=331.36  Aligned_cols=263  Identities=24%  Similarity=0.274  Sum_probs=200.3

Q ss_pred             hhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC-----CccHHHHHHHHHHHhccC---cceeEEEeeeecccC-
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE-----NRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERS-  573 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-----~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~-  573 (818)
                      ..+.+.++||+|+||+||+|+. .+++.||||++....     ......+.+|++++++++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            3455667899999999999996 468999999986322     122356778888777764   999999999997755 


Q ss_pred             ----cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEee
Q 043017          574 ----NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIAD  649 (818)
Q Consensus       574 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  649 (818)
                          ..++||||+. ++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence                4789999996 69999886543 24489999999999999999999998   999999999999999999999999


Q ss_pred             cCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch
Q 043017          650 FGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC  729 (818)
Q Consensus       650 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~  729 (818)
                      ||+++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..........
T Consensus       164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            999986644322  233468999999999999999999999999999999999999998765544433332221111000


Q ss_pred             hhc------cccCc-Ccc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 DLV------DKKSE-DMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 ~~~------d~~~~-~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...      ..... ...     ........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000      00000 000     011234678899999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.9e-37  Score=327.08  Aligned_cols=266  Identities=19%  Similarity=0.258  Sum_probs=204.4

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeee-cccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC-AERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||+|+. .+++.||||.+.....  ..++.+|++++..++|++++..++.+ ..+...++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            345567899999999999996 5689999998654332  34588999999999888777766655 5666789999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceecccC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~  659 (818)
                       +++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        88 -~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           88 -GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             -CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             -CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence             999999986432  3589999999999999999999998   99999999999999   88999999999999987654


Q ss_pred             CCc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          660 QSH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       660 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      ...      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+....... ......
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~  240 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPIE  240 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-HHSCHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-ccchhh
Confidence            331      1233568999999999999999999999999999999999999998654322111111111100 000000


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCC
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTD  785 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~  785 (818)
                      ..      ....+.++.+++..||+.+|++|||+.++++.|+.+.+......
T Consensus       241 ~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          241 VL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HH------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             hh------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            00      01124678899999999999999999999999999876544333

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-37  Score=332.41  Aligned_cols=261  Identities=21%  Similarity=0.339  Sum_probs=197.5

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            355567899999999999996 468999999987532   2335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          581 YMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      |+++++|.+++... .....+++..+..++.||++||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            99999999998642 2235688999999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ........ ....     ....  
T Consensus       190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-~~~~-----~~~~--  259 (310)
T 2wqm_A          190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE-QCDY-----PPLP--  259 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHH-TTCS-----CCCC--
T ss_pred             Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhh-cccC-----CCCc--
Confidence            222 223458999999999999999999999999999999999999987543221 11111111 1000     0000  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                        ......++.+++.+||+.||.+||++.++++.|+.+...
T Consensus       260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence              122346788999999999999999999999999988754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.5e-37  Score=336.61  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=204.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcE--EEEEEcCCC-CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTK--VAVKRLYPG-ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~--vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+++.. ++..  +|||++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            34556678999999999999975 4554  499988643 334456799999999999 899999999999999999999


Q ss_pred             eeccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCE
Q 043017          579 YEYMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV  645 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~  645 (818)
                      |||+++++|.+++....             ....+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999996542             224689999999999999999999997   99999999999999999999


Q ss_pred             EEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhh
Q 043017          646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAE  724 (818)
Q Consensus       646 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~  724 (818)
                      ||+|||+++.......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......+...+   ..
T Consensus       182 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---~~  256 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQ  256 (327)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG---GG
T ss_pred             EEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh---hc
Confidence            9999999975432211  122346889999999988889999999999999999998 99999765433222211   11


Q ss_pred             hhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       725 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .      ..  .   ..+.....++.+++.+||+.+|.+|||+.++++.|+.+.+.
T Consensus       257 ~------~~--~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          257 G------YR--L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             T------CC--C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             C------CC--C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0      00  0   11223346788999999999999999999999999887654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=328.54  Aligned_cols=247  Identities=23%  Similarity=0.388  Sum_probs=181.3

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|+. .+++.||||.+....   ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            34456799999999999997 468999999985431   23357789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        93 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           93 CHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             CTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             CCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            9999999998543  24689999999999999999999997   999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      . .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+            ....   ...
T Consensus       168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~---~~~  231 (278)
T 3cok_A          168 K-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------------VLAD---YEM  231 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------------CSSC---CCC
T ss_pred             c-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------------hhcc---cCC
Confidence            2 12346899999999999988999999999999999999999999765433221110            0000   011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.....++.+++.+||+.||++||++.+++++
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            22234678899999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-37  Score=336.48  Aligned_cols=246  Identities=24%  Similarity=0.324  Sum_probs=179.9

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      +.||+|+||.||++... +++.||||++..   .....+.+|+.++.++. ||||+++++++.++...++||||+++++|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            46999999999999976 589999999853   34567889999999996 99999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---CEEEeecCCceecccCCCccc
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---NVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      .+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++   .+||+|||+++........ .
T Consensus        94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~  166 (325)
T 3kn6_A           94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L  166 (325)
T ss_dssp             HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence            9999653   4689999999999999999999997   999999999999997765   7999999999876543322 2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc----hHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGD----YLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~----~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......    ...+........ ..      .. ...
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-~~------~~-~~~  238 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DF------SF-EGE  238 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-CC------CC-CSH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-CC------CC-Ccc
Confidence            3346899999999999999999999999999999999999999754331    111111111110 00      00 000


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.++.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            012345678899999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=338.08  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=193.9

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCc--ceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHH--FNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|++++.+++|  +||+++++++..+...++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            44557899999999999999889999999986443  2334678999999999976  999999999999999999999 


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +.+++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++ ++.+||+|||+++.......
T Consensus        90 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           90 CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            5688999999653   4588999999999999999999997   999999999999997 57899999999987755433


Q ss_pred             c-cccCCCCCCcccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch
Q 043017          662 H-VSTMPKGTPGYMAPELTRG-----------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC  729 (818)
Q Consensus       662 ~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~  729 (818)
                      . ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  ...+...       
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~-------  233 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI-------  233 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH-------
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH-------
Confidence            2 2234569999999999864           67899999999999999999999999754321  1111111       


Q ss_pred             hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       730 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                        ++.... ...+.....++.+++.+||+.||.+|||+.|++++-
T Consensus       234 --~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          234 --IDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             --HCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --hcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence              111100 011112235688999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=341.82  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=202.9

Q ss_pred             hHHhhhhcccccceeEEEeEe----cCCcEEEEEEcCCCC----CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL----NDGTKVAVKRLYPGE----NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      .+.+.+.||+|+||.||+++.    .+++.||||++....    ....+.+.+|++++.++ +|+||+++++++......
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            345567899999999999997    368999999986532    23346678899999999 699999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ++||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       135 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999654   3588999999999999999999997   999999999999999999999999999987


Q ss_pred             cccCCCccccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      +............||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+......        
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------  280 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--------  280 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--------
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--------
Confidence            65544433444569999999999986  34789999999999999999999999755433222222211110        


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKVL  774 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L  774 (818)
                      ...   ..+......+.+++.+||+.||++||     ++.|++++.
T Consensus       281 ~~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 SEP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             cCC---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            000   11223345788999999999999999     999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-37  Score=338.78  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=205.1

Q ss_pred             HhhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  575 (818)
                      ...+.+.+.||+|+||.||+|+..      +++.||||.+... ......++.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            345566678999999999999843      4778999999644 334456789999999999999999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC----ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEe
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR----IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIA  648 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~  648 (818)
                      ++||||+++++|.+++.....    ...+++..+..++.||++||.|||+.   +|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    24588999999999999999999997   9999999999999984   4569999


Q ss_pred             ecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhh
Q 043017          649 DFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       649 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      |||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.   ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~  262 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT---SGG  262 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---TTC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh---cCC
Confidence            99999865443221 1223457889999999998899999999999999999998 999987654433322221   110


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .        .   .........+.+++.+||+.||.+||++.+++++|+.+...
T Consensus       263 ~--------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          263 R--------M---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             C--------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C--------C---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            0        0   01123346788999999999999999999999999887654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=336.11  Aligned_cols=268  Identities=26%  Similarity=0.408  Sum_probs=207.5

Q ss_pred             hHHhhhhcccccceeEEEeEe-----cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC--ccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-----NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS--NRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~l  577 (818)
                      .+.+.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..++
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  121 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL  121 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence            345567899999999999984     368899999998766666788999999999999999999999987654  7899


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       122 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          122 IMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999996542  4589999999999999999999997   99999999999999999999999999999876


Q ss_pred             cCCCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHh----hhhcchhh
Q 043017          658 QDQSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA----EADRLCDL  731 (818)
Q Consensus       658 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~----~~~~~~~~  731 (818)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .........    ....+.+.
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HHHHHCTTCCTHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-HHHhhccccchhhhHHHHHHH
Confidence            543322  22345778899999999888999999999999999999999887522100 000000000    00001111


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +.... ..+.+.....++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       276 ~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          276 LKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11110 011123345678899999999999999999999999988753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-37  Score=339.69  Aligned_cols=246  Identities=25%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             HhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          507 DFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      ...+.||+|+||.||+|.. .+++.||||++.....   ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus        57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  136 (348)
T 1u5q_A           57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC  136 (348)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence            3445799999999999996 5689999999865432   22457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      + |+|.+++....  ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++......   
T Consensus       137 ~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          137 L-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             S-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             C-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            7 68888775432  4689999999999999999999998   9999999999999999999999999999876432   


Q ss_pred             cccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          663 VSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                        ....||+.|+|||++.   ...++.++||||||+++|||++|+.||...........   .....      .+...  
T Consensus       208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---~~~~~------~~~~~--  274 (348)
T 1u5q_A          208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNE------SPALQ--  274 (348)
T ss_dssp             --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSC------CCCCC--
T ss_pred             --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhcC------CCCCC--
Confidence              2346899999999984   56789999999999999999999999875543222111   11110      00000  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhc
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQG  776 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  776 (818)
                        .......+.+++.+||+.+|++|||+.+++++.--
T Consensus       275 --~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          275 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             --CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence              11234568899999999999999999999987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-37  Score=327.22  Aligned_cols=245  Identities=24%  Similarity=0.352  Sum_probs=198.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++... +++.||||++....   ......+.+|+.++++++||||+++++++.+....++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            344568999999999999876 47789999985431   23356789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++....... 
T Consensus        91 ~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-  163 (279)
T 3fdn_A           91 APLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  163 (279)
T ss_dssp             CTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence            9999999998654   3588999999999999999999997   99999999999999999999999999986543322 


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+...          ....     
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~-----  226 (279)
T 3fdn_A          164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------EFTF-----  226 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------CCCC-----
T ss_pred             --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC----------CCCC-----
Confidence              22346899999999999999999999999999999999999999755433322222110          0001     


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      +......+.+++.+||+.||++|||+.|++++-
T Consensus       227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            122345678999999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.9e-37  Score=325.49  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=200.9

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc------------
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE------------  571 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------------  571 (818)
                      .+.+.+.||+|+||.||++... +++.||||++....    +.+.+|++++.+++||||+++++++..            
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            3445568999999999999986 68999999986543    457789999999999999999998854            


Q ss_pred             ----cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEE
Q 043017          572 ----RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI  647 (818)
Q Consensus       572 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl  647 (818)
                          ....++||||+++++|.+++.... ...+++..+..++.||++||.|||+.   +|+|+||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEE
Confidence                345799999999999999996532 34689999999999999999999997   9999999999999999999999


Q ss_pred             eecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          648 ADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       648 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      +|||++........  .....+++.|+|||.+.+..++.++||||||+++|||++|..|+...     ..... ..    
T Consensus       164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~-~~----  231 (284)
T 2a19_B          164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT-DL----  231 (284)
T ss_dssp             CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH-HH----
T ss_pred             Ccchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH-Hh----
Confidence            99999987755432  22346899999999999999999999999999999999998875310     00000 00    


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                          .....     ......++.+++.+||+.||++||++.|++++|+.+.+...
T Consensus       232 ----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          232 ----RDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             ----HTTCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ----hcccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                00111     11223567899999999999999999999999998876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.6e-37  Score=333.95  Aligned_cols=254  Identities=25%  Similarity=0.338  Sum_probs=201.8

Q ss_pred             HhhHHhh-hhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCccee
Q 043017          503 SATRDFQ-IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       503 ~~t~~f~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (818)
                      ...+.+. +.||+|+||.||++... +++.||||.+....  .....++.+|+.++.++ +||||+++++++......++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            3334444 67999999999999976 58999999986542  34467899999999999 57999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCce
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLAR  654 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~  654 (818)
                      ||||+++++|.+++... ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++
T Consensus       107 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             EEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            99999999999988543 235689999999999999999999997   9999999999999987   7899999999998


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      .......  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+....        ...
T Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------~~~  252 (327)
T 3lm5_A          183 KIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN--------VDY  252 (327)
T ss_dssp             EC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------CCC
T ss_pred             ccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--------ccc
Confidence            7654322  223468999999999999999999999999999999999999997654433322222110        000


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..   .........+.+++.+||+.||++|||+.+++++
T Consensus       253 ~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          253 SE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Cc---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            01   1112345678899999999999999999999886

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-37  Score=354.70  Aligned_cols=251  Identities=25%  Similarity=0.319  Sum_probs=205.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+++.. +|+.||||++...   .......+.+|++++.+++||||+++++++.+.+..++||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            334467999999999999975 6899999998543   234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus       266 ~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          266 MNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            99999999986543 24589999999999999999999998   999999999999999999999999999987754432


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......         ...  .
T Consensus       342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---------~~~--~  408 (576)
T 2acx_A          342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------PEE--Y  408 (576)
T ss_dssp             --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---------CCC--C
T ss_pred             --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---------ccc--C
Confidence              223479999999999999899999999999999999999999998654322222221111110         000  1


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      +...+.++.+++.+||+.||.+||     ++.|++++
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            123346788999999999999999     88999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=335.82  Aligned_cols=260  Identities=23%  Similarity=0.295  Sum_probs=194.9

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.++||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++......++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            34568999999999999976 6899999998654322 22345679999999999999999999999999999999997 


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .
T Consensus        84 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~  157 (324)
T 3mtl_A           84 KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y  157 (324)
T ss_dssp             EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-c
Confidence            68988886543  4688999999999999999999997   9999999999999999999999999999865433222 2


Q ss_pred             cCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---chhhccc------
Q 043017          665 TMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---LCDLVDK------  734 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---~~~~~d~------  734 (818)
                      ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+.   .......      
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            23468999999999876 5689999999999999999999999987655444433332211110   0000000      


Q ss_pred             cCcCc------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDM------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....      ........++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000      0011234577899999999999999999999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.7e-37  Score=338.97  Aligned_cols=260  Identities=23%  Similarity=0.240  Sum_probs=201.9

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-----cceeEEEeeeecccCccee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-----HFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-----H~niv~l~g~~~~~~~~~l  577 (818)
                      ..+.+.++||+|+||.||+++.. +++.||||++... ....+.+..|+.++..++     ||||+++++++...+..++
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l  113 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL  113 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence            34555678999999999999974 6889999998643 233566788999999986     9999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC----------------
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR----------------  641 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~----------------  641 (818)
                      ||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.                
T Consensus       114 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          114 IFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             EECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             EEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence            99999 999999996543 24589999999999999999999997   9999999999999975                


Q ss_pred             ---------CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 043017          642 ---------DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG  712 (818)
Q Consensus       642 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~  712 (818)
                               ++.+||+|||+++......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                     7899999999998654322    234689999999999999999999999999999999999999986654


Q ss_pred             chHHHHHHHHhhhhc-----------chhhccc-----cCcCccCcH---------------HHHHHHHHHHHHccccCC
Q 043017          713 DYLVDTLKVKAEADR-----------LCDLVDK-----KSEDMQSHR---------------DDAVKMIQIAISCLQKNL  761 (818)
Q Consensus       713 ~~l~~~~~~~~~~~~-----------~~~~~d~-----~~~~~~~~~---------------~~~~~l~~li~~cl~~dp  761 (818)
                      ......+........           ....+..     ..+......               .....+.+++.+||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            433333322111000           0000000     000000000               012567899999999999


Q ss_pred             CCCCcHHHHHHH
Q 043017          762 HRRPSASMLVKV  773 (818)
Q Consensus       762 ~~RPt~~evl~~  773 (818)
                      ++|||+.|++++
T Consensus       345 ~~Rpta~elL~h  356 (360)
T 3llt_A          345 TLRPSPAELLKH  356 (360)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             hhCCCHHHHhcC
Confidence            999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.4e-37  Score=330.65  Aligned_cols=261  Identities=24%  Similarity=0.356  Sum_probs=198.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR--GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.++||+|+||.||++... +++.||||++......  ..+.+.+|++++.+++||||+++++++......++||||+
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC   84 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence            344568999999999999986 4899999998654332  2467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        85 ~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           85 DHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             SEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            999999887533   4589999999999999999999997   9999999999999999999999999999876543222


Q ss_pred             cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-----------hcchh
Q 043017          663 VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-----------DRLCD  730 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-----------~~~~~  730 (818)
                       .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......           .....
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence             223468999999999976 56899999999999999999999999766544333322221110           00000


Q ss_pred             hcc-ccCcCcc----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 LVD-KKSEDMQ----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ~~d-~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ... +......    ........+.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000 0000000    011234568899999999999999999999976

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.4e-37  Score=330.09  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=194.5

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      +.||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++++|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            46999999999999964 6899999999766666678899999999885 799999999999999999999999999999


Q ss_pred             hhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC---EEEeecCCceecccCCC---
Q 043017          588 DKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGLARLIAQDQS---  661 (818)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~~~~---  661 (818)
                      .+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.   +||+|||++........   
T Consensus        99 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (316)
T 2ac3_A           99 LSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP  172 (316)
T ss_dssp             HHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred             HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence            9999654   3588999999999999999999998   9999999999999988776   99999999986643221   


Q ss_pred             ---ccccCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH-----------HHHHHHH
Q 043017          662 ---HVSTMPKGTPGYMAPELTRG-----NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL-----------VDTLKVK  722 (818)
Q Consensus       662 ---~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l-----------~~~~~~~  722 (818)
                         .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||........           ...+...
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (316)
T 2ac3_A          173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES  252 (316)
T ss_dssp             ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred             ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence               11123458999999999875     4588999999999999999999999976532210           0001000


Q ss_pred             hhhhcchhhccccCcCccC--cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          723 AEADRLCDLVDKKSEDMQS--HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       723 ~~~~~~~~~~d~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...        ... ..+.  .......+.+++.+||+.||++|||+.|++++
T Consensus       253 i~~--------~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          253 IQE--------GKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHH--------CCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Hhc--------cCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000        000 0000  01234678899999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-36  Score=344.20  Aligned_cols=272  Identities=19%  Similarity=0.250  Sum_probs=212.6

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCc-ceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH-FNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||.||+|+. .+++.||||++.....  ..++..|++++..++| +++..+..++......++||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            44557899999999999996 4689999998754432  3458899999999976 56666666777778889999999 


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++|.+++....  ..+++..+..|+.||+.||+|||+.   +|+||||||+||||   +.++.+||+|||+++.+....
T Consensus        86 g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           86 GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            999999986432  4689999999999999999999997   99999999999999   688999999999999876543


Q ss_pred             Ccc------ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          661 SHV------STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       661 ~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ...      .....||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+....... +...+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VATSIEA  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-HHSCHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-ccccHHH
Confidence            221      124569999999999999999999999999999999999999998765543333332221111 1111100


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCCCCCCCchhh
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDYGFLSFA  792 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~  792 (818)
                      .      ......++.+++..||+.+|++||++.+|++.|+.+...........+++.
T Consensus       240 l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~  291 (483)
T 3sv0_A          240 L------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT  291 (483)
T ss_dssp             H------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred             H------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence            0      012246788999999999999999999999999998766555544445553

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-37  Score=329.65  Aligned_cols=255  Identities=26%  Similarity=0.353  Sum_probs=202.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeec--ccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCA--ERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~lV~e  580 (818)
                      +.+.+.||+|+||.||++... +++.||+|.+....  ....+.+.+|++++++++||||+++++++.  .....++|||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   87 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   87 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence            344568999999999999976 68999999986543  234567899999999999999999999874  4567899999


Q ss_pred             ccCCCChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCC-----eeecccccCeEEEcCCCCEEEeecCCce
Q 043017          581 YMCNGSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPK-----IIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      |+++++|.+++.... ....+++..+..++.|+++||+|||+.   +     |+||||||+||+++.++.+||+|||+++
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999996532 234589999999999999999999997   6     9999999999999999999999999998


Q ss_pred             ecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......+...+..    ...      
T Consensus       165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~----~~~------  233 (279)
T 2w5a_A          165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKF------  233 (279)
T ss_dssp             HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCC------
T ss_pred             eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh----ccc------
Confidence            76543221 1223588999999999998999999999999999999999999976544333222211    110      


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCc
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT  778 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~  778 (818)
                        ..  .+.....++.+++.+||+.+|++||++.|+++++..-.
T Consensus       234 --~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          234 --RR--IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             --CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             --cc--CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence              00  11233467889999999999999999999999875443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=324.97  Aligned_cols=247  Identities=25%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCChhh
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDK  589 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (818)
                      .||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA  108 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence            6999999999999964 588999999976666667889999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-CCCEEEeecCCceecccCCCccccCCC
Q 043017          590 WIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-DLNVKIADFGLARLIAQDQSHVSTMPK  668 (818)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  668 (818)
                      ++........+++..+..++.||++||+|||+.   +|+|+||||+||+++. ++.+||+|||++......... .....
T Consensus       109 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~  184 (295)
T 2clq_A          109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-TETFT  184 (295)
T ss_dssp             HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCC
T ss_pred             HHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc-ccccC
Confidence            997654444577888999999999999999997   9999999999999987 899999999999876543221 22346


Q ss_pred             CCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHH
Q 043017          669 GTPGYMAPELTRGNS--ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDA  746 (818)
Q Consensus       669 gt~~y~aPE~~~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  746 (818)
                      |++.|+|||.+.+..  ++.++||||||+++|||++|+.||.........  .......    . ....     .+....
T Consensus       185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~----~-~~~~-----~~~~~~  252 (295)
T 2clq_A          185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFKVGMF----K-VHPE-----IPESMS  252 (295)
T ss_dssp             CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHHHHHH----C-CCCC-----CCTTSC
T ss_pred             CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHhhccc----c-cccc-----ccccCC
Confidence            899999999997653  889999999999999999999998644322111  1100000    0 0001     122344


Q ss_pred             HHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          747 VKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       747 ~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .++.+++.+||+.||++||++.+++++
T Consensus       253 ~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          253 AEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            678899999999999999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-37  Score=344.43  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=190.4

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccC-cceeEEEeeeecccC--cceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERS--NRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~--~~~lV  578 (818)
                      .+.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  ..++|
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            4455678999999999999865 6899999998643  2334567889999999997 999999999997544  68999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||++ ++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           90 FDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             EECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             ecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            99997 689888854    3588999999999999999999998   999999999999999999999999999987643


Q ss_pred             CC--------------------CccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHH
Q 043017          659 DQ--------------------SHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVD  717 (818)
Q Consensus       659 ~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~  717 (818)
                      ..                    ........||+.|+|||++.+ ..++.++|||||||+++||++|+.||..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            11                    111233569999999999976 678999999999999999999999998665433333


Q ss_pred             HHHHHhhhhcchhh--c-------------------cccCcCc-----------cCcHHHHHHHHHHHHHccccCCCCCC
Q 043017          718 TLKVKAEADRLCDL--V-------------------DKKSEDM-----------QSHRDDAVKMIQIAISCLQKNLHRRP  765 (818)
Q Consensus       718 ~~~~~~~~~~~~~~--~-------------------d~~~~~~-----------~~~~~~~~~l~~li~~cl~~dp~~RP  765 (818)
                      .+......+....+  +                   .......           ........++.+|+.+||+.||++||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            32211111100000  0                   0000000           00002245788999999999999999


Q ss_pred             cHHHHHHH
Q 043017          766 SASMLVKV  773 (818)
Q Consensus       766 t~~evl~~  773 (818)
                      |+.|++++
T Consensus       322 t~~e~l~H  329 (388)
T 3oz6_A          322 SANDALKH  329 (388)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhCC
Confidence            99999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-36  Score=321.76  Aligned_cols=250  Identities=25%  Similarity=0.313  Sum_probs=201.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence            445568999999999999976 68999999986443 3345788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-c
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-H  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~  662 (818)
                      +++|.+++..   ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++........ .
T Consensus        89 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           89 GGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             TEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999998843   24689999999999999999999997   999999999999999999999999999987654322 1


Q ss_pred             cccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...........  .......          ....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~----------~~~~  230 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DWKEKKT----------YLNP  230 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH--HHHTTCT----------TSTT
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH--Hhhhccc----------ccCc
Confidence            2233568999999999987765 7899999999999999999999976543321111  1111000          0001


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......+.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            12334577899999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=335.55  Aligned_cols=239  Identities=23%  Similarity=0.296  Sum_probs=197.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--------ccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--------RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.||+|+||.||+|+.. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  106 (335)
T 3dls_A           27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL  106 (335)
T ss_dssp             EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence            34457999999999999864 688999999865431        133467889999999999999999999999999999


Q ss_pred             eeeccCCC-ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          578 VYEYMCNG-SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       578 V~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ||||+.+| +|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       107 v~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          107 VMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999777 999988543   3589999999999999999999997   9999999999999999999999999999877


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ......  ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....                  .....
T Consensus       181 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------~~~~~  240 (335)
T 3dls_A          181 ERGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------TVEAA  240 (335)
T ss_dssp             CTTCCB--CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------GTTTC
T ss_pred             CCCCce--eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------HHhhc
Confidence            554332  23468999999999988776 8899999999999999999999864211                  00111


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ...   +.....++.+++.+||+.||++|||+.+++++-
T Consensus       241 ~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          241 IHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             CCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             cCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            110   112345788999999999999999999999873

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-36  Score=340.93  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=189.1

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhc-cCcceeEEEeeeecc----cCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGN-IHHFNLVRLVGYCAE----RSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~-l~H~niv~l~g~~~~----~~~~~lV~e~~~  583 (818)
                      +.||+|+||.||++... +++.||||++..     ...+.+|++++.+ .+||||+++++++..    ....++||||++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            46999999999999975 588999999852     3467788888754 489999999998865    567899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~  660 (818)
                      +|+|.+++.... ...+++..+..|+.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus       143 gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          143 GGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            999999996532 24689999999999999999999997   9999999999999987   7899999999998765432


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....................    .......  
T Consensus       219 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~----~~~~~~~--  290 (400)
T 1nxk_A          219 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YEFPNPE--  290 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC----CCCCTTT--
T ss_pred             c--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc----ccCCCcc--
Confidence            2  2335689999999999999999999999999999999999999976543321111111100100    0000000  


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                       ......++.+++.+||+.||++|||+.|++++-
T Consensus       291 -~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          291 -WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             123446788999999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-37  Score=339.96  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=189.6

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHH-HhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVET-IGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~-l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+.+.+.||+|+||.||+++.. +++.||||++....   ......+..|..+ ++.++||||+++++++.+.+..++||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            4456678999999999999976 47899999986543   2234556777776 56789999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.....
T Consensus       119 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          119 DYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999998653   3588999999999999999999997   9999999999999999999999999999864332


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   .         ...  
T Consensus       193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~---------~~~--  257 (373)
T 2r5t_A          193 NS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---K---------PLQ--  257 (373)
T ss_dssp             CC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH---S---------CCC--
T ss_pred             CC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---c---------ccC--
Confidence            22 23345799999999999999999999999999999999999999976544333332221   0         010  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                       .+......+.+++.+||+.||.+||++.
T Consensus       258 -~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          258 -LKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             -CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             -CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence             0112345678999999999999999974

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-36  Score=346.63  Aligned_cols=257  Identities=23%  Similarity=0.284  Sum_probs=192.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccC------cce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~  576 (818)
                      +.+.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      ..+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            445568999999999999865 5899999998654  2334567889999999999999999999996553      469


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||++++ |.+.+.     ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       144 lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          144 LVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            999999764 656552     2388999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh----------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD----------  726 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~----------  726 (818)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......+          
T Consensus       215 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          215 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            5432  2233579999999999999999999999999999999999999997655333222221111000          


Q ss_pred             cchhhccccCc-----------------CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 RLCDLVDKKSE-----------------DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ~~~~~~d~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.....                 ..........++.+|+.+||+.||++|||+.|++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000                 000011235678999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-36  Score=328.17  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecc--cCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAE--RSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||+|.. .+++.||||++..   ...+.+.+|++++.+++ ||||+++++++..  ....++|||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            345567899999999999986 4689999999864   33578999999999997 9999999999987  567899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQD  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  659 (818)
                      |+++++|.+++      +.+++..+..++.||++||+|||+.   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       114 ~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          114 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999987      2488899999999999999999997   999999999999999776 8999999999876544


Q ss_pred             CCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-hHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGD-YLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+........+.+.++....
T Consensus       185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            32  233468999999999977 67899999999999999999999999644322 111111111111111111110000


Q ss_pred             ----------------------CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 ----------------------DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                                            ..........++.+++.+||+.||++|||++|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                  000111245788999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7e-37  Score=341.30  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=194.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccC--cceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIH--HFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|++++.+++  |+||+++++++...+..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            45567899999999999998889999999986443  334578999999999996  5999999999999999999999 


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +.+++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       137 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          137 CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            5789999999654   3588889999999999999999997   999999999999995 57999999999987754432


Q ss_pred             c-cccCCCCCCcccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch
Q 043017          662 H-VSTMPKGTPGYMAPELTRG-----------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC  729 (818)
Q Consensus       662 ~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~  729 (818)
                      . ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  ...+....      
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~------  281 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII------  281 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHH------
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHHHh------
Confidence            2 2234579999999999865           46899999999999999999999999754321  11111111      


Q ss_pred             hhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       730 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                         +.... ...+.....++.+++.+||+.||.+||++.|++++-
T Consensus       282 ---~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          282 ---DPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ---CTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ---Ccccc-CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence               11100 000111245788999999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-36  Score=333.05  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-----cHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-----GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .+.+.+.||+|+||.||+++.. +++.||||++......     ..+.+.+|++++++++||||+++++++.+....++|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            3445568999999999999976 5899999998653221     135788999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++ +|.+++...  ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             EECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             EEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            999975 888888543  34689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc------hhh
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL------CDL  731 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~------~~~  731 (818)
                      ... ......+|+.|+|||.+.+. .++.++||||||+++|||++|..||...........+.........      ...
T Consensus       165 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          165 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             Ccc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence            332 22335689999999999764 5899999999999999999999998766543333332221111100      000


Q ss_pred             ccccC-cCcc-C-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          732 VDKKS-EDMQ-S-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       732 ~d~~~-~~~~-~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .+... ...+ .     ......++.+++.+||+.||++|||+.|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00000 0000 0     122346789999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-36  Score=333.73  Aligned_cols=250  Identities=21%  Similarity=0.332  Sum_probs=198.4

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||++... +++.||||.+.....    .+.+|++++.++ +||||+++++++.++...++||||+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            3445568999999999999976 588999999865433    235688888887 7999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC----CCEEEeecCCceeccc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD----LNVKIADFGLARLIAQ  658 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~~~~~  658 (818)
                      ++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||+.++    +.+||+|||+++....
T Consensus        99 ~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           99 KGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999998643   4589999999999999999999998   99999999999998443    3599999999997655


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........+........ ..    ....  
T Consensus       173 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~----~~~~--  244 (342)
T 2qr7_A          173 ENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-KF----SLSG--  244 (342)
T ss_dssp             TTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-CC----CCCS--
T ss_pred             CCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-Cc----ccCc--
Confidence            4332 23457899999999998888899999999999999999999999764433322222222111 10    0000  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ......+.++.+++.+||+.||++||++.+++++
T Consensus       245 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          245 -GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0112344678899999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.4e-37  Score=325.34  Aligned_cols=245  Identities=22%  Similarity=0.321  Sum_probs=202.0

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||+++.. +++.||||.+...   .....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            4455678999999999999976 5788999998543   22345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           95 FAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             eCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999998654   3588999999999999999999997   99999999999999999999999999997654322


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                         .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.   ..         ..   .
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~---------~~---~  230 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---NV---------DL---K  230 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TT---------CC---C
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh---cc---------cc---C
Confidence               223468999999999999999999999999999999999999997554322221111   00         00   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+......+.+++.+||+.||.+||++.+++++
T Consensus       231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            112234578899999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=332.44  Aligned_cols=265  Identities=26%  Similarity=0.414  Sum_probs=195.3

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHH--HhccCcceeEEEeeeec-----ccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVET--IGNIHHFNLVRLVGYCA-----ERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~--l~~l~H~niv~l~g~~~-----~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||+|+. +++.||||++...   ....+..|.++  +..++|+||+++++.+.     .....++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            344556899999999999987 5899999998533   23455555555  44589999999998543     2335689


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC------CCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC------NPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      ||||+++|+|.+++...    ..++..+..++.||++||+|||+..      +++|+||||||+|||++.++.+||+|||
T Consensus        90 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999999543    3588899999999999999999852      2389999999999999999999999999


Q ss_pred             CceecccCCC-------ccccCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-chH-
Q 043017          652 LARLIAQDQS-------HVSTMPKGTPGYMAPELTRG-------NSITAKIDIYSFGVVILEIICGRRSSNPKGG-DYL-  715 (818)
Q Consensus       652 la~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l-  715 (818)
                      +++.+.....       .......||+.|+|||++.+       ..++.++|||||||++|||++|+.|+..... ... 
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987654321       11223469999999999987       4567899999999999999999777643321 100 


Q ss_pred             ------------HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          716 ------------VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       716 ------------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                                  ...............   ..............++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRP---KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCC---CCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCC---CCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence                        011111111000000   11111122345677899999999999999999999999999988754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-36  Score=347.34  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..|.+.++||+|+||+||+++.. +++.||||++...  .......+.+|++++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            45566678999999999999975 6899999998543  23456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc---CCCCEEEeecCCceecc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIA  657 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~  657 (818)
                      |+++++|.+++...   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||+++...
T Consensus       102 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999988654   3589999999999999999999997   999999999999995   45679999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......+...+....    .    .... 
T Consensus       176 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----~----~~~~-  243 (486)
T 3mwu_A          176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----Y----AFDL-  243 (486)
T ss_dssp             CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----C----CSCS-
T ss_pred             CCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----C----CCCC-
Confidence            4322  233469999999999976 59999999999999999999999997665443333322110    0    0001 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        +.....+.++.+++.+||+.+|++|||+.+++++
T Consensus       244 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 --PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              1122345678899999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.7e-37  Score=339.93  Aligned_cols=261  Identities=24%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  113 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM  113 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence            3444567999999999999976 68899999986553 333567899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||++.......  
T Consensus       114 ~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  186 (360)
T 3eqc_A          114 DGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  186 (360)
T ss_dssp             TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred             CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence            999999999654   3588999999999999999999982  279999999999999999999999999997654322  


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-----------------
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-----------------  725 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-----------------  725 (818)
                       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......+...+......                 
T Consensus       187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence             12346899999999999999999999999999999999999999765433322111000000                 


Q ss_pred             ---------h---c-chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          726 ---------D---R-LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       726 ---------~---~-~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                               .   . +........... .......++.+++.+||+.||++|||+.|++++-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCC-CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCC-CcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                     0   0 000000000000 0112355788999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-36  Score=325.44  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL   96 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence            345568999999999999986 47889999885432   23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        97 ~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           97 CRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             CTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            9999999988543   3589999999999999999999997   999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      . .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.   ..         ..   ..
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~---------~~---~~  234 (294)
T 2rku_A          171 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK---KN---------EY---SI  234 (294)
T ss_dssp             C-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TT---------CC---CC
T ss_pred             c-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---hc---------cC---CC
Confidence            2 233568999999999999889999999999999999999999997554322211111   10         00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      +......+.+++.+||+.||++|||+.+++++-
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          235 PKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            122345788999999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-36  Score=325.53  Aligned_cols=248  Identities=26%  Similarity=0.368  Sum_probs=204.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+....++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            344567999999999999865 58899999986543 3456789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++..    ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||++......... 
T Consensus       104 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  175 (303)
T 3a7i_A          104 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-  175 (303)
T ss_dssp             TEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence            9999999843    4589999999999999999999997   9999999999999999999999999999876543222 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+..   . .     ....     ..
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~-~-----~~~~-----~~  241 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---N-N-----PPTL-----EG  241 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---S-C-----CCCC-----CS
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---C-C-----CCCC-----cc
Confidence            2334689999999999999999999999999999999999999875543322222111   0 0     0000     11


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .....+.+++.+||+.+|++|||+.+++++.-
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            23456889999999999999999999998653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-36  Score=343.11  Aligned_cols=250  Identities=21%  Similarity=0.355  Sum_probs=189.5

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--------CccHHHHHHHHHHHhccCcceeEEEeeeecccCc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--------NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN  574 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  574 (818)
                      ..+.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++.. +.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            34556678999999999999875 57899999986431        1122358899999999999999999999754 45


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFG  651 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg  651 (818)
                      .++||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.+   ..+||+|||
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             eEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence            78999999999999988543   4689999999999999999999997   99999999999999654   459999999


Q ss_pred             CceecccCCCccccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-hHHHHHHHHhhhhc
Q 043017          652 LARLIAQDQSHVSTMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGD-YLVDTLKVKAEADR  727 (818)
Q Consensus       652 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-~l~~~~~~~~~~~~  727 (818)
                      +++......  ......||+.|+|||++..   ..++.++||||||+++|||++|+.||...... .+...+.. .....
T Consensus       288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-~~~~~  364 (419)
T 3i6u_A          288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNF  364 (419)
T ss_dssp             TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-TCCCC
T ss_pred             cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-CCCCC
Confidence            998765432  2233568999999999853   56889999999999999999999999765433 22222211 00000


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .       .   ........++.+++.+||+.||++||++.|++++
T Consensus       365 ~-------~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          365 I-------P---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             C-------H---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             C-------c---hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0       0   0011234678899999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-36  Score=322.13  Aligned_cols=245  Identities=25%  Similarity=0.382  Sum_probs=194.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|... +++.||||.+...   .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            445568999999999999976 6899999998543   223456889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.||++||+|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus        93 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           93 VSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             cCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            9999999999654   3588999999999999999999998   999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                        .....+++.|+|||.+.+... +.++||||||+++|||++|+.||...........+..   . .        .   .
T Consensus       167 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~-~--------~---~  229 (276)
T 2h6d_A          167 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG---G-V--------F---Y  229 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C-C--------C---C
T ss_pred             --eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---C-c--------c---c
Confidence              223458999999999988765 6899999999999999999999976543333222211   0 0        0   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+......+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            011234568899999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-36  Score=348.88  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=205.2

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      ..|.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            34556678999999999999976 68999999985432   345678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE---cCCCCEEEeecCCceec
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLI  656 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~  656 (818)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus       106 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          106 EVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             CCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999988543   4589999999999999999999998   99999999999999   56789999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ......  ....||+.|+|||++.+ .++.++|||||||++|||++|+.||...........+....        .....
T Consensus       180 ~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------~~~~~  248 (484)
T 3nyv_A          180 EASKKM--KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK--------YTFEL  248 (484)
T ss_dssp             CCCCSH--HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------CCCCS
T ss_pred             cccccc--ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence            544322  22458999999999876 68999999999999999999999998665443333322110        00011


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         +.....+..+.+++.+||+.+|++|||+.|++++
T Consensus       249 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          249 ---PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ---GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence               1122345678899999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-36  Score=331.96  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCC---CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE---NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++...+ ++.+|+|.+....   ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  122 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL  122 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence            4455689999999999999764 7889999985432   23456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       123 ~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          123 CRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             CTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            9999999988543   3589999999999999999999997   999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      . .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.   .. .      ...     
T Consensus       197 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~-~------~~~-----  260 (335)
T 2owb_A          197 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK---KN-E------YSI-----  260 (335)
T ss_dssp             C-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HT-C------CCC-----
T ss_pred             c-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh---cC-C------CCC-----
Confidence            2 233468999999999999899999999999999999999999997554322222111   10 0      000     


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +......+.+++.+||+.||++||++.|++++
T Consensus       261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          261 PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11234567899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9e-36  Score=327.62  Aligned_cols=264  Identities=22%  Similarity=0.310  Sum_probs=201.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc--------C
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER--------S  573 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--------~  573 (818)
                      .+.+.++||+|+||.||+++.. +++.||||++....  ......+.+|++++++++||||+++++++...        +
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            4455678999999999999974 68999999986543  23356788999999999999999999998763        4


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++||||+++ +|.+.+...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            67999999975 777777433  24589999999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCC---ccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--
Q 043017          654 RLIAQDQS---HVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--  727 (818)
Q Consensus       654 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--  727 (818)
                      +.+.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........  
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            87653221   22233568999999999876 4589999999999999999999999987655444443332211100  


Q ss_pred             chhhcc---------ccCcCccCcHH------HHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          728 LCDLVD---------KKSEDMQSHRD------DAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       728 ~~~~~d---------~~~~~~~~~~~------~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .....+         ...........      ....+.+++.+||+.||++|||+.|++++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            000000         00000000011      134588999999999999999999999873

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.9e-36  Score=333.38  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=199.0

Q ss_pred             hhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhcc-CcceeEEEeeeecccCccee
Q 043017          508 FQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR--------GKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--------~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (818)
                      +.+.||+|+||.||+|+.. +|+.||||++......        ..+.+.+|+.++.++ +||||+++++++......++
T Consensus        98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  177 (365)
T 2y7j_A           98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL  177 (365)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred             cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence            3467999999999999986 6999999998654321        135678899999999 89999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|||++..+.
T Consensus       178 v~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          178 VFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            99999999999999643   3589999999999999999999997   99999999999999999999999999998775


Q ss_pred             cCCCccccCCCCCCcccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRG------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      ....  .....||+.|+|||++.+      ..++.++||||||+++|||++|+.||...........+..   . ..   
T Consensus       252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~---~-~~---  322 (365)
T 2y7j_A          252 PGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME---G-QY---  322 (365)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---T-CC---
T ss_pred             CCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---C-CC---
Confidence            4332  233569999999999863      3588899999999999999999999976543322222211   0 00   


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ....+.   .......+.+++.+||+.||++|||+.+++++
T Consensus       323 -~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          323 -QFSSPE---WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -CCCHHH---HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCCCcc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             000000   01223568899999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.2e-36  Score=346.83  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=199.0

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .|.+.++||+|+||.||+++.. +++.+|||++....  ......+.+|+.++++++||||+++++++.+....++||||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            4555678999999999999976 58899999986542  34467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCceeccc
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIAQ  658 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~  658 (818)
                      +++|+|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++..   +.+||+|||++.....
T Consensus       118 ~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          118 YKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999988654   3588999999999999999999997   99999999999999764   5599999999987754


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ...  .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.......+...+....    .    ....+.
T Consensus       192 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----~----~~~~~~  260 (494)
T 3lij_A          192 QKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK----Y----TFDSPE  260 (494)
T ss_dssp             TBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----C----CCCSGG
T ss_pred             Ccc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----C----CCCchh
Confidence            322  23356999999999986 468999999999999999999999998765544433332111    0    000000


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ....+..+.+++.+||+.+|.+|||+.|++++
T Consensus       261 ---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          261 ---WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ---GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence               12234578899999999999999999999865

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.5e-38  Score=347.36  Aligned_cols=239  Identities=18%  Similarity=0.216  Sum_probs=185.5

Q ss_pred             HhhhhcccccceeEEEeEe-cCCcEEEEEEcCCC---CCccHHHHHHHH---HHHhccCcceeEEEe-------eeeccc
Q 043017          507 DFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPG---ENRGKKEFLSEV---ETIGNIHHFNLVRLV-------GYCAER  572 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev---~~l~~l~H~niv~l~-------g~~~~~  572 (818)
                      .+.+.||+|+||.||+|+. .+|+.||||++...   .....+.|.+|+   +.+++++||||++++       +++...
T Consensus        76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~  155 (377)
T 3byv_A           76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  155 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred             EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence            3456899999999999996 46899999998643   334457889999   555666899999998       444443


Q ss_pred             C-----------------cceeeeeccCCCChhhHhhhcC----CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 043017          573 S-----------------NRFLVYEYMCNGSLDKWIFHKD----RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFD  631 (818)
Q Consensus       573 ~-----------------~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D  631 (818)
                      +                 ..++||||+ +|+|.+++....    ....+++..+..|+.||++||+|||+.   +|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  231 (377)
T 3byv_A          156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY  231 (377)
T ss_dssp             TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            2                 278999999 689999996532    123455688999999999999999998   999999


Q ss_pred             cccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCC-----------CCCchhhHHHHHHHHHHH
Q 043017          632 IKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-----------SITAKIDIYSFGVVILEI  700 (818)
Q Consensus       632 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwS~Gvll~el  700 (818)
                      |||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||++|||
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            999999999999999999999986432    2233457 999999999887           899999999999999999


Q ss_pred             HhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          701 ICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       701 ltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ++|+.||.........             ..+....      .....++.+++.+||+.||++||++.|++++
T Consensus       307 ltg~~Pf~~~~~~~~~-------------~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          307 WCADLPITKDAALGGS-------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHSSCCC------CCS-------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHCCCCCcccccccch-------------hhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999998644321111             0111111      1223578899999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=335.93  Aligned_cols=251  Identities=17%  Similarity=0.198  Sum_probs=202.5

Q ss_pred             hHHhhhhcccccceeEEEeE------ecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC---cceeEEEeeeecccCcc
Q 043017          505 TRDFQIRLGRGGSGSVFEGL------LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~  575 (818)
                      .+.+.+.||+|+||.||+|.      ..+++.||||++...   ...++..|++++.+++   |+||+++++++...+..
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            34455689999999999994      446889999998654   3567888888888886   99999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcC--CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-----------C
Q 043017          576 FLVYEYMCNGSLDKWIFHKD--RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-----------D  642 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-----------~  642 (818)
                      ++||||+++|+|.+++....  ....+++..+..|+.||++||+|||+.   +|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence            99999999999999996422  235699999999999999999999997   9999999999999998           8


Q ss_pred             CCEEEeecCCceecccC-CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHH
Q 043017          643 LNVKIADFGLARLIAQD-QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV  721 (818)
Q Consensus       643 ~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~  721 (818)
                      +.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......       
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------  292 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------  292 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence            99999999999876532 2233344679999999999999999999999999999999999999985432210       


Q ss_pred             HhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCC-CcHHHHHHHHhcCcCC
Q 043017          722 KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRR-PSASMLVKVLQGLTKL  780 (818)
Q Consensus       722 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~~i~~~  780 (818)
                          ..    +.......    ...+.+.+++..|++.+|.+| |++.++.+.|+.+.+.
T Consensus       293 ----~~----~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 ----CK----PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ----EE----ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----ee----echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                00    11111111    124466788889999999988 6889999998877654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-36  Score=331.64  Aligned_cols=261  Identities=21%  Similarity=0.271  Sum_probs=192.1

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .+.+.++||+|+||.||++... +++.||||++.....  ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            3445568999999999999865 689999999965432  2345678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-----CCCCEEEeecCCceec
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-----RDLNVKIADFGLARLI  656 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~Dfgla~~~  656 (818)
                      ++ ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++     .++.+||+|||+++..
T Consensus       115 ~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          115 AE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             CS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             CC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            97 5999988654   3589999999999999999999997   999999999999994     4556999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh--hcc
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD--LVD  733 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~--~~d  733 (818)
                      ...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......+....  ...
T Consensus       188 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          188 GIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            543222 2234579999999999875 489999999999999999999999976554333322221111000000  000


Q ss_pred             ------ccCcCcc-C------cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 ------KKSEDMQ-S------HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ------~~~~~~~-~------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            ....... .      ......++.+++.+||+.||++|||+.|++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence                  0000000 0      01134678899999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.9e-37  Score=327.60  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=198.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      +.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG  100 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence            445568999999999999986 4889999999877666778999999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      ++|.+++....  ..+++..+..++.||++||.|||+.   +++||||||+||+++.++.+||+|||++........ ..
T Consensus       101 ~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  174 (302)
T 2j7t_A          101 GAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-KR  174 (302)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-C-
T ss_pred             CcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-cc
Confidence            99999886532  4589999999999999999999997   999999999999999999999999999764322111 11


Q ss_pred             cCCCCCCcccccccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          665 TMPKGTPGYMAPELT-----RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~-----~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ....|++.|+|||.+     ....++.++||||||+++|||++|+.|+...........+.   ..         .....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~---------~~~~~  242 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KS---------DPPTL  242 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HS---------CCCCC
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh---cc---------CCccc
Confidence            224589999999998     46678999999999999999999999997654332221111   10         00011


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+......+.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1123345678899999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-36  Score=348.51  Aligned_cols=249  Identities=29%  Similarity=0.383  Sum_probs=201.9

Q ss_pred             hhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          509 QIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.||+|+||.||+++.. +|+.||||++...   .....+.+.+|++++.+++||||+++++++......++||||+++
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g  269 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG  269 (543)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence            357999999999999985 5899999998643   223456789999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcC-CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          585 GSLDKWIFHKD-RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       585 gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      |+|.+++.... ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++........ 
T Consensus       270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~-  345 (543)
T 3c4z_A          270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-  345 (543)
T ss_dssp             CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-
T ss_pred             CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-
Confidence            99999986543 234689999999999999999999997   9999999999999999999999999999976544322 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......        ..   ..+.
T Consensus       346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--------~~---~~p~  414 (543)
T 3c4z_A          346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--------AV---TYPD  414 (543)
T ss_dssp             BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--------CC---CCCT
T ss_pred             cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--------cc---CCCc
Confidence            233479999999999999999999999999999999999999998654322122221111110        00   0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcH-----HHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSA-----SMLVK  772 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~-----~evl~  772 (818)
                      ..+..+.+++.+||+.||++||++     .++++
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            334678899999999999999965     66664

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-36  Score=322.09  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecc----cCcceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~  579 (818)
                      .+.+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ....++||
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  108 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence            44567999999999999875 5788999998643  23345678999999999999999999998865    34579999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCC--eeecccccCeEEEc-CCCCEEEeecCCceec
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK--IIHFDIKPQNILLD-RDLNVKIADFGLARLI  656 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~  656 (818)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.   +  |+||||||+||+++ .++.+||+|||++...
T Consensus       109 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999643   4588999999999999999999997   7  99999999999997 7899999999999754


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ....   .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||........  ..........         
T Consensus       183 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~---------  247 (290)
T 1t4h_A          183 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVK---------  247 (290)
T ss_dssp             CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCC---------
T ss_pred             cccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHHhccCC---------
Confidence            4322   223468999999998874 589999999999999999999999975443211  1111111100         


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ..........++.+++.+||+.||.+|||+.+++++
T Consensus       248 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             000111223568899999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.4e-37  Score=332.68  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=197.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR--GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.+.||+|+||.||+++.. +++.||||++......  ..+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  106 (331)
T 4aaa_A           27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV  106 (331)
T ss_dssp             EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence            444568999999999999976 4899999998654332  2456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      ++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       107 ~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          107 DHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             SEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             CcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            999998876433   3589999999999999999999998   9999999999999999999999999999876543222


Q ss_pred             cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhh------------hhcch
Q 043017          663 VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAE------------ADRLC  729 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~------------~~~~~  729 (818)
                       .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+.....            .+...
T Consensus       181 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          181 -YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             -cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence             2234689999999999875 689999999999999999999999976654332222211100            00000


Q ss_pred             hhccccCcCcc----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 DLVDKKSEDMQ----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 ~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+......    ........+.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000000000    011235678999999999999999999998874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-36  Score=359.87  Aligned_cols=248  Identities=22%  Similarity=0.290  Sum_probs=205.0

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+++.++||+|+||.||+++.. +++.||||++...   .....+.+..|..++..+ +|++|+++++++.+.+..+||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            34455568999999999999976 5788999998643   234456788999999988 799999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.+++...   ..+++..+..|+.||+.||+|||+.   +|+||||||+||||+.++++||+|||+++....
T Consensus       421 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999654   3589999999999999999999997   999999999999999999999999999986543


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ... ......||+.|+|||++.+..++.++||||||++||||++|+.||.......+...+..            ...  
T Consensus       495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~------------~~~--  559 (674)
T 3pfq_A          495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------------HNV--  559 (674)
T ss_dssp             TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS------------SCC--
T ss_pred             CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------CCC--
Confidence            322 23345799999999999999999999999999999999999999987654443333221            001  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcH-----HHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSA-----SMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~  773 (818)
                       ..+.....++.+|+..||+.||++||++     .||+++
T Consensus       560 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          560 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence             1122345678899999999999999997     777754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-36  Score=324.04  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=199.6

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.+.+.||+|+||.||+|... +++.||||.+....  ..+++.+|+.++.+++||||+++++++......++||||++
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            3445568999999999999976 48999999986533  45789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|.+++...  ...+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++......... 
T Consensus       108 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-  181 (314)
T 3com_A          108 AGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-  181 (314)
T ss_dssp             TEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC-
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc-
Confidence            99999998532  24689999999999999999999997   9999999999999999999999999999876543222 


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+   ...         .........
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~---------~~~~~~~~~  249 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTN---------PPPTFRKPE  249 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS---------CCCCCSSGG
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcC---------CCcccCCcc
Confidence            23346899999999999999999999999999999999999999754432211111   100         000111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.+++.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            335678899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-36  Score=331.78  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=195.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC------cce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~  576 (818)
                      +.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++....      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            445567999999999999974 68999999986542  223467889999999999999999999997663      459


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+ +++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       107 lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             EEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            999999 8899998854    3588999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--c-----
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--L-----  728 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--~-----  728 (818)
                      ...    .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...........+......+.  .     
T Consensus       179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            432    233468999999999877 6799999999999999999999999986654333222221111000  0     


Q ss_pred             ----hhhcc---cc-CcC-ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcC
Q 043017          729 ----CDLVD---KK-SED-MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGL  777 (818)
Q Consensus       729 ----~~~~d---~~-~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i  777 (818)
                          ...+.   .. ... ..........+.+++.+||+.||++|||+.|++++  ++.+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                00000   00 000 00112335678899999999999999999999995  4444

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-36  Score=322.65  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=195.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||++... +++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++||||
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~   92 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY   92 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence            444568999999999999986 6899999998654  233456788999999999 999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCC-ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-------------------
Q 043017          582 MCNGSLDKWIFHKDR-IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-------------------  641 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-------------------  641 (818)
                      +++++|.+++..... ...+++..+..++.||++||+|||+.   +|+||||||+||+++.                   
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------
T ss_pred             cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            999999999965321 24589999999999999999999997   9999999999999984                   


Q ss_pred             CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK  720 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~  720 (818)
                      ...+||+|||++........     ..|++.|+|||.+.+. .++.++||||||++++||++|..++...   .....+.
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~  241 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIR  241 (289)
T ss_dssp             CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHH
T ss_pred             ceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHH
Confidence            44799999999987654322     3489999999999876 5678999999999999999998775322   1111111


Q ss_pred             HHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       721 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          ....     +..     +.....++.+++.+||+.||++|||+.+++++
T Consensus       242 ----~~~~-----~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          242 ----QGRL-----PRI-----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ----TTCC-----CCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----cCCC-----CCC-----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                0000     011     11234678899999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.7e-37  Score=329.34  Aligned_cols=261  Identities=28%  Similarity=0.400  Sum_probs=185.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.+.||+|+||.||++... +++.||||++.... ....+++.+|++++.+++||||+++++++...+..++||||+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   95 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL   95 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence            3445568999999999999864 68899999986543 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhc-----CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          583 CNGSLDKWIFHK-----DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       583 ~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ++++|.+++...     .....+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            999999998641     1234589999999999999999999997   99999999999999999999999999998664


Q ss_pred             cCCC----ccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          658 QDQS----HVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       658 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      ....    .......|++.|+|||.+.. ..++.++||||||+++|||++|+.||.............. ........  
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~--  249 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-NDPPSLET--  249 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-SSCCCTTC--
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-cCCCcccc--
Confidence            4321    11223468999999999876 5689999999999999999999999976654332221110 00000000  


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        .............++.+++.+||+.||.+||++.+++++
T Consensus       250 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          250 --GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              000001112234578899999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.8e-36  Score=338.47  Aligned_cols=264  Identities=24%  Similarity=0.291  Sum_probs=197.7

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCc------ceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN------RFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------~~lV~  579 (818)
                      |.+.+.||+|+||.||+|+...+..+|+|++......    ..+|+++++.++||||+++++++.....      .++||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            4556789999999999999988788999988644322    2369999999999999999999865443      78999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~  658 (818)
                      ||++++.+............+++..+..++.||++||+|||+.   +|+||||||+|||++ .++.+||+|||+++....
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            9998765444333233345789999999999999999999997   999999999999999 799999999999987754


Q ss_pred             CCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch---h----
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC---D----  730 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~---~----  730 (818)
                      ....  ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......+...   .    
T Consensus       195 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          195 GEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             TCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             CCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            4332  234689999999998765 58999999999999999999999998765433333222211111000   0    


Q ss_pred             hccccCcCcc-------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCc
Q 043017          731 LVDKKSEDMQ-------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLT  778 (818)
Q Consensus       731 ~~d~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~  778 (818)
                      ......+...       .......++.+++.+||+.||.+|||+.|++++  ++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            0000000000       011244678999999999999999999999986  55443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.4e-36  Score=357.98  Aligned_cols=256  Identities=22%  Similarity=0.362  Sum_probs=204.1

Q ss_pred             hhHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      ..+.+.+.||+|+||.||+|.+..    +..||||.+..... ...+.|.+|+.++++++||||+++++++. .+..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            345556789999999999998742    56799999875433 33478999999999999999999999985 4568999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       469 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999996432  3588999999999999999999997   999999999999999999999999999987755


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+..   ...        . 
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---~~~--------~-  611 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GER--------L-  611 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH---TCC--------C-
T ss_pred             CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---CCC--------C-
Confidence            44333334457789999999998899999999999999999997 9999976554433332221   100        0 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                        +.+......+.+++.+||+.||++||++.++++.|+.+.+
T Consensus       612 --~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          612 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              1122344678899999999999999999999999988753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5e-36  Score=346.04  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-------------ccHHHHHHHHHHHhccCcceeEEEeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-------------RGKKEFLSEVETIGNIHHFNLVRLVGYCA  570 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~  570 (818)
                      .|.+.++||+|+||.||+++.. +++.||||++.....             ...+.+.+|+.++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3445578999999999999976 578999999865421             33567899999999999999999999999


Q ss_pred             ccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---CEEE
Q 043017          571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---NVKI  647 (818)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl  647 (818)
                      +....++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++   .+||
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999988654   3589999999999999999999997   999999999999998775   6999


Q ss_pred             eecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc
Q 043017          648 ADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR  727 (818)
Q Consensus       648 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~  727 (818)
                      +|||++........  .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.......+...+....    
T Consensus       191 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  263 (504)
T 3q5i_A          191 VDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK----  263 (504)
T ss_dssp             CCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred             EECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----
Confidence            99999987755432  23346999999999987 468999999999999999999999998765544433332110    


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .    ....   ......+.++.+++.+||+.||.+|||+.|++++
T Consensus       264 ~----~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          264 Y----YFDF---NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             C----CCCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             C----CCCc---cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0    0000   0011234678899999999999999999999976

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-36  Score=342.11  Aligned_cols=192  Identities=26%  Similarity=0.399  Sum_probs=150.9

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc-----Ccce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER-----SNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~  576 (818)
                      .+.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++.+++||||+++++++...     ...+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            3455678999999999999865 68999999986542  23356789999999999999999999998543     5689


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+ +++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++..
T Consensus       134 lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            999997 57898888533   4689999999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCc--------------------------cccCCCCCCcccccccc-cCCCCCchhhHHHHHHHHHHHHhC
Q 043017          657 AQDQSH--------------------------VSTMPKGTPGYMAPELT-RGNSITAKIDIYSFGVVILEIICG  703 (818)
Q Consensus       657 ~~~~~~--------------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwS~Gvll~elltG  703 (818)
                      ......                          ......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            532211                          12234689999999976 556799999999999999999993

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-36  Score=335.27  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=194.4

Q ss_pred             hHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc-----------
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER-----------  572 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----------  572 (818)
                      .+.+.+.||+|+||.||+|.. .+++.||||++.....    ...+|+++++.++||||+++++++...           
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            344557899999999999986 4689999999864432    224799999999999999999998442           


Q ss_pred             ---------------------------CcceeeeeccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCC
Q 043017          573 ---------------------------SNRFLVYEYMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCN  624 (818)
Q Consensus       573 ---------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~  624 (818)
                                                 ...++||||++ ++|.+.+... .....+++..+..++.||++||+|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                       23789999997 5888777531 2335689999999999999999999997  


Q ss_pred             CCeeecccccCeEEEc-CCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 043017          625 PKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIIC  702 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~ellt  702 (818)
                       +|+||||||+|||++ .++.+||+|||+++........  ....+|+.|+|||.+.+. .++.++|||||||++|||++
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence             999999999999998 6889999999999976544332  234689999999998765 48999999999999999999


Q ss_pred             CCCCCCCCCCchHHHHHHHHhhhhcchhhcc--c-----cCcCc-------cCcHHHHHHHHHHHHHccccCCCCCCcHH
Q 043017          703 GRRSSNPKGGDYLVDTLKVKAEADRLCDLVD--K-----KSEDM-------QSHRDDAVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       703 G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d--~-----~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      |+.||...........+......+....+..  +     ..+..       ..+.....++.+++.+||+.||++|||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            9999987654433333222111111000000  0     00000       01122346788999999999999999999


Q ss_pred             HHHHH
Q 043017          769 MLVKV  773 (818)
Q Consensus       769 evl~~  773 (818)
                      |++++
T Consensus       318 e~l~h  322 (383)
T 3eb0_A          318 EAMAH  322 (383)
T ss_dssp             HHHTS
T ss_pred             HHhcC
Confidence            99864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=329.50  Aligned_cols=256  Identities=21%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.+.||+|+||.||+|...+  .+|+|.+....  ....+.+.+|+.++++++|+||+++++++.+....++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            4456789999999999999864  49999986542  3334668899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC---
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~---  660 (818)
                      +++|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+||+++ ++.+||+|||++.......   
T Consensus       113 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          113 GRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             SEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            99999999543  24689999999999999999999997   999999999999998 6799999999987653221   


Q ss_pred             -CccccCCCCCCcccccccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchh
Q 043017          661 -SHVSTMPKGTPGYMAPELTRG---------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCD  730 (818)
Q Consensus       661 -~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~  730 (818)
                       ........|++.|+|||.+..         ..++.++||||||+++|||++|+.||...........+.   ..     
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~-----  258 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG---TG-----  258 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH---TT-----
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc---cC-----
Confidence             112223458999999999874         357899999999999999999999997655433322221   10     


Q ss_pred             hccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       731 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                       ......    ......++.+++.+||+.+|++|||+.+++++|+.+.+...
T Consensus       259 -~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          259 -MKPNLS----QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             -CCCCCC----CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             -CCCCCC----cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence             001111    11223468899999999999999999999999999987643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.5e-36  Score=320.55  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=200.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---------ccHHHHHHHHHHHhccC-cceeEEEeeeecccCc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---------RGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSN  574 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---------~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~  574 (818)
                      +.+.+.||+|+||.||++... +++.||||.+.....         ...+.+.+|++++.++. ||||+++++++.....
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   98 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence            344567999999999999986 588999999865431         12356889999999995 9999999999999999


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      .++||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        99 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           99 FFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence            99999999999999999653   3589999999999999999999997   99999999999999999999999999998


Q ss_pred             ecccCCCccccCCCCCCccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTR------GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      .......  .....+++.|+|||.+.      ...++.++||||||++++||++|+.||...........+..   . . 
T Consensus       173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~-~-  245 (298)
T 1phk_A          173 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS---G-N-  245 (298)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---T-C-
T ss_pred             hcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc---C-C-
Confidence            7654332  22346899999999985      45688999999999999999999999976543332222211   0 0 


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         .....   +........+.+++.+||+.||++|||+.|++++
T Consensus       246 ---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          246 ---YQFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             ---CCCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---cccCc---ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence               00000   1112345678899999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-36  Score=334.06  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=192.1

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCcc-----------HHHHHHHHHHHhccCcceeEEEeeeecc----
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-----------KKEFLSEVETIGNIHHFNLVRLVGYCAE----  571 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-----------~~~f~~Ev~~l~~l~H~niv~l~g~~~~----  571 (818)
                      .+.+.||+|+||.||+|...+++.||||++.......           .+.+.+|++++++++||||+++++++..    
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (362)
T 3pg1_A           25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP  104 (362)
T ss_dssp             EEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred             EEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence            3446899999999999998889999999986432211           2679999999999999999999999843    


Q ss_pred             -cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeec
Q 043017          572 -RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF  650 (818)
Q Consensus       572 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  650 (818)
                       ....++||||++ |+|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          105 AMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             CcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence             335799999997 6888887533  34689999999999999999999998   9999999999999999999999999


Q ss_pred             CCceecccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch
Q 043017          651 GLARLIAQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC  729 (818)
Q Consensus       651 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~  729 (818)
                      |+++.......  .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+...
T Consensus       179 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          179 NLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             TC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             Ccccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            99985543322  223468999999999877 678999999999999999999999998655433333332211111110


Q ss_pred             -----------hhccccCcCcc------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 -----------DLVDKKSEDMQ------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 -----------~~~d~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                                 +.+........      ........+.+++.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence                       11111111000      011234568899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-35  Score=324.03  Aligned_cols=259  Identities=21%  Similarity=0.305  Sum_probs=203.5

Q ss_pred             hHHhhhhcccccceeEEEeEe--cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce------eEEEeeeecccCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLL--NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN------LVRLVGYCAERSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n------iv~l~g~~~~~~~~~  576 (818)
                      .+.+.+.||+|+||.||++..  .+++.||||++... ....+.+.+|++++..++|++      ++++++++...+..+
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            455667899999999999986  35889999998643 233567889999999997765      999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---------------
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---------------  641 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---------------  641 (818)
                      +||||+ +++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.               
T Consensus        94 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            999999 899999986543 24588999999999999999999997   9999999999999987               


Q ss_pred             ----CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHH
Q 043017          642 ----DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVD  717 (818)
Q Consensus       642 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~  717 (818)
                          ++.+||+|||+++......    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                6789999999998754322    23468999999999999999999999999999999999999998665443333


Q ss_pred             HHHHHhhhhc--c---------------------------hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHH
Q 043017          718 TLKVKAEADR--L---------------------------CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       718 ~~~~~~~~~~--~---------------------------~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      .+........  +                           ...................++.+++.+||+.||++|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            3222111000  0                           0000000011112335678899999999999999999999


Q ss_pred             HHHHH
Q 043017          769 MLVKV  773 (818)
Q Consensus       769 evl~~  773 (818)
                      |++++
T Consensus       325 ell~h  329 (339)
T 1z57_A          325 EALKH  329 (339)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-36  Score=330.25  Aligned_cols=263  Identities=23%  Similarity=0.300  Sum_probs=187.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCc-------c
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN-------R  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-------~  575 (818)
                      ..+.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++.....       .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            34555678999999999999975 58999999885443 234566788889999999999999999865443       7


Q ss_pred             eeeeeccCCCChhhHhhh-cCCccccchhhHHHHHHHHHHHHHHHH--hcCCCCeeecccccCeEEEcC-CCCEEEeecC
Q 043017          576 FLVYEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLH--DYCNPKIIHFDIKPQNILLDR-DLNVKIADFG  651 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg  651 (818)
                      ++||||+++ +|...+.. ......+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+|||
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            899999976 44444432 234456889999999999999999999  65   9999999999999997 8999999999


Q ss_pred             CceecccCCCccccCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--c
Q 043017          652 LARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--L  728 (818)
Q Consensus       652 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--~  728 (818)
                      +++........  ....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...........+......+.  .
T Consensus       178 ~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          178 SAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             TCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            99876544322  2346899999999986654 89999999999999999999999987655443333322111100  0


Q ss_pred             hhhccccCc--------Cc-------cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 CDLVDKKSE--------DM-------QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 ~~~~d~~~~--------~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.+...        ..       ........++.+++.+||+.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000000        00       0011245789999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-36  Score=338.75  Aligned_cols=258  Identities=25%  Similarity=0.326  Sum_probs=191.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccC------cceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV  578 (818)
                      +.+.+.||+|+||.||+|+.. +++.||||++.....    .+.+|++++++++|+||+++++++....      ..++|
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            344568999999999999986 589999999864322    2347999999999999999999885422      35799


Q ss_pred             eeccCCCChhhHhhh-cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCceec
Q 043017          579 YEYMCNGSLDKWIFH-KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLI  656 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~  656 (818)
                      |||+++ +|.+.+.+ ......+++..+..++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999975 56665543 12335689999999999999999999997   99999999999999965 56899999999976


Q ss_pred             ccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---chhhc
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---LCDLV  732 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---~~~~~  732 (818)
                      ......  ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+......+.   +....
T Consensus       208 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          208 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             ccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            544322  234689999999998764 799999999999999999999999986654332222221111000   00000


Q ss_pred             ----cccCcCcc-------CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 ----DKKSEDMQ-------SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 ----d~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          +...+...       .......++.+|+.+||+.||.+||++.|++++
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                00000000       011234678899999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.1e-36  Score=324.91  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--------CccHHHHHHHHHHHhccCcceeEEEeeeecccCc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--------NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN  574 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  574 (818)
                      ..+.+.+.||+|+||.||++... +++.||||.+....        ......+.+|++++++++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            34556678999999999999975 57899999986432        122345889999999999999999999987654 


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC---EEEeecC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFG  651 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg  651 (818)
                      .++||||+++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.   +||+|||
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            89999999999999988533   4689999999999999999999997   9999999999999987654   9999999


Q ss_pred             CceecccCCCccccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-hHHHHHHHHhhhhc
Q 043017          652 LARLIAQDQSHVSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIICGRRSSNPKGGD-YLVDTLKVKAEADR  727 (818)
Q Consensus       652 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~-~l~~~~~~~~~~~~  727 (818)
                      +++......  ......|++.|+|||.+.   ...++.++||||||+++|||++|+.||...... .+...+... ....
T Consensus       163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~  239 (322)
T 2ycf_A          163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-KYNF  239 (322)
T ss_dssp             TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT-CCCC
T ss_pred             cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC-cccc
Confidence            998764322  112235899999999973   567899999999999999999999999765433 222222110 0000


Q ss_pred             chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .        +  ........++.+++.+||+.||++||++.+++++
T Consensus       240 ~--------~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          240 I--------P--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             C--------H--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             C--------c--hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            0        0  0011234678899999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=320.23  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC----CccHHHHHHHHHHHhccCcceeEEEeeee--cccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE----NRGKKEFLSEVETIGNIHHFNLVRLVGYC--AERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~--~~~~~~~lV  578 (818)
                      +.+.+.||+|+||.||++... +++.||||.+....    ....+.+.+|++++++++|+||+++++++  .+....++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            445678999999999999975 58899999986432    23457899999999999999999999998  445678999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||++++ |.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        87 ~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             ehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            9999877 777775433 35689999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCC-ccccCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          659 DQS-HVSTMPKGTPGYMAPELTRGNS--ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       659 ~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ... .......|++.|+|||.+.+..  .+.++||||||+++|||++|+.||...........+..   . .        
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~---~-~--------  229 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK---G-S--------  229 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---C-C--------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc---C-C--------
Confidence            322 2223456899999999998654  47899999999999999999999976543322222211   0 0        


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .   ..+......+.+++.+||+.||.+|||+.|++++-
T Consensus       230 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          230 Y---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             C---CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             C---CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            0   01122345788999999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.2e-36  Score=330.56  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=201.9

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCcc-----------------HHHHHHHHHHHhccCcceeEEEee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRG-----------------KKEFLSEVETIGNIHHFNLVRLVG  567 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-----------------~~~f~~Ev~~l~~l~H~niv~l~g  567 (818)
                      .+.+.+.||+|+||.||++.. +++.||||++.......                 .+.+.+|++++.+++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            344556899999999999999 89999999986432111                 178999999999999999999999


Q ss_pred             eecccCcceeeeeccCCCChhhH------hhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEc
Q 043017          568 YCAERSNRFLVYEYMCNGSLDKW------IFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       568 ~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~  640 (818)
                      ++.+.+..++||||+++++|.++      +.. .....+++..+..++.||++||+|||+ .   +|+||||||+||+++
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD  186 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence            99999999999999999999998      432 124679999999999999999999998 6   999999999999999


Q ss_pred             CCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCC-chHHH
Q 043017          641 RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN-SITA-KIDIYSFGVVILEIICGRRSSNPKGG-DYLVD  717 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~  717 (818)
                      .++.+||+|||++......   ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||..... .....
T Consensus       187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            9999999999999876443   22345689999999999887 5666 99999999999999999999986554 22222


Q ss_pred             HHHHHhhhhcchhhcc---ccCcC---ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          718 TLKVKAEADRLCDLVD---KKSED---MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d---~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+...  .........   .....   .........++.+++.+||+.||.+||++.|++++
T Consensus       264 ~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          264 NIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22110  000000000   00000   00012345678899999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.6e-36  Score=330.00  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeeccc-----Cccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAER-----SNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  577 (818)
                      .+.+.+.||+|+||.||++... +++.||||++..... ...+.+.+|++++.+++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            3445678999999999999865 588999999975433 2346789999999999999999999998654     36799


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+. ++|.+++..    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            999996 589998853    3589999999999999999999997   99999999999999999999999999998775


Q ss_pred             cCCCcc--ccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcch-----
Q 043017          658 QDQSHV--STMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC-----  729 (818)
Q Consensus       658 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~-----  729 (818)
                      ......  .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+......+...     
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            443222  233579999999998754 458999999999999999999999998766554444433221111000     


Q ss_pred             ------hhccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 ------DLVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 ------~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            ...........     .......++.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000000000     011234678899999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.9e-36  Score=333.18  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=200.3

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC--------cceeEEEeeeec----
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH--------HFNLVRLVGYCA----  570 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~--------H~niv~l~g~~~----  570 (818)
                      ..+.+.++||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            34556678999999999999864 5889999998643 234567889999999985        888999999987    


Q ss_pred             ccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-------
Q 043017          571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-------  643 (818)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-------  643 (818)
                      .+...++||||+ +++|.+++.... ...+++..+..++.||++||+|||+.  .+|+||||||+|||++.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhhhh
Confidence            556889999999 667766665432 24689999999999999999999983  2899999999999998775       


Q ss_pred             ------------------------------------------CEEEeecCCceecccCCCccccCCCCCCcccccccccC
Q 043017          644 ------------------------------------------NVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG  681 (818)
Q Consensus       644 ------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  681 (818)
                                                                .+||+|||++......    .....||+.|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999876543    223468999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHH---HHHHHhhh-hcc-----------hhhccc------------
Q 043017          682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVD---TLKVKAEA-DRL-----------CDLVDK------------  734 (818)
Q Consensus       682 ~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~---~~~~~~~~-~~~-----------~~~~d~------------  734 (818)
                      ..++.++|||||||++|||++|+.||..........   .+...... +..           ...+..            
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            999999999999999999999999998665432211   11111000 000           000000            


Q ss_pred             ------cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 ------KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            ..............+.+|+.+||+.||++|||+.|++++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                  000112245677889999999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-36  Score=335.87  Aligned_cols=251  Identities=13%  Similarity=0.044  Sum_probs=177.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcc--CcceeEEEee-------eeccc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNI--HHFNLVRLVG-------YCAER  572 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l--~H~niv~l~g-------~~~~~  572 (818)
                      +.+.+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+.++..+  +||||++++.       ++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            345568999999999999965 689999999976543   2345677885544444  6999888553       33222


Q ss_pred             -----------------CcceeeeeccCCCChhhHhhhcCCccccchhhH------HHHHHHHHHHHHHHHhcCCCCeee
Q 043017          573 -----------------SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIR------KKIIFQISRGLEYLHDYCNPKIIH  629 (818)
Q Consensus       573 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~iiH  629 (818)
                                       ...++||||++ ++|.+++....  ..+.+..+      ..++.||++||+|||+.   +|+|
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH  217 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH  217 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence                             23799999998 99999996542  34556666      78889999999999997   9999


Q ss_pred             cccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 043017          630 FDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSS  707 (818)
Q Consensus       630 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~  707 (818)
                      |||||+|||++.++.+||+|||+++......    ....+++.|+|||++.+  ..++.++|||||||++|||++|+.||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764321    12346799999999987  67999999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          708 NPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       708 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      ..........     .......... ......+........+.+++.+||+.||++|||+.++++
T Consensus       294 ~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          294 GLVTPGIKGS-----WKRPSLRVPG-TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TBCCTTCTTC-----CCBCCTTSCC-CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCcCcccccc-----hhhhhhhhcc-ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            7653321000     0000000000 000011111234567889999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=338.60  Aligned_cols=259  Identities=23%  Similarity=0.295  Sum_probs=180.8

Q ss_pred             hhcccccceeEEEeEec---CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeec--ccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLN---DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA--ERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~  584 (818)
                      ++||+|+||.||+|+..   +++.||||++....  ....+.+|++++++++||||+++++++.  .....++||||++ 
T Consensus        27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             CCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            47999999999999965   47899999996442  3457889999999999999999999994  4668899999986 


Q ss_pred             CChhhHhhhcC------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE----cCCCCEEEeecCCce
Q 043017          585 GSLDKWIFHKD------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL----DRDLNVKIADFGLAR  654 (818)
Q Consensus       585 gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla~  654 (818)
                      ++|.+++....      ....+++..+..|+.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            57887774321      123489999999999999999999998   99999999999999    778999999999998


Q ss_pred             ecccCCC--ccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc---------hHHHHHHHH
Q 043017          655 LIAQDQS--HVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGD---------YLVDTLKVK  722 (818)
Q Consensus       655 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~---------~l~~~~~~~  722 (818)
                      .......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......         ..+..+...
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~  260 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  260 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence            7754322  222335689999999999874 5899999999999999999999999755431         111111111


Q ss_pred             hhhhc---chhh------------ccc-cCcCccC-------cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          723 AEADR---LCDL------------VDK-KSEDMQS-------HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       723 ~~~~~---~~~~------------~d~-~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      ...+.   ...+            +.. .......       ......++.+|+.+||+.||++|||+.|++++=
T Consensus       261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            00000   0000            000 0000000       000135678999999999999999999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.8e-36  Score=336.63  Aligned_cols=258  Identities=21%  Similarity=0.298  Sum_probs=199.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc------CcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI------HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l------~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +.+.++||+|+||.||+|... +++.||||++... ....+++.+|++++..+      +|+||+++++++......++|
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  177 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT  177 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence            455678999999999999875 4889999999643 23346677888888777      577999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC--EEEeecCCceec
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN--VKIADFGLARLI  656 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla~~~  656 (818)
                      |||+. ++|.+++.... ...+++..+..|+.||++||+|||+.   +|+||||||+|||++.++.  +||+|||+++..
T Consensus       178 ~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          178 FELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             ECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            99995 68999886543 24589999999999999999999998   9999999999999999887  999999999765


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---------  727 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---------  727 (818)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......+.         
T Consensus       253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            432    2234689999999999999999999999999999999999999986654433332222111000         


Q ss_pred             chhhcccc------------------------------CcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          728 LCDLVDKK------------------------------SEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       728 ~~~~~d~~------------------------------~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      ....++..                              ......     .......+.+|+.+||+.||++|||+.|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence            00000000                              000000     0011467889999999999999999999998


Q ss_pred             H
Q 043017          773 V  773 (818)
Q Consensus       773 ~  773 (818)
                      +
T Consensus       409 H  409 (429)
T 3kvw_A          409 H  409 (429)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=325.57  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=191.5

Q ss_pred             HHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeec--------------
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA--------------  570 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--------------  570 (818)
                      +.+.+.||+|+||.||+|.... ++.||||++........+++.+|++++++++||||+++++++.              
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            3445679999999999999874 8999999987666566778999999999999999999998874              


Q ss_pred             ccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEee
Q 043017          571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIAD  649 (818)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D  649 (818)
                      +....++||||++ |+|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+||+++ +++.+||+|
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            3456789999997 699998843    4588999999999999999999997   999999999999997 567999999


Q ss_pred             cCCceecccCCCc--cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh-
Q 043017          650 FGLARLIAQDQSH--VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA-  725 (818)
Q Consensus       650 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~-  725 (818)
                      ||+++........  ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+...... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999876543221  1122357889999998865 67899999999999999999999999865543322222111000 


Q ss_pred             -----hcchh----hccccCcCcc-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          726 -----DRLCD----LVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       726 -----~~~~~----~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           ..+..    .+........     .......++.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                 00000    0000000000     011235678899999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-36  Score=322.18  Aligned_cols=252  Identities=28%  Similarity=0.402  Sum_probs=184.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-cc-HHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RG-KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .+.+.+.||+|+||.||++... +++.||||++..... .. .+.+.++...++.++||||+++++++.+++..++||||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~   87 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL   87 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence            3445568999999999999974 689999999875432 22 23344555668888999999999999999999999999


Q ss_pred             cCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          582 MCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       582 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      ++ ++|.+++... .....+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            97 5888877542 2335699999999999999999999983  389999999999999999999999999998765433


Q ss_pred             CccccCCCCCCcccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          661 SHVSTMPKGTPGYMAPELT----RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..  ....|++.|+|||.+    ....++.++||||||+++|||++|+.||.......  ..+......         ..
T Consensus       165 ~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~---------~~  231 (290)
T 3fme_A          165 AK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEE---------PS  231 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHS---------CC
T ss_pred             cc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhcc---------CC
Confidence            22  223589999999996    55678999999999999999999999997543221  111111111         00


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .... ......++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          232 PQLP-ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             CCCC-TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCcc-cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            0100 12234678899999999999999999999873

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-35  Score=335.88  Aligned_cols=196  Identities=29%  Similarity=0.383  Sum_probs=162.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc-----Ccce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER-----SNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~  576 (818)
                      .+.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++|+||+++++++...     ...+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            3455678999999999999975 57899999996542  23356889999999999999999999999776     5689


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+. ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       107 lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            9999985 6999988532   4589999999999999999999998   9999999999999999999999999999977


Q ss_pred             ccCCCc---------------------cccCCCCCCcccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 043017          657 AQDQSH---------------------VSTMPKGTPGYMAPELT-RGNSITAKIDIYSFGVVILEIICGRRSS  707 (818)
Q Consensus       657 ~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwS~Gvll~elltG~~p~  707 (818)
                      ......                     ......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            543211                     12445789999999986 5667999999999999999999865444

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-35  Score=315.50  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      ..+.+.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|++++++++||||+++++++......++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            44555678999999999999976 6899999998543  23456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC---CCEEEeecCCceecc
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD---LNVKIADFGLARLIA  657 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~  657 (818)
                      |+++++|.+++...   ..+++..+..++.||++||+|||+.   +++|+||||+||+++.+   +.+||+|||++....
T Consensus       102 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999988654   3589999999999999999999997   99999999999999764   469999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .....  ....+++.|+|||.+.+ .++.++||||||+++|||++|+.||...........+..   . ..    .... 
T Consensus       176 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~-~~----~~~~-  243 (287)
T 2wei_A          176 QNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET---G-KY----AFDL-  243 (287)
T ss_dssp             CCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C-CC----CCCS-
T ss_pred             CCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---C-CC----CCCc-
Confidence            43221  12247889999999876 489999999999999999999999976544333222211   1 00    0000 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        +.......++.+++.+||+.+|++|||+.|++++
T Consensus       244 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          244 --PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             --GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence              1112334678899999999999999999999984

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-36  Score=331.32  Aligned_cols=256  Identities=25%  Similarity=0.321  Sum_probs=182.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc------Ccce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~  576 (818)
                      +.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      ...+
T Consensus        31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~  110 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY  110 (367)
T ss_dssp             EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence            445568999999999999864 68999999986542  23456788999999999999999999998654      4679


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +|+|++ +++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       111 lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          111 LVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             EEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             EEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            999998 7899988843    4589999999999999999999997   9999999999999999999999999999865


Q ss_pred             ccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--------  727 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--------  727 (818)
                      ...    .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...........+......+.        
T Consensus       183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            432    223468999999999877 6789999999999999999999999976654333332222111100        


Q ss_pred             ---chhhccccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 ---LCDLVDKKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ---~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ....+.........     .......+.+|+.+||+.||++|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence               00000000000000     01224568899999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-35  Score=327.50  Aligned_cols=258  Identities=23%  Similarity=0.278  Sum_probs=189.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccC------cce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~  576 (818)
                      +.+.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.+++.++||||+++++++....      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            445568999999999999865 58899999986532  233467889999999999999999999987654      679


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||++ ++|.+++.     ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       107 lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          107 IVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            9999996 57888773     2488999999999999999999997   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh--h--------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA--D--------  726 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~--~--------  726 (818)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......  +        
T Consensus       178 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          178 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            4332  122346899999999999999999999999999999999999999765433222211110000  0        


Q ss_pred             cchhhccccC-----------------cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          727 RLCDLVDKKS-----------------EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       727 ~~~~~~d~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .....+....                 ...........++.+++.+||+.||++|||+.|++++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            0000000000                 00001123467889999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-35  Score=322.44  Aligned_cols=261  Identities=25%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             HHhhhhcccccceeEEEeEe--cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcc---CcceeEEEeeeec-----ccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLL--NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNI---HHFNLVRLVGYCA-----ERS  573 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~-----~~~  573 (818)
                      +.+.+.||+|+||.||++..  .+++.||||++....  ......+.+|+.+++.+   +||||+++++++.     ...
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   92 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   92 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence            44556899999999999997  468899999885432  22234567788777766   8999999999987     556


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++||||++ ++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        93 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           93 KLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             EEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             eEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence            7899999997 69999986543 24589999999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh--
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL--  731 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~--  731 (818)
                      +......  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+......+.....  
T Consensus       168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            8764322  223356899999999999999999999999999999999999999866543333332221111000000  


Q ss_pred             --------ccc-cC-cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 --------VDK-KS-EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 --------~d~-~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                              ... .. ............+.+++.+||+.||++||++.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                    000 00 0000112345678899999999999999999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-36  Score=324.30  Aligned_cols=249  Identities=27%  Similarity=0.368  Sum_probs=192.7

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecc------cCccee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE------RSNRFL  577 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~------~~~~~l  577 (818)
                      +.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++..      ....++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            344568999999999999974 68999999986443 3457889999999999 89999999999976      457899


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++.... ...+++..+..++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus       105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             EEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            999999999999986532 35688999999999999999999997   99999999999999999999999999998764


Q ss_pred             cCCCccccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      ..... .....|++.|+|||.+.     ...++.++||||||+++|||++|+.||...........+.   ...      
T Consensus       181 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~------  250 (326)
T 2x7f_A          181 RTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNP------  250 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSC------
T ss_pred             cCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh---cCc------
Confidence            43221 22346899999999987     5678999999999999999999999997554322211111   100      


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+...    .......+.+++.+||+.||.+||++.+++++
T Consensus       251 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          251 APRLK----SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CCCCS----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccCC----ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000    11234578899999999999999999999984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-35  Score=325.84  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=196.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeeccc-----Ccceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAER-----SNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~lV  578 (818)
                      +.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++...     ...++|
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            344568999999999999976 589999999965432 3346788999999999999999999988654     578999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+. ++|.+++..    ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           93 QELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             ECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            99996 689998854    3589999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCCc---------cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc-
Q 043017          659 DQSH---------VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR-  727 (818)
Q Consensus       659 ~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~-  727 (818)
                      ....         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...........+......+. 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            3211         1122468999999998754 6789999999999999999999999986643322222211111100 


Q ss_pred             -----------chhhccccCcCc-----cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 -----------LCDLVDKKSEDM-----QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 -----------~~~~~d~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                                 ..+.+.......     ........++.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                       000000000000     0011234678899999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.1e-35  Score=324.96  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=194.2

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCcc------e
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNR------F  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~------~  576 (818)
                      +.+.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+.++++++||||+++++++...+..      +
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  123 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  123 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred             EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence            344567999999999999865 589999999975432  2346788999999999999999999999877654      9


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+. ++|.+++.     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       124 lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          124 LVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             EEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             EEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence            9999996 68887772     2489999999999999999999998   9999999999999999999999999999865


Q ss_pred             ccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--chh---
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--LCD---  730 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--~~~---  730 (818)
                      ...    .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+.  ...   
T Consensus       195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            432    223468999999999987 6789999999999999999999999986554333322221111000  000   


Q ss_pred             ------hccccCcCc-----cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          731 ------LVDKKSEDM-----QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       731 ------~~d~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            .........     .........+.+++.+||+.||++|||+.|++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                  000000000     0011235678899999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.1e-35  Score=319.74  Aligned_cols=259  Identities=18%  Similarity=0.264  Sum_probs=200.7

Q ss_pred             hHHhhhhcccccceeEEEeEec-CC-cEEEEEEcCCCCCccHHHHHHHHHHHhccCcce------eEEEeeeecccCcce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DG-TKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN------LVRLVGYCAERSNRF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g-~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n------iv~l~g~~~~~~~~~  576 (818)
                      .+.+.+.||+|+||.||++... ++ +.||||++... ....+.+.+|+.++++++|++      ++.+.+++......+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            4556678999999999999975 34 78999998643 234567888999999998776      999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE-----------------
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL-----------------  639 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll-----------------  639 (818)
                      +||||+ +++|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||+                 
T Consensus        99 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence            999999 677777775432 24689999999999999999999997   99999999999999                 


Q ss_pred             --cCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHH
Q 043017          640 --DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVD  717 (818)
Q Consensus       640 --~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~  717 (818)
                        +.++.+||+|||+++......    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence              678899999999998654322    23468999999999999999999999999999999999999998665443333


Q ss_pred             HHHHHhhhhc--c---------------------------hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHH
Q 043017          718 TLKVKAEADR--L---------------------------CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       718 ~~~~~~~~~~--~---------------------------~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      .+........  +                           .+..............+..++.+++.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            3222111000  0                           0000000000111234567899999999999999999999


Q ss_pred             HHHHH
Q 043017          769 MLVKV  773 (818)
Q Consensus       769 evl~~  773 (818)
                      |++++
T Consensus       330 e~l~h  334 (355)
T 2eu9_A          330 EALLH  334 (355)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.5e-35  Score=323.76  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=200.0

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cc-----eeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HF-----NLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~-----niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.+.||+|+||.||+|... +++.||||++... .....++..|++++..++ |+     +|+++++++......++
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            3455678999999999999975 5789999998643 233466778888888874 44     59999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc--CCCCEEEeecCCcee
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD--RDLNVKIADFGLARL  655 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfgla~~  655 (818)
                      ||||++ ++|.+++.... ...+++..+..++.||+.||+|||.+ +.+|+||||||+|||++  .++.+||+|||+++.
T Consensus       134 v~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            999995 59999886543 24589999999999999999999952 34899999999999994  578899999999987


Q ss_pred             cccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh---------
Q 043017          656 IAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD---------  726 (818)
Q Consensus       656 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~---------  726 (818)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......+         
T Consensus       211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            6432    223468999999999999999999999999999999999999998765444333332221110         


Q ss_pred             cchhhccccC----------------------------------------cCccCcHHHHHHHHHHHHHccccCCCCCCc
Q 043017          727 RLCDLVDKKS----------------------------------------EDMQSHRDDAVKMIQIAISCLQKNLHRRPS  766 (818)
Q Consensus       727 ~~~~~~d~~~----------------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt  766 (818)
                      .....++...                                        ........+..++.+|+.+||+.||++|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence            0000000000                                        000011234568899999999999999999


Q ss_pred             HHHHHHH
Q 043017          767 ASMLVKV  773 (818)
Q Consensus       767 ~~evl~~  773 (818)
                      +.|++++
T Consensus       367 a~e~L~h  373 (382)
T 2vx3_A          367 PYYALQH  373 (382)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.1e-35  Score=330.34  Aligned_cols=247  Identities=27%  Similarity=0.353  Sum_probs=185.7

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +.||+|+||+||.+...+|+.||||++...   ..+.+.+|++++.++ +||||+++++++.++...++||||+. |+|.
T Consensus        21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             CeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            569999999998776677999999998542   245678999999886 89999999999999999999999995 6999


Q ss_pred             hHhhhcCCc----cccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-------------CCEEEeecC
Q 043017          589 KWIFHKDRI----QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-------------LNVKIADFG  651 (818)
Q Consensus       589 ~~l~~~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-------------~~~kl~Dfg  651 (818)
                      +++......    ...++..+..++.||+.||+|||+.   +|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            999654321    1124556788999999999999997   99999999999999754             489999999


Q ss_pred             CceecccCCCcc---ccCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHH
Q 043017          652 LARLIAQDQSHV---STMPKGTPGYMAPELTRG-------NSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLK  720 (818)
Q Consensus       652 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~  720 (818)
                      +++.........   .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||....... ...+.
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~i~~  252 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SNIIR  252 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HHHHH
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HHHhc
Confidence            999876543221   223569999999999975       568999999999999999999 999986543221 11110


Q ss_pred             HHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       721 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                               ..................++.+++.+||+.||.+|||+.+++++
T Consensus       253 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          253 ---------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ---------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                     00110111111234567889999999999999999999999863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.4e-35  Score=315.12  Aligned_cols=249  Identities=29%  Similarity=0.388  Sum_probs=188.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc-------------
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE-------------  571 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-------------  571 (818)
                      +.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+             
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK   86 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence            344568999999999999975 6899999998532 2345678999999999999999999998754             


Q ss_pred             cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      ....++||||+++++|.+++....  ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           87 KSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             CCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence            356789999999999999996532  4678889999999999999999998   99999999999999999999999999


Q ss_pred             CceecccCC-------------CccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHH
Q 043017          652 LARLIAQDQ-------------SHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVD  717 (818)
Q Consensus       652 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~  717 (818)
                      ++.......             ........|++.|+|||.+.+. .++.++||||||+++|||++   |+...  .....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~~~  236 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MERVN  236 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhHHH
Confidence            998764321             1112234589999999999864 68999999999999999998   44311  11111


Q ss_pred             HHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          718 TLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       718 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ........       ....+. .........+.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~-------~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          237 ILKKLRSV-------SIEFPP-DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHST-------TCCCCT-TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHhcccc-------ccccCc-cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            11111100       000000 1122344678899999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.9e-35  Score=316.34  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=193.1

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccC--cceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIH--HFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.+.||+|+||.||++...+++.||||.+....  ....+.+.+|++++.+++  |+||+++++++......++|||
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            345567899999999999999889999999986442  234578899999999997  5999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                       +.+++|.+++...   ..+++..+..++.||++||.|||+.   +|+||||||+|||+++ +.+||+|||+++......
T Consensus       109 -~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          109 -CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             -CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             -cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence             6789999999653   3588999999999999999999997   9999999999999964 899999999998765433


Q ss_pred             Cc-cccCCCCCCcccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          661 SH-VSTMPKGTPGYMAPELTRG-----------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       661 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      .. ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.......  ..+....     
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~-----  253 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAII-----  253 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHH-----
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHHH-----
Confidence            22 1223468999999999875           468899999999999999999999997543321  1111111     


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                          +.... ...+.....++.+++.+||+.||++||++.|++++-
T Consensus       254 ----~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          254 ----DPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             ----CTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----hcccc-cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                11000 000111245788999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.1e-35  Score=320.31  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=194.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccCc------ce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN------RF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------~~  576 (818)
                      +.+.+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.....      .+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            344567999999999999975 589999999865432  234678899999999999999999999987654      49


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+. ++|.+++.     ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       106 lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             EEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             EEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            9999997 68887762     2489999999999999999999997   9999999999999999999999999999865


Q ss_pred             ccCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh--cch----
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD--RLC----  729 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~--~~~----  729 (818)
                      ...    .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......+  ...    
T Consensus       177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            432    223468999999999877 678999999999999999999999997655433322222111000  000    


Q ss_pred             -----hhcc---cc-CcC-ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          730 -----DLVD---KK-SED-MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       730 -----~~~d---~~-~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           ..+.   .. ... .........++.+++.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 0000   00 000 01112345788899999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.9e-35  Score=321.71  Aligned_cols=261  Identities=25%  Similarity=0.318  Sum_probs=196.8

Q ss_pred             hhHHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-----------cceeEEEeeeecc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-----------HFNLVRLVGYCAE  571 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-----------H~niv~l~g~~~~  571 (818)
                      ..+.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            3455667899999999999996 46899999998643 233567889999998886           8999999999876


Q ss_pred             cC----cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc------C
Q 043017          572 RS----NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD------R  641 (818)
Q Consensus       572 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~------~  641 (818)
                      ..    ..++|||++ +++|.+++.... ...+++..+..++.||+.||+|||+.  .+|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 999999986533 24588999999999999999999983  2899999999999994      3


Q ss_pred             CCCEEEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH---HH
Q 043017          642 DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV---DT  718 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~---~~  718 (818)
                      .+.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........   +.
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            447999999999876543    22346899999999999999999999999999999999999999865432111   11


Q ss_pred             HHHHhh-hhcch-----------hhccc------------------cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHH
Q 043017          719 LKVKAE-ADRLC-----------DLVDK------------------KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS  768 (818)
Q Consensus       719 ~~~~~~-~~~~~-----------~~~d~------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~  768 (818)
                      +..... .+...           ..+..                  .............++.+|+.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            110000 00000           00000                  0001122456778899999999999999999999


Q ss_pred             HHHHH
Q 043017          769 MLVKV  773 (818)
Q Consensus       769 evl~~  773 (818)
                      |++++
T Consensus       330 ell~h  334 (373)
T 1q8y_A          330 GLVNH  334 (373)
T ss_dssp             HHHTC
T ss_pred             HHhhC
Confidence            99985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.3e-35  Score=317.63  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=168.5

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecc----cCcceeeeeccCCC
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLVYEYMCNG  585 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~g  585 (818)
                      .||+|+||.||++... +++.||||++...    .....+....+..++|+||+++++++..    +...++||||+++|
T Consensus        36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            5999999999999986 6899999998542    2222233344566799999999999876    44589999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCceecccCCCc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +|.+++.... ...+++..+..++.||++||+|||+.   +|+||||||+|||++.   ++.+||+|||+++......  
T Consensus       112 ~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--  185 (336)
T 3fhr_A          112 ELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--  185 (336)
T ss_dssp             EHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence            9999996543 24699999999999999999999997   9999999999999976   4559999999998664332  


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....+|+.|+|||.+....++.++||||||+++|||++|+.||....................    .....   +..
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~  257 (336)
T 3fhr_A          186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ----YGFPN---PEW  257 (336)
T ss_dssp             -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCT---TTS
T ss_pred             -cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc----cccCc---hhh
Confidence             2234689999999999888899999999999999999999999976544332211111110000    00000   011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                      .....++.+++.+||+.||++|||+.|++++-
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            23456788999999999999999999999853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=326.38  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=184.8

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeeeccCCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYEYMCNG  585 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (818)
                      ...+.||+|+||+||.....+++.||||++.....   ..+.+|+++++++ +||||+++++++.+....++||||++ |
T Consensus        27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            34467999999996655556789999999865432   3456899999999 89999999999999999999999995 6


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-----CCCEEEeecCCceecccCC
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-----DLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~~~~  660 (818)
                      +|.+++....  ..+.+..+..++.||++||+|||+.   +|+||||||+|||++.     ...+||+|||+++......
T Consensus       103 ~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          103 TLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             EHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            9999986433  3455667789999999999999997   9999999999999943     3468899999998775432


Q ss_pred             C--ccccCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          661 S--HVSTMPKGTPGYMAPELTR---GNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       661 ~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      .  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||........    .......        
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~~~~~~~--------  245 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----NILLGAC--------  245 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----HHHTTCC--------
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----HHHhccC--------
Confidence            2  2223356999999999997   4567889999999999999999 8888854332211    1111000        


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..............+.+++.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            011111123455668899999999999999999999953

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=313.51  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=176.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-c-HHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-G-KKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.+.||+|+||.||++... +++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            344567999999999999986 6899999998654322 2 233445556788889999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                       ++.+..+....  ...+++..+..++.||++||.|||+ .   +|+|+||||+||+++.++.+||+|||++........
T Consensus       107 -~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          107 -GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             -SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             -CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence             45555444322  2468999999999999999999998 4   899999999999999999999999999986654322


Q ss_pred             ccccCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          662 HVSTMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                        .....+++.|+|||.+.     ...++.++||||||+++|||++|+.||.......  +.+......         ..
T Consensus       181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~---------~~  247 (318)
T 2dyl_A          181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTKVLQE---------EP  247 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHHS---------CC
T ss_pred             --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHHHhcc---------CC
Confidence              22345899999999994     4568899999999999999999999997543321  111111111         00


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.......++.+++.+||+.||.+||++.+++++
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0111111234678899999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-34  Score=315.90  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=176.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC-ccHHHHHHHHH-HHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-RGKKEFLSEVE-TIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      +.+.+.||+|+||.||++... +++.||||++..... ....++..|+. +++.++||||+++++++...+..++||||+
T Consensus        24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3aln_A           24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM  103 (327)
T ss_dssp             EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence            344567999999999999985 689999999865432 33445666665 777789999999999999999999999999


Q ss_pred             CCCChhhHhhh--cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          583 CNGSLDKWIFH--KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       583 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      ++ +|.+++..  ......+++..+..++.|+++||.|||+.  .+|+||||||+||+++.++.+||+|||+++......
T Consensus       104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred             CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence            75 88877753  12235689999999999999999999983  389999999999999999999999999998765432


Q ss_pred             CccccCCCCCCcccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          661 SHVSTMPKGTPGYMAPELT----RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      .  .....|++.|+|||.+    .+..++.++||||||+++|||++|+.||......  .+.+         ........
T Consensus       181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---------~~~~~~~~  247 (327)
T 3aln_A          181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQL---------TQVVKGDP  247 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCSCC
T ss_pred             c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHH---------HHHhcCCC
Confidence            2  1223689999999999    4567899999999999999999999999753221  0100         01111111


Q ss_pred             cCc--cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          737 EDM--QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       737 ~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...  .........+.+++.+||+.||++||++.+++++
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            100  0112345678899999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-35  Score=314.02  Aligned_cols=241  Identities=24%  Similarity=0.330  Sum_probs=189.8

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcc----CcceeEEEeeeecc
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR------GKKEFLSEVETIGNI----HHFNLVRLVGYCAE  571 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ev~~l~~l----~H~niv~l~g~~~~  571 (818)
                      ...+.+.+.||+|+||.||+|... +++.||||++......      ....+.+|+.++.++    +|+||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            344556678999999999999864 6889999999654321      233466789988888    89999999999999


Q ss_pred             cCcceeeeec-cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEee
Q 043017          572 RSNRFLVYEY-MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIAD  649 (818)
Q Consensus       572 ~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D  649 (818)
                      .+..++|||+ +++++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||+++ .++.+||+|
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence            9999999999 7899999999653   3589999999999999999999998   999999999999999 889999999


Q ss_pred             cCCceecccCCCccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          650 FGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       650 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      ||++.......   .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....      .+.   .    
T Consensus       184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~---~----  247 (312)
T 2iwi_A          184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL---E----  247 (312)
T ss_dssp             CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH---H----
T ss_pred             cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh---h----
Confidence            99998765432   223458999999999877665 459999999999999999999986321      000   0    


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                           ...   ........++.+++.+||+.+|++||++.|++++
T Consensus       248 -----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 -----AEL---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -----TCC---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----hcc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000   0112234578899999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-34  Score=336.78  Aligned_cols=270  Identities=26%  Similarity=0.341  Sum_probs=203.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecc------cCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE------RSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------~~~~  575 (818)
                      ..+.+.+.||+|+||.||++... +|+.||||++... .....+.+.+|++++.+++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            34666778999999999999975 5899999998654 33345679999999999999999999999765      6678


Q ss_pred             eeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC---EEEeecCC
Q 043017          576 FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN---VKIADFGL  652 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgl  652 (818)
                      ++||||+++++|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999997655555799999999999999999999997   9999999999999997665   99999999


Q ss_pred             ceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHH--------hh
Q 043017          653 ARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVK--------AE  724 (818)
Q Consensus       653 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~--------~~  724 (818)
                      +........  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.+....  ..+....        ..
T Consensus       171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--VQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--HHSSTTCC------CCS
T ss_pred             ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--hhhhhhhhcccchhhhh
Confidence            987654332  23356899999999999999999999999999999999999999754211  0000000        00


Q ss_pred             hhcchhhc--ccc-CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHH-----HHHHHhcCcCC
Q 043017          725 ADRLCDLV--DKK-SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASM-----LVKVLQGLTKL  780 (818)
Q Consensus       725 ~~~~~~~~--d~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-----vl~~L~~i~~~  780 (818)
                      .......+  ... .............+.+++..||+.||++|||+.+     ..+.++.+.+.
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            00000000  000 0011123446788999999999999999999977     44555554443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.5e-35  Score=315.69  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=194.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc------cHHHHHHHHHHHhccC--cceeEEEeeeecccCcc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR------GKKEFLSEVETIGNIH--HFNLVRLVGYCAERSNR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~  575 (818)
                      .+.+.+.||+|+||.||+|+.. +++.||||.+......      ..+.+.+|+.++.+++  |+||+++++++...+..
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~  123 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF  123 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence            3455678999999999999864 6899999998654221      2356778999999995  59999999999999999


Q ss_pred             eeeeeccCC-CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEeecCCc
Q 043017          576 FLVYEYMCN-GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLA  653 (818)
Q Consensus       576 ~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla  653 (818)
                      ++|||++.+ ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++ .++.+||+|||++
T Consensus       124 ~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          124 VLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             EEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999976 8999998653   3588999999999999999999997   999999999999999 7889999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      +......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....      .+.   ..       
T Consensus       198 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~---~~-------  258 (320)
T 3a99_A          198 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII---RG-------  258 (320)
T ss_dssp             EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH---HC-------
T ss_pred             ccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh---cc-------
Confidence            8765432   223468999999999977665 788999999999999999999986321      000   00       


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ...   .......++.+++.+||+.||++|||+.|++++
T Consensus       259 --~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 --QVF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --CCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --ccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000   011234578899999999999999999999885

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-33  Score=299.14  Aligned_cols=231  Identities=17%  Similarity=0.131  Sum_probs=181.3

Q ss_pred             hHHhhhhcccccceeEEEeEecC-CcEEEEEEcCCCCCc---cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGENR---GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .|.+.+.||+|+||.||+|.... ++.||||.+......   ..+.|.+|+..+.+++||||+++++++.+.+..++|||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  111 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE  111 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence            45566789999999999999864 899999999765332   23678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++...     ....++.+|+.||++||+|||+.   +|+||||||+|||++.++.+||++++         
T Consensus       112 ~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          112 WIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             ecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            99999999998421     34456888999999999999998   99999999999999999999997443         


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC-c
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED-M  739 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~  739 (818)
                                  |++       .++.++||||||+++|||++|+.||...........         ....+...... .
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~  226 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------AERDTAGQPIEPA  226 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------CCBCTTSCBCCHH
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------HHHHhccCCCChh
Confidence                        333       368899999999999999999999986543211000         00000000000 0


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCC
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE  781 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~  781 (818)
                      ........++.+++.+||+.||++| |+.|+++.|+.+....
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0012234678899999999999999 9999999999887653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-33  Score=336.14  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=190.7

Q ss_pred             hHHhhhhcccccceeEEEeEec--CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCc-----ce
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN--DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN-----RF  576 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-----~~  576 (818)
                      .+.+.+.||+|+||.||++...  +++.||||++.... ......+.+|++++.+++||||+++++++...+.     .+
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            3455678999999999999975  58999999986543 2345678999999999999999999999987765     69


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+++++|.+++..     .+++..+..|+.||++||.|||+.   +|+||||||+|||++.+ .+||+|||+++..
T Consensus       161 lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            99999999999987732     589999999999999999999997   99999999999999886 9999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccC
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ...     ....||+.|+|||++.+.. +.++||||||++++||++|..|+.......+                     
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------  284 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------  284 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------
T ss_pred             ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------------
Confidence            543     2346899999999987654 8999999999999999999888753211100                     


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCC-cHHHHHHHHhcC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRP-SASMLVKVLQGL  777 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i  777 (818)
                      ............+.+++.+||+.||++|| ++.++.+.|..+
T Consensus       285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            00011223346788999999999999999 566677766654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-33  Score=315.59  Aligned_cols=236  Identities=20%  Similarity=0.241  Sum_probs=177.0

Q ss_pred             hhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCc-ce---------------eEEEe--
Q 043017          509 QIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHH-FN---------------LVRLV--  566 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H-~n---------------iv~l~--  566 (818)
                      .+.||+|+||.||+|.. .+|+.||||++.....   ...+.|.+|+.++..++| +|               ++.+.  
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            35799999999999995 4689999999874332   336789999999999977 21               11111  


Q ss_pred             ----eeecc-----cCcceeeeeccCCCChhhHhhh----cCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccc
Q 043017          567 ----GYCAE-----RSNRFLVYEYMCNGSLDKWIFH----KDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIK  633 (818)
Q Consensus       567 ----g~~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlk  633 (818)
                          .++..     ....+++|+++ +++|.+++..    ......+++..+..++.||++||+|||+.   +|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence                11111     12346667754 7899988842    22345688999999999999999999997   99999999


Q ss_pred             cCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccc----------cCCCCCchhhHHHHHHHHHHHHhC
Q 043017          634 PQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT----------RGNSITAKIDIYSFGVVILEIICG  703 (818)
Q Consensus       634 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwS~Gvll~elltG  703 (818)
                      |+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|||++|
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             cceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999999999999875443    333467 999999999          556688999999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          704 RRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       704 ~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      +.||..........            ..+. ...      ..+.++.+++.+||+.||++||++.++++
T Consensus       314 ~~Pf~~~~~~~~~~------------~~~~-~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          314 DLPNTDDAALGGSE------------WIFR-SCK------NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SCCCCTTGGGSCSG------------GGGS-SCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcchhhhHH------------HHHh-hcc------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99997543221110            1111 011      12367889999999999999999877754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.98  E-value=3.5e-32  Score=292.09  Aligned_cols=224  Identities=22%  Similarity=0.311  Sum_probs=175.1

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHH-hccCcceeEEEeeeecc----cCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETI-GNIHHFNLVRLVGYCAE----RSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e~~~  583 (818)
                      +.||+|+||.||++... +++.||||++..     ...+.+|+.++ +.++||||+++++++..    ....++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            46999999999999974 688999999853     35677888888 55699999999999876    667899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||++....   
T Consensus        99 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---  171 (299)
T 3m2w_A           99 GGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---  171 (299)
T ss_dssp             SCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred             CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence            999999996543 24689999999999999999999997   9999999999999998   7889999999997542   


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                                          +..++.++||||||+++|||++|+.||..........         .....+.......+
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------GMKTRIRMGQYEFP  222 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---------CSCCSSCTTCCSSC
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---------HHHHHHhhccccCC
Confidence                                2346789999999999999999999997543321100         00000000000000


Q ss_pred             --CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHH
Q 043017          741 --SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL  774 (818)
Q Consensus       741 --~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  774 (818)
                        .......++.+++.+||+.||++|||+.|++++-
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence              0022456788999999999999999999999853

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=9.5e-33  Score=301.61  Aligned_cols=243  Identities=20%  Similarity=0.201  Sum_probs=182.3

Q ss_pred             HhhHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--------CccHHHHHHHHHHHhccC---------cceeEEE
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--------NRGKKEFLSEVETIGNIH---------HFNLVRL  565 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--------~~~~~~f~~Ev~~l~~l~---------H~niv~l  565 (818)
                      ...+.+.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+++++.++         |+||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45566778999999999999998 68999999986542        223478899999998886         5555555


Q ss_pred             ee-----------------eecc-------------cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHH
Q 043017          566 VG-----------------YCAE-------------RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG  615 (818)
Q Consensus       566 ~g-----------------~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g  615 (818)
                      .+                 ++.+             ....++||||+++|++.+.+..    ..+++..+..|+.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            54                 4443             6789999999999987776632    458999999999999999


Q ss_pred             HHHHH-hcCCCCeeecccccCeEEEcCCC--------------------CEEEeecCCceecccCCCccccCCCCCCccc
Q 043017          616 LEYLH-DYCNPKIIHFDIKPQNILLDRDL--------------------NVKIADFGLARLIAQDQSHVSTMPKGTPGYM  674 (818)
Q Consensus       616 L~yLH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~  674 (818)
                      |+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 87   999999999999999887                    8999999999876542      236899999


Q ss_pred             ccccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc-ccCcCccCcHHHHHHHHHH
Q 043017          675 APELTRGNSITAKIDIYSFGVV-ILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD-KKSEDMQSHRDDAVKMIQI  752 (818)
Q Consensus       675 aPE~~~~~~~s~ksDVwS~Gvl-l~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~~l~~l  752 (818)
                      |||++.+.. +.++||||+++. .+++++|..||...      .+....  ...+..... ..............++.+|
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYL--TDKMLKQMTFKTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHH--HHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHH--HHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence            999998766 899999998777 77788888886310      010000  001110000 1111111234577889999


Q ss_pred             HHHccccCCCCCCcHHHHH-HH
Q 043017          753 AISCLQKNLHRRPSASMLV-KV  773 (818)
Q Consensus       753 i~~cl~~dp~~RPt~~evl-~~  773 (818)
                      +.+||+.|     |+.|++ ++
T Consensus       316 i~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHhccC-----CHHHHHhcC
Confidence            99999976     999998 53

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=99.97  E-value=3e-30  Score=266.17  Aligned_cols=209  Identities=17%  Similarity=0.192  Sum_probs=148.2

Q ss_pred             CCcceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCC
Q 043017           39 AQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKEN  118 (818)
Q Consensus        39 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~  118 (818)
                      +.|+|+.++.+.+.++|+  +     |.|+|||+.+++.        ++     |.       .+|+||+|||+.|  .+
T Consensus         7 ~~~~i~~g~~L~~g~~l~--~-----g~f~l~f~~~gnl--------~l-----y~-------~~~~vW~an~~~~--~~   57 (236)
T 1dlp_A            7 LSHEGSHPQTLHAAQSLE--L-----SSFRFTMQSDCNL--------VL-----FD-------SDVRVWASNTAGA--TG   57 (236)
T ss_dssp             SSSSSCSCSCCCTTCEEC--S-----TTEEEEECTTSCE--------EE-----EE-------SSSEEECCCCCSC--SC
T ss_pred             ccceeCCCCEECCCCEEE--c-----CCEEEEECCCCcE--------EE-----EE-------CCEEEEECCCCCC--CC
Confidence            346666777777777773  5     8999999876542        11     21       1589999999988  66


Q ss_pred             ceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcc----------cCCCee
Q 043017          119 ATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTW----------LPGQRL  187 (818)
Q Consensus       119 ~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtl----------lpg~kl  187 (818)
                      ++|+|+.||||||+|++|.+||+|++... ....|+|+|+|||||++.   ++|||||||+||+          +||||+
T Consensus        58 ~~l~l~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~  134 (236)
T 1dlp_A           58 CRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGN  134 (236)
T ss_dssp             CBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--C
T ss_pred             eEEEEcCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcC
Confidence            89999999999999999999999988643 345899999999999954   8999999998655          777766


Q ss_pred             ccc-eeEeeccCCCCCCccEEEEEEccCCcEEEEeccceeeeeecccccceecccccccccceeEEecCCC--ceEEEee
Q 043017          188 HVH-KMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSSAVLNKSAILVFNKSG--SHITYDV  264 (818)
Q Consensus       188 ~~~-~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~n~~~--~~~~~~~  264 (818)
                      +.+ ++|++   .+||++|.|+++++++|...+ +.+...+|++++|++. +............++++.++  .+.+|..
T Consensus       135 ~~~~~~L~s---~~d~s~G~~~l~l~~dG~LvL-~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~  209 (236)
T 1dlp_A          135 DNHPQTLHA---TQSLQLSPYRLSMETDCNLVL-FDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNS  209 (236)
T ss_dssp             CCCCCEECS---SCCCBCSSCEEEEETTTEEEE-EBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCC
T ss_pred             CCccceEEc---CcEeecCcEEEEECCCCcEEE-EcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCC
Confidence            653 45664   789999999999999996444 4445689999998643 32222221122112333222  2223332


Q ss_pred             CCCCceEEEEECCCCcEEEEE
Q 043017          265 APRSKFHYMRLEPNGHLNIYQ  285 (818)
Q Consensus       265 ~~~~~~~~~~l~~~G~l~~~~  285 (818)
                      .. ....|++|++||++++|.
T Consensus       210 ~~-~~~~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          210 RS-AGRYVFVLQPDRNLAIYG  229 (236)
T ss_dssp             CS-SSCCEEEECSSSCEEEEC
T ss_pred             CC-CCCEEEEEcCCCcEEEeC
Confidence            22 346899999999999994

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=4.9e-27  Score=273.26  Aligned_cols=183  Identities=19%  Similarity=0.128  Sum_probs=128.1

Q ss_pred             hcccccceeEEEeEe-cCCcEEEEEEcCCCC----------CccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceee
Q 043017          511 RLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE----------NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~----------~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (818)
                      .++.|++|.+..++. .-|+.+|||.+....          ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            467777777666553 348889999986542          12245799999999999 799999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||++|++|.++|....   .++.   .+|+.||+.||+|||++   +||||||||+||||+.++++||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~~~---~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE---EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTTC---CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhCC---CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999996543   3443   35899999999999998   999999999999999999999999999997755


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR  704 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~  704 (818)
                      ..... ....||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus       392 ~~~~~-~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          392 DCSWP-TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             --CCS-HHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CCccc-cCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            43322 23469999999999976 4677899999999988876653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=3.1e-24  Score=248.32  Aligned_cols=182  Identities=16%  Similarity=0.231  Sum_probs=145.0

Q ss_pred             hhhcccccceeEEEeEecCCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          509 QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENR--------GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.||+|+||.||++... ++.+++|+.......        ..+.|.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            357999999999999554 788999986543221        13458999999999999999977777777788899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++++|.+++..           +..++.|+++||+|||+.   +|+||||||+|||++.  ++||+|||+++......
T Consensus       420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            9999999998843           568999999999999997   9999999999999998  99999999999875532


Q ss_pred             Ccc------ccCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 043017          661 SHV------STMPKGTPGYMAPELTRG--NSITAKIDIYSFGVVILEIICGRRSS  707 (818)
Q Consensus       661 ~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvll~elltG~~p~  707 (818)
                      ...      .....||+.|+|||++..  ..|+..+|+|+..+-.++.+.++.++
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            211      123468999999999986  56788899999999888888776654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=2.4e-21  Score=205.48  Aligned_cols=140  Identities=15%  Similarity=0.141  Sum_probs=114.7

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCC------------------ccHHHHHHHHHHHhccCcceeEEEeeeecc
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN------------------RGKKEFLSEVETIGNIHHFNLVRLVGYCAE  571 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~  571 (818)
                      +.||+|+||.||+|...+|+.||||.+.....                  .....+.+|++++++++  | +++.+++. 
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~-  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA-  171 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence            67999999999999997799999999864321                  12456899999999998  4 66666543 


Q ss_pred             cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecC
Q 043017          572 RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFG  651 (818)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  651 (818)
                      .+..++||||+++++|.+ +.         ......++.|+++||.|||+.   +|+||||||+|||++ ++.+||+|||
T Consensus       172 ~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          172 WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            366799999999999987 41         134557999999999999997   999999999999999 9999999999


Q ss_pred             CceecccCCCccccCCCCCCcccccccccC
Q 043017          652 LARLIAQDQSHVSTMPKGTPGYMAPELTRG  681 (818)
Q Consensus       652 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~  681 (818)
                      +++.              +..+.|||++..
T Consensus       238 ~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          238 QSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             TCEE--------------TTSTTHHHHHHH
T ss_pred             CCeE--------------CCCCCHHHHHHH
Confidence            9974              335788988753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=1.1e-17  Score=175.12  Aligned_cols=134  Identities=18%  Similarity=0.140  Sum_probs=104.4

Q ss_pred             hhhhcccccceeEEEeEe-cCCcE--EEEEEcCCCCCc------------------------cHHHHHHHHHHHhccCcc
Q 043017          508 FQIRLGRGGSGSVFEGLL-NDGTK--VAVKRLYPGENR------------------------GKKEFLSEVETIGNIHHF  560 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~l~~~~~~------------------------~~~~f~~Ev~~l~~l~H~  560 (818)
                      +...||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|++.+.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            345799999999999998 67888  999987543111                        013678899999999887


Q ss_pred             ee--EEEeeeecccCcceeeeeccCC-C----ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHH-hcCCCCeeeccc
Q 043017          561 NL--VRLVGYCAERSNRFLVYEYMCN-G----SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH-DYCNPKIIHFDI  632 (818)
Q Consensus       561 ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~iiH~Dl  632 (818)
                      ++  ..++++    ...+|||||+.+ |    +|.++..      ..++..+..++.|++++|.||| +.   +|+||||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl  197 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEA---ELVHADL  197 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence            54  333332    467899999942 4    5655442      1346678899999999999999 76   9999999


Q ss_pred             ccCeEEEcCCCCEEEeecCCceec
Q 043017          633 KPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       633 kp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ||+|||++.  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999988  9999999999764

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.71  E-value=4.5e-17  Score=144.49  Aligned_cols=103  Identities=17%  Similarity=0.355  Sum_probs=81.4

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |.+..++.+.+.+.|.|       |.|.|.|...|+     +   +.|    .        ..++||+|||+.|..+++.
T Consensus         2 n~L~~g~~L~~g~~L~s-------g~y~l~~q~DgN-----L---vly----~--------~~~~vW~ant~~~~~~~~~   54 (105)
T 4h3o_A            2 NILDNNEGLYAGQSLDV-------EPYHFIMQDDCN-----L---VLY----D--------HSTSTWASNTEIGGKSGCS   54 (105)
T ss_dssp             CEECTTEEECTTCEEEE-------TTEEEEECTTSC-----E---EEE----E--------TTEEEEECCCCCTTCCSCE
T ss_pred             CCcCCCCEEcCCCEEEE-------CCEEEEECCCCe-----E---EEE----E--------CCEEEEEecCCCCCCccEE
Confidence            34555666666667776       579999876553     1   111    1        2479999999999988899


Q ss_pred             EEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceec
Q 043017          121 LEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      |.|+.||||||+|+++.+||+|++++ .....|+|+|+|||||++.   .+|||
T Consensus        55 L~l~~dGnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S  105 (105)
T 4h3o_A           55 AVLQSDGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST  105 (105)
T ss_dssp             EEECTTSCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred             EEEeCCccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence            99999999999999999999999864 4456899999999999964   69998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.69  E-value=1.4e-16  Score=142.86  Aligned_cols=108  Identities=19%  Similarity=0.336  Sum_probs=84.7

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |.|..++.+...+.|+ ++     |.|+|+|+..|+-        +     +|    +   ..++||+||++.|. .+++
T Consensus         2 d~l~~g~~L~~g~~l~-~~-----~~~~l~~~~dGnl--------v-----l~----~---~~~~vW~sn~~~~~-~~~~   54 (110)
T 3a0c_A            2 NSLSSPNSLFTGHSLE-VG-----PSYRLIMQGDCNF--------V-----LY----D---SGKPVWASNTGGLG-SGCR   54 (110)
T ss_dssp             CEEETTCEECTTCEEE-ET-----TTEEEEECTTSCE--------E-----EE----E---TTEEEEECCCTTSC-SSCE
T ss_pred             CEeCCCCEECCCCEEE-EC-----CCEEEEEcCCCcE--------E-----EE----E---CCEEEEECCCCCCC-CcEE
Confidence            4455555566667788 77     8999999877641        1     23    1   25799999998763 4578


Q ss_pred             EEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCC
Q 043017          121 LEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPT  178 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Pt  178 (818)
                      ++|..||||||+|.+|.+||+|.+... +...++|+|+|||||++.   .+||||+||.
T Consensus        55 l~l~~dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~  110 (110)
T 3a0c_A           55 LTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA  110 (110)
T ss_dssp             EEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred             EEEeCCCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence            999999999999999999999987643 345899999999999975   7999999983

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.68  E-value=1.7e-16  Score=144.22  Aligned_cols=105  Identities=17%  Similarity=0.277  Sum_probs=84.5

Q ss_pred             CcceeeccCceeeeEEE--ecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCC
Q 043017           40 QESYNFVDGSHVRTLLV--RKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKE  117 (818)
Q Consensus        40 ~~~~~~~~~~~~~~~l~--~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~  117 (818)
                      .|.+..++.+.+.+.|+  |++     |.|+|+|+..|+-        +     ||.    +   .++||+||++.| ..
T Consensus         8 ~~~l~~g~~L~~g~~l~~~S~~-----g~~~L~~~~dgnl--------v-----ly~----~---~~~vW~sn~~~~-~~   61 (119)
T 1b2p_A            8 QPDDNHPQILHATESLEILFGT-----HVYRFIMQTDCNL--------V-----LYD----N---NNPIWATNTGGL-GN   61 (119)
T ss_dssp             CSSSCCCCEEETTCEEEEEETT-----EEEEEEECTTSCE--------E-----EEE----T---TEEEEECCCTTS-CS
T ss_pred             CcccCCCCEEcCCCEEEEeCCC-----CCEEEEEecCCCE--------E-----EEE----C---CEEEEeCCCccC-CC
Confidence            45666666677777899  888     9999999987741        1     331    1   589999999876 34


Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      ++.++|.+||||||+|.++.+||+|++.. .+...++|+|+|||||++   .++|||
T Consensus        62 ~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S  115 (119)
T 1b2p_A           62 GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT  115 (119)
T ss_dssp             SCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred             ceEEEEccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence            57899999999999999999999998763 345689999999999997   388998

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.66  E-value=3.6e-16  Score=141.50  Aligned_cols=108  Identities=16%  Similarity=0.269  Sum_probs=85.9

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |+|..++.+...++|+  +     |.|+|+|+..|+-        +.     |.       ..++||+||++.|. .+++
T Consensus         3 dtl~~gq~L~~g~~L~--~-----g~~~L~~~~dgnl--------vl-----y~-------~~~~vW~sn~~~~~-~~~~   54 (115)
T 2dpf_A            3 NVLLSGQTLHADHSLQ--A-----GAYTLTIQNKCNL--------VK-----YQ-------NGRQIWASNTDRRG-SGCR   54 (115)
T ss_dssp             CEEETTCEEETTEEEE--E-----TTEEEEECTTSCE--------EE-----EE-------TTEEEEECSCTTSC-SSCE
T ss_pred             CEeCCCCEECCCCEEE--C-----CCEEEEEcCCCcE--------EE-----Ee-------CCEEEEeCCCCCCC-CceE
Confidence            5677777777777887  4     7999999876641        11     21       25799999999883 4578


Q ss_pred             EEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceecccCCCC
Q 043017          121 LEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWISFLHPTN  179 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptd  179 (818)
                      |+|.++|||||+|.++.+||+|++.. .....++|+|+|||||++.   ++||||.++..
T Consensus        55 l~l~~~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~  111 (115)
T 2dpf_A           55 LTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR  111 (115)
T ss_dssp             EEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred             EEECCCCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence            99999999999998899999998763 3456899999999999964   89999998754

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.63  E-value=1.3e-15  Score=137.26  Aligned_cols=109  Identities=16%  Similarity=0.309  Sum_probs=83.7

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |+|..++.+.+.++|.  +     |.|+|+|+..|+-        +     +|.    .   .++||+||++.+ ..+++
T Consensus         2 dtl~~gq~L~~g~~L~--~-----~~~~L~~~~dgnl--------v-----l~~----~---~~~vW~sn~~~~-~~~~~   53 (112)
T 1xd5_A            2 DRLNSGHQLDTGGSLA--E-----GGYLFIIQNDCNL--------V-----LYD----N---NRAVWASGTNGK-ASGCV   53 (112)
T ss_dssp             CEEETTEEECTTCEEE--E-----TTEEEEECTTSCE--------E-----EEE----T---TEEEEECCCTTS-CSSEE
T ss_pred             CCCCCCCEECCCCEEe--C-----CCEEEEEcCCCcE--------E-----EEE----C---CEEEEeCCCcCC-CCCEE
Confidence            4555566666666672  3     7899999988752        1     221    1   479999999753 23578


Q ss_pred             EEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceecccCCC
Q 043017          121 LEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWISFLHPT  178 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Pt  178 (818)
                      ++|..+|||||+| ++.+||+|.+.. .....++|+++|||||++..+.++||||+|..
T Consensus        54 l~l~~~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           54 LKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             EEECTTSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCC
T ss_pred             EEEeCCCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCccC
Confidence            9999999999999 888999998753 33468999999999999877789999999853

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=1.6e-15  Score=165.26  Aligned_cols=138  Identities=14%  Similarity=0.068  Sum_probs=97.3

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCC--------------ccHHHHHHHHHHHhccCcceeEEEeeeecc-
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN--------------RGKKEFLSEVETIGNIHHFNLVRLVGYCAE-  571 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-  571 (818)
                      .+...||+|+||.||+|...+|+.||||.++....              ........++++.+...|+|+++++..... 
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v  177 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV  177 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred             EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            34457999999999999999999999998754210              111222333333333344444444332211 


Q ss_pred             -----cCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC---
Q 043017          572 -----RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL---  643 (818)
Q Consensus       572 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~---  643 (818)
                           ....+|||||+++++|.++.         ..+....++.||+.+|.|||+.   +||||||||.|||+++++   
T Consensus       178 p~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          178 PEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSS
T ss_pred             CeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcc
Confidence                 12347999999998886543         1234567889999999999997   999999999999998876   


Q ss_pred             -------CEEEeecCCceec
Q 043017          644 -------NVKIADFGLARLI  656 (818)
Q Consensus       644 -------~~kl~Dfgla~~~  656 (818)
                             .+.|+||+.+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999988754

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.55  E-value=8.2e-15  Score=131.29  Aligned_cols=99  Identities=28%  Similarity=0.434  Sum_probs=77.4

Q ss_pred             EEEEeCCCCCCCCCceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccC
Q 043017          105 ILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLP  183 (818)
Q Consensus       105 ~vW~anr~~p~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllp  183 (818)
                      .+|..+.-. .+...+|.|..||||||+| .+++||++++.+. ....++|+|+|||||++.++.++||||         
T Consensus         9 ~L~~g~~l~-~~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~---------   77 (110)
T 3a0c_A            9 SLFTGHSLE-VGPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK---------   77 (110)
T ss_dssp             EECTTCEEE-ETTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC---------
T ss_pred             EECCCCEEE-ECCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC---------
Confidence            445444433 2345789999999999999 5899999998643 346899999999999999889999999         


Q ss_pred             CCeeccceeEeeccCCCCCCccEEEEEEccCCcEEEEeccceeeeeeccc
Q 043017          184 GQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPY  233 (818)
Q Consensus       184 g~kl~~~~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~  233 (818)
                                      +++++|.|++.++++|+.+++. .  .+|+++++
T Consensus        78 ----------------t~~~~g~~~l~l~~dGnlvl~~-~--~~W~S~~~  108 (110)
T 3a0c_A           78 ----------------TNGKEDHYVLVLQQDRNVVIYG-P--VVWATGSG  108 (110)
T ss_dssp             ----------------CCCSSSCCEEEECTTSCEEEEC-S--EEEECSCC
T ss_pred             ----------------CCCCCCCEEEEEeCCccEEEEC-C--CEecCCCc
Confidence                            3556799999999999966543 2  57777764

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.54  E-value=1.4e-14  Score=130.34  Aligned_cols=91  Identities=23%  Similarity=0.364  Sum_probs=77.1

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAST  196 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~  196 (818)
                      ..+|.|..||||||++. +++||++++.+. ....|+|+++|||||++ ++.++||||+                     
T Consensus        20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~---------------------   76 (112)
T 1xd5_A           20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT---------------------   76 (112)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC---------------------
T ss_pred             CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc---------------------
Confidence            47899999999999987 789999998643 34789999999999999 7789999994                     


Q ss_pred             cCCCCCCccEEEEEEccCCcEEEEeccceeeeeeccccc
Q 043017          197 NSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRN  235 (818)
Q Consensus       197 ~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~~~  235 (818)
                          ++++|.|++.++++|+.+++......+|++++|+|
T Consensus        77 ----~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 ----NRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             ----CCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCC
T ss_pred             ----cCCCCCEEEEEeCCCcEEEECCCCceEEECCCccC
Confidence                45678899999999997766555678999999875

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.53  E-value=3.3e-14  Score=127.20  Aligned_cols=101  Identities=17%  Similarity=0.319  Sum_probs=76.5

Q ss_pred             eeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCceEE
Q 043017           43 YNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLE  122 (818)
Q Consensus        43 ~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~l~  122 (818)
                      |..++.+...+.|+  +     |.|+|+|...|+    +++         |.    .   .++||+||++.+ ..++.|.
T Consensus         4 L~~gq~L~~g~~L~--~-----g~~~L~~q~dGn----Lvl---------y~----~---~~~vW~snt~~~-~~~~~l~   55 (109)
T 3dzw_A            4 LYSGETLSPGEFLN--N-----GRYVFIMQEDCN----LVL---------YD----V---DKPIWATNTGGL-DRRCHLS   55 (109)
T ss_dssp             EETTEEECTTCEEE--E-----TTEEEEECTTSC----EEE---------EE----T---TEEEEECCCTTS-SSSCEEE
T ss_pred             cCCCCEeCCCCEEE--C-----CCEEEEEcCCCc----EEE---------Ee----C---CEEEEECCcccC-CCCEEEE
Confidence            44444455555664  3     799999987764    111         21    1   378999999876 3457899


Q ss_pred             EeecccEEEEcCCCcEEEeeccCCCc-eeEEEEcCCCcEEEecCCCCcceecc
Q 043017          123 FTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYDAENRPHWISF  174 (818)
Q Consensus       123 l~~~g~Lvl~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWqSF  174 (818)
                      |..||||||+|.++.+||+|++.+.. ..+|+|+|+|||||++.   ++|||=
T Consensus        56 l~~dGNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~  105 (109)
T 3dzw_A           56 MQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG  105 (109)
T ss_dssp             ECTTSCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred             EeCCCCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence            99999999999999999999886433 46899999999999974   889984

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.50  E-value=7.8e-14  Score=126.54  Aligned_cols=86  Identities=27%  Similarity=0.387  Sum_probs=71.7

Q ss_pred             ceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeecc
Q 043017          119 ATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTN  197 (818)
Q Consensus       119 ~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~~  197 (818)
                      .+|.|..||||||++. +++||++++.+. ....++|+|+|||||+|.++.++||||                       
T Consensus        32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~-----------------------   87 (119)
T 1b2p_A           32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP-----------------------   87 (119)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred             EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence            5788899999999987 899999998643 246899999999999998899999999                       


Q ss_pred             CCCCCCccEEEEEEccCCcEEEEeccceeeeeeccc
Q 043017          198 STTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPY  233 (818)
Q Consensus       198 s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~  233 (818)
                        ++|++|.|++.++++|+.+++.   ..+|++++.
T Consensus        88 --~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg~~  118 (119)
T 1b2p_A           88 --VAGKAGHYVLVLQPDRNVVIYG---DALWATQTV  118 (119)
T ss_dssp             --CCCCSSCEEEEECTTSCEEEEE---SEEEECCCC
T ss_pred             --CCCCCCCEEEEEECCCcEEEEC---ccEeCCCCC
Confidence              4567899999999999966544   267887763

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.45  E-value=1.9e-13  Score=123.48  Aligned_cols=90  Identities=27%  Similarity=0.402  Sum_probs=75.0

Q ss_pred             CCceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEee
Q 043017          117 ENATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAS  195 (818)
Q Consensus       117 ~~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s  195 (818)
                      ....|.|..||||||++ .+++||++++.+. ....++|+++|||||+|.++.++|||||+                   
T Consensus        20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~-------------------   79 (115)
T 2dpf_A           20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW-------------------   79 (115)
T ss_dssp             TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC-------------------
T ss_pred             CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC-------------------
Confidence            34689999999999998 5789999997643 34689999999999999888899999997                   


Q ss_pred             ccCCCCCCccEEEEEEccCCcEEEEeccceeeeeeccccc
Q 043017          196 TNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRN  235 (818)
Q Consensus       196 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~~~  235 (818)
                            +++|.|++.++++|+.+++. .  .+|++++|..
T Consensus        80 ------~~~g~~~l~l~~dGnlvl~~-~--~~W~S~~~~~  110 (115)
T 2dpf_A           80 ------GDNGKYALVLQKDGRFVIYG-P--VLWSLGPNGC  110 (115)
T ss_dssp             ------CSSSCCEEEECTTSCEEEEC-S--EEECSSTTCB
T ss_pred             ------CCCCCEEEEEeCCCeEEEEC-C--CEEECCCCCC
Confidence                  35678999999999966553 2  7899999864

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.40  E-value=1.3e-12  Score=116.88  Aligned_cols=104  Identities=16%  Similarity=0.179  Sum_probs=79.9

Q ss_pred             CCCcceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCC
Q 043017           38 SAQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKE  117 (818)
Q Consensus        38 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~  117 (818)
                      .+.|+|..++.+...+.|+|       |.|.|-|-..|+     ..        .|    ..    .+||++|++.. ..
T Consensus         4 ~~~dtL~~gq~L~~g~~L~s-------g~~~L~~q~dGn-----Lv--------l~----~~----~~vW~snt~~~-~~   54 (110)
T 3r0e_B            4 FTNNLLFSGQVLYGDGRLTA-------KNHQLVMQGDCN-----LV--------LY----GG----KYGWQSNTHGN-GE   54 (110)
T ss_dssp             CBTTEEETTCEEETTEEEEC-------SSCEEEECTTSC-----EE--------EE----CS----SSCEECCCTTS-SS
T ss_pred             cccCEECCCCEecCCCEEEe-------CCEEEEEcCCCe-----EE--------EE----CC----eEEEECCCcCC-Cc
Confidence            45688888999988999987       459996644342     11        12    11    37999999853 23


Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      ++.|.|..||||||+|.++.+||+|++.+. ...+|+|+|+|||||++   ..+|+|
T Consensus        55 ~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t  108 (110)
T 3r0e_B           55 HCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET  108 (110)
T ss_dssp             SCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred             CEEEEEeCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence            478999999999999999999999988642 34689999999999997   488987

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.38  E-value=3.1e-12  Score=114.93  Aligned_cols=105  Identities=13%  Similarity=0.183  Sum_probs=79.9

Q ss_pred             CcceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCc
Q 043017           40 QESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENA  119 (818)
Q Consensus        40 ~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~  119 (818)
                      .|+|..++.+.....|.+       |.|.|-|...|+     ..   .|    .      ....++||.+|+..+. .+.
T Consensus         6 ~~tL~~gq~L~~g~~L~~-------g~~~L~~q~dGN-----Lv---L~----~------~~~~~~vWssnt~~~~-~~~   59 (113)
T 3mez_B            6 RNVLFSSQVMYDNAQLAT-------RDYSLVMRDDCN-----LV---LT----K------GSKTNIVWESGTSGRG-QHC   59 (113)
T ss_dssp             SSEEETTCEEETTCEEEE-------TTEEEEECTTSC-----EE---EE----E------TTTTEEEEECCCTTSC-SSC
T ss_pred             CCEeCCCCEECCCCEeEc-------CCEEEEEcCCCE-----EE---EE----E------CCCCEEEEECCcccCC-cCE
Confidence            467777777777777764       679999875553     11   11    1      1135799999998652 357


Q ss_pred             eEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceec
Q 043017          120 TLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       120 ~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      .|.|..||||||+|.++.+||+|++.+. ...+|+|+|+|||||++   ..+|+|
T Consensus        60 ~l~l~~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s  111 (113)
T 3mez_B           60 FMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST  111 (113)
T ss_dssp             EEEECTTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred             EEEEeCCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence            8999999999999999999999998643 34689999999999997   689997

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.33  E-value=3.1e-12  Score=114.14  Aligned_cols=101  Identities=17%  Similarity=0.253  Sum_probs=76.8

Q ss_pred             CCcceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCC
Q 043017           39 AQESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKEN  118 (818)
Q Consensus        39 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~  118 (818)
                      +.|+|..++.+.....|  .+     |.|.|.|...|+-        +.     |    .      .+|.+|+..+ ..+
T Consensus         2 ~~dtL~~gq~L~~g~~L--~~-----g~~~L~~q~dGNL--------vl-----~----~------~~Wssnt~~~-~~~   50 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEGHL--KN-----GDFDLVMQDDCNL--------VL-----Y----N------GNWQSNTANN-GRD   50 (109)
T ss_dssp             CCSEEETTCEECTTCEE--EE-----TTEEEEECTTSCE--------EE-----E----T------TTEECCCTTS-CSS
T ss_pred             ccCCcCCCCCcCCCCEe--EC-----CCEEEEEecCCeE--------EE-----E----e------CeEEcCCCCC-CCc
Confidence            34667777777666677  23     7999999765531        11     2    1      1699998764 335


Q ss_pred             ceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceec
Q 043017          119 ATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       119 ~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      ..|+|..||||||+|.++.+||+|++.+. ...+|+|+|+|||||++   ..+|+|
T Consensus        51 ~~l~l~~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s  103 (109)
T 3r0e_A           51 CKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI  103 (109)
T ss_dssp             CEEEECTTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred             EEEEEcCCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence            78999999999999999999999988643 34689999999999997   688998

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.22  E-value=2.3e-11  Score=109.25  Aligned_cols=93  Identities=22%  Similarity=0.329  Sum_probs=71.9

Q ss_pred             CCCCCC-CceEEEeecccEEEEcC-CCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeec
Q 043017          112 QSPVKE-NATLEFTADGDLILKDV-DGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLH  188 (818)
Q Consensus       112 ~~p~~~-~~~l~l~~~g~Lvl~~~-~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~  188 (818)
                      +.|+.+ ..+|.+..||||||++. .+.+||++++.+. ....++|+++|||||++.++.++|||-.+            
T Consensus        18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------   85 (113)
T 3mez_B           18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------   85 (113)
T ss_dssp             TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC------------
T ss_pred             CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc------------
Confidence            455554 47899999999999998 4899999998643 34689999999999999888899998331            


Q ss_pred             cceeEeeccCCCCCCccEEEEEEccCCcEEEEeccceeeeeecc
Q 043017          189 VHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIP  232 (818)
Q Consensus       189 ~~~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p  232 (818)
                                   -..|.|.+.++.+|+.+++.   ...|.++|
T Consensus        86 -------------~~~~~~~~~L~~dGnlvly~---~~~W~s~~  113 (113)
T 3mez_B           86 -------------GQEGDYVLILQINGQAVVYG---PAVWSTAA  113 (113)
T ss_dssp             -------------CSSSCCEEEECTTSCEEEEC---SEEEESCC
T ss_pred             -------------CCCCCEEEEEcCCceEEEec---CCEecCCC
Confidence                         01345889999999988764   35566554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.10  E-value=1.2e-10  Score=121.53  Aligned_cols=139  Identities=10%  Similarity=0.008  Sum_probs=108.7

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCCCC
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            4456788888999999865 6889999986432223446889999999884 6778889999888888999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC-------------------------------------------  623 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------  623 (818)
                      |.+.+        .+......++.+++++|+.||+..                                           
T Consensus        97 l~~~~--------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T 3tm0_A           97 CSEEY--------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             HHHHC--------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred             hhhcc--------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence            87753        122344578899999999999810                                           


Q ss_pred             -------------CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          624 -------------NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       624 -------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                                   ...++|+|+++.||+++++..+.|+||+.+..
T Consensus       169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                         13589999999999998765667999998753

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.09  E-value=2.7e-10  Score=101.83  Aligned_cols=101  Identities=17%  Similarity=0.189  Sum_probs=72.3

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |+|..++.+.....|.  +     |.|.|-|...|+-        +.     |    ..   .. ||.+|+..+ ..+..
T Consensus         3 ~~l~~gq~L~~g~~L~--~-----g~~~L~~q~dGnL--------vl-----~----~~---~~-vW~snt~~~-~~~~~   53 (111)
T 3mez_A            3 NVLLTGDVIHTDNQLS--Y-----ESAAFVMQGDCNL--------VL-----Y----NE---AG-GFQSNTHGR-GVDCT   53 (111)
T ss_dssp             TEEETTCEECTTCEEE--E-----TTEEEEECTTSCE--------EE-----E----CS---SC-CEECCCTTS-CSSCE
T ss_pred             CEeCCCCEeCCCCEEe--c-----CCEEEEEccCCeE--------EE-----E----CC---CC-EEECCcccC-CcCEE
Confidence            3455555555555662  2     7899998655531        11     2    11   12 999999766 33578


Q ss_pred             EEEeecccEEEEcCCCc-EEEeeccC---CCceeEEEEcCCCcEEEecCCCCcceec
Q 043017          121 LEFTADGDLILKDVDGT-RVWSTETS---GSNVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~-~vWst~~~---~~~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      |.|..+|||||+|.++. +||+|++.   ......++|+|+|||||++   ..+|+|
T Consensus        54 l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s  107 (111)
T 3mez_A           54 LRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST  107 (111)
T ss_dssp             EEECTTSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred             EEEcCCCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence            99999999999998876 59999863   2245689999999999997   688997

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.06  E-value=5.1e-10  Score=100.02  Aligned_cols=86  Identities=20%  Similarity=0.376  Sum_probs=66.5

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCCc-eeEEEEcCCCcEEEecCCCC-cceecccCCCCcccCCCeeccceeEee
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYDAENR-PHWISFLHPTNTWLPGQRLHVHKMMAS  195 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~-~lWqSFd~Ptdtllpg~kl~~~~~l~s  195 (818)
                      ...|.+..||||||++.++  +|++++.+.. ...++|+++|||||++.++. ++|||..+                   
T Consensus        21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~-------------------   79 (111)
T 3mez_A           21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS-------------------   79 (111)
T ss_dssp             TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred             CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence            4689999999999999876  9999986432 36899999999999998766 59999731                   


Q ss_pred             ccCCCCCCccEEEEEEccCCcEEEEeccceeeeeec
Q 043017          196 TNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTI  231 (818)
Q Consensus       196 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~  231 (818)
                          .....|.|.+.++.+|+.+++.   ..+|.++
T Consensus        80 ----~~~~~~~~~l~Lq~dGNlvly~---~~~W~s~  108 (111)
T 3mez_A           80 ----VNTVRGNYAATLGPDQHVTIYG---PAIWSTP  108 (111)
T ss_dssp             ----CCCCSSCCEEEECTTSCEEEEC---SEEEECC
T ss_pred             ----cCCCCcCEEEEECCCCeEEEec---cCEEccC
Confidence                1113478899999999988764   3445443

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.03  E-value=7.6e-10  Score=98.70  Aligned_cols=78  Identities=26%  Similarity=0.499  Sum_probs=63.8

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAST  196 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~  196 (818)
                      ...|.|..||||||++. +.+||++++.+. ....++|+++|||||+|.++.++|||....                   
T Consensus        20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~-------------------   79 (109)
T 3dzw_A           20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG-------------------   79 (109)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred             CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence            47899999999999987 789999998643 346899999999999998888999985311                   


Q ss_pred             cCCCCCCccEEEEEEccCCcEEEEe
Q 043017          197 NSTTSLSQGKFILSLSPKGIEVFLN  221 (818)
Q Consensus       197 ~s~~d~s~G~~~~~~~~~g~~~~~~  221 (818)
                            ..+.|.+.++.+|+.+++.
T Consensus        80 ------~~~~~~~~L~ddGNlvly~   98 (109)
T 3dzw_A           80 ------ENGNYVCVLQKDRNVVIYG   98 (109)
T ss_dssp             ------SSSCEEEEECTTSCEEEEE
T ss_pred             ------CCCCEEEEEeCCCEEEEEC
Confidence                  2356889999999988764

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=98.98  E-value=8.4e-10  Score=115.24  Aligned_cols=70  Identities=24%  Similarity=0.521  Sum_probs=60.8

Q ss_pred             CeEEEEeCCCCCCCCCceEEEeecccEEEEcCCCcEEEeeccCCCceeEEEEcCCCcEEEecCCCCcceecccC
Q 043017          103 PVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLH  176 (818)
Q Consensus       103 ~~~vW~anr~~p~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~  176 (818)
                      .+++|.+++..+-  ...+.+..+|+|+++|.++.++|++++.+....+|+|+++|||||++.  +++||||||
T Consensus       183 ~~~yW~Sgt~~~~--~~~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~  252 (276)
T 3m7h_A          183 GAATWNAGTQGKG--AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF  252 (276)
T ss_dssp             SSEEEECCCTTTT--CCEEEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred             CeEEEECCCCCCc--cEEEEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence            4689999998762  378999999999999988899999998755567999999999999986  689999997

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.98  E-value=9.1e-10  Score=114.27  Aligned_cols=130  Identities=14%  Similarity=0.100  Sum_probs=98.0

Q ss_pred             cc-cccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce--eEEEeeeecccCcceeeeeccCCCChh
Q 043017          512 LG-RGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN--LVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       512 LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      ++ .|..+.||+....+|+.+++|.....   ....+..|+++++.+.+.+  +.+++++...++..++||||+++.+|.
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            44 55569999998877888999987543   2346788999999885444  455888888777889999999998884


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC---------------------------------------------  623 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------------  623 (818)
                        .. .        .....++.++++.|+.||+..                                             
T Consensus       104 --~~-~--------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 --SS-H--------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             --TS-C--------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             --cC-c--------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence              21 1        112367778888888888642                                             


Q ss_pred             ----------CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          624 ----------NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       624 ----------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                                ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                      11299999999999998876677999999864

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.97  E-value=1.6e-09  Score=96.69  Aligned_cols=77  Identities=26%  Similarity=0.447  Sum_probs=62.3

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCCc-eeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAST  196 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~  196 (818)
                      ...|.+..||||||++.  .++|++++.+.. ...++|+++|||||+|.++.++|||-.+-                   
T Consensus        25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~-------------------   83 (110)
T 3r0e_B           25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS-------------------   83 (110)
T ss_dssp             SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred             CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence            47899999999999986  589999986433 36899999999999999889999985310                   


Q ss_pred             cCCCCCCccEEEEEEccCCcEEEEe
Q 043017          197 NSTTSLSQGKFILSLSPKGIEVFLN  221 (818)
Q Consensus       197 ~s~~d~s~G~~~~~~~~~g~~~~~~  221 (818)
                            ..|.|.+.++.+|+.+++.
T Consensus        84 ------~~~~~~~~L~~dGNlvly~  102 (110)
T 3r0e_B           84 ------KQGEYVLILQDDGFGVIYG  102 (110)
T ss_dssp             ------SSSCCEEEECTTSCEEEEC
T ss_pred             ------CCCCEEEEEcCCccEEEec
Confidence                  1345788999999988764

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.92  E-value=2.3e-09  Score=95.40  Aligned_cols=90  Identities=21%  Similarity=0.409  Sum_probs=68.6

Q ss_pred             CCCCCC-CceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeecc
Q 043017          112 QSPVKE-NATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHV  189 (818)
Q Consensus       112 ~~p~~~-~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~  189 (818)
                      +.|+++ ...|.+..||||||+++    +|+|++.+. ....++|+++|||||+|.++.++|+|-..             
T Consensus        15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~-------------   77 (109)
T 3r0e_A           15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ-------------   77 (109)
T ss_dssp             TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC-------------
T ss_pred             CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc-------------
Confidence            344444 46899999999999984    799998753 34689999999999999888899976210             


Q ss_pred             ceeEeeccCCCCCCccEEEEEEccCCcEEEEeccceeeeeeccc
Q 043017          190 HKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPY  233 (818)
Q Consensus       190 ~~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p~  233 (818)
                                  -..+.|.+.++++|+.+++.   ...|.+++|
T Consensus        78 ------------~~~~~~~~~L~~dGNlvly~---~~~W~s~t~  106 (109)
T 3r0e_A           78 ------------SVKGNYAAVVHPDGRLVVFG---PSVFKIDPW  106 (109)
T ss_dssp             ------------CSSSCCEEEEETTTEEEEEC---SEEEEECTT
T ss_pred             ------------CCCcCEEEEEcCCCeEEEEe---cCEECCCCc
Confidence                        02356789999999988764   456777765

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.85  E-value=1.1e-08  Score=90.31  Aligned_cols=77  Identities=27%  Similarity=0.525  Sum_probs=62.5

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccC--CCceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEee
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETS--GSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAS  195 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~--~~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s  195 (818)
                      .-+|.+..||||||++ .+++||++++.  +.....+.|.++|||||+|++++++|.|-.                    
T Consensus        20 ~y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------   78 (105)
T 4h3o_A           20 PYHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------   78 (105)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred             CEEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC--------------------
Confidence            3678899999999998 46899999875  334568999999999999999999998721                    


Q ss_pred             ccCCCCCCccEEEEEEccCCcEEEE
Q 043017          196 TNSTTSLSQGKFILSLSPKGIEVFL  220 (818)
Q Consensus       196 ~~s~~d~s~G~~~~~~~~~g~~~~~  220 (818)
                           ....+.+.+.++.+|+.+++
T Consensus        79 -----~~~~~~~~l~L~ddGNlVly   98 (105)
T 4h3o_A           79 -----TRGSGNYILILQDDGNVIIY   98 (105)
T ss_dssp             -----CCCSSCEEEEECTTSCEEEE
T ss_pred             -----CCCCCCEEEEEeCCCeEEEE
Confidence                 11346788999999998875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.80  E-value=1.1e-08  Score=111.93  Aligned_cols=139  Identities=14%  Similarity=0.240  Sum_probs=104.9

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcC--CCC-CccHHHHHHHHHHHhccC--cceeEEEeeeeccc---Ccceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLY--PGE-NRGKKEFLSEVETIGNIH--HFNLVRLVGYCAER---SNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~-~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e~~  582 (818)
                      .|+.|.++.||+....+ ..+++|+..  ... ......+.+|+++++.+.  +..+.+++.++.+.   +..++||||+
T Consensus        45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v  123 (359)
T 3dxp_A           45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV  123 (359)
T ss_dssp             ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred             EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence            58899999999998764 678888765  322 123456788999999886  45678888888776   3578999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC---------------------------------------  623 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------  623 (818)
                      ++..+.+..     ...++...+..++.++++.|+.||+..                                       
T Consensus       124 ~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          124 SGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             CCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            998875422     134677888899999999999999731                                       


Q ss_pred             ----------------CCCeeecccccCeEEEcCCCC--EEEeecCCcee
Q 043017          624 ----------------NPKIIHFDIKPQNILLDRDLN--VKIADFGLARL  655 (818)
Q Consensus       624 ----------------~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla~~  655 (818)
                                      ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999987753  68999999875

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.73  E-value=5e-08  Score=99.81  Aligned_cols=86  Identities=26%  Similarity=0.431  Sum_probs=66.3

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCCceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeecc
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTN  197 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~~  197 (818)
                      .-.|.|..+|+|+|++. +++||.+++.+.....++|+++|||||+|+++.++|+|+++.                    
T Consensus        27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~--------------------   85 (236)
T 1dlp_A           27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG--------------------   85 (236)
T ss_dssp             TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC--------------------
T ss_pred             CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc--------------------
Confidence            45788888999999986 789999997654556789999999999999999999998751                    


Q ss_pred             CCCCCCccEEEEEEccCCcEEEEeccceeeeeecc
Q 043017          198 STTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIP  232 (818)
Q Consensus       198 s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~p  232 (818)
                           +.|.|.+.++.+|+.++...   .+|++..
T Consensus        86 -----~~~~~~~~l~d~Gnlvl~~~---~~W~S~~  112 (236)
T 1dlp_A           86 -----SIGNYVLVLQPDRTVTIYGP---GLWDSGT  112 (236)
T ss_dssp             -----CSSCCEEEECSSSCEEEECS---EEEECSC
T ss_pred             -----cCCcEEEEEeCCCCEEEecC---CEEECCC
Confidence                 23556778888888776521   4555543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.57  E-value=2.5e-08  Score=106.28  Aligned_cols=183  Identities=20%  Similarity=0.235  Sum_probs=118.3

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-Ccce--eEEEeeeecccC---cceeeeeccCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFN--LVRLVGYCAERS---NRFLVYEYMCN  584 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~e~~~~  584 (818)
                      .++.|....||+..    +.+++|.....  .....+.+|+++++.+ .+..  +.+++.......   ..++|||++++
T Consensus        27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            47889999999874    56888875422  3356788999999887 3322  334444443333   34789999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc------------------------------------------
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY------------------------------------------  622 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------  622 (818)
                      .+|.....     ..++.+++..++.++++.|+.||+.                                          
T Consensus       101 ~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A          101 VPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             EECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             eECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            88875332     2366677788888888888888861                                          


Q ss_pred             -------------CCCCeeecccccCeEEEcC--CCCEEEeecCCceecccCCCccccCCCCCCcccccccccC-----C
Q 043017          623 -------------CNPKIIHFDIKPQNILLDR--DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG-----N  682 (818)
Q Consensus       623 -------------~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~  682 (818)
                                   ....++|+|+++.||++++  ...+.|+||+.+..-..... ........ .-..|+....     +
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~-~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDD-EEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTT-TSCCHHHHHHHHHHHT
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhc-cccCHHHHHHHHHHcC
Confidence                         1235899999999999998  45678999999875422110 00000000 0012221110     0


Q ss_pred             C---------CCchhhHHHHHHHHHHHHhCCCC
Q 043017          683 S---------ITAKIDIYSFGVVILEIICGRRS  706 (818)
Q Consensus       683 ~---------~s~ksDVwS~Gvll~elltG~~p  706 (818)
                      .         .....+.|+++.++|++.+|..+
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence            1         11236899999999999999754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.05  E-value=8.1e-06  Score=88.75  Aligned_cols=79  Identities=11%  Similarity=0.015  Sum_probs=54.8

Q ss_pred             hc-ccccceeEEEeEec-------CCcEEEEEEcCCCC---CccHHHHHHHHHHHhccC-c--ceeEEEeeeeccc---C
Q 043017          511 RL-GRGGSGSVFEGLLN-------DGTKVAVKRLYPGE---NRGKKEFLSEVETIGNIH-H--FNLVRLVGYCAER---S  573 (818)
Q Consensus       511 ~L-G~G~fG~Vy~~~~~-------~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~-H--~niv~l~g~~~~~---~  573 (818)
                      .| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.+. +  ..+.+++.++.+.   +
T Consensus        27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g  106 (357)
T 3ats_A           27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG  106 (357)
T ss_dssp             EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred             ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence            46 78888999988765       26788898764322   112246778888888884 3  3466777777655   3


Q ss_pred             cceeeeeccCCCChhh
Q 043017          574 NRFLVYEYMCNGSLDK  589 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~  589 (818)
                      ..++|||++++..+.+
T Consensus       107 ~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          107 TPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SCEEEEECCCCBCCCB
T ss_pred             CceEEEEecCCCChhh
Confidence            5689999999877653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.04  E-value=1.4e-05  Score=85.04  Aligned_cols=134  Identities=20%  Similarity=0.270  Sum_probs=91.0

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc---eeEEEeeeec-ccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF---NLVRLVGYCA-ERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~gs  586 (818)
                      .++.|....||+.    ++.+++|.-.  .......+..|+++|..+.+.   .+.+.+.+.. ..+..++|||++++.+
T Consensus        26 ~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           26 SLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             ecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            3677888899987    5678888742  223346788999999998642   3455566553 4456789999999988


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY--------------------------------------------  622 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------------  622 (818)
                      |.....     ..++......++.++++.|+.||+.                                            
T Consensus       100 l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A          100 LGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             CHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             Cchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            876321     1133444445555555555555532                                            


Q ss_pred             -------------CCCCeeecccccCeEEEcC---CCC-EEEeecCCcee
Q 043017          623 -------------CNPKIIHFDIKPQNILLDR---DLN-VKIADFGLARL  655 (818)
Q Consensus       623 -------------~~~~iiH~Dlkp~NIll~~---~~~-~kl~Dfgla~~  655 (818)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         2335799999999999987   455 48999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.00  E-value=1.9e-05  Score=82.12  Aligned_cols=134  Identities=13%  Similarity=0.145  Sum_probs=96.2

Q ss_pred             cccccce-eEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          512 LGRGGSG-SVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       512 LG~G~fG-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +..|..| .||+.... ++..+++|+-..   ....++..|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445555 68987765 466789997542   23456788999988873 444677888888888899999999998887


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC---------------------------------------------  623 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------------  623 (818)
                      +....       .......+..++++.|+.||...                                             
T Consensus       109 ~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          109 QVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            65421       12334456667777777777420                                             


Q ss_pred             ----------CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          624 ----------NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       624 ----------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                                ...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      12379999999999999887778999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.66  E-value=9.8e-05  Score=81.46  Aligned_cols=73  Identities=14%  Similarity=0.073  Sum_probs=48.2

Q ss_pred             hcccccceeEEEeEec-CCcEEEEEEcCCCCC-------ccHHHHHHHHHHHhccCc--ce-eEEEeeeecccCcceeee
Q 043017          511 RLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN-------RGKKEFLSEVETIGNIHH--FN-LVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------~~~~~f~~Ev~~l~~l~H--~n-iv~l~g~~~~~~~~~lV~  579 (818)
                      .||.|.++.||++... +++.++||.......       .....+..|.+++..+..  +. +.+++.+  +.+..++||
T Consensus        37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm  114 (397)
T 2olc_A           37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM  114 (397)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred             ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence            5899999999999865 468899998653211       224566788888887732  33 3345544  344568999


Q ss_pred             eccCCC
Q 043017          580 EYMCNG  585 (818)
Q Consensus       580 e~~~~g  585 (818)
                      |++++.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.61  E-value=0.00015  Score=77.88  Aligned_cols=139  Identities=17%  Similarity=0.192  Sum_probs=79.2

Q ss_pred             cccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc--eeEEEeee------ecccCcceeeeeccC
Q 043017          512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF--NLVRLVGY------CAERSNRFLVYEYMC  583 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~------~~~~~~~~lV~e~~~  583 (818)
                      |+.|..+.||+....+| .+++|+....    ..++..|+.++..|...  .+.+++..      ....+..+++|||++
T Consensus        40 l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           40 IQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             CC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             ccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            55667889999987654 5889988642    23444556656555311  23333331      123456789999999


Q ss_pred             CCChh-----------hH---hhhc-CCc----------cccchhh-------------------------------HHH
Q 043017          584 NGSLD-----------KW---IFHK-DRI----------QTLSWDI-------------------------------RKK  607 (818)
Q Consensus       584 ~gsL~-----------~~---l~~~-~~~----------~~l~~~~-------------------------------~~~  607 (818)
                      +..+.           ..   ++.. ...          ....|..                               ...
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            86553           00   1111 000          0011211                               011


Q ss_pred             HHHHHHHHHHHHHh----------cCCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          608 IIFQISRGLEYLHD----------YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       608 i~~qia~gL~yLH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +...+.+++.+|++          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            11234446667763          1246899999999999998888999999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.45  E-value=0.00041  Score=72.74  Aligned_cols=74  Identities=19%  Similarity=0.202  Sum_probs=54.1

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-c--ceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-H--FNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H--~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      .+|.|..+.||+..+.+|+.++||+-..........|..|++.|+.|. .  --+.+++++    +..++||||++.+..
T Consensus        22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCCC
T ss_pred             ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccCC
Confidence            589999999999999999999999876554444556888999888773 2  123344443    235789999987654


Q ss_pred             h
Q 043017          588 D  588 (818)
Q Consensus       588 ~  588 (818)
                      .
T Consensus        98 ~   98 (288)
T 3f7w_A           98 T   98 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.33  E-value=0.00067  Score=71.96  Aligned_cols=73  Identities=16%  Similarity=0.145  Sum_probs=57.7

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC---cceeEEEeeeecccCcceeeeeccCCCCh
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH---HFNLVRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      .|+.|....+|+.... ++.+++|+....   ....|..|++.|+.|.   ...+.+++.++...+..++||||+++..+
T Consensus        43 ~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           43 KLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4888999999998864 678889976432   3567888999888883   35677888888777889999999998865

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.22  E-value=0.0011  Score=73.54  Aligned_cols=79  Identities=10%  Similarity=0.018  Sum_probs=48.0

Q ss_pred             CCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHH
Q 043017          624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN---SITAKIDIYSFGVVILEI  700 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvll~el  700 (818)
                      ...++|+|+++.||+++.++ ++|+||+.+..-............-...|++|+.....   .-....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45899999999999998876 99999999875322111000000011345666655321   112245566777778877


Q ss_pred             HhC
Q 043017          701 ICG  703 (818)
Q Consensus       701 ltG  703 (818)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.80  E-value=0.009  Score=63.75  Aligned_cols=32  Identities=31%  Similarity=0.433  Sum_probs=27.9

Q ss_pred             CCCeeecccccCeEEEcCC----CCEEEeecCCcee
Q 043017          624 NPKIIHFDIKPQNILLDRD----LNVKIADFGLARL  655 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~~  655 (818)
                      ...++|+|+.+.||+++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4579999999999999874    6799999999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.72  E-value=0.0024  Score=67.84  Aligned_cols=142  Identities=13%  Similarity=0.072  Sum_probs=79.4

Q ss_pred             hcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce--eEEEeeee------cccCcceeeeecc
Q 043017          511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN--LVRLVGYC------AERSNRFLVYEYM  582 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~e~~  582 (818)
                      .|+.|....+|+....++ .+++|.....  ....++..|+.++..+....  +.+++...      ...+..+++|+|+
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            366788889999887655 6788987642  12345566777777763222  23333211      1234568999999


Q ss_pred             CCCChhh----H----------hhhcC-C---c-----cccchhhHHH------------HHHHHHHHHHHHHhc----C
Q 043017          583 CNGSLDK----W----------IFHKD-R---I-----QTLSWDIRKK------------IIFQISRGLEYLHDY----C  623 (818)
Q Consensus       583 ~~gsL~~----~----------l~~~~-~---~-----~~l~~~~~~~------------i~~qia~gL~yLH~~----~  623 (818)
                      ++..+..    .          ++... .   .     ....|.....            +...+.+.++.+++.    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8865421    0          11110 0   0     0011222100            111244556666542    2


Q ss_pred             CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ...++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            34799999999999998876668999998763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.69  E-value=0.0047  Score=67.21  Aligned_cols=140  Identities=17%  Similarity=0.159  Sum_probs=82.6

Q ss_pred             hcccccceeEEEeEec--------CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeec
Q 043017          511 RLGRGGSGSVFEGLLN--------DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .|..|-...+|+....        +++.+++|+.-.. ......+.+|.++++.|. +.-..++++++.++    +||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence            3566777889998875        2578999986332 234566778999888873 32235667776543    89999


Q ss_pred             cCCCChhhH-----------------hhhcC--Ccccc--chhhHHHHHHHHH-------------------HHHHHHHh
Q 043017          582 MCNGSLDKW-----------------IFHKD--RIQTL--SWDIRKKIIFQIS-------------------RGLEYLHD  621 (818)
Q Consensus       582 ~~~gsL~~~-----------------l~~~~--~~~~l--~~~~~~~i~~qia-------------------~gL~yLH~  621 (818)
                      +++.+|..-                 |+...  -.+..  -+.++.++..++.                   +.+..|.+
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421                 01110  01111  2344444444332                   12333332


Q ss_pred             ----c-CCCCeeecccccCeEEEcCC----CCEEEeecCCcee
Q 043017          622 ----Y-CNPKIIHFDIKPQNILLDRD----LNVKIADFGLARL  655 (818)
Q Consensus       622 ----~-~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~~  655 (818)
                          . ....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 23468999999999999876    7899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.67  E-value=0.0044  Score=68.88  Aligned_cols=71  Identities=20%  Similarity=0.248  Sum_probs=48.6

Q ss_pred             hcccccceeEEEeEecC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee-EEEeeeecccCcceeeeec
Q 043017          511 RLGRGGSGSVFEGLLND--------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-VRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~  581 (818)
                      .|+.|-...+|+....+        ++.+++|+....  .....+..|..++..+...++ .++++.+..    .+||||
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            47788889999998753        578999987432  112566689998888843333 566666653    389999


Q ss_pred             cCCCCh
Q 043017          582 MCNGSL  587 (818)
Q Consensus       582 ~~~gsL  587 (818)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986444

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.55  E-value=0.0049  Score=64.83  Aligned_cols=137  Identities=12%  Similarity=0.084  Sum_probs=72.6

Q ss_pred             hhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee-EEEeeeecccCcceeeeecc-CCCCh
Q 043017          510 IRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-VRLVGYCAERSNRFLVYEYM-CNGSL  587 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gsL  587 (818)
                      +.|+.|....+|+.     +.+++|+....... .....+|+.+++.+....+ .++++++  .+.-++++||+ ++.+|
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            35788889999998     56888877543221 1123467777776632222 3455543  33457899999 65544


Q ss_pred             hhH--------h----------hhcCC--ccccc-hhhHHHHHH--------------HHHHHHH----HHHh-cCCCCe
Q 043017          588 DKW--------I----------FHKDR--IQTLS-WDIRKKIIF--------------QISRGLE----YLHD-YCNPKI  627 (818)
Q Consensus       588 ~~~--------l----------~~~~~--~~~l~-~~~~~~i~~--------------qia~gL~----yLH~-~~~~~i  627 (818)
                      ...        +          +....  ..... +.....+..              .+.+.+.    .|.. .....+
T Consensus        96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l  175 (301)
T 3dxq_A           96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA  175 (301)
T ss_dssp             CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred             CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence            321        0          11000  00000 111111100              1111111    1111 123458


Q ss_pred             eecccccCeEEEcCCCCEEEeecCCcee
Q 043017          628 IHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       628 iH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +|+|+.+.||+ ..++.+.|+||..+..
T Consensus       176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          176 CHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eccCCCcCCEE-ECCCCEEEEecccccC
Confidence            99999999999 5667889999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.49  E-value=0.012  Score=62.56  Aligned_cols=140  Identities=15%  Similarity=0.123  Sum_probs=80.7

Q ss_pred             cccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcc--eeEEEeee-----ecccCcceeeeeccCC
Q 043017          512 LGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHF--NLVRLVGY-----CAERSNRFLVYEYMCN  584 (818)
Q Consensus       512 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~e~~~~  584 (818)
                      |+ |....||+....+|+.+++|...... .....+..|..++..+...  .+.+++..     ...++..+++||++++
T Consensus        34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           34 LN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            55 77789999887778789999886432 2355677788888777422  23444443     1113345789999987


Q ss_pred             CChhh----H----------hhhc-C-----CccccchhhH-------------------HHHHHHHHHHHHHHHhc---
Q 043017          585 GSLDK----W----------IFHK-D-----RIQTLSWDIR-------------------KKIIFQISRGLEYLHDY---  622 (818)
Q Consensus       585 gsL~~----~----------l~~~-~-----~~~~l~~~~~-------------------~~i~~qia~gL~yLH~~---  622 (818)
                      ..+..    .          ++.. .     .....++...                   ..+...+.+.+..+.+.   
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            55421    1          1110 0     0011111110                   00111112223333322   


Q ss_pred             -CCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          623 -CNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       623 -~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                       ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             234689999999999999 4 899999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.48  E-value=0.011  Score=65.96  Aligned_cols=72  Identities=11%  Similarity=0.026  Sum_probs=46.1

Q ss_pred             hcccccceeEEEeEecC-CcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee-EEEeeeecccCcceeeeeccCCCCh
Q 043017          511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-VRLVGYCAERSNRFLVYEYMCNGSL  587 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL  587 (818)
                      .|+.|-...+|+....+ ++.+++|+....... ...-..|..++..|...++ .++++.+..    .+||||+++.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            47788889999998875 578888877433211 1112578888888854333 466776642    359999987554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.91  E-value=0.013  Score=63.58  Aligned_cols=72  Identities=17%  Similarity=0.190  Sum_probs=42.2

Q ss_pred             hcccccceeEEEeEecC---------CcEEEEEEcCCCCCccHHHHHHHHHHHhccCcce-eEEEeeeecccCcceeeee
Q 043017          511 RLGRGGSGSVFEGLLND---------GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN-LVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e  580 (818)
                      .|+.|....+|+....+         ++.+++|+....... ......|.+++..+...+ ..++++...    -++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence            46778788999988754         268888876543211 112357788777774323 335555442    368999


Q ss_pred             ccCCCCh
Q 043017          581 YMCNGSL  587 (818)
Q Consensus       581 ~~~~gsL  587 (818)
                      |+++..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.86  E-value=0.047  Score=53.73  Aligned_cols=104  Identities=18%  Similarity=0.103  Sum_probs=67.8

Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      .-+|.++|...+  .++++++++.++.|.++.|.-+-...  .-..+=+.|..|++..+|.+.+.+ ..+.         
T Consensus        32 ~vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            457888885443  68999999999999999987763210  111333457999999999988753 1110         


Q ss_pred             ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 043017          664 STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRS  706 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p  706 (818)
                          .....+.+||... ...+.+.=|||+|++||.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1123466888764 4567899999999999998874433

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.66  E-value=0.047  Score=58.41  Aligned_cols=31  Identities=26%  Similarity=0.378  Sum_probs=28.0

Q ss_pred             CCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          625 PKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       625 ~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.87  E-value=0.12  Score=56.93  Aligned_cols=139  Identities=9%  Similarity=0.085  Sum_probs=80.8

Q ss_pred             hcccccceeEEEeEecC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeec
Q 043017          511 RLGRGGSGSVFEGLLND--------GTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .|..|-...+|+....+        ++.+++|+....... .....+|.++++.+. +.-..++++.+.    -++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            36667778999988763        578999886443221 222356777777774 222344555332    3789999


Q ss_pred             cCCCChhh-------Hh----------hhc-------C---CccccchhhHHHHHHHH-------------------HHH
Q 043017          582 MCNGSLDK-------WI----------FHK-------D---RIQTLSWDIRKKIIFQI-------------------SRG  615 (818)
Q Consensus       582 ~~~gsL~~-------~l----------~~~-------~---~~~~l~~~~~~~i~~qi-------------------a~g  615 (818)
                      +++..|..       ..          +..       .   ...+.-+.++.++..++                   .+.
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            99866421       00          100       0   00111233333333222                   223


Q ss_pred             HHHHHhc---------------------CCCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          616 LEYLHDY---------------------CNPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       616 L~yLH~~---------------------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      +..|++.                     ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            3333321                     1346899999999999 7888999999999864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.48  E-value=1.5  Score=47.71  Aligned_cols=29  Identities=28%  Similarity=0.426  Sum_probs=24.9

Q ss_pred             eeecccccCeEEE------cCCCCEEEeecCCcee
Q 043017          627 IIHFDIKPQNILL------DRDLNVKIADFGLARL  655 (818)
Q Consensus       627 iiH~Dlkp~NIll------~~~~~~kl~Dfgla~~  655 (818)
                      ++|+|+.+.||++      +++..++++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999999864

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=85.50  E-value=0.56  Score=33.25  Aligned_cols=23  Identities=17%  Similarity=0.150  Sum_probs=8.2

Q ss_pred             hHHHHHHHHHHHHHHhhheeeee
Q 043017          449 MLLLSVSAFLLLVIGASIYLYKR  471 (818)
Q Consensus       449 ~i~l~~~~~lllli~~~~~~~~~  471 (818)
                      ..++++++++++++++.++++|+
T Consensus        15 ~gVVgGv~~~~ii~~~~~~~~RR   37 (44)
T 2ks1_B           15 TGMVGALLLLLVVALGIGLFMRR   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eehhHHHHHHHHHHHHHHHHhhh
Confidence            33333333333333333333333

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=84.82  E-value=31  Score=34.78  Aligned_cols=63  Identities=13%  Similarity=0.217  Sum_probs=40.2

Q ss_pred             CCeEEEEeCCCCC-------CCCCceEEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEec
Q 043017          102 PPVILWFANGQSP-------VKENATLEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYD  164 (818)
Q Consensus       102 ~~~~vW~anr~~p-------~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~  164 (818)
                      ..+++|...+..+       +...+.+-++.++.+...|.+|..+|...... .....+..+.+||+++-+
T Consensus        24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~   94 (276)
T 3no2_A           24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW   94 (276)
T ss_dssp             TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred             CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence            3467888765431       12234444455666777788899999987642 334556777888877754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	818
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-55
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-51
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-21
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-11
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-07
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-09
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	0.002
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	3e-08
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	4e-07
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	1e-06
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	0.001
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	6e-06
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	6e-06
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	3e-05
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	6e-05
d2p4oa1	302	b.68.6.3 (A:4-305) Hypothetical protein All0351 ho	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 4e-68
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 21/282 (7%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
              +  R+G G  G+V++G  +    V +  +     +  + F +EV  +    H N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
            +GY        +V ++    SL   +   +            I  Q ++G++YLH    
Sbjct: 69  FMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---A 122

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ-SHVSTMPKGTPGYMAPELTRG-- 681
             IIH D+K  NI L  DL VKI DFGLA + ++   SH      G+  +MAPE+ R   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 682 -NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
            N  + + D+Y+FG+V+ E++ G+    P       D +        L   + K   +  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQL---PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
                   M ++   CL+K    RP    ++  ++ L +  P
Sbjct: 240 K------AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 7e-65
 Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 21/271 (7%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
             ++  RLG G  G V+ G  N  TKVAVK L  G       FL+E   +  + H  LVR
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L      +   +++ EYM NGSL  ++     I+ L+ +    +  QI+ G+ ++ +   
Sbjct: 73  LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE--- 127

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
              IH D++  NIL+   L+ KIADFGLARLI  ++       K    + APE     + 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           T K D++SFG+++ EI+   R   P  G    + ++      R+    D   E+      
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYRM-VRPDNCPEE------ 238

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
               + Q+   C ++    RP+   L  VL+
Sbjct: 239 ----LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 8e-65
 Identities = 65/273 (23%), Positives = 125/273 (45%), Gaps = 21/273 (7%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
           +      +G G  G V  G   +  KVA+K +  G    +++F+ E E +  + H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L G C E++   LV+E+M +G L    + + +    + +    +   +  G+ YL +   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
             +IH D+  +N L+  +  +K++DFG+ R +  DQ   ST  K    + +PE+   +  
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           ++K D++SFGV++ E+    +   P       + ++  +   RL              R 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGFRLYK-----------PRL 226

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
            +  + QI   C ++    RP+ S L++ L  +
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-63
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 21/272 (7%)

Query: 506 RDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           +D      LG G  G V  G       VA+K +  G +  + EF+ E + + N+ H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +L G C ++   F++ EYM NG L  ++               ++   +   +EYL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
           + + +H D+  +N L++    VK++DFGL+R +  D+   S   K    +  PE+   + 
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            ++K DI++FGV++ EI    +   P       +T +  A+  RL               
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHIAQGLRLYR-----------PH 224

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
             + K+  I  SC  +    RP+  +L+  + 
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 4e-63
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 22/279 (7%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVR 564
             ++  +LG+G  G V+ G  N  T+VA+K L PG     + FL E + +  + H  LV+
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 565 LVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
           L          ++V EYM  GSL  +    +  + L       +  QI+ G+ Y+     
Sbjct: 77  LYAVV-SEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133

Query: 625 PKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSI 684
              +H D++  NIL+  +L  K+ADFGLARLI  ++       K    + APE       
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 685 TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD 744
           T K D++SFG+++ E+    R   P  G    + L       R+     +  E       
Sbjct: 192 TIKSDVWSFGILLTELTTKGR--VPYPGMVNREVLDQVERGYRM-PCPPECPES------ 242

Query: 745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQG-LTKLEP 782
               +  +   C +K    RP+   L   L+   T  EP
Sbjct: 243 ----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 2e-61
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 27/275 (9%)

Query: 506 RDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           ++ ++   +G+G  G V  G    G KVAVK +        + FL+E   +  + H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 564 RLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           +L+G   E     ++V EYM  GSL  ++  + R   L  D   K    +   +EYL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG- 121

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
                +H D+  +N+L+  D   K++DFGL +  +  Q       K    + APE  R  
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREK 175

Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH 742
             + K D++SFG+++ EI    R   P     L D +    +  ++ D  D         
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKM-DAPDGCPPA---- 228

Query: 743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
                 + ++  +C   +   RPS   L + L+ +
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-61
 Identities = 67/305 (21%), Positives = 114/305 (37%), Gaps = 41/305 (13%)

Query: 501 MKSATRDFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRG-KKEFLSEVETIGN 556
           M+    DF+    LG G  G VF+      G  +A K ++       + + + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
            +   +V   G         +  E+M  GSLD+ +    R   +   I  K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
            YL +    KI+H D+KP NIL++    +K+ DFG++  +    +       GT  YM+P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172

Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E  +G   + + DI+S G+ ++E+  GR    P     L      + E D        ++
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 737 EDMQSHRDDAVKMIQIAI-----------------------------SCLQKNLHRRPSA 767
                          +AI                              CL KN   R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 768 SMLVK 772
             L+ 
Sbjct: 293 KQLMV 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-60
 Identities = 69/276 (25%), Positives = 117/276 (42%), Gaps = 25/276 (9%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFN 561
           D+++   +G G  G   +    +DG  +  K L  G      K+  +SEV  +  + H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 562 LVRLVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRI-QTLSWDIRKKIIFQISRGLEY 618
           +VR      +R+N   ++V EY   G L   I    +  Q L  +   +++ Q++  L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 619 LHD--YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP 676
            H        ++H D+KP N+ LD   NVK+ DFGLAR++  D S        TP YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYMSP 183

Query: 677 ELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
           E     S   K DI+S G ++ E+        P       +    K    +   +  + S
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAG-KIREGKFRRIPYRYS 239

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           +++           +I    L    + RPS   +++
Sbjct: 240 DELN----------EIITRMLNLKDYHRPSVEEILE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 2e-60
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 21/283 (7%)

Query: 507 DFQI--RLGRGGSGSVFEGLLND-GTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           D  +  +LG G  G V+EG+       VAVK L   +    +EFL E   +  I H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +L+G C      +++ E+M  G+L  ++   +R Q +S  +   +  QIS  +EYL    
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK-- 133

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS 683
               IH D+  +N L+  +  VK+ADFGL+RL+  D        K    + APE    N 
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            + K D+++FGV++ EI     S  P              +  ++ +L++K    M+   
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYP------------GIDLSQVYELLEKD-YRMERPE 239

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPVTDY 786
               K+ ++  +C Q N   RPS + + +  + + +   ++D 
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (521), Expect = 2e-60
 Identities = 69/277 (24%), Positives = 112/277 (40%), Gaps = 33/277 (11%)

Query: 505 TRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK---KEFLSEVETIGNIH 558
            + F     +G G  G+V+    + +   VA+K++     +     ++ + EV  +  + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           H N ++  G        +LV EY    + D    HK     L       +     +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL 678
           LH      +IH D+K  NILL     VK+ DFG A ++A   S V     GTP +MAPE+
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182

Query: 679 TRGNS---ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK 735
                      K+D++S G+  +E+   +    P      +  L   A+ +         
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQNESPALQSGHW 239

Query: 736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           SE  +              SCLQK    RP++ +L+K
Sbjct: 240 SEYFR----------NFVDSCLQKIPQDRPTSEVLLK 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-58
 Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 28/273 (10%)

Query: 508 FQIRLGRGGSGSVFEGLLND-GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVR 564
           F I +GRG   +V++GL  +   +VA   L   +     ++ F  E E +  + H N+VR
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 565 LVGYCAE----RSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
                      +    LV E M +G+L  ++        +   + +    QI +GL++LH
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH 129

Query: 621 DYCNPKIIHFDIKPQNILL-DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
               P IIH D+K  NI +     +VKI D GLA L    ++  +    GTP +MAPE+ 
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMY 185

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
                   +D+Y+FG+ +LE+        P         +  +  +       DK +   
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEY---PYSECQNAAQIYRRVTSGVKPASFDKVAIP- 240

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                   ++ +I   C+++N   R S   L+ 
Sbjct: 241 --------EVKEIIEGCIRQNKDERYSIKDLLN 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 2e-58
 Identities = 77/304 (25%), Positives = 134/304 (44%), Gaps = 38/304 (12%)

Query: 496 FSSKAMKSATRDF-----------QIRLGRGGSGSVFEGLLNDGTK----VAVKRLYPGE 540
           F+ +    A R+F           +  +G G  G V  G L    K    VA+K L  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 541 N-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT 599
             + +++FLSE   +G   H N++ L G   + +   ++ E+M NGSLD ++   D   T
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 600 LSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD 659
                   ++  I+ G++YL D      +H D+  +NIL++ +L  K++DFGL+R +  D
Sbjct: 127 --VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 660 QSHVSTM----PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
            S  +       K    + APE  +    T+  D++S+G+V+ E++       P      
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239

Query: 716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
            D +    +  RL   +D  S            + Q+ + C QK+ + RP    +V  L 
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSA-----------LHQLMLDCWQKDRNHRPKFGQIVNTLD 288

Query: 776 GLTK 779
            + +
Sbjct: 289 KMIR 292

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-58
 Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
            ++I   LG G  G V++          A K +        ++++ E++ + +  H N+V
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
           +L+      +N +++ E+   G++D  +   +R   L+    + +  Q    L YLHD  
Sbjct: 73  KLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD-- 128

Query: 624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPEL----- 678
             KIIH D+K  NIL   D ++K+ADFG++    +      +   GTP +MAPE+     
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCET 186

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK--VKAEADRLCDLVDKKS 736
           ++      K D++S G+ ++E+        P      +  L    K+E   L        
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKIAKSEPPTL-------- 235

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                   +    ++    CL+KN+  R + S L++
Sbjct: 236 AQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-58
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 32/273 (11%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGK---KEFLSEVETIGNIHHF 560
           DF+I   LG+G  G+V+          +A+K L+  +        +   EVE   ++ H 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           N++RL GY  + +  +L+ EY   G++ + +    +            I +++  L Y H
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH 123

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
                ++IH DIKP+N+LL     +KIADFG +      +        GT  Y+ PE+  
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177

Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL-KVKAEADRLCDLVDKKSEDM 739
           G     K+D++S GV+  E + G+    P   +   +T  ++        D V       
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISRVEFTFPDFVT------ 228

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
               + A  +I      L+ N  +RP    +++
Sbjct: 229 ----EGARDLIS---RLLKHNPSQRPMLREVLE 254

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 7e-58
 Identities = 69/305 (22%), Positives = 118/305 (38%), Gaps = 33/305 (10%)

Query: 506 RDFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
           R   +   +G+G  G V+ G    G +VAVK     E R      +E+     + H N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENIL 60

Query: 564 RLVGYCAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
             +    + +      +LV +Y  +GSL  ++       T++ +   K+    + GL +L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHL 116

Query: 620 HDYC-----NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GTP 671
           H         P I H D+K +NIL+ ++    IAD GLA         +   P    GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 672 GYMAPEL------TRGNSITAKIDIYSFGVVILEIICGRR--SSNPKGGDYLVDTLKVKA 723
            YMAPE+       +      + DIY+ G+V  EI         +        D +    
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 724 EADRLCDLVDKKSEDMQ-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLT 778
             + +  +V ++             +    M +I   C   N   R +A  + K L  L+
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 779 KLEPV 783
           + E +
Sbjct: 297 QQEGI 301

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-57
 Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 23/271 (8%)

Query: 505 TRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFN 561
            + +    ++G+G SG+V+  + +  G +VA++++   +   K+  ++E+  +    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V  +         ++V EY+  GSL   +                +  +  + LE+LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
               ++IH DIK  NILL  D +VK+ DFG    I  +QS  STM  GTP +MAPE+   
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTR 190

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
            +   K+DI+S G++ +E+I G     P   +  +  L + A           + ++ + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRALYLIATNGT------PELQNPEK 241

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                   +     CL  ++ +R SA  L++
Sbjct: 242 LSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-57
 Identities = 59/272 (21%), Positives = 115/272 (42%), Gaps = 25/272 (9%)

Query: 510 IRLGRGGSGSVFEGLL---NDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRL 565
           I LG G  GSV +G+         VA+K L  G  +   +E + E + +  + +  +VRL
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C +     LV E    G L K++  K   + +      +++ Q+S G++YL      
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EK 128

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--VSTMPKGTPGYMAPELTRGNS 683
             +H D+  +N+LL      KI+DFGL++ +  D S+    +  K    + APE      
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            +++ D++S+GV + E +   +   P       + +    +  R+ +   +   +     
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRM-ECPPECPPE----- 240

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                +  +   C       RP    + + ++
Sbjct: 241 -----LYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (495), Expect = 8e-57
 Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 47/302 (15%)

Query: 507 DFQI--RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRG-KKEFLSEVETIGNI 557
           + +    +G G  G VF+            T VAVK L    +   + +F  E   +   
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI-------------------- 597
            + N+V+L+G CA      L++EYM  G L++++                          
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 598 -QTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
              LS   +  I  Q++ G+ YL +    K +H D+  +N L+  ++ VKIADFGL+R I
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 657 A-QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
              D             +M PE    N  T + D++++GVV+ EI        P  G   
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL--QPYYGMAH 248

Query: 716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
            + +    + + L    +    +          +  +   C  K    RPS   + ++LQ
Sbjct: 249 EEVIYYVRDGNIL-ACPENCPLE----------LYNLMRLCWSKLPADRPSFCSIHRILQ 297

Query: 776 GL 777
            +
Sbjct: 298 RM 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 9e-57
 Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 27/272 (9%)

Query: 511 RLGRGGSGSVFEGLLND---GTKVAVKRLYPGENRG--KKEFLSEVETIGNIHHFNLVRL 565
            LG G  G+V +G          VAVK L    N    K E L+E   +  + +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +G C E  +  LV E    G L+K++        +      +++ Q+S G++YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ES 126

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMP--KGTPGYMAPELTRGNS 683
             +H D+  +N+LL      KI+DFGL++ +  D+++       K    + APE      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            ++K D++SFGV++ E     +   P  G    +   +  + +R+         +M    
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGERM-GCPAGCPREMY--- 240

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                   +   C   ++  RP  + +   L+
Sbjct: 241 -------DLMNLCWTYDVENRPGFAAVELRLR 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-56
 Identities = 73/287 (25%), Positives = 134/287 (46%), Gaps = 30/287 (10%)

Query: 512 LGRGGSGSVFEGLLNDGT-----KVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRL 565
           +G G  G V++G+L   +      VA+K L  G   + + +FL E   +G   H N++RL
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
            G  ++     ++ EYM NG+LDK++  KD     S      ++  I+ G++YL    N 
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLA---NM 129

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM--PKGTPGYMAPELTRGNS 683
             +H D+  +NIL++ +L  K++DFGL+R++  D     T    K    + APE      
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189

Query: 684 ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR 743
            T+  D++SFG+V+ E++        +  +              +   ++     + +  
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSN------------HEVMKAIN-DGFRLPTPM 236

Query: 744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK----LEPVTDY 786
           D    + Q+ + C Q+   RRP  + +V +L  L +    L+ + D+
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 283

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-55
 Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 46/300 (15%)

Query: 507 DFQI--RLGRGGSGSVFEGLLND------GTKVAVKRLYPGENRG-KKEFLSEVETIGNI 557
           + +    LG G  G V               +VAVK L    +   ++  +SE++ +  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 558 -HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK--------------------DR 596
             H N+V L+G C      +L++EY C G L  ++  K                    + 
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 597 IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI 656
           +  L+++      +Q+++G+E+L        +H D+  +N+L+     VKI DFGLAR I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 657 AQDQSHVS-TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL 715
             D ++V     +    +MAPE       T K D++S+G+++ EI       NP  G  +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPYPGIPV 272

Query: 716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
                   +     D     +E+          +  I  SC   +  +RPS   L   L 
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEE----------IYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-55
 Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 27/279 (9%)

Query: 508 FQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGENRGK-KEFLSEVETIGNIHHFNL 562
           F   +GRG  G V+ G L D        AVK L    + G+  +FL+E   + +  H N+
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 563 VRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           + L+G C        +V  YM +G L  +I ++      +         Q+++G+     
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGM---KF 145

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ---SHVSTMPKGTPGYMAPEL 678
             + K +H D+  +N +LD    VK+ADFGLAR +   +    H  T  K    +MA E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 679 TRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED 738
            +    T K D++SFGV++ E++       P       D      +  RL          
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPDVNTFDITVYLLQGRRLLQ-------- 255

Query: 739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
                     + ++ + C       RPS S LV  +  +
Sbjct: 256 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-55
 Identities = 66/282 (23%), Positives = 113/282 (40%), Gaps = 26/282 (9%)

Query: 507 DFQI--RLGRGGSGSVFEGLL----NDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHH 559
             ++   +G G  G V +G+     N    VA+K      +   +E FL E  T+    H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
            ++V+L+G   E    +++ E    G L    F + R  +L         +Q+S  L YL
Sbjct: 68  PHIVKLIGVITEN-PVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
                 + +H DI  +N+L+  +  VK+ DFGL+R +     + ++  K    +MAPE  
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
                T+  D++ FGV + EI+       P  G    D +      +RL  +       +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERL-PMPPNCPPTL 238

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLE 781
                       +   C   +  RRP  + L   L  + + E
Sbjct: 239 Y----------SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-55
 Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 24/272 (8%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNL 562
           D+ +   LG G  G V           VAVK +         +    E+     ++H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           V+  G+  E + ++L  EY   G L   I        +     ++   Q+  G+ YLH  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG- 121

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPELTRG 681
               I H DIKP+N+LLD   N+KI+DFGLA +    ++  +     GT  Y+APEL + 
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 682 NSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
                  +D++S G+V+  ++ G                    E     +   K      
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA-- 235

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                    + +    L +N   R +   + K
Sbjct: 236 --------PLALLHKILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 6e-55
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 41/297 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGLL------NDGTKVAVKRLYPGENRG-KKEFLSEVETIGNI 557
                  LG G  G V E         +    VAVK L P  +   ++  +SE++ +  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 558 -HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHK---------------DRIQTLS 601
            +H N+V L+G C       ++ EY C G L  ++  K               D    L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
            +      +Q+++G+ +L    +   IH D+  +NILL      KI DFGLAR I  D +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 662 H-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           + V    +    +MAPE       T + D++S+G+ + E+     S  P           
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---------- 250

Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
                 +   ++ +    M S      +M  I  +C   +  +RP+   +V++++  
Sbjct: 251 -MPVDSKFYKMIKEG-FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-54
 Identities = 68/281 (24%), Positives = 109/281 (38%), Gaps = 29/281 (10%)

Query: 506 RDFQI--RLGRGGSGSVFEGLLN----DGTKVAVKRLYP---GENRGKKEFLSEVETIGN 556
           +D ++  +LG G  G V  G  +        VAVK L P    +     +F+ EV  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 557 IHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           + H NL+RL G         +V E    GSL   +               +   Q++ G+
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGM 124

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH--VSTMPKGTPGYM 674
            YL    + + IH D+  +N+LL     VKI DFGL R + Q+  H  +    K    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
           APE  +  + +   D + FGV + E+    +   P  G      L            +DK
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL----------HKIDK 229

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
           + E +    D    +  + + C       RP+   L   L 
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  188 bits (478), Expect = 6e-54
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 23/271 (8%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
            + I   LG G  G V        G   A K +       K+    E++T+  + H  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L     + +   ++YE+M  G L + +   D    +S D   + + Q+ +GL ++H+  
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHE-- 142

Query: 624 NPKIIHFDIKPQNILLDRDLN--VKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
               +H D+KP+NI+     +  +K+ DFGL   +   QS   T   GT  + APE+  G
Sbjct: 143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 199

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
             +    D++S GV+   ++ G     P GG+   +TL+     D      +        
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKSCD-----WNMDDSAFSG 251

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             +D    I+     L  + + R +    ++
Sbjct: 252 ISEDGKDFIR---KLLLADPNTRMTIHQALE 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 8e-54
 Identities = 64/282 (22%), Positives = 122/282 (43%), Gaps = 28/282 (9%)

Query: 507 DFQI--RLGRGGSGSVFEGLLND-----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIH 558
           +F+    LG G  G+V++GL           VA+K L    + +  KE L E   + ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 559 HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEY 618
           + ++ RL+G C   S   L+ + M  G L  ++                   QI++G+ Y
Sbjct: 70  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNY 126

Query: 619 LHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI-AQDQSHVSTMPKGTPGYMAPE 677
           L    + +++H D+  +N+L+    +VKI DFGLA+L+ A+++ + +   K    +MA E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 678 LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE 737
                  T + D++S+GV + E++       P  G            A  +  +++K  E
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGI----------PASEISSILEKG-E 230

Query: 738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK 779
            +       + +  I + C   +   RP    L+     + +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 8e-53
 Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 38/291 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDG---TKVAVKRLYPGENR-GKKEFLSEVETIGNI-HH 559
           D +    +G G  G V +  +         A+KR+    ++   ++F  E+E +  + HH
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQT-------------LSWDIRK 606
            N++ L+G C  R   +L  EY  +G+L  ++     ++T             LS     
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 607 KIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM 666
                ++RG++YL      + IH D+  +NIL+  +   KIADFGL+R   Q+     TM
Sbjct: 131 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTM 185

Query: 667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD 726
            +    +MA E    +  T   D++S+GV++ EI+    +  P  G    +  +   +  
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQGY 243

Query: 727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           RL +      ++          +  +   C ++  + RPS + ++  L  +
Sbjct: 244 RL-EKPLNCDDE----------VYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 4e-52
 Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 35/293 (11%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI 557
              +   LG+G  G V+EG+          T+VA+K +    + R + EFL+E   +   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDR-------IQTLSWDIRKKIIF 610
           +  ++VRL+G  ++     ++ E M  G L  ++            +   S     ++  
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 611 QISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ-DQSHVSTMPKG 669
           +I+ G+ YL      K +H D+  +N ++  D  VKI DFG+ R I + D          
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 670 TPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC 729
              +M+PE  +    T   D++SFGVV+ EI        P  G      L+   E   L 
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLL- 254

Query: 730 DLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP 782
           D  D   +           + ++   C Q N   RPS   ++  ++   ++EP
Sbjct: 255 DKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKE--EMEP 295

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-51
 Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 42/300 (14%)

Query: 507 DFQI--RLGRGGSGSVFEGLL--------NDGTKVAVKRLYPGEN-RGKKEFLSEVETIG 555
              +   LG G  G V             N  TKVAVK L      +   + +SE+E + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 556 NI-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRI-------------QTLS 601
            I  H N++ L+G C +    +++ EY   G+L +++  +                + LS
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 602 WDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS 661
                   +Q++RG+EYL      K IH D+  +N+L+  D  +KIADFGLAR I     
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 662 HVSTM-PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK 720
           +  T   +    +MAPE       T + D++SFGV++ EI     S  P  G  + +  K
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELFK 248

Query: 721 VKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL 780
           +  E  R+ D     + +          +  +   C      +RP+   LV+ L  +  L
Sbjct: 249 LLKEGHRM-DKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-51
 Identities = 58/274 (21%), Positives = 105/274 (38%), Gaps = 28/274 (10%)

Query: 502 KSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG---ENRGKKEFLSEVETIG 555
           K    DF+    LG G   +V     L    + A+K L      +         E + + 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 556 NIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
            + H   V+L     +    +    Y  NG L K+I              +    +I   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 120

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYM 674
           LEYLH      IIH D+KP+NILL+ D++++I DFG A++++ +     +    GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
           +PEL    S     D+++ G +I +++ G     P          +          ++  
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP---PFRAGNEYLIFQ---------KIIKL 225

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
           + +  +     A  +++     L  +  +R    
Sbjct: 226 EYDFPEKFFPKARDLVE---KLLVLDATKRLGCE 256

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  179 bits (454), Expect = 2e-50
 Identities = 62/271 (22%), Positives = 111/271 (40%), Gaps = 23/271 (8%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
            + I   LG G  G V   +    G     K +       K    +E+  +  +HH  L+
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L     ++    L+ E++  G L   I        +S       + Q   GL+++H+  
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE-- 145

Query: 624 NPKIIHFDIKPQNILLD--RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
              I+H DIKP+NI+ +  +  +VKI DFGLA  +  D+    T    T  + APE+   
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDR 202

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
             +    D+++ GV+   ++ G     P  G+  ++TL+     D      +   +   S
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCD-----WEFDEDAFSS 254

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              +A   I+   + LQK   +R +    ++
Sbjct: 255 VSPEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 4e-50
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 40/296 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENRG-KKEFLSEVETIGNI 557
             ++   LGRG  G V E              VAVK L  G      +  +SE++ + +I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 558 -HHFNLVRLVGYCAERSNR-FLVYEYMCNGSLDKWIFHKDRI-------------QTLSW 602
            HH N+V L+G C +      ++ E+   G+L  ++  K                  L+ 
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 603 DIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH 662
           +      FQ+++G+E+L    + K IH D+  +NILL     VKI DFGLAR I +D  +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 663 V-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKV 721
           V     +    +MAPE       T + D++SFGV++ EI     S  P  G  + +    
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCR 248

Query: 722 KAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL 777
           + +        D  + +          M Q  + C      +RP+ S LV+ L  L
Sbjct: 249 RLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 1e-48
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 26/273 (9%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE-FLSEVETIGNIHHFNL 562
            +     LG G    V           VA+K +      GK+    +E+  +  I H N+
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           V L        + +L+ + +  G L   I  K      +     ++IFQ+   ++YLHD 
Sbjct: 70  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL 126

Query: 623 CNPKIIHFDIKPQNILL---DRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
               I+H D+KP+N+L    D D  + I+DFGL+++   D   V +   GTPGY+APE+ 
Sbjct: 127 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVL 181

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
                +  +D +S GV+   ++CG     P   +      +   +A+      +  S   
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAE-----YEFDSPYW 233

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
               D A   I+     ++K+  +R +    ++
Sbjct: 234 DDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  168 bits (426), Expect = 1e-47
 Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 38/285 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN---------RGKKEFLSEVETI 554
           +++    LGRG S  V   +      + AVK +                ++  L EV+ +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 555 GNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
             +  H N+++L       +  FLV++ M  G L  ++  K    TLS    +KI+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGY 673
             +  LH      I+H D+KP+NILLD D+N+K+ DFG +  +  D         GTP Y
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 175

Query: 674 MAPELTRGN------SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
           +APE+   +          ++D++S GV++  ++ G     P      +  L++    + 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGN- 231

Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                   S +   + D    ++      L     +R +A   + 
Sbjct: 232 ----YQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 52/271 (19%), Positives = 103/271 (38%), Gaps = 24/271 (8%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLV 563
            + I   LGRG  G V   +  +       K +   +   +     E+  +    H N++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNIL 64

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L           +++E++    + + I        L+       + Q+   L++LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120

Query: 624 NPKIIHFDIKPQNILLD--RDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
              I HFDI+P+NI+    R   +KI +FG AR +    +         P Y APE+ + 
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQH 177

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
           + ++   D++S G ++  ++ G     P   +     ++    A+          E  + 
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMNAE-----YTFDEEAFKE 229

Query: 742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
              +A+  +      L K    R +AS  ++
Sbjct: 230 ISIEAMDFVD---RLLVKERKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (420), Expect = 8e-47
 Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 34/287 (11%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGK---KEFLSEVETIGNIHHF 560
            +++   LG GG   V     L     VAVK L     R       F  E +    ++H 
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 561 NLVRLVGYCAERSNR----FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
            +V +       +      ++V EY+   +L   +  +     ++     ++I    + L
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQAL 124

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM--PKGTPGYM 674
            + H      IIH D+KP NI++     VK+ DFG+AR IA   + V+      GT  Y+
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
           +PE  RG+S+ A+ D+YS G V+ E++ G     P  GD  V         D +      
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVREDPIPP---- 234

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKVLQG 776
            S   +    D   ++      L KN   R        + LV+V  G
Sbjct: 235 -SARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-45
 Identities = 65/283 (22%), Positives = 119/283 (42%), Gaps = 24/283 (8%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRG-KKEFLSEVETIGNIHHFNLVRLVGY 568
            +G G  G V       +  +VA+K++ P E++   +  L E++ +    H N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
               +   +   Y+    +   ++   + Q LS D     ++QI RGL+Y+H      ++
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131

Query: 629 HFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK--GTPGYMAPE-LTRGNSIT 685
           H D+KP N+LL+   ++KI DFGLAR+   D  H   + +   T  Y APE +      T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191

Query: 686 AKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS 741
             IDI+S G ++ E++  R            ++++  L   ++ D  C +  K    + S
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251

Query: 742 HRDDAV------------KMIQIAISCLQKNLHRRPSASMLVK 772
                             K + +    L  N H+R      + 
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-45
 Identities = 62/273 (22%), Positives = 105/273 (38%), Gaps = 29/273 (10%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPG---ENRGKKEFLSEVETIG-NIHH 559
           DF +   LG+G  G VF           A+K L       +   +  + E   +     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
             L  +      + N F V EY+  G L   I    +              +I  GL++L
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           H      I++ D+K  NILLD+D ++KIADFG+ +      +  +T   GTP Y+APE+ 
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEIL 175

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
            G      +D +SFGV++ E++ G+    P  G    +             +        
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFH---------SIRMDNPFYP 223

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           +    +A  ++        +   +R      ++
Sbjct: 224 RWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-45
 Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 30/278 (10%)

Query: 507 DFQIR---LGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFN 561
           D+++    LG G +G V +        K A+K L     +   +   EVE         +
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 66

Query: 562 LVRLVGYC----AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
           +VR+V       A R    +V E +  G L   I      Q  +     +I+  I   ++
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 618 YLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           YLH      I H D+KP+N+L      +  +K+ DFG A+      S  +     TP Y+
Sbjct: 126 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYV 180

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
           APE+          D++S GV++  ++CG     P   ++ +          R+    + 
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQY-EF 236

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            + +     ++   +I+   + L+    +R + +  + 
Sbjct: 237 PNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (409), Expect = 9e-45
 Identities = 64/268 (23%), Positives = 113/268 (42%), Gaps = 31/268 (11%)

Query: 506 RDFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHH 559
           +DFQI   LG G  G V      ++G   A+K L        +  +    E   +  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYL 619
             ++R+ G   +    F++ +Y+  G L   +    R       + K    ++   LEYL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120

Query: 620 HDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           H      II+ D+KP+NILLD++ ++KI DFG A+ +            GTP Y+APE+ 
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVV 173

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
                   ID +SFG++I E++ G     P      + T +          +++ +    
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT---PFYDSNTMKTYE---------KILNAELRFP 221

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSA 767
               +D   ++      + ++L +R   
Sbjct: 222 PFFNEDVKDLLS---RLITRDLSQRLGN 246

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 2e-44
 Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 24/275 (8%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           ++G G  G ++ G  +  G +VA+K           +   E +    +     +  + +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 570 AERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIH 629
               +  ++   +   SL+       R    S      +  Q+   +EY+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIH 126

Query: 630 FDIKPQNIL---LDRDLNVKIADFGLARLIAQDQSHV------STMPKGTPGYMAPELTR 680
            D+KP N L     +   V I DFGLA+     ++H       +    GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
           G   + + D+ S G V++    G              T + K E      +        +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ 775
            +  +    +     C       +P  S L ++ +
Sbjct: 243 GYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (408), Expect = 4e-44
 Identities = 61/270 (22%), Positives = 111/270 (41%), Gaps = 31/270 (11%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPG---ENRGKKEFLSEVETI---GNI 557
           DF +   +GRGG G V+     + G   A+K L        +G+   L+E   +      
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 558 HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLE 617
               +V +            + + M  G L   +              +    +I  GLE
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGLE 121

Query: 618 YLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE 677
           ++H+     +++ D+KP NILLD   +V+I+D GLA   ++ + H      GT GYMAPE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 175

Query: 678 -LTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKS 736
            L +G +  +  D +S G ++ +++ G    +P       D  ++          +    
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGH---SPFRQHKTKDKHEIDRMT------LTMAV 226

Query: 737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPS 766
           E   S   +   +++     LQ++++RR  
Sbjct: 227 ELPDSFSPELRSLLE---GLLQRDVNRRLG 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-43
 Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 27/281 (9%)

Query: 512 LGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGKKE-----FLSEVETIGNIHHFNLVRL 565
           LG G   +V++    N    VA+K++  G     K+      L E++ +  + H N++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 566 VGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNP 625
           +     +SN  LV+++M          +      L+    K  +    +GLEYLH +   
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 626 KIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE-LTRGNSI 684
            I+H D+KP N+LLD +  +K+ADFGLA+          T    T  Y APE L      
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMY 178

Query: 685 TAKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
              +D+++ G ++ E++         S+      + +TL    E               +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 741 SHRDDAVKMIQIAIS---------CLQKNLHRRPSASMLVK 772
           S     +  I  A               N   R +A+  +K
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-43
 Identities = 62/273 (22%), Positives = 116/273 (42%), Gaps = 30/273 (10%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPG------ENRGKKEFLSEVETIGNIHHFNLV 563
            LG G    V +    + G + A K +             +++   EV  +  I H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 564 RLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYC 623
            L      +++  L+ E +  G L  ++  K+    L+ +   + + QI   L  ++   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI---LNGVYYLH 130

Query: 624 NPKIIHFDIKPQNILLDRD----LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
           + +I HFD+KP+NI+L         +KI DFGLA  I  D  +      GTP ++APE+ 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIV 188

Query: 680 RGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM 739
               +  + D++S GV+   ++ G    +P  GD   +TL   +  +      + + E  
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVSAVN-----YEFEDEYF 240

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +    A   I+     L K+  +R +    ++
Sbjct: 241 SNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (391), Expect = 1e-42
 Identities = 58/288 (20%), Positives = 116/288 (40%), Gaps = 32/288 (11%)

Query: 507 DFQI--RLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNL 562
            +    ++G G  G V++   N G   A+K++   +         + E+  +  + H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 563 VRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY 622
           V+L      +    LV+E++           +     L     K  + Q+  G+ Y HD 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD- 118

Query: 623 CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGN 682
              +++H D+KPQN+L++R+  +KIADFGLAR         +     T  Y AP++  G+
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTLWYRAPDVLMGS 175

Query: 683 S-ITAKIDIYSFGVVILEIICGRR-----------------SSNPKGGDYLVDTLKVKAE 724
              +  IDI+S G +  E++ G                      P   ++   T   K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 725 ADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
            +            ++   +  + ++      L+ + ++R +A   ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (391), Expect = 1e-42
 Identities = 48/295 (16%), Positives = 95/295 (32%), Gaps = 35/295 (11%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGY 568
           R+G G  G +FEG  L +  +VA+K           +   E  T   +     +  +  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 569 CAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKII 628
             E  +  LV + +               +  S         Q+   ++ +H+     ++
Sbjct: 70  GQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 123

Query: 629 HFDIKPQNILLDRDLN-----VKIADFGLARLIAQDQSHV------STMPKGTPGYMAPE 677
           + DIKP N L+ R  +     + + DFG+ +      +             GT  YM+  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 678 LTRGNSITAKIDIYSFGVVILEIICGR---RSSNPKGGDYLVDTLKVKAEADRLCDLVDK 734
              G   + + D+ + G V +  + G    +           + +  K ++  L +L   
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243

Query: 735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVL-QGLTKLEPVTDYGF 788
             E+            +             P    L  +  + L +L    D  F
Sbjct: 244 FPEEFY----------KYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 29/293 (9%)

Query: 504 ATRDFQI--RLGRGGSGSVFEG--LLNDGTKVAVKRLYP--GENRGKKEFLSEVE---TI 554
           A + ++    +G G  G VF+   L N G  VA+KR+    GE       + EV     +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 555 GNIHHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKW---IFHKDRIQTLSWDIRKKIIFQ 611
               H N+VRL   C            +    +D+       K     +  +  K ++FQ
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 612 ISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTP 671
           + RGL++LH +   +++H D+KPQNIL+     +K+ADFGLAR+ +   +  S +   T 
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 179

Query: 672 GYMAPELTRGNSITAKIDIYSFGVVILEIICGRR----SSNPKGGDYLVDTLKVKAEADR 727
            Y APE+   +S    +D++S G +  E+   +     SS+      ++D + +  E D 
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 728 LCDLVDKKSEDMQSHRDDAVKM--------IQIAISCLQKNLHRRPSASMLVK 772
             D+   +            K           + + CL  N  +R SA   + 
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-41
 Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 38/292 (13%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFN 561
           +FQ   ++G G  G V++      G  VA+K++             + E+  +  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +V+L+      +  +LV+E++              +  +   + K  +FQ+ +GL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPE-LTR 680
           +    ++H D+KPQN+L++ +  +K+ADFGLAR         +     T  Y APE L  
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLG 176

Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ 740
               +  +DI+S G +  E++  R       GD  +D L          D V        
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 741 SHR--------------------DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
                                  +D   ++      L  + ++R SA   + 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-41
 Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 44/290 (15%)

Query: 512 LGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCA 570
           +G G  G V++  L + G  VA+K++     + K+    E++ +  + H N+VRL  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83

Query: 571 ERSNR------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCN 624
               +       LV +Y+          +    QTL     K  ++Q+ R L Y+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140

Query: 625 PKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAP-ELTRGN 682
             I H DIKPQN+LLD D   +K+ DFG A+ + + + +VS +      Y AP  +    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPELIFGAT 198

Query: 683 SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK--VKAEADRLCDLVDKKSEDMQ 740
             T+ ID++S G V+ E++ G+       GD  VD L   +K       + + + + +  
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 741 SHR------------------DDAVKMIQIAISCLQKNLHRRPSASMLVK 772
             +                   +A+ +       L+     R +      
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACA 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 58/303 (19%), Positives = 119/303 (39%), Gaps = 46/303 (15%)

Query: 507 DFQI--RLGRGGSGSVFEG-LLNDGTKVAVKRLYPGENRGK--KEFLSEVETIGNIHHFN 561
            ++   ++G+G  G VF+      G KVA+K++     +       L E++ +  + H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 562 LVRLVGYCAERSNR--------FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQIS 613
           +V L+  C  +++         +LV+++  +           +    +    K+++  + 
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML- 126

Query: 614 RGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK---GT 670
             L  L+     KI+H D+K  N+L+ RD  +K+ADFGLAR  +  ++           T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 671 PGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRR------------------SSNPKG 711
             Y  PEL  G       ID++  G ++ E+                        S    
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 712 GDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD--AVKMIQIAISCLQKNLHRRPSASM 769
               VD  ++  + + +     K  + ++++  D  A+ +I      L  +  +R  +  
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDD 301

Query: 770 LVK 772
            + 
Sbjct: 302 ALN 304

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 2e-40
 Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 48/282 (17%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYP------GENRGKKEFLSEVETIGNI 557
            +Q+   LG GG GSV+ G+ ++D   VA+K +        GE         EV  +  +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 558 H--HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
                 ++RL+ +     +  L+ E             +     L  ++ +   +Q+   
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEA 122

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           + + H+     ++H DIK +NIL+D +   +K+ DFG   L+   +  V T   GT  Y 
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 176

Query: 675 APELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA---DRLCD 730
            PE  R +        ++S G+++ +++CG     P   D  +   +V            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRVSSECQH 233

Query: 731 LVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK 772
           L+                       CL      RP+   +  
Sbjct: 234 LIRW---------------------CLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-40
 Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 30/268 (11%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKE---FLSEVETIGNIHHF 560
           DF     LG+G  G V        G   A+K L       K E    ++E   + N  H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 561 NLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
            L  L            V EY   G L   +  +      + +  +    +I   +  L 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEI---VSALE 119

Query: 621 DYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTR 680
              +  +++ DIK +N++LD+D ++KI DFGL +    D +       GTP Y+APE+  
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178

Query: 681 GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTL-KVKAEADRLCDLVDKKSEDM 739
            N     +D +  GVV+ E++CGR    P            +  E  R    +       
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILMEEIRFPRTLS------ 229

Query: 740 QSHRDDAVKMIQIAISCLQKNLHRRPSA 767
                +A  ++      L+K+  +R   
Sbjct: 230 ----PEAKSLLA---GLLKKDPKQRLGG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 5e-39
 Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 30/288 (10%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFN 561
            ++   ++G G  G+VF+         VA+KR+   ++        L E+  +  + H N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 562 LVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD 621
           +VRL           LV+E+        +      +     +I K  +FQ+ +GL + H 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHS 119

Query: 622 YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRG 681
                ++H D+KPQN+L++R+  +K+A+FGLAR         S             L   
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 682 NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLK---------VKAEADRLCDLV 732
              +  ID++S G +  E+    R      G+ + D LK          + +   +  L 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 733 DKKSEDMQSHRDDAVKM--------IQIAISCLQKNLHRRPSASMLVK 772
           D K   M       V +          +  + L+ N  +R SA   ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (361), Expect = 5e-38
 Identities = 66/300 (22%), Positives = 120/300 (40%), Gaps = 32/300 (10%)

Query: 473 REGKRRDKSTDESSVHVANHLVKFSSKAMKSATRD-FQI--RLGRGGSGSVFEGL-LNDG 528
           ++G  ++   +  +    + L K+ + +  +A  D F     LG G  G V        G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 529 TKVAVKRLYPGENRGKKE---FLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNG 585
              A+K L   +    K+    L+E   +  ++   LV+L     + SN ++V EY+  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNV 645
            +   +    R    S    +    QI    EYLH      +I+ D+KP+N+L+D+   +
Sbjct: 127 EMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180

Query: 646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR 705
           ++ DFG A+ +      +     GTP  +APE+         +D ++ GV+I E+  G  
Sbjct: 181 QVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

Query: 706 SSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRP 765
              P   D  +   +               S D++           +  + LQ +L +R 
Sbjct: 237 ---PFFADQPIQIYEKIVSGK--VRFPSHFSSDLK----------DLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 65/275 (23%), Positives = 115/275 (41%), Gaps = 30/275 (10%)

Query: 507 DFQI--RLGRGGSGSVFEGLL----NDGTKVAVKRLYPG----ENRGKKEFLSEVETIGN 556
           +F++   LG G  G VF        + G   A+K L       + +  +   +E + + +
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 557 I-HHFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRG 615
           I     LV L       +   L+ +Y+  G L   +  ++R    +    +  + +I   
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLA 141

Query: 616 LEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMA 675
           LE+LH      II+ DIK +NILLD + +V + DFGL++    D++  +    GT  YMA
Sbjct: 142 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 676 PELTRGN--SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD 733
           P++ RG        +D +S GV++ E++ G     P   D   ++    +        + 
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRI-----LK 250

Query: 734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSAS 768
            +    Q     A  +IQ     L K+  +R    
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCG 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  136 bits (343), Expect = 8e-36
 Identities = 62/297 (20%), Positives = 124/297 (41%), Gaps = 45/297 (15%)

Query: 507 DFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNL 562
           D+Q+  +LGRG    VFE + + +  KV VK L P +   KK+   E++ + N+    N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92

Query: 563 VRLVGYCAERSNR--FLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLH 620
           + L     +  +R   LV+E++ N    +        QTL+    +  +++I + L+Y H
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 146

Query: 621 DYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELT 679
                 I+H D+KP N+++D +   +++ D+GLA      Q +   +   +  +  PEL 
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201

Query: 680 RGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKA-EADRLCDLVDKKSE 737
                    +D++S G ++  +I  +        +Y       K    + L D +DK + 
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 738 DMQSHRDDAVKM----------------------IQIAISCLQKNLHRRPSASMLVK 772
           ++    +D +                        +      L+ +   R +A   ++
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-34
 Identities = 61/283 (21%), Positives = 113/283 (39%), Gaps = 28/283 (9%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVG 567
            +G G  G+V   +    G KVA+K+LY         K    E+  + ++ H N++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 568 YCAERSNRFLVYE-YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPK 626
                       + Y+    +   +    + + L  D  + +++Q+ +GL Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII- 143

Query: 627 IIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNS-IT 685
             H D+KP N+ ++ D  +KI DFGLAR    +     T    T  Y APE+       T
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197

Query: 686 AKIDIYSFGVVILEIICGR---------------RSSNPKGGDYLVDTLKVKAEADRLCD 730
             +DI+S G ++ E+I G+                          V  L+     + +  
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257

Query: 731 LVDKKSEDMQSHRDDAVKM-IQIAISCLQKNLHRRPSASMLVK 772
           L + + +D  S   +A  + + +    L  +  +R +A   + 
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 9e-33
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 506 RDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHF 560
           + +Q    +G G  G V           VA+K+L          K    E+  +  ++H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 561 NLVRLVGYCA------ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISR 614
           N++ L+          E  + +LV E M            D       +    +++Q+  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 615 GLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPKGTPGYM 674
           G+++LH       IH D+KP NI++  D  +KI DFGLAR      S + T    T  Y 
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185

Query: 675 APELTRGNSITAKIDIYSFGVVILEIICGR 704
           APE+  G      +DI+S G ++ E++  +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-29
 Identities = 68/304 (22%), Positives = 115/304 (37%), Gaps = 44/304 (14%)

Query: 499 KAMKSATRDFQI--RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGEN--RGKKEFLSEVET 553
           K +      +Q    +G G  GSV        G +VAVK+L          K    E+  
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 554 IGNIHHFNLVRLVGYCAERS-----NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKI 608
           + ++ H N++ L+            N   +  ++    L+  +      Q L+ D  + +
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFL 126

Query: 609 IFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTMPK 668
           I+QI RGL+Y+H        H D+KP N+ ++ D  +KI DFGLA    +      T   
Sbjct: 127 IYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV 179

Query: 669 GTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR 727
            T  Y APE+          +DI+S G ++ E++ GR       G   +D LK+      
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR---TLFPGTDHIDQLKLILRLVG 236

Query: 728 LCDLVDKKSEDMQSHRDDAVKMIQIAI-------------------SCLQKNLHRRPSAS 768
                  K    +S R+    + Q+                       L  +  +R +A+
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

Query: 769 MLVK 772
             + 
Sbjct: 297 QALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (283), Expect = 9e-28
 Identities = 63/315 (20%), Positives = 112/315 (35%), Gaps = 60/315 (19%)

Query: 511 RLGRGGSGSVFEGL-LNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYC 569
           +LG G   +V+    + + T VA+K +  G+    +    E++ +  ++  +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 570 AERSNRFLVY-------------EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
           A    + L +              +   G     +  K   + +     K+I  Q+  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRD------LNVKIADFGLARLIAQDQSHVSTMPKGT 670
           +Y+H      IIH DIKP+N+L++        + +KIAD G A    +  ++       T
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQT 192

Query: 671 PGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLC- 729
             Y +PE+  G       DI+S   +I E+I G     P  G          A+   L  
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 730 --------------------------------DLVDKKSEDMQSHRDDAVKMIQIAISCL 757
                                            L D  +E  +  +D+A ++       L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 758 QKNLHRRPSASMLVK 772
           Q +  +R  A  LV 
Sbjct: 313 QLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.5 bits (221), Expect = 4e-21
 Identities = 23/158 (14%), Positives = 46/158 (29%), Gaps = 28/158 (17%)

Query: 511 RLGRGGSGSVFEGLLNDGTKVAVKRLYPG----------ENRGKKEFLSEVETIGNIHHF 560
            +G G   +VF        +  VK    G           + G   F             
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 561 NLVRLVGYCAER----SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGL 616
            L +L G    +        ++ E +    L +             +   +++  I   +
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR----------VENPDEVLDMILEEV 116

Query: 617 EYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR 654
              +      I+H D+   N+L+  +  + I DF  + 
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 58.4 bits (141), Expect = 4e-11
 Identities = 14/73 (19%), Positives = 33/73 (45%), Gaps = 4/73 (5%)

Query: 105 ILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETS-GSNVTRITLDGNGNLRLY 163
            +W +N     K+       +DG+ ++ D +G  +W++ +  G+    + L  +GN+ +Y
Sbjct: 39  SVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY 98

Query: 164 DAENRPHWISFLH 176
                  W +  +
Sbjct: 99  G---SDIWSTGTY 108

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 46.9 bits (111), Expect = 4e-07
 Identities = 23/75 (30%), Positives = 31/75 (41%), Gaps = 3/75 (4%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETS--GSNVTRITLDGNGNLRLYD 164
               GQS   E        D +L+L D   + VW++ T   G    +  L  +GN  +YD
Sbjct: 9   GLYAGQSLDVEPYHFIMQEDCNLVLYDHSTS-VWASNTGILGKKGCKAVLQSDGNFVVYD 67

Query: 165 AENRPHWISFLHPTN 179
           AE R  W S     N
Sbjct: 68  AEGRSLWASHSVRGN 82

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 54.4 bits (130), Expect = 1e-09
 Identities = 18/101 (17%), Positives = 35/101 (34%), Gaps = 6/101 (5%)

Query: 82  YLVTVRFMGTITSSSN---HQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTR 138
            L    ++  I +  N   + N+  V  W +           L+   DG+L++       
Sbjct: 15  SLAEGGYLFIIQNDCNLVLYDNNRAV--WASGTNGKA-SGCVLKMQNDGNLVIYSGSRAI 71

Query: 139 VWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTN 179
             S     +    + L  + N+ +YD  N   W +  +  N
Sbjct: 72  WASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 36.3 bits (83), Expect = 0.002
 Identities = 11/75 (14%), Positives = 23/75 (30%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAE 166
               G S  +         D +L+L D +     S     ++   + +  +GNL +Y   
Sbjct: 9   QLDTGGSLAEGGYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS 68

Query: 167 NRPHWISFLHPTNTW 181
                 +       +
Sbjct: 69  RAIWASNTNRQNGNY 83

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 50.7 bits (121), Expect = 3e-08
 Identities = 19/85 (22%), Positives = 29/85 (34%), Gaps = 5/85 (5%)

Query: 91  TITSSSNHQNHPPVILWFAN-GQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV 149
            + S+  + NHP       +  QS       L    D +L+L D D     +        
Sbjct: 12  ILYSTQGNDNHP----QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTG 67

Query: 150 TRITLDGNGNLRLYDAENRPHWISF 174
            R  L  NG + +   +N   W S 
Sbjct: 68  CRAVLQPNGRMDVLTNQNIAVWTSG 92

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 47.2 bits (112), Expect = 4e-07
 Identities = 12/77 (15%), Positives = 24/77 (31%), Gaps = 3/77 (3%)

Query: 91  TITSSSN-HQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSN- 148
           ++ +  N         +W  N  +            +G + +       VW++  S S  
Sbjct: 40  SMETDCNLVLFDRDDRVWSTN-TAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAG 98

Query: 149 VTRITLDGNGNLRLYDA 165
                L  + NL +Y  
Sbjct: 99  RYVFVLQPDRNLAIYGG 115

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 45.7 bits (108), Expect = 1e-06
 Identities = 19/69 (27%), Positives = 31/69 (44%), Gaps = 1/69 (1%)

Query: 111 GQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPH 170
            QS    +      +D +L+L D    RVW++ T+G+   R  L  +G L +  A+N   
Sbjct: 20  AQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIR 78

Query: 171 WISFLHPTN 179
           W S    + 
Sbjct: 79  WSSGTKGSI 87

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 37.2 bits (86), Expect = 0.001
 Identities = 11/51 (21%), Positives = 19/51 (37%), Gaps = 1/51 (1%)

Query: 116 KENATLEFTADGDLILKDVDGTRVWSTETSGSNVT-RITLDGNGNLRLYDA 165
                    +DG L++     T  WS+ T GS     + L  +  + +Y  
Sbjct: 55  ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP 105

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 43.9 bits (103), Expect = 6e-06
 Identities = 20/97 (20%), Positives = 30/97 (30%), Gaps = 9/97 (9%)

Query: 90  GTITSSSNHQNHPPVI-----LWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET 144
             I S     NHP ++     L    G    +         D +L+L D +     +   
Sbjct: 2   NIIFSKQPDDNHPQILHATESLEILFGTHVYR----FIMQTDCNLVLYDNNNPIWATNTG 57

Query: 145 SGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTW 181
              N  R  L  +G L +   EN   W S +      
Sbjct: 58  GLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGH 94

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 43.9 bits (103), Expect = 6e-06
 Identities = 12/69 (17%), Positives = 23/69 (33%), Gaps = 5/69 (7%)

Query: 106 LWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYD 164
           +W  N               DG L++   +   VW +  +G      + L  + N+ +Y 
Sbjct: 51  IWATNTGGL-GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG 109

Query: 165 AENRPHWIS 173
                 W +
Sbjct: 110 ---DALWAT 115

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 41.9 bits (98), Expect = 3e-05
 Identities = 17/73 (23%), Positives = 30/73 (41%)

Query: 107 WFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAE 166
             + G+     +       D +L+L DVD     +     S    +++  +GNL +Y+  
Sbjct: 9   TLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS 68

Query: 167 NRPHWISFLHPTN 179
           N+P W S     N
Sbjct: 69  NKPIWASNTGGQN 81

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 40.8 bits (95), Expect = 6e-05
 Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 5/77 (6%)

Query: 101 HPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSGSNV-TRITLDGNGN 159
                +W  N     + +  L    DG+L++ +     +W++ T G N      L  + N
Sbjct: 35  DVDKPIWATNTGGLSR-SCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRN 93

Query: 160 LRLYDAENRPHWISFLH 176
           + +Y       W +  H
Sbjct: 94  VVIYG---TDRWATGTH 107

>d2p4oa1 b.68.6.3 (A:4-305) Hypothetical protein All0351 homologue {Nostoc punctiforme [TaxId: 272131]} Length = 302

class: All beta proteins
fold: 6-bladed beta-propeller
superfamily: Calcium-dependent phosphotriesterase
family: All0351-like
domain: Hypothetical protein All0351 homologue
species: Nostoc punctiforme [TaxId: 272131]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 20/202 (9%), Positives = 50/202 (24%), Gaps = 5/202 (2%)

Query: 123 FTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWL 182
              DG + + + +   + S    G+     T++G  +   + +        +   +   +
Sbjct: 35  SAPDGTIFVTNHEVGEIVSITPDGNQQIHATVEGKVSGLAFTSNGDLVATGWNADSIPVV 94

Query: 183 PGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTIPYRNYFLNMSS 242
              +         T        G   LS +          +        P  + +L    
Sbjct: 95  SLVKSDGTVETLLTLPDAIFLNGITPLSDTQYLTADSYRGAIWLIDVVQPSGSIWLEHPM 154

Query: 243 AVLNKSAILVFNKSGSHITYDVAPRSKFHYMRLEPNGHLNIYQLDNGYSDNADLSRDEHY 302
              + S  +    +G     +    S    M L      +  +             ++  
Sbjct: 155 LARSNSESVFPAANGLKRFGNFLYVSNTEKMLLLRIPVDSTDKPGEPEIFV-----EQTN 209

Query: 303 GDCIYPTKCGNYGVCSNGECTC 324
            D       GN    ++   + 
Sbjct: 210 IDDFAFDVEGNLYGATHIYNSV 231

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	818
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.69
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.68
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.65
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.56
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.48
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.34
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.01
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.88
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.79
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.78
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.69
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.52
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.07
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.65
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.11
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.42
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.16

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=412.84  Aligned_cols=253  Identities=26%  Similarity=0.446  Sum_probs=199.9

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      ++.++||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++|||||+++|+|.+.+..++||||+++|+
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            455789999999999999998999999999754 3456789999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |.+++...  ...++++.+..|+.|||+||+|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus        87 L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          87 LSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             HHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             HHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            99988543  35688999999999999999999997   99999999999999999999999999998876654444444


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR-RSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ..||+.|+|||++.+..++.++|||||||++|||+|+. .|+.......+...+..   ..+           ...+...
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~-----------~~~p~~~  227 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFR-----------LYKPRLA  227 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TCC-----------CCCCTTS
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cCC-----------CCCcccc
Confidence            67899999999999999999999999999999999954 44443333333332221   100           0112233


Q ss_pred             HHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          746 AVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +.++.+++.+||+.||++||||+||+++|+++.+
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            4678899999999999999999999999998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-48  Score=413.79  Aligned_cols=266  Identities=27%  Similarity=0.475  Sum_probs=205.8

Q ss_pred             cCHHHHHHhhHHhh-----------hhcccccceeEEEeEecC-C---cEEEEEEcCCCC-CccHHHHHHHHHHHhccCc
Q 043017          496 FSSKAMKSATRDFQ-----------IRLGRGGSGSVFEGLLND-G---TKVAVKRLYPGE-NRGKKEFLSEVETIGNIHH  559 (818)
Q Consensus       496 ~~~~~l~~~t~~f~-----------~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H  559 (818)
                      +++++...++.+|.           ++||+|+||+||+|.+.. +   ..||||++.... ....++|.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            44555666666663           469999999999999753 2   358999986543 3445689999999999999


Q ss_pred             ceeEEEeeeecccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEE
Q 043017          560 FNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILL  639 (818)
Q Consensus       560 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll  639 (818)
                      ||||+++|++.+++..++||||+++|+|.+++...  ...+++.++..|+.|||+||+|||+.   +|+||||||+||||
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            99999999999999999999999999999988543  34689999999999999999999997   99999999999999


Q ss_pred             cCCCCEEEeecCCceecccCCCccc----cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 043017          640 DRDLNVKIADFGLARLIAQDQSHVS----TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDY  714 (818)
Q Consensus       640 ~~~~~~kl~Dfgla~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~  714 (818)
                      +.++.+||+|||+++.+........    ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999997765432211    12357899999999999999999999999999999998 899997665444


Q ss_pred             HHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          715 LVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       715 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      +...+.   ...        .   .+.+...+.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       242 ~~~~i~---~~~--------~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 VINAIE---QDY--------R---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHH---TTC--------C---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHH---cCC--------C---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            333322   110        0   111233456788999999999999999999999999987653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=408.10  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=202.8

Q ss_pred             HHhhhhcccccceeEEEeEecCCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||+||+|+++  ..||||++...  .....+.|++|++++++++|||||+++|++.+ +..++||||++
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            345678999999999999876  36999998654  34456789999999999999999999998765 56899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC-c
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS-H  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~  662 (818)
                      +|+|.+++...+  ..+++..+..|+.|||+||+|||+.   +||||||||+||||+.++.+||+|||+++....... .
T Consensus        87 ~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          87 GSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            999999996432  4689999999999999999999997   999999999999999999999999999987754332 2


Q ss_pred             cccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          663 VSTMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ......||+.|+|||++.+   ..++.++|||||||+||||+||+.||...............   ...    .+...  
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~---~~~----~p~~~--  232 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---GYL----SPDLS--  232 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH---TSC----CCCGG--
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc---CCC----CCcch--
Confidence            3344579999999999864   35899999999999999999999999866543322221111   100    00010  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ......+.++.+++.+||+.||++||||+||+++|+.+.+.
T Consensus       233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            11223456788999999999999999999999999988653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=407.78  Aligned_cols=253  Identities=30%  Similarity=0.457  Sum_probs=207.8

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.++||+|+||+||+|.+++++.||||++... ....++|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            34456789999999999999998899999999754 3456789999999999999999999998865 567899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++.... ...+++..+.+|+.||++||+|||+.   +|+||||||+||||++++.+||+|||+++..........
T Consensus        92 g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          92 GSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             CBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             CcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence            99999875432 24589999999999999999999997   999999999999999999999999999998876555445


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPK-GGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....||+.|+|||++.++.++.++|||||||++|||+||..|+... ....+...+.   ...        ..   ..+.
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---~~~--------~~---~~p~  233 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RGY--------RM---VRPD  233 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC--------CC---CCCT
T ss_pred             cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcC--------CC---CCcc
Confidence            5567999999999999889999999999999999999976665433 2222222221   110        00   1122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..+.++.+|+.+||+.||++||||+||++.|+.+
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            3446788999999999999999999999999854

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-48  Score=408.49  Aligned_cols=259  Identities=29%  Similarity=0.410  Sum_probs=214.4

Q ss_pred             HhhHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          503 SATRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       503 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      ...+.+.++||+|+||+||+|++. +++.||||++.... ...++|++|++++++++|||||+++|+|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            334556678999999999999986 48899999987543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++.... ...+++..+..|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999986543 35789999999999999999999997   999999999999999999999999999998766555


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-chHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-DYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+...+.    ..       ..+   +
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~----~~-------~~~---~  236 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KD-------YRM---E  236 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----TT-------CCC---C
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh----cC-------CCC---C
Confidence            444445688999999999999999999999999999999998777643332 22221111    10       001   1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      .+...+.++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1223456788999999999999999999999999887654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=397.72  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=213.4

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      .|.++||+|+||+||+|++++++.||||+++... ...++|++|+.++++++||||++++|+|.+.+..++||||+++|+
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence            4567899999999999999988999999997543 346789999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccccC
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVSTM  666 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  666 (818)
                      |..++...  ...+++..+.+++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus        86 l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          86 LLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             HHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             HHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            99987543  34688999999999999999999997   99999999999999999999999999998776655544445


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHHH
Q 043017          667 PKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRDD  745 (818)
Q Consensus       667 ~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  745 (818)
                      ..+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......+...+.   ...+           ...+...
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~---~~~~-----------~~~p~~~  226 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QGLR-----------LYRPHLA  226 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---TTCC-----------CCCCTTC
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH---hCCC-----------CCCcccc
Confidence            679999999999999999999999999999999998 899998766544433222   1110           0112234


Q ss_pred             HHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          746 AVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..++.+++.+||+.||++|||+++++++|..|
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            46788999999999999999999999999653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=396.29  Aligned_cols=247  Identities=25%  Similarity=0.401  Sum_probs=201.4

Q ss_pred             hhcccccceeEEEeEecC---CcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          510 IRLGRGGSGSVFEGLLND---GTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++||+|+||+||+|.+.+   ++.||||++....  ....++|++|++++++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            369999999999998653   4689999986542  2335689999999999999999999999864 567899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++...   ..+++..+..|+.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+........
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            9999998643   4589999999999999999999997   999999999999999999999999999998765443322


Q ss_pred             --cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          665 --TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       665 --~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        ....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......+...+.   ...        .+   +.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~---~~~--------~~---~~  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGE--------RM---GC  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC--------CC---CC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH---cCC--------CC---CC
Confidence              33568999999999999999999999999999999998 899998665443333222   111        01   11


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      +...+.++.+|+.+||+.||++||||++|++.|+..
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            223456788999999999999999999999988753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=396.62  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=207.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      |.+.++||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            445568999999999999964 6899999998766666678899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++.+    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.+...... .
T Consensus       102 g~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~  173 (293)
T d1yhwa1         102 GSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  173 (293)
T ss_dssp             CBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred             CcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence            999998754    3589999999999999999999997   9999999999999999999999999999987554332 2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   ...         ......+..
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~---------~~~~~~~~~  241 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNG---------TPELQNPEK  241 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHC---------SCCCSSGGG
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH---hCC---------CCCCCCccc
Confidence            34579999999999999999999999999999999999999997554332222111   110         011111233


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+.++.+++.+||+.||++|||+.|++++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            45678899999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=395.99  Aligned_cols=247  Identities=24%  Similarity=0.427  Sum_probs=204.6

Q ss_pred             hcccccceeEEEeEec---CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCCCC
Q 043017          511 RLGRGGSGSVFEGLLN---DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCNGS  586 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (818)
                      +||+|+||+||+|.+.   ++..||||++..... ...++|++|++++++++|||||+++|++.. +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999864   355799999975533 345789999999999999999999999865 56899999999999


Q ss_pred             hhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc--c
Q 043017          587 LDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV--S  664 (818)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~  664 (818)
                      |.+++...  ...+++..+..|+.|||+||+|||+.   +|+||||||+||||+.++.+||+|||+++.+.......  .
T Consensus        95 L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (285)
T d1u59a_          95 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  169 (285)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             HHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence            99988433  34689999999999999999999997   99999999999999999999999999999876543322  2


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....||+.|+|||++....++.++|||||||++|||+| |+.||.......+...+.   ...+        +   +.+.
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~---~~~~--------~---~~p~  235 (285)
T d1u59a_         170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QGKR--------M---ECPP  235 (285)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---TTCC--------C---CCCT
T ss_pred             cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCC--------C---CCCC
Confidence            23468999999999999999999999999999999998 899998766544433322   1110        1   1122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                      ..+.++.+|+.+||+.+|++||||.+|++.|+.+
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            3456788999999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=397.39  Aligned_cols=256  Identities=28%  Similarity=0.444  Sum_probs=203.3

Q ss_pred             hHHhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      .+.+.+.||+|+||.||+|+++++++||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            45566789999999999999998889999998644 4456889999999999999999999999865 567899999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|..++.... ...++|..+..|+.||++||+|||+.   +|+||||||+||||+.++++||+|||+++..........
T Consensus        96 g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          96 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             Cchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            99998885432 24589999999999999999999997   999999999999999999999999999998765544444


Q ss_pred             cCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CchHHHHHHHHhhhhcchhhccccCcCccCcH
Q 043017          665 TMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKG-GDYLVDTLKVKAEADRLCDLVDKKSEDMQSHR  743 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  743 (818)
                      ....||+.|+|||++..+.++.++|||||||++|||++|..|+.... ...+...+.   ...           ..+.+.
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~~~-----------~~~~~~  237 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGY-----------RMPCPP  237 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC-----------CCCCCT
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcC-----------CCCCCc
Confidence            45679999999999999999999999999999999999776654333 222222221   110           011123


Q ss_pred             HHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          744 DDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ..++++.+++.+||+.||++||+|++|+++|+.....
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            3456788999999999999999999999999886543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-47  Score=399.30  Aligned_cols=255  Identities=27%  Similarity=0.477  Sum_probs=199.7

Q ss_pred             HhhhhcccccceeEEEeEecCC-----cEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDG-----TKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      .+.+.||+|+||+||+|.++..     ..||||++..... ....+|++|++++++++|||||+++|++.+.+..++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            3456799999999999997642     4799999865433 335679999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+.+++|.+++....  ..+++..+.+++.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        90 ~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          90 YMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             CCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             ecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence            999999998875433  4689999999999999999999997   99999999999999999999999999998775443


Q ss_pred             Cc--cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCchHHHHHHHHhhhhcchhhccccCc
Q 043017          661 SH--VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPK-GGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       661 ~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|..|+... ....+...+.   ...           
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~---~~~-----------  230 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---DGF-----------  230 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTC-----------
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh---ccC-----------
Confidence            22  222346899999999999999999999999999999999976665433 2222222211   110           


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                      ..+.+...+.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            0111223456788999999999999999999999999987654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=393.98  Aligned_cols=250  Identities=25%  Similarity=0.315  Sum_probs=201.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            445578999999999999975 68999999986543 3345678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc-
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH-  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  662 (818)
                      +|+|.++|..   ...+++..+..++.||++||+|||+.   +|+||||||+|||+++++++||+|||+++........ 
T Consensus        87 gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          87 GGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             TEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999853   34699999999999999999999997   9999999999999999999999999999987654332 


Q ss_pred             cccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          663 VSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.............  ......          ...
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~--~~~~~~----------~~~  228 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKKTY----------LNP  228 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH--HTTCTT----------STT
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCC----------CCc
Confidence            2344679999999999988775 678999999999999999999997554322211111  111000          011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+.++.+++.+||+.||++|||++|++++
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         229 WKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            12234577789999999999999999999764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=391.94  Aligned_cols=244  Identities=24%  Similarity=0.365  Sum_probs=204.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +.+.+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            455678999999999999985 5889999998543   234467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        88 ~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          88 APLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             cCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            9999999999654   3589999999999999999999997   99999999999999999999999999998665432 


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+.   ...       ..     .
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~~-------~~-----~  223 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---RVE-------FT-----F  223 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TTC-------CC-----C
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH---cCC-------CC-----C
Confidence              223569999999999999999999999999999999999999997655433332221   110       00     1


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +...+.++.+++.+||+.||++|||++|++++
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            12234678899999999999999999999863

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=397.18  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=208.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      |++.++||+|+||+||+|+.. +++.||||++........+.|.+|++++++++|||||++++++.+.+..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            345568999999999999975 5889999999776666678899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      |+|.+++.+..  ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++++||+|||+++....... ..
T Consensus        94 g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~  167 (288)
T d2jfla1          94 GAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  167 (288)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence            99999886533  4699999999999999999999997   999999999999999999999999999986644322 12


Q ss_pred             cCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          665 TMPKGTPGYMAPELTR-----GNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+...            ..+..
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~------------~~~~~  235 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------------EPPTL  235 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS------------CCCCC
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------------CCCCC
Confidence            3357999999999984     456899999999999999999999999876655444332211            01111


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ..+...+.++.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1123445678899999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=394.20  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=193.5

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecc--cCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAE--RSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e  580 (818)
                      +++.+.||+|+||+||+|+.. +|+.||||.+....  ....+.|.+|++++++++|||||++++++.+  ....++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            445678999999999999875 68999999986553  2335678999999999999999999999865  446789999


Q ss_pred             ccCCCChhhHhhhc-CCccccchhhHHHHHHHHHHHHHHHHhcC--CCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          581 YMCNGSLDKWIFHK-DRIQTLSWDIRKKIIFQISRGLEYLHDYC--NPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       581 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      |+++|+|.+++... .....+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            99999999998643 22356999999999999999999999861  1249999999999999999999999999999875


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..    ...        .
T Consensus       166 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~----~~~--------~  232 (269)
T d2java1         166 HDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKF--------R  232 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----TCC--------C
T ss_pred             cCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc----CCC--------C
Confidence            54332 2345799999999999999999999999999999999999999986554433332221    111        0


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .  .+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       233 ~--~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 R--IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C--CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0  112334678899999999999999999999863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=402.98  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=206.3

Q ss_pred             hhHHhhhhcccccceeEEEeEecC------CcEEEEEEcCCC-CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLND------GTKVAVKRLYPG-ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.++||+|+||+||+|+...      ...||||++... .......|.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            345566789999999999998753      236999998654 334457899999999998 899999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcCC--------------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccC
Q 043017          576 FLVYEYMCNGSLDKWIFHKDR--------------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQ  635 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~  635 (818)
                      ++||||+++|+|.++|.....                    ...+++..+..|+.||++||+|||+.   +||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            999999999999999965421                    23589999999999999999999997   9999999999


Q ss_pred             eEEEcCCCCEEEeecCCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 043017          636 NILLDRDLNVKIADFGLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGD  713 (818)
Q Consensus       636 NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~  713 (818)
                      |||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998776554332 233468999999999999999999999999999999998 89999866554


Q ss_pred             hHHHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHh
Q 043017          714 YLVDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQ  775 (818)
Q Consensus       714 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  775 (818)
                      .....+.   ....       .   .+.+...+.++.+|+.+||+.||++||||+||+++|.
T Consensus       274 ~~~~~~~---~~~~-------~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ANFYKLI---QNGF-------K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHHHH---HTTC-------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHH---hcCC-------C---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3322221   1100       0   1112234567889999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=386.06  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=195.2

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecc----cCcceeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAE----RSNRFLVY  579 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~  579 (818)
                      .|.++||+|+||+||+|+.. +++.||+|.+....  ....+.|.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            35567999999999999975 58899999986442  3345679999999999999999999999865    34578999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc-CCCCEEEeecCCceeccc
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD-RDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~  658 (818)
                      ||+++|+|.+++...   ..+++..+..++.||++||+|||+. .++|+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999654   4589999999999999999999986 12399999999999996 578999999999986433


Q ss_pred             CCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      ..   .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.........  .........          .
T Consensus       168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~~i~~~~~----------~  231 (270)
T d1t4ha_         168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVK----------P  231 (270)
T ss_dssp             TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTTTCC----------C
T ss_pred             Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HHHHHcCCC----------C
Confidence            22   233579999999999875 5999999999999999999999999754432211  111111100          0


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .........++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            00111233568899999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=399.90  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=202.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.+.++||+|+||+||+|+.. +|+.||||++.... ....+++.+|+.+|++++|||||+++++|.+..+.++||||++
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~   87 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   87 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            444568999999999999975 68999999986543 3335689999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHh-cCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHD-YCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      +|+|.+++.+.   ..+++..+..++.||++||.|||+ +   +|+||||||+||||+.++++||+|||+|+......  
T Consensus        88 gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  159 (322)
T d1s9ja_          88 GGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  159 (322)
T ss_dssp             TEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred             CCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence            99999999654   358999999999999999999996 4   89999999999999999999999999998765432  


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhh----------------
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEAD----------------  726 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~----------------  726 (818)
                       .....||+.|+|||++.+..++.++||||+||++|||++|+.||...................                
T Consensus       160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence             223579999999999999999999999999999999999999997654432211100000000                


Q ss_pred             ----------c----chhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 ----------R----LCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ----------~----~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                                .    .........+..+ ....+.++.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                      0    0000000000000 11234678899999999999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-45  Score=392.37  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=208.7

Q ss_pred             HHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGENR-GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +++.++||+|+||+||+|++.      +++.||||++...... ..++|.+|++++++++||||++++++|......+++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            445568999999999999864      3578999999755433 356799999999999999999999999999999999


Q ss_pred             eeccCCCChhhHhhhcC---------------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeE
Q 043017          579 YEYMCNGSLDKWIFHKD---------------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNI  637 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NI  637 (818)
                      |||+++|+|.++|....                     ....+++..+..|+.|+++||+|||+.   +||||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence            99999999999996432                     123488999999999999999999997   999999999999


Q ss_pred             EEcCCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCchH
Q 043017          638 LLDRDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR-RSSNPKGGDYL  715 (818)
Q Consensus       638 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~l  715 (818)
                      ||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. .|+.......+
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence            999999999999999987654432 2233456889999999999999999999999999999999986 56665544443


Q ss_pred             HHHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          716 VDTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       716 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ...+.   .. ..       .   +.+...+.++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus       252 ~~~v~---~~-~~-------~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         252 IYYVR---DG-NI-------L---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHHH---TT-CC-------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHH---cC-CC-------C---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            33322   11 11       0   1122334578899999999999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=388.98  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=198.9

Q ss_pred             hHHhhhhcccccceeEEEeEecC----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      .+++.+.||+|+||.||+|++..    +..||||.+..... ...+.|.+|++++++++|||||+++|++. .+..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence            45566789999999999998753    45799999865433 33567999999999999999999999996 46789999


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+++|+|.+++...  ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        87 E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          87 ELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             ECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            999999999987543  24689999999999999999999997   9999999999999999999999999999987655


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                      .........||+.|+|||.+.+..++.++|||||||++|||++ |+.|+.......+...+..   ..+        .  
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~---~~~--------~--  228 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GER--------L--  228 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCC--------C--
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCC--------C--
Confidence            5544555678999999999999999999999999999999998 8899887766555444321   110        0  


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                       +.+...+.++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       229 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         229 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             1122345678899999999999999999999999988754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=389.90  Aligned_cols=247  Identities=22%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +++.+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            556678999999999999975 6899999998643   234467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus        90 ~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          90 AKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999988654   3589999999999999999999997   999999999999999999999999999998764432


Q ss_pred             -ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          662 -HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       662 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+.   ..         ..   .
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~---~~---------~~---~  228 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII---KL---------EY---D  228 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---TT---------CC---C
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH---cC---------CC---C
Confidence             23334579999999999999999999999999999999999999998654433332221   11         00   0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .+...+.++.+|+.+||+.||++|||++|+++.
T Consensus       229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            112234578899999999999999999997654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.2e-45  Score=394.89  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=209.1

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            4566778999999999999975 689999999977666667789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC--CCCEEEeecCCceecccCCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR--DLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +|+|.+++...  ...+++..+..|+.||+.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++.+.....
T Consensus       107 gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         107 GGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             SCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            99999988533  24699999999999999999999998   9999999999999954  57899999999998765433


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      .  ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....          ... ...
T Consensus       182 ~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----------~~~-~~~  248 (350)
T d1koaa2         182 V--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------NMD-DSA  248 (350)
T ss_dssp             E--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------CSC-CGG
T ss_pred             c--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------CCC-ccc
Confidence            2  234699999999999999999999999999999999999999976654443333321100          000 011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ....+.++.+|+.+||+.||++|||++|++++
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12334678899999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=384.27  Aligned_cols=248  Identities=27%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc-CcceeeeeccCCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER-SNRFLVYEYMCNG  585 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~g  585 (818)
                      .|.+.||+|+||.||+|+++ |++||||+++..  ...++|.+|++++++++||||++++|+|.+. +..++||||+++|
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence            45578999999999999986 789999999643  3467899999999999999999999998654 5689999999999


Q ss_pred             ChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcccc
Q 043017          586 SLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVST  665 (818)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  665 (818)
                      +|.++|... ....+++..+++|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......    .
T Consensus        87 ~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~  158 (262)
T d1byga_          87 SLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D  158 (262)
T ss_dssp             EHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC----c
Confidence            999999643 224589999999999999999999997   99999999999999999999999999998754432    2


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCcHH
Q 043017          666 MPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSHRD  744 (818)
Q Consensus       666 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  744 (818)
                      ...++..|+|||++.+..++.++||||||+++|||+| |+.|+.......+...+...         .  .+   +.+..
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~---------~--~~---~~~~~  224 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------Y--KM---DAPDG  224 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------C--CC---CCCTT
T ss_pred             cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------C--CC---CCCcc
Confidence            2357889999999999999999999999999999998 67777766555554443211         0  00   11223


Q ss_pred             HHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          745 DAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ...++.+|+.+||+.||.+||||.+++++|+.++.
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            34678899999999999999999999999988753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-45  Score=389.10  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=190.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++|||||++++++.+++..++||||+
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~   89 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV   89 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            3566678999999999999975 58999999986543 233467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc---CCCCEEEeecCCceecccC
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~  659 (818)
                      ++|+|.++|...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||+.   +++.+||+|||+++.....
T Consensus        90 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          90 SGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             CCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999543   4699999999999999999999997   999999999999994   5789999999999876543


Q ss_pred             CCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCc
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDM  739 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  739 (818)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   ..     ...   ..
T Consensus       164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~~-----~~~---~~  230 (307)
T d1a06a_         164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK---AE-----YEF---DS  230 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT---TC-----CCC---CT
T ss_pred             Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc---cC-----CCC---CC
Confidence            22  2335699999999999999999999999999999999999999976554333332221   10     000   00


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          740 QSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      +.....+.++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1122345678899999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-44  Score=391.95  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=210.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      |++.++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            556678999999999999974 6999999998766555567889999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc--CCCCEEEeecCCceecccCCCc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD--RDLNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~~~  662 (818)
                      |+|.+++...  ...+++.++..|+.||++||+|||+.   +|+||||||+||||+  .++.+||+|||+++.+......
T Consensus       111 g~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         111 GELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             CBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             ChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            9998877432  34699999999999999999999997   999999999999997  5789999999999987654332


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....        .  ... ....
T Consensus       186 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------~--~~~-~~~~  252 (352)
T d1koba_         186 --KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--------W--EFD-EDAF  252 (352)
T ss_dssp             --EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--------C--CCC-SSTT
T ss_pred             --eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------C--CCC-cccc
Confidence              33468999999999999999999999999999999999999997665444333322110        0  000 0111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcC
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGL  777 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i  777 (818)
                      ...+.++.+|+.+||+.||.+|||+.|++++  +++.
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            2345678899999999999999999999986  5443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-45  Score=387.77  Aligned_cols=244  Identities=25%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +...++||+|+||+||+|+.. +++.||||++.....   ...+.|.+|++++++++|||||++++++.+.+..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            344567999999999999964 688999999865533   2345789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|..++...   ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.....  
T Consensus        97 ~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          97 CLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             CSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             cCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            9999998766443   4689999999999999999999997   9999999999999999999999999999865432  


Q ss_pred             ccccCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcC
Q 043017          662 HVSTMPKGTPGYMAPELTRG---NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSED  738 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  738 (818)
                         ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||...........+   ....      .+... 
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i---~~~~------~~~~~-  235 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNE------SPALQ-  235 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSC------CCCCS-
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---HhCC------CCCCC-
Confidence               23469999999999864   45899999999999999999999999755432222111   1110      00111 


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          739 MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                         ....+.++.+++.+||+.||++|||+.|++++
T Consensus       236 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence               12234678899999999999999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=381.99  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=205.3

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC------CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE------NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .|++.++||+|+||+||+|+.. +|+.||||++....      ....+.|.+|++++++++|||||++++++.+.+..++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3556678999999999999974 68999999985432      1235789999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC----CEEEeecCCc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL----NVKIADFGLA  653 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla  653 (818)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        91 v~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          91 ILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999654   3599999999999999999999998   999999999999998776    5999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD  733 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d  733 (818)
                      +.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..   ..       
T Consensus       165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~~-------  232 (293)
T d1jksa_         165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA---VN-------  232 (293)
T ss_dssp             EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---TC-------
T ss_pred             hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh---cC-------
Confidence            88754433  2334689999999999999999999999999999999999999986654433332221   10       


Q ss_pred             ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .... .......+.++.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 YEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 00011234578899999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=385.68  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             HhhhhcccccceeEEEeEecCC----cEEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecc-cCcceeeee
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDG----TKVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE-RSNRFLVYE  580 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g----~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e  580 (818)
                      +|.++||+|+||+||+|++.++    ..||||++... .....++|.+|++++++++||||++++|++.. +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4566899999999999997542    35899999754 33445789999999999999999999999875 457899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...  ...+++..+..++.|+++||.|||+.   +|+||||||+||||++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999999988543  34677888999999999999999997   99999999999999999999999999999876543


Q ss_pred             Cc---cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-chHHHHHHHHhhhhcchhhccccC
Q 043017          661 SH---VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGG-DYLVDTLKVKAEADRLCDLVDKKS  736 (818)
Q Consensus       661 ~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~~  736 (818)
                      ..   ......||+.|+|||.+....++.++||||||+++|||++|+.|+..... ..+...+.   ...+        +
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~---~g~~--------~  253 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRR--------L  253 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH---TTCC--------C
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCC--------C
Confidence            22   22235689999999999999999999999999999999998888764322 11222211   1111        1


Q ss_pred             cCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          737 EDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       737 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      .   .+.....++.+++.+||+.||++||+|.||+++|+++.+.-.
T Consensus       254 ~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         254 L---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             C---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence            1   122334678899999999999999999999999999976533

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=387.07  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=204.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCc----EEEEEEcCCC-CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGT----KVAVKRLYPG-ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (818)
                      +++.++||+|+||+||+|.+. +|+    +||||++... ..+..++|++|++++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            445578999999999999875 343    6999998654 445578899999999999999999999999864 567889


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      ||+.+|+|.+++...  ...+++..+.+|+.|||+||+|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus        90 e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          90 QLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             ECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            999999999988654  35689999999999999999999997   9999999999999999999999999999987654


Q ss_pred             CCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          660 QSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       660 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      .... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......+...+...   .        .+ 
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~---~--------~~-  232 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---E--------RL-  232 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---C--------CC-
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---C--------CC-
Confidence            4332 233468999999999999999999999999999999998 78888776655544433211   0        01 


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                        +.+...+.++.+|+.+||+.||++|||+.|++++|+.+.+
T Consensus       233 --~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence              1122345678899999999999999999999999987653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=387.24  Aligned_cols=260  Identities=30%  Similarity=0.390  Sum_probs=197.4

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcc-CcceeEEEeeeeccc-Cc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNI-HHFNLVRLVGYCAER-SN  574 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~-~~  574 (818)
                      ..+.+.++||+|+||.||+|...      +++.||||++.... ....+++.+|...+.++ +|+||+.+++++.+. ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            34556678999999999999864      35689999997543 33456788888888877 799999999998665 46


Q ss_pred             ceeeeeccCCCChhhHhhhcCC-------------ccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDR-------------IQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      .++||||+++|+|.++|.....             ...+++..+..++.||++||+|||+.   +|+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            8999999999999999965321             24589999999999999999999997   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCchHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR-RSSNPKGGDYLVDTL  719 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~l~~~~  719 (818)
                      ++++||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .||............
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999876554332 233457999999999999999999999999999999999975 567654433222111


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      ..  ...+        +   ..+...+.++.+++.+||+.||++||||.|++++|+.+.+
T Consensus       250 ~~--~~~~--------~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         250 LK--EGTR--------M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HH--HTCC--------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hh--cCCC--------C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11  1100        0   1122334578899999999999999999999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=379.10  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=196.7

Q ss_pred             HHhhhhcccccceeEEEeEecC----CcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND----GTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +++.++||+|+||.||+|++..    ...||||++...   .....++|.+|+.++++++||||++++|++.+ ...++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence            3455689999999999998642    237899998654   23345789999999999999999999999976 467899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.+++...  ...+++..+..++.|||+||.|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          89 TELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            9999999999987543  24699999999999999999999997   999999999999999999999999999998765


Q ss_pred             CCCcc--ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          659 DQSHV--STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       659 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||+| |+.||...........+.   ....        
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~---~~~~--------  232 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---KEGE--------  232 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TSCC--------
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH---hCCC--------
Confidence            43322  233467889999999999999999999999999999998 899997665444333322   1110        


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcC
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGL  777 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i  777 (818)
                        ..+.+...+.++.+++.+||+.||++||||.||++.|++.
T Consensus       233 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 --RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              0111223346788999999999999999999999999764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=382.38  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             hhhhcccccceeEEEeEecCCcEEEEEEcCCCCCccHHHHHH--HHHHHhccCcceeEEEeeeecccC----cceeeeec
Q 043017          508 FQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLS--EVETIGNIHHFNLVRLVGYCAERS----NRFLVYEY  581 (818)
Q Consensus       508 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~--Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~  581 (818)
                      +.++||+|+||.||+|+++ |+.||||++...   ..+++..  |+..+.+++|||||+++++|.+.+    ..++||||
T Consensus         7 l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            4567999999999999975 899999998643   2334444  555556789999999999998654    57899999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhc-----CCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDY-----CNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +++|+|.++|..    ..++|+.+.+++.|+|.||+|||+.     .+++|+||||||+||||+.++++||+|||+++..
T Consensus        83 ~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999954    3589999999999999999999973     2469999999999999999999999999999987


Q ss_pred             ccCCCcc---ccCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCc-----------hHH
Q 043017          657 AQDQSHV---STMPKGTPGYMAPELTRGNS------ITAKIDIYSFGVVILEIICGRRSSNPKGGD-----------YLV  716 (818)
Q Consensus       657 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~s~ksDVwS~Gvll~elltG~~p~~~~~~~-----------~l~  716 (818)
                      .......   .....||+.|+|||++....      ++.++|||||||+||||+||..|+......           ...
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            6544322   23457999999999987643      577999999999999999998876532211           111


Q ss_pred             HHHHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCCC
Q 043017          717 DTLKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEPV  783 (818)
Q Consensus       717 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  783 (818)
                      ..+.......    ..++..+......+....+.+++.+||+.||++||||.||++.|+++.+.+.+
T Consensus       239 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             HHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            2222111111    11122222222345667799999999999999999999999999988765443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=384.62  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=204.3

Q ss_pred             HHhhhhcccccceeEEEeEecC-Cc--EEEEEEcCCC-CCccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLND-GT--KVAVKRLYPG-ENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +++.++||+|+||.||+|++.+ +.  .||||++... .....++|.+|+++|+++ +|||||+++|+|.+++..++|||
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e   91 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   91 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence            3455789999999999999864 43  5788887544 344567899999999999 79999999999999999999999


Q ss_pred             ccCCCChhhHhhhc-------------CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEE
Q 043017          581 YMCNGSLDKWIFHK-------------DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKI  647 (818)
Q Consensus       581 ~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl  647 (818)
                      |+++|+|.++|+..             .....+++..+.+++.|||+||.|||+.   +|+||||||+|||++.++.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence            99999999999643             2345689999999999999999999997   9999999999999999999999


Q ss_pred             eecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCchHHHHHHHHhhhh
Q 043017          648 ADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRR-SSNPKGGDYLVDTLKVKAEAD  726 (818)
Q Consensus       648 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~-p~~~~~~~~l~~~~~~~~~~~  726 (818)
                      +|||+++........  ....||..|+|||.+....++.++|||||||++|||++|.. |+.......+...+.   ...
T Consensus       169 ~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~---~~~  243 (309)
T d1fvra_         169 ADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---QGY  243 (309)
T ss_dssp             CCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---GTC
T ss_pred             ccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH---hcC
Confidence            999999865443222  22458999999999999999999999999999999999765 565544333322221   110


Q ss_pred             cchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCC
Q 043017          727 RLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKL  780 (818)
Q Consensus       727 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~  780 (818)
                              .+   +.+...+.++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus       244 --------~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         244 --------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             --------CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --------CC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                    11   11223456788999999999999999999999999988654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-44  Score=381.98  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=209.4

Q ss_pred             hHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhccCcceeEEEeeeecccCccee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGE-NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFL  577 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  577 (818)
                      .+.+.++||+|+||+||+|.+.      +++.||||+++... ......|.+|++++++++|||||+++|+|......++
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  100 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  100 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence            3345578999999999999874      35789999997543 3334578999999999999999999999999999999


Q ss_pred             eeeccCCCChhhHhhhc-------CCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeec
Q 043017          578 VYEYMCNGSLDKWIFHK-------DRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF  650 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  650 (818)
                      ||||+++|+|.+++...       .....+++..+.+++.|+|+||.|||+.   +|+||||||+|||++.++++||+||
T Consensus       101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_         101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence            99999999999998643       1223578899999999999999999997   9999999999999999999999999


Q ss_pred             CCceecccCCCcc-ccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCchHHHHHHHHhhhhcc
Q 043017          651 GLARLIAQDQSHV-STMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGR-RSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       651 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      |+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++|+ .|+...........+.   ... .
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~---~~~-~  253 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM---EGG-L  253 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH---TTC-C
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hCC-C
Confidence            9998775543322 33346899999999999999999999999999999999985 6665544333332221   111 0


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                                .+.+...+..+.+++.+||+.+|++||||.+|+++|++..+
T Consensus       254 ----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         254 ----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                      11122344679999999999999999999999999987755

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=380.95  Aligned_cols=258  Identities=29%  Similarity=0.404  Sum_probs=205.6

Q ss_pred             hHHhhhhcccccceeEEEeEecC--------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLND--------GTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSN  574 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  574 (818)
                      .+.+.+.||+|+||.||+|+...        +..||||++..... ....++.+|+..+.++ +|||||+++++|.++..
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            44456789999999999998642        34799999976543 3457889999999888 89999999999999999


Q ss_pred             ceeeeeccCCCChhhHhhhcC-------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC
Q 043017          575 RFLVYEYMCNGSLDKWIFHKD-------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR  641 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~  641 (818)
                      .++||||+++|+|.++|....             ....+++..+..++.||+.||+|||+.   +||||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence            999999999999999996442             124589999999999999999999998   9999999999999999


Q ss_pred             CCCEEEeecCCceecccCCCc-cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHHH
Q 043017          642 DLNVKIADFGLARLIAQDQSH-VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDTL  719 (818)
Q Consensus       642 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~~  719 (818)
                      ++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |+.||.......+...+
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i  250 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  250 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            999999999999987654333 2334568999999999999999999999999999999998 67787655443333222


Q ss_pred             HHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          720 KVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       720 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .   ...+        +   +.+...+.++.+|+.+||+.||++||||.||++.|+++..
T Consensus       251 ~---~~~~--------~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         251 K---EGHR--------M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             H---TTCC--------C---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---cCCC--------C---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1   1110        1   1122334678899999999999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=381.66  Aligned_cols=246  Identities=25%  Similarity=0.333  Sum_probs=206.0

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +++.+.||+|+||.||+++.. +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            445678999999999999974 6899999998643   234467889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|.+++...   ..++++.+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          87 ANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             CTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999998654   3588999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                      . .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+...+...+..   . .        .   ..
T Consensus       161 ~-~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~---~-~--------~---~~  224 (337)
T d1o6la_         161 T-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---E-E--------I---RF  224 (337)
T ss_dssp             C-BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C-C--------C---CC
T ss_pred             c-cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc---C-C--------C---CC
Confidence            2 2345799999999999999999999999999999999999999987654443332221   0 0        0   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                      +...+.++.+|+.+||+.||.+||+     +.|++++
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            2233456789999999999999994     8888875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-44  Score=382.10  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=209.6

Q ss_pred             hhHHhhhhcccccceeEEEeEec------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcc-CcceeEEEeeeecccCcc
Q 043017          504 ATRDFQIRLGRGGSGSVFEGLLN------DGTKVAVKRLYPGEN-RGKKEFLSEVETIGNI-HHFNLVRLVGYCAERSNR  575 (818)
Q Consensus       504 ~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  575 (818)
                      ..+.+.++||+|+||.||+|++.      +++.||||++..... ....+|.+|+.++.++ +|||||+++|+|.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            34556678999999999999852      467899999976543 3456799999999999 699999999999999999


Q ss_pred             eeeeeccCCCChhhHhhhcC---------------CccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc
Q 043017          576 FLVYEYMCNGSLDKWIFHKD---------------RIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD  640 (818)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~  640 (818)
                      ++||||+++|+|.+++....               ....+++..+..++.||++||+|||++   +++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            99999999999999996532               123588999999999999999999998   999999999999999


Q ss_pred             CCCCEEEeecCCceecccCCC-ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCchHHHH
Q 043017          641 RDLNVKIADFGLARLIAQDQS-HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIIC-GRRSSNPKGGDYLVDT  718 (818)
Q Consensus       641 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~l~~~  718 (818)
                      .++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |++|+........+..
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999998765433 33344578999999999999999999999999999999999 5555554444332222


Q ss_pred             HHHHhhhhcchhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          719 LKVKAEADRLCDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       719 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      +..   .+.       ..   ..+...+.++.+|+.+||+.||++||||+||+++|+++..
T Consensus       260 ~i~---~~~-------~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         260 MIK---EGF-------RM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHH---HTC-------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHh---cCC-------CC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            111   100       00   1122344678899999999999999999999999987643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-43  Score=377.14  Aligned_cols=243  Identities=24%  Similarity=0.332  Sum_probs=203.4

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +++.++||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            445578999999999999974 5899999998643   234467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +++|+|..++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.....  
T Consensus        86 ~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          86 IEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             cCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999988654   3578888999999999999999997   9999999999999999999999999999876543  


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   ..         .   ..
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~---------~---~~  220 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---AE---------L---RF  220 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---CC---------C---CC
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc---CC---------C---CC
Confidence              2345799999999999999999999999999999999999999986554333332211   10         0   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      +...+.++.+++.+||+.||.+||     |+++++++
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            122345688999999999999996     89999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.2e-43  Score=369.62  Aligned_cols=256  Identities=24%  Similarity=0.341  Sum_probs=199.8

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhccCcceeEEEeeeecccCc----cee
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN---RGKKEFLSEVETIGNIHHFNLVRLVGYCAERSN----RFL  577 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~----~~l  577 (818)
                      |.+.+.||+|+||+||+|.. .+|+.||||.+.....   ...+.|.+|++++++++||||+++++++...+.    .++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            45667899999999999996 4689999999975433   234578999999999999999999999876543    789


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+++++|.+++...   ..+++.++..++.||++||+|||+.   +|+||||||+|||++.++..+|+|||.+....
T Consensus        89 vmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence            99999999999988554   3589999999999999999999997   99999999999999999999999999998664


Q ss_pred             cCCC--ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcccc
Q 043017          658 QDQS--HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKK  735 (818)
Q Consensus       658 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  735 (818)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||............   ......       
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~---~~~~~~-------  232 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH---VREDPI-------  232 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHCCCC-------
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH---HhcCCC-------
Confidence            4322  2233457999999999999999999999999999999999999999765433322211   111100       


Q ss_pred             CcCccCcHHHHHHHHHHHHHccccCCCCCC-cHHHHHHHHhcCc
Q 043017          736 SEDMQSHRDDAVKMIQIAISCLQKNLHRRP-SASMLVKVLQGLT  778 (818)
Q Consensus       736 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~  778 (818)
                       .........+.++.+++.+||+.||++|| |++++++.|.++.
T Consensus       233 -~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 -PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence             00001123346788999999999999999 8999999887653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.7e-43  Score=367.20  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCc---------cHHHHHHHHHHHhccC-cceeEEEeeeecccCc
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR---------GKKEFLSEVETIGNIH-HFNLVRLVGYCAERSN  574 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---------~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~  574 (818)
                      +++.+.||+|+||+||+++.. +++.||||++......         ..+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            445678999999999999974 6899999998654321         1246889999999996 9999999999999999


Q ss_pred             ceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCce
Q 043017          575 RFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLAR  654 (818)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  654 (818)
                      .+|||||+++|+|.++|...   ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999654   3589999999999999999999997   99999999999999999999999999999


Q ss_pred             ecccCCCccccCCCCCCcccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcc
Q 043017          655 LIAQDQSHVSTMPKGTPGYMAPELTRG------NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRL  728 (818)
Q Consensus       655 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~  728 (818)
                      .+.....  .....||+.|+|||.+.+      ..++.++||||+||++|||++|+.||...........+..   .. .
T Consensus       159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~---~~-~  232 (277)
T d1phka_         159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS---GN-Y  232 (277)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TC-C
T ss_pred             EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh---CC-C
Confidence            8765432  233569999999999853      3468899999999999999999999986654333322221   10 0


Q ss_pred             hhhccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          729 CDLVDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       729 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          ....   +.....+.++.+++.+||+.||++|||+.|++++
T Consensus       233 ----~~~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         233 ----QFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ----CCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ----CCCC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                0001   1122345678899999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=370.08  Aligned_cols=257  Identities=23%  Similarity=0.270  Sum_probs=197.7

Q ss_pred             hhcccccceeEEEeEec-CCcEEEEEEcCCCCCc-----cHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENR-----GKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      +.||+|+||+||+|+.. +|+.||||++......     ..+.+++|+.++++++|||||++++++..++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            46999999999999975 5899999998654321     13568999999999999999999999999999999999998


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ++++..++.   ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          84 TDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             EEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             chHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            887766552   235689999999999999999999997   9999999999999999999999999999876554332 


Q ss_pred             ccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhcc---------
Q 043017          664 STMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVD---------  733 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d---------  733 (818)
                      .....||+.|+|||++... .++.++|||||||++|||++|+.||...........+......+......+         
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            2335699999999998654 579999999999999999999999986655443333322211110000000         


Q ss_pred             -ccCcCcc---CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 -KKSEDMQ---SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 -~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                       ......+   .......++.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence             0000000   011234678899999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=371.86  Aligned_cols=249  Identities=18%  Similarity=0.295  Sum_probs=203.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      |.+.++||+|+||+||+|+.. +++.||||.+.... .....+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            455678999999999999975 58899999996543 3345688999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC--CCEEEeecCCceecccCCCc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD--LNVKIADFGLARLIAQDQSH  662 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~~~  662 (818)
                      |+|.+++...  ...+++.++..|+.||++||+|||+.   +|+||||||+|||++.+  ..+||+|||+++....... 
T Consensus        86 g~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-  159 (321)
T d1tkia_          86 LDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence            9999999533  23689999999999999999999997   99999999999999854  5799999999987654332 


Q ss_pred             cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccCc
Q 043017          663 VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQSH  742 (818)
Q Consensus       663 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  742 (818)
                       .....+++.|+|||.+.+..++.++||||+||++|||++|+.||...........+.....  ..        . ....
T Consensus       160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~--------~-~~~~  227 (321)
T d1tkia_         160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY--TF--------D-EEAF  227 (321)
T ss_dssp             -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CC--------C-HHHH
T ss_pred             -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CC--------C-hhhc
Confidence             2234589999999999999999999999999999999999999986654443333321100  00        0 0001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          743 RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...+.++.+++.+||+.||++|||+.|++++
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1234568899999999999999999999984

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-42  Score=376.60  Aligned_cols=243  Identities=23%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeec
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      +++.++||+|+||.||+|+.. +|+.||||++...   .....+.+++|+++|++++|||||++++++......++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            444568999999999999975 6999999998542   234457789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCC
Q 043017          582 MCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQS  661 (818)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  661 (818)
                      +.+|+|..++....   .+++..+..++.||+.||.|||+.   +||||||||+||||+.++++||+|||+++.....  
T Consensus       123 ~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         123 VAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999999986543   589999999999999999999997   9999999999999999999999999999976542  


Q ss_pred             ccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCccC
Q 043017          662 HVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQS  741 (818)
Q Consensus       662 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  741 (818)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+..   .         ..   ..
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~---------~~---~~  257 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---G---------KV---RF  257 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C---------CC---CC
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc---C---------CC---CC
Confidence              2235699999999999999999999999999999999999999976544333332221   1         00   01


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          742 HRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       742 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                      +...+.++.+++.+||+.||.+|+     |+++++++
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            123446788999999999999994     89999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-42  Score=377.00  Aligned_cols=247  Identities=22%  Similarity=0.285  Sum_probs=198.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHH---HHHHhccCcceeEEEeeeecccCcceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSE---VETIGNIHHFNLVRLVGYCAERSNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E---v~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (818)
                      +++.+.||+|+||.||+|+.. +|+.||||++...   .......+.+|   +++++.++|||||++++++.+.+..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            445578999999999999975 5899999998532   12223344444   6777788899999999999999999999


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceeccc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQ  658 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  658 (818)
                      |||+++|+|.++|...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        86 mE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             ECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999654   3578899999999999999999997   999999999999999999999999999997755


Q ss_pred             CCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCc
Q 043017          659 DQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSE  737 (818)
Q Consensus       659 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  737 (818)
                      ..   .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.................         ....
T Consensus       160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------~~~~  227 (364)
T d1omwa3         160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------MAVE  227 (364)
T ss_dssp             SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS---------CCCC
T ss_pred             Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------CCCC
Confidence            42   233569999999999975 4689999999999999999999999986654433322211110         0110


Q ss_pred             CccCcHHHHHHHHHHHHHccccCCCCCCc-----HHHHHHH
Q 043017          738 DMQSHRDDAVKMIQIAISCLQKNLHRRPS-----ASMLVKV  773 (818)
Q Consensus       738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  773 (818)
                         .+...+.++.+++.+||+.||++|||     ++|++++
T Consensus       228 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         228 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ---CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ---CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence               11223467889999999999999999     6888864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-43  Score=374.66  Aligned_cols=245  Identities=24%  Similarity=0.345  Sum_probs=202.3

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC---CCccHHHHHHHHHHHh-ccCcceeEEEeeeecccCcceeeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG---ENRGKKEFLSEVETIG-NIHHFNLVRLVGYCAERSNRFLVYE  580 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~-~l~H~niv~l~g~~~~~~~~~lV~e  580 (818)
                      +++.++||+|+||+||+|+.. +++.||||++...   .....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            456678999999999999975 5899999998643   2344566777777765 6899999999999999999999999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  660 (818)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus        84 y~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          84 YLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             ecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999654   3588999999999999999999997   99999999999999999999999999998765433


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+...+...  .        .     .
T Consensus       158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~--------~-----~  221 (320)
T d1xjda_         158 AK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N--------P-----F  221 (320)
T ss_dssp             CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--------C-----C
T ss_pred             cc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------C-----C
Confidence            32 33457999999999999999999999999999999999999999876554443333210  0        0     0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHH-HHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSAS-MLVK  772 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~  772 (818)
                      .+...+.++.+|+.+||+.||++||++. ++++
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1122346688999999999999999995 7764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-42  Score=370.61  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=195.3

Q ss_pred             hhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhcc-CcceeEEEeeeecc----cCcceeeeeccC
Q 043017          510 IRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNI-HHFNLVRLVGYCAE----RSNRFLVYEYMC  583 (818)
Q Consensus       510 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~  583 (818)
                      +.||+|+||.||+|+. .+++.||||++..     ...+.+|+.++.++ +|||||++++++.+    ....++||||++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~   92 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   92 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence            3599999999999996 4689999999853     35678899987655 89999999999865    456899999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC---CCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR---DLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~  660 (818)
                      +|+|.++|.... ...+++..+..|+.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus        93 gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          93 GGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             SEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence            999999996432 24699999999999999999999997   9999999999999975   5679999999999776543


Q ss_pred             CccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccccCcCcc
Q 043017          661 SHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDKKSEDMQ  740 (818)
Q Consensus       661 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  740 (818)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+........    .  ..+ .+
T Consensus       169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~----~--~~~-~~  239 (335)
T d2ozaa1         169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----Y--EFP-NP  239 (335)
T ss_dssp             C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS----S--SCC-TT
T ss_pred             c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC----C--CCC-Cc
Confidence            3  2345799999999999999999999999999999999999999976654433332221111000    0  000 01


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          741 SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....+.++.+|+.+||+.||++|||+.|++++
T Consensus       240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            122445788999999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-42  Score=363.80  Aligned_cols=265  Identities=22%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             HhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      .+.++||+|+||+||+|+. .+|+.||||++....  ....+++.+|++++++++|||||++++++.++...++||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            3446899999999999997 468999999986543  2345789999999999999999999999999999999999996


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      ++ +..++... ....+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|||+++........ 
T Consensus        85 ~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-  158 (298)
T d1gz8a_          85 QD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  158 (298)
T ss_dssp             EE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred             Cc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence            54 44444332 335699999999999999999999997   9999999999999999999999999999876543332 


Q ss_pred             ccCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc------chhhcc--c
Q 043017          664 STMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR------LCDLVD--K  734 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~------~~~~~d--~  734 (818)
                      .....||+.|+|||.+.... .+.++|||||||++|||++|+.||...........+......+.      .....+  .
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            23346999999999887665 58899999999999999999999986654333222221111100      000000  0


Q ss_pred             cCcCc-c-----CcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcC
Q 043017          735 KSEDM-Q-----SHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGL  777 (818)
Q Consensus       735 ~~~~~-~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i  777 (818)
                      ..... .     .....+.++.+++.+||+.||++|||+.|++++  |+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00000 0     011234678899999999999999999999987  5544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-41  Score=359.78  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=199.6

Q ss_pred             HhhhhcccccceeEEEeEecCCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccCC
Q 043017          507 DFQIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMCN  584 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (818)
                      ++.++||+|+||+||+|+.++|+.||||++....  ....+.+.+|+.+|++++||||+++++++...+..+++||++.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            3456899999999999999999999999986543  33357899999999999999999999999999999999999987


Q ss_pred             CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCccc
Q 043017          585 GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHVS  664 (818)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  664 (818)
                      +.+..+..   ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......... .
T Consensus        85 ~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~  157 (286)
T d1ob3a_          85 DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y  157 (286)
T ss_dssp             EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc-c
Confidence            77666553   235699999999999999999999997   9999999999999999999999999999876543322 2


Q ss_pred             cCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---c---hhh------
Q 043017          665 TMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---L---CDL------  731 (818)
Q Consensus       665 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---~---~~~------  731 (818)
                      ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+........   .   ...      
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            234589999999998754 579999999999999999999999986654333332222111100   0   000      


Q ss_pred             ccc--cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          732 VDK--KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       732 ~d~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      ...  .............++.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  000001112234678899999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-41  Score=360.56  Aligned_cols=266  Identities=26%  Similarity=0.304  Sum_probs=198.6

Q ss_pred             HHhhhhcccccceeEEEeEec-C-CcEEEEEEcCCC--CCccHHHHHHHHHHHhcc---CcceeEEEeeeecc-----cC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-D-GTKVAVKRLYPG--ENRGKKEFLSEVETIGNI---HHFNLVRLVGYCAE-----RS  573 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~-----~~  573 (818)
                      |++.++||+|+||+||+|+.. + ++.||||++...  .......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            445568999999999999963 3 667999998543  222344566787777666   79999999999853     34


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..+++|||+.++.+.....  .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             eEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence            6799999998887654442  2335688999999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh--
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL--  731 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~--  731 (818)
                      +......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+......+.....  
T Consensus       164 ~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         164 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            8654432  233457999999999999999999999999999999999999999876544433333222111000000  


Q ss_pred             --------cccc--CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCc
Q 043017          732 --------VDKK--SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLT  778 (818)
Q Consensus       732 --------~d~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~  778 (818)
                              ....  .............+.+|+.+||+.||++|||+.|++++  |+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                    0000  00000112234567889999999999999999999986  55443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=354.70  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=192.6

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC------ccHHHHHHHHHHHhccC--cceeEEEeeeecccCcc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN------RGKKEFLSEVETIGNIH--HFNLVRLVGYCAERSNR  575 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~  575 (818)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++.....      ....++.+|+.++++++  |||||++++++.+.+..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            3456678999999999999975 689999999864321      12244678999999986  99999999999999999


Q ss_pred             eeeeeccCC-CChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCC-CCEEEeecCCc
Q 043017          576 FLVYEYMCN-GSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRD-LNVKIADFGLA  653 (818)
Q Consensus       576 ~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla  653 (818)
                      ++||||+.+ +++.+++...   ..++++.+..++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||++
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence            999999976 5777777543   4589999999999999999999997   99999999999999854 78999999999


Q ss_pred             eecccCCCccccCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhc
Q 043017          654 RLIAQDQSHVSTMPKGTPGYMAPELTRGNSI-TAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLV  732 (818)
Q Consensus       654 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~  732 (818)
                      +.....   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....      .+.   .. .    .
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~---~~-~----~  221 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII---RG-Q----V  221 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH---HC-C----C
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh---hc-c----c
Confidence            875433   2234579999999999987665 677999999999999999999996421      111   00 0    0


Q ss_pred             cccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          733 DKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       733 d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ..     +...+.++.+++.+||+.||++|||++|++++
T Consensus       222 --~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 --FF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --CC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CC-----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              00     11234578899999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=350.81  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=196.6

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCC--CCccHHHHHHHHHHHhccCcceeEEEeeeecc--------cC
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPG--ENRGKKEFLSEVETIGNIHHFNLVRLVGYCAE--------RS  573 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--------~~  573 (818)
                      .|.+.++||+|+||+||+|+.. +|+.||||++...  .....+++.+|+++|++++|+||+++++.+..        ..
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            3445568999999999999974 6999999998544  33445788999999999999999999998855        34


Q ss_pred             cceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCc
Q 043017          574 NRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLA  653 (818)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  653 (818)
                      ..++||||+.++.+..+.   .....+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence            678999999887766544   2334688899999999999999999997   9999999999999999999999999999


Q ss_pred             eecccCCCc---cccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--
Q 043017          654 RLIAQDQSH---VSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--  727 (818)
Q Consensus       654 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--  727 (818)
                      +.+......   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            876543221   22234699999999998765 689999999999999999999999987655444333332221100  


Q ss_pred             chhhc---------cccCcCccCc------HHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 LCDLV---------DKKSEDMQSH------RDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ~~~~~---------d~~~~~~~~~------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .....         ..........      ......+.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000         0000000001      1123466789999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-40  Score=358.36  Aligned_cols=264  Identities=24%  Similarity=0.297  Sum_probs=195.6

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCcceeEEEeeeeccc------Ccceee
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNRFLV  578 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~lV  578 (818)
                      |+..++||+|+||+||+|+.. +|+.||||++.....    .+.+|+++|++++|+||+++++++...      .+.+||
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            344567999999999999975 589999999865432    234799999999999999999998543      246899


Q ss_pred             eeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecc
Q 043017          579 YEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIA  657 (818)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  657 (818)
                      |||++++.+............+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++...
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99998765444433333445799999999999999999999997   999999999999999775 89999999998775


Q ss_pred             cCCCccccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---ch----
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---LC----  729 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---~~----  729 (818)
                      .....  ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+........   ..    
T Consensus       175 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         175 RGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             TTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             CCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            54332  23469999999998765 5689999999999999999999999976654333222211110000   00    


Q ss_pred             hhccccCcC-------ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCc
Q 043017          730 DLVDKKSED-------MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLT  778 (818)
Q Consensus       730 ~~~d~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~  778 (818)
                      ...+.....       .........++.+|+.+||+.||++|||+.|++++  |+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            000000000       00112345678899999999999999999999975  55443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-39  Score=342.57  Aligned_cols=259  Identities=19%  Similarity=0.231  Sum_probs=195.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee-EEEeeeecccCcceeeeeccC
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL-VRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~  583 (818)
                      |.+.++||+|+||.||+|+.. +|+.||||.+.....  .+++..|++++++++|+|+ +.+.++..+++..++||||+ 
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            556678999999999999964 689999998765432  3467899999999976665 45555667777889999998 


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEc---CCCCEEEeecCCceecccCC
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLD---RDLNVKIADFGLARLIAQDQ  660 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~  660 (818)
                      +++|...+....  ..+++..+..++.|+++||+|||+.   +|+||||||+|||++   .+..+||+|||+++.+....
T Consensus        86 ~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          86 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            566666654332  4689999999999999999999997   999999999999985   45679999999999876543


Q ss_pred             Cc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          661 SH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       661 ~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ..      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||................... .......
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~  239 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPIEV  239 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-HHSCHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-CCCChhH
Confidence            21      2234579999999999999999999999999999999999999998665433332222111110 0000000


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcC
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTK  779 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~  779 (818)
                      .      ....+.++.+++..||+.+|++||+++++.+.|+.+..
T Consensus       240 ~------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         240 L------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             H------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             h------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0      11234678899999999999999999999999887643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-39  Score=350.88  Aligned_cols=262  Identities=24%  Similarity=0.337  Sum_probs=193.8

Q ss_pred             HHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeecccC------cce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAERS------NRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~  576 (818)
                      |.+.++||+|+||+||+|... +|+.||||++.....  ...+.+.+|+++|++++|||||+++++|...+      +.+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            344567999999999999965 599999999975422  33467899999999999999999999997654      469


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      +||||+ +.+|..++.+    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       100 lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             EEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence            999999 5677776633    3599999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--------
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--------  727 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--------  727 (818)
                      ...    .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||....................        
T Consensus       172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            443    2335689999999998764 578999999999999999999999976654333222221111000        


Q ss_pred             ------chhhccc-cCcC-ccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcCcC
Q 043017          728 ------LCDLVDK-KSED-MQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGLTK  779 (818)
Q Consensus       728 ------~~~~~d~-~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~  779 (818)
                            ....+.. .... .........++.+|+.+||+.||++|||+.|++++  |+.+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                  0000000 0000 00112234567899999999999999999999997  665543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-39  Score=348.40  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=194.5

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhccCcceeEEEeeeecccC----cceeee
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN-RGKKEFLSEVETIGNIHHFNLVRLVGYCAERS----NRFLVY  579 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~  579 (818)
                      |.+.++||+|+||+||+|+. .+|+.||||++..... ...+.+++|+++|++++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            33446899999999999986 4799999999975432 33567899999999999999999999987654    235556


Q ss_pred             eccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccC
Q 043017          580 EYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQD  659 (818)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  659 (818)
                      +++.+|+|.+++..    ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          90 THLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            67789999999853    3589999999999999999999997   9999999999999999999999999999876543


Q ss_pred             CCc--cccCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc---------
Q 043017          660 QSH--VSTMPKGTPGYMAPELTRG-NSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR---------  727 (818)
Q Consensus       660 ~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~---------  727 (818)
                      ...  ......||+.|+|||++.. ..++.++||||+||+++||++|+.||....................         
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            322  2334569999999999855 4578999999999999999999999976543222222111111000         


Q ss_pred             --chhhccccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 --LCDLVDKKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 --~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                        ..............     ......++.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00000000000000     01123568899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.4e-39  Score=339.78  Aligned_cols=263  Identities=16%  Similarity=0.183  Sum_probs=206.2

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccCc-ceeEEEeeeecccCcceeeeecc
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIHH-FNLVRLVGYCAERSNRFLVYEYM  582 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~  582 (818)
                      .+.+.++||+|+||+||+|+.. +|+.||||.+....  ....+.+|++.+..++| +|++.+++++.++...++||||+
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            3456678999999999999965 68999999875432  23457789999999964 89999999999999999999998


Q ss_pred             CCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcC-----CCCEEEeecCCceecc
Q 043017          583 CNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDR-----DLNVKIADFGLARLIA  657 (818)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~  657 (818)
                       +++|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.     ++.+||+|||+++.+.
T Consensus        84 -~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          84 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             -CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence             789999885433  4689999999999999999999997   9999999999999964     5789999999999876


Q ss_pred             cCCCc------cccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhh
Q 043017          658 QDQSH------VSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDL  731 (818)
Q Consensus       658 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~  731 (818)
                      .....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...................... .
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-P  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-C
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-C
Confidence            43221      1223569999999999999999999999999999999999999998665543333222221111100 0


Q ss_pred             ccccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHHHhcCcCCCC
Q 043017          732 VDKKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKVLQGLTKLEP  782 (818)
Q Consensus       732 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  782 (818)
                      .....      ...++++.+++..|++.+|++||+++.+.+.|+.+.+...
T Consensus       237 ~~~l~------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         237 LRELC------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHHHT------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hHHhc------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            00000      1123568899999999999999999999999988754433

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-40  Score=351.84  Aligned_cols=251  Identities=24%  Similarity=0.300  Sum_probs=204.6

Q ss_pred             HHhhhhcccccceeEEEeEec----CCcEEEEEEcCCC----CCccHHHHHHHHHHHhccCc-ceeEEEeeeecccCcce
Q 043017          506 RDFQIRLGRGGSGSVFEGLLN----DGTKVAVKRLYPG----ENRGKKEFLSEVETIGNIHH-FNLVRLVGYCAERSNRF  576 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~----~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~  576 (818)
                      +++.++||+|+||+||+|...    +|+.||||.+...    .....+.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            566779999999999999852    4789999998643    22345678899999999966 89999999999999999


Q ss_pred             eeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceec
Q 043017          577 LVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLI  656 (818)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  656 (818)
                      ++|||+.+|+|.+++....   .+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+
T Consensus       106 ~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999986543   467888999999999999999997   9999999999999999999999999999887


Q ss_pred             ccCCCccccCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhcchhhccc
Q 043017          657 AQDQSHVSTMPKGTPGYMAPELTRGN--SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADRLCDLVDK  734 (818)
Q Consensus       657 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~~~~~~d~  734 (818)
                      ............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+........       
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------  252 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------  252 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------
Confidence            65554444556799999999999764  478899999999999999999999987665554444433221111       


Q ss_pred             cCcCccCcHHHHHHHHHHHHHccccCCCCCC-----cHHHHHHH
Q 043017          735 KSEDMQSHRDDAVKMIQIAISCLQKNLHRRP-----SASMLVKV  773 (818)
Q Consensus       735 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  773 (818)
                       .   ..+...+.++.+++.+||++||.+||     |++|++++
T Consensus       253 -~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 -P---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -C---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence             1   11223557888999999999999999     47888763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-39  Score=339.53  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeecccCcceeeeeccC
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAERSNRFLVYEYMC  583 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (818)
                      ++.++||+|+||+||+|+.. +++.||||+++...  ....+++++|+.++++++||||+++++++.+....++|+|++.
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~   84 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence            34568999999999999974 68899999985443  2345789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecccCCCcc
Q 043017          584 NGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIAQDQSHV  663 (818)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  663 (818)
                      +++|..++...   +.+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||.++........ 
T Consensus        85 ~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-  157 (292)
T d1unla_          85 QDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred             ccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence            99988877433   4688999999999999999999997   9999999999999999999999999999987554322 


Q ss_pred             ccCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCC-chHHHHHHHHhhhhc------chhhcc--
Q 043017          664 STMPKGTPGYMAPELTRGNS-ITAKIDIYSFGVVILEIICGRRSSNPKGG-DYLVDTLKVKAEADR------LCDLVD--  733 (818)
Q Consensus       664 ~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~l~~~~~~~~~~~~------~~~~~d--  733 (818)
                      .....+++.|+|||.+.... ++.++|||||||++|||++|+.||....+ ......+........      .....+  
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            22345788899999987665 69999999999999999999999753322 222222222111100      000000  


Q ss_pred             ------ccCcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          734 ------KKSEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       734 ------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                            ...............+.+|+.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0000011122334578889999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-38  Score=343.14  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=195.5

Q ss_pred             hHHhhhhcccccceeEEEeEec-CCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeeccc--Ccceeeee
Q 043017          505 TRDFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAER--SNRFLVYE  580 (818)
Q Consensus       505 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e  580 (818)
                      .+.+.++||+|+||+||+|+.. +++.||||++...   ..+++.+|+++|.+++ ||||+++++++...  ...++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            4555678999999999999974 6899999998643   3578899999999995 99999999998743  46899999


Q ss_pred             ccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCC-CEEEeecCCceecccC
Q 043017          581 YMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDL-NVKIADFGLARLIAQD  659 (818)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  659 (818)
                      |+.+++|..+.      +.+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 ~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         113 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             ecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999997754      3589999999999999999999998   999999999999998765 5899999999877554


Q ss_pred             CCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHH-HHHHHHhhhh-----------
Q 043017          660 QSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLV-DTLKVKAEAD-----------  726 (818)
Q Consensus       660 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~-~~~~~~~~~~-----------  726 (818)
                      ..  .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||......... ..+......+           
T Consensus       184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            33  2334689999999998765 4799999999999999999999999765432211 1111000000           


Q ss_pred             ----cchhhcccc-------CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          727 ----RLCDLVDKK-------SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       727 ----~~~~~~d~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                          .........       ..........+.++.+|+.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000000000       00001122345678899999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-38  Score=344.06  Aligned_cols=256  Identities=23%  Similarity=0.266  Sum_probs=187.6

Q ss_pred             HhhhhcccccceeEEEeEec-CCcEEEEEEcCCCC--CccHHHHHHHHHHHhccCcceeEEEeeeeccc------Cccee
Q 043017          507 DFQIRLGRGGSGSVFEGLLN-DGTKVAVKRLYPGE--NRGKKEFLSEVETIGNIHHFNLVRLVGYCAER------SNRFL  577 (818)
Q Consensus       507 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~l  577 (818)
                      ++.++||+|+||+||+|... +|+.||||++....  ......+.+|+.++++++||||+++++++...      .+.++
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence            34468999999999999975 69999999986542  23345789999999999999999999998643      57799


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      ||||+.++.+. .+.     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+++...
T Consensus       100 v~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1         100 VMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence            99999765554 442     3588999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhh----------hc
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEA----------DR  727 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~----------~~  727 (818)
                      ....  .....+|+.|+|||.+.+..++.++||||+||+++||++|+.||...+.......+......          ..
T Consensus       171 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            4322  23346899999999999999999999999999999999999999765433322222111100          00


Q ss_pred             chhhccc---------------c--CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHHH
Q 043017          728 LCDLVDK---------------K--SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVKV  773 (818)
Q Consensus       728 ~~~~~d~---------------~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  773 (818)
                      .......               .  ..........+.++.+|+.+||+.||++|||++|+|++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000               0  00111123456788999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=340.25  Aligned_cols=261  Identities=24%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhccCcceeEEEeeeeccc-----Cccee
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGEN--RGKKEFLSEVETIGNIHHFNLVRLVGYCAER-----SNRFL  577 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  577 (818)
                      |...++||+|+||+||+|+. .+|+.||||++.....  ...+++.+|+++|++++|||+|++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            44456899999999999996 4699999999975432  3345788999999999999999999998643     34577


Q ss_pred             eeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeecCCceecc
Q 043017          578 VYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADFGLARLIA  657 (818)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  657 (818)
                      +++|+.+|+|.+++..    +.+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||++....
T Consensus       100 i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             EEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             EEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            7888899999998843    3599999999999999999999997   99999999999999999999999999997653


Q ss_pred             cCCCccccCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCchHHHHHHHHhhhhc--c------
Q 043017          658 QDQSHVSTMPKGTPGYMAPELTRGN-SITAKIDIYSFGVVILEIICGRRSSNPKGGDYLVDTLKVKAEADR--L------  728 (818)
Q Consensus       658 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l~~~~~~~~~~~~--~------  728 (818)
                      ..    .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+........  .      
T Consensus       173 ~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         173 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             GG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            32    2335688999999987665 468999999999999999999999986654433333322111100  0      


Q ss_pred             ---hhhccccCcCccC-----cHHHHHHHHHHHHHccccCCCCCCcHHHHHHH--HhcC
Q 043017          729 ---CDLVDKKSEDMQS-----HRDDAVKMIQIAISCLQKNLHRRPSASMLVKV--LQGL  777 (818)
Q Consensus       729 ---~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i  777 (818)
                         .............     ......++.+|+.+||+.||++|||+.|++++  |.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence               0000000000000     01234567899999999999999999999985  4444

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-34  Score=316.01  Aligned_cols=265  Identities=23%  Similarity=0.283  Sum_probs=191.5

Q ss_pred             HHhhhhcccccceeEEEeEe-cCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-----------cceeEEEeeeeccc-
Q 043017          506 RDFQIRLGRGGSGSVFEGLL-NDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-----------HFNLVRLVGYCAER-  572 (818)
Q Consensus       506 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-----------H~niv~l~g~~~~~-  572 (818)
                      |.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++++.++           |+||+++++++... 
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            55677899999999999997 469999999997542 22467788998888775           57899999988654 


Q ss_pred             -CcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCC------E
Q 043017          573 -SNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLN------V  645 (818)
Q Consensus       573 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~------~  645 (818)
                       ...+++|+++..+..............+++..+..++.||+.||+|||+.  .+|+||||||+||||+.++.      +
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence             34566666665555444443444456788999999999999999999983  38999999999999987653      9


Q ss_pred             EEeecCCceecccCCCccccCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCchH-------HHH
Q 043017          646 KIADFGLARLIAQDQSHVSTMPKGTPGYMAPELTRGNSITAKIDIYSFGVVILEIICGRRSSNPKGGDYL-------VDT  718 (818)
Q Consensus       646 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~l-------~~~  718 (818)
                      +++|||.+.......    ....||+.|+|||.+....++.++||||+||+++||++|+.||.+......       ...
T Consensus       172 kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         172 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            999999998664432    335689999999999999999999999999999999999999976543211       111


Q ss_pred             HHHHhhhh--------cchhhccc-----c-------------CcCccCcHHHHHHHHHHHHHccccCCCCCCcHHHHHH
Q 043017          719 LKVKAEAD--------RLCDLVDK-----K-------------SEDMQSHRDDAVKMIQIAISCLQKNLHRRPSASMLVK  772 (818)
Q Consensus       719 ~~~~~~~~--------~~~~~~d~-----~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  772 (818)
                      +......+        ......+.     .             ............++.+|+.+||+.||.+|||++|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11110000        00000000     0             0011223567788999999999999999999999998


Q ss_pred             H--HhcC
Q 043017          773 V--LQGL  777 (818)
Q Consensus       773 ~--L~~i  777 (818)
                      +  |+..
T Consensus       328 Hp~f~~~  334 (362)
T d1q8ya_         328 HPWLKDT  334 (362)
T ss_dssp             CGGGTTC
T ss_pred             CcccCCC
Confidence            6  5433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=3.6e-21  Score=189.61  Aligned_cols=161  Identities=14%  Similarity=0.165  Sum_probs=119.8

Q ss_pred             hhhcccccceeEEEeEecCCcEEEEEEcCCCCC------------------ccHHHHHHHHHHHhccCcceeEEEeeeec
Q 043017          509 QIRLGRGGSGSVFEGLLNDGTKVAVKRLYPGEN------------------RGKKEFLSEVETIGNIHHFNLVRLVGYCA  570 (818)
Q Consensus       509 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~  570 (818)
                      .++||+|+||+||+|+..+|++||||.++....                  .....+..|...+.++.|.+++..+++. 
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence            467999999999999998999999998753211                  0012345688899999999998887653 


Q ss_pred             ccCcceeeeeccCCCChhhHhhhcCCccccchhhHHHHHHHHHHHHHHHHhcCCCCeeecccccCeEEEcCCCCEEEeec
Q 043017          571 ERSNRFLVYEYMCNGSLDKWIFHKDRIQTLSWDIRKKIIFQISRGLEYLHDYCNPKIIHFDIKPQNILLDRDLNVKIADF  650 (818)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  650 (818)
                         ..+++|||+++..+.          .++......++.|++++|+|||+.   +|+||||||+|||++++ .++|+||
T Consensus        84 ---~~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          84 ---GNAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ---TTEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ---CCEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence               247999999876543          255666788999999999999997   99999999999999865 5899999


Q ss_pred             CCceecccCCCccccCCCCCCccccc------ccccCCCCCchhhHHHHHHHH
Q 043017          651 GLARLIAQDQSHVSTMPKGTPGYMAP------ELTRGNSITAKIDIYSFGVVI  697 (818)
Q Consensus       651 gla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~ksDVwS~Gvll  697 (818)
                      |+|.....+...         .|+..      |.+ .+.++.++|+||..--+
T Consensus       147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            999865432211         11111      111 24577889999975443

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.69  E-value=6.9e-17  Score=141.96  Aligned_cols=106  Identities=17%  Similarity=0.312  Sum_probs=83.3

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |.|..++.+.+...|.+       |.|.|+|...|+     +   +.     |.       ..++||+||++.|+...+.
T Consensus         2 ~~L~~g~~L~~g~~l~~-------g~~~l~~q~dgn-----L---vl-----~~-------~~~~vW~ant~~~~~~~~~   54 (109)
T d1kj1a_           2 NLLTNGEGLYAGQSLDV-------EPYHFIMQEDCN-----L---VL-----YD-------HSTSVWASNTGILGKKGCK   54 (109)
T ss_dssp             CEEETTCEEETTCEEEE-------TTEEEEECTTSC-----E---EE-----EE-------TTEEEEECCCCCTTCCCCE
T ss_pred             CCccCCCEEeCCCEEEe-------CCEEEEecCCCe-----E---EE-----Ee-------CCEEEEEeCCCCCCceeEE
Confidence            34555566666666654       689999986653     1   11     11       2368999999999988899


Q ss_pred             EEEeecccEEEEcCCCcEEEeeccC-CCceeEEEEcCCCcEEEecCCCCcceecccC
Q 043017          121 LEFTADGDLILKDVDGTRVWSTETS-GSNVTRITLDGNGNLRLYDAENRPHWISFLH  176 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~~vWst~~~-~~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~  176 (818)
                      |.|+.||+|||+|++|.+||+|+++ +.+...|+|+|+|||||++.   .+|||+-|
T Consensus        55 l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~  108 (109)
T d1kj1a_          55 AVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY  108 (109)
T ss_dssp             EEECTTSCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred             EEEcCCceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence            9999999999999999999999886 34556899999999999963   69999865

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.68  E-value=8e-17  Score=142.87  Aligned_cols=110  Identities=15%  Similarity=0.296  Sum_probs=87.3

Q ss_pred             cceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCce
Q 043017           41 ESYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENAT  120 (818)
Q Consensus        41 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~  120 (818)
                      |+|..++.+.+...|++       |.|.|+|...|+     +.       ++.        ..++||.||++.|. ..+.
T Consensus         2 DtL~~gq~L~~g~~l~~-------g~~~l~~q~DGN-----Lv-------ly~--------~~~~vW~s~~~~~~-~~~~   53 (112)
T d1xd5a_           2 DRLNSGHQLDTGGSLAE-------GGYLFIIQNDCN-----LV-------LYD--------NNRAVWASGTNGKA-SGCV   53 (112)
T ss_dssp             CEEETTEEECTTCEEEE-------TTEEEEECTTSC-----EE-------EEE--------TTEEEEECCCTTSC-SSEE
T ss_pred             CEecCCCEecCCCEEEE-------CCEEEEEcCCCC-----EE-------EEc--------CCcEEEEccCccCC-CCcE
Confidence            66777777777778875       789999987774     11       111        24789999998774 3468


Q ss_pred             EEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceecccCCCC
Q 043017          121 LEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWISFLHPTN  179 (818)
Q Consensus       121 l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptd  179 (818)
                      +.|+.||+|||+|. +.++|++++++ .+..+|+|+|+|||||++.++.++|||+.+|+|
T Consensus        54 l~l~~dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          54 LKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN  112 (112)
T ss_dssp             EEECTTSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred             EEEeccccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence            99999999999996 56778877654 345689999999999999999999999999986

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.65  E-value=3.8e-16  Score=137.09  Aligned_cols=104  Identities=17%  Similarity=0.285  Sum_probs=79.3

Q ss_pred             ceeeccCceeeeEEEecCCCCCCCeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCceE
Q 043017           42 SYNFVDGSHVRTLLVRKGTSKSYPKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATL  121 (818)
Q Consensus        42 ~~~~~~~~~~~~~l~~~~~~~~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~l  121 (818)
                      .|..++.+.++..|.  +     |.|.|+|...|+     +.       ++.        ..++||.||++.|. ..+.+
T Consensus         3 ~L~~g~~L~~G~~l~--n-----g~~~l~~q~DGN-----Lv-------ly~--------~~~~vW~s~~~~~~-~~~~l   54 (108)
T d1jpca_           3 ILYSGETLSTGEFLN--Y-----GSFVFIMQEDCN-----LV-------LYD--------VDKPIWATNTGGLS-RSCFL   54 (108)
T ss_dssp             EEETTEEECTTCEEE--E-----TTEEEEECTTSC-----EE-------EEE--------TTEEEEECCCTTSC-SSCEE
T ss_pred             CccCCCEecCCCEEE--c-----CCEEEEECCCCe-----EE-------EEe--------CCceeeEeCCCCCC-CccEE
Confidence            444455555555664  2     799999998875     11       111        24689999998773 34689


Q ss_pred             EEeecccEEEEcCCCcEEEeeccCCCc-eeEEEEcCCCcEEEecCCCCcceecccC
Q 043017          122 EFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYDAENRPHWISFLH  176 (818)
Q Consensus       122 ~l~~~g~Lvl~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWqSFd~  176 (818)
                      .|..+|+|||+|++|.+||+|++.+.. ..+|+|+|+|||||++   ..+||||+|
T Consensus        55 ~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~---~~~W~S~t~  107 (108)
T d1jpca_          55 SMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG---TDRWATGTH  107 (108)
T ss_dssp             EECTTSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEE---CCCCCCCCC
T ss_pred             EEeccceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeC---CCcccCCCC
Confidence            999999999999999999999876443 4578999999999995   358999987

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.56  E-value=1.7e-15  Score=135.11  Aligned_cols=101  Identities=24%  Similarity=0.337  Sum_probs=83.5

Q ss_pred             EEEeecCCCCCCCCeEEEEeCCCCCCCCC-ceEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCC
Q 043017           90 GTITSSSNHQNHPPVILWFANGQSPVKEN-ATLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAEN  167 (818)
Q Consensus        90 ~~~~~~~~~~~~~~~~vW~anr~~p~~~~-~~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~  167 (818)
                      .|||    .+++.++.+|++|++.|+..+ .+|.+..||||||++. +.+||++++.+. ....|+|+++|||||+|.++
T Consensus        11 ~il~----~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~   85 (120)
T d1dlpa2          11 SILY----STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN   85 (120)
T ss_dssp             EECC----CC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT
T ss_pred             eEEE----cCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCC
Confidence            3566    345667789999999999875 5899999999999985 678999988754 35689999999999999999


Q ss_pred             CcceecccCCCCcccCCCeeccceeEeeccCCCCCCccEEEEEEccCCcEEEE
Q 043017          168 RPHWISFLHPTNTWLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFL  220 (818)
Q Consensus       168 ~~lWqSFd~Ptdtllpg~kl~~~~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~  220 (818)
                      +++|||+.                         +..+|.|.+.|+++|+..++
T Consensus        86 ~~lW~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          86 IAVWTSGN-------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             EEEEECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             CEEEEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence            99999974                         34578899999999998875

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.48  E-value=9.3e-15  Score=128.89  Aligned_cols=93  Identities=24%  Similarity=0.365  Sum_probs=80.4

Q ss_pred             CCeEEEEeCCCCCCCCC-ceEEEeecccEEEEcCCCcEEEeeccCCCceeEEEEcCCCcEEEecCCCCcceecccCCCCc
Q 043017          102 PPVILWFANGQSPVKEN-ATLEFTADGDLILKDVDGTRVWSTETSGSNVTRITLDGNGNLRLYDAENRPHWISFLHPTNT  180 (818)
Q Consensus       102 ~~~~vW~anr~~p~~~~-~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdt  180 (818)
                      ..+..|+.+.+.++.++ .+|.|..||||||++ ++.++|++++.+..+..+.|+++|||||++.++.++|||+.     
T Consensus        10 ~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t-----   83 (115)
T d1dlpa1          10 EGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGT-----   83 (115)
T ss_dssp             SSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCC-----
T ss_pred             CCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcCC-----
Confidence            44566889999999875 689999999999998 57899999988777789999999999999999999999863     


Q ss_pred             ccCCCeeccceeEeeccCCCCCCccEEEEEEccCCcEEEE
Q 043017          181 WLPGQRLHVHKMMASTNSTTSLSQGKFILSLSPKGIEVFL  220 (818)
Q Consensus       181 llpg~kl~~~~~l~s~~s~~d~s~G~~~~~~~~~g~~~~~  220 (818)
                                          +.+.|.|.+.|+++|+.+++
T Consensus        84 --------------------~~~~g~y~l~Lq~DGNlvlY  103 (115)
T d1dlpa1          84 --------------------KGSIGNYVLVLQPDRTVTIY  103 (115)
T ss_dssp             --------------------CCCSSCCEEEECSSSCEEEE
T ss_pred             --------------------CCCCCCEEEEECCCCcEEEe
Confidence                                34679999999999998764

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.34  E-value=4.5e-12  Score=112.23  Aligned_cols=87  Identities=15%  Similarity=0.320  Sum_probs=69.5

Q ss_pred             CeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCceEEEeecccEEEEcCCCcEEEeecc
Q 043017           65 PKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET  144 (818)
Q Consensus        65 ~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~  144 (818)
                      |+|.|.|-..|+     ++   .|     .       ..++||.||+..+. ....|.|..||+|||.|++|.+||++++
T Consensus        30 ~~y~l~mQ~DGN-----LV---Ly-----~-------~~~~vWssnt~~~~-~~~~l~l~~dGnLvL~d~~g~~vWsS~t   88 (119)
T d1b2pa_          30 HVYRFIMQTDCN-----LV---LY-----D-------NNNPIWATNTGGLG-NGCRAVLQPDGVLVVITNENVTVWQSPV   88 (119)
T ss_dssp             EEEEEEECTTSC-----EE---EE-----E-------TTEEEEECCCTTSC-SSCEEEECTTSCEEEECTTCCEEEECSC
T ss_pred             ceEEEEECCCCc-----EE---EE-----E-------CCeEEEEecCCCCC-cceEEEEEeCCCEEEECCCCcEEEECCC
Confidence            899999988775     11   12     1       24689999998663 3478999999999999999999999988


Q ss_pred             CCC-ceeEEEEcCCCcEEEecCCCCcceeccc
Q 043017          145 SGS-NVTRITLDGNGNLRLYDAENRPHWISFL  175 (818)
Q Consensus       145 ~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd  175 (818)
                      .+. ...+++|+|+|||||++   .++|||-.
T Consensus        89 ~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T  117 (119)
T d1b2pa_          89 AGKAGHYVLVLQPDRNVVIYG---DALWATQT  117 (119)
T ss_dssp             CCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred             cCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence            653 34578999999999995   47999965

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.01  E-value=1.5e-10  Score=101.48  Aligned_cols=86  Identities=21%  Similarity=0.378  Sum_probs=66.6

Q ss_pred             CeeEeeeecCCCCCcceeEEEEEEEEEEeecCCCCCCCCeEEEEeCCCCCCCCCceEEEeecccEEEEcCCCcEEEeecc
Q 043017           65 PKFGFGFLRNGTTDEIFYLVTVRFMGTITSSSNHQNHPPVILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTET  144 (818)
Q Consensus        65 ~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~anr~~p~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~  144 (818)
                      |.|.|.|...|+     .++   |    .        ...+||.+|...  ...+.+.|.++|||||+|.++.+||++.+
T Consensus        26 g~~~l~~q~DGN-----LvL---~----~--------~~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~~~~~vWsS~t   83 (115)
T d1dlpa1          26 SSFRFTMQSDCN-----LVL---F----D--------SDVRVWASNTAG--ATGCRAVLQSDGLLVILTAQNTIRWSSGT   83 (115)
T ss_dssp             TTEEEEECTTSC-----EEE---E----E--------SSSEEECCCCCS--CSCCBCCBCSSSCBCCBCTTTCCSCCCCC
T ss_pred             CCEEEEECCCCe-----EEE---E----c--------CCeeEEEcccCC--CCceEEEEeccCCEEEEccCCCEEEEcCC
Confidence            789999998775     111   1    1        135799998753  24578999999999999999999999987


Q ss_pred             CC-CceeEEEEcCCCcEEEecCCCCcceeccc
Q 043017          145 SG-SNVTRITLDGNGNLRLYDAENRPHWISFL  175 (818)
Q Consensus       145 ~~-~~~~~~~l~d~GNlvl~~~~~~~lWqSFd  175 (818)
                      .. .....++|+++|||||++   .++|+|-.
T Consensus        84 ~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt  112 (115)
T d1dlpa1          84 KGSIGNYVLVLQPDRTVTIYG---PGLWDSGT  112 (115)
T ss_dssp             CCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred             CCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence            64 344579999999999994   47899853

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.88  E-value=3.7e-09  Score=93.10  Aligned_cols=75  Identities=29%  Similarity=0.470  Sum_probs=61.7

Q ss_pred             eEEEeecccEEEEcCCCcEEEeeccCCC-ceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeeccC
Q 043017          120 TLEFTADGDLILKDVDGTRVWSTETSGS-NVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMASTNS  198 (818)
Q Consensus       120 ~l~l~~~g~Lvl~~~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~~s  198 (818)
                      .|.+..||||||+++ +.+||++++.+. ....+.|.++|||||+|..+.++|+|.-                       
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t-----------------------   88 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV-----------------------   88 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred             EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence            577889999999975 579999988754 3578999999999999999999998632                       


Q ss_pred             CCCCCccEEEEEEccCCcEEEE
Q 043017          199 TTSLSQGKFILSLSPKGIEVFL  220 (818)
Q Consensus       199 ~~d~s~G~~~~~~~~~g~~~~~  220 (818)
                        .-..|.|.+.|+++|+.+++
T Consensus        89 --~~~~~~~~l~Lq~DGNlvlY  108 (119)
T d1b2pa_          89 --AGKAGHYVLVLQPDRNVVIY  108 (119)
T ss_dssp             --CCCSSCEEEEECTTSCEEEE
T ss_pred             --cCCCCceEEEEcCCCCEEEE
Confidence              12457788999999998875

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.79  E-value=1e-08  Score=88.98  Aligned_cols=77  Identities=30%  Similarity=0.535  Sum_probs=62.4

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCC--CceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEee
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSG--SNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAS  195 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~--~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s  195 (818)
                      .-.|.+..||||||++ .+.+||++++..  .....+.|.++|||||+++++.++|+|-                     
T Consensus        20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~---------------------   77 (109)
T d1kj1a_          20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH---------------------   77 (109)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC---------------------
T ss_pred             CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe---------------------
Confidence            3678888999999997 568999998763  3456799999999999999999999871                     


Q ss_pred             ccCCCCCCccEEEEEEccCCcEEEE
Q 043017          196 TNSTTSLSQGKFILSLSPKGIEVFL  220 (818)
Q Consensus       196 ~~s~~d~s~G~~~~~~~~~g~~~~~  220 (818)
                          +.-..|.|.+.|+++|+.+++
T Consensus        78 ----t~~~~~~~~l~L~ddGNlvly   98 (109)
T d1kj1a_          78 ----SVRGNGNYVLVLQEDGNVVIY   98 (109)
T ss_dssp             ----CCCCSSCCEEEECTTSCEEEE
T ss_pred             ----eECCCCCEEEEEeCCCcEEEE
Confidence                112356788999999998875

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.78  E-value=9.3e-09  Score=89.14  Aligned_cols=77  Identities=26%  Similarity=0.504  Sum_probs=63.1

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCCCc-eeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSGSN-VTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAST  196 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~  196 (818)
                      .-+|.+..||||||++ .+.+||++++.+.. .+.++|.++|||||+++++.++|.|                       
T Consensus        20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS-----------------------   75 (108)
T d1jpca_          20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS-----------------------   75 (108)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred             CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence            3578899999999998 56899999886543 4689999999999999999999987                       


Q ss_pred             cCCCCCCccEEEEEEccCCcEEEE
Q 043017          197 NSTTSLSQGKFILSLSPKGIEVFL  220 (818)
Q Consensus       197 ~s~~d~s~G~~~~~~~~~g~~~~~  220 (818)
                        .+....+.|.+.|+.+|+.+++
T Consensus        76 --~t~~~~~~~~l~L~ddGNlVly   97 (108)
T d1jpca_          76 --NTGGQNGNYVCILQKDRNVVIY   97 (108)
T ss_dssp             --CCCCSCSCEEEEECTTSCEEEE
T ss_pred             --cccCCCCcEEEEEcCCCCEEEe
Confidence              1122456788999999998876

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.69  E-value=2.2e-08  Score=88.30  Aligned_cols=66  Identities=17%  Similarity=0.343  Sum_probs=52.7

Q ss_pred             eEEEEeCCCCCCCCCceEEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceec
Q 043017          104 VILWFANGQSPVKENATLEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWIS  173 (818)
Q Consensus       104 ~~vW~anr~~p~~~~~~l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqS  173 (818)
                      .+||.+|.... .....+.|..+|||||+|.++.+||+|++.+ .....+.|+++|||||++   ..+|.|
T Consensus        54 ~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t  120 (120)
T d1dlpa2          54 DRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---GALWTT  120 (120)
T ss_dssp             BCCSCCCCCSS-CSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred             cEEEEEccccC-CCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence            56899885422 2346899999999999999999999999864 344578999999999994   468875

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.52  E-value=1.2e-07  Score=82.67  Aligned_cols=87  Identities=25%  Similarity=0.445  Sum_probs=65.8

Q ss_pred             CceEEEeecccEEEEcCCCcEEEeeccCC-CceeEEEEcCCCcEEEecCCCCcceecccCCCCcccCCCeeccceeEeec
Q 043017          118 NATLEFTADGDLILKDVDGTRVWSTETSG-SNVTRITLDGNGNLRLYDAENRPHWISFLHPTNTWLPGQRLHVHKMMAST  196 (818)
Q Consensus       118 ~~~l~l~~~g~Lvl~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWqSFd~Ptdtllpg~kl~~~~~l~s~  196 (818)
                      .-.|.+..||||||++ .+.+||++++.+ ...+.++|..+|||||++. ++.+|.|                       
T Consensus        20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s-----------------------   74 (112)
T d1xd5a_          20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS-----------------------   74 (112)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC-----------------------
T ss_pred             CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE-----------------------
Confidence            4678889999999997 568999998764 3456899999999999986 4566754                       


Q ss_pred             cCCCCCCccEEEEEEccCCcEEEEeccceeeeeec
Q 043017          197 NSTTSLSQGKFILSLSPKGIEVFLNMSTVKRFQTI  231 (818)
Q Consensus       197 ~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~  231 (818)
                        .+.-..|.+.+.|+.+|+.+++.......|.++
T Consensus        75 --~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~  107 (112)
T d1xd5a_          75 --NTNRQNGNYYLILQRDRNVVIYDNSNNAIWATH  107 (112)
T ss_dssp             --CCCCSCCCCEEEECTTSCEEEECTTSCEEEECC
T ss_pred             --eeccCCCceEEEEcCCCCEEEECCCCcEEecCC
Confidence              122234678899999999998765555566554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.07  E-value=7e-06  Score=82.46  Aligned_cols=130  Identities=11%  Similarity=0.033  Sum_probs=91.2

Q ss_pred             ceeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeeccCCCChhhHhhhcC
Q 043017          517 SGSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEYMCNGSLDKWIFHKD  595 (818)
Q Consensus       517 fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~  595 (818)
                      .+.||+.... ++.++||+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+...   
T Consensus        27 ~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~---  102 (263)
T d1j7la_          27 PAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---  102 (263)
T ss_dssp             SSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT---
T ss_pred             CCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc---
Confidence            4689988654 5667888876554444556778888887763 4445677777777888899999999988765431   


Q ss_pred             CccccchhhHHHHHHHHHHHHHHHHhcC----------------------------------------------------
Q 043017          596 RIQTLSWDIRKKIIFQISRGLEYLHDYC----------------------------------------------------  623 (818)
Q Consensus       596 ~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------------------  623 (818)
                           +......++.++++.++.||+..                                                    
T Consensus       103 -----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (263)
T d1j7la_         103 -----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             -----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred             -----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence                 12223445556666666666421                                                    


Q ss_pred             ----CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          624 ----NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       624 ----~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                          ...++|+|+.|.||+++++..+-|+||+.+..
T Consensus       178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                12379999999999999876677999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.65  E-value=0.00012  Score=72.59  Aligned_cols=130  Identities=15%  Similarity=0.109  Sum_probs=84.0

Q ss_pred             cccccc-eeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccC--cceeEEEeeeecccCcceeeeeccCCCChh
Q 043017          512 LGRGGS-GSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIH--HFNLVRLVGYCAERSNRFLVYEYMCNGSLD  588 (818)
Q Consensus       512 LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (818)
                      +..|.. +.||+....++..+++|.-.....   ..+..|+..++.+.  .-.+.+++++..+++..++||+++++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344443 679999988888899998654432   34567777777663  333566777777888889999999887654


Q ss_pred             hHhhhcCCccccchhhHHHHHHHHHHH---------------------------------------------------HH
Q 043017          589 KWIFHKDRIQTLSWDIRKKIIFQISRG---------------------------------------------------LE  617 (818)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~qia~g---------------------------------------------------L~  617 (818)
                      +...           ....++.++++.                                                   +.
T Consensus        95 ~~~~-----------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          95 SSHL-----------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TSCC-----------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccc-----------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            3110           001111122222                                                   23


Q ss_pred             HHHhcC----CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          618 YLHDYC----NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       618 yLH~~~----~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      .+....    ...++|+|+.|.||+++++..+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            332221    22479999999999999876678999998763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.11  E-value=0.00093  Score=70.80  Aligned_cols=74  Identities=15%  Similarity=0.099  Sum_probs=47.0

Q ss_pred             hcccccceeEEEeEecC-CcEEEEEEcCCC------C-CccHHHHHHHHHHHhccC-c--ceeEEEeeeecccCcceeee
Q 043017          511 RLGRGGSGSVFEGLLND-GTKVAVKRLYPG------E-NRGKKEFLSEVETIGNIH-H--FNLVRLVGYCAERSNRFLVY  579 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~------~-~~~~~~f~~Ev~~l~~l~-H--~niv~l~g~~~~~~~~~lV~  579 (818)
                      .||.|....||+....+ ++.++||.-.+.      . .....+...|++.|..+. +  ..+.+++.+  +.+..++||
T Consensus        33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm  110 (392)
T d2pula1          33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM  110 (392)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred             EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence            58999999999998765 678999964321      1 112344556777777662 2  345555554  445678999


Q ss_pred             eccCCCC
Q 043017          580 EYMCNGS  586 (818)
Q Consensus       580 e~~~~gs  586 (818)
                      |++++..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.42  E-value=0.0043  Score=63.59  Aligned_cols=135  Identities=14%  Similarity=0.110  Sum_probs=78.4

Q ss_pred             eeEEEeEecCCcEEEEEEcCCCCCccHHHHHHHHHHHhccCccee--EEEee-----eecccCcceeeeeccCCCChhh-
Q 043017          518 GSVFEGLLNDGTKVAVKRLYPGENRGKKEFLSEVETIGNIHHFNL--VRLVG-----YCAERSNRFLVYEYMCNGSLDK-  589 (818)
Q Consensus       518 G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL~~-  589 (818)
                      -.||+...++|+.+++|...+. ....+++..|...+..|....+  +..+.     ....++..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999999999999987654 2346778889888877742221  11111     1223445678899887643321 


Q ss_pred             ---Hh----------hh----c--CCccc-------------------cchhhHHHHHHHHHHHHHHHHh----cCCCCe
Q 043017          590 ---WI----------FH----K--DRIQT-------------------LSWDIRKKIIFQISRGLEYLHD----YCNPKI  627 (818)
Q Consensus       590 ---~l----------~~----~--~~~~~-------------------l~~~~~~~i~~qia~gL~yLH~----~~~~~i  627 (818)
                         .+          +.    .  .....                   ++.+.+..+...+.+.++.+..    ....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               01          00    0  00011                   1111122222233333334432    224578


Q ss_pred             eecccccCeEEEcCCCCEEEeecCCcee
Q 043017          628 IHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       628 iH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ||+|+.+.|||++++  ..++||+.+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.47  E-value=0.022  Score=59.69  Aligned_cols=71  Identities=18%  Similarity=0.213  Sum_probs=47.5

Q ss_pred             hcccccceeEEEeEecC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhccC-cceeEEEeeeecccCcceeeeec
Q 043017          511 RLGRGGSGSVFEGLLND--------GTKVAVKRLYPGENRGKKEFLSEVETIGNIH-HFNLVRLVGYCAERSNRFLVYEY  581 (818)
Q Consensus       511 ~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (818)
                      .|+.|-.-.+|+....+        .+.|.++..- . ........+|..+++.+. +.-..++++++..    .+||||
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            47778888999988654        3456666654 2 223445667888888874 4334477777754    588999


Q ss_pred             cCCCCh
Q 043017          582 MCNGSL  587 (818)
Q Consensus       582 ~~~gsL  587 (818)
                      +++..|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.16  E-value=0.2  Score=49.99  Aligned_cols=32  Identities=25%  Similarity=0.268  Sum_probs=28.4

Q ss_pred             CCCeeecccccCeEEEcCCCCEEEeecCCcee
Q 043017          624 NPKIIHFDIKPQNILLDRDLNVKIADFGLARL  655 (818)
Q Consensus       624 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  655 (818)
                      ..++||+|+.+.||+++.+...-|.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            55799999999999999887778999999863